PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Post, A; Hoshizaki, TB; Gilchrist, MD				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Comparison of MADYMO and physical models for brain injury reconstruction	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						injury reconstruction, MADYMO; traumatic brain injury; concussion	DIFFUSE AXONAL INJURY; CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT; SUBDURAL-HEMATOMA; BIOMECHANICS; FALLS; PREDICTORS; TISSUE; SKULL; MILD	Brain injury is researched using physical, mathematical, anatomical, and computational models. However, there has been little research to quantify the expected differences between these methods of brain injury research. The purpose of this research was to compare the brain deformation responses of identical traumatic brain injury (TBI) reconstructions, which were conducted first with Mathematical Dynamic Models (MADYMO) and then again with a Hybrid III headform. The ensuing finite element modelling was done using the University College Dublin Brain Trauma Model. The brain deformation parameters were analysed in discrete regions of interest which matched the TBI lesion as identified on computed tomography scans of the subject. The results indicated that overall the Hybrid III provided responses which were of considerably larger magnitude than the MADYMO simulation for all metrics analysed. The larger magnitude responses are likely a product of the more rigid nature of the Hybrid III in comparison to the MADYMO simulations. Interestingly, when the results are compared to the literature, the Hybrid III results match well with mild traumatic brain injury (mTBI) and TBI research, while the MADYMO simulations produce what would be considered very low local brain deformation responses for TBI lesions.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Dept Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland		Post, A (corresponding author), Univ Ottawa, Dept Human Kinet, Ottawa, ON, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gurdjian E S, 1980, Surg Annu, V12, P223; Gurdjian ES, 1944, J NEUROSURG, V1, P393, DOI 10.3171/jns.1944.1.6.0393; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sosin DM, 1996, BRAIN INJURY, V10, P47; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	32	4	4	2	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	MAY 4	2014	19	3					301	310		10.1080/13588265.2014.897413			10	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AE3MD	WOS:000333879700008		Green Submitted			2022-02-06	
J	Luo, JM; Chen, G; Wei, L; Qian, H; Lai, XP; Wang, D; Lv, JY; Yu, XJ				Luo, Jianming; Chen, Guang; Wei, Lai; Qian, Hong; Lai, Xiaoping; Wang, Dian; Lv, Junyao; Yu, Xiaojun			Severe Diffuse Axon Injury in Chronic Alcoholic Rat Medulla Oblongata Following a Concussion Blow	ALCOHOL AND ALCOHOLISM			English	Article							TRAUMATIC BRAIN-INJURY; GLYCOGEN-SYNTHASE KINASE-3-BETA; AMYLOID PRECURSOR PROTEIN; HIPPOCAMPAL-NEURONS; BETA; ETHANOL; TAU; PHOSPHORYLATION; ACTIVATION; DISEASE	Aims: We investigated the axonal morphological changes and expression of both tau protein and beta-APP following concussion to the medulla oblongata, in a rat model of chronic alcoholism. Methods: Fifty-nine male Sprague-Dawley rats were randomly divided into EtOH, EtOH-TBI and control groups (water group, water-TBI group). To establish chronic alcoholic rats, rats were intragastrically given edible spirituous liquor twice daily. Rats also received a blow on the occipital tuberosity with an iron pendulum. Morphological changes and expression of tau and beta-APP proteins in the medulla oblongata were examined. Results: (a) Nerve fibre thickening and twisting were observed in alcoholic rats, with nerve fibre changes becoming more significant following a concussion blow, which leads to some nerve fibres fracturing. (b) Transmission electron microscopy revealed that the nerve fibre myelin became loosened and displayed lamellar separation, which became more significant following concussion. (c) The integral optical density (IOD) sum value of beta-APP of the EtOH-TBI group was lower than that in the EtOH group (P < 0.05); the Tau IOD sum value of the EtOH-TBI group was higher than that in the EtOH group (P < 0.05). Conclusion: (a) Chronic alcoholism caused nerve fibre and neuronal morphology damage in the rat medulla oblongata, with structural damage becoming more significant following concussion. (b) Concussion changed the expression of beta-APP and tau protein in chronic alcoholic rat medulla oblongata, suggesting that chronic alcoholism can lead to severe axonal injury following a concussion blow. (c) The effect of chronic alcoholism may be synergistic the concussion blow to promote animal injury and death.	[Luo, Jianming] Shantou Univ Med Coll, Dept Neurosurg, Affiliated Hosp 2, Shantou City, Guangdong, Peoples R China; [Luo, Jianming; Chen, Guang; Wang, Dian; Lv, Junyao; Yu, Xiaojun] Shantou Univ Med Coll, Dept Forens Med, Shantou City, Guangdong, Peoples R China; [Wei, Lai] Hubei Univ Med, Dept Forens Med, Shiyan City, Hubei Province, Peoples R China; [Qian, Hong] Univ South China, Dept Pathol, Affiliated Nanhua Hosp, Hengyang City, Hunan, Peoples R China; [Lai, Xiaoping] Guangdong Med Coll, Dept Forens Med, Dongguan, Guangdong, Peoples R China		Yu, XJ (corresponding author), Shantou Univ Med Coll, Dept Forens Med, Shantou City, Guangdong, Peoples R China.	xjyustu@gmail.com			National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458]	This work was supported by grants from the National Natural Science Foundation Council of China (No. 30772458).	Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; CULLEN KM, 1995, NEUROPATH APPL NEURO, V21, P312, DOI 10.1111/j.1365-2990.1995.tb01065.x; Daly NL, 2000, BIOCHEMISTRY-US, V39, P9039, DOI 10.1021/bi0004807; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Lai XP, 2013, CELL BIOCHEM BIOPHYS, V67, P1049, DOI 10.1007/s12013-013-9603-y; Leclercq PD, 2002, J NEUROTRAUM, V19, P1183, DOI 10.1089/08977150260337985; MCENTEE WJ, 1990, TRENDS NEUROSCI, V13, P340, DOI 10.1016/0166-2236(90)90146-2; Melia KR, 1996, NEUROSCIENCE, V74, P313, DOI 10.1016/0306-4522(96)00138-8; NAKADA T, 1984, MED CLIN N AM, V68, P121, DOI 10.1016/S0025-7125(16)31245-7; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Rintala J, 2001, ALCOHOL, V23, P1, DOI 10.1016/S0741-8329(00)00116-6; Shea TB, 1997, J NEUROSCI RES, V49, P759, DOI 10.1002/(SICI)1097-4547(19970915)49:6<759::AID-JNR10>3.3.CO;2-P; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; TOMIMOTO H, 1995, BRAIN RES, V672, P187, DOI 10.1016/0006-8993(94)01160-J; TUCK RR, 1991, MED J AUSTRALIA, V155, P225, DOI 10.5694/j.1326-5377.1991.tb142226.x; Wang HP, 2011, J TRAUMA, V70, pE6, DOI 10.1097/TA.0b013e3181cda3b9; WILKINSON P, 1971, MED J AUSTRALIA, V1, P1217, DOI 10.5694/j.1326-5377.1971.tb50304.x; ZIMITAT C, 1990, ALCOHOL, V7, P493, DOI 10.1016/0741-8329(90)90038-E; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	32	4	4	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414	1464-3502		ALCOHOL ALCOHOLISM	Alcohol Alcohol.	MAY-JUN	2014	49	3					231	237		10.1093/alcalc/agu009			7	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	AG3PF	WOS:000335331100002	24595328				2022-02-06	
J	Maung, AA; Kaplan, LJ				Maung, Adrian A.; Kaplan, Lewis J.			Mechanical Ventilation After Injury	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						Injury; mechanical ventilation; trauma; respiratory failure	EXTRACORPOREAL MEMBRANE-OXYGENATION; PRESSURE RELEASE VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; SMOKE-INHALATION INJURY; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; PROLONGED HYPERVENTILATION; TRAUMA PATIENTS; MANAGEMENT	Injury is a major cause of critical illness worldwide. Severely injured patients often require mechanical ventilation not only to manage primary respiratory failure but also as adjunct to manage other conditions. Injury induces fundamental changes in multiple organ systems which directly impact ventilator management; these changes are not shared by patients without concomitant tissue injury. In this article, we review the physiologic changes after injury and discuss the impact of injury on ventilator strategies and management. We also explore the special considerations in patients with traumatic brain injury, thermal injury, blast injury or bronchopleural fistula.	[Maung, Adrian A.; Kaplan, Lewis J.] Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, New Haven, CT 06520 USA		Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, 330 Cedar St,BB 310, New Haven, CT 06520 USA.	lewis.kaplan@yale.edu					Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Blum JM, 2011, ANESTHESIOLOGY, V115, P75, DOI 10.1097/ALN.0b013e31821a8d63; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cancio LC, 2009, CLIN PLAST SURG, V36, P555, DOI 10.1016/j.cps.2009.05.013; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Chung KK, 2010, CRIT CARE MED, V38, P1970, DOI 10.1097/CCM.0b013e3181eb9d0b; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; Desai MH, 1998, J BURN CARE REHABIL, V19, P210, DOI 10.1097/00004630-199805000-00004; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; DOWNS JB, 1987, CRIT CARE MED, V15, P459; Dries DJ, 2009, J BURN CARE RES, V30, P128, DOI 10.1097/BCR.0b013e318191fe44; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Holt J, 2008, J BURN CARE RES, V29, P192, DOI 10.1097/BCR.0b013e31815f596b; Isgro S, 2011, INT J ARTIF ORGANS, V34, P1052, DOI 10.5301/ijao.5000011; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Johnson DC, 2011, CURR OPIN CRIT CARE, V17, P362, DOI 10.1097/MCC.0b013e328348bfc8; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Kaplan LJ, 2001, CRIT CARE, V5, P221, DOI 10.1186/cc1027; Kapur GB, 2005, J TRAUMA, V59, P1436, DOI 10.1097/01.ta.0000197853.49084.3c; Kimura F, 2010, SURG TODAY, V40, P793, DOI 10.1007/s00595-010-4323-z; Kirkman E, 2011, PHILOS T R SOC B, V366, P286, DOI 10.1098/rstb.2010.0249; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lynch JE, 2011, CRIT CARE CLIN, V27, P609, DOI 10.1016/j.ccc.2011.05.002; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Mackenzie IMJ, 2011, PHILOS T R SOC B, V366, P295, DOI 10.1098/rstb.2010.0252; Malarkkan N, 2003, ANAESTHESIA, V58, P647, DOI 10.1046/j.1365-2044.2003.03201.x; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Maung AA, 2012, ACS SURG PRINCIPLES; Maung AA, 2012, J TRAUMA ACUTE CARE, V72, P624, DOI 10.1097/TA.0b013e318247668f; Maxwell RA, 2010, J TRAUMA, V69, P501, DOI 10.1097/TA.0b013e3181e75961; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; NAVAR PD, 1985, AM J SURG, V150, P716, DOI 10.1016/0002-9610(85)90415-5; Neumann P, 2005, CRIT CARE MED, V33, P1090, DOI 10.1097/01.CCM.0000163226.34868.0A; Park PK, 2011, CRIT CARE CLIN, V27, P627, DOI 10.1016/j.ccc.2011.05.009; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pinsky MR, 2007, CHEST, V132, P2020, DOI 10.1378/chest.07-0073; Plurad DS, 2011, MIL MED, V176, P276, DOI 10.7205/MILMED-D-10-00147; Polanco PM, 2006, SURG CLIN N AM, V86, P1431, DOI 10.1016/j.suc.2006.09.003; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Schierhout G, 2009, COCHRANE DB SYST REV; Shimazu T, 1996, J APPL PHYSIOL, V81, P2250, DOI 10.1152/jappl.1996.81.5.2250; Sorkine P, 1998, J TRAUMA, V45, P35, DOI 10.1097/00005373-199807000-00006; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Uehara M, 1999, CRIT CARE MED, V27, P1295, DOI 10.1097/00003246-199907000-00015; Vellinga NAR, 2010, CURR OPIN CRIT CARE, V16, P377, DOI 10.1097/MCC.0b013e32833a0633; Wang SH, 2002, AM J SURG, V183, P151, DOI 10.1016/S0002-9610(01)00870-4; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wolf S, 2002, ACT NEUR S, V81, P99; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang XY, 2011, AM J EMERG MED, V29, P699, DOI 10.1016/j.ajem.2010.01.042	65	4	5	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	MAY	2014	29	3					128	137		10.1177/0885066612457339			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1XS	WOS:000335210100002	22956744				2022-02-06	
J	McKinlay, A; van Vliet-Ruissen, C; Taylor, A				McKinlay, Audrey; van Vliet-Ruissen, Cora; Taylor, Annabel			Traumatic Brain Injury Among Mothers Identified as Having a High Risk of Child Maltreatment: A Pilot Study	JOURNAL OF FAMILY VIOLENCE			English	Article						Traumatic brain injury; Prevalence; Mothers; Child abuse	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BIRTH COHORT; YOUNG-ADULTS; HEAD-INJURY; ADOLESCENTS; PREDICTORS	Traumatic brain injury (TBI) occurs frequently and may result in deficits in concentration, fatigue, attention, aggression and emotion regulation; significantly impacting an individual's ability to function. This study examined reports of TBI among mothers identified as having high risk for child abuse/maltreatment. Participants were 206 Mothers referred to a child abuse prevention programme (The Family Help Trust, Christchurch, New Zealand) between 2003 and 2010 (n = 206); TBI prevalence of 36.4 % (n = 75). One-third had experienced multiple TBI (n = 24), and 58.7 % (n = 44) of those reporting TBI had experienced their first injury prior to age 16. TBI in at-risk mothers was more than three times the TBI found in community samples, with many injuries occurring in childhood. Given the increased prevalence of TBI among mothers at high risk of child abuse, there is a need for greater information regarding the long-term outcomes of TBI, particularly for vulnerable groups requiring assistance to manage life roles.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [McKinlay, Audrey; van Vliet-Ruissen, Cora; Taylor, Annabel] Univ Canterbury, Christchurch 1, New Zealand		McKinlay, A (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Clayton Campus, Clayton, Vic 3800, Australia.	audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514; Taylor, Annabel/0000-0002-4646-9248			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bowen A, 1999, BRAIN INJURY, V13, P547; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Rodriguez CM, 1997, CHILD ABUSE NEGLECT, V21, P367, DOI 10.1016/S0145-2134(96)00177-9; Turner M., 2009, MONITORING VULNERABL	16	4	4	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7482	1573-2851		J FAM VIOLENCE	J. Fam. Violence	MAY	2014	29	4					391	395		10.1007/s10896-014-9591-8			5	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	AH2AU	WOS:000335923900006					2022-02-06	
J	Faltus, J				Faltus, John			REHABILITATION STRATEGIES ADDRESSING NEUROCOGNITIVE AND BALANCE DEFICITS FOLLOWING A CONCUSSION IN A FEMALE SNOWBOARD ATHLETE: A CASE REPORT	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; neurocognitive rehabilitation; reaction training	STATES HIGH-SCHOOL; UNITED-STATES; COGNITIVE TASK; REACTION-TIME; ALPINE SKI; INJURIES; PERFORMANCE; EPIDEMIOLOGY; SPORTS; RISK	Head injuries, including concussions, in athletes can account for an extended period of time lost from sports competition. Neurocognitive and balance deficits which may linger following a concussion affect an athlete's ability to return to sport safely. If these deficits are not specifically addressed in a rehabilitation program then the athlete may be at risk for not only additional concussions but possible musculoskeletal injury. ImPACT testing is a reliable method for identifying neurocognitive deficits and assists in the development of a neurocognitive training program. The information gathered from ImPACT may also indicate risk for musculoskeletal injuries. Research evidence suggesting specific rehabilitation strategies and interventions addressing neurocognitive deficits following a concussion is lacking. Progressions in a neurocognitive training program may include the integration of balance, reaction training, and activities that address memory deficits. The purpose of this case report is to discuss the evaluation and treatment plan for a female snowboard athlete following a concussion.	[Faltus, John] Howard Head Sports Med, Westin Riverfront Resort & Spa 126 Riverfront Lan, Avon, CO 81620 USA		Faltus, J (corresponding author), Howard Head Sports Med, Westin Riverfront Resort & Spa 126 Riverfront Lan, Avon, CO 81620 USA.	john.faltus@vvmc.com					Andersen MB, 1999, J SPORT SCI, V17, P735, DOI 10.1080/026404199365597; Bladin C, 2004, SPORTS MED, V34, P133, DOI 10.2165/00007256-200434020-00006; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Davidson TM, 1996, WESTERN J MED, V164, P231; Dohjima T, 2001, ACTA ORTHOP SCAND, V72, P657, DOI 10.1080/000164701317269111; Fountain JL, 1996, SPORTS MED, V22, P360, DOI 10.2165/00007256-199622060-00004; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gillen G., 2009, COGNITIVE PERCEPTUAL; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Idzikowski JR, 2000, AM J SPORT MED, V28, P825, DOI 10.1177/03635465000280061001; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Langran M, 2002, BRIT J SPORT MED, V36, P135, DOI 10.1136/bjsm.36.2.135; Liu B., 2008, COCHRANE DATABASE SY, V1; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; MCLEOD B, 1991, PERCEPT MOTOR SKILL, V72, P863, DOI 10.2466/PMS.72.3.863-866; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; NEISTADT ME, 1994, AM J OCCUP THER, V48, P225, DOI 10.5014/ajot.48.3.225; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Williams JM, 1997, BEHAV MED, V22, P160, DOI 10.1080/08964289.1997.10543549	35	4	4	0	0	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2014	9	2					232	241					10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA1HQ	WOS:000409659300011	24790784				2022-02-06	
J	Helton, MS				Helton, Matthew S.			Conservative Treatment of a Proximal Full-Thickness Biceps Brachii Muscle Tear in a Special Operations Soldier	PHYSICAL THERAPY			English	Article							TRAUMATIC CLOSED TRANSECTION; SHORT HEAD; RUPTURE; MANAGEMENT; ARM	Background. A transection of the short head of the biceps brachii muscle is an uncommon injury seen among outpatient sports physical therapy clinics. The highest rate of occurrence and the majority of literature that discusses this specific injury are related to US military parachuting. The purpose of this case report is to outline the episode of care from 2 days after the injury through 6 months of conservative treatment, which consisted of therapeutic exercise, manual therapy, and cryotherapy, within an outpatient sports physical therapy clinic in a military setting. Case Description. This case report outlines the initial evaluation, diagnostic imaging, treatment, and 6-month follow-up measures for a 23-year-old male patient who sustained a static line injury resulting in a full-thickness tear of his biceps brachii muscle and a partial tear of the coracobrachialis muscle. Outcomes. The individual described in this case report reported having no functional limitations in regard to his job and leisure activities or any pain at his 6-month follow-up, with a score of 0% noted on his Shortened Disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH). Isokinetic testing revealed a 39.1% decrease in elbow flexion peak torque and a 60.8% decrease in elbow flexion total work output at this same follow-up interval. Discussion. In determining the appropriate course of treatment for this injury type, conservative physical therapy intervention should be considered as a viable treatment option, as there have been no decisive studies to suggest superior outcomes with other methods such as surgical correction. It is further recommended that research be conducted in an effort to prevent such injuries from occurring, as this mechanism of injury has proven to be much higher among the US military population compared with other military populations.	US Army Phys Therapy, Pooler, GA 31322 USA		Helton, MS (corresponding author), US Army Phys Therapy, 106 Cumberland Way, Pooler, GA 31322 USA.	matthew.helton3@us.army.mil					American Physical Therapy Association, 2003, GUID PHYS THER PRACT; ASKEW LJ, 1987, CLIN ORTHOP RELAT R, P261; CARROLL RE, 1967, J BONE JOINT SURG AM, VA 49, P1016; DICHRISTINA DG, 1992, CLIN ORTHOP RELAT R, P139; FEIRING D C, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P298; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gilcreest EL, 1934, SURG GYNECOL OBSTET, V58, P322; Gummesson C, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-44; HALLEL T, 1975, J TRAUMA, V15, P14; HECKMAN JD, 1978, J BONE JOINT SURG AM, V60, P369, DOI 10.2106/00004623-197860030-00019; Kragh JF, 2002, J BONE JOINT SURG AM, V84A, P992, DOI 10.2106/00004623-200206000-00014; Moon ES, 2010, KNEE SURG SPORT TR A, V18, P1759, DOI 10.1007/s00167-010-1108-2; Moorman CT, 1996, J BONE JOINT SURG AM, V78A, P1749, DOI 10.2106/00004623-199611000-00018; Pascual-Garrido C, 2012, KNEE SURG SPORT TR A, V20, P1019, DOI 10.1007/s00167-011-1654-2; Pratt DA, 2007, BRIT J SPORT MED, V41, P459, DOI 10.1136/bjsm.2006.031708; Shah AK, 2004, J SHOULDER ELB SURG, V13, P562, DOI 10.1016/j.jse.2004.02.005; Wilson DJ, 2011, ORTHOPEDICS, V34, P890, DOI 10.3928/01477447-20110922-25	17	4	4	0	3	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	APR	2014	94	4					571	577		10.2522/ptj.20130336			7	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	AE3LB	WOS:000333876900013	24231228	Bronze			2022-02-06	
J	Turner, RC; VanGilder, RL; Naser, ZJ; Lucke-Wold, BP; Bailes, JE; Matsumoto, RR; Huber, JD; Rosen, CL				Turner, Ryan C.; VanGilder, Reyna L.; Naser, Zachary J.; Lucke-Wold, Brandon P.; Bailes, Julian E.; Matsumoto, Rae R.; Huber, Jason D.; Rosen, Charles L.			Elucidating the Severity of Preclinical Traumatic Brain Injury Models: A Role for Functional Assessment?	NEUROSURGERY			English	Article						Concussion; Diffuse axonal injury; Functional assessment; Subconcussive injury; Traumatic brain injury	FLUID PERCUSSION INJURY; CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; FOOTBALL-LEAGUE PLAYER; AXONAL INJURY; MOUSE MODEL; HEAD-INJURY; BEHAVIORAL DEFICITS; COGNITIVE IMPAIRMENT; HISTOLOGICAL-CHANGES	BACKGROUND: Concussion remains a symptom-based diagnosis clinically, yet preclinical studies investigating traumatic brain injury, of which concussion is believed to represent a "mild" form, emphasize histological end points with functional assessments often minimized or ignored all together. Recently, clinical studies have identified the importance of cognitive and neuropsychiatric symptoms, in addition to somatic concerns, following concussion. How these findings may translate to preclinical studies is unclear at present. OBJECTIVE: To address the contrasting end points used clinically compared with those in preclinical studies and the potential role of functional assessments in a commonly used model of diffuse axonal injury (DAI). METHODS: Animals were subjected to DAI by the use of the impact-acceleration model. Functional and behavioral assessments were conducted during 1 week following DAI before the completion of the histological assessment at 1 week post-DAI. RESULTS: We show, despite the suggestion that this model represents concussive injury, no functional impairments as determined by using the common measures of motor, sensorimotor, cognitive, and neuropsychiatric function following injury over the course of 1 week. The lack of functional deficits is in sharp contrast to neuropathological findings indicating neural degeneration, astrocyte reactivity, and microglial activation. CONCLUSION: Future studies are needed to identify functional assessments, neurophysiologic techniques, and imaging assessments more apt to distinguish differences following so-called "mild" traumatic brain injury in preclinical models and determine whether these models are truly studying concussive or subconcussive injury. These studies are needed not only to understand the mechanism of injury and production of subsequent deficits, but also to rigorously evaluate potential therapeutic agents.	[Turner, Ryan C.; Naser, Zachary J.; Lucke-Wold, Brandon P.; Rosen, Charles L.] W Virginia Univ, Dept Neurosurg, Sch Med, Morgantown, WV 26506 USA; [Turner, Ryan C.; VanGilder, Reyna L.; Naser, Zachary J.; Lucke-Wold, Brandon P.; Matsumoto, Rae R.; Huber, Jason D.; Rosen, Charles L.] W Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; [VanGilder, Reyna L.] W Virginia Univ, Sch Med, Dept Nursing, Morgantown, WV 26506 USA; [Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Bailes, Julian E.; Matsumoto, Rae R.; Huber, Jason D.] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA		Rosen, CL (corresponding author), W Virginia Univ, Dept Neurosurg, Sch Med, Hlth Sci Ctr, One Med Ctr Dr,POB 9183, Morgantown, WV 26506 USA.	crosen@hsc.wvu.edu	Lucke-Wold, Brandon/AAW-1881-2021; Lucke-Wold, Brandon/AAW-3525-2021	Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM08174, 5RO1-NS061954]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [S06GM008174, T32GM081741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061954] Funding Source: NIH RePORTER	This work was supported by grant funding to Dr Turner (5T32GM08174) and Dr Huber (5RO1-NS061954) from the National Institutes of Health. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Beaumont A, 2000, NEUROL RES, V22, P665; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Blokland A, 1998, NEUROSCI BIOBEHAV R, V22, P847, DOI 10.1016/S0149-7634(98)00013-X; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Bushnell P. J., 2009, METHODS BEHAV ANAL N; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mehan ND, 2012, NEUROBIOL AGING, V33, P1857, DOI 10.1016/j.neurobiolaging.2011.09.029; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2012, NEUROSURGERY, V70, P205, DOI 10.1227/NEU.0b013e3182250918; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2010, J NEUROTRAUMA; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Turner RC, 2012, J NEUROSURG, V117, P629, DOI 10.3171/2012.5.JNS112224; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang Y, 2013, J NEUROTRAUMA; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; ZHOU YL, 1995, PHYSIOL BEHAV, V57, P1107, DOI 10.1016/0031-9384(95)00019-F; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	81	4	4	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2014	74	4					382	394		10.1227/NEU.0000000000000292			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AJ5KW	WOS:000337722100027	24448183	Green Accepted			2022-02-06	
J	Ustinova, KI; Silkwood-Sherer, DJ				Ustinova, Ksenia I.; Silkwood-Sherer, Debbie J.			Postural Perturbations Induced by a Moving Virtual Environment Are Reduced in Persons With Brain Injury When Gripping a Mobile Object	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						light touch; postural control; virtual perturbation; virtual reality; TBI	CLOSED-HEAD INJURY; PRECISION CONTACT; FINGERTIP CONTACT; STABILIZATION; TASK; SWAY; INDIVIDUALS; BALANCE; MOTION; GAIT	Background and Purpose: Gripping a mobile (unfixed) object increases standing postural stability in healthy individuals. We tested whether the same strategy is effective for stabilizing upright posture perturbed by a moving environment (virtual perturbation) in participants with traumatic brain injury (TBI). Methods: Fifteen participants with mild-to-moderate postural deficits after TBI and a comparison group of 15 age-matched healthy subjects participated in the study. Participants stood for 1 minute in front of a large screen with a projected three-dimensional image of a boat; for 30 seconds the boat remained stationary (no visual stimulation condition), and for 30 seconds the boat rocked on the water at a speed of 15 degrees/s (visual stimulation condition). The visual stimulation was applied in pseudorandom order (during either the first or second half of the 1-minute trial). To analyze postural stability, the displacement and velocity of the center of mass in the sagittal and frontal planes were compared between groups and across 4 experimental conditions, including standing with/without visual stimulation and with/without gripping a 300-g object (short wooden stick) in the dominant hand. Results: Participants with TBI showed greater instability under all experimental conditions. The visual stimulation significantly increased postural oscillations in the sagittal plane by 35% to 63% across groups. Gripping a stick significantly reduced the stimulation-induced instability in the sagittal plane by 19% to 29%, although not to the level of the no-stimulation condition in either group. Conclusion: The stabilizing effect of gripping an external object in participants with TBI was confirmed. A possibility of using this effect as a balance aid strategy requires further investigation. Audio Abstract available (see Audio, Supplemental Digital Content 1, http://links.lww.com/JNPT/A68 for more insights from the authors).	[Ustinova, Ksenia I.; Silkwood-Sherer, Debbie J.] Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48858 USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48858 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591			Agostini V, 2011, GAIT POSTURE, V34, P248, DOI 10.1016/j.gaitpost.2011.05.008; Albertsen IM, 2010, HUM MOVEMENT SCI, V29, P999, DOI 10.1016/j.humov.2010.07.013; Arce FI, 2004, HUM MOVEMENT SCI, V22, P749, DOI 10.1016/j.humov.2003.12.002; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bensoussan L, 2007, ARCH PHYS MED REHAB, V88, P1009, DOI 10.1016/j.apmr.2007.05.009; BERG K, 1989, Physiotherapy Canada, V41, P304; Bernstein NA., 1967, COORDINATION REGULAT; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Colarusso RP., 1996, MOTOR FREE VISUAL PE; Cunha BP, 2012, NEUROSCI LETT, V513, P6, DOI 10.1016/j.neulet.2012.01.053; de Lima AC, 2010, GAIT POSTURE, V32, P615, DOI 10.1016/j.gaitpost.2010.09.003; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Fushiki H, 2005, ACTA OTO-LARYNGOL, V125, P60, DOI 10.1080/00016480410015794; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hausbeck CJ, 2009, GAIT POSTURE, V29, P509, DOI 10.1016/j.gaitpost.2008.11.014; Hein G, 2005, EXP BRAIN RES, V160, P223, DOI 10.1007/s00221-004-2006-y; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Holden M, 1994, J Vestib Res, V4, P285; Huang CY, 2010, J ELECTROMYOGR KINES, V20, P413, DOI 10.1016/j.jelekin.2009.06.003; Hulse P, 2010, NEUROREHABILITATION, V27, P269, DOI 10.3233/NRE-2010-0608; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyndman D, 2009, NEUROREHAB NEURAL RE, V23, P847, DOI 10.1177/1545968309338192; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; JEKA JJ, 1995, EXP BRAIN RES, V103, P267; Kazennikov O V, 2008, Fiziol Cheloveka, V34, P51; Keshner EA, 2004, ASSIST TECHNOL, V16, P54, DOI 10.1080/10400435.2004.10132074; Keshner EA, 2000, J VESTIBUL RES-EQUIL, V10, P207; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Krishnamoorthy V, 2002, EXP BRAIN RES, V147, P71, DOI 10.1007/s00221-002-1206-6; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Meyers JE., 1995, REY COMPLEX FIGURE T; Mitra S, 2004, HUM MOVEMENT SCI, V23, P1, DOI 10.1016/j.humov.2004.03.003; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Riley MA, 1999, HUM MOVEMENT SCI, V18, P795, DOI 10.1016/S0167-9457(99)00041-X; Schmidt RA, 2011, MOTOR CONTROL LEARNI, P348; Slobounov S, 2006, BIOL PSYCHOL, V72, P188, DOI 10.1016/j.biopsycho.2005.10.005; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Swan L, 2007, GAIT POSTURE, V26, P470, DOI 10.1016/j.gaitpost.2006.11.201; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tremblay F, 2004, EXP BRAIN RES, V157, P275, DOI 10.1007/s00221-004-1830-4; Ustinova KI, 2013, GAIT POSTURE, V38, P97, DOI 10.1016/j.gaitpost.2012.10.020; Van de Water EJ, 2009, PRESENTED AT INTERNA; Wang Y, 2010, EXP BRAIN RES, V201, P663, DOI 10.1007/s00221-009-2082-0; WARREN R, 1976, J EXP PSYCHOL HUMAN, V2, P448, DOI 10.1037/0096-1523.2.3.448; Wechsler D., 2009, WECHSLER MEMORY SCAL; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wulf G, 2004, J MOTOR BEHAV, V36, P189, DOI 10.3200/JMBR.36.2.189-199; Zharikova A V, 2012, Fiziol Cheloveka, V38, P41	58	4	5	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	APR	2014	38	2					125	133		10.1097/NPT.0000000000000035			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AL3TV	WOS:000339053200005	24572500				2022-02-06	
J	Rocha, NBF; Marques, AB; Fortuna, RB; Antunes, A; Hoaken, PNS				Rocha, Nuno B. F.; Marques, Alina B.; Fortuna, Rita B.; Antunes, Ana; Hoaken, Peter N. S.			Effectiveness of cognitive remediation for female inmates: a pilot study	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						incarcerated female offenders; neurocognition; cognitive remediation; rehabilitation; executive functions	TRAUMATIC BRAIN-INJURY; ANTISOCIAL-BEHAVIOR; NEUROPSYCHOLOGICAL MEASURES; EXECUTIVE DYSFUNCTION; AGGRESSIVE-BEHAVIOR; INCARCERATED WOMEN; SCHIZOPHRENIA; POPULATION; PREVALENCE; PSYCHOPATHOLOGY	There is considerable evidence that neurocognitive deficits are frequent among incarcerated offenders. However, current correctional programming does not directly seek to remediate deficits in offenders' neurocognitive deficits. In this pilot project, we sought to treat neurocognitive deficits in incarcerated Portuguese adult women offenders (n=28) using cognitive remediation to target cognitive flexibility, memory, and planning. Statistically significant positive changes, with medium to large effect sizes, were discovered across several neurocognitive domains, including attention, speed of processing, verbal learning and memory, cognitive flexibility, and planning. We also found a decrease in the negative emotional states of depression, anxiety, tension/stress, and on disturbed behavior in prison. Cognitive remediation has the potential to enhance the neurocognitive functioning of incarcerated women. Controlled research is needed to establish cognitive remediation fully as an intervention for the treatment of neurocognitive deficits of incarcerated women.	[Rocha, Nuno B. F.; Fortuna, Rita B.; Antunes, Ana] Inst Politecn Porto, Escola Super Tecnol Saude, Oporto, Portugal; [Marques, Alina B.] Estabelecimento Pris Especial Santa Cruz do Bispo, Oporto, Portugal; [Hoaken, Peter N. S.] Univ Western Ontario, Dept Psychol, London, ON N6A 3K7, Canada		Rocha, NBF (corresponding author), Inst Politecn Porto, Escola Super Tecnol Saude, Oporto, Portugal.	nrocha@eu.ipp.pt	Rocha, Nuno/M-9821-2013	Rocha, Nuno/0000-0002-3139-2786			Abbate-Daga G, 2012, J CLIN EXP NEUROPSYC, V34, P1009, DOI 10.1080/13803395.2012.704900; Allnutt S, 2008, AUST NZ J PSYCHIAT, V42, P969, DOI 10.1080/00048670802415350; Anaya C, 2012, J AFFECT DISORDERS, V142, P13, DOI 10.1016/j.jad.2012.04.020; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brickenkamp R., 2007, D2 TESTE ATENCAO AUF; Brunton I, 2013, J FORENSIC PRACT, V15, P68, DOI 10.1108/14636641311299095; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cohen J., 2013, STAT POWER ANAL BEHA; COID J, 1984, BRIT J PSYCHIAT, V145, P78, DOI 10.1192/bjp.145.1.78; Cooke DJ, 1998, CRIM JUSTICE BEHAV, V25, P482, DOI 10.1177/0093854898025004005; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Doyle M, 2013, J FORENSIC PSYCHI PS, V24, P1, DOI 10.1080/14789949.2012.752519; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Gadon L, 2006, CLIN PSYCHOL REV, V26, P515, DOI 10.1016/j.cpr.2006.02.002; Giancola PR, 2004, J ABNORM PSYCHOL, V113, P541, DOI 10.1037/0021-843X.113.4.541; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Herrero O, 2010, PERS INDIV DIFFER, V48, P133, DOI 10.1016/j.paid.2009.09.009; Hoaken PNS, 2007, AGGRESSIVE BEHAV, V33, P412, DOI 10.1002/ab.20194; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; Ishikawa SS, 2003, CAUSES OF CONDUCT DISORDER AND JUVENILE DELINQUENCY, P277; James D.J., 2006, MENTAL HLTH PROBLEMS; Jordan BK, 1996, ARCH GEN PSYCHIAT, V53, P513; Keaveny M E, 1999, Issues Ment Health Nurs, V20, P73, DOI 10.1080/016128499248790; Kjelsberg E, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-27; Kontis D, 2013, AM J GERIAT PSYCHIAT, V21, P218, DOI 10.1016/j.jagp.2012.12.013; Krabbendam L, 2003, PSYCHOPHARMACOLOGY, V169, P376, DOI 10.1007/s00213-002-1326-5; Lewis C, 2006, PSYCHIAT CLIN N AM, V29, P773, DOI 10.1016/j.psc.2006.04.013; Lipsey, 2005, J EXPT CRIMINOLOGY, V1, P451, DOI [DOI 10.1007/S11292-005-3541-7, 10.1007/s11292-005-3541-7]; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MADEN T, 1994, BRIT J PSYCHIAT, V164, P44, DOI 10.1192/bjp.164.1.44; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nuechterlein K. H., 2006, MCCB MATRICS CONSENS; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Pinese CSV, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-34; Raaijmakers MAJ, 2008, J ABNORM CHILD PSYCH, V36, P1097, DOI 10.1007/s10802-008-9235-7; Raine A, 2002, J CHILD PSYCHOL PSYC, V43, P417, DOI 10.1111/1469-7610.00034; Reeder C, 2004, SCHIZOPHRENIA BULL, V30, P87, DOI 10.1093/oxfordjournals.schbul.a007070; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 1992, TRAIL MAKING TEST MA; Ross E., 2012, THESIS U W ONTARIO; Ross EH, 2011, CAN J CRIMINOL CRIM, V53, P377, DOI 10.3138/cjccj.53.4.377; Ross EH, 2010, CRIM JUSTICE BEHAV, V37, P656, DOI 10.1177/0093854810363104; Sansone Randy A, 2009, Psychiatry (Edgmont), V6, P16; Schenk AM, 2012, AGGRESS VIOLENT BEH, V17, P430, DOI 10.1016/j.avb.2012.05.005; Seguin JR, 2004, J ABNORM PSYCHOL, V113, P603, DOI 10.1037/0021-843X.113.4.603; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Spaulding WD, 1999, SCHIZOPHRENIA BULL, V25, P657, DOI 10.1093/oxfordjournals.schbul.a033409; Vaughn MG, 2007, BEHAV SCI LAW, V25, P803, DOI 10.1002/bsl.789; Villemarette-Pittman N. R., 2002, PERSONALITY INDIVIDU, V34, P1533, DOI DOI 10.1016/S0191-8869(02)00136-8; Warren JI, 2004, CRIM JUSTICE BEHAV, V31, P624, DOI 10.1177/0093854804267096; Wechsler, 2008, ESCALA INTELIGENCIA; Wright K., 1985, IMPROVING CORRECTION; Wykes T, 2005, COGNITIVE REMEDIATIO; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; [No title captured]	64	4	5	0	24	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	MAR 4	2014	25	2					224	237		10.1080/14789949.2014.884617			14	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	AH0YQ	WOS:000335847100008		Green Submitted			2022-02-06	
J	McGlinchey, RE; Fortier, CB; Venne, JR; Maksimovskiy, AL; Milberg, WP				McGlinchey, Regina E.; Fortier, Catherine B.; Venne, Jonathan R.; Maksimovskiy, Arkadiy L.; Milberg, William P.			Effects of OEF/OIF-Related Physical and Emotional Co-Morbidities on Associative Learning: Concurrent Delay and Trace Eyeblink Classical Conditioning	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						posttraumatic stress disorder; mild traumatic brain injury; alcohol	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; HIPPOCAMPAL VOLUME; COMBAT VETERANS; IMPAIRED DELAY; MENTAL-HEALTH; SUBSTANCE USE; WHITE-MATTER	This study examined the performance of veterans and active duty personnel who served in Operation Enduring Freedom and/or Operation Iraqi Freedom (OEF/OIF) on a basic associative learning task. Eighty-eight individuals participated in this study. All received a comprehensive clinical evaluation to determine the presence and severity of posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI). The eyeblink conditioning task was composed of randomly intermixed delay and trace conditioned stimulus (CS) and unconditioned stimulus (US) pairs (acquisition) followed by a series of CS only trials (extinction). Results revealed that those with a clinical diagnosis of PTSD or a diagnosis of PTSD with comorbid mTBI acquired delay and trace conditioned responses (CRs) to levels and at rates similar to a deployed control group, thus suggesting intact basic associative learning. Differential extinction impairment was observed in the two clinical groups. Acquisition of CRs for both delay and trace conditioning, as well as extinction of trace CRs, was associated with alcoholic behavior across all participants. These findings help characterize the learning and memory function of individuals with PTSD and mTBI from OEF/OIF and raise the alarming possibility that the use of alcohol in this group may lead to more significant cognitive dysfunction.	[McGlinchey, Regina E.; Fortier, Catherine B.; Venne, Jonathan R.; Maksimovskiy, Arkadiy L.; Milberg, William P.] Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [McGlinchey, Regina E.; Fortier, Catherine B.; Venne, Jonathan R.; Maksimovskiy, Arkadiy L.; Milberg, William P.] Translat Res Ctr TBI & Stress Related Disorders T, Boston, MA 02130 USA; [McGlinchey, Regina E.; Fortier, Catherine B.; Milberg, William P.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Maksimovskiy, Arkadiy L.] Boston Univ, Sch Med, Dept Behav Neurosci, Boston, MA 02118 USA		McGlinchey, RE (corresponding author), Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA.	Regina_McGlinchey@hms.harvard.edu; Catherine_Fortier@hms.harvard.edu; jon.venne@gmail.com; arkadiym@bu.edu; William_Milberg@hms.harvard.edu	Maksimovskiy, Arkadiy/AAR-3596-2021; McGlinchey, Regina E/R-1971-2016; Fortier, Catherine/AAS-2163-2021	Maksimovskiy, Arkadiy/0000-0001-6696-7853; Fortier, Catherine/0000-0002-8953-9904	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; VA CSR&D Merit Review Award; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG024898]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258, K01AG024898] Funding Source: NIH RePORTER	This research was support by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C). In addition, support for this work was provided by VA CSR&D Merit Review Award to Regina McGlinchey and NIH NIA K01AG024898 to Catherine Brawn Fortier. The authors would like to thank the members of the Core B TRACTS team for their contributions to the data presented in this manuscript, in particular: Melissa Amick, Alexandra Kenna, Ann Rasmusson, Erica Scoli, and David Zade for clinical assessment, as well as Lindsay Morra, Roxana Moayer and Andrea Levine for neuropsychological assessment. We are very grateful to Walter Musto for his extraordinary recruitment efforts.	Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Atkinson MP, 2009, MANAGE SCI, V55, P1454, DOI 10.1287/mnsc.1090.1042; Ayers ED, 2003, INTEGR PHYS BEH SCI, V38, P230, DOI 10.1007/BF02688856; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bolbecker AR, 2011, BEHAV NEUROSCI, V125, P687, DOI 10.1037/a0025150; Bolbecker AR, 2009, SCHIZOPHR RES, V111, P182, DOI 10.1016/j.schres.2009.03.016; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brown SM, 2005, BRAIN COGNITION, V58, P94, DOI 10.1016/j.bandc.2004.09.011; Burriss L, 2007, J PSYCHIATR RES, V41, P785, DOI 10.1016/j.jpsychires.2006.04.004; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Cheng DT, 2010, PSYCHOL AGING, V25, P684, DOI 10.1037/a0017978; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Corp I, 2010, IBM SPSS STAT MAC; Department of Veterans Affairs Office of Quality and Performance and Department of Defense Quality Management Directorate USAMC, 2009, VA DOD CLIN PRACT GU; Desai RA, 2008, MIL MED, V173, P721, DOI 10.7205/MILMED.173.8.721; Edwards CR, 2008, PSYCHIAT RES-NEUROIM, V162, P185, DOI 10.1016/j.pscychresns.2007.06.001; Fein G, 2002, ALCOHOL CLIN EXP RES, V26, P558, DOI 10.1097/00000374-200204000-00017; Fortier CB, 2011, ALCOHOL CLIN EXP RES, V35, P2193, DOI 10.1111/j.1530-0277.2011.01576.x; Fortier CB, 2008, NEUROPSYCHOLOGY, V22, P196, DOI 10.1037/0894-4105.22.2.196; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fortier CB, 2009, INT J ENV RES PUB HE, V6, P2007, DOI 10.3390/ijerph6072007; Fortier CB, 2000, NEUROPSYCHOLOGY, V14, P537, DOI 10.1037/0894-4105.14.4.537; GABRIELI JDE, 1995, BEHAV NEUROSCI, V109, P819, DOI 10.1037/0735-7044.109.5.819; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Ginsberg JP, 2008, J ANXIETY DISORD, V22, P809, DOI 10.1016/j.janxdis.2007.08.009; GORMEZANO I, 1966, EXPT METHODS INSTRUM, V1, P385; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; HARPER C, 1987, BRIT MED J, V294, P534, DOI 10.1136/bmj.294.6571.534; HARPER C, 1982, MED J AUSTRALIA, V2, P277, DOI 10.5694/j.1326-5377.1982.tb124389.x; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; JERNIGAN TL, 1991, NEUROPSYCHOPHARMACOL, V4, P175; Kalmbach BE, 2012, J NEUROPHYSIOL, V107, P226, DOI 10.1152/jn.00381.2011; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Knuttinen MG, 2001, BEHAV NEUROSCI, V115, P747, DOI 10.1037//0735-7044.115.4.747; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; MCCORMICK DA, 1982, BRAIN RES, V245, P239, DOI 10.1016/0006-8993(82)90806-X; McGlinchey RE, 2005, NEUROPSYCHOLOGY, V19, P159, DOI 10.1037/0894-4105.19.2.159; McGlinchey RE, 2008, NEUROPSYCHOLOGY, V22, P278, DOI 10.1037/0894-4105.22.2.278; McGlinchey-Berroth R., 2000, SOC NEUR ABSTR, V26, P41; MCGLINCHEYBERROTH R, 1995, ALCOHOL CLIN EXP RES, V19, P1127, DOI 10.1111/j.1530-0277.1995.tb01590.x; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; McLaughlin J, 2002, BEHAV NEUROSCI, V116, P37, DOI 10.1037//0735-7044.116.1.37; Mills KL, 2006, AM J PSYCHIAT, V163, P652, DOI 10.1176/appi.ajp.163.4.652; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Morrow CE, 2011, PSYCHOL SERV, V8, P224, DOI 10.1037/a0024040; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; National R.C., 2008, GULF WAR HLTH, V7; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1111/j.1530-0277.2000.tb02086.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Robleto K, 2004, LEARN MEMORY, V11, P517, DOI 10.1101/lm.80004; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; SOLOMON PR, 1989, PSYCHOL AGING, V4, P34, DOI 10.1037/0882-7974.4.1.34; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; THOMPSON RF, 1988, TRENDS NEUROSCI, V11, P152, DOI 10.1016/0166-2236(88)90141-5; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vythilingam M, 2006, NEUROPSYCHOPHARMACOL, V31, P182, DOI 10.1038/sj.npp.1300843; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weible AP, 2000, BEHAV NEUROSCI, V114, P1058, DOI 10.1037/0735-7044.114.6.1058; Woodruff-Pak DS, 2000, EYEBLINK CLASSICAL C, VI	88	4	4	0	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2014	11	3					3046	3073		10.3390/ijerph110303046			28	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AF0XM	WOS:000334438200043	24625622	Green Published, Green Submitted, gold			2022-02-06	
J	Sherer, M; Yablon, SA; Nick, TG				Sherer, Mark; Yablon, Stuart A.; Nick, Todd G.			Psychotic Symptoms as Manifestations of the Posttraumatic Confusional State: Prevalence, Risk Factors, and Association With Outcome	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						confusion; delirium; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DELIRIUM; SCALE; RECOVERY; AMNESIA	Objectives: To (1) determine factors associated with psychotic-type symptoms in persons with moderate or severe traumatic brain injury (TBI) during early recovery and (2) investigate the prognostic significance of early psychotic-type symptoms for patient outcome. Setting: Acute neurorehabilitation inpatient unit. Participants: A total of 168 persons with moderate or severe TBI were admitted for inpatient rehabilitation. Of these, 107 had psychotic-type symptoms on at least 1 examination. One-year productivity outcome was available for 87 of the 107 participants. Design: Prospective, inception cohort, observational study. Main Measures: Confusion Assessment Protocol, productivity outcome at 1 year postinjury. Results: Presence of sleep disturbance, a shorter interval from admission to assessment, and greater cognitive impairment were associated with a greater incidence of psychotic-type symptoms. Younger age, more years of education, and lower frequency and severity of psychotic-type symptoms were associated with a greater likelihood of favorable productivity outcome. Conclusions: We identified risk factors for the occurrence of psychotic-type symptoms and extended previous findings regarding the significance of these symptoms for outcome after TBI. These findings suggest that improved sleep in early TBI recovery may decrease the occurrence of psychotic-type symptoms.	[Sherer, Mark] Univ Houston, Baylor Coll Med, Sch Med, TIRR Mem Hermann, Houston, TX USA; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Nick, Todd G.] Univ Arkansas Med Sci, Dept Pediat & Biostat, Little Rock, AR 72205 USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org			US Department of Education National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133A070043, H133A020514]	This research was supported by US Department of Education National Institute on Disability and Rehabilitation Research Grants H133A070043 and H133A020514.	Charlton BG, 2002, MED HYPOTHESES, V58, P24, DOI 10.1054/mehy.2001.1436; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; GRAMBSCH PM, 1991, STAT MED, V10, P697, DOI 10.1002/sim.4780100504; Gupta N, 2008, J PSYCHOSOM RES, V65, P215, DOI 10.1016/j.jpsychores.2008.05.020; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; Nakase-Thompson R, 2002, BRAIN INJURY, V18, P131; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M., 2005, FORENSIC NEUROPSYCHO, P237; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	17	4	4	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					E11	E18		10.1097/HTR.0b013e318287f894			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600002	23535390				2022-02-06	
J	Tyagi, E; Agrawal, R; Ying, Z; Gomez-Pinilla, F				Tyagi, Ethika; Agrawal, Rahul; Ying, Zhe; Gomez-Pinilla, Fernando			TBI and sex: Crucial role of progesterone protecting the brain in an omega-3 deficient condition	EXPERIMENTAL NEUROLOGY			English	Article						Anxiety; Neuroplasticity; Omega-3 fatty acid; Progesterone; Traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID; LIPID-PEROXIDATION; NEUROPEPTIDE-Y; DIETARY SUPPLEMENTATION; PHOSPHOLIPASE A(2); POSSIBLE MECHANISM; CONTUSION INJURY; FATTY-ACIDS; CELL-DEATH	We assessed whether the protective action of progesterone on traumatic brain injury (TBI) could be influenced by the consumption of omega 3 fatty acids during early life. Pregnant Sprague-Dawley rats were fed on omega 3 adequate or deficient diet from 3rd day of pregnancy and their female offspring were kept on the same diets up to the age of 15 weeks. Ovariectomy was performed at the age of 12 weeks to deprive animals from endogenous steroids until the time of a fluid percussion injury (FPI). Dietary n-3 fatty add deficiency increased anxiety in sham animals and TBI aggravated the effects of the deficiency. Progesterone replacement counteracted the effects of TBI on the animals reared under n-3 deficiency. A similar pattern was observed for markers of membrane homeostasis such as 4-Hydroxynonenal (HNE) and secreted phospholipases A2 (sPLA2), synaptic plasticity such as brain derived neurotrophic factor (BDNF), syntaxin (STX)-3 and growth associated protein (GAP)-43, and for growth inhibitory molecules such as myelin-associated glycoprotein (MAG) and Nogo-A. Results that progesterone had no effects on sham n-3 deficient animals suggest that the availability of progesterone is essential under injury conditions. Progesterone treatment counteracted several parameters related to synaptic plasticity and membrane stability reduced by FPI and n-3 deficiency suggest potential targets for therapeutic applications. These results reveal the importance of n-3 preconditioning during early life and the efficacy of progesterone therapy during adulthood to counteract weaknesses in neuronal and behavioral plasticity. (C) 2014 Elsevier Inc. All rights reserved.	[Tyagi, Ethika; Agrawal, Rahul; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS056413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS050465 and NS056413. We are thankful to Ms. Rusvelda Cruz for her assistance with animal feeding. There is no conflict of interest for any of the contributing authors. We thank The Letten Foundation and Professor Saugstadt for kind support.	Andrade S, 2012, CELL BIOCHEM FUNCT, V30, P696, DOI 10.1002/cbf.2854; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334; BENOWITZ LI, 1990, MOL BRAIN RES, V8, P17, DOI 10.1016/0169-328X(90)90004-W; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BLEAKMAN D, 1992, BRIT J PHARMACOL, V107, P334, DOI 10.1111/j.1476-5381.1992.tb12747.x; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Camacho-Arroyo I, 2012, MINI-REV MED CHEM, V12, P1037, DOI 10.2174/138955712802762257; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Croll SD, 1998, BRAIN RES, V812, P200, DOI 10.1016/S0006-8993(98)00993-7; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Deecher D, 2008, PSYCHONEUROENDOCRINO, V33, P3, DOI 10.1016/j.psyneuen.2007.10.006; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; FILBIN MT, 1995, CURR OPIN NEUROBIOL, V5, P588, DOI 10.1016/0959-4388(95)80063-8; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; HSU CY, 1989, ANN NY ACAD SCI, V559, P282; Jacka FN, 2013, BRIT J NUTR, V109, P2059, DOI 10.1017/S0007114512004102; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kang JX, 2013, CNS NEUROL DISORD-DR, V12, P460, DOI 10.2174/1871527311312040004; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kinsley CH, 2012, MINI-REV MED CHEM, V12, P1063, DOI 10.2174/138955712802762248; Kishimoto K, 1999, NEUROSCIENCE, V92, P1061, DOI 10.1016/S0306-4522(99)00051-2; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Mark RJ, 1997, J NEUROCHEM, V68, P255; Martin-Martin B, 1999, J LEUKOCYTE BIOL, V65, P397, DOI 10.1002/jlb.65.3.397; McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026; Melcangi RC, 2005, BRAIN RES REV, V48, P328, DOI 10.1016/j.brainresrev.2004.12.021; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Molloy GY, 1998, NEUROSCI LETT, V258, P139, DOI 10.1016/S0304-3940(98)00838-6; Morrow AL, 1995, ANN NY ACAD SCI, V771, P257, DOI 10.1111/j.1749-6632.1995.tb44687.x; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Prevot V, 2000, ENDOCRINOLOGY, V141, P1648, DOI 10.1210/en.141.5.1648; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Robinson JG, 2010, WOMENS HEALTH, V6, P119, DOI 10.2217/WHE.09.75; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shibata A, 1998, J CELL BIOL, V142, P191, DOI 10.1083/jcb.142.1.191; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	80	4	4	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2014	253						41	51		10.1016/j.expneurol.2013.12.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8QS	WOS:000332055700005	24361060	Green Accepted			2022-02-06	
J	Lavrnja, I; Trifunovic, S; Ajdzanovic, V; Pekovic, S; Bjelobaba, I; Stojiljkovic, M; Milosevic, V				Lavrnja, Irena; Trifunovic, Svetlana; Ajdzanovic, Vladimir; Pekovic, Sanja; Bjelobaba, Ivana; Stojiljkovic, Mirjana; Milosevic, Verica			Sensorimotor cortex ablation induces time-dependent response of ACTH cells in adult rats: Behavioral, immunohistomorphometric and hormonal study	PHYSIOLOGY & BEHAVIOR			English	Article						Traumatic brain injury; Pituitary; ACTH; Locomotor activity; Rat	TRAUMATIC BRAIN-INJURY; LOCOMOTOR ABILITY; AXONAL INJURY; EXPRESSION; MECHANISMS; RECOVERY; HUMANS; DAMAGE	Traumatic brain injury (TBI) represents a serious event with far reaching complications, including pituitary dysfunction. Pars distalis corticotropes (ACTH cells), that represent the active module of hypothalamo-pituitary-adrenocortical axis, seem to be affected as well. Since pituitary failure after TBI has been associated with neurobehavioral impairments the aim of this study was to evaluate the effects of TBI on recovery of motor functions, morphology and secretory activity of ACTH cells in the pituitary of adult rats. Wistar male rats, initially exposed to sensorimotor cortex ablation (SCA), were sacrificed at the 2nd, 7th, 14th and 30th days post-surgery (dps). A beam walking test was used to evaluate the recovery of motor functions. Pituitary glands and blood were collected for morphological and hormonal analyses. During the first two weeks post-injury increased recovery of locomotor function was detected, reaching almost the control value at day 30. SCA induces significant increase of pituitary weights compared to their time-matched controls. The volume of ACTH-immunopositive cells was reduced at the 7th dps, while at the 14th dps their volume was enlarged, in comparison to corresponding sham controls. Volume density of ACTH cells was increased only at 14th dps, while at day 30 this increase was insignificant. The plasma level of ACTH transiently increased after the injury. The most pronounced changes were observed at the 7th and 14th dps, and were followed by decrease toward control levels at the 30th dps. Thus, temporal changes in the hypothalamic-pituitary-adrenal axis after traumatic brain injury appear to correlate with the recovery process. (C) 2013 Elsevier Inc. All rights reserved.	[Lavrnja, Irena; Pekovic, Sanja; Bjelobaba, Ivana; Stojiljkovic, Mirjana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade, Serbia; [Trifunovic, Svetlana; Ajdzanovic, Vladimir; Milosevic, Verica] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Cytol, Belgrade, Serbia		Lavrnja, I (corresponding author), Inst Biol Res Dr Sinisa Stankovic, Blvd Despota Stefana 142, Belgrade 11060, Serbia.	irenam@ibiss.bg.ac.rs	Bjelobaba, Ivana/ABA-1538-2020; Lavrnja, Irena/ABA-1558-2020	Bjelobaba, Ivana/0000-0002-7649-0304; Lavrnja, Irena/0000-0002-0607-5594; Ajdzanovic, Vladimir/0000-0002-6540-9603	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 41014, ON 173009]	The authors would like to thank Assistant MSc Sanja Dacic for performing the beam walking test. This work was supported by Ministry of Education, Science and Technological Development of the Republic of Serbia Grants III 41014, and ON 173009.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Brkic P, 2012, BRAIN INJURY, V26, P1273, DOI 10.3109/02699052.2012.667593; Conti AC, 1998, J NEUROSCI, V18, P5663; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; Ferrari E, 2001, EUR J ENDOCRINOL, V144, P319, DOI 10.1530/eje.0.1440319; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Giuliani D, 2012, FRONT NEUROENDOCRIN, V33, P179, DOI 10.1016/j.yfrne.2012.04.001; Goldstein LB, 2003, ILAR J, V44, P125, DOI 10.1093/ilar.44.2.125; Gong DS, 2000, ZHONGHUA CHUANGSHANG, V16, P32; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Huo J, 2012, NEURAL REGEN RES, V7, P1729, DOI 10.3969/j.issn.1673-5374.2012.22.008; MALENDOWICZ LK, 1974, CELL TISSUE RES, V151, P537, DOI 10.1007/BF00222998; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; Nichols NR, 2001, BRAIN RES REV, V37, P273, DOI 10.1016/S0165-0173(01)00131-X; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Paxinos G, 2004, RAT BRAIN STEREOTAXI; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Smiljanic K, 2010, HISTOCHEM CELL BIOL, V134, P159, DOI 10.1007/s00418-010-0718-6; SUN SQ, 1991, J ELECTRON MICROSC, V40, P29; SZELE FG, 1995, J NEUROSCI, V15, P4429; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; WEIBEL ER, 1979, STEREOLOGICAL METHOD; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	33	4	4	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	FEB 10	2014	125						30	37		10.1016/j.physbeh.2013.11.005			8	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	AB0JT	WOS:000331478700005	24291385				2022-02-06	
J	Ostberg, A; Tenovuo, O				Ostberg, Anna; Tenovuo, Olli			Smoking and outcome of traumatic brain injury	BRAIN INJURY			English	Article						Neurological; outcome; traumatic brain injury	CULTURED CORTICAL-NEURONS; ALZHEIMERS-DISEASE; HEAD-INJURY; TRANSDERMAL NICOTINE; CHOLINERGIC DYSFUNCTION; COGNITIVE PERFORMANCE; PARKINSON-DISEASE; MEMORY; ATTENTION; RISK	Objective: There is evidence that the cholinergic system is involved in cognitive sequels of traumatic brain injury (TBI). Nicotinic acetylcholine receptors (nAChRs) are known to have a major role in cognitive functions. Smokers have up-regulation of these receptors. This study investigated whether smoking is associated with the outcome from TBI. Methods: A specific questionnaire was sent, after checking inclusion and exclusion criteria, to 1022 subjects with TBI who had visited the neurological outpatient clinic of a university hospital during a 14-year period. Of these, 689 (67.4%) responded, forming the final study population. Associations between demographic variables, injury severity and outcome and smoking history were analysed using multivariate methods. Results: Smokers were more often men (p<0.001), younger at the time of the injury (p =.008) and had less education (p<0.0001). In univariate analysis, non-smokers did not differ for outcome of TBI by GOS-E (p = 0.08). Furthermore, in multivariate analysis, no association was found between smoking history and TBI outcome. Conclusions: This study does not suggest that smoking affects the outcome of TBI.	Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; Turku Univ Cent Hosp, Turku, Finland		Ostberg, A (corresponding author), Turku Cent Univ Hosp, Turku, Finland.	aesuom@utu.fi					AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Hatsukami D, 1989, J Subst Abuse, V1, P407; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Huisman M, 2005, PREV MED, V40, P756, DOI 10.1016/j.ypmed.2004.09.022; JENNETT B, 1975, LANCET, V1, P480; Kaneko S, 1997, BRAIN RES, V765, P135, DOI 10.1016/S0006-8993(97)00556-8; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Levin ED, 1998, PSYCHOPHARMACOLOGY, V140, P135, DOI 10.1007/s002130050750; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; Mumenthaler MS, 2003, NEUROPSYCHOPHARMACOL, V28, P1366, DOI 10.1038/sj.npp.1300202; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newhouse P A, 2000, Pharm Acta Helv, V74, P91, DOI 10.1016/S0031-6865(99)00047-3; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; OWMAN C, 1989, PROG BRAIN RES, V79, P267; Picciotto MR, 2008, FRONT BIOSCI-LANDMRK, V13, P492, DOI 10.2741/2695; Poltavski DV, 2005, PHYSIOL BEHAV, V83, P833, DOI 10.1016/j.physbeh.2004.10.005; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Quik M, 2008, MOVEMENT DISORD, V23, P1641, DOI 10.1002/mds.21900; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Thacker EL, 2007, NEUROLOGY, V68, P764, DOI 10.1212/01.wnl.0000256374.50227.4b; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; WARBURTON DM, 1994, PSYCHOPHARMACOLOGY, V115, P539, DOI 10.1007/BF02245578; White HK, 1999, PSYCHOPHARMACOLOGY, V143, P158, DOI 10.1007/s002130050931; White HK, 2004, PSYCHOPHARMACOLOGY, V171, P465, DOI 10.1007/s00213-003-1614-8; WILSON AL, 1995, PHARMACOL BIOCHEM BE, V51, P509, DOI 10.1016/0091-3057(95)00043-V	43	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					155	160		10.3109/02699052.2013.860468			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900004	24456055				2022-02-06	
J	Vigue, B; Ract, C				Vigue, B.; Ract, C.			Treatments and outcome, the point in head trauma	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			English	Article						Traumatic brain injury; Outcome; Ethics; Diffusion tensor imaging; Self-fulfilling prophecies	BRAIN-INJURY; CARE; PREDICTION; PROGNOSIS; RESUSCITATION; COHORT	When a severe traumatic brain-injured patient arrives to hospital, fear of failure and definite opinions about the outcome modify early care and provoke self-fulfilling prophecies. It is obvious that working on prognosis is not only useful to inform relatives but also permits to maintain a high level of care, key for a better outcome. Mortality is high (40-50%) if deaths in the first days are not excluded. Following guidelines in all cases will permit to decrease the number of preventable death and a decrease in morbidity. Well-defined networks of care leading to specialized centres with multimodal monitoring give best results. However, only 20% of living patients return to their previous life with mild handicap. These unsatisfactory results require intensifying research, notably in early rehabilitation in intensive care unit. Ethic issues should be discussed after few days of care and dialogue with relatives in a defined "window of opportunity". Ideally, we need to find strong and early indicators of outcome to limit fears on presumed handicap. A magnetic resonance imaging (MRI) sequence called diffusion tensor imaging (TDI) permits to visualise traumatic axonal injury. Studies with complex statistical methodology give a good estimated probability of bad outcome but must be confirmed by more validation studies. Progress will come from a better understanding of physiopathology. Focuses on processing chain, rapid multi-monitoring, biomarkers, and investigations in MRI and TDI will help to establish opportunities for treatments and to determine limits. (C) 2014 Published by Elsevier Masson SAS on behalf of the Societe francaise d'anesthesie et de reanimation (Sfar).	[Vigue, B.; Ract, C.] CHU Bicetre, AP HP, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France		Vigue, B (corresponding author), CHU Bicetre, AP HP, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France.	bernard.vigue@bct.aphp.fr					Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Brain Trauma Foundation, 2007, J NEUROTRAUMA S, V24, pS1; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Caulfield AF, 2010, NEUROLOGY, V74, P1096, DOI 10.1212/WNL.0b013e3181d8197f; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Creutzfeldt CJ, 2011, CRIT CARE MED, V39, P158, DOI 10.1097/CCM.0b013e3181fb7b49; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hough CL, 2013, CURR OPIN CRIT CARE, V19, P488, DOI 10.1097/MCC.0b013e328364d7ef; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rabinstein AA, 2010, NEUROLOGY, V74, P1086, DOI 10.1212/WNL.0b013e3181d7d928; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Vigue B, 2011, SFAR 2011, pR169; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	36	4	4	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2014	33	2					110	114		10.1016/j.annfar.2013.11.008			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AD8IS	WOS:000333510300008	24361282				2022-02-06	
J	Winkelmann, M; Wilhelmi, M				Winkelmann, M.; Wilhelmi, M.			Prehospital resuscitation of patients with multiple injuries	UNFALLCHIRURG			German	Article						Multiple trauma; Hemorrhage; Damage control resuscitation; Hypotension, permissive; Coagulopathy, trauma-induced	EARLY COAGULOPATHY; HEMORRHAGIC-SHOCK; TRAUMA-REGISTRY; MORTALITY; ACIDOSIS	Polytrauma is the leading cause of morbidity and mortality in young adults (aged 35-45 years). At 30-40%, traumatic hemorrhage is the most frequent preventable cause of death. Approximately every fourth patient with multiple injuries suffers from trauma-induced coagulopathy. The current knowledge of prehospital resuscitation of patients with multiple injuries based on a selective literature research and experience in a level I trauma center are presented. Hemorrhagic shock is a clinical diagnosis and the recognition by the first responding emergency physician requires rapid evaluation of the accident situation, injury pattern and patient's hemodynamic status. In the future, tools will help to reliably estimate shock. Development of trauma-induced coagulopathy is multifactorial and is characterized by interaction of tissue damage, shock, hypothermia, acidosis and dilution. Preclinical therapy follows the concept of damage control resuscitation and involves bleeding hemostasis, permissive hypotension with a target systolic blood pressure between 80 and 90 mmHg (a parts per thousand yen80 mmHg in presence of traumatic brain injury) by modest infusion of primarily crystalloid solutions, avoiding hypothermia and acidosis. The current knowledge and therapy recommendations are presented.	[Winkelmann, M.; Wilhelmi, M.] Hannover Med Sch, Unfallchirurg Klin, D-30625 Hannover, Germany		Winkelmann, M (corresponding author), Hannover Med Sch, Unfallchirurg Klin, Carl Neuberg Str 1, D-30625 Hannover, Germany.	winkelmann.marcel@mh-hannover.de					Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Coats T J, 2002, J R Army Med Corps, V148, P140; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Groeneveld ABJ, 2011, ANN SURG, V253, P470, DOI 10.1097/SLA.0b013e318202ff00; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Kheirabadi BS, 2005, J TRAUMA, V59, P25, DOI 10.1097/01.TA.0000171458.72037.EE; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Lakstein D, 2003, J TRAUMA, V54, pS221, DOI 10.1097/01.TA.0000047227.33395.49; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Martini WZ, 2007, CRIT CARE MED, V35, P1568, DOI 10.1097/01.CCM.0000266682.74602.6A; Martini WZ, 2006, J TRAUMA, V61, P99, DOI 10.1097/01.ta.0000215574.99093.22; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Mutschler M, 2014, EMERG MED J, V31, P35, DOI 10.1136/emermed-2012-202130; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Mutter TC, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD007594.PUB3; Naimer SA, 2004, INJURY, V35, P974, DOI 10.1016/S0020-1383(03)00316-4; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perkins JG, 2008, CRIT CARE MED, V36, pS325, DOI 10.1097/CCM.0b013e31817e2ec5; Pusateri AE, 2006, J TRAUMA, V60, P674, DOI 10.1097/01.ta.0000196672.47783.fd; Rehm M, 2013, ANAESTHESIST, V62, P644, DOI 10.1007/s00101-013-2220-8; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Sorensen B, 2012, BRIT J SURG, V99, P40, DOI 10.1002/bjs.7770; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Walcher F, 2006, BRIT J SURG, V93, P238, DOI 10.1002/bjs.5213	31	4	4	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	FEB	2014	117	2					99	104		10.1007/s00113-013-2487-x			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	AB2US	WOS:000331648200003	24477802				2022-02-06	
J	Bianchi, A; Bhanu, B; Donovan, V; Obenaus, A				Bianchi, Anthony; Bhanu, Bir; Donovan, Virginia; Obenaus, Andre			Visual and Contextual Modeling for the Detection of Repeated Mild Traumatic Brain Injury	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Brain injury; contextual modeling; magnetic resonance imaging (MRI); textural modeling	TEMPORAL WINDOW; SEGMENTATION; VULNERABILITY; LESIONS	Currently, there is a lack of computational methods for the evaluation of mild traumatic brain injury (mTBI) from magnetic resonance imaging (MRI). Further, the development of automated analyses has been hindered by the subtle nature of mTBI abnormalities, which appear as low contrast MR regions. This paper proposes an approach that is able to detect mTBI lesions by combining both the high-level context and low-level visual information. The contextual model estimates the progression of the disease using subject information, such as the time since injury and the knowledge about the location of mTBI. The visual model utilizes texture features in MRI along with a probabilistic support vector machine to maximize the discrimination in unimodal MR images. These two models are fused to obtain a final estimate of the locations of the mTBI lesion. The models are tested using a novel rodent model of repeated mTBI dataset. The experimental results demonstrate that the fusion of both contextual and visual textural features outperforms other state-of-the-art approaches. Clinically, our approach has the potential to benefit both clinicians by speeding diagnosis and patients by improving clinical care.	[Bianchi, Anthony; Bhanu, Bir] Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA; [Donovan, Virginia] Univ Calif Riverside, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92354 USA		Bianchi, A (corresponding author), Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA.	abianchi@vislab.ee.ucr.edu; bhanu@cris.ucr.edu; virginia.donovan@ucr.edu; aobenaus@llu.edu		Bhanu, Bir/0000-0001-8971-6416	National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) in Video Bioinformatics [DGE-0903667]; National Science Foundation: Learning Concepts in Morphological Image Databases [DCMRP-DR080470, 0641076]	This work was supported in part by the National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) in Video Bioinformatics (DGE-0903667), in part by the National Science Foundation: Learning Concepts in Morphological Image Databases (DCMRP-DR080470), and in part by the National Science Foundation: Learning Concepts in Morphological Image Databases (0641076). Asterisk indicates corresponding author.	Ahmed S, 2011, IEEE T INF TECHNOL B, V15, P206, DOI 10.1109/TITB.2011.2104376; Anbeek P, 2004, MED IMAGE ANAL, V8, P205, DOI 10.1016/j.media.2004.06.019; Bianchi A, 2012, IEEE IMAGE PROC, P1261, DOI 10.1109/ICIP.2012.6467096; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Center for Disease Control and Prevention, 2002, HEADS FACTS PHYS MIL; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choi MJ, 2012, IEEE T PATTERN ANAL, V34, P240, DOI 10.1109/TPAMI.2011.119; Cifu D., 2009, J REHABIL RES DEV, V46, pCP1; Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Costa L. F., 2001, SHAPE ANAL CLASSIFIC; de Boer R, 2009, NEUROIMAGE, V45, P1151, DOI 10.1016/j.neuroimage.2009.01.011; Divvala SK, 2009, PROC CVPR IEEE, P1271, DOI 10.1109/CVPRW.2009.5206532; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P694, DOI 10.1109/42.736021; Gallage C. P., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587799; Galleguillos C, 2010, COMPUT VIS IMAGE UND, V114, P712, DOI 10.1016/j.cviu.2010.02.004; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Horsfield MA, 2007, IEEE T MED IMAGING, V26, P1670, DOI 10.1109/TMI.2007.901431; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Kafai M, 2012, IEEE T IND INFORM, V8, P100, DOI 10.1109/TII.2011.2173203; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kruggel F, 2008, NEUROIMAGE, V39, P987, DOI 10.1016/j.neuroimage.2007.09.058; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Marques O, 2011, MULTIMED TOOLS APPL, V51, P303, DOI 10.1007/s11042-010-0631-y; Mazzara GP, 2004, INT J RADIAT ONCOL, V59, P300, DOI 10.1016/j.ijrobp.2004.01.026; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Morris T, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P17, DOI 10.1007/978-1-4419-1364-7_2; Niimi T, 2007, EUR J RADIOL, V61, P362, DOI 10.1016/j.ejrad.2006.09.009; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Perko R, 2010, COMPUT VIS IMAGE UND, V114, P700, DOI 10.1016/j.cviu.2010.03.005; Platt JC, 2000, ADV NEUR IN, P61; Rabinovich A, 2007, IEEE I CONF COMP VIS, P1237, DOI 10.1109/iccv.2007.4408986; Rajan J, 2010, PHYS MED BIOL, V55, pN441, DOI 10.1088/0031-9155/55/16/N02; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Thevenaz P, 2000, IEEE T MED IMAGING, V19, P739, DOI 10.1109/42.875199; Tong K. A., 2003, APPL RADIOL, V32, P29; Torralba A, 2010, COMMUN ACM, V53, P107, DOI 10.1145/1666420.1666446; Tu ZW, 2010, IEEE T PATTERN ANAL, V32, P1744, DOI 10.1109/TPAMI.2009.186; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Xuan Guorong, 1996, Proceedings of the 13th International Conference on Pattern Recognition, P195, DOI 10.1109/ICPR.1996.546751; Yu Sun, 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P79, DOI 10.1109/CVPR.2009.5204052; Zhang N, 2011, COMPUT VIS IMAGE UND, V115, P256, DOI 10.1016/j.cviu.2010.09.007	46	4	5	0	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	JAN	2014	33	1					11	22		10.1109/TMI.2013.2269317			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	AA7SI	WOS:000331296800002	23797243	Green Published			2022-02-06	
J	Bird, J; Parente, R				Bird, Julie; Parente, Rick			Recognition of nonverbal communication of emotion after traumatic brain injury	NEUROREHABILITATION			English	Article						Emotion recognition; brain injury; nonverbal communication; cognitive rehabilitation	FACIAL EMOTION; HEAD-INJURY; PERCEPTION; EXPRESSION; DEFICITS; SENTENCES; ADULTS; DAMAGE	BACKGROUND: Individuals who have had a traumatic brain injury (TBI) often have difficulty processing nonverbal communication (Ekman, 1976) The published research in this area has focused on a TBI patient's ability to recognize facial expression, vocal intonation, and postural expression (Croker, 2005; Hopkins, Dywan & Segalowitz, 2002). OBJECTIVE: This study compared the non-verbal processing skills of brain-injured patients versus non-injured controls in all three domains. METHODS: The stimuli were photographs of facial and postural expressions and audio recordings of intonational expressions. RESULTS: The results indicated that persons with TBI have particular difficulty recognizing non-verbal communication resulting from vocal intonations. CONCLUSIONS: The TBI patients had difficulty processing tonality, therefore, it is reasonable to suggest that clinicians, friends, and family members should emphasize the explicit verbal content of spoken language when speaking to a person with TBI.	[Bird, Julie] Univ Maryland, Sch Med, College Pk, MD 20742 USA; [Parente, Rick] Towson Univ, Dept Psychol, Towson, MD 21252 USA		Parente, R (corresponding author), Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21252 USA.	rparente007@yahoo.com	Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; BENOWITZ LI, 1983, CORTEX, V19, P5, DOI 10.1016/S0010-9452(83)80046-X; Birdwhistell R.L., 1970, KINESICS CONTEXT ESS, P427; BOROD JC, 1993, J NERV MENT DIS, V181, P494, DOI 10.1097/00005053-199308000-00004; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Ekman P., 1976, PICTURES FACIAL AFFE; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mandal MK, 1999, J NERV MENT DIS, V187, P603, DOI 10.1097/00005053-199910000-00003; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; SCHLANGER BB, 1976, BRAIN LANG, V3, P396, DOI 10.1016/0093-934X(76)90035-3; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; SUBERI M, 1977, NEUROPSYCHOLOGIA, V15, P757, DOI 10.1016/0028-3932(77)90006-9; Yip JTH, 2004, BRAIN INJURY, V18, P1209, DOI 10.1080/02699050410001719916	24	4	4	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					39	43		10.3233/NRE-131006			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000006	24284451				2022-02-06	
S	Bonfield, CM; Wecht, DA; Lunsford, LD		Niranjan, A; Lunsford, LD		Bonfield, Christopher M.; Wecht, Daniel A.; Lunsford, L. Dade			Concussion in Ice Hockey	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							INTERNATIONAL-CONFERENCE; BRAIN-INJURY; RISK-FACTORS; EPIDEMIOLOGY; SPORT; RATES; HEAD; MENS; STATEMENT; HELMETS	Ice hockey is an aggressive and fast-paced sport which has a high risk of injury, concussions in particular. Although serious head injury has been recognized for nearly 50 years, an increase in mainstream media attention in recent years has led to unprecedented public awareness. As a result, the National Hockey League (NHL) and other professional leagues around the world have initiated concussion protocols in order to better prevent, recognize, and treat concussions. With over 1,000,000 youth hockey participants in Canada and the USA combined, concussion is an issue that reaches beyond the professional level. In this report we review the incidence, evaluation, treatment, return-to-play protocol, and prevention efforts related to concussion in ice hockey. (C) 2014 S. Karger AG, Basel	[Bonfield, Christopher M.; Wecht, Daniel A.; Lunsford, L. Dade] Univ Pittsburgh, Med Ctr, Ctr Sports Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA		Bonfield, CM (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Sports Med, Dept Neurol Surg, 200 Lothrop St Suite B-400, Pittsburgh, PA 15213 USA.	bonfieldcm@upmc.edu					Agel J, 2010, CAN J SURG, V53, P319; Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Branch J, 2011, HOCKEY PLAYERS DEATH; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Garofalo P, 2013, NHL PLAYERS CONCUSSI; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hemond C, 2012, CAN MED ASSOC J, V184, P861, DOI 10.1503/cmaj.109-4167; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Peters C, 2013, NHL CONCUSSION CRISI; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Roarke S, 2011, STUDY TIME LOST ILLE; Roarke S, 2011, BETTMAN DISCUSSES CO; rosen D., 2011, NEW CONCUSSION PROTO; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Whamsby T, 2012, FINAL CONCUSSIONS SU; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	53	4	4	3	12	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						161	170		10.1159/000358777	10.1159/isbn.978-3-318-02649-8		10	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000015	24923401				2022-02-06	
J	DeQuesada, IM; Chokshi, FH				DeQuesada, Ivan M., II; Chokshi, Falgun H.			Neuroimaging of Acute Traumatic Brain Injury: Emphasis on Magnetic Resonance Imaging and Prognostic Factors	SEMINARS IN ROENTGENOLOGY			English	Article							DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; NEW-ORLEANS CRITERIA; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; MEDICAL LITERATURE; MR-ANGIOGRAPHY; CT ANGIOGRAPHY; PREDICTION; DIAGNOSIS		[DeQuesada, Ivan M., II] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Chokshi, Falgun H.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Neuroradiol, Atlanta, GA 30322 USA		Chokshi, FH (corresponding author), Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Neuroradiol, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	falgun.chokshi@emory.edu					Aiken AH, 2010, SEMIN ROENTGENOL, V45, P63, DOI 10.1053/j.ro.2009.09.007; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chen CCC, 2005, AM J NEURORADIOL, V26, P2349; Chokshi FH, 2011, AM J ROENTGENOL, V196, pW309, DOI 10.2214/AJR.10.4548; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hijaz TA, 2011, RADIOL CLIN N AM, V49, P81, DOI 10.1016/j.rcl.2010.07.012; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maeda M, 2003, EUR RADIOL, V13, pL192, DOI 10.1007/s00330-003-1877-9; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McKenna C, 2009, BRAIN INJURY, V23, P597, DOI 10.1080/02699050902973921; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shimoda M, 2010, NEUROL MED-CHIR, V50, P530, DOI 10.2176/nmc.50.530; Stallmeyer MJB, 2006, RADIOL CLIN N AM, V44, P13, DOI 10.1016/j.rcl.2005.08.003; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	43	4	4	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0037-198X	1558-4658		SEMIN ROENTGENOL	Semin. Roentgenology	JAN	2014	49	1					64	75		10.1053/j.ro.2013.10.003			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	277DW	WOS:000328800100008	24342676				2022-02-06	
J	Fabian, LA; Thygerson, SM; Merrill, RM				Fabian, Leslie A.; Thygerson, Steven M.; Merrill, Ray M.			Boarding Injuries: The Long and the Short of It	EMERGENCY MEDICINE INTERNATIONAL			English	Article								As the popularity of longboarding increases, trauma centers are treating an increased number of high severity injuries. Current literature lacks descriptions of the types of injuries experienced by longboarders, a distinct subset of the skateboarding culture. A retrospective review of longboarding and skateboarding injury cases was conducted at a level II trauma center from January 1, 2006, through December 31, 2011. Specific injuries in addition to high injury severity factors (hospital and intensive care unit (ICU) length of stay (LOS), Injury Severity Score (ISS), patient treatment options, disposition, and outcome) were calculated to compare longboarder to skateboarder injuries. A total of 824 patients met the inclusion criteria. Skull fractures, traumatic brain injuries (TBI), and intracranial hemorrhage (ICH) were significantlymore common among longboard patients than skateboarders (P < 0.0001). All patients with an ISS above 15 were longboarders. Hospital and ICU LOS in days was also significantly greater for longboarders compared with skateboarders (P < 0.0001). Of the three patients that died, each was a longboarder and each experienced a head injury. Longboard injuries account for a higher incidence rate of severe head injuries compared to skateboard injuries. Our data show that further, prospective investigation into the longboarding population demographics and injury patterns is necessary to contribute to effective injury prevention in this population.	[Fabian, Leslie A.] Utah Valley Reg Med Ctr, Provo, UT 84604 USA; [Thygerson, Steven M.; Merrill, Ray M.] Brigham Young Univ, Dept Hlth Sci, 229-C Richards Bldg, Provo, UT 84602 USA		Thygerson, SM (corresponding author), Brigham Young Univ, Dept Hlth Sci, 229-C Richards Bldg, Provo, UT 84602 USA.	steventhygerson@yahoo.com					[Anonymous], FAST SKAT SPEED STAN; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Forsman L, 2001, BRIT J SPORT MED, V35, P325, DOI 10.1136/bjsm.35.5.325; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Kyle SB, 2002, J TRAUMA, V53, P686, DOI 10.1097/00005373-200210000-00011; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Tominaga GT, 2013, INJURY, V44, P645, DOI 10.1016/j.injury.2012.01.022; Zalavras C, 2005, AM J SPORT MED, V33, P568, DOI 10.1177/0363546504269256	9	4	4	3	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.		2014	2014								924381	10.1155/2014/924381			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V34MP	WOS:000215837400024	24660063	Green Published, Green Submitted, gold			2022-02-06	
J	Iba, J; Tasaki, O; Hirao, T; Mohri, T; Yoshiya, K; Hayakawa, K; Shiozaki, T; Hamasaki, T; Nakamori, Y; Fujimi, S; Ogura, H; Kuwagata, Y; Shimazu, T				Iba, Jiro; Tasaki, Osamu; Hirao, Tomohito; Mohri, Tomoyoshi; Yoshiya, Kazuhisa; Hayakawa, Koichi; Shiozaki, Tadahiko; Hamasaki, Toshimitsu; Nakamori, Yasushi; Fujimi, Satoshi; Ogura, Hiroshi; Kuwagata, Yasuyuki; Shimazu, Takeshi			Outcome prediction model for severe traumatic brain injury	ACUTE MEDICINE & SURGERY			English	Article						Glasgow Coma Scale; logistic regression; outcome prediction; repeated random subsampling method; severe traumatic brain injury		Aim: Treatment of severe traumatic brain injury is aided by better prediction of outcomes. The purpose of the present study was to develop and validate a prediction model using retrospective analysis of prospectively collected clinical data from two tertiary critical care medical centers in Japan. Methods: Data were collected from 253 patients with a Glasgow Coma Scale score of < 9. Within 24 h of their admission, 15 factors possibly related to outcome were evaluated. The dataset was randomly split into training and validation datasets using the repeated random subsampling method. A logistic regression model was fitted to the training dataset and predictive accuracy was assessed using the validation data. Results: The best model included the variables age, pupillary light reflex, extensive subarachnoid hemorrhage, intracranial pressure, and midline shift. The estimated area under the curve for the model development data was 0.957, with a 95% confidence interval of 0.926-0.987, and that for validation data was 0.947, with a 95% confidence interval of 0.909-0.980. Conclusion: Our predictive model was shown to have high predictive value. It will be useful for review of treatment, family counseling, and efficient allocation of resources for patients with severe traumatic brain injury.	[Iba, Jiro] Osaka Police Hosp, Emergency & Crit Care Med Ctr, Osaka, Japan; [Tasaki, Osamu; Hirao, Tomohito] Nagasaki Univ, Grad Sch Biomed Sci, Dept Emergency Med, Unit Clin Med, 1-7-1 Sakamoto, Nagasaki 852 8501, Japan; [Mohri, Tomoyoshi] Hyogo Prefectural Nishinomiya Hosp, Emergency & Crit Care Ctr, Nishinomiya, Hyogo, Japan; [Yoshiya, Kazuhisa; Shiozaki, Tadahiko; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Osaka, Japan; [Hayakawa, Koichi; Nakamori, Yasushi; Kuwagata, Yasuyuki] Kansai Med Univ, Hirakata Hosp, Dept Emergency & Crit Care Med, Osaka, Japan; [Fujimi, Satoshi] Osaka Gen Med Ctr, Dept Emergency & Crit Care, Osaka, Japan		Tasaki, O (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Emergency Med, Unit Clin Med, 1-7-1 Sakamoto, Nagasaki 852 8501, Japan.	tasaki-o@nagasaki-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160	The General Insurance Association of Japan; Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24390401]	O SAMU TASAKI RECEIVED a grant from The General Insurance Association of Japan; Tadahiko Shiozaki received a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24390401).	*AM COLL SURG COMM, 1999, ADV TRAUM LIF SUPP P; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1975, LANCET, V1, P480; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f	11	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JAN	2014	1	1					31	36		10.1002/ams2.5			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3Y4Z	WOS:000218702400006	29930819	Bronze, Green Published			2022-02-06	
J	Kennedy, MRT; Krause, MO; O'Brien, KH				Kennedy, Mary R. T.; Krause, Miriam O.; O'Brien, Katy H.			Psychometric properties of the college survey for students with brain injury: Individuals with and without traumatic brain injury	BRAIN INJURY			English	Article						Academics; cognition; college; post-secondary	MENTAL-HEALTH; COPING STYLE; IMPAIRMENT; FREQUENCY; QUALITY; FATIGUE; ANXIETY; RETURN; TBI	Purpose: The psychometric properties of the college challenges sub-set from The College Survey for Students with Brain Injury (CSS-BI) were investigated with adults with and without traumatic brain injury (TBI). Methods: Adults with and without TBI completed the CSS-BI. A sub-set of participants with TBI were interviewed, intentional and convergent validity were investigated, and the internal structure of the college challenges was analysed with exploratory factor analysis/principle component analysis. Results: Respondents with TBI understood the items describing college challenges with evidence of intentional validity. More individuals with TBI than controls endorsed eight of the 13 college challenges. Those who reported more health issues endorsed more college challenges, demonstrating preliminary convergent validity. Cronbach's alphas of 40.85 demonstrated acceptable internal reliability. Factor analysis revealed a four-factor model for those with TBI: studying and learning (Factor 1), time management and organization (Factor 2), social (Factor 3) and nervousness/anxiety (Factor 4). This model explained 72% and 69% of the variance for those with and without TBI, respectively. Conclusion: The college challenges sub-set from the CSS-BI identifies challenges that individuals with TBI face when going to college. Some challenges were related to two factors in the model, demonstrating the inter-connections of these experiences.	[Kennedy, Mary R. T.; Krause, Miriam O.; O'Brien, Katy H.] Univ Minnesota, Minneapolis, MN USA; [Kennedy, Mary R. T.] Chapman Univ, Orange, CA 92866 USA		Kennedy, MRT (corresponding author), Chapman Univ, One Univ Dr, Orange, CA 92866 USA.	markenne@chapman.edu	Krause, Miriam/AAD-1197-2022	Krause, Miriam/0000-0002-6798-3991			Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Harris JR, 1997, J HEAD TRAUMA REHAB, V12, P67, DOI 10.1097/00001199-199704000-00007; Haycock LA, 1998, J COUNS DEV, V76, P317, DOI 10.1002/j.1556-6676.1998.tb02548.x; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Kennedy M. R. T., 2009, COLL SURVEY STUDENTS; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kennedy MR, 2012, PERSPECTIVES NEUROPH, V22, P143, DOI DOI 10.1044/NNSLD22.4.143; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lombardi A, 2011, J STUD AFF RES PRACT, V48, P107, DOI 10.2202/1949-6605.6214; Malec J., 2005, MAYO PORTLAND ADAPTA; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Pintrich P., 1991, MANUAL USE MOTIVATED; Roth RM, 2005, BRIEF A BEHAV RATING; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Taylor DJ, 2013, BEHAV THER, V44, P339, DOI 10.1016/j.beth.2012.12.001; TINSLEY HEA, 1987, J COUNS PSYCHOL, V34, P414, DOI 10.1037/0022-0167.34.4.414; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014	35	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1748	1757		10.3109/02699052.2014.955883			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600015	25265382				2022-02-06	
J	Kim, D; Kobayashi, L; Chang, D; Fortlage, D; Coimbra, R				Kim, Dennis; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul			Development of a preliminary risk index to identify trauma patients at risk for an unplanned intubation	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	PROMMTT Symposium held at the 71st Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 12-15, 2012	HI	Amer Assoc Surg Trauma		Unplanned intubation; risk index; outcomes	POSTOPERATIVE RESPIRATORY-FAILURE; RIB FRACTURES; PREDICTORS; VENTILATION; VALIDATION; MORTALITY; OUTCOMES; SURGERY	BACKGROUND: The development of respiratory failure requiring an emergent unplanned intubation (UI) is a potentially preventable complication associated with increased morbidity and mortality. The objective of this study was to develop a clinical risk index for UI based on readily available clinical data to assist in the identification of trauma patients at risk for this complication. We also sought to determine the impact of UI on patient outcomes. METHODS: This is a 3-year retrospective analysis of our Level 1 trauma center registry to identify all patients requiring a UI. Patients who required a UI were compared with patients who were never intubated. An additive risk index consisting of 10 clinical variables was created using the final significant variables from a stepwise logistic regression model. The sensitivity and specificity of every possible index score were calculated and added together to calculate the "gain in certainty" values. RESULTS: During the 3-year period, 7,552 patients were admitted, of whom 967 (12.8%) required intubation. Of these, 55 (5.7%) underwent a UI. The final risk index consisted of 10 variables as follows: age 55 years to 64 years, age 65 years or older, male sex, Glasgow Coma Scale (GCS) score of 9 to 13, seizures, chronic obstructive pulmonary disease, traumatic brain injury, four or more rib fractures, spine fractures, and long-bone fractures. Gain in certainty was maximized at an index score of 4, with the highest combined sensitivity and specificity of 86.0% and 74.9%, respectively. The probability of UI increased from 0.9% at a score of 1 to 2.9% at 4 and 43% at 9. UI was associated with increased overall complications, length of stay, and mortality (p < 0.001). CONCLUSION: UI is a potentially preventable adverse event associated with poor outcomes. Identification of patients at risk for this complication may be possible through the development of an additive risk index. Prospective validation of the risk index is potentially warranted. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Kim, Dennis; Kobayashi, Leslie; Chang, David; Fortlage, Dale; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA USA		Coimbra, R (corresponding author), 200 W Arbor Dr,8896 San Diego, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			American College of Surgeons, 2012, NAT SURG QUAL IMPR P; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Bulger EM, 2004, SURGERY, V136, P426, DOI 10.1016/j.surg.2004.05.019; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; CONNELL FA, 1985, AM J EPIDEMIOL, V121, P744; Durga P, 2010, ANESTH ANALG, V110, P134, DOI 10.1213/ANE.0b013e3181c293a9; Gupta H, 2011, CHEST, V140, P1207, DOI 10.1378/chest.11-0466; Hernandez G, 2010, CHEST, V137, P74, DOI 10.1378/chest.09-1114; Holcomb JB, 2003, J AM COLL SURGEONS, V196, P549, DOI 10.1016/S1072-7515(02)01894-X; Johnson RG, 2007, J AM COLL SURGEONS, V204, P1188, DOI 10.1016/j.jamcollsurg.2007.02.070; Mangram AJ, 2012, J TRAUMA ACUTE CARE, V72, P119, DOI 10.1097/TA.0b013e318241f0ba; Miraflor E, 2011, J SURG RES, V170, P286, DOI 10.1016/j.jss.2011.03.044; Nafiu OO, 2011, EUR J ANAESTH, V28, P220, DOI 10.1097/EJA.0b013e328342659c; Pressley CM, 2012, AM J SURG, V204, P910, DOI 10.1016/j.amjsurg.2012.05.015; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; Snyder CW, 2009, AM SURGEON, V75, P834; Truitt MS, 2012, AM J SURG, V204, P913	18	4	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2014	76	1					167	171		10.1097/TA.0b013e3182a92596			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	AH8JN	WOS:000336384200031	24368373				2022-02-06	
J	Laalo, JP; Kurki, TJ; Tenovuo, OS				Laalo, Jussi P.; Kurki, Timo J.; Tenovuo, Olli S.			Interpretation of magnetic resonance imaging in the chronic phase of traumatic brain injury: What is missed in the original reports?	BRAIN INJURY			English	Article						Diagnostic accuracy; head trauma; MRI	DIFFUSE AXONAL INJURY; ABNORMALITIES; MODERATE; MICROBLEEDS; CONTUSIONS; ATROPHY; MRI; CT	Primary objective: To find eventual differences in detecting the late stage TBI findings in MRI between two neuroradiologists and to compare the results with the original reports. Methods and procedure: Two neuroradiologists with different levels of experience (R1 and R2) reviewed 89 cranial 1.5 T MRI examinations of patients with clinically evident TBI. They recorded the nature, location and side of the finding and stated their view of traumatic axonal injury (TAI). The original reports were reviewed accordingly. Main outcomes and results: TAI was reported as being evident or possible in 51 patients with TBI. However, only 30 (76%) of these concerned the same patients. R1 reported more contusion findings, but both found the same number of spot-like haemorrhages. The most striking difference was in the reporting of localized atrophy. R1 reported atrophy in 51/178 (29%) frontal lobes, whereas R2 in 14/178 (8%). Many of the findings were missed in the original reports. Conclusions: The interpretation of TBI findings in late stage MRI yields significant variability between neuroradiologists. This may endanger diagnostics and lead to false treatment decisions and medico-legal problems. Standardized quantitative imaging analysis programs and advances in MRI technology should be utilized to improve radiological TBI diagnosis.	[Laalo, Jussi P.] Suomen Terveystalo Med Imaging, FI-20100 Turku, Finland; [Laalo, Jussi P.; Tenovuo, Olli S.] Univ Turku, Fac Med, Turku, Finland; [Kurki, Timo J.] Suomen Terveystalo, Pulssi Med Imaging Ctr, Turku, Finland; [Tenovuo, Olli S.] Turku Univ, Cent Hosp, Dept Neurol, Turku, Finland		Laalo, JP (corresponding author), Suomen Terveystalo Med Imaging, Aninkaistenkatu 13, FI-20100 Turku, Finland.	jlaalo@utu.fi		Kurki, Timo/0000-0001-5532-3534			Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; FAZEKAS F, 1989, EUR NEUROL, V29, P164, DOI 10.1159/000116401; Filippi CG, 2008, RADIOLOGY, V249, P972, DOI 10.1148/radiol.2493071543; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	27	4	4	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					66	70		10.3109/02699052.2013.857791			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700008	24328801				2022-02-06	
J	Li, YH; Hou, XL; Qi, Q; Wang, L; Luo, L; Yang, SQ; Zhang, YM; Miao, ZH; Zhang, YL; Wang, F; Wang, HY; Huang, WD; Wang, ZH; Shen, Y; Wang, Y				Li, Yunhong; Hou, Xiaolin; Qi, Qi; Wang, Le; Luo, Lan; Yang, Shaoqi; Zhang, Yumei; Miao, Zhenhua; Zhang, Yanli; Wang, Fei; Wang, Hongyan; Huang, Weidong; Wang, Zhenhai; Shen, Ying; Wang, Yin			Scavenging of blood glutamate for enhancing brain-to-blood glutamate efflux	MOLECULAR MEDICINE REPORTS			English	Article						blood-brain-barrier; glutamate scavenging; pyruvate; oxaloacetate; lipoamide	ALPHA-LIPOIC-ACID; PYRUVATE; PROTECTION; ISCHEMIA; NEURONS; SUPPLEMENTATION; NEUROTOXICITY; APOPTOSIS; PREVENTS; LACTATE	The presence of excess glutamate in the brain interstitial fluid characterizes several acute pathological conditions of the brain, including traumatic brain injury and stroke. It has been demonstrated that it is possible to eliminate excess glutamate in the brain by decreasing blood glutamate levels and, accordingly, accelerating the brain-to-blood glutamate efflux. It is feasible to accomplish this process by activating blood resident enzymes in the presence of the respective glutamate cosubstrates. In the present study, several glutamate cosubstrates and cofactors were studied in an attempt to identify the optimal conditions to reduce blood glutamate levels. The administration of a mixture of 1 mM pyruvate and oxaloacetate (Pyr/Oxa) for 1 h decreased blood glutamate levels by 50%. The addition of lipoamide to this mixture resulted in a further reduction in blood glutamate levels of >80%. In addition, in vivo experiments showed that lipoamide together with Pyr/Oxa is able to decrease blood glutamate levels to a greater extent than Pyr/Oxa alone, and accordingly, this enhances the glutamate efflux from the brain to the blood. These results may outline a novel neuroprotective strategy with increased effectiveness for the removal of excess brain glutamate in various neurodegenerative conditions.	[Li, Yunhong; Qi, Qi; Zhang, Yumei; Miao, Zhenhua; Zhang, Yanli; Wang, Fei; Wang, Hongyan; Huang, Weidong; Wang, Yin] Ningxia Med Univ, Dept Neurobiol, Basic Med Coll, Ctr Sci Technol,Key Lab Cranial Cerebral Dis, Ningxia 750004, Peoples R China; [Hou, Xiaolin; Wang, Le; Yang, Shaoqi; Wang, Zhenhai] Ningxia Med Univ, Gen Hosp, Ningxia 750004, Peoples R China; [Luo, Lan] Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming 650500, Yunnan, Peoples R China; [Shen, Ying] Zhejiang Univ, Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol, Minist Hlth,Sch Med,Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China		Wang, Y (corresponding author), Ningxia Med Univ, Dept Neurobiol, Basic Med Coll, 1160 Shengli St, Ningxia 750004, Peoples R China.	yin-wang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31060140, 81060034, 81060126, 81060112, 31260243]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education MinistryScientific Research Foundation for the Returned Overseas Chinese Scholars; Program for New Century Excellent Talents in University (NCET), State Education MinistryProgram for New Century Excellent Talents in University (NCET)	This study was supported by the National Natural Science Foundation of China (grant nos. 31060140, 81060034, 81060126, 81060112 and 31260243). The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and the Program for New Century Excellent Talents in University (NCET), State Education Ministry for Dr Yin Wang	Basuroy S, 2013, AM J PHYSIOL-CELL PH, V304, pC1105, DOI 10.1152/ajpcell.00023.2013; BERKSON BM, 1979, NEW ENGL J MED, V300, P371; Berkson BM, 1980, AMANITA TOXINS POISO, P203; Connell BJ, 2011, BRAIN RES, V1375, P128, DOI 10.1016/j.brainres.2010.12.045; Cremer DR, 2006, REGUL TOXICOL PHARM, V46, P193, DOI 10.1016/j.yrtph.2006.06.003; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Emmez H, 2010, ACTA NEUROCHIR, V152, P1591, DOI 10.1007/s00701-010-0703-9; Freitas RM, 2009, NEUROSCI LETT, V455, P140, DOI 10.1016/j.neulet.2009.03.065; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hosoya K, 1999, J NEUROCHEM, V73, P1206, DOI 10.1046/j.1471-4159.1999.0731206.x; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; Jia ZQ, 2009, MOL CELL BIOCHEM, V323, P131, DOI 10.1007/s11010-008-9971-6; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kim DC, 2013, GUT LIVER, V7, P221, DOI 10.5009/gnl.2013.7.2.221; Lee JY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0002.2001; Mainini G, 2012, CLIN EXP OBSTET GYN, V39, P489; MATSUMOTO K, 1994, NEUROL RES, V16, P460; Maus M, 1999, EUR J NEUROSCI, V11, P3215, DOI 10.1046/j.1460-9568.1999.00745.x; Mongan PD, 1999, AM J PHYSIOL-HEART C, V277, pH2253, DOI 10.1152/ajpheart.1999.277.6.H2253; REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93; Ruiz F, 1998, NEUROREPORT, V9, P1277; Suchy J, 2009, NUTR RES, V29, P70, DOI 10.1016/j.nutres.2008.11.004; Wang Y, 2004, NEUROCHEM RES, V29, P755, DOI 10.1023/B:NERE.0000018847.98742.60; Zhang L, 2001, NEUROSCI LETT, V312, P125, DOI 10.1016/S0304-3940(01)02205-4; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x	26	4	5	3	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2014	9	1					305	310		10.3892/mmr.2013.1793			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AA0KJ	WOS:000330783700048	24220720	Bronze			2022-02-06	
J	Negro-Demontel, ML; Saccardo, P; Giacomini, C; Yanez-Munoz, RJ; Ferrer-Miralles, N; Vazquez, E; Villaverde, A; Peluffo, H				Negro-Demontel, Maria Luciana; Saccardo, Paolo; Giacomini, Cecilia; Yanez-Munoz, Rafael Joaquin; Ferrer-Miralles, Neus; Vazquez, Esther; Villaverde, Antonio; Peluffo, Hugo			Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							PARKINSONS-DISEASE; ARTIFICIAL VIRUSES; NERVOUS-SYSTEM; NUCLEIC-ACIDS; DELIVERY; OVEREXPRESSION; NEURONS; CELLS; NEUROPROTECTION; EXPRESSION	Traumatic brain injury (TBI) remains as one of the leading causes of mortality and morbidity worldwide and there are no effective treatments currently available. Gene therapy applications have emerged as important alternatives for the treatment of diverse nervous system injuries. New strategies are evolving with the notion that each particular pathological condition may require a specific vector. Moreover, the lack of detailed comparative studies between different vectors under similar conditions hampers the selection of an ideal vector for a given pathological condition. The potential use of lentiviral vectors versus several modular protein-based nanovectors was compared using a controlled cortical impact model of TBI under the same gene therapy conditions. We show that variables such as protein/DNA ratio, incubation volume, and presence of serum or chloroquine in the transfection medium impact on both nanovector formation and transfection efficiency in vitro. While lentiviral vectors showed GFP protein 1 day after TBI and increased expression at 14 days, nanovectors showed stable and lower GFP transgene expression from 1 to 14 days. No toxicity after TBI by any of the vectors was observed as determined by resulting levels of IL-1 beta or using neurological sticky tape test. In fact, both vector types induced functional improvement per se.	[Negro-Demontel, Maria Luciana; Peluffo, Hugo] Inst Pasteur Montevideo, Neuroinflammat & Gene Therapy Lab, Montevideo, Uruguay; [Negro-Demontel, Maria Luciana; Peluffo, Hugo] UDELAR, Fac Med, Dept Histol & Embriol, Montevideo, Uruguay; [Saccardo, Paolo; Ferrer-Miralles, Neus; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Barcelona, Spain; [Saccardo, Paolo; Ferrer-Miralles, Neus; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Dept Genet & Microbiol, Barcelona, Spain; [Saccardo, Paolo; Ferrer-Miralles, Neus; Vazquez, Esther; Villaverde, Antonio] CIBER BBN, Barcelona, Spain; [Giacomini, Cecilia] UDELAR, Fac Quim, Dept Biociencias, Catedra Bioquim, Montevideo, Uruguay; [Yanez-Munoz, Rafael Joaquin] Royal Holloway Univ London, Egham, Surrey, England		Peluffo, H (corresponding author), Inst Pasteur Montevideo, Neuroinflammat & Gene Therapy Lab, Montevideo, Uruguay.		Villaverde, Antonio/N-3986-2018; Ferrer-Miralles, Neus/G-7934-2016; Saccardo, Paolo/C-2503-2017	Villaverde, Antonio/0000-0002-2615-4521; Ferrer-Miralles, Neus/0000-0003-2981-3913; Saccardo, Paolo/0000-0002-3092-1404; Yanez-Munoz, Rafael J/0000-0001-7113-1938; Vazquez, Esther/0000-0003-1052-0424; Peluffo, Hugo/0000-0001-6111-8668	Fundacio Marato TV3, Catalunya, Spain [110533]; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Uruguay; Agencia Nacional de Investigacion e Innovacion (ANII), Uruguay; PEDECIBA, Uruguay; FOCEM (MERCOSUR Structural Convergence Fund) [COF 03/1111]; Genoma Espana (Project GENAME); Ministerio de Ciencia e Innovacion (MICINN)Spanish Government [ACI2009-0919]; Agencia de Gestio d'Ajuts Universitaris i de RecercaAgencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR) [2009SGR-108]; Centro de Investigacion Biomedica en Red (CIBER) de Bioingenieria, Biomateriales y Nanomedicina; ICREA ACADEMIA awardICREA	We thank Fundacio Marato TV3 (110533), Catalunya, Spain, Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Uruguay, Agencia Nacional de Investigacion e Innovacion (ANII), Uruguay, PEDECIBA, Uruguay, FOCEM (MERCOSUR Structural Convergence Fund), COF 03/1111 (to H.P. and M.L.N.), and Genoma Espana (Project GENAME, to R.J.Y.-M.) for financial support. We thank Pau Gonzalez for critical comments on this manuscript, Agustin Correa, Gonzalo Obal and Sabina Victoria for technical assistance, and Paul Gill for English language editing service. A.V. received support from from Ministerio de Ciencia e Innovacion (MICINN) (ACI2009-0919), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009SGR-108), and Centro de Investigacion Biomedica en Red (CIBER) de Bioingenieria, Biomateriales y Nanomedicina, with assistance from the European Regional Development Fund. A. V. has been distinguished with an ICREA ACADEMIA award.	Aris A, 2000, BIOCHEM BIOPH RES CO, V278, P455, DOI 10.1006/bbrc.2000.3824; Aris A, 2000, BIOTECHNOL BIOENG, V68, P689, DOI 10.1002/(SICI)1097-0290(20000620)68:6<689::AID-BIT13>3.0.CO;2-A; Aris A, 2004, TRENDS BIOTECHNOL, V22, P371, DOI 10.1016/j.tibtech.2004.05.004; Aris A, 2003, BIOCHEM BIOPH RES CO, V304, P625, DOI 10.1016/S0006-291X(03)00644-2; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Debinski W, 2009, EXPERT REV NEUROTHER, V9, P1519, DOI [10.1586/ern.09.99, 10.1586/ERN.09.99]; DeGeorge ML, 2011, BRAIN RES, V1403, P45, DOI 10.1016/j.brainres.2011.05.058; Delepine P, 2002, GENE THER, V9, P736, DOI 10.1038/sj.gt.3301742; DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116; Domingo-Espin J, 2012, NANOMED-NANOTECHNOL, V8, P1263, DOI 10.1016/j.nano.2012.06.005; Domingo-Espin J, 2011, NANOMEDICINE-UK, V6, P1047, DOI [10.2217/NNM.11.28, 10.2217/nnm.11.28]; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Ferrer-Miralles N, 2008, TRENDS BIOTECHNOL, V26, P267, DOI 10.1016/j.tibtech.2008.02.003; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Gonzalez P, 2012, J NEUROSCI RES, V90, P143, DOI 10.1002/jnr.22741; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Hermens WTJMC, 1997, HUM GENE THER, V8, P1049, DOI 10.1089/hum.1997.8.9-1049; Hermens WTJMC, 1997, J NEUROSCI METH, V71, P85, DOI 10.1016/S0165-0270(96)00129-X; Hwang BY, 2013, GENE THER, V20, P807, DOI 10.1038/gt.2013.1; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kenny GD, 2013, BIOMATERIALS, V34, P9190, DOI 10.1016/j.biomaterials.2013.07.081; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Lu B, 2009, MOL BIOSYST, V5, P629, DOI 10.1039/b822505b; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peluffo H, 2013, GENE THER, V20, P645, DOI 10.1038/gt.2012.78; Peluffo H, 2003, HUM GENE THER, V14, P1215, DOI 10.1089/104303403767740759; Peluffo H, 2007, ANN NEUROL, V62, P251, DOI 10.1002/ana.21170; Peluffo H, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-35; Peluffo H, 2011, NON-VIRAL GENE THERAPY, P597; Peluffo H, 2013, NEUROL RES, V35, P308, DOI 10.1179/1743132812Y.0000000139; Peluffo H, 2012, BRAIN PATHOL, V22, P318, DOI 10.1111/j.1750-3639.2011.00537.x; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Skinner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074925; Stoessl AJ, 2014, LANCET, V383, P1107, DOI 10.1016/S0140-6736(13)62108-X; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506; Vazquez E, 2010, BIOMATERIALS, V31, P9333, DOI 10.1016/j.biomaterials.2010.08.065; Vazquez E, 2010, NANOMEDICINE-UK, V5, P259, DOI 10.2217/NNM.09.98; Xavier J, 2009, J CONTROL RELEASE, V133, P154, DOI 10.1016/j.jconrel.2008.09.090; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251	54	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2329-0501		MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.		2014	1								14047	10.1038/mtm.2014.47			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	V46YD	WOS:000209918600059	26015985	Green Published, gold			2022-02-06	
J	Rogers, TJ; Smith, BM; Weaver, FM; Ganesh, S; Saban, KL; Stroupe, KT; Martinez, RN; Evans, CT; Pape, TLB				Rogers, Thea J.; Smith, Bridget M.; Weaver, Frances M.; Ganesh, Shanti; Saban, Karen L.; Stroupe, Kevin T.; Martinez, Rachael N.; Evans, Charlesnika T.; Pape, Theresa L. -B.			Healthcare utilization following mild traumatic brain injury in female veterans	BRAIN INJURY			English	Article						Administrative data; healthcare utilization; traumatic brain injury; women veterans	GENDER-DIFFERENCES; SEX-DIFFERENCES; COSTS; SYMPTOMS; MODERATE; DIAGNOSES; SEVERITY	Background: Mild traumatic brain injury (TBI) is a significant problem for Veterans. Gender differences in mild TBI outcomes such as return-to-work, resolution of symptoms and mental health diagnoses have been reported. The purpose of the study is to characterize gender differences in VA healthcare utilization in the year following mild TBI diagnosis. Methods: This was a retrospective database study of 12 144 Veterans diagnosed with mild TBI in fiscal year 2008 and their healthcare utilization in the following year. Results: The mean age was 43.6 +/- 17 and the majority were men (94.1%). Overall, women had more outpatient utilization than men with mild TBI (mean: 48 vs. 37 visits; p <= 0.001). Adjusted analyses indicated that women had a rate of outpatient utilization 25% higher than men (IRR=1.25, 95% CI=1.17-1.33). It was found that 13.6% of the difference in outpatient utilization by gender could be explained by other factors such as race, age, marital status, geographic location and illness burden. Conclusion: Male Veterans had less outpatient utilization than females in the year following mild TBI diagnosis. Gender and other factors only accounted for a small portion of the differences observed; therefore, gender only partially accounts for differences in healthcare utilization following mild TBI.	[Rogers, Thea J.; Smith, Bridget M.; Weaver, Frances M.; Ganesh, Shanti; Saban, Karen L.; Stroupe, Kevin T.; Martinez, Rachael N.; Evans, Charlesnika T.; Pape, Theresa L. -B.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Ctr Management Complex Chron Care, Hines, IL USA; [Rogers, Thea J.; Smith, Bridget M.; Weaver, Frances M.] Edward Hines Jr VA Hosp, Spinal Cord Injury Qual Enhancement Res Initiat S, Hines, IL USA; [Smith, Bridget M.; Weaver, Frances M.; Stroupe, Kevin T.] Loyola Univ Chicago, Stritch Sch Med, Program Hlth Serv Res, Maywood, IL USA; [Saban, Karen L.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Maywood, IL USA; [Evans, Charlesnika T.] Northwestern Univ, Inst Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa L. -B.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Hines, IL USA; [Pape, Theresa L. -B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Rogers, TJ (corresponding author), 5000 S 5th Ave 151H, Hines, IL USA.	thea.rogers@va.gov	Weaver, Frances/S-1540-2019; Saban, Karen/H-4837-2011	Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR 07-188-3]	The authors report no conflicts of interest. This study was supported by the Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service as grant IIR 07-188-3. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bhattacharjee S, 2012, DRUG AGING, V29, P971, DOI 10.1007/s40266-012-0032-1; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Clark DE, 2009, ICDPIC STATA MODULE; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fairlie R.W., 2005, J ECON SOC MEAS, V30, P305, DOI [10.3233/JEM-2005-0259, DOI 10.3233/JEM-2005-0259]; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frayne SM, 2010, SOURCEBOOK WOMEN VET, V1; Frayne SM, 2008, MED CARE, V46, P549, DOI 10.1097/MLR.0b013e3181608115; Frayne SM, 2007, J WOMENS HEALTH, V16, P1188, DOI 10.1089/jwh.2006.0205; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Center for Veterans Analysis and Statistics, 2013, TRENDS UT VET BEN; National Center for Veterans Analysis and Statistics, 2011, AM WOM VET MIL SERV; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pfizer US Pharmaceuticals, 2003, PFIZ FACTS UT VET AF; RAND Corporation Center for Military Health Policy Research, 2008, RB9336CCF RAND CORP; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Steiner CA, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.120292, 10.5888/pcd10.120292e]; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas AJ, 2006, AM J EPIDEMIOL, V164, P586, DOI 10.1093/aje/kwj234; VA Information Resource Center (VIREC) HSR&D, 2000, NAT PAT CAR DAT NPCD; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	42	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1406	1412		10.3109/02699052.2014.919537			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200007	24945602				2022-02-06	
J	Stewart, CL; Moscariello, MA; Hansen, KW; Moulton, SL				Stewart, Camille L.; Moscariello, Megan A.; Hansen, Kristine W.; Moulton, Steven L.			Infant car safety seats and risk of head injury	JOURNAL OF PEDIATRIC SURGERY			English	Article						Car safety sea; Traumatic brain injury; Infants; Motor vehicle crash	CHILD PASSENGER SAFETY; PATTERNS; CRASHES	Background/Purpose: We observed a high incidence of traumatic brain injuries (TBI) in properly restrained infants involved in higher speed motor vehicle crashes (MVCs). We hypothesized that car safety seats are inadequately protecting infants from TBI. Methods: We retrospectively queried scene crash data from our State Department of Transportation (20072011) and State Department of Public Health data (2000-2011) regarding infants who presented to a trauma center after MVC. Results: Department of Transportation data revealed 94% of infants in MVCs were properly restrained (782/833) with average speed of 44.6 miles/h when there was concern for injury. Department of Public Health data showed only 67/119 (56.3%) of infants who presented to a trauma center after MVC were properly restrained. Properly restrained infants were 12.7 times less likely to present to a trauma center after an MVC (OR = 12.7, CI 95% 5.6-28.8, p < 0.001). TBI was diagnosed in 73/119 (61.3%) infants; 42/73 (57.5%) properly restrained, and 31/73 (42.5%) improperly/unrestrained (p = 0.34). Average head abbreviated injury scale was similar for properly restrained (3.2 +/- 0.2) and improperly/unrestrained infants (3.5 +/- 0.2, p = 0.37). Conclusion: Car safety seats prevent injuries. However, TBI is similar among properly restrained and improperly/unrestrained infants involved in higher speed MVCs who present to a trauma center. (C) 2014 Elsevier Inc. All rights reserved.	[Stewart, Camille L.; Moscariello, Megan A.; Moulton, Steven L.] Univ Colorado, Denver, CO 80202 USA; [Stewart, Camille L.; Hansen, Kristine W.; Moulton, Steven L.] Childrens Hosp Colorado, Aurora, CO USA		Stewart, CL (corresponding author), Univ Colorado, Sch Med, Dept Surg, 12631 E 17th Ave,C302, Aurora, CO 80045 USA.	camille.stewart@ucdenver.edu					Abrogast KB, 2009, PEDIATRICS, V124, P1281; Abrogast KB, 2004, ACCIDENT ANAL PREV, V36, P585; Abrogast KB, 2010, J TRAUMA, V69, P913; [Anonymous], 2009, REAR FAC INF SEAT TE; Arbogast KB, 2012, TRAFFIC INJ PREV, V13, P172, DOI 10.1080/15389588.2011.642834; Brown JK, 2006, J PEDIATR SURG, V41, P362, DOI 10.1016/j.jpedsurg.2005.11.014; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; Gardner HG, 2011, PEDIATRICS, V127, P788, DOI 10.1542/peds.2011-0213; Ghati Yoganand, 2009, Ann Adv Automot Med, V53, P221; Hanna R, 2010, 811325 DOT HS US DOT; Henary B, 2007, INJURY PREV, V13, P398, DOI 10.1136/ip.2006.015115; JOHNSTON C, 1994, PEDIATRICS, V93, P960; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Manary Miriam A, 2006, Annu Proc Assoc Adv Automot Med, V50, P397; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; US Department of Transportation, 2005, NHTSA200418682 US DE; US Department of Transportation Federal Motor Carrier Safety Administration, 2013, 213 US DEP TRANSP FE; Valent F, 2002, J TRAUMA, V52, P745, DOI 10.1097/00005373-200204000-00023; Webber, 2000, UMTRI RES REV, V31, P1; Winston FK, 2004, ACCIDENT ANAL PREV, V36, P507, DOI 10.1016/S0001-4575(03)00056-3; Winston FK, 2008, ARCH PEDIAT ADOL MED, V162, P253, DOI 10.1001/archpediatrics.2007.52	22	4	4	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JAN	2014	49	1					193	197		10.1016/j.jpedsurg.2013.09.054			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	291SI	WOS:000329849200037	24439608				2022-02-06	
J	Teasdale, TW; Frosig, AJ; Engberg, AW				Teasdale, Thomas W.; Frosig, Anna J.; Engberg, Aase W.			Adult cognitive ability and educational level in relation to concussions in childhood and adolescence: A population study of young men	BRAIN INJURY			English	Article						Concussion; cognition; education	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; HISTORY; INTELLIGENCE; PERFORMANCE; DYSFUNCTION; SPORTS; RISK; COMA	Objective: To investigate the relationship of concussion(s) suffered through childhood and adolescence with completed level of school education and cognitive ability in young adulthood. Methods: Educational level and scores on a test of cognitive ability were obtained for a cohort of 130 298 young men processed by the Danish draft board. Of these, 6146 had, at some age from birth onwards, been briefly admitted to hospital with a main discharge diagnosis of concussion. A further 402 had two such concussions and 48 had three or more. Results: Educational level and cognitive ability test scores were negatively associated with the number of concussions and the age at concussion(s). Most markedly, compared to the 123 684 non-concussed men, those with two or more concussions had lower educational levels (OR = 0.48; 95% CI = 0.26-0.89), as also did those sustaining one concussion between the age of 13 up to the time of testing (OR = 0.47: 0.42-0.52). Conclusions: Since concussions do not generally have long-term effects, the results suggest that lower educational level is primarily a risk factor for sustaining a concussion at all ages, but in particular in adolescence more than in childhood and in the case of multiple concussions. It should, however, be recognized that, in some proportion of cases, the educational deficits have probably arisen as a consequence of the persistent symptoms of a lengthy post-concussional syndrome.	[Teasdale, Thomas W.; Frosig, Anna J.] Univ Copenhagen, Dept Psychol, DK-1353 Copenhagen K, Denmark; [Engberg, Aase W.] Univ Copenhagen, Ctr Rehabil Brain Injury, DK-1353 Copenhagen K, Denmark		Teasdale, TW (corresponding author), Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	tom.teasdale@psy.ku.dk	Meijer, Anna/K-5118-2016				American Academy of Neurology, 2013, NEUROLOGY, V48, P581; Andersen TF, 1999, DAN MED BULL, V46, P263; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silva SCFE, 2007, REV LAT-AM ENFERM, V15, P651, DOI 10.1590/S0104-11692007000400020; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2012, BRAIN IMPAIR, V13, P197, DOI 10.1017/BrImp.2012.17; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Teasdale TW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002321; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	30	4	4	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1721	1725		10.3109/02699052.2014.955880			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600011	25265191				2022-02-06	
J	Vaughan, CP; Johnson, TM; Goode, PS; Redden, DT; Burgio, KL; Markland, AD				Vaughan, Camille P.; Johnson, Theodore M., II; Goode, Patricia S.; Redden, David T.; Burgio, Kathryn L.; Markland, Alayne D.			Military Exposure and Urinary Incontinence among American Men	JOURNAL OF UROLOGY			English	Article						urinary bladder; veterans; urinary incontinence; male; public health	TRAUMATIC BRAIN-INJURY; WAR VETERANS; OLDER-ADULTS; UNITED-STATES; HEALTH; NOCTURIA; DISEASE; ASSOCIATION; DYSFUNCTION; VALIDITY	Purpose: We examined the association between military exposure and urinary incontinence in American men. Materials and Methods: Data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2008 were merged to include 5,297 men 20 years old or older. The question, "Did you ever serve in the Armed Forces of the United States?" (yes/no) was used to assess military exposure. Urinary incontinence was categorized as any or moderate/severe urinary incontinence vs none. Because the impact of military exposure varied by age, multivariate logistic regression models were used to estimate the OR and 95% CI stratified by 3 age groups, including 55 or less, 56 to 69 and 70 years or greater. Analysis was adjusted for race/ethnicity, education, body mass index, self-reported health status, number of chronic conditions, depression and prostate conditions, the latter in men 40 years old or older. Results: Overall 23% of male respondents reported military exposure. Men with military exposure were more likely to report any urinary incontinence (18.6% vs 10.4%) and moderate/severe urinary incontinence (9.0% vs 3.1%, each p <0.001) than men without military exposure. After multivariate adjustment in men 55 years old or younger those with military exposure had 3 times greater odds of urinary incontinence (OR 3.28, 95% CI 1.38-7.77). Military exposure did not increase the odds of urinary incontinence in men 56 to 69 years old (OR 0.97, 95% CI 0.44-2.18), or 70 years old or older (OR 0.91, 95% CI 0.55-1.50). Conclusions: Prior military exposure was associated with moderate/severe urinary incontinence in American men 55 years old or younger even after controlling for known risk factors. Case finding is warranted for urinary incontinence in younger men with a history of military service.	[Vaughan, Camille P.; Johnson, Theodore M., II; Goode, Patricia S.; Redden, David T.; Burgio, Kathryn L.; Markland, Alayne D.] Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Dept Vet Affairs Med Ctr, Birmingham, AL USA; [Vaughan, Camille P.; Johnson, Theodore M., II; Goode, Patricia S.; Redden, David T.; Burgio, Kathryn L.; Markland, Alayne D.] Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Dept Vet Affairs Med Ctr, Atlanta, GA USA; [Vaughan, Camille P.; Johnson, Theodore M., II] Emory Univ, Dept Med, Div Gen Med & Geriatr, Atlanta, GA 30322 USA; [Goode, Patricia S.; Burgio, Kathryn L.; Markland, Alayne D.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL USA; [Redden, David T.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Goode, Patricia S.; Redden, David T.; Burgio, Kathryn L.; Markland, Alayne D.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA		Vaughan, CP (corresponding author), Atlanta Vet Affairs Med Ctr, 1670 Clairmont Rd,Mailstop 11B, Decatur, GA 30033 USA.	camille.vaughan@emory.edu	Vaughan, Camille/I-3758-2014; , Theodore M. Johnson/A-6374-2014	, Theodore M. Johnson/0000-0001-8332-5369	Veterans Health Administration Rehabilitation Research and Development Career Development Awards [(CDA-2) B6126-W, 1 IK2 RX000747-01]	Supported by Veterans Health Administration Rehabilitation Research and Development Career Development Awards (CDA-2) B6126-W (ADM) and Vaughan 1 IK2 RX000747-01 (CPV).	Abrams P, 2009, J UROLOGY, V181, P1779, DOI 10.1016/j.juro.2008.11.127; Anger JT, 2008, UROLOGY, V72, P37, DOI 10.1016/j.urology.2007.11.163; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Burgio KL, 2010, J AM GERIATR SOC, V58, P861, DOI 10.1111/j.1532-5415.2010.02822.x; BURGIO KL, 1994, J AM GERIATR SOC, V42, P208, DOI 10.1111/j.1532-5415.1994.tb04954.x; Chamie K, 2008, CANCER-AM CANCER SOC, V113, P2464, DOI 10.1002/cncr.23695; DuBeau C, 2008, INT CONS INC PAR FRA; FitzGerald MP, 2007, J UROLOGY, V177, P1385, DOI 10.1016/j.juro.2006.11.057; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Haley RW, 2013, JAMA NEUROL, V70, P191, DOI 10.1001/jamaneurol.2013.596; Johnson TM, 1998, J AM GERIATR SOC, V46, P693, DOI 10.1111/j.1532-5415.1998.tb03802.x; Keller JJ, 2013, NEUROUROL URODYNAM, V32, P354, DOI 10.1002/nau.22309; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; Markland AD, 2010, J UROLOGY, V184, P1022, DOI 10.1016/j.juro.2010.05.025; Rogers William H, 2004, J Ambul Care Manage, V27, P249; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; Sohn Min-Woong, 2006, BMC Urol, V6, P30, DOI 10.1186/1471-2490-6-30; Tibbles C, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a; Toomey R, 2007, BRIT J PSYCHIAT, V190, P385, DOI 10.1192/bjp.bp.105.019539; Vaughan CP, 2009, BJU INT, V104, P69, DOI 10.1111/j.1464-410X.2009.08353.x	21	4	4	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JAN	2014	191	1					125	129		10.1016/j.juro.2013.07.016			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Urology & Nephrology	282RY	WOS:000329191700042	23871759				2022-02-06	
J	Wang, HC; Yang, TM; Lin, YJ; Chen, WF; Ho, JT; Lin, YT; Kwan, AL; Lu, CH				Wang, Hung-Chen; Yang, Tzu-Ming; Lin, Yu-Jun; Chen, Wu-Fu; Ho, Jih-Tsun; Lin, Yu-Tsai; Kwan, Aij-Lie; Lu, Cheng-Hsien			Serial Serum Leukocyte Apoptosis Levels as Predictors of Outcome in Acute Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							NEURONAL APOPTOSIS; DNA FRAGMENTATION; CELL-DEATH; TEMPORAL PROFILE; EXPRESSION; ISCHEMIA; BCL-2; PHOSPHATIDYLSERINE; DEGENERATION; LYMPHOCYTES	Background. Apoptosis associates with secondary brain injury after traumatic brain injury (TBI). This study posits that serum leukocyte apoptosis levels in acute TBI are predictive of outcome. Methods. Two hundred and twenty-nine blood samples from 88 patients after acute TBI were obtained on admission and on Days 4 and 7. Serial apoptosis levels of different leukocyte subsets were examined in 88 TBI patients and 27 control subjects. Results. The leukocyte apoptosis was significantly higher in TBI patients than in controls. Brief unconsciousness (P = 0.009), motor deficits (P <= 0.001), GCS (P <= 0.001), ISS (P = 0.001), WBC count (P = 0.015), late apoptosis in lymphocytes and monocytes on Day 1 (P = 0.004 and P = 0.022, resp.), subdural hemorrhage on initial brain CT (P = 0.002), neurosurgical intervention (P <= 0.001), and acute posttraumatic seizure (P = 0.046) were significant risk factors of outcome. Only motor deficits (P = 0.033) and late apoptosis in monocytes on Day 1 (P = 0.037) were independently associated with outcome. A cutoff value of 5.72% of late apoptosis in monocytes was associated with poor outcome in acute TBI patients. Conclusion. There are varying degrees of apoptosis in patients following TBI and in healthy individuals. Such differential expression suggests that apoptosis in different leukocyte subsets plays an important role in outcome following injury.	[Wang, Hung-Chen; Lin, Yu-Jun; Chen, Wu-Fu; Ho, Jih-Tsun] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wang, Hung-Chen; Lin, Yu-Jun; Chen, Wu-Fu; Ho, Jih-Tsun; Lin, Yu-Tsai; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung 80708, Taiwan; [Wang, Hung-Chen; Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 80708, Taiwan; [Yang, Tzu-Ming] Yuans Gen Hosp, Dept Surg, Div Neurosurg, Kaohsiung 80249, Taiwan; [Lin, Yu-Jun; Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Lin, Yu-Tsai] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung 83301, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 83301, Taiwan		Kwan, AL (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 80708, Taiwan.	a_lkwan@yahoo.com; chlu99@ms44.url.com.tw		WANG, HUNG-CHEN/0000-0003-3962-1958			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boersma HH, 2005, J NUCL MED, V46, P2035; Carthy CM, 1999, LAB INVEST, V79, P953; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; FADOK VA, 1992, J IMMUNOL, V148, P2207; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Johnston SC, 1998, NEUROLOGY, V51, P411, DOI 10.1212/WNL.51.2.411; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Niesen WD, 2004, STROKE, V35, P1873, DOI 10.1161/01.STR.0000132195.17366.2b; NITATORI T, 1995, J NEUROSCI, V15, P1001; Niu G, 2010, J NUCL MED, V51, P1659, DOI 10.2967/jnumed.110.078584; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; OYESIKU NM, 1993, NEUROSURGERY, V32, P518; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Potts Mathew B, 2006, NeuroRx, V3, P143; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Soares HD, 1995, J NEUROSCI, V15, P8223; Soruri A, 2002, IMMUNOLOGY, V105, P222, DOI 10.1046/j.0019-2805.2001.01355.x; Su YJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-261; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zimmermann M, 2011, METHODS MOL BIOL, V740, P57, DOI 10.1007/978-1-61779-108-6_8; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	37	4	5	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								720870	10.1155/2014/720870			11	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AF9RT	WOS:000335053000001	24864256	Green Published, Green Submitted, gold			2022-02-06	
J	Wheeler, L; Nickerson, S; Long, K; Silver, R				Wheeler, Lisa; Nickerson, Sherry; Long, Kayla; Silver, Rebecca			Expressive writing in people with traumatic brain injury and learning disability	NEUROREHABILITATION			English	Article						Writing disorder; expressive writing skill; TBI; cognition	DISABLED STUDENTS; LANGUAGE; CHILDREN; INSTRUCTION; ADOLESCENTS; READABILITY; STRATEGIES; ESSAYS; SKILLS	BACKGROUND: There is a dearth of systematic studies of expressive writing disorder (EWD) in persons with Traumatic Brain Injury (TBI). It is unclear if TBI survivors' written expression differs significantly from that experienced by persons with learning disabilities. It is also unclear which cognitive or neuropsychological variables predict problems with expressive writing (EW) or the EWD. OBJECTIVE: This study investigated the EW skill, and the EWD in adults with mild traumatic brain injuries (TBI) relative to those with learning disabilities (LD). It also determined which of several cognitive variables predicted EW and EWD. METHODS: Principle Component Analysis (PCA) of writing samples from 28 LD participants and 28 TBI survivors revealed four components of expressive writing skills: Reading Ease, Sentence Fluency, Grammar and Spelling, and Paragraph Fluency. RESULTS: There were no significant differences between the LD and TBI groups on any of the expressive writing components. Several neuropsychological variables predicted skills of written expression. The best predictors included measures of spatial perception, verbal IQ, working memory, and visual memory. CONCLUSIONS: TBI survivors and persons with LD do not differ markedly in terms of expressive writing skill. Measures of spatial perception, visual memory, verbal intelligence, and working memory predict writing skill in both groups. Several therapeutic interventions are suggested that are specifically designed to improve deficits in expressive writing skills in individuals with TBI and LD.	[Wheeler, Lisa; Nickerson, Sherry; Long, Kayla] Towson Univ, Towson, MD 21120 USA; [Silver, Rebecca] Syracuse Univ, Syracuse, NY USA		Nickerson, S (corresponding author), Towson Univ, 17905 Bunker Hill Rd, Towson, MD 21120 USA.	sherrydudley@verizon.net					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1991, GRAMM WIND 2 0; [Anonymous], 1990, RIGHTWRITER 4 0; Berninger VW, 1998, J EDUC PSYCHOL, V90, P587, DOI 10.1037/0022-0663.90.4.587; Borkowski J.G., 1994, SELF REGULATION LEAR, P45; Butler DL, 2000, LEARN DISABILITY Q, V23, P196, DOI 10.2307/1511164; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; CONNOR MJ, 1991, ED PSYCHOL PRACTICE, V7, P93; Dale E, 1948, EDUC RES BULL, V27, P11; De La Paz, 1997, J EDUC PSYCHOL, V89, P203; Docking KM, 2007, BRAIN LANG, V103, P236, DOI 10.1016/j.bandl.2007.07.021; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Ferreti R.P., 2000, J EDUC PSYCHOL, V92, P94; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Giordano G., 1984, TEACHING WRITING LEA; Goodglass H., 1983, ASSESSMENT APHASIA O; GRAHAM S, 1989, EXCEPT CHILDREN, V56, P201, DOI 10.1177/001440298905600305; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Hammell D.D., 1996, TEST WRITTEN LANGUAG; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; Kincaid J., 1975, 875 NAV AIR STAT MEM; LANE SE, 1994, J PSYCHOEDUC ASSESS, V12, P142, DOI 10.1177/073428299401200204; LEVANDER M, 1989, INTELLIGENCE, V13, P93, DOI 10.1016/0160-2896(89)90009-3; Lewis FM, 2011, DEV NEUROREHABIL, V14, P348, DOI 10.3109/17518423.2011.620576; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; MCLAUGHLIN H, 1969, J READING, V22, P639; MORAN MR, 1987, TOP LANG DISORD, V7, P42, DOI 10.1097/00011363-198709000-00006; NEWCOMER PL, 1991, J LEARN DISABIL, V24, P578, DOI 10.1177/002221949102401001; ODONNELL JP, 1990, J CLIN PSYCHOL, V46, P310, DOI 10.1002/1097-4679(199005)46:3<310::AID-JCLP2270460311>3.0.CO;2-G; Parente F., 2002, RETRAINING COGNITION; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROSENBLUTH GS, 1992, COMPUT HUM BEHAV, V8, P71, DOI 10.1016/0747-5632(92)90020-F; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Short E.J., 1992, J CLIN CHILD PSYCHOL, V21, P232; Thomas C.C., 1996, READ WRIT Q, V12, P59; THOMAS CC, 1987, REM SPEC EDUC, V8, P21, DOI 10.1177/074193258700800105; Troia G., 1999, EXCEPT CHILDREN, V65, P235; WHITEHURST GJ, 1988, DEV PSYCHOL, V24, P690, DOI 10.1037/0012-1649.24.5.690; Wong B. Y. L., 1991, LEARNING DISABILITIE, V6, P117; Wong BYL, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020040-00005	43	4	4	0	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					29	37		10.3233/NRE-131007			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000005	24284454				2022-02-06	
J	Zollman, FS; Starr, C; Kondiles, B; Cyborski, C; Larson, EB				Zollman, Felise S.; Starr, Christine; Kondiles, Bethany; Cyborski, Cherina; Larson, Eric B.			The Rehabilitation Institute of Chicago Military Traumatic Brain Injury Screening Instrument: Determination of Sensitivity, Specificity, and Predictive Value	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						military; screen; PTSD; brain injury; veterans; TBI; concussion; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; NEUROPSYCHOLOGICAL STATUS RBANS; SERIAL-ADDITION TASK; REPEATABLE BATTERY; TBI; PTSD; IDENTIFICATION; RELIABILITY; VETERANS; VALIDITY	Background: Traumatic brain injury (TBI) is referred to as the signature injury of the wars in Iraq and Afghanistan. Given the prevalence of TBI in military personnel, there is a need for validated instruments tailored to accurately screen for TBI in this population. Methods: Three hundred service members or veterans underwent a novel screen and a comprehensive diagnostic assessment to identify the occurrence of TBI and/or the presence of posttraumatic stress disorder. Negative predictive value, positive predictive value, sensitivity, and specificity were calculated. Results: This screening tool for TBI yielded sensitivity of 96%, specificity of 64%, negative predictive value of 95%, and positive predictive value of 69%. Conclusion: The Rehabilitation Institute of Chicago Military Traumatic Brain Injury Screening Instrument has a high negative predictive value and high sensitivity for TBI. This tool identifies individuals likely to have sustained a TBI. Moreover, it detects those who are likely not to have sustained such an injury and can be reassured in this regard. Because such distinction can be made with a high degree of accuracy in rapid and cost-effective fashion, it represents an important contribution to the armamentarium of TBI screening tools.	[Zollman, Felise S.] NorthShore Univ Hlth Syst, Dept Neurol, Memory & Cognit Disorders Program, Glenview, IL 60026 USA; [Starr, Christine; Kondiles, Bethany; Larson, Eric B.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Cyborski, Cherina] Natl Intrepid Ctr Excellence, Rehabil Serv, Bethesda, MD USA; [Larson, Eric B.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Zollman, FS (corresponding author), NorthShore Univ Hlth Syst, Dept Neurol, Memory & Cognit Disorders Program, 2180 Pfingston Rd, Glenview, IL 60026 USA.	fzollman@northshore.org	Larson, Eric/AAD-9567-2021	Starr, Christine/0000-0002-8662-0387	Robert M. McCormick Tribune Foundation; Julius N. Frankel Foundation; Joseph G. Nicholas Foundation; Barker Welfare Foundation	This study was funded by grants from the Robert M. McCormick Tribune Foundation, the Julius N. Frankel Foundation, the Joseph G. Nicholas Foundation, and the Barker Welfare Foundation.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Barzilai DA, 2005, J AM ACAD DERMATOL, V52, P559, DOI 10.1016/j.jaad.2004.09.019; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Davis TD, 2012, PSYCHOL TRAUMA-US, V4, P447, DOI 10.1037/a0025501; Department of Veterans Affairs, 2007, SCREEN EV POSS TRAUM; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Golden CJ, 1978, STROOP COLOR WORD TE; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martinez L, 2011, ABC NEWS; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; National Center for Veterans Analysis and Statistics, 2011, AM WOM VET MIL SERV; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; *RES TRAIN CTR COM, 1997, BRAIN INJ SCREEN QUE; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; *SPSS INC, 2008, SPSS STAT GRADPACK W; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; WechslerD, 2001, WECHSLER TEST ADULT	36	4	4	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					99	107		10.1097/HTR.0b013e318294dd37			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400015	23756432				2022-02-06	
J	Fecteau, S; Levasseur-Moreau, J; Garcia-Molina, A; Kumru, H; Vergara, RP; Bernabeu, M; Roig, T; Pascual-Leone, A; Tormos, JM				Fecteau, Shirley; Levasseur-Moreau, Jean; Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose			Risk Taking in Hospitalized Patients with Acute and Severe Traumatic Brain Injury	PLOS ONE			English	Article							DECISION-MAKING PROCESSES; COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; HEAD-INJURY; TASK BART; ATTENTION; DYSFUNCTION; PROPENSITY; MORTALITY; BEHAVIOR	Rehabilitation can improve cognitive deficits observed in patients with traumatic brain injury (TBI). However, despite rehabilitation, the ability of making a choice often remains impaired. Risk taking is a daily activity involving numerous cognitive processes subserved by a complex neural network. In this work we investigated risk taking using the Balloon Analogue Risk Task (BART) in patients with acute TBI and healthy controls. We hypothesized that individuals with TBI will take less risk at the BART as compared to healthy individuals. We also predicted that within the TBI group factors such as the number of days since the injury, severity of the injury, and sites of the lesion will play a role in risk taking as assessed with the BART. Main findings revealed that participants with TBI displayed abnormally cautious risk taking at the BART as compared to healthy subjects. Moreover, healthy individuals showed increased risk taking throughout the task which is in line with previous work. However, individuals with TBI did not show this increased risk taking during the task. We also investigated the influence of three patients' characteristics on their performance at the BART: Number of days post injury, Severity of the head injury, and Status of the frontal lobe. Results indicate that performance at the BART was influenced by the number of days post injury and the status of the frontal lobe, but not by the severity of the head injury. Reported findings are encouraging for risk taking seems to naturally improve with time postinjury. They support the need of conducting longitudinal prospective studies to ultimately identify impaired and intact cognitive skills that should be trained postinjury.	[Fecteau, Shirley; Levasseur-Moreau, Jean] Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada; [Fecteau, Shirley; Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Sch Med, Boston, MA 02215 USA; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Inst Univ Neurorehabil Adscrit UAB, Inst Guttmann, Barcelona, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain		Fecteau, S (corresponding author), Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada.	shirley.fecteau@fmed.ulaval.ca	Fecteau, Shirley/N-3017-2016; Kumru, Hatice/ABB-1109-2021; Pascual-Leone, Alvaro/AAC-5101-2019	Fecteau, Shirley/0000-0002-9781-4451; Pascual-Leone, Alvaro/0000-0001-8975-0382; Tormos Munoz, Jose Maria/0000-0002-8764-2289	Canada Research Chair in Cognitive Neuroplasticity; National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [NCRR MO1 RR01032]; Harvard Clinical and Translational Science Center [UL1 RR025758]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K24 RR018875]; Foundation La Marato TV3 [071931]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI082004]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR001032, K24RR018875, UL1RR025758] Funding Source: NIH RePORTER	This work was supported by grants from the Canada Research Chair in Cognitive Neuroplasticity to SF, from the National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC (NCRR MO1 RR01032) and Harvard Clinical and Translational Science Center (UL1 RR025758), NIH grant K24 RR018875 to APL, and by the Foundation La Marato TV3 (071931) and grant PI082004 from the Instituto de Salud Carlos III to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baguley I, 2000, BRAIN INJURY, V14, P505; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Boyle PA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-53; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chiu CYP, 2012, DEV NEUROPSYCHOL, V37, P176, DOI 10.1080/87565641.2011.632796; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Dams-O'Connor K, 2010, PSYCHIAT CLIN N AM, V33, P893, DOI 10.1016/j.psc.2010.08.002; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Drechsler R, 2008, J NEURAL TRANSM, V115, P201, DOI 10.1007/s00702-007-0814-5; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; Gentleman D, 2001, TRAUMA, V3, P193; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Krishnan M, 2012, CLIN NEUROPSYCHOL, V26, P951, DOI 10.1080/13854046.2012.708166; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lu J, 2005, ACT NEUR S, V95, P281; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; Nybo T, 1999, BRAIN INJURY, V13, P759; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P655; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83598	10.1371/journal.pone.0083598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	WOS:000329116700061	24386232	Green Published, gold, Green Submitted			2022-02-06	
J	Kelly, M; McDonald, S; Kellett, D				Kelly, Michelle; McDonald, Skye; Kellett, David			The psychological effects of ostracism following traumatic brain injury	BRAIN INJURY			English	Article						awareness; social reintegration; traumatic brain injury	SEVERE HEAD-INJURY; SOCIAL EXCLUSION; PSYCHIATRIC-DISORDERS; EMOTION PERCEPTION; CONSECUTIVE SERIES; NEED-THREAT; SELF-ESTEEM; REJECTION; BELONG; ADULTS	Primary objective: This study examines the psychological effects of ostracism. It was predicted that adults with brain injury would have an attenuated response to an acute experience of ostracism. Research design: A within-subject, fixed order design was used. The two conditions were ostracism and inclusion. Methods and procedures: A group of 20 adults with severe traumatic brain injury (TBI) were compared with a group of 19 matched control participants. Both groups participated in a pseudo online ball tossing game, Cyberball. On one occasion they were excluded from the game and on the following occasion they were included fairly. Following each game they completed a self-report questionnaire about their experience. Main outcomes and results: Persons with brain injury self-reported negative psychological effects of ostracism including a lower sense of belonging, self-esteem and meaningful existence, however, were affected to a lesser degree than control participants [F(1,37) = 5.39, p = 0.026]. Persons with brain injury also reported that their feelings were hurt to a lesser extent than did control participants, t(37) = 2.10, p = 0.04. Conclusions: These results are discussed in terms of the role of the negative experience of ostracism in motivating and guiding behaviour to re-establish group membership to prevent future social isolation.	[Kelly, Michelle; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Kellett, David] Hunter Brain Injury Serv, Newcastle, NSW, Australia		Kelly, M (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	michelle.kelly@hnehealth.nsw.gov.au	McDonald, Skye/G-4118-2014; Kelly, Michelle/J-9739-2019	McDonald, Skye/0000-0003-0723-6094; Kelly, Michelle/0000-0003-0375-816X	National Health and Medical Research Council AustraliaNational Health and Medical Research Council of Australia	The authors report no conflicts of interest. This research was supported by a grant awarded to the second author from the National Health and Medical Research Council Australia.	Annoni J M, 1992, Disabil Rehabil, V14, P23; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Buckley KE, 2004, J EXP SOC PSYCHOL, V40, P14, DOI 10.1016/S0022-1031(03)00064-7; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jamieson JP, 2010, PERS SOC PSYCHOL B, V36, P690, DOI 10.1177/0146167209358882; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kelly M, 2012, INT J PSYCHOPHYSIOL, V83, P309, DOI 10.1016/j.ijpsycho.2011.11.008; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lau G, 2009, EMOTION, V9, P430, DOI 10.1037/a0015350; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Nezlek JB, 1997, PERS SOC PSYCHOL B, V23, P1235, DOI 10.1177/01461672972312001; Nietlisbach G, 2009, PSYCHOL TRAUMA-US, V1, P323, DOI 10.1037/a0017832; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Ouwerkerk J. W., 2005, SOCIAL OUTCAST OSTRA, P321; Perry Y, 2011, BRIT J CLIN PSYCHOL, V50, P339, DOI 10.1348/014466510X523490; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Ruggieri S, 2013, SWISS J PSYCHOL, V72, P103, DOI 10.1024/1421-0185/a000103; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sethi N, 2013, GROUP DYN-THEOR RES, V17, P110, DOI 10.1037/a0032436; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; Waldrip AM, 2007, POWER OSTRACISM CAN; Warburton WA, 2006, J EXP SOC PSYCHOL, V42, P213, DOI 10.1016/j.jesp.2005.03.005; Watson RI, 1978, GREAT PSYCHOL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Williams K.D., 2005, SOCIAL OUTCAST OSTRA; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 1997, PERS SOC PSYCHOL B, V23, P693, DOI 10.1177/0146167297237003; WILLIAMS KD, 1997, PL S SOC CL, P133; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Williams KD, 2011, CURR DIR PSYCHOL SCI, V20, P71, DOI 10.1177/0963721411402480; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Williamson JG, 1996, NEUROPSYCHOLOGY CLIN; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zadro L, 2006, J EXP SOC PSYCHOL, V42, P692, DOI 10.1016/j.jesp.2005.10.007	62	4	4	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1676	1684		10.3109/02699052.2013.834381			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400025	24131358				2022-02-06	
J	Lai, XP; Yu, XJ; Qian, H; Wei, L; Lv, JY; Xu, XH				Lai, Xiao-ping; Yu, Xiao-jun; Qian, Hong; Wei, Lai; Lv, Jun-yao; Xu, Xiao-hu			Chronic Alcoholism-Mediated Impairment in the Medulla Oblongata: A Mechanism of Alcohol-Related Mortality in Traumatic Brain Injury?	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Traumatic brain injury; Synapse; Alcoholism; Synaptophysin; Postsynaptic density-95	SYNAPSE LOSS; ETHANOL; RATS; INTOXICATION; EXPOSURE; FAMILY; ABUSE	Alcohol-related traumatic brain injury (TBI) is a common condition in medical and forensic practice, and results in high prehospital mortality. We investigated the mechanism of chronic alcoholism-related mortality by examining the effects of alcohol on the synapses of the medulla oblongata in a rat model of TBI. Seventy adult male Sprague-Dawley rats were randomly assigned to either ethanol (EtOH) group, EtOH-TBI group, or control groups (water group, water-TBI group). To establish chronic alcoholism model, rats in the EtOH group were given EtOH twice daily (4 g/kg for 2 weeks and 6 g/kg for another 2 weeks). The rats also received a minor strike on the occipital tuberosity with an iron pendulum. Histopathologic and ultrastructure changes and the numerical density of the synapses in the medulla oblongata were examined. Expression of postsynaptic density-95 (PSD-95) in the medulla oblongata was measured by ELISA. Compared with rats in the control group, rats in the chronic alcoholism group showed: (1) minor axonal degeneration; (2) a significant decrease in the numerical density of synapses (p < 0.01); and (3) compensatory increase in PSD-95 expression (p < 0.01). Rats in the EtOH-TBI group showed: (1) high mortality (50 %, p < 0.01); (2) inhibited respiration before death; (3) severe axonal injury; and (4) decrease in PSD-95 expression (p < 0.05). Chronic alcoholism induces significant synapse loss and axonal impairment in the medulla oblongata and renders the brain more susceptible to TBI. The combined effects of chronic alcoholism and TBI induce significant synapse and axon impairment and result in high mortality.	[Lai, Xiao-ping; Yu, Xiao-jun; Qian, Hong; Wei, Lai; Lv, Jun-yao; Xu, Xiao-hu] Shantou Univ, Coll Med, Dept Forens Med, Shantou 515031, Guangdong, Peoples R China; [Lai, Xiao-ping] Guangdong Med Coll, Dept Forens Med, Dongguan 523808, Guangdong, Peoples R China		Yu, XJ (corresponding author), Shantou Univ, Coll Med, Dept Forens Med, Xinling Rd 22, Shantou 515031, Guangdong, Peoples R China.	cnxjyu@yahoo.com.cn; xhxu@stu.edu.cn			National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458, 81072508]	The authors are grateful to Dr. Chien Fu Lin for reviewing this article. This study was supported by the National Natural Science Foundation Council of China (Grant Nos. 30772458 and 81072508).	Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Brun A, 2001, DEMENT GERIATR COGN, V12, P289, DOI 10.1159/000051271; Carpenter-Hyland EP, 2006, EUR J NEUROSCI, V24, P3496, DOI 10.1111/j.1460-9568.2006.05247.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Dlugos CA, 1997, ALCOHOL ALCOHOLISM, V32, P161; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Guillery RW, 2000, TRENDS NEUROSCI, V23, P594, DOI 10.1016/S0166-2236(00)01635-0; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; KJELLSTROM C, 1993, ALCOHOL CLIN EXP RES, V17, P406, DOI 10.1111/j.1530-0277.1993.tb00784.x; Kranenburg M, 2004, FEBS LETT, V568, P15, DOI 10.1016/j.febslet.2004.04.090; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Liu Z. R., 1996, NEW ADV BIOMECHANICS, P188; [陆一 LU Yi], 2009, [毒理学杂志, Journal of Toxicology], V23, P96; LUNDQVIST C, 1994, ACTA NEUROPATHOL, V87, P242; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Morrow A L, 1994, Alcohol Alcohol Suppl, V2, P89; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Niethammer M, 1996, J NEUROSCI, V16, P2157; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Singh AK, 2007, ALCOHOL ALCOHOLISM, V42, P385, DOI 10.1093/alcalc/agl120; SOLONSKY AV, 1991, ZH NEVROPATOL PSIKH, V91, P91; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Tang Y, 2004, BRAIN RES, V1029, P162, DOI 10.1016/j.brainres.2004.09.035; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; Wang HP, 2011, J TRAUMA, V70, pE6, DOI 10.1097/TA.0b013e3181cda3b9; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; ZIMITAT C, 1990, ALCOHOL, V7, P493, DOI 10.1016/0741-8329(90)90038-E; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	41	4	5	1	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	DEC	2013	67	3					1049	1057		10.1007/s12013-013-9603-y			9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	258JL	WOS:000327455400031	23546937				2022-02-06	
J	War, FA; Rajeswaren, J				War, Firdous A.; Rajeswaren, Jamuna			Quality of life and perception of illness in patients with traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Quality of life; Illness perception; TBI		Objective: To examine QoL and perception of illness in adult patients with a mild to moderate traumatic brain injury (TBI). Methods and procedure: Thirty patients gave consent for participation in the study. Questionnaires included Rivermead Post Concussion Symptoms Questionnaire (RPQ), Depression Anxiety Stress Scales (DASS), WHO Quality of Life - BREF Version and Brief Illness Perception Questionnaire (IPQ). Results: Cognitive and emotional complaints were reported by most of the patients. Higher percentages of patients fall in the medium range on all the four domains QoL. However on social and physical domain of QoL, the percentage is to some extent higher on the low range. On IPQ higher percentages fall within low and medium range. However on the coherence and emotional subscales of the IPQ, a higher percentage of patients fall in the higher range. Physical, psychological, environmental domains of QoL were found significantly correlated with overall subscale of IPQ at 0.01 and 0.05 level of significance. And a significant difference was also noted between mild and moderate TBI on IPQ but not on QoL. Conclusions: The research findings highlight the need to emphasis not on physical but on psychosocial dimensions of individual as well, which may lead to better recovery and outcome. Copyright (C) 2013, Neurotrauma Society of India. All rights reserved.	[War, Firdous A.] Govt Med Coll & Hosp, Dept Psychiat, Chandigarh 160030, India; [Rajeswaren, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India		War, FA (corresponding author), Govt Med Coll & Hosp, Dept Psychiat, Chandigarh 160030, India.	mailfaw@gmail.com					Berzon RA, 1998, OX MED PUBL, P3; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Goodman H, 2013, INT J NURS STUD, V50, P945, DOI 10.1016/j.ijnurstu.2012.11.007; Gururaj G, 2005, NATL I MENTAL HLTH N, P61; Janssen V, 2012, INT J BEHAV MED; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Lazarus RS, 1988, COGNITION EMOTION, V2, P281, DOI [10.1080/02699938808412701, DOI 10.1080/02699938808412701]; Leventhal H, 1997, PERCEPTIONS HLTH ILL, P19; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Miller SM, 1996, PSYCHOL BULL, V119, P70, DOI 10.1037/0033-2909.119.1.70; Perry C.L., 1990, HLTH BEHAV HLTH ED T, P161; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; Rajkumari K, 2011, THESIS; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Sudarsanan S, 2006, MED J ARMED FORCES I, V62, P259; Suh E. M., 2008, SCI SUBJECTIVE WELL, P414; Upadhyay D., 2007, WORLD APPL SCI J, V2, P687	24	4	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2013	10	2					115	119		10.1016/j.ijnt.2013.12.004			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M4U	WOS:000218389900009					2022-02-06	
J	Wischmann, M; Heinemann, A; Puschel, K; Seifert, D				Wischmann, M.; Heinemann, A.; Pueschel, K.; Seifert, D.			Women as victims of violence. Study population of the medico-legal investigation in Hamburg	RECHTSMEDIZIN			German	Article						Family conflict; Injuries; Robbery; Age factors; Wounds and injuries	INJURIES	Background. The subject of violence against women focuses on domestic violence by intimate (ex) partners and sexual violence. This is not unfounded because it could be shown that most experiences of violence result from these conflict categories. However, women are also victims of other relevant forms of violence which are often in the background. Material and methods. After exclusion of cases of domestic intimate (ex) partner violence and sexual violence, 1,198 cases could be analyzed. Results. The results show that younger women in particular were affected. The conflict situations were predominantly in the family or close social environnment. In particular conflicts with unknown offenders and robbery took place in public places. The most frequent form of violence was physical violence. The combination of physical violence and use of weapons predominated in family conflicts. Violence with sharp weapons was characteristic for victims of robbery. Injuries of the upper extremities were diagnosed most frequently followed by head injuries. The severity of the injuries increased with the age of the victim. Conclusion. Violence against women is manifold and leads to serious consequences. These women need attention and assistance. Above all prevention against violence should be intensified and developed further in these conflict categories.	[Wischmann, M.; Heinemann, A.; Pueschel, K.; Seifert, D.] Univ Klinikum Hamburg Eppendorf, Inst Rechtsmed, D-22529 Hamburg, Germany		Wischmann, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Rechtsmed, Butenfeld 34, D-22529 Hamburg, Germany.	Marie.Wischmann@web.de					Allen T, 2007, VIOLENCE AGAINST WOM, V13, P802, DOI 10.1177/1077801207302040; Bundeskriminalamt, 2010, POL KRIM BUND DEUTSC; Fanslow JL, 1998, ANN EMERG MED, V32, P341, DOI 10.1016/S0196-0644(98)70011-3; FARRINGTON DP, 1992, BRIT J CRIMINOL, V32, P521, DOI 10.1093/oxfordjournals.bjc.a048255; Heinz W, 2002, JUGENDKRIMINALITAT D; Lundgren E., 2002, CAPTURED QUEEN MENS; Muller U., 2004, LEBENSSITUATION SICH; Seifert D, 2006, RECHTSMEDIZIN, V16, P205; Seifert D, 2007, MODELLPROJEKT IMPLEM; Tjaden P, 2000, FULL REPORT PREVALEN; WALBY S, 2004, RES STUDY HOME OFFIC, V276	11	4	4	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	DEC	2013	23	6					466	471		10.1007/s00194-013-0922-5			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	272YJ	WOS:000328499000004					2022-02-06	
J	Qi, Z; Wang, QY				Qi, Zhao; Wang, Qiuying			Error Analysis and the Development of an Error Mitigation Approach for Use in the Rotation Fiber Optic Gyro Inertial Navigation System	ENGINEERING LETTERS			English	Article						Rotation FOG INS; inertial measurement unit error; attitude error; navigation parameters; error mitigation	MODEL	The fiber optic gyro (FOG) inertial navigation system (INS) outputs its own absolute position containing an error that increases with time caused by the FOG error. According to our method, the INS was placed on a turntable with the assumption that the INS is typically fixed inside an autonomous underwater vehicle (AUV). Then, the INS was rotated on the turntable around one rotational axis according to specified rules. Consequently, the INS position error was decreased by the rotational motion. However, the INS attitude error was increased by the rotational motion. During rotation, a new type of concussion error was developed and added to the attitude error; the new error was found to be related to the rotational period. A method for error mitigation based on adjustments in the navigational parameters is proposed that is capable of rejecting the concussion error related to the rotational angular velocity, which then improves the attitude precision. The experiment was conducted with a FOG INS that was developed in our lab, and the results demonstrate that attitude error is inhibited by the introduction of the navigational parameters in the calculation process.	[Qi, Zhao; Wang, Qiuying] Harbin Engn Univ, Coll Automat, Harbin 150001, Heilongjiang, Peoples R China		Qi, Z (corresponding author), Harbin Engn Univ, Coll Automat, Harbin 150001, Heilongjiang, Peoples R China.	xuelang0106@163.com; wqy869087@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51009036, 51109041]	This work was supported by the National Natural Science Foundation of China under Grant No. 51009036 and 51109041.	BAI Yanping, 2006, COMPLEX FUNCTION INT, P166; Bingjun LI, 2008, THESIS, P60; Broxmeyer C, 1962, GUIDANCE AND CONTROL; Cheng J., 2005, J HARBIN ENG U, V26, P744; Curey RK, 2004, IEEE POSITION LOCAT, P83; Danao LA, 2013, ENG LET, V21, P149; GELB A, 1965, IEEE TRANS AEROSP N, VAN12, P119, DOI 10.1109/TANE.1965.4319323; HUANG Deming, 1999, INERTIAL NAVIGATION, P77; Ishibashi S, 2007, 2007 SYMPOSIUM ON UNDERWATER TECHNOLOGY AND WORKSHOP ON SCIENTIFIC USE OF SUBMARINE CABLES AND RELATED TECHNOLOGIES, VOLS 1 AND 2, P495, DOI 10.1109/UT.2007.370772; Lee CM, 2004, INT OFFSHORE POLAR E, P214; Lei Yuanchao, 1978, INERTIAL NAVIGATION, P89; LEVINSON E, 1994, IEEE 1994 POSITION LOCATION AND NAVIGATION SYMPOSIUM, P121, DOI 10.1109/PLANS.1994.303304; Liu Wen-ren, 2011, Journal of Chinese Inertial Technology, V19, P16; Miller PA, 2010, IEEE J OCEANIC ENG, V35, P663, DOI 10.1109/JOE.2010.2052691; NASH RA, 1968, IEEE T AUTOMAT CONTR, V13, P329; Strano S, 2013, ENG LET, V21, P52; Sun Feng, 2009, Chinese Journal of Scientific Instrument, V30, P2511; Tamura K, 2013, ENG LET, V21, P81; Tucker T., 2000, P 2000 NAT TECHN M I, P348; Wei Gao, 2011, IEEE T AERO ELEC SYS, P2887; Weston JL, 2000, ELECTRON COMMUN ENG, V12, P49, DOI 10.1049/ecej:20000202; Yueyang Ben, 2009, IEEE T AERO ELEC SYS, P1565; ZHANG ling, 2008, T NANJING U AERONAUT, V25, P289	23	4	4	0	0	NEWSWOOD LTD	HONG KONG	UNIT 1, 1/F, 37-39 HUNG TO RD, HONG KONG, 00000, HONG KONG	1816-093X	1816-0948		ENG LET	Eng. Lett.	NOV 29	2013	21	4					203	211					9	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	V23KN	WOS:000215088400006					2022-02-06	
J	Al-Qattan, MM; Al-Motairi, MI; Al-Naeem, HA				Al-Qattan, M. M.; Al-Motairi, M. I.; Al-Naeem, H. A.			The diaphysial axis - metacarpal head angle in the management of fractures of the base of the proximal phalanx in children	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Proximal phalanx; children; fracture	HAND; FINGERS; INJURIES; PHYSEAL; WRIST	The diaphysial axis - metacarpal head angle (DHA) is the angle formed between the longitudinal axis of the diaphysis of the proximal phalanx and central point of the metacarpal head. The normal DHA ranges from 177.1 degrees and 180.0 degrees. There were no significant differences between DHA measurements when taken by the same observer at two separate occasions (P = 0.986) or when taken by two different observers (P = 0.948). We have put an algorithm of management of paediatric phalangeal base fractures incorporating the DHA in the decision making. A prospective study of 92 children (5-14 years) with phalangeal base fractures was conducted. Closed reduction was possible in all but one case in which open reduction and K-wire fixation was required. Closed reduction of the remaining 91 fractures yielded a good' reduction in 80 cases (no finger deformity on clinical examination with a post-reduction DHA greater than 177 degrees). After a mean follow-up of 4.2 months, all these 80 cases qualified for an excellent outcome as per Al-Qattan's criteria. The remaining 11 children were considered to have an acceptable' reduction (no scissoring, but there was a mild residual lateral deviation of the finger with a DHA angle of 169.4 degrees to 176.2 degrees). At a mean follow-up of 28 months, all these 11 mal-united fractures remodelled with normalization of the DHA; and all 11 children qualified for an excellent outcome as per Al-Qattan's criteria. The current series stresses on the advantages of using DHA in the objective assessment of paediatric phalangeal base fractures and demonstrates the remodelling of fractures with about 10 degrees of lateral deviation.	[Al-Qattan, M. M.; Al-Motairi, M. I.; Al-Naeem, H. A.] King Saud Univ, Div Plast Surg, Riyadh 11415, Saudi Arabia		Al-Qattan, MM (corresponding author), King Saud Univ, Div Plast Surg, POB 18097, Riyadh 11415, Saudi Arabia.	moqattan@hotmail.com			College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia	The project was funded by the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.	Al-Qattan MM, 2008, J HAND SURG-EUR VOL, V33E, P465, DOI 10.1177/1753193408090146; Al-Qattan MM, 2002, J HAND SURG-BRIT EUR, V27B, P24, DOI 10.1054/jhsb.2001.0661; Al-Qattan MM, 2001, J HAND SURG-BRIT EUR, V26, P112, DOI 10.1054/jhsb.2000.0506; BARTON NJ, 1979, HAND, V11, P134, DOI 10.1016/S0072-968X(79)80025-X; BARTON NJ, 1984, J BONE JOINT SURG BR, V66, P159, DOI 10.1302/0301-620X.66B2.6707048; BEATTY E, 1990, HAND CLIN, V6, P723; CAMPBELL RM, 1990, ORTHOP CLIN N AM, V21, P217; FISCHER MD, 1994, HAND CLIN, V10, P287; HARRYMAN DT, 1990, CLIN ORTHOP RELAT R, P194; LEONARD MH, 1970, CLIN ORTHOP RELAT R, P160; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; VONRAFFLER W, 1964, J BONE JOINT SURG BR, V46, P229, DOI 10.1302/0301-620X.46B2.229; WOOD VE, 1976, ORTHOP CLIN N AM, V7, P527	13	4	4	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	NOV	2013	38	9					984	990		10.1177/1753193413480311			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	240HK	WOS:000326085800012	23456926				2022-02-06	
J	Davis, B				Davis, Ben			Late Reconstruction of Condylar Neck and Head Fractures	ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA			English	Article						Condyle fracture; Complication; Reconstruction; Costochondral graft; Total joint prosthesis	TEMPOROMANDIBULAR-JOINT ANKYLOSIS; HELICAL COMPUTED-TOMOGRAPHY; CLOSED TREATMENT; FOLLOW-UP; SURGICAL-TREATMENT; INTERNAL-FIXATION; MANAGEMENT; REPLACEMENT; REDUCTION; COMPLICATIONS	Condyle fractures are a common injury, but only a few of these injuries require immediate or late reconstruction. The complications that most frequently necessitate condylar reconstruction include proximal segment degeneration, malunion, and ankylosis. Costochondral grafts and total joint prostheses, both stock and custom, remain the most common methods of reconstruction. Reconstruction plates with condylar extensions should only be used temporarily as an'unacceptable number cause serious complications. Distraction osteogenesis may have an occasional role in reconstructing the posttraumatic condyle.	Dalhousie Univ, Dept Oral & Maxillofacial Sci, Halifax, NS B3H 1W2, Canada		Davis, B (corresponding author), Dalhousie Univ, Dept Oral & Maxillofacial Sci, Halifax, NS B3H 1W2, Canada.	bdavis@dal.ca		Davis, Benjamin/0000-0002-5970-5246			Cai XY, 2010, J ORAL MAXIL SURG, V68, P731, DOI 10.1016/j.joms.2009.07.060; Carlson ER, 2002, J ORAL MAXIL SURG, V60, P176, DOI 10.1053/joms.2002.29815; Chen MJ, 2010, J ORAL MAXIL SURG, V68, P2189, DOI 10.1016/j.joms.2009.09.063; Cheung LK, 2009, ORAL SURG ORAL MED O, V108, P32, DOI 10.1016/j.tripleo.2009.02.030; Choi J, 2005, INT J ORAL MAX SURG, V34, P851, DOI 10.1016/j.ijom.2005.04.005; DAHLSTROM L, 1989, INT J ORAL MAX SURG, V18, P18, DOI 10.1016/S0901-5027(89)80009-8; Davis BR, 2005, INT J ORAL MAX SURG, V34, P871, DOI 10.1016/j.ijom.2005.04.002; DePuySynthes, COND HEAD ADD ON SYS; Ellis E, 1998, INT J ORAL MAX SURG, V27, P255, DOI 10.1016/S0901-5027(05)80506-5; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; Emshoff R, 2007, J ORAL MAXIL SURG, V65, P1550, DOI 10.1016/j.joms.2006.10.068; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; He D, 2008, J ORAL MAXIL SURG, V66, P77, DOI 10.1016/j.joms.2007.08.013; Hovinga J, 1999, INT J ORAL MAX SURG, V28, P429, DOI 10.1034/j.1399-0020.1999.280606.x; Ishihara Y, 2012, AM J ORTHOD DENTOFAC, V142, P534, DOI 10.1016/j.ajodo.2011.02.029; Kaban LB, 2009, J ORAL MAXIL SURG, V67, P1966, DOI 10.1016/j.joms.2009.03.071; Laine P, 2004, J ORAL MAXIL SURG, V62, P1312, DOI 10.1016/j.joms.2004.02.014; Li Z, 2009, DENT TRAUMATOL, V25, P136, DOI 10.1111/j.1600-9657.2008.00753.x; Lovato C, 2009, J ORAL MAXIL SURG, V67, P827, DOI 10.1016/j.joms.2008.06.093; Marx RE, 2008, J ORAL MAXIL SURG, V66, P2515, DOI 10.1016/j.joms.2007.12.005; Mehra P, 2009, J ORAL MAXIL SURG, V67, P1046, DOI 10.1016/j.joms.2008.12.036; Mercuri Louis G, 2006, Oral Maxillofac Surg Clin North Am, V18, P399, DOI 10.1016/j.coms.2006.03.003; Mercuri LG, 2007, J ORAL MAXIL SURG, V65, P1140, DOI 10.1016/j.joms.2006.10.006; Mercuri LG, 2012, J ORAL MAXIL SURG, V70, P2280, DOI 10.1016/j.joms.2012.06.174; Mercuri LG, 2011, J ORAL MAXIL SURG, V69, P2106, DOI 10.1016/j.joms.2011.01.006; Mercuri LG, 2009, J ORAL MAXIL SURG, V67, P1979, DOI 10.1016/j.joms.2009.05.430; Nitzan DW, 2012, J ORAL MAXIL SURG, V70, pE683, DOI 10.1016/j.joms.2012.08.007; Oezmen Y, 1998, INT J ORAL MAX SURG, V27, P33, DOI 10.1016/S0901-5027(98)80092-1; Park JM, 2010, J ORAL MAXIL SURG, V68, P2986, DOI 10.1016/j.joms.2010.02.034; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Roth FS, 2005, J CRANIOFAC SURG, V16, P394, DOI 10.1097/01.scs.0000171964.01616.a8; RUBENS BC, 1990, INT J ORAL MAX SURG, V19, P22, DOI 10.1016/S0901-5027(05)80563-6; Schneider M, 2008, J ORAL MAXIL SURG, V66, P2537, DOI 10.1016/j.joms.2008.06.107; Shintaku WH, 2009, DENT TRAUMATOL, V25, P358, DOI 10.1111/j.1600-9657.2009.00795.x; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; TAKENOSHITA Y, 1990, J ORAL MAXIL SURG, V48, P1191, DOI 10.1016/0278-2391(90)90535-A; US Food and Drug Administration, FDA ORD POSTM SURV C; WARD T G, 1961, Ann R Coll Surg Engl, V28, P139; Wilson IF, 2001, PLAST RECONSTR SURG, V107, P1369, DOI 10.1097/00006534-200105000-00008; Wolford LM, 2012, J ORAL MAXIL SURG, V70, P2835, DOI 10.1016/j.joms.2012.02.010; Zhang Y, 2006, INT J ORAL MAX SURG, V35, P1096, DOI 10.1016/j.ijom.2006.09.003; Zimmermann CE, 2006, INT J ORAL MAX SURG, V35, P1, DOI 10.1016/j.ijom.2005.06.015	43	4	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3699	1558-1365		ORAL MAXIL SURG CLIN	Oral Maxillofac. Surg. Clin. N. Am.	NOV	2013	25	4					661	+		10.1016/j.coms.2013.07.006			22	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	264ZN	WOS:000327919600011	24021625				2022-02-06	
J	Shao, AW; Guo, SX; Chen, S; Sun, CR; Wu, HJ; Hong, Y; Zhang, JM				Shao, Anwen; Guo, Songxue; Chen, Sheng; Sun, Chongran; Wu, Haijian; Hong, Yuan; Zhang, Jianmin			Comparison Between Routine and Improved Decompressive Craniectomy on Patients With Malignant Cerebral Artery Infarction Without Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cerebral infarction; decompressive craniectomy; surgical treatment	TERRITORY INFARCTION; ISCHEMIC-STROKE; HEMICRANIECTOMY; MORTALITY; MULTICENTER; MANAGEMENT; SURGERY; EDEMA	Background: Malignant cerebral artery infarction is one kind of ischemic stroke with high mortality. The aim of this study was to analyze comparatively the preoperative and postoperative clinical data as well as the prognostic factors in these patients who underwent improved decompressive craniectomy or routine decompressive craniectomy. Methods: A total of 131 patients with malignant cerebral artery infarction were included during the period from January 2000 to December 2012. The patients were divided into 2 groups: the improved decompressive craniectomy group (n = 85) and the routine decompressive craniectomy group (control group) (n = 46). We reviewed the detailed information of the patients; moreover, a comparative analysis of the 2 groups based on age (<= 60 or >60 y) was performed. Results: The improved decompressive craniectomy group had a significant decrease (P < 0.05) in mortality without clinical functional improvement. The patients who were treated through routine decompressive craniectomy had a higher incidence of hydrocephalus and pulmonary infection (P = 0.011 and 0.003). Moreover, younger patients usually took less resident time in the hospital than did the patients in the elderly group (P = 0.047 vs P < 0.05). Statistical results indicated that the younger patients took a better recovery than did the elderly patients. There was a significant difference between the groups A and B both in the Barthel index and the modified Rankine scale for 3 or 6 months after discharge (P < 0.05). Conclusions: In comparison with the routine decompressive craniectomy, the improved decompressive craniectomy can reduce the mortality rate and improve the neurologic outcome. However, it increases the incidence of encephalocele and pulmonary infection, which may cause secondary vital injury to patients after surgery. In addition, younger patients can gain a better further functional recovery by undergoing improved decompressive craniectomy.	[Shao, Anwen; Guo, Songxue; Chen, Sheng; Sun, Chongran; Wu, Haijian; Hong, Yuan; Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China		Hong, Y (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China.	hy0904@live.cn	邵, 安文/R-9023-2019; Shao, Anwen/L-4860-2019	Shao, Anwen/0000-0001-5616-0394; Shao, Anwen/0000-0001-9986-6290	Department of Science and Technology of the Zhejiang Province in China [2009C33023]	Supported by the Research Fund grant no. 2009C33023 from the Department of Science and Technology of the Zhejiang Province in China.	Alshekhlee A, 2011, J STROKE CEREBROVASC, V20, P196, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.019; Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heinsius T, 1998, NEUROLOGY, V50, P341, DOI 10.1212/WNL.50.2.341; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huh JS, 2007, J KOREAN NEUROSURG S, V42, P331, DOI 10.3340/jkns.2007.42.4.331; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Mattos JP, 2010, ARQ NEURO-PSIQUIAT, V68, P339, DOI 10.1590/S0004-282X2010000300002; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Yao Y, 2007, ACTA NEUROCHIR, V149, P1219, DOI 10.1007/s00701-007-1415-7; Yao Y, 2005, SURG NEUROL, V64, P165, DOI 10.1016/j.surneu.2004.10.021	17	4	5	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2013	24	6					2085	2088		10.1097/SCS.0b013e3182a2435a			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	298WF	WOS:000330354500081	24220412				2022-02-06	
J	Fujiwara, T; Morimoto, K				Fujiwara, Takeshi; Morimoto, Koji			A compound CP-31398 suppresses excitotoxicity-induced neurodegeneration	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						CP-31398; Excitotoxicity; Mitochondrial dysfunction; Neurodegeneration; p53	MICROTUBULE STABILIZATION; AXONAL DEGENERATION; NEURONAL DEATH; PROTECTS MICE; P53; MITOCHONDRIA; INHIBITION; APOPTOSIS; BINDING; LOADS	Neurodegeneration causes dysfunction and degeneration of neurons and is triggered by various factors including genetic defects, free radicals, injury, and glutamate excitotoxicity. Among those, glutamate excitotoxicity is implicated in chronic disorders including AD and ALS, and in acute insults in the CNS including traumatic brain injury. Neurological disorders show hallmark morphological abnormalities such as axon degeneration and cell body death. The molecular mechanisms underlying excitotoxicity-induced neurodegeneration are complex and deciphering a molecular mechanism from one angle is beneficial to understand the process, however, still difficult to develop strategies to suppress excitotoxicity-induced degeneration due to existence of other mechanisms. Thus, directly identifying compounds that can modulate excitotoxicity-induced neurodegeneration and subsequently clarifiying the molecular mechanism is a valid approach to develop effective strategies to suppress neurodegeneration. We searched for compounds that can suppress excitotoxicity-induced neurodegeneration and found that CP-31398, a known compound that can rescue the structure and function of the tumor suppressor protein p53 mutant form and stabilize the active conformation of the p53 wild-type form, suppresses excitotoxicity-induced axon degeneration and cell body death. Moreover, CP-31398 suppresses mitochondrial dysfunction which has a strong correlation with excitotoxicity. Thus, our findings identify a compound that can serve as a novel modulator of neurodegeneration induced by glutamate excitotoxicity. (C) 2013 Elsevier Inc. All rights reserved.	[Fujiwara, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Dept Biomol Networks, Biomol Dynam Lab, Suita, Osaka 5650871, Japan; [Morimoto, Koji] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Suita, Osaka 5650871, Japan		Fujiwara, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Biomol Networks, Biomol Dynam Lab, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	fujiwara@anat3.med.osaka-u.ac.jp			Osaka University Global COE Program (Frontier Biomedical Science Underlying Organelle Network Biology); Kurata Memorial Hitachi Science and Technology Foundation; Takeda Science FoundationTakeda Science Foundation (TSF); Japan Health FoundationJapan Health Foundation	We thank Drs. Y. Yoneda and Y. Shima for their support. This work was supported in part by The Osaka University Global COE Program (Frontier Biomedical Science Underlying Organelle Network Biology), The Kurata Memorial Hitachi Science and Technology Foundation, Takeda Science Foundation, and The Japan Health Foundation.	Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Fujiwara T, 2012, BIOCHEM BIOPH RES CO, V427, P100, DOI 10.1016/j.bbrc.2012.09.017; Fujiwara T, 2012, BIOCHEM BIOPH RES CO, V424, P82, DOI 10.1016/j.bbrc.2012.06.071; Fujiwara T, 2012, J NEUROCHEM, V122, P162, DOI 10.1111/j.1471-4159.2012.07746.x; Hasbani DM, 2006, EXP NEUROL, V202, P93, DOI 10.1016/j.expneurol.2006.05.017; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Luu Y, 2002, EXP CELL RES, V276, P214, DOI 10.1006/excr.2002.5526; Morrison RS, 1996, J NEUROSCI, V16, P1337; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; THAYER SA, 1995, CLIN EXP PHARMACOL P, V22, P303, DOI 10.1111/j.1440-1681.1995.tb02004.x; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Xiang H, 1996, J NEUROSCI, V16, P6753	31	4	4	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 25	2013	440	3					359	363		10.1016/j.bbrc.2013.08.052			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	250MS	WOS:000326857500001	23988450				2022-02-06	
J	Atabaki, SM				Atabaki, Shireen M.			Updates in the General Approach to Pediatric Head Trauma and Concussion	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Prediction rules; Computed tomography; Intracranial hemorrhage; Concussion	SPORT-RELATED CONCUSSION; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; POSTTRAUMATIC SEIZURES; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; CHILDREN; PREVENTION; EPIDEMIOLOGY	Acute recognition and management of traumatic brain injury along the spectrum from mild to severe is essential in optimizing neurocognitive outcomes. Concussion is common following head trauma in children, and resulting symptoms can last for months if not diagnosed and managed properly. Emerging evidence and consensus demonstrate that a program of cognitive and physical activity with a graduated return to play, sport, and school may improve outcomes following concussion. "Return to Play" legislation for youth has been adopted by most states. Outcomes of patients with severe traumatic brain injury have improved.	Childrens Natl Med Ctr, Dept Pediat & Emergency Med, Div Emergency Med, Washington, DC 20010 USA		Atabaki, SM (corresponding author), Childrens Natl Med Ctr, Dept Pediat & Emergency Med, Div Emergency Med, 111 Michigan Ave Northwest, Washington, DC 20010 USA.	satabaki@cnmc.org	Meijer, Anna/K-5118-2016				Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; [Anonymous], 2008, PREHOSP EMERG CAR S1, V12, pS1; [Anonymous], 2012, LOV SPORTS CAN START; Atabaki S, 2010, BRAIN INJURY, V24, P115; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dayan P, 2008, ACAD EMERG MED, V15, pS82; FANCONI S, 1988, INTENS CARE MED, V14, P163; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigal DW, 2002, PEDIATR RADIOL, V32, P314, DOI 10.1007/s00247-002-0687-6; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gilchrist J, 2011, MMWR-MORBID MORTAL W, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Klein P, 2012, EPILEPSY BEHAV, V24, P457, DOI 10.1016/j.yebeh.2012.05.011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2008, ACAD EMERG MED, V15, pS82; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lichenstein R, 2012, ARCH PEDIAT ADOL MED, V166, P725, DOI 10.1001/archpediatrics.2011.1919; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Luber SD, 1996, AM J EMERG MED, V14, P543, DOI 10.1016/S0735-6757(96)90094-7; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Cancer Institute, RAD RISKS PED COMP T; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; *WHO OMS, 2009, GLOB STAT REP ROAD S	61	4	5	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2013	60	5					1107	+		10.1016/j.pcl.2013.06.001			17	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	247XW	WOS:000326659300007	24093898				2022-02-06	
J	Cherry, JD; Williams, JP; O'Banion, MK; Olschowka, JA				Cherry, Jonathan D.; Williams, Jacqueline P.; O'Banion, M. Kerry; Olschowka, John A.			Thermal Injury Lowers the Threshold for Radiation-Induced Neuroinflammation and Cognitive Dysfunction	RADIATION RESEARCH			English	Article							NECROSIS-FACTOR-ALPHA; HIPPOCAMPAL NEUROGENESIS; MICROGLIAL ACTIVATION; OBJECT RECOGNITION; ALZHEIMERS-DISEASE; BURN INJURY; SEPSIS; BRAIN; EXPRESSION; MODELS	The consequences of radiation exposure alone are relatively well understood, but in the wake of events such as the World War II nuclear detonations and accidents such as Chernobyl, other critical factors have emerged that can substantially affect patient outcome. For example, similar to 70% of radiation victims from Hiroshima and Nagasaki received some sort of additional traumatic injury, the most common being thermal burn. Animal data has shown that the addition of thermal insult to radiation results in increased morbidity and mortality. To explore possible synergism between thermal injury and radiation on brain, C57BL/6J female mice were exposed to either 0 or 5 Gy whole-body gamma irradiation. Irradiation was immediately followed by a 10% total-body surface area full thickness thermal burn. Mice were sacrificed 6 h, 1 week or 6 month post-injury and brains and plasma were harvested for histology, mRNA analysis and cytokine ELISA. Plasma analysis revealed that combined injury synergistically upregulates IL-6 at acute time points. Additionally, at 6 h, combined injury resulted in a greater upregulation of the vascular marker, ICAM-1 and TNF-alpha mRNA. Enhanced activation of glial cells was also observed by CD68 and Iba1 immunohistochemistry at all time points. Additionally, doublecortin staining at 6 months showed reduced neurogenesis in all injury conditions. Finally, using a novel object recognition test, we observed that only mice with combined injury had significant learning and memory deficits. These results demonstrate that thermal injury lowers the threshold for radiation-induced neuroinflammation and long-term cognitive dysfunction. (C) 2013 by Radiation Research Society	[Cherry, Jonathan D.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Williams, Jacqueline P.] Univ Rochester, Sch Med & Dent, Dept Radiat Oncol, Rochester, NY 14642 USA; [O'Banion, M. Kerry; Olschowka, John A.] Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA		Olschowka, JA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, 601 Elmwood Ave, Rochester, NY 14642 USA.	John_Olschowka@urmc.rochester.edu	Cherry, Jonathan/D-5394-2015	O'Banion, M. Kerry/0000-0003-1246-3363	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 ES01247, U19-AI067733, U19AI091036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI091036, U19AI067733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES001247] Funding Source: NIH RePORTER	The authors thank Jack Walter, Lee Trojanczyk, Mallory Olschowka and Sage Begolly for their assistance during mouse irradiations, thermal injury, animal management and tissue processing. We thank Katherine Bachmann in the University of Rochester Environmental Health Sciences Center Behavioral Science Facility Core (supported in part by NIH grant P30 ES01247) for assisting in set up of the novel object recognition test. Finally, the authors wish to thank Amy K. Huser for editorial assistance. This work was supported by NIH grants U19-AI067733 and U19AI091036.	ALPEN EL, 1954, ANN SURG, V140, P113, DOI 10.1097/00000658-195407000-00013; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; BROOKS JW, 1952, ANN SURG, V136, P533, DOI 10.1097/00000658-195209000-00018; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002; Clark RE, 2000, J NEUROSCI, V20, P8853; Coban YK, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/16492; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; FUJITA S, 1991, J RADIAT RES, V32, P154, DOI 10.1269/jrr.32.SUPPLEMENT_154; Gamache GL, 2005, ARCH CLIN NEUROPSYCH, V20, P81, DOI 10.1016/j.acn.2004.03.005; GAMELLI RL, 1994, SHOCK, V1, P395, DOI 10.1097/00024382-199406000-00001; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heinrich SA, 2003, WOUND REPAIR REGEN, V11, P110, DOI 10.1046/j.1524-475X.2003.11206.x; Herber DL, 2007, J NEUROIMMUNE PHARM, V2, P222, DOI 10.1007/s11481-007-9069-z; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Johnston CJ, 2011, INT J RADIAT BIOL, V87, P902, DOI 10.3109/09553002.2011.573439; Kallinen O, 2012, J BURN CARE RES, V33, P206, DOI 10.1097/BCR.0b013e3182331e73; Kieburtz K, 2008, CLIN NEUROPHARMACOL, V31, P141, DOI 10.1097/WNF.0b013e3181342f32; Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li J, 2008, INT J RADIAT ONCOL, V71, P64, DOI 10.1016/j.ijrobp.2007.09.059; Manthous CA, 2007, CRIT CARE MED, V35, P716, DOI 10.1097/01.CCM.0000257328.31668.22; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Orman MA, 2012, CYTOKINE, V58, P307, DOI 10.1016/j.cyto.2012.01.017; Orman MA, 2011, CYTOKINE, V55, P362, DOI 10.1016/j.cyto.2011.05.010; Palmer JL, 2011, J BURN CARE RES, V32, P317, DOI 10.1097/BCR.0b013e31820aafa9; Pellmar TC, 2005, NATO RTG; Plackett TP, 2010, J AM COLL SURGEONS, V210, P73, DOI 10.1016/j.jamcollsurg.2009.09.019; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schwacha MG, 2003, BURNS, V29, P1, DOI 10.1016/S0305-4179(02)00187-0; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Swann K, 2007, BRAIN RES, V1129, P26, DOI 10.1016/j.brainres.2006.10.061; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Wu MD, 2012, BRAIN BEHAV IMMUN, V26, P292, DOI 10.1016/j.bbi.2011.09.012	47	4	4	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	OCT	2013	180	4					398	406		10.1667/RR3363.1			9	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AA3KS	WOS:000330991900008	24059681	Green Accepted			2022-02-06	
J	Ettenhofer, ML; Reinhardt, LE; Barry, DM				Ettenhofer, Mark L.; Reinhardt, Lindsay E.; Barry, David M.			Predictors of Neurobehavioral Symptoms in a University Population: A Multivariate Approach Using a Postconcussive Symptom Questionnaire	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Concussion; Postconcussive symptoms; Post-Concussion Syndrome; Chronic; Orthopedic injury; Neurobehavioral symptoms	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; COGNITIVE SYMPTOMS; SUBSTANCE-ABUSE; ALCOHOL-USE; DEPRESSION; COMPLAINTS; METAANALYSIS; PERFORMANCE; CONCUSSION	Several factors have been linked to severity of postconcussive-type (neurobehavioral) symptoms. In this study, predictors of neurobehavioral symptoms were examined using multivariate methods to determine the relative importance of each. Data regarding demographics, symptoms, current alcohol use, history of traumatic brain injury (TBI), orthopedic injuries, and psychiatric/developmental diagnoses were collected via questionnaire from 3027 university students. The most prominent predictors of symptoms were gender, history of depression or anxiety, history of attention-deficit/hyperactivity disorder or learning disability diagnosis, and frequency of alcohol use. Prior mild TBI was significantly related to overall symptoms, but this effect was small in comparison to other predictors. These results provide further evidence that neurobehavioral symptoms are multi-determined phenomena, and highlight the importance of psychiatric comorbidity, demographic factors, and health behaviors to neurobehavioral symptom presentation after mild TBI.	[Ettenhofer, Mark L.; Reinhardt, Lindsay E.; Barry, David M.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA		Ettenhofer, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mark.ettenhofer@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578			Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; GAYTON WF, 1986, PERCEPT MOTOR SKILL, V63, P801, DOI 10.2466/pms.1986.63.2.801; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Miller Carlin J, 2005, J Atten Disord, V9, P444, DOI 10.1177/1087054705279048; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; NELSON VS, 1992, PHYS MED REH CLIN N, V3, P461; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047	53	4	4	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2013	19	9					977	985		10.1017/S1355617713000763			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	223RY	WOS:000324827700004	23885692				2022-02-06	
J	Li, T; Zhang, YS; Gu, Z; Ma, XK; Yang, XJ				Li, Tong; Zhang, Yisen; Gu, Zheng; Ma, Xiangke; Yang, Xijian			Traumatic pseudoaneurysm of the basilar artery presenting with fatal epistaxis: A rare case report	BRAIN INJURY			English	Article						Basilar artery; endovascular treatment; epistaxis; intracranial pseudoaneurysm; traumatic brain injury	INTRACRANIAL ANEURYSMS; OCCLUSION; FISTULA	Background: To the best of the authors' knowledge, this is the first report of a traumatic pseudoaneurysm of the basilar artery presenting with epistaxis. Case study: This study reports a rare case in which a patient suffered from fatal epistaxis because of a pseudoaneurysm of basilar artery and fracture of skull base after a motorcycle accident. Clinical manifestation, diagnostic imaging and endovascular treatment are described. Formation mechanisms and the treatment of traumatic pseudoaneurysm of basilar artery are discussed.	[Li, Tong; Zhang, Yisen; Gu, Zheng; Ma, Xiangke] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurosurg, Beijing, Peoples R China; [Yang, Xijian] Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing Neurosurg Inst, Beijing 100050, Peoples R China		Yang, XJ (corresponding author), Beijing Tiantan Hosp, Beijing Neurosurg Inst, Tiantan Xili 6, Beijing 100050, Peoples R China.	yang-xj@163.net		Zhang, Yisen/0000-0002-6685-0126	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772234, 81171079, 81220108007]; High-Level Health Technique Talent Training Plan of Beijing Health System [2009-3-22]	This work was supported by the National Science Foundation of China (grant nos. 30772234, 81171079 and 81220108007), High-Level Health Technique Talent Training Plan of Beijing Health System (grant no. 2009-3-22).	BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; Connor SEJ, 2001, NEURORADIOLOGY, V43, P249, DOI 10.1007/s002340000466; Kai Y, 2004, J NEUROSURG, V100, P1072, DOI 10.3171/jns.2004.100.6.1072; Li Tielin, 2000, Chin J Traumatol, V3, P253; Loevner LA, 1998, AM J NEURORADIOL, V19, P386; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Sato Y, 1997, AM J FOREN MED PATH, V18, P129, DOI 10.1097/00000433-199706000-00004; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; STEINBERG GK, 1993, J NEUROSURG, V79, P161, DOI 10.3171/jns.1993.79.2.0161; Teitelbaum GP, 1998, NEUROSURGERY, V42, P1394, DOI 10.1097/00006123-199806000-00134; Yang X, 2007, INTERV NEURORADIOL, V13, P369, DOI 10.1177/159101990701300408; Zhao GM, 2007, J DIAGNOSTICS CONCEP, V6, P26	14	4	4	2	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1316	1319		10.3109/02699052.2013.812242			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800012	23924339				2022-02-06	
J	Ren, WY; Jing, GJ; Shen, Q; Yao, XT; Jing, YC; Lin, F; Pan, WD				Ren, Wanyin; Jing, Guojie; Shen, Qin; Yao, Xiaoteng; Jing, Yingchao; Lin, Feng; Pan, Weidong			Occludin and connexin 43 expression contribute to the pathogenesis of traumatic brain edema	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; traumatic brain injury; brain edema; connexin 43; occludin; nerve cells; pathology; tight junction; grants-supported paper; neuroregeneration	INTERCELLULAR COMMUNICATION; BARRIER PERMEABILITY; MIMETIC PEPTIDES; TIGHT JUNCTIONS; ISCHEMIC-STROKE; INJURY; ASTROCYTES; CLAUDIN-5; CELLS; RATS	The experimental model of traumatic brain injury was established in Sprague-Dawley rats according to Feeney's free falling method. The brains were harvested at 2, 6 and 24 hours, and at 3 and 5 days after injury. Changes in brain water content were determined using the wet and dry weights. Our results showed that water content of tissue significantly increased after traumatic brain injury, and reached minimum at 24 hours. Hematoxylin-eosin staining revealed pathological impairment of brain tissue at each time point after injury, particularly at 3 days, with nerve cell edema, degeneration, and necrosis observed, and the apoptotic rate significantly increased. Immunohistochemistry and western blot analysis revealed that the expression of occludin at the injured site gradually decreased as injury time advanced and reached a minimum at 3 days after injury; the expression of connexin 43 gradually increased as injury time advanced and reached a peak at 24 hours after injury. The experimental findings indicate that changes in occludin and connexin 43 expression were consistent with the development of brain edema, and may reflect the pathogenesis of brain injury.	[Ren, Wanyin; Lin, Feng; Pan, Weidong] Guangdong Med Coll, Zhanjiang 524023, Guangdong, Peoples R China; [Jing, Guojie; Shen, Qin; Yao, Xiaoteng; Jing, Yingchao] Huizhou First Peoples Hosp, Huizhou 516003, Guangdong, Peoples R China		Jing, GJ (corresponding author), Huizhou First Peoples Hosp, Huizhou 516003, Guangdong, Peoples R China.	jingguojie888@163.com			Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [10151600101000002]	This study was supported by the Natural Science Foundation of Guangdong Province, No. 10151600101000002.	Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; Avila MA, 2011, J NEUROTRAUM, V28, P1803, DOI 10.1089/neu.2011.1900; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Brokamp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047775; Cui XN, 2005, ZHONGGUO KANGFU LILU, V11, P719; Ding Z, 2012, J DIGEST DIS, V13, P179, DOI 10.1111/j.1751-2980.2011.00568.x; Duval N, 2002, J CELL SCI, V115, P3241; Ebong EE, 2006, AM J PHYSIOL-HEART C, V290, pH2015, DOI 10.1152/ajpheart.00204.2005; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Kago T, 2006, BIOCHEM BIOPH RES CO, V339, P1197, DOI 10.1016/j.bbrc.2005.11.133; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Liao Y, 2001, P NATL ACAD SCI USA, V98, P9989, DOI 10.1073/pnas.171305298; Lichter-Konecki U, 2008, GLIA, V56, P365, DOI 10.1002/glia.20624; Lin JY, 2007, ZHONGGUO XIANDAI YIS, V45, P18; Ling YP, 2002, CELL BIOL; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Nakase T, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/147946; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Old EA, 2012, CURR OPIN PHARMACOL, V12, P67, DOI 10.1016/j.coph.2011.10.015; Paxions G., 2005, RAT BRAIN STEREOTAXI; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Sun YX, 2010, ZHONGGUO XIANDAI YIX, V20, P3210; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Wang ZC, 2005, WANG ZC NEUROSURGERY; Wilson AC, 2008, BBA-MOL BASIS DIS, V1782, P401, DOI 10.1016/j.bbadis.2008.02.011; Wu Li-Wen, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P513; Wu ZL, 2008, ZHONGHUA SHENJING WA, V7, P201; Xie MJ, 2011, ANN NEUROL, V70, P121, DOI 10.1002/ana.22386; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Zhang L, 2008, SHOUDU YIKE DAXUE XU, V29, P732; Zhang YM, 2010, ZHONGHUA SHENJING YI, V9, P460	44	4	5	0	5	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	OCT	2013	8	29					2703	2712		10.3969/j.issn.1673-5374.2013.29.002			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	244VW	WOS:000326419300002	25206581				2022-02-06	
J	Manko, G; Ziolkowski, A; Mirski, A; Klosinski, M				Manko, Grzegorz; Ziolkowski, Artur; Mirski, Andrzej; Klosinski, Michal			The effectiveness of selected Tai Chi exercises in a program of strategic rehabilitation aimed at improving the self-care skills of patients aroused from prolonged coma after severe TBI	MEDICAL SCIENCE MONITOR			English	Article						program of rehabilitation; activities of daily living (ADL); brainstem contusion; goal-oriented rehabilitation; health behavior; therapeutic behavior; preventative (rehabilitative) behavior; quality of life	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; NEUROTHERAPY; ANOSOGNOSIA; OUTCOMES; PAIN	Background: Difficulties in self-care constitute a very common problem for patients recovering from prolonged coma after a severe TBI, and a major factor reducing their quality of life. Effective new rehabilitation programs that would help solve this problem are urgently needed. The purpose of our experiment was to evaluate improvement in this respect in a group of patients aroused from prolonged coma who participated in a goal-oriented rehabilitation program (Rehab-3), enhanced with selected elements of Tai-Chi. Material/Methods: We examined 40 patients aroused from prolonged coma after a severe TBI, undergoing long-term rehabilitation according to a standard phased rehabilitation program. These patients were divided into two numerically even groups: a control group treated according to the standard program, and an experimental group, who received an additional goal oriented program enhanced with selected Tai-Chi exercises. The research methods included analysis of documentation (MRI, CT), a structured clinical interview, and the Standard Self-Care Scale. Results: The experimental group achieved significant improvement of self-care skills, whereas in the control group the improvement was slight and not statistically significant. The value of co-efficient j (0.64) indicates a very strong association between the rehabilitation procedure and improved self-care in the experimental group, but not in the control group. Conclusions: Our results confirmed that a goal-oriented rehabilitation program enhanced with elements of Tai-Chi was more effective than the standard program in improving the performance of activities of daily living.	[Manko, Grzegorz] Jagiellonian Univ, Coll Med, Fac Allied Hlth Sci, Dept Ergon & Exert Physiol,Inst Physiotherapy, Krakow, Poland; [Ziolkowski, Artur] Jedrzej Sniadecki Univ Phys Educ & Sport Gdansk, Gdansk, Poland; [Mirski, Andrzej] Andrzej Frycz Modrzewski Cracow Univ, Dept Neuropsychol, Krakow, Poland; [Klosinski, Michal] Jagiellonian Univ, Coll Med, Dept Anat, Krakow, Poland		Mirski, A (corresponding author), Andrzej Frycz Modrzewski Cracow Univ, Dept Neuropsychol, Krakow, Poland.	artmir@o2.pl					Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Christensen A, 2005, ACTA NEUROPSYCHOLOGI, V3, P60; Christensen AL, 2005, ACT NEUR S, V93, P195; Cocchini G, 2012, ACTA NEUROPSYCHOL, V10, P419, DOI 10.5604/17307503.1023693; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Field Tiffany, 2011, Complement Ther Clin Pract, V17, P141, DOI 10.1016/j.ctcp.2010.10.002; Girard TD, 2012, RESP CARE, V57, P947, DOI 10.4187/respcare.01708; Hall A, 2009, ARTHRIT RHEUM-ARTHR, V61, P717, DOI 10.1002/art.24515; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kunski H, 1999, MED AKTYWNOSCI RUCHO; Kuramoto Alice M, 2006, WMJ, V105, P42; Lazarus L, 2012, MOSC INT C DEC 110 A; Lee MS, 2008, CLIN RHEUMATOL, V27, P211, DOI 10.1007/s10067-007-0700-4; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pachalska M, 2000, STANDARDOWA SKALA BA; Pachalska M, 2003, NEUROREHABILITACJA P, P36; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; PACHALSKA M, 2002, US OTHERS SOCIAL IDE, P481; Pachalska M, 2010, MED SCI MONITOR, V16, pCS325; Pachalska M, 2012, ACTA NEUROPSYCHOL, V10, P399, DOI 10.5604/17307503.1023689; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; Pappadis MR, 2012, ACTA NEUROPSYCHOL, V10, P385, DOI 10.5604/17307503.1023681; Prigatano GP, 2012, ACTA NEUROPSYCHOL, V10, P371, DOI 10.5604/17307503.1023676; Sahuquillo J, 2000, QUALITY MANAGEMENT H, P109; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Talar J., 2003, NEUROREHABILITACJA P; Talar J, 2003, NEUROREHABILITACJA P, P22; Talar Jan, 2002, Med Sci Monit, V8, pCS31; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Tomaszewski W, 2011, MED SCI MONITOR, V17, pCR35; Tomaszewski W, 2013, ANN AGR ENV MED, V20, P361; Tomaszewski W, 2012, ARCH BUDO, V8, P169, DOI 10.12659/AOB.883450; Uhlig T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-43; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird	40	4	4	0	11	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP 16	2013	19						767	772					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	217PC	WOS:000324370400001	24036691	Green Published, Green Submitted			2022-02-06	
J	Atighechi, S; Zolfaghari, A; Baradaranfar, M; Dadgarnia, M				Atighechi, Saeid; Zolfaghari, Aliasghar; Baradaranfar, Mohammadhossein; Dadgarnia, Mohammadhossein			Estimation of sensitivity and specificity of brain magnetic resonance imaging and single photon emission computed tomography in the diagnosis of olfactory dysfunction after head traumas	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article							POSTTRAUMATIC ANOSMIA; INJURY	Background: Olfactory dysfunction has an incidence of 5-10% after head injury. Several objective and subjective tests had been proposed. Recent studies showed that brain single photon emission computed tomography (SPECT) and brain magnetic resonance imaging (MRI) have good diagnostic value in this era in which the most common sites of involvement were olfactory bulb and olfactory nerve in MRI and frontal lobe in SPECT. This study aimed to estimate the sensitivity and specificity of brain MRI and brain SPECT in the diagnosis of traumatic hyposmia and anosmia. Methods: From February 2009 to March 2011, 63 patients with head injury and smell complaint were selected for this study. Using an identification test and a threshold smell test, 28 were anosmic and 27 had hyposmia and the remaining 8 were normosmic. All of them underwent brain MRI and SPECT. Results: The sensitivity of SPECT was 81.5 and 85.7% in hyposmia and anosmia, respectively. Its specificity was 87.5% in anosmia and 87.7% in anosmia. MRI sensitivity was 66.7% in hyposmia but 82.1% in anosmia. Its specificity was 85.7% in anosmia and 87.7% in anosmia. If MRI and SPECT were considered together, the sensitivity was 92.3% in hyposmia and 92% in anosmia, but the specificity was 87% in both cases. Conclusion: According to our study, both brain MRI and SPECT have high sensitivity and specificity in the diagnosis of traumatic anosmia, although brain SPECT is slightly superior to MRI. If the two techniques are applied together, the accuracy will be increased.	[Atighechi, Saeid; Zolfaghari, Aliasghar; Baradaranfar, Mohammadhossein; Dadgarnia, Mohammadhossein] Shahid Sadooghi Univ Med Sci, Dept Otolaryngol, Rhinol Res Ctr, Shahid Sadooghi Hosp, Yazd 8915887857, Iran		Atighechi, S (corresponding author), Shahid Sadooghi Univ Med Sci, Dept Otolaryngol, Shahid Sadooghi Hosp, Ibn E Sina St, Yazd 8915887857, Iran.	saeidatighechi@yahoo.com	dadgarnia, mohammad hossein/F-6364-2017; atighechi, saeid/F-6352-2017; baradaranfar, Mohammad hossein/F-6328-2017	dadgarnia, mohammad hossein/0000-0002-2802-9601; atighechi, saeid/0000-0002-9330-5342; baradaranfar, Mohammad hossein/0000-0002-3995-6822			Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; CAIN WS, 1983, AM J OTOLARYNG, V4, P252, DOI 10.1016/S0196-0709(83)80068-4; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Eftekhari M, 2006, AM J RHINOL, V20, P577, DOI 10.2500/ajr.2006.20.2906; Gaines AD, 2010, ALLERGY ASTHMA PROC, V31, P185, DOI 10.2500/aap.2010.31.3357; Gopinath B, 2011, AM J GERIAT PSYCHIAT, V19, P830, DOI 10.1097/JGP.0b013e318211c205; HUGHES B, 1964, ACUTE INJURIES HEAD, P410; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Kokan N, 2011, AM J RHINOL ALLERGY, V25, P163, DOI 10.2500/ajra.2011.25.3634; Leigh AD, 1943, LANCET, V1, P38; Leopold DA, 2010, CUMMINGS OTOLARYNGOL, P631; Mann NM, 2006, CLIN NUCL MED, V31, P458, DOI 10.1097/01.rlu.0000227010.72925.6d; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Summer D, 1976, HDB CLIN NEUROLOGY, P235; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	18	4	4	0	2	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1945-8924	1945-8932		AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	SEP-OCT	2013	27	5					403	406		10.2500/ajra.2013.27.3931			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	249EL	WOS:000326759700017	24119604				2022-02-06	
J	Kim, SW; Kim, JH; Han, ZA				Kim, Seong Woo; Kim, Jong Hun; Han, Zee-A			Self-inflicted trans-oral intracranial stab wound	BRAIN INJURY			English	Article						Brain stem; head injuries; penetrating	SUICIDE	Background: Intracranial stab wounds are low-velocity, penetrating injuries to the brain and fatality and outcome significantly depend on route, depth and location of cranial penetration. Due to the effective barrier provided by the adult calvarium, most injuries occur through the orbitae or temporal regions where bony layers are thin. Self-inflicted intracranial stab wounds are an even rarer form of traumatic brain injury, with common entry points being the orbital space and the nose. Intracranial brainstem injuries mostly result in death, with reported penetration areas being the pons or midbrain. Case: The following report reviews a first reported case of self-inflicted intracranial stabbing via a trans-oral route with lesions to the medulla oblongata and cerebellum. Unlike previous cases of low velocity penetrating injuries to the brainstem, the patient underwent full neurologic recovery after manual knife removal and intensive rehabilitation. Conclusion: Self-inflicted transcranial injuries have been mentioned only briefly and sporadically in the literature. This article highlights a rare case of self-inflicted intracranial stabbing with a not yet reported entry route and brainstem lesion. Unlike the other fatal outcomes associated with such injuries, the patient underwent full neurological and functional recovery through a comprehensive approach that included intensive rehabilitation.	[Kim, Seong Woo] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Phys Med & Rehabil, Gyeonggi Do, South Korea; [Kim, Jong Hun] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Neurol, Gyeonggi Do, South Korea; [Han, Zee-A] Natl Rehabil Ctr, Dept Phys Med & Rehabil, Gyeonggi Do, South Korea		Han, ZA (corresponding author), Natl Rehabil Ctr, 58 Samgaksan Ro, Seoul 142884, South Korea.	zeeahan@catholic.ac.kr					Ihama Y, 2012, FORENSIC SCI INT, V214, pE9, DOI 10.1016/j.forsciint.2011.07.004; Karger B, 2001, INT J LEGAL MED, V115, P167, DOI 10.1007/s004140100244; Kreisel SH, 2006, CEREBROVASC DIS, V21, P6, DOI 10.1159/000089588; Large M, 2012, AM J FOREN MED PATH, V33, P13, DOI 10.1097/PAF.0b013e3181dd5b47; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Saint-Martin P, 2008, AM J FOREN MED PATH, V29, P268, DOI 10.1097/PAF.0b013e318183456f; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6	7	4	4	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1206	1209		10.3109/02699052.2013.801514			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200014	23895312				2022-02-06	
J	Lannin, NA; Cusick, A; McLachlan, R; Allaous, J				Lannin, Natasha A.; Cusick, Anne; McLachlan, Robyn; Allaous, Jeanine			Observed Recovery Sequence in Neurobehavioral Function After Severe Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; clinical audit; coma; consciousness disorders; outcome assessment (health care); recovery of function	VEGETATIVE STATE; CONSCIOUSNESS; DISORDERS; COMA; SCALE	OBJECTIVE. The Western Neuro Sensory Stimulation Profile (WNSSP) presents a hierarchy of items suggestive of a sequence of recovery. The aim of this study was to understand the sequence of recovery of neurobehavioral function in patients with brain injury and determine whether this sequence was consistent with the WNSSP test item order. METHOD. We conducted a retrospective clinical chart audit of 37 adult inpatients (mean age = 29 yr; 31 men, 6 women) with a diagnosis of traumatic brain injury and a minimum of two medical record entries on the WNSSP. The sequence of recovery was statistically derived from the content and structure of the WNSSP. RESULTS. Our analysis did not support the current item ordering of the WNSSP as a function of the sequence of recovery from coma, with the exception of the Arousal/Attention subscale. CONCLUSION. WNSSP item performance suggested a sequence of recovery; clinicians may consider a revised item order that reflects this observed order.	[Lannin, Natasha A.] La Trobe Univ, Fac Hlth Sci, Occupat Therapy Dept, Melbourne, Vic, Australia; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic 3181, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Ryde, NSW, Australia; [Cusick, Anne] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia; [McLachlan, Robyn] Univ Western Sydney, Fac Hlth Sci, Penrith, NSW 1797, Australia; [Allaous, Jeanine] Royal Rehabil Ctr Sydney, Ryde, NSW, Australia		Lannin, NA (corresponding author), La Trobe Univ, Fac Hlth Sci, Occupat Therapy Dept, Melbourne, Vic, Australia.	N.Lannin@latrobeedu.au	Lannin, Natasha A/A-4195-2013; Cusick, Anne/H-5797-2019	Lannin, Natasha A/0000-0002-2066-8345; Cusick, Anne/0000-0001-9614-1462			Ansell B. J., 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199309000-00011; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1995, ARCH PHYS MED REHAB, V76, P726, DOI 10.1016/S0003-9993(95)80526-5; Aspen Neurobehavioral Conference Work Group, 2002, NEUROLOGY, V58, P349; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Dolce G, 2010, J PSYCHOPHYSIOL, V24, P107, DOI 10.1027/0269-8803/a000020; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Hagen C., 1972, RANCHO AMIGOS LEVEL; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Mackintosh S, 2009, AUST J PHYSIOTHER, V55, P65, DOI 10.1016/S0004-9514(09)70066-2; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Rosenberg RN, 2009, JAMA-J AM MED ASSOC, V301, P1172, DOI 10.1001/jama.2009.224; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; TEASDALE G, 1974, LANCET, V2, P81; Uniform Data Set for Medical Rehabilitation, 1997, GUID UN DAT SET MED; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Watson M., 1992, CLIN REHABIL, V6, P169; Watson MJ, 1997, NEUROPSYCHOL REHABIL, V7, P441	28	4	4	0	8	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2013	67	5					543	549		10.5014/ajot.2013.008094			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	220EQ	WOS:000324565400007	23968792				2022-02-06	
J	Lou, YF; Irimia, A; Vela, PA; Chambers, MC; Van Horn, JD; Vespa, PM; Tannenbaum, AR				Lou, Yifei; Irimia, Andrei; Vela, Patricio A.; Chambers, Micah C.; Van Horn, John D.; Vespa, Paul M.; Tannenbaum, Allen R.			Multimodal Deformable Registration of Traumatic Brain Injury MR Volumes via the Bhattacharyya Distance	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Bhattacharyya distance (BD); deformable image registration; multimodal registration; mutual information(MI); traumatic brain injury (TBI)	IMAGE REGISTRATION; FLUID REGISTRATION; ACTIVE CONTOURS; MEDICAL IMAGES; SEGMENTATION; DIVERGENCE	An important problem of neuroimaging data analysis for traumatic brain injury (TBI) is the task of coregistering MR volumes acquired using distinct sequences in the presence of widely variable pixel movements which are due to the presence and evolution of pathology. We are motivated by this problem to design a numerically stable registration algorithm which handles large deformations. To this end, we propose a new measure of probability distributions based on the Bhattacharyya distance, which is more stable than the widely used mutual information due to better behavior of the square root function than the logarithm at zero. Robustness is illustrated on two TBI patient datasets, each containing 12 MR modalities. We implement our method on graphics processing units (GPU) so as to meet the clinical requirement of time-efficient processing of TBI data. We find that 6 sare required to register a pair of volumes with matrix sizes of 256 x 256 x 60 on the GPU. In addition to exceptional time efficiency via its GPU implementation, this methodology provides a clinically informative method for the mapping and evaluation of anatomical changes in TBI.	[Lou, Yifei; Vela, Patricio A.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Irimia, Andrei; Chambers, Micah C.; Van Horn, John D.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurol & Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Tannenbaum, Allen R.] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Tannenbaum, Allen R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA		Lou, YF (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	louyifei@gmail.com; andrei.irimia@loni.ucla.edu; pvela@ece.gatech.edu; micahcc@ucla.edu; jack.vanhorn@loni.ucla.edu; pvespa@mednet.ucla.edu; tannenba@bu.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Lou, Yifei/0000-0003-1973-5704; Van Horn, John/0000-0003-1537-0816; Vela, Patricio/0000-0002-6888-7002	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41-RR-013218]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) [P41-EB-015902]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH82918]; AFOSRUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR); National Institutes of Health through the NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 EB005149]; NIH through STTRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R41 NS081792]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB005149, P41EB015902, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH082918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS081792] Funding Source: NIH RePORTER; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [0846750] Funding Source: National Science Foundation	This work was supported in part by the National Center for Research Resources under Grant P41-RR-013218, in part by the National Institute of Biomedical Imaging and Bioengineering under Grant P41-EB-015902 of the National Institutes of Health (NIH), in part by the NIH under Grant R01 MH82918 as well as a grant from AFOSR. This work is part of the National Alliance for Medical Image Computing (NAMIC) supported by the National Institutes of Health through the NIH Roadmap for Medical Research under Grant U54 EB005149. The work of J. D. V. Horn was supported by the NIH through STTR under Grant R41 NS081792. Information on the National Centers for Biomedical Computing can be obtained from http://nihroadmap.nih.gov/bioinformatics. Asterisk indicates corresponding author.	Acosta-Cabronero J, 2008, NEUROIMAGE, V39, P1654, DOI 10.1016/j.neuroimage.2007.10.051; Aherne FJ, 1998, KYBERNETIKA, V34, P363; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Bhattacharyya A., 1943, Bulletin of the Calcutta Mathematical Society, V35, P99; BroNielsen M, 1996, LECT NOTES COMPUT SC, V1131, P267; Cahill ND., 2007, IEEE C COMP VIS PATT, P1; Chappelow J, 2011, MED PHYS, V38, P2005, DOI 10.1118/1.3560879; Chesnut RM, 1998, SURG NEUROL, V50, P187, DOI 10.1016/S0090-3019(98)00075-5; Chiang MC, 2006, I S BIOMED IMAGING, P193; Christensen GE, 1996, IEEE T IMAGE PROCESS, V5, P1435, DOI 10.1109/83.536892; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; D'Agostino E., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P541; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; Faul M, 2010, TRAUMATIC BRAIN INJU; Freedman D, 2004, IEEE T IMAGE PROCESS, V13, P518, DOI 10.1109/TIP.2003.821445; Goudail F, 2004, J OPT SOC AM A, V21, P1231, DOI 10.1364/JOSAA.21.001231; Huh S, 2002, COMPUT BIOL MED, V32, P311, DOI 10.1016/S0010-4825(02)00023-9; Irimia A., 2012, FRONT NEUROL, V3, P1; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Johnson H. J., 2007, BRAINSFIT MUTUAL INF; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Khan I. R., 2010, P IEEE INT S COMM IN, P26; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; Loeckx D, 2010, IEEE T MED IMAGING, V29, P19, DOI 10.1109/TMI.2009.2021843; Lou Y., 2011, INSIGHT J; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Michailovich O, 2007, IEEE T IMAGE PROCESS, V16, P2787, DOI 10.1109/TIP.2007.908073; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Niethammer M, 2011, LECT NOTES COMPUT SC, V6892, P639, DOI 10.1007/978-3-642-23629-7_78; Niethammer M, 2011, LECT NOTES COMPUT SC, V6892, P655, DOI 10.1007/978-3-642-23629-7_80; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Pluim JPW, 2004, IEEE T MED IMAGING, V23, P1508, DOI 10.1109/TMI.2004.836872; Razlighi QR, 2009, IEEE T IMAGE PROCESS, V18, P2629, DOI 10.1109/TIP.2009.2029988; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Skerl D, 2008, MED IMAGE ANAL, V12, P42, DOI 10.1016/j.media.2007.06.001; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wang B., 2012, P SPIE MED IMAG, V8413; Wang B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1152, DOI 10.1109/ISBI.2012.6235764; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Yi Z, 2009, PROC CVPR IEEE, P2200, DOI 10.1109/CVPRW.2009.5206637; Younes L, 2009, NEUROIMAGE, V45, pS40, DOI 10.1016/j.neuroimage.2008.10.050; Zhuang AH, 2006, NEUROIMAGE, V32, P79, DOI 10.1016/j.neuroimage.2006.03.019	48	4	5	1	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	SEP	2013	60	9					2511	2520		10.1109/TBME.2013.2259625			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	206KG	WOS:000323518900015	23962986	Green Accepted			2022-02-06	
J	Mejaddam, AY; Elmer, J; Sideris, AC; Chang, YC; Petrovick, L; Alam, HB; Fagenholz, PJ				Mejaddam, Ali Y.; Elmer, Jonathan; Sideris, Antonios C.; Chang, Yuchiao; Petrovick, Laurie; Alam, Hasan B.; Fagenholz, Peter J.			PROLONGED EMERGENCY DEPARTMENT LENGTH OF STAY IS NOT ASSOCIATED WITH WORSE OUTCOMES IN TRAUMATIC BRAIN INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article						traumatic brain injury; Emergency Department; length of stay; Glasgow Outcome Scale; mortality	CRITICALLY-ILL PATIENTS; MYOCARDIAL-INFARCTION; HOSPITAL MORTALITY; DELAYED TRANSFER; UNITED-STATES; QUALITY; IMPACT; CARE; INDICATORS; PROGNOSIS	Background: Data suggest that prolonged Emergency Department length of stay (EDLOS) has a detrimental effect on outcomes in some critically ill patients. However, the relationship between EDLOS and outcomes in traumatic brain injury (TBI) has not been examined. Objective: Our objective was to determine the effect of EDLOS on neurologic outcomes in TBI patients. Methods: We performed a retrospective analysis of a prospectively identified cohort of patients with moderate (Glasgow Coma Scale [GCS] score 9-13) and severe (GCS <= 8) TBI who presented to a Level 1 trauma center (2006-2010). Inclusion criteria were transfer to the intensive care unit (ICU) or operating room(OR) from the ED. Primary outcome was Glasgow Outcome Scale (GOS) score, a measure of neurologic function, at discharge. We used a proportional odds model to control for significant predictors of GOS in univariate analysis. Results: Two hundred and twenty-four patients were included in the analysis, 77 (34%) of which were transferred to the OR. Median EDLOS was 3.3 h and 81.2% of patients had a GOS score <= 3 (e.g., severe disability, vegetative, or deceased). In multivariable analyses, EDLOS was not associated with GOS score in either ICU bound (p = 0.57) or OR bound (p = 0.11) patients. Younger age, pupil reactivity, and absence of intubation were independent predictors of good outcomes in the ICU group. In OR patients, predictors of higher GOS score included presence of an epidural hemorrhage, absence of midline shift, and pupil reactivity. Conclusions: Our study demonstrates that EDLOS was not associated with poor outcomes in patients with moderate to severe TBI who required intensive care or early operative intervention in an academic Level 1 trauma center. (C) 2013 Elsevier Inc.	[Mejaddam, Ali Y.; Sideris, Antonios C.; Chang, Yuchiao; Petrovick, Laurie; Alam, Hasan B.; Fagenholz, Peter J.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Elmer, Jonathan] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Elmer, Jonathan] Harvard Univ, Sch Med, Boston, MA USA		Fagenholz, PJ (corresponding author), Massachusetts Gen Hosp, Dept Surg, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.						BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Carr BG, 2007, J TRAUMA, V63, P9, DOI 10.1097/TA.0b013e31805d8f6b; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Diercks DB, 2007, ANN EMERG MED, V50, P489, DOI 10.1016/j.annemergmed.2007.03.033; Elmer J, 2012, NEUROCRIT CARE, V17, P334, DOI 10.1007/s12028-011-9629-1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; Mowery NT, 2011, J TRAUMA, V70, P1317, DOI 10.1097/TA.0b013e3182175199; Rincon F, 2010, NEUROCRIT CARE, V13, P75, DOI 10.1007/s12028-010-9347-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saukkonen KA, 2006, J INTERN MED, V260, P586, DOI 10.1111/j.1365-2796.2006.01716.x; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Tilluckdharry L, 2005, AM J EMERG MED, V23, P336, DOI 10.1016/j.ajem.2005.02.038; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	17	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	SEP	2013	45	3					384	390		10.1016/j.jemermed.2013.04.015			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	213IC	WOS:000324048400025	23769388				2022-02-06	
J	Un, KC; Wang, YC; Wu, WT; Leung, GKK				Un, Ka Chun; Wang, Yue Chun; Wu, Wutian; Leung, Gilberto Ka Kit			Systemic progesterone for modulating electrocautery-induced secondary brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Electrocautery; Haemostasis; Neuroprotection; Progesterone; Traumatic brain injury		Bipolar electrocautery is an effective and commonly used haemostatic technique but it may also cause iatrogenic brain trauma due to thermal injury and secondary inflammatory reactions. Progesterone has anti-inflammatory and neuroprotective actions in traumatic brain injury. However, its potential use in preventing iatrogenic brain trauma has not been explored. We conducted a pilot animal study to investigate the effect of systemic progesterone on brain cellular responses to electrocautery-induced injury. Adult male Sprague-Dawley rats received standardized bipolar electrocautery (40 W for 2 seconds) over the right cerebral cortex. The treatment group received progesterone intraperitoneally 2 hours prior to surgery; the control group received the drug vehicle only. Immunohistochemical studies showed that progesterone could significantly reduce astrocytic hypertrophy on postoperative day 1, 3 and 7, as well as macrophage infiltration on day 3. The number of astrocytes, however, was unaffected. Our findings suggest that progesterone should be further explored as a neuroprotective agent against electrocautery-induced or other forms of iatrogenic trauma during routine neurosurgical procedures. Future studies may focus on different dosing regimens, neuronal survival, functional outcome, and to compare progesterone with other agents such as dexamethasone. (C) 2013 Elsevier Ltd. All rights reserved.	[Un, Ka Chun; Wang, Yue Chun; Leung, Gilberto Ka Kit] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Wang, Yue Chun] Jinan Univ, Sch Med, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China		Leung, GKK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Queen Mary Hosp, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	gilberto@hkucc.hku.hk	Leung, Gilberto Ka Kit/C-4337-2009	Leung, Gilberto Ka Kit/0000-0003-3147-3057			Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549	3	4	4	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2013	20	9					1329	1330		10.1016/j.jocn.2012.10.032			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212TP	WOS:000324006000036	23830688				2022-02-06	
J	Vavilala, MS				Vavilala, Monica S.			Treating Cerebral Edema in Diabetic Ketoacidosis: Caveats in Extrapolating From Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral edema; diabetic ketoacidosis; hypertonic saline; pediatrics	HYPERTONIC SALINE; HEAD-INJURY; MANNITOL; CHILDREN		[Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pain Med & Pediat, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA.				NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS072308 03]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD049832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Supported, in part, by grant NINDS R01-NS072308 03.; Dr. Vavilala received support for article research from the National Institutes of Health.	Colomer CB, 2012, PEDIATR NEUROSURG, V48, P205, DOI 10.1159/000343385; Brenkert TE, 2013, PEDIATR EMERG CARE, V29, P71, DOI 10.1097/PEC.0b013e31827b54c3; DeCourcey DD, 2013, PEDIATR CRIT CARE ME, V14, P694, DOI 10.1097/PCC.0b013e3182975cab; Dervan L, PEDIAT RES IN PRESS; Foster JR, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/219706; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRANE EJ, 1985, NEW ENGL J MED, V312, P1147, DOI 10.1056/NEJM198505023121803; Kuppermann N, 2008, ARCH PEDIAT ADOL MED, V162, P544, DOI 10.1001/archpedi.162.6.544; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Ma RCW, 2009, NAT REV ENDOCRINOL, V5, P529, DOI 10.1038/nrendo.2009.180; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Ransom GH, 2003, CHILD ABUSE NEGLECT, V27, P381, DOI 10.1016/S0145-2134(03)00025-5; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Tasker Robert C, 2005, Pediatr Crit Care Med, V6, P405, DOI 10.1097/01.PCC.0000164343.20418.37; Vavilala MS, 2010, PEDIATR CRIT CARE ME, V11, P332, DOI 10.1097/PCC.0b013e3181c013f4	20	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2013	14	7					723	724		10.1097/PCC.0b013e31829f6c77			2	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	235GN	WOS:000325705100019	24162960	Green Accepted			2022-02-06	
J	Wang, HC; Wang, PM; Lin, YJ; Kwan, AL; Lin, WC; Tsai, NW; Cheng, BC; Chang, WN; Su, BYJ; Kung, CT; Lu, CH				Wang, Hung-Chen; Wang, Pei-Ming; Lin, Yu-Jun; Kwan, Aij-Lie; Lin, Wei-Che; Tsai, Nai-Wen; Cheng, Ben-Chung; Chang, Wen-Neng; Su, Ben Yu-Jih; Kung, Chia-Te; Lu, Cheng-Hsien			Serum adhesion molecules, outcome and neuro-psychological function in acute traumatic brain injury patients	CLINICA CHIMICA ACTA			English	Article						Adhesion molecules; Neuropsychological function; Outcome; Traumatic brain injury	L-SELECTIN; INFLAMMATORY RESPONSE; ASSOCIATION; ACTIVATION; NEUROINFLAMMATION; COAGULATION; EXPRESSION; LEUKOCYTES; MICROGLIA; CORRELATE	Background: Serum concentrations of adhesion molecules may be associated with secondary brain injury after acute traumatic brain injury (TBI). Methods: Blood samples of 68 patients admitted within 24 h after TBI were obtained on admission and on Days 4 and 7 after TBI. Patients received neuro-psychological testing on discharge and at 3 months after TBI. Results: Compared to controls, patients with acute TBI had markedly increased sICAM-1 and sVCAM-1 on presentation (p = 0.002 and p = 0.021, respectively), but markedly decreased sL-selectin and sE-selectin (p = 0.009 and p <= 0.001, respectively). Outcome was assessed upon discharge using the Glasgow Outcome Scale (GOS). Good outcome was defined as GOS >= 4 and poor outcome as GOS <= 3. Motor deficits on admission (p <= 0.001), Glasgow Coma Scale score on admission (p = 0.002), Injury Severity Score on admission (p = 0.009), neuro-surgical intervention (p = 0.004), post-traumatic seizure (p = 0.04), and sVCAM-1 level on admission (p = 0.033) were significant risk factors of outcome. A sVCAM-1 cut-off value of 752.5 ng/ml on admission had 80.0% sensitivity and 68.1% specificity for predicting outcome. Conclusion: Serum adhesion molecules are not specific for predicting outcome in patients with TBI. However, higher mean levels of these molecules on admission may imply more severe inflammatory response causing secondary brain injury and worse neuro-psychological function. These molecules may be added as evaluation markers in clinical practice. 2013 Elsevier B.V. All rights reserved.	[Wang, Hung-Chen; Lin, Yu-Jun] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Wang, Hung-Chen; Wang, Pei-Ming; Lin, Yu-Jun; Lin, Wei-Che; Tsai, Nai-Wen; Cheng, Ben-Chung; Chang, Wen-Neng; Su, Ben Yu-Jih; Kung, Chia-Te; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Hung-Chen; Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Pei-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan; [Lin, Yu-Jun; Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Wei-Che] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Chang, Wen-Neng; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Cheng, Ben-Chung; Su, Ben Yu-Jih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Kaohsiung, Taiwan; [Kung, Chia-Te] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan		Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, 123 Ta Pei Rd, Kaohsiung, Taiwan.	chlu99@ms44.url.com.tw		WANG, HUNG-CHEN/0000-0003-3962-1958; Su, Yu-Jih/0000-0002-7274-3458	Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG890791]	This study was supported by grants from the Chang Gung Memorial Hospital (Research Project CMRPG890791).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bednar MM, 1997, NEUROL RES, V19, P588; Blann AD, 1996, BRIT J HAEMATOL, V95, P192, DOI 10.1046/j.1365-2141.1996.7562378.x; Brown WR, 2007, J NEUROL SCI, V257, P67, DOI 10.1016/j.jns.2007.01.014; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Castellanos M, 2002, STROKE, V33, P982, DOI 10.1161/hs0402.105339; Chang CC, 2008, EUR J NEUROL, V15, pE66, DOI 10.1111/j.1468-1331.2008.02151.x; Dimopoulos N, 2006, NEUROSCI LETT, V398, P118, DOI 10.1016/j.neulet.2005.12.064; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; FASSBENDER K, 1995, STROKE, V26, P1361, DOI 10.1161/01.STR.26.8.1361; Ferri LE, 2009, SURGERY, V145, P384, DOI 10.1016/j.surg.2008.12.011; Giddings JC, 2005, BIOCHEM SOC T, V33, P406, DOI 10.1042/BST0330406; Giwa MO, 2012, NEUROLOGY, V78, P167, DOI 10.1212/WNL.0b013e3182407968; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kung CT, 2013, CLIN CHIM ACTA, V421, P116, DOI 10.1016/j.cca.2013.02.023; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; LAW MM, 1994, J TRAUMA, V37, P100, DOI 10.1097/00005373-199407000-00017; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Schmidt OI, 2007, ORTHOPADE, V36, P248, DOI 10.1007/s00132-007-1061-z; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Seekamp A, 2001, SHOCK, V15, P254, DOI 10.1097/00024382-200115040-00002; Soriano SG, 2008, EUR J ANAESTH, V25, P154, DOI 10.1017/S0265021507003390; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Szewieczek J, 2011, J NUTR HEALTH AGING, V15, P618, DOI 10.1007/s12603-011-0334-8; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HC, 2011, CRIT CARE, V15, DOI 10.1186/cc10568; Wang HC, 2011, NEUROSURGERY, V68, P1611, DOI 10.1227/NEU.0b013e318210c871; Wechsler, 1997, WECHSLER ADULT INTEL; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	44	4	4	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG 23	2013	423						122	129		10.1016/j.cca.2013.04.023			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	172BY	WOS:000320976100023	23643853				2022-02-06	
J	Huertas-Hoyas, E; Pedrero-Perez, EJ; Aguila-Maturana, AM; Gonzalez-Alted, C				Huertas-Hoyas, Elisabet; Pedrero-Perez, Eduardo J.; Aguila-Maturana, Ana M.; Gonzalez-Alted, Carlos			Evaluation of the community integration of persons with lateralised post-acute acquired brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						Acquired brain injury; Community integration; Hemispheric specialization; Laterality	PROTEIN DEPOSITION; CHRONIC APHASIA; HEAD-INJURY; STROKE; REHABILITATION; OUTCOMES; QUESTIONNAIRE; ADULTS; PERFORMANCE; PROFILE	Introduction. Hemispheric specialization is a topic of interest that has motivated an enormous amount of research in recent decades. After a unilateral brain injury, the consequences can affect various areas of specialization, leading, depending on the location of the injury, impairment in quality of life and community integration. Patients and methods. Cross-sectional study with a sample of 58 patients, 28 traumatic brain injury (TBI) and 30 cerebrovascular accidents, both lateralized. The level of integration in the community is measured by the Community Integration Questionnaire. Results. There were three groups analyzed by considering unilateral injury (full sample, stroke sample, and TBI sample). Results showed a significantly high community integration of people with right hemisphere injury. However, to measure the level of community integration between TBI and stroke, the results showed no significant differences. Conclusion. According to the results of the study people with brain injury in the right hemisphere have a better community integration than people with lesions in the left hemisphere regardless of the origin of the lesions (vascular or traumatic). We discussed the reasons that may motivate the differences and clinical implications.	[Pedrero-Perez, Eduardo J.] Ayuntamiento Madrid, Inst Adicc Madrid, Madrid, Spain; [Gonzalez-Alted, Carlos] CEADAC, Ctr Referencia Estatal Atenc Dano Cerebral Adquir, Madrid, Spain; [Huertas-Hoyas, Elisabet; Aguila-Maturana, Ana M.] Univ Rey Juan Carlos, Dept Fisioterapia Terapia Ocupac Rehabil & Med Fi, Madrid, Spain		Huertas-Hoyas, E (corresponding author), Univ Rey Juan Carlos, Dept Fisioterapia Terapia Ocupac Rehabil & Med Fi, E-28922 Alcorcon, Madrid, Spain.	elisabet.huertas@urjc.es	HUERTAS-HOYAS, ELISABET/ABD-4303-2020; Pedrero-Perez, Eduardo Jose/P-8127-2015; Aguila, Ana/ABF-8167-2020	HUERTAS-HOYAS, ELISABET/0000-0002-5840-541X; Pedrero-Perez, Eduardo Jose/0000-0002-3940-5609; AGUILA MATURANA, ANA MARIA/0000-0001-5996-2632			Alvarez-Linera J, 2002, REV NEUROLOGIA, V35, P115, DOI 10.33588/rn.3502.2001508; Arnadottir G, 2010, J REHABIL MED, V42, P903, DOI 10.2340/16501977-0621; Bausela E, 2005, REV COMPLUTENSE ED, V16, P571; BERNSPANG B, 1995, ARCH PHYS MED REHAB, V76, P1144, DOI 10.1016/S0003-9993(95)80124-3; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dalemans RJP, 2010, INT J LANG COMM DIS, V45, P537, DOI 10.3109/13682820903223633; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Defensor del Pueblo, 2005, DAN CER SOBR ESP AC; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; del Pozo NO, 2000, REV NEUROLOGIA, V30, P783, DOI 10.33588/rn.3008.99650; Diaz-Gil G, 2012, NEURORREHABILITACION, P1; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Fan LZ, 2010, BRAIN RES, V1353, P60, DOI 10.1016/j.brainres.2010.07.031; Garcia-Molina A, 2010, REHABILITACION MAD, V44, P105; GARCIAMOLINA A, 2008, REHABILITACION, V42, P67, DOI DOI 10.1016/S0048-7120(08)73616-8; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gomez-Fernandez L, 2000, REV NEUROLOGIA, V31, P749, DOI 10.33588/rn.3108.2000358; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; Hinckley JJ, 2002, J COMMUN DISORD, V35, P543, DOI 10.1016/S0021-9924(02)00119-3; Hinckley JJ, 2001, J COMMUN DISORD, V34, P241, DOI 10.1016/S0021-9924(01)00049-1; Hoofien D, 2001, BRAIN INJURY, V15, P189; Iwabuchi SJ, 2011, NEUROPSYCHOLOGIA, V49, P3599, DOI 10.1016/j.neuropsychologia.2011.09.011; Johnston KC, 2002, STROKE, V33, P466, DOI 10.1161/hs0202.102881; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kettunen JE, 2012, SCI WORLD J, P1, DOI 10.1100/2012/434120; Kim HJ, 2012, NEUROIMAGE, V60, P2054, DOI 10.1016/j.neuroimage.2012.02.025; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Letts L, 2001, MEASURING OCCUPATION, P121; Lust JM, 2011, BEHAV BRAIN RES, V217, P293, DOI 10.1016/j.bbr.2010.10.029; Macfarlane DP, 1999, NEUROREPORT, V10, P3945, DOI 10.1097/00001756-199912160-00040; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MUNOZCESPEDES JM, 1998, POLIBEA, V48, P38; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Ramos-Cabrer P, 2011, REV NEUROLOGIA, V52, P355, DOI 10.33588/rn.5206.2010322; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Salvado-Figueras M, 2011, REV NEUROLOGIA, V53, P321, DOI 10.33588/rn.5306.2011104; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; van der Ham IJM, 2011, NEUROPSYCHOLOGIA, V49, P999, DOI 10.1016/j.neuropsychologia.2011.02.024; Van Willemse AHP, 2009, J REHABIL MED, V41, P521; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	50	4	5	0	13	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	AUG 16	2013	57	4					150	156		10.33588/rn.5704.2013121			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	224RI	WOS:000324905400002	23884869				2022-02-06	
J	Cao, JH; Cheng, XH; Zhou, ZM; Sun, HQ; Zhou, F; Zhao, J; Liu, YH; Cui, G				Cao, Jianhua; Cheng, Xinghai; Zhou, Zhengming; Sun, Huiqing; Zhou, Feng; Zhao, Jing; Liu, Yonghua; Cui, Gang			Changes in the Foxj1 expression of Schwann cells after sciatic nerve crush	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Foxj1; Sciatic nerve crush; Schwann cells; Regeneration	TRANSCRIPTION FACTORS; WALLERIAN DEGENERATION; GENE-EXPRESSION; DIFFERENTIATION; INJURY; HOMOLOG-4; PCNA; PROLIFERATION; MORPHOGENESIS; CILIOGENESIS	Foxj1 is a member of the Forkhead box family of transcription factors expressed in multiple tissues during development and a major regulator of cilia development. It was reported that Foxj1 has a significant up-regulation after traumatic brain injury and plays an important role in central nervous system injury and repair. However, its expression and function in the peripheral nervous system lesion are not well understood. In this study, we investigated the spatiotemporal expression of Foxj1 in a rat sciatic nerve crush model. After never injury, we observed that Foxj1 had a significant up-regulation from 1 day, peaked at day 3 and then gradually decreased to the normal level at 4 weeks. At its peak expression, Foxj1 expressed mainly in Schwann cells (SCs) of the distal sciatic nerve segment from injury, but had few co-localizations in axons. Besides, the peak expression of Foxj1 was in parallel with proliferating cell nuclear antigen (PCNA), and numerous SCs expressing Foxj1 were PCNA positive. Collectively, we hypothesized that peripheral nerve crush-induced up-regulation of Foxj1 in the sciatic nerve was associated with Schwann cells proliferation.	[Cao, Jianhua; Cheng, Xinghai; Zhao, Jing; Liu, Yonghua; Cui, Gang] Nantong Univ, Affiliated Mental Hlth Ctr, Dept Orthopaed, Nantong 226001, Peoples R China; [Zhou, Zhengming; Sun, Huiqing; Zhou, Feng] Nantong Univ, Affiliated Jiangyin Hosp, Dept Orthopaed, Wuxi 214000, Peoples R China		Liu, YH (corresponding author), Nantong Univ, Affiliated Mental Hlth Ctr, Dept Orthopaed, Nantong 226001, Peoples R China.	liuyonghuantu@yahoo.com.cn; cuigangntu@yahoo.com.cn					Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3; Beckers A, 2007, P NATL ACAD SCI USA, V104, P15765, DOI 10.1073/pnas.0704344104; Bicknell Katrina A., 2004, V296, P247; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen HW, 2012, MOL CARCINOG, DOI 10.1002/mc.21904; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cui G, 2011, J MOL NEUROSCI, V45, P145, DOI 10.1007/s12031-011-9504-8; Deng XL, 2012, J MOL HISTOL, V43, P669, DOI 10.1007/s10735-012-9450-y; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gao SF, 2008, NEUROCHEM RES, V33, P1090, DOI 10.1007/s11064-007-9555-y; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Jackson Brian C., 2010, Human Genomics, V4, P345; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Jin R, 2006, CELL MOL IMMUNOL, V3, P341; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; Lee KY, 2008, MOL CELLS, V26, P5; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Lin L, 2005, J IMMUNOL, V175, P951, DOI 10.4049/jimmunol.175.2.951; Loreti S, 2007, NEURON GLIA BIOL, V3, P269, DOI 10.1017/S1740925X08000045; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Srivatsan S, 2005, J IMMUNOL, V175, P7805, DOI 10.4049/jimmunol.175.12.7805; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Tao T, 2009, J NEUROCHEM, V111, P647, DOI 10.1111/j.1471-4159.2009.06346.x; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Tichelaar JW, 1999, DEV BIOL, V213, P405, DOI 10.1006/dbio.1999.9380; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang QH, 2011, CELL MOL NEUROBIOL, V31, P509, DOI 10.1007/s10571-010-9644-3; Wang YH, 2013, J MOL HISTOL, V44, P27, DOI 10.1007/s10735-012-9459-2; Wang YH, 2009, NEUROCHEM RES, V34, P891, DOI 10.1007/s11064-008-9849-8	49	4	4	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	AUG	2013	44	4					391	399		10.1007/s10735-013-9500-0			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	190JL	WOS:000322335700003	23515839				2022-02-06	
J	Mala, H; Arnberg, K; Chu, D; Nedergaard, SK; Witmer, J; Mogensen, J				Mala, Hana; Arnberg, Kasper; Chu, David; Nedergaard, Signe Kjaer; Witmer, Jacqlyn; Mogensen, Jesper			Only repeated administration of the serotonergic agonist 8-OH-DPAT improves place learning of rats subjected to fimbria-fornix transection	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Neurotrauma; Pharmacological therapy; Serotonergic agonists; 8-OH-DPAT; Place learning; Functional recovery	TRAUMATIC BRAIN-INJURY; 5-HT1A RECEPTOR AGONIST; GLOBAL CEREBRAL-ISCHEMIA; BAY X 3702; PREFRONTAL CORTEX; WATER-MAZE; MEMORY FORMATION; SPATIAL MEMORY; INTRAHIPPOCAMPAL SCOPOLAMINE; NEUROBEHAVIORAL BENEFIT	Serotonergic agonists may act neuroprotectively against brain injury. This study addressed the therapeutic potential of 8-hydroxy-2-di-n-propylamino-tetralin (8-OH-DPAT), a selective 5-HT1A/7 receptor agonist, after mechanical brain injury, and evaluated its effects in terms of acquisition of an allocentric place learning task in a water maze. Rats were divided into 6 experimental groups, three of which were subjected to bilateral transection of fimbria-fornix (FF), while three groups were given control surgery (Sham). After surgery, within both the lesioned, and sham-operated animals, respectively, one group was administered a single dose of saline, one group was given a single dose (0.5 mg/kg/b.w.) of 8-OH-DPAT, and one group was treated with daily administration of 8-OH-DPAT (0.5 mg/kg/b.w.) for eight days. The acquisition of the water maze based place learning task started on the 8th day post-surgery and continued for 20 days. The results show that the lesioned group subjected to repeated administration of 8-OH-DPAT demonstrated a significantly improved acquisition of the place learning task compared to the vehicle injected lesion group. In contrast, the lesioned group treated with a single administration displayed impaired performance compared to the baseline lesion group. There were no significant effects of the 8-OH-DPAT administration in the sham control groups. We conclude that only the repeated stimulation of the 5-HT1(A/7) An system was associated with beneficial, recovery enhancing effects. (C) 2013 Elsevier Inc. All rights reserved.	[Mala, Hana; Arnberg, Kasper; Chu, David; Nedergaard, Signe Kjaer; Witmer, Jacqlyn; Mogensen, Jesper] Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, DK-1353 Copenhagen K, Denmark		Mogensen, J (corresponding author), Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	jesper.mogensen@psy.ku.dk		Mogensen, Jesper/0000-0003-1959-581X; Rytter, Hana Mala/0000-0002-2910-372X	Danish National Research FoundationDanmarks Grundforskningsfond	The present study was supported by a grant from the Danish National Research Foundation.	Almaguer W, 2005, RESTOR NEUROL NEUROS, V23, P43; ARVIDSSON LE, 1981, J MED CHEM, V24, P921, DOI 10.1021/jm00140a002; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bonaventure P, 2004, NEUROSCIENCE, V124, P901, DOI 10.1016/j.neuroscience.2004.01.014; Brasted PJ, 2003, BRAIN, V126, P1202, DOI 10.1093/brain/awg103; Brasted PJ, 2002, J NEUROPHYSIOL, V87, P631, DOI 10.1152/jn.00656.2001; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Carli M, 2000, BRIT J PHARMACOL, V131, P375, DOI 10.1038/sj.bjp.0703567; Carli M, 1998, EUR J NEUROSCI, V10, P221, DOI 10.1046/j.1460-9568.1998.00034.x; CARLI M, 1995, BEHAV BRAIN RES, V67, P67, DOI 10.1016/0166-4328(94)00105-O; Carli M, 2000, PSYCHOPHARMACOLOGY, V149, P259, DOI 10.1007/s002139900368; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; COLE BJ, 1994, PSYCHOPHARMACOLOGY, V116, P135, DOI 10.1007/BF02245055; Costa L, 2012, HIPPOCAMPUS, V22, P790, DOI 10.1002/hipo.20940; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; De Vry J, 1998, J PHARMACOL EXP THER, V284, P1082; De Vry J, 1998, EUR J PHARMACOL, V357, P1, DOI 10.1016/S0014-2999(98)00503-2; Depoortere R, 2010, EUR NEUROPSYCHOPHARM, V20, P641, DOI 10.1016/j.euroneuro.2010.04.005; Dijkhuizen R. M., 1992, Brain Topography, V5, P147, DOI 10.1007/BF01129042; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Ehrenreich H, 2004, TRANSFUS APHER SCI, V31, P39, DOI 10.1016/j.transci.2004.05.001; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Elvander-Tottie E, 2009, HIPPOCAMPUS, V19, P1187, DOI 10.1002/hipo.20596; Eriksson TM, 2008, EUR J PHARMACOL, V596, P107, DOI 10.1016/j.ejphar.2008.08.026; Galeotti N, 2000, JPN J PHARMACOL, V84, P418, DOI 10.1254/jjp.84.418; Garcia-Alcocer G, 2006, GENE EXPRESSION, V13, P53, DOI 10.3727/000000006783991935; Gasbarri A, 2008, BEHAV BRAIN RES, V195, P164, DOI 10.1016/j.bbr.2007.12.020; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hedlund PB, 2004, TRENDS PHARMACOL SCI, V25, P481, DOI 10.1016/j.tips.2004.07.002; Hedlund PB, 2010, NEUROSCI LETT, V481, P12, DOI 10.1016/j.neulet.2010.06.036; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Helsley S, 1998, PROG NEURO-PSYCHOPH, V22, P1179, DOI 10.1016/S0278-5846(98)00068-2; HJORTH S, 1988, N-S ARCH PHARMACOL, V338, P463, DOI 10.1007/BF00179315; Ikonen S, 2002, HIPPOCAMPUS, V12, P386, DOI 10.1002/hipo.1109; Jeltsch H, 2004, PSYCHOPHARMACOLOGY, V175, P37, DOI 10.1007/s00213-004-1783-0; Kikuchi C, 1999, J MED CHEM, V42, P533, DOI 10.1021/jm980519u; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Koenig J, 2008, HIPPOCAMPUS, V18, P99, DOI 10.1002/hipo.20368; Liy-Salmeron G, 2008, HIPPOCAMPUS, V18, P965, DOI 10.1002/hipo.20459; Liy-Salmeron G, 2007, BRAIN RES, V1147, P140, DOI 10.1016/j.brainres.2007.02.007; Lovell PJ, 2000, J MED CHEM, V43, P342, DOI 10.1021/jm991151j; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luttgen M, 2005, NEUROPHARMACOLOGY, V48, P830, DOI 10.1016/j.neuropharm.2005.01.007; Madjid N, 2006, J PHARMACOL EXP THER, V316, P581, DOI 10.1124/jpet.105.092262; Mala H, 2008, BRAIN RES, V1217, P221, DOI 10.1016/j.brainres.2008.04.005; Mala H, 2007, J NEUROTRAUM, V24, P1647, DOI 10.1089/neu.2007.0292; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Martin-Cora FJ, 2004, BRIT J PHARMACOL, V141, P92, DOI 10.1038/sj.bjp.0705576; Meneses A, 2008, BEHAV BRAIN RES, V195, P112, DOI 10.1016/j.bbr.2007.11.023; Meneses A, 2001, DRUG NEWS PERSPECT, V14, P396, DOI 10.1358/dnp.2001.14.7.660941; Meneses A, 2007, NEUROSCI BIOBEHAV R, V31, P705, DOI 10.1016/j.neubiorev.2007.02.001; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J., 2011, HDB LAB ANIMAL SCI, VII, P47; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nolte J., 1999, HUMAN BRAIN INTRO IT; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; Perez-Garcia G, 2006, BEHAV BRAIN RES, V169, P83, DOI 10.1016/j.bbr.2005.12.013; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Roberts AJ, 2012, HIPPOCAMPUS, V22, P762, DOI 10.1002/hipo.20938; Roberts C, 2001, BRIT J PHARMACOL, V132, P1574, DOI 10.1038/sj.bjp.0703979; Salazar-Colocho P, 2007, J PHYSIOL BIOCHEM, V63, P203, DOI 10.1007/BF03165783; Santucci AC, 2004, BEHAV NEUROSCI, V118, P248, DOI 10.1037/0735-7044.118.1.248; Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stiedl O, 2000, J NEUROSCI, V20, P8515, DOI 10.1523/JNEUROSCI.20-22-08515.2000; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Thinschmidt JS, 2005, EXP NEUROL, V195, P342, DOI 10.1016/j.expneurol.2005.05.006; Torup L, 2000, EUR J PHARMACOL, V395, P137, DOI 10.1016/S0014-2999(00)00175-8; Warburton EC, 1997, BEHAV BRAIN RES, V84, P247; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Youn J, 2009, NEUROPHARMACOLOGY, V57, P567, DOI 10.1016/j.neuropharm.2009.07.011; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816	94	4	4	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	AUG	2013	109						50	58		10.1016/j.pbb.2013.05.008			9	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	180OT	WOS:000321605200008	23680575				2022-02-06	
J	McIlvain, SM; Walter, KH; Chard, KM				McIlvain, Susan M.; Walter, Kristen H.; Chard, Kathleen M.			Using Cognitive Processing Therapy-Cognitive in a Residential Treatment Setting With an OIF Veteran With PTSD and a History of Severe Traumatic Brain Injury: A Case Study	COGNITIVE AND BEHAVIORAL PRACTICE			English	Article						PTSD; Severe Traumatic Brain Injury; Cognitive Processing Therapy-Cognitive	POSTTRAUMATIC-STRESS-DISORDER; CLINICIAN; OUTCOMES	The co-occurrence of posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) is common among military personnel returning from deployments in Iraq and Afghanistan. Despite the prevalence, scant evidence exists to inform clinicians as how to best treat these individuals, particularly for individuals with PTSD and a history of severe TBI. This case study presents the course of treatment in a VA residential PTSD/TBI program for an Operation Iraqi Freedom Veteran with PTSD, a history of severe TBI, and other psychiatric comorbidities. Cognitive Processing Therapy Cognitive (CPT-C) was utilized as the primary PTSD treatment in conjunction with ancillary treatment. Data obtained during and following treatment suggest that CPT-C, without modifications to the protocol, offered within a residential treatment program may be an effective treatment for veterans with PTSD and a history of severe TBI.	[McIlvain, Susan M.; Walter, Kristen H.; Chard, Kathleen M.] Cincinnati VA Med Ctr, Cincinnati, OH 45220 USA; [Chard, Kathleen M.] Univ Cincinnati, Sch Med, Cincinnati, OH 45221 USA		Chard, KM (corresponding author), Cincinnati VA Med Ctr, 3200 Vine St, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blake D.D., 1990, CLIN ADM PTSD SCALE; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chard KM, 2005, J CONSULT CLIN PSYCH, V73, P965, DOI 10.1037/0022-006X.73.5.965; Chard KM, 2008, COGNITIVE PROCESSING; Defense and Veterans Brain Injury Center, 2010, DEP DEF NUMB TRAUM B; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reitan R, 1985, HALSTEAD REITAN NEUR; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wechsler D., 2008, WECHLSER ADULT INTEL	29	4	4	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1077-7229	1878-187X		COGN BEHAV PRACT	Cogn. Behav. Pract.	AUG	2013	20	3					375	382		10.1016/j.cbpra.2012.09.002			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	170FB	WOS:000320834700013					2022-02-06	
J	Prieto-Valderrey, F; Muniz-Montes, JR; Lopez-Garcia, JA; Villegas-del Ojo, J; Malaga-Gil, J; Galvan-Garcia, R				Prieto-Valderrey, F.; Muniz-Montes, J. R.; Lopez-Garcia, J. A.; Villegas-del Ojo, J.; Malaga-Gil, J.; Galvan-Garcia, R.			Utility of diffusion-weighted magnetic resonance imaging in severe focal traumatic brain injuries	MEDICINA INTENSIVA			Spanish	Article						Diffusion-Weighted Magnetic Resonance Imaging; Apparent diffusion coefficient; Echo-planar imaging; Brain injuries; Vasogenic brain edema; Cytotoxic brain edema; Glasgow Outcome Scale	CELLULAR EDEMA; MR DIFFUSION; HEAD-INJURY; COEFFICIENT; STROKE; TISSUE; COMA	Objective: To describe the apparent diffusion coefficient (ADC) in a series of severe traumatic brain injuries, their clinical and outcome features, and possible implications. Design: A descriptive, observational case-series study was carried out. Patients and interventions: Patients with severe traumatic brain injuries (TBIs) admitted to the ICU were subjected to MRI study using a 1.5 T scanner. Diffusion-weighted images (DWMR) were obtained using the following echo-planar pulse sequence: TR 10000 ms, TE 126.9 ms, with b values 1000 s/mm2 in the three spatial dimensions. Combining the three sets of images, an isotropic image conforming a map of the mean ADCs was obtained. Results: DWMR was performed in 23 patients with severe TBI admitted to the ICU between 2001 and 2004. In the MR images we selected 26 regions of interest (ROIs) where ADC was recorded. We observed a clear increase in diffusion in non-treated space-occupying lesions versus other types of injuries and the normal values. A poorer outcome was recorded in patients with lower ADC values. Conclusions: Mean ADC in the lesions was greater than the normal values and greater in contusions than in other types of injuries, as an expression of extracellular edema. ADCs were decreased in patients with a poor outcome, suggesting an association between ischemia and the patient prognosis. (c) 2011 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Prieto-Valderrey, F.; Villegas-del Ojo, J.] Hosp Santa Barbara, Serv Med Intens, Ciudad Real, Spain; [Muniz-Montes, J. R.; Lopez-Garcia, J. A.] Hosp Univ Canarias, Unidad Resonancia Magnet, Dept Radiol, Tenerife, Spain; [Malaga-Gil, J.; Galvan-Garcia, R.] Hosp Univ Canarias, Serv Med Intens, Tenerife, Spain		Prieto-Valderrey, F (corresponding author), Hosp Santa Barbara, Serv Med Intens, Ciudad Real, Spain.	fprietom@sescam.jccm.es					Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P115; Barzo P, 1997, ACT NEUR S, V70, P119; Beauchamp NJ, 1998, RADIOGRAPHICS, V18, P1269, DOI 10.1148/radiographics.18.5.9747619; Beaumont A, 2000, ACT NEUR S, V76, P147; Cercignani M, 2001, J NEUROL SCI, V186, pS11, DOI 10.1016/S0022-510X(01)00486-5; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Grant PE, 2001, RADIOLOGY, V221, P43, DOI 10.1148/radiol.2211001523; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENNETT B, 1975, LANCET, V1, P480; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2000, ACT NEUR S, V76, P349; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miyasaka N, 2000, RADIOLOGY, V215, P199, DOI 10.1148/radiology.215.1.r00ap24199; Moritani T, 2000, CLIN IMAG, V24, P181, DOI 10.1016/S0899-7071(00)00203-5; Mullins ME, 2002, RADIOLOGY, V224, P353, DOI 10.1148/radiol.2242010873; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1080/028418501127346990; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Portella G, 2000, ACT NEUR S, V76, P273; Schaefer P, 1998, P 36 ANN M AM SOC NE; Schaefer PW, 2003, AM J NEURORADIOL, V24, P436; Schaefer PW, 2001, J NEUROL SCI, V186, pS25, DOI 10.1016/S0022-510X(01)00488-9; Schaefer PW, 2001, J NEUROIMAGING, V11, P369, DOI 10.1111/j.1552-6569.2001.tb00065.x; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; TEASDALE G, 1974, LANCET, V2, P81; Unterberg AW, 1997, ACT NEUR S, V70, P106; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Xing D, 1997, MAGN RESON IMAGING, V15, P771, DOI 10.1016/S0730-725X(97)00037-4	39	4	4	0	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	AUG-SEP	2013	37	6					375	382		10.1016/j.medin.2012.07.002			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197PB	WOS:000322862000002	23009901				2022-02-06	
J	Cullen, N; Vimalesan, K; Taggart, C				Cullen, Nora; Vimalesan, Kalyani; Taggart, Christina			Efficacy of a functionally-based neurorehabilitation programme: A retrospective case-matched study of rehabilitation outcomes following traumatic brain injury	BRAIN INJURY			English	Article						Health service delivery; rehabilitation outcome	DISABILITY RATING-SCALE; HEAD-INJURY; INDEPENDENCE MEASURE; RECOVERY; STAY; COMA; MODERATE; LENGTH	Objective: To investigate the efficacy of a functionally-based neurorehabilitation programme. Design: Retrospective, case-matched cohort design. Setting: An inpatient acquired brain injury (ABI) service at a post-acute rehabilitation facility. In 2001, a functionally-based rehabilitation model was introduced that streams patients into neurocognitive (NC) and neurophysical (NP) treatment groups based on predominant functional deficits. Methods: Sixty-nine patients with TBI admitted to the ABI service before implementation of the functionally-based programme comprised a historical control group. These patients were individually case-matched to 69 participants admitted after the functionally-based programme began. Rehabilitation outcomes were compared between matched patients treated before and after implementation of the programme. Outcome measures: Rehabilitation length of stay (RLOS), Functional Independence Measure (FIM) and Disability Rating Scale (DRS) at rehabilitation discharge and FIM efficiency. Results: At discharge, the NP-stream had a significantly higher FIM motor efficiency compared to the historical control (0.41 vs. 0.29; p = 0.01). The NC-stream had significantly less disability, as measured by the DRS, compared to its control (3.63 vs. 5.05; p = 0.01). Conclusions: This study presents preliminary evidence that a rehabilitation programme that targets functional needs rather than diagnosis may be useful in improving function after traumatic brain injury.	[Cullen, Nora; Taggart, Christina] Univ Hlth Network, Toronto Rehabil Inst, Res Dept, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Dept Med, Div Physiatry, Toronto, ON, Canada; [Vimalesan, Kalyani] Univ Toronto, Dept Med, Toronto, ON, Canada		Cullen, N (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	nora.cullen@uhn.ca		Cullen, Nora/0000-0001-6359-9418	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Ontario; Physician's Services Incorporated Foundation	Equipment and space have been funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care. This research has been funded by the Physician's Services Incorporated Foundation. The authors report no conflicts of interest.	[Anonymous], 2008, ANN REPORT; Campbell M., 2000, REHABILITATION TRAUM; Chua KSG, 2010, J REHABIL MED, V42, P27, DOI 10.2340/16501977-0476; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gleeny C., 2009, BMC GETRIATRICS, V9, P1; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	30	4	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					799	806		10.3109/02699052.2013.775488			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200005	23730824				2022-02-06	
J	Hoffer, ME; Balaban, C; Nicholas, R; Marcus, D; Murphy, S; Gottshall, K				Hoffer, Michael E.; Balaban, Carey; Nicholas, Rena; Marcus, Dawn; Murphy, Sara; Gottshall, Kim			Neurosensory Sequelae of Mild Traumatic Brain Injury	PSYCHIATRIC ANNALS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EXPOSURE VESTIBULAR CONSEQUENCES; AXIS-I; IRAQ; INDIVIDUALS; HEADACHE; REHABILITATION; COMORBIDITY; AFGHANISTAN; DYSFUNCTION		[Hoffer, Michael E.; Murphy, Sara; Gottshall, Kim] Naval Med Ctr San Diego, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92134 USA; [Hoffer, Michael E.] Hearing Ctr Excellence, San Antonio, TX USA; [Balaban, Carey] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Marcus, Dawn] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA		Hoffer, ME (corresponding author), Naval Med Ctr San Diego, Dept Otolaryngol, Spatial Orientat Ctr, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	Michael.hoffer@med.navy.mil	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844			Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Anke KM, 2013, J NEUROTRAU IN PRESS; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Balaban CD, 2012, BRAIN RES, V1482, P101, DOI 10.1016/j.brainres.2012.08.040; Balaban CD, 2004, SPR HDB AUD, P286; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Cathcart S, 2010, CEPHALALGIA, V30, P1250, DOI 10.1177/0333102410362927; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; MARCUS DA, 1993, CLIN J PAIN, V9, P159, DOI 10.1097/00002508-199309000-00002; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stalder-Luthy F, 2013, ARCH PHYS MED REHABI; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; Waldron-Perrine B, 2008, REHABIL PSYCHOL, V53, P426, DOI 10.1037/a0013530; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	41	4	4	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713			PSYCHIAT ANN	Psychiatr. Ann.	JUL	2013	43	7					318	323		10.3928/00485713-20130703-06			6	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	205HH	WOS:000323433600006					2022-02-06	
J	Mansour, N; deSouza, RM; Sikorski, C; Kahana, M; Frim, D				Mansour, Nassir; deSouza, Ruth-Mary; Sikorski, Christian; Kahana, Madelyn; Frim, David			Role of barbiturate coma in the management of focally induced, severe cerebral edema in children Report of 3 cases	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pentobarbital; focal; intracranial; hypertension; brain; pediatric	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; PENTOBARBITAL THERAPY; MODERATE HYPOTHERMIA; INTENSIVE-CARE; PRESSURE	Barbiturates are widely used in the management of high intracranial pressure (ICP) caused by diffuse brain swelling. The cardiovascular, renal, and immunological side effects of these drugs limit them to last-line therapy. There are few published data regarding the role of barbiturates in focal brain lesions causing refractory elevated ICP and intraoperative brain swelling in the pediatric population. The authors here present 3 cases of nontraumatic, focally induced, refractory intracranial hypertension due to 2 tumors and 1 arteriovenous malformation, in which barbiturate therapy was used successfully to control elevated ICP. They focus on cardiovascular, renal, and immune function during the course of pentobarbital therapy. They also discuss the role of pentobarbital-induced hypothermia. From this short case series, they demonstrate that barbiturates in conjunction with standard medical therapy can be used to safely reduce postoperative refractory intracranial hypertension and intraoperative brain swelling in children with focal brain lesions.	[Mansour, Nassir; Frim, David] Univ Chicago, Neurosurg Sect, Chicago, IL 60637 USA; [deSouza, Ruth-Mary] Kings Coll Hosp London, London, England; [Sikorski, Christian] Lake Michigan Neurol Surg, St Joseph, MI USA; [Kahana, Madelyn] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA		Mansour, N (corresponding author), Univ Chicago, Neurosurg Sect, MC 3026, Chicago, IL 60637 USA.	nmonim@surgery.bsd.uchicago.edu		Mansour, Nassir/0000-0002-1518-9913			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; AOKI N, 1985, NEUROSURGERY, V16, P660, DOI 10.1227/00006123-198505000-00013; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; FREWEN TC, 1982, J PEDIATR-US, V100, P663, DOI 10.1016/S0022-3476(82)80782-8; Kageyama G, 2000, NEUROL RES, V22, P601; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Koch JD, 2011, CURR OPIN PEDIATR, V23, P275, DOI 10.1097/MOP.0b013e3283460584; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1978, CRIT CARE MED, V6, P1, DOI 10.1097/00003246-197801000-00001; MARSHALL LF, 1983, NEUROSURGERY, V13, P412, DOI 10.1227/00006123-198310000-00011; NUSSBAUM E, 1988, PEDIATRICS, V81, P630; Oda Shinri, 1992, Neurological Surgery, V20, P1241; PIATT JH, 1984, NEUROSURGERY, V15, P427, DOI 10.1227/00006123-198409000-00023; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; SCHAIBLE DH, 1982, J PEDIATR-US, V100, P655, DOI 10.1016/S0022-3476(82)80780-4; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; SWEDLOW D, 1980, CRIT CARE MED, V8, P236, DOI 10.1097/00003246-198004000-00053; TRAEGER SM, 1983, CRIT CARE MED, V11, P697, DOI 10.1097/00003246-198309000-00005; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785	25	4	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2013	12	1					37	43		10.3171/2013.3.PEDS12196			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	168WU	WOS:000320739400007	23641961				2022-02-06	
J	Mrozek, S; Gaussiat, F; Geeraerts, T				Mrozek, S.; Gaussiat, F.; Geeraerts, T.			The management of femur shaft fracture associated with severe traumatic brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			English	Article; Proceedings Paper	Monothematic Meeting of Societe-Francaise-d'Anesthesie-et-de-Reanimation - Severe Trauma - The First 24 Hours	MAY 29, 2013	Paris, FRANCE	Soc Francaise Anesthesie & Reanimat		Severe traumatic brain injury; Femoral fracture; Double hit; Damage-control orthopedic	EARLY INTERNAL-FIXATION; EARLY TOTAL CARE; DAMAGE CONTROL; FEMORAL FRACTURES; MULTIPLE TRAUMA; HEAD-INJURY; EXTERNAL FIXATION; LOWER-EXTREMITY; INFLAMMATORY RESPONSE; POLYTRAUMA PATIENTS	The aim of this article is to describe the management of femoral shaft fractures in patients with severe traumatic brain injury (TBI). This is a major problem and two questions remain currently of interest: When and how to perform orthopedic surgery in severe TBI patients? The main point of perioperative management remains the prevention of secondary brain insults and the monitoring of intracranial pressure is essential especially in patients with intracranial lesions on the CT-scan. The "double hit" concept, suggesting that surgery by itself might increase the preexisting systemic inflammatory response, gives argument for very early or delayed surgery. Early definitive femoral osteosynthesis, if requires lengthy surgical procedure, does not seem appropriate in this context and "damage-control orthopedics" with external fixation seems to be a good alternative. (c) 2013 Published by Elsevier Masson SAS on behalf of the Societe francaise d'anesthesie et de reanimation (Sfar).	[Mrozek, S.; Gaussiat, F.; Geeraerts, T.] Univ Toulouse 3, Dept Anesthesiol & Intens Care, Equipe Accueil Modelisat Agress Tissulaire & Noci, Univ Hosp Toulouse,Hop Purpan, F-31059 Toulouse 9, France		Geeraerts, T (corresponding author), Univ Toulouse 3, Dept Anesthesiol & Intens Care, Equipe Accueil Modelisat Agress Tissulaire & Noci, Univ Hosp Toulouse,Hop Purpan, 1 Pl Dr Baylac, F-31059 Toulouse 9, France.	geeraerts.t@chu-toulouse.fr					Anglen JO, 2003, J TRAUMA, V54, P1166, DOI 10.1097/01.TA.0000057232.66613.AC; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BONE LB, 1994, J TRAUMA, V37, P262, DOI 10.1097/00005373-199408000-00019; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; BROOS PLO, 1987, INJURY, V18, P235, DOI 10.1016/0020-1383(87)90004-0; Brundage SI, 2002, J TRAUMA, V52, P299, DOI 10.1097/00005373-200202000-00016; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Flierl MA, 2010, J ORTHOP TRAUMA, V24, P107, DOI 10.1097/BOT.0b013e3181b6bdfc; Forteza AM, 1999, STROKE, V30, P2687, DOI 10.1161/01.STR.30.12.2687; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Gebhard F, 2008, LANGENBECK ARCH SURG, V393, P825, DOI 10.1007/s00423-008-0334-2; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; Giannoudis PV, 2002, CLIN ORTHOP RELAT R, P378, DOI 10.1097/01.blo.00000236813.17269.24; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; GORIS RJA, 1982, J TRAUMA, V22, P895, DOI 10.1097/00005373-198211000-00002; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grotz MRW, 2004, INJURY, V35, P1077, DOI 10.1016/j.injury.2004.05.025; Hanrin JA, 2012, J TRAUMA ACUTE CARE, V73, P1442; Hanrin JA, 2012, J TRAUMA ACUTE CARE, V73, P1448; Hara M, 1998, NEUROL RES, V20, P225, DOI 10.1080/01616412.1998.11740510; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; HOFMAN PAM, 1991, J TRAUMA, V31, P261, DOI 10.1097/00005373-199131020-00020; Husebye EE, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-2; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JOHNSON EE, 1990, CLIN ORTHOP RELAT R, P251; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kemp CD, 2008, AM SURGEON, V74, P866; KOTWICA Z, 1990, ACTA NEUROCHIR, V102, P19, DOI 10.1007/BF01402180; Lehmann U, 2001, UNFALLCHIRURG, V104, P196, DOI 10.1007/s001130050715; LEHMANN U, 1995, UNFALLCHIRURG, V98, P437; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mommsen P, 2011, PATHOL RES PRACT, V207, P142, DOI 10.1016/j.prp.2010.12.003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mousavi M, 2001, INJURY, V32, P679, DOI 10.1016/S0020-1383(01)00048-1; Nahm NJ, 2012, J TRAUMA ACUTE CARE, V73, P1046, DOI 10.1097/TA.0b013e3182701ded; Nau T, 2003, WORLD J SURG, V27, P365, DOI 10.1007/s00268-002-6412-7; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Nowotarski PJ, 2000, J BONE JOINT SURG AM, V82A, P781, DOI 10.2106/00004623-200006000-00004; NUTZ V, 1994, UNFALLCHIRURG, V97, P399; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Pape HC, 2008, J ORTHOP RES, V26, P1478, DOI 10.1002/jor.20697; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Pape HC, 2003, J TRAUMA, V55, P7, DOI 10.1097/01.TA.0000075787.69695.4E; Pape HC, 2002, J TRAUMA, V53, P452, DOI 10.1097/00005373-200209000-00010; Pape HC, 2002, AM J SURG, V183, P622, DOI 10.1016/S0002-9610(02)00865-6; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; POOLE GV, 1992, J TRAUMA, V32, P654, DOI 10.1097/00005373-199205000-00019; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Ransohoff RM, 2002, ANN NY ACAD SCI, V961, P346, DOI 10.1111/j.1749-6632.2002.tb03120.x; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; REYNOLDS MA, 1995, ANN SURG, V222, P470; RISKA EB, 1982, J TRAUMA, V22, P891, DOI 10.1097/00005373-198211000-00001; RISKA EB, 1976, INJURY, V8, P110, DOI 10.1016/0020-1383(76)90043-7; Roberts Craig S, 2005, Instr Course Lect, V54, P447; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Schmidt Bernhard, 2002, Eur J Ultrasound, V16, P37, DOI 10.1016/S0929-8266(02)00044-7; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stahel PF, 2009, CURR OPIN ANESTHESIO, V22, P289, DOI 10.1097/ACO.0b013e32832678ed; Starr AJ, 1998, J ORTHOP TRAUMA, V12, P38, DOI 10.1097/00005131-199801000-00007; Taeger G, 2005, J TRAUMA, V59, P408, DOI 10.1097/01.ta.0000175088.29170.3e; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Tuttle MS, 2009, J TRAUMA, V67, P602, DOI 10.1097/TA.0b013e3181aa21c0; Velly L, 2010, Ann Fr Anesth Reanim, V29, pe183, DOI 10.1016/j.annfar.2010.06.008; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Waydhas C, 1996, J TRAUMA, V40, P624, DOI 10.1097/00005373-199604000-00018; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	91	4	8	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	JUL-AUG	2013	32	7-8					510	515		10.1016/j.annfar.2013.07.010			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	218SM	WOS:000324452800009	23910064				2022-02-06	
J	Sadeghi, K; Hadi, F; Ahmadi, A; Hamishehkar, H; Beigmohammadi, MT; Mahmoodpoor, A; Rouini, MR; Farhudi, S; Hendoui, N; Najafi, A; Mojtahedzadeh, M				Sadeghi, Kourosh; Hadi, Farin; Ahmadi, Arezoo; Hamishehkar, Hadi; Beigmohammadi, Mohammad-Taghi; Mahmoodpoor, Ata; Rouini, Mohammad Reza; Farhudi, Shirin; Hendoui, Narjes; Najafi, Atabak; Mojtahedzadeh, Mojtaba			Total Phenytoin concentration is not well correlated with active free drug in critically-ill head trauma patients	JOURNAL OF RESEARCH IN PHARMACY PRACTICE			English	Article						Critically-ill patients; free drug concentration; head trauma; hypoalbuminemia; Phenytoin		Objective: Phenytoin is an antiepileptic drug used widely for prophylaxis and treatment of seizure after neurotrauma. Phenytoin has a complex pharmacokinetics and monitoring of its serum concentrations is recommended during treatment. Total phenytoin concentration is routinely measured for monitoring of therapy. In this study, we evaluated the correlation between phenytoin total and free concentrations in neurotrauma critically-ill patients to determine whether the phenytoin total concentration is a reliable predictor of free drug, which is responsible for the therapeutic effects. Methods: A total of 40 adult head trauma patients evaluated for free (unbound) and total serum phenytoin concentrations. Patients were divided into two groups. Group A consists of 20 unconscious patients with severe head injury under mechanical ventilation and Group B consists of 20 conscious self-ventilated patients. Correlation and agreement between total and free phenytoin plasma concentrations were analyzed. Findings: Pearson correlation analysis and Bland-Altman test showed weak to moderate correlation (r = 0.528) and poor agreement between free and total phenytoin concentrations in patients with severe trauma and higher Acute Physiology And Chronic Health Evaluation II (APACHE II) scores (Group A) and good correlation (r = 0.817) and moderate agreement in patients with mild to moderate trauma and lower APACHE II scores (Group B). Conclusion: Our results indicated that total phenytoin serum concentration is not a reliable therapeutic goal for drug monitoring in severely-ill head trauma patients even in the absence of hypoalbuminemia, renal and hepatic failure. It seems justifiable to measure free phenytoin concentration in all severely ill neurotrauma patients.	[Sadeghi, Kourosh; Mojtahedzadeh, Mojtaba] Univ Tehran Med Sci, Dept Clin Pharm, Tehran, Iran; [Hadi, Farin] Islamic Azad Univ, Dept Clin Pharm, Tehran, Iran; [Ahmadi, Arezoo; Najafi, Atabak; Mojtahedzadeh, Mojtaba] Univ Tehran Med Sci, Sina Hosp, Dept Anesthesia & Intens Care, Tehran, Iran; [Hamishehkar, Hadi] Tabriz Univ Med Sci, Dept Clin Pharm, Tabriz, Iran; [Hamishehkar, Hadi] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Beigmohammadi, Mohammad-Taghi] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Anesthesia & Intens Care, Tehran, Iran; [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Dept Anesthesia & Intens Care, Tabriz, Iran; [Rouini, Mohammad Reza] Univ Tehran Med Sci, Dept Biopharmaceut & Pharmacokinet, Tehran, Iran; [Farhudi, Shirin] Tabriz Univ Med Sci, Students Res Ctr, Tabriz, Iran; [Hendoui, Narjes] Mazandaran Univ Med Sci, Dept Clin Pharm, Sari, Iran		Mojtahedzadeh, M (corresponding author), Univ Tehran Med Sci, Dept Clin Pharm, Tehran, Iran.	mojtahed@sina.tums.ac.ir	Sadeghi, Kourosh/T-2211-2018; mahmoodpoor, Ata/AAD-6597-2021; Rouini, Mohammadreza/AAT-8557-2021; Sadeghi, Kourosh/O-2155-2019; mahmoodpoor, ata/AAR-9972-2021	Sadeghi, Kourosh/0000-0003-2876-4937; mahmoodpoor, Ata/0000-0002-4361-6230; Rouini, Mohammadreza/0000-0003-0412-8581; Sadeghi, Kourosh/0000-0003-2876-4937; 	Tehran University of Medical SciencesTehran University of Medical Sciences	This sudy was under supports of Tehran University of Medical Sciences, Conflict of Interest: None declared.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bailey DN, 2004, THER DRUG MONIT, V26, P40, DOI 10.1097/00007691-200402000-00009; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; Boucher BA, 2006, CRIT CARE CLIN, V22, P255, DOI 10.1016/j.ccc.2006.02.011; EDWARDS DJ, 1982, CLIN PHARMACOL THER, V31, P62, DOI 10.1038/clpt.1982.10; Fedler C, 1999, THER DRUG MONIT, V21, P155, DOI 10.1097/00007691-199904000-00003; FRIEL PN, 1989, EPILEPSY RES, V3, P82, DOI 10.1016/0920-1211(89)90072-7; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hong JM, 2009, YONSEI MED J, V50, P517, DOI 10.3349/ymj.2009.50.4.517; JOHNO I, 1988, THER DRUG MONIT, V10, P39, DOI 10.1097/00007691-198810010-00007; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krasowski MD, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-7; LINDOW J, 1994, CHEST, V105, P602, DOI 10.1378/chest.105.2.602; RICHENS A, 1979, CLIN PHARMACOKINET, V4, P153, DOI 10.2165/00003088-197904030-00001; RIMMER EM, 1984, BRIT J CLIN PHARMACO, V17, P99, DOI 10.1111/j.1365-2125.1984.tb05007.x; Shohrati M, 2007, DARU, V15, P34; Shohrati Majid, 2002, Daru, V10, P1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Winckelmann SL, 2008, PHARMACOTHERAPY, V28, P1391, DOI 10.1592/phco.28.11.1391; Wolf GK, 2006, PEDIATR CRIT CARE ME, V7, P434, DOI 10.1097/01.PCC.0000235252.43921.DE; ZIELMANN S, 1994, THER DRUG MONIT, V16, P139, DOI 10.1097/00007691-199404000-00005	22	4	4	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2319-9644	2279-042X		J RES PHARM PRACT	J. Res. Pharm. Pract.	JUL-SEP	2013	2	3					105	109		10.4103/2279-042X.122376			5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	V3V3E	WOS:000218619700003	24991615	Green Published, gold			2022-02-06	
J	Sharf, MS; El-Gebali, MA				Sharf, Mohammed Samy; El-Gebali, Mohammed A.			Correlation between Glasgow coma scale and Jugular venous oxygen saturation in severe traumatic brain injury	EGYPTIAN JOURNAL OF ANAESTHESIA			English	Article						Traumatic brain injury; Glasgow coma scale; Jugular venous oxygen saturation	CEREBRAL PERFUSION-PRESSURE; MANAGEMENT; CARE	Background: Glasgow Coma Scale (GCS) remains a key measure in neurological assessment after head injury and in most studies classification of the severity of the trauma is still based on the admission GCS. The aim of the work: The aim of the work was to correlate between Jugular venous oxygen saturation (Sjvo2) with GCS in cases with severe traumatic brain injury. Patients and methods: A 44 patients met the inclusion criteria, were included in the present study. They were selected from the neurosurgical and intensive care units at Al-Azhar University hospital during the period from June 2010 till June 2012. All therapeutic interventions were performed in accordance with Guidelines for the Management of Severe Traumatic Brain Injury. The following variables were collected: patients' demographics, Sjvo2, ICP, MAP, CPP and GCS. All pressures were monitored invasively and with identical transducers connected to monitors, and expressed numerically in mmHg. Measurements were always performed at 8.00 a.m. At the same time, patients were neurologically examined and these data were expressed as GCS score. Results: There was statistically significant increase of GCS, MAP, CPP, Sjvo2 and Extended Glasgow Outcome Scale (GOSE) and decrease of ICP in survived in comparison to non-survived cases. In survived cases, there was positive significant correlation between Sjvo2 and GCS, MAP, CPP and GOSE, while there was significant negative correlation with ICT. On the other hand, in non-survived cases, there was only positive moderate, significant correlation between Sjvo2 and GCS. Running simple linear regression analysis, only GCS and Sjvo2 can predict mortality in studied cases. Conclusion: Results of the present study proved that, Sjvo2 is proportionally correlated with GCS and both can predict the prognosis of severe traumatic injury. (C) 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V. Open access under CC BY-NC-ND license.	[Sharf, Mohammed Samy] Al Azhar Univ, Al Azhar Fac Med, Anesthesia & Intens Care Dept, Cairo, Egypt; [El-Gebali, Mohammed A.] Al Azhar Univ, Al Azhar Fac Med, Neurolosurg Dept, Cairo, Egypt		Sharf, MS (corresponding author), Al Azhar Univ, Al Azhar Fac Med, Anesthesia & Intens Care Dept, Cairo, Egypt.	ms_sharf@hotmail.comm	Sharaf, Mohammed Samy/AAM-3693-2021; Ahmed Alhady Elgebali, Mohamed Elgebali/AAY-5836-2021				Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney NA, 2007, METHODS J NEUROTR S1, V24, pS3; Cormio M, 1999, J NEUROSURG, V91, P167; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dagal A, 2011, CURR OPIN ANESTHESIO, V24, P131, DOI 10.1097/ACO.0b013e3283445898; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Klemenc-Ketis Z, 2011, ULUS TRAVMA ACIL CER, V17, P509, DOI 10.5505/tjtes.2011.35336; Lam JMK, 1996, BRIT J NEUROSURG, V10, P357; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; MATTA BF, 1994, ANESTH ANALG, V79, P745; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; Moreno J, 2000, NEUROSURG FOCUS, V8, P1; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a	28	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND		1110-1849		EGYPT J ANAESTH	Egypt. J. Anaesth.	JUL	2013	29	3					267	272		10.1016/j.egja.2013.02.008			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V0U0D	WOS:000216557800014		gold			2022-02-06	
J	Thaler, NS; Scott, JG; Duff, K; Mold, J; Adams, RL				Thaler, Nicholas S.; Scott, James G.; Duff, Kevin; Mold, James; Adams, Russell L.			RBANS Cluster Profiles in a Geriatric Community-Dwelling Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						RBANS; Geriatric; Cluster analysis	NEUROPSYCHOLOGICAL STATUS RBANS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ADULT LIFE-SPAN; OLDER-ADULTS; STANDARDIZATION SAMPLE; REPEATABLE BATTERY; BASE RATES; DISEASE; AGE	Neuropsychological heterogeneity is prevalent in geriatric individuals and is due to a number of factors including the onset of neuropathology, increased risk of emotional complications, and normal cognitive changes associated with aging. In order to better characterize normal neurocognitive variability in this population, cluster analysis was used on a sample of 699 community-dwelling geriatric patients who completed The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Three-, four-, five-, and six-cluster solutions were examined and based on a number of criteria, the four-cluster solution was selected for further analysis. Clusters were defined primarily by measures of immediate memory, delayed memory, and processing speed, and differed on self-reported measures of functioning. These findings provide insights on normal neuropsychological variation in community-dwelling geriatric individuals.	[Thaler, Nicholas S.; Scott, James G.; Adams, Russell L.] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73126 USA; [Duff, Kevin] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Mold, James] Univ Oklahoma, Hlth Sci Ctr, Dept Family & Prevent Med, Family Med Ctr, Oklahoma City, OK 73126 USA		Thaler, NS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73126 USA.	nick.thaler@gmail.com	Schultz, Susan K./M-3516-2019				Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Blashfield R.K., 1984, CLUSTER ANAL; Brickman AM, 2006, BIOL PSYCHIAT, V60, P444, DOI 10.1016/j.biopsych.2006.01.011; Chen CCH, 2011, INT J NURS STUD, V48, P338, DOI 10.1016/j.ijnurstu.2010.03.011; Cherbuin N, 2010, AM J GERIAT PSYCHIAT, V18, P723, DOI 10.1097/JGP.0b013e3181cdecf1; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P281, DOI 10.1016/j.acn.2004.07.007; Duff K, 2003, CLIN NEUROPSYCHOL, V17, P351, DOI 10.1076/clin.17.3.351.18082; Duff K, 2008, CLIN NEUROPSYCHOL, V22, P651, DOI 10.1080/13854040701448785; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Duff K, 2011, J CLIN EXP NEUROPSYC, V33, P448, DOI 10.1080/13803395.2010.533156; Duff K, 2011, APPL NEUROPSYCHOL, V18, P11, DOI 10.1080/09084282.2010.523354; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045; Duff K, 2010, J CLIN EXP NEUROPSYC, V32, P231, DOI 10.1080/13803390902926184; Duff K, 2009, J CLIN EXP NEUROPSYC, V31, P90, DOI 10.1080/13803390801998664; Goldstein G, 2005, ARCH CLIN NEUROPSYCH, V20, P153, DOI 10.1016/j.acn.2004.03.008; Gunstad J, 2006, J GERIATR PSYCH NEUR, V19, P59, DOI 10.1177/0891988705284738; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Mooney S, 2007, ARCH CLIN NEUROPSYCH, V22, P175, DOI 10.1016/j.acn.2006.12.005; Morgan DR, 2010, CLIN NEUROPSYCHOL, V24, P1365, DOI 10.1080/13854046.2010.516769; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Patton DE, 2005, CLIN NEUROPSYCHOL, V19, P27, DOI 10.1080/13854040490888477; Patton DE, 2003, CLIN NEUROPSYCHOL, V17, P515, DOI 10.1076/clin.17.4.515.27948; Pedraza O, 2010, ARCH CLIN NEUROPSYCH, V25, P347, DOI 10.1093/arclin/acq030; Perez-Madrinan G, 2004, AM J GERIAT PSYCHIAT, V12, P449, DOI 10.1176/appi.ajgp.12.5.449; Peters KR, 2008, AM J GERIAT PSYCHIAT, V16, P136, DOI 10.1097/JGP.0b013e3181462288; Rabbitt P, 2005, J GERONTOL B-PSYCHOL, V60, pP106, DOI 10.1093/geronb/60.2.P106; Rabbitt P, 2011, PSYCHOL BULL, V137, P785, DOI 10.1037/a0024580; Randolph C., 1998, REPEATABLE BATTERY A; Romesburg CH., 1984, CLUSTER ANAL RES; Sachdev PS, 2010, AM J GERIAT PSYCHIAT, V18, P657, DOI 10.1097/JGP.0b013e3181e6c2af; Singer T, 2003, PSYCHOL AGING, V18, P318, DOI 10.1037/0882-7974.18.2.318; Small BJ, 2003, PSYCHOL AGING, V18, P193, DOI 10.1037/0882-7974.18.2.193; Smits CHM, 1999, AM J EPIDEMIOL, V150, P978; Stein J, 2012, AM J GERIAT PSYCHIAT, V20, P84, DOI 10.1097/JGP.0b013e318209dd08; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Wilhoit BE, 2002, SCHOOL PSYCHOL REV, V31, P263	41	4	4	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 1	2013	27	5					794	807		10.1080/13854046.2013.783121			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	170OR	WOS:000320863200004	23548200				2022-02-06	
J	Wang, K; Xue, YJ; Chen, XZ; Zhou, B; Lou, MQ				Wang, Ke; Xue, Yajun; Chen, Xianzhen; Zhou, Bin; Lou, Meiqing			Uncorrected traumatic coagulopathy is associated with severe brain swelling during decompressive surgery to evacuate a supratentorial intradural mass lesion in patients with traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Severe brain swelling; Decompressive surgery; Traumatic coagulopathy; Traumatic brain injury; Delayed brain injury	ACUTE SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA	Objective: This study investigated the relationship between traumatic coagulopathy and severe brain swelling (SBS) during decompressive surgery to evacuate a supratentorial intradural mass lesion in patients with traumatic brain injury (TBI). Methods: A retrospective study was conducted in 96 patients who consecutively suffered from isolated TBI and underwent decompressive surgery to evacuate a supratentorial traumatic mass lesion by unilateral craniotomy. Their medical history, radiographic information, and surgical notes were reviewed. The relationship between traumatic coagulopathy and intraoperative SBS was evaluated. Results: Fifty-six patients presented with traumatic coagulopathy according to their preoperative coagulation panels. Thirty of them had the disorder corrected before surgery while the remaining patients did not. Twenty-four patients developed intraoperative SBS, and 22 (91.7%) of them were related to new or progressive formation of distal intracranial lesions during the surgery. Patients with uncorrected coagulopathy demonstrated a significantly higher risk of intraoperative SBS than those with corrected and no coagulopathy (61.5% vs 11.4%, P < 0.001). There was no significant difference in the incidence of intraoperative SBS between patients with corrected and no coagulopathy (13.3% versus 10.0%, P > 0.05). Multivariate logistic regression analysis showed that uncorrected coagulopathy was an independent risk factor and related to an 11.5-fold increased risk of intraoperative SBS. Conclusions: Intraoperative SBS is not a rare event during decompressive surgery to evacuate a supratentorial intradural mass lesion in patients with TBI. Such surgery should be cautiously considered and performed given the existence of uncorrected traumatic coagulopathy, which is associated with an increased risk of intraoperative SBS.	[Wang, Ke; Xue, Yajun; Chen, Xianzhen; Zhou, Bin; Lou, Meiqing] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Shanghai, Peoples R China		Wang, K (corresponding author), 301 Middle Yanchang Rd, Shanghai, Peoples R China.	trizzt@gmail.com			Young Talent Cultivation Project of Shanghai Tenth People's Hospital; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201708]	This study is supported by the Young Talent Cultivation Project of Shanghai Tenth People's Hospital and the National Natural Science Foundation of China (No. 81201708).	Brohi K, 2009, BRIT J SURG, V96, P963, DOI 10.1002/bjs.6691; Brown CVR, 2012, AM SURGEON, V78, P57; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Stanworth Simon J, 2007, Hematology Am Soc Hematol Educ Program, P179; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; THIBODEAU M, 1987, J CAN ASSOC RADIOL, V38, P52; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	25	4	5	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2013	35	6					642	648		10.1179/1743132813Y.0000000187			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174BR	WOS:000321128200015	23561830				2022-02-06	
J	Lemoyne, R; Mastroianni, T; Grundfest, W				Lemoyne, Robert; Mastroianni, Timothy; Grundfest, Warren			WIRELESS ACCELEROMETER SYSTEM FOR QUANTIFYING DISPARITY OF HEMIPLEGIC GAIT USING THE FREQUENCY DOMAIN	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Wireless accelerometers; gait analysis; gait rehabilitation; locomotion; hemiplegic gait; traumatic brain injury; frequency domain	PHYSICAL-ACTIVITY; WALKING; TIME; PROPRIOCEPTION; CLASSIFICATION; RELIABILITY; VALIDATION; RESPONSES; POSTURE; REFLEX	The proper allocation of a therapy strategy and dosage is fundamentally associated with the quantified evaluation of gait quality. Wireless accelerometer systems for the evaluation of quantified hemiplegic gait characteristics has been successfully applied in inherently autonomous environments through the consideration of the temporal domain of the gait acceleration waveform. The frequency domain has notable potential for identifying the quantified disparity of the affected leg and unaffected leg through the application of a tandem-activated wireless accelerometer system mounted to the lateral malleolus of each lower leg through an elastic band. The quantification of disparity for hemiplegic gait via the application of wireless accelerometers was applied in an outdoor environment, while walking on a sidewalk. In addition, the wireless accelerometers were tandem activated while the subject had achieved steady-state gait status, which mitigated the need to subjectively remove starting acceleration and stopping deceleration aspects of the gait cycle. Four predominant frequencies within the 0-5 Hz bandwidth demonstrated a considerable degree of accuracy and reliability. The organization of the four predominant frequencies for both affected leg and unaffected leg were found to be disparate in a statistically significant manner, implicating a disparity of the rhythmicity respective of the affected leg in contrast to the unaffected leg in hemiplegic gait. These preliminary findings may advance gait quantification techniques, which may improve the efficacy of gait rehabilitation therapy. Enclosed are the initial test and evaluation of a tandem-activated wireless accelerometer system using the frequency domain for ascertaining a quantified disparity of hemiplegic gait.	[Lemoyne, Robert; Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Independent, Pittsburgh, PA USA		Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn IDP, Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Aminian K, 1999, MED BIOL ENG COMPUT, V37, P304, DOI 10.1007/BF02513304; [Anonymous], G LXRSTM; Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Bekey G.A., 2005, AUTONOMOUS ROBOTS BI; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Bugane F, 2012, COMPUT METHODS PROGR; Busser HJ, 1997, MED ENG PHYS, V19, P440, DOI 10.1016/S1350-4533(97)00007-6; Capaday C, 1999, J NEUROPHYSIOL, V81, P129, DOI 10.1152/jn.1999.81.1.129; Chapman RF, 2012, MED SCI SPORT EXER, V44, P917, DOI 10.1249/MSS.0b013e3182400520; Chung WY, 2008, IEEE ENG MED BIO, P1120, DOI 10.1109/IEMBS.2008.4649357; Clark M. A., 2008, NASM ESSENTIALS PERS; Culhane KM, 2005, AGE AGEING, V34, P556, DOI 10.1093/ageing/afi192; Dietz V., 2001, Neural Plasticity, V8, P83, DOI 10.1155/NP.2001.83; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dobkin BH, 2003, CLIN SCI NEUROLOGIC; Elson LM, 1985, HUMAN BRAIN COLORING; ENGLUND C, 2004, THESIS ROYAL I TECHN; Fahrenberg J, 1997, PSYCHOPHYSIOLOGY, V34, P607, DOI 10.1111/j.1469-8986.1997.tb01747.x; Farris D. A., 1993, Experimental Techniques, V17, P33, DOI 10.1111/j.1747-1567.1993.tb00273.x; Finney R. L., 1990, CALCULUS; Giakas G, 1997, GAIT POSTURE, V5, P189, DOI 10.1016/S0966-6362(96)01083-1; Guo Y., 2012, TELEMED J E HLTH; Hoos MB, 2004, EUR J CLIN NUTR, V58, P1425, DOI 10.1038/sj.ejcn.1601991; Hsu CC, 2011, SENSORS-BASEL, V11, P10094, DOI 10.3390/s111110094; JANKOWSKA E, 1981, TRENDS NEUROSCI, V4, P230, DOI 10.1016/0166-2236(81)90072-2; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Lai DTH, 2008, IEEE ENG MED BIO, P4899, DOI 10.1109/IEMBS.2008.4650312; Lee JA, 2007, P ANN INT IEEE EMBS, P483, DOI 10.1109/IEMBS.2007.4352328; Lee JA, 2010, J MED SYST, V34, P959, DOI 10.1007/s10916-009-9311-8; LeMoyne R, 2009, UCLA BRAIN RES I 200; LeMoyne R, 2010, THESIS UCLA LOS ANGE; LeMoyne R., 2009, BIOMEDICAL ENG; LeMoyne R., 2009, P IEEE ICME INT C CO, P1; LeMoyne R, 2009, 39 SOC NEUR ANN M CH; LeMoyne R., 2010, P ASME 2010 5 FRONT, P1; LeMoyne R, 2011, IEEE ENG MED BIO, P7904, DOI 10.1109/IEMBS.2011.6091949; Lemoyne R, 2011, J MECH MED BIOL, V11, P471, DOI 10.1142/S0219519410003733; LeMoyne R, 2010, IEEE ENG MED BIO, P3847, DOI 10.1109/IEMBS.2010.5627699; LeMoyne R, 2009, IEEE ENG MED BIO, P5283, DOI 10.1109/IEMBS.2009.5333086; Lemoyne R, 2009, J MECH MED BIOL, V9, P329, DOI 10.1142/S0219519409003024; LeMoyne R, 2008, IEEE ENG MED BIO, P4238, DOI 10.1109/IEMBS.2008.4650145; Lemoyne R, 2008, J MECH MED BIOL, V8, P317, DOI 10.1142/S0219519408002693; Lyons GM, 2005, MED ENG PHYS, V27, P497, DOI 10.1016/j.medengphy.2004.11.006; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Mizuike C, 2009, GAIT POSTURE, V30, P60, DOI 10.1016/j.gaitpost.2009.02.017; NAKAMURA S, 1996, NUMERICAL ANAL GRAPH; Nolte J., 2002, HUMAN BRAIN INTRO IT; Nyan MN, 2006, J BIOMECH, V39, P2647, DOI 10.1016/j.jbiomech.2005.08.014; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Perry J, 1992, GAIT ANAL NORMAL PAT; Prajapati SK, 2011, NEUROREHAB NEURAL RE, V25, P6, DOI 10.1177/1545968310374189; Rong L, 2007, C IND ELECT APPL, P2654; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Schubert M, 1997, EXP BRAIN RES, V115, P234, DOI 10.1007/PL00005693; Schubert M, 1999, EXP BRAIN RES, V126, P583, DOI 10.1007/s002210050767; Sekine M, 2000, P ANN INT IEEE EMBS, V22, P1879, DOI 10.1109/IEMBS.2000.900456; Serway R. A., 1990, PHYS SCI ENG; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Uiterwaal M, 1998, J MED ENG TECHNOL, V22, P168, DOI 10.3109/03091909809032535; Watanabe T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/975193; Watson C., 2010, BRAIN INTRO FUNCTION; Yeoh WS, 2008, IEEE ENG MED BIO, P5184, DOI 10.1109/IEMBS.2008.4650382; Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7	65	4	4	1	10	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	JUN	2013	13	3							1350035	10.1142/S0219519413500358			19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	146VV	WOS:000319123800014					2022-02-06	
J	Moinard, C; Delpierre, E; Loi, C; Neveux, N; Butel, MJ; Cynober, L; Charrueau, C				Moinard, Christophe; Delpierre, Eric; Loi, Cecile; Neveux, Nathalie; Butel, Marie-Jose; Cynober, Luc; Charrueau, Christine			An Oligomeric Diet Limits the Response to Injury in Traumatic Brain-Injured Rats	JOURNAL OF NEUROTRAUMA			English	Article						enteral nutrition; head injury; intestine; muscle; protein metabolism	ORNITHINE ALPHA-KETOGLUTARATE; IMMUNE-ENHANCING DIET; GLUTAMINE DEPLETION; WHEY PROTEINS; AMINO-ACIDS; HEAD; PEPTIDES; MUCOSA; LYMPHOCYTE; NUTRITION	Adequate nutritional support is a major challenge in brain injury patients, because malnutrition cannot be reversed by standard enteral nutrition. We hypothesized that an oligomeric formula could improve nutritional status by restoring intestinal trophicity. Eighteen male Sprague-Dawley rats (300-330 g) underwent gastrostomy on day -7 (D-7) and traumatic brain injury (TBI) by hydraulic percussion (D0) and were then fed for 4 days with either a polymeric formula (Sondalis (R) HP, TBIP, n = 9), or an oligomeric formula (Peptamen (R) HN, TBIO, n = 9). In addition, a control group of healthy gastrostomized rats was fed the polymeric diet (control, n = 8). All rats were weighed daily. On D+4, the rats were euthanized. Blood was collected for plasma amino acid determination. Organs were removed and weighed. Intestinal morphometry was studied. Protein content was assessed on intestine and muscles. Enterobacterial translocation and dissemination were evaluated. Results were expressed as means +/- SEM and compared using analysis of variance + Newman-Keuls test. TBI induced a significant decrease in whole body weight (TBIP vs. control, p < 0.05) that was totally blunted by the oligomeric diet (TBIP vs. TBIO, p < 0.01). Thymus weight significantly decreased after TBI (TBIP vs. control, p < 0.05) and was restored by the oligomeric formula (TBIO vs. TBIP, p < 0.05). Glutamine (GLN) concentration was improved by the oligomeric diet in both plasma (TBIO: 688 +/- 19 vs. control: 591 +/- 45 and TBIP: 615 +/- 42 mu mol/L, p < 0.05) and soleus muscle. These results show that the use of an oligomeric diet may limit response to injury after brain injury and could be a simple nutritional strategy in this setting.	[Moinard, Christophe; Delpierre, Eric; Loi, Cecile; Neveux, Nathalie; Cynober, Luc] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol,EA 4466, Lab Biol Nutr, Paris, France; [Delpierre, Eric] Hop St Antoine, APHP, F-75571 Paris, France; [Neveux, Nathalie; Cynober, Luc] Cochin Hotel Dieu, APHP, Serv Biochim Interhosp, Paris, France; [Butel, Marie-Jose] Univ Paris 05, Fac Sci Pharmaceut & Biol, Sorbonne Paris Cite,EA 4065, Microbiol Lab, Paris, France; [Charrueau, Christine] Univ Paris 05, Fac Sci Pharmaceut & Biol, Sorbonne Paris Cite,EA 4466, Pharm Galen Lab, Paris, France		Charrueau, C (corresponding author), Fac Sci Pharmaceut & Biol Paris, Pharm Galen Lab, 4 Ave Observ, F-75270 Paris 06, France.	christine.charrueau@parisdescartes.fr	Cynober, Luc/ABB-2368-2020		Nestle Clinical Nutrition (NCN), Noisiel, France	This work was supported by an unrestricted grant from Nestle Clinical Nutrition (NCN), Noisiel, France.	Aydin S, 2005, SURG TODAY, V35, P751, DOI 10.1007/s00595-005-3034-3; Belabed L, 2006, CLIN NUTR, V25, P832, DOI 10.1016/j.clnu.2006.02.003; Boza JJ, 2000, EUR J NUTR, V39, P237, DOI 10.1007/s003940070001; Charrueau C, 2011, HANDBOOK OF BEHAVIOR, FOOD AND NUTRITION, P1585, DOI 10.1007/978-0-387-92271-3_103; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; COLLINVIDAL C, 1994, AM J PHYSIOL-ENDOC M, V267, pE907, DOI 10.1152/ajpendo.1994.267.6.E907; COSNES J, 1992, NUTRITION, V8, P406; Darbar A, 2001, NUTRITION, V17, P71, DOI 10.1016/S0899-9007(00)00476-7; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Lasnier E, 1996, CLIN NUTR, V15, P197, DOI 10.1016/S0261-5614(96)80241-X; Le Boucher J, 1999, NUTRITION, V15, P773, DOI 10.1016/S0899-9007(99)00155-0; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Martindale RG, 2001, JPEN-PARENTER ENTER, V25, pS27, DOI 10.1177/014860710102500207; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2006, NUTRITION, V22, P1039, DOI 10.1016/j.nut.2006.06.005; Moinard C, 2012, J NEUROTRAUM, V29, P335, DOI 10.1089/neu.2011.1862; Neveux N, 2004, METABOLIC THERAPEUTI, P17; Oudemans-van Straaten HM, 2001, INTENS CARE MED, V27, P84, DOI 10.1007/s001340000703; POULLAIN MG, 1991, CLIN NUTR, V10, P49, DOI 10.1016/0261-5614(91)90081-M; POULLAIN MG, 1989, AM J CLIN NUTR, V49, P71, DOI 10.1093/ajcn/49.1.71; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Tiengou LE, 2006, JPEN-PARENTER ENTER, V30, P1, DOI 10.1177/014860710603000101; Ventura G, 2009, BRIT J NUTR, V101, P843, DOI 10.1017/S0007114508043389; ZIEGLER F, 1990, GUT, V31, P1277, DOI 10.1136/gut.31.11.1277; Ziegler F, 1998, AM J CLIN NUTR, V67, P124, DOI 10.1093/ajcn/67.1.124	27	4	4	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					975	980		10.1089/neu.2012.2707			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300008	23186230				2022-02-06	
J	Moreno, P; Alvarez, A; Illana, J; Espinosa, D; Baamonde, C; Cerezo, F; Algar, FJ; Salvatierra, A				Moreno, Paula; Alvarez, Antonio; Illana, Jennifer; Espinosa, Dionisio; Baamonde, Carlos; Cerezo, Francisco; Javier Algar, Francisco; Salvatierra, Angel			Early lung retrieval from traumatic brain-dead donors does not compromise outcomes following lung transplantation	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	20th European Conference on General Thoracic Surgery	JUN 10-13, 2012	Essen, GERMANY			Lung transplantation; Lung donors; Brain death; Lung injury; Primary graft dysfunction	INTERNATIONAL-SOCIETY; GRAFT DYSFUNCTION; INJURY; HEART; REGISTRY	OBJECTIVES: To determine whether lung retrieval from traumatic donors performed within 24 h of brain death has a negative impact on early graft function and survival after lung transplantation (LT), when compared with those retrieved after 24 h. METHODS: Review of lung transplants performed from traumatic donors over a 17-year period. Recipients were distributed into two groups: transplants from traumatic donor lungs retrieved within 24 h of brain death (Group A), and transplants from traumatic donor lungs retrieved after 24 h of brain death (Group B). Demographic data of donors and recipients, early graft function, perioperative complications and mortality were compared between both groups. RESULTS: Among 356 lung transplants performed at our institution, 132 were from traumatic donors (70% male, 30% female). Group A: 73 (55%); Group B: 59 (45%). There were 53 single, 77 double, and 2 combined LT. Indications were emphysema in 41 (31%), pulmonary fibrosis in 31 (23%), cystic fibrosis in 38 (29%), bronchiectasis in 9 (7%) and other indications in 13 patients (10%). Donor and recipient demographic data, need or cardiopulmonary bypass, postoperative complications and Intensive Care Unit and hospital stay did not differ between groups. Primary graft dysfunction (A vs B): 9 (16%) vs 13 (26%) P = 0.17. PaO2/FiO(2) 24 h post-transplant (A vs B): 303 mmHg vs 288 mmHg (P = 0.57). Number of acute rejection episodes (A vs B): 0.93 vs 1.49 (P = 0.01). Postoperative intubation time (A vs B): 99 vs 100 h (P = 0.99). 30-day mortality (A vs B): 7 (10%) vs 2 (3.5%) (P = 0.13). Freedom from bronchiolitis obliterans syndrome (A vs B): 82, 72, 37, 22 vs 78, 68, 42, 15%, at 3, 5, 10 and 15 years, respectively (P = 0.889). Survival (A vs B): 65, 54, 46, 42 and 27 vs 60, 50, 45, 43 and 29% at 3, 5, 7, 10 and 15 years, respectively (P = 0.937). CONCLUSIONS: In our experience, early lung retrieval after brain death from traumatic donors does not adversely affect early and long-term outcomes after LT.	[Moreno, Paula; Alvarez, Antonio; Illana, Jennifer; Espinosa, Dionisio; Baamonde, Carlos; Cerezo, Francisco; Javier Algar, Francisco; Salvatierra, Angel] Hosp Univ Reina Sofia, Unidad Cirugia Torac & Trasplante Pulm, Cordoba 14004, Spain; [Moreno, Paula; Alvarez, Antonio; Baamonde, Carlos; Cerezo, Francisco; Javier Algar, Francisco; Salvatierra, Angel] Univ Cordoba, Grp Study Thorac Neoplasms & Lung Transplantat, IMIBIC Inst Maimonides Invest Biomed Cordoba, Cordoba, Spain		Moreno, P (corresponding author), Hosp Univ Reina Sofia, Unidad Cirugia Torac & Trasplante Pulm, Ave Menendez Pidal S-N, Cordoba 14004, Spain.	pmoreno39@gmail.com	Alvarez, Antonio/AAM-6126-2021; Salvatierra, Angel/E-4530-2015	Alvarez, Antonio/0000-0003-1531-9543; MORENO, PAULA/0000-0003-4403-7035			Alvarez A, 1999, TRANSPLANT P, V31, P1088, DOI 10.1016/S0041-1345(98)01915-0; Alvarez A, 2010, EUR J CARDIO-THORAC, V37, P432, DOI 10.1016/j.ejcts.2009.08.011; Avlonitis VS, 2007, AM J TRANSPLANT, V7, P83, DOI 10.1111/j.1600-6143.2006.01593.x; Avlonitis VS, 2003, TRANSPLANTATION, V75, P1928, DOI 10.1097/01.TP.0000066351.87480.9E; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Ganesh JS, 2005, J THORAC CARDIOV SUR, V129, P1153, DOI 10.1016/j.jtcvs.2004.09.029; Rostron AJ, 2008, TRANSPLANTATION, V85, P597, DOI 10.1097/TP.0b013e31816398dd; Singhal AK, 2009, TRANSPL P, V41, P3539, DOI 10.1016/j.transproceed.2009.06.192; SUNDARESAN S, 1993, ANN THORAC SURG, V56, P1409, DOI 10.1016/0003-4975(93)90699-I; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; van der Hoeven JAB, 2003, KIDNEY INT, V64, P1874, DOI 10.1046/j.1523-1755.2003.00272.x; WALLER DA, 1995, J HEART LUNG TRANSPL, V14, P318; Wauters S, 2011, EUR J CARDIO-THORAC, V39, pE68, DOI 10.1016/j.ejcts.2010.11.049	16	4	4	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940			EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUN	2013	43	6					E190	E197		10.1093/ejcts/ezt033			8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Respiratory System; Surgery	151MB	WOS:000319463500013	23425678	Bronze			2022-02-06	
J	Masson, M; Michael, GA; Desert, JF; Rhein, FO; Foubert, L; Colliot, P				Masson, Marjolaine; Michael, George Andrew; Desert, Jean-Francois; Rhein, Francois; Foubert, Lucie; Colliot, Pascale			Specific attention disorders in drivers with traumatic brain injury	BRAIN INJURY			English	Article						Attention disorders; attentional load; attentional processes; traumatic brain injury; driving	DIVIDED ATTENTION; DUAL-TASK; IMPAIRMENTS	Objective: To highlight the impact of the increasing attentional load on performance of both normal drivers and drivers with traumatic brain injury. Background: Patients with brain injury have a higher accident risk than people with no brain injury [1], probably as a result of persistent attention disorders. Method: Ten patients and 10 paired controls took part in a computerized selective attention task involving specific attentional processes. They were asked to monitor a speedometer and to ignore sudden changes in the surrounding environment in three separate experimental situations involving different attentional load. Results: Although, in the control situation, patients' results were equivalent to controls', they displayed specific disorders in more complex situations where the attentional load increased. Conclusion: These difficulties may have a negative impact on real driving situations.	[Masson, Marjolaine; Michael, George Andrew; Colliot, Pascale] Univ Lyon 2, EMC Lab, EA 3082, F-69365 Lyon 07, France; [Desert, Jean-Francois; Rhein, Francois; Foubert, Lucie] Phys Med & Rehabil Ctr, Coubert, France		Masson, M (corresponding author), IFSTTAR LESCOT, 25 Ave Francois Mitterrand,Case 24, F-69675 Bron, France.	marjolaine.masson@gmail.com	COLLIOT, Pascale/H-5422-2017; Michael, George/H-1530-2017	COLLIOT, Pascale/0000-0002-2429-7932; MICHAEL, George A./0000-0001-9071-4303	two Region Rhone-Alpes/France grantsRegion Auvergne-Rhone-Alpes [Cluster 11-2009/2010, CIBLE 2010]; LABEX Cortex grant	The authors report no conflicts of interest. This research study was supported by two Region Rhone-Alpes/France grants (Cluster 11-2009/2010 and CIBLE 2010), a LABEX Cortex grant and doctoral funding.	Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 1998, REV NEUROPSYCHOL, V8, P125; Brickenkamp R., 1994, D2 TEST ATTENTION CO; Brouwer WH, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P230; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Collet C, 2009, APPL ERGON, V40, P1041, DOI 10.1016/j.apergo.2009.01.007; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Kahneman D., 1973, ATTENTION EFFORT; Leclercq M., 2002, REEDUCATION COGNITIV, P277; Leclercq M, 2000, TRAITE NEUROPSYCHOLO, V1, P95; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Michael GA, 2009, BEHAV NEUROSCI, V123, P86, DOI 10.1037/a0013726; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner, 1978, CHRONOMETRIC EXPLORA; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Schultheis MT, 2007, ASSIST TECHNOL, V19, P1, DOI 10.1080/10400435.2007.10131860; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Van Zomeren AH, 1995, NEUROPSYCHOLOGIE TRA, P133; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WICKENS C. D., 1984, VARIETIES ATTENTION, P63; Zimmermann PFB., 1994, TESTBATTERIE AUFMERK	31	4	4	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					538	547		10.3109/02699052.2013.766926			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000004	23472884				2022-02-06	
J	Springer, BA				Springer, Barbara A.			Ride 2 Recovery's Project HERO: Using cycling as part of rehabilitation	PHYSICAL THERAPY IN SPORT			English	Article						Cycling; Rehabilitation; Military; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; ANTERIOR CRUCIATE LIGAMENT; MILITARY SERVICE MEMBERS; HEALTH-BENEFITS; KNEE OSTEOARTHRITIS; NCAA CONCUSSION; PREVALENCE; DISABILITIES	Ride 2 Recovery was founded in 2008 by a former world-class cycling competitor and coach to enhance the physical and psychological recovery of our nation's wounded, ill and injured service members and veterans through the sport of cycling. Ride 2 Recovery's most notable endeavor is Project HERO (Healing Exercise Rehabilitation Opportunity) which uses staff members and volunteers to promote cycling as an integral part of rehabilitation at select military facilities to enhance physical, psychological, spiritual and social recovery. Project HERO is directed by a retired military physical therapist that spent the last decade caring for service men and women wounded in Iraq and Afghanistan. This article describes all facets of the Project HERO initiative and highlights the profound impact it has had in the lives of US military members and veterans. (C) 2012 Elsevier Ltd. All rights reserved.	Ride 2 Recovery, Calabasas, CA 91302 USA		Springer, BA (corresponding author), Ride 2 Recovery, 23679 Calabasas Rd 420, Calabasas, CA 91302 USA.	r2rherodirector@aol.com					Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; Carnall D, 2000, BRIT MED J, V320, P888, DOI 10.1136/bmj.320.7239.888; Cavill N., 2007, CYCLING HLTH WHATS E; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, 2012, RET DUT; Delaney B., 2011, SURVIVING SHADOWS JO; Dominick KL, 2006, J RHEUMATOL, V33, P348; Dunn WR, 2003, J BONE JOINT SURG AM, V85A, P1656, DOI 10.2106/00004623-200309000-00002; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harris IA, 2008, ANZ J SURG, V78, P583, DOI 10.1111/j.1445-2197.2008.04578.x; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hsiao M, 2010, AM J SPORT MED, V38, P1997, DOI 10.1177/0363546510371423; Johnston TE, 2007, PHYS THER, V87, P1243, DOI 10.2522/ptj.20060210; Kopec J. A., 2008, ARTHRITIS RHEUMATISM, V15, P929; Kopec JA, 2007, J RHEUMATOL, V34, P386; Mangione KK, 1999, J GERONTOL A-BIOL, V54, pM184, DOI 10.1093/gerona/54.4.M184; Matheny F., 2003, F MATHENYS COMPLETE; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Mersy D. J., 1991, POSTGRAD MED, V90, P110; MERSY DJ, 1991, POSTGRAD MED, V90, P103; National Institute of Mental Health, 2009, POSTTR STRESS DIS; Neal Matthew T, 2012, Surg Neurol Int, V3, P16, DOI 10.4103/2152-7806.92930; Norvell DC, 2005, ARCH PHYS MED REHAB, V86, P487, DOI 10.1016/j.apmr.2004.04.034; Ongecha-Owuor F A, 2004, East Afr Med J, V81, P362; Owens BD, 2007, MIL MED, V172, P90, DOI 10.7205/MILMED.172.1.90; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Springer B. A., 2012, PROFILES COURAGE; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; U.S Department of Defense, 2012, US DEP DEF CAS STAT; Valent LJ, 2008, ARCH PHYS MED REHAB, V89, P1016, DOI 10.1016/j.apmr.2007.10.034; Wen LM, 2008, PREV MED, V46, P29, DOI 10.1016/j.ypmed.2007.08.009; Wordin J. W., 2012, RIDE 2 RECOVERY MAKI	43	4	4	1	22	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2013	14	2					77	86		10.1016/j.ptsp.2012.11.001			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	154BO	WOS:000319646700003	23257397				2022-02-06	
J	Thampatty, BP; Klamerus, MM; Oberly, PJ; Feldman, KL; Bell, MJ; Tyler-Kabara, EC; Adelson, PD; Clark, RSB; Kochanek, PM; Poloyac, SM				Thampatty, Bhavani P.; Klamerus, Megan M.; Oberly, Patrick J.; Feldman, Kerri L.; Bell, Michael J.; Tyler-Kabara, Elizabeth C.; Adelson, P. David; Clark, Robert S. B.; Kochanek, Patrick M.; Poloyac, Samuel M.			Hypothermia Decreases Cerebrospinal Fluid Asymmetric Dimethylarginine Levels in Children With Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						asymmetric dimethyl arginine; cerebrospinal fluid; neuroprotection; nitric oxide synthase; traumatic brain injury; therapeutic hypothermia	NITRIC-OXIDE SYNTHASE; CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; L-ARGININE; POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; HUMAN PLASMA; ENDOTHELIAL DYSFUNCTION; THERAPEUTIC HYPOTHERMIA; ENDOGENOUS INHIBITOR	Objectives: Pathological increases in asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, have been implicated in endothelial dysfunction and vascular diseases. Reduced nitric oxide early after traumatic brain injury may contribute to hypoperfusion. Currently, methods to quantify asymmetric dimethylarginine in the cerebrospinal fluid have not been fully explored. We aimed to develop and validate a method to determine asymmetric dimethylarginine in the cerebrospinal fluid of a pediatric traumatic brain injury population and to use this method to assess the effects of 1) traumatic brain injury and 2) therapeutic hypothermia on this mediator. Design, Setting, and Patients: An ancillary study to a prospective, phase II randomized clinical trial of early hypothermia in a tertiary care pediatric intensive care unit for children with Traumatic brain injury admitted to Children's Hospital of Pittsburgh. Interventions: None. Measurements and Main Results: A UPLC-MS/MS method was developed and validated to quantitate asymmetric dimethylarginine. A total of 56 samples collected over 3 days with injury onset were analyzed from the cerebrospinal fluid of consented therapeutic hypothermia (n = 9) and normothermia (n = 10) children. Children undergoing diagnostic lumbar puncture (n = 5) were enrolled as controls. Asymmetric dimethylarginine was present at a quantifiable level in all samples. Mean asymmetric dimethylarginine levels were significantly increased in normothermic Traumatic brain injury children compared with that in control (0.19 +/- 0.08 mu mol/L and 0.11 +/- 0.02 mu mol/L, respectively, p = 0.01), and hypothermic children had significantly reduced mean asymmetric dimethylarginine levels (0.11 +/- 0.05 mu mol/L) vs. normothermic (p = 0.03) measured on day 3. Patient demographics including age, gender, and nitric oxide levels (measured as nitrite and nitrate using liquid chromatography coupled with Griess reaction) did not significantly differ between normothermia and hypothermia groups. Also, nitric oxide levels did not correlate with asymmetric dimethylarginine concentrations. Conclusions: Asymmetric dimethylarginine levels were significantly increased in the cerebrospinal fluid of traumatic brain injury children. Early hypothermia attenuated this increase. The implications of attenuated asymmetric dimethylarginine on nitric oxide synthases activity and regional cerebral blood flow after traumatic brain injury by therapeutic hypothermia deserve future study.	[Thampatty, Bhavani P.; Oberly, Patrick J.; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Klamerus, Megan M.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Feldman, Kerri L.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bell, Michael J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Thampatty, BP (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.	poloyac@pitt.edu	Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019; Tyler-Kabara, Elizabeth/H-4930-2013	Kochanek, Patrick M/0000-0002-2627-913X; Tyler-Kabara, Elizabeth/0000-0003-3286-1094	NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM073031, 5UL1 NCRR RR024153-04, NCRR S10RR023461, NS30318]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023461, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM073031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318] Funding Source: NIH RePORTER	This work was funded, in part, by NIGMS R01GM073031, 5UL1 NCRR RR024153-04, NCRR S10RR023461, and NS30318.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; Arlt S, 2008, DEMENT GERIATR COGN, V26, P58, DOI 10.1159/000144026; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Brouns R, 2009, NEUROCHEM RES, V34, P1642, DOI 10.1007/s11064-009-9954-3; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Conte C, 2005, ANAL BIOCHEM, V338, P347, DOI 10.1016/j.ab.2004.11.018; DALKARA T, 1994, NEUROPHARMACOLOGY, V33, P1447, DOI 10.1016/0028-3908(94)90048-5; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Lucke T, 2007, CLIN CHEM LAB MED, V45, P1525, DOI 10.1515/CCLM.2007.300; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; Martens-Lobenhoffer J, 2004, J MASS SPECTROM, V39, P1287, DOI 10.1002/jms.684; Martens-Lobenhoffer J, 2003, J CHROMATOGR B, V798, P231, DOI 10.1016/j.jchromb.2003.09.050; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vishwanathan K, 2000, J CHROMATOGR B, V748, P157, DOI 10.1016/S0378-4347(00)00399-6; Yamada K, 1997, J NEUROCHEM, V68, P1234; YAMASHITA K, 1991, STROKE, V22, P1574, DOI 10.1161/01.STR.22.12.1574	56	4	4	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2013	14	4					403	412		10.1097/PCC.0b013e31827212c0			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	140UA	WOS:000318680000015	23439461	Green Accepted			2022-02-06	
J	Nguyen, T; Cho, YH; Jang, YJ; Park, MC; Shin, SJ				Trang Nguyen; Cho, Young Hoo; Jang, Yu Jin; Park, Myong Chul; Shin, Seung Jun			Long Delayed Traumatic Carotid-Cavernous Sinus Fistula	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Carotid-cavernous sinus fistula; trauma; skull basal fracture; zygomatic complex fracture		Traumatic carotid-cavernous sinus fistula (TCCF) is a rare but significant vascular abnormality in the skull base found after craniomaxillofacial trauma. Although the direct type is usually caused by trauma, the onset of symptoms in TCCF may present several weeks after injury. We present the case of a patient who sustained a blunt head injury from falling down and was hospitalized with skull base fracture associated with zygomatic complex fractures on the right side. After surgery, the recovery was uneventful and the patient was discharged without any problems. On the eighth week postoperatively, the patient returned to hospital presenting tinnitus, bruit on the right orbital area, diplopia, eye pain, and headache. The patient also had severe limitation of ocular movement on lateral gaze. After having brain angio-CT, which showed a dilated superior ophthalmic vein, the diagnosis of CCF with cranial nerve VI was confirmed. The fistula was occluded successfully by using coils. After the procedure, tinnitus, bruit, and headache were reduced immediately. On following up 4 months after coiling, cranial nerve VI palsy and related symptoms-diplopia and limit of ocular movement-were improved significantly. Although TCCFs usually manifest symptoms early after trauma, in this case, the patient presented clinical signs 8 weeks post-injury, while the longest time that was acknowledged in another previously released article was 6 weeks. According to this case, we recommend a careful follow-up until 2 months for patients with skull base fracture in order to rule out the risk of CCF.	[Trang Nguyen] Vietnam Cuba Hosp, Dept Reconstruct & Maxillofacial Surg, Hanoi, Vietnam; [Cho, Young Hoo; Jang, Yu Jin; Park, Myong Chul; Shin, Seung Jun] Ajou Univ Hosp, Dept Plast & Reconstruct Surg, Suwon, Yeonggi Do, South Korea		Shin, SJ (corresponding author), Ajou Univ Hosp, Dept Plast & Reconstruct Surg, Suwon, Yeonggi Do, South Korea.	prolixcom@gmail.com					ARSENI C, 1970, PSYCHIAT NEUROL NEUR, V73, P237; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Fabian TS, 1999, J TRAUMA, V47, P275, DOI 10.1097/00005373-199908000-00009; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Holmes JD, 2001, J ORAL MAXIL SURG, V59, P102, DOI 10.1053/joms.2001.19306; LANIGAN DT, 1987, J ORAL MAXIL SURG, V45, P969, DOI 10.1016/0278-2391(87)90452-6; Vadivelu S, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09257	7	4	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2013	24	3					E237	E239		10.1097/SCS.0b013e31828609ee			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	294WI	WOS:000330078200018	23714975				2022-02-06	
J	Brophy, GM; Candeloro, CL; Robles, JR; Brophy, DF				Brophy, Gretchen M.; Candeloro, Christina L.; Robles, Jaime R.; Brophy, Donald F.			Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events	ANNALS OF PHARMACOTHERAPY			English	Article							OFF-LABEL USE; DOUBLE-BLIND; INTRACEREBRAL HEMORRHAGE; TRAUMA PATIENTS; SAFETY; EFFICACY; REVERSAL; COAGULOPATHY; CIRRHOSIS	BACKGROUND: Hemorrhage and coagulopathy are associated with morbidity and mortality in critically ill patients. Recombinant activated factor VII (rFVIIa) is frequently used in these situations to control bleeding; however, few controlled clinical trials have demonstrated clinical benefit and prolonged survival. OBJECTIVE: To compare clinical outcomes and thromboembolic events in intensive care unit (ICU) patients who received rFVIIa versus ICU patients who did not between 2000 and 2005. METHODS: A total of 2918 nonhemophiliac adult ICU patients, which included 1459 who received at least 1 dose of rFVIIa and 1459 matched controls who did not, were included in a retrospective database study. Data were extracted from the Solucient ACTracker database, which included 550 hospitals across the US. Measures included patient demographics, rFVIIa prescribing, death, thromboembolic events, discharge disposition, length of stay, and transfusion data. RESULTS: The most common primary diagnoses for patients receiving rFVIIa included traumatic brain injury, cirrhosis, and nontraumatic intracranial hemorrhage. Patients receiving rFVIIa were more likely to have comorbidities, including mechanical ventilation, acute kidney injury, sepsis, hemodialysis, and gastrointestinal bleeding (p < 0.0001). The average rFVIIa dose was 4.8 mg and 82% of patients received 1 dose. Compared to controls, patients receiving rFVIIa had greater odds of death (OR 2.1, 95% CI 1.8-2.6, p < 0.0001), transfusion (OR 2.1, 95% CI 1.8-2.5, p < 0.0001), and longer length of stay (p < 0.001). There was no significant difference in thromboembolic events between groups. CONCLUSIONS: While we cannot show direct causality between rFVIIa and the poor clinical outcomes documented in ICU patients, they provide important insight for critical care clinicians.	[Brophy, Gretchen M.; Robles, Jaime R.; Brophy, Donald F.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA; [Candeloro, Christina L.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA		Brophy, GM (corresponding author), Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA.	gbrophy@vcu.edu	Brophy, Donald F./AAJ-3805-2021	Brophy, Donald F./0000-0003-3447-8523; Brophy, Gretchen/0000-0002-4749-2693	Novo NordiskNovo Nordisk	This study was supported by an investigator-initiated study grant from Novo Nordisk.	3M Health Information Systems, 2006, ALL PAT REF DIANG RE; Agresti A., 2013, CATEGORICAL DATA ANA, V3; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Brophy DF, 2012, ANEMIA, V2012; Brown CVR, 2012, AM SURGEON, V78, P57; Da'as N, 2006, ISR MED ASSOC J, V8, P807; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Ferrari L, 2011, INTERN EMERG MED, V6, P261, DOI 10.1007/s11739-011-0593-8; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Grounds RM, 2005, CRIT CARE, V9, pS29, DOI 10.1186/cc3783; Gunst M, 2004, J TRAUMA, V58, P217; Harrison TD, 2005, J TRAUMA, V59, P150, DOI 10.1097/01.TA.0000171470.39742.8E; Ingerslev J, 2007, J POSTGRAD MED, V53, P17, DOI 10.4103/0022-3859.30322; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Johansson PI, 2008, VOX SANG, V95, P1, DOI 10.1111/j.1423-0410.2008.01063.x; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Lin YL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub3; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Logan AC, 2010, HEMATOL-AM SOC HEMAT, P153, DOI 10.1182/asheducation-2010.1.153; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2006, NEUROCRIT CARE, V4, P206, DOI 10.1385/NCC:4:3:206; Mohr AM, 2005, CRIT CARE, V9, pS37, DOI 10.1186/cc3784; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nishijima DK, 2010, ACAD EMERG MED, V17, P244, DOI 10.1111/j.1553-2712.2010.00666.x; Pickard JD, 2000, BLOOD COAGUL FIBRIN, V11, pS117, DOI 10.1097/00001721-200004001-00022; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Product information, 1999, NOVOSEVEN COAG FACT; Robinson MT, 2010, STROKE, V41, P1459, DOI 10.1161/STROKEAHA.110.581538; RUBIN DB, 1973, BIOMETRICS, V29, P159, DOI 10.2307/2529684; Scheike T.H., 2006, STAT BIOL HEALTH; Shao YF, 2006, AM J SURG, V191, P245, DOI 10.1016/j.amjsurg.2005.10.019; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Willis CD, 2009, J THROMB HAEMOST, V7, P2016, DOI 10.1111/j.1538-7836.2009.03632.x; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	45	4	4	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	APR	2013	47	4					447	454		10.1345/aph.1R729			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	225UF	WOS:000324987900007	23535812				2022-02-06	
J	Apori, AA; Brozynski, MN; El-Sayed, IH; Herr, AE				Apori, Akwasi A.; Brozynski, Martina N.; El-Sayed, Ivan H.; Herr, Amy E.			Microfluidic Validation of Diagnostic Protein Markers for Spontaneous Cerebrospinal Fluid Rhinorrhea	JOURNAL OF PROTEOME RESEARCH			English	Article						cerebrospinal fluid rhinorrhea; immunosubtraction; transthyretin; beta-2-transferrin; biomarker validation; traumatic brain injury; microfluidic; electrophoresis	GEL ELECTROPHORESIS; CAPILLARY-ELECTROPHORESIS; POLYACRYLAMIDE-GELS; PROTEOMIC ANALYSIS; CHIP; IMMUNOASSAYS; IMMUNOSUBTRACTION; SEPARATION; ANTIBODY; FISTULAS	Cerebrospinal fluid (CSF) rhinorrhea is a potentially dangerous condition identified by CSF leakage into the nasal cavity. This malady stands to benefit from rapid and non-invasive screening diagnostics to complement low-throughput imaging based methods currently in use. To address this gap, we demonstrate on-chip immunosubtraction to accelerate biomarker validation and immunoassay development for a putative CSF rhinorrhea diagnostic marker, transthyretin, by combining high specificity immunoaffinity capture with subsequent polyacrylamide gel electrophoresis (PAGE). We demonstrate the on-chip assay using photopatterned polyacrylamide immunofilters. The filter consists of polymer with controlled pore-sizes to size-exclude (i.e., "subtract") large antibody-target immune complexes from downstream PAGE separation. A control PAGE separation is also performed for comparison without immunoaffinity capture (i.e., no antibody present). We compare on-chip immunosubtraction to Western blotting and ELISA to validate CSF rhinorrhea biomarkers from nasal surgery samples. For samples representative of spontaneous rhinorrhea, the 5 min on-chip assay achieved clinical specificity of 100%, compared to 50% for ELISA which required 6 h On chip immunosubtraction also generated results for clinical samples not assayable via ELISA due to matrix protein spurious signals. The pilot study suggests the capability of a rapid on chip validation tool to expedite scrutiny of putative protein markers for new clinical assays.	[Apori, Akwasi A.; Brozynski, Martina N.; Herr, Amy E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [El-Sayed, Ivan H.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA		Herr, AE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aeh@berkeley.edu		Herr, Amy/0000-0002-6906-2985	Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-1-2118]; National Institutes of Health through the NIH Director's New Innovator Award ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2OD007294]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD007294] Funding Source: NIH RePORTER	This material is based upon work supported by the Defense Advanced Research Projects Agency (DARPA) under Award N66001-09-1-2118 and the National Institutes of Health through the NIH Director's New Innovator Award Program (AEH, 1DP2OD007294). A.A.A. is a National Defense Science and Engineering Graduate (NDSEG) Fellow and UNCF/Merck Fellow. A.E.H. is an Alfred P. Sloan Foundation Research Fellow in chemistry.	Apori A. A., 2010, 14 INT C MIN SYST CH, P2056; Apori A. A., 2012, CLIN APPL CAPILLARY; Apori AA, 2011, ANAL CHEM, V83, P2691, DOI 10.1021/ac103219x; Bateman N, 2000, J LARYNGOL OTOL, V114, P462; Bossuyt X, 1998, CLIN CHEM, V44, P760; Burkhard PR, 2001, ELECTROPHORESIS, V22, P1826, DOI 10.1002/1522-2683(200105)22:9<1826::AID-ELPS1826>3.0.CO;2-L; CATON JE, 1973, ABSTR PAP AM CHEM S, P31; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; GALLO P, 1985, J NEUROL SCI, V70, P81, DOI 10.1016/0022-510X(85)90190-X; Goyal V, 2011, J GEN INTERN MED, V26, P345, DOI 10.1007/s11606-010-1565-9; He M, 2010, J AM CHEM SOC, V132, P2512, DOI 10.1021/ja910164d; HEKMAN A, 1971, BIOCHIM BIOPHYS ACTA, V251, P380, DOI 10.1016/0005-2795(71)90126-7; Herr AE, 2005, ANAL CHEM, V77, P585, DOI 10.1021/ac0489768; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hou CL, 2010, ANAL CHEM, V82, P3343, DOI 10.1021/ac100182j; Irani D.N, 2009, CEREBROSPINAL FLUID; Karns K, 2011, ANAL CHEM, V83, P8115, DOI 10.1021/ac202061v; Karns K, 2011, BIOANALYSIS, V3, P2161, DOI [10.4155/BIO.11.207, 10.4155/bio.11.207]; Keerl R, 2004, LARYNGOSCOPE, V114, P266, DOI 10.1097/00005537-200402000-00016; Keren DF, 1999, ARCH PATHOL LAB MED, V123, P126; Keren DF, 2003, PROTEIN ELECTROPHORE; Marchi N, 2003, J NEUROSCI, V23, P1949; McMains KC, 2004, LARYNGOSCOPE, V114, P1833, DOI 10.1097/00005537-200410000-00029; Meco C, 2004, LARYNGOSCOPE, V114, P991, DOI 10.1097/00005537-200406000-00007; Nwosu CC, 2012, J PROTEOME RES, V11, P2912, DOI 10.1021/pr300008u; Palfrey SM, 1999, METH MOLEC MED, V27, P39, DOI 10.1385/1-59259-689-4:39; Paquette DM, 2001, ELECTROPHORESIS, V22, P2391, DOI 10.1002/1522-2683(200107)22:12<2391::AID-ELPS2391>3.0.CO;2-B; Phillips TM, 2006, J CHROMATOGR A, V1111, P106, DOI 10.1016/j.chroma.2006.01.102; Phillips TM, 2004, ELECTROPHORESIS, V25, P1652, DOI 10.1002/elps.200305873; Schlosser RJ, 2004, LARYNGOSCOPE, V114, P255, DOI 10.1097/00005537-200402000-00015; Schnabel C, 2004, CLIN CHEM, V50, P661, DOI 10.1373/clinchem.2003.024158; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Thongboonkerd V, 2007, J PROTEOME RES, V6, P2011, DOI 10.1021/pr060586+; VANLANDEGHEM GF, 1996, ANAL BIOANAL CHEM, V355, P96; Waller LN, 2008, J PROTEOME RES, V7, P4577, DOI 10.1021/pr8001518; Warnecke A, 2004, ARCH OTOLARYNGOL, V130, P1178, DOI 10.1001/archotol.130.10.1178; Yue GE, 2006, ANAL CHIM ACTA, V564, P116, DOI 10.1016/j.aca.2005.11.003	37	4	4	0	26	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893			J PROTEOME RES	J. Proteome Res.	MAR	2013	12	3					1254	1265		10.1021/pr300928p			12	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	100NN	WOS:000315708000018	23343621				2022-02-06	
J	Babbitt, CJ; Halpern, R; Liao, E; Lai, K				Babbitt, Christopher J.; Halpern, Rebekah; Liao, Eileen; Lai, Khanh			Hyperglycemia Is Associated With Intracranial Injury in Children Younger Than 3 Years of Age	PEDIATRIC EMERGENCY CARE			English	Article						hyperglycemia; traumatic brain injury; intracranial hemorrhage	COMPUTED-TOMOGRAPHY; RISK	Objectives: The objective was to see if hyperglycemia in the emergency department predicted traumatic intracranial hemorrhage (ICH) for infants and young children. Methods: A 6-year retrospective chart review was performed on patients younger than 3 years. Patients identified from the pediatric intensive care unit (PICU) database with ICH on computer tomography were compared with those with a history of trauma without ICH identified from a radiology database. Subgroup analysis was performed on the ICH group comparing abusive head trauma (AHT) and accidental. Primary outcomes measured were initial serum glucose level, length of stay, length of ventilation, mortality, and disability on discharge. Results: Fifty-three patients were admitted to the PICU with traumatic ICH with an overall mortality of 7.5%. The average initial glucose in the emergency department was significantly higher for the patients with ICH than those without (164 vs 99 mg/dL, P < 0.0001). Combining elevated serum glucose with any abnormality in Glasgow Coma Scale score yielded sensitivity and specificity of 100%. The average presenting glucose was higher for AHT compared with accidental injury (190 vs 133 mg/dL, P < 0.001). Patients with AHT had greater PICU and hospital length of stay and more severe disabilities on discharge (P G 0.001). Conclusions: Elevated serum glucose is a good marker of ICH in children younger than 3 years. When correlated with an abnormal neurological examination, it is highly sensitive and specific. Patients with AHT have further elevation of serum glucose at presentation. Emergency department physicians should consider measuring the serum glucose in children younger than 3 years with abnormal neurological examinations and obtaining a head computer tomography if it is elevated.	[Babbitt, Christopher J.; Halpern, Rebekah] Miller Childrens Hosp, Long Beach, CA 90806 USA; [Liao, Eileen] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 92668 USA; [Lai, Khanh] Univ Calif Irvine, Childrens Hosp Orange Cty, Dept Pediat, Orange, CA 92668 USA		Babbitt, CJ (corresponding author), Miller Childrens Hosp, Long Beach, CA 90806 USA.	cbabbitt@memorialcare.org					[Anonymous], 2006, TRAUM BRAIN INJ US A; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Faul M, 2010, TRAUMATIC BRAIN INJU; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Zuckerman GB, 1998, ARCH PEDIAT ADOL MED, V152, P134	19	4	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2013	29	3					279	282		10.1097/PEC.0b013e3182850409			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	103WA	WOS:000315949000002	23426241				2022-02-06	
J	Bon, J; Koritnik, B; Bresjanac, M; Repovs, G; Pregelj, P; Dobnik, B; Pirtosek, Z				Bon, Jurij; Koritnik, Blaz; Bresjanac, Mara; Repovs, Grega; Pregelj, Peter; Dobnik, Bogdan; Pirtosek, Zvezdan			Cost of disorders of the brain in Slovenia in 2010	ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL			Slovene	Article						mental disorders; neurological disorders; costs; prevalence; disease burden	MENTAL-DISORDERS; EUROPE; BURDEN; SIZE	Background: The spectrum of disorders of the brain is large, covering a wide range of neurological and psychiatric conditions. They have a high prevalence and cause short- and long-term impairments and disabilities, representing approximately one third of the whole disease burden in Western societies. In a European Brain Council (EBC) landmark study, the costs for 12 major groups of disorders of the brain in Europe in year 2004 were estimated for the first time. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. An updated EBC study on cost of disorders of the brain in Europe for 2010 covered 19 major groups of disorders with an increased range of age groups and more cost items. Revised estimates also included the new EU member states, and hence a population of 514 million people. Based on the same methodology, individual countries are now shaping their respective national cost estimates. Here we present the relevant data on estimated cost of brain disorders in Slovenia for 2010. Aims: To employ the EBC methodology to estimate the number of persons with defined disorders of the brain in Slovenia in 2010, the total cost per person related to individual disease in terms of direct and indirect costs, and an estimate of the total cost per disorder. Methods: The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. The following range of mental and neurologic groups of disorders was covered: addictive disorders, affective disorders, anxiety disorders, brain tumors, childhood and adolescence disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. A cost model developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in European countries was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010. Results: The total cost of disorders of the brain for Slovenia is estimated at 2,425 billion in 2010, adjusted for purchasing power parities ((sic)PPP). Direct costs constitute the majority of costs (42.3 % direct healthcare costs and 22.0 % direct non-medical costs) whereas the remaining 35.7 % were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Slovenia ranged between (sic)PPP 178 for headache and (sic)PPP 2,2045 for neuromuscular disorders. The Slovenian per capita cost of disorders of the brain was (sic)PPP 1,185. The cost (in million (sic)PPP for 2010) of the disorders of the brain included in this study was as follows: mood disorders: 329.3; anxiety disorders: 289.4; stroke: 284.7; psychotic disorders: 277.3; dementia: 214.9; addiction: 195.0; mental retardation: 144.7; headache: 113.1; sleep disorders: 105.3; brain injury: 93.8; personality disorders: 79.1; childhood/adolescence disorders: 64.4; somatoform disorder: 62.7; multiple sclerosis: 57.7; Parkinson's disease: 36.1; epilepsy: 35.8; neuromuscular disorders: 22.6; brain tumors: 16.4; eating disorders: 2.6. Conclusion: This EBC study is based on the best currently available data in Europe and the model enables extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in estimates and may imply over- or underestimations in some disorders and countries, including Slovenia, where there are still no reliable epidemiological and health-economic data on brain disorders. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. The estimate of the total cost of brain disorders in Europe and Slovenia is therefore considered to be conservative. In terms of the health economic burden outlined in the EBC report and here, disorders of the brain likely constitute the number one economic challenge for health care in all European countries, now and in the future. The results are consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe, while being lower than analogous estimates from the US. The reported results should be considered by all stakeholders, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and shape a coordinated national action-plan to address the imminent challenges posed by disorders of the brain.	[Bon, Jurij; Koritnik, Blaz; Pirtosek, Zvezdan] Univ Klin Ctr Ljubljana, Nevroloska Klin, Klin Oddelek Bolezni Zivcevja, Ljubljana, Slovenia; [Bon, Jurij; Pregelj, Peter] Psihiatricna Klin Ljubljana, Ljubljana 1260, Slovenia; [Koritnik, Blaz] Univ Klin Ctr Ljubljana, Nevroloska Klin, Klin Inst Klin Nevrofiziol, Ljubljana, Slovenia; [Bresjanac, Mara] Univ Ljubljani, Fak Med, Lab Regeneracijo Plasticnost & Zivcevja, Inst Patolosko Fiziol, Ljubljana, Slovenia; [Repovs, Grega] Univ Ljubljani, Filozofska Fak, Oddelek Psihol, Ljubljana, Slovenia		Bon, J (corresponding author), Psihiatricna Klin Ljubljana, Studenec 48, Ljubljana 1260, Slovenia.	jure.bon@psih-klinika.si	Pirtosek, Zvezdan/AAB-4729-2020; Koritnik, Blaz/N-7487-2019	Pirtosek, Zvezdan/0000-0002-5495-944X; Koritnik, Blaz/0000-0002-5083-8261; Bon, Jurij/0000-0002-5303-2044; Repovs, Grega/0000-0003-1837-3879			Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; [Anonymous], 2012, CARDIOVASCULAR DIS; Di Luca M, 2011, EUR J NEUROSCI, V33, P768, DOI 10.1111/j.1460-9568.2010.07596.x; European Commission, 2009, BRAIN RES EU FUND 20; Grogelj S, 2011, PLACE SLOVENIJA 2010; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hren K, 2011, BRUTO DOMACI PROIZVO; Marn S, 2012, IZDATKI VIRI FINANCI; Marn S, 2007, 3 K POD INF ZDRAVSTV; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nutt D.J., 2012, EUR NEUROPSYCHOPHARM, V21, P495; Nutt DJ, 2011, EUR NEUROPSYCHOPHARM, V21, P715, DOI 10.1016/j.euroneuro.2011.09.005; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; OLESEN J, 2006, J NEUROL NEUROSUR S1, V77, P1; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Pecar-Cad S, 2011, AMBULANTNO PREDPISOV; Sobocki P, 2006, EUR J NEUROSCI, V24, P2691, DOI 10.1111/j.1460-9568.2006.05116.x; Vodusek DB, 2008, ZDRAVNISKI VESTNI S2, V77; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; World Health Organization (WHO), 2005, MENT HLTH FAC CHALL	21	4	4	0	9	SLOVENE MEDICAL SOC	LJUBLJANA	ZDRAVNISKI VESTNIK, DALMATINOVA 10, P P 26, LJUBLJANA, 1001, SLOVENIA	1318-0347	1581-0224		ZDR VESTN	Zdr. Vestn.	MAR	2013	82	3					164	175					12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120GB	WOS:000317157700006					2022-02-06	
J	Chandra, N; Ojha, BK; Chandwani, V; Srivastava, C; Singh, SK; Chandra, A				Chandra, Nagesh; Ojha, Bal Krishan; Chandwani, Vashdev; Srivastava, Chhitij; Singh, Sunil Kumar; Chandra, Anil			A rare case of posttraumatic eyelid swelling: cerebrospinal fluid blepharocele	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						blepharocele; posttraumatic eyelid swelling; blunt head trauma; skull base fracture	TRAUMATIC ORBITAL ENCEPHALOCELE; LEAKAGE; ADULT	Posttraumatic herniation of brain and CSF into the eyelid, variously termed as blepharocele, blepharoencephalocele, or encephalocele, is not a common entity, with only a few reported cases in the literature. A 4-year-old girl was seen for gradually increasing left upper eyelid swelling after she had sustained a head injury due to a fall from height. A few days later she developed swelling of the upper eyelid. Posttraumatic CSF blepharocele was suspected. The patient underwent surgery with excellent cosmetic outcome. This case is discussed with a review of literature. (http://thejns.org/doi/abs/10.3171/2012.12.PEDS11500)	[Chandra, Nagesh; Ojha, Bal Krishan; Chandwani, Vashdev; Srivastava, Chhitij; Singh, Sunil Kumar; Chandra, Anil] King George Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India		Chandra, N (corresponding author), King George Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India.	naggupta@yahoo.com					ANTWORTH MV, 1989, CAN J OPHTHALMOL, V24, P129; Arslantas A, 2003, CHILD NERV SYST, V19, P54, DOI 10.1007/s00381-002-0632-x; BAGOLINI B, 1957, ARCH OPHTHALMOL-CHIC, V57, P454; BHANDARI YS, 1969, J NEUROSURG, V30, P612, DOI 10.3171/jns.1969.30.5.0612; Bhatoe HS, 2002, SKULL BASE-INTERD AP, V12, P73; Brodie HA, 1997, AM J OTOL, V18, P188; Duhem-Tonnelle V, 2008, NEUROCHIRURGIE, V54, P28, DOI 10.1016/j.neuchi.2008.01.004; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Galzio R J, 1981, J Neurosurg Sci, V25, P105; GARZAMERCADO R, 1982, NEUROSURGERY, V11, P525; Greenwald M J, 1987, J Pediatr Ophthalmol Strabismus, V24, P141; Matthew JM, 1997, NEUROL INDIA, V45, P46; Morihara H, 2010, NEUROL MED-CHIR, V50, P1126, DOI 10.2176/nmc.50.1126; Salame K, 2000, Neurosurg Focus, V9, pe3	14	4	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2013	11	3					242	244		10.3171/2012.12.PEDS11500			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	094DV	WOS:000315244100002	23331213				2022-02-06	
J	Gagnon, J; Henry, A; Decoste, FP; Ouellette, M; McDuff, P; Daelman, S				Gagnon, Jean; Henry, Anne; Decoste, Francois-Pierre; Ouellette, Michel; McDuff, Pierre; Daelman, Sacha			Response to Hypothetical Social Scenarios in Individuals with Traumatic Brain Injury Who Present Inappropriate Social Behavior: A Preliminary Report	BEHAVIORAL SCIENCES			English	Article						inappropriate social behavior; traumatic brain injury; decision making; social interaction		Background: Very little research thus far has examined the decision making that underlies inappropriate social behavior (ISB) post-TBI (traumatic brain injury). Objectives: To verify the usefulness of a new instrument, the Social Responding Task, for investigating whether, in social decision making, individuals with TBI, who present inappropriate social behavior (ISB), have difficulty anticipating their own feelings of embarrassment and others' angry reactions following an ISB. Methods: Seven subjects with TBI presenting with inappropriate social behavior (TBI-ISB), 10 presenting with appropriate social behavior (TBI-ASB), and 15 healthy controls were given 12 hypothetical scenarios three times, each time ending with a different behavioral response. Subjects were asked to gauge the likelihood of their displaying the behavior in that situation (part A) and of it being followed by an angry reaction from the other or by feelings of embarrassment in themselves (part B). Results: TBI-ISB subjects scored higher than TBI-ASB and healthy controls on a scale of likelihood of displaying an ISB. Results regarding expectations of angry reactions from others and feelings of embarrassment after an ISB were similar among groups. Negative correlations between endorsement of an inappropriate behavior and anticipation of negative emotional consequences were significant for both TBI-ASB and control subjects, but not for TBI-ISB subjects. Conclusions: Results suggest that the TBI-ISB participants were likely to endorse an ISB despite being able to anticipate a negative emotional response in themselves or others, suggesting that there were other explanations for their poor behavior. A self-reported likely response to hypothetical social scenarios can be a useful approach for studying the neurocognitive processes behind the poor choices of individuals with TBI-ISB, but the task needs further validation studies. A comprehensive discussion follows on the underlying mechanisms affecting social behaviors after a TBI.	[Gagnon, Jean; Henry, Anne; Decoste, Francois-Pierre; McDuff, Pierre; Daelman, Sacha] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Gagnon, Jean; Henry, Anne; Decoste, Francois-Pierre; Ouellette, Michel; Daelman, Sacha] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H2H 2N8, Canada; [Gagnon, Jean] Univ Sherbrooke, Dept Psychol, Sherbrooke, PQ H2V 2S9, Canada; [Gagnon, Jean] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ H3C 3J7, Canada		Gagnon, J (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada.	jean.gagnon@umontreal.ca; annehenry@videotron.ca; frank0996@gmail.com; m.ouellette@umontreal.ca; pierre.mcduff@umontreal.ca; sacha.daelman@umontreal.ca			Centre de readaptation Lucie-Bruneau; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR)	We thank Donna Riley for her help with translation of the manuscript. This study was supported by research grants to JG from the Centre de readaptation Lucie-Bruneau and from the Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR).	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Damasio A., 1994, DESCARTESS ERROR EMO; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Fontaine RG, 2006, AGGRESSIVE BEHAV, V32, P604, DOI 10.1002/ab.20150; Franulic A, 2000, BRAIN INJURY, V14, P431; Franzen M D, 2000, Crit Care Nurs Q, V23, P58; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Gravetter FJ., 2004, STAT BEHAV SCI, V6; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Leland JW, 2005, GAME ECON BEHAV, V52, P386, DOI 10.1016/j.geb.2004.09.001; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; SHALLICE T, 1989, BRAIN, V112, P1587, DOI 10.1093/brain/112.6.1587; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wiederkehr S, 2005, REV NEUROL-FRANCE, V161, P201, DOI 10.1016/S0035-3787(05)85023-4	46	4	4	0	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-328X			BEHAV SCI-BASEL	Behav. Sci.	MAR	2013	3	1					72	98		10.3390/bs3010072			27	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V28GI	WOS:000215415500005	25379227	gold, Green Submitted, Green Published			2022-02-06	
J	Martinakis, VG; Dalainas, I; Katsikas, VC; Xiromeritis, K				Martinakis, V. G.; Dalainas, I.; Katsikas, V. C.; Xiromeritis, K.			Endovascular treatment of carotid injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Carotid injury; Carotid blunt trauma; Acute carotid injury; Endovascular treatment; Iatrogenic carotid injury; Carotid artery stenting	BLUNT CEREBROVASCULAR INJURIES; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; STENT-GRAFT TREATMENT; VASCULAR INJURIES; ARTERIAL INJURIES; NEUROLOGIC COMPLICATIONS; PENETRATING INJURIES; TRAUMATIC THROMBOSIS; CEREBRAL-ANGIOGRAPHY; EARLY-DIAGNOSIS	This is a systematic review of the International Literature regarding the role of endovascular treatment in cases of carotid injury. Injury to the carotid artery is not very common but is a serious consequence associated with either blunt or penetrating cervical trauma. They are difficult to evaluate due to associated injuries. The frequent coexistence of traumatic brain injuries seems to obscure its presentation and concurrent systemic injuries make the management somewhat challenging from the perspective of both diagnosis and treatment. Although bleeding is a serious and potentially fatal complication of these injuries, the main concern should be the impairment of cerebral blood supply. In the modern era of increasing usage of minimally invasive treatment options and technological advances, endovascular approach seems to gain acceptance as a sufficient alternative treatment modality in carefully selected groups of these trauma population. Interesting issues facing this emerging technology include the adequate definition of the types of injuries ideally indicated for endovascular treatment. Those traumatic carotid lesions located proximal to aortic arch or near the skull base are particularly hazardous to approach and difficult to repair surgically and may benefit of an endovascular approach. Specifically, iatrogenic injuries of carotid vessels are often occur in patients with significant comorbidities that make their management challenging.	[Martinakis, V. G.; Katsikas, V. C.] G Gennimatas Gen Hosp, Dept Vasc Surg, Athens, Greece; [Dalainas, I.; Xiromeritis, K.] Attikon Univ Hosp, Dept Vasc Surg, Athens, Greece		Dalainas, I (corresponding author), Attikon Univ Hosp, Dept Vasc Surg, Athens, Greece.	dalainas@freemail.gr					Arthurs ZM, 2008, INJURY, V39, P1232, DOI 10.1016/j.injury.2008.02.042; Assadian A, 2004, J VASC SURG, V40, P484, DOI 10.1016/j.jvs.2004.06.031; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2008, J TRAUMA, V64, P398, DOI 10.1097/TA.0b013e31815eb788; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 2001, WORLD J SURG, V25, P1036, DOI 10.1007/s00268-001-0056-x; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bousson V, 1999, AM J ROENTGENOL, V173, P139, DOI 10.2214/ajr.173.1.10397114; Bush RL, 2001, J ENDOVASC THER, V8, P53, DOI 10.1583/1545-1550(2001)008<0053:ESPACE>2.0.CO;2; Cloft HJ, 2000, AM J NEURORADIOL, V21, P541; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cohen JE, 2005, STROKE, V36, pE45, DOI 10.1161/01.STR.0000158910.08024.7f; Coldwell DM, 2000, J TRAUMA, V48, P470, DOI 10.1097/00005373-200003000-00016; Cothren CC, 2005, ARCH SURG-CHICAGO, V140, P480, DOI 10.1001/archsurg.140.5.480; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; CRISSEY MM, 1974, SURGERY, V75, P543; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; Demetriades D, 1997, WORLD J SURG, V21, P41, DOI 10.1007/s002689900191; Demetriades D, 1996, SURG CLIN N AM, V76, P661, DOI 10.1016/S0039-6109(05)70475-8; DEMETRIADES D, 1989, J TRAUMA, V29, P91, DOI 10.1097/00005373-198901000-00019; Demetriades D, 2007, CURR PROB SURG, V44, P13, DOI 10.1067/j.cpsurg.2006.10.004; DiPerna CA, 2002, AM SURGEON, V68, P441; du Toit DF, 2009, EUR J VASC ENDOVASC, V38, P267, DOI 10.1016/j.ejvs.2009.05.003; du Toit DF, 2003, J VASC SURG, V38, P257, DOI 10.1016/S0741-5214(03)00143-5; Duane TM, 2002, J TRAUMA, V52, P149, DOI 10.1097/00005373-200201000-00025; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Duke BJ, 1997, J NEUROSURG, V87, P825, DOI 10.3171/jns.1997.87.6.0825; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Edwards NM, 2007, J AM COLL SURGEONS, V204, P1007, DOI 10.1016/j.jamcollsurg.2006.12.041; Fabian TC, 2002, ANN SURG, V235, P706; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Feugier P, 2007, EUR J VASC ENDOVASC, V34, P663, DOI 10.1016/j.ejvs.2007.06.011; Franz RW, 2010, VASC ENDOVASC SURG, V44, P198, DOI 10.1177/1538574409359429; Ginzburg E, 1996, ARCH SURG-CHICAGO, V131, P691; Giswold ME, 2004, AM J SURG, V187, P590, DOI 10.1016/j.amjsurg.2004.01.013; Goodwin RB, 2009, J TRAUMA, V67, P1046, DOI 10.1097/TA.0b013e3181b83b63; Hershberger RC, 2009, J TRAUMA, V67, P660, DOI 10.1097/TA.0b013e3181b2894c; Hobson Robert W 2nd, 2007, Perspect Vasc Surg Endovasc Ther, V19, P215, DOI 10.1177/1531003507305267; HOCKADAY TDR, 1959, J NEUROL NEUROSUR PS, V22, P229, DOI 10.1136/jnnp.22.3.229; Jonker FHW, 2010, J CARDIOTHOR VASC AN, V24, P322, DOI 10.1053/j.jvca.2009.09.004; Joo JY, 2005, J TRAUMA, V58, P1159, DOI 10.1097/01.TA.0000171550.01402.ED; Kadkhodayan Y, 2005, AM J NEURORADIOL, V26, P2328; Kalish J, 2010, SEMIN VASC SURG, V23, P243, DOI 10.1053/j.semvascsurg.2010.10.004; Kotsis T, 2008, VASC ENDOVASC SURG, V42, P599, DOI 10.1177/1538574408320528; LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213; Luo CB, 2007, ACTA NEUROCHIR, V149, P675, DOI 10.1007/s00701-007-1229-7; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Maras D, 2006, CARDIOVASC INTER RAD, V29, P958, DOI 10.1007/s00270-005-0367-7; Martin JB, 2000, CARDIOVASC SURG, V8, P499, DOI 10.1016/S0967-2109(00)00050-8; MEYER JP, 1987, ARCH SURG-CHICAGO, V122, P592; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; MONSON DO, 1969, J TRAUM, V9, P987, DOI 10.1097/00005373-196912000-00003; Moulakakis KG, 2010, EUR J VASC ENDOVASC, V40, P312, DOI 10.1016/j.ejvs.2010.05.003; Munera Felipe, 2004, Emerg Radiol, V10, P303; MURRAY DS, 1957, BRIT J SURG, V44, P556, DOI 10.1002/bjs.18004418803; Navsaria P, 2002, EUR J VASC ENDOVASC, V24, P349, DOI 10.1053/ejvs.2002.1736; Nehler M R, 1998, Semin Vasc Surg, V11, P283; Nunez DB, 2004, RADIOGRAPHICS, V24, P1087, DOI 10.1148/rg.244035035; PANETTA TF, 1992, J VASC SURG, V16, P867; Patel JV, 2002, CLIN RADIOL, V57, P308, DOI 10.1053/crad.2001.0808; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Redekop G, 2001, J NEUROSURG, V95, P412, DOI 10.3171/jns.2001.95.3.0412; ROON AJ, 1979, J TRAUMA, V19, P391, DOI 10.1097/00005373-197906000-00001; Rudstrom H, 2008, EUR J VASC ENDOVASC, V35, P131, DOI 10.1016/j.ejvs.2007.11.007; Ruesch S, 2002, CRIT CARE MED, V30, P454, DOI 10.1097/00003246-200202000-00031; SCHNEIDER RC, 1952, J NEUROSURG, V9, P495, DOI 10.3171/jns.1952.9.5.0495; Schulte S, 2008, CARDIOVASC INTER RAD, V31, P870, DOI 10.1007/s00270-008-9311-y; Simionato F, 2000, J ENDOVASC THER, V7, P136, DOI 10.1583/1545-1550(2000)007<0136:SGTOAC>2.3.CO;2; Singh RR, 2004, EUR J VASC ENDOVASC, V27, P577, DOI 10.1016/j.ejvs.2004.01.005; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Taha MM, 2007, SURG NEUROL, V68, P431, DOI 10.1016/j.surneu.2006.11.036; THOMAS MR, 1993, CATHETER CARDIO DIAG, V30, P169, DOI 10.1002/ccd.1810300219; Verniuel M, 1872, B ACAD NATL MED PARI, V1, P44; Vilke GM, 2011, J EMERG MED, V40, P355, DOI 10.1016/j.jemermed.2010.02.018; Wangensteen O H, 1972, Bull Hist Med, V46, P207; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071; Wyers MC, 2004, J VASC SURG, V39, P1335, DOI 10.1016/j.jvs.2004.01.030	82	4	6	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	MAR	2013	17	5					673	688					16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	148EM	WOS:000319225900013	23543452				2022-02-06	
J	Rodriguez, RA; Nair, S; Bussiere, M; Nathan, HJ				Rodriguez, Rosendo A.; Nair, Shona; Bussiere, Miguel; Nathan, Howard J.			Long-Lasting Functional Disabilities in Patients Who Recover From Coma After Cardiac Operations	ANNALS OF THORACIC SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; FOLLOW-UP; STROKE; SURGERY; TERM; REHABILITATION; DURATION; PREDICTORS; PROGNOSIS	Background. Uncertainty regarding the long-term functional outcome of patients who awaken from coma after cardiac operations is difficult for families and physicians and may delay rehabilitation. We studied the long-term functional status of these patients to determine if duration of coma predicted outcome. Methods. We followed 71 patients who underwent cardiac operations; recovered their ability to respond to verbal commands after coma associated with postoperative stroke, encephalopathy, and/or seizures; and were discharged from the hospital. The Glasgow Outcome Scale Extended (GOSE) was used to assess functional disability 2 to 4 years after discharge. Outcomes were classified as favorable (GOSE scores 7 and 8) and unfavorable (GOSE scores 1-6). Results. Of 71 patients identified, 39 were interviewed, 15 died, 1 refused to be interviewed, and 16 were lost to follow-up. Of the 54 patients with completed GOSE evaluations, only 15 (28%) had favorable outcomes. Among patients with unfavorable outcomes, 15 (28%) died, 14 (26%) survived with moderate disabilities, and 10 (18%) had severe disabilities. Factors associated with unfavorable outcomes were increases in duration of coma (p = 0.007), time in intensive care (p = 0.006), length of hospitalization (p = 0.004), and postoperative serum creatine kinase levels (p = 0.006). Only duration of coma was an independent predictor of unfavorable outcome (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.008-1.537; p = 0.042). Patients with durations of coma greater than 4 days were more likely to have unfavorable outcomes (OR, 5.1; 95% CI, 1.3-21.3; p = 0.02). Conclusions. Two thirds of comatose patients who survived to discharge after cardiac operations had unfavorable long-term functional outcomes. A longer duration of unconsciousness is a predictor of unfavorable outcome. (Ann Thorac Surg 2013;95:884-91) (C) 2013 by The Society of Thoracic Surgeons	Univ Ottawa, Inst Heart, Dept Surg, Div Cardiac Surg, Ottawa, ON, Canada; Univ Ottawa, Inst Heart, Dept Anesthesia, Div Cardiac Anesthesia, Ottawa, ON, Canada; Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON K1H 8L6, Canada; Ottawa Hosp, Res Inst, Thrombosis Program, Ottawa, ON K1H 8L6, Canada		Rodriguez, RA (corresponding author), Ottawa Hosp, Gen Campus,L-2217,Box 180,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	rrodriguez@toh.on.ca					Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Fang YN, 2003, CLIN REHABIL, V17, P608, DOI 10.1191/0269215503cr655oa; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Gottesman RF, 2008, SEMIN NEUROL, V28, P703, DOI 10.1055/s-0028-1105973; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Ibrahim GM, 2012, NEUROSURGERY, V70, P102, DOI 10.1227/NEU.0b013e31822e5a8e; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; McKhann GM, 2006, STROKE, V37, P562, DOI 10.1161/01.STR.0000199032.78782.6c; Paolucci S, 1998, CEREBROVASC DIS, V8, P228, DOI 10.1159/000015856; Paolucci S, 2000, CEREBROVASC DIS, V10, P25, DOI 10.1159/000016021; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rodriguez RA, 2013, ANN THORAC SURG, V95, P884, DOI 10.1016/j.athoracsur.2012.09.032; Rodriguez RA, 2011, J CARDIOTHOR VASC AN, V25, P961, DOI 10.1053/j.jvca.2010.10.001; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Schielke E, 2005, J NEUROL, V252, P648, DOI 10.1007/s00415-005-0711-5; Schiemanck SK, 2006, STROKE, V37, P1050, DOI 10.1161/01.STR.0000206462.09410.6f; TAUB NA, 1994, STROKE, V25, P352, DOI 10.1161/01.STR.25.2.352; TWEED WA, 1982, CAN MED ASSOC J, V126, P1058; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466	25	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975			ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2013	95	3					884	891		10.1016/j.athoracsur.2012.09.032			9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	095KI	WOS:000315332800026	23438523				2022-02-06	
J	Russo, AC				Russo, Arthur C.			Ethical, Legal and Risk Management Considerations in the Neuropsychological Assessment of Veterans	PSYCHOLOGICAL INJURY & LAW			English	Article						Ethics; Veterans; Neuropsychological; Assessment; Evaluation	TRAUMATIC BRAIN-INJURY; NATIONAL-ACADEMY; OFFICIAL STATEMENT; AMERICAN-ACADEMY; TEST-PERFORMANCE; DISABILITY; PTSD; CONSISTENCY; AFFAIRS; ISSUES	This article examines the ethical and regulatory issues facing neuropsychologists practicing within the Department of Veterans Affairs (VA) system, either as Veteran Health Administration neuropsychologists or as consultants. The focus is proactive, with an emphasis on preparation consistent with a positive approach to ethical practice and risk management. Given the sheer magnitude of applicable Federal regulations and guidelines, the scope is limited to an overview of select ethical complexities involved in the professional practice of neuropsychology with veterans within VA settings. The article uses a top-down structure, with each section (a) identifying the relevant core biomedical ethical principles, followed by (b) an elaboration of the relevant ethical requirements as defined by the American Psychological Association's Code of Ethics, and (c) applicable Federal regulations. Suggestions for translating core ethical principles and relevant ethical requirements into pragmatic action consistent with Federal regulation follow. Topics include (a) establishing professional competence, (b) understanding the type of assessment, (c) understanding consent requirements, and (d) understanding the ethical and regulatory issues in assessing veteran symptom presentation.	[Russo, Arthur C.] VA New York Harbor Healthcare Syst, Psychol Dept, Brooklyn Campus,800 Poly Pl, Brooklyn, NY 11209 USA		Russo, AC (corresponding author), VA New York Harbor Healthcare Syst, Psychol Dept, Brooklyn Campus,800 Poly Pl, Brooklyn, NY 11209 USA.	Arthur.Russo@va.gov					American Psychological Association, 2017, ETH PRINC PSYCH COD; American Psychological Association, 2010, AM PSYCH ASS ETH PRI; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Bennet B., 1990, PROFESSIONAL LIABILI; Bush S., 2012, NEUROPSYCHOLOGICAL P, P333; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Chafetz MD, 2011, PSYCHOL INJ LAW, V4, P235, DOI 10.1007/s12207-011-9112-5; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Department of Veterans Affairs, 2006, STAFF VA HDB; Department of Veterans Affairs, 2012, DEP VET AFF STRAT PL; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs Department of Defense, 2010, VA DOD CLIN PRACT GU; Department of Veterans Affairs Office of the Inspector General, 2010, EV PHYS CRED PRIV VE; Department of Veterans Affairs Office of the Inspector General, 2012, 110073395 DEP VET AF; Durant Will, 1926, STORY PHILOS LIVES O; Frueh BC, 2007, AM J PUBLIC HEALTH, V97, P2143, DOI 10.2105/AJPH.2007.115436; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; House Committee on Veterans Affairs, 2012, 112 C JUN 19 2012 TE; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jackson JC, 2011, J TRAUMA STRESS, V24, P609, DOI 10.1002/jts.20688; Johnson-Greene D, 2005, ARCH CLIN NEUROPSYCH, V20, P335, DOI 10.1016/j.acn.2004.08.003; Kilpatrick DG., 2011, SERVING THOSE WHO HA; KNAPP SJ, 2006, PRACTICAL ETHICS PSY; Koocher G., 1998, ETHICS PSYCHOL MENTA; Marx B. P., 2011, PTSD RES Q, V22, P1; McGrath JM, 2002, PSYCHIAT SERV, V53, P345, DOI 10.1176/appi.ps.53.3.345; Poyner G, 2010, PSYCHOL INJ LAW, V3, P130, DOI 10.1007/s12207-010-9076-x; Ridgway JD, 2011, PSYCHOL INJ LAW, V4, P171, DOI 10.1007/s12207-011-9113-4; Roemer L, 1997, AM J PSYCHIAT, V154, P1628, DOI 10.1176/ajp.154.11.1628; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Russo A., 2012, CLIN HDB NEUROPSYCHO; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schoenhard W., 2010, CREDENTIALING PRIVIL; Sweet J, 2003, CLIN NEUROPSYCHOL, V17, P443; Veterans Benefits Administration, 2007, CLIN GUID COMP PENS; Veterans Benefits Administration, 2002, ADJ PROC MAN REWR M2; Veterans Health Administration, 2009, INF CONS CLIN TREATM; Veterans Health Administration, 2006, HLTH INF MAN HLTH RE; Veterans Health Administration, 2008, CRED PRIV HDB; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; Veterans Health Initiative, 2010, TRAUM BRAIN INJ IND; Veterans Health Initiative, 2002, POSTTR STRESS DIS IM; Watson P., 2002, BEST PRACTICE MANUAL; Worthen MD, 2011, PSYCHOL INJ LAW, V4, P187, DOI 10.1007/s12207-011-9115-2	48	4	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2013	6	1			SI		21	30		10.1007/s12207-013-9145-z			10	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB4FM	WOS:000415467900003					2022-02-06	
J	Yeo, SS; Jang, SH				Yeo, Sang Seok; Jang, Sung Ho			Corticospinal tract recovery in a patient with traumatic transtentorial herniation	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; neuroimaging; diffusion tensor imaging; diffusion tensor tractography; transcranial magnetic stimulation; traumatic brain injury; intracerebral hemorrhage; transtentorial herniation; corticospinal tract; motor paralysis; neuroimaing; grants-supported paper; photographs-containing paper; neuroregeneration	DIFFUSE AXONAL INJURY; LONG-TERM RECOVERY; BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; IMPAIRMENT; MULTICENTER; STROKE; IMAGE	Transtentorial herniation is one of the causes of motor weakness in traumatic brain injury. In this study, we report on a patient who underwent decompressive craniectomy due to traumatic intracerebral hemorrhage. Brain CT images taken after surgery showed intracerebral hemorrhage in the left fronto-temporal lobe and left transtentorial herniation. The patient presented with severe paralysis of the right extremities at the time of intracerebral hemorrhage onset, but the limb motor function recovered partially at 6 months after onset and to nearly normal level at 27 months. Through diffusion tensor tractography, the left corticospinal tract was disrupted below the cerebral peduncle at 1 month after onset and the disrupted left corticospinal tract was reconstructed at 27 months. These findings suggest that recovery of limb motor function in a patient with traumatic transtentorial herniation can come to be true by recovery of corticospinal tract.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, No. 2012R1A1A4A01001873.	ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cho HK, 2011, BRAIN INJURY, V25, P1005, DOI 10.3109/02699052.2011.605095; Cho SH, 2007, NEUROSCI LETT, V421, P142, DOI 10.1016/j.neulet.2007.04.052; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P154, DOI 10.1097/HTR.0b013e31820fc480; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Kwon HG, 2011, NEUROREHABILITATION, V29, P243, DOI 10.3233/NRE-2011-0699; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Seitz RJ, 2010, J MAGN RESON IMAGING, V32, P756, DOI 10.1002/jmri.22315; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Yeo SS, 2010, EUR NEUROL, V63, P154, DOI 10.1159/000281900; Yoo WK, 2008, J NEUROL NEUROSUR PS, V79, P1295, DOI 10.1136/jnnp.2007.138131	24	4	4	0	3	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB 15	2013	8	5					469	473		10.3969/j.issn.1673-5374.2013.05.011			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	103RI	WOS:000315936200011	25206689				2022-02-06	
J	Aubuchon, MMF; Hemmes, B; Poeze, M; Jansen, J; Brink, PRG				Aubuchon, M. M. F.; Hemmes, B.; Poeze, M.; Jansen, J.; Brink, P. R. G.			Prehospital care in patients with severe traumatic brain injury: does the level of prehospital care influence mortality?	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Prehospital care; Mortality; Advanced Life Support; Basic Life Support	ADVANCED LIFE-SUPPORT; QUALITY-OF-LIFE; ENDOTRACHEAL INTUBATION; MANAGEMENT; OUTCOMES; IMPACT; HYPOTENSION; PREDICTOR; SURVIVAL; MODERATE	Introduction and purpose The controversy between the "scoop and run" versus the "stay and play" approach in severely injured trauma patients has been an ongoing issue for decades. The present study was undertaken to investigate whether changes in prehospital care for patients with severe traumatic brain injury in the Netherlands have improved outcome. Methods In this retrospective study, files (n = 60) were analyzed from a prospectively collected database including all patients admitted to one of six hospitals in the Limburg region in the Netherlands with a Glasgow Coma Scale (GCS) score <= 8 on admittance over the period from January 2006 to December 2008. All patients had traumatic brain damage proven on computed tomography (CT) or magnetic resonance imaging (MRI). Relevant prehospital and clinical data from the present cohort were compared to data from a similar study (n = 30) conducted 20 years ago. The primary outcome assessed was mortality. Results The two study groups had similar characteristics with regard to the GCS score. In the historic cohort, Basic Life Support (BLS) and the "scoop and run" approach in patients with major traumatic brain injury was common, with an average time on scene of 7.5 min. Currently, prehospital care is performed mainly on the level of prehospital Advanced Life Support (ALS), with the average time on scene being about four times as long as in the historic cohort. However, the overall mortality rate for the current cohort compared to the historic cohort has not changed. Conclusion Despite more on-site ALS in severely head injured patients nowadays compared to the historic cohort, there was no reduction in mortality.	[Aubuchon, M. M. F.; Hemmes, B.; Brink, P. R. G.] Network Acute Care Limburg, NL-6202 AZ Maastricht, Netherlands; [Poeze, M.; Brink, P. R. G.] Univ Hosp Maastricht, Dept Surg, NL-6202 AZ Maastricht, Netherlands; [Jansen, J.] Univ Hosp Maastricht, Dept Anaesthesiol, NL-6202 AZ Maastricht, Netherlands		Hemmes, B (corresponding author), Bogaartsborg 3, NL-6228 AK Maastricht, Netherlands.	b.hemmes@mumc.nl					Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chapleau Will, 2002, Emerg Med Serv, V31, P102; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; de Knegt C, 2008, INJURY, V39, P993, DOI 10.1016/j.injury.2008.03.033; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Deuning CM., 2011, DISTANCE KILOMETERS; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Draaisma JMT., 1987, THESIS NIJMEGEN U; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; JACOBS LM, 1984, J TRAUMA, V24, P8, DOI 10.1097/00005373-198401000-00002; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liberman M, 2003, ANN SURG, V237, P153, DOI 10.1097/00000658-200302000-00001; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; POTTER D, 1988, ANN EMERG MED, V17, P582, DOI 10.1016/S0196-0644(88)80397-4; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Stichting Landelijke Ambulance & Meldkamer Protocollen (LAMP), 2006, LAND PROT AMB VERS 7; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; van der Velden MWA, 2008, EMERG MED J, V25, P444, DOI 10.1136/emj.2007.052662; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	46	4	4	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2013	39	1					35	41		10.1007/s00068-012-0218-6			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	119FK	WOS:000317083000006	26814921				2022-02-06	
J	Lamontagne, ME; Poncet, F; Careau, E; Sirois, MJ; Boucher, N				Lamontagne, Marie-Eve; Poncet, Frederique; Careau, Emmanuelle; Sirois, Marie-Josee; Boucher, Normand			Life habits performance of individuals with brain injury in different living environments	BRAIN INJURY			English	Article						Brain injuries; participation; activities of daily living; housing	REHABILITATION; PARTICIPATION; ADULTS; EPIDEMIOLOGY; POPULATION; COMMUNITY; OUTCOMES; CARE	Background: Little is known about variations in social participation among individuals with traumatic brain injury (TBI) living in different environments. Objective: To examine the social participation of individuals with moderate-to-severe TBI across various living arrangements. Methods: One hundred and thirty-six individuals with moderate-to-severe TBI, living either in natural settings (e.g. home), intermediate settings (e.g. group homes or foster families) or structured settings (e.g. nursing home or long-term care facilities) and requiring daily assistance, were interviewed using the LIFE-H tool, which measures the level of difficulty and the assistance required to carry out life habits and resulting social participation. Participation in six categories of life habits pertaining to Activities of Daily Living and five categories pertaining to Social Roles were examined. Results: The level of difficulty and the assistance required to carry out the life habits and the overall level of social participation were associated with living arrangements. Participation scores in Activities of Daily Living varied across living arrangements while Social Roles scores did not. Conclusion: Living arrangements (such as intermediate settings) may better support social participation in individuals with TBI. There is a need to further study the issue of living arrangements as they seem to facilitate the performance of life habits, which impacts the social participation of individuals with TBI.	[Lamontagne, Marie-Eve; Careau, Emmanuelle; Boucher, Normand] CIRRIS, Quebec City, PQ G1M 2S8, Canada; [Lamontagne, Marie-Eve; Poncet, Frederique] Univ Montreal, Sch Rehabil, Quebec City, PQ, Canada; [Poncet, Frederique] Univ Paris 06, ER6, Paris, France; [Careau, Emmanuelle] Univ Laval, Fac Med, Rehabil Dept, Quebec City, PQ G1K 7P4, Canada; [Sirois, Marie-Josee] CHU Quebec, Ctr Rech, Ctr HospAffilie Univ, Axe Rech Traumatol Urgence Soins Intensifs Ctr Re, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Univ Laval, Dept Readaptat, Quebec City, PQ, Canada		Lamontagne, ME (corresponding author), CIRRIS, IRDPQ Room H-1402,525 Boul Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada.	lamontagne_marie@hotmail.com		Sirois, Marie-josee/0000-0001-9775-6960; Lamontagne, Marie-Eve/0000-0002-3301-7429	Regroupement des associations de personnes traumatisees cranio-cerebrales du Quebec (RAPTCCQ); Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	Preparation of this article was supported by the Regroupement des associations de personnes traumatisees cranio-cerebrales du Quebec (RAPTCCQ) and by scholarships awarded to the first author by the Canadian Institutes for Health Research.	Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Canadian Institutes of Health Research, 2005, TRIC POL STAT ETH CO; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Desrosiers J, 2008, NEUROREHAB NEURAL RE, V22, P288, DOI 10.1177/1545968307307116; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Fougeyrollas P, 1998, QUEBEC CLASSIFICATIO; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; LABBE A, 1999, PROPRIETES PSYCHOMET; Lamontagne ME, 2009, BRAIN INJURY, V23, P693, DOI 10.1080/02699050902970760; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levasseur M, 2007, CANADIAN J OCCUPATIO, V74, P233; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; Vincent C., 2002, TECHNOLOGY DISABILIT, V14, P113, DOI DOI 10.3233/TAD-2002-14306; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; World Health Organization, 2007, INT CLASS FUNCT DIS; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	27	4	4	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2013	27	2					135	144		10.3109/02699052.2012.722253			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500002	23384212				2022-02-06	
J	Martinez-Lage, JF; Alarcon, F; Alfaro, R; Gilabert, A; Reyes, SB; Almagro, MJ; Lopez-Guerrero, AL				Martinez-Lage, Juan F.; Alarcon, Fernando; Alfaro, Raul; Gilabert, Amparo; Reyes, Susana B.; Almagro, Maria-Jose; Lopez-Guerrero, Antonio Lopez			Severe spinal cord injury in craniocervical dislocation. Case-based update	CHILDS NERVOUS SYSTEM			English	Article						Atlanto-axial luxation; Atlanto-occipital distraction injuries; Cervical spine fusion; Cervical spine injuries; Pediatric spinal cord injuries; Post-traumatic apnea; Quadriplegia	CERVICAL-SPINE; TRAUMA	Craniocervical distraction injuries, including atlanto-axial dislocation (AAD) and atlanto-ocipital dislocation (AOD), are often associated with severe spinal cord involvement with high morbidity and mortality rates. Many patients with these injuries die at the accident scene, but advances in emergency resuscitation and transport permit that many patients arrive alive to hospitals. Children with craniocervical distraction injuries usually present with a severe cranioencephalic traumatism that is the most relevant lesion at admission. After resuscitation and hemodynamic stabilization, the spinal cord damage appears as the main lesion. Apnea and quadriparesis, or quadriplegia, are usually present at the onset. Early diagnosis and management perhaps decrease life-threatening manifestations of the spinal lesion. But even so, the primary spinal cord insult is often irreversible and precludes obtaining a satisfactory functional outcome. We report the findings of four children with craniocervical distraction injuries (AOD and AAD) who presented with severe spinal cord damage. All patients were admitted with respiratory distress or apnea together with significant brain injuries. The medical records pertaining to these patients are summarized in regard to clinical features, management, and outcome. In spite of timely and aggressive management, craniocervical injuries with spinal cord involvement continue to have a dismal prognosis. Outcome is closely related to the severity of the initial brain and spinal cord damage and is nearly always fatal in cases of complete spinal cord transection. Priority should be given to life-threatening complications. Ethic issues on indications for surgery deserve a detailed discussion with the children's parents.	[Martinez-Lage, Juan F.; Almagro, Maria-Jose; Lopez-Guerrero, Antonio Lopez] Virgen de la Arrixaca Univ Childrens Hosp, Reg Serv Neurosurg, Unit Pediat Neurosurg, Murcia 30120, Spain; [Alarcon, Fernando; Alfaro, Raul] Virgen de la Arrixaca Univ Childrens Hosp, Reg Serv Neurosurg, Unit Spine Neurosurg, Murcia 30120, Spain; [Gilabert, Amparo] Virgen de la Arrixaca Univ Childrens Hosp, Sect Pediat Radiol, Murcia 30120, Spain; [Reyes, Susana B.] Virgen de la Arrixaca Univ Childrens Hosp, Pediat Intens Care Unit, Murcia 30120, Spain		Martinez-Lage, JF (corresponding author), Virgen de la Arrixaca Univ Childrens Hosp, Reg Serv Neurosurg, Unit Pediat Neurosurg, Murcia 30120, Spain.	juanf.martinezlage@cablemurcia.com					Ahmed R, 2008, CHILD NERV SYST, V24, P1209, DOI 10.1007/s00381-008-0607-7; Anderson RCE, 2006, J NEUROSURG, V105, P55, DOI 10.3171/ped.2006.105.1.55; HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700; Lena G, 1999, PEDIAT NEUROSURGERY, P381; Levy ML, 1996, NEUROSURGERY, V38, P11; Lowry DW, 1997, J NEUROSURG, V87, P671, DOI 10.3171/jns.1997.87.5.0671; Lustrin ES, 2003, RADIOGRAPHICS, V23, P539, DOI 10.1148/rg.233025121; McWorther AE, 1976, J NEUROSURG, V45, P211; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; Rahimi Scott Y, 2003, Neurosurg Focus, V15, pECP1; Roche C, 2001, PEDIATR RADIOL, V31, P677, DOI 10.1007/s002470100532	11	4	4	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2013	29	2					187	194		10.1007/s00381-012-1915-5			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	077LB	WOS:000314028100005	22961360				2022-02-06	
J	Tajali, S; Negahban, H; Shaterzadeh, MJ; Mehravar, M; Salehi, R; Narimani, R; Parnianpour, M				Tajali, Shirin; Negahban, H.; Shaterzadeh, M. J.; Mehravar, M.; Salehi, R.; Narimani, R.; Parnianpour, M.			MULTIJOINT COORDINATION DURING SIT-TO-STAND TASK IN PEOPLE WITH NON-SPECIFIC CHRONIC LOW BACK PAIN	BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS			English	Article						Sit-to-stand; Joint coordination; Uncontrolled manifold; Low back pain	JOINT COORDINATION; LUMBAR SPINE; POSTURAL CONTROL; KINEMATICS; CHAIR	Sit-to-stand (STS) is an important functional task affected by low back pain (LBP). It requires fundamental coordination among all segments of the body to control important performance variables such as body's center of mass (CM) and head positions. This study was conducted to determine whether LBPs could coordinate their multiple joints to achieve the task stability to the same extent as healthy controls. About 11 non-specific chronic LBP and 12 healthy control subjects performed STS task at three postural difficulty levels: rigid surface - open eyes (RO), rigid surface - closed eyes (RC) and narrow surface - closed eyes (NC). Motion variability of seven body segments, CM and head positions were calculated across 15 trials, and uncontrolled manifold (UCM) approach was used to investigate joint coordination. This approach partitioned segment angle variations into component that stabilizes a given performance variable and leads to task performance flexibility (UCM variability: V-UCM) and that which does not stabilize the performance variable and leads to task performance error (orthogonal variability: V-ORT). The results showed that LBPs demonstrated significantly less VUCM regarding the control of horizontal CM position and greater VORT regarding the control of horizontal head position. The current findings revealed that multijoint coordination was impaired in the LBP subjects. These altered motor coordination strategies would make their postural control system less adaptive to altered postural demands and may predispose these subjects to re-injury.	[Tajali, Shirin; Negahban, H.; Shaterzadeh, M. J.; Mehravar, M.; Salehi, R.] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran; [Mehravar, M.; Narimani, R.; Parnianpour, M.] Sharif Univ Technol, Fac Mech Engn, Tehran, Iran; [Parnianpour, M.] Hanyang Univ, Dept Informat & Ind Engn, Ansan, South Korea		Negahban, H (corresponding author), Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran.	shirintajali@yahoo.com; honegahban@yahoo.com	Tajali, shirin/AAN-5113-2020; Tajali, Shirin/AAC-9576-2020; Mehravar, Mohamad/L-8621-2017; Salehi, Reza/Q-5721-2017; Negahban, Hossein/O-7405-2018	Mehravar, Mohamad/0000-0001-8834-6521; Salehi, Reza/0000-0001-6793-7293; Negahban, Hossein/0000-0001-8387-1781; Tajali, Shirin/0000-0002-5707-5551	Ahvaz Jundishapur University of Medical Sciences	The authors shall thank Mr Latifi for his valuable comments on statistical analysis of the manuscript. This study is part of M. Sc. thesis for Shirin Tajali. Special thanks to Ahvaz Jundishapur University of Medical Sciences for the financial support.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Carr JH., 2010, NEUROLOGICAL REHABIL, V2nd; COGHLIN SS, 1994, CLIN BIOMECH, V9, P85, DOI 10.1016/0268-0033(94)90029-9; Deursen LV., 2002, J ORTHOPAEDIC MED, V24, P74, DOI [10.1080/1355297X.2002.11736168, DOI 10.1080/1355297X.2002.11736168]; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; Latash ML, 2010, MED LITH, V46, P382, DOI 10.3390/medicina46060054; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Loney PL, 1999, PHYS THER, V79, P384, DOI 10.1093/ptj/79.4.384; Marras WS, 2001, SPINE, V26, P2566, DOI 10.1097/00007632-200112010-00009; McMillan AG, 2000, HUM MOVEMENT SCI, V19, P21, DOI 10.1016/S0167-9457(00)00007-5; Mehravar M, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400015; Mousavi SJ, 2006, SPINE, V31, pE454, DOI 10.1097/01.brs.0000222141.61424.f7; Newell D., 2010, CLIN CHIROPRACTIC, V13, P8; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Reisman DS, 2002, J ELECTROMYOGR KINES, V12, P493, DOI 10.1016/S1050-6411(02)00029-9; Reisman DS, 2002, GAIT POSTURE, V15, P45, DOI 10.1016/S0966-6362(01)00158-8; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; Salavati M, 2009, SPINE, V34, P1415, DOI 10.1097/BRS.0b013e3181a3a917; Schoner G, 2007, MOTOR CONTROL, V11, P259, DOI 10.1123/mcj.11.3.259; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Scholz JP, 2001, EXP BRAIN RES, V141, P485, DOI 10.1007/s002210100878; Shum GL, 2009, ARCH PHYS MED REHAB, V90, P127, DOI 10.1016/j.apmr.2008.06.028; Shum GLK, 2007, SPINE, V32, pE211, DOI 10.1097/01.brs.0000259204.05598.10; Shum GLK, 2005, SPINE, V30, P1998, DOI 10.1097/01.brs.0000176195.16128.27; Silfies SP, 2009, GAIT POSTURE, V29, P370, DOI 10.1016/j.gaitpost.2008.10.053; Vogt L, 2001, SPINE, V26, P1910, DOI 10.1097/00007632-200109010-00019; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1	33	4	4	1	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1016-2372	1793-7132		BIOMED ENG-APP BAS C	Biomed. Eng.-Appl. Basis Commun.	FEB	2013	25	1							1350010	10.4015/S1016237213500105			9	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	V98LI	WOS:000213400500005					2022-02-06	
J	Tseng, CH; Wu, KL; Tsai, SJ; Lew, HL				Tseng, Chih-Hung; Wu, Kun-Lin; Tsai, Su-Ju; Lew, Henry L.			Development of Carotid Cavernous Fistula After Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article									[Tseng, Chih-Hung; Wu, Kun-Lin] Tungs Taichung MetroHarbor Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Tsai, Su-Ju] Chung Shan Med Univ, Dept Phys Med & Rehabil, Sch Med, Taichung 402, Taiwan; [Tsai, Su-Ju] Chung Shan Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Lew, Henry L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA		Tsai, SJ (corresponding author), Chung Shan Med Univ, Dept Phys Med & Rehabil, Sch Med, 110,Sect 1,Jianguo N Rd, Taichung 402, Taiwan.						Fabian TS, 1999, J TRAUMA, V47, P275, DOI 10.1097/00005373-199908000-00009; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Liang Wen, 2007, J Trauma, V63, P1014; Subramanian Prem S, 2009, Int Ophthalmol Clin, V49, P81, DOI 10.1097/IIO.0b013e3181a8d7ac	4	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2013	92	2					187	188		10.1097/PHM.0b013e318246648c			2	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	072KA	WOS:000313668600012	22286893				2022-02-06	
J	Morales, SOC; Enriquez, GB; Romero, FT				Caballero Morales, Santiago Omar; Bonilla Enriquez, Gladys; Trujillo Romero, Felipe			Speech-Based Human and Service Robot Interaction: An Application for Mexican Dysarthric People Regular Paper	INTERNATIONAL JOURNAL OF ADVANCED ROBOTIC SYSTEMS			English	Article						Dysarthria; Assistive Technology; Service Robot Control; Speech Recognition; Mexican Spanish	CORPUS	Dysarthria is a motor speech disorder due to weakness or poor coordination of the speech muscles. This condition can be caused by a stroke, traumatic brain injury, or by a degenerative neurological disease. Commonly, people with this disorder also have muscular dystrophy, which restricts their use of switches or keyboards for communication or control of assistive devices (i.e., an electric wheelchair or a service robot). In this case, speech recognition is an attractive alternative for interaction and control of service robots, despite the difficulty of achieving robust recognition performance. In this paper we present a speech recognition system for human and service robot interaction for Mexican Spanish dysarthric speakers. The core of the system consisted of a Speaker Adaptive (SA) recognition system trained with normal-speech. Features such as on-line control of the language model perplexity and the adding of vocabulary, contribute to high recognition performance. Others, such as assessment and text-to-speech (TTS) synthesis, contribute to a more complete interaction with a service robot. Live tests were performed with two mild dysarthric speakers, achieving recognition accuracies of 90-95% for spontaneous speech and 95-100% of accomplished simulated service robot tasks.	[Caballero Morales, Santiago Omar; Bonilla Enriquez, Gladys; Trujillo Romero, Felipe] Technol Univ Mixteca, Huajuapan De Leon, Oaxaca, Mexico		Morales, SOC (corresponding author), Technol Univ Mixteca, Huajuapan De Leon, Oaxaca, Mexico.	scaballero@mixteco.utm.mx					[Anonymous], 2010, DISC MEX; Ballard HF., 1995, AUGMENT ALT COMMUN, V11, P165, DOI [10.1080/07434619512331277289, DOI 10.1080/07434619512331277289]; Brown J.R., 1975, MOTOR SPEECH DISORDE; Caballero S., 2011, AUTOMATIC RECOGNITIO; Caballero S., 2009, EURASIP J ADV SIGNAL; Cannarozzi G., 2011, STRING ALIGNMENT USI; Chen Stanley F, 1998, DARPA BROADC NEWS TR; Copalcua M., 2009, THESIS TECHNOLOGICAL; Cuetara J., 2004, THESIS NATL AUTONOMO; Green P., 2003, P ASS ADV ASS TECHN; Hamidi F, 2010, LECT NOTES COMPUT SC, V6179, P605, DOI 10.1007/978-3-642-14097-6_97; HATZIS A, 2003, P 8 EUR C SPEECH COM, P2213; Hawley MS, 2007, MED ENG PHYS, V29, P586, DOI 10.1016/j.medengphy.2006.06.009; Hux K., 2000, AUGMENTATIVE ALTERNA, V16, P186, DOI DOI 10.1080/07434610012331279044; JAYARAM G, 1995, J REHABIL RES DEV, V32, P162; Jurafsky D., 2009, SPEECH LANGUAGE PROC; LEGGETTER CJ, 1995, COMPUT SPEECH LANG, V9, P171, DOI 10.1006/csla.1995.0010; Lizandra R., 2007, DIFICULTADES DESARRO; Manasse NJ, 2000, BRAIN INJURY, V14, P1015; Matsumasa H, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2234; MENENDEZPIDAL X, 1996, P 4 INT C SPOK LANG; Miranda C., 2007, P WORKSH PERSP CHALL; Montalto L., 1997, FIESTA MONTANA; Moriana M., 2009, REV DIGITAL INNOVACI, P1; Mukai T, 2008, IEEE T ROBOT, V24, P505, DOI 10.1109/TRO.2008.917006; National Institute of Standards and Technology (NIST), 2009, HIST AUT SPEECH REC; NimbRo@Home, 2012, ROB COS; PAL Robotics, 2011, REEM HUM ROB; Pineda LA, 2010, LANG RESOUR EVAL, V44, P347, DOI 10.1007/s10579-009-9109-9; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Raghavendra P., 2001, AUGMENTATIVE ALTERNA, V17, P265, DOI [DOI 10.1080/AAC.17.4.265.275, DOI 10.1080/aac.17.4.265.275]; ROBINSON T, 1995, INT CONF ACOUST SPEE, P81, DOI 10.1109/ICASSP.1995.479278; Sanders E., 2002, P INTERSPEECH, P661; Tapus A., 2006, INT J ROBOTICS SOC J, V24, P576, DOI DOI 10.7210/JRSJ.24.576; Uraga E., 2002, P INT C COMP LING IN, P300; Young S., 2006, HTK BOOK HTK VERSION	36	4	4	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1729-8814			INT J ADV ROBOT SYST	Int. J. Adv. Robot. Syst.	JAN 7	2013	10								11	10.5772/54001			14	Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Robotics	143CQ	WOS:000318844300002		gold			2022-02-06	
J	Akutsu, N; Athara, H; Sakurai, A; Kusaka, J; Yasuda, M; Kohmura, E				Akutsu, Nobuyuki; Athara, Hideo; Sakurai, Atsushi; Kusaka, Junko; Yasuda, Michinori; Kohmura, Eiji			New Technique of Decompressive Skinplasty With Artificial Dermis for Severe Brain Swelling-Technical Note-	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						artificial dermis; decompressive craniectomy; traumatic brain injury	CRANIECTOMY; INJURY	In cases of severe uncontrollable brain swelling, simple skin closure often increases intracranial pressure. This study examined the efficacy of a new technique of decompressive skinplasty to decrease intracranial pressure following decompressive craniectomy in cases of severe traumatic brain injury with uncontrollable brain swelling. In our technique, we use artificial dermis to avoid elevation of intracranial pressure. After performing decompressive craniectomy and duraplasty with artificial dura, decompressive skinplasty with artificial dermis was performed in 5 patients for whom simple skin closure caused the intracranial pressure to elevate under intracranial pressure monitoring. Artificial dermis was grafted onto the region to cover the skin defect and sutured to the skin with 4-0 nylon sutures. Two weeks after surgery, the silicone layer of the artificial dermis was removed and ointment treatment was continued until complete epithelialization was achieved. In all cases, decompressive skinplasty contributed dramatically to decreasing the intracranial pressure in patients with uncontrollable brain swelling. The technique of decompressive skinplasty with artificial dermis contributed to dramatically decreasing the intracranial pressure. More cases are required to investigate the indications for this technique.	[Akutsu, Nobuyuki; Athara, Hideo] Hyogo Prefectural Kakogawa Med Ctr, Dept Neurosurg, Kakogawa, Hyogo 6758555, Japan; [Sakurai, Atsushi; Kusaka, Junko; Yasuda, Michinori] Hyogo Prefectural Kakogawa Med Ctr, Dept Plast Surg, Kakogawa, Hyogo 6758555, Japan; [Kohmura, Eiji] Kobe Univ, Dept Neurosurg, Grad Sch Med, Kobe, Hyogo 657, Japan		Akutsu, N (corresponding author), Hyogo Prefectural Kakogawa Med Ctr, Dept Neurosurg, 230 Kanno,Kanno Cho, Kakogawa, Hyogo 6758555, Japan.	nakutsu@med.kobe-u.ac.jp		Akutsu, Nobuyuki/0000-0002-6285-9115			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Eo S, 2011, INT WOUND J, V8, P261, DOI 10.1111/j.1742-481X.2011.00780.x; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	11	4	5	0	4	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2013	53	1					56	60		10.2176/nmc.53.56			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	085NH	WOS:000314621000013	23358173	Bronze			2022-02-06	
J	Andruszkow, H; Urner, J; Deniz, E; Probst, C; Gruen, O; Lohse, R; Frink, M; Hildebrand, F; Zeckey, C				Andruszkow, Hagen; Urner, Julia; Deniz, Ezin; Probst, Christian; Gruen, Orna; Lohse, Ralf; Frink, Michael; Hildebrand, Frank; Zeckey, Christian			Subjective impact of traumatic brain injury on long-term outcome at a minimum of 10 years after trauma- first results of a survey on 368 patients from a single academic trauma center in Germany	PATIENT SAFETY IN SURGERY			English	Article						Traumatic brain injury; TBI; Outcome; SF-12; GOS		Background: Traumatic Brain Injury (TBI) may lead to significant impairments in personal, social and professional life. However, knowledge of the influence on long-term outcome after TBI is sparse. We therefore aimed to investigate the subjective effects of TBI on long-term outcome at a minimum of 10 years after trauma in one of the largest study populations in Germany. Methods: The current investigation represents a retrospective cohort study at a level I trauma center including physical examination or standardized questionnaires of patients with mild, moderate or severe isolated TBI with a minimum follow up of 10 years. We investigated the subjective physical, psychological and social outcome evaluating the Glasgow Outcome Scale, short-form 12, and social as well as vocational living circumstances. Results: 368 patients aged 0 to 88 years were included. Patients with severe TBI were younger compared to patients with moderate or mild TBI (p < 0.05). Patients with severe TBI lived more often as single after the trauma impact. A significantly worse outcome was associated with higher severity of TBI resulting in an increased incidence of mental disability. A professional decline was analyzed in case of severe TBI resulting in significant loss of salary. Conclusions: The severity of TBI significantly influenced the subjective social and living conditions. Subjective mental and physical outcome as well as professional life depended on the severity of TBI 10 years after the injury.	[Andruszkow, Hagen; Hildebrand, Frank] Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, Pauwelsstraae 30, Aachen, Germany; [Probst, Christian] Univ Witten Herdecke, Cologne Merheim Med Ctr, Fac Hlth Sch Med, Dept Trauma & Orthopaed Surg, D-51109 Cologne, Germany; [Gruen, Orna; Lohse, Ralf] Hannover Re Insurance, Karl Wiechert Allee 50, D-30625 Hannover, Germany; [Andruszkow, Hagen; Urner, Julia; Deniz, Ezin; Hildebrand, Frank; Zeckey, Christian] Hannover Med Sch, Trauma Dept, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Frink, Michael] Univ Med Ctr Marburg, Dept Trauma, Hand & Reconstruct Surg, Baldingerstr, D-35043 Marburg, Germany		Andruszkow, H (corresponding author), Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, Pauwelsstraae 30, Aachen, Germany.	handruszkow@ukaachen.de	Hildebrand, Frank/J-3176-2017				Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; JENNETT B, 1975, LANCET, V1, P480; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Probst C, 2010, J TRAUMA, V68, P706, DOI 10.1097/TA.0b013e3181a8b21c; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; TEASDALE G, 1974, LANCET, V2, P81; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zeckey C, 2011, BRAIN INJURY, V25, P551, DOI 10.3109/02699052.2011.568036; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	31	4	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.		2013	7								32	10.1186/1754-9493-7-32			8	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V13PQ	WOS:000214425700032	24112807	Green Published, gold			2022-02-06	
J	Foy, CML; Somers, JS				Foy, Catherine M. L.; Somers, Julian S.			Increase in functional abilities following a residential educational and neurorehabilitation programme in young adults with acquired brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; functional independence measure; outcomes; education	REHABILITATION; STROKE; OUTCOMES	OBJECTIVES: To characterize and determine the pre-injury and injury-related variables that are linked to the extent of functional recovery following rehabilitation at a mixed therapy and educational residential programme and whether these variables differ for traumatic brain injury (TBI) and non traumatic brain injury (nonTBI). METHODS: 106 young adults (age 16-36 years) with moderate-to-severe TBI who had attended and been discharged from the centre since 2002 were included. Clients received 5 hours of education and/or therapy each day. Functional level was assessed using the FIM + FAM. Regression analysis was used to determine possible predictors of functional independence at discharge. MAIN OUTCOMES AND RESULTS: Clients with TBI and nonTBI made clinically and statistically significant improvements in their functional abilities during their neurorehabilitation. For the combined TBI and nonTBI group, FIM + FAM scores at discharge were predicted by FIM + FAM at admission and length of stay. These two predictors explained 80% of the variance in the FIM + FAM score at discharge. CONCLUSION: Both clients with TBI and nonTBI benefited from a mixed inpatient neurorehabilitation programme. This benefit was predicted by their functional abilities at admission and the length of stay. These findings are of importance as it becomes increasingly necessary to demonstrate who will benefit from residential intensive neurorehabilitation as opposed to community therapy.	[Foy, Catherine M. L.] QEF Neurorehabil Serv, Banstead SM7 3EE, Surrey, England; [Somers, Julian S.] Sutton Hosp, Sutton & Merton IAPT, Sutton, Surrey, England		Foy, CML (corresponding author), QEF Neurorehabil Serv, Banstead Pl,Pk Rd, Banstead SM7 3EE, Surrey, England.	Catherine.Foy@QEF.org.uk					Adams RA, 2004, BRAIN INJURY, V18, P811, DOI 10.1080/02699050410001671810; BELL KR, 1995, BRAIN INJURY, V9, P315, DOI 10.3109/02699059509008201; Braunling-McMorrow D, 2010, BRAIN INJURY, V24, P928, DOI 10.3109/02699052.2010.490518; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Central Brain Tumor Registry of the United States, 2000, STAT REP PRIM BRAIN STAT REP PRIM BRAIN; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Demain S, 2006, DISABIL REHABIL, V28, P815, DOI 10.1080/09638280500534796; Elkind MS, 1998, SEMIN NEUROL, V18, P429, DOI 10.1055/s-2008-1040896; Freeman JA, 2005, J NEUROL NEUROSUR PS, V76, P723, DOI 10.1136/jnnp.2004.035956; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Najenson T, 1980, Int Rehabil Med, V2, P17; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Wilson FC, 2009, NEUROREHABILITATION, V24, P377, DOI 10.3233/NRE-2009-0492; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X	24	4	5	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	3					671	678		10.3233/NRE-130890			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200026	23648622				2022-02-06	
J	Fyrberg, A				Fyrberg, Asa			Communication after traumatic brain injury in adolescence: A single subject comparative study of two methods for analysis	JOURNAL OF INTERACTIONAL RESEARCH IN COMMUNICATION DISORDERS			English	Article						ADOLESCENTS; FUNCTIONAL COMMUNICATION; METHODS FOR ANALYSES; TRAUMATIC BRAIN INJURY	EFFECTIVENESS INDEX; HEAD-INJURY; CHILDREN; REHABILITATION; DISCOURSE; RECOVERY; ABILITY; SKILLS; DISABILITY; DISORDERS	Communication in everyday life can be severely affected in adolescence after a traumatic brain injury (TBI). Abilities associated with vocal verbal response, gesture, gaze, facial expression and posture are frequently impaired. While much effort is often invested in clinical assessments, altered communicative functions in a real life setting are explored to a much lesser extent. In this case study, we discuss the usability of a triangulation of methods for analysis, involving a 16-year-old adolescent with TBI. Communication Management (CM) is explored, based on self-evaluation by the participant in video recordings of dyadic and triadic conversations. Ratings created independently by the subject and his parents on the The Communicative Effectiveness Index (CETI) are analysed. A comparison is made with a selection of clinical test results on cognition, speech and language. We discuss how the methods can be applied to analyse communicative functions that are not readily detected in a clinical environment.	[Fyrberg, Asa] Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden		Fyrberg, A (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden.	asa.fyrberg@vgregion.se					Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Ahlsen E., 2006, INTRO NEUROLINGUISTI; Ahlsen E., 2010, 13 M INT CLIN PHON L; Allwood J, 2002, TEXT SPEECH LANG TEC, V19, P7; Allwood J., 2007, CURRENT TRENDS RES S, V2, P10; ALLWOOD J, 1990, NORD J LINGUIST, V13, P3, DOI DOI 10.1017/S0332586500002092; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Baxter L. A., 1990, W J SPEECH COMMUNICA, V54, P377; Bazeley P., 2007, QUALITATIVE DATA ANA; Bishop D. V., 2009, TROG 2 TEST RECEPTIO; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CLARK LW, 1994, GERIATRICS, V49, P51; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; DUFFY RJ, 1984, BRAIN LANG, V21, P260, DOI 10.1016/0093-934X(84)90051-8; Dunn L.M., 1997, PPVT 3 PEABODY PICTU; EMANUELSON I, 1999, EPIDEMIOLOGY MANAGEM; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Fyrberg A, 2007, INT J REHABIL RES, V30, P153; Holland A., 1999, COMMUNICATION ACTIVI; Hugdahl K, 1994, DIKOTISK LYSSNING ME; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Jacobson C., 2001, LUSKEDJOR MANUAL; Kaplan E, 1983, BNT BOSTON NAMING TE; Kertesz A., 1982, W APHASIA BATTERY TE; LaPointe L. L., 2010, BRAIN BASED COMMUNIC; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Larkins Brigette, 2010, Seminars in Speech and Language, V31, P187, DOI 10.1055/s-0030-1257535; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; MORRELSAMUELS P, 1992, J EXP PSYCHOL LEARN, V18, P615, DOI 10.1037/0278-7393.18.3.615; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Paul D.R., 2005, QUALITY COMMUNICATIO; Pedersen PM, 2001, APHASIOLOGY, V15, P787, DOI 10.1080/02687040143000195; Peirce C.S., 1894, ESSENTIAL PEIRCE SEL, V2, P1893; Penn C, 1992, S Afr J Commun Disord, V39, P74; Perkins MR, 2005, CLIN LINGUIST PHONET, V19, P367, DOI 10.1080/02699200400027155; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Saldert C., 2006, GOTHENBURG MONOGRAPH; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Turkstra LS, 2005, J SPEECH LANG HEAR R, V48, P1429, DOI 10.1044/1092-4388(2005/099); Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wechsler D., 2003, WAIS 3 WECHSLER ADUL; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; World Health Organization, 2007, INT CLASS FUNCT DIS; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	64	4	4	0	2	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	2040-5111	2040-512X		J INTERACT RES COM D	J. Interact. Res. Commun. Disord.		2013	4	2					157	183		10.1558/jircd.v4i2.157			27	Linguistics	Emerging Sources Citation Index (ESCI)	Linguistics	V2W8N	WOS:000217983600001					2022-02-06	
B	Harrison-Felix, CL; Hawley, LA; Brown, AW; DeVivo, MJ		Zasler, ND; Katz, DI; Zafonte, RD		Harrison-Felix, Cynthia L.; Hawley, Lenore A.; Brown, Allen W.; DeVivo, Michael J.			Life Expectancy and Wellness	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVAL; HEAD-INJURY; EARLY PREDICTORS; SOCIAL SUPPORT; FOLLOW-UP; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; MORTALITY TRENDS; SUBSTANCE-ABUSE		[Harrison-Felix, Cynthia L.; Hawley, Lenore A.] Craig Hosp, Res Dept, Englewood, CO USA; [Harrison-Felix, Cynthia L.] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Brain Rehabil Serv, Rochester, MN USA; [Brown, Allen W.] Mayo Clin, Coll Med, Rochester, MN USA; [DeVivo, Michael J.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Harrison-Felix, CL (corresponding author), Craig Hosp, Res Dept, Englewood, CO USA.						American College of Surgeons, TRAUM PROGR; Anderson R N, 2000, Vital Health Stat 2, P1; Anderson TW, 2002, LIFE EXPECTANCY COUR; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2011, HLTH CHOIC HLT UNPUB; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Barnard RJ, 2004, EVID-BASED COMPL ALT, V1, P233, DOI 10.1093/ecam/neh036; Berkowitz M, 1992, EC CONSEQUENCES TRAU, P145; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; Boto GR, 2009, NEUROSURG REV, V32, P343, DOI 10.1007/s10143-008-0178-9; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Brown AW, 2005, NEUROREHABILITATION, V20, P67; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cao Y., 2011, TOPICS SPINAL CORD I, V16, P10, DOI DOI 10.1310/SCI1604-10; Centers for Disease Control and Prevention, AD SEAT BELT US US; Chapital Alyssa D, 2007, Hawaii Med J, V66, P318; Chase T, 1996, PRACTICAL GUIDE HLTH; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Czosnyka M, 2008, ACTA NEUROCHIR SUPPL, V102, P25, DOI 10.1007/978-3-211-85578-2_5; Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Deb S, 1999, AM J PSYCHIAT, V156, P374; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DeVivo M, 1995, SPINAL CORD INJURY C, P234; DeVivo M. J, 2002, TOP SPINAL CORD INJ, V7, P49; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Elliott J, 2008, EPILEPSY BEHAV, V12, P547, DOI 10.1016/j.yebeh.2007.11.008; Epilepsy Foundation, LIV EP; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Friedenreich CM, 2001, EPIDEMIOLOGY, V12, P604, DOI 10.1097/00001648-200111000-00005; FRIEDMAN HS, 1995, AM PSYCHOL, V50, P69, DOI 10.1037/0003-066X.50.2.69; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hawley L, 2008, SELF ADVOCACY INDEPE; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; HOUSE JS, 1982, AM J EPIDEMIOL, V116, P123, DOI 10.1093/oxfordjournals.aje.a113387; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kemp CD, 2008, AM SURGEON, V74, P866; Keulers BJ, 2007, PATIENT EDUC COUNS, V67, P176, DOI 10.1016/j.pec.2007.03.012; KLEINMAN JC, 1981, MED CARE, V19, P1011, DOI 10.1097/00005650-198110000-00004; Kochanek KD, 2011, NATL VITAL STAT REPO, V59; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; MANTON KG, 1987, MILBANK Q, V65, P129, DOI 10.2307/3349954; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; National Highway Traffic Safety Administration DoT, 2010, TRAFF SAF FACTS CRAS; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; O'Donnell M P, 1986, Am J Health Promot, V1, P4; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; OFFNER PJ, 1992, J TRAUMA, V32, P32, DOI 10.1097/00005373-199201000-00007; Ornish D, 2005, J UROLOGY, V174, P1065, DOI 10.1097/01.ju.0000169487.49018.73; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ponsford J, 2011, BRAIN IMPAIR S, V12, P44; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Post SG, 2005, INT J BEHAV MED, V12, P66, DOI 10.1207/s15327558ijbm1202_4; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Roberts A.V., 1979, SEVERE ACCIDENTAL HE, P140; Rothman K.J., 2008, Modern epidemiology, V3rd; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Schumacher Vera, 2009, Curr Aging Sci, V2, P200; Schwarzer R, 2002, NATO SCI SER I LIFE, V327, P185; Sekulovic N, 1979, Acta Neurochir Suppl (Wien), V28, P203; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Strauss D, 2000, J Insur Med, V32, P217; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Strawbridge WJ, 1997, AM J PUBLIC HEALTH, V87, P957, DOI 10.2105/AJPH.87.6.957; Takata Y, 2007, GERONTOLOGY, V53, P46, DOI 10.1159/000095934; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; U.S. Department of Health and Human Services, DIET GUID AM; University of California-Riverside, SOC WELLN; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vanderbilt University, WELLN WHEEL; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; WALKER AE, 1989, ARCH NEUROL-CHICAGO, V46, P23, DOI 10.1001/archneur.1989.00520370025013; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLIAMS CM, 1990, BRIT J ADDICT, V85, P911; Williams David R, 2007, Med J Aust, V186, pS47; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Zasler ND, 2009, PROG BRAIN RES, V177, P111, DOI 10.1016/S0079-6123(09)17709-9	158	4	4	0	1	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							319	331					13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100021					2022-02-06	
J	Krbila, S; Waczulikova, I; Sobona, V; Zahorec, R				Krbila, S.; Waczulikova, I; Sobona, V; Zahorec, R.			Impact of intracranial pressure measurement on survival in patients with severe traumatic brain injury	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						craniocerebral trauma; intracranial pressure monitoring; survival analysis; prediction of neurologic outcome; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; CHANCE	Objective: The aim of the study was to assess (i) a group of patients with established intracranial pressure (ICP) sensor in severe brain injuries scoring 3 points of Glasgow Coma Scale, (ii) mortality and survival of the patients within periods of 7, 30, 180 and 270 days; and (iii) predictive value of intracranial pressure and cerebral perfusion pressure for short and long-term survival of patients with traumatic brain injury. Material and methods: The group consisted of 61 patients with trauma brain injury scoring 3 points of Glasgow Coma Scale, continuously monitored for intracranial pressure cerebral perfusion pressure at the Intensive Care Unit setting in Nove Zamky. Follow-up period was between 7 and 270 days. Measured values and other recorded data were analysed using methods of descriptive and inferential statistics. Results: ICP values below 20 mmHg were associated with a significantly lower risk of death of an individual patient at particular time. Accordingly, cerebral perfusion pressure values above 70 mmHg during 0-2 days were associated with a significantly higher long-term survival. Overall mortality rates within 30 days showed no peaks on survival curves. In the periods of 0-7 days, within 30 days, and between 30 and 180 days we recorded 24, 51 and 2 deaths, respectively. In the period between 180 and 270 days, mortality was zero. Conclusion: The survival of trauma brain injury patients depends on the speed and quality of pre-hospital care and adequate follow-up treatment at specialized intensive care units. High levels of intracranial pressure and low cerebral perfusion pressure values in the early period after brain injury are closely related to mortality of patients within 30 days. Intracranial pressure monitoring may help to avoid problems and allow intervention before they become life-threatening (Tab. 4, Fig. 4, Ref. 23). Text in PDF www.elis.sk.	[Krbila, S.] Fac Hosp, Dept Anesthesiol, SK-94034 Nove Zamky, Slovakia		Krbila, S (corresponding author), Fac Hosp, Dept Anesthesiol, Slovenska 11-A, SK-94034 Nove Zamky, Slovakia.	stefan.krbila@gmail.com	Zahorec, Roman/P-1115-2015	Zahorec, Roman/0000-0003-2791-6281; Waczulikova, Iveta/0000-0002-1749-2780	Cultural and Educational Grant Agency of the Ministry of Education in Slovakia [MZ SR 2007/29-UK-06, KEGA 003UK-4/2012]	This study was partially supported by a scientific grant MZ SR 2007/29-UK-06 and by grant KEGA 003UK-4/2012 from the Cultural and Educational Grant Agency of the Ministry of Education in Slovakia.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUMA S1, V24, P37; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Fearnside MR, 1997, BRIT J NEUROSURG, V7, P267; Gasko R, 2010, ROZUMIEME STAT VYSLE; Ghajar J, 1995, New Horiz, V3, P395; GUILLAUME J, 1951, PRESSE MED, V59, P953; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Krbila S, 2011, ANEST INTENZIV MED, V22, P272; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Ralph JK, JR ARMY MED CORPS, V155, P122; Reilly Peter, 1997, INTRACRANIAL PRESSUR; Sahipaul R, 2000, CAN J NEUROL SCI, V27, P143; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Waczulikova I, 2009, STAT MED RES RADIOLO; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a	22	4	4	1	4	COMENIUS UNIV	BRATISLAVA I	SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA	0006-9248	1336-0345		BRATISL MED J	Bratisl. Med. J.		2013	114	12					696	701		10.4149/BLL_2013_147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299SJ	WOS:000330415700004	24329507	Bronze			2022-02-06	
J	Krpan, KM; Anderson, ND; Stuss, DT				Krpan, Katherine M.; Anderson, Nicole D.; Stuss, Donald T.			Obstacles to remediating coping following traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; coping; rehabilitation; inter-patient variability; mechanisms	QUALITY-OF-LIFE; FRONTAL LOBES; COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; SOCIAL SUPPORT; HEAD-INJURY; DYSFUNCTION; STRATEGIES; CORTEX; INTERVENTION	BACKGROUND: Coping has been suggested as the final common pathway related to outcome after traumatic brain injury (TBI). Different types of coping have been related to either positive or negative psychosocial outcomes. As a result, a small set of studies have attempted to remediate coping through intervention, but the effectiveness of these studies has been modest. CONCLUSION: We propose that three primary factors are limiting our ability to effectively remediate coping following TBI through intervention TBI: 1) limited understanding of inter-patient variability following TBI; 2) limited understanding of the mechanisms underlying coping following TBI; and 3) reliance on self-report measures of coping. We discuss these obstacles in the context of a model of frontal lobe function, and in light of recent behavioural work on coping.	[Krpan, Katherine M.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Krpan, Katherine M.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Anderson, Nicole D.] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Stuss, Donald T.] Ontario Brain Inst, Toronto, ON, Canada		Krpan, KM (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 1012 East Hall,530 Church St, Ann Arbor, MI 48109 USA.	kkrpan@umich.edu	Anderson, Nicole D/E-9101-2011	Anderson, Nicole D/0000-0002-5979-2220	University of Michigan Advanced Rehabilitation Research Training Program [H133P090008]; National Institute on Disability Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitation Services (OSERS) of the U.S. Department of Education, Washington, D.C.	This work was supported by the University of Michigan Advanced Rehabilitation Research Training Program (Grant #H133P090008) funded by the National Institute on Disability Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitation Services (OSERS) of the U.S. Department of Education, Washington, D.C.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Benson D.F., 1986, FRONTAL LOBES; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COURVILLE CB, 1937, PATHOLOGY CENTRAL 4; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Finset A, 2000, BRAIN INJURY, V14, P887; Folkman S., 1984, STRESS; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Harlow J. M., 1993, HIST PSYCHIATR, V4, P271, DOI DOI 10.1177/0957154X9300401406; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 2001, BRAIN IMPAIR, V2, P81; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B., 2008, COGNITIVE NEUROREHAB, V2nd, P464, DOI [10.1017/CBO9781316529898.033, DOI 10.1017/CBO9781316529898.033]; Levine B., 2002, PRINCIPLES FRONTAL L, P448; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Norman D., 1980, ATTENTION ACTION WIL; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spitz G., 2012, J HEAD TRAUMA REHAB, P1; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D. T., 2008, COGNITIVE NEUROREHAB; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; Wood R. L., 2012, J HEAD TRAUMA REHAB, P1; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; [No title captured]	69	4	4	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					721	728		10.3233/NRE-130897			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100004	23867399				2022-02-06	
J	McFadd, E; Hustad, KC				McFadd, Emily; Hustad, Katherine C.			Assessment of social function in four-year-old children with cerebral palsy	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Dysarthia; language disorders; communication	GROSS MOTOR FUNCTION; FUNCTION CLASSIFICATION-SYSTEM; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SPEECH-INTELLIGIBILITY; HAND FUNCTION; PEDI-CAT; RELIABILITY; HEALTH; ICF	Objective: To determine whether scores from the social function domain of the Paediatric Evaluation of Disability Inventory (PEDI) would reflect differences among speech-language profile groups for children with cerebral palsy (CP). Methods: Thirty-four children with CP participated (mean age 54.4 months). PEDI social function raw scores, developmentally stratified skill levels, and types of skills mastered at a 75% criterion level were examined. Results: Significant differences were observed in social function scores overall and within early and age-appropriate skills among all profile groups with one exception. Skill mastery varied based on profile group and on developmental age category of each skill. Conclusions: The PEDI appears to capture language delay in children with CP, but it may not be sensitive to the impact of speech intelligibility deficits on social function. Findings call for the development of a new tool that more accurately assesses communicative activities and participation in children with CP.	[McFadd, Emily; Hustad, Katherine C.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53705 USA; [McFadd, Emily; Hustad, Katherine C.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA		McFadd, E (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1500 Highland Ave, Madison, WI 53705 USA.	mcfadd@wisc.edu		Hustad, Katherine/0000-0002-8544-7754	National Institutes of Health (NIDCD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC009411]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC009411] Funding Source: NIH RePORTER	This study was funded by a research grant from the National Institutes of Health (NIDCD), R01DC009411. This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352). The authors report no conflicts of interests. The authors alone are responsible for the content and writing of this article.	Armstrong DC, 2010, DEV NEUROREHABIL, V13, P383, DOI 10.3109/17518423.2010.509750; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Beukelman D. R., 2005, AUGMENTATIVE ALTERNA; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Dumas H M, 2001, Pediatr Rehabil, V4, P177, DOI 10.1080/13638490210121720; Dumas H, 2010, PHYS OCCUP THER PEDI, V30, P168, DOI 10.3109/01942631003640493; Dumas HM, 2012, DISABIL REHABIL, V34, P393, DOI 10.3109/09638288.2011.607217; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Dykstra Allyson D., 2007, Seminars in Speech and Language, V28, P301, DOI 10.1055/s-2007-986527; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fedrizzi E, 2003, DEV MED CHILD NEUROL, V45, P85, DOI 10.1017/S0012162203000173; Gorter JW, 2004, DEV MED CHILD NEUROL, V46, P461, DOI 10.1017/S0012162204000763; Haley S, 1992, PEDIAT EVALUATION DI; Haley SM, 2009, QUAL LIFE RES, V18, P359, DOI 10.1007/s11136-009-9447-5; Hanna SE, 2003, DEV MED CHILD NEUROL, V45, P448, DOI 10.1017/S0012162203000847; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; Holsbeeke L, 2009, ARCH PHYS MED REHAB, V90, P849, DOI 10.1016/j.apmr.2008.11.015; Hustad Katherine C, 2010, Early Child Serv (San Diego), V4, P129; Hustad KC, 2012, J SPEECH LANG HEAR R, V55, P1177, DOI 10.1044/1092-4388(2011/11-0083); Hustad KC, 2010, J SPEECH LANG HEAR R, V53, P1496, DOI 10.1044/1092-4388(2010/09-0176); Ketelaar M, 2010, PHYS OCCUP THER PEDI, V30, P185, DOI 10.3109/01942638.2010.486352; Liptak GS, 2001, DEV MED CHILD NEUROL, V43, P364, DOI 10.1017/S001216220100069X; Lowing K, 2011, DEV NEUROREHABIL, V14, P79, DOI 10.3109/17518423.2011.552088; Morris C, 2006, DEV MED CHILD NEUROL, V48, P950, DOI 10.1017/S001216220600209X; Nadeau L, 2009, DISABIL REHABIL, V31, P302, DOI 10.1080/09638280801945899; Ostensjo S, 2003, DEV MED CHILD NEUROL, V45, P603, DOI 10.1017/S0012162203001105; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Pennington L, 2005, DEV MED CHILD NEUROL, V47, P57; Pennington L, 2001, DEV MED CHILD NEUROL, V43, P83, DOI 10.1017/S0012162201000147; Pennington L, 2001, INT J LANG COMM DIS, V36, P371; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Rosenbaum PL, 2002, JAMA-J AM MED ASSOC, V288, P1357, DOI 10.1001/jama.288.11.1357; Threats TT, 2006, J COMMUN DISORD, V39, P251, DOI 10.1016/j.jcomdis.2006.02.002; Whittingham K, 2010, RES DEV DISABIL, V31, P1346, DOI 10.1016/j.ridd.2010.07.006; Wichers M, 2009, J REHABIL MED, V41, P367, DOI 10.2340/16501977-0339; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529; World Health Organization, 2007, INT CLASS FUNCT DIS; Yorkston K. M., 2010, MANAGEMENT MOTOR SPE, V3rd; Yude C, 1999, DEV MED CHILD NEUROL, V41, P4, DOI 10.1017/S001216229900002X	42	4	4	1	15	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423			DEV NEUROREHABIL	Dev. Neurorehabil.		2013	16	2					102	112		10.3109/17518423.2012.723762			11	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	105KM	WOS:000316067500003	23477463	Green Accepted			2022-02-06	
J	Mohanty, M; Gupta, SK				Mohanty, Manju; Gupta, Sunil K.			Home based neuropsychological rehabilitation in severe traumatic brain injury: a case report	ANNALS OF NEUROSCIENCES			English	Article						Brain injury; Neuropsychological impairment; Cognitive remediation; Rehabilitation		Traumatic Brain Injury (TBI) is the most common cause of death and disability in young people. The patients with TBI often suffer impairments in psycho motor speed, memory, attention, speed of information processing, executive functioning, fluid intelligence, language and visuo-spatial skills. These impairments need to be addressed as these have a significant impact on their social and occupational functioning. Neuropsychological rehabilitation has been found to be useful in improving cognitive and day to day functioning. It focuses on the improvement of basic abilities which in turn enhance cognitive functioning. The aim of the present study was to develop a home based neuropsychological rehabilitation programme and examine its usefulness in severe TBI. A single case study method was adopted. A detailed assessment was done at 11/2 months (pre-assessment) and 9 months (post-intervention) to evaluate the changes. Post-intervention improvement was observed in her cognitive functions and day to day functioning. She had resumed her previous job also. Home based neuropsychological rehabilitation emerged to be useful in brain damaged patients.	[Mohanty, Manju; Gupta, Sunil K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh, India		Mohanty, M (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh, India.	manjumohanty2011@gmail.com					Alladi S, 2002, NEUROL INDIA, V50, pS102; Anderson SW, 1996, HEAD INJURY POST CON; Christiana S, 2009, INDIAN J CLIN PSYCHO, V2, P11; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coelho CA, 2000, APHASIOLOGY, V14, P133, DOI 10.1080/026870300401513; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hillis AE, 1998, J INT NEUROPSYCH SOC, V4, P648, DOI 10.1017/S135561779846613X; Jamuna N, 2010, INDIAN J NEUROTRAUM, V7, P93; JAMUNA N, 1992, 6 ANN C BEH MED SOC; Kumar K, NEUROPSYCHOLOGY ASIA, P219; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mukundan C. R, 1996, P NAT WORKSH CLIN NE; Nag S, 2009, NEUROL INDIA, V47, P32; Nangia D, NEUROPSYCHOLOGICAL T; Pershad D, REVISED MANUAL DYSFU; Pershad DVS., 1990, HDB PGI BATTERY BRAI; Rao S.L., 1998, NEUROREHABILITATION, P165; Rao SL, 2004, NIMHANS PUBLICATION; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Sarkar A, 1996, 48T ANN NAT C IND PS; SOHLBERG MM, 2002, PERSPECTIVES NEUROPH, V12, P4; Sohlberg MM, 2001, COGNITIVE RETRAINING	26	4	4	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0972-7531	0976-3260		ANN NEUROSCI	Ann. Neurosci.	JAN	2013	20	1					31	35		10.5214/ans.0972.7531.200111			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V2O2S	WOS:000217760500010	25206008	Green Published			2022-02-06	
J	Munivenkatappa, A; Pruthi, N; Philip, M; Devi, BI; Somanna, S				Munivenkatappa, Ashok; Pruthi, Nupur; Philip, Mariamma; Devi, Bhagavatula I.; Somanna, Sampath			Elderly pedestrian neurotrauma: A descriptive study from a premier neurotrauma center in India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Bangalore; elderly pedestrian; neurotrauma	OLDER PEDESTRIANS; TRAUMA; INJURY; FATALITIES; VICTIMS; PATTERN; COST	Context: Experience with elderly pedestrian neurotrauma at a major neurotrauma tertiary center. Aims: To highlight the specific injuries and outcome of the elderly pedestrian neurotrauma patients within the city of Bangalore and its surrounding districts. Settings and Design: A retrospective study consisting of demographic data, clinical findings, radiological details, and outcomes. Materials and Methods: A study was conducted at the casualty services, in which 143 consecutive elderly pedestrian (age >60 years) head injury victims were studied from June to September 2009. The records from the hospital mortuary were analyzed from 2007 to 2009. An analysis of 77 elderly patients who died as a pedestrian in accidents during this period was performed. Statistical Analysis Used: SPSS 15. Results: The elderly pedestrians constituted 27% (143/529) of all pedestrian traumas. Two wheelers were the most common accident vehicle (56.6%, 81/143). Most of the injuries (38.5%, 55/143) occurred during peak traffic hours, that is, 4 pm to 9 pm. Majority sustained moderate to severe head injury (61%, 87/143). More than three-fourths of patients required a computed tomography (CT) scan (77%, 110/143), in which there was a higher frequency of contusion (31.5%, 45/143), and subdural hemorrhage (23.1%, 33/143). Most of the injured (43.3%, 13/30) underwent surgery for intracranial hematoma. The mortality rate was 22.8% (8/35). Nearly one-fourth of conducted postmortems among pedestrians belonged to the elderly age group (77/326, 23.6%). Conclusions: Elderly pedestrian neurotrauma patients sustain a more severe injury as evident by poorer Glasgow Coma Score (GCS) scores and CT scan findings, and hence have a higher mortality rate.	[Munivenkatappa, Ashok; Pruthi, Nupur; Devi, Bhagavatula I.; Somanna, Sampath] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore, Karnataka, India; [Philip, Mariamma] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India		Pruthi, N (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore, Karnataka, India.	pruthi_nupur@yahoo.co.in	Munivenkatappa, Ashok/ABA-5952-2021; Philip, Mariamma/AAR-4349-2020	Philip, Mariamma/0000-0001-6047-1494			Abou-Raya S, 2009, GERIATR GERONTOL INT, V9, P290, DOI 10.1111/j.1447-0594.2009.00535.x; Adam SH, 2008, ARCH GERONTOL GERIAT, V47, P377, DOI 10.1016/j.archger.2007.08.018; Akkose Aydin Sule, 2006, Ulus Travma Acil Cerrahi Derg, V12, P230; Beck LF, 2007, J SAFETY RES, V38, P613, DOI 10.1016/j.jsr.2007.10.001; Bureau. National Crime Records, 2007, ACC DEATHS SUIC IND; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gorrie CA, 2006, DEMENT GERIATR COGN, V22, P20, DOI 10.1159/000093066; Gururaj G, 2006, USITC PUBL, V56; Moharamzad Y, 2008, CHIN J TRAUMATOL, V11, P329, DOI 10.1016/S1008-1275(08)60067-X; Odebode TO, 2008, NIGER J CLIN PRACT, V11, P265; Romero-Ortuno R, 2010, AGE AGEING, V39, P80, DOI 10.1093/ageing/afp206; Selway JS, 2008, J TRAUMA, V65, P442, DOI 10.1097/TA.0b013e31817c553b; Small TJ, 2006, ANZ J SURG, V76, P43, DOI 10.1111/j.1445-2197.2006.03646.x; Takanishi DM, 2008, ASIA-PAC J PUBLIC HE, V20, P327, DOI 10.1177/1010539508322539; Tokdemir M, 2009, MED SCI MONITOR, V15, pPI1; Wang Zhengguo, 2003, Traffic Inj Prev, V4, P9, DOI 10.1080/15389580309860; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	17	4	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2013	4	1					29	32		10.4103/0976-3147.105606			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W3S	WOS:000218647100009	23546344	Green Published, gold			2022-02-06	
J	Sarajuuri, J; Pasanen, M; Rinne, M; Vartiainen, M; Lehto, T; Alaranta, H				Sarajuuri, Jaana; Pasanen, Matti; Rinne, Marjo; Vartiainen, Matti; Lehto, Tomnni; Alaranta, Hannu			RELATIONSHIP BETWEEN COGNITIVE AND MOTOR PERFORMANCE IN PHYSICALLY WELL-RECOVERED MEN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; motor skills; neurobehavioral manifestations; rehabilitation; neuropsychology	DIVIDED ATTENTION; VIRTUAL-REALITY; TEST BATTERY; BALANCE; ADULTS; REHABILITATION; CAPACITY; EXERCISE; WALKING; GAIT	Objective: To explore the relationship between cognitive and motor performance in physically well-recovered men with traumatic brain injury. Design: Cross-sectional explorative study in a national neurorehabilitation centre. Subjects: Men with post-acute traumatic brain injury (n=34; aged 19-55 years) who had recovered well physically. Methods: Cognitive performance (attention, information processing, cognitive flexibility, motor regulation, praxis of the upper limbs) and motor performance (postural balance, agility, rhythm-co-ordination) were assessed. Partial rank correlation coefficients and analyses of covariance were used to assess the associations between these tests. Results: Associations were found between the time taken in both Trail Making tests and performance time in the agility test (r=0.57). The score on the Digit Symbol test correlated with time in the agility test (r=-0.52). Patients with normal performance in verbal fluency performed the tests of dynamic balance and agility 26% more quickly than those with abnormal performance. Moreover, patients with normal performance in the reproduction of rhythmic structures were 20% faster in the dynamic balance test. Motor functions of the hands associated with all the motor-performance test results. Conclusion: Measures of information processing, attention and executive functioning may be associated with motor performance. Apart from the theoretical relevance, the finding of an association between cognitive and motor performance may have clinical relevance with regard to rehabilitation.	[Sarajuuri, Jaana; Lehto, Tomnni; Alaranta, Hannu] Kapyla Rehabil Ctr, FI-00251 Helsinki, Finland; [Pasanen, Matti; Rinne, Marjo; Vartiainen, Matti] UKK Inst Hlth Promot Res, Tampere, Finland		Sarajuuri, J (corresponding author), Kapyla Rehabil Ctr, Nordenskioldinkatu 18 B,POB 103, FI-00251 Helsinki, Finland.	jaana.sarajuuri@invalidiliitto.fi	Sarajuuri, Jaana/AAD-8665-2019	Sarajuuri, Jaana/0000-0002-6432-0295	Ministry of Education, Finland [196/722/2000]; Medical Fund of Helsinki and Uusimaa Hospital District	The authors gratefully acknowledge the support of the Ministry of Education, Finland Grant No. 196/722/2000 and the Medical Fund of Helsinki and Uusimaa Hospital District. The authors would like to thank Jukka Turkka, MD, PhD, for his expertise in confirming the injury-related variables of the patients and for his review of the manuscript; Sanna Koskinen, PhD, for her helpful advice and comments while reviewing the manuscript, and all the participants for their collaboration in this study. The authors express their deepest gratitude and honour the memory of their senior co-author, Professor Hannu Alaranta, who passed away on 10 June 2008.	[Anonymous], 1999, JAMA, V282, P974; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Christensen AL, 1979, LURIAS NEUROPSYCHOLO; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Hillier SL, 1997, BRAIN INJURY, V11, P661; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Laukkanen R, 1993, THESIS, V23; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Pang D, 1985, HEAD INJURY REHABILI, P3; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Ponsdorf J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rinne MB, 2001, INT J SPORTS MED, V22, P192, DOI 10.1055/s-2001-16384; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Suni JH, 1998, PHYS THER, V78, P134, DOI 10.1093/ptj/78.2.134; TEGNER Y, 1986, AM J SPORT MED, V14, P156, DOI 10.1177/036354658601400212; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Vartiainen MV, 2006, EUR J PHYSIOTHER, V8, P50, DOI 10.1080/14038190600700195; Wechsler D., 1981, WAIS R MANUAL; Welsh K, 1997, NEUROLOGY, V44, P609	39	4	4	1	21	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2013	45	1					38	46		10.2340/16501977-1060			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	071OF	WOS:000313603400006	23096058	gold, Green Submitted			2022-02-06	
J	Skadorwa, T; Zyganska, E; Eibl, M; Ciszek, B				Skadorwa, Tymon; Zyganska, Elzbieta; Eibl, Mikolaj; Ciszek, Bogdan			Distinct Strategies in the Treatment of Epidural Hematoma in Children: Clinical Considerations	PEDIATRIC NEUROSURGERY			English	Article						Epidural hematoma; Children; Operative treatment; Conservative treatment	TRAUMATIC BRAIN-INJURY; MINOR HEAD TRAUMA; COMPUTED-TOMOGRAPHY; MANAGEMENT	Background: Epidural hematoma (EDH) is the most common form of intracranial bleeding following head trauma in pediatric patients. It may develop into a life-threatening pathology, requiring an immediate neurosurgical intervention. However, due to an increasing number of posttrauma CT scans most pediatric EDH patients can be treated conservatively, because of minor dimensions of the clot and the possibility of quick control scanning. Aim: Evaluation of distinct strategies in the treatment of EDH patients in our department between January 2007 and December 2012. Results: During this period a total number of 221 patients with EDH were enrolled in the study. Seventy-seven of them (35%) underwent surgical procedures. One hundred and forty-four patients (65%) were treated conservatively. The dominating age group among nonsurgical patients was 0-4 years (85 cases, 61% of the nonsurgical group). In most of these cases a small epidural blood collection with inconsiderable dynamics was observed. Twenty-one patients from this age group (20%) were treated operatively. Among older children (5-18 years) surgical treatment was implemented in 56 (49%) cases. Conclusions: (1) EDH may be successfully treated conservatively with the use of control CT scans. (2) Smaller blood clots dominate in younger patients. (3) Surgical intervention is required more commonly in older patients. (C) 2014 S. Karger AG, Basel	[Skadorwa, Tymon; Zyganska, Elzbieta; Eibl, Mikolaj; Ciszek, Bogdan] Bogdanowicz Mem Hosp Children, Dept Pediat Neurosurg, PL-03924 Warsaw, Poland; [Skadorwa, Tymon; Ciszek, Bogdan] Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland		Skadorwa, T (corresponding author), Bogdanowicz Mem Hosp Children, Dept Pediat Neurosurg, 4-24 Nieklanska St, PL-03924 Warsaw, Poland.	tskadorwa@wum.edu.pl	Ciszek, Bogdan/N-7879-2018	Ciszek, Bogdan/0000-0002-0740-5049; Skadorwa, Tymon/0000-0002-3775-3968			Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Beijani GK, 1996, PEDIATR NEUROSURG, V25, P302; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Jung SW, 2012, J KOREAN NEUROSURG S, V51, P215, DOI 10.3340/jkns.2012.51.4.215; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Mehta S, 2007, PAED CHILD HEALT-CAN, V12, P482, DOI 10.1093/pch/12.6.482; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Zimmerman R A, 1994, Neuroimaging Clin N Am, V4, P349; Zuckerman GB, 1997, PEDIATR ANN, V26, P621, DOI 10.3928/0090-4481-19971001-09	15	4	6	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2013	49	3					166	171		10.1159/000359954			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AL8OO	WOS:000339398900007	24732678				2022-02-06	
J	Auxemery, Y				Auxemery, Y.			Post-traumatic stress disorder: Clinical aspects and pharmacological approach	REVUE DE MEDECINE INTERNE			French	Article						Post-traumatic stress disorder; Trauma; Addictive behaviour; Suicidality; Somatisations; Post-traumatic psychosis; Comorbidity; Etiopathogeny; Treatment	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; HEALTH-STATUS; SYMPTOMS; VETERANS; PTSD; RISPERIDONE; MECHANISMS; PSYCHOSIS; SCHIZOPHRENIA	All medical specialities are interested in the clinical aspects of psychological trauma. Due to psychopathological determinants which structure the trauma, although pathognomonic of posttraumatic stress disorder, flashbacks arc. rarely highlighted by the psychotraumatised patient in their contact with the health care system. Contact with the medical profession is expressed by somatic symptoms or psychiatric comorbidities. Addictive and suicidal problems, as well as somatisations and physical pain, are more traditional methods of contact with the health care system. In relation to the evolution of investigative techniques, modern wars have highlighted other dissociative and psychotic dimensions of the psycho- and craniatraumatic repercussions. These different clinical forms of posttraumatic stress disorder can receive a specific pharmacological treatment according to the predominant impairment of the incriminated monoaminergic neuromodulatory system. (C) 2012 Published by Elsevier Masson SAS on behalf of the Societe nationale francaise de medecine interne (SNFMI).	[Auxemery, Y.] HIA Legouest, Serv Psychiat, F-57077 Metz 3, France; [Auxemery, Y.] Ecole Val de Grace, F-75005 Paris, France; [Auxemery, Y.] Univ Paris 07, Ctr Rech Psychanal Med & Soc, F-75010 Paris, France		Auxemery, Y (corresponding author), HIA Legouest, Serv Psychiat, 27 Ave Plantieres, F-57077 Metz 3, France.	yann.auxemery@hotmail.fr					Ahearn Eileen P, 2003, Ann Clin Psychiatry, V15, P193, DOI 10.1023/B:ACLI.0000008173.01153.4e; American Psychiatric Association, 2004, DIAGN STAT MAN MENT; Artiss KL, 2010, MIL MED, V175, P259, DOI 10.7205/MILMED-D-10-00045; Auxemery Y, 2011, ENCEPHALE, V37, P433, DOI 10.1016/j.encep.2010.12.001; Auxemery Y, 2011, ENCEPHALE, V37, P153, DOI 10.1016/j.encep.2010.04.009; Auxemery Y, 2011, ENCEPHALE; Auxemery Y, 2010, NEUROPSYCHIAT ENFAN, V58, P500, DOI [10.1016/j.neurenf.2010.05.009, DOI 10.1016/J.NEURENF.2010.05.009]; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Bergeret, 1974, PERSONNALITE NORMALE; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Briole G., 1994, 92 SESS C PSYCH NEUR; Cabane J, 2011, REV MED INTERNE, V32, P455, DOI 10.1016/j.revmed.2010.10.359; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Cathebras P, 2006, TROUBLES FONCTIONNEL, V1; Croisile B, 2011, PRESSE MED, V40, P197, DOI 10.1016/j.lpm.2010.09.027; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; El-Hage W, 2006, PRESSE MED, V35, P1683, DOI 10.1016/S0755-4982(06)74881-3; Fear NT, 2008, PSYCHOL MED, V39, P1; Fiszman A, 2004, EPILEPSY BEHAV, V5, P818, DOI 10.1016/j.yebeh.2004.09.002; Flyckt L, 2006, J CLIN PSYCHIAT, V67, P916, DOI 10.4088/JCP.v67n0608; Freeman TW, 2000, J NERV MENT DIS, V188, P460, DOI 10.1097/00005053-200007000-00011; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Goldstein LH, 2000, SEIZURE-EUR J EPILEP, V9, P314, DOI 10.1053/seiz.2000.0421; Harder LH, 2011, J NERV MENT DIS, V199, P940, DOI 10.1097/NMD.0b013e3182392bfb; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Kenardy J, 2011, SPINE, V36, pS233, DOI 10.1097/BRS.0b013e3182387fcd; Kozaric-Kovacic D, 2005, J CLIN PSYCHIAT, V66, P922, DOI 10.4088/JCP.v66n0716; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Krystal JH, 2011, NEUROPSYCHOPHARMACOL, V36, P911, DOI 10.1038/npp.2011.2; Lebigot F, 2011, TRAITER TRUAMATISMES; LEBIGOT F, 1995, MALADIES DEPRESSIVES, P234; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Monterore D, 2007, ENCEPHALE, V33, P352; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Norman SB, 2012, NEUROPHARMACOLOGY, V62, P542, DOI 10.1016/j.neuropharm.2011.04.032; Ouimette P, 2010, ADDICT BEHAV, V35, P64, DOI 10.1016/j.addbeh.2009.08.009; Pae CU, 2008, INT CLIN PSYCHOPHARM, V23, P1, DOI 10.1097/YIC.0b013e32825ea324; POLLOCK DA, 1990, AM J PSYCHIAT, V147, P772; Rabhi H, 2010, REV MED INTERNE, V31, P17; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reuber M, 2003, EPILEPSY BEHAV, V4, P205, DOI 10.1016/S1525-5050(03)00104-5; Roggenbach J, 2002, PSYCHIAT RES, V113, P193, DOI 10.1016/S0165-1781(02)00230-5; Rose S, 2009, PRESSE MED, V38, P695, DOI 10.1016/j.lpm.2008.11.013; Roth RS, 2008, J PAIN, V9, P588, DOI 10.1016/j.jpain.2008.01.333; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Shad MU, 2011, HUM PSYCHOPHARM CLIN, V26, P4, DOI 10.1002/hup.1171; Shaw K, 2002, J TRAUMA STRESS, V15, P39, DOI 10.1023/A:1014331211311; Stein DJ, 2000, INT CLIN PSYCHOPHARM, V15, pS31, DOI 10.1097/00004850-200008002-00006; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Tournier JN, 2002, PRESSE MED, V31, P3; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	66	4	5	0	27	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0248-8663			REV MED INTERNE	Rev. Med. Interne	DEC	2012	33	12					703	708		10.1016/j.revmed.2012.08.016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054PP	WOS:000312356000009	23036781				2022-02-06	
J	Paidakakos, NA; Rokas, E; Theodoropoulos, S; Dimogerontas, G; Konstantinidis, E				Paidakakos, Nikolaos A.; Rokas, Evangelos; Theodoropoulos, Spyridon; Dimogerontas, George; Konstantinidis, Epaminondas			Posttraumatic Benedikt's Syndrome: A Rare Entity with Unclear Anatomopathological Correlations	WORLD NEUROSURGERY			English	Article						Benedikt's syndrome; Crossed paralysis; Midbrain injury; Oculomotor nerve palsy; Traumatic brain injury		BACKGROUND: This study sought to present a very rare case of a posttraumatic midbrain lesion producing a debilitating constellation of symptoms identified as Benedikt's syndrome. METHODS: A 20-year-old woman with traumatic brain injury presented with ipsilateral internal and external ophthalmoplegia, and contralateral hemiataxia, proprioception disturbances, hypertonicity, slight hemiparesis, and hyperactive tendon reflexes. A bibliographic search was performed in PubMed. RESULTS: Neuroimaging revealed a left midbrain lesion at the level of the superior colliculi. In the literature, virtually all Benedikt's syndrome cases, which are rare anyway, are due to midbrain infarcts (basilar or posterior cerebral artery branches). There is only one case from 1963, reported as a posttraumatic Benedikt-type dyskinesia (French language). The historical evolution of the anatomopathologic correlations of the syndrome is also discussed. CONCLUSIONS: Benedikt's syndrome is a very rare condition, usually of vascular etiology. Our case is just the second one of traumatic pathogenesis ever reported, the first in the English language literature.	[Paidakakos, Nikolaos A.; Rokas, Evangelos; Theodoropoulos, Spyridon; Dimogerontas, George; Konstantinidis, Epaminondas] Asclepe Gen Hosp, Dept Neurosurg, Athens, Greece		Paidakakos, NA (corresponding author), Asclepe Gen Hosp, Dept Neurosurg, Athens, Greece.	n.paidakakos@gmail.com		Paidakakos, Nikolaos/0000-0002-1081-2809			Benedikt M., 1889, B MED, V3, P547; BOGOUSSLAVSKY J, 1989, REV NEUROL, V145, P546; Chadan N, 1989, Ophtalmologie, V3, P114; Charcot JM, 1893, MED MODERNE, V4, P194; DENYS W J, 1963, Acta Neurol Psychiatr Belg, V63, P225; DUHAMEL E, 1960, Bull Soc Ophtalmol Fr, V8, P495; Le Rebeller M J, 1973, Bull Soc Ophtalmol Fr, V73, P1027; LIU GT, 1992, NEUROLOGY, V42, P1820, DOI 10.1212/WNL.42.9.1820; Souques Crouzon, 1930, REV NEUROL PARIS, V2, P377; WEERTS JGM, 1990, REV NEUROL, V146, P762	10	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	DEC	2012	78	6							715.e13	10.1016/j.wneu.2012.03.028			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	062VC	WOS:000312950100040	22484069				2022-02-06	
J	Pandya, N; Khan, NUH; Prathap, KJ; Kureshy, RI; Abdi, SHR; Mishra, S; Bajaj, HC				Pandya, Nirali; Khan, Noor-Ul H.; Prathap, K. Jeya; Kureshy, Rukhsana I.; Abdi, Sayed H. R.; Mishra, Sandhya; Bajaj, Hari C.			DNA Binding, Antioxidant Activity, and DNA Damage Protection of Chiral Macrocyclic Mn(III) Salen Complexes	CHIRALITY			English	Article						chiral macrocyclic Mn(III) salen complex; DNA binding; superoxide radical; hydroxyl radical; plasmid DNA; WBC cell DNA protection	TRAUMATIC BRAIN-INJURY; SUPEROXIDE-DISMUTASE; LIGAND; INTERCALATORS; ANTICANCER; SCAVENGERS; THERAPY; DESIGN; AGENTS; MODEL	We are reporting the synthesis, characterization, and calf thymus DNA binding studies of novel chiral macrocyclic Mn(III) salen complexes S-1, R-1, S-2, and R-2. These chiral complexes showed ability to bind with DNA, where complex S-1 exhibits the highest DNA binding constant 1.20?x?106?M-1. All the compounds were screened for superoxide and hydroxyl radical scavenging activities; among them, complex S-1 exhibited significant activity with IC50 1.36 and 2.37?mu M, respectively. Further, comet assay was used to evaluate the DNA damage protection in white blood cells against the reactive oxygen species wherein complex S-1 was found effective in protecting the hydroxyl radicals mediated plasmid and white blood cells DNA damage. Chirality 24:10631073, 2012.(c) 2012 Wiley Periodicals, Inc.	[Pandya, Nirali; Khan, Noor-Ul H.; Prathap, K. Jeya; Kureshy, Rukhsana I.; Abdi, Sayed H. R.; Bajaj, Hari C.] CSIR, Cent Salt & Marine Chem Res Inst, Discipline Inorgan Mat & Catalysis, Bhavnagar 364021, Gujarat, India; [Mishra, Sandhya] CSIR, Cent Salt & Marine Chem Res Inst, Discipline Marine Biotechnol & Ecol, Bhavnagar 364021, Gujarat, India		Khan, NUH (corresponding author), CSIR, Cent Salt & Marine Chem Res Inst, Discipline Inorgan Mat & Catalysis, GB Marg, Bhavnagar 364021, Gujarat, India.	khan251293@yahoo.in	Mishra, Sandhya/D-1963-2010; Khan, Noor-ul/L-5371-2014; Bajaj, Hari/E-9212-2014; Amravati, Singh/X-7648-2019; Kureshy, Rukhsana/K-3544-2014	Mishra, Sandhya/0000-0002-2412-4927; Bajaj, Hari/0000-0003-3364-311X; Kaniraj, Jeya Prathap/0000-0001-5602-6339	CSIRCouncil of Scientific & Industrial Research (CSIR) - India	N. H. Khan and N. Pandya are thankful to the Council of Scientific & Industrial Research (CSIR) Net Working Project on Catalysis. K. J. Prathap is thankful to CSIR for awarding senior research fellowship.	Aldrich-Wright J, 2004, CHEM COMMUN, P1018, DOI 10.1039/b316917k; Anderson I, 2001, BIOCHEM SOC SYMP, V67, P141, DOI 10.1042/bss0670141; Arbuse A, 2009, INORG CHEM, V48, P11098, DOI 10.1021/ic901488j; Arjmand F, 2011, CHIRALITY, V23, P557, DOI 10.1002/chir.20970; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; Boon EM, 2002, ANGEW CHEM INT EDIT, V41, P3402, DOI 10.1002/1521-3773(20020916)41:18<3402::AID-ANIE3402>3.0.CO;2-6; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312; CORY M, 1985, J AM CHEM SOC, V107, P2528, DOI 10.1021/ja00294a054; Cuzzocrea S, 2005, ARTHRITIS RHEUM-US, V52, P1929, DOI 10.1002/art.21044; Dalton SR, 2008, J BIOL INORG CHEM, V13, P1133, DOI 10.1007/s00775-008-0399-y; Doctrow SR, 2002, J MED CHEM, V45, P4549, DOI 10.1021/jm020207y; Durot S, 2005, EUR J INORG CHEM, P2789, DOI 10.1002/ejic.200400834; Eckshtain M, 2009, DALTON T, P7879, DOI 10.1039/b911278b; Garcia O, 2007, MUTAT RES-GEN TOX EN, V627, P186, DOI 10.1016/j.mrgentox.2006.11.007; Goswami TK, 2011, INORG CHEM, V50, P8452, DOI 10.1021/ic201028e; Haber A, 2008, ANGEW CHEM INT EDIT, V47, P7896, DOI 10.1002/anie.200801149; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Kalim MD, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-77; Khan NUH, 2010, ORG BIOMOL CHEM, V8, P4297, DOI 10.1039/c0ob00010h; Khan NUH, 2009, SPECTROCHIM ACTA A, V74, P113, DOI 10.1016/j.saa.2009.05.016; Kos I, 2009, J MED CHEM, V52, P7868, DOI 10.1021/jm900576g; Kureshy RI, 2011, TETRAHEDRON, V67, P8300, DOI 10.1016/j.tet.2011.08.077; Lahaye D, 2007, BIOORGAN MED CHEM, V15, P7066, DOI 10.1016/j.bmc.2007.07.015; Lan-Mei C, 2008, J INORG BIOCHEM, V102, P330; Lewis EA, 2004, DALTON T, P187, DOI 10.1039/b314955b; Lewis EA, 2001, J CHEM SOC DALTON, P1159, DOI 10.1039/b102103f; Maheswari PU, 2006, J INORG BIOCHEM, V100, P3, DOI 10.1016/j.jinorgbio.2005.09.008; Maheswari PU, 2006, INORG CHEM, V45, P37, DOI 10.1021/ic050940q; Moreno D, 2010, J INORG BIOCHEM, V104, P496, DOI 10.1016/j.jinorgbio.2009.12.016; Mudasir, 2007, SPECTROCHIM ACTA A, V66, P163, DOI 10.1016/j.saa.2006.02.037; Mudasir, 2008, J INORG BIOCHEM, V102, P1638, DOI 10.1016/j.jinorgbio.2008.03.003; Munroe W, 2007, J INORG BIOCHEM, V101, P1875, DOI 10.1016/j.jinorgbio.2007.07.008; Nadin SB, 2001, J HISTOCHEM CYTOCHEM, V49, P1183, DOI 10.1177/002215540104900912; Noroozi M, 1998, AM J CLIN NUTR, V67, P1210, DOI 10.1093/ajcn/67.6.1210; Oliveri V, 2011, DALTON T, V40, P2913, DOI 10.1039/c0dt01480j; Patel M, 1999, TRENDS PHARMACOL SCI, V20, P359, DOI 10.1016/S0165-6147(99)01336-X; Pellei M, 2004, DALTON T, P2822, DOI 10.1039/b407061e; Pollard JM, 2009, FREE RADICAL BIO MED, V47, P250, DOI 10.1016/j.freeradbiomed.2009.04.018; Pong K, 2000, BRAIN RES, V881, P182, DOI 10.1016/S0006-8993(00)02841-9; Prabhakara MC, 2007, BIOINORG CHEM APPL, P1; Puglisi A, 2012, DALTON T, V41, P2877, DOI 10.1039/c1dt11677k; Raja DS, 2012, DALTON T, V41, P4365, DOI 10.1039/c2dt12274j; Rajput C, 2006, CHEM-EUR J, V12, P4611, DOI 10.1002/chem.200501349; Ramachandran E, 2012, METALLOMICS, V4, P218, DOI 10.1039/c1mt00143d; Ray S, 2007, J AM CHEM SOC, V129, P15042, DOI 10.1021/ja075889z; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; Roy M, 2009, DALTON T, P4671, DOI 10.1039/b901337g; Saha S, 2009, INORG CHEM, V48, P2652, DOI 10.1021/ic8022612; Salvemini D, 2002, NAT REV DRUG DISCOV, V1, P367, DOI 10.1038/nrd796; SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sun YT, 2008, SENSOR ACTUAT B-CHEM, V129, P799, DOI 10.1016/j.snb.2007.09.082; Vijayalakshmi R, 2006, BIOORGAN MED CHEM, V14, P3300, DOI 10.1016/j.bmc.2005.12.049; Wang Q, 2009, BIOMETALS, V22, P927, DOI 10.1007/s10534-009-9245-0; Westerlund F, 2005, J PHYS CHEM B, V109, P17327, DOI 10.1021/jp0517091; Wu N, 2010, J AGR FOOD CHEM, V58, P4737, DOI [10.1021/jf904593n, 10.1021/jf103970b]; Xiong Y, 1999, COORDIN CHEM REV, V185-6, P711, DOI 10.1016/S0010-8545(99)00019-3; Yang PM, 2005, TOXICOL SCI, V85, P551, DOI 10.1093/toxsci/kfi096; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Zeglis BM, 2007, CHEM COMMUN, P4565, DOI 10.1039/b710949k; Zhang FL, 2010, J CHEM CRYSTALLOGR, V40, P681, DOI 10.1007/s10870-010-9721-y	62	4	4	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	DEC	2012	24	12					1063	1073		10.1002/chir.22098			11	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy; Chemistry	045OU	WOS:000311707100014	22969041				2022-02-06	
J	Salinas, CM; Webbe, FM				Salinas, Christine M.; Webbe, Frank M.			Sports Neuropsychology With Diverse Athlete Populations: Contemporary Findings and Special Considerations	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						Concussion; Traumatic Brain Injury; Sport; Diversity; Neuropsychology		This paper aims to familiarize readers with the contemporary scientific literature available on sports concussion as it relates to populations divergent from adult males who play football and hockey. Herein, we focus on important issues such as age, gender, culture, language, sport type, and premorbid conditions (such as learning disabilities [LD] and attention deficit/hyperactive disorder [ADHD]) that can influence concussion incidence, severity, and recovery.	[Salinas, Christine M.] Florida Hosp Children, Orlando, FL 32803 USA; [Webbe, Frank M.] Florida Inst Technol, Melbourne, FL 32901 USA		Salinas, CM (corresponding author), Florida Hosp Children, Orlando, FL 32803 USA.			Webbe, Frank/0000-0002-4370-5698			Agel J, 2007, J ATHL TRAINING, V42, P270; Agranovich AV, 2011, J INT NEUROPSYCH SOC, V17, P692, DOI 10.1017/S1355617711000592; Alves W., 1992, PHYS MED REHABIL STA, V6, P21; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 1989, MILD HEAD INJURY, P257; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; BERGANDI TA, 1988, INT J SPORT PSYCHOL, V19, P226; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2004, STUD NEUROPSYCHOL DE, P255; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cheslock J., 2007, WHOS PLAYING COLL SP; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T., 2010, FDN SPORT NEUROPSYCH, P53; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Donnelly M, 2006, J SPORT SOC ISSUES, V30, P219, DOI 10.1177/0193723506287187; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; ECHEMENDIA R, 2008, CONC SPORT CLIN S NE; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson G.L., 2010, HDB SPORT NEUROPSYCH, P131; Johnson R., 2000, J ATTEN DISORD, V4, P150, DOI [10.1177/108705470000400302, DOI 10.1177/108705470000400302]; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klonoff P., 1996, CLIN NEUROPSYCHOL, V12, P31; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Puente AE., 2009, MULTICULTURAL PSYCHO, P417; Randolph C, 2005, J ATHL TRAINING, V40, P139; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tsushima William T, 2008, Hawaii Med J, V67, P93; Webbe F.M., 2010, HDB SPORT NEUROPSYCH, P275; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Willig C, 2008, J HEALTH PSYCHOL, V13, P690, DOI 10.1177/1359105307082459; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; YOSHIMI T, 1968, STEROIDS, V11, P527, DOI 10.1016/S0039-128X(68)80066-2	91	4	4	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	DEC	2012	6	4					363	384		10.1123/jcsp.6.4.363			22	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SP	WOS:000215041800005					2022-02-06	
J	Woodard, JL; Rahman, AAM				Woodard, John L.; Rahman, Annalise A. M.			The Human-Computer Interface in Computer-Based Concussion Assessment	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						computer; assessment; neuropsychology; sport; concussion		Recent progress in technology has allowed for the development and validation of computer-based adaptations of existing pencil-and-paper neuropsychological measures and comprehensive cognitive test batteries. These computer-based assessments are frequently implemented in the field of clinical sports psychology to evaluate athletes' functioning postconcussion. These tests provide practical and psychometric advantages over their pencil-and-paper counterparts in this setting; however, these tests also provide clinicians with unique challenges absent in paper-and-pencil testing. The purpose of this article is to present advantages and disadvantages of computer-based testing, generally, as well as considerations for the use of computer-based assessments for the evaluation of concussion among athletes. Furthermore, the paper provides suggestions for further development of computerized assessment of sports concussion given the limitations of the current technology.	[Woodard, John L.; Rahman, Annalise A. M.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA		Woodard, JL (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.			Woodard, John/0000-0001-9196-3336			Askar P, 2012, PSYCHOL REP, V110, P383, DOI 10.2466/03.22.PR0.110.2.383-396; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bergeron B P, 1996, Proc AMIA Annu Fall Symp, P802; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Botella C, 2006, PSYCHNOLOGY J, V4, P129; BRACKEN CC, 2010, J MEDIA PSYCHOL-GER, V22, P125, DOI DOI 10.1027/1864-1105/A000017; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Campbell Z, 2009, APPL NEUROPSYCHOL, V16, P295, DOI 10.1080/09084280903297891; Carstairs J, 2009, COMPUT HUM BEHAV, V25, P738, DOI 10.1016/j.chb.2009.01.011; Castelnuovo G., 2003, PSYCH NOL J, V1, P310; Cedrus, 2012, RB SER RESP PADS; Cedrus, 2012, SUPERLAB 4 5 MAN; Centers for Disease Control and Prevention, 2012, FAQS BAS TEST YOUNG; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Chambers CD, 2003, BEHAV RES METH INS C, V35, P96, DOI 10.3758/BF03195501; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; *COGSTATE, 1999, COGSP COMP SOFTW; Diedrichsen J., 2012, 2 DISTINCT IPSILATER; Doniger GM, 2009, ALZHEIMERS DEMENT, V5, P439, DOI 10.1016/j.jalz.2009.03.003; Dux MC, 2005, CLIN NEUROPSYCHOL, V19, P149; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erlanger DM, 1999, CONCUSSION RESOLUTIO; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; FELIPE A, 1993, VISION RES, V33, P2461, DOI 10.1016/0042-6989(93)90126-H; Gofen A, 1997, SPATIAL VISION, V10, P361, DOI 10.1163/156856897X00285; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hudnell HK, 1996, NEUROTOXICOL TERATOL, V18, P391, DOI 10.1016/0892-0362(96)00040-2; Johnson D, 2009, ARCH CLIN NEUROPSYCH, V24, P513; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kallinen K, 2007, COMPUT HUM BEHAV, V23, P303, DOI 10.1016/j.chb.2004.10.014; Kveton P, 2007, COMPUT HUM BEHAV, V23, P32, DOI 10.1016/j.chb.2004.03.034; Lange T, 2000, Surg Oncol Clin N Am, V9, P61; Letz R, 2003, NEUROTOXICOLOGY, V24, P479, DOI 10.1016/S0161-813X(03)00047-0; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lovell M, 2000, IMPACT IMMEDIATE POS; MAKHOUL J, 1995, P NATL ACAD SCI USA, V92, P9956, DOI 10.1073/pnas.92.22.9956; Mantovani F, 2003, CYBERPSYCHOL BEHAV, V6, P389, DOI 10.1089/109493103322278772; MCCORMACK PD, 1972, CAN J PSYCHOLOGY, V26, P19, DOI 10.1037/h0082413; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McDonald AS, 2002, COMPUT EDUC, V39, P299, DOI 10.1016/S0360-1315(02)00032-5; Microsoft, 2012, MICE ENDS SUPP WIND; Microsoft, 2012, MICR WIND MILL ED; MOON GW, 1991, PROF PSYCHOL-RES PR, V22, P256, DOI 10.1037/0735-7028.22.3.256; Noyes JM, 2008, ERGONOMICS, V51, P1352, DOI 10.1080/00140130802170387; Pearson Education, 2009, TEST MEAS RES SERV B, V9; Plant RR, 2003, BEHAV RES METH INS C, V35, P276, DOI 10.3758/BF03202553; Pommerich M., 2004, J TECHNOLOGY LEARNIN, V2; Psychology Software Tools, 2011, E PRIM TIM; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Riggs L.A., 1971, WOODWORTH SCHLOSBERG, P273; RIVA G, 1998, VIRTUAL REALITY NEUR, P1; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schlegel RE, 2007, ARCH CLIN NEUROPSYCH, V22, pS49, DOI 10.1016/j.acn.2006.10.005; Schneider W., 2002, E PRIME REFERENCE GU; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Shieh KK, 2005, PERCEPT MOTOR SKILL, V100, P943, DOI 10.2466/PMS.100.4.943-954; Tombaugh TN, 2000, MANUAL COMPUTERIZED; Vincent A, 2010, ARCH CLIN NEUROPSYCH, V25, P582; Wang SS, 1999, J AM MED INFORM ASSN, P435; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wechsler D., 2009, WECHSLER MEMORY SCAL; Weniger G, 2011, NEUROPSYCHOLOGIA, V49, P518, DOI 10.1016/j.neuropsychologia.2010.12.031; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woodard JL, 1992, NEUROPSYCHOLOGY, V6, P173, DOI DOI 10.1037/0894-4105.6.2.173; Zheltukhin A.Y., 2001, J INT NEUROPSYCH SOC, V7, P254; Zheltukhin A.Y., 2002, J INT NEUROPSYCH SOC, V8, P151; Zheltukhin A.Y., 2004, J INT NEUROPSYCH SOC, V10, P218; Zheltukhin A.Y., 2001, J INT NEUROPSYCH SOC, V7, P254	74	4	4	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	DEC	2012	6	4					385	408		10.1123/jcsp.6.4.385			24	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SP	WOS:000215041800006					2022-02-06	
J	Fox, AW; Payne-James, JJ				Fox, Anthony W.; Payne-James, J. Jason			Conducted energy devices: Pilot analysis of (non-)attributability of death using a modified Naranjo algorithm	FORENSIC SCIENCE INTERNATIONAL			English	Article						Conducted energy device; Fatality; Naranjo algorithm; Adverse event attributability	ADVERSE DRUG-REACTIONS; EXCITED DELIRIUM; PROBABILITY; TASER	Alleged fatalities associated with conductive-energy devices (CEDs) are similar to alleged serious adverse events (SAEs) after the use of pharmaceutical products: both types of case arise rarely, in complex (if not unique) combinations of circumstances, frequently when there are multiple concomitant putative aetiologies for the injury, and after the suspected product has been previously well-designed and tested. Attribution (or otherwise) of SAEs to pharmaceutical products is often assessed by use of the Naranjo algorithm. The purpose of this study was to investigate whether an adapted Naranjo algorithm could be used to assess alleged CED-associated fatalities. Unique cases had four independent identifiers. Prospectively, 7 (of the 10) Naranjo algorithm questions were chosen as being potentially applicable to CED use. These had maximum score 9, and the associated ordinal probability scale (doubtful, possible, probable, and definite) was retained by linear proportion to the integral scores. An arbitrary requirement was for database sufficiency >= 50% = ([n unique cases x 7 questions answerable] x 0.5); a pilot sample (n = 29 unique cases) suggested feasibility (see below). One hundred and seventy-five unique cases were found, with a data sufficiency of 56.8%. Modified Naranjo algorithm scores had an unequally bimodal distribution. CED-attributability was suggested in 21 (12% of 175) cases. Substantial numbers of concomitant conditions existed among cases with low algorithm scores, all being potentially lethal under field conditions without CED exposure. The number of CED-administered shocks sustained was unrelated to CED-attributability of fatality. Two of the Naranjo questions (regarding dechallenge and the effects of challenge with a non-identical but similar agent) proved to be non-contributory. An algorithmic approach to assessment of CED-associated fatality seems feasible. By these pharmacovigilance standards, some published case fatality rates attributable to CED exposure seem exaggerated. CED-attributable deaths have close similarity to Type-B SAEs. The latter are rare, unpredictable, and usually due to a patient idiosyncrasy. In the person being restrained, such idiosyncratic factors may be unavoidable by law enforcement officers (LEO) in the field. These are unlike predictable (Type-A) SAEs, which have their corollary amongst secondary CED-associated deaths, e.g., head injury among cyclists or ignition of an inflammable atmosphere by the CED, and are identifiable risk factors for which LEO can train. Regardless, absolute CED tolerability is obviously greater than that for firearms. A prospective registry of CED deployments would measure this more precisely. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Fox, Anthony W.; Payne-James, J. Jason] Barts & London Queen Marys Sch Med & Dent, London, England; [Fox, Anthony W.] EBD Consulting, London, England; [Fox, Anthony W.] EBD Consulting, Carlsbad, CA 92011 USA; [Payne-James, J. Jason] Forens Healthcare Serv Ltd, Leigh On Sea, Essex, England		Fox, AW (corresponding author), Kings Coll London, Dept Pharmaceut Med, Sackler Inst Pharmaceut Sci, Sch Biomed Sci,Acad Ctr, Room 3-54,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	Tony.Fox@kcl.ac.uk	Payne-James, Jason/AAP-6588-2021	Payne-James, J Jason/0000-0002-3713-8922			American College of Emergency Physicians (ACEP),, 2009, WHIT PAP REP EX DEL; Amnesty International, 2008, AMR512462008 AMN INT, P1; Bleetman A, 2004, EMERG MED J, V21, P136, DOI 10.1136/emj.2003.008581; Bozeman WP, 2009, ANN EMERG MED, V53, P480, DOI 10.1016/j.annemergmed.2008.11.021; BUSTO U, 1982, BRIT J CLIN PHARMACO, V13, P223, DOI 10.1111/j.1365-2125.1982.tb01361.x; Eastman AL, 2008, J TRAUMA, V64, P1567, DOI 10.1097/TA.0b013e31817113b9; Esquivel AO, 2007, ANN EMERG MED, V50, P576, DOI 10.1016/j.annemergmed.2007.05.003; Grant JR, 2009, AM J FOREN MED PATH, V30, P1, DOI 10.1097/PAF.0b013e31818738a0; HAMLIN ROBERT L., 1965, ANN N Y ACAD SCI, V127, P195, DOI 10.1111/j.1749-6632.1965.tb49403.x; Hamlin RL, 2010, J PHARMACOL TOXICOL, V62, P4, DOI 10.1016/j.vascn.2010.04.009; Ho J.D., 2009, J EMERGENCY MED, V10, P68; Ideker RE, 2007, AM J FOREN MED PATH, V28, P195, DOI 10.1097/PAF.0b013e31803179a9; Independent Police Complaints Commission, 2010, DEATHS FOLL CUST 199; Inquest Deaths in Police Custody 2000-2010, 2011, DEATHS POL CUST 2000; International Amnesty, 2004, AMR200022004 AMN INT, P1; International Amnesty, 2007, AMR200022007 AMN INT, P1; Jauchem JR, 2006, FORENSIC SCI INT, V161, P20, DOI 10.1016/j.forsciint.2005.10.014; Lee Ching Kwan, 2007, REENVISIONING CHINES, P1; MICHEL DJ, 1986, AM J HOSP PHARM, V43, P1709, DOI 10.1093/ajhp/43.7.1709; NARANJO CA, 1981, CLIN PHARMACOL THER, V29, P267; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Payne-James J., 2010, BRIT MED J, V340, P608; San Diego District Attorney, 2007, OFF INV SHOOT REV AN, P1; Stratton SJ, 2001, AM J EMERG MED, V19, P187, DOI 10.1053/ajem.2001.22665; STRAZIS KP, 1993, ANESTH ANALG, V77, P297, DOI 10.1213/00000539-199377020-00014; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P59; Sun H., 2010, Journal of Medical Engineering & Technology, V34, P178, DOI 10.3109/03091900903509149; Swerdlow CD, 2009, ACAD EMERG MED, V16, P726, DOI 10.1111/j.1553-2712.2009.00432.x; United Kingdom Home Office, 2010, STAT POL US FIR ENGL; Vilke GM, 2011, J EMERG MED	30	4	4	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	NOV 30	2012	223	1-3					261	265		10.1016/j.forsciint.2012.09.016			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	041WJ	WOS:000311432100054	23092849				2022-02-06	
J	Bjorkdahl, A; Lundgren-Nilsson, A; Sunnerhagen, KS				Bjorkdahl, Ann; Lundgren-Nilsson, Asa; Sunnerhagen, Katharina S.			How Can We Tell Who Is Aware? Where Does the Veracity Lie?	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Assessment; awareness; proxy; stroke	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL-INSTITUTE SCREEN; SELF-AWARENESS; REHABILITATION; STROKE; DEFICITS; QUESTIONNAIRE; LIMITATIONS; POPULATION; VALIDATION	Background: The first aim of this study was to compare the subjective experiences of social, cognitive, and emotional problems of the patient and his/her next of kin, and explore if this related to cognitive testing. The second aim was to explore how these results reflect the patient's awareness. Methods: This is a subanalysis from a longitudinal study in the first year after discharge with comparisons of patient and next of kin scores on the European Brain Injury Questionnaire (EBIQ) and analyses of the relationship of their scores to an objective cognitive screening on 3 occasions. A paired t test was used to explore differences between 35 stroke patients and their next of kin on the EBIQ. Gamma analyses were made to explore the relationship between the EBIQ scores and the Barrow Neurological Institute Screening (BNIS) of higher cognitive functions, with the entire sample grouped into aware and unaware according to the BNIS item of awareness. Results: We found significant differences between the patient and next of kin assessments on all occasions, apart from at discharge. When grouped, only the group of aware patients differed significantly from their next of kin. Significant relations of the patient ratings on the EBIQ and BNIS were only found at the 1-year follow-up for the unaware group and the entire sample. Next of kin EBIQ scores did not correlate with the BNIS. Conclusions: Neither next of kin ratings nor an objective measurement was feasible to use for evaluation of the patient's awareness of social, cognitive, and emotional problems.	[Bjorkdahl, Ann; Lundgren-Nilsson, Asa; Sunnerhagen, Katharina S.] Gothenburg Univ, Dept Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, S-40043 Gothenburg, Sweden; [Bjorkdahl, Ann] Bracke Diakoni Fdn, Res Unit, Gothenburg, Sweden		Bjorkdahl, A (corresponding author), Gothenburg Univ, Dept Rehabil Med, Inst Neurosci & Physiol, Pehr Dubbsgatan 14,Box 301 10, S-40043 Gothenburg, Sweden.	ann.bjorkdahl@rehab.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Bjorkdahl, Ann/ABD-6197-2021	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Bjorkdahl, Ann/0000-0002-2194-6773	County of Vastra Gotaland	Supported by the County of Vastra Gotaland.	Benson D.F., 1986, FRONTAL LOBES; Bergersen H, 2010, J STROKE CEREBROVASC, V19, P364, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.005; Bjorkdahl A, 2007, J REHABIL MED, V39, P27, DOI 10.2340/16501977-0001; Bjorkdahl A, 2006, CLIN REHABIL, V20, P1038, DOI 10.1177/0269215506071230; Bjorkdahl A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-209; Bjorkdahl Ann, 2004, J Stroke Cerebrovasc Dis, V13, P122, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.004; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gauggel S, 2002, Z GERONTOL GERIATR, V35, P102, DOI 10.1007/s003910200014; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Jorgensen HS, 1999, CLIN GERIATR MED, V15, P785; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1991, BNI Q, P2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Toglia J, 2000, NEUROREHABILITATION, V15, P57	33	4	4	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057			J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	NOV	2012	21	8					812	818		10.1016/j.jstrokecerebrovasdis.2011.04.013			7	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	031LM	WOS:000310641900031	21640606				2022-02-06	
J	Ismailoglu, O; Atilla, P; Palaoglu, S; Cakar, N; Yasar, U; Kilinc, K; Kaptanoglu, E				Ismailoglu, Ozgur; Atilla, Pergin; Palaoglu, Selcuk; Cakar, Nur; Yasar, Umit; Kilinc, Kamer; Kaptanoglu, Erkan			The Therapeutic Effects of Melatonin and Nimodipine in Rats after Cerebral Cortical Injury	TURKISH NEUROSURGERY			English	Article						Melatonin; Nimodipine; Head trauma; Rat	SPONTANEOUSLY HYPERTENSIVE RATS; BRAIN-INJURY; LIPID-PEROXIDATION; SUBARACHNOID HEMORRHAGE; HEAD TRAUMA; ISCHEMIA; ANTAGONISTS; EDEMA; TRIAL	AIM: Secondary brain injury starts after the initial traumatic impact and marked by an increase in the intracellular calcium concentrations. This cascadeeventually results in membrane lipid peroxidation and neuronal cell death. MATERIAL and METHODS: We investigated the neuro-protective effects of nimodipine and melatonin in 38 rats after 6 hours of head trauma using the cortical impact injury model of Marmarou. RESULTS: Brain water in the melatonin-given group decreased significantly comparing to that of control group the brain water in the nimodipine given group increased significantly comparing to that of trauma group. Histopathologically, brain edema was significantly low in melatonin-administered group comparing to that of control group while there were no changes in brain edema in the nimodipine given group and in the group that both nimodipine and melatonin were administered in combination. MDA levels in the brain tissues were significantly lower in the melatonin and nimodipine groups comparing to those of trauma and control group however this difference was by far significant in melatonin group comparing to nimodipine group. CONCLUSION: Melatonin appears to have neuro-protective effects on the secondary brain damage while nimodipine and nimodipine plus melatonin combination did not show such neuro-protective effects on the secondary brain injury.	[Ismailoglu, Ozgur] Suleyman Demirel Univ, Med Fac Hosp, Dept Neurosurg, TR-32200 Isparta, Turkey; [Palaoglu, Selcuk] Hacettepe Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey; [Atilla, Pergin; Cakar, Nur] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey; [Yasar, Umit] Hacettepe Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey; [Kilinc, Kamer] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey		Ismailoglu, O (corresponding author), Suleyman Demirel Univ, Med Fac Hosp, Dept Neurosurg, TR-32200 Isparta, Turkey.	ozguri_36@hotmail.com	Yasar, Umit/A-1602-2008; Cakar, A.Nur/ABG-7405-2020	Yasar, Umit/0000-0001-6758-0335; ATILLA, PERGIN/0000-0001-5132-0002			Ak A, 2001, ANAESTH INTENS CARE, V29, P484, DOI 10.1177/0310057X0102900506; Akbulut KG, 1999, GERONTOLOGY, V45, P67, DOI 10.1159/000022065; Amenta F, 1995, CLIN EXP PHARM PHY S, V22, P331; Antunes F, 1999, FREE RADICAL BIO MED, V26, P117, DOI 10.1016/S0891-5849(98)00168-3; Becker DP, 1988, TXB HEAD INJURY, P23; Benloucif S, 1999, NEUROSCI LETT, V272, P67, DOI 10.1016/S0304-3940(99)00554-6; Chesnut RM, 1988, SURG SCI PRINCIPLES, P2991; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; Di Bella L, 2006, NEUROENDOCRINOL LETT, V27, P425; Dundar K, 2005, CLIN EXP PHARMACOL P, V32, P926, DOI 10.1111/j.1440-1681.2005.04286.x; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Gaab M R, 1990, Adv Neurol, V52, P391; Gorgulu AK, 2001, NEUROSURGERY, V49, P1434; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; HEFFEZ DS, 1990, NEUROSURGERY, V27, P789, DOI 10.1227/00006123-199011000-00018; Karbownik M, 2000, INT J CANCER, V88, P7, DOI 10.1002/1097-0215(20001001)88:1<7::AID-IJC2>3.0.CO;2-T; Kaynar MY, 1998, NEUROSURG REV, V21, P260, DOI 10.1007/BF01105782; Langham J, 2003, COCHRANE DB SYST REV; Levati A, 1998, J Neurosurg Sci, V42, P27; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Macdonald RL, 2006, NEUROSURG REV, V29, P179, DOI 10.1007/s10143-005-0013-5; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer TE, 2008, CARDIOVASC INTERVENT, V4, P30; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; PIERI C, 1994, LIFE SCI, V55, pPL271, DOI 10.1016/0024-3205(94)00666-0; Pillai SV, 2003, NEUROL INDIA, V51, P361; Sabbatini M, 2001, CLIN EXP HYPERTENS, V23, P143, DOI 10.1081/CEH-100001205; Sabbatini M, 2001, MECH AGEING DEV, V122, P795, DOI 10.1016/S0047-6374(01)00233-0; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; SCRIABINE A, 1988, ANN NY ACAD SCI, V522, P698; TAKAYASU M, 1988, J NEUROSURG, V69, P104, DOI 10.3171/jns.1988.69.1.0104; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; WADWORTH AN, 1992, DRUG AGING, V2, P262, DOI 10.2165/00002512-199202040-00002; Watson BD, 1998, CELL MOL NEUROBIOL, V18, P581, DOI 10.1023/A:1020209616428; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Weyer GW, 2006, NEUROSURG FOCUS, V15, P21; WHITFIELD PC, 1994, BRIT J HOSP MED, V52, P539; Yang Shu-yuan, 2003, Chin J Traumatol, V6, P326	38	4	7	0	6	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2012	22	6					740	746		10.5137/1019-5149.JTN.6197-12.1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	056XN	WOS:000312524800012	23208906	Green Published, Bronze			2022-02-06	
J	Jolly, T; McLean, HS				Jolly, Tonya; McLean, Heather S.			Use of Ketamine During Procedural Sedation Indications, Controversies, and Side Effects	JOURNAL OF INFUSION NURSING			English	Article						dissociative anesthesia; ketamine; NMDA antagonist; procedural sedation		Ketamine is a well-described anesthetic and analgesic, unique in its ability to preserve laryngeal reflexes and airway protection, and offered to a wide range of patients, although not necessarily widely used. Because it is considered an anesthetic, widespread use by all sedation providers is often limited despite its long history as a safe sedative. Because of its sympathomimetic effects, ketamine may be used in patients who are hypovolemic, including those who are experiencing traumatic or obstetric emergencies. The use of ketamine in patients with epilepsy or traumatic brain injury is more controversial. This article will explore the side effects of ketamine and current research that support or discourage its use in a variety of settings.	[Jolly, Tonya] Duke Univ, Med Ctr, Div Pediat Neurosurg, Durham, NC 27706 USA; [McLean, Heather S.] Duke Univ, Med Ctr, Durham, NC 27706 USA		Jolly, T (corresponding author), Duke Univ, Med Ctr, Div Pediat Neurosurg, Durham, NC 27706 USA.	tonyajolly@msn.com	McLean, Heather/L-6797-2019				Adler CM, 1999, AM J PSYCHIAT, V156, P1646, DOI 10.1176/ajp.156.10.1646; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BENNETT DR, 1973, NEUROLOGY, V23, P449, DOI 10.1212/WNL.23.5.449; Borris DJ, 2000, EPILEPSY RES, V42, P117, DOI 10.1016/S0920-1211(00)00175-3; CELESIA GG, 1975, NEUROLOGY, V25, P169, DOI 10.1212/WNL.25.2.169; CHURCH J, 1988, ANESTHESIOLOGY, V69, P702, DOI 10.1097/00000542-198811000-00011; Copeland J, 2005, INT J DRUG POLICY, V16, P122, DOI 10.1016/j.drugpo.2004.12.003; CORSSEN G, 1972, ANESTH ANAL CURR RES, V51, P588; CORSSEN G, 1974, ANESTH ANALG, V53, P319; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Erden IA, 2009, PEDIATR ANESTH, V19, P500, DOI 10.1111/j.1460-9592.2009.02971.x; FUJIKAWA DG, 1995, EPILEPSIA, V36, P186, DOI 10.1111/j.1528-1157.1995.tb00979.x; GALLOON S, 1976, ANESTHESIOLOGY, V44, P522, DOI 10.1097/00000542-197606000-00011; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; GREEN SM, 1990, ANN EMERG MED, V19, P1033, DOI 10.1016/S0196-0644(05)82569-7; HICKEY PR, 1985, ANESTHESIOLOGY, V62, P287, DOI 10.1097/00000542-198503000-00013; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kaube H, 2000, NEUROLOGY, V55, P139, DOI 10.1212/WNL.55.1.139; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Melendez E, 2009, PEDIATR EMERG CARE, V25, P325, DOI 10.1097/PEC.0b013e3181a341e0; MORRAY JP, 1984, ANESTH ANALG, V63, P895; Nikolajsen L, 1996, PAIN, V67, P69, DOI 10.1016/0304-3959(96)03080-1; Pasero C, 2005, AM J NURS, V105, P60, DOI 10.1097/00000446-200504000-00028; Quan D, 2003, NEUROLOGY, V60, P1391, DOI 10.1212/01.WNL.0000055848.00032.39; REICH DL, 1989, CAN J ANAESTH, V36, P186, DOI 10.1007/BF03011442; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; STRUBE PJ, 1986, ANAESTHESIA, V41, P1017, DOI 10.1111/j.1365-2044.1986.tb12744.x; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; TWEED WA, 1972, ANESTHESIOLOGY, V37, P613, DOI 10.1097/00000542-197212000-00008; Williams GD, 2007, ANESTH ANALG, V105, P1578, DOI 10.1213/01.ane.0000287656.29064.89; Yang CY, 1996, CAN J ANAESTH, V43, P379, DOI 10.1007/BF03011718; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	35	4	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1533-1458	1539-0667		J INFUS MURS	J. Infus.Nurs.	NOV-DEC	2012	35	6					377	382		10.1097/NAN.0b013e31827068c1			6	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V98BR	WOS:000213375400004	23132086				2022-02-06	
J	Madder, H				Madder, Hilary			Treatment interventions for severe traumatic brain injury: limited evidence, choice limitations	JOURNAL OF MEDICAL ETHICS			English	Article									John Radcliffe Hosp, Neurosci Intens Care Unit, Oxford OX3 9DU, England		Madder, H (corresponding author), John Radcliffe Hosp, Neurosci Intens Care Unit, Headley Way, Oxford OX3 9DU, England.	hilary.madder@ouh.nhs.uk					Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Wildman MJ, 2007, BRIT MED J, V335, P1132, DOI 10.1136/bmj.39371.524271.55	5	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	NOV	2012	38	11					662	663		10.1136/medethics-2012-100869			2	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	030PE	WOS:000310581800005	23019181				2022-02-06	
J	Allain, P; Fasotti, L; Roy, A; Chauvire, V; Etcharry-Bouyx, F; Le Gall, D				Allain, Philippe; Fasotti, Luciano; Roy, Arnaud; Chauvire, Valerie; Etcharry-Bouyx, Frederique; Le Gall, Didier			Script-event representation in patients with severe traumatic brain injury	CORTEX			English	Article						Traumatic brain injury; Action categorization; Action sequencing	FRONTAL-LOBE LESION; MENTAL REPRESENTATION; KNOWLEDGE; IMPAIRMENTS; BOUNDARIES; SEQUENCE; DEFICITS; DAMAGE	The aim of the present study was to examine the syntactic and semantic dimensions of script representation in patients with structural damage within the cerebral cortex following a severe traumatic brain injury (TBI). Forty TBI patients and 38 healthy control subjects (HC) were asked to sort cards describing actions belonging to eight scripts according to the script to which they belonged and according to their order of execution. Each script included actions which were low in centrality and distinctiveness (NCA & NDA), and high in centrality (CA), distinctiveness (DA), and CA and DA. Actions were presented in three conditions. In the scripts with headers (SH) condition, the actions were given with each script header written on a separate card. In the scripts without headers condition (SwH) no script header was provided. In the scripts with distractor header (SDH) condition, the actions were given with each script header and a distractor header written on separate cards. The results showed that performance of TBI patients was significantly lower in all conditions. Overall, TBI patients made significantly more sequencing and sorting errors (for all types of actions) than HC subjects. These data are consistent with the view that TBI produces impairment of both the syntactic and semantic dimensions of script representation. (C) 2011 Elsevier Srl. All rights reserved.	[Allain, Philippe] CHU Angers, Dept Neurol, Unite Neuropsychol, F-49033 Angers 09, France; [Allain, Philippe; Roy, Arnaud; Etcharry-Bouyx, Frederique; Le Gall, Didier] Univ Angers, Psychol Lab, EA 2646, Angers, France; [Fasotti, Luciano] Sint Maartensklin Res Dev & Educ, Nijmegen, Netherlands; [Fasotti, Luciano] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands		Allain, P (corresponding author), CHU Angers, Dept Neurol, Unite Neuropsychol, 4 Rue Larrey, F-49033 Angers 09, France.	PhAllain@chu-angers.fr		ALLAIN, Philiooe/0000-0003-0668-0986			Allain P, 1999, J CLIN EXP NEUROPSYC, V21, P643, DOI 10.1076/jcen.21.5.643.871; Allain P, 2001, J CLIN EXP NEUROPSYC, V23, P465, DOI 10.1076/jcen.23.4.465.1231; Allain P, 2008, CORTEX, V44, P294, DOI 10.1016/j.cortex.2006.07.003; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Corbett F, 2009, NEUROPSYCHOLOGIA, V47, P2721, DOI 10.1016/j.neuropsychologia.2009.05.020; CORSON Y, 1990, CAH PSYCHOL COGN, V10, P157; Cosentino S, 2006, NEUROPSYCHOLOGY, V20, P307, DOI 10.1037/0894-4105.20.3.307; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; Dimou A, 2011, J PANCREAS, V12, P1; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; GALAMBOS JA, 1983, BEHAV RES METH INSTR, V15, P327, DOI 10.3758/BF03203654; Godbout L, 2004, J CLIN EXP NEUROPSYC, V26, P857, DOI 10.1080/13803390490510671; Godbout L, 1995, NEUROPSYCHOLOGIA, V33, P1671, DOI 10.1016/0028-3932(95)00047-X; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 2002, HDB NEUROPSYCHOLOGY; Grafman J., 1989, INTEGRATING THEORY P, P93; Kahneman D., 1973, ATTENTION EFFORT; MAZAUX JM, 1981, BOSTON DIAGNOSTIC AP; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman D.A., 1986, CONSCIOUSNESS SELF R; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schank R, 1977, SCRIPTS PLANS GOALS; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8; Zanini S, 2002, NEUROCASE, V8, P88, DOI 10.1076/neur.8.1.88.16233; Zanini S, 2008, CORTEX, V44, P140, DOI 10.1016/j.cortex.2006.03.002	32	4	4	0	6	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452			CORTEX	Cortex	OCT	2012	48	9					1155	1164		10.1016/j.cortex.2011.05.016			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	996VC	WOS:000308121900005	21689812				2022-02-06	
J	Nyakale, NE; Clauss, RP; Nel, HW; Sathekge, MM				Nyakale, N. E.; Clauss, R. P.; Nel, H. W.; Sathekge, M. M.			Blood-brain barrier integrity in a zolpidem-responder patient	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							AROUSAL; STROKE; SPECT; STATE	A 27-year-old neurologically disabled but fully conscious male zolpidem-responder patient was investigated for blood-brain barrier (BBB) dysfunction 5 years after a traumatic brain injury. A baseline single-photon emission computed tomography (SPECT) technetium-99m-labelled hexamethylpropylene amine oxime ((99m)TcHMPAO) brain scan was performed and the patient was administered 10 mg zolpidem daily. The patient was rescanned 2 weeks later when (99m)TcHMPAO was injected 1 hour after zolpidem application. SPECT technetium-99m-labelled diethylene-triamine-pentacetic acid ((99m)TcDTPA) BBB scans were also performed before and after zolpidem treatment. There was decreased uptake of (99m)TcHMPAO in the left frontoparietal brain region, left temporal region and left thalamus on baseline scanning; this improved within 1 hour after zolpidem treatment at the follow-up scan. The (99m)TcDTPA scan remained within normal limits before and after zolpidem treatment. The patient's neurological disabilities, especially coordination, speech and gait, improved markedly. The Barthel index remained normal, but the Tinetti falls efficacy scale improved from 21/100 to 15/100. The results implied that the underlying cause for the patient's long-term neurological disability and brain suppression was not due to a long-term dysfunctional BBB.	[Clauss, R. P.] Royal Surrey Cty Hosp, Dept Nucl Med, Guildford, Surrey, England; [Nyakale, N. E.; Sathekge, M. M.] Univ Pretoria, Dept Nucl Med, Steve Biko Acad Hosp, ZA-0002 Pretoria, South Africa; [Nel, H. W.] Wellco Med Ctr, Pollack Pk, Springs, South Africa		Clauss, RP (corresponding author), Royal Surrey Cty Hosp, Dept Nucl Med, Guildford, Surrey, England.	claussrp@yahoo.com	Sathekge, Mike/AAJ-6466-2020	Sathekge, Mike/0000-0002-2806-0625			Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2000, S AFR MED J, V90, P68; Hall SD, 2010, CLIN NEUROPHYSIOL, V121, P549, DOI 10.1016/j.clinph.2009.11.084; Lorberboym M, 2003, J NUCL MED, V44, P1898; Nyakale NE, 2010, ARZNEIMITTELFORSCH, V60, P177, DOI 10.1055/s-0031-1296269	5	4	4	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	OCT	2012	102	10					790	791		10.7196/SAMJ.5993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029IM	WOS:000310488700014	23034205	gold, Green Submitted			2022-02-06	
J	Paiva, WS; De Andrade, AF; Amorim, RL; Figueiredo, EG; Teixeira, MJ				Paiva, Wellingson Silva; De Andrade, Almir Ferreira; Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen			Brainstem injury by penetrating head trauma with a knife	BRITISH JOURNAL OF NEUROSURGERY			English	Article						traumatic brain Injury; penetrating head trauma; brainstem		The authors describe a rare case about a traumatic lesion of brain and brain stem with a knife. In this case the patient had good clinical condition, diagnosed with TBI by infectious complications. We have highlighted the unusual diagnosis, proximity of vascular structures, the technique used in the treatment and the good outcome of the injury.	[Paiva, Wellingson Silva; De Andrade, Almir Ferreira; Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Div Neurosurg, BR-05403010 Sao Paulo, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, Div Neurol Surg, Eneas Aguiar 255,Off 4080, BR-05403010 Sao Paulo, Brazil.		Figueiredo, Eberval Gadelha/H-3488-2012; Figueiredo, Eberval G/E-2071-2016; Teixeira, Manoel J/E-3110-2012; Amorim, Robson/AAK-1368-2021; Paiva, Wellingson S/G-5517-2013	Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040			Bauer M, 2002, FORENSIC SCI INT, V129, P122, DOI 10.1016/S0379-0738(02)00271-2; Paiva WS, 2010, CLIN OPHTHALMOL, V4, P1103, DOI 10.2147/OPTH.S9638; Paiva WS, 2009, ANN ITAL CHIR, V80, P463; Prat S, 2006, AM J FOREN MED PATH, V29, P268	4	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2012	26	5					779	781		10.3109/02688697.2012.655809			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	002JE	WOS:000308527100030	22616797				2022-02-06	
J	Beische, D; Hautzinger, M; Becker, C; Pfeiffer, K				Beische, Denis; Hautzinger, Martin; Becker, Clemens; Pfeiffer, Klaus			Problem-Solving Counselling for Caregivers of Stroke Survivors An Analysis of the Addressed Topics	PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE			German	Article						problem-solving; card-sorting; caregiver; stroke survivor	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; POINT-OF-VIEW; FAMILY CAREGIVERS; EXPECTED QUALITY; INTERVENTION; PREDICTORS; DEPRESSION; DEMENTIA; SPOUSES	Problem-solving therapies for family caregivers have been described for different dyads and care recipients with various chronic conditions. Only little attention is directed to the specific topics worked on with informal caregivers. This study focuses on the intensive intervention period of 3 months of an individualized mainly telephone-based problem-solving training for informal carers of stroke survivors (TIPS-Study). We present data of 47 strained caregivers who cared for their spouses and partners (n = 42) or (grand-) parents (n = 5). Results show that effective changes in burden can be achieved with only few contacts concentrating on problems that can be controlled by problem-focused coping mechanisms. Problems that require emotion-focused coping were processed rarely. Future perspectives of the approach are discussed.	[Beische, Denis; Becker, Clemens; Pfeiffer, Klaus] Robert Bosch Krankenhaus, Klin Geriatr Rehabil, D-70376 Stuttgart, Germany; [Hautzinger, Martin] Univ Tubingen, Abt Klin Psychol & Entwicklungspsychol, D-72074 Tubingen, Germany		Pfeiffer, K (corresponding author), Robert Bosch Krankenhaus, Klin Geriatr Rehabil, Auerbachstr 110, D-70376 Stuttgart, Germany.	klaus.pfeiffer@rbk.de	Becker, Clemens/ABI-5405-2020				Bambara JK, 2009, INVEST OPHTH VIS SCI, V50, P1585, DOI 10.1167/iovs.08-2744; Berg A, 2005, STROKE, V36, P639, DOI 10.1161/01.STR.0000155690.04697.c0; Bevans M, 2010, CANCER NURS, V33, pE24, DOI 10.1097/NCC.0b013e3181be5e6d; Caress AL, 2009, INT J NURS STUD, V46, P1516, DOI 10.1016/j.ijnurstu.2009.03.008; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; Demiris G, 2010, J PALLIAT MED, V13, P1005, DOI 10.1089/jpm.2010.0022; Donath C, 2009, PSYCHIAT PRAX, V36, P175, DOI 10.1055/s-0028-1090044; Dreer LE, 2007, REHABIL PSYCHOL, V52, P351, DOI 10.1037/0090-5550.52.3.351; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; DZurilla TJ, 2006, PROBLEM SOLVING THER; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2000, COGNITIVE BEHAV INTE, P309; Forsberg-Warleby G, 2004, CLIN REHABIL, V18, P430, DOI 10.1191/0269215504cr740oa; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; GKV Spitzenverband, 2008, EMPF GKV SPITZ NACH; GKV-Spitzenverband, 2012, SCHRIFTENREIHE MODEL, V8; Grassel E, 2010, FORTSCHR NEUROL PSYC, V78, P536, DOI 10.1055/s-0029-1245249; Grant JS, 2004, REHABIL PSYCHOL, V49, P172, DOI 10.1037/0090-5550.49.2.172; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Grassel E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-219; Haley WE, 2009, STROKE, V40, P2129, DOI 10.1161/STROKEAHA.108.545269; Han B, 1999, STROKE, V30, P1478, DOI 10.1161/01.STR.30.7.1478; Hautzinger M., 2012, ALLGEMEINE DEPRESSIO, V2nd ed.; Janis, 1980, PRACTICAL GUIDE MAKI; Jungbauer J, 2003, NERVENARZT, V74, P1110, DOI 10.1007/s00115-003-1624-0; Kurylo MF, 2001, J COUNS DEV, V79, P275, DOI 10.1002/j.1556-6676.2001.tb01972.x; Lazarus R.S., 1999, STRESS EMOTION NEW S; Marquez-Gonzalez M, 2010, CASEBOOK CLIN GEROPS, P33; Nezu C. M., 2004, SOCIAL PROBLEM SOLVI, P223; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; TOSELAND RW, 1995, SOC SCI MED, V40, P517, DOI 10.1016/0277-9536(94)E0093-8; Visser-Meily A, 2005, PATIENT EDUC COUNS, V56, P257, DOI 10.1016/j.pec.2004.02.013; Vitaliano PP, 1997, ANN BEHAV MED, V19, P75, DOI 10.1007/BF02883322; Wilz G, 2006, ABSCHLUSSBERICHT ZUM	37	4	4	1	30	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0937-2032			PSYCHOTHER PSYCH MED	Psychother. Psychosom. Med. Psychol.	SEP	2012	62	9-10					375	382		10.1055/s-0032-1321881			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	018HM	WOS:000309650900007	23027391				2022-02-06	
J	Belousov, AB				Belousov, Andrei B.			The regulation and role of neuronal gap junctions during neuronal injury	CHANNELS			English	Article						gap junctions; connexin 36; metabotropic glutamate receptors; neuronal death; ischemia; traumatic brain injury; epilepsy; electrical synapses	TRAUMATIC BRAIN-INJURY; CELL-DEATH; EPILEPTIFORM ACTIVITY; GLOBAL-ISCHEMIA; NERVOUS-SYSTEM; RAT-BRAIN; IN-VIVO; GLUTAMATE; EXPRESSION; STROKE	In the mammalian CNS, excessive release of glutamate and overactivation of glutamate receptors are responsible for the secondary (delayed) neuronal death following neuronal injury, including ischemia, traumatic brain injury (TBI) and epilepsy. The coupling of neurons by gap junctions (electrical synapses) increases during neuronal injury. In a recent study with the use of in vivo and in vitro models of cortical ischemia in mice, we have demonstrated that the ischemic increase in neuronal gap junction coupling is regulated by glutamate via group II metabotropic glutamate receptors (mGluR). Specifically, we found that activation of group II mGluRs increases background levels of neuronal gap junction coupling and expression of connexin 36 (Cx36; neuronal gap junction protein), whereas inactivation of group II mGluRs prevents the ischemia-mediated increases in the coupling and Cx36 expression. Using the analysis of neuronal death, we also established that inactivation of group II mGluRs or genetic elimination of Cx36 both dramatically reduce ischemic neuronal death in vitro and in vivo. Similar results were obtained using in vitro models of TBI and epilepsy. Our study demonstrated that mechanisms for the injury-mediated increase in neuronal gap junction coupling are part of the mechanisms for glutamate-dependent neuronal death.	Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA		Belousov, AB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	abelousov@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS064256]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064256] Funding Source: NIH RePORTER	I thank the contributors to this study: Dr. Yongfu Wang, Ji-Hoon Song, Janna V. Denisova, Dr. Won-Mee Park, and Dr. Joseph D. Fontes. This research was supported by NIH (R01 NS064256).	Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Cusato K, 2006, CELL DEATH DIFFER, V13, P1707, DOI 10.1038/sj.cdd.4401876; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; Peixoto PM, 2009, BIOCHEM BIOPH RES CO, V390, P38, DOI 10.1016/j.bbrc.2009.09.054; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vaccari JCDR, 2007, J NEUROPHYSIOL, V98, P2878, DOI 10.1152/jn.00362.2007; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Wong M, 2001, DEV BRAIN RES, V128, P113, DOI 10.1016/S0165-3806(01)00149-3	26	4	6	0	4	LANDES BIOSCIENCE	AUSTIN	1806 RIO GRANDE ST, AUSTIN, TX 78702 USA	1933-6950			CHANNELS	Channels	SEP-OCT	2012	6	5					390	392		10.4161/chan.21685			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030JT	WOS:000310567700008	22976616	Green Published, gold			2022-02-06	
J	Comper, P; Hutchison, M; Richards, D; Mainwaring, L				Comper, Paul; Hutchison, Michael; Richards, Doug; Mainwaring, Lynda			A Model of Current Best Practice for Managing Concussion in University Athletes: The University of Toronto Approach	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						Neuropsychology; concussion; sport; athlete; mild traumatic brain injury		Along with the ever growing awareness among the scientific community and the general public that concussion is a serious health care issue at all levels of sport, with potentially devastating long term health effects, the number of concussion surveillance clinical monitoring programs has significantly increased internationally over the past 10-15 years. An effective concussion program (a "best practice" model) is clinically prudent and evidence-based, one that is an interdisciplinary model involving health professionals who manage, educate, and provide psychosocial support to athletes. The integration of neuropsychological assessment is a component of many present day programs, and therefore, the neuropsychologist is an integral member of the concussion management team. The University of Toronto Concussion Program, operational since 1999, integrates best practices and current evidence into a working model of concussion management for university athletes. The model uses an interdisciplinary approach to monitor and assess athletes with concussions, as well as to educate its athletes, coaches, and administrators. A research component is also integral to the program.	[Comper, Paul; Hutchison, Michael; Richards, Doug; Mainwaring, Lynda] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Comper, P (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.						Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker Robert J., 2000, Indian Journal of Pediatrics, V67, P317, DOI 10.1007/BF02820676; Barth JT, 1989, MILD HEAD INJURY, P257; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen CJ, 2001, HEALTH PSYCHOL, V20, P267, DOI 10.1037/0278-6133.20.4.267; Hutchison M., NORMATIVE DATA UNPUB; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Lane AM, 2001, J SPORT MED PHYS FIT, V41, P539; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2006, BRIT J SPORT MED, V40, P659, DOI 10.1136/bjsm.2006.029710; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	51	4	4	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	SEP	2012	6	3					231	246		10.1123/jcsp.6.3.231			16	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SM	WOS:000215041500003					2022-02-06	
J	Garcia-Coiradas, J; Rodriguez-Niedenfuhr, M; Lopiz, Y; Garcia-Fernandez, C; Sanudo, JR; Vazquez, T; Marco, F				Garcia-Coiradas, Javier; Rodriguez-Niedenfuehr, Marc; Lopiz, Yaiza; Garcia-Fernandez, Carlos; Sanudo, Jose R.; Vazquez, Teresa; Marco, Fernando			A new straight proximal humeral nail: a cadaveric study of its anatomical relationships	EUROPEAN JOURNAL OF ANATOMY			English	Article						Shoulder; Fractures; Fixation; Neurovascular injury		New humeral nailing systems appear constantly in the market, but few anatomical studies assessing the potential risks of neurovascular injury, exist. The aim of this study is to determine the potential risk of neurovascular injury during proximal and distal locking. An anatomical analysis was carried out in cadavers where a new straight proximal humeral nail had been inserted. The nail entry point was always located medially to the myotendinous junction of the supraspinatus muscle, therefore affecting only muscle fibres. The nail entry point was surrounded by articular cartilage of the humeral head. The axillary nerve and the posterior humeral circumflex artery were at safe distances (> 2cm) from all proximal and distal locking screws. The radial nerve and its accompanying artery, the profunda brachii artery, were at risk whenever medial cortex violation happened, as they were located within 1cm of the exit point of the most distal locking screw. The straight humeral nail analysed in the current study seems to be more secure in relation to the neurovascular injury potential when compared to previously reported ones. Only the incorrect selection of the length of the most distal locking screw may lead to injury of the radial nerve and/or profunda brachii artery; therefore, close monitorisation during the insertion of this distal locking screw is recommended.	[Garcia-Coiradas, Javier; Lopiz, Yaiza; Garcia-Fernandez, Carlos; Marco, Fernando] Univ Complutense Madrid, Hosp Clin San Carlos, Dept Orthoped, Shoulder & Elbow Unit, Madrid, Spain; [Rodriguez-Niedenfuehr, Marc; Sanudo, Jose R.; Vazquez, Teresa] Univ Complutense Madrid, Sch Med, Dept Human Anat & Embryol 1, Madrid, Spain		Vazquez, T (corresponding author), Univ Complutense, Fac Med, Dept Anatom & Embriol Humana 1, Madrid, Spain.	tvazquez@med.ucm.es		/0000-0002-0678-5086; VAZQUEZ, TERESA/0000-0003-3537-0901	UCM920547 group	This research was supported by funds obtained through postgraduate training courses by the UCM920547 group.	Akpinar F, 2003, TOHOKU J EXP MED, V199, P35, DOI 10.1620/tjem.199.35; Albritton MJ, 2003, J ORTHOP TRAUMA, V17, P411, DOI 10.1097/00005131-200307000-00004; Apaydin N, 2010, SURG RADIOL ANAT, V32, P193, DOI 10.1007/s00276-009-0594-8; Boardman N, 1999, CLIN ORTHOP RELAT R, P44; BROOKS CH, 1992, J BONE JOINT SURG BR, V74, P151, DOI 10.1302/0301-620X.74B1.1732247; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; Cetik O, 2006, J BONE JOINT SURG AM, V88A, P2395, DOI 10.2106/JBJS.E.01375; Chou PH, 2008, CLIN ORTHOP RELAT R, V466, P135, DOI 10.1007/s11999-007-0019-0; Duparc F, 1997, SURG RADIOL ANAT, V19, P127, DOI 10.1007/s00276-997-0127-2; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; Hettrich CM, 2010, J BONE JOINT SURG AM, V92A, P943, DOI 10.2106/JBJS.H.01144; Kamineni S, 2004, INJURY, V35, P1133, DOI 10.1016/j.injury.2003.08.008; Karataglis D, 2011, INJURY, V42, P330, DOI 10.1016/j.injury.2010.10.016; LIPPERT H, 1985, ARTERIAL VARIATIONS, P67; Nijs S, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-33; Nolan BM, 2011, J SHOULDER ELB SURG, V20, P1241, DOI 10.1016/j.jse.2010.12.010; Park JY, 2008, J ORTHOP TRAUMA, V22, P419, DOI 10.1097/BOT.0b013e318173f751; Prince EJ, 2004, J ORTHOP TRAUMA, V18, P585, DOI 10.1097/00005131-200410000-00001; RIEMER BL, 1992, ORTHOPEDICS, V15, P697; RIEMER BL, 1993, ORTHOPEDICS, V16, P1219; Uz A, 2007, J SHOULDER ELB SURG, V16, P240, DOI 10.1016/j.jse.2006.05.003	21	4	4	0	0	SOC ANATOMICA ESPANOLA	SALAMANCA	POLIGONO EL MONTALVO PARCELA 49, SALAMANCA, 37008, SPAIN	1136-4890	2340-311X		EUR J ANAT	Eur. J. Anat.	SEP	2012	16	3					184	189					6	Anatomy & Morphology	Emerging Sources Citation Index (ESCI)	Anatomy & Morphology	V02AP	WOS:000213643000004					2022-02-06	
J	Hoshizaki, TB; Walsh, E; Post, A; Rousseau, P; Kendall, M; Karton, C; Oeur, A; Foreman, S; Gilchrist, MD				Hoshizaki, Thomas B.; Walsh, Evan; Post, Andrew; Rousseau, Philippe; Kendall, Marshall; Karton, Clara; Oeur, Anna; Foreman, Scott; Gilchrist, Michael D.			The application of brain tissue deformation values in assessing the safety performance of ice hockey helmets	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Brain injury; ice hockey; concussion; finite element modelling; injury reconstruction; helmet testing	DIFFUSE AXONAL INJURY; ANGULAR ACCELERATION; HEAD; FOOTBALL	This research was undertaken to examine a new method for assessing the performance of ice hockey helmets. It has been proposed that the current centric impact standards for ice hockey helmets, measuring peak linear acceleration, have effectively eliminated traumatic head injuries in the sport, but that angular acceleration and brain tissue deformation metrics are more sensitive to the conditions associated with concussive injuries, which continue to be a common injury. Ice hockey helmets were impacted using both centric and non-centric impact protocols at 7.5 m/s using a linear impactor. Dynamic impact responses and brain tissue deformations from the helmeted centric and non-centric head form impacts were assessed with respect to proposed concussive injury thresholds from the literature. The results of the helmet impacts showed that the method used was sensitive enough to distinguish differences in performance between helmet models. The results have shown that peak linear acceleration yielded low magnitudes of response to an impact, but peak angular acceleration and brain deformation metrics consistently reported higher magnitudes, reflecting a high risk for incurring a mild traumatic brain injury.	[Hoshizaki, Thomas B.; Walsh, Evan; Post, Andrew; Rousseau, Philippe; Kendall, Marshall; Karton, Clara; Oeur, Anna; Foreman, Scott; Gilchrist, Michael D.] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON K1S 5S9, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Hoshizaki, TB (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave,A-106, Ottawa, ON K1S 5S9, Canada.	thoshiza@uottawa.ca	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Canadian Standard Association, 2009, Z262109200938 CANCSA, P38; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Holbourn AHS, 1943, LANCET, V2, P438; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hoshizaki TB, 2009, J ASTM INT, V6, P1; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Marino GW, 2002, INT RES SPORTS BIOME; Miller R., 1998, 19983154 SAE; Nahum AM, 1997, 19770922 SAE; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2010, PROCEDIA ENGINEER, V2, P3451, DOI 10.1016/j.proeng.2010.04.183; Post A, 2011, COMPUT METH BIOMECH; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; RUAN JS, 1993, 37 STAPP CAR CRASH C; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schreiber DI, 1997, 19973335 SAE; Trosseille X, 1992, 36 STAPP CAR CRASH C; Walsh ES, 2012, P I MECH ENG P-J SPO, V226, P220, DOI 10.1177/1754337112442299; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, 39 STAPP CAR CRASH C, P121	36	4	4	2	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		226	236		10.1177/1754337112448765			11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000010		Green Submitted			2022-02-06	
J	Vikram, M; Sundaraganesh, K; Justine, M; Kurup, M; Leonard, JH				Vikram, M.; Sundaraganesh, K.; Justine, M.; Kurup, M.; Leonard, J. H.			Evaluation of postural control impairment using Balance Error Scoring System among athletes with ankle injury: an effective tool in daily clinical practice	CLINICA TERAPEUTICA			English	Article						balance; injury; postural control; rehabilitation; therapy	INSTABILITY; STABILITY; CONCUSSION; PERFORMANCE; DEFICITS; PLAYERS; SPRAINS	Objective. The main objective of the study was to investigate postural control impairment in athletes with history of ankle injury by using Balance Error Scoring System (HESS) and to compare with the controls. Patients and Methods. This is a case-control study that compared postural control among subjects with history of ankle injury with the matched controls. A total of sixty subjects (n=60) were recruited from the department of physical education and sports science from a higher learning institute. Thirty athletes who had history of ankle injury were recruited for case group and the control group had an another thirty participants who were healthy athletes with no history of ankle injury. HESS was used to measure postural control by estimating the errors committed in standing between the two group of athletes. Independent sample t test was used to compare the means between two groups and the level of significance is set at level of 0.05. Results. The athletes with history of ankle injury scored more number of errors in BESS with high mean value of (15.10 +/- 6.52 errors) than the control group (5.63/3.81 errors which was significant at p=0.01 level. Conclusion. Postural control impairment was identified among athletes with history of ankle injury when compared with control group. Clin Ter 2012; 163(5):383-386	[Vikram, M.; Justine, M.; Leonard, J. H.] Univ Teknol Mara, Fac Hlth Sci, Dept Physiotherapy, Selangor, Malaysia; [Sundaraganesh, K.; Kurup, M.] Annamalai Univ, Raja Mutiah Med Coll Hosp, Div Phys Med & Rehabil, Chidambaram, India		Leonard, JH (corresponding author), Univ Kebangsaan Malaysia, Fac Allied Hlth Sci, Kuala Lumpur 50300, Malaysia.	leonardjoseph85@hotmail.com	Mohan, Vikram/AAI-9592-2021; Mohan, Vikram/E-2877-2019	Mohan, Vikram/0000-0002-9067-2817; Mohan, Vikram/0000-0002-9067-2817			Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; FRIDEN T, 1989, AM J SPORT MED, V17, P118, DOI 10.1177/036354658901700120; GARN SN, 1988, PHYS THER, V68, P1667, DOI 10.1093/ptj/68.11.1667; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Johnson BG, 2005, WILD ENVIRON MED, V16, P62, DOI 10.1580/PR02-04.1; Jonsson E, 2005, CLIN BIOMECH, V20, P202, DOI 10.1016/j.clinbiomech.2004.09.008; LEE AJY, 2006, J EXERC SCI FIT, V4, P117; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Olmsted LC, 2002, J ATHL TRAINING, V37, P501; Onate JA, 2007, J ATHL TRAINING, V42, P446; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Robbins S, 1998, SPORTS MED, V25, P63, DOI 10.2165/00007256-199825010-00005; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Sefton JM, 2009, CLIN BIOMECH, V24, P451, DOI 10.1016/j.clinbiomech.2009.03.003; TROPP H, 1986, INT J SPORTS MED, V7, P291, DOI 10.1055/s-2008-1025777; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wu G, 1997, EXP BRAIN RES, V114, P163, DOI 10.1007/PL00005616	24	4	5	0	10	SOC EDITRICE UNIV	ROME	VIA G B MORGAGNI 1, ROME, 10061, ITALY	0009-9074	1972-6007		CLIN TER	Clin. Ter.	SEP-OCT	2012	163	5					383	386					4	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	048AP	WOS:000311882900002	23099965				2022-02-06	
J	Kuo, CY; Liao, SC; Lin, KH; Wu, CL; Lee, MB; Guo, NW; Guo, YL				Kuo, Chun-Ya; Liao, Shih-Cheng; Lin, Kuan-Han; Wu, Chen-Long; Lee, Ming-Been; Guo, Nai-Wen; Guo, Yue Leon			Predictors for suicidal ideation after occupational injury	PSYCHIATRY RESEARCH			English	Article						Suicidal ideation; Occupational injury; Population attributable risk; Psychiatric diseases; Traumatic event	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; RISK-FACTORS; ATTRIBUTABLE RISK; MARITAL-STATUS; POPULATION; PREVALENCE; PREVENTION; STRATEGIES; EARTHQUAKE	Risk of suicide has been associated with trauma and negative life events in several studies. Our aim was to investigate the prevalence and risk factors of suicidal ideation, and the population attributable risk among workers after occupational injuries. We investigated workers who had been hospitalized for >= 3 days after occupational injuries between February 1 and August 31, 2009. A self-reported questionnaire including demographic data, injury condition, and the question of suicidal ideation was sent to 4498 workers at 3 months after their occupational injury. A total of 2001 workers (45.5%) completed the questionnaires and were included in final analysis. The prevalence of reporting suicidal ideation was 8.3%. After mutual adjustment, significant risk factors for suicidal ideation higher than "serious" in a self-rated severity scale (adjusted odds ratio, aOR = 2.31; adjusted population attributable risk, aPAR = 34.7%), total hospital stay for 8 days or longer (OR = 1.98; aPAR = 20.5%), intracranial injury (OR = 2.30; aPAR = 10.2%), and marriage status of being divorced/separated/widowed (OR = 2.70; aPAR = 10.0%). Three months after occupational injury, a significant proportion of workers suffered from suicidal ideation. Significant predictors of suicidal ideation after occupational injury included broken marriage, intracranial injury, injury severity, and total hospital stay. Identification of high risk subjects for early intervention is warranted. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Lin, Kuan-Han; Guo, Yue Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Taipei 10764, Taiwan; [Kuo, Chun-Ya; Liao, Shih-Cheng; Lee, Ming-Been] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Lin, Kuan-Han; Guo, Yue Leon] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Lin, Kuan-Han; Guo, Yue Leon] NTU Hosp, Taipei, Taiwan; [Wu, Chen-Long] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Wu, Chen-Long] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Guo, Nai-Wen] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan		Guo, YL (corresponding author), Natl Taiwan Univ, Dept Environm & Occupat Med, Rm 339,17 Xuzhou Rd, Taipei 10764, Taiwan.	leonguo@ntu.edu.tw	Guo, Yue-Liang Leon/ABF-2314-2020; Lin, Kuan-Han/AAF-7584-2020; LEE, MING-BEEN/AAT-9206-2020; LIAO, SHIH-CHENG/C-5665-2017	LEE, MING-BEEN/0000-0002-1556-5130; Lin, Kuan-Han/0000-0003-2047-6025; GUO, Yue Leon/0000-0002-8530-4809; LIAO, SHIH-CHENG/0000-0003-4129-0879	Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R.O.C. [IOSH98-M315]	Support for this study was provided by grants IOSH98-M315 from the Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R.O.C.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; Bullman TA, 1996, AM J PUBLIC HEALTH, V86, P662, DOI 10.2105/AJPH.86.5.662; Bureau of Labor Insurance, 2010, OCC INJ INC RAT LAB; Bureau of labor Insurance, 2010, REAL OCC BEN PAYM 19; Bureau of Labor Statistics, 2009, WORKPL INJ ILLN; Chan SSM, 2009, PSYCHIAT SERV, V60, P1135, DOI 10.1176/appi.ps.60.8.1135; Chang SS, 2010, PUBLIC HEALTH, V124, P49, DOI 10.1016/j.puhe.2009.11.005; Chou YJ, 2003, INT J EPIDEMIOL, V32, P1007, DOI 10.1093/ije/dyg296; Corcoran P, 2010, SOC PSYCH PSYCH EPID, V45, P795, DOI 10.1007/s00127-009-0120-7; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Department of Health, 2009, PROF TAIW REG 10 LEA; Esposito CL, 2002, J TRAUMA STRESS, V15, P137, DOI 10.1023/A:1014860024980; Gau SSF, 2009, COMPR PSYCHIAT, V50, P276, DOI 10.1016/j.comppsych.2008.08.009; Holma KM, 2010, AM J PSYCHIAT, V167, P801, DOI 10.1176/appi.ajp.2010.09050627; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254; Krysinska Karolina, 2009, J Trauma Nurs, V16, P103, DOI 10.1097/JTN.0b013e3181ac921f; Lee JI, 2010, J FORMOS MED ASSOC, V109, P138, DOI 10.1016/S0929-6646(10)60034-4; Lee M B, 1990, J Formos Med Assoc, V89, P1081; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lin JJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-6; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Page A, 2009, SUICIDE LIFE-THREAT, V39, P471, DOI 10.1521/suli.2009.39.5.471; Pan YJ, 2009, GEN HOSP PSYCHIAT, V31, P181, DOI 10.1016/j.genhosppsych.2008.12.010; Ryb GE, 2006, J TRAUMA, V61, P799, DOI 10.1097/01.ta.0000196763.14289.4e; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Szanto K, 2002, DRUG AGING, V19, P11, DOI 10.2165/00002512-200219010-00002; Thoresen S, 2006, ARCH SUICIDE RES, V10, P353, DOI 10.1080/13811110600791106; Vehid HE, 2006, TOHOKU J EXP MED, V208, P19, DOI 10.1620/tjem.208.19; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867; Wilhelm K, 2004, SOC PSYCH PSYCH EPID, V39, P866, DOI 10.1007/s00127-004-0869-7; World Health Organization, 2009, SUIC PREV SUPRE	41	4	5	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	AUG 15	2012	198	3					430	435		10.1016/j.psychres.2012.02.011			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	050HQ	WOS:000312044800015	22436350				2022-02-06	
J	Jacobs, B; van Ekert, J; Vernooy, LPL; Dieperink, P; Andriessen, TMJC; Hendriks, MPH; van Vugt, AB; Emons, MAA; Borm, GF; Vos, PE				Jacobs, Bram; van Ekert, Janneke; Vernooy, Lotje P. L.; Dieperink, Peter; Andriessen, Teuntje M. J. C.; Hendriks, Marc P. H.; van Vugt, Arie B.; Emons, Marjolein A. A.; Borm, George F.; Vos, Pieter E.			Development and external validation of a new PTA assessment scale	BMC NEUROLOGY			English	Article						Traumatic brain injury (TBI); Head injury; Post-traumatic amnesia (PTA); PTA assessment scale	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; GLASGOW COMA SCALE; POSTTRAUMATIC AMNESIA; COMPUTED-TOMOGRAPHY; MULTICENTER; RECOVERY; DURATION; MEMORY; RETURN	Background: Post-traumatic amnesia (PTA) is a key symptom of traumatic brain injury (TBI). Accurate assessment of PTA is imperative in guiding clinical decision making. Our aim was to develop and externally validate a short, examiner independent and practical PTA scale, by selecting the most discriminative items from existing scales and using a three-word memory test. Methods: Mild, moderate and severe TBI patients and control subjects were assessed in two separate cohorts, one for derivation and one for validation, using a questionnaire comprised of items from existing PTA scales. We tested which individual items best discriminated between TBI patients and controls, represented by sensitivity and specificity. We then created our PTA scale based on these results. This new scale was externally evaluated for its discriminative value using Receiver Operating Characteristic (ROC) analysis and compared to existing PTA scales. Results: The derivation cohort included 126 TBI patients and 31 control subjects; the validation cohort consisted of 132 patients and 30 controls. A set of seven items was eventually selected to comprise the new PTA scale: age, name of hospital, time, day of week, month, mode of transport and recall of three words. This scale demonstrated adequate discriminative values compared to existing PTA scales on three consecutive administrations in the validation cohort. Conclusion: We introduce a valid, practical and examiner independent PTA scale, which is suitable for mild TBI patients at the emergency department and yet still valuable for the follow-up of more severely injured TBI patients.	[Jacobs, Bram; van Ekert, Janneke; Vernooy, Lotje P. L.; Dieperink, Peter; Andriessen, Teuntje M. J. C.; Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Hendriks, Marc P. H.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Hendriks, Marc P. H.] Epilepsy Ctr Kempenhaeghe, Dept Behav Sci, Heeze, Netherlands; [van Vugt, Arie B.; Emons, Marjolein A. A.] Radboud Univ Nijmegen, Med Ctr, Dept Emergency Med, NL-6525 ED Nijmegen, Netherlands; [Borm, George F.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands		Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	P.Vos@neuro.umcn.nl	Hendriks, Marc P.H./D-9688-2012	Hendriks, Marc P.H./0000-0002-5321-7970; van Ekert, Janneke/0000-0002-3046-5867			Andriessen TMJC, 2009, BRAIN INJURY, V23, P345, DOI 10.1080/02699050902791414; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412	28	4	4	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	AUG 8	2012	12								69	10.1186/1471-2377-12-69			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	010FA	WOS:000309078900001	22873279	Green Published, gold			2022-02-06	
J	Huo, J; Liu, JC; Wang, JB; Zhang, YM; Wang, CL; Yang, YY; Sun, WJ; Xu, SN				Huo, Jian; Liu, Jiachuan; Wang, Jinbiao; Zhang, Yongming; Wang, Chunlin; Yang, Yanyan; Sun, Wenjiang; Xu, Shaonian			Early hyperbaric oxygen therapy inhibits aquaporin 4 and adrenocorticotropic hormone expression in the pituitary gland of rabbits with blast-induced craniocerebral injury	NEURAL REGENERATION RESEARCH			English	Article						hyperbaric oxygen; blast-induced injury; craniocerebral injury; aquaporin 4; pituitary gland; adrenocorticotropic hormone	TRAUMATIC BRAIN-INJURY; TRANSGENIC MICE; EDEMA; HEMORRHAGE; MODEL; RATS; HYPOPITUITARISM; ONSET	In the present study, rabbits were treated with hyperbaric oxygen for 1 hour after detonator-blast-induced craniocerebral injury. Immunohistochemistry showed significantly reduced aquaporin 4 expression and adrenocorticotropic hormone expression in the pituitary gland of rabbits with craniocerebral injury. Aquaporin 4 expression was positively correlated with adrenocorticotropic hormone expression. These findings indicate that early hyperbaric oxygen therapy may suppress adrenocorticotropic hormone secretion by inhibiting aquaporin 4 expression.	[Huo, Jian; Liu, Jiachuan; Wang, Jinbiao; Zhang, Yongming; Wang, Chunlin; Yang, Yanyan; Sun, Wenjiang; Xu, Shaonian] Chinese PLA, Dept Neurosurg, Hosp 105, Hefei 230032, Anhui, Peoples R China		Liu, JC (corresponding author), Chinese PLA, Dept Neurosurg, Hosp 105, Hefei 230032, Anhui, Peoples R China.	ljc571017@sina.com			Eleventh-Five Major Subjects of Nanjing Military Area Command [06Z19]; Military Medical Science and Technology Innovation Foundation [09Z009]	This study was supported by the Eleventh-Five Major Subjects of Nanjing Military Area Command, No. 06Z19; and the Military Medical Science and Technology Innovation Foundation in 2009, No. 09Z009.	Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Euser AG, 2008, EXP PHYSIOL, V93, P254, DOI 10.1113/expphysiol.2007.039966; Gong DS, 2000, ZHONGHUA CHUANGSHANG, V16, P32; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nielsen S, 1997, J NEUROSCI, V17, P171; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Peng XH, 2004, JIEPOU XUEBAO, V35, P132; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; SUN SQ, 1991, J ELECTRON MICROSC, V40, P29; Sun WJ, 2011, ZHONGGUO WEIQINXI WA, V16, P136; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Tomassoni D, 2010, BRAIN RES, V1325, P155, DOI 10.1016/j.brainres.2010.02.023; Tong H, 2007, PHYSIOL BEHAV, V91, P290, DOI 10.1016/j.physbeh.2007.03.008; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Venero JL, 1999, NEUROSCIENCE, V94, P239, DOI 10.1016/S0306-4522(99)00182-7; Wei SC, 2009, XUMU SHOUYI XUEBAO, V40, P191; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yan JH, 2005, JIEPOU XUE ZAZHI, V28, P264; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhang YM, 2010, ZHONGGUO WEIQINXI SH, V15, P74; Zhu ZA, 2004, ZHONGGUO LINCHUANG S, V9, P367	31	4	5	0	7	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG 5	2012	7	22					1729	1735		10.3969/j.issn.1673-5374.2012.22.008			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	002YV	WOS:000308575900008	25624795				2022-02-06	
J	Baranski, GM; Sifri, ZC; Cook, KM; Alzate, WD; Livingston, DH; Mohr, AM				Baranski, Gregg M.; Sifri, Ziad C.; Cook, Kristen M.; Alzate, Walter D.; Livingston, David H.; Mohr, Alicia M.			Is the sympathetic system involved in shock-induced gut and lung injury?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Propranolol; bone marrow; anemia; trauma	MULTIPLE ORGAN FAILURE; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; INTESTINAL DYSFUNCTION; ISCHEMIA-REPERFUSION; CYTOKINE RESPONSE; BETA-BLOCKADE; KAPPA-B; CATECHOLAMINES; CELLS	BACKGROUND: A-blockade (BB) has been shown to prevent bone marrow (BM) dysfunction after trauma and hemorrhagic shock (HS). The impact of the sympathetic system and the role of BB on shock-induced distant organ injury is not known. This study will determine if BB has systemic effects and can diminish gut and lung injury after trauma and HS. METHODS: Male Sprague-Dawley rats were subjected to lung contusion (LC) followed by 45 minute of HS. Animals (n = 6 per group) were then randomized to either receive propranolol (LCHS + BB) immediately after resuscitation or not (LCHS). Gut permeability was evaluated in by diffusion of M-r 4,000 of fluorescein dextran (FD4) from a segment of small bowel into peripheral blood. Villous injury and lung injury were graded histologically by a blinded reader. Plasma-mediated effects of BB were evaluated in vitro by an assessment of BM progenitor growth. RESULTS: Animals undergoing LCHS had significantly higher plasma levels of FD4 compared with control animals (mean [SEM], 2.8 [0.4] mu g/mL vs. 0.8 [0.2] mu g/mL). However, animals receiving BB had a significant reduction in plasma FD4 compared with the LCHS group. With the use of BB after LCHS, both ileal and lung injury scores were similar to control. In addition, BM progenitor growth was inhibited by the addition of LCHS plasma, and LCHS + BB plasma showed no inhibition of BM progenitor growth. CONCLUSION: Propranolol can protect against the detrimental effects of trauma and HS on gut permeability, villous, and lung injury. The effects of BB are likely systemic and appear to be mediated through plasma. BB likely blunts the exaggerated sympathetic response after shock and injury. Propranolol's reduction of both BM dysfunction and distant organ injury further demonstrates the importance of the sympathetic nervous system and its role in potentiating end organ dysfunction after severe trauma. (J Trauma Acute Care Surg. 2012; 73: 343-350. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Baranski, Gregg M.; Sifri, Ziad C.; Cook, Kristen M.; Alzate, Walter D.; Livingston, David H.; Mohr, Alicia M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma, Newark, NJ 07103 USA		Mohr, AM (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Univ Hosp, 185 S Orange Ave G-592, Newark, NJ 07103 USA.	mohr@umdnj.edu	Mohr, Alicia M/E-3016-2015	Mohr, Alicia/0000-0003-1732-1313	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NIH GM078304]; Clowes American College of Surgeons/American Association for the Surgery of Trauma Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM078304] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health grant K08 NIH GM078304 and the Clowes American College of Surgeons/American Association for the Surgery of Trauma Award.	Abraham E, 2001, J IMMUNOL, V166, P522, DOI 10.4049/jimmunol.166.1.522; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Anjaria DJ, 2001, CRIT CARE MED, V29, P1780, DOI 10.1097/00003246-200109000-00021; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arcaroli J, 2002, J LEUKOCYTE BIOL, V72, P571; Badami CD, 2007, J TRAUMA, V63, P596, DOI 10.1097/TA.0b013e318142d231; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Beiermeister KA, 2010, J TRAUMA, V69, P338, DOI 10.1097/TA.0b013e3181e5d35e; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Claridge JA, 2000, J SURG RES, V92, P206, DOI 10.1006/jsre.2000.5899; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Deitch E A, 2001, Curr Opin Crit Care, V7, P92, DOI 10.1097/00075198-200104000-00007; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; ELHASSAN IO, 2010, SURG INF, V11, P214; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Fonseca RB, 2005, J TRAUMA, V59, P884, DOI 10.1097/01.ta.0000187653.64300.f5; Fonseca Rodrigo B, 2004, Surg Infect (Larchmt), V5, P385, DOI 10.1089/sur.2004.5.385; Fu TL, 2005, WORLD J GASTROENTERO, V11, P1070, DOI 10.3748/wjg.v11.i7.1070; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kao RLC, 2010, J TRAUMA, V68, P1342, DOI 10.1097/TA.0b013e3181d27dbe; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; LeTulzo Y, 1997, J CLIN INVEST, V99, P1516, DOI 10.1172/JCI119314; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Martel Marie-Jocelyne, 2002, J Obstet Gynaecol Can, V24, P504; Mohr AM, 2011, J TRAUMA, V70, P1043, DOI 10.1097/TA.0b013e3182169326; Moomey CB, 1999, CRIT CARE MED, V27, P154, DOI 10.1097/00003246-199901000-00044; Penn A, 2010, J SURG RES, V163, pE85, DOI 10.1016/j.jss.2010.03.051; Song XM, 2010, BURNS, V36, P75, DOI 10.1016/j.burns.2009.02.002; Wu JC, 2001, ANN SURG, V234, P224, DOI 10.1097/00000658-200108000-00013; Yazdi CA, 2009, SHOCK, P295	37	4	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73	2					343	350		10.1097/TA.0b013e31825a785a			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	992VG	WOS:000307807400011	22846938	Green Accepted			2022-02-06	
J	Greenberg, J; Tesfazion, AA; Robinson, CS				Greenberg, Jeffrey; Tesfazion, Anderson A.; Robinson, Christopher S.			Screening, Diagnosis, and Treatment of Depression	MILITARY MEDICINE			English	Article							SEROTONIN REUPTAKE INHIBITORS; STRUCTURED CLINICAL INTERVIEW; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; MAJOR DEPRESSION; RISK-FACTORS; PSYCHOMETRIC PROPERTIES; STRESS-DISORDER; SUICIDE RISK; EFFICACY	The U.S. military and its civilian partners have identified that psychological health problems such as depression and traumatic brain injury represent a significant threat to the health and readiness of the military force. Depression is a growing problem in the military with rates increasing from 2007 to 2010 across all services. Depression can be correlated with negative outcomes such as risk of suicide, risk of harm to others, incarceration, family problems including divorce, and occupational and social problems such as unemployment and homelessness. The military seeks to mitigate and prevent these negative outcomes through screening, diagnosis, and treatment of disorders such as depression. To support that effort, we have reviewed a sample of the literature base to support best practices for the screening, assessment, and treatment of depression within the Military Health System.	[Greenberg, Jeffrey; Tesfazion, Anderson A.; Robinson, Christopher S.] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Silver Spring, MD 20910 USA		Greenberg, J (corresponding author), Def Ctr Excellence Psychol Hlth & Traumat Brain I, 1335 East West Highway, Silver Spring, MD 20910 USA.						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychological Association, ETH PRINC PSYCH COD; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; [Anonymous], 2009, VA DOD CLIN PRACTICE; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blair-West GW, 1999, J AFFECT DISORDERS, V55, P171, DOI 10.1016/S0165-0327(99)00004-X; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Borkovec TD, 2001, J CLIN PSYCHIAT, V62, P37; BRUCE ML, 1992, AM J PSYCHIAT, V149, P914; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Comtois KA, 2011, DEPRESS ANXIETY, V28, P963, DOI 10.1002/da.20895; CUNNINGHAM MR, 1988, MOTIV EMOTION, V12, P309, DOI 10.1007/BF00992357; Datto CJ, 2000, DEPRESS ANXIETY, V12, P130, DOI 10.1002/1520-6394(2000)12:3<130::AID-DA4>3.0.CO;2-C; de Maat SM, 2007, EUR PSYCHIAT, V22, P1, DOI 10.1016/j.eurpsy.2006.10.008; Dowrick C, 2000, PSYCHOL MED, V30, P413, DOI 10.1017/S0033291799001531; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Feighner JP, 1999, J CLIN PSYCHIAT, V60, P4; FENDRICH M, 1990, DEV PSYCHOL, V26, P40, DOI 10.1037/0012-1649.26.1.40; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Furr SR, 2001, PROF PSYCHOL-RES PR, V32, P97, DOI 10.1037/0735-7028.32.1.97; Gangwisch J. E., 2011, INT J CLIN REV, V1; Gariballa S, 2011, AGE AGEING, V40, P702, DOI 10.1093/ageing/afr086; Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015; Guze SB, 2005, BRIT J PSYCHIAT, V117, P437; Hartung CM, 1998, PSYCHOL BULL, V123, P260, DOI 10.1037/0033-2909.123.3.260; Harwitz D, 2000, EMERG MED CLIN N AM, V18, P263, DOI 10.1016/S0733-8627(05)70123-1; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hollon SD, 2005, J CLIN PSYCHIAT, V66, P455, DOI 10.4088/JCP.v66n0408; KASHANI JH, 1980, PSYCHIAT RES, V3, P185, DOI 10.1016/0165-1781(80)90035-9; Kazdin AE, 2008, AM PSYCHOL, V63, P146, DOI 10.1037/0003-066X.63.3.146; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MAIURO RD, 1988, J CONSULT CLIN PSYCH, V56, P17, DOI 10.1037/0022-006X.56.1.17; MALONE KM, 1995, J AFFECT DISORDERS, V34, P173, DOI 10.1016/0165-0327(95)00015-F; Markowitz John C, 2004, World Psychiatry, V3, P136; Melton GB, 2007, PSYCHOL EVALUATIONS, P47; MERIKANGAS KR, 1984, AM J PSYCHIAT, V141, P74; Morgenstern J, 2001, PSYCHOL ADDICT BEHAV, V15, P83, DOI 10.1037/0893-164X.15.2.83; Nemeroff CB, 2005, J CLIN PSYCHIAT, V66, P13; Nemeroff CB, 2007, GUIDE TREATMENTS WOR; Nezu A.M., 2007, HDB PSYCHOTHERAPY CA; Nezu AM, 2004, COGNITIVE BEHAV CASE, P33; Pagnin D, 2004, J ECT, V20, P13, DOI 10.1097/00124509-200403000-00004; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; RISKIND JH, 1987, ARCH GEN PSYCHIAT, V44, P817; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8; Rupke SJ, 2006, AM FAM PHYSICIAN, V73, P83; Shen YC, 2012, AM J PUBLIC HEALTH, V102, pS80, DOI 10.2105/AJPH.2011.300425; Simon RI, 1999, J AM ACAD PSYCHIATRY, V27, P445; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trauer T, 1996, MENTAL HLTH OUTCOME; Ventura J, 1998, PSYCHIAT RES, V79, P163, DOI 10.1016/S0165-1781(98)00038-9; Weilburg Jeffrey B, 2004, Manag Care, V13, P25; Yang S, 2009, WILEY ENCY FORENSIC, P1737; Young JE, 2008, PSYCHOL DISORDERS ST; Zettle RD, 2011, BEHAV MODIF, V35, P265, DOI 10.1177/0145445511398344	63	4	4	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		60	66		10.7205/MILMED-D-12-00102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OB	WOS:000209027000009	22953442	Bronze			2022-02-06	
J	Kim, JH; Cho, YE; Seo, M; Baek, MC; Suk, K				Kim, Jong-Heon; Cho, Young-Eun; Seo, Minchul; Baek, Moon-Chang; Suk, Kyoungho			Glial proteome changes in response to moderate hypothermia	PROTEOMICS			English	Article						Biomedicine; Glia; Hypothermia; Inflammation; IPA	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INFLAMMATORY RESPONSE; REACTIVE ASTROCYTES; EXPERIMENTAL STROKE; ISCHEMIC-STROKE; EXPRESSION; ACTIVATION	Reactive glia plays a central role in neuroinflammation associated with secondary damage after brain injury. In order to understand the global effects of therapeutic hypothermia on glial activation and neuroinflammation, we performed proteomic profiling of glial cultures following inflammatory stimulation and hypothermic exposure. Primary mixed glial cultures prepared from mouse brains were stimulated with lipopolysaccharide and interferon-? under normothermic (37 degrees C) or moderate hypothermic (29 degrees C) conditions, and their proteome profiles were compared by LC-ESI-MS/MS. Differentially expressed proteins were determined by high-throughput label-free quantification. Under hypothermic conditions, 64 and 16 proteins were upregulated (=1.5-fold) and downregulated (= 0.7-fold), respectively, compared to normothermic conditions. More importantly, hypothermia altered the abundance of 143 proteins that were either increased or decreased by inflammatory stimulation. The results were validated for several proteins (ICAM-1, STAT-1, YWHAB, and IFIT-3) by Western blot analysis. Pathway and network analysis indicate that hypothermia influences various biological functions of glia such as molecular transport, cell movement, immune response, cell death, and stress response. In conclusion, moderate hypothermia seems to have a significant effect on the protein expression profiles of brain glia and possibly ensuing neuroinflammation. These proteins may be involved in the protective mechanism of hypothermia against brain injuries.	[Kim, Jong-Heon; Seo, Minchul; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst, Taegu 700422, South Korea; [Cho, Young-Eun; Baek, Moon-Chang] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Cell & Matrix Biol Res Inst, Taegu 700422, South Korea		Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr			Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A100870]; National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST) of Korean governmentMinistry of Education, Science and Technology, Republic of Korea [2011-0028240]	This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100870), and by the National Research Foundation (NRF) grants funded by the Ministry of Education, Science and Technology (MEST) of Korean government (2011-0028240).	Alva N, 2010, RESUSCITATION, V81, P609, DOI 10.1016/j.resuscitation.2010.01.023; Bemeur C, 2010, METAB BRAIN DIS, V25, P23, DOI 10.1007/s11011-010-9186-x; Cao CY, 1998, MOL BRAIN RES, V56, P45, DOI 10.1016/S0169-328X(98)00025-4; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Ceulemans AG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-60; Chen J, 2007, J NEUROSCI RES, V85, P1724, DOI 10.1002/jnr.21304; Choi JS, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/846716; Czlonkowska A, 2011, J NEUROIMMUNOL, V231, P78, DOI 10.1016/j.jneuroim.2010.09.020; Diestel A, 2010, EUR J NEUROSCI, V31, P779, DOI 10.1111/j.1460-9568.2010.07128.x; Dietrich WD, 2012, CRIT CARE MED, V40, P691, DOI 10.1097/CCM.0b013e318236eacb; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Groysman LI, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.4.FOCUS1154; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Han CL, 2008, MOL CELL PROTEOMICS, V7, P1983, DOI 10.1074/mcp.M800068-MCP200; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Jordan J, 2008, CURR PHARM DESIGN, V14, P3549, DOI 10.2174/138161208786848766; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim JH, 2011, RECENT PATENTS INFLA, V5, P155, DOI 10.2174/187221311795399219; Klassman L, 2011, J NEUROSCI NURS, V43, P94, DOI 10.1097/JNN.0b013e31820b5fcd; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Kurz A, 2012, J NEURAL TRANSM, V119, P297, DOI 10.1007/s00702-011-0717-3; LEE CGL, 1994, J IMMUNOL, V152, P5758; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lou YJ, 2011, EXP CELL RES, V317, P513, DOI 10.1016/j.yexcr.2010.10.025; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ramirez G, 2005, NEUROBIOL DIS, V19, P243, DOI 10.1016/j.nbd.2005.01.007; Ryu HH, 2007, J NEURO-ONCOL, V82, P125, DOI 10.1007/s11060-006-9262-6; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Shintani Y., 2010, STROKE RES TREAT, V2011; Silasi G, 2011, J CEREBR BLOOD F MET, V31, P1725, DOI 10.1038/jcbfm.2011.25; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Xiong M, 2011, NEUROCHEM INT, V58, P625, DOI 10.1016/j.neuint.2011.01.026; Yenari MA, 2002, J CEREBR BLOOD F MET, V22, P29, DOI 10.1097/00004647-200201000-00004; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014	52	4	5	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	AUG	2012	12	15-16			SI		2571	2583		10.1002/pmic.201200024			13	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996NZ	WOS:000308098200018	22778045				2022-02-06	
J	Liang, WB; Chikritzhs, T				Liang, Wenbin; Chikritzhs, Tanya			Obstetric conditions and risk of first ever mental health contact during infancy, childhood and adolescence	MIDWIFERY			English	Article						Obstetric complications; Mental disorder; Children; Adolescence	ASSISTED VAGINAL DELIVERY; TRAUMATIC BRAIN-INJURY; LOW-BIRTH-WEIGHT; INTRACRANIAL HEMORRHAGE; TERM INFANTS; HEAD-INJURY; FOLLOW-UP; DEPRESSION; SCHIZOPHRENIA; SYMPTOMS	Objective: the main aim of this study was to investigate whether risk of first ever occasion of outpatient or inpatient service for a mental disorder among male children and adolescents may be associated with obstetric conditions. Design, setting and participants: this study was a population-based birth-cohort study of males born between 1980 and 1984 in Western Australia (WA). Males were identified using birth registry records and followed-up over a 19 year period using linked health data available through the Western Australian Data Linkage System. Measurements: multivariate logistic regression was employed to estimate the risk of first ever mental health contact at different stages of mental development in childhood and adolescence. Main findings: vacuum and forceps assisted delivery and emergency caesarean were associated with an increased risk of first ever mental health contact. The risk of first ever mental health contact was similar for spontaneous vaginal delivery and elective caesarean. Although outcomes varied by age group, children with stillborn siblings were at increased risk of first ever mental health contact as were babies with 7-9 Apgar score at 5 mins and those born to mothers with several previous live births. Conclusions and implications: vacuum and forceps assisted delivery and/or the pathophysiological causes that lead to these clinical procedures, as well as other obstetric conditions, which may be associated with (asymptomatic) brain injury at birth, which may increase the risk of mental disorders. (C) 2011 Elsevier Ltd. All rights reserved.	[Liang, Wenbin; Chikritzhs, Tanya] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA 6845, Australia		Liang, WB (corresponding author), Curtin Univ Technol, Natl Drug Res Inst, GPO Box U1987, Perth, WA 6845, Australia.	w.liang@curtin.edu.au	liang, wenbin/M-2454-2013	Chikritzhs, Tanya/0000-0001-8871-3205			Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Black SE, 2005, Q J ECON, V120, P669, DOI 10.1162/0033553053970179; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brouwer AJ, 2010, NEURORADIOLOGY, V52, P567, DOI 10.1007/s00234-010-0698-1; Byrne M, 2007, SCHIZOPHR RES, V97, P51, DOI 10.1016/j.schres.2007.07.018; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Contag SA, 2010, AM J PERINAT, V27, P493, DOI 10.1055/s-0030-1247605; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; Cournos F, 2005, J CLIN PSYCHIAT, V66, P27; Dalman C, 1999, ARCH GEN PSYCHIAT, V56, P234, DOI 10.1001/archpsyc.56.3.234; Gardella C, 2001, AM J OBSTET GYNECOL, V185, P896, DOI 10.1067/mob.2001.117309; Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P1569, DOI 10.1097/00004583-199912000-00019; Jhawar BS, 2003, NEUROSURGERY, V52, P581, DOI 10.1227/01.NEU.0000047819.33177.72; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; Johanson RB, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD000224, DOI 10.1002/14651858.CD000224]; Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; MacDorman MF, 2006, BIRTH-ISS PERINAT C, V33, P175, DOI 10.1111/j.1523-536X.2006.00102.x; McLennan W., 1998, 1996 CENSUS POPULATI; McQuistion HL, 1997, PSYCHIATR SERV, V48, P833; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; O'Leary CM, 2007, BJOG-INT J OBSTET GY, V114, P855, DOI 10.1111/j.1471-0528.2007.01307.x; Okunwobi-Smith Y, 2000, BRIT J OBSTET GYNAEC, V107, P467, DOI 10.1111/j.1471-0528.2000.tb13263.x; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Rosenberg K, 2002, BJOG-INT J OBSTET GY, V109, P1199, DOI 10.1016/S1470-0328(02)00410-X; Ross M G, 2000, J Matern Fetal Med, V9, P321; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Simms R., 2011, OBSTET GYNAECOLOGY R, V21, P7; Strik JJMH, 2003, J AM COLL CARDIOL, V42, P1801, DOI 10.1016/j.jacc.2003.07.007; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21	37	4	4	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-6138	1532-3099		MIDWIFERY	Midwifery	AUG	2012	28	4					439	444		10.1016/j.midw.2011.06.003			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	977LN	WOS:000306662700011	21820779				2022-02-06	
J	Sloan, EP; Koenigsberg, M; Clark, JM; Desai, A				Sloan, Edward P.; Koenigsberg, Max; Clark, James M.; Desai, Amol			The Use of the Revised Trauma Score as an Entry Criterion in Traumatic Hemorrhagic Shock Studies: Data from the DCLHb Clinical Trials	PREHOSPITAL AND DISASTER MEDICINE			English	Article						clinical trial; diaspirin cross-linked hemoglobin (DCLHb); entry criteria; exclusion criteria; Glasgow Coma Scale (GCS); mid-range mortality; Revised Trauma Score (RTS); traumatic hemorrhagic shock resuscitation		Introduction: The Revised Trauma Score (RTS) has been proposed as an entry criterion to identify patients with mid-range survival probability for traumatic hemorrhagic shock studies. Hypothesis/Problem: Determination of which of four RTS strata (1-3.99, 2-4.99, 1-4.99, and 2-5.99) identifies patients with predicted and actual mortality rates near 50% for use as an entry criterion in traumatic hemorrhagic shock clinical trials. Methods: Existing database analysis in which demographic and injury severity data from two prior international Diaspirin Cross-Linked Hemoglobin (DCLHb) clinical trials were used to identify an RTS range that could be an optimal entry criterion in order to find the population of trauma patients with mid-range predicted and actual mortality rates. Results: Of 208 study patients, the mean age was 37 years, 65% sustained blunt trauma, 49% received DCLHb, and 57% came from the European Union study arm. The mean values were: ISS, 31 (SD = 18); RTS, 5.6 (SD = 1.8); and Glasgow Coma Scale (GCS), 10.4 (SD = 4.8). The mean TRISS-predicted mortality was 34% and the actual 28-day mortality was 35%. The initially proposed 1-3.99 RTS range (n = 41) had the highest predicted (79%) and actual (71%) mortality rates. The 2-5.99 RTS range (n = 79) had a 62% predicted and 53% actual mortality, and included 76% blunt trauma patients. Removal of GCS <5 patients from this RTS 2-5.99 subgroup caused a 48% further reduction in eligible patients, leaving 41 patients (20% of 208 total patients), 66% of whom sustained a blunt trauma injury. This subgroup had 54% predicted and 49% actual mortality rates. Receiver operator curve (ROC) analysis found the GCS to be as predictive of mortality as the RTS, both in the total patient population and in the RTS 2-5.99 subgroup. Conclusion: The use of an RTS 2-5.99 inclusion criterion range identifies a traumatic hemorrhagic shock patient subgroup with predicted and actual mortality that approach the desired 50% rate. The exclusion of GCS <5 from this RTS 2-5.99 subgroup patients yields a smaller, more uniform patient subgroup whose mortality is more likely related to hemorrhagic shock than traumatic brain injury. Future studies should examine whether the RTS or other physiologic criteria such as the GCS score are most useful as traumatic hemorrhagic shock study entry criteria.	[Sloan, Edward P.] Univ Illinois, Dept Emergency Med, Chicago, IL 60612 USA; [Koenigsberg, Max] Advocate Illinois Masonic Med Ctr, Chicago, IL USA; [Clark, James M.] Rush Univ, Rush Med Coll, Med Ctr, Chicago, IL 60612 USA; [Desai, Amol] Univ Arizona, Dept Emergency Med, Tucson, AZ USA		Sloan, EP (corresponding author), Univ Illinois, Coll Med, Dept Emergency Med, Mail Code 724,Room 471H CME 808 South Wood St, Chicago, IL 60612 USA.	edsloan@uic.edu			Henry M. Jackson Foundation	This research was supported by a contract with the Henry M. Jackson Foundation.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Ahmad Hafiz Naweed, 2004, J Coll Physicians Surg Pak, V14, P286; Alayash AI, 2007, EXPERT OPIN BIOL TH, V7, P665, DOI 10.1517/14712598.7.5.665; Atroshi I, 1998, J HAND SURG-AM, V23A, P759, DOI 10.1016/S0363-5023(98)80071-3; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BUYSE ME, 1990, ACTA CHIR BELG, P129; Carmichael FJL, 2000, CRIT CARE MED, V28, P2283, DOI 10.1097/00003246-200007000-00017; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Dellinger RP, 2008, J CRIT CARE, V23, P493, DOI 10.1016/j.jcrc.2007.12.022; Duranteau Jacques, 2006, Rev Prat, V56, P849; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Freilich D, 2006, REV PROPOSED CLIN TR; Freilich D, 2009, J TRAUMA, V66, P365, DOI 10.1097/TA.0b013e3181820d5c; Gabbe BJ, 2003, ANZ J SURG, V73, P944, DOI 10.1046/j.1445-1433.2003.02833.x; George SL, 2008, CLIN CANCER RES, V14, P5954, DOI 10.1158/1078-0432.CCR-07-4537; Giannakopoulos GF, 2011, EUR J EMERG MED, V18, P197, DOI 10.1097/MEJ.0b013e328344912e; Guzzo JL, 2005, J AM COLL SURGEONS, V201, P891, DOI 10.1016/j.jamcollsurg.2005.07.013; Jahr JS, 2008, J TRAUMA, V64, P1484, DOI 10.1097/TA.0b013e318173a93f; Jahr JS, 2007, CURR OPIN ANESTHESIO, V20, P325, DOI 10.1097/ACO.0b013e328172225a; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kerner T, 2003, INTENS CARE MED, V29, P378, DOI 10.1007/s00134-002-1622-x; KRAUSZ MM, 1995, SHOCK, V3, P69, DOI 10.1097/00024382-199501000-00012; Lichtveld RA, 2008, INT J EMERG MED, V1, P21, DOI 10.1007/s12245-008-0013-7; Marinaro J, 2009, TRANSFUSION, V49, P2054, DOI 10.1111/j.1537-2995.2009.02235.x; McMahon AD, 2002, STAT MED, V21, P1365, DOI 10.1002/sim.1120; Mongan PD, 2009, J TRAUMA, V67, P51, DOI 10.1097/TA.0b013e3181838030; Moore EE, 2005, SHOCK, V24, P197, DOI 10.1097/01.shk.0000180075.76766.fe; Moore EE, 2009, CRIT CARE CLIN, V25, P325, DOI 10.1016/j.ccc.2009.01.002; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Moore L, 2009, ANN SURG, V249, P1040, DOI 10.1097/SLA.0b013e3181a6cd97; Peelen L, 2007, INT J MED INFORM, V76, P176, DOI 10.1016/j.ijmedinf.2006.05.036; Rehn M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-1; Riou B, 2001, ANESTHESIOLOGY, V95, P56, DOI 10.1097/00000542-200107000-00014; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Winslow RM, 2008, BBA-PROTEINS PROTEOM, V1784, P1382, DOI 10.1016/j.bbapap.2008.04.032	42	4	4	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	AUG	2012	27	4					330	344		10.1017/S1049023X12000970			15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VG1AF	WOS:000445127900006	22840198	Green Submitted			2022-02-06	
J	Zhu, L; Tang, Y; Wang, HD; Zhang, ZY; Pan, H				Zhu, Lin; Tang, Yong; Wang, Han-dong; Zhang, Zhi-yuan; Pan, Hao			Immersion autometallographic demonstration of pathological zinc accumulation in human acute neural diseases	NEUROLOGICAL SCIENCES			English	Article						Zinc; Autometallography (AMG); Histochemistry; Ischemia; Epilepsy; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; SILVER ENHANCEMENT; AXONAL DAMAGE; ION CHANNELS; HEAD-INJURY; METAL-IONS; ACID; SECTIONS; BIOPSIES	Zinc is the second most prevalent trace element in the body and is present in particularly large concentrations in the mammalian brain. In animal experiments, several lines of studies show that zinc is involved in the pathological process of ischemia, epilepsy, and mechanical head trauma. However, little is known about the change of zinc in the human neural diseases. In the present study, using immersion autometallography, we found that pathological zinc accumulation was extensively present in the human neurons following ischemia, epilepsy, and mechanical head trauma. Under H&E, apparently damaged neurons were observed in all of the brain regions that showed zinc ions labeled neuronal somata. In conclusion, the data provide the evidence of an active involvement of zinc in neuronal damage.	[Zhu, Lin; Tang, Yong; Wang, Han-dong; Zhang, Zhi-yuan; Pan, Hao] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	wanghandong61@126.com			Jinling Hospital of Nanjing [2008033]; Postdoctoral Foundation of Jiangsu Province [1002049C]	The authors gratefully acknowledge Professor Zhang-You Wang (Department of Cell Engineering, China Medical University, Shenyang) for providing us with silver lactate. This work was financially supported by grants of the Jinling Hospital of Nanjing (Grant No 2008033), the Postdoctoral Foundation of Jiangsu Province (Grant No 1002049C).	BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bomboi G, 2010, NEUROL SCI, V31, P1, DOI 10.1007/s10072-009-0151-6; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Danscher G, 1997, J HISTOCHEM CYTOCHEM, V45, P1503, DOI 10.1177/002215549704501107; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; DYCK RF, 1980, LANCET, V2, P607; Elleder M, 2001, HISTOCHEM J, V33, P273, DOI 10.1023/A:1017925023408; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Franco-Pons N, 2000, NEUROSCIENCE, V98, P429, DOI 10.1016/S0306-4522(00)00153-6; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; HARRISON NL, 1994, NEUROPHARMACOLOGY, V33, P935, DOI 10.1016/0028-3908(94)90152-X; HOWELL GA, 1990, BRAIN RES, V515, P277, DOI 10.1016/0006-8993(90)90607-D; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; JAARSMA D, 1990, J NEUROSCI METH, V35, P125, DOI 10.1016/0165-0270(90)90102-L; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Stoltenberg M, 2005, HISTOCHEM CELL BIOL, V123, P605, DOI 10.1007/s00418-005-0787-0; Stoltenberg M, 2000, HISTOCHEM J, V32, P645, DOI 10.1023/A:1004115130843; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Surendran S, 2010, NEUROL SCI, V31, P531, DOI 10.1007/s10072-010-0245-1; Theaudin M, 2010, STROKE, V41, P727, DOI 10.1161/STROKEAHA.109.572909; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	31	4	6	1	14	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2012	33	4					855	861		10.1007/s10072-011-0847-2			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	975ZT	WOS:000306551000018	22076483				2022-02-06	
J	Al-Qattan, MM				Al-Qattan, Mohammad M.			Saw Injuries Causing Phalangeal Neck Fractures in Adults	ANNALS OF PLASTIC SURGERY			English	Article						phalangeal neck fracture; adult; phalanx	CHILDREN; HAND	The outcome of adult phalangeal neck fractures caused by saws has not been previously investigated. Over a 15-year period, a total of 36 cases of saw-related injuries resulting in phalangeal neck fractures of the middle phalanx of the finger or the proximal phalanx of the thumb were treated. All injuries were industrial and covered by insurance. They were all adult males with type II fractures. The fracture were managed by K-wire fixation, immobilizing the distal joint only. The proximal joints were mobilized immediately after surgery and the K-wire was removed after 5 weeks. The following 2 patterns of saw injuries were observed: dorsal impact injuries resulting in a phalangeal neck fracture and concurrent extensor tendon injury (group I, n = 20 patients), and dorsolateral impact injuries resulting in concurrent extensor (+/- partial flexor) tendon and nerve injury (group II, n = 16 patients). The outcome with respect to range of motion and return to work was significantly better in the former group. Major complications such as nonunion, malunion, avascular necrosis of the phalangeal head, osteomyelitis, or contractures of the proximal interphalangeal joints were not observed. Two patients (1 in each group) had superficial pin-site infection. It was concluded that adult phalangeal neck fractures caused by saws is a separate entity from the previously reported series of closed phalangeal neck fractures in adults.	King Saud Univ, Dept Surg, Riyadh 11415, Saudi Arabia		Al-Qattan, MM (corresponding author), King Saud Univ, Dept Surg, POB 18097, Riyadh 11415, Saudi Arabia.	moqattan@hotmail.com			College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia	Conflicts of interest and sources of funding: Supported by the College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia.	Al-Qattan MM, 2006, J HAND SURG-BRIT EUR, V31B, P484, DOI 10.1016/j.jhsb.2006.06.005; Al-Qattan MM, 2010, INJURY, V41, P1084, DOI 10.1016/j.injury.2010.06.017; Al-Qattan MM, 2010, J HAND SURG-AM, V35A, P1269, DOI 10.1016/j.jhsa.2010.03.038; Al-Qattan MM, 2001, J HAND SURG-BRIT EUR, V26, P112, DOI 10.1054/jhsb.2000.0506; BARTON NJ, 1979, HAND, V11, P134, DOI 10.1016/S0072-968X(79)80025-X; CAMPBELL RM, 1990, ORTHOP CLIN N AM, V21, P217; DIXON GL, 1972, CLIN ORTHOP RELAT R, P151; NEWINGTON DP, 1995, J HAND SURG-BRIT EUR, V20B, P353, DOI 10.1016/S0266-7681(05)80093-2	8	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043			ANN PLAS SURG	Ann. Plast. Surg.	JUL	2012	69	1					38	40		10.1097/SAP.0b013e31821ee453			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	961RJ	WOS:000305485200010	21629050				2022-02-06	
J	Jimenez-Cortes, MP; Pelegrin-Valero, C; Tirapu-Ustarroz, J; Guallart-Balet, M; Benabarre-Ciria, S; Olivera-Pueyo, J				Jimenez-Cortes, Marta P.; Pelegrin-Valero, Carmelo; Tirapu-Ustarroz, Javier; Guallart-Balet, Maria; Benabarre-Ciria, Sergio; Olivera-Pueyo, Javier			Empathy disorders in traumatic brain damage	REVISTA DE NEUROLOGIA			Spanish	Article						Brain damage; Empathy; Eslinger's social executors model; Premorbid intellectual ability; Previous personality; Right fronto-temporal cortex	EMOTION RECOGNITION; SOCIAL-BEHAVIOR; INJURY; DEFICITS; SURVIVORS; MODERATE; ABILITY	Introduction. Social cognition is a complex theoretical concept that includes many great high level mental functions. Within this concept is included the empathy, which is so significant and relevant to be evaluated separately but it has been one of the least studied areas in traumatic brain injury. Patients and methods. A large sample of patients with a traumatic brain injury has been studied. The aim was to evaluate the decrease of the empathic ability. One of the validated instruments in our area has been used: the Interpersonal Reactivity Index. The study has been completed by using partially the Eslinger's social executors model as we consider that clinic display of the empathic response changes observed in those with a traumatic brain injury are influenced by previous personality and other different factors. Results and conclusions. With regard to the percentage of empathic ability decrease our results are similar to those documented in the few existing studies on this subject. According to the results the Eslinger's social executors model has been confirmed as a suitable model to carry out a longitudinal and analytical study of neuropsychiatric disorders like the empathy. We have realized that the empathic ability in traumatic brain injury is modulated by previous personality and intelligence. Finally, right hemisphere traumatic damage could be a warning signal in posttraumatic social cognition changes.	[Pelegrin-Valero, Carmelo] Hosp San Jorge, Serv Psiquiatria, E-22004 Huesca, Spain; [Jimenez-Cortes, Marta P.] Hosp Barbastro, Huesca, Spain; [Tirapu-Ustarroz, Javier] Clin Ubarmin, Navarra, Spain; [Guallart-Balet, Maria] ATECEA, Zaragoza, Spain; [Benabarre-Ciria, Sergio] Univ Zaragoza, Fdn Agustin Serrate, Huesca, Spain		Pelegrin-Valero, C (corresponding author), Hosp San Jorge, Serv Psiquiatria, Avda Martinez de Velasco 36, E-22004 Huesca, Spain.	cpelegrin@salud.aragon.es					Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Batson C. D, 1992, EMPATIA DESARROLLO, P181; Castellanos-Pinedo F, 2012, REV NEUROLOGIA, V54, P357, DOI 10.33588/rn.5406.2011714; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 1980, CATALOG SELECTED DOC, V10, P1; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; De Waal F, 2009, EDAD EMPATIA SOMOS A; Eslinger PJ, 2007, J NEUROL NEUROSUR PS, V78, P457, DOI 10.1136/jnnp.2006.098228; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Farrow TFD, 2007, EMPATHY IN MENTAL ILLNESS, P201, DOI 10.1017/CBO9780511543753.013; Garcia-Molina A, 2010, REV NEUROLOGIA, V50, P738, DOI 10.33588/rn.5012.2009713; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Grossman M, 2010, NEUROPSYCHOLOGIA, V48, P3505, DOI 10.1016/j.neuropsychologia.2010.07.036; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; IPDE, 1996, EX INT TRAST PERS; Johson J, 2001, TERAPIA FAMILIAR TRA; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LoBello SC, 2003, J REHABIL RES DEV, V40, P293, DOI 10.1682/JRRD.2003.07.0293; LORANGER AW, 1988, PERSONALITY DISORDER; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montreys CR, 1998, INT J NEUROSCI, V96, P269, DOI 10.3109/00207459808986474; Munoz DG, 2010, REV NEUROLOGIA, V50, P387, DOI 10.33588/rn.5007.2010191; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pelegrin C, 2009, PSICOGERIATRIA, V1, P49; Perez-Albeniz A, 2003, PSICOTHEMA, V15, P267; Perry RJ, 2001, NEUROCASE, V7, P145, DOI 10.1076/neur.7.2.145.16267; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Retuerto A., 2004, APUNTES PSICOLOGIA, V22, P323; Semerari A, 2010, TRATADO TRASTORNOS P, P221; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler D., 1999, ESCALA INTELIGENCIA; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	48	4	4	0	20	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUL 1	2012	55	1					1	10					10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	975UT	WOS:000306537700001	22718403				2022-02-06	
J	Lee, DH; Hwang, SM; Lim, OK; Kim, JK				Lee, Deok Hee; Hwang, Seon Moon; Lim, Ok Kyun; Kim, Jae Kyun			In Vitro Observation of Air Bubbles during Delivery of Various Detachable Aneurysm Embolization Coils	KOREAN JOURNAL OF RADIOLOGY			English	Article						Air bubble; Air embolization; Cerebral aneurysm; Embolization coil; Detachable coil	CEREBRAL BLOOD-FLOW; THROMBOEMBOLIC EVENTS; SILENT EMBOLISM; HEAD-INJURY; ANGIOGRAPHY; BRAIN; AVOIDANCE; ISCHEMIA; LACTATE; TRIAL	Objective: Device- or technique-related air embolism is a drawback of various neuro-endovascular procedures. Detachable aneurysm embolization coils can be sources of such air bubbles. We therefore assessed the formation of air bubbles during in vitro delivery of various detachable coils. Materials and Methods: A closed circuit simulating a typical endovascular coiling procedure was primed with saline solution degassed by a sonification device. Thirty commercially available detachable coils (7 Axium, 4 GDCs, 5 MicroPlex, 7 Target, and 7 Trufill coils) were tested by using the standard coil flushing and delivery techniques suggested by each manufacturer. The emergence of any air bubbles was monitored with a digital microscope and the images were captured to measure total volumes of air bubbles during coil insertion and detachment and after coil pusher removal. Results: Air bubbles were seen during insertion or removal of 23 of 30 coils (76.7%), with volumes ranging from 0 to 23.42 mm(3) (median: 0.16 mm(3)). Air bubbles were observed most frequently after removal of the coil pusher. Significantly larger amounts of air bubbles were observed in Target coils. Conclusion: Variable volumes of air bubbles are observed while delivering detachable embolization coils, particularly after removal of the coil pusher and especially with Target coils.	[Lee, Deok Hee; Hwang, Seon Moon; Lim, Ok Kyun] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol,Dept Radiol, Seoul 138736, South Korea; [Kim, Jae Kyun] Chung Ang Univ, Coll Med, Dept Radiol, Seoul 156861, South Korea		Lee, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol,Dept Radiol, 88 Olympic Ro,43 Gil, Seoul 138736, South Korea.	dhlee@amc.seoul.kr			Asan Institute for Life Science, Seoul, Korea [2011-329]	This study was supported by a grant (2011-329) from the Asan Institute for Life Science, Seoul, Korea.	ANNANE D, 1995, J NEUROIMAGING, V5, P183, DOI 10.1111/jon199553183; Bendszus M, 1999, LANCET, V354, P1594, DOI 10.1016/S0140-6736(99)07083-X; Bendszus M, 2004, CIRCULATION, V110, P2210, DOI 10.1161/01.CIR.0000144301.82391.85; Chuah Kenneth C, 2004, Australas Radiol, V48, P133, DOI 10.1111/j.1440-1673.2004.01273.x; Chung SW, 2008, J KOREAN NEUROSURG S, V43, P275, DOI 10.3340/jkns.2008.43.6.275; Derdeyn CP, 2001, AM J NEURORADIOL, V22, P1234; DUNN GD, 1993, LANCET, V341, P1215, DOI 10.1016/0140-6736(93)91044-M; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gupta R, 2007, NEUROCRIT CARE, V7, P241, DOI 10.1007/s12028-007-0041-9; Han MH, 2003, AM J NEURORADIOL, V24, P539; Heiserman JE, 1999, LANCET, V354, P1577, DOI 10.1016/S0140-6736(99)00277-9; HELPS SC, 1990, STROKE, V21, P94, DOI 10.1161/01.STR.21.1.94; HELPS SC, 1990, STROKE, V21, P1340, DOI 10.1161/01.STR.21.9.1340; Hossmann KA, 1998, CARDIOVASC RES, V39, P106, DOI 10.1016/S0008-6363(98)00075-3; Kim SJ, 2007, KOREAN J RADIOL, V8, P276, DOI 10.3348/kjr.2007.8.4.276; Mamourian AC, 2001, AM J NEURORADIOL, V22, P709; MARKUS H, 1993, STROKE, V24, P1246, DOI 10.1161/01.STR.24.8.1246; MARKUS H, 1993, LANCET, V341, P784, DOI 10.1016/0140-6736(93)90561-T; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Muth CM, 2000, NEW ENGL J MED, V342, P476, DOI 10.1056/NEJM200002173420706; Sayama T, 2000, NEURORADIOLOGY, V42, P192, DOI 10.1007/s002340050043; Soeda A, 2003, AM J NEURORADIOL, V24, P2035; Um SJ, 2009, KOREAN J RADIOL, V10, P81, DOI 10.3348/kjr.2009.10.1.81; van Hulst RA, 2003, ACTA NEUROL SCAND, V108, P118, DOI 10.1034/j.1600-0404.2003.00100.x	24	4	5	0	0	KOREAN RADIOLOGICAL SOC	SEOUL	121-8 YANGJAE-DONG, SEOCHO-GU, SEOUL 137-130, SOUTH KOREA	1229-6929			KOREAN J RADIOL	Korean J. Radiol.	JUL-AUG	2012	13	4					412	416		10.3348/kjr.2012.13.4.412			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	973YN	WOS:000306396600004	22778562	Green Published, Green Submitted			2022-02-06	
J	Mesfin, MN; von Reyn, CR; Mott, RE; Putt, ME; Meaney, DF				Mesfin, Mahlet N.; von Reyn, Catherine R.; Mott, Rosalind E.; Putt, Mary E.; Meaney, David F.			In Vitro Stretch Injury Induces Time- and Severity-Dependent Alterations of STEP Phosphorylation and Proteolysis in Neurons	JOURNAL OF NEUROTRAUMA			English	Article						altered signal transduction; in vitro studies; neural injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TYROSINE-PHOSPHATASE STEP; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; EXTRASYNAPTIC NMDA RECEPTORS; CALPAIN-MEDIATED CLEAVAGE; CORTICAL-NEURONS; HIPPOCAMPAL-NEURONS; CELL-DEATH; ALZHEIMERS-DISEASE	Striatal-enriched tyrosine phosphatase (STEP) has been identified as a component of physiological and pathophysiological signaling pathways mediated by N-methyl-D-aspartate (NMDA) receptor/calcineurin/calpain activation. Activation of these pathways produces a subsequent change in STEP isoform expression or activation via dephosphorylation. In this study, we evaluated changes in STEP phosphorylation and proteolysis in dissociated cortical neurons after sublethal and lethal mechanical injury using an in vitro stretch injury device. Sublethal stretch injury produces minimal changes in STEP phosphorylation at early time points, and increased STEP phosphorylation at 24 h that is blocked by the NMDA-receptor antagonist APV, the calcineurin-inhibitor FK506, and the sodium channel blocker tetrodotoxin. Lethal stretch injury produces rapid STEP dephosphorylation via NR2B-containing NMDA receptors, but not calcineurin, and a subsequent biphasic phosphorylation pattern. STEP61 expression progressively increases after sublethal stretch with no change in calpain-mediated STEP33 formation, while lethal stretch injury results in STEP33 formation via a NR2B-containing NMDA receptor pathway within 1 h of injury. Blocking calpain activation in the initial 30 min after stretch injury increases the ratio of active STEP in cells and blocks STEP33 formation, suggesting that STEP is an early substrate of calpain after mechanical injury. There is a strong correlation between the amount of STEP33 formed and the degree of cell death observed after lethal stretch injury. In summary, these data demonstrate that previously characterized pathways of STEP regulation via the NMDA receptor are generally conserved in mechanical injury, and suggest that calpain-mediated cleavage of STEP33 should be further examined as an early marker of neuronal fate after stretch injury.	[Mesfin, Mahlet N.; von Reyn, Catherine R.; Mott, Rosalind E.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; von Reyn, Catherine/0000-0002-5753-2134	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-35712, RO1 HD41699, P30 HD026979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD026979] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035712] Funding Source: NIH RePORTER	The authors would like to acknowledge Dr. Paul Lombroso (Yale University, New Haven, CT) for the generous donation of the STEP plasmids. Portions of this work were presented at the National Neurotrauma Society and Society for Neuroscience annual meetings. Funds were provided by the National Institutes of Health (grants NS-35712, RO1 HD41699, and P30 HD026979).	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2008, EUR J NEUROSCI, V27, P2444, DOI 10.1111/j.1460-9568.2008.06209.x; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Briggs SW, 2011, EPILEPSIA, V52, P497, DOI 10.1111/j.1528-1167.2010.02912.x; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Bult A, 1997, EUR J CELL BIOL, V72, P337; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Choi YS, 2007, J NEUROSCI, V27, P2999, DOI 10.1523/JNEUROSCI.4913-06.2007; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; HORI N, 1994, NEUROSCI LETT, V173, P75, DOI 10.1016/0304-3940(94)90153-8; Hu Y, 2007, J NEUROCHEM, V103, P531, DOI 10.1111/j.1471-4159.2007.04749.x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mukherjee S, 2011, BIOCH J; Mukhin AG, 1997, NEUROREPORT, V8, P2561, DOI 10.1097/00001756-199707280-00028; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Paul S, 2007, BIOL PSYCHIAT, V61, P1049, DOI 10.1016/j.biopsych.2006.08.005; Paul S, 2010, J NEUROCHEM, V114, P1107, DOI 10.1111/j.1471-4159.2010.06835.x; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107	93	4	4	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1982	1998		10.1089/neu.2011.2253			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400400	22435660	Green Published			2022-02-06	
J	Yeh, DD; Velmahos, GC				Yeh, Daniel Dante; Velmahos, George C.			Prehospital intubation for traumatic brain injury: do it correctly, or not at all	ANZ JOURNAL OF SURGERY			English	Article							RAPID-SEQUENCE INTUBATION; NEUROMUSCULAR BLOCKING-AGENTS; HEAD-INJURY; CEREBRAL OXYGENATION; HEMORRHAGIC-SHOCK; HYPERVENTILATION; HYPOXIA; IMPACT; VENTILATION; HYPOVENTILATION		[Yeh, Daniel Dante; Velmahos, George C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA		Yeh, DD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA.						Baker CC, 2005, J TRAUMA, V58, P723; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marion DW, 2000, J TRAUMA, V48, P1032; McSwain NE, 2004, J TRAUMA, V57, P8; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Omert L, 2001, J TRAUMA, V51, P1065, DOI 10.1097/00005373-200112000-00007; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	25	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUL-AUG	2012	82	7-8					484	485		10.1111/j.1445-2197.2012.06130.x			2	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	984BN	WOS:000307163500003	22863220				2022-02-06	
J	Archavlis, E; Nievas, MC				Archavlis, E.; Nievas, M. C.			Cranioplasty after supratentorial decompressive craniectomy. When is the optimal timing	NERVENARZT			English	Article						Skull defect; Decompressive craniectomy; Cranioplasty; Reimplantation; Timing	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; SINKING SKIN FLAP; DELAYED CRANIOPLASTY; MALIGNANT INFARCTION; RANDOMIZED-TRIAL; BLOOD-FLOW; CT; HEMICRANIECTOMY; MULTICENTER	The purpose of this study was to evaluate the outcome and complication rates of different cranioplastic procedures. This study retrospectively reviewed 242 consecutive patients who underwent cranioplasty. The indications for craniectomy, the timing and materials employed for the cranial repair procedures were analysed in all patients as well as their early and long-term results. The immediate patient's outcome after cranioplasty was assessed by reviewing medical records and the late outcome was evaluated with a telephone questionnaire. The patients were divided into three groups depending on the timing of cranioplasty [ultra early group (until 6 weeks), early group (7-12 weeks) and delayed group (after 13 weeks following craniectomy)]. The ultra early cranioplasty in the form of reimplantation of the patient's own skull flap led to a rapid improvement of the patient's neurological function and late outcome. The analysis of the registered postoperative complications revealed that there were no significant differences between the groups examined. This study found that ultra early cranioplasty by reimplanting the patient's own previously removed and frozen skull bone was a safe and successful strategy.	[Archavlis, E.] JWG Univ Frankfurt Main, Akad Lehrkrankenhaus, Klinikum Offenbach, Neurochirurg Klin, D-63069 Offenbach, Germany; [Nievas, M. C.] Stadt Kliniken Frankfurt Main Hochst, Neurochirurg Klin, Frankfurt, Germany		Archavlis, E (corresponding author), JWG Univ Frankfurt Main, Akad Lehrkrankenhaus, Klinikum Offenbach, Neurochirurg Klin, Starkenburgring 66, D-63069 Offenbach, Germany.	neurosurgery@t-online.de					Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Arnaud E, 2000, CHILD NERV SYST, V16, P659, DOI 10.1007/s003810000321; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; DELACURE MD, 1994, OTOLARYNG CLIN N AM, V27, P859; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Erman T, 2005, SURG NEUROL, V63, P107, DOI 10.1016/j.surneu.2004.04.024; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Park HK, 2001, NEUROL RES, V23, P267, DOI 10.1179/016164101101198424; Park JS, 2007, J KOREAN NEUROSURG S, V42, P89; Regel JP, 2004, NEUROCHIRURGIE, P231; Richaud J, 1985, NEUROCHIRURGIE, P31183; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Schimidek H., 2000, OPERATIVE NEUROSURGI; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Steiger HJ, 1999, MANUAL NEUROCHIRURGI, P299; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Unterberg A, 2006, ACTA NEUROCHIR, V96, P17; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166; Zingale A, 2003, J Neurosurg Sci, V47, P137	38	4	4	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804			NERVENARZT	Nervenarzt	JUN	2012	83	6					751	758		10.1007/s00115-011-3424-2			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	953NS	WOS:000304876100006	22215218	Bronze			2022-02-06	
J	Astrand, R; Romner, B; Reinstrup, P; Friis-Hansen, L; Unden, J				Astrand, Ramona; Romner, Bertil; Reinstrup, Peter; Friis-Hansen, Lennart; Unden, Johan			Comparison between capillary, venous and arterial levels of protein S100B in patients with severe brain pathology	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						arterial measurements; capillary; protein S100B; severe brain injury; venous	MINOR HEAD-INJURY; NEURON-SPECIFIC ENOLASE; SERUM S-100B PROTEIN; SEX-RELATED CHANGES; CEREBROSPINAL-FLUID; CARE PATIENTS; BLOOD; ADULTS; MULTICENTER; CHILDREN	Background: Protein S100B is soon in clinical use as a sensitive marker after mild traumatic head injury in adults. Initial studies of S100B in pediatric head injury have shown promising results. Venous sampling can be challenging in children and capillary samples are often a preferred option. The aim of the study was to investigate the relation between capillary, venous and arterial measurements of protein S100B, primarily by determining whether capillary S100B differ from venous and if capillary S100B can predict venous S100B levels, and secondarily, if arterial S100B samples can substitute venous samples in severely brain-injured patients. Methods: Venous, arterial and capillary blood samples for S100B were collected simultaneously once a day for a maximum of 6 days. Patients were >= 18 years old and admitted to neurointensive care due to severe brain pathology. Results: Capillary S100B samples were on average 0.08 mu g/L higher than venous S100B samples. Prediction of venous concentration from capillary samples yielded a prediction error of 0.07 mu g/L. The mean difference between venous and arterial samples was 0.01 mu g/L. The mean prediction error was 0.03 mu g/L. Conclusions: Capillary and venous serum S100B are not interchangeable, and should be considered as two separate, although related, variables. Arterial measurements of S100B can successfully predict the corresponding venous concentration.	[Astrand, Ramona] Rigshosp, Dept Neurosurg, Ctr Neurosci, Sect NK 2092, DK-2100 Copenhagen, Denmark; [Astrand, Ramona] Lund Univ, Dept Neurosurg, Lund, Sweden; [Reinstrup, Peter] Skane Univ Hosp, Dept Anesthesiol, Lund, Sweden; [Friis-Hansen, Lennart] Rigshosp, Dept Clin Chem, DK-2100 Copenhagen, Denmark; [Unden, Johan] Skane Univ Hosp, Dept Anesthesiol & Intens Care, Malmo, Sweden		Astrand, R (corresponding author), Rigshosp, Dept Neurosurg, Ctr Neurosci, Sect NK 2092, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	raastrand@gmail.com		Friis-Hansen, Lennart/0000-0002-7222-0163	Ake-Wiberg Foundation; Laerdal Foundation for Acute Medicine; Crafoord Foundation	This study was funded by non-commercial grants from the Ake-Wiberg Foundation, the Laerdal Foundation for Acute Medicine and the Crafoord Foundation. Reagents for S100B analysis were given as contribution from Roche Diagnostics, Mannheim Germany. The initiation of the study, the protocol and results has not been influenced by any of the funders or contributors.	Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; GREENLAND P, 1990, CLIN CHEM, V36, P628; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; McNally JD, 2008, J STEROID BIOCHEM, V112, P164, DOI 10.1016/j.jsbmb.2008.08.006; Neufeld L, 2002, SALUD PUBLICA MEXICO, V44, P219, DOI 10.1590/S0036-36342002000300005; Nygaard O, 1997, CLIN CHEM, V43, P541; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schalk E, 2007, VOX SANG, V93, P348, DOI 10.1111/j.1423-0410.2007.00978.x; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Wiesmann M, 1998, CLIN CHEM, V44, P1056	24	4	5	1	2	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621			CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JUN	2012	50	6					1055	1061		10.1515/cclm-2011-0639			7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	963OO	WOS:000305631600014	22706246	Green Published			2022-02-06	
J	Haenggi, M; Andermatt, A; Anthamatten, C; Galimanis, A; Mono, ML; Alfieri, A; Fung, C; Takala, J; Jakob, SM				Haenggi, Matthias; Andermatt, Anna; Anthamatten, Claudia; Galimanis, Aikaterini; Mono, Marie-Luise; Alfieri, Alexander; Fung, Christian; Takala, Jukka; Jakob, Stephan M.			CO2-Dependent Vasomotor Reactivity of Cerebral Arteries in Patients with Severe Traumatic Brain Injury: Time Course and Effect of Augmentation of Cardiac Output with Dobutamine	JOURNAL OF NEUROTRAUMA			English	Article						dobutamine; NE; TBI; vasoreactivity	PRESSURE AUTOREGULATION; PERFUSION-PRESSURE; CARBON-DIOXIDE; HEAD-INJURY; BLOOD-FLOW; VASOREACTIVITY; SONOGRAPHY; GENDER; OXYGEN	Failing cerebral blood flow (CBF) autoregulation may contribute to cerebral damage after traumatic brain injury (TBI). The purpose of this study was to describe the time course of CO2-dependent vasoreactivity, measured as CBF velocity in response to hyperventilation (vasomotor reactivity [VMR] index). We included 13 patients who had had severe TBI, 8 of whom received norepinephrine (NE) based on clinical indication. In these patients, measurements were also performed after dobutamine administration, with a goal of increasing cardiac output by 30%. Blood flow velocity was measured with transcranial Doppler ultrasound in both hemispheres. All patients except one had an abnormal VMR index in at least one hemisphere within the first 24 h after TBI. In those patients who did not receive catecholamines, mean VMR index recovered within the first 48 to 72 h. In contrast, in patients who received NE within the first 48 h period, VMR index did not recover on the second day. Cardiac output and mean CBF velocity increased significantly during dobutamine administration, but VMR index did not change significantly. In conclusion, CO2 vasomotor reactivity was abnormal in the first 24 h after TBI in most of the patients, but recovered within 48 h in those patients who did not receive NE, in contrast to those eventually receiving the drug. Addition of dobutamine to NE had variable but overall insignificant effects on CO2 vasomotor reactivity.	[Haenggi, Matthias] Univ Hosp Bern, Inselspital, Dept Intens Care Med, CH-3010 Bern, Switzerland; [Galimanis, Aikaterini; Mono, Marie-Luise] Univ Hosp Bern, Dept Neurol Neurovasc Diagnost, CH-3010 Bern, Switzerland; [Fung, Christian] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland; [Alfieri, Alexander] Univ Hosp Halle, Dept Neurosurg, Halle, Germany		Haenggi, M (corresponding author), Univ Hosp Bern, Inselspital, Dept Intens Care Med, CH-3010 Bern, Switzerland.	matthias.haenggi@insel.ch	Haenggi, Matthias/O-2642-2019; Haenggi, Matthias/A-8073-2008; Alfieri, Alex/B-5936-2013	Haenggi, Matthias/0000-0001-5845-031X; Haenggi, Matthias/0000-0001-5845-031X; Alfieri, Alex/0000-0002-0209-4114			Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; Kochanowicz J, 2006, NEURORADIOLOGY, V48, P31, DOI 10.1007/s00234-005-0009-4; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; Kulik T, 2008, NEUROPHARMACOLOGY, V55, P281, DOI 10.1016/j.neuropharm.2008.04.017; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHOEMAKER WC, 1992, CHEST, V102, pS617, DOI 10.1378/chest.102.5_Supplement_2.617S; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686	22	4	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2012	29	9					1779	1784		10.1089/neu.2011.1809			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	954CN	WOS:000304924000007	21501044				2022-02-06	
J	Kemp, S; Kim, SDH; Cordato, DJ; Fung, VSC				Kemp, S.; Kim, S. D. H.; Cordato, D. J.; Fung, V. S. C.			Delayed-onset focal dystonia of the leg secondary to traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Focal dystonia; Lower limb dystonia; Delayed-onset dystonia; Traumatic brain injury; Botulinum toxin therapy		A 42-year-old man presented with action-induced, stereotyped posturing of the left leg with task specificity following major traumatic brain injury less than a year earlier. Although adult onset primary leg dystonia is a recognised entity, our patient is unusual in that dystonia was an isolated abnormality without associated spasticity, was not preceded by ipsilateral hemiparesis and remained focal without progression to involve other body regions. MRI brain showed a small area of gliosis in the left frontal subcortical white matter but with no lesions in the basal ganglia or thalamus. The dystonia in our patient almost completely resolved with botulinum toxin therapy. (C) 2011 Elsevier Ltd. All rights reserved.	[Kemp, S.; Kim, S. D. H.; Fung, V. S. C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Kim, S. D. H.; Fung, V. S. C.] Westmead Hosp, Dept Neurol, Movement Disorders Unit, Westmead, NSW 2145, Australia; [Cordato, D. J.] Liverpool Hosp, Dept Neurol, Liverpool, Merseyside, Australia		Fung, VSC (corresponding author), Univ Sydney, Sydney Med Sch, Darlington Campus,City Rd, Sydney, NSW 2006, Australia.	vscfung@ozemail.com.au					Factor SA, 2003, MOVEMENT DISORD, V18, P1492, DOI 10.1002/mds.10602; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; PERLMUTTER JS, 1984, ANN NEUROL, V15, P228, DOI 10.1002/ana.410150303; Schneider SA, 2006, MOVEMENT DISORD, V21, P767, DOI 10.1002/mds.20794	7	4	4	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2012	19	6					916	917		10.1016/j.jocn.2011.08.025			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	955SH	WOS:000305040700037	22341145				2022-02-06	
J	Shi, BZ; Meng, XF; Yang, JX; Hao, XW; Cui, T; Lu, ZF; Zhang, HR; Zhou, JC; Liu, JF				Shi, Bao-Zhong; Meng, Xiao-Feng; Yang, Jian-Xue; Hao, Xiao-Wei; Cui, Tao; Lu, Zhao-Feng; Zhang, Hong-Ri; Zhou, Jiang-Chao; Liu, Jin-Fang			Effect of erythrocytes on brain water content and haem oxygenase-1 expression in rats with traumatic intracerebral haemorrhage	ACTA NEUROCHIRURGICA			English	Article						Traumatic intracerebral haemorrhage; Erythrocyte; Brain oedema; Haem oxygenase-1	RED-BLOOD-CELLS; BARRIER PERMEABILITY; CARBON-MONOXIDE; EDEMA FORMATION; NITRIC-OXIDE; IN-VIVO; INJURY; HEMOGLOBIN; THROMBIN; FLOW	Studies have demonstrated that brain oedema formation following spontaneous intracerebral haemorrhage is associated with substances derived from blood clots or blood components. However, these studies did not completely reveal the role of blood components in brain oedema formation following traumatic intracerebral haemorrhage (TICH). Here, we explore the role of erythrocytes in brain oedema development by studying the effect of erythrocytes on brain water content (BWC) and expression of haem oxygenase-1 (HO-1) in rats with TICH. A total of 120 Sprague-Dawley rats were randomly divided into four experimental treatment groups: traumatic brain injury (TBI), TBI plus whole blood (WB), TBI plus lysed red blood cells (RBCs; LRBC) and TBI plus packed RBCs (PRBC). Following TBI, which was established by applying a free-falling device, WB, LRBC or PRBC were infused with stereotactic guidance into the injured cortex to produce a model of TICH. All rats were killed at 1, 3 or 5 days after TBI or TICH. BWC was measured, and immunohistochemistry for HO-1 was performed. In the WB, PRBC and TBI groups, BWC at 3 days post-TBI or post-TICH was the greatest. However, BWC in the LRBC group at 1 day was markedly higher than that at 3 and 5 days. Comparisons among the four groups showed that BWC in the LRBC group was the highest at 1 day, and the highest at 3 days in the WB and PRBC groups; there was no significant difference at 5 days. Positive expression of HO-1 in the WB, PRBC and LRBC groups coincided with changes in BWC. Our results indicate that erythrocytes play an important role in delayed brain oedema formation (3 days post-injury) following TICH, but have no significant influence on brain oedema at early stages (1 day post-injury), and that the mechanisms of delayed brain oedema involve RBC breakdown products.	[Shi, Bao-Zhong; Meng, Xiao-Feng; Hao, Xiao-Wei; Cui, Tao; Lu, Zhao-Feng; Zhang, Hong-Ri; Zhou, Jiang-Chao] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang 471003, Henan, Peoples R China; [Yang, Jian-Xue] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurol, Luoyang 471003, Henan, Peoples R China; [Liu, Jin-Fang] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China		Shi, BZ (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, 24 Jinghua Rd, Luoyang 471003, Henan, Peoples R China.	sbzmd20569@163.com					Bhasin RR, 2002, ACTA NEUROCHIR SUPPL, V81, P249; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Matz PG, 1997, NEUROSURGERY, V40, P152, DOI 10.1097/00006123-199701000-00034; Ono S, 2002, J NEUROSURG, V96, P1094, DOI 10.3171/jns.2002.96.6.1094; Park CC, 1997, J NEUROSURG, V87, P294, DOI 10.3171/jns.1997.87.2.0294; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; Tan YF, 2001, CHIN J TRAUMATOL, V17, P212; Wagner KR, 2000, CELL MOL BIOL, V46, P597; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi G, 2003, ACT NEUR S, V86, P449; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093	26	4	4	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2012	154	6					1081	1086		10.1007/s00701-012-1335-z			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	943II	WOS:000304113800018	22466153				2022-02-06	
J	Yang, CH; Li, Q; Wu, C; Ma, JP; You, C				Yang Chao-hua; Li Qiang; Wu Cong; Ma Jun-peng; You Chao			Decompressive craniectomy or not: intraoperative experience in 41 patients with severe traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Decompressive craniectomy; Brain injury; Intracranial pressure	HEAD-INJURY; MANAGEMENT; CHILDREN	Objective: To present our experience in using decompressive craniectomy (DC) among severe traumatic brain injury (TBI) patients during operation and to discuss its indication. Methods: From October 2008 to May 2009, 41 patients aged between 18 and 75 years with severe TBI were included in this study. They underwent DC or non-DC (NDC) according to their intraoperative findings. Postoperative intracranial pressure (ICP), complications, requiring second operation or not and outcomes were observed. Results: Fifteen patients underwent DC and 26 patients did not. The average postoperative ICP of each patient was lower than 20 mm Hg. For patients received DC, 2 had seizures after operation and 1 developed cerebrocele in the follow-up period; only 1 NDC patient had post-traumatic seizures, but none of them had delayed haematoma, cerebrospinal fluid fistula, cerebrocele or infections. At the end of follow-up, 10 patients died, 6 had the GOS of 2, 2 of 3, 9 of 4 and 14 of 5. Conclusions: DC is necessary to manage fulminant intracranial hypertension or intraoperative brain swelling. If there was not brain swelling after removal of the haematoma and necrotized neural tissues, it is safe to replace skull flap. The intraoperative finding is an important factor to decide whether to perform DC or not.	[Yang Chao-hua; Li Qiang; Wu Cong; Ma Jun-peng; You Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China		Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China.	yangchaohua999@126.com					Alexander E, 2001, NEUROSURGERY, V48, P704, DOI 10.1097/00006123-200103000-00065; Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	19	4	5	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2012	15	3					158	161		10.3760/cma.j.issn.1008-1275.2012.03.006			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1FP	WOS:000441988500006	22663910				2022-02-06	
J	Ruisanchez, E; Cselenyak, A; Papp, RS; Nemeth, T; Kaldi, K; Sandor, P; Benyo, Z				Ruisanchez, Eva; Cselenyak, Attila; Papp, Rege Sugarka; Nemeth, Tamas; Kaldi, Krisztina; Sandor, Peter; Benyo, Zoltan			Perivascular Expression and Potent Vasoconstrictor Effect of Dynorphin A in Cerebral Arteries	PLOS ONE			English	Article							RAT SPINAL-CORD; SENSITIVE K+ CHANNELS; SMOOTH-MUSCLE-CELLS; NEWBORN PIGS; BRAIN-INJURY; TRAUMATIC INJURY; OPIOID RECEPTORS; CEREBROVASCULAR RESPONSES; NEUROPEPTIDE-Y; NERVE-FIBERS	Background: Numerous literary data indicate that dynorphin A (DYN-A) has a significant impact on cerebral circulation, especially under pathophysiological conditions, but its potential direct influence on the tone of cerebral vessels is obscure. The aim of the present study was threefold: 1) to clarify if DYN-A is present in cerebral vessels, 2) to determine if it exerts any direct effect on cerebrovascular tone, and if so, 3) to analyze the role of kappa-opiate receptors in mediating the effect. Methodology/Principal Findings: Immunohistochemical analysis revealed the expression of DYN-A in perivascular nerves of rat pial arteries as well as in both rat and human intraparenchymal vessels of the cerebral cortex. In isolated rat basilar and middle cerebral arteries (BAs and MCAs) DYN-A (1-13) and DYN-A (1-17) but not DYN-A (1-8) or dynorphin B (DYN-B) induced strong vasoconstriction in micromolar concentrations. The maximal effects, compared to a reference contraction induced by 124 mM K+, were 115 +/- 6% and 104 +/- 10% in BAs and 113 +/- 3% and 125 +/- 9% in MCAs for 10 mM of DYN-A (1-13) and DYN-A (1-17), respectively. The vasoconstrictor effects of DYN-A (1-13) could be inhibited but not abolished by both the kappa-opiate receptor antagonist nor-Binaltorphimine dihydrochloride (NORBI) and blockade of G(i/o)-protein mediated signaling by pertussis toxin. Finally, des-Tyr(1) DYN-A (2-13), which reportedly fails to activate kappa-opiate receptors, induced vasoconstriction of 45 +/- 11% in BAs and 50 +/- 5% in MCAs at 10 mu M, which effects were resistant to NORBI. Conclusion/Significance: DYN-A is present in rat and human cerebral perivascular nerves and induces sustained contraction of rat cerebral arteries. This vasoconstrictor effect is only partly mediated by kappa-opiate receptors and heterotrimeric G(i/o)-proteins. To our knowledge our present findings are the first to indicate that DYN-A has a direct cerebral vasoconstrictor effect and that a dynorphin-induced vascular action may be, at least in part, independent of kappa-opiate receptors.	[Ruisanchez, Eva; Cselenyak, Attila; Nemeth, Tamas; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary; [Papp, Rege Sugarka] Hungarian Acad Sci, Budapest, Hungary; [Papp, Rege Sugarka] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary		Ruisanchez, E (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary.	ruisanchez.eva@med.semmelweis-univ.hu	Kaldi, Krisztina/X-4080-2019	Kaldi, Krisztina/0000-0002-5724-0182; Benyo, Zoltan/0000-0001-6015-0359	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA K-68960, K-101775]; Health Science Council [ETT 427/2009, 477/2009]; Hungarian Science and Technology Foundation (TET-SIN-CELLTHER); National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EMBO/HHMI Startup Grant	This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), Hungarian Scientific Research Fund (OTKA K-68960 and K-101775), Health Science Council (ETT 427/2009 and 477/2009), Hungarian Science and Technology Foundation (TET-SIN-CELLTHER), National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001) and by an EMBO/HHMI Startup Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTURA BT, 1984, BRIT J PHARMACOL, V82, P459, DOI 10.1111/j.1476-5381.1984.tb10781.x; ALTURA BT, 1983, P NATL ACAD SCI-BIOL, V80, P865, DOI 10.1073/pnas.80.3.865; ARENDT RM, 1995, J PHARMACOL EXP THER, V272, P1; ARMSTEAD WM, 1995, BRAIN RES, V689, P183, DOI 10.1016/0006-8993(95)00533-V; ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; Armstead WM, 1997, BRAIN RES, V747, P252, DOI 10.1016/S0006-8993(96)01284-X; ARMSTEAD WM, 1992, BRAIN RES, V571, P97, DOI 10.1016/0006-8993(92)90513-9; ARMSTEAD WM, 1992, J PHARMACOL EXP THER, V260, P1107; ARMSTEAD WM, 1992, AM J PHYSIOL, V262, pH862, DOI 10.1152/ajpheart.1992.262.3.H862; Benyo Z, 1996, CEREBROVAS BRAIN MET, V8, P326; Benyo Z, 2000, BRAIN RES, V877, P79, DOI 10.1016/S0006-8993(00)02611-1; Brugos B, 2004, PHARMAZIE, V59, P339; CAUDLE RM, 1988, BRAIN RES, V443, P329, DOI 10.1016/0006-8993(88)91628-9; CAUDLE RM, 1987, BRAIN RES, V435, P1, DOI 10.1016/0006-8993(87)91579-4; Deli M, 1992, NEUROCHEM INT, V21, pC3; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; Evans SJ, 2000, ENDOCRINOLOGY, V141, P2294, DOI 10.1210/en.141.7.2294; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1983, EUR J PHARMACOL, V91, P321, DOI 10.1016/0014-2999(83)90487-9; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1985, NEUROLOGY, V35, P1311, DOI 10.1212/WNL.35.9.1311; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; GRIDER JR, 1991, AM J PHYSIOL, V260, pG103, DOI 10.1152/ajpgi.1991.260.1.G103; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HARDEBO JE, 1994, J AUTONOM NERV SYST, V47, P171, DOI 10.1016/0165-1838(94)90178-3; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; Horvath B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014477; HU J, 1993, PHARMACOLOGY, V47, P351, DOI 10.1159/000139118; KAPADIA SE, 1984, BRAIN RES, V292, P33, DOI 10.1016/0006-8993(84)90887-4; KLEIN RL, 1990, J AUTONOM NERV SYST, V30, P37, DOI 10.1016/0165-1838(90)90162-C; KONG JY, 1990, PEPTIDES, V11, P565, DOI 10.1016/0196-9781(90)90060-I; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; MASSARDIER D, 1989, EUR J PHARMACOL, V170, P125, DOI 10.1016/0014-2999(89)90149-0; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; MIURA M, 1994, AM J PHYSIOL-ENDOC M, V267, pE702, DOI 10.1152/ajpendo.1994.267.5.E702; MOSKOWITZ MA, 1987, NEUROSCIENCE, V23, P731, DOI 10.1016/0306-4522(87)90090-X; MOSKOWITZ MA, 1986, CEPHALALGIA, V6, P81, DOI 10.1046/j.1468-2982.1986.0602081.x; MULLER S, 1995, PHARMACEUT RES, V12, P1165, DOI 10.1023/A:1016211910107; Muller S, 1996, NEUROCHEM RES, V21, P1213, DOI 10.1007/BF02532398; OUYANG A, 1988, AM J PHYSIOL, V254, pG224, DOI 10.1152/ajpgi.1988.254.2.G224; PICKEL VM, 1994, J NEUROSCI RES, V37, P735, DOI 10.1002/jnr.490370608; Quillan JM, 1997, PHARMACEUT RES, V14, P713, DOI 10.1023/A:1012185919153; Roy C S, 1890, J Physiol, V11, P85; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; SEVERI C, 1988, LIFE SCI, V42, P2373, DOI 10.1016/0024-3205(88)90191-9; SHANKAR V, 1995, AM J PHYSIOL-HEART C, V269, pH997, DOI 10.1152/ajpheart.1995.269.3.H997; Tada H, 2002, EUR J PHARMACOL, V454, P53, DOI 10.1016/S0014-2999(02)02474-3; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; THURESONKLEIN A, 1989, BLOOD VESSELS, V26, P177; TONG JF, 1994, ACTA PHARM SINIC, V15, P488; UDDMAN R, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P230; Venteicher A, 1998, AM J PHYSIOL-HEART C, V275, pH2072, DOI 10.1152/ajpheart.1998.275.6.H2072; Willis T., 1664, CEREBRI ANATOME CUI; YOUNG EA, 1987, PEPTIDES, V8, P701, DOI 10.1016/0196-9781(87)90046-5; ZHANG L, 1992, AM J PHYSIOL, V262, pG461, DOI 10.1152/ajpgi.1992.262.3.G461; ZHANG SW, 1995, J BIOL CHEM, V270, P22772, DOI 10.1074/jbc.270.39.22772	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37798	10.1371/journal.pone.0037798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	WOS:000305342300116	22662226	gold, Green Published, Green Submitted			2022-02-06	
J	Ageberg, E; Bjorkman, A; Rosen, B; Roos, EM				Ageberg, Eva; Bjorkman, Anders; Rosen, Birgitta; Roos, Ewa M.			Principles of brain plasticity in improving sensorimotor function of the knee and leg in patients with anterior cruciate ligament injury: a double-blind randomized exploratory trial	BMC MUSCULOSKELETAL DISORDERS			English	Article							SELECTIVE TEMPORARY ANESTHESIA; OUTCOME SCORE KOOS; CUTANEOUS ANESTHESIA; MUSCLE POWER; HAND SENSIBILITY; NERVE REPAIR; RECONSTRUCTION; REHABILITATION; OSTEOARTHRITIS; STRENGTH	Background: Severe traumatic knee injury, including injury to the anterior cruciate ligament (ACL), leads to impaired sensorimotor function. Although improvements are achieved by training, impairment often persists. Because good sensorimotor function is associated with better patient-reported function and a potential lower risk of future joint problems, more effective treatment is warranted. Temporary cutaneous anesthesia of adjacent body parts was successfully used on the hand and foot to improve sensorimotor function. The aim of this study was to test whether this principle of brain plasticity could be used on the knee. The hypothesis was that temporary anesthesia of the skin area above and below the knee would improve sensorimotor function of the ipsilateral knee and leg in subjects with ACL injury. Methods: In this double-blind exploratory study, 39 subjects with ACL injury (mean age 24 years, SD 5.2, 49% women, mean 52 weeks after injury or reconstruction) and self-reported functional limitations and lack of trust in the knee were randomized to temporary local cutaneous application of anesthetic (EMLA (R)) (n = 20) or placebo cream (n = 19). Fifty grams of EMLA (R), or placebo, was applied on the leg 10 cm above and 10 cm below the center of patella, leaving the area around the knee without cream. Measures of sensory function (perception of touch, vibration sense, knee kinesthesia) and motor function (knee muscle strength, hop test) were assessed before and after 90 minutes of treatment with EMLA (R) or placebo. The paired t-test was used for comparisons within groups and analysis of variance between groups, except for ordinal data where the Wilcoxon signed rank test, or Mann-Whitney test, was used. The number of subjects needed was determined by an a priori sample size calculation. Results: No statistically significant or clinically relevant differences were seen over time (before vs. after) in the measures of sensory or motor functions in the EMLA (R) group or in the placebo group. There were no differences between the groups due to treatment effect (EMLA (R) vs. placebo). Conclusions: Temporary cutaneous anesthesia of adjacent body parts had no effect in improving sensorimotor function of the knee and leg in subjects with severe traumatic knee ligament injury.	[Ageberg, Eva] Lund Univ, Dept Orthoped, Lund, Sweden; [Ageberg, Eva] Lund Univ, Dept Hlth Sci, SE-22100 Lund, Sweden; [Bjorkman, Anders; Rosen, Birgitta] Lund Univ, Dept Hand Surg, Lund, Sweden; [Roos, Ewa M.] Univ So Denmark, Res Unit Musculoskeletal Funct & Physiotherapy, Inst Sports Sci & Clin Biomech, Odense, Denmark		Ageberg, E (corresponding author), Lund Univ, Dept Orthoped, Lund, Sweden.	eva.ageberg@med.lu.se	Roos, Ewa/X-5028-2019; Bjorkman, Anders/AAR-5375-2020; Roos, Ewa M/A-5416-2012	Roos, Ewa/0000-0001-5425-2199; Roos, Ewa M/0000-0001-5425-2199; Ageberg, Eva/0000-0002-8639-3006	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Faculty of Medicine, Lund University	We thank the physical therapists at "Idrottsh Isan" in Lund, Sweden, for providing the patients for this study. Grant supporters: The Swedish Research Council, and the Faculty of Medicine, Lund University.	Ageberg E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-57; Ageberg Eva, 2002, J Electromyogr Kinesiol, V12, P205, DOI 10.1016/S1050-6411(02)00022-6; Ageberg E, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-99; Ageberg E, 2009, KNEE SURG SPORT TR A, V17, P162, DOI 10.1007/s00167-008-0645-4; Ageberg E, 2008, ARTHRIT RHEUM-ARTHR, V59, P1773, DOI 10.1002/art.24066; *ASHT, 1992, CLIN ASS REC; Beynnon BD, 2011, AM J SPORT MED, V39, P2536, DOI 10.1177/0363546511422349; Bjorkman A, 2004, EUR J NEUROSCI, V20, P2733, DOI 10.1111/j.1460-9568.2004.03742.x; Bjorkman A, 2009, EUR J NEUROSCI, V29, P837, DOI 10.1111/j.1460-9568.2009.06629.x; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Donoghue JP, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P363; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Eitzen I, 2009, BRIT J SPORT MED, V43, P371, DOI 10.1136/bjsm.2008.057059; FRENETTE B, 1990, EUR J APPL PHYSIOL O, V61, P386, DOI 10.1007/BF00236057; Friden T, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P217, DOI 10.1007/BF01567966; Gokeler A, 2012, BRIT J SPORT MED, V46, P180, DOI 10.1136/bjsm.2010.082578; Hassan-Zadeh R, 2009, NEUROREHABILITATION, V24, P383, DOI 10.3233/NRE-2009-0493; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.ne.14.030191.001033; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Kapreli E, 2007, CORTEX, V43, P219, DOI 10.1016/S0010-9452(08)70477-5; Kapreli E, 2009, AM J SPORT MED, V37, P2419, DOI 10.1177/0363546509343201; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Lundborg G, 2007, ACTA NEUROCHIR SUPPL, V100, P121; Lundborg GN, 2010, DIABETIC MED, V27, P823, DOI 10.1111/j.1464-5491.2010.03014.x; Maldjian JA, 1999, NEUROIMAGE, V10, P55, DOI 10.1006/nimg.1999.0448; Neeter C, 2006, KNEE SURG SPORT TR A, V14, P571, DOI 10.1007/s00167-006-0040-y; PATERNO MV, 1996, ISOKINET EXERC SCI, V6, P1; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W., 1950, CEREBRAL CORTEX MAN; Pinczewski LA, 2007, AM J SPORT MED, V35, P564, DOI 10.1177/0363546506296042; Purves D., 2004, NEUROSCIENCE, V3rd; Risberg MA, 2004, PHYS THER SPORT, V5, P125, DOI 10.1016/j.ptsp.2004.02.003; Risberg MA, 2007, PHYS THER, V87, P737, DOI 10.2522/ptj.20060041; Risberg MA, 2009, AM J SPORT MED, V37, P1958, DOI 10.1177/0363546509335196; Roberts D, 2000, J ORTHOPAED RES, V18, P565, DOI 10.1002/jor.1100180408; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos EM, 1998, SCAND J MED SCI SPOR, V8, P439, DOI 10.1111/j.1600-0838.1998.tb00465.x; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; Rosen B, 2006, J HAND SURG-BRIT EUR, V31B, P126, DOI 10.1016/j.jhsb.2005.10.017; Rosen B, 2009, NEUROREPORT, V20, P37, DOI 10.1097/WNR.0b013e32831b4486; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; Stippich C, 1999, NEUROSCI LETT, V277, P25, DOI 10.1016/S0304-3940(99)00835-6; Taylor DC, 2009, CLIN ORTHOP RELAT R, V37, P1946; Thorlund JB, 2012, ARTHRIT CARE RES, V64, P144, DOI 10.1002/acr.20624; Trulsson A, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-143; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3; Zatterstrom R, 1998, SCAND J MED SCI SPOR, V8, P154; Zech A, 2009, MED SCI SPORT EXER, V41, P1831, DOI 10.1249/MSS.0b013e3181a3cf0d	49	4	4	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	MAY 10	2012	13								68	10.1186/1471-2474-13-68			8	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	010BY	WOS:000309070600001	22574814	Green Published, gold			2022-02-06	
J	Da Silva, RB; McCusker, J; Roberge, D; Ciampi, A; Vadeboncoeur, A; Levesque, JF; Belzile, E				Da Silva, Roxane Borges; McCusker, Jane; Roberge, Daniele; Ciampi, Antonio; Vadeboncoeur, Alain; Levesque, Jean-Frederic; Belzile, Eric			Classification of Emergency Departments According to Their Services for Community-welling Seniors	ACADEMIC EMERGENCY MEDICINE			English	Article							HEALTH-INSURANCE COVERAGE; TRAUMATIC BRAIN-INJURY; MEDICAL-CARE USE; PEDIATRIC TRAUMA; UNITED-STATES; US CHILDREN; SOCIOECONOMIC-STATUS; NONFATAL INJURIES; SEVERITY SCORE; MORTALITY	Objectives: The goal was to develop a classification of emergency departments (EDs) based on their organization of services for seniors discharged to the community. Methods: This was a secondary analysis of data collected in a survey of key informants (chief physicians and head nurses) in EDs in Quebec on the organization of services for community-dwelling seniors discharged to the community. Organizational characteristics were classified a priori in the following three categories: 1) availability of human resources, 2) care processes, and 3) links to community services. A multifactorial analysis (MFA) was used to analyze the variables by category and globally, thus investigating not only the relationships between variables within each category, but also the relationships between different categories. The authors then proceeded to classify EDs using Ward's method (hierarchical ascendant classification) applied to reduced data dimensions. Results: The sample consisted of 103 EDs. Analyses were carried out on data from the 68 (66%) of these EDs that supplied complete data. These 68 EDs did not differ in terms of their size or geographical location from the 35 other departments that supplied incomplete or no data. We identified three groups of EDs: most specialized (with regard to internal staff and care processes) and less community-oriented (n = 12), moderately specialized and less community-oriented (n = 28), and least specialized and more community-oriented (n = 28). Conclusions: This classification of EDs with respect to their organization of services for community-welling seniors may be helpful to those planning services, to decision-makers, and to researchers. The three groups of EDs identified in this study represent three types of organizations with differing assets and limitations. The generalizability of these groups to other settings and the implications for patient outcomes should be investigated. ACADEMIC EMERGENCY MEDICINE 2012; 19:552-561 (C) 2012 by the Society for Academic Emergency Medicine	[Da Silva, Roxane Borges; McCusker, Jane; Ciampi, Antonio] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Da Silva, Roxane Borges; McCusker, Jane; Ciampi, Antonio; Belzile, Eric] St Marys Res Ctr, Montreal, PQ, Canada; [Roberge, Daniele] Hop Charles LeMoyne, Ctr Rech, Montreal, PQ, Canada; [Roberge, Daniele] Univ Sherbrooke, Montreal, PQ, Canada; [Vadeboncoeur, Alain] Montreal Inst Cardiol, Emergency Med Serv, Montreal, PQ, Canada; [Levesque, Jean-Frederic] Ctr Rech CHUM, Montreal, PQ, Canada; [Levesque, Jean-Frederic] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada		Da Silva, RB (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	roxane.borgesdasilva@mail.mcgill.ca	Levesque, Jean-Frederic/ABH-7122-2020	Levesque, Jean-Frederic/0000-0002-5418-8593	Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Reseau de Recherche en Sante des Populations du Quebec	This work was financed by a grant from Fonds de la Recherche en Sante du Quebec. RBDS was funded by the Canadian Institutes of Health Research and Reseau de Recherche en Sante des Populations du Quebec Strategic Training Program in Transdisciplinary Research on Public and Population Health Interventions: Promotion, Prevention and Public Policy (4P).	Abdullah F, 2010, J PUBLIC HEALTH-UK, V32, P236, DOI 10.1093/pubmed/fdp099; [Anonymous], 2009, DEP AMB SURGR DAT SE; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BLUSTEIN J, 1995, MED CARE, V33, P864, DOI 10.1097/00005650-199508000-00010; Borse NN, 2008, CDC CHILDHOOD INJURY; BRAVEMAN P, 1994, NEW ENGL J MED, V331, P444, DOI 10.1056/NEJM199408183310706; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; BULL JP, 1991, INJURY, V22, P127, DOI 10.1016/0020-1383(91)90073-N; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; Centers for Disease Control and Prevention, REC FRAM PRES INJ MO; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Clark DE, 2009, ICDPIC STATA MODULE; Coben JH, 2009, AM J PREV MED, V36, P49, DOI 10.1016/j.amepre.2008.10.001; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; DeNavas-Walt C, 2010, INCOME POVERTY HLTH; Eber GB, 2004, PEDIATRICS, V113, P1686, DOI 10.1542/peds.113.6.1686; Fingerhut LA, 2012, RECOMMENDED DEFINITI; GLONEK GFV, 1995, J ROY STAT SOC B MET, V57, P533; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Heron M., DEATHS LEADING CAUSE; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Institute of Medicine, 2002, HLTH INS IS FAM MATT; Institute of Medicine, 2009, AM UN CRIS CONS HLTH; Johnson WG, 2004, PEDIATRICS, V113, P483, DOI 10.1542/peds.113.3.483; Lewit EM, 2003, FUTURE CHILD, V13, P5; Lynch V, 2010, UNINSURED CHILDREN W; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Nagaraja J, 2005, PEDIATRICS, V116, P454, DOI 10.1542/peds.2004-1415; National Center for Injury Prevention and Control, 2011, REC FRAM E C3D GROUP; Newacheck PW, 2000, PEDIATRICS, V105, P989; Newacheck PW, 1998, NEW ENGL J MED, V338, P513, DOI 10.1056/NEJM199802193380806; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; SCHEIDT PC, 1995, AM J PUBLIC HEALTH, V85, P932, DOI 10.2105/AJPH.85.7.932; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; State of California Office of Statewide Health Planning and Development, 2009, INP HOSP DISCH DAT S; State of California Regional Council of Rural Counties, MEMB COUNT MAP; STODDARD JJ, 1994, NEW ENGL J MED, V330, P1421, DOI 10.1056/NEJM199405193302006; Tiesman H, 2007, INJURY PREV, V13, P115, DOI 10.1136/ip.2006.013201; U. S. Department of Health and Human Services, 2004 HLTH HUM SERV P; Wang NE, 2007, ACAD EMERG MED, V14, P309, DOI 10.1197/j.aem.2006.11.012; Wang NE, 2006, ACAD EMERG MED, V13, P840, DOI 10.1197/j.aem.2006.04.021; Wang NE, 2003, ACAD EMERG MED, V10, P1278, DOI 10.1197/S1069-6563(03)00499-8; Wise PH, 2004, HEALTH AFFAIR, V23, P9, DOI 10.1377/hlthaff.23.5.9	60	4	4	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	MAY	2012	19	5					552	561		10.1111/j.1553-2712.2012.01343.x			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	943OI	WOS:000304133300010		Bronze			2022-02-06	
J	Johnson, K; Asher, J; Kisielewski, M; Lawry, L				Johnson, Kirsten; Asher, Jana; Kisielewski, Michael; Lawry, Lynn			Former Combatants in Liberia: The Burden of Possible Traumatic Brain Injury Among Demobilized Combatants	MILITARY MEDICINE			English	Article							MENTAL-HEALTH OUTCOMES; CHILDHOOD TRAUMA; SEXUAL VIOLENCE; NORTHERN UGANDA; ASSOCIATION; DISPLACEMENT; NEUROBIOLOGY; DISORDERS; CONFLICT; SYMPTOMS	Objective: To provide a better understanding of any associations between Disarmament, Demobilization, and Reintegration, previous head injury, and mental health symptoms among former combatants in Liberia. Methods: A cluster-sampled national survey of the adult household-based Liberian population. Findings: Former combatants with reported head injury were more likely to experience major depressive disorder symptoms, suicidal ideation and attempts, and current substance abuse. Former combatants with head injury are 2.83 times more likely to have major depressive disorder symptoms, and those with suspected traumatic brain injury are five times more likely to have post-traumatic stress disorder. Interpretation: The poor mental health of former combatants in Liberia, both child and adult, might be mitigated if Disarmament, Demobilization, and Reintegration programming assessed participants for head trauma and traumatic brain injury using simple screening methods. The specific health and mental health needs of ex-combatants-a highly vulnerable group-will need to be addressed by Liberia. If left untreated, ex-combatants with high rates of suicidal ideation and post-traumatic stress disorder might be susceptible to re-recruitment into new conflicts in the region.	[Johnson, Kirsten] McGill Univ, Int Div, Dept Family Med, Montreal, PQ H2W 1S4, Canada; [Asher, Jana; Kisielewski, Michael] StatAid, Takoma Pk, MD 20910 USA; [Lawry, Lynn] Off Assistant Secretary Def Hlth Affairs, Int Hlth Div, Falls Church, VA 22041 USA		Johnson, K (corresponding author), McGill Univ, Int Div, Dept Family Med, 515 Pine Ave W, Montreal, PQ H2W 1S4, Canada.		Asher, Jana/AAB-1393-2021; Johnson, Kirsten/AAF-7009-2020; Lawry, Lynn/ABE-8391-2021	Asher, Jana/0000-0003-0559-0372; Lawry, Lynn/0000-0001-8229-8768	IMC through Schooner Foundation; Center for Disaster and Humanitarian Assistance Medicine through the Henry Jackson Foundation; Hunt Family Foundation	We are grateful to the Liberian Ministry of Health and International Medical Corps (IMC) as well as our paid Liberian interviewers and our paid data entry colleagues. The funding for this manuscript was provided by IMC, through a donation by the Schooner Foundation; the Center for Disaster and Humanitarian Assistance Medicine, through the Henry Jackson Foundation and the Hunt Family Foundation.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Betancourt Theresa, 2008, PSYCHOSOCIAL ADJUSTM; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Burnam A, 2009, HEALTH AFFAIR, V28, P771, DOI 10.1377/hlthaff.28.3.771; Burt CDB, 2001, MEM COGNITION, V29, P127, DOI 10.3758/BF03195747; *CDCP, SUIC ID; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Human Rights Watch, FIGHT KILL CHILD SOL; *INT COMM RED CROS, GEN CONV; Johnson K, 2008, JAMA-J AM MED ASSOC, V300, P676, DOI 10.1001/jama.300.6.676; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Karney BR, 2008, RAND HLTH WORKING PA; Keller SD, 1997, HEALTH SERV RES, V32, P367; Kim G, 2007, AM J PUBLIC HEALTH, V97, P353, DOI 10.2105/AJPH.2005.073635; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Pugel J, UN DEV PROGRAM KEY F; Shackman G, 2003, NEWSLETTER SURVEY RE, V16, P8; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; United Nations, UN MISS LIB; United Nations Children's Fund, 1997, CAP TOWN PRINC BEST; United Nations Human Rights Office of the High Commissioner, 2010, DEM REP CONG 1993 20; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	30	4	4	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2012	177	5					531	540		10.7205/MILMED-D-11-00185			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936XK	WOS:000303623100011	22645879	Bronze			2022-02-06	
J	Valerio, J; Illes, J				Valerio, J.; Illes, J.			Ethical Implications of Neuroimaging in Sports Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; neuroethics; neuroimaging; sports	TRAUMATIC BRAIN-INJURY; COLLEGE FOOTBALL PLAYERS; DIFFUSION-TENSOR; FUNCTIONAL MRI; HEAD-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; INTERNATIONAL-CONFERENCE; AXONAL INJURY; LIE DETECTION; MILD	The Centers for Disease Control and Prevention estimates that 1.6 to 3.8 million traumatic brain injuries that occur each year are related to sports injuries. New research has broadened the understanding of the acute and chronic pathophysiology of concussion associated with brain injury, and recent advances in diagnostic capabilities with neuroimaging are leading to new ethical questions around sport and care of the head-injured athlete. In this review, we synthesize the current literature on neuroimaging for assessing concussed athletes and explore ethical issues in the context of return to play, short- and long-term neurologic health effects following concussion and resource allocation that are emerging with new implications as neurotechnology becomes an increasingly powerful tool on the playing field of health.	[Valerio, J.; Illes, J.] Univ British Columbia, Dept Med, Div Neurol, Natl Core Neuroeth, Vancouver, BC V6T 1W5, Canada		Valerio, J (corresponding author), Univ British Columbia, Dept Med, Div Neurol, Natl Core Neuroeth, 2211 Wesbrook Mall,S124, Vancouver, BC V6T 1W5, Canada.	jvale093@uottawa.ca			CIHR/INMHA CNECanadian Institutes of Health Research (CIHR) [85117]; Canadian Foundation for InnovationCanada Foundation for Innovation; British Columbia Knowledge Development Fund; NIH/NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH084282]; Vancouver Coastal Health Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084282] Funding Source: NIH RePORTER	The work related to this paper is also supported by CIHR/INMHA CNE #85117, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, and NIH/NIMH R01# MH084282.; The authors are grateful to the Vancouver Coastal Health Research Institute for supporting this clinical neuroethics work.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Beauchamp TL, 1979, PRINCIPLES BIOMEDICA, P314; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Brach B, 2010, CTV NEWS        0814; Burger IM, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902790583; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Echemendia RJ, 2009, MTBI C PROGR AUG 12; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gazzinaga M, 2006, ETHICAL BRAIN; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Illes J, 2009, INTELLECTUAL MUSCLE; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jonsen AR, 2002, CLIN ETHICS PRACTICA, V5; Katz D, 2003, JAMA-J AM MED ASSOC, V290, P2404, DOI 10.1001/jama.290.18.2404-c; Katz D, 2003, JAMA-J AM MED ASSOC, V290, P2406; Kutcher Jeffrey S, 2010, Continuum (Minneap Minn), V16, P41, DOI 10.1212/01.CON.0000391452.30299.67; Lau PW, 2009, AM J BIOETHICS, V9, P21, DOI 10.1080/15265160802716845; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; MacMullan J, 2007, BOSTON GLOBE     020, p1E; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2008, SCIENCE, V321, P626, DOI 10.1126/science.321.5889.626b; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Piantanida Nicholas A, 2004, Curr Sports Med Rep, V3, P89; Racine E, 2005, NAT REV NEUROSCI, V6, P159, DOI 10.1038/nrn1609; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sadatsafavi M, 2010, VALUE HEALTH, V13, P761, DOI 10.1111/j.1524-4733.2010.00755.x; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Simpson JR, 2008, J AM ACAD PSYCHIATRY, V36, P491; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spriggs M, 2004, J MED ETHICS, V30, P515, DOI 10.1136/jme.2003.003541; Wesolowski K, 2010, NEUROLOGY TODAY; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	58	4	4	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					216	221		10.1097/HTR.0b013e3182229b6c			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500010	21897290				2022-02-06	
J	Jiang, SY; Wu, XH; Yan, YH; Xu, J; Shao, B; Zhuang, X; Han, YY; Gu, XS				Jiang, Shengyang; Wu, Xiaohong; Yan, Yaohua; Xu, Jian; Shao, Bai; Zhuang, Xun; Han, Yingying; Gu, Xiaosong			The expression changes of Numblike in rat brain cortex after traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Numbl; Traumatic brain injury; Rats; Neurons	CORTICAL NEUROGENESIS; MECHANISMS; APOPTOSIS; CALCIUM; TRAF6; DEATH; CELLS	Numblike (Numbl) plays an important role in ependymal wall integrity and subventricular zone neuroblast survival. And Numbl is specifically expressed in the brain. However, its expression and function in the central nervous system lesion are still unclear. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the dynamic changes of Numbl expression in the brain cortex. Western blot and immunohistochemistry analysis revealed that Numbl was present in normal brain. It gradually decreased, reached the lowest point at day 3 after TBI, and then increased during the following days. Double immunofluorescence staining showed that Numbl immunoreactivity was found in neurons, but not astrocytes and microglia. Moreover, the 3rd day post injury was the apoptotic peak implied by the alteration of caspase-3. All these results suggested that Numbl may be involved in the pathophysiology of TBI and further research is needed to have a good understanding of its function and mechanism.	[Jiang, Shengyang; Wu, Xiaohong; Xu, Jian; Shao, Bai; Gu, Xiaosong] Soochow Univ, Coll Med, Dept Anat, Sch Basic Med & Biol Sci, Suzhou 215021, Peoples R China; [Jiang, Shengyang; Zhuang, Xun; Han, Yingying] Nantong Univ, Sch Publ Hlth, Nantong 226001, Peoples R China; [Yan, Yaohua] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Coll Med, Nantong 226001, Peoples R China; [Gu, Xiaosong] Nantong Univ, Key Lab Neurosci, Nantong 226001, Peoples R China		Gu, XS (corresponding author), Soochow Univ, Coll Med, Dept Anat, Sch Basic Med & Biol Sci, Suzhou 215021, Peoples R China.	ntguxiaosong@163.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	priority academic program development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by a project funded by the priority academic program development of Jiangsu Higher Education Institutions (PAPD).	Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Erhardt L, 1996, EUR HEART J, V17, P1781; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lomaga MA, 2000, J NEUROSCI, V20, P7384; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Shen Q, 2002, DEVELOPMENT, V129, P4843; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tokumitsu H, 2005, J BIOL CHEM, V280, P35108, DOI 10.1074/jbc.M503912200; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhou L, 2010, BIOCHEM BIOPH RES CO, V392, P409, DOI 10.1016/j.bbrc.2010.01.037	20	4	5	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379			J MOL HISTOL	J. Mol. Histol.	APR	2012	43	2					195	201		10.1007/s10735-011-9383-x			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	933JO	WOS:000303357100009	22476811				2022-02-06	
J	Nesnidal, P; Stulik, J; Barna, M				Nesnidal, P.; Stulik, J.; Barna, M.			Spinal Cord Concussion: A Retrospective Study of Twenty-Four Patients	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						spinal cord concussion; spinal cord injury; spinal trauma; SCIWORA	RADIOGRAPHIC ABNORMALITY; INJURY; CHILDREN; PATHOMECHANICS; NEURAPRAXIA; TRAUMA	PURPOSE OF THE STUDY Spinal cord concussion is characterised as fully reversible, temporary inhibition of conductive function due to trauma, without signs of structural changes. Although neurological deficit is usually related to the severity of spinal injury, this is different in spinal cord concussion. The aim of this retrospective study was to evaluate a group of 24 patients with spinal cord concussion, to design a diagnostic algorithm and propose an effective therapy with a good prognosis for the patients. MATERIAL We reviewed clinical records of 9 768 patients hospitalised at the Department of Spinal Surgery, University Hospital in Motol, from September 2002 till December 2010, and of 457 patients treated at other departments of the Hospital between January 2008 and December 2010; this was a total of 10 225 patients. The data were retrospectively analysed and only the patients with a clear history of trauma and subsequent conservative therapy were selected to comprise a group characterised by the generally known criteria of spinal cord concussion: (1) spinal injury with immediate neurological deficit of varying degree; (2) neurological deficit corresponding to the level of spinal injury; (3) recovery of neurological function within 72 hours of injury; (4) no morphological evidence of injury to the spinal structures obtained by imaging methods. This group comprised 24 patients. METHODS The patients were followed up from 6 to 95 months, with a mean of 46 months and a median of 48 months, at intervals of 6 and 12 weeks and 6 and 12 months after injury, and then every following year. The recorded information included the patient's age at the time of injury, their gender, the mechanism of injury, reports on alcohol consumption, the first detected neurological deficit, its development immediately after injury, during the hospital stay and at follow-ups in the out-patient department, methylprednisolone administration according to the National Acute Spinal Cord Injury Study (NASCIS) 2, and findings of imaging methods, particularly MRI. RESULTS Our group consisted of 22 men (91.7%) and two women (8.3%), with an average age of 29 years; the average age was 30 years in men and 18.5 years in women. Seven patients (29.2%) were younger than 18 years, with an average of 16.14 years; the remaining 17 patients (70.8%) were older than 18 years, with an average of 34.35 years. The major mechanisms of injury included falls from a height in 10 patients (41.7%) and injury due to alcohol consumption in five patients (20.1%). Clinical findings involved lesions of the medullary cone in 12 (50.0%), cervical spinal cord in seven (29.2%) and thoracic spinal cord in five (20.8%) patients. Motor function deficit was present in all patients, of whom 10 (41.2%) showed a complete loss of motor function. Impaired sensory function was found in 21 (87.5%) patients. One patient had perianal and genital sensory deficit and one (4.2%) had urinary retention. Neither radiograms nor CT scans showed traumatic changes in any of the patients; MRI findings free of any traumatic spinal changes were recorded in 21 patients (87.5%). One patient had oedema of the T5 and T8 vertebral bodies. No complications were recorded. All patients experienced rapid resolution of neurological deficit, which occurred within 6 hours of injury in two (8.4%), within 12 hours in two (8.4%), within 24 hours in 12 (50.0%) and within 48 hours in six (25.0%) patients, and later than 48 hours after injury in two patients (8.4%). However, recovery always occurred within 72 hours of injury. DISCUSSION A good prognosis for patients with this injury is supported by our findings, because all patients experienced rapid resolution of neurological deficit within 72 hours of injury. This result is in agreement with the relevant international studies reporting no serious complications associated with spinal trauma. There are no clear recommendations for administration of high doses of methylprednisolone according to the NASCIS system. CONCLUSIONS Spinal cord concussion is not a frequent injury; in our study, it accounted for 3.54% of the patients with trauma histories out of the total number of 678 patients, or for 2.40% out of 997 injured spinal levels. The first steps should be the same as in any other injury to the spinal cord. An early examination of the patient with imaging methods including MRI is of primary importance. At present administration of methylprednisolone according to the NASCIS system is disputable. The patient diagnosed with spinal cord concussion has a good prognosis, with rehabilitation as the main therapeutic approach.	[Nesnidal, P.; Stulik, J.; Barna, M.] Spondylochirurg Oddeleni FN Motol, Prague 15006 5, Czech Republic; [Stulik, J.] III Chirurg Klin 1 LF UK Praha, Prague, Czech Republic; [Stulik, J.] Ortoped Klin Deti & Dospelych 2 LF UK Praha, Prague, Czech Republic		Nesnidal, P (corresponding author), Spondylochirurg Oddeleni FN Motol, V Uvalu 84, Prague 15006 5, Czech Republic.	pnesnidal@centrum.cz	Barna, Michal/I-8000-2017; Nesnidal, Petr/I-6683-2017; Stulik, Jan/I-6650-2017	Barna, Michal/0000-0002-9786-9188; Nesnidal, Petr/0000-0003-1630-8168; Stulik, Jan/0000-0002-8980-849X			BAKER GS, 1946, J NEUROSURG, V3, P206, DOI 10.3171/jns.1946.3.3.0206; BASTIAN H. CH., 1867, MED CHIR T, V50, P466; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Dare AO, 2002, J NEUROSURG, V97, P33, DOI 10.3171/spi.2002.97.1.0033; DELBIGIO MR, 1989, SPINE, V14, P37, DOI 10.1097/00007632-198901000-00007; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FREEMAN LW, 1953, ANN SURG, V137, P433, DOI 10.1097/00000658-195304000-00001; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Liao CC, 2005, J NEUROSURG, V103, P17, DOI 10.3171/ped.2005.103.1.0017; Newton A, 1913, BRIT MED J, V1913, P1101, DOI 10.1136/bmj.1.2734.1101; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; SCHER AT, 1991, AM J SPORT MED, V19, P485, DOI 10.1177/036354659101900511; Smejkal K, 2009, ACTA CHIR ORTHOP TR, V76, P335; Smrcka M, 2001, PORANENI MOZKU; Sramek J, 2009, ACTA CHIR ORTHOP TR, V76, P128; Stulik J, 2007, ACTA CHIR ORTHOP TR, V74, P189; Stulik J, 2006, Acta Chir Orthop Traumatol Cech, V73, P313; Tomcovcik L, 2010, ACTA CHIR ORTHOP TR, V77, P320; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; TORG JS, 1995, CLIN ORTHOP RELAT R, P259; Werinberg RA, 2008, NEUROL CLIN, V26, P243, DOI 10.1016/j.ncl.2007.12.002; Winder MJ, 2011, J NEUROSURG-SPINE, V14, P677, DOI 10.3171/2011.1.SPINE10345; Yucesoy K, 2008, CLIN NEUROL NEUROSUR, V110, P429, DOI 10.1016/j.clineuro.2008.02.004; Zeman M., 2004, SPECIALNI CHIRURG; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	33	4	4	0	8	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	APR	2012	79	2					150	155					6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	932KB	WOS:000303288900010	22538107				2022-02-06	
J	Hwang, IK; Ahn, JH; Yoo, DY; Lee, CH; Yoo, KY; Choi, JH; Moon, SM; Shin, HC; Won, MH				Hwang, In Koo; Ahn, Ji Hyeon; Yoo, Dae Young; Lee, Choong Hyun; Yoo, Ki-Yeon; Choi, Jung Hoon; Moon, Seung Myung; Shin, Hyung-Cheul; Won, Moo-Ho			Increased Immunoreactivities of Cleaved alpha II-Spectrin and Cleaved Caspase-3 in the Aged Dog Spinal Cord	NEUROCHEMICAL RESEARCH			English	Article						Aging; Apoptosis; Gray matter; Spinal neurons; German shepherds	TRAUMATIC AXONAL INJURY; BRAIN-INJURY; ACTIVATION; EXPRESSION; APOPTOSIS; CALPAIN; NEURONS; MODEL; PROTEOLYSIS; MOUSE	The activation of caspase-3 is considered to be a reliable marker for apoptotic cell death, and a 120-kDa fragment of alpha II-spectrin is generated by caspase-3 mediated cleavage of this structural protein. In the present study, we compared cleaved alpha II-spectrin (120-kDa) and cleaved caspase-3-immunoreactive cells and their protein levels in the cervical (C-5-C-6) and lumbar (L-3-L-4) levels of the spinal cord in adult (1-2 year-old) and aged (10-12 year-old) dogs (German shepherds). Weak cleaved alpha II-spectrin and cleaved caspase-3 immunoreactivity was found in neurons of the adult group; however, their immunoreactivity was distinctively increased in the neuronal cytoplasm in the aged group compared to those in the adult group, although the distribution pattern of their neurons was similar between the adult and age group. In addition, cleaved alpha II-spectrin and cleaved caspase-3 levels in the aged spinal cord were markedly increased compared to those in the adult group. These findings suggest that the increases of cleaved alpha II-spectrin and cleaved caspase-3 immunoreactivity may be related to aging of the spinal cord in dogs.	[Shin, Hyung-Cheul] Hallym Univ, Dept Physiol, Coll Med, Chunchon 200702, South Korea; [Hwang, In Koo; Yoo, Dae Young] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Vet Med, Seoul 151742, South Korea; [Hwang, In Koo; Yoo, Dae Young] Seoul Natl Univ, Res Inst Vet Sci, Seoul 151742, South Korea; [Ahn, Ji Hyeon] Daegu Univ, Lab Neurosci, Dept Phys Therapy, Coll Rehabil, Gyongsan 712714, South Korea; [Lee, Choong Hyun] Dankook Univ, Coll Pharm, Dept Anat & Physiol, Cheonan 330714, South Korea; [Yoo, Ki-Yeon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Anat, Kangnung 210702, South Korea; [Choi, Jung Hoon] Kangwon Natl Univ, Coll Vet Med, Dept Anat, Chunchon 200701, South Korea; [Moon, Seung Myung] Hallym Univ, Coll Med, Hangang Sacred Heart Hosp, Dept Neurosurg, Seoul 150719, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 200701, South Korea		Shin, HC (corresponding author), Hallym Univ, Dept Physiol, Coll Med, Chunchon 200702, South Korea.	hcshin@hallym.ac.kr; mhwon@kangwon.ac.kr		MOON, Seung-Myung/0000-0001-6248-9049	Technology Innovation Program; Ministry of Knowledge Economy (MKE, Korea)Ministry of Knowledge Economy, Republic of Korea; Regional Core Research Program; Korea Ministry of Education, Science and Technology (Medical & Bio-material Research Center)Ministry of Education, Science and Technology, Republic of Korea	The authors would like to thank Mr. Seung Uk Lee for their technical help in this study. This work was supported by and by the Technology Innovation Program funded by the Ministry of Knowledge Economy (MKE, Korea), and by the Regional Core Research Program funded by the Korea Ministry of Education, Science and Technology (Medical & Bio-material Research Center).	Ahn JH, 2011, EXP GERONTOL, V46, P703, DOI 10.1016/j.exger.2011.03.001; Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; BAHR BA, 1994, NEUROSCI LETT, V175, P49, DOI 10.1016/0304-3940(94)91075-8; BAHR BA, 1991, NEUROSCI LETT, V131, P237, DOI 10.1016/0304-3940(91)90622-Z; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Candelario-Jalil E, 2003, NEUROSCI RES, V47, P245, DOI 10.1016/S0168-0102(03)00184-6; Chopek JW, 2010, MECH AGEING DEV, V131, P650, DOI 10.1016/j.mad.2010.09.001; Chung JY, 2010, NEUROCHEM RES, V35, P620, DOI 10.1007/s11064-009-0108-4; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Cui N, 2007, NEUROCHEM RES, V32, P1566, DOI 10.1007/s11064-007-9359-0; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hwang IK, 2011, RES VET SCI, V91, pE10, DOI 10.1016/j.rvsc.2011.02.010; Karmakar S, 2007, NEUROCHEM RES, V32, P2103, DOI 10.1007/s11064-007-9376-z; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Khalaj L, 2011, NEUROCHEM RES, V36, P268, DOI 10.1007/s11064-010-0314-0; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee HJ, 2011, NEUROCHEM RES, V36, P435, DOI 10.1007/s11064-010-0361-6; Li JH, 1998, MOL BRAIN RES, V53, P174, DOI 10.1016/S0169-328X(97)00295-7; LOWY MT, 1995, J NEUROCHEM, V65, P268; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Newcomb JK, 2000, METH MOL B, V144, P219; Okabayashi S, 2007, CELL MOL NEUROBIOL, V27, P819, DOI 10.1007/s10571-007-9205-6; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; de Amorim MAR, 2010, EXP GERONTOL, V45, P457, DOI 10.1016/j.exger.2010.03.015; Rohn TT, 2002, NEUROBIOL DIS, V11, P341, DOI 10.1006/nbdi.2002.0549; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sarasa M, 2009, CURR ALZHEIMER RES, V6, P171, DOI 10.2174/156720509787602834; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x; Tan HB, 2006, ARCH HISTOL CYTOL, V69, P297, DOI 10.1679/aohc.69.297; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yang FS, 1998, AM J PATHOL, V152, P379	39	4	4	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2012	37	3					480	486		10.1007/s11064-011-0633-9			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	920KW	WOS:000302404300003	22037840				2022-02-06	
J	McLay, RN; Webb-Murphy, J; Hammer, P; Volkert, S; Klam, W				McLay, Robert N.; Webb-Murphy, Jennifer; Hammer, Paul; Volkert, Stacy; Klam, Warren			Post-traumatic stress disorder symptom severity in service members returning from Iraq and Afghanistan with different types of injuries	CNS SPECTRUMS			English	Article						Afghanistan; epidemiology; injury; Iraq; PTSD; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PTSD; SOLDIERS; PREVALENCE; ETIOLOGY; EVENTS; BLAST; RISK	Introduction. Risk for post-traumatic stress disorder (PTSD) varies in part due to the nature of the traumatic event involved. Both injury and return from combat pose high risk of PTSD symptoms. How different injuries may predispose towards PTSD is less well understood. Methods. A retrospective record review was conducted from 1402 service members who had returned to Naval Medical Center San Diego from Iraq or Afghanistan and who had completed the PTSD Checklist as part of their post-deployment screening. Rates of PTSD were examined in relation to mechanism of injury. Results. Of those without injury, 8% met Diagnostic and Statistical Manual criteria for PTSD. Thirteen percent of those with a penetrating injury, 29% with blunt trauma, and 33% with combination injuries met criteria for PTSD. PTSD severity scores varied significantly according to type of injury. Discussion. The World War I concept of "shell shock" implied that blast-related injuries were more likely to result in psychological symptoms than were other injuries. These data may support that idea. Circumstance of injury, population differences, and reporting bias could also have influenced the results. Conclusion. These results suggest that service members with blunt or combination injuries merit particular attention when screening for PTSD.	[McLay, Robert N.] USN, San Diego Med Ctr, Mental Hlth Serv, Dept Mental Hlth, San Diego, CA 92134 USA; [Webb-Murphy, Jennifer; Hammer, Paul] USN, Ctr Combat & Operat Stress Control, San Diego, CA 92152 USA		McLay, RN (corresponding author), USN, San Diego Med Ctr, Mental Hlth Serv, Dept Mental Hlth, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	robert.mclay@med.navy.mil					Amir M, 1999, J TRAUMA STRESS, V12, P139, DOI 10.1023/A:1024754618063; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bourke J, SHELL SHOCK DURING W; Bromet E, 1998, AM J EPIDEMIOL, V147, P353; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400; Mclay RN, 2008, AM J PSYCHIAT, V165, P775, DOI 10.1176/appi.ajp.2008.07121960; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604	22	4	4	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529			CNS SPECTRUMS	CNS Spectr.	MAR	2012	17	1					11	15		10.1017/S1092852912000016			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	951KM	WOS:000304719400003	22790113				2022-02-06	
J	Murdoch, BE; Kuruvilla, MS; Goozee, JV				Murdoch, Bruce E.; Kuruvilla, Mili S.; Goozee, Justine V.			RETRACTED: Effect of speech rate manipulations on articulatory dynamics in severe traumatic brain injury: An EMA and EPG study (Retracted article. See vol. 30, pg. 1041, 2016)	BRAIN INJURY			English	Article; Retracted Publication						Traumatic brain injury; articulatory kinematics; speech rate manipulations; electromagnetic articulatography; electropalatography	DIFFERENT SPEAKING CONDITIONS; ORAL DIADOCHOKINESIS; MUSCLE-ACTIVITY; DYSARTHRIA; MOVEMENTS; TASK; CONSONANTS; DISORDERS; STABILITY; VELOCITY	Background: Manipulation of speech rate forms an integral part of the treatment of dysarthria and the effects of changes in speech rate on articulatory dynamics in persons with traumatic brain injury (TBI) is poorly documented. Objective: To determine the effects of manipulations of speech rate (habitual vs fast) on lingual kinematics and tongue-to-palate contacts in adult speakers with severe TBI and matched normal controls. Materials and methods: Six adults with severe TBI and five matched non-neurologically impaired controls underwent testing of their articulatory function using electromagnetic articulography (EMA) and electropalatography (EPG). Results: The results demonstrated that the TBI and control groups selected different strategies for increasing speech rate, with the TBI group showing an increase in articulatory effort estimated from an increase in maximum velocity and maximum acceleration/deceleration of tongue movement when speaking at the fast rate. The control group demonstrated no effects of a fast speech rate on articulatory kinematics for sentence productions. Conclusions: When speaking at a fast rate, individuals with severe TBI appear to use greater articulatory effort, possibly to preserve the distinctiveness of phonetic segments in order to avoid articulatory undershoot. In contrast, control subjects show a greater economy of effort when speaking at a fast rate, possibly to preserve articulatory precision.	[Murdoch, Bruce E.; Goozee, Justine V.] Univ Queensland, Ctr Neurogen Commun Disorders Res, St Lucia, Qld, Australia; [Kuruvilla, Mili S.] Munroe Meyer Inst Genet & Rehabil, Neurogenet Commun Disorders Ctr, Omaha, NE USA		Murdoch, BE (corresponding author), Third Mil Med Univ, Dept Neurobiol, Coll Basic Med Sci, Chongqing Key Lab Neurobiol, Chongqing 400038, Peoples R China.	b.murdoch@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Kuruvilla-Dugdale, Mili/0000-0001-7900-2364	Motor Accident Insurance Commission of Queensland, Australia	This work was supported by a research grant from the Motor Accident Insurance Commission of Queensland, Australia. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Brooks V., 1986, NEURAL BASIS MOTOR C; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Dembowski J., 1993, ANN B RES I LOGOPEDI, V27, P13; DENIL LF, 1991, J ACOUST SOC AM, V89, P845, DOI 10.1121/1.1894645; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; FLEGE JE, 1988, J ACOUST SOC AM, V84, P901, DOI 10.1121/1.396659; GAY T, 1973, PHONETICA, V27, P44, DOI 10.1159/000259425; GAY T, 1981, PHONETICA, V38, P148, DOI 10.1159/000260020; GIBBON F, 1990, BRIT J DISORD COMMUN, V25, P329; Goozee JV, 2003, CLIN LINGUIST PHONET, V17, P375, DOI 10.1080/0269920031000079967; Goozee JV, 2000, THESIS U QUEENSLAND; Hall KD, 1997, INT CONGR SER, V1146, P547; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; KENT RD, 1972, J SPEECH HEAR RES, V15, P453, DOI 10.1044/jshr.1503.453; Kleinow J, 2001, J SPEECH LANG HEAR R, V44, P1041, DOI 10.1044/1092-4388(2001/082); Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; Lindblom B, 1988, C LANG CHANG BIOL EV; McClean MD, 2003, J SPEECH LANG HEAR R, V46, P1387, DOI 10.1044/1092-4388(2003/108); MCHENRY M, 1994, BRAIN INJURY, V8, P363, DOI 10.3109/02699059409150987; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; OSTRY DJ, 1985, J ACOUST SOC AM, V77, P640, DOI 10.1121/1.391882; Perkell JS, 2002, J ACOUST SOC AM, V112, P1642, DOI 10.1121/1.1506368; Perkell JS, 2002, J ACOUST SOC AM, V112, P1627, DOI 10.1121/1.1506369; Scott D, 2002, EPGLAB MANUAL UNPUB; Smith A, 2000, J SPEECH LANG HEAR R, V43, P521, DOI 10.1044/jslhr.4302.521; SMITH A, 1995, EXP BRAIN RES, V104, P493; Sonoda Y, 1986, J ACOUSTICAL SOC JAP, V7, P51; Tasko SM, 2004, J SPEECH LANG HEAR R, V47, P85, DOI 10.1044/1092-4388(2004/008); Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P155; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Weismer G, 2000, FOLIA PHONIATR LOGO, V52, P201, DOI 10.1159/000021536; Wohlert AB, 2000, J SPEECH LANG HEAR R, V43, P1229, DOI 10.1044/jslhr.4305.1229; Yorkston KM, 1991, CLIN MANAGEMENT DYSA; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614; [No title captured]	43	4	4	0	24	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					241	260		10.3109/02699052.2011.650664			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100005	22372412				2022-02-06	
J	Staudenmayer, K; Hsia, R; Wang, E; Sporer, K; Ghilarducci, D; Spain, D; Mackersie, R; Sherck, J; Kline, R; Newgard, C				Staudenmayer, Kristan; Hsia, Renee; Wang, Ewen; Sporer, Karl; Ghilarducci, David; Spain, David; Mackersie, Robert; Sherck, John; Kline, Richard; Newgard, Craig			The forgotten trauma patient: Outcomes for injured patients evaluated by emergency medical services but not transported to the hospital	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Outcomes assessment; traumatic brain injury; quality of health care	PROBABILISTIC LINKAGE; AMBULANCE; RECORDS	BACKGROUND: Injured patients who are not transported by an ambulance to the hospital are often not included in trauma registries. The outcomes of these patients have until now been unknown. Understanding what happens to nontransports is necessary to better understand triage validity, patient outcomes, and costs associated with injury. We hypothesized that a subset of patients who were not transported from the scene would later present for evaluation and that these patients would have a nonzero mortality rate. METHODS: This is a population-based, retrospective cohort study of injured adults and children for three counties in California from 2006 to 2008. Prehospital data for injured patients for whom an ambulance was dispatched were probabilistically linked to trauma registry data from four trauma centers, state-level discharge data, emergency department records, and death files (1-year mortality). RESULTS: A total of 69,413 injured persons who were evaluated at the scene by emergency medical services were included in the analysis. Of them, 5,865 (8.5%) were not transported. Of those not transported, 1,616 (28%) were later seen in an emergency department and discharged and 92 (2%) were admitted. Seven (0.2%) patients later died. CONCLUSION: Patients evaluated by emergency medical services, but not initially transported from the field after injury, often present later to the hospital. The mortality rate in this population was not zero, and these patients may represent preventable deaths. (J Trauma. 2012; 72: 594-600. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Staudenmayer, Kristan; Wang, Ewen; Spain, David] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Hsia, Renee; Sporer, Karl] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Mackersie, Robert] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Ghilarducci, David] Santa Clara Cty EMS, San Jose, CA USA; [Sherck, John] Santa Clara Valley Med Ctr, Dept Surg, San Jose, CA 95128 USA; [Kline, Richard] Reg Med Ctr, Trauma Serv, San Jose, CA USA; [Newgard, Craig] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA		Staudenmayer, K (corresponding author), 300 Pasteur Dr,H3591, Stanford, CA 94305 USA.	kristans@stanford.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001085] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR024146, UL1 RR024131, 1UL1 RR025744, UL1 RR025744, C06 RR011234, UL1 RR025764, UL1-RR025764, UL1 RR024140] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024131, UL1RR025764, UL1RR025744, UL1RR024140, UL1RR024146, C06RR011234] Funding Source: NIH RePORTER		Burstein JL, 1996, AM J EMERG MED, V14, P23, DOI 10.1016/S0735-6757(96)90007-8; Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580; Dean JM, 2001, ANN EMERG MED, V37, P616, DOI 10.1067/mem.2001.115214; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Knight S, 2003, ANN EMERG MED, V42, P689, DOI 10.1016/S0196-0644(03)00524-9; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Newgard CD, ACAD EMERG IN PRESS; Newgard CD, 2011, PREHOSP EMERG CARE, V15, P303, DOI 10.3109/10903127.2011.561404; Pringle RP, 2005, J EMERG MED, V28, P449, DOI 10.1016/j.jemermed.2004.11.025; Schmidt T, 2000, ACAD EMERG MED, V7, P663, DOI 10.1111/j.1553-2712.2000.tb02041.x; Schmidt T A, 2001, Prehosp Emerg Care, V5, P366, DOI 10.1080/10903120190939526; Schmidt TA, 1998, ACAD EMERG MED, V5, P796, DOI 10.1111/j.1553-2712.1998.tb02506.x	12	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2012	72	3					594	599		10.1097/TA.0b013e31824764ef			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	906TR	WOS:000301371100016	22491541	Green Accepted			2022-02-06	
J	Whitney, N; Raslan, AM; Ragel, BT				Whitney, Nathaniel; Raslan, Ahmed M.; Ragel, Brian T.			Decompressive craniectomy in a neurologically devastated pregnant woman to maintain fetal viability	JOURNAL OF NEUROSURGERY			English	Article						decompressive hemicraniectomy; pregnant; fetus	MATERNAL BRAIN-DEATH; SOMATIC SUPPORT; ANESTHETICS; INJURY; ISSUES	Severe traumatic brain injury (TBI) in pregnant women can result in devastating outcomes for both the mother and the fetus. Historically, there has been concern regarding the issues involved when the fetus is not yet viable outside the womb. Currently, the ability to treat severe TBI with aggressive management of intracranial pressure (ICP) has led to the possibility of sustaining maternal life until the fetus is of a viable age and can be delivered. The authors present the case of a young woman 21 weeks pregnant with a severe TBI (Glasgow Coma Scale Score 3) in whom safe medical ICP management became ineffective. A decompressive craniectomy was performed to obviate the need for aggressive medical management of elevated ICP using fetal-toxic medications, and thus providing the fetus the best chance of continued in utero development until a viable gestational age was reached. (DOI: 10.3171/2011.11.JNS11707)	[Whitney, Nathaniel; Raslan, Ahmed M.; Ragel, Brian T.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97239 USA		Ragel, BT (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol Surg, 3303 SW Bond Ave,CH8N, Portland, OR 97239 USA.	ragelb@ohsu.edu	Whitney, Nathaniel/AAC-4496-2019				Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Creeley CE, 2010, ANESTH ANALG, V110, P442, DOI 10.1213/ANE.0b013e3181c6b9ca; DILLON WP, 1982, JAMA-J AM MED ASSOC, V248, P1089, DOI 10.1001/jama.248.9.1089; Farragher RA, 2005, NEUROCRIT CARE, V3, P99, DOI 10.1385/NCC:3:2:099; FIELD DR, 1988, JAMA-J AM MED ASSOC, V260, P816, DOI 10.1001/jama.260.6.816; Lane A, 2004, INTENS CARE MED, V30, P1484, DOI 10.1007/s00134-004-2305-6; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Loepke AW, 2010, PEDIATR CRIT CARE ME, V11, P217, DOI 10.1097/PCC.0b013e3181b80383; Powner DJ, 2003, CRIT CARE MED, V31, P1241, DOI 10.1097/01.CCM.0000059643.45027.96; SAMPSON MB, 1979, OBSTET GYNECOL, V53, pS2; van Bogaert LJ, 2008, BEST PRACT RES CL OB, V22, P983, DOI 10.1016/j.bpobgyn.2008.06.012; Webb GW, 1996, CLIN PERINATOL, V23, P453, DOI 10.1016/S0095-5108(18)30220-3	12	4	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2012	116	3					487	490		10.3171/2011.11.JNS11707			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	897LL	WOS:000300652100006	22196099				2022-02-06	
J	Wong, V; Cheuk, DKL; Lee, S; Chu, V				Wong, V.; Cheuk, D. K. L.; Lee, S.; Chu, V.			Acupuncture for acute management and rehabilitation of traumatic brain injury	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Acupuncture; Brain injuries; Rehabilitation	CLINICAL-TRIALS; EPIDEMIOLOGY; IMPACT	Aim. Traumatic brain injury (TB!) can be life threatening depending on the severity of the insult to the brain. It can also cause a range of debilitating sequelae which require cognitive, motor, communication, emotional, or behavioral rehabilitation of varying intensity and duration. A number of studies conducted and published in China have suggested that acupuncture may be beneficial in the acute treatment and rehabilitation of TBI. The aim of this paper was to determine the efficacy and safety of acupuncture in the acute management or rehabilitation (or both) of patients with a TB!, including cognitive, neurological, motor, communication, emotional, or behavioral complications, or a combination of such complications. Methods. We searched the Cochrane Injuries Group Specialised Register, Cochrane Central Register of Controlled Trials 2008, Issue 2 (The Cochrane Library), MEDLINE, EMBASE, CINAHL, AMED, Psy-cINFO and others. We also searched the Chinese Acupuncture Studies Register, the Studies Register of the Cochrane Complementary Medicine Field, NC-CAM, and NIH Clinical Studies Database. Three major Mainland Chinese academic literature databases (CNKI, VIP and Wang Fang Data) were also searched using keywords in simplified Chinese. Searches were completed in December 2009. Randomized controlled studies evaluating different variants of acupuncture and involving participants of any age who had suffered a TBI. Included trials compared acupuncture with placebo or sham treatment, or acupuncture plus other treatments compared with the same other treatments. We excluded trials that only compared different variants of acupuncture or compared acupuncture alone against other treatments alone, as they did not yield the net effect of acupuncture. Two review authors identified potential articles from the literature search and extracted data independently using a data extraction form. We performed methodological assessment of included studies using the Cochrane Collaboration's tool for assessing risk of bias. We were unable to perform quantitative data analysis due to insufficient included studies and available data. Results. Four RCTs, including 294 participants, reported outcomes specified by this review. Three investigated electro-acupuncture for TBI while one investigated acupuncture for acute The results seem to suggest that acupuncture is efficacious for these indications, however the low methodological quality of these studies renders the results questionable. No adverse effects of acupuncture were reported in any of the studies. Conclusion. The low methodological quality of the included studies does not allow us to make conclusive judgments on the efficacy and safety of acupuncture in either the acute treatment and/or rehabilitation of TBI. Its beneficial role for these indications remains uncertain. Further research with high quality trials is required.	[Wong, V.; Cheuk, D. K. L.; Lee, S.; Chu, V.] Univ Hong Kong, Dept Pediat & Adolescent Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China		Wong, V (corresponding author), Univ Hong Kong, Dept Pediat & Adolescent Med, Queen Mary Hosp, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	vcnwong@hkucc.hku.hk		Cheuk, Daniel/0000-0001-9553-3528			Cao WS, 2001, MODERN REHABILITATIO, V5, P110; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Chang Z, 2005, CHINESE J MED DEVICE, V18, P38; Chen Y., 2007, JILIN J TRADITIONAL, V27, P38; Cheuk DKL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005375.pub2; Cheuk DKL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005062.pub2; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; De Georgia M, 1999, CEREBROVASC DIS, V9, P28, DOI 10.1159/000015892; Ding J, 2002, ZHONGGUO ZHENJIU, V22, P445; Donnellan Clare P, 2006, Acupunct Med, V24, P129; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERNST E, 2001, DESKTOP GUIDE COMPLE; Gao ZY, 2007, J NEW CHINESE MED, V39, P29; Gu Q, 2004, JIANGXI J TRADITIONA, V259, P57; Guo Y, 2006, SHANXI J TRADITIONAL, V22, P40; Han GZ, 2005, CHINESE COMMUNITY DO, V50, P42; [何竟 He Jing], 2004, [中医杂志, Journal of Traditional Chinese Medicine], V45, P504; He L, 2008, COCHRANE DB SYST REV; Higgins J.P., 2011, COCHRANE HDB SYSTEMA; Huang XL, 2006, J QILU NURSING, V12, P736; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JANSEN G, 1989, NEUROSCI LETT, V97, P305, DOI 10.1016/0304-3940(89)90615-0; Jia J, 2001, SHANGHAI J ACUPUNCTU, V20, P7; JOHANSSON K, 1993, NEUROLOGY, V43, P2189, DOI 10.1212/WNL.43.11.2189; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li HY, 2005, HUBEI COLL TRADITION, V27, P46; Li Y, 1993, J Tradit Chin Med, V13, P5; [李壮志 Li Zhuangzhi], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P380; Liang W, 2000, NEW J TRADITIONAL CH, V32, P21; Liu HR, 2006, SHANGHAI J ACUPUNCTU, V25, P5; Lu YZ, 2007, JIANGSU J TRADITIONA, V39, P43; Lund Irene, 2006, Acupunct Med, V24, P13; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; MAGNUSSON M, 1994, STROKE, V25, P1176, DOI 10.1161/01.STR.25.6.1176; Melchart D, 2008, COCHRANE DB SYST REV; Mukkamala Sridevi, 2003, ARCH PHYS MED REHAB, V84, pA7; National Institutes of Health Consensus Panel, AC NAT I HLTH CONS D; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pomeranz B, 1989, SCI BASES ACUPUNCTUR, p[1, 97]; ROSENTHAL M, 1990, REHABILITATION ADULT; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Scott SG, 2005, FEDERAL PRACTITIONER, V22, P67; [石奕丽 Shi Yili], 2004, [中国针灸, Chinese Acupuncture and Moxibustion], V24, P670; Song Y, 2007, SHANGHAI J ACUPUNCT, V26, P11; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Sun H, 2001, CHINESE ACUPUNCTURE, V21, P275; Sun Y, 2005, J CLIN ACUPUNCTURE M, V21, P25; Tian XG, 2007, GANSU J TRADITIONAL, V20, P40; University of Michigan Health System, BRAIN INJ PAT NOW TU; Wei L, 2001, CHINESE ACUPUNCTURE, V21, P483; Wei YX, 2007, GUANGXI J TRADITIONA, V30, P20; White AR, 2001, COMPLEMENT THER MED, V9, P237, DOI 10.1054/ctim.2001.0489; Wong V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007700.pub2; Wu HM, 2008, COCHRANE DB SYST REV; Wu J N, 1996, J Altern Complement Med, V2, P19, DOI 10.1089/acm.1996.2.19; Wu YF, 2007, CHINESE J MODERN DRU, V1, P43; Xiang GB, 2007, J ANHUI TRADITIONAL, V26, P27; Xu XL, 2006, J CLIN ACUPUNCTURE M, V22, P39; Xu YL, 2007, CHINESE J PRACTICAL, V10, P19; Yang XH, 2004, J NURSING SCI, V19, P30; Zhang AR, 1996, CHINESE J INTEGRATIV, V15, P262; Zhang JH, 2005, CHINESE J REHABILITA, V20, P23; Zhang SH, 2008, COCHRANE DB SYST REV; Zhao JP, 2000, SHANGHAI J TRADITION, V16, P35; Zheng JJ, 2005, J CLIN ACUPUNCTURE M, V21, P38; 王建成, 2007, [中医杂志, Journal of Traditional Chinese Medicine], V48, P149; 廖琳, 2006, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V28, P124	70	4	4	0	16	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2012	48	1					71	86					16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	944VT	WOS:000304232600008	22679638				2022-02-06	
J	Fife, GP; Harter, RA				Fife, Gabriel P.; Harter, Rod A.			A comparison of concussion assessment and management protocols used by medical personnel at elite taekwondo tournaments in the Republic of Korea and the United States	ARCHIVES OF BUDO			English	Article						taekwondo; concussion assessment; concussion management; appropriate medical personnel	SPORT	Background and Study Aim: Little is known about the assessment and management protocols used by taekwondo tournament medical personnel to evaluate concussions. The purpose of this study was to compare the methods used by medical personnel in the Republic of Korea and the United States to assess and manage concussions sustained at elite taekwondo tournaments. Material/Methods: Between 2006 and 2008, pencil-and-paper questionnaires were administered to 18 medical personnel providing sports medicine services at three national-level taekwondo tournaments in South Korea, and at one national-level taekwondo tournament in the United States. Results: Four of 11 South Korean medical personnel (36%) held registered nursing (RN) credentials, four were physical therapists (36%), and three (27%) were emergency medical technicians (EMTs). In comparison, 2 of 7 American medical personnel were physicians (29%), two were certified athletic trainers (29%), two were EMTs (29%), and one was a physical therapist (14%). Of the South Korean medical personnel, 55% had less than 1 year experience serving as medical providers at taekwondo tournaments. In contrast, 71% of the American medical practitioners had greater than or equal to 5 years of experience serving as medical personnel at taekwondo tournaments, with the majority reporting greater than 10 years of experience at national level taekwondo tournaments. Both groups reported using symptoms checklists and clinical examination as their principal methods of concussion assessment. Conclusions: We recommend that taekwondo national governing bodies assign medical personnel who have extensive direct experience with the sport of taekwondo to provide medical services at national-level tournaments.	[Fife, Gabriel P.] Dong A Univ, Dept Phys Educ, Pusan, South Korea; [Harter, Rod A.] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX USA		Fife, GP (corresponding author), Dong A Univ, Dept Phys Educ, 180 Hadan,2 Dong Sahagu, Pusan, South Korea.	fifeg.dau.ac.kr@gmail.com					Ferrara Michael S., 2001, J Athl Train, V36, P145; Fife G, 2011, BRIT J SPORT MED, V45, P318, DOI [10.1136/bjsm.2011.084038.25, DOI 10.1136/BJSM.2011.084038.25]; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Football League, 2011, NFL ANN NEW SID CONC; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zemper E, 1994, AM SOC TEST MATER, P116	11	4	4	0	1	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-8698			ARCH BUDO	Arch. Budo	JAN 14	2012	8	1											6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	904KP	WOS:000301194800001					2022-02-06	
J	Aragona, CJD; Arango-Lasprilla, JC; Bartolome, MP; Fernandez, VL; Krch, D				Aragona, Carlos Jose De los Reyes; Arango-Lasprilla, Juan Carlos; Bartolome, Maria Perea; Fernandez, Valentina Ladera; Krch, Denise			The effect of cognitive impairment on self-generation in Hispanics with TBI	NEUROREHABILITATION			English	Article						Traumatic brain injury; self-generation technique; cognitive rehabilitation	MULTIPLE-SCLEROSIS; OLDER-ADULTS; MEMORY; DEMENTIA; MULTIPLICATION; DISTINCTIVENESS; STRATEGY; PEOPLE; WORDS; DEPTH	The objective of this study was to determine the moderating effect of cognitive impairment (CI) on the usefulness of the generation effect to improve learning and memory in Hispanics with traumatic brain injury (TBI). Sixty-one Hispanic individuals with TBI (29 without CI, 22 with mild to moderate CI, and 10 with severe CI) and 44 healthy controls (HC) were required to remember the last word in each of 32 sentences. Target words were presented in a self-generated and provided condition. Recall and recognition were examined immediately, after 30 minutes, and at one week. Individuals remembered and recalled significantly more words in the generated condition than the provided condition, regardless of group or time. The self-generation technique equally benefitted all participants regardless of TBI status or degree of CI. Future cognitive rehabilitation programs designed to improve short-term recall and recognition in Hispanic individuals with TBI should include the self-generation technique. Further research into the longer-term effects of the generation effects is warranted.	[Aragona, Carlos Jose De los Reyes] Univ Norte, Dept Psychol, Barranquilla, Colombia; [Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Bartolome, Maria Perea; Fernandez, Valentina Ladera] Univ Salamanca, Dept Basic Psychol Psychobiol & Behav Sci, E-37008 Salamanca, Spain; [Krch, Denise] Kessler Fdn Res Ctr, W Orange, NJ USA		Aragona, CJD (corresponding author), Univ Norte, Dept Psicol, Km 5 Via Puerto Colombia, Barranquilla, Colombia.	cdelosreyes@uninorte.edu.co	De los Reyes Aragon, Carlos Jose CDA/E-2585-2015; Perea, M. Victoria/B-2904-2018; De los Reyes Aragon, Carlos Jose/P-3516-2019; Ladera, Valentina/Q-6132-2017	De los Reyes Aragon, Carlos Jose CDA/0000-0003-4472-0635; Perea, M. Victoria/0000-0002-0258-8480; De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635; Ladera, Valentina/0000-0003-4075-4483			Andren S, 2005, SCAND J CARING SCI, V19, P157, DOI 10.1111/j.1471-6712.2005.00328.x; Arango-Lasprilla J., 2009, J MINORITY DISABILIT, V1, P47; Arango-Lasprilla J. C., 2006, REHABILITACION NEURO, P117; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; BEGG I, 1991, MEM COGNITION, V19, P487, DOI 10.3758/BF03199571; Bertsch S, 2007, MEM COGNITION, V35, P201, DOI 10.3758/BF03193441; BRAINERD CJ, 1995, J MEM LANG, V34, P157, DOI 10.1006/jmla.1995.1008; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CLARK SE, 1995, MEM COGNITION, V23, P442, DOI 10.3758/BF03197245; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Delos Reyes-Aragon C., 2009, PSICOLOGIA DESDE CAR, V24, pvii; Derwinger A, 2005, NEUROPSYCHOL REHABIL, V15, P37, DOI 10.1080/09602010343000336; EINSTEIN GO, 1984, J EXP PSYCHOL LEARN, V10, P133; FLORY P, 1995, Q J EXP PSYCHOL-A, V48, P153, DOI 10.1080/14640749508401382; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; GARDINER JM, 1985, J EXP PSYCHOL LEARN, V11, P732, DOI 10.1037/0278-7393.11.1-4.732; GARDINER JM, 1989, AM J PSYCHOL, V102, P295, DOI 10.2307/1423051; Goverover Y., 2005, J INT NEUROPSYCHO S1, V11, P49; Howe ML, 1998, J EXP CHILD PSYCHOL, V71, P170, DOI 10.1006/jecp.1998.2469; Hunt RR, 2003, J MEM LANG, V48, P811, DOI 10.1016/S0749-596X(03)00018-4; JACOBY LL, 1978, J VERB LEARN VERB BE, V17, P649, DOI 10.1016/S0022-5371(78)90393-6; JOHNS EE, 1988, J EXP PSYCHOL LEARN, V14, P180; Kinjo H, 2000, AM J PSYCHOL, V113, P95, DOI 10.2307/1423462; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Marsh EJ, 2001, MEM COGNITION, V29, P798, DOI 10.3758/BF03196409; Marsh EJ, 2006, J EXP PSYCHOL LEARN, V32, P1216, DOI 10.1037/0278-7393.32.5.1216; MCMURRAY DW, 1981, AUST J PSYCHOL, V33, P197, DOI 10.1080/00049538108258736; McNamara DS, 2000, J MEM LANG, V43, P652, DOI 10.1006/jmla.2000.2720; Mejia S, 2004, APPL NEUROPSYCHOL, V11, P196; Moreno Moreno Jhon Alexander, 2010, Psicol. caribe, P1; Mulligan NW, 2001, J EXP PSYCHOL LEARN, V27, P436, DOI 10.1037//0278-7393.27.2.436; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Ostrosky-Solis F., 2001, NEUROPSI EVALUACION; Pesta BJ, 1996, EXP AGING RES, V22, P155, DOI 10.1080/03610739608254004; Pesta BJ, 1999, MEM COGNITION, V27, P106, DOI 10.3758/BF03201217; PEYNIRCIOGLU ZF, 1993, MEM COGNITION, V21, P367, DOI 10.3758/BF03208269; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Soraci SA, 1999, J MEM LANG, V41, P541, DOI 10.1006/jmla.1999.2661; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Taconnat L, 2004, J EXP PSYCHOL LEARN, V30, P827, DOI 10.1037/0278-7393.30.4.827; Westmacott R, 2003, MEM COGNITION, V31, P761, DOI 10.3758/BF03196114	46	4	4	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	1					55	64		10.3233/NRE-2011-0727			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	904ZT	WOS:000301240900007	22349842	Green Published			2022-02-06	
J	Cagnin, A; Gasparoli, E; Santelli, L; Marcante, A; Briani, C				Cagnin, Annachiara; Gasparoli, Elisabetta; Santelli, Luca; Marcante, Andrea; Briani, Chiara			Posttraumatic Dystonia and Hemiplegic Migraine Different Expressions of Neuronal Hyperexcitability?	NEUROLOGIST			English	Article						post-traumatic dystonia; hemiplegic migraine; focal hand dystonia	FOCAL HAND DYSTONIA; ABNORMALITIES	The development of focal hand dystonia after a traumatic injury of the central or the peripheral nervous system is a rare condition with multifactorial predisposing factors. We report on a patient who developed focal dystonia of the left hand after a cervical whiplash injury. Magnetic resonance imaging did not show cerebral or spinal lesions, whereas a brain F-18-FDG PET scan revealed hypometabolism of the right primary sensory-motor cortex extending to the inferior and superior parietal lobule. The patient had a history of recurrent migraine attacks. Four months before the whiplash injury, she had transient dystonic posture of the left hand during a hemiplegic migraine attack. Brain magnetic resonance imaging scan and neurovascular investigations were negative. Among the predisposing factors to the development of trauma-induced dystonia, a putative role of neuronal hyperexcitability, shared by migraine and dystonia, is discussed.	[Cagnin, Annachiara; Gasparoli, Elisabetta; Santelli, Luca; Marcante, Andrea; Briani, Chiara] Univ Padua, Dept Neurosci, I-35128 Padua, Italy; [Gasparoli, Elisabetta] Osped San Camillo, IRCCS, Venice, Italy		Cagnin, A (corresponding author), Univ Padua, Dept Neurosci, Via Giustiniani 5, I-35128 Padua, Italy.	annachiara.cagnin@unipd.it	Marcante, Andrea/K-7703-2016	Marcante, Andrea/0000-0002-0869-6175			Abbruzzese G, 2001, BRAIN, V124, P537, DOI 10.1093/brain/124.3.537; Bara-Jimenez W, 1998, ANN NEUROL, V44, P828, DOI 10.1002/ana.410440520; de Vries B, 2007, NEUROLOGY, V69, P2170, DOI 10.1212/01.wnl.0000295670.01629.5a; Garraux G, 2004, ANN NEUROL, V55, P736, DOI 10.1002/ana.20113; Hill MD, 1999, MOVEMENT DISORD, V14, P684, DOI 10.1002/1531-8257(199907)14:4<684::AID-MDS1021>3.0.CO;2-G; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Lang E, 2004, BRAIN, V127, P2459, DOI 10.1093/brain/awh295; Meunier S, 2001, ANN NEUROL, V50, P521, DOI 10.1002/ana.1234; Quartarone A, 1998, J NEUROL NEUROSUR PS, V65, P272, DOI 10.1136/jnnp.65.2.272; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stam AH, 2008, CURR OPIN NEUROL, V21, P288, DOI 10.1097/WCO.0b013e3282fd171a; Tamburin S, 2005, MOVEMENT DISORD, V20, P354, DOI 10.1002/mds.20301; Tamburin S, 2003, J NEUROL NEUROSUR PS, V74, P134, DOI 10.1136/jnnp.74.1.134	15	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	JAN	2012	18	1					36	38		10.1097/NRL.0b013e31823d7aa9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877FN	WOS:000299162800005	22217613				2022-02-06	
J	Caracuel, A; Cuberos-Urbano, G; Santiago-Ramajo, S; Vilar-Lopez, R; Coin-Megias, MA; Verdejo-Garcia, A; Perez-Garcia, M				Caracuel, A.; Cuberos-Urbano, G.; Santiago-Ramajo, S.; Vilar-Lopez, R.; Coin-Megias, M. A.; Verdejo-Garcia, A.; Perez-Garcia, M.			Effectiveness of holistic neuropsychological rehabilitation for Spanish population with acquired brain injury measured using Rasch analysis	NEUROREHABILITATION			English	Article						Acquired brain injury; stroke; traumatic brain injury; holistic neuropsychological rehabilitation; outcome measures; Rasch analysis	COGNITIVE REHABILITATION; SUBSTANCE-ABUSERS; MEASUREMENT MODEL; SCALE; QUESTIONNAIRE; OUTCOMES; PATIENT	Introduction: The Rasch model is increasingly used in the field of rehabilitation because it improves the accuracy of measurements of patient status and their changes after therapy. Objective: To determine the long-term effectiveness of a holistic neuropsychological rehabilitation program for Spanish outpatients with acquired brain injury (ABI) using Rasch analysis. Methods: Eighteen patients (ten with long evolution - patients who started the program >6 months after ABI- and eight with short evolution) and their relatives attended the program for 6 months. Patients' and relatives' answers to the European Brain Injury Questionnaire and the Frontal Systems Behavior Scale at 3 time points (pre-intervention. post-intervention and 12 month follow-up) were transformed into linear measures called logits. Results: The linear measures revealed significant improvements with large effects at the follow-up assessment on cognitive and executive functioning, social and emotional self-regulation, apathy and mood. At follow-up, the short evolution group achieved greater improvements in mood and cognitive functioning than the long evolution patients. Conclusions: The program showed long-term effectiveness for most of the variables, and it was more effective for mood and cognitive functioning when patients were treated early. Relatives played a key role in the effectiveness of the rehabilitation program.	[Caracuel, A.; Cuberos-Urbano, G.; Santiago-Ramajo, S.; Vilar-Lopez, R.; Coin-Megias, M. A.; Verdejo-Garcia, A.; Perez-Garcia, M.] Dept Personalidad Evaluaci & Tratamiento Psicol, Granada, Spain; [Caracuel, A.; Vilar-Lopez, R.; Verdejo-Garcia, A.; Perez-Garcia, M.] Univ Granada, Inst Neurociencias F Oloriz, Granada, Spain; [Caracuel, A.] Hosp Univ Virgen Nieves, Granada, Spain		Caracuel, A (corresponding author), Fac Psicol, Campus Cartuja, Granada 18071, Spain.	acaracuel@ugr.es	Santiago-Ramajo, Sandra/H-6801-2015; Verdejo-Garcia, Antonio/AAV-1147-2021; Vilar-Lopez, Raquel/I-7847-2016; Caracuel, Alfonso/V-3695-2019; Garcia, Miguel Perez/F-9630-2010	Santiago-Ramajo, Sandra/0000-0002-6358-6155; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Vilar-Lopez, Raquel/0000-0001-9639-0143; Caracuel, Alfonso/0000-0002-9738-8456; Garcia, Miguel Perez/0000-0003-4775-7556			ANDERSEN EB, 1977, PSYCHOMETRIKA, V42, P69, DOI 10.1007/BF02293746; Andrich D., 2003, RUMM2020; Andrich D., 1988, RASCH MODELS MEASURE; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Ben-Yishay Y, 2000, INT HDB NEUROPSYCHOL, P127, DOI DOI 10.1007/978-1-4757-5569-5_8; Bennett TL, 2001, ARCH CLIN NEUROPSYCH, V16, P237, DOI 10.1016/S0887-6177(00)00082-2; BOND MR, 1990, REHABILITATION ADULT; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Bure-Reyes A, 2008, ARCH CLIN NEUROPSYCH, V23, P681; Caetano C, 1999, NEUROPSYCHOL REHABIL, V9, P447, DOI 10.1080/096020199389509; Caracuel A., BRAIN INJUR IN PRESS; Caracuel A., 2005, REHABILITACION, V39, P95; Caracuel A, 2011, J HEAD TRAUMA REHAB, V26, P478, DOI 10.1097/HTR.0b013e3181fc042c; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Christensen AL, 2005, ACT NEUR S, V93, P195; CHRISTENSEN AL, 1996, RECOVERY TRAUMATIC B, P235; CHRISTENSEN AL, 2000, INT HDB NEUROPSYCHOL; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Fisher W. J., 2004, RASCH MEAS TRANS, V18, P980; Fletcher-Janzen E., 2000, HDB CROSS CULTURAL N; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Mermis BJ, 2005, REHABIL PSYCHOL, V50, P15, DOI 10.1037/0090-5550.50.1.15; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; Odgaard EC, 2010, J CONSULT CLIN PSYCH, V78, P287, DOI 10.1037/a0019294; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pedrero-Perez EJ, 2009, REV NEUROLOGIA, V48, P624, DOI 10.33588/rn.4812.2008654; Prigatano G., 2002, CLIN NEUROPSYCHOLOGY; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rasch Georg, 1980, PROBABILISTIC MODELS; Siegal S., 1988, NONPARAMETRIC STAT B; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tesio L, 2007, Eura Medicophys, V43, P515; Tesio L, 2007, Eura Medicophys, V43, P417; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wilson M., 2005, CONSTRUCTING MEASURE; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; Wright BD., 1982, RATING SCALE ANAL	52	4	4	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	30	1					43	53		10.3233/NRE-2011-0726			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	904ZT	WOS:000301240900006	22349841				2022-02-06	
J	Chan, WY; Chew, NJL; Nasron, LIB; Fook-Chong, SMC; Ng, YS				Chan, Wai Yin; Chew, Natalie Jin Lin; Nasron, Leila Ilmami Binte; Fook-Chong, Stephanie Man Chung; Ng, Yee Sien			A cross-sectional study of the demographic, cultural, clinical and rehabilitation associated variables predicting return to employment after disability onset in an Asian society	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						In-patient rehabilitation; re-employment factors; return-to-work rate; employment	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE; MULTICENTER ANALYSIS; ISCHEMIC-STROKE; WORK	Objectives: This study examined the rate of return to work, and to find demographic, clinical and functional factors associated with successful re-employment after in-patient rehabilitation. Methods: We performed a cross-sectional cohort study of Singaporeans aged 15 and above who underwent inpatient rehabilitation in a Singapore hospital between 2000 and 2007. Phone interviews were conducted in 2007 to 2008, via a structured questionnaire to evaluate factors of return to work. Results: Four hundred and eight patients met with the inclusion criteria, and 123 participants completed the questionnaire. Forty-five (44.7%) participants successfully returned to work with a mean time of 7 months post-discharge. Statistical significant differences were found between the "return to work" group and "non-return to work" group based on age group (p = 0.04), education level (p = 0.001), pre-morbid job category (0.013) and functional status (p < 0.0005) as determined by Functional Independence Measure scores. Cox regression analysis controlling the period between discharge and survey indicated that higher FIM scores and higher education level predicted successful re-employment. Conclusion: This result re-affirmed the importance of functional status to the success of return-to-work in Singapore. Further qualitative studies might be useful in exploring the social or environmental factors affecting return-to-work outcomes.	[Chan, Wai Yin; Chew, Natalie Jin Lin; Nasron, Leila Ilmami Binte] Singapore Gen Hosp, Rehabil Ctr, Occupat Therapy Dept, Singapore 169608, Singapore; [Fook-Chong, Stephanie Man Chung] Singapore Gen Hosp, Div Res, Singapore 169608, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore 169608, Singapore		Chan, WY (corresponding author), Singapore Gen Hosp, Rehabil Ctr, Occupat Therapy Dept, Blk 1 Level 1,Outram Rd, Singapore 169608, Singapore.	yetta.chan.w.y@sgh.com.sg		Ng, Yee-Sien/0000-0003-1377-5852			BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Conroy L, 1999, SPINAL CORD, V37, P624, DOI 10.1038/sj.sc.3100904; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dionne CE, 2005, CAN MED ASSOC J, V172, P1559, DOI 10.1503/cmaj.1041159; Engel S, 1998, INT J REHABIL RES, V21, P223, DOI 10.1097/00004356-199806000-00009; Fisher K, 2003, INT J REHABIL RES, V26, P51, DOI 10.1097/00004356-200303000-00007; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hess DW, 2000, ARCH PHYS MED REHAB, V81, P359, DOI 10.1053/apmr.2000.0810359; HOWARD G, 1985, JAMA-J AM MED ASSOC, V253, P226, DOI 10.1001/jama.253.2.226; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Juvonen-Posti P, 2002, INT J REHABIL RES, V25, P313, DOI 10.1097/00004356-200212000-00009; McLean R, 2007, ANN ACAD MED SINGAP, V36, P18; MELAMED S, 1985, SCAND J REHABIL MED, P129; SAEKI S, 1993, STROKE, V24, P1182, DOI 10.1161/01.STR.24.8.1182; Saeki S, 2000, DISABIL REHABIL, V22, P578, DOI 10.1080/09638280050138241; Saeki Satoru, 2004, J Stroke Cerebrovasc Dis, V13, P160, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.006; Sanford AA, 2006, THESIS U IOWA; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568; Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516; Wozniak MA, 2000, INT STROK C 2000 NEW, V32, P362; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	29	4	4	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2012	43	4					461	468		10.3233/WOR-2012-1374			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	039EJ	WOS:000311226500010	22927588				2022-02-06	
J	Dionyssiotis, Y; Kiourtidis, D; Karvouni, A; Kaliontzoglou, A; Kliafas, I				Dionyssiotis, Y.; Kiourtidis, D.; Karvouni, A.; Kaliontzoglou, A.; Kliafas, I.			Consequences of neurologic lesions assessed by Barthel Index after Botox (R) injection may be underestimated	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						botulinum toxin type A; spasticity; stroke; multiple sclerosis	TOXIN TYPE-A; UPPER EXTREMITY SPASTICITY; QUALITY-OF-LIFE; BOTULINUM-TOXIN; DOUBLE-BLIND; STROKE PATIENTS; MANAGEMENT; ASSOCIATION; MULTICENTER; PREVALENCE	Purpose: The aim of this study was to investigate whether the consequences of neurologic lesions are underestimated when the Barthel Index (BI) is used to assess the clinical outcome of botulinum toxin injection. Patients and methods: The records for all in- and outpatients with various neurologic lesions (stroke, multiple sclerosis, spinal cord injury, traumatic brain injury, and so forth) who had been referred to the authors' departments and who had received botulinum toxin type A (Botox (R)) for spasticity within a 4-year period (2008-2011) were examined retrospectively. BI data were collected and analyzed. Results: The BI score was found to have increased in follow-up assessments (P = 0.048). No correlation was found between the degree of spasticity and the BI score. Conclusion: The specific injection of Botox in patients with neurologic lesions was not strongly correlated with a significant functional outcome according to the BI. The results of this study suggest that clinicians need to look at other measurement scales for the assessment of significant outcomes of Botox in the rehabilitation process after neurologic lesions.	[Dionyssiotis, Y.] Gen Hosp Florina, Rehabil Ctr Amyntaio, Dept Med, Amyntaio 53200, Florina, Greece; [Dionyssiotis, Y.] Rhodes Gen Hosp, Dept Phys Med & Rehabil, Rhodes, Dodecanese, Greece; [Kiourtidis, D.; Karvouni, A.; Kaliontzoglou, A.; Kliafas, I.] Rhodes Gen Hosp, Dept Neurol, Rhodes, Dodecanese, Greece		Dionyssiotis, Y (corresponding author), Gen Hosp Florina, Rehabil Ctr Amyntaio, Dept Med, 2nd Km Natl Rd, Amyntaio 53200, Florina, Greece.	yannis_dionyssiotis@hotmail.com	Dionyssiotis, Yannis/G-1306-2010	Dionyssiotis, Yannis/0000-0001-6962-1583			Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Bakheit A., 1996, CLIN REHABIL, V10, P40, DOI [10.1177/026921559601000108, DOI 10.1177/026921559601000108]; Baricich A, 2008, J REHABIL MED, V40, P870, DOI 10.2340/16501977-0251; Barnes M, 2002, EUR J NEUROL, V9, P53; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Borg J, 2011, J REHABIL MED, V43, P15, DOI 10.2340/16501977-0663; Brashear A, 2000, CLIN THER, V22, P1516, DOI 10.1016/S0149-2918(00)83049-0; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Campbell SE, 2005, AGE AGEING, V34, P467, DOI 10.1093/ageing/afi141; Caty GD, 2008, STROKE, V39, P2803, DOI 10.1161/STROKEAHA.108.516153; Collin C, 1988, Int Disabil Stud, V10, P61; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Dionyssiotis Y, 2010, 8TH MEDITERRANEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE, P47; Dionyssiotis Y, 2011, INT J GEN MED, V4, P505, DOI 10.2147/IJGM.S22255; KATRAK PH, 1992, ARCH PHYS MED REHAB, V73, P4; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Leathley MJ, 2004, CLIN REHABIL, V18, P438, DOI 10.1191/0269215504cr727oa; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayer NH, 2002, SPASTICITY ETIOLOGY, P154; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; O'Brien CF, 1997, MUSCLE NERVE, pS176; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pathak MS, 2006, EUR J NEUROL, V13, P42, DOI 10.1111/j.1468-1331.2006.01444.x; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Thorley M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-120; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; van Kuijk AA, 2002, J REHABIL MED, V34, P51, DOI 10.1080/165019702753557836; Ward AB, 2002, EUR J NEUROL, V9, P48, DOI 10.1046/j.1468-1331.2002.0090s1048.x; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; We Move Spasticity Study Group, 2002, WE MOVE SELF STUDY C, P154; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9	39	4	5	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-203X		THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2012	8						385	391		10.2147/TCRM.S32974			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	022OQ	WOS:000309969100001	23112577	Green Published, Green Submitted, gold			2022-02-06	
J	Fischer, BR; Yasin, Y; Holling, M; Hesselmann, V				Fischer, Bernhard R.; Yasin, Yousef; Holling, Markus; Hesselmann, Volker			Good clinical practice in dubious head trauma - the problem of retained intracranial foreign bodies	INTERNATIONAL JOURNAL OF GENERAL MEDICINE			English	Article						head trauma; guidelines; retained object; neuroimaging		Objective: In young people, traumatic head and brain injuries are the leading cause of morbidity and mortality. In some cases, no neurological deficits are present, even after penetrating trauma. These patients have a greater risk of suffering from secondary injuries due to secondary infections, brain edema, and hematomas. We present a case report which illustrates that brain injuries that do not induce neurological deficits can still result in a fatal clinical course and death, with medicolegal consequences. Clinical presentation: A 19-year-old patient was admitted to hospital suffering from a head injury due to an assault. He reported that he was attacked from behind. Medical examination showed no neurological deficits, and only a small occipital wound. Neuroimaging of the cranium revealed that a knife blade was penetrating the cranial bone and touching the superior sagittal sinus. Intervention: After removing the foreign body, magnetic resonance imaging showed that the superior sagittal sinus remained open. Conclusion: We want to stress that possible problems can arise due to the retention of objects in the cranium, while also highlighting the risk of superficial clinical examination.	[Fischer, Bernhard R.] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Neurotraumatol, Burkle de la Camp Pl 1, D-44789 Bochum, Germany; [Yasin, Yousef; Holling, Markus] Univ Hosp Muenster, Dept Neurosurg, Munster, Germany; [Hesselmann, Volker] Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany		Fischer, BR (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Neurotraumatol, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	bernhard.fischer@bergmannsheil.de					Ardill W, 2003, SURG NEUROL, V60, P120, DOI 10.1016/S0090-3019(03)00158-7; Bauer M, 2002, FORENSIC SCI INT, V129, P122, DOI 10.1016/S0379-0738(02)00271-2; Bhootra B L, 2007, J Forensic Leg Med, V14, P31, DOI 10.1016/j.jcfm.2005.11.011; Davis NL, 2004, AM J FOREN MED PATH, V25, P259, DOI 10.1097/01.paf.0000127388.00255.85; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; HERRING CJ, 1988, NEUROSURGERY, V23, P658, DOI 10.1227/00006123-198811000-00022; Iwakura M, 2005, NEUROL MED-CHIR, V45, P172, DOI 10.2176/nmc.45.172; Lesieur O, 2006, EMERG MED J, V23, DOI 10.1136/emj.2004.021923; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Pascual-Castroviejo I, 2006, J CHILD NEUROL, V21, P340, DOI 10.1177/08830738060210040501; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; TEASDALE G, 1974, LANCET, V2, P81; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Willis AP, 2008, CLIN RADIOL, V63, P165, DOI 10.1016/j.crad.2007.05.027; Youssef AS, 2008, J TRAUMA, V64, P1622, DOI 10.1097/01.ta.0000224892.52945.16	19	4	5	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7074			INT J GEN MED	Int. J. Gen. Med.		2012	5						899	902		10.2147/IJGM.S35925			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V05IK	WOS:000213866100123	23118548	Green Published, gold, Green Submitted			2022-02-06	
B	Halstead, ME		Apps, JN; Walter, KD		Halstead, Mark E.			Historical Perspectives on Concussion	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							INJURY		Washington Univ, Sch Med, Dept Pediat & Orthoped, Sports Concuss Clin, St Louis, MO 63130 USA		Halstead, ME (corresponding author), Washington Univ, Sch Med, Dept Pediat & Orthoped, Sports Concuss Clin, St Louis, MO 63130 USA.	halsteadm@wustl.edu					Abernathy J., 1830, INJURIES HEAD SURG P, V2; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Coiter V., 1573, EXTERNARUM INTERNARU; DENCKER S J, 1958, Acta Psychiatr Neurol Scand Suppl, V122, P1; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Erichsen J., 1895, SCI ART SURG; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hilton J., 1877, REST PAIN; Hippocrates, 1849, GENUINE WORKS HIPPOC; KELLY R, 1981, J ROY SOC MED, V74, P242; Kirkland T., 1792, COMMENTARY APOPLECTI; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lidvall H F, 1974, Acta Neurol Scand Suppl, V56, P3; Littre M., 1705, HIST ACAD ROYALE SCI; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; MCHENRY LC, 1969, GARRISONS HIST NEURO; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; Pare A, 1579, WORKS FAMOUS CHIRURG; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Putti Vittoro, 1937, BERENGARIO CARPI SAG; Romanis W., 1934, SCI PRACTICE SURG, V2; RUESCH J, 1945, AM J PSYCHIAT, V102, P145, DOI 10.1176/ajp.102.2.145; SYMONDS C, 1962, LANCET, V1, P1; Wrightson P, 2000, J CLIN NEUROSCI, V7, P384, DOI 10.1054/jocn.1999.0678	28	4	4	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							3	8		10.1007/978-0-387-89545-1_1	10.1007/978-0-387-89545-1		6	Psychology, Clinical; Clinical Neurology; Pediatrics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500001					2022-02-06	
J	Hudac, CM; Kota, S; Nedrow, JL; Molfese, DL				Hudac, Caitlin M.; Kota, Srinivas; Nedrow, James L.; Molfese, Dennis L.			Neural mechanisms underlying neurooptometric rehabilitation following traumatic brain injury	EYE AND BRAIN			English	Article						traumatic brain injury; posttrauma vision syndrome; visual midline shift syndrome; visual event-related potentials; source localization; neural reorganization		Mild to severe traumatic brain injuries have lasting effects on everyday functioning. Issues relating to sensory problems are often overlooked or not addressed until well after the onset of the injury. In particular, vision problems related to ambient vision and the magnocellular pathway often result in posttrauma vision syndrome or visual midline shift syndrome. Symptoms from these syndromes are not restricted to the visual domain. Patients commonly experience proprioceptive, kinesthetic, vestibular, cognitive, and language problems. Neurooptometric rehabilitation often entails the use of corrective lenses, prisms, and binasal occlusion to accommodate the unstable magnocellular system. However, little is known regarding the neural mechanisms engaged during neurooptometric rehabilitation, nor how these mechanisms impact other domains. Event- related potentials from noninvasive electrophysiological recordings can be used to assess rehabilitation progress in patients. In this case report, high- density visual event-related potentials were recorded from one patient with posttrauma vision syndrome and secondary visual midline shift syndrome during a pattern reversal task, both with and without prisms. Results indicate that two factors occurring during the end portion of the P148 - component (168-256 milliseconds poststimulus onset) map onto two separate neural systems that were engaged with and without neurooptometric rehabilitation. Without prisms, neural sources within somatosensory, language, and executive brain regions engage inefficient magnocellular system processing. However, when corrective prisms were worn, primary visual areas were appropriately engaged. The impact of using early neurooptometric rehabilitation for posttrauma vision syndrome, visual midline shift syndrome, and other similar subtle vision disorders to support neural reorganization is discussed.	[Hudac, Caitlin M.; Kota, Srinivas; Molfese, Dennis L.] Univ Nebraska Lincoln, Dept Psychol, 238 Burnett Hall, Lincoln, NE 68588 USA; [Nedrow, James L.] Univ Nebraska Lincoln, Oculi Vis Rehabil, Lincoln, NE USA; [Molfese, Dennis L.] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE USA		Molfese, DL (corresponding author), Univ Nebraska Lincoln, Dept Psychol, 238 Burnett Hall, Lincoln, NE 68588 USA.	dlmolfese@mac.com	Kota, Srinivas/L-7946-2019	Kota, Srinivas/0000-0001-7870-4903	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43 HD062072, 1R01EB007684]; DOE IEW [R305K05186]	The authors thank their patient for her time and patience. They would also like to thank Nathan M Petro for his assistance in data collection and Madonna Rehabilitation Hospital for their cooperation. This work was supported in part by grants to DLM: NIH R43 HD062072, NIH 1R01EB007684, and DOE IEW R305K05186.	Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cate Y, 2000, AM J OCCUP THER, V54, P326, DOI 10.5014/ajot.54.3.326; Colarusso R., 1995, MOTOR FREE VISUAL PE; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Houwen S, 2009, MED SCI SPORT EXER, V41, P103, DOI 10.1249/MSS.0b013e318183389d; Johnston A, 2008, VISION RES, V48, P1852, DOI 10.1016/j.visres.2008.04.029; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Keane S, 2006, ARCH PHYS MED REHAB, V87, P1668, DOI 10.1016/j.apmr.2006.08.322; Kerkhoff, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00753-4; Kota S, 2009, IEEE T BIO-MED ENG, V56, P1040, DOI 10.1109/TBME.2008.2006985; Legault I, 2010, INT J AUDIOL, V49, P904, DOI 10.3109/14992027.2010.509112; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Malamut D, 2001, VISUAL VESTIBULAR CO, P201; McMillan T, 1999, BRIT J PSYCHIAT, V174, P274, DOI 10.1192/bjp.174.3.274; Molfese DL, 2008, DEV NEUROPSYCHOL, V33, P682, DOI 10.1080/87565640802418647; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Padula WV, 2000, VISION REHABILITATIO, P114; ROCKSTROH B, 1982, PSYCHOPHYSIOLOGY, V19, P211, DOI 10.1111/j.1469-8986.1982.tb02549.x; Rosen S. A., 2001, VISUAL VESTIBULAR CO, P174; ROSSI PW, 1990, NEUROLOGY, V40, P1597, DOI 10.1212/WNL.40.10.1597; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Skoyles J, 2004, BRAIN LANG, V88, P79, DOI 10.1016/S0093-934X(03)00162-7; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x	35	4	4	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-2744			EYE BRAIN	EYE BRAIN		2012	4						1	12		10.2147/EB.S27290			12	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	V35PM	WOS:000215912500001	28539777	Green Published, gold			2022-02-06	
J	Kikkawa, Y; Natori, Y; Sasaki, T				Kikkawa, Yuichiro; Natori, Yoshihiro; Sasaki, Tomio			Delayed Post-traumatic Pseudoaneurysmal Formation of the Intracranial Ophthalmic Artery After Closed Head Injury -Case Report-	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic intracranial aneurysm; ophthalmic artery; pseudoaneurysm; closed head injury; angiography	INTERNAL CAROTID-ARTERY; SUBARACHNOID HEMORRHAGE; BALLOON EMBOLIZATION; ANEURYSM; PRESERVATION	A 42-year-old male presented with a rare case of delayed aneurysmal formation of the intracranial ophthalmic artery after closed head injury manifesting as subarachnoid hemorrhage. Initial magnetic resonance angiography revealed no aneurysmal formation, but angiography 7 days after the injury demonstrated an intracranial ophthalmic artery aneurysm. Follow-up computed tomography angiography demonstrated enlargement of the aneurysm. The aneurysm was successfully treated by surgical resection. Histological examination revealed that the aneurysm was a pseudoaneurysm. Traumatic intracranial aneurysm (TICA) is rare and usually occurs in the peripheral arteries of the cerebral circulation or the basal portion of the internal carotid artery. The present case shows that failure to demonstrate an aneurysm on the initial angiography in the acute stage does not exclude the presence of traumatic aneurysm. This case clearly shows the time course of development of a TICA of the ophthalmic artery after closed head injury.	[Kikkawa, Yuichiro] Kyushu Univ, Dept Neurosurg, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Natori, Yoshihiro] Aso Iizuka Hosp, Dept Neurosurg, Iizuka, Fukuoka, Japan		Kikkawa, Y (corresponding author), Kyushu Univ, Dept Neurosurg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ykikkawa@ns.med.kyushu-u.ac.jp					BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Chun HJ, 2009, SURG NEUROL, V71, P701, DOI 10.1016/j.surneu.2007.11.018; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HAHN YS, 1987, NEUROSURGERY, V21, P86, DOI 10.1227/00006123-198707000-00019; HIESHIMA GB, 1986, AM J NEURORADIOL, V7, P916; Hopkins JK, 2007, J NEUROSURG, V107, P1043, DOI 10.3171/JNS-07/11/1043; Komiyama M, 2001, NEUROL MED-CHIR, V41, P264, DOI 10.2176/nmc.41.264; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Phuong HL, 2005, NEUROSURGERY, V57, P236, DOI 10.1227/01.NEU.000177442.96517.3D; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SALMON JH, 1968, J THORAC CARDIOV SUR, V56, P28, DOI 10.1016/S0022-5223(19)42868-7; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; TANTANA S, 1987, AM J NEURORADIOL, V8, P923	14	4	8	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2012	52	1					41	43		10.2176/nmc.52.41			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	879SE	WOS:000299351700003	22278026	Bronze			2022-02-06	
J	Krishnan, M; Smith, N; Donders, J				Krishnan, Mohan; Smith, Nichole; Donders, Jacobus			Use of the Tower of London - Drexel University, Second Edition (TOLDX) in Adults With Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Tower of London; Traumatic brain injury; Executive functioning	EXECUTIVE DYSFUNCTION; VALIDITY; TASK; ABILITY; TESTS; COMA	The Tower of London - Drexel University, Second Edition (TOLDX) was investigated in order to determine the efficacy of using this instrument in evaluating the impact of traumatic brain injury on cognitive functioning in adults. Performance on the TOLDX was compared among 56 individuals with complicated mild to severe traumatic brain injury ("sTBI"), 68 individuals with uncomplicated, mild traumatic brain injury ("mTBI"), and 124 demographically matched, healthy controls. Both TBI groups performed worse than controls on TOLDX measures of executive time (ET) and number of moves used (TMS), but only patients with sTBI were more likely to be impaired on TMS (i.e., performing at least 1.5 SD below the mean). Poorer performance on TMS was associated with increasing length of coma. Although poor sensitivity of this measure limits its use in isolation, the TOLDX may provide a complementary measurement of aspects of problem-solving deficit in TBI that may not be captured by other tests.	[Krishnan, Mohan; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Smith, Nichole] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com			Campbell Foundation	This work was supported by a grant from the Campbell Foundation.	Anderson P., 2008, EXECUTIVE FUNCTIONS; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P236, DOI 10.1007/s00406-004-0486-1; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Culbertson WC., 2001, TOWER LONDON DREXEL; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Dodson MB, 2010, WORK, V36, P449, DOI 10.3233/WOR-2010-1044; DONDERS J, 1991, CLIN NEUROPSYCHOL, V5, P78, DOI DOI 10.1080/13854049108401844; Donders J, 2012, DEV NEUROPSYCHOL, V37, P333, DOI 10.1080/87565641.2011.646448; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Larochette AC, 2009, APPL NEUROPSYCHOL, V16, P275, DOI 10.1080/09084280903098695; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Mataix-Cols D., 2009, APPL NEUROPSYCHOL, V9, P117; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKinlay A, 2009, APPL NEUROPSYCHOL, V16, P177, DOI 10.1080/09084280903098661; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; Rasmussen IA, 2006, ACTA NEUROPSYCHIATR, V18, P216, DOI 10.1111/j.1601-5215.2006.00145.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574	45	4	4	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	6					951	964		10.1080/13854046.2012.708166			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	984ZK	WOS:000307232300007	22849344				2022-02-06	
J	McKinlay, A; McLellan, T; Daffue, C				McKinlay, Audrey; McLellan, Tracey; Daffue, Christopher			The invisible brain injury: The importance of identifying deficits following brain injury in children with intellectual disability	NEUROREHABILITATION			English	Article						Intellectual disability; traumatic brain injury; childhood; head injury	HEAD-INJURY; ADOLESCENTS; PREVALENCE; CHILDHOOD; OUTCOMES	Introduction: Traumatic brain injury (TBI) is common during childhood. However, most of the extant literature about outcomes following childhood TBI is based on children who were functioning "normally" prior to the injury event. But, with the increasing community integration of children with Intellectual Disability (ID) there is an urgent need for specific information regarding problems following TBI for this group. Method: Using a case study, this paper presents an overview of problems faced by these children who subsequently experience a TBI event, and examines questions pertinent to this dual diagnosis. Outcomes: In the case study presented, despite supposedly having access to an internationally acclaimed comprehensive no fault accident compensation and rehabilitation system, a lack of assessment, intervention and support was evident for both the child and the family following a severe TBI because he had pre-existing ID. Conclusions: This case study highlights the need for clinicians to consider the impact of TBI for children with ID, to avoid incorrectly attributing TBI symptoms to pre-existing problems. Children with ID are at increased risk; appropriate treatment plans are vital to maximize quality of life for them and their caregivers.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3800, Australia; [McKinlay, Audrey; McLellan, Tracey] Univ Canterbury, Dept Psychol, Canterbury, New Zealand; [Daffue, Christopher] Canterbury Dist Hlth Board, Canterbury, New Zealand		McKinlay, A (corresponding author), Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3800, Australia.	audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	New Zealand Health Research councilHealth Research Council of New Zealand; Accident Compensation Corporation	This research was sponsored by a grant from the New Zealand Health Research council. The research was conducted during tenure of an ACC Post-Doctoral Research Career Development Award from the Health Research Council of New Zealand and the Accident Compensation Corporation.	Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Barrett K, 1999, CURR OPIN PSYCHIATR, V12, P405, DOI 10.1097/00001504-199907000-00004; Begali V., 1997, HEAD INJURY CHILDREN; Christianson J.S., 2001, CHILDREN TRAUMATIC B, P77; Farmer J., 1997, CHILDHOOD TRAUMATIC, P261; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Slayter EM, 2006, MENT RETARD, V44, P212, DOI 10.1352/0047-6765(2006)44[212:IPACAA]2.0.CO;2; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Wade S.L., 1997, CHILDHOOD TRAUMATIC, P261; ZIGLER E, 1990, AM J MENT RETARD, V95, P1	19	4	4	2	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	3					183	187		10.3233/NRE-2012-0743			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	948CD	WOS:000304480300004	22635122				2022-02-06	
J	Ohayon, S; Gruenbaum, SE; Artru, AA; Boyko, M; Gruenbaum, BF; Dubilet, M; Leibowitz, A; Shapira, Y; Teichberg, VI; Zlotnik, A				Ohayon, Sharon; Gruenbaum, Shaun E.; Artru, Alan A.; Boyko, Matthew; Gruenbaum, Benjamin F.; Dubilet, Michael; Leibowitz, Akiva; Shapira, Yoram; Teichberg, Vivian I.; Zlotnik, Alexander			Anatomical location of arterial and venous lines significantly affects motor performance in rats	ANIMAL SCIENCE JOURNAL			English	Article						animal model; catheter location; motor function; neurological severity score	CLOSED-HEAD TRAUMA; BRAIN EDEMA; NEUROLOGICAL STATUS; CEREBRAL-ISCHEMIA; OCCLUSION; MODELS; STROKE; HETASTARCH; IMPAIRMENT; ALBUMIN	Several motor-function scales have been developed to assess neurological function in animal models of stroke, subarachnoid hemorrhage and closed head injury. We hypothesize that the location of arterial and venous catheters, even in the absence of brain injury, may impact rats' motor performance. Our study examined the effect of catheter location, rate of infection and the time required for catheter placement. We further describe an original technique of tail artery cannulation without exposure of the artery. Sixty-one rats were anesthetized and randomly assigned to one of seven groups, including no catheter, tail artery or artery + vein catheters, or femoral artery or artery + vein catheters. A neurological severity score (NSS) was determined at 1 h, 24 h and 48 h after surgical preparation or catheter placement. NSS at 1 h after placement of unilateral and bilateral femoral catheters was higher than the NSS observed at 1 h after placement of tail arterial and venous catheters (P < 0.01). The NSS also was higher at 24 h in the bilateral femoral catheter groups as compared with the tail catheter groups (P < 0.05). There were no differences in the NSS observed between the groups that had tail catheters and the sham group at 1 h, 24 h or 48 h. Infection rate at the site of catheter placement and the time required for catheter placement was also higher in the femoral catheter groups (P < 0.001). Thus, we propose that the line location may bias a study's results and lead to deceptive interpretations of neurological assessment following rat head injury. Compared to femoral vessels, tail blood vessels are preferable locations for lines placement.	[Ohayon, Sharon; Boyko, Matthew; Gruenbaum, Benjamin F.; Dubilet, Michael; Leibowitz, Akiva; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Artru, Alan A.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, POB 151, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Leibowitz, Akiva/F-1397-2012	Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			Aspey BS, 1998, NEUROPATH APPL NEURO, V24, P487; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; GERMANO A, 1992, NEUROSURGERY, V30, P882, DOI 10.1227/00006123-199206000-00011; Ginsberg MD, 1996, ARCH NEUROL-CHICAGO, V53, P1065, DOI 10.1001/archneur.1996.00550100151024; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Ivashkova Y, 2006, J TRAUMA, V61, P879, DOI 10.1097/01.ta.0000234722.98537.01; Kirshtein B, 2008, RESUSCITATION, V77, P127, DOI 10.1016/j.resuscitation.2007.10.019; Mao JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-5; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Rachinsky M, 2001, J TRAUMA, V51, P944, DOI 10.1097/00005373-200111000-00020; Reglodi D, 2003, BRAIN RES BULL, V59, P459, DOI 10.1016/S0361-9230(02)00962-0; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Speiser Z, 1999, J NEURAL TRANSM, V106, P593, DOI 10.1007/s007020050182; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; YEN JK, 1978, J NEUROL NEUROSUR PS, V41, P1125, DOI 10.1136/jnnp.41.12.1125; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	30	4	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.		2012	83	9					656	662		10.1111/j.1740-0929.2012.01008.x			7	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	999HQ	WOS:000308300900006	22943533				2022-02-06	
J	Pai, AB; Jasper, NR; Cifu, DX				Pai, Ajit B.; Jasper, Nicholas R.; Cifu, David X.			Rehabilitation of injured US servicemember with traumatic brain injury, stroke, spinal cord injury, and bilateral amputations: A case report	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Active Duty; amputation; Department of Defense; Department of Veterans Affairs; polytrauma; rehabilitation; spinal cord injury; stroke; traumatic brain injury; veteran		The complexity of injuries that can arise from combat situations, specifically as a result of the Operation Iraqi Freedom/Operation Enduring Freedom conflicts, is challenging. As injured troops leave the war zone early for medical care, they are treated by an interwoven system of care that includes both the Department of Defense and Veterans Health Administration. Physicians across these settings are increasingly faced with patients who have multiple rehabilitation diagnoses as a result of the severity of blast injuries; therefore, the importance of active communication across the system must be highlighted. This case describes the seamless transition of an injured soldier across the continuum of care.	[Pai, Ajit B.] Hunter Holmes McGuire Dept Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA; [Pai, Ajit B.; Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Jasper, Nicholas R.] Orthopaed & Spine Specialists Phys Med & Rehabil, York, PA USA; [Cifu, David X.] Vet Hlth Adm, Phys Med Serv, Richmond, VA USA; [Cifu, David X.] Vet Hlth Adm, Rehabil Serv, Richmond, VA USA		Pai, AB (corresponding author), Hunter Holmes McGuire VA Med Ctr, Phys Med & Rehabil Serv, 1201 Broad Rock Blvd,PM & RS 652-117, Richmond, VA 23249 USA.	ajit.pai@va.gov		Cifu, David/0000-0003-1600-9387			Cifu D.X., 2009, CRIT REV PHYS REHABI, V21, P197, DOI DOI 10.1615/CRITREVPHYSREHABI1MED.V2113-4.10; Department of Veterans Affairs, POL TBI SYST CAR; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Hagen C, 1979, REHABILITATION HEAD; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; TEASDALE G, 1974, LANCET, V2, P81; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	9	4	4	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	8					1191	1196		10.1682/JRRD.2011.11.0224			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FA	WOS:000319303200006	23341311	Bronze			2022-02-06	
J	Ramanathan, DM; Rabinowitz, AR; Barwick, FH; Arnett, PA				Ramanathan, Deepa M.; Rabinowitz, Amanda R.; Barwick, Fiona H.; Arnett, Peter A.			Validity of Affect Measurements in Evaluating Symptom Reporting in Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Affect; Concussion; Symptom reports; Depression; Traumatic brain injury; Sports injuries	TRAUMATIC BRAIN-INJURY; CONCUSSION; DEPRESSION; SPORTS; DISTRESS; MEMORY; NEUROTICISM; CONSTRUCT; IMPACT; MOOD	Identifying factors that improve the assessment of athletes' psychological functioning is imperative to make proper return-to-play decisions following concussion. Prior research indicates that an individual's affect is related to symptom reporting. The present study examines two novel methods of affect assessment in college athletes at baseline participating in a sports-concussion management program. A total of 256 athletes completed a neuropsychological baseline battery with measurements of psychological symptoms (BDI-Fast Screen, Post-Concussion Symptom Scale, and ImPact Total Symptom Score) and a measure of affective memory bias (the Affective Verbal Learning Test; AVLT). Examiners completed an observation-based rating of affect. Multivariate analysis of variance and chi(2) analyses were conducted to examine the effect of affect on symptom reports. Examiners' Affect Ratings were predictive of broad symptom reporting, while the performance based index of affect (Affective Verbal Learning Test, AVLT) was more predictive of depressive symptoms. These findings suggest that performance on the AVLT may be a useful indicator of self-reported depression in a collegiate athlete sample. Additionally, these results demonstrate that examiners' behavioral assessments of affect are important in the assessment of psychological functioning in athletes. Continued work should focus on developing objective measures that are sensitive and valid for the evaluation of outcomes from concussion. (JINS, 2012, 18, 101-107)	[Ramanathan, Deepa M.; Rabinowitz, Amanda R.; Barwick, Fiona H.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Ramanathan, DM (corresponding author), Penn State Univ, Dept Psychol, 610 Moore Bldg, University Pk, PA 16802 USA.	deepar@psu.edu		Ramanathan-Elion, Deepa/0000-0001-7723-7346			AFFLECK G, 1992, J CONSULT CLIN PSYCH, V60, P119, DOI 10.1037/0022-006X.60.1.119; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barth JT, 1989, MILD HEAD INJURY, P257; BARWICK FH, 2007, AFFECTIVE VERB UNPUB; Beck ATSB., 2000, BDI FAST SCREEN MED; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Bruce JM, 2005, J INT NEUROPSYCH SOC, V11, P514, DOI 10.1017/S1355617705050629; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Christensen B. K., 2001, PSYCHOPATHOLOGY RES, V11, P4; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; COSTA PT, 1987, BRIT J PSYCHOL, V78, P299, DOI 10.1111/j.2044-8295.1987.tb02248.x; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; FRANN JR, 2000, J NEUROPSYCHIATRY CL, V12, P226; KATON W, 1984, AM J MED, V77, P101, DOI 10.1016/0002-9343(84)90443-1; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Levens SM, 2010, J EXP PSYCHOL GEN, V139, P654, DOI 10.1037/a0020283; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Moriya J, 2009, COGNITION EMOTION, V23, P1090, DOI 10.1080/02699930802335018; PERSSON LO, 1987, J PSYCHOSOM RES, V31, P499, DOI 10.1016/0022-3999(87)90008-0; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Salovey P., 1991, EMOTION SOCIAL JUDGM, P241; Sanjuan P, 2008, PERS INDIV DIFFER, V45, P187, DOI 10.1016/j.paid.2008.03.004; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scher CD, 2005, CLIN PSYCHOL REV, V25, P487, DOI 10.1016/j.cpr.2005.01.005; Schwarz A, 2010, NY TIMES        0217, pA1; SEGAL ZV, 1988, PSYCHOL BULL, V103, P147, DOI 10.1037/0033-2909.103.2.147; VANHEMERT AM, 1993, INT J PSYCHIAT MED, V23, P295, DOI 10.2190/TC5N-AQ3R-9CFK-EC9G; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wisco B. E., 2009, J RATL EMOTIVE COGN, V27, P144, DOI [10.1007/s10942-009-0096-y, DOI 10.1007/S10942-009-0096-Y]	35	4	4	0	34	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2012	18	1					101	107		10.1017/S1355617711001457			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	874LL	WOS:000298958800010	22088829				2022-02-06	
J	Selyanina, NV; Karakulova, YV				Selyanina, N. V.; Karakulova, Yu V.			The effect of neurotrophic treatment on the activation of reparative processes in patients with acute traumatic brain injury	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; cognitive disorders; serotonin; a brain-derived neurotrophic factor; cerebrolysin		The complex study of cognitive and emotional status, levels of serum serotonin and brain-derived neurotrophic factor (BDNF) were performed in 72 patients with acute traumatic brain injury, with a special focus on middle brain injuries (MBI), treated with Cerebrolysin. The neurological and cognitive impairment, mild state anxiety and depression and increased levels of humoral serotonin, which depends on the severity of the injury, were identified in patients with MBI before treatment. After the treatment, there were the decrease in the severity of neurological symptoms and a significant positive dynamics on the FAB scale as well as the increase in blood BDNF and serotonin levels. It has been concluded that using cerebrolysin in complex treatment of acute MBI promotes activation of neurotrophic processes and improves outcomes of closed craniocerebral injury.	[Selyanina, N. V.; Karakulova, Yu V.] Minist Publ Hlth & Sotial Dev, Perm State Acad Med, State Educ Estab Higher Profess Educ, Dept Neurol,Med Fac, Perm, Russia		Selyanina, NV (corresponding author), Minist Publ Hlth & Sotial Dev, Perm State Acad Med, State Educ Estab Higher Profess Educ, Dept Neurol,Med Fac, Perm, Russia.	nselyanina@mail.ru; julia.karakulova@mail.ru					CHUBAKOV AR, 1988, BIOGENNYE AMINY RAZV; Gomazkov O.A, 2006, NEYROTROFICHESKAYA R; GOMAZKOV OA, 2010, PLEYOTROPNYE EFFEKTY; Gromova O. A., 2007, MEZHDUNARODN NEVROLO, V2, P94; GROMOVA OA, 2006, ZHURN NEVROL PSIKHIA, V7, P73; Kispaeva TT, 2008, ZH NEVROL PSIKHIATR, V108, P102; KONOVALOV AN, 2002, KLIN RUK CHEREP MOZG; Likhterman LB, 2009, NEVROLOGIYA CHEREPNO; Mikheeva I. G., 2008, Pediatriya (Moscow), V87, P40; Muresanu DF, 2007, J NEUROL SCI, V257, P38, DOI 10.1016/j.jns.2007.01.041; OTELLIN VA, 2003, PRIRODA, V9, P23	11	4	8	0	1	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2012	112	5					46	49					4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	979YU	WOS:000306861600008	22951781				2022-02-06	
J	Szczepanski, TA; Weiser, A; Zub, WL; Jarmundowicz, W; Kozba-Gosztyla, M; Czapiga, B				Szczepanski, Tomasz A.; Weiser, Artur; Zub, Wojciech L.; Jarmundowicz, Wlodzimierz; Kozba-Gosztyla, Marta; Czapiga, Bogdan			Assessment of Cerebral Blood Flow During Infusion Test in the Diagnosis of Normal Pressure Hydrocephalus	ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						normal pressure hydrocephalus; cerebral blood flow; transcranial Doppler	TRANSCRANIAL DOPPLER PULSATILITY; INTRACRANIAL-PRESSURE; WAVE-FORM; AUTOREGULATION; VELOCITY; HEMODYNAMICS	Background. Many studies indicate that the increase in intracranial pressure (ICP) leads to cerebral blood flow velocity (CBFV) changes. This relationship was accurately determined in patients with traumatic brain injury. Objectives. The aim of this study was to determine how the changes in intracranial pressure induced during an infusion test influence cerebral blood flow. Material and Methods. 40 patients with enlarged ventricular systems (Evan's ration > 30%) who underwent a diagnostic lumbar infusion test (LIT) were included. Tests were performed at the Department of Neurosurgery, Wroclaw Medical University. CBFV in the middle cerebral artery was measured using transcranial Doppler (TCD) simultaneously during the standard lumbar infusion test. TCD measurements were continued with simultaneous recording of CSF pressure with a frequency of 100 Hz. A total number of 5800 measurements (10-second periods) performed during the three phases of the infusion test (stable, infusion and decrease) was obtained. Results. In the stable phase of LIT, a weak positive correlation between ICP and mean CBFV (R = 0.193, p < 0.01) was observed. There was no statistically significant correlation between ICP and the pulsatility index (PI, Gosling Index), During the increased-ICP phase of LIT (infusion, decrease), we observed significant changes in CBFV expressed by a decrease of diastolic velocity and an increase of systolic velocity. A simultaneous increase of pulsation correlated with an increase in ICP (R = 0.371, p < 0.01). There were no significant changes in mean CBFV. Conclusions. In patients with ventriculomegaly, the mean cerebral blood flow is maintained despite a significant increase in ICP, within the limits of the infusion test. It is noted the relative increase of the pulsatility indices of CBF may indicate preserved cerebrovascular reactivity (Adv Clin Exp Med 2012, 21, 1, 55-61).	[Szczepanski, Tomasz A.; Weiser, Artur; Zub, Wojciech L.; Jarmundowicz, Wlodzimierz; Kozba-Gosztyla, Marta; Czapiga, Bogdan] Wroclaw Med Univ, Dept Neurosurg, PL-50556 Wroclaw, Poland		Szczepanski, TA (corresponding author), Wroclaw Med Univ, Dept Neurosurg, Borowska 213, PL-50556 Wroclaw, Poland.	tomek-md@wp.pl		Weiser, Artur/0000-0002-6614-7721			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; Czosnyka ZH, 2002, NEUROSURGERY, V50, P526, DOI 10.1097/00006123-200203000-00018; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; GIULIONI M, 1988, NEUROSURGERY, V22, P807, DOI 10.1227/00006123-198805000-00001; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Hunter G, 2010, CAN J NEUROL SCI, V37, P235, DOI 10.1017/S0317167100009987; Jarus-Dziedzic K, 2005, POL J RADIOL, V70, P27; Lavinio A, 2008, INTENSIVE CARE MED; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Markus KS, 1999, J NEUROL NEUROSUR PS, V67, P135, DOI 10.1136/jnnp.67.2.135; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Rainov NG, 2000, NEUROSURG REV, V23, P34, DOI 10.1007/s101430050029; Rasulo EA, 2008, EUR J ANAESTH, V25, P167, DOI 10.1017/S0265021507003341; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Richards UK, 1995, AM J PHYSIOL, V268, pH212; ROMNER B, 1991, British Journal of Neurosurgery, V5, P31, DOI 10.3109/02688699108998444; Rudzinski W, 2007, NUCL MED REV, V10, P29; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Schmidt B, 2009, J NEUROTRAUM, V26, P651, DOI 10.1089/neu.2008.0784; Sliwka S, 1984, I METODA NEUROL NEUR, V18, P533; Soehle M, 2007, ACTA NEUROCHIR, V149, P575, DOI 10.1007/s00701-007-1149-6; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	29	4	6	0	1	WROCLAW MEDICAL UNIV	WROCLAW	UL K MARCINKOWSKIEGO 2-6, WROCLAW, 50-368, POLAND	1899-5276	2451-2680		ADV CLIN EXP MED	Adv. Clin. Exp. Med.	JAN-FEB	2012	21	1					55	61					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	948PJ	WOS:000304514800008	23214300				2022-02-06	
J	Teng, TL; Ngo, VL				Teng, T-L; Ngo, V-L			Redesign of the vehicle bonnet structure for pedestrian safety	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Article						pedestrian; head injury; bonnet reinforcement structure; headform impactor; European Enhanced Vehicle-Safety Committee Working Group 17		Redesign of the structure of the bonnet to improve pedestrian head protection has recently received considerable attention from automobile manufacturers and industry institutes. The fatality of a head injury is based on the head injury criterion (HIC) value. This HIC value is calculated on the basis of the resultant acceleration of the head's centre of gravity (hereafter called the head centre) during head impacts. This study analyses the constitution of and variation in the resultant acceleration in head-to-bonnet impacts, and how each component of acceleration exactly contributes to the resultant acceleration of the head centre. This study also considers how the structural design parameters affect each component of acceleration. The causes that make the characteristic variation in the resultant acceleration differ from the optimal characteristic pulse will be analysed and discussed in detail. Based on the results of this analysis, the sudden increase in K (the curvature of the head centre's motion) after several milliseconds of the impact process must be eliminated. The sudden increase in K in this duration does not depend on the mass and stiffness of the bonnet but does depend on the characteristics of the reinforcement structure. Therefore, a new design of the bonnet reinforcement structure has eliminated the sudden increase in K. The bonnet reinforcement structure, as well as the bonnet thickness, have been designed to make the resultant acceleration of the head centre close to the optimal acceleration pulse. The results of this study contribute to efforts to design an improved vehicle bonnet structure and to pave the way for developing pedestrian protection technologies.	[Teng, T-L] Hsiuping Univ Sci & Technol, Dept Mech Engn, Taichung 41280, Taiwan; [Ngo, V-L] Hung Yen Univ Technol & Educ, Dept Mech Technol, Khoai Chau, Hung Yen, Vietnam		Teng, TL (corresponding author), Hsiuping Univ Sci & Technol, Dept Mech Engn, 11 Gongye Rd, Taichung 41280, Taiwan.	tlteng@mail.dyu.edu.tw	Ngo, Van-Luc/AAD-4992-2019				[Anonymous], 2000, APPL FIN EL MOD ARCH; Balandin DV, 2005, J COMPUT SYS SC INT+, V44, P247; Berg F. A., 2003, PEDESTRIAN PROTECTIO; Carter E, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P2113; Col D., 1998, P MSC US C TUR IT 15; Han Y. H., 2003, 2003011232 SAE; Improved test methods to evaluate pedestrian protection afforded by passenger cars, 2002, IMPR TEST METH EV PE; Ishikawa T., 2003, P 18 INT TECHN C ENH; Kalliske I., 2001, P 17 INT TECHN C ENH; Kerkeling C., 2005, P 19 INT TECHN C ENH; National Centre for Statistics & Analysis, 2009, DOTHS881111003344 NA; Nielen S., 2008, LS OPT USERS MANUAL; Okamoto Y., 1994, P 14 INT TECHN C ENH; Otubushin A., 1998, P 16 INT TECHN C ENH; Payne A. R., 2001, HEAD INJURY CRITERIA; Simms C. K., 2008, PERSPECTIVES DESIGN, P39; Teng TL, 2008, J MECH SCI TECHNOL, V22, P1660, DOI 10.1007/s12206-008-0512-8; Untaroiu C., 2006, P 9 INT LS DYNA US C, P6; World Health Organization, 2009, WORLD REP ROAD TRAFF	19	4	4	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070	2041-2991		P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.		2012	226	D1					70	84		10.1177/0954407011413985			15	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	881LD	WOS:000299485400005					2022-02-06	
J	Zakzanis, KK; Gammada, E; Jeffay, E				Zakzanis, Konstantine K.; Gammada, Emnet; Jeffay, Eliyas			The Predictive Utility of Neuropsychological Symptom Validity Testing as It Relates to Psychological Presentation	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						malingering; mild traumatic brain injury; neuropsychology; Personality Assessment Inventory; symptom validity testing		The present study examined the relationship between multiple neuropsychological symptom validity tests (SVTs) and psychological presentation. More formally, we set out to determine if performance on neuropsychological SVTs was related to psychological symptom credibility and which specific neuropsychological SVTs were most associated with noncredible psychological presentation. Archival records from 106 litigating examinees were utilized in this study. Our results illustrate that neuropsychological SVTs are modestly related to psychological symptom credibility and that specific neuropsychological SVTs are variably associated to this end. We conclude that when multiple, but not independent, neuropsychological SVTs are employed within the context of a neuropsychological examination, they do have clinical utility as it relates to credibility of psychological presentation and these constructs do share variance reciprocally in clinically meaningful ways. When independently employed, however, the observed relationship is modest at best. Hence, to place clinical opinion on firmer scientific grounds within the context of a neuropsychological examination, multiple cognitive SVTs, in hand with psychological test instruments that include validity indexes, are essential to derive opinion that is based on science rather than faith in the instance of litigation when an incentive to manifest disability for the sake of an external reward holds probable.	[Zakzanis, Konstantine K.; Gammada, Emnet; Jeffay, Eliyas] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca					Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BOONE KB, 1995, J CLIN PSYCHOL, V51, P457, DOI 10.1002/1097-4679(199505)51:3<457::AID-JCLP2270510322>3.0.CO;2-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Davis R, 1994, MANUAL MCMI 3; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Mattis S, 1988, DEMENTIA RATING SCAL; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; REITAN RM, 1992, J CLIN PSYCHOL, V48, P521, DOI 10.1002/1097-4679(199207)48:4<521::AID-JCLP2270480414>3.0.CO;2-C; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Schroeder R. W., 2011, ASSESSMENT; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside D. M., 2008, CLIN NEUROPSYCHOL, V1, P1; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	36	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	2					98	107		10.1080/09084282.2011.644099			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	949SL	WOS:000304596100004	23373576				2022-02-06	
J	Brosch, JR; Golomb, MR				Brosch, Jared R.; Golomb, Meredith R.			American Childhood Football as a Possible Risk Factor for Cerebral Infarction	JOURNAL OF CHILD NEUROLOGY			English	Article						football; ischemic stroke; dissection; head injury	VERTEBRAL ARTERY DISSECTION; TRAUMATIC BRAIN-INJURY; PEDIATRIC STROKE; ISCHEMIC-STROKE; HEAD-INJURY; CHILDREN; ANGIOGRAPHY; PLAYERS; HYPERVENTILATION; CONCUSSION	Three adolescent football players who had ischemic stroke associated with football practice and play are described. The literature on stroke associated with childhood sports and football in particular is reviewed, and the multiple mechanisms by which football can contribute to ischemic stroke are discussed.	[Brosch, Jared R.; Golomb, Meredith R.] Indiana Univ, Sch Med, Dept Neurol, Div Pediat Neurol, Indianapolis, IN 46202 USA		Golomb, MR (corresponding author), Indiana Univ, Sch Med, Dept Neurol, Div Pediat Neurol, Bldg XE,Room 040,575 Riley Hosp Dr, Indianapolis, IN 46202 USA.	mgolomb@iupui.edu		Golomb, Meredith/0000-0002-9707-6735	Department of Neurology at Indiana University School of Medicine; Indiana University Health Physicians	The authors disclosed receipt of the following financial support for the research and/or authorship of this article: Dr Golomb was supported by the Department of Neurology at Indiana University School of Medicine and Indiana University Health Physicians.	American Youth Football, 2011, AM YOUTH FOOTB NEW M; Amlie-Lefond C, 2008, LANCET NEUROL, V7, P425, DOI 10.1016/S1474-4422(08)70086-3; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Bahrke MS, 2004, CURR OPIN PHARMACOL, V4, P614, DOI 10.1016/j.coph.2004.05.006; Bernard TJ, 2007, J CHILD NEUROL, V22, P1050, DOI 10.1177/0883073807306271; Boston University Center for the Study of Traumatic Encephalopathy, 18 YEAR OLD HIGH SCH; Boyd JL, 2009, J ALZHEIMERS DIS, V16, P657, DOI 10.3233/JAD-2009-1014; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chandra A, 2007, ANN VASC SURG, V21, P178, DOI 10.1016/j.avsg.2006.10.020; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dowling MM, 2011, J CHILD NEUROL, V26, P72, DOI 10.1177/0883073810383913; Enterprise Media, 2010, MOR VALL TEEN STROK; Felker MV, 2010, PEDIATR NEUROL, V43, P435, DOI 10.1016/j.pediatrneurol.2010.06.010; FindLaw a Thomson Reuters Business, 2010, CA BRAIN INJ LAWS HI; Forbes K, 2009, UNREGULATED HLTH SUP; Fox News Network LLC, 2008, NJ TEEN SUFF BRAIN H; Foxford RJ, 2003, CLIN J SPORT MED, V13, P183, DOI 10.1097/00042752-200305000-00010; Fullerton HJ, 2007, PEDIATRICS, V119, P495, DOI 10.1542/peds.2006-2791; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Ganesan V, 1999, PEDIATR NEUROL, V20, P38, DOI 10.1016/S0887-8994(98)00112-X; Husson B, 2002, STROKE, V33, P1280, DOI 10.1161/01.STR.0000014504.18199.0D; Kanwar Manreet, 2009, Clin Cardiol, V32, pE43, DOI 10.1002/clc.20341; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kenny D, 2008, ARCH DIS CHILD, V93, P255, DOI 10.1136/adc.2006.110098; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Laurson KR, 2007, JAMA-J AM MED ASSOC, V297, P363, DOI 10.1001/jama.297.4.363; LLC FNN, 2009, MOM SAYS COACH IGN S; Luken M G 3rd, 1979, Clin Neurosurg, V26, P353; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; Miller G, 2009, SCIENCE, V325, P670, DOI 10.1126/science.325_670; Millichap JG, 2006, CLIN EEG NEUROSCI, V37, P190, DOI 10.1177/155005940603700305; Mueller F, 2008, ANN SURVEY CATASTROP; Mueller F, 2009, ANN SURVEY CATASTROP; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; PATEL H, 1995, PEDIATR NEUROL, V13, P55, DOI 10.1016/0887-8994(95)00056-L; Podberesky DJ, 2009, PEDIATR RADIOL, V39, P1264, DOI 10.1007/s00247-009-1359-6; Pop Warner Little Scholars Inc, 2011, FOOTB AG WEIGHT STRU; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; Santamarina RD, 2008, CLIN NEUROPHARMACOL, V31, P80, DOI 10.1097/WNF.0b013e3180ed4485; SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604; SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607, DOI 10.1212/WNL.44.9.1607; Schwerzmann M, 2001, ANN INTERN MED, V134, P21, DOI 10.7326/0003-4819-134-1-200101020-00009; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Sentinel Santa Cruz, 2008, SOQ FOOTB PLAYER SUF; Sepelyak K, 2010, EUR J PEDIATR, V169, P557, DOI 10.1007/s00431-009-1066-1; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Shiiya N, 2004, ANN THORAC SURG, V77, P2034, DOI 10.1016/j.athoracsur.2003.12.057; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Spengos K, 2004, EUR NEUROL, V51, P172, DOI 10.1159/000077665; Sweeney B, 1996, EUR NEUROL, V36; Talavage T, J NEUROTRAUMA; Tekin S, 1997, PEDIATR NEUROL, V16, P67, DOI 10.1016/S0887-8994(96)00252-4; Times LA, 1997, TIMES LA; Touze E, 2003, NEUROLOGY, V61, P1347, DOI 10.1212/01.WNL.0000094325.95097.86; Uchihara T, 2004, GLIA, V45, P180, DOI 10.1002/glia.10318; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; WANG MQ, 1993, PERCEPT MOTOR SKILL, V76, P379, DOI 10.2466/pms.1993.76.2.379; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; WIZNITZER M, 1991, ANN NEUROL, V29, P585, DOI 10.1002/ana.410290603; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	67	4	4	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2011	26	12					1493	1498		10.1177/0883073811418114			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	851ZT	WOS:000297312100004	21968983				2022-02-06	
J	Trevena, L; Cameron, I				Trevena, Lyndal; Cameron, Ian			Traumatic brain injury Long term care of patients in general practice	AUSTRALIAN FAMILY PHYSICIAN			English	Article						brain injuries; rehabilitation	HEAD-INJURY; COGNITIVE REHABILITATION; RISK-FACTORS; MULTICENTER; DEPRESSION; THERAPY; MANAGEMENT; SYMPTOMS; INDIVIDUALS; DISORDERS	Background Traumatic brain injury is a significant cause of disability worldwide. Patients with a traumatic brain injury may have a range of physical, mental, cognitive and social problems involving care from a general practitioner. Objective This article provides a summary of the available evidence for managing the common mental health, somatic and cognitive/behavioural issues associated with traumatic brain injury. Discussion The long term sequelae of traumatic brain injury pose a number of challenges for patients, their families and GPs. Common somatic complaints include seizures, headache, dizziness and sleep disturbance. Common mental health problems include depression, psychosis and anxiety. Cognitive and behavioural or personality changes can be significant and persist for some time following injury. Quality of life is closely predicted by return to the workforce and long term functional status is often linked to the severity of the injury. There is limited evidence for effective treatments of these sequelae and a need for more research. However, there are a number of proven treatments and an emerging understanding of the long term sequelae of traumatic brain injury.	[Trevena, Lyndal] Univ Sydney, Off Global Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia; [Cameron, Ian] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Cameron, Ian] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia		Trevena, L (corresponding author), Univ Sydney, Off Global Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia.	lyndalt@health.usyd.edu.au		Trevena, Lyndal/0000-0003-1419-1832	Motor Accident Authority	Lyndal Trevena works for the Sydney School of Public Health which receives funding from the Motor Accident Authority.	Albera R, 2003, ACTA OTO-LARYNGOL, V123, P588, DOI 10.1080/00016480310001475; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1999, REHABILITATION TRAUM; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Guetin S., 2009, Annals of Physical and Rehabilitation Medicine, V52, P30, DOI 10.1016/j.annrmp.2008.08.009; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Helps Y., 2008, HOSP SEPARATIONS DUE; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; McGorry P, 2004, ROYAL AUSTR NZ COLL; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAMARATNAM S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001524; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Schierhout G, 2001, COCHRANE DATABASE SY, V2; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sinnakaruppan I, 2001, INT J REHABIL RES, V24, P35, DOI 10.1097/00004356-200103000-00005; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136	46	4	4	0	16	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	DEC	2011	40	12					956	+					5	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862BP	WOS:000298065100004	22146322				2022-02-06	
J	Ziaja, M; Pyka, J; Boczkus, B; Plonka, BK; Plonka, PM				Ziaja, Marek; Pyka, Janusz; Boczkus, Bozena; Plonka, Beata K.; Plonka, Przemyslaw M.			Changes in the nitric oxide level in the rat liver as a response to brain injury	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Article						DETC; Transplantation; NO; EPR; ESR	ELECTRON-SPIN-RESONANCE; NERVOUS-SYSTEM; ANIMAL-TISSUES; DEATH; MCP-1; EXPRESSION; NO; LIPOPOLYSACCHARIDE; TRANSPLANTATION; CYTOKINES	Liver disturbances stimulate inflammatory reaction in the brain but little is known if injury to the brain can significantly influence liver metabolism. This problem is crucial in modern transplantology, as the condition of the donor brain seems to strongly affect the quality (viability) of the graft, which is often obtained from brain-dead donors, usually after traumatic brain injury. Because nitric oxide is one of the significant molecules in brain and liver biology, we examined if brain injury can affect NO level in the liver. Liver samples of Wistar rats were collected and studied with EPR NO-metry to detect NO level changes at different time points after brain injury. Shortly after the trauma, NO level in the liver was similar to the control. However, later there was a significant increase in the NO content in the livers starting from the 2nd day after brain injury and lasting up to the 7th day. It seems that the response to a mechanical brain injury is of the systemic, rather than local character. Therefore brain metabolism disturbances can influence liver metabolism at least by stimulating the organ to produce NO. (C) 2011 Elsevier Inc. All rights reserved.	[Ziaja, Marek] Jagiellonian Univ, Inst Zool, Dept Neuroanat, PL-30348 Krakow, Poland; [Pyka, Janusz] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut, PL-30348 Krakow, Poland; [Pyka, Janusz; Boczkus, Bozena] Jagiellonian Univ, Lab Radiospectroscop Studies Struct & Dynam Macro, Dept Biophys, Fac Biochem Biophys & Biotechnol, PL-30348 Krakow, Poland; [Boczkus, Bozena; Plonka, Beata K.; Plonka, Przemyslaw M.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Lab Radiospect Canc & Radiobiol, PL-30348 Krakow, Poland		Ziaja, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neuroanat, Gronostajowa 9, PL-30348 Krakow, Poland.	marek.ziaja@uj.edu.pl		Plonka, Przemyslaw/0000-0002-0261-3439; Ziaja, Marek/0000-0002-8576-0206; Pyka, Janusz/0000-0002-7723-5321	Jagiellonian University [BW/IZ/71/2006, BW16a, WRBW/BiNoZ/IZ/77/2007]; European UnionEuropean Commission [POIG.02.01.00-12-064/08]	This work was supported by Jagiellonian University grants BW/IZ/71/2006, BW16a and WRBW/BiNoZ/IZ/77/2007. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (Grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health").	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; ANTHOLINE W, 1976, PHYS MED BIOL, V21, P840, DOI 10.1088/0031-9155/21/5/012; ASCENZI P, 1990, J INORG BIOCHEM, V40, P157, DOI 10.1016/0162-0134(90)80049-4; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Campbell ME, 2005, PEDIATR RES, V58, P840, DOI 10.1203/01.PDR.0000181376.83137.ED; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2010, BRAIN BEHAV IMMUN, V24, P738, DOI 10.1016/j.bbi.2010.01.011; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chlopicki S, 1999, J PHYSIOL PHARMACOL, V50, P551; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Fujii H, 1999, MAGNET RESON MED, V42, P599, DOI 10.1002/(SICI)1522-2594(199909)42:3<599::AID-MRM24>3.3.CO;2-P; GOODMAN BA, 1969, J CHEM SOC A, P2572, DOI 10.1039/j19690002572; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Halejcio-Delophont P, 2001, J HEART LUNG TRANSPL, V20, P71, DOI 10.1016/S1053-2498(00)00207-2; Hoeger S., 2010, AM J TRANSPLANT; Hu MZ, 2010, TRANSPL IMMUNOL, V23, P6, DOI 10.1016/j.trim.2010.02.001; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; James PE, 1999, NITRIC OXIDE-BIOL CH, V3, P292, DOI 10.1006/niox.1999.0238; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Kirima K, 2003, AM J PHYSIOL-HEART C, V285, pH589, DOI 10.1152/ajpheart.01010.2002; Kitade H, 1996, HEPATOLOGY, V23, P797, DOI 10.1002/hep.510230421; Kolios G, 2008, MOL CELL BIOCHEM, V319, P91, DOI 10.1007/s11010-008-9881-7; KON H, 1968, J BIOL CHEM, V243, P4350; KONOREV EA, 1995, J PHARMACOL EXP THER, V274, P200; Koudstaal LG, 2005, TRANSPLANT P, V37, P448, DOI 10.1016/j.transproceed.2004.12.258; KUBRINA LN, 1992, BIOCHIM BIOPHYS ACTA, V1099, P233, DOI 10.1016/0005-2728(92)90032-W; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Levesque E, 2009, METABOLISM, V58, P1550, DOI 10.1016/j.metabol.2009.04.032; Lewis M, 2003, QJM-INT J MED, V96, P623, DOI 10.1093/qjmed/hcg110; Lewis MB, 2003, NEUROLOGY, V61, P1174, DOI 10.1212/01.WNL.0000089487.42870.C6; Lewis MB, 2000, NEUROLOGY, V54, P1011, DOI 10.1212/WNL.54.4.1011; Mirzayan M.J., 2008, NEUROL RES; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakanishi AL, 1998, FREE RADICAL BIO MED, V25, P201, DOI 10.1016/S0891-5849(98)00051-3; Olinga P, 2005, LIVER INT, V25, P109, DOI 10.1111/j.1478-3231.2005.01035.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pieper GM, 2008, FREE RADICAL BIO MED, V44, P1536, DOI 10.1016/j.freeradbiomed.2008.01.020; Plonka PM, 2003, ACTA BIOCHIM POL, V50, P807; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Rankine EL, 2006, EUR J NEUROSCI, V24, P77, DOI 10.1111/j.1460-9568.2006.04891.x; Rodrigo J, 2004, CEREBELLUM, V3, P194, DOI 10.1080/14734220410017941; Ronco MT, 2004, BBA-MOL BASIS DIS, V1690, P70, DOI 10.1016/j.bbadis.2004.05.004; SAPRIN AN, 1969, DOKL AKAD NAUK SSSR+, V189, P889; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Suzuki H, 1995, ADV NEUROIMMUNOL, V5, P379, DOI 10.1016/0960-5428(95)00024-0; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; van der Hoeven JAB, 2003, TRANSPLANTATION, V76, P1150, DOI 10.1097/01.TP.0000080983.14161.95; Van der Hoeven JAB, 2001, TRANSPLANTATION, V72, P1632, DOI 10.1097/00007890-200111270-00009; VANIN AF, 1984, STUD BIOPHYS, V102, P135; Vanin A, 2009, FRONT BIOSCI-LANDMRK, V14, P4427, DOI 10.2741/3538; VANZEE KJ, 1992, J IMMUNOL, V148, P1746; Wertz J.E., 1986, ELECT SPIN RESONANCE; Wojcikowski J, 2009, EXPERT OPIN DRUG MET, V5, P631, DOI 10.1517/17425250902973703; Zhang SJ, 2004, TRANSPL P, V36, P1925, DOI 10.1016/j.transproceed.2004.07.008; Ziaja M, 1999, J NEUROSCI RES, V58, P379, DOI 10.1002/(SICI)1097-4547(19991101)58:3<379::AID-JNR3>3.3.CO;2-A; Ziaja M., 2005, CURR TOP BIOPHYS, V29, P73; Ziaja M, 2007, J NEUROTRAUM, V24, P1845, DOI 10.1089/neu.2007.0303; Ziaja M, 2011, BRAIN RES, V1367, P319, DOI 10.1016/j.brainres.2010.10.006	65	4	4	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	NOV 30	2011	25	4					423	430		10.1016/j.niox.2011.07.004			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	860TM	WOS:000297970600007	21911070				2022-02-06	
J	Hayashi, S; Osuka, K; Watanabe, Y; Yasuda, M; Takayasu, M; Wakabayashi, T				Hayashi, Shigemasa; Osuka, Koji; Watanabe, Yasuo; Yasuda, Muneyoshi; Takayasu, Masakazu; Wakabayashi, Toshihiko			Hypothermia enhances the colocalization of calmodulin kinase II alpha with neuronal nitric oxide synthase in the hippocampus following cerebral ischemia	NEUROSCIENCE LETTERS			English	Article						Cerebral ischemia; Hypothermia; Calmodulin kinase II alpha; Neuronal nitric oxide synthase	DEPENDENT PROTEIN-KINASE; MILD HYPOTHERMIA; MESSENGER-RNA; THERAPEUTIC HYPOTHERMIA; RAT HIPPOCAMPUS; BRAIN; DEATH; IMMUNOREACTIVITY; PHOSPHORYLATION; TRANSLOCATION	Hypothermia has been shown to have neuroprotective effects against neurotrauma and cerebrovascular disease. Cerebral ischemia induces the activation of calcium/calmodulin kinase II (CaM-KII), which modulates many enzymes. We have previously demonstrated that CaM-KII alpha downregulates neuronal nitric oxide synthase (nNOS) activity. However, precise details regarding the neuroprotective mechanism of hypothermia largely remain to be elucidated. Therefore, in this study, we investigated the neuroprotective mechanism of hypothermia, focusing on the association between CaM-KII alpha and nNOS in CA1 hippocampus after focal cerebral ischemia in mice. The temperature was maintained at normothermia (36.5-37.5 degrees C) or mild hypothermia (31.5-32.5 degrees C) during these procedures. Focal cerebral ischemia induced significant dissociation of CaM-KII alpha from nNOS in the CA1 hippocampus but not in the cerebral cortex under normothermia. Hypothermia did not change the expression of nNOS, but it significantly induced the colocalization of CaM-KII alpha with nNOS in CA1 hippocampus immediately after cerebral ischemia. These results presumably result in the attenuation of nNOS activity and could contribute to the tolerance to post-ischemic damage. This effect could be one of the neuroprotective mechanisms of hypothermia. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Osuka, Koji; Yasuda, Muneyoshi; Takayasu, Masakazu] Aichi Med Univ, Dept Neurol Surg, Nagakute, Aichi 4801195, Japan; [Hayashi, Shigemasa; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Watanabe, Yasuo] Showa Pharmaceut Univ, High Technol Res Ctr, Tokyo 1948543, Japan		Osuka, K (corresponding author), Aichi Med Univ, Dept Neurol Surg, 21 Karimata Yazako, Nagakute, Aichi 4801195, Japan.	kosuka@aichi-med-u.ac.jp	Wakabayashi, Toshihiko/I-3526-2012	Wakabayashi, Toshihiko/0000-0001-5254-2088; Watanabe, Yasuo/0000-0003-2232-0091	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19-8]	This work was supported in part by a Grant-in-Aid for Scientific Research and High Technology Research Center Project (19-8) (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Babcock AM, 1995, BRAIN RES, V705, P307, DOI 10.1016/0006-8993(95)01155-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; Harada K, 2002, J NEUROSCI RES, V67, P664, DOI 10.1002/jnr.10159; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; HIESTAND DM, 1992, NEUROSCI LETT, V144, P75, DOI 10.1016/0304-3940(92)90719-N; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; HU BR, 1995, J NEUROCHEM, V64, P277; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; Karabiyikoglu M, 2003, J NEUROSURG, V98, P1271, DOI 10.3171/jns.2003.98.6.1271; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Komeima K, 2000, J BIOL CHEM, V275, P28139; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; ONODERA H, 1990, NEUROSCI LETT, V113, P134, DOI 10.1016/0304-3940(90)90292-H; Osuka K, 2002, J CEREBR BLOOD F MET, V22, P1098, DOI 10.1097/00004647-200209000-00007; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; Uno H, 1999, ACTA NEUROCHIR, V141, P287, DOI 10.1007/s007010050300; Van Hemelrijck A, 2005, EUR J NEUROSCI, V22, P1327, DOI 10.1111/j.1460-9568.2005.04331.x; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001	27	4	6	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 21	2011	505	3					228	232		10.1016/j.neulet.2011.10.013			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	867PE	WOS:000298465500003	22015767				2022-02-06	
J	Escribano, JA; Meseguer, IH; Garcia-Quijada, RC				Acosta Escribano, J.; Herrero Meseguer, I.; Conejero Garcia-Quijada, R.			Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus SEMICYUC-SENPE: Neurocritical patient	NUTRICION HOSPITALARIA			English	Article						Neurocritical patient; Traumatic brain injury; Early nutrition; Hyperglycemia	EARLY ENTERAL NUTRITION; INTENSIVE-CARE-UNIT; INTRAVENOUS GLUTAMINE SUPPLEMENTATION; MECHANICALLY VENTILATED PATIENTS; CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; ENERGY-EXPENDITURE; INSULIN THERAPY; BODY POSITION; BRAIN-INJURY	Neurocritical patients require specialized nutritional support due to their intense catabolism and prolonged fasting. The preferred route of nutrient administration is the gastrointestinal route, especially the gastric route. Alternatives are the transpyloric route or mixed enteral-parenteral nutrition if an effective nutritional volume of more than 60% cannot be obtained. Total calore intake ranges from 20-30 kcal/kg/day, depending on the period of the clinical course, with protein intake higher than 20% of total calories (hyperproteic diet). Nutritional support should be initiated early. The incidence of gastrointestinal complications is generally higher to other critically-ill patients, the most frequent complication being an increase in gastric residual volume. As in other critically-ill patients, glycemia should be closely monitored and maintained below 150 mg/dL.	[Acosta Escribano, J.] Hosp Gen Univ, Alicante, Spain; [Herrero Meseguer, I.] Hosp Univ Bellvitge, Barcelona, Spain; [Conejero Garcia-Quijada, R.] Hosp Univ San Juan, Alicante, Spain		Escribano, JA (corresponding author), Hosp Gen Univ, Alicante, Spain.	acostesc@gmail.com					Acosta Escribano J A, 2001, Nutr Hosp, V16, P262; Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Bonet A., 2007, Med. Intensiva, V31, P402; Bullock MR, 2006, NEUROSURGERY, V58, pS2; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Faisy C, 2003, AM J CLIN NUTR, V78, P241, DOI 10.1093/ajcn/78.2.241; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Garcia-de-Lorenzo A, 2003, NUTRITION, V19, P805, DOI 10.1016/S0899-9007(03)00103-5; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Hsu CW, 2009, CRIT CARE MED, V37, P1866, DOI 10.1097/CCM.0b013e31819ffcda; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Klein S, 1997, JPEN-PARENTER ENTER, V21, P133, DOI 10.1016/S0261-5614(97)80006-4; Kompan L, 2004, CLIN NUTR, V23, P527, DOI 10.1016/j.clnu.2003.09.013; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; Latorre JGS, 2009, STROKE, V40, P1644, DOI 10.1161/STROKEAHA.108.535534; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Montejo JC, 2002, CRIT CARE MED, V30, P796, DOI 10.1097/00003246-200204000-00013; Neumann DA, 2002, CRIT CARE MED, V30, P1436, DOI 10.1097/00003246-200207000-00006; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Nguyen NQ, 2008, INTENS CARE MED, V34, P1246, DOI 10.1007/s00134-008-1036-5; Nguyen NQ, 2008, CRIT CARE MED, V36, P1469, DOI 10.1097/CCM.0b013e31816fc457; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25	42	4	4	0	6	ARAN EDICIONES, S L	MADRID	C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN	0212-1611	1699-5198		NUTR HOSP	Nutr. Hosp.	NOV	2011	26			2			72	75					4	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	871CL	WOS:000298715100016	22411525				2022-02-06	
J	Arshavsky, YI				Arshavsky, Y. I.			Neural Mechanisms of Memory: Synaptic and Genomic Hypotheses	ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA			Russian	Article						long-term memory; synaptic hypothesis; genomic hypothesis; epigenetics; Alzheimer's disease	BLOOD-BRAIN-BARRIER; LONG-TERM-MEMORY; END-JOINING PROTEINS; ALZHEIMERS-DISEASE; DNA METHYLATION; REMOTE MEMORY; ELECTROCONVULSIVE-THERAPY; EPIGENETIC MECHANISMS; HISTONE MODIFICATIONS; TRANSCRIPTION FACTORS	Memorizing of new facts and events means that entering signals produce definite changes within the brain. According to the commonly accepted hypothesis, traces of memory are stored through modifications in the strength of synaptic connections, resulting in formations of new patterns of neural activity. This synaptic hypothesis of memory determines the main direction of experimental studies in the field. It is shown in this review that the synaptic hypothesis can hardly explain the mechanism of long-term (often life-long) memory storage as well as memory resistance to both uncontrolled synaptic activity (epileptic seizures) and various adverse effects on the brain (anesthesia, injury, concussion, etc.). Arguments for an alternative hypothesis are given that long-term memory is mainly formed at the intraneural level through modifications of DNA molecules and associated proteins. This genomic hypothesis allows for a new approach to understanding the etiology of Alzheimer's disease, whose initial symptom is solely memory impairment.	Univ Calif San Diego, San Diego, CA 92103 USA		Arshavsky, YI (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.	yarshavs@ucsd.edu					Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Anokhin KV, 1997, ZH VYSSH NERV DEYAT+, V47, P261; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; [АРШАВСКИЙ Ю.И. Arshavskii Yu.I.], 2010, [Вестник Российской академии наук, Vestnik Rossiiskoi akademii nauk], V80, P937; ARSHAVSKIY YI, 2011, IMMUNOLOGIYA, V32; [Аршавский Ю.И. Arshavsky Y.I.], 2011, [Сенсорные системы, Sensornye sistemy], V25, P3; Arshavsky YI, 2003, BRAIN RES REV, V41, P229, DOI 10.1016/S0165-0173(02)00249-7; Arshavsky YI, 2006, PROG NEUROBIOL, V79, P190, DOI 10.1016/j.pneurobio.2006.07.007; Arshavsky YI, 2010, J ALZHEIMERS DIS, V20, P5, DOI 10.3233/JAD-2009-1339; Arshavsky YI, 2009, BRAIN RES REV, V60, P327, DOI 10.1016/j.brainresrev.2009.01.001; BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; CHAYLAKHYAN LM, 1992, ISTOKI PROISKHOZHDEN; CHEEK DB, 1968, CLIN HYPNOTHERAPY; [Черниговская Т.В. Chernigovskaya T.V.], 2007, [Человек, Human Being, Chelovek], P63; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chun J, 1999, NEURON, V22, P7, DOI 10.1016/S0896-6273(00)80671-6; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Collas P, 2007, J CELL MOL MED, V11, P602, DOI 10.1111/j.1582-4934.2007.00079.x; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; de Ortiz SP, 2003, NEUROREPORT, V14, P1141, DOI 10.1097/01.wnr.00000.74771.23712.4f; de Ortiz SP, 2001, J NEUROSCI RES, V63, P72; DEORTIZ SP, 2004, DYNAMICAL GENETICS, P345; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; ECCLES JC, 1972, BRAIN HUM BEHAV, P39; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Greenberg RM, 2005, AM J GERIAT PSYCHIAT, V13, P268; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawkins J., 2004, INTELLIGENCE; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; LeDoux J, 2003, ANN NY ACAD SCI, V1001, P295, DOI 10.1196/annals.1279.017; Leritz EC, 2006, EPILEPSY BEHAV, V9, P1, DOI 10.1016/j.yebeh.2006.04.012; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LIBERMAN EA, 1989, BIOSYSTEMS, V22, P135, DOI 10.1016/0303-2647(89)90042-7; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Luriya A. R, 1968, MALENKAYA KNIZHKA BO; Maroun M, 2001, NEURONAL MECHANISMS OF MEMORY FORMATION, P137; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Medini P, 2008, FRONT BIOSCI-LANDMRK, V13, P3000, DOI 10.2741/2905; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2010, ANN NY ACAD SCI, V1191, P27, DOI 10.1111/j.1749-6632.2010.05443.x; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; PENFIELD W, 1958, P NATL ACAD SCI USA, V44, P51, DOI 10.1073/pnas.44.2.51; Pluta R, 2006, NEUROL RES, V28, P665, DOI 10.1179/016164106X130399; RAPOPORT SI, 1989, MED HYPOTHESES, V29, P147, DOI 10.1016/0306-9877(89)90185-0; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skrebitsky V. G., 1999, Uspekhi Fiziologicheskikh Nauk, V30, P3; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; Squire L.R., 1999, MEMORY MIND MOL; SQUIRE LR, 1976, BEHAV BIOL, V18, P335, DOI 10.1016/S0091-6773(76)92295-1; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Taniura H, 2007, NEUROCHEM INT, V51, P85, DOI 10.1016/j.neuint.2007.04.018; THIEL G, 2006, TRANSCRIPTION FACTOR; Thompson P J, 1991, Adv Neurol, V55, P369; Treffert DA, 2005, SCI AM, V293, P108, DOI 10.1038/scientificamerican1205-108; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016	98	4	5	0	5	MEZHDUNARODNAYA KNIGA	MOSCOW	39 DIMITROVA UL., MOSCOW, 113095, RUSSIA	0044-4677			ZH VYSSH NERV DEYAT+	Zhurnal Vyss. Nervn. Deyatelnosti Im. I P Pavlov.	NOV-DEC	2011	61	6					660	674					15	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	873RN	WOS:000298900800002	22384727				2022-02-06	
J	Settervall, CHC; de Sousa, RMC; Silva, SCFE				Costanti Settervall, Cristina Helena; Cardoso de Sousa, Regina Marcia; Fuerbringer e Silva, Silvia Cristina			In-hospital mortality and the Glasgow Coma Scale in the first 72 hours after traumatic brain injury	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						Brain Injuries; Trauma Severity Indices; Glasgow Coma Scale; Prognosis; Mortality	PREDICTIVE-VALUE; SCORE; OUTCOMES	This study verifies and compares the performance of three different scores obtained in the Glasgow Coma Scale (GCS) in the first 72 hours post trauma in predicting in-hospital mortality. The studied scores included those obtained after initial care was provided at the hospital, and the worst and best scores obtained in the scale in the first 72 hours post trauma. The scale's predictive ability was assessed by the Receiver Operator Characteristic (ROC) curve. A total of 277 victims with different severity levels of blunt traumatic brain injuries were studied. The performance of the three scores that were analyzed to predict hospital mortality was moderate (0.74 to 0.79) and the areas under the curve did not present statistically significant differences. These findings suggest that any of the three studied scores can be applied in clinical practice to estimate the outcome of victims with blunt traumatic brain injuries, taking into consideration the instrument's moderate discriminatory power.	[Costanti Settervall, Cristina Helena; Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Escola Enfermagem, BR-05508 Sao Paulo, Brazil; [Fuerbringer e Silva, Silvia Cristina] Univ Grande ABC, Santo Andre, SP, Brazil; [Fuerbringer e Silva, Silvia Cristina] Univ Paulista, Santos, SP, Brazil		Settervall, CHC (corresponding author), Av Prof Ida Kolb 225,Bloco 4,Apto 191, BR-02518000 Sao Paulo, Brazil.	settervall@usp.br; vian@usp.br; silviafur@uol.com.br	Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Calil AM, 2009, REV LAT-AM ENFERM, V17, P120, DOI 10.1590/S0104-11692009000100019; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dutton RP, 2010, J TRAUMA, V20, P1; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Heim C, 2004, ANAESTHESIST, V53, P1245, DOI 10.1007/s00101-004-0777-y; Hickey J, 2003, CLIN PRACTICE NEUROL; Itabashi HH, 2007, APPENDEX B GLASGOW C; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Martinez EZ., 2003, CADERNOS SAUDE COLET, V11, P7; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McNett M, 2009, J NEUROSCI NURS, V39, P68; *MIN SAUD BR, DATASUS; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	24	4	6	0	3	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	NOV-DEC	2011	19	6					1337	1343		10.1590/S0104-11692011000600009			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	871CE	WOS:000298714400009	22249667	gold			2022-02-06	
J	Moreno-Lopez, A; Holttum, S; Oddy, M				Moreno-Lopez, Agueda; Holttum, Sue; Oddy, Michael			A grounded theory investigation of life experience and the role of social support for adolescent offspring after parental brain injury	BRAIN INJURY			English	Article						acquired brain injury; head injury; traumatic brain injury	PSYCHOLOGICAL DISTRESS; CHILDREN; TBI; CONSEQUENCES; DEPRESSION; APPRAISAL; FAMILIES; STRESS	Primary objective: The purpose of this study was to explore the experiences of adolescent offspring following parental acquired brain injury (ABI) and the role of supportive relationships in offspring coping. Design: The study was qualitative using grounded theory methodology. Methods and procedure: Nine adolescent offspring of parents with ABI were interviewed individually. For the purposes of triangulation, three of their noninjured parents were interviewed individually. Results: Findings indicate that following the shock of the ABI, adolescents appeared to go through a dynamic process of reevaluation of life priorities, a sudden realization of the fragility of life, and an increase in their appreciation of the family's needs. The study's findings also show that adolescent offspring can have a protective role in the family, assisting the family with the long-term challenges that ABI may present. Alternative parental figures and peer friendships appeared to have a central role for participants, providing a sense of normality and stability to their lives, and acted as an important connection with their lives prior to their parents' ABI. Conclusions: Findings indicated that supportive relationships were crucial as a coping strategy for adolescent offspring. Assessment of adolescents' coping strategies and support networks should be conducted by the best-placed clinician working with the family. Preventative interventions are recommended. A strength-based view of the adolescent may be beneficial.	[Moreno-Lopez, Agueda] Kent & Medway NHS & Social Partnership Trust, Tonbridge, Kent, England; [Holttum, Sue] Canterbury Christ Church Univ, Dept Appl Psychol, Tunbridge Wells, Kent, England; [Oddy, Michael] Brain Injury Rehabil Trust, Horsham, W Sussex, England		Moreno-Lopez, A (corresponding author), Balt Rd Clin, Baltic Rd, Tonbridge TN9 2NA, Kent, England.	aguedamoreno@hotmail.com		Holttum, Sue/0000-0003-2618-8518			Aldwin C. M, 2007, STRESS COPING DEV; ALTSHULER JL, 1989, CHILD DEV, V60, P1337, DOI 10.2307/1130925; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 2002, QSR I USING NVIVO QU; Boyle GJ, 2002, PSYCHOL REP, V90, P415, DOI 10.2466/PR0.90.2.415-425; Brooks N, 1987, J NEUROL NEUROSUR PS, V49, P664; Brooks N, 1986, J HEAD TRAUMA REHAB, V2, P1; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Cairns RB., 1994, LIFELINES RISKS PATH; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Carr A., 1999, HDB CHILD ADOLESCENT; Carr A., 2004, POSITIVE PSYCHOL SCI; Charmaz K., 2014, BROKERAGE CLOSURE IN; Chiland C, 1974, CHILD HIS FAMILY CHI; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Compas B, 1991, ADOLESCENT STRESS CA; COMPAS BE, 1988, J CONSULT CLIN PSYCH, V56, P405, DOI 10.1037/0022-006X.56.3.405; Daisley A, 1999, P BRIT PSYCHOL SOC, V7, P71; Daisley A, 2008, PSYCHOL APPROACHES R; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Department of Health, 2005, NAT SERV FRAM LONG T; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Eschenbeck H., 2007, J INDIVID DIFFER, V28, P18, DOI DOI 10.1027/1614-0001.28.1.18; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Gilligan R., 2001, PROMOTING RESILIENCE; Gosling J, 1999, BRAIN INJURY, V13, P785; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris D, 2006, HLTH SA GESONDHEID, V11, P46; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Kirk L, 2005, PHENOMENOLOGICAL STU; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Landman-Peeters KMC, 2005, SOC SCI MED, V60, P2549, DOI 10.1016/j.socscimed.2004.10.024; Levitt MJ, 2005, SOC DEV, V14, P398, DOI 10.1111/j.1467-9507.2005.00308.x; Lezak DH, 2004, NEUROPSYCHOLOGICAL A, V4; Marshall C., 2016, DESIGNING QUALITATIV, V6th ed.; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Minuchin S., 1974, FAMILIES FAMILY THER; National Institute of Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Newman B, 1991, DEV LIFE; Ostman M, 2002, SOC PSYCH PSYCH EPID, V37, P243, DOI 10.1007/s00127-002-0540-0; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Salmon P., 2000, PSYCHOL MED SURG GUI; Sander A, 1999, REHABILITATION ADULT; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Urbach J R, 1989, Psychiatr Med, V7, P17; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wasserstein SB, 1996, J CLIN CHILD PSYCHOL, V25, P177, DOI 10.1207/s15374424jccp2502_6; Willig C., 2001, INTRO QUALITATIVE RE; Winnicott D, 1983, CHILDREN DEPRESSED P; Wood R, 2000, NEUROBEHAVIOURAL DIS; Yeates G, 2008, NEUROLOGICAL REHABIL	61	4	4	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1221	1233		10.3109/02699052.2011.608205			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200009	21932996				2022-02-06	
J	Csokay, A; Lang, J; Lajgut, A; Pentelenyi, T; Valalik, I				Csokay, Andras; Lang, Jozsef; Lajgut, Attila; Pentelenyi, Tamas; Valalik, Istvan			In vitro and in vivo surgical and MRI evidence to clarify the effectiveness of the vascular tunnel technique in the course of decompressive craniectomy	NEUROLOGICAL RESEARCH			English	Article						Decompressive craniectomy; Head injury; Traumatic brain swelling; Vascular tunnel	TRAUMATIC BRAIN-INJURY	Objective: To demonstrate the efficacy of a vascular protection technique during decompressive craniectomy (DC) which can reduce the risk of secondary venous infarction due to the blocking pressure for venous outflow through bridging veins. Method: The observation was carried out in vitro (cadaver) and in vivo (surgery and magnetic resonance imaging) in order to verify the durability of the vascular tunnel. Results: In vivo observation proved the durability of vascular tunnel even 2 months later. The cadaveric experimental model showed that after the 12 x 13 cm size DC had been obtained, the observed vein was occluded at 18-21 mmHg without vascular protection; however, the control preparation remained open even at 50 mmHg. Conclusion: The in vivo case study and the cadaver experiment suggest that vascular protection helps prevent secondary venous infarction after DC. This is therefore an aid in preventing further injury and cerebral oedema. The vascular tunnel guarantees the efficacy of DC even at a high level of intracranial pressure.	[Csokay, Andras; Lang, Jozsef; Lajgut, Attila; Valalik, Istvan] BAZ Cty Hosp, Dept Neurosurg, H-3526 Miskolc, Hungary; [Pentelenyi, Tamas] Peterfi S Hosp, Dept Neurosurg, Budapest, Hungary		Csokay, A (corresponding author), BAZ Cty Hosp, Dept Neurosurg, 72-76 Szentpeteri Kapu, H-3526 Miskolc, Hungary.	csokaya@gmail.com					Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Csokay A, 2002, NEUROL RES, V24, P157, DOI 10.1179/016164102101199701; CSOKAY A, 2001, HUNGARIAN MED J, V142, P75; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; SAHUQUILLO J, COCHRANE DATABASE SY; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	10	4	4	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	SEP	2011	33	7					747	749		10.1179/1743132811Y.0000000001			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	790MI	WOS:000292591700011	21756555				2022-02-06	
J	Lopez, C				Lopez C, Carolina			THE STRUGGLE FOR WHOLENESS: ADDRESSING INDIVIDUAL AND COLLECTIVE TRAUMA IN VIOLENCE-RIDDEN SOCIETIES	EXPLORE-THE JOURNAL OF SCIENCE AND HEALING			English	Article						Trauma; individual healing; collective healing; wholeness; ideological-structural analysis; human dignity; re-building societies; self-care		The present article begins with an overview of how staff at the Center for Dialogue and Human Wellbeing (CDBH)-at Tecnologico de Monterrey University in Chihuahua, Mexico approach the process of conflict transformation. Specifically, it focuses on CDBH's strategies for dealing with historical injury, as well as the individual and collective trauma existing between and among communities engaged in ongoing conflict. It proceeds to examine how traumatic memories are stored in the mind/brain, and how trauma can impact on individuals and communities locked into a cycle of violence. The ensuing section provides an overview of the debate and the literature concerning psychotherapeutic and holistic-kinesthetic approaches for addressing individual and collective trauma. A hypothetical workshop is then offered to give readers a clear idea of how trauma work is actually carried out. The article ends by asking what approaches can best be applied for transforming collective trauma into sacred memories, which can become the driving force for a continuing commitment to building and sustaining peace among segments of communities that had previously been in conflict with one another.	[Lopez C, Carolina] Univ Malaya, Ctr Civilisat Dialogue, Kuala Lumpur 50603, Malaysia; [Lopez C, Carolina] Tecnol Monterrey Univ, Ctr Dialogue & Human Wellbeing, Chihuahua, Mexico		Lopez, C (corresponding author), Univ Malaya, Ctr Civilisat Dialogue, 2nd Floor,Siswarama Bldg, Kuala Lumpur 50603, Malaysia.	dialog@um.edu.my					Agger I., 1996, TRAUMA CURA SITUACIO; Anckermann S, 2005, J COMMUNITY APPL SOC, V15, P136, DOI 10.1002/casp.811; BASAGLIA F, 2004, RAZON LOCURA SOC PSI; Becker D., 2004, DEALING CONSEQUENCES; BRACKEN P, 1998, RESPONSES TRAUMA CUR; Bracken Patrick., 2002, TRAUMA CULTURE MEANI; BRAVEHEART MY, TAKINIS HIST TRAUMA; CALLAHAN R, 1996, FIELD THERAPY TRAUMA; CANE PM, 2002, TRAUMA SANACION TRAN; CIENFUEGOS AJ, 1983, AM J ORTHOPSYCHIAT, V53, P43, DOI 10.1111/j.1939-0025.1983.tb03348.x; Goleman D., 1995, EMOTIONAL INTELLIGEN; GOMEZ LN, 2003, ELEMENTOS BASICOS TE; GUTLOVE P, 2003, PSYCHOSOCIAL HEALING; HERMAN J, 1997, TRAUMA RECOVERY PSYC; Jensen Soren Buus, 1996, TRAUMA HEALING STATE; Kordon D., 2007, PORVENIRES MEMORIA; Levine P. A., 1997, WAKING TIGER HEALING; Martin-Baro I, 1990, PSICOLOGIA SOCIAL GU; SAJQUIMTORRES MD, 1999, THESIS NO ARIZONA U; SERVANSCHREIBER D, 2005, CURACION EMOCIONAL A; Shapiro F., 2001, EYE MOVEMENT DESENSI; Somasundaram Daya, 2007, Int J Ment Health Syst, V1, P5, DOI 10.1186/1752-4458-1-5; Sonpar S., 2008, TRAUM DEV PEAC C NEW; SUMMERFIELD D, 1996, 14 REL REH NETW; Van Der Kolk Bessel, 1996, P303; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; VANDERKOLK BA, 2001, TRAUMA COGN SCI, V2, P9; VOLCAN V, 2001, GROUP ANAL, V34, P79	28	4	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1550-8307			EXPLORE-NY	Explore-J Sci. Heal.	SEP-OCT	2011	7	5					300	313		10.1016/j.explore.2011.06.001			14	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	821PS	WOS:000294987500011	21907153				2022-02-06	
J	Mehrazin, M; Nezameddini-Kachooei, SA; Fallahi, B; Derakhshan, MK; Beiki, D; Ghodsi, SM; Assadi, M; Pooyafard, F; Eftekhari, M				Mehrazin, Masoud; Nezameddini-Kachooei, Seyed Akbar; Fallahi, Babak; Derakhshan, Mohammad Kamran; Beiki, Davood; Ghodsi, Seyed Mohammad; Assadi, Majid; Pooyafard, Farzaneh; Eftekhari, Mohammad			Prospective evaluation of technetium-99m ECD SPET in mild traumatic brain injury for the prediction of sustained neuropsychological sequels	HELLENIC JOURNAL OF NUCLEAR MEDICINE			English	Article						Technetium-99m ECD; Traumatic brain injury; SPET; Memory deficit	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; CT; PERFUSION	Our aim was to evaluate whether single photon emission tomography (SPET) versus computed tomography (CT) in acute phase of mild traumatic brain injury (MTBI) was better for the prediction of sustained neuropsychological symptoms beyond a typical recovery period. Forty five patients with MTBI were prospectively evaluated with clinical and neuropsychological exams, structural imaging using CT and perfusion study by Tc-99m-ethylene cysteinate dimer (Tc-99m-ECD) SPET within a week of the head trauma. After an interval ranging from 6 to 12 (median: 9) months, all patients were re-evaluated by standard neuropsychological tests for the assessment of sustained personality changes, imbalance and memory deficits. Our results showed that, 25 patients had abnormal brain perfusion on Tc-99m-ECD SPET. In 19 cases of total 20 normal Tc-99m-ECD SPET studies, no sign of memory deficit and imbalance was observed. Negative predictive value (NPV) for both complications was 95%. NPV of CT for the prediction of memory deficit and imbalance were 77.4% and 90.3%, respectively. The risk of developing sustained memory deficits and imbalance in patients with positive Tc-99m-ECD SPET were 40% and 20%, respectively. A perfusion abnormality on Tc-99m-ECD SPET was associated with a greater chance of long-standing memory deficits (odds ratio=13.49, P=0.020) while neither CT nor Tc-99m-ECD SPET could independently predict the personality changes in these patients. The patients with abnormalities on both CT and SPET images faced a significant relative risk of complications, 1.63 times, higher than the others. In conclusion, our study indicated that Tc-99m-ECD SPET imaging or CT imaging alone, could not predict the occurrence of sustained complications after MTBI. Concurrent use of both imaging modalities performed shortly after MTBI may yield the best results, as the combination of abnormalities in both cerebral structure and perfusion could indicate the patients with 1.63 times higher risk of sustained memory deficits, personality changes and imbalance.	[Mehrazin, Masoud; Nezameddini-Kachooei, Seyed Akbar; Ghodsi, Seyed Mohammad] Dr Shariati Hosp, Fac Med, Dept Neurosurg, Tehran, Iran; [Fallahi, Babak; Beiki, Davood; Pooyafard, Farzaneh; Eftekhari, Mohammad] Univ Tehran Med Sci, Res Inst Nucl Med, Tehran, Iran; [Derakhshan, Mohammad Kamran] Arak Univ Med Sci, Dept Psychiat, Arak, Iran; [Assadi, Majid] Bushehr Univ Med Sci, Persian Gulf Hlth Inst, Bushehr Res Ctr Nucl Med, Bushehr, Iran		Fallahi, B (corresponding author), Shariati Hosp, Res Inst Nucl Med, N Kargar Ave 1411713135, Tehran, Iran.	bfallahi@sina.tums.ac.ir	Beiki, Davood/J-2595-2016; Fallahi, Babak/B-2061-2019; Assadi, Majid/H-2812-2017; Assadi, Majid/U-5316-2019; eftekhari, Mohammad Hassan/P-6003-2019	Beiki, Davood/0000-0002-2862-0581; Assadi, Majid/0000-0003-3862-9472; Assadi, Majid/0000-0002-2166-3765; 	Tehran University of Medical Sciences, Tehran, IranTehran University of Medical Sciences [6005]	This research has been supported by Tehran University of Medical Sciences, grant 6005, Tehran, Iran. The authors would like to thank Mrs. M. Darvishha, Mr. Morteza Faghih Joibari, Mr. H.R. Naghavi, Ms. Khosroparviz, Ms. Yahiazadeh, and Ms. Kheiri for their assistance in this research.	ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; DellaCorte F, 1997, ACTA NEUROCHIR, V139, P636; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Granacher RP, 2008, J AM ACAD PSYCHIATRY, V36, P323; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; ROPER SN, 1991, J NUCL MED, V32, P1684; Umile EM, 1998, BRAIN INJURY, V12, P577; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310	16	4	4	0	1	HELLENIC SOC NUCLEAR MEDICINE	THESSALONIKI	51 HERMU ST, THESSALONIKI, 546 23, GREECE	1790-5427			HELL J NUCL MED	Hell. J. Nucl. Med.	SEP-DEC	2011	14	3					243	250					8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	855NA	WOS:000297569900008	22087443				2022-02-06	
J	Ness, BM; Sohlberg, MM; Albin, RW				Ness, Bryan Michael; Sohlberg, McKay Moore; Albin, Richard W.			Evaluation of a Second-Tier Classroom-Based Assignment Completion Strategy for Middle School Students in a Resource Context	REMEDIAL AND SPECIAL EDUCATION			English	Article						strategy instruction; assignment completion; special education; middle school; initiation; on-task	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; LEARNING-DISABILITIES; EXECUTIVE FUNCTION; BIPOLAR DISORDER; SELF-REGULATION; HOMEWORK; ADHD; ADOLESCENTS; CHILDREN	Students who struggle academically often struggle with assignment completion. Poor assignment completion is attributable to both student cognitive and motivational barriers. This study evaluates the effectiveness of an intervention designed to improve assignment completion for middle school students who struggle academically. Seventh graders with diverse educational and behavioral profiles in a resource room context learned to use an organization system to facilitate assignment management while in the resource classroom. The intervention was applied at the classroom level to address implementation barriers encountered while piloting the system with individual students. Using a single-subject design methodology, we demonstrated a functional relation between the intervention and assignment completion skills for two of three participants. Classroom-wide application facilitated implementation and positive effects were maintained 1 month postintervention. Additional implementation and intervention implications are discussed.	[Sohlberg, McKay Moore] Univ Oregon, Commun Disorders & Sci Program, Eugene, OR 97403 USA; [Albin, Richard W.] Univ Oregon, Dept Special Educ & Clin Sci, Eugene, OR 97403 USA		Ness, BM (corresponding author), Univ New Hampshire, 151 Hewitt Hall,4 Lib Way, Durham, NH 03824 USA.	Bryan.Ness@unh.edu	Berger, Emily/N-7268-2017; Ness, Bryan/G-7242-2012	Berger, Emily/0000-0001-5550-807X; 			BADDELY A, 2004, ESSENTIALS HUMAN MEM; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boekaerts M, 2006, EDUC PSYCHOL REV, V18, P199, DOI 10.1007/s10648-006-9013-4; Bryan T, 2001, EDUC PSYCHOL-US, V36, P167, DOI 10.1207/S15326985EP3603_3; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; Epstein M. H., 1997, LEARNING DISABILITIE, V12, P221; EPSTEIN MH, 1993, REM SPEC EDUC, V14, P40, DOI 10.1177/074193259301400507; Franklin R. D., 1997, DESIGN ANAL SINGLE C, P119; GAJRIA M, 1995, J LEARN DISABIL, V28, P291, DOI 10.1177/002221949502800504; Gureasko-Moore S, 2007, SCHOOL PSYCHOL REV, V36, P647; Harris KR, 2005, J SPEC EDUC, V39, P145, DOI 10.1177/00224669050390030201; Hill EL, 2004, DEV REV, V24, P189, DOI 10.1016/j.dr.2004.01.001; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; HUGHES CA, 2002, LEARNING DISABILITIE, V17, P1; Kennedy CH., 2005, SINGLE CASE DESIGNS; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Mooney P, 2005, J BEHAV EDUC, V14, P203, DOI 10.1007/s10864-005-6298-1; Munk D., 2001, READ WRIT Q, V17, P189; Nelson JS, 2002, REM SPEC EDUC, V23, P379; NESS B, 2007, ANN M OR SPEECH LANG; Olvera RL, 2005, BIPOLAR DISORD, V7, P57, DOI 10.1111/j.1399-5618.2004.00167.x; Parker RI, 2007, BEHAV THER, V38, P95, DOI 10.1016/j.beth.2006.05.002; PATTON JR, 1994, J LEARN DISABIL, V27, P570, DOI 10.1177/002221949402700904; Pavuluri MN, 2006, BIOL PSYCHIAT, V60, P951, DOI 10.1016/j.biopsych.2006.03.027; PENNINGTON BF, 1996, J CHILD PSYCHOL PSYC, V37, P57; Primavera LH, 1997, DESIGN ANAL SINGLE C, P41; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Reid R, 1996, J LEARN DISABIL, V29, P317, DOI 10.1177/002221949602900311; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Rucklidge JJ, 2006, BIOL PSYCHIAT, V60, P921, DOI 10.1016/j.biopsych.2006.03.067; SALEND J. S., 2004, TEACHING EXCEPTIONAL, V36, P64; Sawyer V, 1996, LEARN DISABILITY Q, V19, P70, DOI 10.2307/1511249; Shimabukuro SM, 1999, ED TREATMENT CHILDRE, V22, P397; Sikora DA, 2002, DEV NEUROPSYCHOL, V21, P243, DOI 10.1207/S15326942DN2103_2; Struyk L. R, 1995, CLEARING HOUSE, V69, P50; Sugai G., 2000, J POSIT BEHAV INTERV, V2, P131, DOI [DOI 10.1177/109830070000200302, 10.1177/109830070000200302]; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005	40	4	4	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0741-9325	1538-4756		REM SPEC EDUC	Remedial Spec. Educ.	SEP-OCT	2011	32	5					406	416		10.1177/0741932510362493			11	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	818WM	WOS:000294786600005					2022-02-06	
J	Sakallioglu, O; Polat, C; Soylu, E; Orhan, I; Altinsoy, HB				Sakallioglu, O.; Polat, C.; Soylu, E.; Orhan, I.; Altinsoy, H. B.			Contralateral profound hearing loss after head trauma: A case report	TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY			English	Article						Labyrinthine concussion; contralateral hearing loss; head trauma		Hearing loss is a known outcome following head trauma. The conductive as well as sensorineural hearing loss have been demonstrated both in cases of head injury. The labyrinthine concussion is postulated to be the underlying mechanism, and it is a common finding in head traumas. There is no specific treatment for labyrinthine concussion. The diagnosis mainly relies on audiometric tests. We reported a case of labyrinthine concussion in the opposite ear of a patient who had head trauma. At 2-month of follow-up, we observed that the contralateral hearing loss of our case persisted.	[Sakallioglu, O.; Polat, C.] Elazig Egitim & Arastirma Hastanesi, Kulak Burun Bogaz Klin, Elazig, Turkey; [Soylu, E.; Orhan, I.] Medipol Univ, Kulak Burun Hastaliklari Anabilim Dali, Istanbul, Turkey; [Altinsoy, H. B.] Elazig Egitim & Arastirma Hastanesi, Radyol Klin, Elazig, Turkey		Sakallioglu, O (corresponding author), Elazig Egitim & Arastirma Hastanesi, Kulak Burun Bogaz Klin, Elazig, Turkey.	onersakallioglu@yahoo.com	Orhan, Irfan/W-7694-2018; Altinsoy, Hasan Baki/AAO-5274-2020	Orhan, Irfan/0000-0002-7827-4840; Altinsoy, Hasan Baki/0000-0003-0934-3600			Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Chujo K, 2008, AURIS NASUS LARYNX, V35, P273, DOI 10.1016/j.anl.2007.04.005; Daud MKM, 2009, ANN ACAD MED SINGAP, V38, P1017; Hunchaisri N., 2009, J MED ASS THAI, V92, P76; Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069; Yeakley J W, 1999, Curr Probl Diagn Radiol, V28, P65, DOI 10.1016/S0363-0188(99)90002-6	8	4	4	0	0	GALENOS YAYINCILIK	FINDIKZADE	MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21, FINDIKZADE, ISTANBUL 34093, TURKEY	2667-7466	2667-7474		TURK ARCH OTORHINOL	Turk. Arch. Otorhinolaryn.	SEP	2011	49	3					58	60		10.5152/tao.2011.15			3	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	V7K7C	WOS:000421047900003					2022-02-06	
J	Tu, CJ; Liu, JS; Song, DG; Zhen, G; Luo, HM; Liu, WG; Dong, XQ				Tu, C. J.; Liu, J. S.; Song, D. G.; Zhen, G.; Luo, H. M.; Liu, W. G.; Dong, X. Q.			Maximum Thickness of Subarachnoid Blood is Associated with Mortality in Patients with Traumatic Subarachnoid Haemorrhage	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						TRAUMATIC SUBARACHNOID HAEMORRHAGE; MAXIMUM THICKNESS OF SUBARACHNOID BLOOD; MORTALITY; PREDICTION	TRANSCRANIAL DOPPLER ULTRASOUND; NONPENETRATING HEAD-INJURY; GLASGOW COMA SCALE; BRAIN-INJURY; IMPACT; PROGNOSIS; MODERATE; FLOW	This study was designed to evaluate whether the maximum thickness of subarachnoid blood is an independent prognostic marker of mortality after traumatic subarachnoid haemorrhage. Multivariate analysis showed the maximum thickness of subarachnoid blood was an independent predictor of death versus survival 1 month after injury and was inversely associated with Glasgow Coma Scale (GCS) score. Receiver operating characteristic curve analysis showed that maximum thickness of subarachnoid blood > 6.7 mm immediately after non-surgical resuscitation predicted 1-month mortality with 83.9% sensitivity and 67.1% specificity; its predictive value was similar to that of the GCS score. Addition of maximum thickness of subarachnoid blood to the GCS score did not significantly improve predictive performance. Hence, the maximum thickness of subarachnoid blood is a new independent prognostic marker of mortality and might become an additional, valuable tool for risk stratification and decision making in the acute phase of traumatic subarachnoid haemorrhage.	[Tu, C. J.; Liu, J. S.; Song, D. G.; Zhen, G.; Luo, H. M.] Shaoxing Cty Cent Hosp, Dept Neurosurg, Shaoxing 312030, Peoples R China; [Liu, W. G.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, X. Q.] First Hangzhou Municipal Peoples Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Song, DG (corresponding author), Shaoxing Cty Cent Hosp, Dept Neurosurg, 1 Huayu Rd, Shaoxing 312030, Peoples R China.	lwgxjf@163.com			Zhejiang Medical Research Fund Scheme A Class Project [2009A209]	This study was supported by a grant from Zhejiang Medical Research Fund Scheme A Class Project (2009A209).	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; FREYTAG E, 1963, ARCH PATHOL, V75, P402; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KOBAYASHI S, 1982, Neurologia Medico-Chirurgica, V22, P838, DOI 10.2176/nmc.22.838; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miki T, 1998, J CLIN NEUROSCI, V5, P49, DOI 10.1016/S0967-5868(98)90202-8; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Paiva WS, 2010, INT SURG, V95, P172; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	29	4	7	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2011	39	5					1757	1765		10.1177/147323001103900518			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	854ZD	WOS:000297532400018	22117976	Bronze			2022-02-06	
J	Lipke, KJ				Lipke, K. J.			Possibilities in the surgical management of eyelid trauma	HNO			German	Article						Eyelid; Reconstruction; Lid margin defect; Hughes plastic; Blepharoplasty	LID RECONSTRUCTION; OCULAR TRAUMA; GLOBE INJURIES; CLASSIFICATION; LACERATIONS; SYSTEM	The face plays a central role in interpersonal communication and aesthetic perception. Moreover, due to the heavy dependence of ocular function on lid anatomy, the treatment of periocular injuries, particularly those involving soft tissue loss, requires profound knowledge of both anatomy and reconstructive plastic surgery. Numerous surgical procedures are described in the literature. The aim of these procedures is to achieve an optimal functional and aesthetic result according to injury localization and extent. Against this background, treating eyelid injuries presents certain challenges. Close collaboration between all areas of head surgery is required particularly in the case of large defects.	Bundeswehrkrankenhaus Ulm, Abt Augenheilkunde, D-89081 Ulm, Germany		Lipke, KJ (corresponding author), Bundeswehrkrankenhaus Ulm, Abt Augenheilkunde, Oberer Eselsberg 40, D-89081 Ulm, Germany.	dr.lipke@lidoperationen.de	Lipke, Klaus/ABA-5824-2020				*BER AUG DTSCH OPH, 2006, 8 BER AUG DTSCH OPHT; BEYERMACHULE CK, 1991, KLIN MONATSBL AUGENH, V198, P75, DOI 10.1055/s-2008-1045933; Biehl JW, 1999, MIL MED, V164, P780, DOI 10.1093/milmed/164.11.780; BORN CP, 1983, POSTGRAD MED, V73, P311, DOI 10.1080/00325481.1983.11697776; Breeze J., 2010, BR J ORAL MAXILLOFAC; COLLIN JRO, 1982, T OPHTHAL SOC UK, V102, P214; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; CUTLER NL, 1955, AM J OPHTHALMOL, V39, P1; Engelmann V, 2011, OPHTHALMOLOGE, V108, P33, DOI 10.1007/s00347-010-2212-x; Han JK, 2008, AM J RHINOL, V22, P522, DOI 10.2500/ajr.2008.22.3217; Herde J, 2001, OPHTHALMOLOGE, V98, P472, DOI 10.1007/s003470170132; HORNBLASS A, 1981, International Ophthalmology Clinics, V21, P121, DOI 10.1097/00004397-198102140-00008; HUBNER H, 1976, KLIN MONATSBL AUGENH, V168, P677; Hughes W L, 1976, Trans Am Ophthalmol Soc, V74, P321; Kuhn F, 1996, GRAEF ARCH CLIN EXP, V234, P399, DOI 10.1007/BF00190717; Kuhn F, 2008, GRAEF ARCH CLIN EXP, V246, P169, DOI 10.1007/s00417-007-0735-x; May DR, 2000, GRAEF ARCH CLIN EXP, V238, P153, DOI 10.1007/PL00007884; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Mustarde J C, 1972, Ann Ophthalmol, V4, P883; Muzaffar W, 2000, BRIT J OPHTHALMOL, V84, P626, DOI 10.1136/bjo.84.6.626; Nguyen Quan Dong, 2002, International Ophthalmology Clinics, V42, P167, DOI 10.1097/00004397-200207000-00018; Pfeiffer MJ, 2004, OPHTHALMOLOGE, V101, P466, DOI 10.1007/s00347-004-1006-4; Pokhrel PK, 2007, AM FAM PHYSICIAN, V76, P829; Rustemeyer J, 2007, BRIT J ORAL MAX SURG, V45, P556, DOI 10.1016/j.bjoms.2007.01.003; Sobaci G, 2000, AM J OPHTHALMOL, V129, P47, DOI 10.1016/S0002-9394(99)00254-8; Sommer F, 2008, KLIN MONATSBL AUGENH, V225, P691, DOI 10.1055/s-2008-1027486; Struck HG, 2009, OPHTHALMOLOGE, V106, P223, DOI 10.1007/s00347-008-1906-9; Wong TY, 1997, MIL MED, V162, P744, DOI 10.1093/milmed/162.11.744; Wong TY, 1997, SURV OPHTHALMOL, V41, P433, DOI 10.1016/S0039-6257(97)00022-2	29	4	4	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0017-6192			HNO	HNO	AUG	2011	59	8					783	790		10.1007/s00106-011-2350-8			8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	806FN	WOS:000293791800005	21769580				2022-02-06	
J	Alvarez, JML; Lemaur, MEV; Quevedo, OP; Canal, JML; de Laguna, AJB; Llapurt, EC; de Casas, AMS; Jorge, RG				Lopez Alvarez, J. M.; Valeron Lemaur, M. E.; Perez Quevedo, O.; Liminana Canal, J. M.; Jimenez Bravo de Laguna, A.; Consuegra Llapurt, E.; Moron Saen de Casas, A.; Gonzalez Jorge, R.			Severe pediatric head injuries (I). Epidemiology, clinical manifestations and course	MEDICINA INTENSIVA			Spanish	Article						Pediatric head injury; Epidemiology; Clinical manifestations; Evolution	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; CHILDREN; PREDICTORS; SCALE; RISK	Objective: To describe the epidemiology, clinical manifestations and evolutive characteristics of pediatric patients with severe head injury (SHI). Material and method: A review was made of the patients admitted to the pediatric intensive care unit (PICU) with SHI between July 1983 and December 2009. Results: Of the 389 patients with head injuries admitted to the PICU during the study period, 174 (45%) presented SHI. The mean age in this group was of 67 +/- 9 months, with a Glasgow Coma Score (GCS) of 5.5 +/- 1.8 and a PRISM score of 10.7 +/- 6.7. The most frequent etiology of SHI was traffic accidents (56%), though these have decreased significantly in the last decade (58.5% vs 45.3%; P<.001). Twenty-one percent of the patients required evacuation of the lesions detected by computed tomography (CT), and 39% presented severe diffuse encephalic injury (DEI). Seventy-nine percent of the patients in whom intracranial pressure (ICP) was monitored presented intracranial hypertension. Sequelae of clinical relevance were recorded in 59 patients (39%), and proved serious in 64% of the cases. The mortality rate in this patient series was 24.7%. Intracranial hypertension decreased significantly in the last decade (88% vs 54%; P<.05), and clinical recovery has improved (23.3% vs 63.1%; P<.001). Conclusions: a) The incidence of traffic accidents has decreased in the last decade in the studied population; b) patients with SHI in which ICP was monitored showed a high incidence of intracranial hypertension; c) morbidity-mortality among pediatric patients with SHI has decreased over the course of the study period. (C) 2010 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Lopez Alvarez, J. M.; Valeron Lemaur, M. E.; Perez Quevedo, O.; Jimenez Bravo de Laguna, A.; Consuegra Llapurt, E.; Moron Saen de Casas, A.; Gonzalez Jorge, R.] Complejo Hosp Univ Insular Materno Infantil Canar, Unidad Med Intens Pediat, Las Palmas Gran Canaria, Spain; [Liminana Canal, J. M.] Fac Med, Dept Bioestadist, Las Palmas Gran Canaria, Spain		Alvarez, JML (corresponding author), Complejo Hosp Univ Insular Materno Infantil Canar, Unidad Med Intens Pediat, Las Palmas Gran Canaria, Spain.	jmloal@hotmail.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; ADELSON PD, 2003, PEDIATR CRIT CARE ME, V4, pS20; ADELSON PD, 2003, PEDIATR CRIT CARE ME, V4, pS66; Alted López Emilio, 2009, Med. Intensiva, V33, P16; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAIST F, 1983, J TRAUMA, V23, P775; FERNANDEZ A, 2001, MED INTENSIVA, V25, P8; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; Gedeit R, 2001, Pediatr Rev, V22, P118, DOI 10.1542/pir.22-4-118; GIZA C, 2006, PEDIAT NEUROLOGY PRI, P1401; HENAO FJ, 1991, J TRAUMA, V31, P74, DOI 10.1097/00005373-199101000-00014; James HE, 1999, ACT NEUR S, V73, P85; JENNETT B, 1975, LANCET, V1, P480; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; LOPEZ JM, 2003, MED INTENSIVA, V27, P155; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rodriguez N, 2006, REV NEUROLOGIA, V43, P143, DOI 10.33588/rn.4303.2004453; TEADALE G, 1974, LANCET, V2, P81; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	30	4	5	0	4	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691			MED INTENSIVA	Med. Intensiv.	AUG-SEP	2011	35	6					331	336		10.1016/j.medin.2011.02.001			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	796NI	WOS:000293057600003	21496963				2022-02-06	
J	Gilardino, MS; Jandali, S; Whitaker, LA; Bartlett, SP				Gilardino, Mirko S.; Jandali, Shareef; Whitaker, Linton A.; Bartlett, Scott P.			Does the Incidence of Traumatic Brain Injury in Children Increase After Craniofrontal Surgery?	JOURNAL OF CRANIOFACIAL SURGERY			English	Article; Proceedings Paper	13th International Congress of the International-Society-of-Craniofacial-Surgery	OCT, 2009	Oxford, ENGLAND	Int Soc Craniofacial Surg		Traumatic brain injury (TBI); bony defects; craniofrontal surgery	CRANIOFACIAL SURGERY; COMPLICATIONS	Background: Craniofrontal reshaping (CR) for the treatment of craniosynostosis results in a temporary cranial defect due to the advancement and/or expansion of the supraorbital and frontal bones. The goal of the present study was to determine whether the incidence traumatic brain injury (TBI) was increased in patients after CR as a result of this breach in skull integrity. Methods: We performed a retrospective chart review of all patients with a diagnosis of craniosynostosis who underwent CR between 1997 and 2007 at our institution. The incidence of TBI (defined as a computed tomography-documented brain or skull injury or loss of consciousness) was determined during a 2-year postoperative follow-up period. Patients older than 1 year at the time of surgery, or those with less than 2 years of follow-up after surgery, were excluded. Results: A total of 396 patients met the inclusion criteria. The incidence of TBI was zero (95% confidence interval, 0-760/100,000). Conclusions: The estimated incidence of TBI after CR surgery is between 0 and 760 per 100,000 patients in our clinic population. These data indicate that although CR may be associated with a slightly increased risk of TBI while the skull is healing, the absolute incidence of such injury remains extremely rare.	[Gilardino, Mirko S.] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, H Bruce Williams Craniofacial & Cleft Surg Unit, Montreal, PQ H3H 1P3, Canada; [Jandali, Shareef; Whitaker, Linton A.; Bartlett, Scott P.] Univ Penn, Philadelphia, PA 19104 USA		Gilardino, MS (corresponding author), McGill Univ, Ctr Hlth, Montreal Childrens Hosp, H Bruce Williams Craniofacial & Cleft Surg Unit, Montreal, PQ H3H 1P3, Canada.	mirko.gilardino@muhc.mcgill.ca					Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dunn K, 1999, NIH CONS DEV C REH P; Fearon JA, 1997, PLAST RECONSTR SURG, V100, P862, DOI 10.1097/00006534-199709001-00006; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Horowitz I, 1983, Int Rehabil Med, V5, P32; JONES BM, 1992, BRIT J PLAST SURG, V45, P225, DOI 10.1016/0007-1226(92)90083-A; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1995, TRAUMATIC HEAD INJUR; McCarthy JG, 1993, J CRANIOFAC SURG, V4, P255; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Paige KT, 2006, PLAST RECONSTR SURG, V118, P977, DOI 10.1097/01.prs.0000232353.44086.af; POOLE MD, 1988, BRIT J PLAST SURG, V41, P608, DOI 10.1016/0007-1226(88)90168-3; Prevot M, 1993, J Craniofac Surg, V4, P247; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Sayers P, 1976, MORPHOGENESIS MALFOR, P344; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; WHITAKER L A, 1976, Journal of Maxillofacial Surgery, V4, P131, DOI 10.1016/S0301-0503(76)80021-5; WHITAKER LA, 1987, PLAST RECONSTR SURG, V80, P195, DOI 10.1097/00006534-198708000-00006; WHITAKER LA, 1979, PLAST RECONSTR SURG, V64, P198, DOI 10.1097/00006534-197908000-00011; Whitaker LA, 1982, ATLAS CRANIOMAXILLOF	25	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2011	22	4					1284	1286		10.1097/SCS.0b013e31821c6b2d			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	796OT	WOS:000293062100024	21772197				2022-02-06	
J	Jastrzebska, M; Chelstowski, K; Siennicka, A; Grzelec, H; Bajer-Czajkowska, A; Rybicka, M; Clark, J; Nowacki, P				Jastrzebska, Maria; Chelstowski, Kornel; Siennicka, Aldona; Grzelec, Halina; Bajer-Czajkowska, Anna; Rybicka, Marta; Clark, Jeremy; Nowacki, Przemyslaw			The character of haemostatic disorders and level of protein S-100 in acute ischaemic stroke can affect survival in the first week of follow-up: a pilot study	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						coagulation; fibrinogen; fibrinolysis; ischaemic stroke; NIHSS score; S-100 protein	DISSEMINATED INTRAVASCULAR COAGULATION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COAGULOPATHY; MARKERS; SYSTEM	Disorders of haemostasis which result in ischaemic stroke usually appear as thromboembolism in peripheral veins and the pulmonary circulation, and to a lesser extent as coagulopathy. The S-100 protein, a marker of stroke, correlates positively with the neurological deficit National Institutes of Health Stroke Scale (NIHSS). We adopted the hypothesis that early death of patients with acute ischaemic stroke can be explained by changes in blood coagulation and fibrinolysis. The study included 84 patients hospitalized with acute ischaemic stroke. Three groups were created: I (death between 1 and 2 days), II (death between 5 and 7 days) and III (with no deaths in hospital). We measured levels of fibrinogen, antithrombin, D-dimers, plasmin-antiplasmin complexes, plasminogen and clotting times (prothrombin time and activated partial thromboplastin time), platelet number, euglobulin clot lysis time (ECLT(index)) and S-100 protein, C-reactive protein and white blood cells (WBCs). Group I had lower concentrations of fibrinogen compared to groups II (3.13 vs. 4.18, P<0.01) and III (3.13 vs. 3.77, P<0.02) and higher levels of D-dimers (3643 vs. 2278, P<0.05), higher concentrations of plasmin-antiplasmin complexes (1410 vs. 882, P=0.03) and a lower ECLTindex (152 vs. 219, P<0.02) when compared with group III. Group I also had higher concentrations of protein S-100 (2.09 vs. 0.61, P<0.001), higher NIHSS (18.0 vs. 13.2, P=0.073) and number of WBC (14.1 vs. 11.1, P<0.02) than in group III. The observed abnormalities in haemostasis, either found systemically or locally as cerebral microvascular thrombosis, may be factors potentially associated with death of patients with the shortest survival time. Blood Coagul Fibrinolysis 22: 388-395 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Jastrzebska, Maria; Chelstowski, Kornel; Siennicka, Aldona; Clark, Jeremy] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, PL-70111 Szczecin, Poland; [Grzelec, Halina; Bajer-Czajkowska, Anna; Nowacki, Przemyslaw] Pomeranian Med Univ, Dept Neurol, PL-70111 Szczecin, Poland; [Rybicka, Marta] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland		Jastrzebska, M (corresponding author), Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Powstancow Wlkp 72, PL-70111 Szczecin, Poland.	mariajas1949@gmail.com	Goschorska, Marta/O-7739-2014; Clark, Jeremy S.C./E-1665-2016; Nowacki, Przemyslaw/B-5895-2016; Siennicka, Aldona/K-6559-2014; Siennicka, Aldona/AAD-5293-2019	Clark, Jeremy S.C./0000-0003-3179-5638; Siennicka, Aldona/0000-0002-5240-7676; Siennicka, Aldona/0000-0002-5240-7676; Nowacki, Przemyslaw/0000-0002-6536-2905	State Committee for Scientific Research at the Pomeranian Medical University	The research was supported by the State Committee for Scientific Research at the Pomeranian Medical University.	Antovic J, 2002, SCAND J CLIN LAB INV, V62, P195, DOI 10.1080/003655102317475452; Asakura H, 2002, CRIT CARE MED, V30, P161, DOI 10.1097/00003246-200201000-00023; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CATE H, 1999, THROMB HAEMOSTASIS, V82, P713; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hill MD, 2000, CAN MED ASSOC J, V162, P1139; Kokocinska D, 2005, ACTA ANGIOL, V11, P105; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Pathak A, 2005, Neurol India, V53, P178; SEOKMANN Y, 2008, J KOREAN NEUROSURG S, V44, P308; Shirasaki Y, 2004, BRAIN RES, V1021, P159, DOI 10.1016/j.brainres.2004.06.012; Stott DJ, 2001, BLOOD COAGUL FIBRIN, V12, P651, DOI 10.1097/00001721-200112000-00006; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Tohgi H, 2000, THROMB RES, V100, P373, DOI 10.1016/S0049-3848(00)00356-X; Vergouwen MDI, 2004, STROKE, V35, P1280, DOI 10.1161/01.STR.0000128707.48644.7e; Wada H, 2004, CLIN CHIM ACTA, V344, P13, DOI 10.1016/j.cccn.2004.02.015; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Weglewski Arkadiusz, 2005, Neurol Neurochir Pol, V39, P310; ZAREMBA J, 2004, NEUROL NEUROCHIR POL, V38, P57	27	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235			BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	JUL	2011	22	5					388	395		10.1097/MBC.0b013e328345c081			8	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	789HP	WOS:000292506600006	21451398				2022-02-06	
J	Khalil, A; Spiotta, AM; Barnett, GH				Khalil, Amer; Spiotta, Alejandro M.; Barnett, Gene H.			Difficulties with the neurological assessment of humans following a chimpanzee attack Case report	JOURNAL OF NEUROSURGERY			English	Article						chimpanzee attack; neurological assessment; traumatic brain injury	FREE-LIVING CHIMPANZEES; KIBALE-NATIONAL-PARK; INTERGROUP AGGRESSION; WILD CHIMPANZEES; CANNIBALISM; COMMUNITY; INFANTICIDE; UGANDA; NGOGO	Chimpanzee attacks can be vicious, mutilating, and disabling if not fatal. Stereotypically, the hands and face are targeted, and in male victims, genitalia are mutilated. The authors present a case highlighting the difficulties with early neurological assessment following such an attack. This 55-year-old woman was attacked by a 14-year-old chimpanzee. She suffered mutilation of both hands, severe midface bony, soft-tissue, and eye injuries, and scalp degloving. An emergency tracheotomy was performed at the scene, with an unclear duration of hypoxia. The patient was unresponsive without spontaneous movements, papillary or corneal reflexes, cough, or gag. Attempts to lighten sedation were not tolerated. Brain CTs were normal. Intracranial pressure monitoring was deemed infeasible. Brain MR imaging suggested diffuse axonal injury consistent with severe shaking trauma. Diffusion tensor imaging indicated intact corticospinal tracts, confirmed by somatosensory evoked potentials. Magnetic resonance imaging suggested left optic nerve transaction, and right retinal detachment was diagnosed. Electroencephalography showed severe diffuse encephalopathy. Auditory evoked potentials showed absent auditory pathway responses except for a right delayed wave V. Visual evoked potentials indicated absent visual function. At 1 month after the attack, sedation and analgesia weaning revealed lower-extremity movement to command, but no upper-limb response. Cervical spine and brachial plexus MR imaging showed brachial plexus edema. Two months after the attack, the patient regained strength in all her extremities and verbally communicated using a Passy-Muir tracheostomy valve. Chimpanzee attacks on humans can cause extensive, life-threatening injuries. The neurological assessment of such patients is challenging, complicated by limb and craniofacial disfigurement and the need for heavy sedation. Initial assessment of nervous system integrity may rely on costly imaging and electrophysiological studies. (DOI: 10.3171/2011.2.JNS101911)	[Barnett, Gene H.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Neurol Inst, Taussig Canc Inst, Cleveland, OH 44195 USA; [Khalil, Amer; Spiotta, Alejandro M.; Barnett, Gene H.] Cleveland Clin, Neurol Inst, Dept Neurol Surg, Cleveland, OH 44195 USA		Barnett, GH (corresponding author), Cleveland Clin, Brain Tumor & Neurooncol Ctr, Neurol Inst, Taussig Canc Inst, S73,9500 Euclid Ave, Cleveland, OH 44195 USA.	barnetg@ccf.org					[Anonymous], 2006, BBC NEWS        0424; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; BYGOTT JD, 1972, NATURE, V238, P410, DOI 10.1038/238410a0; BYGOTT JD, 1979, GREAT APES, P404; Fawcett K, 2000, AM J PRIMATOL, V51, P243, DOI 10.1002/1098-2345(200008)51:4<243::AID-AJP3>3.0.CO;2-P; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; GOODALL J, 1977, FOLIA PRIMATOL, V28, P259, DOI 10.1159/000155817; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hockings KJ, 2010, AM J PRIMATOL, V72, P887, DOI 10.1002/ajp.20784; Kutsukake N, 2002, AM J PRIMATOL, V58, P175, DOI 10.1002/ajp.10058; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; NISHIDA T, 1985, Primates, V26, P274, DOI 10.1007/BF02382402; SCHAPIRO R, 2009, ESQUIRE          APR, P1; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; Watts DP, 2002, PRIMATES, V43, P263, DOI 10.1007/BF02629601; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046	18	4	4	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	2011	115	1					140	144		10.3171/2011.2.JNS101911			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	782JO	WOS:000292004700028	21417702				2022-02-06	
J	Kumar, A; Pandey, R; Singh, K; Sharma, V				Kumar, Apoorva; Pandey, Rajendra; Singh, Kulwant; Sharma, Vivek			Scissors in Brain: An Unusual Presentation of Tribal Culture in India	TURKISH NEUROSURGERY			English	Article						Penetrating injury; Brain; Scissors; Tribal culture; Head injury	INJURY	AIM:To observe the neurological complications arising from various tribal practices and their management. Penetrating head injuries comprise only a small number of total head injuries. A penetrating head injury by deliberate attempt to treat an ailment is almost unheard of. MATERIAL and METHODS: We present here a case of penetrating head injury caused by stabbing a scissor in head by a local witch doctor in order to treat a psychiatric ailment. RESULTS: The patient was taken up for for surgery and managed accordingly. Relevant literature was reviewed regarding various foreign bodies in traumatic missile and non missile brain injuries and their surgical management.	[Kumar, Apoorva; Pandey, Rajendra; Singh, Kulwant; Sharma, Vivek] Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India		Kumar, A (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India.	apoorvakumar80@gmail.com					Anderson S A, 1996, J Ophthalmic Nurs Technol, V15, P103; BAKAY L, 1977, ACTA NEUROCHIR, V39, P219, DOI 10.1007/BF01406732; Davis NL, 2004, AM J FOREN MED PATH, V25, P259, DOI 10.1097/01.paf.0000127388.00255.85; Evans RJ, 1996, AM J FOREN MED PATH, V17, P70, DOI 10.1097/00000433-199603000-00013; FACKLER ML, 1988, JAMA-J AM MED ASSOC, V259, P2730, DOI 10.1001/jama.259.18.2730; HERRING CJ, 1988, NEUROSURGERY, V23, P658, DOI 10.1227/00006123-198811000-00022; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; Kaufman H H, 1991, Neurosurg Clin N Am, V2, P387; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Nakayama Yoshiya, 1995, Brain and Nerve (Tokyo), V47, P1192; Salar G, 2004, J NEUROSURG, V100, P963, DOI 10.3171/jns.2004.100.5.0963	11	4	4	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JUL	2011	21	3					413	417		10.5137/1019-5149.JTN.2838-09.3			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	806KB	WOS:000293805200021	21845581	Bronze			2022-02-06	
J	Lee, DH; Han, SB; Park, JH; Park, SY; Jeong, WK; Lee, SH				Lee, Dae-Hee; Han, Seung-Beom; Park, Jong-Hoon; Park, Si-Young; Jeong, Woong-Kyo; Lee, Soon-Hyuck			Elbow arthrography in children with an ulnar fracture and occult subluxation of the radial head	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						arthrography; children; Monteggia fracture; radius; ulna	MISSED MONTEGGIA FRACTURE; DISLOCATION; DEFORMATION; REDUCTION; DIAGNOSIS; OLECRANON; INJURIES; INFANTS; END	The purpose of this study was to investigate the use of elbow arthrography for detecting an occult subluxation of the radial head and for verifying the quality of reduction in children with ulnar fractures. The study involved 15 children who underwent closed reduction (with or without percutaneous pinning) based on arthrography for minimally displaced fractures with or without radial head subluxation. The mean age of the patient at the time of surgery was 6 years (range, 3-12 years). Initial diagnoses based on conventional radiographs were compared with arthrographically confirmed final diagnoses in groups of children with ulnar fractures of the olecranon, proximal, and diaphysis. Arthrography confirmed initial radiographic diagnoses in 10 and altered diagnoses in five patients. We conclude that arthrography can be useful for detecting an occult subluxation of the radial head and for evaluating adequate reduction in children of less than 6 years with ulnar fractures. J Pediatr Orthop B 20: 257-263 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Lee, Dae-Hee; Han, Seung-Beom; Park, Jong-Hoon; Park, Si-Young; Jeong, Woong-Kyo; Lee, Soon-Hyuck] Korea Univ, Coll Med, Dept Orthopaed Surg, Anam Hosp, Seoul 136705, South Korea		Lee, SH (corresponding author), Korea Univ, Coll Med, Dept Orthopaed Surg, Anam Hosp, 126-1,5 Ga Anam Dong, Seoul 136705, South Korea.	soonlee@korea.ac.kr	lee, dae hee/I-9390-2017				AKBARNIA BA, 1986, J BONE JOINT SURG AM, V68A, P599, DOI 10.2106/00004623-198668040-00018; Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; David-West KS, 2005, INJURY, V36, P1206, DOI 10.1016/j.injury.2004.12.033; DAVIDSON RS, 1994, J BONE JOINT SURG AM, V76A, P1804, DOI 10.2106/00004623-199412000-00006; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P251; GLEESON AP, 1994, J ACCID EMERG MED, V11, P192; GRAVES SC, 1993, J PEDIATR ORTHOPED, V13, P239; Heinrich SD, 2007, CLIN ORTHOP RELAT R, P258, DOI 10.1097/BLO.0b013e31804b20fa; Javed A, 2001, J BONE JOINT SURG BR, V83B, P542, DOI 10.1302/0301-620X.83B4.10945; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; Maeda H, 2003, J ORTHOP TRAUMA, V17, P128, DOI 10.1097/00005131-200302000-00010; MEHTA SD, 1993, J BONE JOINT SURG BR, V75, P337, DOI 10.1302/0301-620X.75B2.8444966; MILES KA, 1989, INJURY, V20, P365, DOI 10.1016/0020-1383(89)90016-8; NANNO M, 2007, AM J ORTHOP, V36, P2; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; PAPAVASILIOU VA, 1987, INJURY, V18, P100, DOI 10.1016/0020-1383(87)90182-3; Peter N, 2007, CAN J EMERG MED, V9, P383; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000156480.76450.04; SKIBO L, 1994, CAN ASSOC RADIOL J, V45, P287; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; THEODOROU SD, 1988, CLIN ORTHOP RELAT R, P240; YATES C, 1987, J PEDIATR ORTHOPED, V7, P54, DOI 10.1097/01241398-198701000-00011	26	4	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2011	20	4					257	263		10.1097/BPB.0b013e3283474292			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	774ZG	WOS:000291424700011	21552149				2022-02-06	
J	Osen, KK; Furness, DN; Hackney, CM				Osen, Kirsten K.; Furness, David N.; Hackney, Carole M.			The border between the central and the peripheral nervous system in the cat cochlear nerve: A light and scanning electron microscopical study	HEARING RESEARCH			English	Article							ADULT SPINAL-CORD; TRANSITIONAL ZONE; FUNCTIONAL REGENERATION; FIBER REGENERATION; AUDITORY-NERVE; HEARING-LOSS; DORSAL-ROOT; HEAD-INJURY; RAT; NUCLEUS	The transition between the central (CNS) and peripheral nervous system (PNS) in cranial and spinal nerve roots, referred to here as the CNS PNS border, is of relevance to nerve root disorders and factors that affect peripheral-central regeneration. Here, this border is described in the cat cochlear nerve using light microscopical sections, and scanning electron microscopy of the CNS PNS interfaces exposed by fracture of the nerve either prior to or following critical point drying. The CNS PNS border represents an abrupt change in type of myelin, supporting elements, and vascularization. Because central myelin is formed by oligodendrocytes and peripheral myelin by Schwann cells, the myelinated fibers are as a rule equipped with a node of Ranvier at the border passage. The border is shallower and smoother in cat cochlear nerve than expected from other nerves, and the borderline nodes are largely in register. The loose endoneurial connective tissue of the PNS compartment is closed at the border by a compact glial membrane, the mantle zone, of the CNS compartment. The mantle zone is penetrated by the nerve fibers, but is otherwise composed of astrocytes and their interwoven processes like the external limiting membrane of the brain surface with which it is continuous. The distal surface of the mantle zone is covered by a fenestrated basal lamina. Only occasional vessels traverse the border. From an anatomical point of view, the border might be expected to be a weak point along the cochlear nerve and thus vulnerable to trauma. In mature animals, the CNS-PNS border presents a barrier to regrowth of regenerating nerve fibers and to invasion of the CNS by Schwann cells. An understanding of this region in the cochlear nerve is therefore relevant to head injuries that lead to hearing loss, to surgery on acoustic Schwannomas, and to the possibility of cochlear nerve regeneration. (C) 2011 Elsevier B.V. All rights reserved.	[Furness, David N.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Osen, Kirsten K.] Univ Oslo, Inst Anat, Oslo, Norway; [Hackney, Carole M.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England		Furness, DN (corresponding author), Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.	coa14@keele.ac.uk			Henry Smith Charity	The experimental part of this study, including the scanning electron microscopy, was performed at the Institute of Medical Biology, University of Tromso, Norway, in the 1970s. We dedicate this article to the late Atle Ronning Arnesen, Ear Nose and Throat Department, Oslo City Hospital (now Oslo University Hospital), who participated in the experiments. We are indebted to Enrico Mugnaini, Department of Behavioral Sciences, University of Connecticut (now at Northwestern University Institute of Neuroscience), for his early advice, particularly with respect to the fixation procedure. DNF was supported by the Henry Smith Charity.	Altschuler RA, 2008, HEARING RES, V242, P110, DOI 10.1016/j.heares.2008.06.004; ARNESEN AR, 1978, J COMP NEUROL, V178, P661, DOI 10.1002/cne.901780405; Bao JX, 2010, HEARING RES, V264, P93, DOI 10.1016/j.heares.2009.10.009; BERTHOLD CH, 1977, ACTA PHYSIOL SCAND, P73; BERTHOLD CH, 1977, ACTA PHYSIOL SCAND, P23; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; BRIGHTMAN MW, 1965, AM J ANAT, V117, P193, DOI 10.1002/aja.1001170204; CARLSTEDT T, 1989, BRAIN RES BULL, V22, P93, DOI 10.1016/0361-9230(89)90133-0; CARLSTEDT T, 1977, ACTA PHYSIOL SCAND, P5; Carlstedt T, 1997, J ANAT, V190, P51, DOI 10.1046/j.1469-7580.1997.19010051.x; Chen Y, 2007, HEARING RES, V228, P3, DOI 10.1016/j.heares.2006.11.014; DALCANTO MC, 1984, AM J PATHOL, V116, P30; Duncan ID, 1997, J ANAT, V191, P318; FLOOD PR, 1975, SCANNING ELECTRON MI, P287; Fraher J, 2002, J ANAT, V200, P415, DOI 10.1046/j.1469-7580.2002.00037.x; Fraher JP, 2000, J ANAT, V196, P137; FRAHER JP, 1992, PROG NEUROBIOL, V38, P261, DOI 10.1016/0301-0082(92)90022-7; Geuna Stefano, 2010, Italian Journal of Anatomy and Embryology, V115, P91; Guevara N, 2008, EUR ARCH OTO-RHINO-L, V265, P397, DOI 10.1007/s00405-007-0471-1; JACOBS JM, 1988, J ANAT, V157, P153; Kim PD, 2010, MICROSURG, V30, P392, DOI 10.1002/micr.20760; LIVESEY FJ, 1992, NEUROPATH APPL NEURO, V18, P376, DOI 10.1111/j.1365-2990.1992.tb00799.x; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MATSUNAGA T, 1995, ACTA OTO-LARYNGOL, P149; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; O'Brien D, 2001, J NEUROCYTOL, V30, P11, DOI 10.1023/A:1011961106703; OSEN KK, 1979, J ULTRA MOL STRUCT R, V69, P148; OSEN KK, 1991, J NEUROCYTOL, V20, P17, DOI 10.1007/BF01187131; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; PEKER S, 2006, NEUROSURGERY, V60, pE582; PETTERSSON CAV, 1993, ACTA NEUROPATHOL, V86, P636, DOI 10.1007/BF00294304; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Remahl IN, 1998, J NEUROCYTOL, V27, P85, DOI 10.1023/A:1006943221434; ROSS MD, 1971, AM J ANAT, V130, P73, DOI 10.1002/aja.1001300106; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; SEKIYA T, 1987, J NEUROSURG, V67, P244, DOI 10.3171/jns.1987.67.2.0244; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Skinner HA, 1931, ARCH NEURO PSYCHIATR, V25, P356, DOI 10.1001/archneurpsyc.1931.02230020144008; Sloniewski P, 1999, Folia Morphol (Warsz), V58, P37; SPOENDLIN H, 1969, ACTA OTO-LARYNGOL, V67, P239, DOI 10.3109/00016486909125448; SPOENDLIN H, 1972, ACTA OTO-LARYNGOL, V73, P235, DOI 10.3109/00016487209138937; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Tang XQ, 2007, J NEUROSCI, V27, P6068, DOI 10.1523/JNEUROSCI.1442-07.2007; Tarlov IM, 1937, ARCH NEURO PSYCHIATR, V37, P555, DOI 10.1001/archneurpsyc.1937.02260150085005; THOMSEN R, 1887, VIRCHOWS ARCH PATH A, V109, P459; Tomii M, 2003, J NEUROSURG, V99, P121, DOI 10.3171/jns.2003.99.1.0121; WAGNER HJ, 1983, ANAT EMBRYOL, V166, P427, DOI 10.1007/BF00305928	48	4	4	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUL	2011	277	1-2					44	53		10.1016/j.heares.2011.03.012			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	805KZ	WOS:000293726600006	21447373				2022-02-06	
J	Shahsavari, S; McKelvey, T; Ritzen, CE; Rydenhag, B				Shahsavari, Sima; McKelvey, Tomas; Ritzen, Catherine Eriksson; Rydenhag, Bertil			Cerebrovascular Mechanical Properties and Slow Waves of Intracranial Pressure in TBI Patients	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Cerebral autoregulation; compliance; distensibility; intracranial pressure (ICP) dynamics; model-based framework; plateau waves; pulse wave propagation; traumatic brain injury (TBI)	CEREBRAL AUTOREGULATION; VALIDATION; REACTIVITY; AORTA; FLOW	Myogenic autoregulation of cerebral blood flow is one of the mechanisms affecting cerebral hemodynamics. Short or long-lasting changes in intracranial pressure (ICP) are believed to reveal the responses of the cerebral system to myogenic stimuli. Through the incorporation of a theoretical model into the experimental measurements of cerebrovascular distensibility and compliance in patients with traumatic brain injury (TBI), the current study is an attempt to explain ICP dynamics in either presence or absence of cerebral autoregulation. The pulse wave velocity and transfer function between arterial blood pressure and ICP were utilized as the major tools to reflect variations in the mechanical properties of distant cerebral artries/arteriols. The results imply that different states of cerebral autoregulation and associated regimes within the cerebrovascular system can lead to different types of interrelationship between the slow variations of ICP, cerebral arterial distensibility, and compliance. Consequently, each of these classes may require different types of treatment on patients with TBI.	[Shahsavari, Sima; McKelvey, Tomas] Chalmers Univ Technol, Dept Signals & Syst, S-41296 Gothenburg, Sweden; [Ritzen, Catherine Eriksson] Sahlgrens Univ Hosp, Dept Anesthesia, SE-46280 Gothenburg, Sweden; [Ritzen, Catherine Eriksson] Sahlgrens Univ Hosp, Dept Intens Care Med, SE-46280 Gothenburg, Sweden; [Rydenhag, Bertil] Sahlgrens Univ Hosp, Dept Neurosci & Physiol, SE-46280 Gothenburg, Sweden		Shahsavari, S (corresponding author), Chalmers Univ Technol, Dept Signals & Syst, S-41296 Gothenburg, Sweden.	shahsava@chalmers.se; tomas.mckelvey@chalmers.se; ritzen@vgregion.se; Bertil.Rydenhag@neuro.gu.se	McKelvey, Tomas/B-6801-2016; McKelvey, Tomas/R-7193-2019	McKelvey, Tomas/0000-0003-2982-5535; McKelvey, Tomas/0000-0003-2982-5535	Health and Medical Care Committe of the Region Vastra Gotaland, Sweden; Swedish Research CouncilSwedish Research CouncilEuropean Commission	This work was supported by the Health and Medical Care Committe of the Region Vastra Gotaland, Sweden and by the Swedish Research Council.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Arnett DK, 1999, ULTRASOUND MED BIOL, V25, P175, DOI 10.1016/S0301-5629(98)00165-3; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Asmar R, 1999, ARTERIAL STIFFNESS P; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; BANK AJ, 1995, CIRC RES, V77, P1008, DOI 10.1161/01.RES.77.5.1008; BERGEL D, 1960, THESIS MED COLL ST B; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Heil M, 2003, FLOW HIGHLY COMPLIAN; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; HUGHES DJ, 1979, ULTRASONIC IMAGING, V1, P356, DOI 10.1016/0161-7346(79)90028-2; Izzo Jr JL, 2003, HYPERTENSION PRIMER; KATZ AI, 1969, BIOPHYS J, V9, P1261, DOI 10.1016/S0006-3495(69)86451-9; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Klabunde R, 2005, CARDIOVASCULAR PHYSL; LAWTON RW, 1954, CIRC RES, V2, P344, DOI 10.1161/01.RES.2.4.344; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LIAO JK, 1991, CIRC RES, V68, P1027, DOI 10.1161/01.RES.68.4.1027; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Nichols W. W., 2005, MCDONALDS BLOOD FLOW; PATEL DJ, 1963, J APPL PHYSIOL, V18, P1111, DOI 10.1152/jappl.1963.18.6.1111; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PETERSON LH, 1960, CIRC RES, V8, P622, DOI 10.1161/01.RES.8.3.622; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Raamat R, 1999, MED BIOL ENG COMPUT, V37, P784, DOI 10.1007/BF02513382; REILLY P, 2005, HEAD INJURY PATHOPHY; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SHAHSAVARI S, 2010, P 32 ANN INT C IEEE, P5277; Shahsavari S., 2008, P 30 ANN INT C IEEE, P2644; SHAPIRO AH, 1977, ASME J BIOMECH ENG, V99, P126, DOI DOI 10.1115/1.3426281; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	38	4	4	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUL	2011	58	7					2072	2082		10.1109/TBME.2011.2142415			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	780WL	WOS:000291890000022	21507769				2022-02-06	
J	Weinrich, M; Stuart, M				Weinrich, Michael; Stuart, Mary			Coverage Policy for Neurorehabilitation: An International Perspective	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						neurologic rehabilitation; insurance; coverage; health policy	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; HEALTH-CARE REFORM; SUB-SAHARAN AFRICA; STROKE REHABILITATION; INPATIENT REHABILITATION; MEDICAL REHABILITATION; UNITED-STATES; MANAGED CARE; INSURANCE	Background. Coverage policy ultimately determines the delivery of services. This article summarizes the authors' effort to ascertain the extent of publically available information on coverage for neurorehabilitation services internationally. Objective. Present available data on neurorehabilitation coverage and examine the needs for further research in this area. Methods. Review of published literature, review of government Web sites, survey of World Federation of NeuroRehabilitation (WFNR) program chairs, and attendees of the 2010 World Congress of NeuroRehabilitation. Results. A wide variation in coverage was found internationally. Data are not routinely accessible. Conclusions. Informed policy requires current data. There is an opportunity for the WFNR to provide leadership in policy for neurorehabilitation services by assembling and maintaining current data on coverage policy internationally.	[Weinrich, Michael] NIH, Natl Ctr Med Rehabil Res, Eunice Kennedy Shriver Inst Child Hlth & Human De, Rockville, MD 20852 USA; [Stuart, Mary] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA		Weinrich, M (corresponding author), NIH, Natl Ctr Med Rehabil Res, Eunice Kennedy Shriver Inst Child Hlth & Human De, Rockville, MD 20852 USA.	weinricm@mail.nih.gov					Anderson C, 2002, PHARMACOECONOMICS, V20, P537, DOI 10.2165/00019053-200220080-00004; BENTUR N, 2009, HLTH POLICY MONI APR; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Breckenkamp Juergen, 2007, Health Res Policy Syst, V5, P7, DOI 10.1186/1478-4505-5-7; Carinci F, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-95; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Chan YFY, 2010, J STROKE CEREBROVASC, V19, P209, DOI 10.1016/j.jstrokecerebrovasdis.2009.04.009; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; Czlonkowska Anna, 2006, Neurol Neurochir Pol, V40, P471; Department of Health and Human Services, COMP EFF RES FUND; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; DURANDZALESKI I, 2008, FRENCH HLTH CARE SYS; Elrod CS, 2008, ARCH PHYS MED REHAB, V89, P114, DOI 10.1016/j.apmr.2007.08.122; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Gommans John, 2003, N Z Med J, V116, pU435; Graham Susan K, 2008, Aust New Zealand Health Policy, V5, P15, DOI 10.1186/1743-8462-5-15; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; Gruber J, 2010, NEW ENGL J MED, V362, P2050, DOI 10.1056/NEJMp1005117; Haig AJ, 2009, J REHABIL MED, V41, P401, DOI 10.2340/16501977-0367; Hecke TL, 2005, HEALTH CARE FINANC R, V27, P59; Hurst SA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-137; *KAIS COMM MED UN, HLTH REF; Kalra L, 2009, TOP STROKE REHABIL, V16, P27, DOI 10.1310/tsr1601-27; Kendall MB, 2003, DISABIL REHABIL, V25, P1008, DOI 10.1080/0963828031000122285; Kiekens C, 2007, KCE REPORTS S; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Komaroff E, 2009, J SPINAL CORD MED, V32, P3, DOI 10.1080/10790268.2009.11760747; Kopunek SP, 2007, AM J PREV MED, V32, P408, DOI 10.1016/j.amepre.2007.01.021; Kozub E, 2010, J NEUROSCI NURS, V42, P143, DOI 10.1097/JNN.0b013e3181d4a395; Kramer AM, 2000, J AM GERIATR SOC, V48, P726, DOI 10.1111/j.1532-5415.2000.tb04745.x; Lanier WL, 2006, AM SURGEON, V72, P985; Lanier WL, 2006, AM SURGEON, V72, P1133; Lee HC, 2010, AM J MANAG CARE, V16, pE67; Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Ma Edna, 2004, J Am Med Dir Assoc, V5, P71, DOI 10.1097/01.JAM.0000110658.01514.F7; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; Middleton JW, 2008, ARCH PHYS MED REHAB, V89, P1941, DOI 10.1016/j.apmr.2008.04.011; *NAT HLTH SERV, WELC NAT I HLTH CLIN; *NHS NAT I HLTH CL, STROK REH; *OECD, 2003, DIS BAS COMP HLTH SY; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Osterthun R, 2009, SPINAL CORD, V47, P339, DOI 10.1038/sc.2008.127; Polk HC, 2006, AM SURGEON, V72, P1021; Putman K, 2007, J REHABIL MED, V39, P21, DOI 10.2340/16501977-0006; Putman K, 2009, TOP STROKE REHABIL, V16, P20, DOI 10.1310/tsr1601-20; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; Reinhardt UE, 2004, JAMA-J AM MED ASSOC, V292, P1227, DOI 10.1001/jama.292.10.1227; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Rosenbaum S, 2010, NEW ENGL J MED, V362, P1952, DOI 10.1056/NEJMp1003890; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Sarzynska-Dlugosz I, 2007, NEUROL NEUROCHIR POL, V41, P107; Stuart M, 2005, NEUROREHAB NEURAL RE, V19, P139, DOI 10.1177/1545968305277088; Stuart M, 2010, DISABIL HEALTH J, V3, P271, DOI 10.1016/j.dhjo.2009.11.003; Stuart M, 2009, NEUROREHAB NEURAL RE, V23, P726, DOI 10.1177/1545968309332734; Stuart ME, 1998, MILBANK Q, V76, P251, DOI 10.1111/1468-0009.00088; TATE DG, 1994, ARCH PHYS MED REHAB, V75, P407, DOI 10.1016/0003-9993(94)90164-3; Teasell R, 2009, TOP STROKE REHABIL, V16, P11, DOI 10.1310/tsr1601-11; Tinney MJ, 2007, DISABIL REHABIL, V29, P921, DOI 10.1080/09638280701240482; Townsend J, 1992, Health Trends, V24, P136; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Uhrig JD, 2006, MED CARE, V44, P1020, DOI 10.1097/01.mlr.0000228019.47200.f2; *UN DEP EC SOC AFF, WORLD POP 2009; United Nations Department of Economic and Social Affairs Population Division, WORLD POP AG 1950 20; Wolfe CDA, 1999, STROKE, V30, P350, DOI 10.1161/01.STR.30.2.350; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe; ZIEBARTH N, 2009, DO I REALLY NEED GO	69	4	4	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL-AUG	2011	25	6					531	539		10.1177/1545968310397207			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	774KL	WOS:000291384200005	21427275				2022-02-06	
J	Becker, J; da Silva, IG; da Silva, HF; Schuch, A; Ramos, FLD; Ghisolfi, ES; Lara, DR; da Costa, JC				Becker, Jefferson; da Silva Filho, Irenio Gomes; da Silva Filho, Helio Fernandes; Schuch, Alice; de Paula Ramos, Fernanda Lia; Ghisolfi, Eduardo Soerensen; Lara, Diogo Rizzato; da Costa, Jaderson Costa			Pattern of P50 suppression deficit in patients with epilepsy and individuals with schizophrenia	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						epilepsy; P50 auditory evoked potential; schizophrenia; sensory filter	AUDITORY-EVOKED POTENTIALS; MACHADO-JOSEPH-DISEASE; TRAUMATIC BRAIN-INJURY; TEMPORAL VARIABILITY; HIPPOCAMPAL; RESPONSES; SURGERY	Objective: To identify P50 suppression in patients with epilepsy, to investigate the effect of seizure control on P50 suppression, and to compare epilepsy patients with individuals with schizophrenia and healthy volunteers. Method: P50 evoked potential parameters and P50 suppression were studied crossectionally in patients with uncontrolled or controlled epilepsy, in individuals with schizophrenia and in healthy volunteers. Results: Individuals with schizophrenia had significantly smaller conditioning stimulus (Si) amplitude, and patients with epilepsy had larger test stimulus (S2) amplitude. Mean S2/S1 ratio was 0.71+/-0.33 for patients with uncontrolled epilepsy; 0.68+/-0.36 for patients with controlled epilepsy; 0.96+/-0.47 for individuals with schizophrenia, and 0.42+/-0.24 for healthy volunteers. Conclusion: The sensory filter of patients with epilepsy is altered, and this alteration is not associated with seizure control. Also, it works differently from the sensory filter of individuals with schizophrenia.	[Becker, Jefferson; da Silva Filho, Irenio Gomes; da Silva Filho, Helio Fernandes; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande do Sul, Neurol Serv, Hosp Sao Lucas, Porto Alegre, RS, Brazil; [Lara, Diogo Rizzato] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Psychiat Serv, Porto Alegre, RS, Brazil; [da Silva Filho, Irenio Gomes; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Dept Internal Med, Porto Alegre, RS, Brazil; [Schuch, Alice; de Paula Ramos, Fernanda Lia; Ghisolfi, Eduardo Soerensen; Lara, Diogo Rizzato] Pontificia Univ Catolica Rio Grande do Sul, Dept Biochem, Fac Biociencias, Porto Alegre, RS, Brazil		Becker, J (corresponding author), Rua Ely Costa 60, BR-90480110 Porto Alegre, RS, Brazil.	jeffersonbecker@hotmail.com	Ghisolfi, Eduardo Sorensen/AAW-2654-2021; DaCosta, Jaderson/C-4968-2015; Becker, Jefferson/G-6417-2012	DaCosta, Jaderson/0000-0001-6776-1515; , Jefferson/0000-0002-9981-3620			Ambrosini A, 2001, NEUROSCI LETT, V306, P132, DOI 10.1016/S0304-3940(01)01871-7; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Becker J, 2004, CLIN NEUROPHYSIOL, V115, P396, DOI 10.1016/j.clinph.2003.09.018; Boutros NN, 2006, J NEUROPSYCH CLIN N, V18, P409, DOI 10.1176/appi.neuropsych.18.3.409; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; Etchebehere ECSC, 2001, ARCH NEUROL-CHICAGO, V58, P1257, DOI 10.1001/archneur.58.8.1257; Fein G, 1996, BIOL PSYCHIAT, V39, P955, DOI 10.1016/0006-3223(95)00299-5; FEIN G, 1994, ELECTROEN CLIN NEURO, V92, P536, DOI 10.1016/0168-5597(94)90138-4; Freedman R, 1996, ARCH GEN PSYCHIAT, V53, P1114; Ghisolfi ES, 2004, CLIN NEUROPHYSIOL, V115, P2231, DOI 10.1016/j.clinph.2004.04.025; Ghisolfi ES, 2004, INT J PSYCHOPHYSIOL, V51, P209, DOI 10.1016/j.ijpsycho.2003.09.002; Ghisolfi ES, 2002, NEUROPSYCHOPHARMACOL, V27, P629; Grunwald T, 2003, BIOL PSYCHIAT, V53, P511, DOI 10.1016/S0006-3223(02)01673-6; Hetrick WP, 1996, BIOL PSYCHIAT, V39, P51, DOI 10.1016/0006-3223(95)00067-4; Jin Y, 1997, PSYCHIAT RES, V70, P71, DOI 10.1016/S0165-1781(97)03091-6; Jin Y, 1998, BIOL PSYCHIAT, V43, P873, DOI 10.1016/S0006-3223(98)00115-2; Kurthen M, 2007, PSYCHIAT RES-NEUROIM, V155, P121, DOI 10.1016/j.pscychresns.2006.10.003; NAGAMOTO HT, 1991, SCHIZOPHR RES, V4, P31, DOI 10.1016/0920-9964(91)90007-E; Patrick G, 1999, BIOL PSYCHIAT, V45, P1307, DOI 10.1016/S0006-3223(98)00155-3; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Pirker S, 2003, J NEUROPATH EXP NEUR, V62, P820, DOI 10.1093/jnen/62.8.820; Rosburg T, 2008, CLIN NEUROPHYSIOL, V119, P1310, DOI 10.1016/j.clinph.2008.02.007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SIEGEL C, 1984, ARCH GEN PSYCHIAT, V41, P607; Tregellas JR, 2009, AM J PSYCHIAT, V166, P354, DOI 10.1176/appi.ajp.2008.08030411; Uc EY, 2003, J NEUROL SCI, V212, P1, DOI 10.1016/S0022-510X(03)00082-0; WEATE SJ, 1995, CLIN ELECTROENCEPHAL, V26, P214, DOI 10.1177/155005949502600407; Weiland BJ, 2008, NEUROIMAGE, V42, P827, DOI 10.1016/j.neuroimage.2008.05.042; Zimmerman RS, 2003, MAYO CLIN PROC, V78, P109, DOI 10.4065/78.1.109	30	4	4	0	4	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2011	69	3					460	465		10.1590/S0004-282X2011000400010			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	783WR	WOS:000292115600010	21755122	Green Submitted, gold			2022-02-06	
J	Bjerring, PN; Eefsen, M; Larsen, FS; Bernal, W; Wendon, J				Bjerring, Peter Nissen; Eefsen, Martin; Larsen, Fin Stolze; Bernal, William; Wendon, Julia			Hypermagnesemia Does Not Prevent Intracranial Hypertension and Aggravates Cerebral Hyperperfusion in a Rat Model of Acute Hyperammonemia	HEPATOLOGY			English	Article							ACUTE LIVER-FAILURE; INDUCED BRAIN EDEMA; MAGNESIUM-SULFATE; AQUAPORIN-4 IMMUNOREACTIVITY; PORTACAVAL ANASTOMOSIS; ARTERIAL AMMONIA; INJURY; HYPONATREMIA; PERMEABILITY	Intravenous infusion of magnesium sulfate prevents seizures in patients with eclampsia and brain edema after traumatic brain injury. Neuroprotection is achieved by controlling cerebral blood flow (CBF), intracranial pressure, neuronal glutamate release, and aquaporin-4 (Aqp4) expression. These factors are also thought to be involved in the development of brain edema in acute liver failure. We wanted to study whether hypermagnesemia prevented development of intracranial hypertension and hyperperfusion in a rat model of portacaval anastomosis (PCA) and acute hyperammonemia. We also studied whether hypermagnesemia had an influence on brain content of glutamate, glutamine, and aquaporin-4 expression. The study consisted of three experiments: The first was a dose-finding study of four different dosing regimens of magnesium sulfate (MgSO4) in healthy rats. The second involved four groups of PCA rats receiving ammonia infusion/vehicle and MgSO4/saline. The effect of MgSO4 on mean arterial pressure (MAP), intracranial pressure (ICP), CBF, cerebral glutamate and glutamine, and aquaporin-4 expression was studied. Finally, the effect of MgSO4 on MAP, ICP, and CBF was studied, using two supplementary dosing regimens. In the second experiment, we found that hypermagnesemia and hyperammonemia were associated with a significantly higher CBF (P < 0.05, two-way analysis of variance [ANOVA]). Hypermagnesemia did not lead to a reduction in ICP and did not affect the brain content of glutamate, glutamine, or Aqp-4 expression. In the third experiment, we achieved higher P-Mg but this did not lead to a significant reduction in ICP or CBF. Conclusion: Our results demonstrate that hypermagnesemia does not prevent intracranial hypertension and aggravates cerebral hyperperfusion in rats with PCA and hyperammonemia. (HEPATOLOGY 2011;53:1986-1994)	[Bjerring, Peter Nissen; Eefsen, Martin; Larsen, Fin Stolze] Univ Hosp Copenhagen, Rigshosp, Dept Hepatol, Copenhagen, Denmark; [Bernal, William; Wendon, Julia] Kings Coll Hosp London, Liver Intens Therapy Unit, London, England		Bjerring, PN (corresponding author), Univ Hosp Copenhagen, Rigshosp, Dept Hepatol, Copenhagen, Denmark.	peter.nissen.bjerring@rh.regionh.dk		Bjerring, Peter Nissen/0000-0001-8636-0709; Larsen, Fin Stolze/0000-0003-2205-8265	Rigshospitalet Research Foundation; University of Copenhagen, Denmark	Supported by The Rigshospitalet Research Foundation, University of Copenhagen, Denmark. Savvaerksejer Jeppe Juhl and Wife Ovita Juhls Foundation.	Acharya SK, 2009, GASTROENTEROLOGY, V136, P2159, DOI 10.1053/j.gastro.2009.02.050; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bjerring PN, 2009, METAB BRAIN DIS, V24, P5, DOI 10.1007/s11011-008-9116-3; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Cordoba J, 1998, J HEPATOL, V29, P589, DOI 10.1016/S0168-8278(98)80154-2; Eefsen M, 2010, METAB BRAIN DIS, V25, P315, DOI 10.1007/s11011-010-9213-y; Euser AG, 2008, EXP PHYSIOL, V93, P254, DOI 10.1113/expphysiol.2007.039966; Ghabriel MN, 2006, ACTA NEUROCHIR SUPPL, V96, P402; Imer M, 2009, NEUROL RES, V31, P977, DOI 10.1179/174313209X385617; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Larsen FS, 1996, SEMIN LIVER DIS, V16, P281, DOI 10.1055/s-2007-1007241; Larsen FS, 2001, J HEPATOL, V34, P548, DOI 10.1016/S0168-8278(00)00069-6; Lazard EM, 1925, AM J OBSTET GYNECOL, V9, P178, DOI 10.1016/S0002-9378(25)90068-3; Lin JY, 2002, LIFE SCI, V71, P803, DOI 10.1016/S0024-3205(02)01738-1; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Monfort P, 2002, METAB BRAIN DIS, V17, P237, DOI 10.1023/A:1021993431443; Rao KVR, 2010, J NEUROPATH EXP NEUR, V69, P869, DOI 10.1097/NEN.0b013e3181ebe581; Reddy PVB, 2009, J NEUROSCI RES, V87, P2677, DOI 10.1002/jnr.22097; Schmidt LE, 2006, CRIT CARE MED, V34, P337, DOI 10.1097/01.CCM.0000194724.70031.B6; Tofteng F, 2004, METAB BRAIN DIS, V19, P207, DOI 10.1023/B:MEBR.0000043970.34533.04; Turkoglu OF, 2008, J CLIN NEUROSCI, V15, P60, DOI 10.1016/j.jocn.2007.03.005; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Ytrebo LM, 2009, HEPATOLOGY, V50, P165, DOI 10.1002/hep.22917; Zwingmann C, 2005, NEUROCHEM INT, V47, P19, DOI 10.1016/j.neuint.2005.04.003	25	4	4	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139			HEPATOLOGY	Hepatology	JUN	2011	53	6					1986	1994		10.1002/hep.24274			9	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	773KX	WOS:000291307300023	21384403	Bronze			2022-02-06	
J	Bracken, BK; Penetar, DM; Rodolico, J; Ryan, ET; Lukas, SE				Bracken, Bethany K.; Penetar, David M.; Rodolico, John; Ryan, Elizabeth T.; Lukas, Scott E.			Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Citicoline; CDP-choline; Sleep; Cocaine	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CDP-CHOLINE; ORAL CITICOLINE; USERS; ABSTINENCE; MEMORY; BIOSYNTHESIS; EFFICACY; TRIAL	Background: Citicoline (cytidine-5'-diphosphate) is a mononucleotide composed of ribose, cytosine, pyrophosphate, and choline, and is involved in the biosynthesis of the structural phosopholipids of cell membranes. Treatment with citicoline, improves memory in patients with dementia, and reduces damage to the brain after traumatic brain injury or stroke. Recent research has been conducted to assess whether citicoline is an effective treatment for cocaine dependence. In cocaine-dependent individuals, withdrawal from cocaine is associated with disturbed sleep, which may contribute to the high rate of relapse to cocaine use. Therefore, it is important to know the impact of citicoline on the sleep/wake cycle in these individuals in order to rate its overall efficacy. Method: In this double-blind, placebo-controlled trial, the effects of citicoline treatment on the sleep/wake cycles of cocaine dependent participants were assessed. The results of the current study are reported as part of a larger study, consisting of an eight-week treatment period to assess the efficacy of longer-term treatment with citicoline at decreasing cocaine consumption in cocaine-dependent polydrug using participants. Results: In this non-abstinent, cocaine-dependent population, citicoline had no effect on any of the sleep parameters measured including sleep efficiency, sleep latency, total sleep time, number of waking episodes, time awake per episode, amount of time in bed spent moving, number of sleep episodes, time asleep per episode, and amount of time in bed spent immobile. Conclusions: These data suggest that eight weeks of citicoline administration does not disturb sleep/wake cycles of cocaine-dependent individuals. (C) 2011 Elsevier Inc. All rights reserved.	[Bracken, Bethany K.] Harvard Univ, McLean Hosp, Sch Med, Behav Psychopharmacol Res Lab, Belmont, MA 02478 USA; [Bracken, Bethany K.; Penetar, David M.; Lukas, Scott E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA		Bracken, BK (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Behav Psychopharmacol Res Lab, 115 Mill St, Belmont, MA 02478 USA.	bbracken@mclean.harvard.edu			NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA011098, T32 DA15036, K05DA00343]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA015036, K05DA000343, R01DA011098] Funding Source: NIH RePORTER	Clinical Trial Identification Number: NCT00158249. This research was supported by NIDA grants DA011098, T32 DA15036, and K05DA00343. ETR is currently in the Department of Psychology, Ohio State University, Columbus, Ohio, USA. We thank Ronna Shostak, Carol Buchanan, and Barbara Beake for administrative support in conducting these studies.	Alvarez XA, 1999, METHOD FIND EXP CLIN, V21, P633; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Brown ES, 2007, J CLIN PSYCHOPHARM, V27, P498, DOI 10.1097/jcp.0b013e31814db4c4; CALATAYUD M, 1991, J NEUROL SCI S, V103, pS15; CHIDA N, 1973, TOHOKU J EXP MED, V111, P41, DOI 10.1620/tjem.111.41; Cho HJ, 2009, METHOD FIND EXP CLIN, V31, P171, DOI 10.1358/mf.2009.31.3.1364241; Clark WM, 2001, NEUROLOGY, V57, P1595, DOI 10.1212/WNL.57.9.1595; Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; DRAGO F, 1993, BRAIN RES BULL, V31, P485, DOI 10.1016/0361-9230(93)90113-P; First M., 1997, STRUCTURED CLIN INTE; GALLETTI P, 1991, J NEUROL SCI, V103, pS19; Hurtado O, 2007, NEUROBIOL DIS, V26, P105, DOI 10.1016/j.nbd.2006.12.005; Johanson CE, 1999, EXP CLIN PSYCHOPHARM, V7, P338; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; Licata SC, 2011, J ADDICT MED, V5, P57, DOI 10.1097/ADM.0b013e3181d80c93; Lukas SE, 2001, PSYCHOPHARMACOLOGY, V157, P163, DOI 10.1007/s002130100824; Morgan Peter T, 2007, ScientificWorldJournal, V7, P223; Morgan PT, 2008, ADDICTION, V103, P1344, DOI 10.1111/j.1360-0443.2008.02233.x; Morgan PT, 2010, AM J PSYCHIAT, V167, P331, DOI 10.1176/appi.ajp.2009.09050613; Morgan PT, 2006, DRUG ALCOHOL DEPEN, V82, P238, DOI 10.1016/j.drugalcdep.2005.09.014; MOSHARROF A H, 1987, Acta Physiologica et Pharmacologica Bulgarica, V13, P17; Pace-Schott EE, 2005, PSYCHOPHARMACOLOGY, V179, P873, DOI 10.1007/s00213-004-2088-z; *PHILL, 2009, ACT ACT CT SOFTW HAR; Renshaw PF, 1999, PSYCHOPHARMACOLOGY, V142, P132, DOI 10.1007/s002130050871; Ross BM, 2002, DRUG ALCOHOL DEPEN, V67, P73, DOI 10.1016/S0376-8716(02)00022-4; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; Silveri MM, 2008, NMR BIOMED, V21, P1066, DOI 10.1002/nbm.1281; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; Spiers PA, 1999, J INT NEUROPSYCH SOC, V5, P260, DOI 10.1017/S1355617799533092; Teather LA, 2003, PROG NEURO-PSYCHOPH, V27, P711, DOI 10.1016/S0278-5846(03)00086-1; Thompson PM, 1995, BIOL PSYCHIAT, V38, P831, DOI 10.1016/0006-3223(95)00070-4; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#; WATSON R, 1992, AM J DRUG ALCOHOL AB, V18, P21, DOI 10.3109/00952999209001608; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T	36	4	4	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUN	2011	98	4					518	524		10.1016/j.pbb.2011.03.003			7	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	773GP	WOS:000291295300004	21397626	Green Accepted			2022-02-06	
J	Couch, CM; Leathem, JM				Couch, Clare M.; Leathem, Janet M.			An Initial Study to Establish Symptom Base Rates of Traumatic Brain Injury in Children	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						child; traumatic brain injury; symptoms; base rates	PERSONAL-INJURY; HEAD-INJURY; PERFORMANCE; CHILDHOOD; AWARENESS; SEQUELAE; RECALL	Traumatic brain injury (TBI) is associated with complaints including headaches, restlessness, memory problems, or irritability, which are assumed to be a consequence of the TBI. The current study is a first attempt to establish the prevalence of common TBI complaints reported by non-brain-injured children aged 11-13. In a 38-item self-report questionnaire, 124 children reported high base rates for symptoms over the past year, especially "grumpy/cross" (79.4%), "frustration" (74.0%), and "fatigue (mental or physical)" (72.2%). This was comparable with base rate information reported by Lees-Haley and Brown (1993) for non-brain-injured adults for a longer period (24-month period). Approximately 20% of children reported five or more symptoms on a daily or weekly basis. They were most likely to be in behavioral and emotional rather than somatic or cognitive domains. Therefore, further research is needed to establish base rate information in order to clarify the true significance of symptom reporting and caution is recommended in interpretation of these symptoms in neuropsychological assessment of TBI in children.	[Leathem, Janet M.] Massey Univ, Sch Psychol, Dept Psychol, Wellington 6140, New Zealand		Leathem, JM (corresponding author), Massey Univ, Sch Psychol, Dept Psychol, Private Box 756, Wellington 6140, New Zealand.	j.m.leathem@massey.ac.nz			Massey University	This research was funded by Massey University.	Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2000, BRAIN INJURY, V14, P679; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; BEERS SR, 2006, CLIN NEUROPSYCHOLOGY; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; CATROPPA C, 1999, PEDIAT REHABILITATIO, V394, P167; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; D, 2001, PSYCHOL TESTING PRIN; DEATON AV, 1994, ED DIMENSIONS ACQUIR, P239; Dennis M, 1995, TRAUMATIC HEAD INJUR; ELWOOD RW, 1993, CLIN PSYCHOL REV, V13, P409, DOI 10.1016/0272-7358(93)90012-B; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Gouvier WD, 2002, STUD NEUROPSYCHOL DE, P375; Gouvier WD, 1999, STUD NEUROPSYCHOL DE, P27; Gouvier WD, 1998, CRIT ISS NE, P55; HAREL Y, 1994, AM J PUBLIC HEALTH, V84, P599, DOI 10.2105/AJPH.84.4.599; HARTLAGE LC, 1995, ARCH CLIN NEUROPSYCH, V10, P279, DOI 10.1016/0887-6177(94)E0011-D; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KRAUS JF, 1995, TRAUMATIC HEAD INJUR; Leathem JM, 1997, BRAIN INJURY, V11, P565, DOI 10.1080/026990597123269; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1995, TRAUMATIC HEAD INJUR; LOFTUS EF, 1982, G STANLEY HALL LECT; McCaffrey R. J., 2003, PRACTITIONERS GUIDE; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; THOMAS DL, 1990, J PERS SOC PSYCHOL, V59, P291, DOI 10.1037/0022-3514.59.2.291; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Visser PS, 2000, HDB RES METHODS SOCI; WILLIS WG, 1988, ASSESSMENT ISSUES CH; Yeates K., 2000, PEDIAT NEUROPSYCHOLO	41	4	4	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2011	26	4					349	355		10.1093/arclin/acr028			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	766VZ	WOS:000290816000007	21558282	Bronze			2022-02-06	
J	Shussman, N; Mintz, A; Zamir, G; Shalev, A; Abu Gazala, M; Rivkind, AI; Isenberg, Y; Bala, M; Almogy, G				Shussman, Noam; Mintz, Ayelet; Zamir, Gideon; Shalev, Arye; Abu Gazala, Mahmoud; Rivkind, Avraham I.; Isenberg, Yonatan; Bala, Miklosh; Almogy, Gidon			Posttraumatic Stress Disorder in Hospitalized Terrorist Bombing Attack Victims	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	11th European Congress of Trauma and Emergency Surgery of the European-Society-for-Trauma-and-Emergency-Surgery (ESTES)	MAY 15-18, 2010	Brussels, BELGIUM	European Soc Trauma & Emergency Surg (ESTES)		Posttraumatic stress disorder; Suicide bombing attack; Blast lung injury; Intracranial injury	TRAUMATIC BRAIN-INJURY; SURVIVORS; POPULATION; BLAST	Background: Posttraumatic stress disorder (PTSD) is a psychiatric disorder that results from exposure to a traumatic event and consists of intrusive and unwanted recollections; avoidance followed by emotional withdrawal; and heightened physiologic arousal. Hospitalized victims of suicide bombing attacks (SBAs) are unique because of the circumstances and severity of their injuries, which could affect the occurrence and delay the recognition of PTSD. Our objectives were to evaluate the prevalence and severity of PTSD among hospitalized SBA victims and to assess variables of physical injury as risk factors for the development of PTSD. Methods: Forty-six hospitalized SBA victims were evaluated for PTSD using the PTSD symptom scale self-report questionnaire by phone. Demographic and medical data regarding the severity and type of injury and medical treatment were collected from medical files. Injury Severity Score was used to assess severity of physical injury. Results: Twenty-four of 46 (52.2%) hospitalized SBA victims developed PTSD. Presence of blast lung injury was significantly higher in the PTSD group compared with the non-PTSD group (37.5% versus 9.1%, respectively; p < 0.04). There was no significant difference in Injury Severity Score between PTSD and non-PTSD groups. Blast lung injury and intracranial injury were found to be positive predictors of PTSD (odds ratio, 125 and 25, respectively). No correlation was found between the length of stay, length of intensive care unit stay, or severity of physical injuries and the severity of PTSD. Conclusions: Hospitalized victims of SBA are considerably vulnerable to develop PTSD. Victims should be monitored closely and treated in conjunction with their physical treatment. Blast lung injury and intracranial injury are predictors of PTSD.	[Shussman, Noam; Mintz, Ayelet; Zamir, Gideon; Abu Gazala, Mahmoud; Rivkind, Avraham I.; Isenberg, Yonatan; Bala, Miklosh; Almogy, Gidon] Hadassah Hebrew Univ, Med Ctr, Dept Surg, IL-91120 Jerusalem, Israel; [Shussman, Noam; Mintz, Ayelet; Zamir, Gideon; Abu Gazala, Mahmoud; Rivkind, Avraham I.; Isenberg, Yonatan; Bala, Miklosh; Almogy, Gidon] Hadassah Hebrew Univ, Med Ctr, Trauma Unit, IL-91120 Jerusalem, Israel; [Shalev, Arye] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, IL-91120 Jerusalem, Israel		Almogy, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Surg, POB12000, IL-91120 Jerusalem, Israel.	GAlmogy@hadassah.org.il		Shalev, Arieh/0000-0001-9425-050X			Almogy G, 2006, ANN SURG, V243, P541, DOI 10.1097/01.sla.0000206418.53137.34; Almogy G, 2007, CURR PROB SURG, V44, P562, DOI 10.1067/j.cpsurg.2007.06.002; Ameratunga S, 2009, PSYCHIAT SERV, V60, P402, DOI 10.1176/appi.ps.60.3.402; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Boscarino JA, 1996, J CONSULT CLIN PSYCH, V64, P191, DOI 10.1037/0022-006X.64.1.191; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KILPATRICK DG, 1989, BEHAV THER, V20, P199, DOI 10.1016/S0005-7894(89)80069-3; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Shalev AY, 2005, AM J PSYCHIAT, V162, P1188, DOI 10.1176/appi.ajp.162.6.1188; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Zatzick DF, 1997, MIL MED, V162, P661, DOI 10.1093/milmed/162.10.661; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941	21	4	5	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2011	70	6					1546	1550		10.1097/TA.0b013e318202edcf			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	775QR	WOS:000291478500050	21817991				2022-02-06	
J	Kinsella, GJ				Kinsella, Glynda J.			What Are the Characteristics of Traumatic Brain Injury in Older Adults?	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; older adults; cause of injury; comorbidities; gender	CONCUSSION; MORTALITY	The Australian community is ageing; over the next 40 years, our population over the age of 65 years will double to around 23%, and this considerable increase in older adults means an increasing number of people will be at risk of sustaining trauma through falls or road traffic accidents. In contrast to the increasingly well-documented outcome literature on younger adults, very few studies have focused on older adults. Instead of assuming that outcomes posttraumatic brain injury (post-TBI) will follow similar patterns as in younger samples, there are several reasons to investigate older age recovery separately, and these issues will be discussed by reviewing some of the primary characteristics of older adults who experience traumatic brain injury.	[Kinsella, Glynda J.] La Trobe Univ, Melbourne, Vic 3086, Australia; [Kinsella, Glynda J.] Caulfield Hosp, Dept Psychol, Melbourne, Vic, Australia		Kinsella, GJ (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934	Victorian Neurotrauma Initiative	This article has been completed within the context of an ongoing study on outcome following TBI in older adults (funded by the Victorian Neurotrauma Initiative to Glynda Kinsella, John Olver, Ben Ong, Sarah Price and Samuel Parsons). The views in this article have been influenced by many discussions with my colleagues and collaborators in the study, namely Ben Ong and John Giver; and postgraduate students - Brooke Froud, Bethan Plowright, Eleanor Hammersley, Sarah Mclean, Sarah Price, Samuel Parsons and Jodie Tucker.	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; BRADLEY C, 2008, HOSP DUE FALLS OLDER; Camilloni L, 2008, INT J INJ CONTROL SA, V15, P25, DOI 10.1080/17457300701800118; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Goleburn CR, 2001, J CLIN GEROPSYCHOL, V7, P161; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Helps Y., 2008, HOSP SEPARATIONS DUE; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; KINSELLA GJ, 2010, TRAUMATIC BRAIN INJU; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; McCrae M., 2008, MILD TRAUMATIC BRAIN; O'Connor P., 2002, INJURY RES STAT SERI; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Rushworth N., 2009, BRAIN INJURY AUSTR P; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001	22	4	4	1	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2011	12	1					71	75		10.1375/brim.12.1.71			5	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	795EH	WOS:000292953800007					2022-02-06	
J	Subhas, K; Appleby, I				Subhas, Kamalakkannan; Appleby, Ian			Traumatic brain injury: initial resuscitation and transfer	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						airway management; cerebral perfusion pressure; cervical spine; Glasgow Coma Score; hyperosmolar therapy; imaging; intracranial pressure; transfer; traumatic brain injury		Traumatic brain injury (TBI) is common and carries a high morbidity and mortality. Initial management of the traumatic brain injury patient is directed towards preventing and limiting secondary brain injury while facilitating rapid transport to an appropriate facility capable of providing definitive neurocritical care. During resuscitation of the TBI patient, management is directed at correcting and maintaining mean arterial pressure (MAP), blood glucose, PaO2 and PaCO2 within their normal ranges. After the initial resuscitation, management is directed at limiting secondary damage to the brain which occurs in response to inflammatory changes, expanding haematomas, cellular swelling, seizures, and systemic complications such as haemodynamic or pulmonary changes, fever and pain. The transport of critically ill brain-injured patients carries inherent risks. Although both intra-and inter-hospital transport must comply with regulations, patient safety is enhanced during transport by establishing an organized, efficient process supported by appropriate equipment and personnel. This review examines the evidence base for the initial resuscitation and transfer of headinjured patients.	[Subhas, Kamalakkannan] North Cent London Rotat, London, England; [Appleby, Ian] Natl Hosp Neurol & Neurosurg, Neuroanaesthesia & Neurocrit Care, London, England		Subhas, K (corresponding author), North Cent London Rotat, London, England.						AAGBI, 2006, REC SAF TRANSF PAT B; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; NICE, 2007, HEAD INJ TRIAG ASS I; SIGN, 2009, EARL MAN PAT HEAD IN	10	4	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	MAY	2011	12	5					201	203		10.1016/j.mpaic.2011.02.001			3	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V09DH	WOS:000214123200006					2022-02-06	
J	Thibault-Halman, G; Tallon, JM; Ackroyd-Stolarz, S; Fenerty, L; Karim, SA; Sealy, B; Clarke, DB				Thibault-Halman, Ginette; Tallon, John M.; Ackroyd-Stolarz, Stacy; Fenerty, Lynne; Karim, Saleema A.; Sealy, Beth; Clarke, David B.			Major Traumatic Brain Injury: Time to Tertiary Care and the Impact of a Clinical Guideline	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Traumatic brain injury; Transportation of patients; Clinical guideline; Emergency care	PROCESS-OUTCOME EVALUATION; LEVEL FACILITIES IMPACT; ACUTE SUBDURAL-HEMATOMA; DIRECT SCENE TRANSFER; DIRECT TRANSPORT; INTERHOSPITAL TRANSFER; COMATOSE PATIENTS; HEAD-INJURIES; MORTALITY; MANAGEMENT	Background:To achieve timely access to neurosurgical care for adult brain-injured patients, a Head Injury Guideline was implemented to standardize the emergency department evaluation and management of these patients. The goals of this study were to document times to neurosurgical care for patients with major traumatic brain injury presenting to a Provincial emergency room and to evaluate the impact of the Guideline on timely access to definitive care. Methods:Data collected prospectively and stored in the Nova Scotia Trauma Registry and the Emergency Health Services Communications and Dispatch Centre database were analyzed for patients with head abbreviated injury scale score (AIS) >= 3. Several time intervals from admission to a referring hospital to access to tertiary care were determined and compared for the periods before Guideline implementation, the implementation phase, and after implementation. Results:The time elapsed before calling the provincial Trauma Hotline was not statistically different after Guideline implementation for polytrauma patients with head AIS score >= 3 (n = 388) during the preimplementation (2:34 +/- 1:30; median time in hours:minutes +/- standard deviation), implementation (1:57 +/- 2:33) and postimplementation (2:31 +/- 4:06) periods. Subset group analysis of patients with isolated head injuries AIS score >= 3 (n = 99) also showed no statistical difference in preimplementation (1:51 +/- 1:42), implementation (2:49 +/- 2:57), and postimplementation (3:10 +/- 4:58) times. Examination of overall time to tertiary care revealed prolonged transfer times and that the Guideline had no influence on either the polytrauma patient group (preimplementation, 4:20 +/- 1:41; implementation, 5:01 +/- 2:55; and postimplementation 4:46 +/- 4:22) or those with isolated head injuries (preimplementation, 3:39 +/- 1:47; implementation, 6:06 +/- 4:00; and postimplementation, 5:13 +/- 4:59). Conclusions:Times to tertiary care are lengthy and have not been reduced by Guideline implementation. System changes beyond Guideline implementation are required to provide timely access to tertiary care for patients with major head injury.	[Thibault-Halman, Ginette; Fenerty, Lynne; Clarke, David B.] Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS, Canada; [Tallon, John M.; Ackroyd-Stolarz, Stacy] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Karim, Saleema A.; Sealy, Beth] Dalhousie Univ, Nova Scotia Trauma Program, Halifax, NS, Canada		Clarke, DB (corresponding author), QEII Hlth Sci Ctr, Div Neurosurg, 1796 Summer St,Suite 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca		Karim, Saleema/0000-0002-8946-9897	Nova Scotia Health Research Foundation	Supported by the Nova Scotia Health Research Foundation.	Boyd CR, 1998, AM SURGEON, V64, P91; Bulters D, 2009, ANAESTHESIA, V64, P277, DOI 10.1111/j.1365-2044.2008.05779.x; Cayten CG, 1997, J TRAUMA, V43, P295; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Deverill J, 2007, EMERG MED AUSTRALAS, V19, P325, DOI 10.1111/J.1742-6723.2007.00969.x; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Eastman AB, 1999, J TRAUMA, V46, P579; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hayward RSA, 1997, CAN MED ASSOC J, V156, P1715; Hebb MO, 2007, CAN J SURG, V50, P187; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Mcvey J, 2010, PREHOSP EMERG CARE, V14, P45, DOI 10.3109/10903120903349788; Moen KG, 2008, EUR J EMERG MED, V15, P249, DOI 10.1097/MEJ.0b013e3282f4d111; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; *STAT CAN DEM DIV, 2009, STAT CAN, V2316; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Tallon JM, 2006, J TRAUMA, V60, P548, DOI 10.1097/01.ta.0000209336.66283.ea; Tallon JM, 2008, CAN J SURG, V51, P339; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2; Young JS, 1998, AM SURGEON, V64, P88	32	4	5	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5					1134	1140		10.1097/TA.0b013e3182146c79			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	762LQ	WOS:000290480300033	21610427				2022-02-06	
J	Velde, K; Linsbichler, B; Egerbacher, M; Stashak, T				Velde, K.; Linsbichler, B.; Egerbacher, M.; Stashak, T.			Use of reversed periosteal flaps in the repair of large nasocutaneous fistulas in two horses	EQUINE VETERINARY EDUCATION			English	Article						horse; periosteal flap; nasocutaneous fistula; sinus surgery; reconstructive surgery	DEFECTS	P>Head injuries occur frequently in horses and a successful outcome after repair depends upon the severity of the initial trauma, the anatomical structures involved and the extent of tissue loss. Often these injuries involve facial bones and enter into the nasal passages or paranasal sinus system. When these injuries occur in conjunction with substantial tissue loss, the resulting defect may be difficult to close and naso/sinocutaneous fistulae can develop. These defects can be challenging and time consuming to repair and an appropriate reconstructive technique must be selected. We describe the use of reverse periosteal flaps as a technique in repairing large nasocutaneous fistulae in 2 horses after previous attempts to close the defects by other means had failed.	[Velde, K.; Linsbichler, B.] VetMedUni Vienna, Equine Clin, Dept Compan Anim & Horses, Vienna, Austria; [Egerbacher, M.] VetMedUni Vienna, Pathobiol, Microscop Anat Histol, Vienna, Austria; [Stashak, T.] Colorado State Univ, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA		Velde, K (corresponding author), VetMedUni Vienna, Equine Clin, Dept Compan Anim & Horses, Vienna, Austria.	karsten.velde@vetmeduni.ac.at					Barber S., 2008, EQUINE WOUND MANAGEM, P273; Barber SM, 2005, VET CLIN N AM-EQUINE, V21, P191, DOI 10.1016/j.cveq.2004.11.010; Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162; CAMPBELL ML, 1984, VET SURG, V13, P185, DOI 10.1111/j.1532-950X.1984.tb00786.x; Charman R, 2007, AUST VET J, V85, P341, DOI 10.1111/j.1751-0813.2007.00150.x; Danesh-Meyer M J, 2001, J Int Acad Periodontol, V3, P48; DeRossi R, 2009, ACTA CIR BRAS, V24, P276, DOI 10.1590/S0102-86502009000400006; Knox Rebecca L, 2006, J Extra Corpor Technol, V38, P260; MADISON JB, 1989, VET SURG, V18, P15, DOI 10.1111/j.1532-950X.1989.tb01037.x; SCHUMACHER J, 1985, VET SURG, V14, P235, DOI 10.1111/j.1532-950X.1985.tb00871.x; Stashak TS, 1991, EQUINE WOUND MANAGEM, P89; Waldridge BM, 1997, EQUINE PRACT, V19, P7	12	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0957-7734	2042-3292		EQUINE VET EDUC	Equine Vet. Educ.	MAY	2011	23	5					235	241		10.1111/j.2042-3292.2010.00170.x			7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	750CS	WOS:000289522500004					2022-02-06	
J	Yararbas, G; Pogun, S				Yararbas, Gorkem; Pogun, Sakire			Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats	BRAIN RESEARCH BULLETIN			English	Article						Estrogen receptors; Progestin receptors; Conditioned place preference; Tamoxifen; RU486	PROTEIN-KINASE-C; TRAUMATIC BRAIN INJURY; MENSTRUAL-CYCLE; SMOKING-CESSATION; TOBACCO WITHDRAWAL; REQUIRE ACTIONS; SEX-DIFFERENCES; ESTROUS-CYCLE; PHASE; BEHAVIOR	An increasing number of studies suggest that nicotine/tobacco addiction is modulated by ovarian hormones. The levels of estrogen and progesterone appear to be important in the success of quit attempts and smoking cessation. In women smokers with the diagnosis or risk of breast cancer, the estrogen receptor modulator tamoxifen (TAM) is widely used, and even though the detrimental health effects of smoking are known, this vulnerable group has difficulty quitting and continues to smoke. The current study tested the effect of the estrogen receptor modulator TAM and the progesterone receptor antagonist mifepriston (RU486) on nicotine-induced conditioned place preference (CPP) in adult female rats. A three chambered CPP apparatus was used and nicotine was paired with the initially non-preferred chamber. Rats received nicotine or saline and hormone receptor modulators (vehicle, TAM, RU486) in a 2 x 3 experimental design. We have previously shown that nicotine induces CPP in male Sprague-Dawley rats but not in females. Our results show that while nicotine alone does not induce CPP in female rats, rats treated with TAM exhibit nicotine-induced CPP. Although RU486 has an aversive effect when applied alone, this is ameliorated by nicotine. These results confirm the role of ovarian hormone receptors in nicotine-induced CPP and may have clinical implications for developing more efficient smoking cessation approaches in women smokers. (C) 2011 Elsevier Inc. All rights reserved.	[Pogun, Sakire] Ege Univ, Ctr Brain Res, Tip Fak Dekanlik Binasi, TR-35100 Izmir, Turkey; Ege Univ, Inst Drug Abuse Toxicol & Pharmaceut Sci BATI, TR-35100 Izmir, Turkey		Pogun, S (corresponding author), Ege Univ, Ctr Brain Res, Tip Fak Dekanlik Binasi, TR-35100 Izmir, Turkey.	sakire.pogun@ege.edu.tr	Pogun, Sakire/A-5816-2010	Pogun, Sakire/0000-0003-1758-2425	Ege UniversityEge University [2006-BAM-02]	This work was supported by Ege University Research Fund (Grant Number: 2006-BAM-02).	Allen S S, 1999, Nicotine Tob Res, V1, P129, DOI 10.1080/14622299050011241; Allen SS, 2008, ADDICTION, V103, P809, DOI 10.1111/j.1360-0443.2008.02146.x; Allen SS, 2009, ADDICT BEHAV, V34, P107, DOI 10.1016/j.addbeh.2008.08.009; Auger CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003606; Benowitz NL, 2006, CLIN PHARMACOL THER, V79, P480, DOI 10.1016/j.clpt.2006.01.008; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; BRUNTON LL, 2008, GOODMAN GILMAN MANUA; Carpenter MJ, 2008, J WOMENS HEALTH, V17, P293, DOI 10.1089/jwh.2007.0415; Carpenter MJ, 2006, NICOTINE TOB RES, V8, P627, DOI 10.1080/14622200600910793; Carroll ME, 2010, HORM BEHAV, V58, P44, DOI 10.1016/j.yhbeh.2009.10.001; Cyr M, 2001, BRAIN RES REV, V37, P153, DOI 10.1016/S0165-0173(01)00115-1; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Diel P, 2002, TOXICOL LETT, V127, P217, DOI 10.1016/S0378-4274(01)00503-3; Dluzen DE, 2002, ANN NY ACAD SCI, V965, P136; Dluzen DE, 2000, J NEUROCYTOL, V29, P387, DOI 10.1023/A:1007117424491; Donath J, 1998, J STEROID BIOCHEM, V66, P247, DOI 10.1016/S0960-0760(98)00033-8; Donny EC, 2000, PSYCHOPHARMACOLOGY, V151, P392, DOI 10.1007/s002130000497; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Esmaeili B, 2009, PSYCHOPHARMACOLOGY, V204, P191, DOI 10.1007/s00213-008-1448-5; ETGEN AM, 1986, HORM BEHAV, V20, P166, DOI 10.1016/0018-506X(86)90015-2; Franklin TR, 2004, NICOTINE TOB RES, V6, P171, DOI 10.1080/14622200310001656984; Frye CA, 2006, PSYCHOPHARMACOLOGY, V186, P312, DOI 10.1007/s00213-006-0309-3; Frye CA, 2001, BRAIN RES REV, V37, P201, DOI 10.1016/S0165-0173(01)00119-9; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Gomez C, 2002, PHARMACOL BIOCHEM BE, V72, P543, DOI 10.1016/S0091-3057(02)00722-0; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Halbreich U, 2000, Expert Opin Pharmacother, V1, P1385, DOI 10.1517/14656566.1.7.1385; Hamilton KR, 2009, PHARMACOL BIOCHEM BE, V92, P51, DOI 10.1016/j.pbb.2008.10.010; Harrod SB, 2007, PHARMACOL BIOCHEM BE, V86, P32, DOI 10.1016/j.pbb.2006.12.004; HEIKINHEIMO O, 1994, HUM REPROD, V9, P40, DOI 10.1093/humrep/9.suppl_1.40; Lynch WJ, 2009, PHARMACOL BIOCHEM BE, V94, P43, DOI 10.1016/j.pbb.2009.07.004; Lynch WJ, 2001, PHARMACOL BIOCHEM BE, V68, P641, DOI 10.1016/S0091-3057(01)00455-5; Martinez E, 2009, CANCER CAUSE CONTROL, V20, P97, DOI 10.1007/s10552-008-9222-x; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mwenifumbo Jill C, 2009, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-540-69248-5_9; OBRIAN CA, 1990, BIOPOLYMERS, V29, P97, DOI 10.1002/bip.360290114; OHARA P, 1989, ADDICT BEHAV, V14, P595, DOI 10.1016/0306-4603(89)90001-4; PARSONS B, 1982, J NEUROSCI, V2, P1446; Perkins KA, 2000, J CONSULT CLIN PSYCH, V68, P176, DOI 10.1037/0022-006X.68.1.176; Pogun Sakire, 2009, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-540-69248-5_10; POMERLEAU CS, 1992, PSYCHONEUROENDOCRINO, V17, P627, DOI 10.1016/0306-4530(92)90021-X; Priyadarshani A, 2009, J ENDOCRINOL INVEST, V32, P837, DOI [10.1007/BF03345755, 10.3275/6435]; Schwartz J, 2004, FRONT BIOSCI-LANDMRK, V9, P2827, DOI 10.2741/1440; Sershen H, 2010, BRAIN RES BULL, V81, P120, DOI 10.1016/j.brainresbull.2009.07.015; Sershen H, 2009, BRAIN RES BULL, V79, P458, DOI 10.1016/j.brainresbull.2009.04.005; Slotkin TA, 2010, BRAIN RES BULL, V82, P124, DOI 10.1016/j.brainresbull.2010.02.015; Slotkin TA, 2010, BRAIN RES BULL, V81, P552, DOI 10.1016/j.brainresbull.2009.11.003; Sofuoglu M, 2009, HUM PSYCHOPHARM CLIN, V24, P559, DOI 10.1002/hup.1055; Sun XL, 2004, NEUROSCI LETT, V367, P19, DOI 10.1016/j.neulet.2004.05.072; Tamura T, 2009, J TOXICOL SCI, V34, pSP31, DOI 10.2131/jts.34.S31; TORRES OV, 2009, PSYCHOPHARMACOLOGY B; Tower AM, 2009, ONCOL REP, V22, P49, DOI 10.3892/or_00000405; Tyndale RF, 2002, THER DRUG MONIT, V24, P163, DOI 10.1097/00007691-200202000-00026; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1598, DOI 10.1038/sj.npp.1300713; Walf AA, 2007, NEUROPSYCHOPHARMACOL, V32, P522, DOI 10.1038/sj.npp.1301124; Walker QD, 2002, PHARMACOL BIOCHEM BE, V73, P743, DOI 10.1016/S0091-3057(02)00883-3; Wang YJ, 2006, INT IMMUNOPHARMACOL, V6, P892, DOI 10.1016/j.intimp.2005.12.006; Yararbas G, 2010, NEUROPHARMACOLOGY, V58, P374, DOI 10.1016/j.neuropharm.2009.10.001; Yildiz A, 2008, ARCH GEN PSYCHIAT, V65, P255, DOI 10.1001/archgenpsychiatry.2007.43; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P881, DOI 10.1016/S0893-133X(01)00301-3; Zarate CA, 2007, BIPOLAR DISORD, V9, P561, DOI 10.1111/j.1399-5618.2007.00530.x; Zhan M, 2007, CANCER DETECT PREV, V31, P384, DOI 10.1016/j.cdp.2007.10.004	64	4	4	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR 5	2011	84	6					425	429		10.1016/j.brainresbull.2011.01.013			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	755TC	WOS:000289958600009	21272620				2022-02-06	
J	Campbell, BA; Panicker, J				Campbell, Brook Ashley; Panicker, Jyoti			New Onset Psychosis in an Adolescent During Treatment of Testicular Germ Cell Tumor	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						psychosis; nonseminomatous; germ cell tumor; testicular cancer	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; CANCER; CORTICOSTEROIDS; SCHIZOPHRENIA; ORGANIZATION; INDIVIDUALS; MANAGEMENT; GERMINOMA; LEUKEMIA	Germ cell tumor of the testis is the most common malignancy in young males between 15 and 45 years of age. Side effects of treatment are common, but psychiatric reactions have not been reported. We describe a case of a 16-year-old male patient with nonseminomatous germ cell tumor of the testis treated with orchiectomy and bleomycin, etoposide, and cisplatin chemo therapy. Treatment was complicated by the development of psychosis after first chemotherapy cycle. Etiology of psychosis was most likely multifactorial including stress related to cancer diagnosis and treatment, psychosocial and family stressors, history of traumatic brain injury, and corticosteroid medication.	[Panicker, Jyoti] Univ Kansas, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol, Kansas City, KS 66103 USA		Panicker, J (corresponding author), KU Pediat, MS 2031,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jpanicker@kumc.edu					Berard RMF, 1998, PEDIATR HEMAT ONCOL, V15, P211, DOI 10.3109/08880019809028787; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carson BS, 1997, J NEUROSURG, V87, P103, DOI 10.3171/jns.1997.87.1.0103; Craven C, 2001, J AM ACAD CHILD PSY, V40, P6, DOI 10.1097/00004583-200101000-00008; de Wit R, 2001, J CLIN ONCOL, V19, P1629, DOI 10.1200/JCO.2001.19.6.1629; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; DUCORE JM, 1983, J PEDIATR-US, V103, P477, DOI 10.1016/S0022-3476(83)80432-6; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Harter M, 2001, EUR J CANCER, V37, P1385, DOI 10.1016/S0959-8049(01)00136-8; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; IRWIN M, 1984, SOUTHERN MED J, V77, P1458, DOI 10.1097/00007611-198411000-00025; Kaufman MR, 2007, UROL CLIN N AM, V34, P259, DOI 10.1016/j.ucl.2007.02.011; Mordecai D, 2000, J AM ACAD CHILD PSY, V39, P116, DOI 10.1097/00004583-200001000-00024; Pectasides D, 2006, ONCOLOGY-BASEL, V71, P151, DOI 10.1159/000106063; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Stuart FA, 2005, ARCH DIS CHILD, V90, P500, DOI 10.1136/adc.2003.041541; Tandstad T, 2009, J CLIN ONCOL, V27, P2122, DOI 10.1200/JCO.2008.18.8953; Warrington TP, 2006, MAYO CLIN PROC, V81, P1361, DOI 10.4065/81.10.1361	20	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1077-4114			J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	APR	2011	33	3					E125	E126		10.1097/MPH.0b013e3182036e06			2	Oncology; Hematology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Hematology; Pediatrics	739DW	WOS:000288694700011	21383636				2022-02-06	
J	Coskun, S; Coskun, A; Gursan, N; Aydin, MD				Coskun, Suleyman; Coskun, Aysenur; Gursan, Nesrin; Aydin, Mehmet Dumlu			Post-Traumatic Glioblastoma Multiforme: A Case Report	EURASIAN JOURNAL OF MEDICINE			English	Article						Brain injury; Glial cell tumors; Trauma		Malignant glioma development after trauma is a rare occurrence. We report a glioblastoma multiforme case that developed after a depressed skull fracture. A 65-year-old man was admitted because of right sided hemiplegia, epilepsy and changes in consciousness due to a malignant glial tumor. He had been operated on for a left calvarial depression fracture caused by cerebral laceration thirty-five years before. Radiologic imaging revealed a large contrast-enhanced mass lesion at the left frontotemporoparietal junction under the depression site. The patient underwent urgent surgery, and radical excision of the mass was achieved. The histopathologic diagnosis was a high-grade glial tumor. Although the possibility of a pre-existing tumor rather than a trauma-induced tumor is very high, the presented case suggests that traumatic cerebral lesions may also be a predisposing factor for the development of malignant glial tumors.	[Coskun, Suleyman; Aydin, Mehmet Dumlu] Ataturk Univ, Fac Med, Dept Neurosurg, Erzurum, Turkey; [Coskun, Aysenur] Ataturk Univ, Fac Med, Dept Anesthesiol, Erzurum, Turkey; [Gursan, Nesrin] Ataturk Univ, Fac Med, Dept Pathol, Erzurum, Turkey		Coskun, S (corresponding author), Ataturk Univ, Fac Med, Dept Neurosurg, Erzurum, Turkey.	dr.scoskun@hotmail.com					ALLING C, 1980, J NEUROL, V223, P225, DOI 10.1007/BF00313336; ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; Bohnen NI, 2004, SURG NEUROL, V61, P180; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; DIEZEL P, 1949, Frankf Z Pathol, V60, P316; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; FINKEMEYER H, 1956, Zentralbl Neurochir, V16, P318; Hallervorden J, 1948, NERVENARZT, V19, P163; Henderson RD, 2000, J CLIN NEUROSCI, V7, P262, DOI 10.1054/jocn.1999.0204; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; Heyck H, 1954, MON PSYCHIATR NEUROL, V128, P180; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; JANDA J, 1987, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V133, P55; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Manuelidis EE, 1978, PATHOLOGY NERVOUS SY, V2, P2237; MESSIMY R, 1953, REV NEUROL, V89, P620; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; Sabel M, 1999, J NEUROSURG, V91, P1041, DOI 10.3171/jns.1999.91.6.1041; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; WITZMANN A, 1981, NEUROCHIRURGIA, V24, P202; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; Zulch K, 1974, TUMOURS BRAIN SKUL 1, P1	25	4	5	0	0	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY	1308-8734	1308-8742		EURASIAN J MED	Eurasian J. Med.	APR	2011	43	1					50	53		10.5152/eajm.2011.10			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V6M7S	WOS:000420425500010	25610160	Green Published, gold			2022-02-06	
J	Grimm, D; Mion, LC				Grimm, Dawn; Mion, Lorraine C.			Falls Resulting in Traumatic Injury Among Older Adults Nursing Care Issues	AACN ADVANCED CRITICAL CARE			English	Article						older adults; falls; skeletal spine injury; trauma; traumatic brain injury		Falls among community-dwelling older adults are common and dangerous, often leading to traumatic brain injury, cervical fractures, and spinal cord injury. Physical and physiologic changes with aging, preexisting diseases, and treatments result in increased morbidity and mortality for this population. Trauma critical care nurses can expect to see increasing numbers of older adults in intensive care units as the US population of those older than 65 years increases to 53 million by 2020. Older adults pose additional dilemmas in care. This article reviews falls, mechanism of injury, and nursing care issues of particular significance to this vulnerable population in the critical care setting.	[Grimm, Dawn] MetroHlth Med Ctr, Dept Nursing, 2500 MetroHlth Dr, Cleveland, OH 44109 USA; [Mion, Lorraine C.] Vanderbilt Univ, Sch Nursing, Nursing, Nashville, TN 37240 USA		Grimm, D (corresponding author), MetroHlth Med Ctr, Dept Nursing, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	dgrimm@metrohealth.org					BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Branco BC, 2010, J TRAUMA; Browner B, 2008, SKELETAL TRAUMA; Bub LD, 2005, RADIOLOGY, V234, P143, DOI 10.1148/radiol.2341031692; CAMPION EW, 1994, NEW ENGL J MED, V330, P1819, DOI 10.1056/NEJM199406233302509; *CDCP, COSTS FALLS OLD AD; Centers for Disease Control and Prevention, FALLOLD AD OV; Centers for Medicare & Medicaid Services, 2006, FED REGISTER, V71, P71378; Choi J, 2008, BIOL RES NURS, V10, P21, DOI 10.1177/1099800408319055; Currie L, 2008, AHRQ PUBLICATION, P195; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Department of Health and Human Services, 2007, FED REGISTER, V72, P47130; Emergency Nurses Association, 2007, TRAUM NURS COR COURS, P7; Evans D, 2003, J ADV NURS, V41, P274, DOI 10.1046/j.1365-2648.2003.02501.x; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Gillis A, 2008, J CONTIN EDUC NURS, V39, P547, DOI 10.3928/00220124-20081201-07; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Golob JF, 2008, J TRAUMA, V64, P311, DOI 10.1097/TA.0b013e3181627625; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; HOYERT D, 1999, NATL VITAL STAT REPO, V47; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Kagan SH, 2011, GERIATR NURS, V32, P55, DOI 10.1016/j.gerinurse.2010.12.005; Kamer Aaron P, 2009, J Trauma, V66, pE57, DOI 10.1097/TA.0b013e3180341f78; Kennedy RL, 2001, J TRAUMA, V51, P717, DOI 10.1097/00005373-200110000-00016; KNOPP R, 1988, ANN EMERG MED, V17, P895, DOI 10.1016/S0196-0644(88)80666-8; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lomoschitz FM, 2002, AM J ROENTGENOL, V178, P573, DOI 10.2214/ajr.178.3.1780573; Maccioli GA, 2003, CRIT CARE MED, V31, P2665, DOI 10.1097/01.CCM.0000095463.72353.AD; Malik SA, 2008, EUR SPINE J, V17, P585, DOI 10.1007/s00586-008-0603-3; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MILES SH, 1993, J AM GERIATR SOC, V41, P1013, DOI 10.1111/j.1532-5415.1993.tb06775.x; Mion LC, 2008, EVIDENCE BASED GERIA, P503; National Trauma Data Bank, NAT TRAUM DAT BANK 2; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Olivieri I, 2007, RHEUMATOLOGY, V46, P1709, DOI 10.1093/rheumatology/kem227; Papadopoulos MC, 1999, BRIT MED J, V319, P171, DOI 10.1136/bmj.319.7203.171; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sreedharan S, 2005, ANN ACAD MED SINGAP, V34, P257; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Truong AD, 2009, CRIT CARE, V13, DOI 10.1186/cc7885; US Department of Veterans Affairs, VHA NCPS FALL PREV M; Vasilevskis EE, 2010, CRIT CARE MED, V38, pS683, DOI 10.1097/CCM.0b013e3181f245d3; Vincent G. K., 2010, NEXT 4 DECADES OLDER; Washington State Department of Health, 2002, FALLS OLD AD STRAT P; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222, DOI 10.1007/s002560050225	49	4	4	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	APR-JUN	2011	22	2					161	168		10.1097/NCI.0b013e3182157cb3			8	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF8RG	WOS:000443777800008	21521958				2022-02-06	
J	Islam, MJ; Saha, SK; Elahy, MF; Islam, KMT; Ahamed, SU				Islam, M. J.; Saha, S. K.; Elahy, M. F.; Islam, K. M. T.; Ahamed, S. U.			Factors influencing the outcome of patients with acute extradural haematomas undergonig surgery	BANGLADESH JOURNAL OF MEDICAL SCIENCE			English	Article						Acute Extradural Haematoma (EDH); Glasgow Coma Scale (GCS); Glasgow Outcome Scale (GOS)	ACUTE EPIDURAL HEMATOMA; POSTERIOR-FOSSA; VOLUME	Background: Acute extradural haematoma (EDH) remains most common cause of mortality and disability resulting from traumatic brain injury. In the last three decades, improvements in rescue, neuromonitoring, diagnostic procedure and intensive care have led to better outcomes. The purpose of this study was to evaluate the factors influencing the outcome in patients with EDH undergoing surgery treated in a tertiary hospital in Bangladesh. Methods: In this retrospective study, 102 consecutive patients with acute EDH who underwent craniotomy were included. The study was carried out from July 2003 to December 2005. The diagnosis was made clinically and radiologically by CT scan. Patients were grouped on the basis of Glasgow Coma Scale (GCS) and operative outcomes were evaluated by Glasgow Outcome Scale (GOS) Results: More than half sampled respondents' (57%) age were more than 20 years while rests of the patients below 20 years with male predominance (Male: Female -12: 1). About 7 in 10 respondents (70.6%) were working. Similarly, majority of the respondents (79.4%) had lost more than 30 ml blood. A notable proportion of the respondents (73.5%) had good GCS score (9-15 score) during admission. Similarly majority of the respondents (70.6%) had GCS score 9-15 and 29.4% had GCS score 3-8 before surgery. Road Traffic Accident (RTA) (65%) is the most common cause of EDH followed by assault (20%) and fall from height (12%). Temporal and temporo-parietal locations were the most common site of EDH (56%). Patients with good GCS before surgery had significantly better outcome (89%) compare to those who had bad GCS (10%). Conclusion: Level of consciousness before surgery is the most important factor affecting the outcome. Hence, early diagnosis and surgical intervention is very essential.	[Islam, M. J.; Saha, S. K.] Sir Salimullah Med Coll, Dept Neurosurg, Dhaka, Bangladesh; [Islam, M. J.; Saha, S. K.] Mitford Hosp, Dhaka, Bangladesh; [Elahy, M. F.] Dhaka Med Coll, Dept Neurosurg, Dhaka, Bangladesh; [Islam, K. M. T.] BSMMU, Dept Neurosurg, Dhaka, Bangladesh; [Ahamed, S. U.] Dhaka Med Coll Hosp, Neurosurg, Dhaka, Bangladesh		Islam, MJ (corresponding author), Sir Salimullah Med Coll, Dept Neurosurg, Dhaka, Bangladesh.	joynul67@yahoo.com					AGRAWAL A, 2007, NJOT, V6, P74; Babu ML, 2005, JK SCI, V7, P205; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Carlos UP, 2005, INTERNET J EMERGENCY, V2; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; Dubey A, 2004, NEUROL INDIA, V52, P443; ERSAHIN Y, 1993, CHILD NERV SYST, V9, P96, DOI 10.1007/BF00305316; ERSAHIN Y, 1993, PEDIATR NEUROSURG, V19, P31, DOI 10.1159/000120697; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Husain M, 2007, INDIAN J NEUROTRAUM, V4, P41, DOI 10.1016/S0973-0508(07)80010-4; Hutchinson J., 1867, LOND HOSP REP, V4, P51; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Khan M. H.-M., 2009, P 2 IFIP WIR DAYS PA P 2 INT C IM SIGN PR, P1, DOI DOI 10.1109/NTMS.2009.5384685; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KVARNES TL, 1978, ACTA NEUROCHIR, V41, P223, DOI 10.1007/BF01809151; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marion DW, 2006, NEUROSURGERY, V58, P655; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; Mishra A, 2001, NEUROL INDIA, V49, P94; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; NEUBAUER UJ, 1987, ACTA NEUROCHIR, V87, P105, DOI 10.1007/BF01476060; Ozkan U., 2007, DICLE TIP DERGISI, V1, P14; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Teasdale G, 1981, Prog Neurol Surg, V10, P252, DOI 10.1159/000384771; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Yurt I, 1996, TURKISH NEUROSURG, V6, P63; Zuccarello M, 1983, ADV NEUROTRAUMATOLOG, P238	38	4	4	0	0	IBN SINA TRUST	DHAKA	1-1B KALLYANPUR, MIRPUR RD, DHAKA, 1216, BANGLADESH	2223-4721	2076-0299		BANGLADESH J MED SCI	Bangladesh J. Med. Sci.	APR	2011	10	2					112	120					9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V1E5J	WOS:000216831400007		hybrid			2022-02-06	
J	Moin, P; Khalighinejad, N; Yusefi, A; Farajzadegan, Z; Barekatain, M				Moin, Payam; Khalighinejad, Nima; Yusefi, Arash; Farajzadegan, Ziba; Barekatain, Majid			Converting Three General-Cognitive Function Scales into Persian and Assessment of Their Validity and Reliability!	INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE			English	Article						Disability Rating Scale; Glasgow Outcome Scale Extended; Galveston Amnesia and Orientation Test; Closed Head Injury; Cognitive function; General function; Rehabilitation		Objectives: Glasgow Outcome Scale Extended (GOSE), Galveston Amnesia and orientation Test (GOAT) and Disability Rating Scale (DRS) are three popular outcome measure tools used principally in traumatic brain injury (TBI) patients. We conducted this study to provide a Farsi version of these outcome scales for use in Iran. Methods: Following a comprehensive literature review, Farsi transcripts were prepared by "forward-backward"translation and reviewed by subject experts. After a pretest on a few patients, the final versions were obtained. 38 patients with closed head injury were interviewed simultaneously by two interviewers. Main statistics used to assess validity and reliability included "Factor analysis"for construct validity, Cronbach's alpha for internal consistency, and Pearson Correlation and Kappa Coefficient for inter-rater agreement. Results: Factor analysis for Farsi-GOAT (FGOAT) revealed 5 independent factors with a total distribution variance of 80.2%. For Farsi- DRS (FDRS), 3 independent factors were found with a 92.3% variance. The Cronbach's alpha (95% confidence interval) was 0.84 (0.763-0.919) and 0.91 (0.901-0.919) for FGOAT and FDRS, respectively. Pearson Correlation between total scores of two raters was 0.98 and 0.97 for FGOAT and FDRS, in order. Kappa coefficient (95% CI) between outcome rankings of raters was 0.73 (0.618-0.852) and 0.68 (0.594-0.770) for FGOAT and FDRS, respectively. As for Farsi- GOSE scale, Kappa value was 0.4 (0.285-0.507) for 8-level outcome ranking and improved to 0.7 (0.585-0.817)for 5-level scale. We found a good correlation between FDRS and FGOSE predicted prognoses (Spearman's rho=0.74, 95% CI: 0.676-0.802). Conclusions: FDRS and FGOAT had appropriate validity and reliability. The 8-level outcome FGOSE scale disclosed a low inter-rater agreement, but a suitable observer agreement was achieved when the 5-level outcome was applied.	[Moin, Payam; Khalighinejad, Nima; Yusefi, Arash] Isfahan Univ Med Sci, Sch Med, Hezarjerib St, Esfahan, Iran; [Farajzadegan, Ziba] Isfahan Univ Med Sci, Sch Med, Commmunity & Prevent Med Dept, Community Med, Esfahan, Iran; [Barekatain, Majid] Isfahan Univ Med Sci, Behav Sci Res Ctr, Dept Psychiat, Esfahan, Iran		Moin, P (corresponding author), Isfahan Univ Med Sci, Sch Med, Hezarjerib St, Esfahan, Iran.	payammoin@yahoo.com	farajzadegan, ziba/AAA-1362-2020	farajzadegan, ziba/0000-0001-8548-2843	Isfahan University of Medical Sciences	Source of funding: Isfahan University of Medical Sciences	GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hambleton R. K., 2005, ADAPTING ED PSYCHOL; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Naghavi M, 2003, POPUL HEALTH METR, V7, P9, DOI DOI 10.1186/1478-7954-7-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander A., 2002, EXTENDED GLASGOW OUT; SMITH RM, 1979, CLIN NEUROPSYCHOL, V1, P48; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright J, 2000, DISABILITY RATING SC	13	4	4	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2008-7802	2008-8213		INT J PREVENTIVE MED	Int. J. Preventive Med.	APR	2011	2	2					82	87					6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V08EL	WOS:000214058600006	21603013				2022-02-06	
J	Kinoshita, K; Naito, M; Shiramizu, K; Kamada, S				Kinoshita, Koichi; Naito, Masatoshi; Shiramizu, Kei; Kamada, Satoshi			Prevention of obturator artery injury during pubic osteotomy in periacetabular osteotomy	CURRENT ORTHOPAEDIC PRACTICE			English	Article						complication; dysplasia; obturator artery; osteotomy; pubis		Background Periacetabular osteotomy has been performed to treat developmental dysplasia of the hip, which is characterized by insufficient coverage of the femoral head. However, there is a potential risk of intraoperative obturator artery injury. We aimed to evaluate the distance between the obturator artery and the site of the pubic osteotomy, when done through an anterior approach, during periacetabular osteotomy. Methods We examined 32 cadaver hemipelves. In the cross-section of the medial base of the iliopubic ramus, three anatomical guide points were defined along the lower edge of the pubic cross-section. The vertical and horizontal distances from these guide points to the obturator artery and the diameters of the pubic cross-section were measured. Results The range of mean vertical distances from the three guide points to the obturator artery was 1.8-3.3mm (range of mean horizontal distances, 0.8-2.5 mm). The horizontal distance at the most distal guide point was 6mm. The range of mean maximal vertical diameters of the pubis was 7-29mm. Conclusions The obturator artery lies close to the base of the pubis. The chisel should be inserted into the pubis at a distance of more than 6mm from its base during pubic osteotomy. The anatomical characteristics of the obturator artery around the pubis and the thickness of the pubis should be determined to prevent obturator artery injury.	[Kinoshita, Koichi; Naito, Masatoshi; Shiramizu, Kei; Kamada, Satoshi] Fukuoka Univ, Sch Med, Dept Orthopaed Surg, Fukuoka, Japan		Kinoshita, K (corresponding author), Fukuoka Univ, Sch Med, Dept Orthopaed Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	kinopfukuoka@yahoo.co.jp					Agur AMR, 1991, GRANTS ATLAS ANATOMY, P147; Biedermann R, 2008, INT ORTHOP, V32, P611, DOI 10.1007/s00264-007-0372-3; Brenoe Anne-Sofie, 2006, Ugeskr Laeger, V168, P1453; CARLIOZ H, 1982, REV CHIR ORTHOP, V68, P497; Clemente CD, 2007, ANATOMY REGIONAL ATL, P265; Colton CL, 1972, J BONE JOINT SURG BR, V58, P164; Ezoe M, 2006, CLIN ORTHOP RELAT R, P161, DOI 10.1097/01.blo.0000196475.40151.8b; Ganz R, 1998, CLIN ORTHOP RELAT R, V232, P26; Garras DN, 2007, J BONE JOINT SURG BR, V89B, P721, DOI 10.1302/0301-620X.89B6.18805; HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474; Kambe Taichi, 2003, J Orthop Sci, V8, P323, DOI 10.1007/s10776-002-0630-7; Matta JM, 1999, CLIN ORTHOP RELAT R, P21; Naito M, 2005, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000153281.75265.1d; Nakamura Y, 2006, CLIN ORTHOP RELAT R, V454, P120; NINOMIYA S, 1984, J BONE JOINT SURG AM, V66A, P430, DOI 10.2106/00004623-198466030-00017; Nishibe N, 2008, HIP JOINT, V28, P165; Siebenrock KA, 1999, CLIN ORTHOP RELAT R, P9; SNELL RS, 2004, CLIN ANATOMY MED STU, P329; STEEL HH, 1973, J BONE JOINT SURG AM, VA 55, P343, DOI 10.2106/00004623-197355020-00010; Takeshi T, 2007, HIP JOINT, V33, P67; Wall E J, 2001, J Am Acad Orthop Surg, V9, P150	21	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1940-7041	1941-7551		CURR ORTHOP PRACT	Curr. Orthop. Pract.	MAR-APR	2011	22	2					171	175		10.1097/BCO.0b013e31820afad6			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V2P6S	WOS:000217796900012					2022-02-06	
J	Nakagawa, K; Tang, JF				Nakagawa, Kazuma; Tang, Julin F.			Physiologic response of human brain death and the use of vasopressin for successful organ transplantation	JOURNAL OF CLINICAL ANESTHESIA			English	Article						Brain death; Cushing reflex; Organ donation; Organ harvesting; Organ transplantation; Vasopressin	DONOR; MANAGEMENT; MODEL; RESUSCITATION; DYSFUNCTION	The dynamic physiologic response of human brain death and the impact of vasopressin on successful organ transplantation is reported. A 60-year-old woman was admitted to the intensive care unit after severe traumatic brain injury resulting in brain death. Initial Cushing reflex was followed by a precipitous decrease in systemic blood pressure that was refractory to the alpha-agonist phenylephrine. After intravenous vasopressin was given, hemodynamic stability was restored and maintained until successful organ transplantation. Vasopressin, a catecholamine-sparing vasopressor and antidiuretic agent, may be an effective agent in the treatment of refractory hypotension after brain death prior to organ transplantation. (C) 2011 Elsevier Inc. All rights reserved.	[Tang, Julin F.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, Crit Care Div, San Francisco, CA 94110 USA; [Nakagawa, Kazuma] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Neurol, Neurovasc Serv, San Francisco, CA 94110 USA		Tang, JF (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, Crit Care Div, San Francisco, CA 94110 USA.	tangj@anesthesia.ucsf.edu					BITTNER HB, 1995, J CRIT CARE, V10, P56, DOI 10.1016/0883-9441(95)90017-9; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Chen JM, 1999, CIRCULATION, V100, P244; Ferrera R, 2005, J HEART LUNG TRANSPL, V24, P921, DOI 10.1016/j.healun.2004.05.010; GRAMM HJ, 1992, TRANSPLANTATION, V54, P851, DOI 10.1097/00007890-199211000-00016; Hing AJ, 2007, AM J TRANSPLANT, V7, P809, DOI 10.1111/j.1600-6143.2007.01735.x; Hunt SA, 1996, CRIT CARE MED, V24, P1599; Katz K, 2000, RESUSCITATION, V47, P33, DOI 10.1016/S0300-9572(00)00196-9; MACKERSIE RC, 1991, ANN SURG, V213, P143, DOI 10.1097/00000658-199102000-00009; PENNEFATHER SH, 1995, TRANSPLANTATION, V59, P58, DOI 10.1097/00007890-199501150-00011; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Rosendale JD, 2003, TRANSPLANTATION, V75, P1336, DOI 10.1097/01.TP.0000062839.58826.6D; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; Seguin C, 2001, CIRCULATION, V104, pI197; Shah VR, 2008, TRANSPL P, V40, P1087, DOI 10.1016/j.transproceed.2008.03.029; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8; YOSHIOKA T, 1986, NEUROSURGERY, V18, P565, DOI 10.1227/00006123-198605000-00009	20	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	MAR	2011	23	2					145	148		10.1016/j.jclinane.2009.12.015			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	739MX	WOS:000288723100013	21377081				2022-02-06	
J	Schmehl, I; Johl, U; Sparenberg, P; Kinze, S; Dahne, F; Rogge, W				Schmehl, I.; Johl, U.; Sparenberg, P.; Kinze, S.; Daehne, F.; Rogge, W.			Brain check following traumatic brain injury. Diagnostic algorithm to evaluate secondary complications	TRAUMA UND BERUFSKRANKHEIT			German	Article						Traumatic brain injury (TBI); Interdisciplinary care; Brain check; Rehabilitation; Workers' compensation		Early diagnosis of neurological, neuropsychological, and psychiatric deficits and disorders after traumatic brain injury (TBI) represents the most important task for all disciplines involved in the post-acute phase following mild to severe TBI. This is often not, or insufficiently, the case in mild TBI. The interdisciplinary "Brain Check" module is a novel diagnostic algorithm to be used in the inpatient setting in patients insured under the German statutory accident insurance. It comprises a detailed clinical and neurological examination; a cerebral MRI scan (including T2* and FLAIR sequences as well as MRI angiography); neuropsychological testing; an assessment by a psycho-traumatologist; and an ergotherapeutic evaluation. Between 2008 and 2009, we admitted and screened 48 patients with TBI using the Brain Check cascade. Preliminary experience suggests that the Brain Check algorithm may identify patients at high risk for early chronic neuropsychiatric conditions after TBI. This needs to be validated on a larger scale, and by a properly designed clinical trial.	[Schmehl, I.; Johl, U.; Sparenberg, P.; Kinze, S.; Daehne, F.; Rogge, W.] Unfallkrankenhaus Berlin, Klin Neurol, Stroke Unit & Fruhrehabil, Warener Str 7, D-12683 Berlin, Germany		Schmehl, I (corresponding author), Unfallkrankenhaus Berlin, Klin Neurol, Stroke Unit & Fruhrehabil, Warener Str 7, D-12683 Berlin, Germany.	Ingo.schmehl@ukb.de					Deutsche Gesellschaft fur Neurologie, 2008, LEITL; DGUV, 2000, LAND NORDW NORD PROJ; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Rickels E, 2006, SCHADEL HIRN VERLETZ, P202; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	14	4	4	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1436-6274			TRAUMA BERUFSKRANKH	Trauma Berufskrankh.	MAR	2011	13	1					12	17		10.1007/s10039-010-1703-y			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	VE0NB	WOS:000438288800003					2022-02-06	
J	Siu, G; Marino, M; Desai, A; Nissley, F				Siu, Gilbert; Marino, Michael; Desai, Anjuli; Nissley, Frederick			Sympathetic Storming in a Patient with Intracranial Basal Ganglia Hemorrhage	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Sympathetic Storming; Intracranial Hemorrhage; Noxious Stimuli; Foley Catheter	TRAUMATIC BRAIN-INJURY; PAROXYSMAL AUTONOMIC INSTABILITY; DYSAUTONOMIA; MANAGEMENT; HYPERACTIVITY; DYSFUNCTION	Siu G, Marino M, Desai A, Nissley F: Sympathetic storming in a patient with intracranial basal ganglia hemorrhage. Am J Phys Med Rehabil 2011; 90: 243-246. Neurologic deficits and medical complications are common sequelae after intracranial hemorrhage. Among the medical complications, sympathetic storming is relatively rare. We describe a case of a patient with an acute right basal ganglia hemorrhage. During the patient's hospital course, he developed tachypnea, diaphoresis, hypertension, hyperthermia, and tachycardia for three consecutive days. A complete laboratory work-up and imaging studies were unremarkable for infectious etiology, new intracranial hemorrhage, and deep vein thrombosis. The patient was diagnosed with sympathetic storming, a relatively uncommon cause of these symptoms. The storming was secondary to a kinked Foley catheter, and subsequent placement of a new catheter resulted in the resolution of his symptoms.	[Siu, Gilbert; Marino, Michael; Desai, Anjuli] Temple Univ Hosp & Med Sch, Dept Phys Med & Rehabil MossRehab, Philadelphia, PA 19140 USA; [Nissley, Frederick] Temple Univ Hosp & Med Sch, Dept Phys Med & Rehabil, Philadelphia, PA 19140 USA		Siu, G (corresponding author), Temple Univ Hosp & Med Sch, Dept Phys Med & Rehabil MossRehab, 3401 N Broad St, Philadelphia, PA 19140 USA.						Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Graham LN, 2002, CIRCULATION, V106, P793, DOI 10.1161/01.CIR.0000025610.14665.21; Leenen F H, 2001, Curr Hypertens Rep, V3, P314, DOI 10.1007/s11906-001-0094-7; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Srinivasan S, 2007, CLIN AUTON RES, V17, P378, DOI 10.1007/s10286-007-0428-x; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738	18	4	6	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2011	90	3					243	246		10.1097/PHM.0b013e31820b1336			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	716MO	WOS:000286973500008	21297401				2022-02-06	
J	Zou, XL; Li, YQ; Wang, TH; Zhou, CY; Zeng, HY				Zou, Xiaoli; Li, Yuanqian; Wang, Tinghua; Zhou, Chunyan; Zeng, Hongyan			Determination of Nerve Growth Factor in Rat Spinal Cord by Capillary Electrophoresis-Based Immunoassay with a Laser Induced Fluorescence Detector	CHROMATOGRAPHIA			English	Article						Capillary electrophoresis-based immunoassay; Laser-induced fluorescence; Nerve growth factor; Spinal cord of rat	TRAUMATIC BRAIN-INJURY; EXPRESSION; CHILDREN	In order to study the relationship between spinal cord injury and the change of nerve growth factor (NGF), an analytical method for NGF by capillary electrophoresis-based immunoassay (CEIA) with laser-induced fluorescence (LIF) was developed. Having been dissolved in phosphate buffer solution and concentrated with vacuum freeze-drying, NGF in spinal cord of rat was allowed to react with NGF monoclonal antibody labeled with fluorescence isothiocyanate (FITC). Then the immuno-complex, FITC-labeled anti-NGF and FITC were separated and determined by LIF-CEIA using Kiton red as the internal standard. The linear range of the method was 2-30 ng mL(-1) and the limit of detection was 0.35 ng mL(-1). The relative standard derivations for relative migration time and relative fluorescence intensity ratio were 7.98% and 6.52%, respectively. The contents of NGF from spinal cord of rat were determined by both the proposed method and Western blotting. The results with the two methods agreed well. The spiked recoveries of the samples were 88.5-116.3%. The proposed method was rapid, precise and inexpensive.	[Zou, Xiaoli; Li, Yuanqian; Wang, Tinghua; Zhou, Chunyan; Zeng, Hongyan] Sichuan Univ, W China Sch Publ Hlth, Dept Sanit Technol, Chengdu 610041, Sichuan, Peoples R China		Li, YQ (corresponding author), Sichuan Univ, W China Sch Publ Hlth, Dept Sanit Technol, 16 Renming S Rd, Chengdu 610041, Sichuan, Peoples R China.	Liyuanqian@hotmail.com			National Natural Science Foundation Of ChinaNational Natural Science Foundation of China (NSFC) [30571566]; Youth Foundation Of Sichuan UniversitySichuan University [0040405505016]	This study was supported financially by National Natural Science Foundation Of China (30571566) and The Youth Foundation Of Sichuan University (0040405505016).	Batchelor PE, 2008, BRAIN RES, V1209, P49, DOI 10.1016/j.brainres.2008.02.098; Chen HX, 2008, ELECTROPHORESIS, V29, P3406, DOI 10.1002/elps.200700660; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chung EKY, 2007, NEUROSCIENCE, V149, P685, DOI 10.1016/j.neuroscience.2007.07.055; Huang XQ, 2008, CHIN J SICHUAN U MED, V39, P757; Jiang HM, 2008, CHIN J BIOTECHNOL, V24, P509; Kalish H, 2010, J CHROMATOGR B, V878, P194, DOI 10.1016/j.jchromb.2009.10.022; Li YQ, CHIN J SICHUAN U MED, V35, P103; Moser AC, 2008, ELECTROPHORESIS, V29, P3279, DOI 10.1002/elps.200700871; Qi H, 2007, MOL VIS, V13, P1934; Schmalzing D, 2000, ELECTROPHORESIS, V21, P3919, DOI 10.1002/1522-2683(200012)21:18<3919::AID-ELPS3919>3.0.CO;2-F; SCHULTZ NM, 1993, ANAL CHEM, V65, P3161, DOI 10.1021/ac00069a035; Shinichi M, 2001, J CHROMATOGR B, V759, P337, DOI [DOI 10.1016/S0378-4347(01)00228-6, 10.1016/S0378-4347(01)00228-6]; Sowell J, 2001, J CHROMATOGR B, V752, P1, DOI 10.1016/S0378-4347(00)00508-9; Tarsa L, 2009, NEUROPEPTIDES, V43, P47, DOI 10.1016/j.npep.2008.09.009; Yang WC, 2005, ANAL CHEM, V77, P4489, DOI 10.1021/ac050231u; Yeung WSB, 2003, J CHROMATOGR B, V797, P217, DOI 10.1016/S1570-0232(03)00489-6; Zhang C, 2008, J AGR FOOD CHEM, V56, P8832, DOI 10.1021/jf801645m	19	4	4	1	16	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	FEB	2011	73	3-4					307	312		10.1007/s10337-010-1844-y			6	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	719KQ	WOS:000287204000013					2022-02-06	
S	Adwanikar, H; Noble-Haeusslein, L; Levin, HS		Raber, J		Adwanikar, Hita; Noble-Haeusslein, Linda; Levin, Harvey S.			Traumatic Brain Injury in Animal Models and Humans	ANIMAL MODELS OF BEHAVIORAL ANALYSIS	Neuromethods		English	Article; Book Chapter							CLOSED-HEAD INJURY; MORRIS WATER MAZE; PORTLAND ADAPTABILITY INVENTORY; FUNCTIONAL INDEPENDENCE MEASURE; CONTROLLED CORTICAL IMPACT; RATS POSSIBLE ROLE; COGNITIVE DEFICITS; GENDER-DIFFERENCES; MEMORY IMPAIRMENT; WORKING-MEMORY	Clinical/behavioral measures have traditionally been used to assess neurologic Outcomes after human traumatic brain injury (TBI) as well as in experimental models of TBI. In this chapter, we address the metrics to assess injury/recovery in human TBI and consider the determinants of outcome. Further, we describe the commonly used experimental rodent models of TBI and the behavioral assays employed in these models for three major categories of neurologic assessments: sensorimotor (aggregate and individual tests), cognitive (memory and avoidance paradigms), and affective (novelty, social interaction, and anxiety) behaviors. Finally, we discuss the issues underlying use of behavioral assays in successful translation of candidate therapeutics from experimental models to human TBI.	[Adwanikar, Hita; Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Levin, Harvey S.] Univ Texas Houston Med Sch, Houston, TX USA; [Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA		Adwanikar, H (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.						Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; ADER D, 2007, DEV PATIENT REPORTED, P45; Ali R, 2002, ADDICTION, V97, P1183; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bimonte HA, 2000, PHYSIOL BEHAV, V70, P311, DOI 10.1016/S0031-9384(00)00259-6; Bimonte HA, 2000, PHYSIOL BEHAV, V68, P495, DOI 10.1016/S0031-9384(99)00201-2; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; EPSTEIN NB, 2000, HDB PSYCHIAT MEASURE; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAFMAN J, 1986, INT J NEUROSCI, V29, P125, DOI 10.3109/00207458608985643; Grafman J., 2007, VIETNAM HEAD INJURY; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1995, J NEUROTRAUM, V12, P307, DOI 10.1089/neu.1995.12.307; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAMM TM, 1990, J NEUROPHYSIOL, V63, P395, DOI 10.1152/jn.1990.63.3.395; Hanten G, 2003, BRAIN INJURY, V17, P871, DOI 10.1080/02699050210147220; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hides L, 2009, ADDICT BEHAV, V34, P821, DOI 10.1016/j.addbeh.2009.03.001; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; HUMENIK R, 2006, VALIDATION ALCOHOL S; *IOM, 2009, GULFW HLTH, V7; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; Kacew S, 1998, BIOMED ENVIRON SCI, V11, P203; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Miller DM, 2005, QUAL LIFE RES, V14, P2031; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller JW, 2004, AM J PREV MED, V27, P197, DOI 10.1016/j.amepre.2004.05.004; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Moussas George, 2009, Ann Gen Psychiatry, V8, P11, DOI 10.1186/1744-859X-8-11; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Perez Lori, 2007, J Neurosci Nurs, V39, P342; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; PRINS ML, 2009, NEUROREHABILITATION, V12, P255; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD G, 2009, GULFWAR HLTH, V7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TULSKY DS, 2009, NEW INITIATIVES DEV; TULSKY DS, 2009, DEV TAILORED OUTCOME; van den Burg W, 1999, ARCH CLIN NEUROPSYCH, V14, P545, DOI 10.1016/S0887-6177(98)00042-0; VANAGT HME, 1994, SOC SCI MED, V39, P1537, DOI 10.1016/0277-9536(94)90005-1; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F. W., 1993, 9 ANN CONV INT SOC T; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; WILDE EA, ARCH PHYS MED REHABI; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yamaguchi T, 1996, NEUROPHARMACOLOGY, V35, P329, DOI 10.1016/0028-3908(95)00171-9; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; [No title captured]	135	4	4	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-60761-882-9	NEUROMETHODS	Neuromethods		2011	50						237	265		10.1007/978-1-60761-883-6_10	10.1007/978-1-60761-883-6		29	Behavioral Sciences; Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Cell Biology; Neurosciences & Neurology	BRN68	WOS:000283191100010					2022-02-06	
J	Amirabdollahian, F; Johnson, G				Amirabdollahian, Farshid; Johnson, Garth			Analysis of the results from use of haptic peg-in-hole task for assessment in neurorehabilitation	APPLIED BIONICS AND BIOMECHANICS			English	Article						Haptics; peg-in-hole; i-match; robotic for assessment; outcome measures	BRAIN-INJURY; REHABILITATION; MOVEMENT; SYSTEM	Haptic and robotic technologies have the potential to provide assessment during interaction with humans. This manuscript presents our earlier research during the I-Match project where a haptic peg-in-hole test was used in order to compare between healthy volunteers' performance and those with neurological impairment. Subjects all performed a series of haptic virtual peg-in-hole tasks with varying degrees of difficulty determined by the hole diameter. Haptic instrument, Phantom Desktop 1.5, allowed for recording of biomechanical data which is used to present some variant features between the two subject groups. This paper analyses the placement time, maximum peg transfer velocity, collision forces recorded during peg placement and also insertion accuracy. The first three parameters showed statistically significant differences between the two groups while the last, insertion accuracy, showed insignificant differences (p = 0.152). This is thought to be due to the large clearance value between the smallest hole diameter and the peg. To identify differences between the haptic peg-in-hole and the established NHPT, we are currently in process of conducting a further experiment with a haptic replica of the NHPT test, in order to investigate effects resulting from addition of haptic force feedback compared to the original NHPT test, as well as allowing to explore influences caused by the 1 mm clearance value as originally proposed by Wade. Furthermore, in order to investigate if this method can identify differences between subjects with different neurological conditions, a larger group of subjects with neurological conditions such as stroke, multiple sclerosis, and traumatic brain injury is required to explore potency of this approach for identifying differences between these different conditions.	[Amirabdollahian, Farshid] Univ Hertfordshire, Adapt Syst Res Grp, Sch Comp Sci, Hatfield AL10 9AB, Herts, England; [Johnson, Garth] Univ Newcastle, Ctr Rehabil & Engn Studies, Sch Mech & Syst Engn, Newcastle Upon Tyne, Tyne & Wear, England		Amirabdollahian, F (corresponding author), Univ Hertfordshire, Adapt Syst Res Grp, Sch Comp Sci, Coll Lane, Hatfield AL10 9AB, Herts, England.	f.amirabdollahian2@herts.ac.uk		Amirabdolahian, Farshid/0000-0001-7007-2227			Bardorfer A, 2001, IEEE-ASME T MECH, V6, P253, DOI 10.1109/3516.951363; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; Krebs HI, 2000, J REHABIL RES DEV, V37, P639; Krebs HI, 1999, P NATL ACAD SCI USA, V96, P4645, DOI 10.1073/pnas.96.8.4645; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MacKenzie I.S., 1992, P CHI 92 C HUM FACT, P219; Murata A, 2001, HUM MOVEMENT SCI, V20, P791, DOI 10.1016/S0167-9457(01)00058-6; Reinkensmeyer DJ, 2000, J REHABIL RES DEV, V37, P653; Salazar-Torres JD, 2004, DISABIL REHABIL, V26, P756, DOI 10.1080/09638280410001704359; Scott Mackenzie I.S., 1995, READINGS HUMAN COMPU, V2nd, P483; Spyers-Ashby JM, 1999, MED ENG PHYS, V21, P713, DOI 10.1016/S1350-4533(00)00004-7; WADE DT, 1992, MEASUREMENT NEUROLOG, P408	15	4	4	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1176-2322			APPL BIONICS BIOMECH	Appl. Bionics Biomech.		2011	8	1					1	11		10.3233/ABB-2011-0017			11	Engineering, Biomedical; Robotics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Robotics	951XC	WOS:000304752400001		Green Submitted, gold			2022-02-06	
B	Crandall, M	Zollman, FS			Crandall, Marie	Zollman, FS		Epidemiology of Traumatic Brain Injury	MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT			English	Article; Book Chapter							HEAD TRAUMA; PATHOPHYSIOLOGY; SYMPTOMS		Northwestern Univ, Dept Surg, Chicago, IL 60611 USA		Crandall, M (corresponding author), Northwestern Univ, Dept Surg, Chicago, IL 60611 USA.		Crandall, Marie/L-9066-2019; Maas, Andrew IR/C-5584-2013	Crandall, Marie/0000-0002-6536-3123; Maas, Andrew IR/0000-0003-1612-1264			Bastos M L, 1976, J Forensic Sci, V21, P176; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; *CDC, 2006, INJ FACTB; *CDC, 2010, TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; FAUL M, 2010, TRAUM BRAIN US EM DE; Finkelstein E., 2006, INCIDENCE EC BURDEN; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Plurad D, 2006, J AM COLL SURGEONS, V202, P919, DOI 10.1016/j.jamcollsurg.2006.02.024; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; *WHO, 2010, INJURY; [No title captured]	28	4	4	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-01-7				2011							25	29					5	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BUN80	WOS:000289864500004					2022-02-06	
J	Czyz, CN; Harder, JD; Cahill, KV; Kuennen, RA; Foster, JA				Czyz, Craig N.; Harder, Jonathan D.; Cahill, Kenneth V.; Kuennen, Rebecca A.; Foster, Jill A.			Isolated Bilateral Abducens Nerve Palsy without Radiographic Etiology and Unique Mechanism of Injury	ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY			English	Article						Abducens palsy; Pathophysiologic injury mechanism; Isolated bilateral; Closed head injury		Isolated bilateral abducens palsy is a rare event, especially in the setting of closed head injury. Cases that lack radiographic or pathologic findings to explain the etiology of the palsy are limited to case reports. Injury mechanisms have been postulated, but a consensus does not exist. The authors describe a case of traumatic isolated bilateral abducens palsy lacking radiographic and pathologic findings. A previously unreported potential pathophysiologic injury mechanism is theorized based upon anatomical structure and mode of injury.	[Czyz, Craig N.; Harder, Jonathan D.; Foster, Jill A.] Ohio Univ, Doctors Hosp, Sect Oculofacial Plast & Reconstruct Surg, Div Ophthalmol, Columbus, OH USA; [Czyz, Craig N.; Cahill, Kenneth V.; Foster, Jill A.] Grant Med Ctr, Dept Ophthalmol & Oral Maxillofacial Surg, Columbus, OH USA; [Cahill, Kenneth V.; Kuennen, Rebecca A.; Foster, Jill A.] Ohio State Univ, Dept Ophthalmol, Columbus, OH USA		Czyz, CN (corresponding author), 1100 Oregon Ave, Columbus, OH 43201 USA.	dsp4000@aol.com		Czyz, Craig/0000-0001-6357-8019			Advani RM, 2003, ANN EMERG MED, V41, P27, DOI 10.1067/mem.2003.46; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Dobbs Michael, 2003, J Ky Med Assoc, V101, P507; Marconi F, 1994, J Neurosurg Sci, V38, P177; Sam B, 2004, FORENSIC SCI INT, V140, P25, DOI 10.1016/j.forsciint.2003.11.020	5	4	4	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0167-6830	1744-5108		ORBIT	Orbit		2011	30	5					239	241		10.3109/01676830.2011.579683			3	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	VB4XH	WOS:000415514300009	21957954				2022-02-06	
B	Iverson, GL		Schoenberg, MR; Scott, JG		Iverson, Grant L.			Sport-Related Concussion	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; VOLUNTARY EXERCISE; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL ASSESSMENT; INTERNATIONAL-CONFERENCE	Concussions in sports typically arise from a hard blow to the head. In soccer, for example, head-to-head impacts carry a high risk for concussion (Withnall et al., Br J Sports Med 39(Suppl 1):i49-i57, 2005). In the National Football League (NFL), an injury reconstruction study revealed that a striking player often lines up his head, neck, and torso to deliver maximum force to the other player in helmet-to-helmet impacts that result in concussive injuries to the player being struck (Viano and Pellman, Neurosurgery 56(2):266-280, 2005). Fortunately, most injuries in sports fall on the milder end of the spectrum of mild traumatic brain injuries (MTBI). Occasionally, however, athletes experience complicated mild, moderate, or severe traumatic brain injuries. In equestrian and auto racing, for example, accidents can result in much more serious injuries to the brain.	[Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC V5Z 1M9, Canada		Iverson, GL (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	giverson@interchange.ubc.ca					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown CN, 2007, J ATHL TRAINING, V42, P515; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, pXI, DOI 10.1016/S0278-5919(05)70055-7; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GAETZ M, 2006, BRAIN INJ AM C N AM; GAETZ M, 2005, BRIT COLUMBIA CONCUS; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; IVERSON GL, 2006, BRAIN INJ AM C N AM; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kaushik T., 2006, SPORTS NEUROPSYCHOLO, P216; Kelly JP, 1997, NEUROLOGY, V48, P581; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 1999, SPORTS RELATED CONCU; Lovell M. R., 2004, TRAUMATIC BRAIN INJU; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2004, STUD NEUROPSYCHOL DE, P221; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; LOVELL MR, 1996, NEW DEV SPORTS REL C; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pietropaolo S, 2008, BEHAV BRAIN RES, V192, P42, DOI 10.1016/j.bbr.2008.03.014; *PSYCH CORP, 2002, UPD WAIS III WMS III; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; THORNTON AE, 2007, J CLIN EXPT NEUROPSY, V27, P1; Tsushima William T, 2008, Hawaii Med J, V67, P93; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	105	4	4	0	12	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							721	744		10.1007/978-0-387-76978-3_23	10.1007/978-0-387-76978-3		24	Clinical Neurology; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800023					2022-02-06	
J	Khan, N; Jehan, B; Khan, A; Khan, H				Khan, Nowshad; Jehan, Bakht; Khan, Adnan; Khan, Habibullah			AUDIT OF 100 CASES OF EPILEPSY IN A TERTIARY CARE HOSPITAL	GOMAL JOURNAL OF MEDICAL SCIENCES			English	Article						Epilepsy; Tonic-clonic seizures; Aetiology		Background: Epilepsy is not an uncommon disease. Around 50 million people worldwide have epilepsy. The objective of this study was to evaluate the frequency and causes of epilepsy in our set up. Methodology: This descriptive study was conducted at epilepsy clinic Postgraduate Medical Institute, Lady Reading Hospital Peshawar from 1st January 2008 to 30th June 2008. Patients above the age of five years were included in the study. Those with post traumatic seizures were excluded. Detailed history, thorough physical examination and relevant investigations were done in each patient. Results: One hundred patients of epilepsy were studied. Sixty-six (66%) were males and 34(34%) were females. Forty seven percent of the patients were in the age group of 11-20 years. Seventy (70%) of the patients were suffering from generalized tonic-clonic seizures, 11(11%) from partial seizures secondarily generalized, 7(7%) from absence seizures, 6(6%) from complex partial, 4(4%) simple partial seizures and 2(2%) unclassified and non-epileptic seizures. Positive family history of epilepsy was found in 24(24%) and febrile fits in 17(17%) patients. Fourteen (14%) patients had fits after having injury at some time of their life. Electroencephalographic changes were positive in 55(55%) and CT brain findings were helpful in 24(24%) patients. Conclusions: Epilepsy is a common medical problem in Pakistan. Generalized tonic clonic seizures was the most common followed by partial seizure secondarily generalized and complex partial seizure. Majority of the cases were idiopathic.	Lady Reading Hosp, Dept Neurol, Peshawar, Pakistan; [Khan, Nowshad] Gomal Med Coll, Dept Med, Dera Ismail Khan, Pakistan		Khan, N (corresponding author), Gomal Med Coll, Dept Med, Dera Ismail Khan, Pakistan.	knowshad70@yahoo.com					Afzal M, 1999, JCPSP-J COLL PHYSICI, V9, P132; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; AZIZ H, 1994, EPILEPSIA, V35, P950, DOI 10.1111/j.1528-1157.1994.tb02539.x; Aziz H, 1997, EPILEPSIA, V38, P1069, DOI 10.1111/j.1528-1157.1997.tb01195.x; Bell G S, 2002, Seizure, V11 Suppl A, P306; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen DK, 2005, NEUROLOGY, V65, P668, DOI 10.1212/01.wnl.0000178391.96957.d0; Cleary P, 2004, LANCET, V363, P1184, DOI 10.1016/S0140-6736(04)15946-1; Fisher RS, 2005, EPILEPSIA, V46, P1426, DOI 10.1111/j.1528-1167.2005.31405.x; Harding G, 2005, EPILEPSIA, V46, P1423, DOI 10.1111/j.1528-1167.2005.31305.x; Khan M. N. S., 2002, JCPSP, Journal of the College of Physicians and Surgeons Pakistan, V12, P728; Khatri I A, 2003, J Pak Med Assoc, V53, P594; Rose SW, 1996, EPILEPSIA, V14, P152; Saeed K, 2000, SOC PSYCH PSYCH EPID, V35, P480, DOI 10.1007/s001270050267; Shukla G, 2004, EPILEPSY BEHAV, V5, P517, DOI 10.1016/j.yebeh.2004.03.004; Siddiqui Tahir Saeed, 2002, J Ayub Med Coll Abbottabad, V14, P26; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; VOSSLER DG, 1995, J EPILEPSY, V8, P1, DOI 10.1016/0896-6974(94)00014-Q	18	4	4	0	0	GOMAL MEDICAL COLL	DERA ISMAIL KHAN	NORTH CIRCULAR RD, DERA ISMAIL KHAN, 00000, PAKISTAN	1819-7973	1997-2067		GOMAL J MED SCI	Gomal J. Med. Sci.	JAN-JUN	2011	9	1					42	45					4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V6E5K	WOS:000420211500011					2022-02-06	
J	Kim, JH; Lee, JY; Suk, K				Kim, Jong-Heon; Lee, Jea-Young; Suk, Kyoungho			Therapeutic Hypothermia in Brain Injuries and Related Diseases	RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY			English	Article						Hypothermia; brain; inflammation; neuroinflammation; cannabinoid; central nervous system	FOCAL CEREBRAL-ISCHEMIA; HOSPITAL CARDIAC-ARREST; TERM MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; DECOMPRESSIVE CRANIECTOMY; COMATOSE SURVIVORS; POSTTRAUMATIC HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; INFLAMMATORY RESPONSE; BARRIER DISRUPTION	Mild or moderate hypothermia is a useful therapeutic method for improving the outcome for patients who have suffered brain injuries including traumatic brain injury and strokes, as well as secondary damages such as neuroinflammation and edema. The feasibility and safety of therapeutic hypothermia have been evaluated in experimental settings and clinical trials. Because the efficacy of therapeutic hypothermia, however, is dependent on the cooling method, application time, duration, and strategies, a continuous effort for obtaining optimal standard protocols of controlling temperature and the documentation of hypothermic devices and drugs are required. Here, we discuss the most recent hypothermia applications in brain injury and related diseases, and review the latest patents in hypothermic devices and cannabinoid-based hypothermia-inducing drugs. Ultimately, we conclude that a localized hypothermia may overcome the limitations, risks, and side effects of systemic hypothermia, and the combination of local hypothermia and drug treatment may improve clinical benefits.	[Kim, Jong-Heon; Lee, Jea-Young; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Daegu, South Korea		Suk, K (corresponding author), Kyungpook Natl Univ, Dept Pharmacol, Sch Med, 101 Dong In, Daegu 700422, South Korea.	ksuk@knu.ac.kr			Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100870]	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100870).	Abbott Inc, 2009, [No title captured], Patent No. [7560481B2, 7560481]; ABBOTT LAB, 2009, Patent No. 2009009550; ABBOTT LAB, 2009, Patent No. 2009067613; ABBOTT LAB, 2008, Patent No. 2008130953; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alanine A, 2009, Patent No. [US7576088, 7576088]; Badjatia N, 2004, NEUROCRIT CARE, V1, P201, DOI 10.1385/NCC:1:2:201; Balding D. P, 2003, Patent No. [US6572640, 6572640]; Barber PA, 2004, STROKE, V35, P1720, DOI 10.1161/01.STR.0000129653.22241.d7; Batista LM, 2010, RESUSCITATION, V81, P398, DOI 10.1016/j.resuscitation.2009.12.016; Baumann E, 2009, BRAIN RES, V1269, P185, DOI 10.1016/j.brainres.2009.02.062; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Beckett P. R, 2009, Patent No. [US20090149450, 20090149450]; Bellamy R, 1996, CRIT CARE MED, V24, pS24; Berke L. D, 1992, Patent No. [US5165400, 5165400]; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Berry A., 2010, PCT Int. Appl, Patent No. [W02010077836, 2010077836]; Bian JY, 2006, NEUROSURG REV, V29, P168, DOI 10.1007/s10143-005-0010-8; Bigio M. R. D, 2009, Patent No. [US20090048582, 20090048582]; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Boller M, 2010, RESUSCITATION, V81, P1025, DOI 10.1016/j.resuscitation.2010.04.005; Bonfils PK, 2006, NEUROCHEM INT, V49, P508, DOI 10.1016/j.neuint.2006.03.015; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Braida D, 2000, NEUROSCI LETT, V296, P69, DOI 10.1016/S0304-3940(00)01634-7; Busch HJ, 2010, RESUSCITATION, V81, P943, DOI 10.1016/j.resuscitation.2010.04.027; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cao JP, 2008, BIOSCI TRENDS, V2, P241; Carroll W. A, 2010, Patent No. [US20100063022, 20100063022]; Carroll W. A, 2009, Patent No. [US20090105306, 20090105306]; Carroll W. A, 2010, Patent No. [US20100069349, 20100069349]; Carroll W. A, 2008, Patent No. [US20080287510, 20080287510]; Carroll W. A, 2009, Patent No. [US20090018114, 20090018114]; Carroll W. A, 2009, Patent No. [WO2009114566, 2009114566]; Carroll W.A., 2010, Patent No. [US20100069348A1, 20100069348]; Carroll W. A, 2010, Patent No. [WO2010054024, 2010054024]; Carroll W. A, 2010, Patent No. [US20100041720, 20100041720]; Carroll W. A, 2009, Patent No. [US20090023789, 20090023789]; Carroll W. A, 2010, Patent No. [WO2010019547, 2010019547]; Carroll W.A., 2009, PCT Int. Pat., Patent No. [2009048936, WO 2009048936]; Carroll W.A., 2010, Patent No. [WO 2010033543, 2010033543]; Carroll W. A., 2010, Patent No. [W02010028338A2, 2010028338]; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chaudhari S. S., 2009, PCT Int. Appl., Patent No. [WO 2009/095752 Al, 2009095752]; Clifton G. L, 2002, Patent No. [US6375673, 6375673]; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Dart M. J, 2010, Patent No. [US7745440, 7745440]; Dart M. J, 2009, Patent No. [MX2009010363, 2009010363]; Demong D. E., 2009, [No title captured], Patent No. [WO 2009/005645 Al, 2009005645]; den Hertog Heleen, 2007, Expert Rev Neurother, V7, P155, DOI 10.1586/14737175.7.2.155; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Diestel A, 2010, EUR J NEUROSCI, V31, P779, DOI 10.1111/j.1460-9568.2010.07128.x; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Doerfler A, 2001, STROKE, V32, P2675, DOI 10.1161/hs1101.098369; Dolle R. E, 2010, Patent No. [US7671052, 7671052]; Els T, 2006, CEREBROVASC DIS, V21, P79, DOI 10.1159/000090007; Evans S. M, 2003, Patent No. [US20030060761, 20030060761]; Federico A, 2010, J PERIANESTH NURS, V25, P141, DOI 10.1016/j.jopan.2010.03.011; Flick R. E, 2005, Patent No. [US6871365, 6871365]; Florjancic A. S, 2008, Patent No. [WO2008121558, 2008121558]; Fox JL, 2010, CAN J EMERG MED, V12, P355; Froehler MT, 2010, EXPERT REV CARDIOVAS, V8, P593, DOI [10.1586/erc.09.129, 10.1586/ERC.09.129]; Frost J. M, 2009, Patent No. [US20090149501, 20090149501]; Frost JM, 2010, US Patent, Patent No. [US 7750039 B2, 7750039]; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Gilbert E. J, 2009, Patent No. [WO2009005646, 2009005646]; Gilbert E. J, 2009, Patent No. [WO2009005671, 2009005671]; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonzalez B, 2009, J PHARMACOL EXP THER, V328, P822, DOI 10.1124/jpet.108.145425; Gordan ML, 2010, PERFUSION-UK, V25, P349, DOI 10.1177/0267659110377946; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; Hato N, 2010, AURIS NASUS LARYNX, V37, P626, DOI 10.1016/j.anl.2010.01.008; Heard KJ, 2010, RESUSCITATION, V81, P9, DOI 10.1016/j.resuscitation.2009.09.015; Hinz J, 2007, J NEUROSURG ANESTH, V19, P130, DOI 10.1097/ANA.0b013e318032a208; Hoque N, 2010, PEDIATRICS, V126, pE124, DOI 10.1542/peds.2009-2995; Hua Y, 2010, J ANESTH, V24, P726, DOI 10.1007/s00540-010-0999-x; Huang FP, 1998, CHINESE MED J-PEKING, V111, P368; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Kawanishi Masahiko, 2008, J Stroke Cerebrovasc Dis, V17, P187, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.003; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Koda Y, 2010, BRAIN RES, V1311, P197, DOI 10.1016/j.brainres.2009.11.028; Kolasa T, 2009, Patent No. [US20090247500, 20090247500]; Kolasa T, 2008, Patent No. [US20080242654, 20080242654]; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Kushnir I, 2003, Patent No. [US6508831, 6508831]; Laish-Farkash A, 2007, ISR MED ASSOC J, V9, P252; Lazzari P, 2010, Patent No. [7,659,407, 7659407, US7659407]; Lazzari P, 2009, Patent No. [US20100105896A1, 20100105896]; Lazzaro MA, 2008, EXPERT OPIN INV DRUG, V17, P1161, DOI 10.1517/13543784.17.8.1161 ; Lin Shu-Han, 2006, Acta Neurol Taiwan, V15, P177; Linares G, 2009, CRIT CARE MED, V37, pS243, DOI 10.1097/CCM.0b013e3181aa5de1; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Liu LP, 2009, NEUROL RES, V31, P331, DOI 10.1179/174313209X444099; Liu YQ, 2004, STROKE, V35, P1460, DOI 10.1161/01.STR.0000128029.50221.fa; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Mack WJ, 2003, STROKE, V34, P1994, DOI 10.1161/01.STR.0000079813.31539.6D; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mattos JP, 2010, ARQ NEURO-PSIQUIAT, V68, P339, DOI 10.1590/S0004-282X2010000300002; Mayweg A, 2009, Patent No. [US7579369, 7579369]; Mayweg A, 2009, Patent No. [EP1749002, 1749002]; Mayweg A, 2009, Patent No. [EP1583742, 1583742]; Mayweg A, 2009, Patent No. [US7563910, 7563910]; Merenda A, 2010, CURR OPIN NEUROL, V23, P53, DOI 10.1097/WCO.0b013e328334bdf4; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Meyer M. D, 2008, US Patent, Patent No. [2008/0255123A1, 20080255123]; Milhaud D, 2005, J NEUROSURG ANESTH, V17, P49; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Nelson DW., 2010, US Patent, Patent No. [20100093814, US 2010/0093814 A1]; Noda W, 2003, Patent No. [US6530946, 6530946]; Okuyama M. M, 2009, Patent No. [EP1745011, 1745011]; Olsson R., 2009, Preparation of dibenzothiazepinecarboxamides and their analogs as cannabinoid CBI modulators, Patent No. [W02009075691A1, 2009075691]; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pfefferkorn T, 2009, STROKE, V40, P3045, DOI 10.1161/STROKEAHA.109.550871; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Prandini MN, 2005, ARQ NEURO-PSIQUIAT, V63, P779, DOI 10.1590/S0004-282X2005000500012; Prunet Bertrand, 2009, Cases J, V2, P8857, DOI 10.1186/1757-1626-0002-0000008857; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Rawls SM, 2004, PHARMACOL BIOCHEM BE, V78, P83, DOI 10.1016/j.pbb.2004.02.006; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Riether D, 2009, Patent No. [US20090275611, 20090275611]; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Slikker W, 2001, FREE RADICAL BIO MED, V31, P405, DOI 10.1016/S0891-5849(01)00593-7; Sonna LA, 2010, CELL STRESS CHAPERON, V15, P687, DOI 10.1007/s12192-010-0181-2; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Su J, 2003, INT J DEV NEUROSCI, V21, P353, DOI 10.1016/S0736-5748(03)00070-4; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Swiat M, 2010, NEUROL NEUROCHIR POL, V44, P131; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Torrens Jover A, 2008, Patent No. [US20080300278, 20080300278]; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Univ. Connecticut, 2010, [No title captured], Patent No. [7666867B2, 7666867]; Univ. Connecticut, 2010, [No title captured], Patent No. [7741365B2, 7741365]; Viscomi MT, 2010, EXP NEUROL, V224, P56, DOI 10.1016/j.expneurol.2010.03.023; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Weber U. J, 2009, Patent No. [WO2009124552, 2009124552]; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006; Yacovan A, 2009, Patent No. [US20090068143, 20090068143]; Yacovan A, 2009, Patent No. [US20090054376, 20090054376]; Yang XF, 2005, J PHYSIOL-LONDON, V567, P215, DOI 10.1113/jphysiol.2005.088948; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510; Zindell R, 2006, Patent No. [US7595397, 7595397]	183	4	4	0	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1872-213X	2212-2710		RECENT PATENTS INFLA	Recent Patents Inflamm. Allergy Drug Discov.		2011	5	2					155	164		10.2174/187221311795399219			10	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	VG2PJ	WOS:000445891100006	21366539				2022-02-06	
J	Kwon, HG; Lee, DG; Choi, BY; Chang, CH; Kim, SH; Jang, SH				Kwon, Hyeok Gyu; Lee, Dong Gyu; Choi, Byung Yeon; Chang, Chul Hoon; Kim, Seong Ho; Jang, Sung Ho			Recovery of the corticospinal tract after injury by transtentorial herniation: A case report	NEUROREHABILITATION			English	Article						Diffusion tensor tractography; transcranial magnetic stimulation; transtentorial herniation; corticospinal tract; motor recovery	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; DIFFUSION TENSOR TRACTOGRAPHY; CLINICAL-APPLICATION; HEMORRHAGE; MECHANISM; STROKE	Little is known about recovery of the corticospinal tract (CST) after injury by transtentorial herniation (TH). We present with a patient who showed recovery of the CST after injury by TH, using diffusion tensor tractography (DTT) and transcranial magnetic stimulation (TMS). A 69-year-old female underwent craniotomy and drainage of an intracerebral hemorrhage in the left corona radiata and basal ganglia. Brain CT showed left TH and brain MRI revealed a leukomalactic lesion at the left cerebral peduncle. The patient presented with complete paralysis of the right extremities at ICH onset, but slowly recovered some function to the point of being able to move the affected extremities against gravity at about 6 months after onset. Three-week DTT showed disruption of the left CST below the cerebral peduncle; however, this disruption was recovered on 1-year DTT. Three-week TMS showed no motor evoked potential for the affected hemisphere; in contrast, motor evoked potentials that were compatible with regenerated CST were obtained from the affected hand muscle at 6 months. Using DTT and TMS in a patient with ICH, we demonstrated recovery of the CST after injury by TH.	[Lee, Dong Gyu; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kwon, Hyeok Gyu] Daegu Univ, Dept Rehabil Sci, Grad Sch, Taegu, South Korea; [Choi, Byung Yeon; Chang, Chul Hoon; Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Cho SH, 2007, NEUROSCI LETT, V421, P142, DOI 10.1016/j.neulet.2007.04.052; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Jang SH, 2009, NEUROREHABILITATION, V24, P159, DOI 10.3233/NRE-2009-0464; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Seitz R.J., J MAGN RESON IMAGING, V32, P756; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Udayakumaran S, 2010, CHILD NERV SYST, V26, P267, DOI 10.1007/s00381-009-1027-z; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Xu SW, 2010, NEURAL REGEN RES, V5, P1010, DOI 10.3969/j.issn.1673-5374.2010.13.009; Yoo WK, 2008, J NEUROL NEUROSUR PS, V79, P1295, DOI 10.1136/jnnp.2007.138131	19	4	4	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2011	29	3					243	246		10.3233/NRE-2011-0699			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	859EX	WOS:000297860700005	22142757				2022-02-06	
J	Nayak, P; Mahapatra, AK				Nayak, Pralaya; Mahapatra, Ashok K.			Single photon emission computed tomography scanning: A predictor of outcome in vegetative state of head injury	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Glasgow outcome scale; severe head injury; single photon emission computed tomography; vegetative state		Background: Neurotrauma is one of the most important causes of death and disability. Some of the severely head injured patients, failed to show significant improvement despite aggressive neurosurgical management and ended up in a vegetative state. Aims: To assess the outcome at six months and one year using Glasgow outcome scale (GOS), in this prospective study on patients with severe head injury, who remained vegetative at one month. Materials and Methods: This prospective study was carried out in the department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), New Delhi, over a period of a year and a half (March 2002 through July 2003). Materials and Methods: In patients with severe head injury (GCS < 8), post resuscitation, neurological assessment was done with Glasgow coma scale (GCS), pupillary light reflex, doll's eye movement and cold caloric test in all cases. Fifty patients, who remained vegetative post injury according to the criteria of Jennett and Plum, at one month, were considered for the study. Brain SPECT (Single Photon Emission Computed T omography) Scanning was carried out in selected cases. Statistical analysis: Data analysis was done by Pearson's chi-square test on computer software SPSS, Version 10 (California, USA). Results: Patients with preserved brainstem reflex and with no perfusion defect on SPECT scan had statistically significant favorable outcome. More than 40% of vegetative patients regained consciousness by the end of one year, of whom 24% had favorable outcome in the form of moderate disability and good recovery. Conclusion: SPECT is better than computed tomography/magnetic resonance imaging (CT/MRI) as it assesses the cerebral perfusion and functional injury rather than detecting the lesions only. Further study with a control group is necessary to establish the role of SPECT in head injury.	[Nayak, Pralaya] Hi Tech Med Coll, Bhubaneswar, Orissa, India; [Mahapatra, Ashok K.] Sanjay Gandhi Postgrad Inst, Lucknow, Uttar Pradesh, India		Nayak, P (corresponding author), Royal Garden, 82,Patia, Bhubaneswar 751031, Orissa, India.	drmichaelpn@rediffmail.com					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Baumann B. B, 2003, NUCL MED COMMUN, V24, P643; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Facco E, 1998, NEUROL RES, V20, pS40; Fergusson A., 2000, PERSISTENT VEGETATIV, P1; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; HEISS WD, 1972, J NEUROL SCI, V16, P373, DOI 10.1016/0022-510X(72)90045-7; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; MAHAPATRA AK, 1987, ACTA NEUROCHIR, V87, P40, DOI 10.1007/BF02076013; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; PODREKA I, 1987, J NUCL MED, V28, P1657; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075	17	4	6	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-JUN	2011	2	1					12	16		10.4103/0976-3147.80079			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3V3P	WOS:000218620800003	21716866	Green Published, gold			2022-02-06	
B	O'Phelan, K	Zollman, FS			O'Phelan, Kristine	Zollman, FS		Traumatic Brain Injury Definitions and Nomenclature	MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT			English	Article; Book Chapter							CONCUSSION; MANAGEMENT; STATEMENT; SPORTS		Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA		O'Phelan, K (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.						[Anonymous], 1997, NEUROLOGY, V48, P581; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x	7	4	4	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-01-7				2011							3	9					7	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BUN80	WOS:000289864500001					2022-02-06	
B	Rhodes, RL; D'Amato, RC; Rothlisberg, BA		Reynold, CR; FletcherJanzen, E		Rhodes, Robert L.; D'Amato, Rik Carl; Rothlisberg, Barbara A.			Utilizing a Neuropsychological Paradigm for Understanding Common Educational and Psychological Tests	HANDBOOK OF CLINICAL CHILD NEUROPSYCHOLOGY, THIRD EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SCHOOL-PSYCHOLOGY; CHILDREN; AMERICAN; STUDENTS		[Rhodes, Robert L.] New Mexico State Univ, Special Educ Commun Disorders Dept, Las Cruces, NM 88003 USA; [D'Amato, Rik Carl] Fac Social Sci & Humanities, Dept Psychol, Taipa, Macau, Peoples R China; [Rothlisberg, Barbara A.] Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA		Rhodes, RL (corresponding author), New Mexico State Univ, Special Educ Commun Disorders Dept, Las Cruces, NM 88003 USA.						BAILEY DB, 1987, J PSYCHOEDUCATIONAL, V3, P217; Bayley N., 2006, BAYLEY SCALES INFANT; BECKER KA, 2004, ASSESSMENT SERVICE B, V1; BEERY KE, 2004, BEERYBUKTENICA DEV T; BEGALI C, 1994, ED DIMENSIONS ACQUIR, P453; Bellak L., 1997, TAT CAT SAT CLIN USE; BENDELLESTROFF D, 1989, J PEDIATR PSYCHOL, V14, P549, DOI 10.1093/jpepsy/14.4.549; Bender L, 1938, AM ORTHOPSYCHIATRIC; Braden J. P., 2005, 16 MENTAL MEASUREMEN, P517; Brannigan G.G., 2003, BENDER VISUAL MOTOR, V2nd ed.; Chattin S. H., 1989, J PSYCHOEDUCATIONAL, V7, P112; CHITTOORAN MM, 1993, PSYCHOL SCHOOLS, V30, P109, DOI 10.1002/1520-6807(199304)30:2<109::AID-PITS2310300202>3.0.CO;2-Q; Christenson SL, 2003, SCHOOL PSYCHOL QUART, V18, P454, DOI 10.1521/scpq.18.4.454.26995; Crockett D, 2003, SCHOOL PSYCHOL QUART, V18, P446, DOI 10.1521/scpq.18.4.446.26997; D'Amato R. C., 1999, HDB SCH PSYCHOL, P452; DAMATO RC, 1992, J SCHOOL PSYCHOL, V30, P175, DOI 10.1016/0022-4405(92)90029-5; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; DAMATO RC, 1988, J SCHOOL PSYCHOL, V26, P283, DOI 10.1016/0022-4405(88)90007-6; DAMATO RC, 1988, SCH PSYCHOL REV, V18, P416; DAMATO RC, 1992, PREVENTABLE BRAIN DA, P193; DAMATO RC, 2005, HDB SCH NEUROPSYCHOL; DAMATO RC, 1987, SCHOOL PSYCHOL QUART, V2, P93; DAMATO RC, 1990, SCHOOL PSYCHOL QUART, V2, P93; DAMATO RC, 1992, PSYCHOL PERSPECTIVES; DAMATO RC, 1989, SCH PSYCHOL NONTRADI; Das J. P., 1994, ASSESSMENT COGNITIVE; DAVIS AS, 2005, HDB SCH NEUROPSYCHOL, P264; DEAN RS, 2003, DEANWOODCOCK NEUROPS; DEAN RS, 1986, CHILD NEUROPSYCHOL, V2, P10; DEAN RS, 1986, BUROS NEBRASKA SERIE, P203; DEAN RS, 1990, HDB PSYCHOL ED ASSES, P371; Dean RS, 1985, PSYCHIATRY, P1; Doll EA, 1935, AM J ORTHOPSYCHIAT, V5, P180, DOI 10.1111/j.1939-0025.1935.tb06339.x; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Elliot C. D., 2007, DIFFERENTIAL ABILITY, VSecond; Elliot CD., 1990, DIFFERENTIAL ABILITY; Gaddes W.H., 1994, LEARNING DISABILITIE; GADDES WH, 1985, LEARNING DISABILITIE; Garbarino J., 1995, RAISING CHILDREN SOC; GOLDSTEIN DJ, 1986, J CLIN PSYCHOL, V42, P890, DOI 10.1002/1097-4679(198611)42:6<890::AID-JCLP2270420611>3.0.CO;2-Y; GOLDSTEIN G, 1993, ARCH CLIN NEUROPSYCH, V8, P41; GRAY JW, 1987, PSYCHOL SCHOOLS, V24, P15, DOI 10.1002/1520-6807(198701)24:1<15::AID-PITS2310240103>3.0.CO;2-T; Hartlage LC, 1990, HDB SCH PSYCHOL, P431; HEATHFIELD LT, 2005, HDB SCH NEUROPSYCHOL, P684; HESS RS, 2005, HDB SCH NEUROPSYCHOL, P637; HYND GW, 2005, HDB SCH NEUROPSYCHOL, P314; HYND GW, 1990, ASSESSING ADOLESCENT, P638; HYND GW, 1988, PEDIAT NEUROPSYCHOLO; HYND GW, 1981, NEUROPSYCHOLOGICAL A; KALAT JW, 1999, HDB SCH PSYCHOL, P271; Kamphaus RW, 2005, CLIN ASSESSMENT CHIL; KAMPHAUS RW, 1993, CLIN ASSESSMENT CHIL; Kaufman, 1979, INTELLIGENT TESTING; Kaufman A. S., 1993, MANUAL KAUFMAN ADOLE; Kaufman A. S, 1983, KAUFMAN ASSESSMENT B; Kaufman A.S., 2005, ASSESSING ADOLESCENT; Kaufman Alan S., 1993, KAUFMAN ADOLESCENT A; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KAUFMAN AS, 1993, ASSESSING ADOLESCENT; Kaufman AS., 2004, KAUFMAN ASSESSMENT B, V2; KING JD, 2002, TESTS PRINT, V6; Knoff H.M., 2003, ASSESSMENT CHILD ADO; Korkman M, 1999, NEUROPSYCHOL REV, V9, P89, DOI 10.1023/A:1025659808004; Lanyon R. I., 1997, PERSONALITY ASSESSME; LEE D, 2005, HDB SCH NEUROPSYCHOL, V701; LEU PW, 1994, 26 ANN CONV NAT ASS; LEWIS M, 1986, INTELLIGENCE, V10, P331, DOI 10.1016/0160-2896(86)90003-6; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A. R., 1970, TRAUMATIC APHASIA IT; LURIA AR, 1977, AM PSYCHOL, V32, P959, DOI 10.1037/0003-066X.32.11.959; LURIA AR, 1980, WORKING BRAIN; Markwardt Jr. F. C., 1997, PEABODY INDIVIDUAL A; Moore A. D., 1990, PSYCHOL ASSESSMENT, V2, P98, DOI [10.1037/1040-3590.2.1.98, DOI 10.1037/1040-3590.2.1.98]; MOORE AD, 1992, CAN J BEHAV SCI, V25, P605; Murray H.A., 1938, EXPLOR PERS; Murray H. A, 1943, THEMATIC APPERCEPTIO; PALISANO RJ, 1989, PERCEPT MOTOR SKILL, V68, P1099, DOI 10.2466/pms.1989.68.3c.1099; RAPPPAGLICCI LA, 2004, HDB PREVENTATIVE INT; Reitan R M, 1989, Arch Clin Neuropsychol, V4, P385, DOI 10.1016/0887-6177(89)90029-2; Reitan R.M., 1993, HALSTEADREITAN NEURO; Reynolds C. R., 2005, HDB SCH NEUROPSYCHOL, P86; Reynolds Cecil R., 2003, HDB PSYCHOL ED ASSES; REYNOLDS CR, 1986, SCHOOL PSYCHOL REV, V15, P256; REYNOLDS CR, 1994, TESTS MEMORY LEARNIN; REYNOLDS CR, 1981, SCH PSYCHOL REV, V10, P343; ROID GH, 2003, STANFORDBINET INTELL; ROOT KA, 2005, HDB SCH NEUROPSYCHOL, V15; ROTHLISBERG BA, 2003, HDB PSYCHOL ED ASSES; ROTHLISBERG BA, 1989, J PSYCHOED ASSESS, V7, P304; RUSSELL EW, 1987, NEUROPSYCHOLOGY, V1, P2; SALVIA J, 2007, ASSESSMENT SPECIAL I, P499; SALVIA J, 1991, ASSESSMENT, P465; Sattler J. M., 2002, ASSESSMENT CHILDREN; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SELZ M, 1989, HDB CLIN CHILD NEURO, P129; SEMRUDCLIKEMAN M, 2005, HDB SCH NEUROPSYCHOL, P287; Sheridan SM, 2000, SCHOOL PSYCHOL REV, V29, P485; SNYDER P, 1993, TOP EARLY CHILD SPEC, V13, P216, DOI 10.1177/027112149301300209; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; TELZROW CF, 1986, NEUROPSYCHOLOGY INDI, P271; TELZROW CF, 2005, HDB SCH NEUROPSYCHOL, P533; TELZROW CF, 1990, TRAUMATIC BRAIN INJU, P251; TELZROW CF, 1987, REHABILITATION COGNI, P191; Traughber M. C., 2005, HDB SCH NEUROPSYCHOL, P827; TULSKY DS, 2003, CLIN INTERPRETATION; Urbina S, 1997, PSYCHOL TESTING; URBINA S, 2005, 16 MENTAL MEASUREMEN, P769; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2001, WECHSLER INDIVIDUAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHATLEY JL, 1987, PSYCHOL PERSPECTIVES, P112; WILLIAMS PE, 2003, 3 WISC4; Work P. H. L., 2005, HDB SCH NEUROPSYCHOL, P663; [No title captured]; [No title captured]; [No title captured]	119	4	5	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-8145-5				2011							321	348		10.1007/978-0-387-78867-8_15			28	Psychology, Clinical; Clinical Neurology; Psychology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology	BSK48	WOS:000284746000015					2022-02-06	
J	Moreira, CLRL; Brietzke, E; Lafer, B				Roganti Leite Moreira, Camila Luzia; Brietzke, Elisa; Lafer, Beny			General medical comorbidities in Brazilian outpatients with bipolar disorder type I	REVISTA DE PSIQUIATRIA CLINICA			Portuguese	Article						Bipolar disorder; general medical comorbidity; migraine	CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; PREVALENCE; BURDEN; MIGRAINE; OBESITY; ILLNESS; COSTS; WOMEN; AGE	Background: Bipolar disorder (BD) has been associated with high rates of general medical comorbidities (GMC) and medical risk factors. There have been scarce reports about this prevalence in Brazilian subjects with BD. Objective: Describe the prevalence of GMC in a sample of BD type 1 patients. Methods: Clinical records of 195 patients with BD type I were reviewed for identification of GMC. Patients with and without GMC were compared using the Mann-Whitney nonparametric test and the chi-Square test. Results: Sixty-three percent of patients had at least one medical comorbidity. The most prevalent conditions were: migraine (31.8%), hypothyroidism (24.1%), hypertension (11.3%), traumatic brain injuries (10.3%), asthma (9.7%), epilepsy (8.2%), diabetes (5.1%), stroke (2.1%) and hyperthyroidism (1%). Age and duration of illness were positively associated with the presence of GMC (p < 0.001). Discussion: In our study, in accordance with previous reports, the majority of patients presented at least one general medical disorder. The principal limitation of this study is the fact that diagnose of GMC was made based on self-report. There are scarce studies addressing GMC in the Brazilian population with BD and this report can contribute to improve diagnostic vigilance, assessment, treatment planning and decrease the burden associated with BD.	[Roganti Leite Moreira, Camila Luzia; Brietzke, Elisa; Lafer, Beny] Univ Sao Paulo, Inst Psiquiatria, Programa Transtorno Bipolar PROMAN, BR-05508 Sao Paulo, Brazil		Moreira, CLRL (corresponding author), Rua Dr Ovidio Pires de Campos 785,3 Andar, BR-05403010 Sao Paulo, Brazil.	camilaenf.moreira@gmail.com	Lafer, Beny/F-9390-2015; Brietzke, Elisa/G-9559-2012; Lafer, Beny/C-1055-2012	Lafer, Beny/0000-0002-6132-9999; Brietzke, Elisa/0000-0003-2697-1342; Lafer, Beny/0000-0002-6132-9999			American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P377; Bauer MS, 2001, J AFFECT DISORDERS, V65, P231, DOI 10.1016/S0165-0327(00)00247-0; Beyer J, 2005, NEUROPSYCHOPHARMACOL, V30, P401, DOI 10.1038/sj.npp.1300608; Blehar MC, 1998, PSYCHOPHARMACOL BULL, V34, P239; Calabrese JR, 2003, J CLIN PSYCHIAT, V64, P425, DOI 10.4088/JCP.v64n0412; Carney CP, 2006, PSYCHOSOM MED, V68, P684, DOI 10.1097/01.psy.0000237316.09601.88; Cassidy F, 1999, AM J PSYCHIAT, V156, P1417; de Almeida KM, 2009, ACTA NEUROPSYCHIATR, V21, P84, DOI 10.1111/j.1601-5215.2009.00366.x; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112; Fasmer O B, 2001, World J Biol Psychiatry, V2, P149; Fasmer OB, 2001, CEPHALALGIA, V21, P894, DOI 10.1046/j.1468-2982.2001.00279.x; Fenn HH, 2005, J AFFECT DISORDERS, V86, P47, DOI 10.1016/j.jad.2004.12.006; Fiedorowicz JG, 2008, ANN CLIN PSYCHIATRY, V20, P131, DOI 10.1080/10401230802177722; Gau CS, 2010, BIPOLAR DISORD, V12, P253, DOI 10.1111/j.1399-5618.2010.00814.x; Gomes Bernardo Carramão, 2007, Arch. Clin. Psychiatry (São Paulo), V34, P84; Goodwin FK, 2007, MANIC DEPRESSIVE ILL, p[162, 240]; Guo JJ, 2007, PSYCHIAT SERV, V58, P1073, DOI 10.1176/appi.ps.58.8.1073; Hajek T, 2005, BIPOLAR DISORD, V7, P286, DOI 10.1111/j.1399-5618.2005.00182.x; Kilbourne AM, 2004, BIPOLAR DISORD, V6, P368, DOI 10.1111/j.1399-5618.2004.00138.x; Kim B, 2009, PSYCHIAT INVEST, V6, P78, DOI 10.4306/pi.2009.6.2.78; Klumpers UMH, 2004, PHARMACOPSYCHIATRY, V37, P211, DOI 10.1055/s-2004-832594; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Low NCP, 2003, HEADACHE, V43, P940, DOI 10.1046/j.1526-4610.2003.03184.x; McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420; McElroy SL, 2002, J CLIN PSYCHIAT, V63, P207, DOI 10.4088/JCP.v63n0306; McIntyre RS, 2006, PSYCHIAT SERV, V57, P1140, DOI 10.1176/appi.ps.57.8.1140; Costa AMN, 2008, REV PSIQ CLIN-BRAZIL, V35, P104, DOI 10.1590/S0101-60832008000300003; Ortiz A, 2010, BIPOLAR DISORD, V12, P397, DOI 10.1111/j.1399-5618.2010.00832.x; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Perron BE, 2009, J CLIN PSYCHIAT, V70, P1407, DOI 10.4088/JCP.08m04586yel; Rea MM, 2003, J CONSULT CLIN PSYCH, V71, P482, DOI 10.1037/0022-006X.71.3.482; Sicras A, 2008, BIPOLAR DISORD, V10, P607, DOI 10.1111/j.1399-5618.2008.00599.x; Soreca I, 2008, J PSYCHIATR RES, V42, P956, DOI 10.1016/j.jpsychires.2007.10.009; Valle J, 1999, EUR PSYCHIAT, V14, P341, DOI 10.1016/S0924-9338(99)00158-3; van Winkel R, 2008, BIPOLAR DISORD, V10, P342, DOI 10.1111/j.1399-5618.2007.00520.x	36	4	6	0	3	UNIV SAO PAULO, INST PSIQUIATRIA	SAO PAULO	RUA OVIDIO PIRES CAMPOS, 785, 1 ANDAR, SAO PAULO, 05403-010, BRAZIL	0101-6083			REV PSIQ CLIN-BRAZIL	Rev. Psiquiatr. Clin.		2011	38	6					227	230					4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	889KO	WOS:000300072800003					2022-02-06	
S	Shohami, E; Kohen, R		Gadoth, N; Gobel, HH		Shohami, Esther; Kohen, Ron			The Role of Reactive Oxygen Species in the Pathogenesis of Traumatic Brain Injury	OXIDATIVE STRESS AND FREE RADICAL DAMAGE IN NEUROLOGY	Oxidative Stress in Applied Basic Research and Clinical Practice		English	Article; Book Chapter						Antioxidant enzymes; Low molecular weight antioxidants; Lipid peroxidation; Mitochondria; Oxidative stress	CLOSED-HEAD INJURY; NF-KAPPA-B; OXIDATIVE STRESS; NITRIC-OXIDE; LIPID-PEROXIDATION; TRANSGENIC MICE; ANTIOXIDANT ACTIVITY; NITROXIDE RADICALS; CEREBRAL-ISCHEMIA; HEME OXYGENASE	Traumatic brain injury (TBI) is a major cause of death in the young age group and leads to persisting neurological impairment in many of its victims. TBI involves a primary mechanical impact followed by the development of vasogenic and cytotoxic edema and impairment of energy metabolism and ionic homeostasis. Primary injury sets in motion a cascade of events that activate molecular and cellular responses. The relatively rapid process of primary cell death is followed by secondary degeneration of adjacent neurons having escaped the initial insult. The primary death of brain cells concomitantly also causes accumulation of harmful physiological substances such as glutamate, reactive oxygen species (ROS), and pro-inflammatory cytokines, creating a toxic environment for neighboring neurons and resulting in functional deficits. The mammalian brain is vulnerable to oxidative stress because of the high oxygen consumption needed for maintaining neuronal ion homoeostasis during the propagation of action potentials. Interruption of mitochondrial function involves oxidative stress and leads to impaired energy production, followed by rapidly developing brain damage. For nearly three decades, ROS have been the focus of interest as possible candidates for the elicitation of deleterious responses in the pathogenesis of ischemia and TBI; however, despite numerous clinical trials, no antioxidants have made their way into clinical practice. This chapter focuses on the role of oxidative stress and tissue antioxidant capacity in the pathogenesis of TBI. Oxidative stress in the brain and its biological targets are discussed along with the tissue's intrinsic defense mechanisms, including antioxidant enzymes and low molecular weight antioxidants (LMWA). Post-TBI oxidative stress-induced damage is described, highlighting its major hallmarks, namely mitochondrial damage, lipid peroxidation, antioxidant enzymes, and LMWA. Finally, several therapeutic agents harboring antioxidant properties are presented at the end of the chapter for their implications in both experimental and clinical settings.	[Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	esty@cc.huji.ac.il	Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845			AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANKEL EG, 1987, LIFE SCI, V40, P495, DOI 10.1016/0024-3205(87)90116-0; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; BARD AJ, 1980, ELECTROCHEMICAL METH, V9, P316; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Benzie IFF, 1996, REDOX REP, V2, P231, DOI 10.1080/13510002.1996.11747055; BERLINER LJ, 1985, SCIENCE, V227, P517, DOI 10.1126/science.2981437; Boldyrev AA, 1999, NEUROSCI LETT, V263, P169, DOI 10.1016/S0304-3940(99)00150-0; BOLDYREV AA, 1987, BIOCHEM INT, V15, P1105; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Boldyrev AA, 1997, CELL MOL NEUROBIOL, V17, P259, DOI 10.1023/A:1026374114314; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRODIE BB, 1954, J BIOL CHEM, V208, P741; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; COTTER MA, 1995, DIABETOLOGIA, V38, P1285; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; DEGRAFF WG, 1992, ENVIRON MOL MUTAGEN, V19, P21, DOI 10.1002/em.2850190105; DUGAN LL, 1994, ANN NEUROL, V35, pS17, DOI 10.1002/ana.410350707; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Fujimura M, 2001, BRAIN RES, V889, P208, DOI 10.1016/S0006-8993(00)03134-6; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Glantz L, 2005, EXP NEUROL, V192, P117, DOI 10.1016/j.expneurol.2004.11.012; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; HAHN SM, 1992, CANCER RES, V52, P1750; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1991, STROKE, V22, P361, DOI 10.1161/01.STR.22.3.361; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hall ED, 1989, J NEUROTRAUM, V6, P227, DOI 10.1089/neu.1989.6.227; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Halliwell B, 1996, FREE RADICAL RES, V25, P439, DOI 10.3109/10715769609149066; Halliwell B., 1989, FREE RADICAL BIO MED, P160; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; HILLERED L, 1991, RES EXP MED, V191, P219, DOI 10.1007/BF02576677; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Joseph JA, 2000, MECH AGEING DEV, V116, P141, DOI 10.1016/S0047-6374(00)00128-7; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; KELNER MJ, 1995, FREE RADICAL BIO MED, V18, P497, DOI 10.1016/0891-5849(94)00167-I; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; KOHEN R, 1991, FREE RADICAL RES COM, V12-3, P179, DOI 10.3109/10715769109145784; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Maines MD, 1996, BRAIN RES, V722, P83, DOI 10.1016/0006-8993(96)00184-9; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; McDonald MC, 1999, FREE RADICAL BIO MED, V27, P493, DOI 10.1016/S0891-5849(99)00100-8; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Mota-Filipe H, 1999, SHOCK, V12, P255, DOI 10.1097/00024382-199910000-00002; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICKANDER KK, 1994, J NEUROL SCI, V126, P6, DOI 10.1016/0022-510X(94)90088-4; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; PeledKamar M, 1997, P NATL ACAD SCI USA, V94, P3883, DOI 10.1073/pnas.94.8.3883; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POZO D, 1994, LIFE SCI, V55, pPL455, DOI 10.1016/0024-3205(94)00532-X; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Raub TJ, 1993, J DRUG TARGET, V1, P269, DOI 10.3109/10611869308996085; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; REITER RJ, 1995, NEUROCHEM INT, V27, P453, DOI 10.1016/0197-0186(95)80002-3; RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; SAMUNI A, 1991, FREE RADICAL RES COM, V12-3, P187, DOI 10.3109/10715769109145785; SAMUNI A, 1990, FREE RADICAL RES COM, V9, P241, DOI 10.3109/10715769009145682; Schwartz M, 2000, INVEST OPHTH VIS SCI, V41, P349; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Virag L, 2002, EXP DERMATOL, V11, P189, DOI 10.1034/j.1600-0625.2002.110301.x; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P332, DOI 10.1016/S0891-5849(97)00267-0	124	4	4	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	2197-7224	2197-7232	978-1-60327-513-2	OXID STRESS APPL BAS	Oxid. Stress Appl. Basic Res. Clin. Pract.		2011							99	118		10.1007/978-1-60327-514-9_7	10.1007/978-1-60327-514-9		20	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BSM94	WOS:000284978600007					2022-02-06	
B	Sondej, MA; Doran, P; Loo, JA; Wanner, IB		Ivanov, AR; Lazarev, AV		Sondej, Melissa A.; Doran, Philip; Loo, Joseph A.; Wanner, Ina-Beate			Sample Preparation of Primary Astrocyte Cellular and Released Proteins for 2-D Gel Electrophoresis and Protein Identification by Mass Spectrometry	SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY			English	Article; Book Chapter						Astrocytes; Biomarker; Neurotrauma; Tandem mass spectrometry; Two-dimensional gel electrophoresis	STRETCH-INDUCED INJURY; REACTIVE ASTROCYTES; BRAIN-INJURY; ION CHANNELS; METABOLISM; BIOMARKERS; DIAGNOSIS; ROLES; MODEL; GLIA	The neurotrauma field needs more accurate and sensitive tools to diagnose and evaluate damage to the brain or spinal cord. A controlled, in vitro mechanical trauma model to study protein changes during astrocyte activation after injury is used as a means to discover neurotrauma biomarkers. This model offers several advantages over analyzing cerebrospinal fluid (CSF) or microdialysates including increased sample amount, higher reproducibility between biological samples, enrichment of undegraded proteins due to fewer extracellular matrix proteases in the in vitro versus in vivo system and the ability to relate trauma changes to one eel type. This protocol describes an approach for preparing intact protein samples from conditioned medium (CM) and whole cell lysates of murine cortical astrocytes. The proteins from these samples are separated using 2-D gel electrophoresis, and the protein spot intensities are measured. Proteins showing statistically significant trauma induced changes are then identified using tandem mass spectrometry. This protocol contains optimization steps to enrich proteins of interest, to remove substances that interfere with isoelectric focusing (IEF) and to improve IEF conditions. With this procedure, the 2-D gels show high resolution spot separation and allow for high confidence protein identifications from 107 released and 22 whole cell lysates protein spots so far. Some proteins were identified from multiple spots, suggesting post-translational modification had occurred as a result of the mechanical trauma.	[Sondej, Melissa A.; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Wanner, Ina-Beate] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Doran, Philip; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA		Sondej, MA (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951569,MSB 1424, Los Angeles, CA 90095 USA.	masondej@ucla.edu; Philip-doran@yahoo.co.uk; jloo@chem.ucla.edu; IWanner@mednet.ucla.edu					Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BERKELMAN T, 1998, HDB AMERSHAM BIOSCIE; BOWMAN CL, 1992, BRAIN RES, V584, P272, DOI 10.1016/0006-8993(92)90906-P; CASTLE L, B BIO RAD LAB, V2651; de Vellis J, 2010, SPRINGER PROTOC HAND, P193, DOI 10.1007/978-1-60761-292-6_11; Di X, 2000, ACT NEUR S, V76, P379; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Friedman DB, 2009, METHOD ENZYMOL, V463, P515, DOI 10.1016/S0076-6879(09)63030-5; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Reier P J, 1988, Adv Neurol, V47, P87; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sanchez JC, 1997, ELECTROPHORESIS, V18, P324, DOI 10.1002/elps.1150180305; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; Smith Richard, 2009, V519, P3, DOI 10.1007/978-1-59745-281-6_1; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; WESTERMEIER R, 2006, GE HEALTHC SEM HUM P; WESTERMEIER R, 2002, PROTEOMICS PRACTICE, P283	32	4	4	0	0	SPRINGER	DORDRECHT	PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS			978-94-007-0758-0				2011							829	849		10.1007/978-94-007-0828-0_39	10.1007/978-94-007-0828-0		21	Biochemical Research Methods	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BVY63	WOS:000293148700040					2022-02-06	
J	Sullivan, SJ; Schneiders, AG; Handcock, P; Gray, A; McCrory, PR				Sullivan, S. John; Schneiders, Anthony G.; Handcock, Phil; Gray, Andrew; McCrory, Paul R.			Changes in the timed finger-to-nose task performance following exercise of different intensities	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ERROR SCORING SYSTEM; EXERTION	Objective The purpose of this study was to determine the effect of different levels of exercise intensity on the timed finger-to-nose (FTN) task, a measure of upper limb coordination included in the Sport Concussion Assessment Tool (SCAT2). Methods A three-group crossover randomised design was used to investigate changes in FTN times at three levels of exercise intensity; no exercise/rest (NE), moderate intensity exercise (ME) and high-intensity exercise (HE). Heart rates and a rating of perceived exertion (Borg Scale) were recorded to verify the level of exercise intensity. Participants performed three trials of the timed FTN task: pre-exercise, post-exercise and 15 min after the cessation of exercise. Linear mixed models were used to compare FTN change scores associated with exercise. Results Ninety asymptomatic participants (45 male:45 female) aged 18-32 years completed the study. Changes in FTN scores from pre-exercise showed that the HE condition was facilitated relative to NE at post-exercise (8% faster, 95% CI 5% to 10%, p<0.001) and at post-15 (3% faster, 95% CI 1% to 6%, p=0.005). ME did not show such a facilitation following exercise (2% faster, 95% CI 0% to 4%, p=0.081 and 1% faster, 95% CI 1% to 4%, p=0.225 respectively). Conclusions Performance on the FTN task is enhanced by a short period of HE, and this effect persists for at least 15 min. There was no evidence of such an effect with ME.	[Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [Handcock, Phil] Univ Otago, Sch Phys Educ, Dunedin 9054, New Zealand; [Gray, Andrew] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [McCrory, Paul R.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia		Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Handcock, Phil/P-2400-2019; Gray, Andrew Robert/L-9161-2015; Schneiders, Anthony/F-4212-2015	Handcock, Phil/0000-0002-0753-1117; Gray, Andrew Robert/0000-0003-4299-2194; McCrory, Paul/0000-0003-4850-0568; Schneiders, Anthony/0000-0002-1583-3879	University of Otago	University of Otago Research Grant.	[Anonymous], 2009, BRIT J SPORT MED, V43, pi85; Arent SM, 2003, RES Q EXERCISE SPORT, V74, P436, DOI 10.1080/02701367.2003.10609113; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Susco TM, 2004, J ATHL TRAINING, V39, P241; Swaine Bonnie R., 2005, Physiotherapy Theory and Practice, V21, P271, DOI 10.1080/09593980500321119; Swaine BR, 2005, ARCH PHYS MED REHAB, V86, P1665, DOI 10.1016/j.apmr.2004.11.021; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	14	4	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JAN	2011	45	1					46	48		10.1136/bjsm.2009.071225			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	695QQ	WOS:000285388100011	20558528				2022-02-06	
J	Valle, B; Bounes, V; Dehours, E; Roux, P; Concina, F; Tabarly, J; Pujos, M; Ducasse, JL				Valle, Baptiste; Bounes, Vincent; Dehours, Emilie; Roux, Patrick; Concina, Francois; Tabarly, Julien; Pujos, Michel; Ducasse, Jean-Louis			Use of morbidity and mortality conferences to analyze causes of death at sea: a useful tool in the process of training in maritime medicine	INTERNATIONAL MARITIME HEALTH			English	Article						morbidity and mortality conference; maritime medicine; quality; tele-consultation		Background. Morbidity and mortality conferences (M&MC) are collective reviews of records of patients, whose evolution was marked by an undesirable event: death or the occurrence of complications. The M&MC aim to improve the quality of care. This article intends to present three cases analyzed in M&MC in the French Telemedical Assistance Service (TMAS). Material and methods. Three cases were selected according to the occurrence of a death at sea or according to particular cases of pathology on board. The case presentation was done in plenary session in our French TMAS, describing the facts, analyzing the defective processes, and suggesting possible improvements for each case. Results. Description of 3 cases: Gastroenteritis in Papua New Guinea with septic shock; traumatic brain injury on a training boat with organizational and evacuation problems, and fever in the Gulf of Guinea with negative thick blood smear test. Conclusions. The M&MC tend to develop in all medical fields and are of particular interest in maritime medicine. The achievement of M&MC in our TMAS highlighted some difficulties in our daily work: diagnosis difficulty in tele-consultation and organizational or operational difficulties related to maritime medicine. However, we hope that the proposals for improvement will be applied to improve the quality of maritime medical care.	[Valle, Baptiste; Bounes, Vincent; Dehours, Emilie; Roux, Patrick; Concina, Francois; Tabarly, Julien; Pujos, Michel; Ducasse, Jean-Louis] CHU Purpan, Hop Univ Toulouse, Ctr Consultat Med Maritimes, Serv Aide Med Urgente,Pole Med Urgence, Pl Dr Baylac, F-31000 Toulouse, France		Valle, B (corresponding author), CHU Purpan, Hop Univ Toulouse, Ctr Consultat Med Maritimes, Serv Aide Med Urgente,Pole Med Urgence, Pl Dr Baylac, F-31000 Toulouse, France.	valle.b@chu-toulouse.fr					Bal G, 2010, PRESSE MED, V39, P161, DOI 10.1016/j.lpm.2009.11.005; Bechtold ML, 2007, QUAL SAF HEALTH CARE, V16, P422, DOI 10.1136/qshc.2006.021139; Bretonniere Cedric, 2010, Ann Fr Anesth Reanim, V29, P259, DOI 10.1016/j.annfar.2010.03.002; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Denis B, 2003, GASTROEN CLIN BIOL, V27, P1100; Francois P, 2011, TRANSFUS CLIN BIOL, V7; Gillies RA, 2007, FAM MED, V39, P82; Gore DC, 2006, AM J SURG, V191, P708, DOI 10.1016/j.amjsurg.2006.01.029; Harbison SP, 1999, AM J SURG, V177, P136, DOI 10.1016/S0002-9610(98)00319-5; HAS, 2006, EV PRAT PROF EST SAN; Hobgood CD, 2000, ACAD EMERG MED, V7, P1317, DOI 10.1111/j.1553-2712.2000.tb00482.x; Indresano A Thomas, 2004, J Am Coll Dent, V71, P23; Kajfasz P, 2009, INT MARIT HEALTH, V60, P67; Kim C, 2006, FAM MED, V38, P550; Ksouri H, 2010, AM J CRIT CARE, V19, P135, DOI 10.4037/ajcc2010590; Larrazet F, 2006, PRESSE MED, V35, P1223, DOI 10.1016/S0755-4982(06)74793-5; Miller DC, 2006, UROLOGY, V68, P931, DOI 10.1016/j.urology.2006.06.018; Orlander JD, 2003, J GEN INTERN MED, V18, P656, DOI 10.1046/j.1525-1497.2003.20824.x; Orlander JD, 2002, ACAD MED, V77, P1001, DOI 10.1097/00001888-200210000-00011; Pierluissi E, 2003, JAMA-J AM MED ASSOC, V290, P2838, DOI 10.1001/jama.290.21.2838; Prince Jose M, 2007, J Surg Educ, V64, P266, DOI 10.1016/j.jsurg.2007.06.007; Risucci Donald A, 2003, Curr Surg, V60, P204, DOI 10.1016/S0149-7944(02)00735-3; Rosen P, 2008, J EMERG MED, V34, P471, DOI 10.1016/j.jemermed.2007.05.053; Scerbaviciene R, 2009, INT MARIT HEALTH, V60, P29; Seigel TA, 2010, J EMERG MED, V38, P507, DOI 10.1016/j.jemermed.2008.09.018	25	4	4	0	1	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1641-9251	2081-3252		INT MARIT HEALTH	Int. Marit. Health		2011	62	2					104	109					6	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	V0Y3F	WOS:000216669800003	21910113				2022-02-06	
J	Wang, A; Cohen, AR; Robinson, S				Wang, Arthur; Cohen, Alan R.; Robinson, Shenandoah			The "swing-ding": a golf-related head injury in children Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						golf; head injury; head trauma; prevention; pediatric; swing-ding		Object. In recent years there has been an increased incidence of golf-associated head injuries in children and adolescents. At the authors' institution, they have identified a unique pattern of head injury associated with a swinging golf club. In this study, the authors highlight the mechanism of this injury and report their experience treating it. Methods. The authors reviewed the database of Rainbow Babies and Children's Hospital Trauma Center and performed a retrospective analysis of golf injuries recorded over a 10-year period (January 2000 April 2010). They identified 13 children (9 boys and 4 girls) who sustained head injuries in golfing accidents. All patients were 10 years of age or younger. The medical charts were reviewed and follow-up interviews were conducted to better delineate the details of the injuries. Results. Injuries included 13 depressed skull fractures, 7 epidural hematomas, and 1 cerebral contusion. All 13 patients sustained their injuries after being struck in the head by a golf club. Seven sustained injuries on the follow-through of the initial swing and 3 sustained injuries on the backswing. All but one patient required neurosurgical intervention. Five patients developed neurological sequelae. None of the children had prior experience with golf equipment. All but one injury occurred in the child's own backyard. There was no direct supervision by an adult in any of the cases. Conclusions. Golfing can lead to serious head injuries in children. The authors noticed a unique pattern of golf-related head injuries, previously not described, that they have termed the "swing-ding." This golf club inflicted injury occurs when a child stands too close to a swinging golfer and is struck in the head, subsequently sustaining a comminuted depressed skull fracture in the frontal or temporal region, with or without further intracranial injury. The study suggests that a lack of adult supervision, minimal previous golf experience, and proximity of the child to the swinging golfer are all implicated in this head injury pattern. (DOI: 10.3171/2010.10.PEDS10283)	[Wang, Arthur; Cohen, Alan R.; Robinson, Shenandoah] Case Western Reserve Univ, Div Pediat Neurosurg, Univ Hosp Rainbow Babies & Childrens Hosp, Neurol Inst,Sch Med, Cleveland, OH 44106 USA		Robinson, S (corresponding author), Case Western Reserve Univ, Div Pediat Neurosurg, Univ Hosp Rainbow Babies & Childrens Hosp, Neurol Inst,Sch Med, B501,11100 Euclid Ave, Cleveland, OH 44106 USA.	shenandoah.robinson@uhhospitals.org	liu, ting/AAA-1112-2022				Fountas KN, 2006, CHILD NERV SYST, V22, P1282, DOI 10.1007/s00381-006-0077-8; Fradkin Andrea J, 2005, Int J Inj Contr Saf Promot, V12, P201, DOI 10.1080/17457300500088972; Macgregor DM, 2002, EMERG MED J, V19, P576, DOI 10.1136/emj.19.6.576; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Ridenour MV, 1998, PERCEPT MOTOR SKILL, V86, P747, DOI 10.2466/pms.1998.86.3.747; Rosenow JM, 1998, SURG NEUROL, V50, P608; SMITH RA, 1991, BRIT MED J, V302, P1505, DOI 10.1136/bmj.302.6791.1505	7	4	4	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2011	7	1					111	115		10.3171/2010.10.PEDS10283			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	699NH	WOS:000285669600020	21194295				2022-02-06	
J	Youse, KM; Gathof, M; Fields, RD; Lobianco, TF; Bush, HM; Noffsinger, JT				Youse, Kathleen M.; Gathof, Mackenzie; Fields, Rachel D.; Lobianco, Tony F.; Bush, Heather M.; Noffsinger, Jennifer T.			Conversational discourse analysis procedures: A comparison of two paradigms	APHASIOLOGY			English	Article						Closed head injury; Conversational discourse; Assessment	TRAUMATIC BRAIN-INJURY; ADULTS	Background: Previous research has suggested that individuals with closed head injury (CHI) have difficulty with the communication skills required for a successful conversational exchange. A variety of analysis paradigms have been used with this population and provide evidence to support that conversational discourse deficits do exist in individuals with CHI. However, the use of various analytical procedures renders it difficult for researchers to draw consistent conclusions and hinders the development of evidence-based practice guidelines for conversational discourse evaluation or treatment for individuals with CHI. Aims: The purpose of this study was to evaluate two conversational discourse analysis procedures. It was hypothesised that modifying a Conversational Appropriateness paradigm used successfully in previous research would provide additional information about conversational ability ultimately leading to more conclusive results. Methods Procedures: A series of conversations elicited from one individual with CHI were analysed using two analysis schemes: Conversational Appropriateness (e.g., Blank Franklin, 1980; Coelho, Youse, Le, 2002) and a Modified Conversational Appropriateness paradigm designed for this study. Outcomes Results: The results supported the hypothesis suggesting the original Conversational Appropriateness paradigm may not be completely representational of conversation ability of individuals with CHI. A Modified Conversational Appropriateness procedure may be more appropriate for the CHI population, as it appears to capture the nuances that are known to affect conversational performance in individuals with CHI revealing greater detail regarding deficits in conversational participation. Conclusions: Comparing two conversational discourse analysis paradigms provided valuable insight into measures that may more adequately define the conversation ability of individuals with CHI. Modifying a discourse analysis procedure that has been shown to be successful in the past can provide additional detail for therapists to utilise when assessing and designing therapy goals for an individual with CHI. Although further research is needed, if a reliable, valid procedure can be developed for clinical use the possibility of developing evidence-based practice guidelines for discourse assessment and treatment may be more attainable.	[Youse, Kathleen M.] Univ Kentucky, Coll Hlth Sci, Div Commun Sci & Disorders, Lexington, KY 40536 USA; [Noffsinger, Jennifer T.] Cardinal Hill Rehabil Hosp, Lexington, KY USA		Youse, KM (corresponding author), Univ Kentucky, Coll Hlth Sci, Div Commun Sci & Disorders, 900 S Limestone St,Rm 120J, Lexington, KY 40536 USA.	kathleen.youse@uky.edu			University of Kentucky [1012118180]; Cardinal Hill Rehabilitation Hospital	This research was funded by Research Support Grant #1012118180 from the University of Kentucky. The authors wish to thank A.J. for participating in this study, and Cardinal Hill Rehabilitation Hospital for their support of this research.	BLANK M, 1980, APPL PSYCHOLINGUIST, V1, P127, DOI 10.1017/S0142716400000801; BOLES L, 1993, ANN M AM SPEECH LANG; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; COELHO CA, 2007, MED SPEECH LANGUAGE, P71; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hagen C, 1979, REHABILITATION HEAD; McDonald S., 1999, BRAIN DAM B; Snow P, 1997, BRAIN INJURY, V11, P409; Struchen M. A., 2005, REHABILITATION TRAUM, P88; Turkstra LS, 2001, J COMMUN DISORD, V34, P151, DOI 10.1016/S0021-9924(00)00046-0; World Health Organization, 2007, INT CLASS FUNCT DIS; YLVISAKER M, 2008, LANGUAGE INTERVENTIO, P745; Youse KM, 2005, APHASIOLOGY, V19, P297, DOI 10.1080/02687030444000769	18	4	4	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology		2011	25	1					106	118	PII 924585253	10.1080/02687031003714467			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	714TK	WOS:000286831700007					2022-02-06	
J	Broder, JS				Broder, Joshua Seth			Head Computed Tomography Interpretation in Trauma: A Primer	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Head; Computed tomography; Trauma; Interpretation; Brain; CT; Diagnosis	DIFFUSE AXONAL INJURY; SUBDURAL HEMATOMAS; MIXED-DENSITY; CT; DIAGNOSIS; ACCURACY; MR; SENSITIVITY; HEMORRHAGE; FRACTURES	Noncontrast computed tomography (CT) provides important diagnostic information for patients with traumatic brain injury A systematic approach to image interpretation optimizes detection of pathologic air fractures hemorrhagic lesions brain parenchymal injury and abnormal cerebrospinal fluid spaces Bone and brain windows should be reviewed to enhance injury detection Findings of midline shift and mass effect should be noted as well as findings of increased intracranial pressure such as hydrocephalus and cerebral edema because these may immediately influence management Compared with CT magnetic resonance imaging may provide more sensitive detection of diffuse axonal injury but has no proven improvement in clinical outcomes This article discusses key CT interpretation skills and reviews important traumatic brain injuries that can be discerned on head CT It focuses on imaging findings that may deserve immediate surgical intervention In addition the article reviews the limits of noncontrast CT and discusses some advanced imaging modalities that may reveal subtle injury patterns not seen with CT scan	Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA		Broder, JS (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Box 3096,2301 Erwin Rd, Durham, NC 27710 USA.			Broder, Joshua/0000-0001-8030-2831			Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; American College of Radiology, 2008, ACR APPR CRIT HEAD T; Bhattacharyya N, 2004, ARCH OTOLARYNGOL, V130, P1029, DOI 10.1001/archotol.130.9.1029; Bhattacharyya N, 2003, LARYNGOSCOPE, V113, P125, DOI 10.1097/00005537-200301000-00023; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; BRODER JS, 2006, MIDNIGHT RADIOLOGY H; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Callaway CW, 2008, ANN EMERG MED, V51, P705, DOI 10.1016/j.annemergmed.2007.12.031; Choi HS, 2004, RADIOGRAPHICS, V24, P787, DOI 10.1148/rg.243035502; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; Downer JJ, 2009, CLIN RADIOL, V64, P298, DOI 10.1016/j.crad.2008.08.012; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Holodny AI, 2001, J EMERG MED, V20, P413, DOI 10.1016/S0736-4679(01)00292-X; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Huisman TAGM, 2009, J NEURORADIOLOGY, V36, P93, DOI 10.1016/j.neurad.2008.06.003; Jagoda A, 2008, ANN EMERG MED, V52, pS3, DOI 10.1016/j.annemergmed.2008.04.030; Marion DW, 2006, NEUROSURGERY, V58, P655; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; *NAT GUID CLEAR, 2006, SURG MAN AC EP HEM; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Noguchi K, 2000, AM J NEURORADIOL, V21, P923; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Perron AD, 1998, ANN EMERG MED, V32, P554, DOI 10.1016/S0196-0644(98)70032-0; Probst MA, 2009, ACAD EMERG MED, V16, P145, DOI 10.1111/j.1553-2712.2008.00312.x; Pruthi N, 2009, SURG NEUROL, V71, P202, DOI 10.1016/j.surneu.2007.10.032; Raju TNK, 1999, LANCET, V354, P1653, DOI 10.1016/S0140-6736(05)77147-6; Ratilal B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004884.pub2; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sloan T, 2010, J NEUROSURG ANESTH, V22, P59, DOI 10.1097/ANA.0b013e3181ba99a7; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; Subramanian SK, 2002, NEUROL RES, V24, P125, DOI 10.1179/016164102101199657; Syed ON, 2009, J CLIN NEUROSCI, V16, P1361, DOI 10.1016/j.jocn.2008.10.024; Wittkopf ML, 2009, OTOLARYNG HEAD NECK, V140, P306, DOI 10.1016/j.otohns.2008.12.007; WOODROW PK, 1981, CT-J COMPUT TOMOGR, V5, P199, DOI 10.1016/0149-936X(81)90031-X; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; 2009, SKULL FRACTURE TREAT	40	4	5	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					821	+		10.1016/j.psc.2010.08.006			35	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700007	21093681				2022-02-06	
J	Mclay, R; Spira, J; Reeves, D				McLay, Robert; Spira, James; Reeves, Dennis			Use of Computerized Neuropsychological Testing to Help Determine Fitness to Return to Combat Operations When Taking Medication That Can Influence Cognitive Function	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MONITORING RECOVERY; ASSESSMENT METRICS; PERFORMANCE; SOLDIERS; ANAM; IRAQ	Nowhere is it more important to maintain peek mental functioning than in a combat zone. Conditions ranging from pain to head injury to post-traumatic stress disorder can cause impairments in neuropsychological function and place service members at risk. Medications can sometimes help alleviate these problems, but also have the risk of further slowing cognitive function or impairing reaction time. Standard methods of neuropsychological testing are often not available in a combat environment. New technologies are being advanced that can allow portable, computerized neuropsychological testing to be performed at almost any location. We present a case that demonstrates how the use of such handheld technology can assist a military physician in assessing the influence of medication on reaction time and in determining if and when a service member is ready to return to combat.	[McLay, Robert] USN, San Diego Med Ctr, Dept Mental Hlth, San Diego, CA 92134 USA; [Spira, James] RTI Int, San Diego, CA 92130 USA; [Reeves, Dennis] Def Ctr Excellence, Arlington, VA 22202 USA		Mclay, R (corresponding author), USN, San Diego Med Ctr, Dept Mental Hlth, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.						BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Bleiberg J., 2006, SPORTS NEUROPSYCHOLO, P263; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Farmer K., 2003, REDUCING BURDEN HEAD, P46; Kay GG, 1997, ARCH INTERN MED, V157, P2350, DOI 10.1001/archinte.157.20.2350; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Tang V, 2007, J HEAD TRAUMA REHAB, V22, P409, DOI 10.1097/01.HTR.0000300236.21114.bc; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Warner CH, 2007, MIL MED, V172, P918, DOI 10.7205/MILMED.172.9.918; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Xydakis MS, 2008, NEW ENGL J MED, V358, P2177, DOI 10.1056/NEJMc086083	15	4	4	0	1	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	DEC	2010	175	12					945	946		10.7205/MILMED-D-09-00237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691KO	WOS:000285078900004	21265298	Bronze			2022-02-06	
J	Whyte, J				Whyte, J.			Pharmacologic treatment of cognitive and behavioral sequelae of traumatic brain injury: practicing in the absence of strong evidence	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Psychotropic drugs; Evidence-based medicine	REHABILITATION	Cognitive and behavioral sequelae of traumatic brain injury (TBI) interfere with the rehabilitation process and are among the most important sources of long-term disability. Many psychoactive drugs that have been studied in other patient populations are widely used to treat these deficits, but rigorous evidence of their efficacy in TBI is lacking. Use of psychoactive medications in the early post-injury period may appear to be clinically effective, because of the confounding effects of natural recovery. Even single subject assessment methods have limited ability to disentangle drug effects from natural recovery in this period because of the rapid pace and variability of recovery, requiring the application of more traditional parallel group controlled designs. However, the prevalent use of unproven psychoactive drugs in clinical practice can promote a culture of intervention that makes enrollment in controlled studies more challenging. For these reasons, we argue that the early use of unproven psychoactive medications after TBI should be limited, that placebo controlled group studies should be encouraged, and that single subject methods can be most productively used in later periods when natural recovery has slowed.	Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	jwhyte@einstein.edu		Whyte, John/0000-0002-4381-1474			Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; FEENEY DM, 1982, SCIENCE, P217; GUYATT G, 1988, CAN MED ASSOC J, V139, P497; Hersen M., 1976, SINGLE CASE EXPT DES; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Ritenbaugh C, ROUTINE VITAMIN SUPP; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WHYTE J, PHYS MED RE IN PRESS; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434	14	4	4	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2010	46	4					557	562					6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	712SX	WOS:000286687600012	21224788				2022-02-06	
J	Denes, Z; Lantos, A; Szel, I; Thomka, M; Vass, M; Barsi, P				Denes Zoltan; Lantos Agnes; Szel Istvan; Thomka Magdolna; Vass Matyas; Barsi Peter			IMPORTANCE OF HYDROCEPHALUS FOLLOWING SEVERE BRAIN INJURY DURING POSTACUTE REHABILITATION	IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE			Hungarian	Article						hydrocephalus; brain injury; cerebral shunt; complication; rehabilitation	POSTTRAUMATIC HYDROCEPHALUS	Objectives - We report our experiences with hydrocephalus in early rehabilitation over a seven-year period. Method - Retrospective study in Brain Injury Rehabilitation Unit of the National Institute for Medical Rehabilitation, between 1 January 2002 and 31 December 2008. Results - At our institute in the last seven years, we treated 83 patients with secondary and six patients with primary hydrocephalus. The majority of hydrocephalus was of post traumatic origin (52) and remaining 23 following stroke (SAH, AVM, ICH) or brain operation (tumour - seven, and one cranioplasty), and all these patients had undergone ventricular shunt implantation. Mean age of patients was 36 (14-80) years. Hydrocephalus was diagnosed in our rehabilitation unit in 20 of 83 cases and the other patients were shunted before transfer to our unit. The median time point of shunting was 70 (range: 20-270) days after trauma, brain surgery or stroke. Post-operative complications were seen in 12 of 89 patients: six infections and six shunt failure and revision was necessary in 14%. In PTH cases, the post-operative improvement was seen in 40 of 52 patients being shunted and corresponded to FIM scores. At the other 31 cases, with non-traumatic origin, only two patients remain unchanged. Conclusions - Hydrocephalus is considered to be a frequent and important complication after severe brain damage. The incidence of hydrocephalus treated with shunt implantation in our neuro-rehabilitation unit was 4.4%. The postoperative improvement was 77%. Posttraumatic hydrocephalus concerns 5.2% of patients with severe TBI during last seven years in our institution. Diagnosis of posttraumatic hydrocephalus was established in 24%, and complication after shunt implantation (14%) was also recognized in the post-acute rehabilitation unit. It is strongly recommended for the team working at such type of units to obtain clinical practice. Teamwork, good cooperation between acute and postacute-care is necessary for successful rehabilitation of these patients.	[Denes Zoltan; Lantos Agnes; Szel Istvan; Thomka Magdolna; Vass Matyas] Orszagos Orvosi Rehabil Int, H-1121 Budapest, Hungary; [Barsi Peter] Semmelweis Egyet, Szentagothai Janos Tudaskozpont, MR Kutatokozpont, Budapest, Hungary		Denes, Z (corresponding author), Orszagos Orvosi Rehabil Int, Szanatorium Utca 19, H-1121 Budapest, Hungary.	z.denes@rehabint.hu	Denes, Zoltan/ABD-3470-2021				ADAMS RD, 2005, PRINCIPLES NEUROLOGY, P529; Dandy WE, 1914, AM J DIS CHILD, V8, P406; DOCZI T, 1995, IDEGGYOGYASZATI SZEM, V48, P156; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guyot LL, 2000, NEUROL RES, V22, P25; Kim Seok Won, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P211; KORDAS M, 2001, IDEGGYOGY SZERNLE, V54, P207; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MORI K, 1995, BRAIN DEV-JPN, V17, P338, DOI 10.1016/0387-7604(95)00070-R; Paoletti P, 1983, J Neurosurg Sci, V27, P171; Tribl G, 2000, BRAIN INJURY, V14, P345	11	4	6	0	1	LITERATURA MEDICA	BUDAPEST	MARGIT KRT 31-33, BUDAPEST, 1024, HUNGARY	0019-1442			IDEGGYOGY SZEMLE	Ideggyogy. Szle.	NOV 30	2010	63	11-12					397	401					5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	716KI	WOS:000286967100004	21413441				2022-02-06	
J	Rapoport, M				Rapoport, Mark			Depression Complicating Traumatic Brain Injury: The Path to a Poor Prognosis	PSYCHIATRIC ANNALS			English	Article							RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSION; HEAD-INJURY; PSYCHIATRIC-DISORDERS; FOLLOW-UP; MILD; SYMPTOMS; MODERATE; REHABILITATION; CONSEQUENCES		[Rapoport, Mark] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Rapoport, Mark] Sunnybrook Hlth Sci Ctr, Geriatr Traumat Brain Injury Clin, Toronto, ON, Canada		Rapoport, M (corresponding author), Bayview Ave, Toronto, ON M4N 3M5, Canada.	mark.rapo-port@sunnybrook.ca	Rapoport, Mark/AAD-8581-2020				Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FEDOROFF JP, 1991, AM J PSYCHIAT, V148, P1172; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	47	4	4	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	NOV	2010	40	11					581	587		10.3928/00485713-20101015-08			7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	736IX	WOS:000288488200008					2022-02-06	
J	Van Dyke, SA; Axelrod, BN; Schutte, C				Van Dyke, Sarah A.; Axelrod, Bradley N.; Schutte, Christian			The Utility of the Post-concussive Symptom Questionnaire	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Post-concussion syndrome; Test validity; Effort	FAKE-BAD SCALE; PERSONAL-INJURY CLAIMANTS; MILD HEAD-INJURY; RESPONSE BIAS; BRAIN-INJURY; MMPI-2; VALIDITY; RBS	The Post-concussive Symptom Questionnaire (PCSQ) and its short forms were evaluated to determine their utility in measuring symptom validity as brief self-report measures in 112 individuals referred for a neuropsychological evaluation. First, the relationships between the PCSQ forms and measures of cognitive performance (Wechsler Adult Intelligence Scale-Fourth Edition Full-Scale IQ, California Verbal Learning Test-Second Edition Trials 1-5 Total T-score, Trails B, FAS), general distress (Minnesota Multiphasic Personality Inventory [MMPI]-2 M8), and self-report symptom validity (MMPI-2 FBS Symptom Validity Scale [FBS] and Response Bias Scale [RBS]) were investigated to determine construct validity. Measures of self-report symptom validity explained the greatest amount of variance. Second, receiver operating characteristics curve analyses were conducted to determine the predictive value of the PCSQ forms in detecting over reporting on the FBS and the RBS in addition to establishing optimal cutoff scores. On the basis of the proposed cutoff scores, sensitivity, specificity, positive predictive power, negative predictive power, and hit rates were calculated.	[Van Dyke, Sarah A.; Axelrod, Bradley N.; Schutte, Christian] Psychol Serv MH11 PS, John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA		Van Dyke, SA (corresponding author), Psychol Serv MH11 PS, John D Dingell Vet Affairs Med Ctr, 4646 John R St, Detroit, MI 48201 USA.	sarah.vandyke@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs	This work was supported by the Department of Veterans Affairs Predoctoral Associated Health Rehabilitation Research Fellowship Program.	Allen L., 1997, CARB 97 MANUAL COMPU; BOONE KB, 1995, J CLIN PSYCHOL, V51, P457, DOI 10.1002/1097-4679(199505)51:3<457::AID-JCLP2270510322>3.0.CO;2-7; Butcher J, 1989, MANUAL ADM SCORING M; Delis D.C., 2000, CALIFORNIA VERBAL LE; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Graham JR, 2002, J PERS ASSESS, V78, P334, DOI 10.1207/S15327752JPA7802_08; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Green P, 1995, MANUAL ORAL WORD MEM; Heaton R. K., 2004, REVISED COMPREHENSIV; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILLIS SR, 2007, INT NEUR SOC 35 ANN; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Psychological Corporation, 2009, ADV CLIN SOL WAIS 4; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; The Psychological Corporation, 2008, WECHSL AD INT SCAL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsanadis J., 2007, INT NEUR SOC 35 ANN; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928	28	4	4	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2010	25	7					634	639		10.1093/arclin/acq063			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	673KK	WOS:000283658500005	20710017	Bronze			2022-02-06	
J	Adeleye, AO; Olayemi, O				Adeleye, Amos Olufemi; Olayemi, Oladapo			Basilar Skull Fracture: Outcome of Acute Care without Antibiotic Prophylaxis in a Nigerian Neurosurgical Unit	TURKISH NEUROSURGERY			English	Article						Basal skull fracture; Antibiotic prophylaxis; Developing countries; Skull facture	CEREBROSPINAL-FLUID LEAKAGE; HEAD-INJURY; MANAGEMENT; MENINGITIS; TRAUMA	AIM: A prospective observational study of the in-hospital outcome of the management of BSF without antibiotic prophylaxis in a Nigerian neurosurgical unit. MATERIAL and METHODS: All cases of HI with clinical diagnosis of BSF over an 8-month period were reviewed. Their demographic, clinical, and in-hospital outcome parameters were analysed. We also compared some clinical and outcome characteristics between this study group and a contemporary cohort of patients in our unit with Head Injury but without CSF leak RESULTS: There were 47 cases. The CSF leak was from the nostrils in 18 (38.3%), the ears in 16 (34.04%), and both ears and nostrils in 12 (25.53%). The cause of injury was road accidents in 91%, and the severity of the Head Injury was mild, moderate and severe respectively in 42.55, 25.53 and 31.91%. Meningitis occurred in 2 patients (4.25%); in-hospital outcome was good in 68.1% and poor in 31.9% and this was significantly (p <0.05) affected primarily by the severity of the brain injuries. These in-hospital outcome rates and their determinants were similar to those in our unit's contemporary cohort of Head Injury without BSF. CONCLUSION: Management of traumatic BSF without antibiotic prophylaxis in a developing country setting has not been accompanied with an increased rate of unfavourable outcome.	[Adeleye, Amos Olufemi] Univ Ibadan, Div Neurol Surg, Dept Surg, Coll Med, Ibadan, Nigeria; [Olayemi, Oladapo] Univ Ibadan, Dept Obstet & Gynaecol, Coll Med, Ibadan, Nigeria		Adeleye, AO (corresponding author), Univ Ibadan, Div Neurol Surg, Dept Surg, Coll Med, Ibadan, Nigeria.	femdoy@yahoo.com					Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Ash G. J., 1992, Brain Injury, V6, P521, DOI 10.3109/02699059209008149; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; CLEMENZA JW, 1995, J ORAL MAXIL SURG, V53, P1004, DOI 10.1016/0278-2391(95)90114-0; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; DUNN LT, 1994, ANN ROY COLL SURG, V76, P147; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; Eftekhar B, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-2; ELJAMEL MS, 1993, BRIT J NEUROSURG, V7, P501, DOI 10.3109/02688699308995072; ELJAMEL MS, 1990, R J NEUROSURG, V4, P381; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; HAINES SJ, 1980, NEUROSURGERY, V6, P355, DOI 10.1227/00006123-198004000-00001; HOFF JT, 1976, J NEUROSURG, V44, P649; IGNELZI RJ, 1975, J NEUROSURG, V43, P721, DOI 10.3171/jns.1975.43.6.0721; Klastersky J, 1976, Surg Neurol, V6, P111; LEECH PJ, 1973, LANCET, V1, P1013; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; RATHORE MH, 1991, PEDIATR INFECT DIS J, V10, P87, DOI 10.1097/00006454-199102000-00001; Ratilal B, 2006, COCHRANE DB SYST REV, V25; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	24	4	5	0	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	OCT	2010	20	4					430	436					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	678NU	WOS:000284087100003	20963690	Bronze			2022-02-06	
J	Coll, GF; Del Rio, LT; Nuno, LG; Burniol, JR; Carol, RH				Figueras Coll, Guillem; Torrededia Del Rio, Laura; Garcia Nuno, Laura; Roca Burniol, Jaume; Huguet Carol, Ramon			Traumatic hip dislocation in childhood	HIP INTERNATIONAL			English	Article						Children; Traumatic hip dislocations	CHILDREN	We report the outcome of closed reduction of traumatic hip dislocation in 28 children younger than 16 years of age (average age, 8 years 10 months). At an average follow-up of 8 years and 10 months (range, 2 years - 42 years), 18 patients were asymptomatic and enjoying a normal life, and some of them returned to practice sport activities. The remainder had complications related to associated injuries. There were no cases of avascular necrosis of the femoral head during follow-up. The majority of dislocations were attributable to low energy injuries in children younger than 10 years of age. Traumatic hip dislocation in children is uncommon. Management after reduction is not clearly defined in the literature. It is important to perform reduction as soon as possible to avoid later avascular necrosis.	[Figueras Coll, Guillem; Torrededia Del Rio, Laura; Garcia Nuno, Laura; Roca Burniol, Jaume] Hosp Badalona Germans Trias & Pujol, Dept Traumatol & Orthopaed Surg, Badalona 08916, Spain; [Huguet Carol, Ramon] Hosp Univ St Joan de Deu, Barcelona, Spain		Coll, GF (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Traumatol & Orthopaed Surg, Ctra Canyet S-N, Badalona 08916, Spain.	guillem9279@hotmail.com					ATTIA MW, 1995, PEDIATR EMERG CARE, V11, P291, DOI 10.1097/00006565-199510000-00006; Ayadi K, 2008, REV CHIR ORTHOP, V94, P19, DOI 10.1016/j.rco.2007.10.001; BARQUET A, 1979, ACTA ORTHOP SCAND, V50, P549, DOI 10.3109/17453677908989803; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P815, DOI 10.3109/17453678208992299; FUNK FJ, 1962, J BONE JOINT SURG AM, V44, P1135, DOI 10.2106/00004623-196244060-00008; GIANOM D, 1994, HELV CHIR ACTA, V60, P623; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; Herrera-Soto JA, 2009, J AM ACAD ORTHOP SUR, V17, P15, DOI 10.5435/00124635-200901000-00003; Kumar S, 2005, CLIN ORTHOP RELAT R, P9, DOI 10.1097/01.blo.0000152366.58660.ea; Kumar S, 1999, ACTA ORTHOP SCAND, V70, P599, DOI 10.3109/17453679908997849; Kutty S, 2001, PEDIATR EMERG CARE, V17, P32, DOI 10.1097/00006565-200102000-00009; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Moseley C F, 1992, Instr Course Lect, V41, P397; Muratli Hasan Hilmi, 2004, Acta Orthop Traumatol Turc, V38, P149; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; Prat J, 1971, AN HOSP ST PAU, V31, P249; RIEGER H, 1991, ARCH ORTHOP TRAUM SU, V110, P114, DOI 10.1007/BF00393886; Salisbury RD, 2000, CLIN ORTHOP RELAT R, P106; SCHLONSKY J, 1973, J BONE JOINT SURG AM, VA 55, P1057, DOI 10.2106/00004623-197355050-00015; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Vialle R, 2004, PEDIATR RADIOL, V34, P970, DOI 10.1007/s00247-004-1299-0; Zrig M, 2009, ACTA ORTHOP BELG, V75, P328	22	4	4	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1120-7000	1724-6067		HIP INT	Hip Int.	OCT-DEC	2010	20	4					524	528		10.1177/112070001002000417			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	695ZT	WOS:000285412400016	21157759				2022-02-06	
J	Folker, JE; Murdoch, BE; Cahill, LM; Rosen, KM; Delatycki, MB; Corben, LA; Vogel, AP				Folker, Joanne E.; Murdoch, Bruce E.; Cahill, Louise M.; Rosen, Kristin M.; Delatycki, Martin B.; Corben, Louise A.; Vogel, Adam P.			Differentiating Impairment Levels in Temporal Versus Spatial Aspects of Linguopalatal Contacts in Friedreich's Ataxia	MOTOR CONTROL			English	Article						motor control; neurophysiology; rehabilitation	TRAUMATIC BRAIN-INJURY; TONGUE-PALATE CONTACT; ELECTROPALATOGRAPHIC ASSESSMENT; DYSARTHRIA; PATTERNS; DISEASE	Electropalatography (EPG) was used to describe the pattern of linguopalatal contact and the consonant phase durations exhibited by a group of seven individuals with dysarthria associated with Friedreich's ataxia (FRDA). A group of 14 non-neurologically impaired individuals served as controls. The Reading Electropalatograph (EPG3) system was used to record linguopalatal contact during production of the target consonants (/t/, /l/, /s/, /k/) elicited in five words of CV and CVC construction, with the target consonants in word initial position. These words were embedded into short sentences and repeated five times by each participant. The FRDA group exhibited significantly increased consonant durations compared with the controls while maintaining normal linguopalatal contact patterns. These findings suggest that the articulatory impairment in FRDA manifests as a temporal rather than spatial disturbance.	[Folker, Joanne E.; Murdoch, Bruce E.; Rosen, Kristin M.] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Delatycki, Martin B.; Corben, Louise A.; Vogel, Adam P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; [Cahill, Louise M.] Royal Childrens Hosp, Herston, Qld, Australia		Folker, JE (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia.		Cahill, Louise/C-7919-2012; Delatycki, Martin B/A-5409-2013; Murdoch, Bruce E/C-1397-2012; Vogel, Adam/ABD-7685-2020	Vogel, Adam/0000-0002-3505-2631; Cahill, Louise/0000-0003-3662-896X	Friedreich's Ataxia Research Alliance (FARA), USA; Friedreich's Ataxia Research Association, Australasia	The authors wish to thank the participants involved in this research. This project was funded by a research grant from the Friedreich's Ataxia Research Alliance (FARA), USA, and the Friedreich's Ataxia Research Association, Australasia. MBD is an NHMRC Practitioner Fellow.	ACKERMANN H, 1993, CLIN LINGUIST PHONET, V7, P75, DOI 10.3109/02699209308985545; BARRY RM, 1995, CASE STUDIES CLIN LI, P181; Blaney B, 2007, INT J LANG COMM DIS, V42, P19, DOI 10.1080/13682820600690993; Brown J.R., 1975, MOTOR SPEECH DISORDE; Cheng HY, 2007, J SPEECH LANG HEAR R, V50, P375, DOI 10.1044/1092-4388(2007/027); Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; Delatycki MB, 1999, AM J MED GENET, V87, P168, DOI 10.1002/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Duffy JR., 2020, MOTOR SPEECH DISORDE; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Folker J, 2010, FOLIA PHONIATR LOGO, V62, P97, DOI 10.1159/000287207; GENTIL M, 1990, BRAIN LANG, V38, P438, DOI 10.1016/0093-934X(90)90126-2; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Gibbon FE, 2003, INT J LANG COMM DIS, V38, P47, DOI 10.1080/13682820304816; Gilman S., 1985, CEREBELLAR FUNCTIONS, P148; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; JOANETTE Y, 1980, BRAIN LANG, V10, P39, DOI 10.1016/0093-934X(80)90036-X; KELLER E, 1990, NATO ADV SCI I D-BEH, V55, P343; Kuruvilla MS, 2008, CLIN LINGUIST PHONET, V22, P703, DOI 10.1080/02699200802176378; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P1, DOI 10.1080/02699200400001044; McAuliffe MJ, 2005, J MED SPEECH-LANG PA, V13, P149; McAuliffe MJ, 2003, CLIN LINGUIST PHONET, V17, P43, DOI 10.1080/0269920021000066846; Murdoch BE, 2000, J MED SPEECH-LANG PA, V8, P359; Schols L, 1997, BRAIN, V120, P2131, DOI 10.1093/brain/120.12.2131; SCOTT D, 2002, EPGLAB MANUAL; VIVANI P, 1991, DEV TIMING CONTROL T, P1; [No title captured]	31	4	4	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1087-1640			MOTOR CONTROL	Motor Control	OCT	2010	14	4					490	508		10.1123/mcj.14.4.490			19	Neurosciences; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Sport Sciences	677LL	WOS:000283993800006	21051790				2022-02-06	
J	Kingston, J; Katsaros, J; Vu, Y; Goodrich, GL				Kingston, John; Katsaros, Jennifer; Vu, Yurika; Goodrich, Gregory L.			Neurological Vision Rehabilitation: Description and Case Study	JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS			English	Article							TRAUMATIC BRAIN-INJURY; VISUAL-FIELD DEFECTS; STROKE PATIENTS; IMPAIRMENT; HEMIANOPIA; EXPANSION; HEALTH	The wars in Afghanistan and Iraq have been notable for the high rates of traumatic brain injury (TBI) that have been incurred by the troops. Visual impairments often occur following TBI and present new challenges for rehabilitation. We describe a neurological vision rehabilitation therapy that addresses the unique needs of patients with vision loss that is due to TBI.	[Kingston, John; Katsaros, Jennifer; Vu, Yurika; Goodrich, Gregory L.] VA Palo Alto Hlth Care Syst, Western Blind Rehabil Ctr, Palo Alto, CA 94304 USA			john.kingston@va.gov; jennifer.katsaros@va.gov; yurika.vu@va.gov; gregory.goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019				Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bouwmeester L, 2007, J NEUROL NEUROSUR PS, V78, P555, DOI 10.1136/jnnp.2006.103853; Bowers AR, 2008, ARCH OPHTHALMOL-CHIC, V126, P657, DOI 10.1001/archopht.126.5.657; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Diamond PT, 2001, DISABIL REHABIL, V23, P407, DOI 10.1080/09638280010008834; GELLARLY A, 1998, INTRO MIND BRAIN; Gianutsos R, 1991, J BEHAV OPTOMETRY, V2, P143; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; HOWARD P, 2006, OWNERS MANUAL BRAIN; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Klavora P, 1998, PERCEPT MOTOR SKILL, V86, P23, DOI 10.2466/pms.1998.86.1.23; KOONS P, EYE BRAIN IN PRESS; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Marshall RS, 2009, NEUROLOGIST, V15, P185, DOI 10.1097/NRL.0b013e3181942894; McInnes JK., 2000, VIS IMPAIR RES, V2, P129, DOI DOI 10.1076/VIMR.2.3.129.4422; Pambakian A, 2005, J NEURO-OPHTHALMOL, V25, P136; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; PELI E, 2000, VISION REHABILITATIO, P104; PEREZ AM, 2000, VISION 99 VISION REH, P110; RATEY JJ, 2002, USERS GUIDE BRAIN; Riggs RV, 2007, AM J PHYS MED REHAB, V86, P853, DOI 10.1097/PHM.0b013e318151f907; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; Sabel B A, 2000, Curr Opin Ophthalmol, V11, P430, DOI 10.1097/00055735-200012000-00008; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Szlyk JP, 2005, OPHTHAL PHYSL OPT, V25, P128, DOI 10.1111/j.1475-1313.2004.00265.x; TABER KH, 2008, CLIN NEUROSCI, V18, P141; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; VANDUESEN J, 1993, BODY IMAGE PERCEPTUA; WEBSTER JS, 1984, BEHAV THER, V15, P129, DOI 10.1016/S0005-7894(84)80015-5; Yu W, 2003, MED CARE RES REV, V60, p40S, DOI 10.1177/1077558703256724; [No title captured]	35	4	4	0	7	AMER FOUNDATION BLIND	NEW YORK	J VISUAL IMPAIRMENT BLINDNESS 2 PENN PLAZA, SUITE 1102, NEW YORK, NY 10121 USA	0145-482X			J VISUAL IMPAIR BLIN	J. Vis. Impair. Blind.	OCT	2010	104	10			SI		603	612		10.1177/0145482X1010401006			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	665HN	WOS:000283026100006					2022-02-06	
J	Lamontagne, ME; Swaine, BR; Lavoie, A; Champagne, F; Marcotte, AC				Lamontagne, Marie-Eve; Swaine, Bonnie R.; Lavoie, Andre; Champagne, Francois; Marcotte, Anne-Claire			Consensus group sessions: a useful method to reconcile stakeholders' perspectives about network performance evaluation	INTERNATIONAL JOURNAL OF INTEGRATED CARE			English	Article						integrated health care delivery; network; evaluation; performance; brain injury	HOSPITAL PERFORMANCE	Background: Having a common vision among network stakeholders is an important ingredient to developing a performance evaluation process. Consensus methods may be a viable means to reconcile the perceptions of different stakeholders about the dimensions to include in a performance evaluation framework. Objectives: To determine whether individual organizations within traumatic brain injury (TBI) networks differ in perceptions about the importance of performance dimensions for the evaluation of TBI networks and to explore the extent to which group consensus sessions could reconcile these perceptions. Methods: We used TRIAGE, a consensus technique that combines an individual and a group data collection phase to explore the perceptions of network stakeholders and to reach a consensus within structured group discussions. Results: One hundred and thirty-nine professionals from 43 organizations within eight TBI networks participated in the individual data collection; 62 professionals from these same organisations contributed to the group data collection. The extent of consensus based on questionnaire results (e.g. individual data collection) was low, however, 100% agreement was obtained for each network during the consensus group sessions. The median importance scores and mean ranks attributed to the dimensions by individuals compared to groups did not differ greatly. Group discussions were found useful in understanding the reasons motivating the scoring, for resolving differences among participants, and for harmonizing their values. Conclusion: Group discussions, as part of a consensus technique, appear to be a useful process to reconcile diverging perceptions of network performance among stakeholders.	[Swaine, Bonnie R.] Univ Montreal, Fac Med, Sch Rehabil, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; [Lavoie, Andre] Univ Quebec, Ctr Rech FRSQ CHA Ctr Hosp, Unite Traumatol Urgence Soins Intensifs, Unit Traumatol Emergency Med Intens Care,CHA,FRSQ, Quebec City, PQ G1J 1Z4, Canada; [Champagne, Francois] Univ Montreal, Dept Hlth Adm, Montreal, PQ H3C 3J7, Canada; [Marcotte, Anne-Claire] Agcy Evaluat Hlth Technol & Intervent, Montreal, PQ H3A 2S9, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, Ecole Readaptat, 7077 Ave Parc,CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); ANEIS program; Programme de Recherche en Readaptation et en Integration Sociale (PRISST)	Preparation of this article was supported by scholarships awarded to the first author by the Canadian Institutes for Health Research, the ANEIS program, and the Programme de Recherche en Readaptation et en Integration Sociale (PRISST).	Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4; Bryson JM, 2006, PUBLIC ADMIN REV, V66, P44, DOI 10.1111/j.1540-6210.2006.00665.x; Connolly T., 1980, ACAD MANAGE REV, V5, P211, DOI DOI 10.5465/AMR.1980.4288727; Contandriopoulos AP, 2001, REV TRANSDISCIP SANT, V8, P38; Dijk JAGMV, 1990, TECHNOLOGICAL FORECA, P293; Finucane PM, 2002, MED EDUC, V36, P959, DOI 10.1046/j.1365-2923.2002.01314.x; Fleury MJ, 2006, HEALTH SERV MANAG RE, V19, P153, DOI 10.1258/095148406777888080; Gagliardi A, 2008, INT J HEALTH CARE Q, V21, P175, DOI 10.1108/09526860810859030; Goodwin N, 2004, MANAGING DIVERSE NET; Guisset AL, 2002, SCI SOC SANTE, V20, P65, DOI 10.3406/sosan.2002.1553; Huxham C., 2003, PUBL MANAG REV, V5, P401, DOI [10.1080/1471903032000146964, DOI 10.1080/1471903032000146964]; Huxham C., 2005, MANAGING COLLABORATE; Keast R, 2004, PUBLIC ADMIN REV, V64, P363, DOI 10.1111/j.1540-6210.2004.00380.x; Keast Robyn., 2007, INT PUBLIC MANAG J, V10, P9, DOI [10.1080/10967490601185716, DOI 10.1080/10967490601185716]; Kenis P, 2009, PUBLIC ADMIN, V87, P440, DOI 10.1111/j.1467-9299.2009.01775.x; Lamontagne ME, 2010, BRAIN INJURY, V24, P812, DOI 10.3109/02699051003789252; LEGGAT S, 1997, HEALTHCARE MANAGEMEN, V10, P19; Leutz WN, 1999, MILBANK Q, V77, P77, DOI 10.1111/1468-0009.00125; Mandell Myrna, 2007, PUBLIC PERFORM MANAG, V30, P574, DOI DOI 10.2753/PMR1530-9576300406; Mandell M, 2008, PUBLIC MANAG REV, V10, P715, DOI 10.1080/14719030802423079; Minvielle E, 2008, HEALTH POLICY, V87, P8, DOI 10.1016/j.healthpol.2007.09.017; P?pin G., 2002, EVAL J AUST, V2, P45, DOI [10.1177/1035719X0200200212, DOI 10.1177/1035719X0200200212]; Provan KG, 2005, PUBLIC ADMIN REV, V65, P603, DOI 10.1111/j.1540-6210.2005.00487.x; PROVAN KG, 1995, ADMIN SCI QUART, V40, P1, DOI 10.2307/2393698; Sicotte C, 1998, Health Serv Manage Res, V11, P24; SWAINE B, 2000, BRAIN INJURY, V7, P575; Tregunno D, 2004, HEALTH SERV RES, V39, P771, DOI 10.1111/j.1475-6773.2004.00257.x; Waldfogel J, 1997, SOC SERV REV, V71, P463, DOI 10.1086/604266; Zinn J, 2001, HEALTH CARE MANAGE R, V26, P40, DOI 10.1097/00004010-200101000-00004	29	4	4	1	1	UBIQUITY PRESS LTD	LONDON	2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND	1568-4156			INT J INTEGR CARE	Int. J. Integr. Care	OCT-DEC	2010	10												11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	V25PY	WOS:000208491100003		gold, Green Published			2022-02-06	
J	Samartkit, N; Kasemkitvattana, S; Thosingha, O; Vorapongsathorn, T				Samartkit, Niphawan; Kasemkitvattana, Saipin; Thosingha, Orapan; Vorapongsathorn, Thavatchai			Caregiver Role Strain and Rewards: Caring for Thais with a Traumatic Brain Injury	PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH			English	Article						Caregiver; Traumatic brain injury; Rewards of caregiving; Caregiver role strain		Using a predictive model, this study sought to examine, among 291 traumatic brain injury (TBI) survivor-caregiver pairs, causal relationships among care receiver functional status, relationship of caregiver with care receiver, caregiver mutuality, caregiver preparedness, care receiver amount of care and caregiver health as they relate to caregiver role strain and rewards of caregiving. The conceptual framework was guided by the symbolic interactionist perspective of role strain theory and related literature regarding caregiving and TBI survivors. Data were collected, in eight provinces in eastern Thailand, via nine questionnaires, and analyzed through descriptive statistics, Pearson's correlation coefficient and path analysis. The final model fit the data well and explained variance in caregiver strain (46%), rewards of caregiving (41%), caregiver health (19%) and amount of care (33%). The model illustrated care receiver function had a direct negative effect on amount of care. Care receiver amount of care had a direct positive effect on caregiver role strain, a negative direct effect on caregiver health and mediated the effect of care receiver function on caregiver role strain and health. The caregiver/care receiver relationship had a positive direct effect on the caregiver's health, while the caregiver's health had a positive direct effect on the caregiver's role strain. The caregiver's health mediated the effect of the caregiver/care receiver relationship on the caregiver's role strain. Caregiver mutuality had a direct positive effect on amount of care and rewards of caregiving, but a negative direct effect on caregiver role strain. In addition, care receiver amount of care mediated the effect of caregiver mutuality on caregiver health. Caregiver preparedness had a direct positive effect on rewards of caregiving and caregiver health, and a direct negative effect on caregiver strain. The findings suggest that enhancing caregivers' mutuality, preparedness and health may reduce caregivers' role strain, and increase caregivers' perceptions of the rewards of caregiving.	[Samartkit, Niphawan; Kasemkitvattana, Saipin; Thosingha, Orapan] Mahidol Univ, Fac Nursing, Bangkok, Thailand; [Vorapongsathorn, Thavatchai] Mahidol Univ, Fac Publ Hlth, Bangkok, Thailand		Samartkit, N (corresponding author), Mahidol Univ, Fac Nursing, Bangkok, Thailand.	Niphawan@buu.ac.th					ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; ARCHBOLD PG, 1990, RES NURS HEALTH, V13, P375, DOI 10.1002/nur.4770130605; ARCHBOLD PG, 1995, RES NURS HEALTH, V18, P3, DOI 10.1002/nur.4770180103; Archbold PG, 1992, KEY ASPECTS ELDER CA, P328; Archbold PG, 1986, FAMILY CAREGIV UNPUB; Bookwala J, 2000, PSYCHOL AGING, V15, P607, DOI 10.1037/0882-7974.15.4.607; Bugge C, 1999, STROKE, V30, P1517, DOI 10.1161/01.STR.30.8.1517; Bull M J, 1990, West J Nurs Res, V12, P758, DOI 10.1177/019394599001200605; Carney N., 1998, THESIS; Cavallo MM, 2005, TXB TRAUMATIC BRAIN; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; de Frias CM, 2005, AGING MENT HEALTH, V9, P331, DOI 10.1080/13607860500089674; Eldredge DH, 2006, J PSYCHOSOC ONCOL, V24, P53, DOI 10.1300/J077v24n03_03; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Giarelli E., 2003, J FAMILY NURSING, V9, P453, DOI DOI 10.1177/1074840703258317; Grant G, 1998, J INTELL DISABIL RES, V42, P58, DOI 10.1046/j.1365-2788.1998.00079.x; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Heru AM, 2004, J AFFECT DISORDERS, V83, P221, DOI 10.1016/j.jad.2004.04.013; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kneeshaw MF, 1999, APPL NURS RES, V12, P128, DOI 10.1016/S0897-1897(99)80034-2; Kramer BJ, 1997, GERONTOLOGIST, V37, P218, DOI 10.1093/geront/37.2.218; LaRossa Ralph, 1993, SOURCEBOOK FAMILY TH, P135, DOI DOI 10.1007/978-0-387-85764-0_6; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MUI AC, 1993, RES AGING, V15, P50, DOI 10.1177/0164027593151003; Narayan S, 2001, J Gerontol Nurs, V27, P19; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Potaya S., 2001, THESIS; Reid CE, 2005, AUST J PSYCHOL, V57, P186, DOI 10.1080/00049530500141022; Reiss, 1979, CONT THEORIES FAMILY, P42; Riedel SE, 1998, J GERONTOL B-PSYCHOL, V53, pP165, DOI 10.1093/geronb/53B.3.P165; Scherbring Mary, 2002, Oncol Nurs Forum, V29, pE70, DOI 10.1188/02.ONF.E70-E76; Schumacher KL, 2008, ONCOL NURS FORUM, V35, P49, DOI 10.1188/08.ONF.49-56; Smith A M, 1998, Rehabil Nurs, V23, P252; Tatham, 1998, MULTIVARIATE DATA AN; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wirojratana V., 2002, THESIS	40	4	4	0	0	THAILAND NURSING & MIDWIFERY COUNCIL	NONTHABURI	NAGARINDRASRI BLDG, MINISTRY PUBLIC HEALTH, NONTHABURI, 11000, THAILAND	1906-8107			PAC RIM INT J NURS R	Pac. Rim Int. J. Nurs. Res.	OCT-DEC	2010	14	4					297	+					18	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V6J8D	WOS:000420348600003					2022-02-06	
J	Shehab, HA; Nassar, YH				Shehab, Hany A.; Nassar, Yaser H.			Neuromarkers as diagnostic adjuvant to cranial CT in closed traumatic brain injury patients admitted to ICU: A preliminary comparative study	EGYPTIAN JOURNAL OF ANAESTHESIA			English	Article						Neuromarkers; Traumatic brain injury; S100 protein; NSE; GFAP		Objectives: Evaluating the diagnostic and/or prognostic yield of serum levels of three neuromarkers, serum S100 protein, neuron-specific enolase (NSE) and Glial Fibrillary Acidic Protein (GFAP), in patients who were admitted to surgical intensive care unit (SICU) and had closed traumatic brain injury with suspicious presence of intracranial hematoma compared versus cranial CT (CCT) as a gold standard diagnostic modality. Patients and methods: The study included 70 patients who had sustained a closed traumatic brain injury (TBI) requiring intensive care and/or surgical interference. All patients underwent clinical evaluation for all traumatized organs using Injury Severity Score (ISS) and concerning TBI Glasgow Coma Scale (GCS) score was recorded after non-surgical resuscitation. Then, all underwent CT scanning of the brain and patients with a surgically treatable mass underwent decompressive craniotomy, while patients free of hematoma or with minute-to-small hematoma not necessitating surgical interference were kept under observation. Venous blood samples were obtained from all enrolled patients at time of admission and patients who showed deterioration during conservative treatment gave second sample for ELISA estimation of serum S100 protein, NSE and GFAP. Results: Forty-three patients had intracranial hematoma (Positive CCT); 26 patients underwent surgical interference, while the other 17 hematoma patients and 27 hematoma free patients (Negative CCT) were kept under observation. Of them 15 patients; 10 with hematoma and five who were hematoma free developed symptoms of increased ICP and follow-up CCT examination defined five cases required surgical interference with 66.7% rate for unnecessary follow-up CCT. Thirty-nine patients (55.7%) responded to conservative treatment and were discharged to the ward, while a total of 31 patients (44.3%) had surgical interference. Mean serum levels of studied parameters were significantly higher in all patients compared to controls with significantly higher levels in patients who had positive CCT compared to those who had negative CCT and in patients who required surgical interference compared to those managed conservatively. Patients who showed deterioration had significantly 2nd sample higher serum levels of S100 protein and GFAP, but non-significantly higher serum NSE levels compared to at admission levels. Percentage of increase of serum GFAP levels in follow-up sample obtained from patients who had positive CCT was significantly higher compared to the percentage of increase in serum S100 protein and NSE. Conclusion: Estimation of serum levels of neuromarkers as adjuvant diagnostic and prognostic tools for closed TBI patients, but serum level of GFAP showed superior applicability and was more valid prognostic modality that could spare unnecessary CCT if applied as the percentage of change in comparison to at admission levels. (C) 2010 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.	[Shehab, Hany A.] Cairo Univ, Dept Anaesthesia, Fac Med, Cairo, Egypt; [Nassar, Yaser H.] Cairo Univ, Dept Med Biochem, Fac Med, Cairo, Egypt		Shehab, HA (corresponding author), Cairo Univ, Dept Anaesthesia, Fac Med, Cairo, Egypt.	Hanyshehab603@yahoo.com					Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; Benneker LM, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-13; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Foerch C, 2003, CEREBROVASC DIS, V16, P45; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; HAY E, 1984, J NEUROL NEUROSUR PS, V47, P724, DOI 10.1136/jnnp.47.7.724; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Kligman D, 1998, TRENDS BIOCHEM SCI, V11, P437; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARANGOS PJ, 1979, J NEUROCHEM, V33, P319, DOI 10.1111/j.1471-4159.1979.tb11735.x; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Rallidis LS, 2006, ATHEROSCLEROSIS, V189, P193, DOI 10.1016/j.atherosclerosis.2005.11.032; Svoboda P, 2007, HEPATO-GASTROENTEROL, V54, P359; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Unden J, 2009, J NEUROL, V256, P72, DOI 10.1007/s00415-009-0054-8; Vajtr D, 2007, Soud Lek, V52, P43; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	29	4	4	0	0	EGYPTIAN SOC ANAESTHESIOLOGISTS	CAIRO	CENTRAL SOC EGYPTIAN ANAESTHESIOLOGISTS, PANORAMA OCTOBER, PO BOX 167, CAIRO, 00000, EGYPT	1110-1849	1687-1804		EGYPT J ANAESTH	Egypt. J. Anaesth.	OCT	2010	26	4					267	272		10.1016/j.egja.2010.05.001			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V0T6N	WOS:000216548400002		gold			2022-02-06	
J	Wall, MJ; Tsai, PI; Gilani, R; Mattox, KL				Wall, Matthew J., Jr.; Tsai, Peter I.; Gilani, Ramyar; Mattox, Kenneth L.			Challenges in the Diagnosis and Management of Unusual Presentations of Blunt Injury to the Ascending Aorta and Aortic Sinuses	JOURNAL OF SURGICAL RESEARCH			English	Article						ascending aortic injury; screening	THORACIC TRAUMA	Background. Blunt injury to the thoracic aorta continues to carry significant mortality and the diagnostic algorithms are evolving as new technology is developed. With improved pre-hospital care, patients with unusual blunt injuries to the aorta may survive to evaluation. While current algorithms for screening focus on the more common blunt injuries to the descending thoracic aorta, our service has seen four injuries to the ascending aorta that have had unusual presentations and presented significant challenges in their management. Methods. Retrospective chart review based on a cardiovascular injury database. Results. Four patients were identified who survived to hospitalization with an injury to the ascending thoracic aorta. Two were to the ascending aorta and two to the aortic sinuses. Two presented with closed head injury complicating management. One patient presented with aortic valve insufficiency. Motion artifacts at the aortic sinus made screening by CT challenging. These injuries were managed with primary repair (1), tube graft replacement (2), and aortic root replacement with reimplantation of the coronaries (1), all with cardiopulmonary bypass. Conclusion. Injuries to the ascending aorta and aortic sinus that survive to evaluation present unique challenges to the screening algorithms. All required cardiopulmonary bypass for repair and potentially complex reconstructions with management decisions affected by the presence of associated injuries. New methodologies such as CT scan gated to cardiac motion may offer higher resolution in this area. (C) 2010 Elsevier Inc. All rights reserved.	[Wall, Matthew J., Jr.] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey Dept Surg, Div Vasc & Trauma Surg, Houston, TX 77030 USA		Wall, MJ (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac, 1 Baylor Plaza, Houston, TX 77030 USA.	mwall@bcm.edu					Demetriades D, 1998, ARCH SURG-CHICAGO, V133, P1084, DOI 10.1001/archsurg.133.10.1084; Demetriades D, 2008, J TRAUMA, V64, P1415, DOI 10.1097/TA.0b013e3181715e32; DURHAM RM, 1994, ANN SURG, V220, P699, DOI 10.1097/00000658-199411000-00015; Fisher RG, 1997, RADIOGRAPHICS, V17, P825, DOI 10.1148/radiographics.17.4.9225385; Fisher RG, 1997, RADIOGRAPHICS, V17, P835, DOI 10.1148/radiographics.17.4.9225386; JOHNSTON RH, 1993, J VASC SURG, V17, P134, DOI 10.1016/0741-5214(93)90017-G; MATTOX EL, 2007, ADV ENDOVASCULAR THE, P12; MATTOX KL, 1989, ANN THORAC SURG, V48, P1, DOI 10.1016/0003-4975(89)90164-1; MILLER FB, 1989, SURGERY, V106, P596; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; SMITH RS, 1986, AM J SURG, V152, P660, DOI 10.1016/0002-9610(86)90444-7	11	4	4	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	OCT	2010	163	2					176	178		10.1016/j.jss.2010.04.050			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	653SB	WOS:000282115900002	20599221				2022-02-06	
J	Asif, IM; Harmon, KG; Drezner, JA; O'Kane, JW				Asif, Irfan M.; Harmon, Kimberly G.; Drezner, Jonathan A.; O'Kane, John W.			Cerebral Microhemorrhages in a Collegiate Football Player: Clinical Implications in the Management of Sports Concussion	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						microhemorrhages; microbleeds; concussion	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; INTRACEREBRAL HEMORRHAGE; MICROBLEEDS; ECHO; MR; PREVALENCE; STROKE	Most concussions in sports medicine are managed without advanced neurological imaging. However, computed tomography and magnetic resonance imaging are sometimes used in the management of complex sports concussions to identify acute/ delayed intracranial bleeding or other associated pathology. Advances in imaging techniques have led to greater resolution and the identification of pathology of uncertain clinical significance. This report describes the presence of persistent cerebral microhemorrhages identified on magnetic resonance imaging in a collegiate football player who suffered a concussion. The associated risks and clinical significance of cerebral microhemorrhages have not been determined in the young athletic population. This case highlights provocative issues in the management of sports concussions as related to findings on modern neurological imaging and their potential implication on to return-to-play considerations.	[Asif, Irfan M.; Harmon, Kimberly G.; Drezner, Jonathan A.; O'Kane, John W.] Univ Washington, Dept Family Practice, 4245 Roosevelt Way NE, Seattle, WA 98195 USA; [Harmon, Kimberly G.; O'Kane, John W.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA		Asif, IM (corresponding author), Univ Washington, Dept Family Practice, 4245 Roosevelt Way NE, Seattle, WA 98195 USA.	iasif@u.washington.edu					Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Fan YH, 2004, J NEUROL, V251, P537, DOI 10.1007/s00415-004-0359-6; Fan YH, 2003, STROKE, V34, P2459, DOI 10.1161/01.STR.0000090841.90286.81; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Greenberg SM, 1996, NEUROLOGY, V46, P1751, DOI 10.1212/WNL.46.6.1751; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Kinoshita T, 2000, STROKE, V31, P1646, DOI 10.1161/01.STR.31.7.1646; Kwa VIH, 1998, ANN NEUROL, V44, P372, DOI 10.1002/ana.410440313; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; Offenbacher H, 1996, AM J NEURORADIOL, V17, P573; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Roob G, 2000, CURR OPIN NEUROL, V13, P69, DOI 10.1097/00019052-200002000-00013; Roob G, 2000, STROKE, V31, P2665, DOI 10.1161/01.STR.31.11.2665; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; SCHARF J, 1994, NEURORADIOLOGY, V36, P504, DOI 10.1007/BF00593508; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Tsushima Y, 2003, AM J NEURORADIOL, V24, P88; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253	32	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2010	2	5					391	394		10.1177/1941738110374628			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19RC	WOS:000214835100006	23015965	Green Published			2022-02-06	
J	Kodama, T; Morita, K; Doi, R; Shoji, Y; Shigemori, M				Kodama, Takayuki; Morita, Kiichiro; Doi, Ryo; Shoji, Yoshihisa; Shigemori, Minoru			Neurophysiological Analyses in Different Color Environments of Cognitive Function in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						color environment; cognitive function; P300; rehabilitation; traumatic brain injury	EVENT-RELATED POTENTIALS; AUDITORY P300; ATTENTION; RECOVERY; ANXIETY; ADULTS	Colors are thought to elicit various emotional effects. Red, with its high likelihood of attracting attention, is considered to have an exciting, active effect; whereas green, with its low attention value, is considered to have a relaxing, sedative effect. Colors are also thought to affect human cognition and emotion. However, there have been few studies of the influence of colors in one's surroundings (e. g., the color environment and its effect on cognitive function). In this study, we investigated the influence of differences in color environments (red, green, or darkness) on cognitive function by analyzing the P300 component of event-related potentials (ERPs) elicited by oddball visual paradigms as a measure of cognitive characteristics in patients who had sustained traumatic brain injury (TBI). In 18 patients with TBI and 18 age-matched control subjects, ERPs were recorded in response to photographs of crying babies. We found that P300 amplitudes in the red environment were significantly larger in controls than in TBI patients, while those in both the green environment and darkness showed no difference between controls and patients. P300 latencies in the red environment and in darkness were significantly longer in patients than in controls. P300 latency in the red environment was significantly shorter than that in darkness. However, P300 latency in the green environment showed no difference between controls and patients. In healthy individuals, the emotional effects of the red environment enhanced cognitive function. In patients with TBI, however, cognitive function was reduced in the red environment. Furthermore, P300 amplitude and latency were strongly correlated with the time on the Trail Making Test (TMT), and the value of the intelligence quotient of the Wechsler Adult Intelligence Scale-III (WAIS-III). These findings suggest that P300 amplitude and latency are useful indexes for the evaluation of TBI patients, and that color environments affect cognitive function.	[Morita, Kiichiro] Kurume Univ, Cognit & Mol Res Inst Brain Dis, Sch Med, Kurume, Fukuoka 8300011, Japan; [Doi, Ryo; Shigemori, Minoru] Kurume Univ, Dept Neurosurg, Sch Med, Kurume, Fukuoka 8300011, Japan		Morita, K (corresponding author), Kurume Univ, Cognit & Mol Res Inst Brain Dis, Sch Med, Asahimachi 67, Kurume, Fukuoka 8300011, Japan.	kiichiro@med.kurume-u.ac.jp			Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan	This work was supported by grants from the Japanese Ministry of Health, Labor and Welfare.	Birren F, 1961, COLOR PSYCHOL COLOR; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; *CO DS, 1996, 0042E CO DS; Davey P, 1998, ARCHIT REV, V204, P34; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Doi R, 2007, AM J PHYS MED REHAB, V86, P641, DOI 10.1097/PHM.0b013e318115aca9; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; FLEMINGER S, 2009, PHARM MANAGEMENT AGI; Geisler MW, 1999, J CLIN EXP NEUROPSYC, V21, P108, DOI 10.1076/jcen.21.1.108.935; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hemphill M, 1996, J GENET PSYCHOL, V157, P275, DOI 10.1080/00221325.1996.9914865; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; KODAMA T, 2007, JPN J CLIN NEUROPHYS, V35, P1; Li M, 2005, PARKINSONISM RELAT D, V11, P209, DOI 10.1016/j.parkreldis.2004.11.004; Maeda H, 1996, BIOL PSYCHIAT, V39, P743, DOI 10.1016/0006-3223(95)00612-5; Mahnke FH, 1996, COLOR ENV HUMAN RESP; MORITA K, 2003, SEISHIN IGAKU, V45, P1297; Morita Y, 2001, NEUROSCI RES, V41, P89, DOI 10.1016/S0168-0102(01)00248-6; NAZ K, 2004, COLLEGE STUDENT JOUR, V38, P396; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; POLICH J, 1991, American Journal of EEG Technology, V31, P201; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; PRICHARD WS, 1986, PSYCHOL BULL, V100, P43; Reinholdt-Dunne ML, 2009, BEHAV RES THER, V47, P410, DOI 10.1016/j.brat.2009.01.012; RUCHKIN DS, 1978, ELECTROEN CLIN NEURO, V45, P268, DOI 10.1016/0013-4694(78)90010-X; Saito M, 1996, COLOR RES APPL, V21, P35, DOI 10.1002/(SICI)1520-6378(199602)21:1<35::AID-COL4>3.0.CO;2-6; SVAETICHIN G, 1956, ACTA PHYSL SCAND, P17; Yamamoto Masashi, 2000, Kurume Medical Journal, V47, P285; YOSHIHAMA J, 2006, CLIN ELECTROENCEPHAL, V48, P160; ZEKI S, 1992, SCI AM, V267, P69, DOI 10.1038/scientificamerican0992-68; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	34	4	4	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1577	1584		10.1089/neu.2009.1119			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500004	20649469				2022-02-06	
J	Piquard, A; Derouesne, C; Meininger, V; Lacomblez, L				Piquard, Ambre; Derouesne, Christian; Meininger, Vincent; Lacomblez, Lucette			DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia	PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT			French	Article						DEX; ADL; Alzheimer' disease; frontotemporal dementia; motor neurone disease; anosognosia	TRAUMATIC BRAIN-INJURY; MOTOR-NEURON DISEASE; BEHAVIORAL-ASSESSMENT; DYSEXECUTIVE SYMPTOMS; DIAGNOSIS; VARIANT; CONSENSUS; VALIDITY; DEFICITS; CRITERIA	The questionnaire DEX was designed by Wilson et al. in 1996 to explore the disturbances of executive functions (EF) in activities of daily living (ADL). Objective. This study was performed to explore the specificity of the DEX to evaluate executive dysfunction in ADL, and its contribution to the distinction between Alzheimer's disease (AD) and frontotemporal dementia (FTD). Subjects. 13 patients with the frontal variant of FTD, 19 patients with FTD associated with amyotrophic lateral sclerosis, FTD/SLA, 18 patients with Alzheimer's disease, AD, and 24 controle subjects. Methods. The scores on the DEX completed by a proxy as well as those on two scales assessing ADL (the Cognitive Difficulties Scale by McNair & Kahn, and a composite scale (NADL) including the evaluation of basic (BADL) and instrumental (IADL) by the Lawton & Brody scales, and of social activities (SADL) from Katz & Lyerly) were compared to neuropsychological tests assessing EF (Behavioural Assessment of Dysexecutive Syndrome (BADS), Wisconsin Card Sorting Test, Stroop test, Trail Making Test B, lexical and categorical verbal fluencies, WAIS-III similarities). Results. No correlation was found between the scores on the DEX or the other ADL scales, and the BADS scores. Scores on DEX showed some weak correlations with some executive tasks, but no stronger than those found with the other ADL scales.Analysis of the most frequently perturbed DEX items failed to show a characteristic profile for EF dysfunction. No significant difference was found between patients with AD and DFT on the scores on the DEX as well as on other ADL scales, when adjusted for dementia severity (assessed by the Mattis Dementia Rating Scale (MDRS)). No difference was found between MA and DFT patients neither in the profile of the most frequently perturbed DEX items, nor in decreased awareness of the disorders assessed by comparison of the scores on the DEX completed by patients and familiars. Conclusion. In this study, DEX does not appear as a specific tool for assessing EF dysfunction in ADL compared to other ADL scales. It was more related to global cognitive difficulties as assessed by the CDS and the MDRS. Scores on the DEX as well as on other ADL scales do not contribute to the distinction between AD and FTD.	[Piquard, Ambre] Univ Versailles St Quentin, Hop St Perine, Lab Sante Vieillissement, Paris, France; [Derouesne, Christian; Meininger, Vincent; Lacomblez, Lucette] Univ Paris 06, F-75252 Paris 05, France; [Meininger, Vincent; Lacomblez, Lucette] Grp Hosp Pitie Salpetriere, Dept Pharmacol, F-75634 Paris, France		Piquard, A (corresponding author), Univ Versailles St Quentin, Hop St Perine, Lab Sante Vieillissement, Paris, France.	ambre.piquard@spr.aphp.fr					ALDERMAN N, 1993, J CLIN EXP NEUROPSYC, V15, P69; Back-Madruga C, 2002, CLIN NEUROPSYCHOL, V16, P331, DOI 10.1076/clin.16.3.331.13846; Bak TH, 2001, J NEUROL, V248, P260, DOI 10.1007/s004150170199; Barson FP, 2000, J NEUROL SCI, V180, P107, DOI 10.1016/S0022-510X(00)00413-5; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Benson D.F., 1986, FRONTAL LOBES; Bherer Louis, 2004, Psychol Neuropsychiatr Vieil, V2, P181; Borroni B, 2007, NEUROLOGY, V69, P2110, DOI 10.1212/01.wnl.0000294880.78359.09; Boutoleau-Bretonniere C, 2008, DEMENT GERIATR COGN, V25, P272, DOI 10.1159/000117394; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; BURGESS PW, 1996, BEHAV ASSESSMENT DYS, P7; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Derouesne C, 2002, REV NEUROL-FRANCE, V158, P684; Derouesne C, 2001, REV NEUROL-FRANCE, V157, P162; Derouesne C, 1995, TREATING ALZHEIMERS, P318; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Golden CJ, 1978, DIAGNOSIS REHABILITA; HEATON RK, 2003, WCST TEST CLASSEMENT; Hodges JR, 2003, NEUROLOGY, V61, P349, DOI 10.1212/01.WNL.0000078928.20107.52; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Katz N, 2007, NEUROPSYCHOL REHABIL, V17, P192, DOI 10.1080/09602010600685053; Kipps CM, 2009, NEUROCASE, V15, P182, DOI 10.1080/13554790802632892; Larson EB, 2008, PERCEPT MOTOR SKILL, V106, P725, DOI 10.2466/PMS.106.3.725-736; Laws KR, 2008, PSYCHIAT RES, V160, P8, DOI 10.1016/j.psychres.2007.06.004; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Mattis S., 1976, GERIATRIC PSYCHIAT H, P77; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; McNair D. M., 1983, ASSESSMENT GERIATRIC; Mioshi E, 2007, NEUROLOGY, V68, P2077, DOI 10.1212/01.wnl.0000264897.13722.53; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROLOGY, V54, P2277, DOI 10.1212/WNL.54.12.2277; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Rankin KP, 2005, J NEUROL NEUROSUR PS, V76, P632, DOI 10.1136/jnnp.2004.042879; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; Rascovsky K, 2005, NEUROLOGY, V65, P397, DOI 10.1212/01.wnl.0000171343.43314.6e; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Salmon E, 2008, J NEUROL NEUROSUR PS, V79, P176, DOI 10.1136/jnnp.2007.122853; Serna A, 2007, INT J MED INFORM, V76, pS377, DOI 10.1016/j.ijmedinf.2007.04.002; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Shinagawa Y, 2007, INT J GERIATR PSYCH, V22, P951, DOI 10.1002/gps.1768; SNOWDEN JS, 1996, FRONTOTEMPORAL LOBAR; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P252, DOI 10.1080/17482960903259113; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Traykov L, 2007, ENCEPHALE, V33, P310; Trouillet Raphael, 2003, Psychol Neuropsychiatr Vieil, V1, P99; Vargas ML, 2009, COGN BEHAV NEUROL, V22, P95, DOI 10.1097/WNN.0b013e318192cd08; WESCHLER D, 1997, ECHELLE INTELLIGENCE; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	70	4	4	0	13	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	1760-1703			PSYCHOL NEUROPSYCHIA	Psychol. NeuroPsychiatr. Vieil.	SEP	2010	8	3					215	227		10.1684/pnv.2010.0220			13	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry; Psychology	647ST	WOS:000281640200008	20739260				2022-02-06	
J	Chaturvedi, D; Suri, A; Kasliwal, MK; Mahapatra, AK; Mehta, VS; Shridhar, V; Garg, A; Sarkar, C; Dogra, TD; Singh, R				Chaturvedi, Dhruv; Suri, Ashish; Kasliwal, Manish Kumar; Mahapatra, Ashok Kumar; Mehta, Veer Singh; Shridhar, V.; Garg, Ajay; Sarkar, Chitra; Dogra, T. D.; Singh, Rajvir			Factors Affecting the Development of Hypothalamus and Pituitary Lesions in Fatal Closed Head Injury: A Prospective Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Pituitary; Hypothalamus; Histopathology; Factors; Impact; Ischemia; Herniation	AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; BRAIN; GLAND	Objectives: To determine the factors affecting the development of pituitary and hypothalamic lesions after fatal closed head injury. Materials: Thirty-four patients with severe closed head injury succumbing to the effects of brain trauma before or during admission, whether managed conservatively or surgically, formed the study group. Clinical parameters, injury to death interval, radiologic data, and management details were taken into consideration. Autopsy was performed within 48 hours of death; hypothalamus and pituitary were carefully removed and evaluated for the presence of lesions on hematoxylin and eosin and immunohistochemical staining. Results: Patients were categorized into early death group (n = 11, those succumbing before/on admission) and late death group (n = 23, those succumbing after admission). Histopathologic evaluation of pituitary revealed capsular hemorrhages in 50%, posterior pituitary hemorrhage in 25%, anterior pituitary infarct in 21.8%, and anterior pituitary hemorrhage in 6.2% patients. Hypothalamic hemorrhage was observed in 65.2% patients and infarcts in 17.3%. Lesions in hypothalamus and pituitary were significantly related to the presence of ventricular compression on computed tomography scan and survival of >24 hours after injury (p < 0.05). Capsular hemorrhage, anterior pituitary hemorrhage, and posterior pituitary hemorrhage were present in 40%, 10%, and 30% of the patients in the early death group when compared with 54.5%, 4.5%, and 22.7% of the patients in the late death group. Anterior pituitary infarcts were present in 10% of the patients with early deaths and 27.3% patients in the late death group. Hypothalamic hemorrhages were present in 44.4% of patients in early death and 78.6% in late death groups. Hypothalamic infarcts (40%) were present in the late death group only. Two patients (25%) in the early death group and 11 (84.6%) in the late death group had lesions in pituitary as well as hypothalamus (p < 0.05). Conclusions: Presence of ventricular compression on computed tomography scan and survival >24 hours after severe head injury has a significant correlation with the development of hypothalamic and pituitary lesions. Secondary insults account for a proportion of pituitary and hypothalamic lesions after trauma, which may be amenable to prevention by early intervention to treat raised intracranial pressure (ICP)/herniation.	[Suri, Ashish] All India Inst Med Sci, Dept Neurosurg, Ctr Neurosci, New Delhi 110029, India; [Garg, Ajay] All India Inst Med Sci, Dept Neuroradiol, New Delhi 110029, India; [Shridhar, V.; Sarkar, Chitra] All India Inst Med Sci, Dept Neuropathol, New Delhi 110029, India; [Dogra, T. D.] All India Inst Med Sci, Dept Forens Med, New Delhi 110029, India; [Singh, Rajvir] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India		Suri, A (corresponding author), All India Inst Med Sci, Dept Neurosurg, Ctr Neurosci, New Delhi 110029, India.	surineuro@hotmail.com	Dogra, Tirath Das/R-6517-2019; Garg, Ajay/AAM-2603-2020	Dogra, Tirath Das/0000-0002-5398-2285; Garg, Ajay/0000-0002-9385-291X			BEVILACQUA G, 1975, ACTA NEUROPATHOL, V31, P171, DOI 10.1007/BF00688151; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1958, LANCET, V1, P1101; DANIEL PM, 1976, GREENFIELDS NEUROPAT, P581; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; PORTER RJ, 1946, J NEUROL NEUROSUR PS, V11, P258; PRASAD A, 1990, NEUROL INDIA, V38, P1; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; TREIP CS, 1970, J NEUROL NEUROSUR PS, V33, P715, DOI 10.1136/jnnp.33.5.715-a; Treip CS, 1970, J CLIN PATHOL, V23, P178, DOI DOI 10.1136/JCP.S3-4.1.178	14	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2010	69	2					290	293		10.1097/TA.0b013e3181b403b5			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	638JN	WOS:000280890800008	20016386				2022-02-06	
J	Sinha, S; Gujjar, H; Sharma, BS				Sinha, Sumit; Gujjar, Hitesh; Sharma, B. S.			Survival after a penetrating injury traversing midbrain - case report	BRITISH JOURNAL OF NEUROSURGERY			English	Article						nonfatal schrapnel injury; traumatic Perinaud's syndrome; penetrating injury brain		Penetrating civilian shrapnel injuries to brainstem are quite uncommon, but invariably fatal. We report a rare case of a child who survived following shrapnel injury to tectum of midbrain.	[Sinha, Sumit; Gujjar, Hitesh; Sharma, B. S.] All India Inst Med Sci, Dept Neurosurg, Ctr Neurosci, New Delhi 110029, India		Sinha, S (corresponding author), All India Inst Med Sci, Dept Neurosurg, JPNA Trauma Ctr, Room 307,3rd Floor, New Delhi 110029, India.	sumitaiims@yahoo.com					Khoshyomn S, 2004, J TRAUMA, V56, P1131, DOI 10.1097/01.TA.0000071299.31349.D6; Lawson-Smith MJ, 2006, J CLIN NEUROSCI, V13, P792, DOI 10.1016/j.jocn.2005.09.016; Manning TC, 2008, NEUROSURGERY, V62, P749, DOI 10.1227/01.NEU.0000297128.30936.D1; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018	4	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2010	24	4					477	478		10.3109/02688691003615727			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	649LU	WOS:000281772800019	20726756				2022-02-06	
J	Weinberg, AM; Castellani, C				Weinberg, Annelie-Martina; Castellani, Christoph			Role of Neuroprotein S-100B in the Diagnostic of Pediatric Mild Brain Injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						S-100B; Children; TBI Review; Commotio cerebri	MINOR HEAD-INJURY; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID CSF; COMPUTED-TOMOGRAPHY; SERUM S100B; TRAUMA PATIENTS; PROTEIN; CHILDREN; CT; MANAGEMENT	Traumatic brain injury is one of the leading causes of death and disability in children and adolescents. Patients with moderate or severe lesions can be readily recognized clinically, require immediate radiologic diagnostics by computed tomography (CT) or magnetic resonance imaging (MRI), admission to intensive care units, and, in some cases, will go on to require neurosurgical intervention. Patients with mild traumatic brain injuries (MTBIs) are diagnostically challenging. Often, the event is unobserved and head injury can only be suspected. Clinical symptoms are unreliable and clinical findings from neurological examination have to be interpreted with care. As a small percentage of MTBI patients progress to have a life-threatening intracranial hemorrhage, the recognition of this group of patients and their judicious and timely management is, therefore, an important goal. Subjecting every MTBI patient to a cranial CT scanning results in high costs and unnecessary exposure to ionizing radiation. Admitting all MTBI patients for observation and performing CTs only in case of clinical deterioration is costly and a substantial drain on resources, not to mention the radiation exposure and a source of stress for the majority of patients. Current European guidelines for diagnostics and therapy in MTBI patients are only partially applicable to the pediatric population. This article reviews the clinical problem, treatment options and guidelines, as well as diagnostic tools, with special focus on neuroprotein S-100B in pediatric and adolescent patients with MTBIs.	[Weinberg, Annelie-Martina; Castellani, Christoph] Med Univ Graz, Dept Pediat & Adolescent Surg, A-8036 Graz, Austria; [Castellani, Christoph] Dist Hosp Vorau, Dept Surg, Vorau, Austria		Castellani, C (corresponding author), Med Univ Graz, Dept Pediat & Adolescent Surg, Auenbruggerpl 34, A-8036 Graz, Austria.	christoph.castellani@medunigraz.at		Weinberg, Annelie/0000-0003-0385-4346			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Eide PK, 2003, ACTA NEUROCHIR, V145, P171, DOI 10.1007/s00701-002-1062-y; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Maier B, 2003, UNFALLCHIRURG, V106, P220, DOI 10.1007/s00113-002-0546-9; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; *ROCH DIAGN CORP, 2007, EL S100 PROD INF, P1; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stein SC, 1996, NEUROSURG QUART, V6, P108, DOI 10.1097/00013414-199606000-00004; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; TEASDALE G, 2002, EARLY MANAGEMENT PAT, V46; USUI A, 1989, CLIN CHEM, V35, P1942; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	54	4	4	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2010	36	4					318	324		10.1007/s00068-010-1120-8			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	639AP	WOS:000280943500005	26816036				2022-02-06	
J	Adeleye, AO				Adeleye, Amos Olufemi			Decompressive craniectomy for traumatic brain injury in a developing country: An initial observational study	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Decompressive craniectomy; traumatic brain injury; developing countries		This is a descriptive study of the possible role of decompressive craniectomy (DC) in traumatic brain injury (TBI) management in a Nigerian neurosurgical unit; a practice setting where dedicated neurocritical care service is lacking for the care of TBI. Over a 12-month period cases of TBI with clinical and radiological evidence of intracranial hypertension were selected for 'prophylactic' DC. Utilization of hospital services was quantified and outcome at discharge and at follow up was measured with the Glasgow Outcome Scale Extended. Of the 17 cases, outcome was good in 100% of those with mild head injury (HI), 66.7% of the moderate HI, and 56% of the severe HI. Utilization of hospital services, especially the intensive care unit (ICU), increased in proportion with the severity of the TBI. Decompressive craniectomy may have a role to play in the developing countries in the preemptive treatment of posttraumatic raised intracranial pressure. It appears to hold a great potential in salvaging certain clinically benign cases of HI which usually have unfavorable outcome in this practice setting.	Univ Ibadan, Coll Med, Ibadan, Nigeria; UCH, Ibadan, Nigeria		Adeleye, AO (corresponding author), UCH, Dept Neurol Surg, PMB 5116, Ibadan, Nigeria.	femdoy@yahoo.com					Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Basso A, 2001, WORLD J SURG, V25, P1174; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Toussaint CP, 2008, NEUROSURG QUART, V18, P45, DOI 10.1097/WNQ.0b013e3181642924; Wani AA, 2009, INDIAN J NEUROTRAUM, V6, P103, DOI 10.1016/S0973-0508(09)80002-6	22	4	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2010	7	1					41	46		10.1016/S0973-0508(10)80010-3			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1N	WOS:000218381400009					2022-02-06	
J	Mathai, KI; Sudumbrekar, SM; Shashivadhanan; Sengupta, SK; Rappai, TJ				Mathai, Khalil I.; Sudumbrekar, S. M.; Shashivadhanan; Sengupta, S. K.; Rappai, T. J.			Decompressive craniectomy in traumatic brain injury Rationale and practice	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						brain edema; decompressive craniectomy		Despite the growing fund of knowledge on the pathophysiology of traumatic brain injury, the outcomes of severe TBI remain abysmal. While the necrotic and apoptotic cascades triggered off by the primary traumatic insult remain refractory to treatment, the secondary sequelae of increased intracranial pressure remain within the therapeutic realm. The benefit of evacuation of mass producing hematomas is beyond dispute. The management of brain edema however remains suboptimal despite the best medical management. The role of surgical evacuation of edema inducing contusions recalcitrant to osmotherapy is explored in this paper. The role of decompressive craniectomy in the control of refractory hypertension and the rationale and timing of the procedure are discussed.	Command Hosp SC, Dept Neurosurg, Pune 40, Maharashtra, India; Armed Forces Med Coll, Pune 40, Maharashtra, India		Mathai, KI (corresponding author), INHS Asvini, Dept Neurosurg, Bombay 400005, Maharashtra, India.	khalilmathai@yahoo.co.in					Angelini G, 2001, CRIT CARE CLIN, V17, P863, DOI 10.1016/S0749-0704(05)70184-6; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; BULLOCK R, 1990, ACT NEUR S, V51, P286; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Marmarou A, 2003, ACT NEUR S, V86, P7; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schneider GH, 2002, ACT NEUR S, V81, P77; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456	21	4	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2010	7	1					9	12		10.1016/S0973-0508(10)80004-8			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1N	WOS:000218381400003					2022-02-06	
J	Vadivelu, S; Bell, RS; Crandall, B; DeGraba, T; Armondo, RA				Vadivelu, Sudhakar; Bell, Randy Scott; Crandall, Ben; DeGraba, Tom; Armondo, Rocco A.			Delayed detection of carotid-cavernous fistulas associated with wartime blast-induced craniofacial trauma	NEUROSURGICAL FOCUS			English	Article						craniofacial trauma; blast injury; missile injury; overpressure wave; transarterial embolization; vasospasm	CONTROLLED CORTICAL IMPACT; BRAIN-INJURY; CLASSIFICATION; OVERPRESSURE; RATS	Blast-induced neurotrauma is a leading cause of military casualties. Its effects on cerebrovascular structures are not well understood. Vascular injury resulting from overpressure shock wave impact may have a delayed presentation and detection. The authors present the cases of 2 patients who sustained blast-induced craniofacial trauma and brain injury. Detection of a cervical dissection was delayed in one patient, and detection of carotid-cavernous fistulas was delayed in both patients. The authors report the successful obliteration of both the dissection and the carotid-cavernous fistulas via an endovascular approach. Endovascular management provides both a reasonable and effective therapeutic option to blast-induced cerebrovascular injuries. (DOI: 10.3171/2010.2.FOCUS09257)	[Vadivelu, Sudhakar; Bell, Randy Scott; Crandall, Ben; DeGraba, Tom; Armondo, Rocco A.] Natl Naval Med Ctr, Div Neurosurg, Natl Capital Neurosurg Consortium, Bethesda, MD USA		Armondo, RA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurosurg, 8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rocco.armonda@gmail.com			Comprehensive Neuroscience Program; Uniformed Services University of the Health Sciences [MDA905-02-2 to 007]	This study was supported by the Comprehensive Neuroscience Program and the Uniformed Services University of the Health Sciences (Award No. MDA905-02-2 to 007). The authors have no financial conflicts to disclose in conjunction with the generation of this article.	Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; *DEP DEF, DEF CAS REP 2009; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; GORANSSON AM, 1988, J TRAUMA, V28, pS204; Grant GA, 2007, J TRAUMA, V62, pS100, DOI 10.1097/TA.0b013e318065b42c; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Schlifka B, 2007, J TRAUMA, V62, pS103, DOI 10.1097/TA.0b013e318065b4e5; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007	21	4	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E6	10.3171/2010.2.FOCUS09257			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600006	20568946				2022-02-06	
J	Cramer, D; Miulli, DE; Valcore, JC; Taveau, JW; Do, N; Hutton, DS; Sonti, G; Wogu, E; Boorman, CF; Panchal, RR				Cramer, Dennis; Miulli, Dan E.; Valcore, Jennine C.; Taveau, Jon William; Do, Nguyen; Hutton, Daniel S.; Sonti, Gayatri; Wogu, Elijah; Boorman, Caroline F.; Panchal, Ripul R.			Effect of Pedal Pump and Thoracic Pump Techniques on Intracranial Pressure in Patients With Traumatic Brain Injuries	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article								Context: Although osteopathic manipulative treatment (OMT) is used to manage myriad conditions, there has been some hesitation regarding the safety of applying OMT to patients with intracranial injuries or elevated intracranial pressure (ICP). Objective: To assess the safety of two OMT techniques-pedal pump and thoracic pump-on ICP and cerebral perfusion pressure (CPP) in patients with traumatic brain injuries (Glasgow Coma Scale score <= 8). Methods: We prospectively enrolled consecutive patients admitted to the intensive care unit (ICU) for traumatic brain injury. Patients between the ages of 18 and 75 years and with abnormal CT scans were included in the present study. Patients with baseline ICP values of 20 mm Hg or lower were assigned to group 1, and those with ICP levels greater than 20 mm Hg, group 2. Patients underwent continuous ICP and CPP monitoring, with ICP measured using a ventricular catheter and fiber optic device. Values of ICP and CPP were recorded at baseline, during application of the OMT techniques, and 5 minutes after the two OMT techniques were completed. Patients received up to three treatment cycles. Ventricular drains remained open (stopcock open) during OMT, allowing continued cerebral spinal fluid drainage, except for brief periodic closures (stopcock closed) every minute to register accurate ICP values. Statistical analysis was performed using a dependent t test with repeated measures. Results: Twenty-four comatose patients, aged 18 to 69 years, received a total of 50 sessions of pedal pump and thoracic pump techniques. In group 1 patients, a slight decrease in ICP values (mean, -0.586 mm Hg) and an increase in CPP values (mean, 1.1613 mm Hg) was noted post-OMT. Patients in group 2 also had decreased mean ICP values (-1.20 mm Hg) and increased mean CPP values (2.2105 mm Hg). Changes were not statistically significant in either group. Conclusion: According to the present limited study, pedal pump and thoracic pump techniques may be used safely in patients with severe brain injuries.	[Cramer, Dennis; Miulli, Dan E.; Valcore, Jennine C.; Taveau, Jon William; Do, Nguyen; Hutton, Daniel S.; Sonti, Gayatri; Wogu, Elijah; Boorman, Caroline F.; Panchal, Ripul R.] ARMC, Div Neurosurg, Colton, CA 92324 USA		Miulli, DE (corresponding author), ARMC, Grad Med Educ Off, Div Neurosurg, 400 N Pepper Ave, Colton, CA 92324 USA.	miullid@armc.sbcounty.gov		Panchal, Ripul/0000-0002-0717-8288			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Cantieri MS, 1997, AAO J, V7, P25; Carr RR, 2006, AM J HEALTH-SYST PH, V63, P33, DOI 10.2146/ajhp040613; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Knott EM, 2005, J AM OSTEOPATH ASSOC, V105, P447; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MATTA B, 1994, J NEUROSURG ANESTH, V6, P280; MILLER JD, 1982, CLIN NEUR, V29, P103; Noll Donald R., 2000, Journal of the American Osteopathic Association, V100, P776; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation; The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P479; TOUNG T, 1984, ANESTHESIOLOGY, V61, P169, DOI 10.1097/00000542-198408000-00010; Ward, 2003, FDN OSTEOPATHIC MED	17	4	4	0	1	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	APR	2010	110	4					232	238					7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V04OF	WOS:000213813600009	20430911				2022-02-06	
J	Paiva, WS; de Andrade, AF; de Amorim, RLO; Muniz, RK; Paganelli, PM; Bernardo, LS; Figueiredo, EG; Teixeira, MJ				Paiva, Wellingson S.; de Andrade, Almir Ferreira; Oliveira de Amorim, Robson Luis; Muniz, Renan Kawano; Paganelli, Priscila Messias; Bernardo, Luca Silveira; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen			The Prognosis of the Traumatic Subarachnoid Hemorrhage: A Prospective Report of 121 Patients	INTERNATIONAL SURGERY			English	Article						Brain trauma; Subarachnoid hemorrhage; Head injury; Prognosis	SEVERE HEAD-INJURY; BRAIN-INJURY; CONSORTIUM SURVEY; PRACTICAL SCALE; TOMOGRAPHY; NIMODIPINE; DIAGNOSIS; VARIABLES; SURVIVAL; IMPACT	Recent investigations have shown the significance of subarachnoid bleeding on computed tomography scans first taken after admission for head injuries. In our study, we describe a prospective follow-up of 121 patients with traumatic subarachnoid hemorrhage (tSAH). From January 2004 to January 2007 we collected data prospectively from 121 patients admitted with diagnosis of tSAH to our trauma intensive care unit, on the basis of admission with a computed tomography scan. The classification of tSAH was performed using the Fisher scale with modification, and the follow-up was performed using the Glasgow Outcome Scale (GOS). The minimum period for a follow-up was established 6 months after the injury. Traffic accident was the main cause of head injuries (72% in total; 48% involving cars and 24% involving motorcycles), followed by falls (23%) and aggression (5%). Twenty-eight percent of patients sustained major multiple injuries, with spinal injury as the main associated trauma. The outcome was favorable (GOS score 4 or 5) in 54 patients (45%) and unfavorable (GOS score 1, 2, or 3) in 67 patients (55%). The mortality rate was proportionally greater in patients who had cisternal clots >1 mm (P < 0.001), assessed by the Fisher scale with modification. When functional recovery was evaluated using the GOS, the recovery rate and the daily life activities were lower in patients with intraventricular bleeding (P = 0.001). Our results showed that patients with severe tSAH had the worst prognosis.	[Paiva, Wellingson S.; de Andrade, Almir Ferreira; Oliveira de Amorim, Robson Luis; Muniz, Renan Kawano; Paganelli, Priscila Messias; Bernardo, Luca Silveira; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Div Neurol Surg, Sao Paulo, Brazil		Paiva, WS (corresponding author), Teodoro Sampaio St N 498,Ap 66, BR-05406000 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Amorim, Robson/AAK-1368-2021; Figueiredo, Eberval G/E-2071-2016; Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval Gadelha/H-3488-2012; Teixeira, Manoel J/E-3110-2012	Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040; 			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; de Andrade AF, 2001, WORLD J SURG, V25, P1186; DEMIRCIVI F, 1993, ACTA NEUROCHIR, V122, P45, DOI 10.1007/BF01446985; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; JENNETT B, 1975, LANCET, V1, P480; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; TEASDALE G, 1974, LANCET, V2, P81; VANGIJN J, 1982, NEURORADIOLOGY, V23, P153, DOI 10.1007/BF00347559	24	4	4	0	2	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR-JUN	2010	95	2					172	176					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	815NY	WOS:000294533500014	20718326				2022-02-06	
J	Vincent, C; Bisson, J; Langlois, E; Voyer, M; Cantin, JF				Vincent, Claude; Bisson, Janick; Langlois, Erik; Voyer, Manon; Cantin, Jean-Francois			Use of a brain-computer interface by a client presenting a traumatic brain injury	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			French	Article						Assistive technology; Brain injuries; User-computer interface	STANDARDIZED INSTRUMENT; UNITED-STATES; DISABILITIES; RELIABILITY; PREVALENCE; APRAXIA	Background. There is limited knowledge concerning the effectiveness of computer access modes. This article presents a case report of a client with a serious traumatic brain injury who, four years after his accident, tried a brain-computer interface (Cyberlink software). Purpose. To examine the client's computer performance (keyboard and mouse tasks) and the degree of realisation of three occupations (written communication, interpersonal relations and leisure). Methods. A training over 16 weeks (2 X per week) and a follow-up at 3 months were completed. The activation of the computer with Cyberlink was tested with lateral movements of the eyes, relaxation waves, waves of activation of the brain and facial musculature. Findings. After 8 weeks of training with Cyberlink, no improvements were noted in the use of the keyboard and the mouse. The trial of another interface (tactile screen) finally made the optimization of mouse functions possible. Implications. The endurance and memory problems were circumvented with a long, repetitive and flexible training of the computer use.	[Vincent, Claude] Univ Laval, Fac Med, Dept Readaptat, CIRRIS,Inst Readaptat Deficience Phys Quebec IRDP, Quebec City, PQ G1M 2S8, Canada		Vincent, C (corresponding author), Univ Laval, Fac Med, Dept Readaptat, CIRRIS,Inst Readaptat Deficience Phys Quebec IRDP, 525 Boul Hamel Est, Quebec City, PQ G1M 2S8, Canada.	claude.vincent@rea.ulaval.ca					ANSON D, 1994, AM J OCCUP THER, V48, P121, DOI 10.5014/ajot.48.2.121; Anson D. K., 1997, ALTERNATIVE COMPUTER; BEUKELMAN DR, 1991, COMMUNICATION DISORD; Bisson J, 2005, LOGICIEL MEMODITION; Brain Actuated Technologies Inc, 2007, COH DET PER BRAIN CO; Buning M. E, 2007, OCCUPATIONAL THERAPY, VHigh- technology adaptations to compensate for disability, P510; Cromwell F S, 1986, Occup Ther Health Care, V3, P1, DOI 10.1080/J003v03n01_01; Delis DC., 2001, DELIS KAPLAN EXECUTI; Doherty E, 2001, INTERNATIONAL CONFERENCE ON COMPUTING AND INFORMATION TECHNOLOGIES : EXPLORING EMERGING TECHNOLOGIES, P87; Doherty E, 1999, Cyberpsychol Behav, V2, P249, DOI 10.1089/cpb.1999.2.249; DOHERTY E, 2001, P SIGCHI C HUM FACT, V3, P69, DOI DOI 10.1145/365024.365038; Dumont C, 2000, Can J Occup Ther, V67, P173; Dumont C, 2002, AM J OCCUP THER, V56, P60, DOI 10.5014/ajot.56.1.60; Dumont C, 2006, TEST RENDEMENT; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Fougeyrollas P., 1999, QUEBEC CLASSIFICATIO; Hotz L. R, 2004, THINKING CAP MAY GIV; Huard E, 2006, LOGICIEL RAPIDOLECT; Hux K, 2003, ASSISTING SURVIVORS; MANN WC, 1991, ASSISTIVE TECHNOLOGY; Marler D. M, 2004, CYBERLINK COMPUTER A; Mazer B., 2003, TECHNOL ADN DISABIL, V15, P35; MCEWEN I, 1996, WRITING CASE REPORTS; Ministere de la sante et des Services sociaux, 1999, CONT SERV PERS AY SU; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Noreau L, 2004, DISABIL REHABIL, V26, P346, DOI 10.1080/09638280410001658649; Noreau L., 1998, J SPINAL CORD MED, V21, P192; Pachalska M., 2002, MED SCI MONITOR, V8, P576; Palisano Robert J, 2007, Phys Occup Ther Pediatr, V27, P1, DOI 10.1300/J006v27n01_01; Renton L. B. M., 1997, BRIT J OCCUPATIONAL, V60, P199; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Heugten CM, 1999, CLIN NEUROPSYCHOL, V13, P182; Vincent C, 2003, J VISUAL IMPAIR BLIN, V97, P5, DOI 10.1177/0145482X0309700102; Vincent C., 2002, TECHNOLOGY DISABILIT, V14, P113, DOI DOI 10.3233/TAD-2002-14306; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Willer B, 1994, BRAIN INJURY REHABIL, P355; Wolpaw J, 2007, NONINVASIVE BRAIN CO; Zwinkels A, 2004, CLIN REHABIL, V18, P819, DOI 10.1191/0269215504cr816oa	41	4	4	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2010	77	2					101	112		10.2182/cjot.2010.77.2.6			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	V20TP	WOS:000208162600009	20464895				2022-02-06	
J	Fernandez-Torre, JL				Luis Fernandez-Torre, Jose			Nonconvulsive status epilepticus in comatose adults	REVISTA DE NEUROLOGIA			Spanish	Article						Coma; Continuous EEG monitoring; Generalized status epilepticus; Nonconvulsive seizures; Nonconvulsive status epilepticus; Partial status epilepticus	INTENSIVE-CARE-UNIT; MYOCLONIC STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; CONTINUOUS EEG; ELECTROGRAPHIC SEIZURES; CLINICAL-FEATURES; PATTERNS; DISCHARGES; HEMORRHAGE	Introduction. Nonconvulsive status epilepticus (SE) is a term used to denote a range of conditions in which electrographic seizure activity is prolonged and results in nonconvulsive clinical symptoms. Nowadays, some experts on nonconvulsive SE have emphasized the utility on the clinical practice to consider the classification taking in account both the clinical setting and the severity of consciousness impairment, differentiating between ambulatory patients (from almost normal mental state to stupor) which includes absence SE and complex partial SE; and nonconvulsive SE in coma. Aim. To review the literature in relation to the diagnosis of nonconvulsive SE in comatose and/or critically ill patients. Development. Nonconvulsive SE has been reported with surprising frequency in a wide variety of acute neurological processes such as cerebrovascular disease, anoxia, subarachnoid hemorrhage, cranial trauma, encephalitis and following convulsive SE. Conclusions. Nonconvulsive seizures and episodes of nonconvulsive SE in patients with severe impairment of consciousness are frequent and, therefore, continuous EEG monitoring is an essential neurophysiologic tool in the evaluation of comatose subjects. EEG interpretation in patients with nonconvulsive SE may be particularly difficult and problematic and, therefore, requires expert knowledge and a clinical and neurophysiologic specific training.	Hosp Univ Marques de Valdecilla, Serv Neurofisiol Clin, E-39008 Santander, Cantabria, Spain		Fernandez-Torre, JL (corresponding author), Hosp Univ Marques de Valdecilla, Serv Neurofisiol Clin, Avda Valdecilla S-N, E-39008 Santander, Cantabria, Spain.	jlfernandez@humv.es					Abou Khaled KJ, 2008, NEUROL CLIN, V26, P385, DOI 10.1016/j.ncl.2008.03.017; Afsar N, 2003, SEIZURE-EUR J EPILEP, V12, P23, DOI 10.1016/S1059131102001437; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319; Brenner RP, 2002, EPILEPSIA, V43, P103, DOI 10.1046/j.1528-1157.43.s.3.9.x; Brenner RP, 2009, NONCONVULSIVE STATUS, P63; Callen-Soto A, 2008, REV NEUROLOGIA, V47, P501, DOI 10.33588/rn.4709.2008487; Carrera E, 2006, NEUROLOGY, V67, P99, DOI 10.1212/01.wnl.0000223361.90278.ca; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; CASCINO GD, 1993, EPILEPSIA, V34, pS21, DOI 10.1111/j.1528-1157.1993.tb05903.x; CELESIA GG, 1988, ARCH NEUROL-CHICAGO, V45, P781, DOI 10.1001/archneur.1988.00520310099023; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e; Drislane FW, 2000, EPILEPSY BEHAV, V1, P301, DOI 10.1006/ebeh.2000.0100; DRISLANE FW, 1994, EPILEPSY RES, V19, P111, DOI 10.1016/0920-1211(94)90021-3; Engel J, 2006, EPILEPSIA, V47, P1558, DOI 10.1111/j.1528-1167.2006.00215.x; Fernandez-Torre JL, 2007, CLIN EEG NEUROSCI, V38, P57, DOI 10.1177/155005940703800112; Fernandez-Torre JL, 2009, EPILEPSIA, V50, P87; Fernandez-Torre JL, 2004, AGE AGEING, V33, P78, DOI 10.1093/ageing/afh030; Fernandez-Torre JL, 2003, REV NEUROLOGIA, V37, P744, DOI 10.33588/rn.3708.2003146; Fernandez-Torre JL, 2009, THESIS U CANTABRIA S; Friedman DE, 2008, EPILEPSIA, V49, P281, DOI 10.1111/j.1528-1167.2007.01327.x; Fujikawa DG, 2006, STATUS EPILEPTICUS M, P109; Gerber PA, 2008, J CLIN NEUROPHYSIOL, V25, P241, DOI 10.1097/WNP.0b013e318182ed67; GUBERMAN A, 1986, NEUROLOGY, V36, P1284, DOI 10.1212/WNL.36.10.1284; Herman ST, 2009, NONCONVULSIVE STATUS, P41; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; HIRSCH LJ, 2008, MEDLINK NEUROLOGY; Holtkamp M, 2005, ARCH NEUROL-CHICAGO, V62, P1428, DOI 10.1001/archneur.62.9.1428; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Jirsch J, 2009, NONCONVULSIVE STATUS, P175; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; JORDAN KG, 1992, NEUROLOGY S1, V42, pS194; JUMAOAS A, 1990, NEUROLOGY, V40, P1199, DOI 10.1212/WNL.40.8.1199; Kaplan PW, 2005, NEUROLOGIST, V11, P348, DOI 10.1097/01.nrl.0000162954.76053.d2; Kaplan PW, 1996, SEMIN NEUROL, V16, P33, DOI 10.1055/s-2008-1040957; Kaplan PW, 1999, J CLIN NEUROPHYSIOL, V16, P341, DOI 10.1097/00004691-199907000-00006; Kaplan PW, 2002, EPILEPSY BEHAV, V3, P122, DOI 10.1006/ebeh.2002.0336; Kaplan PW, 2000, EPILEPTIC DISORD, V2, P185; Korabathina Kalyani, 2007, Expert Rev Neurother, V7, P1643, DOI 10.1586/14737175.7.12.1643; KRUMHOLZ A, 1988, NEUROLOGY, V38, P401, DOI 10.1212/WNL.38.3.401; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; LOWENSTEIN DH, 1992, NEUROLOGY, V42, P100, DOI 10.1212/WNL.42.1.100; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Meierkord H, 2007, LANCET NEUROL, V6, P329, DOI 10.1016/S1474-4422(07)70074-1; Mercade-Cerda JM, 2009, REV NEUROLOGIA, V48, P489, DOI 10.33588/rn.4809.2008714; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; Nagayama M, 2005, NEUROCRIT CARE, V2, P252, DOI 10.1385/NCC:2:3:252; Narayanan JT, 2007, EPILEPSIA, V48, P900, DOI 10.1111/j.1528-1167.2007.01099.x; Niedermeyer E, 2000, CLIN ELECTROENCEPHAL, V31, P192, DOI 10.1177/155005940003100407; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Ronner HE, 2009, SEIZURE-EUR J EPILEP, V18, P257, DOI 10.1016/j.seizure.2008.10.010; RUEEGG SJ, 2003, CURR TREAT OPTION NE, V5, P93; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; SHORVON S, 2009, NONCONVULSIVE STATUS, P11; Shorvon S. D., 1994, STATUS EPILEPTICUS I; Shorvon S, 2007, EPILEPSIA, V48, P35, DOI 10.1111/j.1528-1167.2007.01344.x; SIMON RP, 1986, ANN NEUROL, V20, P351, DOI 10.1002/ana.410200313; SO EL, 1995, J EPILEPSY, V8, P11, DOI 10.1016/0896-6974(94)00003-I; Thomas P, 2006, STATUS EPILEPTICUS M, P91; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Treiman DM, 1996, BAILLIERE CLIN NEUR, V5, P821; TREIMAN DM, 1984, EPILEPSIA, V25, P653; TREIMAN DM, 1995, J CLIN NEUROPHYSIOL, V12, P343; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Walker M, 2005, EPILEPTIC DISORD, V7, P253; WATERHOUSE EJ, 2009, NONCONVULSIVE STATUS, P23; YOUNG GB, 1990, NEUROLOGY, V40, P1843, DOI 10.1212/WNL.40.12.1843; Young GB, 1996, NEUROLOGY, V47, P83	81	4	6	1	1	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	MAR 1	2010	50	5					300	308		10.33588/rn.5005.2009333			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571OO	WOS:000275763800007	20217649				2022-02-06	
J	O'Neil-Pirozzi, TM; Goldstein, R; Strangman, GE; Katz, DI; Glenn, MB				O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Katz, Douglas I.; Glenn, Mel B.			Test-re-test reliability of the virtual planning test in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Test-re-test reliability; executive functioning; traumatic brain injury; planning; organization	TEST-RETEST RELIABILITY; VERBAL-LEARNING TEST; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; INTERVENTIONS; DYSFUNCTION; DEFICITS	Primary objective: To determine test-re-test reliability of the VIrtual Planning Test (VIP) in a group of individuals with traumatic brain injury (TBI). Research design: Single-group repeated measures design. Methods and procedures: Seventy-five individuals with TBI were administered the VIP, with 6-8 weeks between the two test sessions. Main outcomes and results: Test-re-test reliability on VIP scoring parameters as measured by Pearson correlation coefficients ranged from 0.341-0.855, with five of the seven scoring parameters exhibiting r>0.6. Conclusions: Based on the findings of the current study, the VIP has overall moderate test-re-test reliability when administered to individuals with TBI. Some VIP scoring parameters, i.e. Total correct/accuracy and Total absence, demonstrated high test-re-test reliability. Others, i.e. Planning time and Total wrong order, demonstrated low test-re-test reliability.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Glenn, Mel B.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Goldstein, Richard; Glenn, Mel B.] Harvard Univ, Sch Med, Boston, MA USA; [Strangman, Gary E.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Boston, MA USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Speech Language Pathol & Audiol Dept, 103 Forsyth Bldg, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Katz, Douglas/0000-0002-7502-8505; Strangman, Gary/0000-0001-8896-2164	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [HI33A020513]	This work was supported in part by grant #HI33A020513 from the National Institute on Disability and Rehabilitation Research, US Department of Education.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Dawson B., 2004, BASIC CLIN BIOSTATIS; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Ettenhofer ML, 2006, NEUROPSYCHOLOGY, V20, P607, DOI 10.1037/0894-4105.20.5.607; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Grace J., 2001, PSYCHOL ASSESS RESOU; Hamster K., 1983, MULTILINGUAL APHASIA; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Miotto EC, 1998, CORTEX, V34, P639, DOI 10.1016/S0010-9452(08)70770-6; O'Neil-Pirozzi TM, 2005, BRAIN INJURY, V19, P1191, DOI 10.1080/02699050500149916; Phillips L. H, 1997, METHODOLOGY FRONTAL, P191; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Reitan R, 1985, HALSTEAD REITAN NEUR; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; SPREEN B, 1977, NEUROSENSORY CTR COM; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	40	4	4	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2010	24	3					509	516		10.3109/02699051003601697			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800006	20184407				2022-02-06	
J	Richards, PM; Kirk, JW				Richards, Paul M.; Kirk, John W.			Traumatic Brain Injury Across the Lifespan: A Neuropsychological Tutorial for Attorneys	PSYCHOLOGICAL INJURY & LAW			English	Article						Traumatic brain injury; Poor outcome; Personal injury litigation; Neuropsychological assessment; Recovery		Traumatic brain injuries (TBIs) are prevalent across the lifespan and occur from multiple sources (e.g., motor vehicle accidents, falls, sports injuries, assaults, abuse). Because many of these injuries are compensable, plaintiff and defense counsel often rely on the expertise of a forensic neuropsychologist to help establish or refute the claim of the presence of TBI, or the degree of severity claimed. In this paper, we offer a tutorial in which we provide information that attorneys need to know in handling of TBI cases: We address definitions, epidemiology, pathophysiology, guidelines for grading TBI severity, and treatment. Also, we cover moderating variables that affect TBI outcome and recovery and specific forensic issues that may arise in the neuropsychological evaluation (e.g., symptom magnification, malingering). Although the focus is on mild TBI in adults, we also cover the more serious variants of moderate and severe adult TBI and include a separate all-severity section on pediatric populations. We consider the special challenges the attorney faces, for example, in establishing causality.	[Kirk, John W.] Childrens Hosp, Dept Phys Med & Rehabil, Aurora, CO 80045 USA		Kirk, JW (corresponding author), Childrens Hosp, Dept Phys Med & Rehabil, Aurora, CO 80045 USA.	paulmrichards@msn.com					Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Allen L. M., 1997, CARB 97 MANUAL COMP; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; [Anonymous], 2009, LOS ANGELES TIMES; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Baron IS, 2008, NEUROPSYCHOLOGY COUR, P66; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler E. D., 2010, PSYCHOL INJURY 2 LAW, V2; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boone K.B., 2007, ASSESSMENT FEIGNED C; Brooks P., 1985, THE INJURED CHILD; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Corrigan J. D., 2005, REHABILITATION TRAUM, P131; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Defense and Veterans Brain Injury Center, 2006, DEF VET BRAIN INJ CT; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Dise-Lewis J. E., 2005, BRAINSTARS; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J., 2005, FORENSIC NEUROPSYCHO, P182; Elovic E, 2000, J HEAD TRAUMA REHAB, V15, P1068, DOI 10.1097/00001199-200008000-00009; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, MANAUL WORD MEMORY T; Green P., 2004, TEST MANUAL MED SYMP; Greiffenstein M. F., 2000, BRAIN INJ SOURCE, V4, P26; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Hamsher K, 2001, CLIN NEUROPSYCHOL, V15, P433; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirk JW, 2009, CLIN NEUROPSYCHOL, V23, P619; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kirkwood M. W., CLIN NEUROP IN PRESS; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kraus J, 1996, NEUROTRAUMA, P13; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Laurent-Vannier A, 2009, Ann Phys Rehabil Med, V52, P436, DOI 10.1016/j.rehab.2009.03.001; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Light R., 2007, WORKSH 5 ANN C AM AC; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McIntosh D. E., 2005, HDB SCH NEUROPSYCHOL, P365; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; National Academy of Neuropsychology, 2000, ARCH CLIN NEUROPSYCH, V15, P379; National Institute on Disability and Rehabilitation Research, 2009, TRAUM BRAIN INJ MOD; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Ruff R. M., 2003, CLIN NEUROPSYCHOL CO, V1; Ruff R. M., 1999, MILD HEAD INJURY CAU, P99; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Sbordonne R., 2010, PSYCHOL INJURY LAW, V2; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P7, DOI 10.4088/JCP.v63n0102; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Suskauer S. J., J PEDIAT RE IN PRESS; Talwar V, 2008, CHILD DEV, V79, P866, DOI 10.1111/j.1467-8624.2008.01164.x; TEASDALE G, 1974, LANCET, V2, P81; TOMBAUGH TN, 1996, TEST MEMORY MALIGERI; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Woodruff L, 2007, INSTANT FAMILYS JOUR; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	137	4	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2010	3	1			SI		3	24		10.1007/s12207-010-9065-0			22	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3XZ	WOS:000415448300002					2022-02-06	
J	Birnbaum, K; Maus, U; Tacke, J				Birnbaum, Klaus; Maus, Uwe; Tacke, Josef			Functional cervical MRI within the scope of whiplash injuries: presentation of a new motion device for the cervical spine	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Cervical spine; Dynamic magnetic resonance imaging; Dynamic sequences; Soft tissue injury; Whiplash injury	ZYGAPOPHYSIAL JOINT PAIN; PERCUTANEOUS RADIOFREQUENCY NEUROTOMY; RESONANCE-IMAGING ASSESSMENT; DISK DEGENERATION; FACET CAPSULE; HEAD POSITION; LIGAMENT; DISORDERS; MEMBRANES; MODEL	Frequently following a whiplash injury of the cervical spine, patients suffer from persistent pain symptoms. The MRI will in some of these cases show changes consistent with disk pathology or spinal stenosis, although in most instances the imaging studies will offer no adequate explanation for the described symptoms. The goal of our research was to develop and test a new MRI compatible device that will allow functional imaging of the cervical spine. A total of 30 patients with whiplash injuries were evaluated during the first 6 weeks following trauma with the functional MRI. The examination was carried out with a T2-weighted turbo spin-echo sequence utilizing a new apparatus consisting of an inflatable air bag contained in a Plexiglas housing. Thanks to a valve placed outside of the examination room, it was possible to individually regulate the amount of air used to fill the pillow, thereby obtaining a full range of motion between flexion and extension. In 25 cases no pathology was found during this examination. Two patients presented with scarring of the alar ligaments, indicative of a traumatic lesion. In two other instances the images in reclination revealed a bulging disk, while in one case a widening of the disk space was found as a sign for a rupture of the anterior longitudinal ligament. Our study was able to demonstrate the applicability of the new functional testing device, which permits a standardized, continuous and dynamic evaluation of the cervical spine in a closed MRI.	[Birnbaum, Klaus] Orthopaed Clin Hennef, D-53773 Hennef, Germany; [Maus, Uwe] Rhein Westfal TH Aachen, Dept Orthopaed, D-52074 Aachen, Germany; [Tacke, Josef] Klinikum Passau, Dept Radiol, D-94032 Passau, Germany		Birnbaum, K (corresponding author), Orthopaed Clin Hennef, Adenauerpl 1, D-53773 Hennef, Germany.	drbirnbaum@web.de					Antonaci F, 2002, CEPHALALGIA, V22, P533, DOI 10.1046/j.1468-2982.2002.00405.x; BARNSLEY L, 1995, SPINE, V20, P20, DOI 10.1097/00007632-199501000-00004; Baumert B, 2009, MAGN RESON IMAGING, V27, P954, DOI 10.1016/j.mri.2009.01.012; Bonelli Aurelio, 2000, Italian Journal of Anatomy and Embryology, V105, P51; Castro W H, 1997, Eur Spine J, V6, P366, DOI 10.1007/BF01834062; Cusick JF, 2001, SPINE, V26, P1252, DOI 10.1097/00007632-200106010-00015; EMBERTON P, 1994, AM J ROENTGENOL, V163, P998, DOI 10.2214/ajr.163.4.8092063; HARRIS JH, 1992, J BONE JOINT SURG BR, V74, P567, DOI 10.1302/0301-620X.74B4.1624517; Heikkila H, 1996, SCAND J REHABIL MED, V28, P133; Indahl A, 1997, SPINE, V22, P2834, DOI 10.1097/00007632-199712150-00006; Ivancic PC, 2008, CLIN BIOMECH, V23, P159, DOI 10.1016/j.clinbiomech.2007.09.003; JONSSON H, 1991, J SPINAL DISORD, V4, P251, DOI 10.1097/00002517-199109000-00001; JONSSON H, 1994, SPINE, V19, P2733; Kaale BR, 2005, J NEUROTRAUM, V22, P1294, DOI 10.1089/neu.2005.22.1294; Kaale BR, 2005, J NEUROTRAUM, V22, P466, DOI 10.1089/neu.2005.22.466; Karlsborg M, 1997, ACTA NEUROL SCAND, V95, P65, DOI 10.1111/j.1600-0404.1997.tb00071.x; Krakenes J, 2006, SPINE, V31, P2820, DOI 10.1097/01.brs.0000245871.15696.1f; Lennarson PJ, 2000, J NEUROSURG, V92, P201, DOI 10.3171/spi.2000.92.2.0201; Lennarson PJ, 2001, J NEUROSURG, V94, P265, DOI 10.3171/spi.2001.94.2.0265; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Lord SM, 1996, SPINE, V21, P1737, DOI 10.1097/00007632-199608010-00005; LORD SM, 1995, NEUROSURGERY, V36, P732, DOI 10.1227/00006123-199504000-00014; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; MARTIN D, 1992, NEURORADIOLOGY, V34, P262, DOI 10.1007/BF00588177; Myran R, 2008, SPINE, V33, P2012, DOI 10.1097/BRS.0b013e31817bb0bd; NAGELE M, 1992, ROFO FORTSCHR RONTG, V157, P222, DOI 10.1055/s-2008-1033003; Nidecker A, 1997, SCHWEIZ MED WSCHR, V127, P1643; Nordin M, 2008, SPINE, V33, pS101, DOI 10.1097/BRS.0b013e3181644ae8; NORRIS SH, 1983, J BONE JOINT SURG BR, V65, P608, DOI 10.1302/0301-620X.65B5.6643566; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008000-00005; OSTI OL, 1992, J BONE JOINT SURG BR, V74, P678, DOI 10.1302/0301-620X.74B5.1388173; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; PETERSSON K, 1994, ACTA ORTHOP SCAND, V65, P525; Pettersson K, 1997, SPINE, V22, P283, DOI 10.1097/00007632-199702010-00010; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; Roy S, 2004, NEURORADIOLOGY, V46, P392, DOI 10.1007/s00234-004-1193-3; SCHNARKOWSKI P, 1995, ROFO FORTSCHR RONTG, V162, P319, DOI 10.1055/s-2007-1015889; Siegmund GP, 2001, SPINE, V26, P2095, DOI 10.1097/00007632-200110010-00010; Solomonow M, 2002, J ELECTROMYOGR KINES, V12, P81, DOI 10.1016/S1050-6411(01)00032-3; Stemper BD, 2005, J NEUROSURG-SPINE, V3, P471, DOI 10.3171/spi.2005.3.6.0471; Tominaga Y, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-103; Tubbs RS, 2007, SURG RADIOL ANAT, V29, P667, DOI 10.1007/s00276-007-0269-2; Volle E, 2000, Int Tinnitus J, V6, P134; Winkelstein BA, 2000, SPINE, V25, P1238, DOI 10.1097/00007632-200005150-00007; Yoganandan N, 2002, ACCIDENT ANAL PREV, V34, P663, DOI 10.1016/S0001-4575(01)00066-5	45	4	4	0	8	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-8517			SURG RADIOL ANAT	Surg. Radiol. Anat.	FEB	2010	32	2					181	188		10.1007/s00276-009-0557-0			8	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	551QG	WOS:000274223500014	19763379				2022-02-06	
J	Crutcher, KA; Lilley, HN; Anthony, SR; Zhou, W; Narayanaswami, V				Crutcher, K. A.; Lilley, H. N.; Anthony, S. R.; Zhou, W.; Narayanaswami, V.			Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide	BRAIN RESEARCH			English	Article						Alzheimer's disease; Neurotoxicity; Neuroprotection; LRP; Proteolysis	DENSITY-LIPOPROTEIN RECEPTOR; E-DERIVED PEPTIDE; ALZHEIMERS-DISEASE PATHOLOGY; THROMBIN-CLEAVAGE FRAGMENT; AMYLOID-INDUCED TOXICITY; CLOSED-HEAD INJURY; E-MIMETIC PEPTIDES; E-DEFICIENT MICE; MURINE MODEL; SPINAL-CORD	Apolipoprotein E was found to protect against the neurotoxic effects of a dimeric peptide derived from the receptor-binding region of this protein (residues 141-149). Both apoE3 and apoE4 conferred protection but the major N-terminal fragment of each isoform did not. Nor was significant protection provided by bovine serum albumin or apoA-I. Full-length apoE3 and apoE4 also inhibited the uptake of a fluorescent-labeled derivative of the peptide, suggesting that the mechanism of inhibition might involve competition for cell surface receptors/proteoglycans that mediate endocytosis and/or signaling pathways. These results might bear on the question of the role of apoE in neuronal degeneration, such as occurs in Alzheimer's disease where apoE4 confers a significantly greater risk of pathology. (C) 2009 Elsevier B.V. All rights reserved.	[Crutcher, K. A.; Lilley, H. N.; Anthony, S. R.; Zhou, W.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Narayanaswami, V.] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Narayanaswami, V.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA		Crutcher, KA (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA.	crutchka@me.com	Crutcher, Keith/B-5435-2019	Crutcher, Keith/0000-0002-9176-5759	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG20249]; TRDRP [17RT-0165]; American Heart AssociationAmerican Heart Association [07551374]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG020249] Funding Source: NIH RePORTER	The technical assistance of Lori Gulley is gratefully acknowledged. This work was supported by the NIH (AG20249) to KC and TRDRP (17RT-0165) and the American Heart Association (07551374) to VN.	Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Baum L, 2000, MICROSC RES TECHNIQ, V50, P278, DOI 10.1002/1097-0029(20000815)50:4<278::AID-JEMT5>3.0.CO;2-T; Bhattacharjee PS, 2008, INVEST OPHTH VIS SCI, V49, P4263, DOI 10.1167/iovs.08-2077; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carrette O, 2006, J CHROMATOGR B, V840, P1, DOI 10.1016/j.jchromb.2006.05.019; Caruso A, 2006, J NEUROCHEM, V98, P364, DOI 10.1111/j.1471-4159.2006.03867.x; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; CLAY MA, 1995, BIOCHEMISTRY-US, V34, P11142, DOI 10.1021/bi00035a020; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; CRUTCHER KA, 1994, EXP NEUROL, V130, P120, DOI 10.1006/exnr.1994.1191; Crutcher KA, 2004, J MOL NEUROSCI, V23, P181, DOI 10.1385/JMN:23:3:181; de Chaves EP, 2008, FUTURE LIPIDOL, V3, P505, DOI 10.2217/17460875.3.5.505; DeMattos RB, 1998, J BIOL CHEM, V273, P4206, DOI 10.1074/jbc.273.7.4206; DYER CA, 1991, J BIOL CHEM, V266, P22803; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gay EA, 2006, J PHARMACOL EXP THER, V316, P835, DOI 10.1124/jpet.105.095505; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Haasdijk ED, 2002, NEUROSCI LETT, V335, P29, DOI 10.1016/S0304-3940(02)01159-X; Hagiwara A, 2000, BIOCHEM BIOPH RES CO, V278, P633, DOI 10.1006/bbrc.2000.3841; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; HUANG Y, 2000, RW NEUROBIOL AGING, V21, pS216; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Jordan J, 1998, J NEUROSCI, V18, P195; Kitagawa K, 2002, ANN NY ACAD SCI, V977, P468, DOI 10.1111/j.1749-6632.2002.tb04852.x; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Marques M, 1997, ALZHEIMER RES, V3, P1; Marques MA, 1996, NEUROREPORT, V7, P2529, DOI 10.1097/00001756-199611040-00025; Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G; Michikawa M., 1997, Society for Neuroscience Abstracts, V23, P826; Moulder KL, 1999, J NEUROCHEM, V72, P1069, DOI 10.1046/j.1471-4159.1999.0721069.x; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Olsen MK, 2001, ANN NEUROL, V50, P730, DOI 10.1002/ana.1252; Puttfarcken PS, 1997, J NEUROCHEM, V68, P760; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Tamamizu-Kato S, 2007, BIOCHEMISTRY-US, V46, P8392, DOI 10.1021/bi700289k; Tolar M, 1997, J NEUROSCI, V17, P5678; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; Veinbergs I, 2002, J NEUROSCI RES, V67, P379, DOI 10.1002/jnr.10138; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang WS, 1997, BRAIN RES, V778, P6, DOI 10.1016/S0006-8993(97)00877-9; Wang XS, 1997, J CELL PHYSIOL, V173, P73, DOI 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.0.CO;2-G; Wilson JMB, 2005, CAN J PHYSIOL PHARM, V83, P131, DOI 10.1139/Y04-140; Zhang D., 2001, ALZHEIMERS REP, V4, P67; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	69	4	4	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 8	2010	1306						106	115		10.1016/j.brainres.2009.10.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534YV	WOS:000272934400013	19836363	Green Accepted			2022-02-06	
B	Anderson, V		Anderson, V; Jacobs, R; Anderson, PJ		Anderson, Vicki			Attention deficits and the frontal lobes	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX ACTIVATION; PEDIATRIC HEAD-INJURY; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; HYPERACTIVITY DISORDER; SELECTIVE ATTENTION; DEFICIT/HYPERACTIVITY DISORDER; CRANIAL IRRADIATION; LATE CHILDHOOD		Univ Melbourne, Sch Behav Sci, Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia		Anderson, V (corresponding author), Univ Melbourne, Sch Behav Sci, Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia.						ACKERLY S, 1948, ASS RES NERVOUS MENT, V27, P479; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Anderson VA, 2004, J CLIN EXP NEUROPSYC, V26, P684, DOI 10.1080/13803390490504344; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; AUGUST GJ, 1990, J ABNORM CHILD PSYCH, V18, P29, DOI 10.1007/BF00919454; Barkley RA, 2000, J AM ACAD CHILD PSY, V39, P1064, DOI 10.1097/00004583-200008000-00025; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 1990, ADHD HDB DIAGNOSIS T; Barkley Russell A., 1994, DISRUPTIVE BEHAV DIS, P11; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; BROUWERS P, 1985, J PEDIATR-US, V106, P723, DOI 10.1016/S0022-3476(85)80343-7; CASEY BJ, 1993, J CLIN EXP NEUROPSYC, V15, P933, DOI 10.1080/01688639308402609; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; *COGSTATE LTD, 2001, SCI VAL MEAS COGN PE; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Dennis M, 1995, TRAUMATIC HEAD INJUR; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P85; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.2307/1130099; DIAMOND A, 1989, DEV PSYCHOBIOL, V22, P271, DOI 10.1002/dev.420220307; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; DOUGLAS VI, 1972, CAN J BEH SCI, V4, P259, DOI 10.1037/h0082313; Douglas VI, 1979, ATTENTION COGNITIVE, P173; DOUGLAS VI, 1983, DEV NEUROPSYCHIATRY, P280; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Drechsler R, 2005, J CHILD PSYCHOL PSYC, V46, P824, DOI 10.1111/j.1469-7610.2004.00384.x; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Garth J, 1997, Pediatr Rehabil, V1, P99; GERARDICAULTON G, 2000, DEVELOPMENTAL SCI, V3, P294; Godefroy O, 1996, BRAIN COGNITION, V30, P155, DOI 10.1006/brcg.1996.0010; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GRATTAN LM, 1994, NEUROPSY NEUROPSY BE, V7, P251; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Halperin JM, 2006, PSYCHOL BULL, V132, P560, DOI 10.1037/0033-2909.132.4.560; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HEILMAN KM, 1991, J CHILD NEUROL, V6, pS76, DOI 10.1177/0883073891006001S09; HOOKS K, 1994, J CLIN CHILD PSYCHOL, V23, P69, DOI 10.1207/s15374424jccp2301_9; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; James W., 1890, PRINCIPLES PSYCHOL; KAIL R, 1988, J EXP CHILD PSYCHOL, V45, P339, DOI 10.1016/0022-0965(88)90036-7; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KINSBOURNE M, 1996, COGNITIVE NEUROSCIEN; Kirk U, 1985, HEMISPHERIC FUNCTION, P193; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; KLIN A, 1995, SYNDROME NONVERBAL L, P93; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Knight R. T., 2002, PRINCIPLES FRONTAL L, P573; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Lajoie G., 2005, BRAIN IMPAIR, V6, P21, DOI DOI 10.1375/BRIM.6.1.21.65479; LANE DM, 1982, MERRILL PALMER QUART, V28, P317; LANE DM, 1979, J EXP CHILD PSYCHOL, V28, P16, DOI 10.1016/0022-0965(79)90099-7; LANG W, 1998, J INT NEUROPSYCH SOC, V4, P221; Langleben DD, 2001, NUCL MED COMMUN, V22, P1333, DOI 10.1097/00006231-200112000-00009; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LOGE DV, 1990, J AM ACAD CHILD PSY, V29, P540, DOI 10.1097/00004583-199007000-00006; Luria A.R., 1973, WORKING BRAIN; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T, 1999, TEA CH TEST EVERYDAY; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; Mecklinger A, 1999, J CLIN EXP NEUROPSYC, V21, P606, DOI 10.1076/jcen.21.5.606.873; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MICHAEL RL, 1981, PSYCHOPHYSIOLOGY, V18, P665, DOI 10.1111/j.1469-8986.1981.tb01841.x; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Newman H, 1988, BRAIN IMPAIR, P223; Northam EA, 1998, DIABETES CARE, V21, P379, DOI 10.2337/diacare.21.3.379; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner M.I., 1988, CLIN NEUROPSYCHOLOGY, P169, DOI DOI 10.1037/10063-005; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRAGAY EB, 1975, EXP NEUROL, V49, P203, DOI 10.1016/0014-4886(75)90205-8; PRAGAY EB, 1987, EXP NEUROL, V96, P481, DOI 10.1016/0014-4886(87)90213-5; PRIOR M, 1985, J CHILD PSYCHOL PSYC, V26, P289, DOI 10.1111/j.1469-7610.1985.tb02267.x; RAY CL, 1982, EXP NEUROL, V77, P544, DOI 10.1016/0014-4886(82)90227-8; Rebok GW, 1997, CHILD NEUROPSYCHOL, V3, P28, DOI 10.1080/09297049708401366; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson I. R., 1999, COGNITIVE NEUROREHAB, P302; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Ruff H. A., 1996, ATTENTION EARLY DEV; Schulz KP, 2005, NEUROPSYCHOLOGY, V19, P390, DOI 10.1037/0894-4105.19.3.390; Schulz KP, 2005, J AM ACAD CHILD PSY, V44, P47, DOI 10.1097/01.chi.0000145551.26813.f9; Schulz KP, 2004, AM J PSYCHIAT, V161, P1650, DOI 10.1176/appi.ajp.161.9.1650; SEIDEL WT, 1990, J ABNORM CHILD PSYCH, V18, P217, DOI 10.1007/BF00910732; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; SHEPP BE, 1987, J EXP CHILD PSYCHOL, V43, P159, DOI 10.1016/0022-0965(87)90057-9; Shiffrin, 1988, STEVENS HDB EXPT PSY, V1-2, P739; Shimamura Arthur P., 1995, P803; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Spalletta G, 2001, J NEURAL TRANSM, V108, P1203, DOI 10.1007/s007020170010; Stuss D., 2002, PR FRONTAL LOBE FUNC, P392, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0025; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Swanson J, 1998, ATTENTIVE BRAIN, P445; SYKES DH, 1973, J CHILD PSYCHOL PSYC, V14, P213, DOI 10.1111/j.1469-7610.1973.tb01189.x; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANDERMEERE J, 1988, J ABNORM CHILD PSYCH, V16, P641, DOI 10.1007/BF00913475; Villella S., 2001, CLIN NEUROPSYCHOL, V21, P1; WAINWRIGHTSHARP JA, 1993, J AUTISM DEV DISORD, V23, P1, DOI 10.1007/BF01066415; Walsh K. W., 1985, UNDERSTANDING BRAIN; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Willmott C, 2000, DEV NEUROPSYCHOL, V17, P361, DOI 10.1207/S15326942DN1703_5; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; Wu KK, 2002, DEV NEUROPSYCHOL, V22, P501, DOI 10.1207/S15326942DN2202_5; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65	153	4	4	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							317	344					28	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500016					2022-02-06	
J	Bakar, B; Tekkok, IH				Bakar, Buelent; Tekkok, Ismail Hakki			Venous sinus thrombosis after closed head injury: case report	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			Turkish	Article						Dural sinus thrombosis; closed head injury; internal jugular vein; sagittal sinus	HEPARIN; ULTRASOUND; INFUSION	Dural sinus thrombosis after closed head injury is seen very rarely and its pathophysiological mechanisms are not yet understood. An 18-year-old man who had been crushed in an automobile had closed head injury with Glasgow Coma Score 4. Computerized tomography showed diffuse cerebral edema and right occipital linear fracture extending to the internal jugular foramen. Because of high-level intracranial pressure, he underwent bilateral frontotemporoparietal craniectomy. After surgery, magnetic resonance scan with venography showed that the right internal jugular vein was obliterated from the torcular Herophili and the left internal jugular vein was very thin in calibration. He was discharged home with Karnofsky performance score of 30/90. Dural sinus thrombosis with dominant side can carry high morbidity and mortality if not treated immediately.	[Bakar, Buelent; Tekkok, Ismail Hakki] Mesa Hosp, Dept Neurosurg, Ankara, Turkey		Bakar, B (corresponding author), Yasam Cad 5, TR-06510 Ankara, Turkey.	bulentbanrs@yahoo.com	Bakar, Bulent/AAS-4247-2020				Alper F, 2004, CEREBROVASC DIS, V18, P236, DOI 10.1159/000079960; Ayanzen RH, 2000, AM J NEURORADIOL, V21, P74; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Frey JL, 1999, STROKE, V30, P489, DOI 10.1161/01.STR.30.3.489; GHORAYEB BY, 1987, ARCH OTOLARYNGOL, V113, P749; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Lichtenstein D, 2001, INTENS CARE MED, V27, P301, DOI 10.1007/s001340000792; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; PERSSON L, 1990, NEUROSURGERY, V26, P117, DOI 10.1227/00006123-199001000-00016; Surendrababu N R S, 2006, Indian J Med Sci, V60, P135; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; TSAI FY, 1995, AM J NEURORADIOL, V16, P1021; Wasay M, 2001, STROKE, V32, P2310, DOI 10.1161/hs1001.096192	18	4	4	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2010	16	1					98	102					5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	546ZW	WOS:000273855400021	20209407				2022-02-06	
B	Cardinali, L; Brozzoli, C; Farne, A		Koob, GF; LeMoal, M; Thompson, RF		Cardinali, L.; Brozzoli, C.; Farne, A.			Peripersonal Space and Body Schema	ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 3: P-Z			English	Article; Book Chapter							PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; TOOL USE; REPRESENTATIONS; RESPONSES; MULTIPLE; SIZE	Bimodal neurons - A particular class of neurons that presents receptive fields for stimulations coming from different sensory modalities. For instance, a visuotactile neuron is driven by a tactile stimulus on the tactile receptive field as well as by a visual stimulus presented in the visual receptive field close to the tactile one. Deafferentation - The elimination or interruption of sensory nerve impulses by destruction of or injury to the sensory nerve fibers. The level at which the disruption happens defines the type of deafferentation: central if the lesion involves the central nervous system, and peripheral if the lesion involves the peripheral nervous system. Double dissociation - Term that was introduced by H.L. Teuber in 1955. This is the demonstration that two experimental manipulations each have different effects on two dependent variables; if one manipulation affects the first variable and not the second, the other manipulation affects the second variable and not the first. If one can demonstrate not only that a lesion in brain structure A impairs function X but not Y, and further demonstrates that a lesion to brain structure B impairs function Y but spares function X, one can make more specific inferences about brain function and function localization. In cognitive neuroscience, double dissociation is an experimental technique by which two cerebral areas are functionally dissociated by two behavioral tests, each test being affected by a lesion in one zone and not the other. In a series of patients with traumatic brain injury, one might find two patients, A and B. Patient A has difficulty performing cognitive tests for, say, auditory memory but has no problem with visual memory. Patient B has the opposite problem. By using neuroimaging (or neuropathology post mortem) to identify the overlap and dissociation among lesioned areas of the brain, one can infer something about the localization of visual and auditory function in the normal brain. Multisensory integration - The way information from the different sensory modalities, such as sight, sound, touch, smell, self-motion, and taste, may be integrated by the nervous system. Such integration may result in unified perceptual experiences that are coherent across sensory modalities. Multisensory integration also concerns how different sensory modalities interact and alter each other's processing. Neuroplasticity - Neuroplasticity (also referred to as brain plasticity, cortical plasticity, or cortical remapping) is the changing of neurons and the organization of their networks and thus their function by experience. This idea was first proposed in 1892 by Santiago Ramon y Cajal - the proposer of the neuron doctrine though the idea was largely neglected for the next 50 years. Proprioception - The sense of the relative position of neighbouring parts of the body. Unlike the six exteroceptive senses (sight, taste, smell, touch, hearing, and balance) by which we perceive the outside world, and interoceptive senses, by which we perceive the pain and the stretching of internal organs, proprioception is a third, distinct sensory modality that provides feedback solely on the status of the body internally. It is the sense that indicates whether the body is moving with required effort, as well as where the various parts of the body are located in relation to each other. Receptive field - The receptive field of a sensory neuron is a region of space in which the presence of a stimulus will alter the firing of that neuron. Receptive fields have been identified for neurons of the auditory system, the somatosensory system, and the visual system. The concept of receptive fields can be extended to further up the neural system; if many sensory receptors all form synapses with a single cell further up, they collectively form the receptive field of that cell. In the somatosensory system, receptive fields are regions of the skin or of internal organs. Some types of mechanoreceptors have large receptive fields, while others have smaller ones. Large receptive fields allow the cell to detect changes over a wider area, but lead to a less precise perception. Thus, the fingers, which require the ability to detect fine detail, have many, densely packed mechanoreceptors with small receptive fields, while the back and legs, for example, have fewer receptors with large receptive fields. Receptors with large receptive fields usually have a hot spot, an area within the receptive field (usually in the center, directly over the receptor) where stimulation produces the most intense response.	[Cardinali, L.] INSERM, UMR S Espace & Act 864, F-69500 Bron, France; Univ Lyon 1, F-69365 Lyon, France; Hosp Civils Lyon, Hop Neurol Mouvement & Handicap, Lyon, France		Cardinali, L (corresponding author), INSERM, UMR S Espace & Act 864, F-69500 Bron, France.		FARNE, ALESSANDRO/G-1238-2015	FARNE, ALESSANDRO/0000-0001-5769-3491			Bender M.B, 1952, DISORDERS PERCEPTION; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Di Russo F, 2006, NEUROIMAGE, V30, P172, DOI 10.1016/j.neuroimage.2005.09.051; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; DRIVER J, 1998, ATTENTION, P297; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Graziano Michael S. A., 1995, P1021; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Iriki A, 1996, NEUROREPORT, V7, P2325; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Yamamoto S, 2001, NAT NEUROSCI, V4, P979, DOI 10.1038/nn721	15	4	4	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-045396-5; 978-0-08-044732-2				2010							40	46					7	Behavioral Sciences; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology	BA3WY	WOS:000335074700009					2022-02-06	
J	Fatigba, OH; Padonou, J				Fatigba, Olatoundji Holden; Padonou, Jidjoho			EPIDEMIOLOGY OF TRAUMATIC BRAIN INJURIES IN PARAKOU (BENIN)	AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES			French	Article						Traumatic brain injury; Road crash; Epidemiology		Introduction Traumatic brain injury (TBI) is the leading cause of death for traumatic injury. It is an major public health problem. Objective This study aimed to investigate the epidemiology of (TBI) in CHD-Borgou (Benin). Method It was prospective study. A total of TBI from admission to output was collected during the period January 1, 2008 to December 31, 2009. Result Of the 755 (31.9%) total TBI admitted, males were 642 (85%) and females 113 (15%). 87,7% cases resulted from road traffic accident. The mean age was 28.6 years +/- 15.4. An risk factor was found in 134(20.3%) cases and Alcohol use was 61,2%. Road crash concerned 492 (74,3%) motorcyclists, 8 (1.2%) cyclist, 119 (18%) pedestrians and 43 (6.5%) motor vehicle occupants. The distribution of head injury severity, on the basis of Glasgow Coma Scale scores, was mild in 482 (63,8%), moderate in 102 (13.5%), and severe in 171 (22.7%) for all cases. TBI was lone in 135 (20.3%) cases. The skull X-rays performed for 414 patients and cerebral CT-Scan for 85. Skull x-ray showed 47 (11.4%) fissure fracture, 38 (9.2%) depressive fracture and 7 (1.7%) pneumocephalus. The most observed brain lesions were the cerebral contusion (30,6%) and hematoma (28.3%). The mean duration of hospitalization was 7.25 days. 674 (89.2%) patients had good recovery. Mortality was 8.5%. Conclusion __ The TBI are a major problem in CHD-Borgou; Prevention of road traffic injuries and improved emergency care and health facility-based treatment is needed.	[Fatigba, Olatoundji Holden; Padonou, Jidjoho] Univ Parakou, Ctr Hospitalier, Unite Neurochirurg, Benin, Turkey		Fatigba, OH (corresponding author), Univ Parakou, Ctr Hospitalier, Unite Neurochirurg, Benin, Turkey.	ftg_holden@yahoo.fr					BAHLOUL M, J TRAUMA INJURY INFE, V57, P255; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; COULIBALY Y, 2004, MALI MED; Crocker P, 2010, AM J EMERG MED, V28, P68, DOI 10.1016/j.ajem.2008.09.011; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Hassan NA, 2010, J FORENSIC LEG MED, V17, P26, DOI 10.1016/j.jflm.2009.07.008; LEVY F, 1997, AFR J NEUR SCI, V16, P2; Maas Andrew I R, 2009, Crit Care, V13, P1016, DOI 10.1186/cc8163; SIDIBE S, 2005, MEDICAL; SURIYAWONGPAISAL P, 2003, INJURY CONTROL SAFET, V10, P104; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	14	4	4	0	1	PAN AMER ASSOC NEUROLOGICAL SCIENCES	BOULOGNE	CMCO COTE D OPALE, ROUTE DESVRES, ST MARTIN, BOULOGNE, 62280, FRANCE	1015-8618	1992-2647		AFR J NEUROL SCI	Afr. J. Neurol. Sci.		2010	29	1					25	33					9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V9S6O	WOS:000422487700004					2022-02-06	
J	Hogsbro, K				Hogsbro, Kjeld			SIMREB - towards a systematic inquiry into models for rehabilitation	SCANDINAVIAN JOURNAL OF DISABILITY RESEARCH			English	Article						rehabilitation; evaluation; models; discourse; traumatic brain injury		Systematic Inquiry into Models for Rehabilitation (SIMREB) is a framework for designing evaluations of rehabilitation models specifically intended for persons who are only to a limited extent regarded as being capable to speak for themselves and who, therefore, are often entrusted to a professional assessment of their needs. The article identifies the general elements in this model. By looking at both the epistemological level and the practice level from a professional as well as a user perspective the model taps into discourse analysis, institutional ethnography and a wide tradition of evaluation research. The article uses an evaluation of a rehabilitation programme for people with traumatic brain injury (TBI) as an example to illustrate the different elements of the SIMREB model.	[Hogsbro, Kjeld] Aalborg Univ, Dept Social Work, Aalborg, Denmark; [Hogsbro, Kjeld] Danish Inst Govt Res, AKF, Copenhagen, Denmark		Hogsbro, K (corresponding author), Aalborg Univ, Dept Social Work, Aalborg, Denmark.	kjeldh@socsci.aau.dk		Hogsbro, Kjeld/0000-0002-6291-5834			Berreman Gerald D., 1962, MANY MASKS ETHNOGRAP; BOGET T, 1997, NEUROPSYCHOL REHABIL, P333; BOURDIEU PIERRE, 1990, LOGIC PRACTICE; Colin Gordon, 1980, POWER KNOWLEDGE SELE; Dean Mitchell, 1999, GOVT POWER RULE MODE; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Fairclough N., 2010, CRITICAL DISCOURSE A; Geertz C., 1973, INTERPRETATION CULTU; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Guba EG., 1989, 4 GENERATION EVALUAT; Habermas J., 1981, THEORIE KOMMUNIKATIV; Hogsbro K., 2002, REHABILITERING MENNE; Hogsbro K., 2007, ETIBA FORSKNINGSBASE; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Leon-Carrion J, 1997, NEUROPSYCHOL REHABIL, P301; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; Levi-Strauss C., 1962, PENSEE SAUVAGE; Luhmann N., 1984, SOZIALE SYSTEME GRUN; Machuca F., 1997, NEUROPSYCHOL REHABIL, p453 ; March N.V, 1991, J CLIN EXPERIENCE NE, V13, P729; McNeill DE, 1997, ARCH CLIN NEUROPSYCH, V12, P645; Patrick P.D., 1997, NEUROPSYCHOL REHABIL, P431; Pawson R., 1997, REALISTIC EVALUATION; Roselli M., 1997, NEUROPSYCHOL REHABIL, P353; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SARTRE JP, 1976, CRITIQUE DIALECTICAL; Sbordone R. J., 1998, ECOLOGICAL VALIDITY, P15; Sgaramella T.M., 1997, NEUROPSYCHOL REHABIL, P399; SMITH DE, 2005, I ETHNOGRAPHY; Spradley J., 1979, ETNOGRAPHIC INT; Stringer AY, 2002, PATHWAYS TO PROMINENCE IN NEUROPSYCHOLOGY, P3; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; World Health Organization, 2001, ICF INT CLASFUNCT	35	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1501-7419	1745-3011		SCAND J DISABIL RES	Scand. J. Disabil. Res.		2010	12	1					1	18		10.1080/15017410903338812			18	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V84TF	WOS:000212474600001		gold			2022-02-06	
J	Hornuss, C; Firsching, M; Dolch, M; Martignoni, A; Peraud, A; Briegel, J				Hornuss, C.; Firsching, M.; Dolch, M.; Martignoni, A.; Peraud, A.; Briegel, J.			Long-Term Isoflurane Therapy for Refractory Bronchospasm Associated with Herpes Simplex Pneumonia in a Heart Transplant Patient	CASE REPORTS IN MEDICINE			English	Article							LOW-FLOW SEVOFLURANE; INTRACRANIAL-PRESSURE; RENAL-FUNCTION; VIRUS; SEDATION; DESFLURANE; ANESTHESIA	A 47-year-old man with a history of heart transplant was admitted after severe traumatic brain injury and seizures. During mechanical ventilation, the patient developed bronchospasm that severely compromised respiratory function that led to cardiac arrest. After resuscitation, application of isoflurane through the Anaesthetic Conserving Device (AnaConDa) in the ICU successfully treated bronchospasm, provided adequate sedation, and enabled appropriate ventilation and diagnostic bronchoscopy. A subsequent bronchoalveolar lavage revealed a high amount of Herpes simplex DNA. Herpes simplex pneumonia was diagnosed and treated with acyclovir. Isoflurane treatment was applied for twelve days total without side effects on renal and cerebral function. The patient recovered quickly after the termination of sedation. At discharge, he was fully awake without focal neurological deficiency and his long-term outcomewas excellent. This case demonstrates that isoflurane is a treatment option in life-threatening cases of bronchospasm and a safe option for long-term sedation.	[Hornuss, C.; Firsching, M.; Dolch, M.; Martignoni, A.; Briegel, J.] Ludwig Maximilians Univ Munchen, Dept Anaesthesiol, Klinikum Grosshadern, D-81377 Munich, Germany; [Hornuss, C.] Univ Calif San Francisco, UCSF Mt Zion Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94115 USA; [Peraud, A.] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Klinikum Grosshadern, D-81377 Munich, Germany		Hornuss, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Anaesthesiol, Klinikum Grosshadern, D-81377 Munich, Germany.	chornuss@ponv.org	Briegel, Josef/AAG-3774-2019; Josef, Briegel/ABF-3522-2021				Artru AA, 1997, ANESTH ANALG, V85, P587, DOI 10.1097/00000539-199709000-00019; Barton R, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.086215; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Conzen PF, 2002, ANESTHESIOLOGY, V97, P578, DOI 10.1097/00000542-200209000-00010; Cunha BA, 2007, HEART LUNG, V36, P72, DOI 10.1016/j.hrtlng.2006.07.005; Eisenstein LE, 2003, HEART LUNG, V32, P65, DOI 10.1067/mhl.2003.4; Fraga M, 2003, ANESTHESIOLOGY, V98, P1085, DOI 10.1097/00000542-200305000-00010; Higuchi H, 2001, ANESTH ANALG, V92, P650, DOI 10.1213/00000539-200103000-00019; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Litz RJ, 2002, ANESTHESIOLOGY, V97, P1133, DOI 10.1097/00000542-200211000-00016; Mazze RI, 2000, ANESTH ANALG, V90, P683, DOI 10.1097/00000539-200003000-00032; Ong GM, 2004, J MED VIROL, V72, P121, DOI 10.1002/jmv.10524; Rooke GA, 1997, ANESTHESIOLOGY, V86, P1294, DOI 10.1097/00000542-199706000-00010; Sackey PV, 2005, PEDIATR ANESTH, V15, P879, DOI 10.1111/j.1460-9592.2005.01704.x; Sackey PV, 2005, CRIT CARE MED, V33, P585, DOI 10.1097/01.ccm.0000156294.92415.E2; Sackey PV, 2004, CRIT CARE MED, V32, P2241, DOI 10.1097/01.CCM.0000145951.76082.77; Shankar V, 2006, INTENS CARE MED, V32, P927, DOI 10.1007/s00134-006-0163-0; Vaschetto R, 2009, CURR DRUG TARGETS, V10, P826, DOI 10.2174/138945009789108747	18	4	4	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2010	2010								746263	10.1155/2010/746263			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V25IJ	WOS:000215218000203	21209746	Green Published, gold, Green Submitted			2022-02-06	
B	Huang, YY; Hamblin, MR; De Taboada, L		Tuchin, VV		Huang, Ying-Ying; Hamblin, Michael R.; De Taboada, Luis			Low-Level Laser Therapy in Stroke and Central Nervous System	HANDBOOK OF PHOTONICS FOR BIOMEDICAL SCIENCE	Series in Medical Physics and Biomedical Engineering		English	Article; Book Chapter						low-level laser therapy; neurological disorders; stroke; ROS; mitochondria; photobiomodulation	LOW-ENERGY LASER; TRAUMATIC BRAIN-INJURY; LOW-POWER LASER; ACUTE ISCHEMIC-STROKE; NEAR-INFRARED LIGHT; PROMOTES REGENERATION; FUNCTIONAL RECOVERY; EMBOLIC STROKES; IRRADIATION; PHOTOTHERAPY	Low-level laser/light therapy (LLLT) for neurological disorders in the central nervous system (CNS) is currently an experimental concept. The broad goals for clinical utilization are the prevention and/or repair of damage, relief of symptoms, slowing of disease progression, and correction of genetic abnormalities. Experimental studies have tested and continue to test these goals by investigating LLLT in animal models of diseases and injuries that affect the brain and spinal cord. Successful clinical trials have been carried out of transcranial laser therapy for stroke. Discoveries concerning the molecular basis of various neurological diseases, combined with advances that have been made in understanding the molecular and cellular mechanisms in LLLT, both in vitro and in vivo, have allowed rational light-based therapeutic approaches for a wide variety of CNS disorders to be investigated. Limitations in knowledge are still apparent, such as the optimal wavelength, light source, doses, pulsed or CW, polarization state, treatment timing, and repetition frequency. Collaborative efforts between clinicians and basic researchers will likely increase the usage and understanding of effective laser-based therapies in the CNS.	[Huang, Ying-Ying; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet Plast Laser Ctr, Nanning, Guangxi, Peoples R China; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [De Taboada, Luis] PhotoThera Inc, Carlsbad, CA USA		Huang, YY (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.		Huang, yingying/J-7329-2012; Hamblin, Michael R/H-2758-2019	Huang, yingying/0000-0002-4038-0277; Hamblin, Michael R/0000-0001-6431-4605			Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Ahmad M, 2007, J NEUROIMMUNOL, V184, P172, DOI 10.1016/j.jneuroim.2006.12.012; ANDERS JJ, 1993, LASER SURG MED, V13, P72, DOI 10.1002/lsm.1900130113; Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Azbel' D. I., 1993, Byulleten' Eksperimental'noi Biologii i Meditsiny, V116, P149; BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Cai YM, 2000, AM J CHINESE MED, V28, P443, DOI 10.1142/S0192415X00000520; Caplan L.R, 2000, CAPLANS STROKE CLIN, VThird; Chen ACH, 2009, PROC SPIE, V7165, DOI 10.1117/12.809605; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Corral M, 2000, AM J PSYCHIAT, V157, P303, DOI 10.1176/appi.ajp.157.2.303-a; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Edvinsson L, 2002, CEREBRAL BLOOD FLOW; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Epperson CN, 2004, J CLIN PSYCHIAT, V65, P421; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Gur A, 2002, RHEUMATOL INT, V22, P188, DOI 10.1007/s00296-002-0221-z; Hacke W, 2004, LANCET, V363, P768; Hommel M, 1996, NEW ENGL J MED, V335, P145; Ignatov Yu D, 2005, Neurosci Behav Physiol, V35, P871, DOI 10.1007/s11055-005-0137-7; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; KARU T, 1989, Journal of Photochemistry and Photobiology B Biology, V3, P638, DOI 10.1016/1011-1344(89)80088-0; Karu TI, 1999, DOKL AKAD NAUK+, V364, P399; KRIPKE DF, 1983, PSYCHIAT RES, V10, P105, DOI 10.1016/0165-1781(83)90109-9; LAM RW, 1994, AM J PSYCHIAT, V151, P744; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lampl Yair, 2007, Expert Rev Neurother, V7, P961, DOI 10.1586/14737175.7.8.961; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2007, EXPERT OPIN EMERG DR, V12, P97, DOI 10.1517/14728214.12.1.97; Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Lychagov VV, 2006, PROC SPIE, V6085, DOI 10.1117/12.650116; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Moore P, 2005, LASER SURG MED, V36, P8, DOI 10.1002/lsm.20117; NISSAN M, 1986, LASER SURG MED, V6, P435, DOI 10.1002/lsm.1900060502; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; PALMER AM, 1993, J NEUROCHEM, V61, pS284; PARRY BL, 1989, AM J PSYCHIAT, V146, P1215; Pasantes-Morales H, 2006, CONTRIB NEPHROL, V152, P221, DOI 10.1159/000096326; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; Quah-Smith Joo Im, 2005, Acupunct Med, V23, P103; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P137, DOI 10.1089/pho.2007.2076; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rybak YE, 2006, J CLIN PSYCHIAT, V67, P1527, DOI 10.4088/JCP.v67n1006; Salomatina E, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398928; Sandercock P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-37; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Squire L., 2008, FUNDAMENTAL NEUROSCI; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Sutherland JC, 2002, PHOTOCHEM PHOTOBIOL, V76, P164, DOI 10.1562/0031-8655(2002)076<0164:BEOPL>2.0.CO;2; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Teasdale GM, 1998, NEUROSURGERY, V43, P1373, DOI 10.1097/00006123-199812000-00068; TERMAN JS, 1990, PSYCHOPHARMACOL BULL, V26, P3; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; Vitreshchak TV, 2003, B EXP BIOL MED+, V135, P430, DOI 10.1023/A:1024950922391; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; WIRZJUSTICE A, 1993, ARCH GEN PSYCHIAT, V50, P929; WOLF PA, 1990, STROKE, V21, P4; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057; Zalewska-Kaszubska J, 2004, LASER MED SCI, V19, P100, DOI 10.1007/s10103-004-0307-9; ZIVIN JA, 2009, STROKE	80	4	4	0	6	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4398-0628-9	SER MED PHYS BIOMED			2010							717	737			10.1201/9781439806296-f		21	Biophysics; Optics; Physics, Applied; Radiology, Nuclear Medicine & Medical Imaging	Book Citation Index – Science (BKCI-S)	Biophysics; Optics; Physics; Radiology, Nuclear Medicine & Medical Imaging	BTC62	WOS:000286455800028					2022-02-06	
J	Koons, P; Johnson, S; Kingston, J; Goodrich, GL				Koons, Paul; Johnson, Scott; Kingston, John; Goodrich, Gregory L.			Scanning training in neurological vision loss: case studies	EYE AND BRAIN			English	Article						neurological vision loss; comprehensive neurological vision rehabilitation (CNVR)	VISUAL-FIELD DEFECTS; REHABILITATION; EYE; HEMIANOPIA; INSIGHTS; PRISMS	The purpose of this paper is to describe the response of a Department of Veterans Affairs medical center's development of a rehabilitation program for patients with hemianopsia. Hemianopsia affects significant numbers of troops returning from Afghanistan and Iraq and their neurological vision loss presented unique challenges in developing an appropriate and effective rehabilitation program. A literature review indicated that existing therapies lacked supporting scientific evidence and that traumatic brain injury (TBI)-related vision loss affects large numbers of civilians. The increasing number of patients with TBI-related vision loss necessitated the development of an innovative program which combined elements of therapies that the literature suggested were most promising. In this paper we briefly review the literature, describe the rehabilitation program developed, and present case studies of two patients who incurred vision loss as a result of a motor vehicle accident and a gunshot wound. The intent of the article is to begin the documentation of our ongoing, evidence-based neurological vision loss rehabilitation program. We also encourage others who do not currently do so to assess the need for implementing vision rehabilitation programs for patients with TBI-related vision loss.	[Koons, Paul] Hunter Holmes McGuire Vet Affairs Med Ctr, Polytrauma Transit Rehabil Program, Richmond, VA USA; [Johnson, Scott; Kingston, John] VA Palo Alto Hlth Care Syst, Western Blind Rehabil Ctr, Palo Alto, CA USA; [Goodrich, Gregory L.] VA Palo Alto Hlth Care Syst, Psychol Serv, Optometr Res Fellowship Program, Palo Alto, CA USA		Goodrich, GL (corresponding author), VA Palo Alto Hlth Care Syst, WBRC 124, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	gregory.goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019				Bouwmeester L, 2007, J NEUROL NEUROSUR PS, V78, P555, DOI 10.1136/jnnp.2006.103853; Bowers AR, 2008, ARCH OPHTHALMOL-CHIC, V126, P657, DOI 10.1001/archopht.126.5.657; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Gianutsos R, 1991, J BEHAV OPTOMETRY, V2, P143; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hirayama Kazumi, 2004, No To Shinkei, V56, P403; Hyvarinen L, 2002, NEURO-OPHTHALMOLOGY, V27, P97, DOI 10.1076/noph.27.1.97.14292; Julkunen L, 2003, RESTOR NEUROL NEUROS, V21, P19; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Marshall RS, 2009, NEUROLOGIST, V15, P185, DOI 10.1097/NRL.0b013e3181942894; MASCORD DJ, 1992, J SAFETY RES, V23, P19, DOI 10.1016/0022-4375(92)90036-9; McInnes JK., 2000, VIS IMPAIR RES, V2, P129, DOI DOI 10.1076/VIMR.2.3.129.4422; Pambakian A, 2005, J NEURO-OPHTHALMOL, V25, P136; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Pelak Victoria S, 2007, Curr Treat Options Neurol, V9, P41, DOI 10.1007/s11940-007-0029-y; PELI E, 2000, VISION REHABILITATIO, P104; Perez AM, 2003, J VISUAL IMPAIR BLIN, V97, P173, DOI 10.1177/0145482X0309700306; Perez AM, 2000, VISION 99 VISION REH, P10; Perlin R R, 1991, J Am Optom Assoc, V62, P58; Reinhard J, 2005, BRIT J OPHTHALMOL, V89, P30, DOI 10.1136/bjo.2003.040543; Riggs RV, 2007, AM J PHYS MED REHAB, V86, P853, DOI 10.1097/PHM.0b013e318151f907; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; Sabel B A, 2000, Curr Opin Ophthalmol, V11, P430, DOI 10.1097/00055735-200012000-00008; Sabel BA, 2004, RESTOR NEUROL NEUROS, V22, P399; Schindler I, 2002, J NEUROL NEUROSUR PS, V73, P412, DOI 10.1136/jnnp.73.4.412; Schuett S, 2008, NEUROPSYCHOLOGIA, V46, P2445, DOI 10.1016/j.neuropsychologia.2008.04.016; Schuett S, 2009, NEUROPSYCHOLOGIA, V47, P733, DOI 10.1016/j.neuropsychologia.2008.12.004; Spitzyna GA, 2007, NEUROLOGY, V68, P1922, DOI 10.1212/01.wnl.0000264002.30134.2a; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Szlyk JP, 2005, OPHTHAL PHYSL OPT, V25, P128, DOI 10.1111/j.1475-1313.2004.00265.x; Young CA, 1929, ARCH OPHTHALMOL-CHIC, V2, P560; Zihl, 1999, VIS IMPAIR RES, V1, P23, DOI [10.1076/vimr.1.1.23.4450, DOI 10.1076/VIMR.1.1.23.4450]; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891	41	4	4	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-2744			EYE BRAIN	EYE BRAIN		2010	2						47	55					9	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	V35PF	WOS:000215911800006	28539762	Green Published, gold, Green Submitted			2022-02-06	
J	Law, LM; Gardner, RD; Allen, TA; Lee, DW				Law, L. M.; Gardner, R. D.; Allen, T. A.; Lee, D. W.			Species-Specific Injury-Induced Cell Proliferation in the Hippocampus and Subventricular Zone of Food-Storing and Nonstoring Wild Birds	DEVELOPMENTAL NEUROBIOLOGY			English	Article						avian; neurogenesis; traumatic brain injury; BrdU; NeuN	NEURONAL REPLACEMENT; STEM-CELLS; ADULT; NEUROGENESIS; BRAIN; MEMORY; RECRUITMENT; AROMATASE; BIRTH; YOUNG	Cells are continuously born and incorporated into the adult hippocampus (HP). Adult neurogenesis might act to increase the total number of cells or replace dead cells. Thus, neurogenesis might be a primary factor in augmenting, maintaining, or even recovering functions. In zebra finches, HP injury increases cell proliferation in the HP and stein cell rich subventricular zone (SVZ). It is unknown what effect injury has on a species dependent upon the HP for survival in the wild. In food-storing birds, recovery of caches is seasonal, necessary for survival, dependent upon the HP and is concomitant with a peak in HP neurogenesis. During the fall, food-storing black-capped chickadees (BCCs) and nonstoring dark-eyed juncos (DEJs) were captured and given a unilateral penetrating lesion to the HP one day later. On day 3, birds were injected with the mitotic marker 5-bromo-2'-deoxyuridine (BrdU.) and perfused on day 10. If unlesioned, more BrdU-labeled cells were observed in the HP and SVZ of BCCs compared to DEJs, indicating higher innate cell proliferation or incorporation in BCCs. If lesioned, BrdU-labeled cells increased in the injured HP of both species.; however, lesions caused larger increases in DEJs. DEJs also showed increases in BrdU-labeled cells in the SVZ and contralateral HP. BCCs showed no such increases on day 10. Thus, during the fall food-storing season, storers showed suppressed injury-induced cell proliferation and/or reduced survival rates of these new cells compared to nonstorers. These species differences may provide a useful model for isolating factors involved in cellular responses following injury. (C) 2009 Wiley Periodicals, Inc. Develop Neurobiol 70: 16-27, 2010	[Law, L. M.; Gardner, R. D.; Allen, T. A.; Lee, D. W.] Calif State Univ Long Beach, Dept Psychol, Long Beach, CA 90840 USA; [Law, L. M.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA		Lee, DW (corresponding author), Calif State Univ Long Beach, Dept Psychol, Long Beach, CA 90840 USA.	dlee6@csulb.edu	Allen, Timothy Alexander/AAD-6903-2020	Allen, Timothy Alexander/0000-0002-3512-9475	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S06-GM063119]; National Science FoundationNational Science Foundation (NSF) [DBI-0116477, DBI 0722757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [S06GM063119] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health: contract grant number: S06-GM063119. Contract grant sponsor National Science Foundation contract gant numbers: DBI-0116477 and DBI 0722757.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; Barnea A, 1996, P NATL ACAD SCI USA, V93, P714, DOI 10.1073/pnas.93.2.714; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Bischof H.J., 2007, STEREOTAXIC ATLAS BR; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cohen J., 2013, STAT POWER ANAL BEHA; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Hampton RR, 1996, BEHAV NEUROSCI, V110, P831, DOI 10.1037/0735-7044.110.4.831; Hoshooley JS, 2007, DEV NEUROBIOL, V67, P406, DOI 10.1002/dneu.20316; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Krushinskya N., 1966, ZH EVOL BIOCH FISIOL, V2, P563; LAW LM, 2006, SOC NEUR ANN M ATL G; Lee DW, 2007, DEV NEUROBIOL, V67, P1107, DOI 10.1002/dneu.20399; Lee DW, 1998, NEUROREPORT, V9, pR15; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; Patel SN, 1997, J NEUROSCI, V17, P3861; Peterson RS, 2007, DEV NEUROBIOL, V67, P1867, DOI 10.1002/dneu.20548; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SHERRY DF, 1989, BEHAV NEUROSCI, V103, P308, DOI 10.1037/0735-7044.103.2.308; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; SMULDERS TV, 1995, J NEUROBIOL, V27, P15, DOI 10.1002/neu.480270103; Tramontin AD, 1998, J COMP NEUROL, V396, P186, DOI 10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X; VELAZQUEZ R, 2008, SOC NEUR ANN M WASH; WALSON RE, 1986, PEPTIDES, V7, P155; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x	37	4	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	JAN	2010	70	1					16	27		10.1002/dneu.20748			12	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	540WZ	WOS:000273373000002	19885828	Green Accepted			2022-02-06	
B	Morganti-Kossmann, C; Semple, B; Ziebell, J; Yan, E; Bye, N; Kossmann, T		Berczi, I		Morganti-Kossmann, Cristina; Semple, Bridgette; Ziebell, Jenna; Yan, Edwin; Bye, Nicole; Kossmann, Thomas			Modulation of Immune Response by Head Injury	NEW INSIGHTS TO NEUROIMMUNE BIOLOGY	Elsevier Insights		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CONTROLLED CORTICAL IMPACT; NERVE GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CEREBROSPINAL-FLUID; TNF-ALPHA; RAT-BRAIN; INFLAMMATORY RESPONSE		[Morganti-Kossmann, Cristina; Semple, Bridgette; Ziebell, Jenna; Yan, Edwin; Bye, Nicole] Alfred Hosp, Dept Trauma Surg, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Morganti-Kossmann, Cristina; Semple, Bridgette; Ziebell, Jenna; Yan, Edwin; Bye, Nicole] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Kossmann, Thomas] Epworth HealthCare, Richmond, Australia		Morganti-Kossmann, C (corresponding author), Alfred Hosp, Dept Trauma Surg, Natl Trauma Res Inst, Melbourne, Vic, Australia.		Ziebell, Jenna/Y-4496-2019	Morganti-Kossmann, Cristina/0000-0002-0807-2063; Ziebell, Jenna/0000-0003-2497-4347			ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Babcock AA, 2003, J NEUROSCI, V23, P7922; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Basu A, 2002, J NEUROSCI, V22, P6071; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berman JW, 1996, J IMMUNOL, V156, P3017; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Choi C, 1999, J IMMUNOL, V162, P1889; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Conti AC, 1998, J NEUROSCI, V18, P5663; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2008, J RENAL NUTR, V18, P146, DOI 10.1053/j.jrn.2007.10.029; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Glabinski AR, 1996, J IMMUNOL, V156, P4363; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Harrison J, 2008, INJURY RES STAT SERI, V45; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hellewell SC, 2009, INJURY S1, V40, pS20; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Horuk R, 1997, J IMMUNOL, V158, P2882; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2005, RESTOR NEUROL NEUROS, V23, P31; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; McIntosh TK, 1996, LAB INVEST, V74, P315; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; Muessel MJ, 2000, BRAIN RES, V870, P211, DOI 10.1016/S0006-8993(00)02450-1; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; Park DR, 2003, J IMMUNOL, V170, P6209, DOI 10.4049/jimmunol.170.12.6209; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Schroeter M, 2003, MOL BRAIN RES, V117, P1, DOI 10.1016/S0169-328X(03)00255-9; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Springborg JB, 2007, ACTA NEUROCHIR, V149, P1089, DOI 10.1007/s00701-007-1284-z; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	158	4	4	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-12-384692-1; 978-0-12-384691-4	ELSEV INSIGHT			2010							193	220		10.1016/B978-0-12-384691-4.00010-9			28	Immunology; Neurosciences	Book Citation Index – Science (BKCI-S)	Immunology; Neurosciences & Neurology	BFF58	WOS:000319664300012					2022-02-06	
J	Pariset, JM; Feldman, KW; Paris, C				Pariset, Jacquelyn M.; Feldman, Kenneth W.; Paris, Carolyn			The Pace of Signs and Symptoms of Blunt Abdominal Trauma to Children	CLINICAL PEDIATRICS			English	Article						abdominal trauma; child abuse; liver injury; bowel injury; spleen injury	GASTROINTESTINAL-TRACT	The authors describe the types, signs, and symptoms of blunt abdominal injury. Record reviews of children <5 years old were carried out at a regional children's hospital or level 1 trauma center between 1994 and 1999. Recognized cases of child abuse, penetrating trauma, or children with an unavailable chart were excluded. The mean age was 38 months (n = 42; range 11-59). Motor vehicle trauma caused most of the injuries (72%); 64% had isolated solid organ, 14% isolated hollow viscous, and 21% both organ injuries. Multisystem trauma included closed head injury (29%) and fractures (43%). Scene reports documented that 80% of those assessed immediately had abdominal pain. Average time taken to arrive at the emergency department was 66 minutes (range 15-420). Hollow viscous perforations were symptomatic from onset. The overall mortality rate was 12%, related to multitrauma. Most children suffering unintentional blunt abdominal trauma have immediate and ongoing injury. Caretakers promptly seek emergency care, and solid organ injuries predominate. The series mortality was low compared with that for abusive abdominal injuries.	[Pariset, Jacquelyn M.; Feldman, Kenneth W.; Paris, Carolyn] Univ Washington, Sch Med, Seattle, WA USA; [Feldman, Kenneth W.] Seattle Childrens, Dept Pediat, Div Gen Pediat, Seattle, WA USA; [Paris, Carolyn] Seattle Childrens, Dept Emergency Med, Seattle, WA USA; [Pariset, Jacquelyn M.] Ranchview Family Med Clin, Highlands Ranch, CO USA		Feldman, KW (corresponding author), 2101 E Yesler Way, Seattle, WA 98122 USA.	kfeldman@u.washington.edu			University of Washington School of Medicine	This study was conducted as Dr Pariset's participation in the Medical Student Research Training Program at the University of Washington School of Medicine. The project was funded through the University of Washington School of Medicine.	Barnes PM, 2005, LANCET, V366, P234, DOI 10.1016/S0140-6736(05)66913-9; BROWN RA, 1992, BRIT J SURG, V79, P522, DOI 10.1002/bjs.1800790615; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; HUYER D, 1994, APSAC ADVISOR, V7, P5; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; RICHARDSON JD, 1972, ANN SURG, V176, P213, DOI 10.1097/00000658-197208000-00016; Wood J, 2005, J TRAUMA, V59, P1203, DOI 10.1097/01.ta.0000196437.07011.b1	8	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JAN	2010	49	1					24	28		10.1177/0009922809342464			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	537EF	WOS:000273095100004	19628759				2022-02-06	
B	Tong, KA; Oyoyo, UE; Holshouser, BA; Ashwal, S; Medina, LS	Medina, LS; Applegate, KE; Blackmore, CC			Tong, Karen A.; Oyoyo, Udochukwu E.; Holshouser, Barbara A.; Ashwal, Stephen; Medina, L. Santiago	Medina, LS; Applegate, KE; Blackmore, CC		Evidence-Based Neuroimaging for Traumatic Brain Injury in Children	EVIDENCE-BASED IMAGING IN PEDIATRICS: OPTIMIZING IMAGING IN PEDIATRIC PATIENT CARE			English	Article; Book Chapter							DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; IMPROVES OUTCOME PREDICTION; COMA SCALE SCORE; INTRACRANIAL INJURY; PROGNOSTIC FACTORS; MR SPECTROSCOPY; YOUNG-CHILDREN; RATING-SCALE; MILD		[Tong, Karen A.; Oyoyo, Udochukwu E.; Holshouser, Barbara A.] Loma Linda Univ, Dept Radiol, Med Ctr, Loma Linda, CA 92354 USA; [Ashwal, Stephen] Loma Linda Univ, Dept Pediat, Div Pediat Neurol, Loma Linda, CA 92350 USA; [Medina, L. Santiago] Miami Childrens Hosp, Dept Radiol, Div Neuroradiol & Brain Imaging, Miami, FL 33155 USA; [Medina, L. Santiago] Miami Childrens Hosp, Dept Radiol, HOPE Ctr, Miami, FL 33155 USA; [Medina, L. Santiago] Harvard Univ, Sch Med, Boston, MA 02114 USA		Tong, KA (corresponding author), Loma Linda Univ, Dept Radiol, Med Ctr, Loma Linda, CA 92354 USA.	ktong@llu.edu					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADEKOYA N, 2002, MMWR SURVEILL    SUM, P1; [Anonymous], 1997, GUIDE UNIFORM DATA S; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bonnier C, 2007, J CHILD NEUROL, V22, P519, DOI 10.1177/0883073807302604; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser SM, 1998, AM SURGEON, V64, P1088; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; PALCHAK M, ANN EMERG MED, V42, P492; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SGANZERLA EP, 1989, CHILD NERV SYST, V5, P168, DOI 10.1007/BF00272121; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stamatakis EA, 2002, J NUCL MED, V43, P476; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Suresh HS, 2003, NEUROL INDIA, V51, P16; SWANN IJ, 1999, TRAUMA, V12, P274; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tomberg T, 1996, ACTA NEUROCHIR, V138, P543, DOI 10.1007/BF01411174; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; TORNER J, 1998, TRAUMATIC BRAIN INJU, P9; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	92	4	4	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-0921-3				2010							85	102		10.1007/978-1-4419-0922-0_7	10.1007/978-1-4419-0922-0		18	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Book Citation Index – Science (BKCI-S)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	BMM24	WOS:000272790700007					2022-02-06	
J	Varon, J				Varon, Joseph			Therapeutic Hypothermia: Implications for Acute Care Practitioners	POSTGRADUATE MEDICINE			English	Article						cardiac arrest; therapeutic hypothermia; traumatic brain injury; hypoxemia; stroke	HOSPITAL CARDIAC-ARREST; MILD INDUCED HYPOTHERMIA; SPINAL-CORD-INJURY; CARDIOPULMONARY-RESUSCITATION; MODERATE HYPOTHERMIA; COMATOSE SURVIVORS; BRAIN-INJURY; SYSTEMIC HYPOTHERMIA; CLINICAL-TRIAL; INDUCTION	The use of therapeutic hypothermia (TH) in acute Care medicine has evolved Over the past 2 Centuries, and its use over the past decade has increased ill emergency departments, intensive care units, and operating rooms. Therapeutic hypothermia has several potential clinical applications based on its putative mechanisms of action. It appears to improve oxygen supply to ischemic areas of the brain and decreases intracranial pressure. Mild-to-moderate TH (33 degrees C +/- 1 degrees C) after resuscitation from cardiac arrest is neuroprotective, and also acts oil the cardiovascular system with evidence of a decrease in heart rate and increase ill systemic vascular resistance. Therapeutic hypothermia decreases cardiac output by 7% for each 1 degrees C decrease ill core body temperature, but maintains the stroke volume and the mean arterial pressure. Despite a growing amount of data. this life-saving technique is underutilized in hospitals worldwide. The purpose of this comprehensive review is to show the evolution and the clinical use of TH as it pertains to acute care practitioners.	[Varon, Joseph] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Varon, Joseph] Univ Texas Med Branch Galveston, Galveston, TX USA		Varon, J (corresponding author), 2219 Dorrington St, Houston, TX 77030 USA.	joseph.varon@uth.tmc.edu	Varon, Joseph/R-5198-2019; Varon, Joseph/T-9481-2019	Varon, Joseph/0000-0002-7622-9974			Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Agnew DM, 2003, PEDIATR RES, V54, P253, DOI 10.1203/01.PDR.0000072783.22373.FF; Aibiki M, 2001, CRIT CARE MED, V29, P1726, DOI 10.1097/00003246-200109000-00012; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; Alzaga AG, 2006, RESUSCITATION, V69, P359, DOI 10.1016/j.resuscitation.2006.02.014; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bell DD, 2005, CAN J ANAESTH, V52, P309, DOI 10.1007/BF03016069; BENSON D W, 1959, Anesth Analg, V38, P423; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BIGELOW WG, 1953, ANN SURG, V137, P361, DOI 10.1097/00000658-195303000-00010; BLOCH JH, 1964, J THORAC CARDIOV SUR, V48, P969, DOI 10.1016/S0022-5223(19)33342-2; BLOCH M, 1967, BRAIN, V90, P769, DOI 10.1093/brain/90.4.769; CABANAC M, 1987, EUR J APPL PHYSIOL O, V56, P534, DOI 10.1007/BF00635366; Chakkarapani E, 2009, ACTA PAEDIATR, V98, P1844, DOI 10.1111/j.1651-2227.2009.01470.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cordoba J, 1999, GASTROENTEROLOGY, V116, P686, DOI 10.1016/S0016-5085(99)70191-5; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; Crowder CM, 1996, J NEUROSURG, V85, P98, DOI 10.3171/jns.1996.85.1.0098; CURRY DL, 1970, ENDOCRINOLOGY, V87, P750, DOI 10.1210/endo-87-4-750; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; FAY T, 1940, P INT SOC POSTGRAD M, P292; Friberg H, 2009, J NEUROTRAUM, V26, P365, DOI 10.1089/neu.2008.0637; GINSBERG MD, 2005, THERAPEUTIC HYPOTHER, P85; Gumina RJ, 2007, MED CLIN N AM, V91, P729, DOI 10.1016/j.mcna.2007.04.003; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Harris B, 2005, THERAPEUTIC HYPOTHER, P323; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hovdenes J, 2007, ACTA ANAESTH SCAND, V51, P137, DOI 10.1111/j.1399-6576.2006.01209.x; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kawamura S, 2000, ACTA NEUROCHIR, V142, P1117, DOI 10.1007/s007010070039; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; KOHT A, 1983, INTENS CARE MED, V9, P275, DOI 10.1007/BF01691254; Konstas AA, 2007, J APPL PHYSIOL, V102, P1329, DOI 10.1152/japplphysiol.00805.2006; Koran Zeb, 2009, J Trauma Nurs, V16, P48, DOI 10.1097/01.JTN.0000348070.09712.40; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; LEHOT JJ, 1992, CHEST, V102, P106, DOI 10.1378/chest.102.1.106; LISS HP, 1986, ANN EMERG MED, V15, P65, DOI 10.1016/S0196-0644(86)80490-5; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Marion DW, 1996, CRIT CARE MED, V24, pS81; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Modell JH, 2004, CHEST, V125, P1948, DOI 10.1378/chest.125.5.1948; MORDECAI Y, 1992, EMERGING STRATEGIES, P289; Mori K, 2001, ACAD EMERG MED, V8, P937, DOI 10.1111/j.1553-2712.2001.tb01089.x; NELSON KB, 1981, PEDIATRICS, V68, P36; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nolan J, 2005, RESUSCITATION, V64, P133, DOI 10.1016/j.resuscitation.2004.11.027; Nolan J, 2005, RESUSCITATION, V64, P5, DOI 10.1016/S0300-9572(04)00468-X; Nolan JP, 2005, RESUSCITATION, V67, P175, DOI 10.1016/j.resuscitation.2005.09.008; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; POOL JL, 1958, J NEUROSURG, V15, P52, DOI 10.3171/jns.1958.15.1.0052; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; Rincon F, 2006, SEMIN NEUROL, V26, P387, DOI 10.1055/s-2006-948319; Roggla M, 2002, WIEN KLIN WOCHENSCHR, V114, P315; Rose C, 2000, HEPATOLOGY, V31, P872, DOI 10.1053/he.2000.5923; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; Ryan M, 2003, EMERG MED J, V20, P487, DOI 10.1136/emj.20.5.487; SAFAR P, 1997, TXB NEUROANESTHESIA, P557; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; SCHUBERT A, 1992, J NEUROSURG ANESTH, V4, P216, DOI 10.1097/00008506-199207000-00013; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SCHWARZ A, 2008, NY TIMES        0115; SEALY WC, 1958, ANN SURG, V147, P603, DOI 10.1097/00000658-195805000-00004; Sessler, 2005, THERAPEUTIC HYPOTHER, P179; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Silfvast T, 2003, RESUSCITATION, V57, P109, DOI 10.1016/S0300-9572(02)00438-0; Skulec R, 2008, ACTA ANAESTH SCAND, V52, P188, DOI 10.1111/j.1399-6576.2007.01510.x; SMITH LAWRENCE W., 1940, AMER JOUR CLIN PATH, V10, P1; Smith TL, 2002, CRIT CARE, V6, P377, DOI 10.1186/cc1545; Sterz Fritz, 2003, Curr Opin Crit Care, V9, P205, DOI 10.1097/00075198-200306000-00006; STONE JG, 1995, ANESTHESIOLOGY, V82, P344, DOI 10.1097/00000542-199502000-00004; Sunde Kjetil, 2004, Tidsskr Nor Laegeforen, V124, P925; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; TOSATTI E, 1952, Rass Clin Sci, V28, P363; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Varon J, 2006, RESUSCITATION, V68, P421, DOI 10.1016/j.resuscitation.2005.07.020; VARON J, 1991, Journal of Emergency Medicine, V9, P503, DOI 10.1016/0736-4679(91)90224-4; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Varon J, 2008, AM J EMERG MED, V26, P244, DOI 10.1016/j.ajem.2007.05.025; Varon J, 2009, RESUSCITATION, V80, P1335, DOI 10.1016/j.resuscitation.2009.08.021; Varon J, 2009, RESUSCITATION, V80, P726, DOI 10.1016/j.resuscitation.2009.04.036; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; Virkkunen I, 2004, RESUSCITATION, V62, P299, DOI 10.1016/j.resuscitation.2004.04.003; WAGNER HR, 1978, PEDIATRICS, V61, P479, DOI 10.1542/peds.61.3.479; WEBB WR, 1962, SURGERY, V52, P643; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Yang SS, 2005, BIOL NEONATE, V87, P60, DOI 10.1159/000081245; Yenari MA, 2005, THERAPEUTIC HYPOTHER, P141; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86; Zeiner A, 2004, RESUSCITATION, V60, P253, DOI 10.1016/j.resuscitation.2003.11.006; Zviman Menekhem M, 2004, Crit Care Med, V32, pS369, DOI 10.1097/01.CCM.0000139461.46564.51; Zweifler RM, 2004, J NEUROSURG ANESTH, V16, P232, DOI 10.1097/00008506-200407000-00008	103	4	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0032-5481	1941-9260		POSTGRAD MED	Postgrad. Med.	JAN	2010	122	1					19	27		10.3810/pgm.2010.01.2095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559GJ	WOS:000274811000003	20107285				2022-02-06	
J	Wortzel, HS; Arciniegas, DB				Wortzel, Hal S.; Arciniegas, David B.			Combat Veterans and the Death Penalty: A Forensic Neuropsychiatric Perspective	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; AGGRESSION; IRAQ; WAR; NEUROPATHOLOGY; NEUROBIOLOGY; AFGHANISTAN; CONSENSUS	With our nation's present conflicts, a new generation of veterans are returning home, many of whom have substantial psychopathology and are encountering significant barriers in accessing care. Headlines from around the nation reflect that some of these wounded warriors go on to commit offenses that are potentially punishable by death. Existing circumstances speak to the urgency with which the subject of combat veterans with post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), or both facing capital crimes ought to be addressed. This publicity has led to a recent call for a legislatively or judicially enacted, narrow, categorical exclusion for combat veterans who were affected by either PTSD or TBI at the time of their capital offenses. In the present article, we illustrate the reality that combat veterans who commit capital offenses may face execution, summarize legal arguments offered in favor of a categorical exclusion, and provide a neuropsychiatric perspective on PTSD, TBI, and aggression, to help inform further dialogue on this weighty subject.	[Wortzel, Hal S.] MIRECC, VISN 19, Denver, VA USA; [Wortzel, Hal S.; Arciniegas, David B.] Univ Colorado, Neurobehav Disorders Program, Denver, CO 80202 USA; [Wortzel, Hal S.] Univ Colorado, Dept Psychiat, Div Forens Psychiat, Denver, CO 80202 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Denver, CO 80202 USA		Wortzel, HS (corresponding author), 1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu					*AM LAW I, 2009, REP COUNC MEMB AM LA; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Courville CB, 1950, PATHOLOGY CENTRAL NE, V3rd; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Giardino AE, 2009, FORDHAM LAW REV, V77, P2955; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Heim C, 2009, CNS SPECTRUMS, V14, P13; Hoge CW, 2006, JAMA-J AM MED ASSOC, V296, P2678, DOI 10.1001/jama.296.22.2678-b; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2006, JAMA-J AM MED ASSOC, V296, P2679; JACOBS C, 2009, NC DEATH ROW INMATE; LIPTAK A, 2008, NY TIMES        0624; LIPTAK A, 2008, NY TIMES        1210; LIPTAK A, 2010, NY TIMES        0104; MCPHEE M, 2009, DENVER POST     0722; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Simon RI, 2008, TXB VIOLENCE ASSESSM, P161; Solomon Z, 2009, J CLIN PSYCHIAT, V70, P837, DOI 10.4088/JCP.08m04347; SONTAG D, 2008, WAR TORN AM DEADLY E; Stein DJ, 2009, CNS SPECTRUMS, V14, P52; *US ARM CTR HLTH P, 2010, 14HKOBIU09 US ARM CT; *VHA, INF REC SERV PROV VH; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; WHITE J, 1999, CALIFORNIA EXECUTES; Wortzel HS, 2009, J AM ACAD PSYCHIATRY, V37, P82; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22; YUDOFSKY SC, 1990, J CLIN PSYCHIAT S, V51, P29; NEW VET COURT SESS P; 2004, COMMUNICATION   0218	39	4	4	0	4	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793			J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2010	38	3					407	414					8	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	663ZL	WOS:000282928600016	20852228				2022-02-06	
B	Wyttenbach, A; Hands, S; O'Connor, V		Simon, S; Arrigo, AP		Wyttenbach, Andreas; Hands, Sarah; O'Connor, Vincent			SMALL STRESS PROTEINS IN THE CENTRAL NERVOUS SYSTEM: FROM NEURODEGENERATION TO NEUROPROTECTION	SMALL STRESS PROTEINS AND HUMAN DISEASES	Protein Science and Engineering		English	Article; Book Chapter							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; FOCAL-CEREBRAL-ISCHEMIA; AMYLOID-BETA-PROTEIN; BOVINE SPONGIFORM ENCEPHALOPATHY; GROWTH-INHIBITORY FACTOR; GENE-EXPRESSION CHANGES; TRAUMATIC BRAIN-INJURY; HEME OXYGENASE-1 HO-1; HUMAN PRION DISEASES	We summarize data on the physiological and stress-induced expression of the small HSPs HspB1, HspB5, HspB6, HspB8, heme-oxygenase 1 (Hsp32) and metallothioneins MT1, -2 and 3 in the central nervous system (CNS). We contrast the stress induction of these proteins during chronic neurodegeneration due to protein misfolding in age-related diseases with their role during acute brain injury (traumatic brain injury and stroke). This evidence is discussed with respect to potential brain region and cell-type specific responses and vulnerability to stress. Although the basal expression of all these proteins is well documented in neurons and astrocytes, their physiological expression in vivo in oligodendro- and microglia is less clear. During acute stress some of these proteins (typically HspB1 and HspB5) are quickly upregulated in the neuronal compartment to likely interfere with cell death cascades. This is followed by a more sustained increase in expression in astroglial and microglial cells of sHSPs, HO-I and MTs. A clear functional role in neuroprotection against ischemia has been shown only for HspB1 using genetic knockout approaches, HspB1 inducing drugs and viral delivery in rodent models paving the way to potential therapeutic treatments during stroke in humans. Such mechanistic studies have not been performed in models of protein misfolding diseases (proteinopathies such as Alzheimer's-Parkinson's-Polyglutamine-and Prion diseases), but `a key similarity is the increased expression of small stress proteins in glial cells, especially associated with an astrocytic stress response. This likely affords cytoprotection through a sustained defense against oxidative stress and modulation of neuroinflammation. The apparent redistribution of many small stress proteins to extracellular protein deposits, and in some cases to intracellular protein inclusion bodies points to a further modulatory function during protein aggregation and/or degradation that could be linked to the neuroprotective activities of these proteins in both neurons and glial cells. Given the chronic nature of proteinopathies and the complex interdependence between protein aggregation, imbalance of the cellular redox-homeostasis and inflammatory and other signalling events, it will be difficult to detail the neuroprotective role(s) of each stress protein in vivo. Nevertheless the induction and manipulation of multiple stress proteins in different cell types and cell compartments has to be considered for the development of effective neuroprotective strategies in the CNS.	[Wyttenbach, Andreas; Hands, Sarah; O'Connor, Vincent] Univ Southampton, Sch Biol Sci, Southampton Neurosci Grp, Southampton SO16 7PX, Hants, England		Wyttenbach, A (corresponding author), Univ Southampton, Sch Biol Sci, Southampton Neurosci Grp, Southampton SO16 7PX, Hants, England.	A.Wyttenbach@soton.ac.uk					Acarin L, 2002, GLIA, V38, P1, DOI 10.1002/glia.10040; Adalbert R, 2007, TRENDS MOL MED, V13, P135, DOI 10.1016/j.molmed.2007.02.004; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Badin RA, 2009, J CEREBR BLOOD F MET, V29, P254, DOI 10.1038/jcbfm.2008.106; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Braak H, 2001, ACTA NEUROPATHOL, V102, P449; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Chang WH, 2005, BIOCHEM BIOPH RES CO, V336, P258, DOI 10.1016/j.bbrc.2005.08.065; Choi YG, 2000, NEUROSCI LETT, V289, P173, DOI 10.1016/S0304-3940(00)01277-5; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dabir DV, 2004, AM J PATHOL, V164, P155, DOI 10.1016/S0002-9440(10)63106-9; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; DWYER BE, 1995, MOL BRAIN RES, V30, P37, DOI 10.1016/0169-328X(94)00273-H; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; Ebadi M, 2006, EXP BIOL MED, V231, P1576, DOI 10.1177/153537020623100919; ERICKSON JC, 1994, BRAIN RES, V649, P297, DOI 10.1016/0006-8993(94)91076-6; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Gauthier MA, 2008, NEUROTOX RES, V14, P317, DOI 10.1007/BF03033856; Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hampel H, 2002, J NEURAL TRANSM, V109, P837, DOI 10.1007/s007020200069; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hanlon J, 2002, J COMP PATHOL, V127, P280, DOI 10.1053/jcpa.2002.0595; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hidalgo J, 2006, EXP BIOL MED, V231, P1450, DOI 10.1177/153537020623100902; Hirose Wataru, 2003, Leg Med (Tokyo), V5 Suppl 1, pS360, DOI 10.1016/S1344-6223(02)00133-5; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Hwang YP, 2008, TOXICOL APPL PHARM, V231, P318, DOI 10.1016/j.taap.2008.04.019; HYMAN M, 2009, J NEUROCHEMISTRY, V9999; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; IRONSIDE JW, 2000, ARCH VIROL S, V16; IWAKI T, 1992, AM J PATHOL, V140, P345; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kawashima T, 2000, DEMENT GERIATR COGN, V11, P251, DOI 10.1159/000017247; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lee DW, 2006, TOXICOL SCI, V90, P159, DOI 10.1093/toxsci/kfj052; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P39; LOWE J, 1992, J PATHOL, V166; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Minami M, 2003, ACTA NEUROPATHOL, V105, P549, DOI 10.1007/s00401-003-0679-0; Mirza B, 2000, NEUROSCIENCE, V95, P425; Miyazaki I, 2002, NEUROSCI RES, V43, P323, DOI 10.1016/S0168-0102(02)00057-3; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nakaso K, 2000, NEUROSCI LETT, V282, P57, DOI 10.1016/S0304-3940(00)00836-3; Neal JW, 1996, NEUROPATH APPL NEURO, V22, P243; NIWA M, 2008, NEUROL RES; OCONNOR V, 2008, NEUR C MADR; Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Panahian N, 1999, J NEUROCHEM, V72, P1187; Perng MD, 2004, CURR BIOL, V14, pR625, DOI 10.1016/j.cub.2004.07.047; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Piao CS, 2005, EXP BRAIN RES, V163, P421, DOI 10.1007/s00221-004-2197-2; Quraishe S, 2008, NEUROSCIENCE, V153, P483, DOI 10.1016/j.neuroscience.2008.01.058; RAMAN B, 2005, BIOCH J, V392; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Reynolds LPR, 2003, CEREBELLUM, V2, P171, DOI 10.1080/14734220310016114; Rizzardini M, 1997, J NEUROCHEM, V68, P715; Robinson PA, 2008, BIOCHEM J, V413, P1, DOI 10.1042/BJ20080295; Rojas P, 2000, PROG NEURO-PSYCHOPH, V24, P143, DOI 10.1016/S0278-5846(99)00077-9; Saleem S, 2008, STROKE, V39, P3389, DOI 10.1161/STROKEAHA.108.523480; Sanz O, 2001, GLIA, V36, P259, DOI 10.1002/glia.1114; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharma SK, 2003, ANTIOXID REDOX SIGN, V5, P251, DOI 10.1089/152308603322110832; Sherman M, 2007, ANN NY ACAD SCI, V1113, P192, DOI 10.1196/annals.1391.030; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; SHIRAGA H, 1993, NEUROCHEM INT, V23, P561, DOI 10.1016/0197-0186(93)90104-D; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1994, AM J PATHOL, V145, P42; Song W, 2008, ALZ DEMEN, V4, pT410; SONG W, 2009, J NEUROCHEMISTR 0513; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Tatzelt J, 1998, CELL MOL NEUROBIOL, V18, P721, DOI 10.1023/A:1020282205041; Thind K, 2007, PANMINERVA MED, V49, P191; Tortosa R, 2008, VET J, V178, P126, DOI 10.1016/j.tvjl.2007.06.002; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1995, J BIOL CHEM, V270, P3365, DOI 10.1074/jbc.270.7.3365; Valentim LM, 2003, NEUROSCIENCE, V118, P379, DOI 10.1016/S0306-4522(02)00919-3; van Noort JM, 2008, J PATHOL, V214, P267, DOI 10.1002/path.2273; Vidal E, 2008, BRAIN RES, V1196, P140, DOI 10.1016/j.brainres.2007.12.034; Villapol S, 2008, NEUROSCIENCE, V153, P108, DOI 10.1016/j.neuroscience.2008.01.054; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wang J, 2008, NEUROBIOL AGING, V29, P586, DOI 10.1016/j.neurobiolaging.2006.11.009; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; WYTTENBACH A, 2006, HEAT SHOCK PROTEINS; YANG C, 2009, BRAIN RES       0513; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Zabel C, 2002, MOL CELL PROTEOMICS, V1, P366, DOI 10.1074/mcp.M200016-MCP200; Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195	132	4	4	0	3	NOVA SCIENCE PUBLISHERS, INC	HAUPPAUGE	400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA			978-1-61668-198-2	PROTEIN SCI ENG			2010							117	146					30	Biochemistry & Molecular Biology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BTE55	WOS:000286642200005					2022-02-06	
J	Zetterqvist, B; Jennische, M				Zetterqvist, Barbara; Jennische, Margareta			Linguistic difficulties in children and adolescents after acquired brain injury: A retrospective study	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Traumatic brain injury; acquired brain injury; brain tumour; word retrieval; language comprehension; language disorders		Objective: The purpose of this study was to focus on two linguistic abilities, word retrieval (expressive language) and comprehension of vocabulary and grammar (receptive language), as well as to investigate to what extent long-term problems exist in these areas in children following traumatic brain injury. Methods: Two groups of children were studied retrospectively: twenty-four children with traumatic brain injury (TBI) and twenty-one children diagnosed with brain tumour. All children had been referred to the rehabilitation team for assessment. The children were between four and seventeen years old when assessed, with the assessments performed at least one year after the injury or brain tumour diagnosis. An established set of tests regarding word retrieval and comprehension of vocabulary and grammar was used, and the results were compared with normative test data. Results: In both clinical groups, significantly more children scored lower than the designated "normal" score than in the normative sample on tests measuring confrontation naming and phonological word retrieval. In addition, in the brain tumour group, more children demonstrated significantly lower results than normal performance on a test for semantic word retrieval. In the TBI group, significantly more children scored below the normal value on tests of word and grammatical comprehension when compared to the normative sample. Conclusions: This study confirms that word retrieval is an area of deficit in many children with acquired brain injuries one year or more after the injury occurred. The study also indicates that children with TBI may have persistent deficits in comprehension of both vocabulary and grammar.	[Zetterqvist, Barbara] Karolinska Inst, Dept Clin Intervent & Tech, Stockholm, Sweden; [Zetterqvist, Barbara] Karolinska Univ Hosp, Stockholm, Sweden; [Jennische, Margareta] Uppsala Univ, Dept Neurosci Speech & Language Pathol, Uppsala, Sweden		Zetterqvist, B (corresponding author), Astrid Lindgren Childrens Hosp, Logopedmottagningen, S-17176 Stockholm, Sweden.	barbara.zetterqvist@karolinska.se					Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bishop D., 1989, TEST RECEPTION GRAMM; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catsman-Berrevoets CE, 1999, J NEUROL NEUROSUR PS, V67, P755, DOI 10.1136/jnnp.67.6.755; CHAPMAN SB, 1999, BRAIN DAM B, P235; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; Dunn L.M., 1997, PEABODY PICTURE VOCA, P55014; Dunn L.M., 1981, PEABODY PICTURE VOCA, P55014; Eklund H., 1996, ORDRACET; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Falk A.C., 2008, THESIS; Fyrberg A., 2004, KARTLAGGNING BEHANDL; Hamsher B., 1978, CONTROLLED WORD ASS; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kirk S.A., 2000, DELTEST ITPA ILLINOI; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; MCDONALD S, 1999, COMMUNICATION DISORD; Nagel BJ, 2006, NEUROPSYCHOLOGY, V20, P105, DOI 10.1037/0894-4105.20.1.105; Reynell J. K., 1977, REYNELL DEV LANGUAGE; Sans A., 2009, REV NEUROLOGIA S2, V27, P23; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Scheid R., 2006, ARCH NEUROL-CHICAGO, P418; Wetherington C. E., 2006, EXCEPTIONALITY, V14, P155, DOI [10.1207/s15327035-x1403_4, DOI 10.1207/S15327035-X1403_4]	27	4	4	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2010	3	4					251	258		10.3233/PRM-2010-0137			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7JX	WOS:000448273200003	21791859				2022-02-06	
J	Dujovny, M; Onyekachi, I; Perez-Arjona, E				Dujovny, Manuel; Onyekachi, Ibe; Perez-Arjona, Eimir			Baseball bats: a silent weapon	NEUROLOGICAL RESEARCH			English	Article						Baseball bat; cranial fracture; traumatic brain injury; orbit; ophthalmology; orthopedic; sport; weapon; forensic medicine	INJURIES; TRAUMA; ASSAULT	Objective: The objective of this work was to understand how the baseball bat is a silent weapon. The baseball bat has been utilized illegally in different areas of the world. In the past, several case reports are known for their lethal effect. In this paper, we analyse the outcome of the utilization of baseball bat for illegal purposes as well as review the principal injury and the utilization of baseball bat as explained by an engineer. Material and Method: The medical and radiographic records of patients admitted to Sinai-Grace and Detroit Receiving Hospitals in Detroit, MI, USA, from June 1997 to June 2000, were reviewed. Ninety patients presented with documented baseball bat injury by history. Clinical data were obtained from the patients charts. Detailed descriptions of those body parts affected by baseball bat injury were registered and classified by anatomical regions. Results: A total of 39 cranial fractures were observed, mainly on the skull base and orbital wall. Discussion: Baseball bat-related injury is an endemic problem in Detroit. This urban use of the baseball bat as a weapon is getting severe. A team approach to this type of injury is recommended. [Neurol Res 2009; 31: 1005-1011]	[Dujovny, Manuel; Perez-Arjona, Eimir] Wayne State Univ, Dept Neurosurg, Detroit, MI 48302 USA; [Dujovny, Manuel; Onyekachi, Ibe; Perez-Arjona, Eimir] Wayne State Univ, Coll Engn, Detroit, MI 48302 USA		Dujovny, M (corresponding author), Wayne State Univ, Dept Neurosurg, 1906 Long Lake Dr Shore,Bloomfield Hills, Detroit, MI 48302 USA.	manueldujovny@hotmail.com					Adair R., 1994, PHYS BASEBALL; BEAUPRE B, 1997, DETROIT NEWS    0420; BERLET AC, 1992, J TRAUMA, V33, P167, DOI 10.1097/00005373-199208000-00001; BERNSTEIN SL, 1994, ANN EMERG MED, V23, P555, DOI 10.1016/S0196-0644(94)70077-X; *FED BUR INV, 1998, FBIS 1998 UN CRIM RE; FLANIGAN B, 1982, DETROIT FREE PR 0701; GROLEAU GA, 1993, J TRAUMA, V34, P366, DOI 10.1097/00005373-199303000-00010; Nathan AM, 2000, AM J PHYS, V68, P979, DOI 10.1119/1.1286119; Nathan AM, 2003, AM J PHYS, V71, P134, DOI 10.1119/1.1522699; NEFT DS, SPORTS ENCY BASEBALL; ORD RA, 1995, J ORAL MAXIL SURG, V53, P514, DOI 10.1016/0278-2391(95)90061-6; PURDY D, TEAM BY TEAM ENCY MA; RICE JO, 1976, J ORAL SURG, V34, P639; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; SAMII M, TRAUMATOLOGY SKULL B; SHESSER R, 1985, AM J EMERG MED, V3, P199, DOI 10.1016/0735-6757(85)90088-9; SMITH LV, SPORTS ENG, V4, P205; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; 2008, CANADIAN SPORTS  AUG, V2, P8; 1949, AM J PHYS, V17, P1; 2004, ENCY BRITANNICA 1, V2	21	4	4	1	11	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	DEC	2009	31	10					1005	1011		10.1179/174313209X385716			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530XR	WOS:000272626800001	19203443				2022-02-06	
J	Haque, A; Enam, A				Haque, Anwarul; Enam, Ather			Implementation of Brain Trauma Foundation guidelines in children with acute traumatic brain injury in tertiary-care hospital in Pakistan	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						child; traumatic brain injury; outcome		Previous reports have shown that the implementation of Brain Trauma Foundation guidelines for management of traumatic brain injury in adults has been associated with significant reduction in mortality and neurological disability. To compare two-cohorts on the clinical outcome in the management of children with TBI in the tertiary-care pediatric intensive care unit before and after the implementation of BTF guidelines, 34 children (age from 1 month to 14 years) with acute traumatic brain injury admitted in Pediatric Intensive Care Unit of AKUH from January 2000 to December 2007 were identified from electronic database. Twenty patients (Group I) were treated with traditional treatment before the implementation of BTF guidelines and 14 patients (Group II) treated with BTF guidelines as multidisciplinary team approach with special emphasis on initial prompt resuscitation to avoid hypoxia, hypotension, and maximize the cerebral oxygenation by reducing intracranial pressure, and optimize cerebral perfusion. We compared the mortality, Glasgow Outcome Scale (GOS) and length of stay (LOS) between two cohorts. Patients in two groups were similar with respect to age, gender, mode of injury, Glasgow Coma Scale and neurosurgical procedure before admission in PICU. Implementation of BTF guidelines was associated with a marked reduction in mortality from 40 % to 0% (relative risk 2.6; 95% confidence interval 1.3 -5.2; p < 0.007) and decreased in the LOS (relative risk 2.2; 95% confidence interval 1.4-3.3; p < 0.002). The absolute risk reduction of mortality is 0.4 Adherence to BTF guidelines in management of children with acute TBI was very effective. It can be successfully implemented in other regional hospitals.	[Haque, Anwarul; Enam, Ather] AKUH, Dept Pediat & Child Hlth, Dept Neurosurg, Karachi, Pakistan		Haque, A (corresponding author), Aga Khan Univ Hosp, Dept Pediat, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	anwar.haq@aku.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hammond J J, 2001, Curr Opin Crit Care, V7, P464, DOI 10.1097/00075198-200112000-00017; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; JENNETT B, 1975, LANCET, V1, P480; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Kunze E, 1998, ACT NEUR S, V71, P16; Murthy TVSP, 2008, INDIAN J NEUROTRAUM, V5, P41, DOI 10.1016/S0973-0508(08)80028-7; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016	17	4	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2009	6	2					111	114		10.1016/S0973-0508(09)80003-8			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1F	WOS:000218380600003					2022-02-06	
J	Kim, KH; Kim, MH; Lim, YH; Park, SR; Choi, BH; Park, HC; Yoon, SH; Min, BH; Park, H				Kim, Kil Hwan; Kim, Moon Hang; Lim, Yoon Hee; Park, So Ra; Choi, Byung Hyune; Park, Hyung Chun; Yoon, Seung Hwan; Min, Byoung-Hyun; Park, Hyeonseon			A Comparative Biocompatibility Study of Chondrocyte-derived ECM and Silk Fibroin Scaffolds In Vitro and in Rat Acute Traumatic Brain Injury	TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						biocompatibility; chondrocyte derived ECM scaffold; silk fibroin scaffold; traumatic brain injury	MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; TISSUE; MARROW; LESION; TRANSPLANTATION; BIOMATERIALS; MEMBRANE; GROWTH; REPAIR	Traumatic brain injury (TBI) often leads to critical tissue damage and loss. Brain tissue engineering is a promising technique for cellular replacement and neurological functional recovery in animals. However, useful biomaterial scaffolds have not been found so far. In order to explore the feasibility of stem cell based brain tissue engineering, it is first necessary to evaluate the biocompatibility of biomaterials with stem cells and brain tissues. In the present study, two biomaterials, chondrocyte derived ECM (ECM) and silk fibroin (SF) scaffolds, were investigated for their biocompatibility in vitro and in acute TBI. We found that when the ECM scaffold was cultured with rat mesenchymal stem cells (rMSCs) or implanted directly into brain injury, had a good biocompatibility. rMSCs, seeded on the ECM scaffold, were evenly distributed with a spindle shape and attached well, while on SF scaffold attached with a round shape relatively weakly. In the TBI model, the SF scaffold resulted in a significant increase in the cavity volume at 6 weeks postimplantation, but not the ECM scaffold. In addition, the ECM scaffold induced a lower inflammatory response, with active microglia/macrophages at 1 week, than the SF scaffold and control. Interestingly, both scaffolds reduced glial fibrillary acidic protein (GFAP) and neurocan expression in the cavity boundary throughout the experimental periods. These results indicate that the scaffolds tested inhibit the glial scar fort-nation in injured brain tissue. Moreover, there were no significant differences in the neurological outcome and weight body gain, when compared with the brain injury alone. Taken together, these findings reveal that the ECM scaffold showed good biocompatibility to the donor rMSCs and host brain tissue. Thus, the ECM scaffold seems to be beneficial as a biomaterial for brain tissue engineering.	[Park, Hyung Chun; Yoon, Seung Hwan; Park, Hyeonseon] Inha Univ, Coll Med, Dept Neurosurg, Inchon 400712, South Korea; [Min, Byoung-Hyun] Ajou Univ, Cell Therapy Ctr, Sch Med, Suwon 443270, South Korea; [Kim, Kil Hwan; Kim, Moon Hang; Lim, Yoon Hee; Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Inchon 400712, South Korea; [Choi, Byung Hyune] Inha Univ, Coll Med, Div Biomed & Bioengn Sci, Inchon 400712, South Korea		Park, H (corresponding author), Inha Univ, Coll Med, Dept Neurosurg, 7-241,3 Ga Shinheung Dong, Inchon 400712, South Korea.	hspark@inha.ac.kr			Ministry for Health, Welfare & Family Affairs, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A084615]; Ministry of Education, Science and Technology, Republic of KoreaMinistry of Education, Science and Technology, Republic of Korea [SC-4181]	This study Was Supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084615) and Stem Cell Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology (Grant No. SC-4181), Republic of Korea. We thank Dr. David L. Kaplan and Dr. Sang-Hyug Park (Tufts University) for generously providing us with the silk fibroin scaffold.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x; Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Min B.H., 1998, J KOREAN ORTHOP RES, V1, P23; MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H; MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4; Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI 10.1016/S0142-9612(03)00630-6; Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004	30	4	4	1	10	KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC	JONGRO-GU	199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA	1738-2696	2212-5469		TISSUE ENG REGEN MED	Tissue Eng. Regen. Med.	DEC	2009	6	14					1420	1428					9	Cell & Tissue Engineering; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering	544IG	WOS:000273647500011					2022-02-06	
J	Drignei, M; Scarlat, MM				Drignei, Marinel; Scarlat, Marius M.			Treatment of chronic dislocations of the shoulder by reverse total shoulder arthroplasty: a clinical study of six cases	EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY			English	Article						Shoulder; Arthroplasty; Chronic shoulder instability; Trauma; Locked dislocations; Reversed shoulder prosthesis; Hydroxyapatite; Cementless stem; Age; Aging; Arthritis; Revision surgery; Complications; Anterior shoulder dislocation; Glenoid; Graft; Shoulder scores; SST; Constant	PROSTHESIS; INSTABILITY; ARTHRITIS	Chronic shoulder dislocation is a disabling pathology that aggravates with the age of the lesion and with recurrences after failed open or closed reduction. The severe alteration of the anterior rim of the glenoid and of the subscapularis tendon limits the therapeutic options. This study presents an original operative procedure for stabilization by means of a constrained reverse arthroplasty, with a minimum follow-up of 12 months, in six cases. In 2005 and 2006, six patients were referred to our Shoulder Service for irreducible shoulder fracture-dislocations that recurred after closed or open reduction at 4 and 78 months from the original injury. The patient's age ranged between 58 and 82 years. There were no neurological complications and the deltoid was functional in all cases. All the patients were treated surgically. In all cases, the destruction of the glenoid, the bone defect of the humeral head and the poor quality of the subscapularis compromised all attempts for a conservative surgery. The option of treatment was for a retentive reverse total shoulder arthroplasty (RTSA) associated with a subscapularis release and repair. Shoulder stabilization by retentive RTSA generated an improvement of the mobility, stability and of the shoulder scores, and the quality of the daily living in all the cases presented. The procedure resulted in important pain relief and in the stabilization of the joint. The eventual restrictions in the range of motion are perfectly accepted by the subjects as an alternative to a preoperative "no-win" situation. Chronic shoulder dislocations are rare. The option of the constraint RTSA in these cases may be an acceptable solution when the bone stock is limited and when the subscapularis tendon is affected, retracted, shortened or compromised. A preoperative bone scanner is useful for defining the glenoid morphology and for planning the orientation of the implant and/or an eventual bone grafting. The number of cases in this study is small, but the originality of this option makes this idea suitable for debate.	[Drignei, Marinel] Cent Mil Univ Hosp, Dept Orthopaed Surg, Bucharest, Romania; [Scarlat, Marius M.] Clin Chirurg St Michel, Shoulder & Elbow Serv, F-83100 Toulon, France		Drignei, M (corresponding author), Cent Mil Univ Hosp, Dept Orthopaed Surg, Str Mircea Vulcanescu 88,Sectorul 6, Bucharest, Romania.	marineldrignei@yahoo.fr; mscarlat@gmail.com					Boileau P, 2005, J SHOULDER ELB SURG, V14, p147S, DOI 10.1016/j.jse.2004.10.006; Boileau P, 2006, J SHOULDER ELB SURG, V15, P527, DOI 10.1016/j.jse.2006.01.003; De Wilde L, 2006, J SHOULDER ELB SURG, V15, P260, DOI 10.1016/j.jse.2005.07.014; De Wilde L, 2001, Acta Orthop Belg, V67, P348; De Wilde Lieven, 2003, Acta Orthop Belg, V69, P495; Gill T J, 1999, Instr Course Lect, V48, P359; Gohlke Frank, 2007, Oper Orthop Traumatol, V19, P185, DOI 10.1007/s00064-007-1202-x; GRAMMONT PM, 1993, ORTHOPEDICS, V16, P65, DOI 10.3928/0147-7447-19930101-11; Gregory T, 2007, P I MECH ENG H, V221, P87, DOI 10.1243/09544119JEIM167; Sanchez-Sotelo J, 2003, J BONE JOINT SURG AM, V85A, P622, DOI 10.2106/00004623-200304000-00006; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; Sperling JW, 2002, J BONE JOINT SURG AM, V84A, P1775, DOI 10.2106/00004623-200210000-00006; Taunton MJ, 2008, J BONE JOINT SURG AM, V90A, P2180, DOI 10.2106/JBJS.G.00966; Walch G, 1998, Acta Orthop Belg, V64 Suppl 2, P46	14	4	5	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1633-8065			EUR J ORTHOP SURG TR	Eur. J. Orthop. Surg. Traumatol.	NOV	2009	19	8					541	546		10.1007/s00590-009-0472-4			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	512PS	WOS:000271262900004					2022-02-06	
J	Hohl, A; Daltrozo, JB; Pereira, CG; Weber, TR; Pinto, HF; Gullo, JD; Bernardini, JD; Coral, MHC; Walz, R				Hohl, Alexandre; Daltrozo, Jordana Bernardi; Pereira, Camila Girardi; Weber, Thais Rossoni; Pinto, Heyde Francine; Gullo, Jackson da Silva; Bernardini, Jucara Deitos; Cesar Coral, Marisa Helena; Walz, Roger			Late evaluation of the pituitary-gonadal axis in survivors of severe traumatic brain injury	ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA			Portuguese	Article						Traumatic brain injury; hypogonadism; hypopituitarism; testosterone	POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; LONG-TERM; PREVALENCE; REHABILITATION; INSUFFICIENCY; DEFICIENCY; MORTALITY; RISK	Objective:The purpose of this study is to evaluate pituitary function impairment in order to verify the prevalence of sex hormone deficiency and to analyze the profile of TBI population. Methods: Thirty patients were studied, 22 were male and 8 were female. All patients had their gonadal function assessed and they were evaluated at a median of 4 years post-trauma. Results: The average age of the men was 38 years at the time of the evaluation, while the mean age of women was 42 years. The majority of TBI was related to traffic accidents (63.3%). Three patients (10%) had low FSH and only 1 patient (3.3%) had low LH. There was no biochemical evidence of hypogonadism in women. Two male patients presented low testosterone (9.1%) and were diagnosed with hypogonadism. Prolactin levels were normal in all patients. Conclusion: Two cases of hypogonadism (9.1%) were diagnosed among men in this study. It is therefore necessary that medical professionals involved in the management of TBI patients are aware of hypogonadism as a complication of TBI, in order to diagnose it early. Arq Bras Endocrinol Metab. 2009;53(8):1012-19	[Hohl, Alexandre; Daltrozo, Jordana Bernardi; Pereira, Camila Girardi; Cesar Coral, Marisa Helena] Univ Fed Santa Catarina, Univ Hosp, Florianopolis, SC, Brazil; [Hohl, Alexandre; Weber, Thais Rossoni; Pinto, Heyde Francine; Gullo, Jackson da Silva; Bernardini, Jucara Deitos; Walz, Roger] Univ Fed Santa Catarina, Nupnec, Florianopolis, SC, Brazil		Hohl, A (corresponding author), Av Rio Branco,404-704,Torre 1, BR-88015200 Florianopolis, SC, Brazil.	alexandrehohl@endocrino.org.br	Walz, Roger/K-9096-2013; Hohl, Alexandre/R-9269-2019	Walz, Roger/0000-0002-9875-6687; Hohl, Alexandre/0000-0002-8073-5837			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; [Anonymous], 1998, NIH CONSENS STATEMEN, V16, P1; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; Clapauch R, 2008, ARQ BRAS ENDOCRINOL, V52, P1439, DOI 10.1590/S0004-27302008000900006; EDWARDS OM, 1986, MEDICINE, V65, P281; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P184, DOI 10.1097/00001199-200403000-00010; Emanuel L, 2000, Qual Manag Health Care, V8, P1; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kimura Akio, 2003, Keio Journal of Medicine, V52, P100; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Masini M, 1994, J BRAS NEUROCIRURG, V5, P61; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	31	4	4	0	0	SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA	RIO DE JANEIRO, RJ	RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL	0004-2730	1677-9487		ARQ BRAS ENDOCRINOL	Arq. Bras. Endocrinol. Metabol.	NOV	2009	53	8					1012	1019		10.1590/S0004-27302009000800016			8		Science Citation Index Expanded (SCI-EXPANDED)		535BG	WOS:000272941000016	20126855	gold			2022-02-06	
J	Chu, SY; Barlow, SM; Lee, J				Chu, Shin-Ying; Barlow, Steven M.; Lee, Jaehoon			Nonparticipatory Stiffness in the Male Perioral Complex	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						upper lip; lower lip; interangle; biomechanics; rigidity	FORCE CONTROL; FINE FORCE; LOWER LIPS; RIGIDITY; STIMULATION; SPASTICITY; REFLEX	Purpose: The objective of this study was to extend previous published findings in the authors' laboratory using a new automated technology to quantitatively characterize nonparticipatory perioral stiffness in healthy male adults. Method: Quantitative measures of perioral stiffness were sampled during a nonparticipatory task using a computer-controlled linear servo motor to impose a series of tensile displacements over a span of approximately 24 mm at the oral angle in 20 healthy young male adults. Perioral electromyograms were simultaneously sampled to confirm nonparticipation or passive muscle state. Perioral stiffness, derived as a quotient from resultant force (Delta F) and oral span (Delta X), was modeled with regression techniques and subsequently compared to previously reported perioral stiffness data for female adults. Results: Multilevel regression analysis revealed a significant quadratic relation between the perioral stiffness and interangle span; however, no significant difference was found between adult males and females. Conclusion: These normative measures will have application to future studies designed to objectively assess the effects of pathology (i.e., progressive neuromotor disease, traumatic brain insult) and intervention (pharmacologic, neurosurgical, and reconstructive surgery of the face [i.e., cleft lip, trauma, missile injuries]) on facial animation and speech kinematics.	[Barlow, Steven M.] Univ Kansas, Dept Speech Language Hearing Sci & Disorders, Commun Neurosci Labs, Lawrence, KS 66045 USA		Barlow, SM (corresponding author), Univ Kansas, Dept Speech Language Hearing Sci & Disorders, Commun Neurosci Labs, 1000 Sunnyside Ave,Rm 3001, Lawrence, KS 66045 USA.	smbarlow@ku.edu	Chu, Shin Ying/M-6047-2017		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE013814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P30DC005803, R01DC003311] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC003311, P30 DC005803, R01 DC003311-06A1, P30 DC005803-079003] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE13814, R01 DE013814-07, R01 DE013814] Funding Source: Medline		ANDREWS CJ, 1972, BRAIN, V95, P795, DOI 10.1093/brain/95.4.795; BARLOW SM, 1985, J SPEECH HEAR RES, V28, P373, DOI 10.1044/jshr.2803.373; BARLOW SM, 1986, EXP NEUROL, V94, P699, DOI 10.1016/0014-4886(86)90248-7; BARLOW SM, 1991, J SPEECH HEAR RES, V34, P252, DOI 10.1044/jshr.3402.252; BARLOW SM, 1986, J SPEECH HEAR RES, V29, P163, DOI 10.1044/jshr.2902.163; BARLOW SM, 1984, NEUROLOGY, V34, P145, DOI 10.1212/WNL.34.2.145; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; Barlow SM, 1998, NEUROMOTOR SPEECH DISORDERS, P117; Barlow SM, 2008, CLIN MANAGEMENT SENS, P80; BARLOW SM, 2008, CLIN MANAGEMENT SENS, P362; BLAIR C, 1986, J SPEECH HEAR RES, V29, P256, DOI 10.1044/jshr.2902.256; DIETRICHSON P, 1971, ACTA NEUROL SCAND, V47, P163, DOI 10.1111/j.1600-0404.1971.tb07474.x; FOGEL ML, 1984, BRIT J PLAST SURG, V37, P542, DOI 10.1016/0007-1226(84)90147-4; FOLKINS JW, 1978, BRAIN RES, V151, P409, DOI 10.1016/0006-8993(78)90898-3; Gentil M, 1998, ARCH ORAL BIOL, V43, P517, DOI 10.1016/S0003-9969(98)00042-9; Gentil M, 1999, J NEUROL NEUROSUR PS, V67, P329, DOI 10.1136/jnnp.67.3.329; Gomi H, 2002, J PHONETICS, V30, P261, DOI 10.1006/jpho.2002.0173; HO TP, 1982, J BIOMECH, V15, P859, DOI 10.1016/0021-9290(82)90051-3; HUNKER CJ, 1982, NEUROLOGY, V32, P749, DOI 10.1212/WNL.32.7.749; ITO T, 2000, P 5 SEM SPEECH PROD, P41; MAGLADERY JW, 1964, CLIN PHARMACOL THER, V5, P805; McHenry MA, 1999, LARYNGOSCOPE, V109, P827, DOI 10.1097/00005537-199905000-00027; Muller E. M., 1985, Mathematics and computers in biomedical applications, P363; NICHOLS TR, 2002, CLIN ORTHOP RELAT R, V403, P43; Pinto S, 2003, J NEUROL, V250, P179, DOI 10.1007/s00415-003-0966-7; Prochazka A, 1997, MOVEMENT DISORD, V12, P24, DOI 10.1002/mds.870120106; *SAS I, 2004, SAS 9 1 3 LANG REF C; SCHWAB RS, 1964, CLIN PHARMACOL THER, V5, P942; Seibel LM, 2007, J SPEECH LANG HEAR R, V50, P1272, DOI 10.1044/1092-4388(2007/089); Sepehri B, 2007, ANN BIOMED ENG, V35, P2196, DOI 10.1007/s10439-007-9379-6; Shiller DM, 2005, J NEUROPHYSIOL, V94, P2207, DOI 10.1152/jn.00164.2005; Shiller DM, 2002, J NEUROPHYSIOL, V88, P2329, DOI 10.1152/jn.00286.2002; SIEGLER EL, 1989, J GEN INTERN MED, V4, P533, DOI 10.1007/BF02599555; Struppler A., 1993, Stereotactic and Functional Neurosurgery, V60, P152, DOI 10.1159/000100603; Trotman CA, 2007, CLEFT PALATE-CRAN J, V44, P617, DOI 10.1597/06-138.1; van Lieshout PHHM, 2002, J SPEECH LANG HEAR R, V45, P5, DOI 10.1044/1092-4388(2002/001); WEBSTER DD, 1966, J NEUROSURG, V24, P299	37	4	4	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	OCT 1	2009	52	5					1353	1359		10.1044/1092-4388(2009/08-0101)			7	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	498KX	WOS:000270140100016	19717655	Green Submitted, Green Accepted			2022-02-06	
J	Frye, CA				Frye, Cheryl A.			Progestogens influence cognitive processes in aging	FUTURE MEDICINAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; ESTROGEN PLUS PROGESTIN; CONDITIONED AVOIDANCE RESPONSES; POSTMENOPAUSAL HORMONE-THERAPY; FOREBRAIN CHOLINERGIC NEURONS; MEDIATING SEXUAL RECEPTIVITY; HEALTH INITIATIVE MEMORY; TRAUMATIC BRAIN-INJURY; AGED FEMALE; WATER-MAZE	Steroid hormones may alter mnemonic processes. The majority of investigations have focused on the effects of 17 beta-estradiol (E-2) to mediate learning. However, progesterone (P-4), which varies across endogenous hormonal milieu with E-2, may also have effects on cognitive processes. P-4 may have effects in the hippocampus, prefrontal cortex (PFC) and/or striatum to enhance cognitive performance. Cognitive performance/learning has been assessed using tasks that are mediated by the hippocampus (water maze), PFC (object recognition) and striatum (conditioning). Our findings suggest that progestogens can have pervasive effects to enhance cognitive performance and learning in tasks mediated by the hippocampus, PFC and striatum and that these effects may be in part independent of actions at intracellular progestin receptors. Progestogens may therefore influence cognitive processes.	SUNY Albany, Dept Psychol, Albany, NY 12222 USA		Frye, CA (corresponding author), SUNY Albany, Dept Psychol, Life Sci Res Bldg 01058,1400 Washington Ave, Albany, NY 12222 USA.	cafrye@albany.edu					AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; AMATAYAKUL K, 1980, CONTRACEPTION, V21, P283, DOI 10.1016/0010-7824(80)90007-4; AMATAYAKUL K, 1984, CONTRACEPTION, V30, P179, DOI 10.1016/0010-7824(84)90102-1; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bajaj P, 2001, EUR J PAIN, V5, P135, DOI 10.1053/eujp.2001.0236; Barbaccia ML, 1996, NEUROENDOCRINOLOGY, V63, P166, DOI 10.1159/000126953; Barrett A M, 1999, J Gend Specif Med, V2, P55; Barrett-Connor E, 2007, AM J EPIDEMIOL, V166, P506, DOI 10.1093/aje/kwm214; BARRIS MC, 1980, DOC OPHTHALMOL, V49, P293, DOI 10.1007/BF01886622; BEACH FA, 1983, CAN J PSYCHOL, V37, P193, DOI 10.1037/h0080723; Berman KF, 1997, P NATL ACAD SCI USA, V94, P8836, DOI 10.1073/pnas.94.16.8836; Bimonte-Nelson HA, 2004, BEHAV NEUROSCI, V118, P707, DOI 10.1037/0735-7044.118.4.707; BIRKE LIA, 1979, ANIM BEHAV, V27, P597, DOI 10.1016/0003-3472(79)90196-9; Bixo M, 1997, BRAIN RES, V764, P173, DOI 10.1016/S0006-8993(97)00455-1; Bodensteiner KJ, 2006, HORM BEHAV, V49, P303, DOI 10.1016/j.yhbeh.2005.08.002; BODNOFF SR, 1994, BEHAV BRAIN RES, V62, P1; Brinton RD, 1999, INT J FERTIL WOMEN M, V44, P174; Caggiula AR, 2002, PSYCHOPHARMACOLOGY, V163, P230, DOI 10.1007/s00213-002-1156-5; Carroll JC, 2008, NEUROSCI LETT, V445, P229, DOI 10.1016/j.neulet.2008.09.010; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; CHAMBERS KC, 1980, PHYSIOL BEHAV, V24, P1061, DOI 10.1016/0031-9384(80)90048-7; Chavez-Delgado ME, 2003, J BIOMED MATER RES B, V67B, P702, DOI 10.1002/jbm.b.10059; Chen HH, 2003, CHINESE J PHYSIOL, V46, P169; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Clark AS, 2004, HORM BEHAV, V45, P314, DOI 10.1016/j.yhbeh.2003.12.010; Concas A, 1998, P NATL ACAD SCI USA, V95, P13284, DOI 10.1073/pnas.95.22.13284; De Beun R, 1999, PHARMACOL BIOCHEM BE, V64, P311, DOI 10.1016/S0091-3057(99)00056-8; DEBEUN R, 1992, PHYSIOL BEHAV, V52, P629, DOI 10.1016/0031-9384(92)90389-J; DELIGNIERES B, 1982, MATURITAS, V4, P67, DOI 10.1016/0378-5122(82)90021-4; DHALL K, 1977, FERTIL STERIL, V28, P156; DIAZVELIZ G, 1989, PHYSIOL BEHAV, V46, P397, DOI 10.1016/0031-9384(89)90010-3; DIAZVELIZ G, 1994, PSYCHONEUROENDOCRINO, V19, P387, DOI 10.1016/0306-4530(94)90018-3; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DOHANICH GP, 1994, BEHAV NEUROSCI, V108, P988, DOI 10.1037/0735-7044.108.5.988; DRUGAN RC, 1995, PHARMACOL BIOCHEM BE, V50, P551, DOI 10.1016/0091-3057(94)00341-6; DUFFY CK, 2008, SOC NEUR 38 ANN M WA; Dunkin J, 2005, PSYCHONEUROENDOCRINO, V30, P284, DOI 10.1016/j.psyneuen.2004.09.002; Edwards HE, 2000, NEUROSCIENCE, V101, P895, DOI 10.1016/S0306-4522(00)00439-5; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eiler WJA, 2007, NEUROPHARMACOLOGY, V52, P1570, DOI 10.1016/j.neuropharm.2007.03.001; El-Bakri NK, 2004, J CELL MOL MED, V8, P537, DOI 10.1111/j.1582-4934.2004.tb00478.x; Evans SEG, 2005, GYNECOL ENDOCRINOL, V21, P268, DOI 10.1080/09513590500361747; Fadalti M, 1999, PEDIATR RES, V46, P323, DOI 10.1203/00006450-199909000-00013; FAHMY K, 1991, CONTRACEPTION, V44, P419, DOI 10.1016/0010-7824(91)90032-B; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Febo M, 2003, J NEUROCHEM, V86, P405, DOI 10.1046/j.1471-4159.2003.01858.x; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Fellows LK, 2007, NEUROLOGY, V68, P991, DOI 10.1212/01.wnl.0000257835.46290.57; Feng Z, 2004, J PINEAL RES, V37, P198, DOI 10.1111/j.1600-079X.2004.00158.x; Fillit HM, 2002, ARCH INTERN MED, V162, P1934, DOI 10.1001/archinte.162.17.1934; Frye CA, 2006, J NEUROENDOCRINOL, V18, P960, DOI 10.1111/j.1365-2826.2006.01494.x; Frye CA, 2008, PHARMACOL BIOCHEM BE, V91, P261, DOI 10.1016/j.pbb.2008.08.018; Frye CA, 2006, NEUROSCIENCE, V138, P1007, DOI 10.1016/j.neuroscience.2005.06.015; Frye CA, 2005, BRAIN RES, V1036, P101, DOI 10.1016/j.brainres.2004.12.014; Frye CA, 2001, BRAIN RES REV, V37, P201, DOI 10.1016/S0165-0173(01)00119-9; FRYE CA, 1995, NEUROBIOL LEARN MEM, V64, P83, DOI 10.1006/nlme.1995.1046; FRYE CA, 1995, PHYSIOL BEHAV, V57, P5, DOI 10.1016/0031-9384(94)00197-D; Frye CA, 1999, J ENDOCRINOL INVEST, V22, P455, DOI 10.1007/BF03343590; Frye CA, 2001, HORM BEHAV, V40, P226, DOI 10.1006/hbeh.2001.1674; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; FRYE CA, NEUROSCI LETT UNPUB; Frye CA, 2008, STEROIDS, V73, P906, DOI 10.1016/j.steroids.2008.01.020; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2008, NEUROSCI LETT, V437, P116, DOI 10.1016/j.neulet.2008.04.004; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2007, REPRODUCTION, V133, P663, DOI 10.1530/rep.1.01208; Frye CA, 2007, PHARMACOL BIOCHEM BE, V86, P209, DOI 10.1016/j.pbb.2006.07.033; Frye Cheryl A., 2008, P449, DOI 10.1007/978-1-4020-6854-6_22; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GEE KW, 1988, J PHARMACOL EXP THER, V246, P803; Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Gibbs RB, 2002, HORM BEHAV, V42, P245, DOI 10.1006/hbeh.2002.1825; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; GODFREY JR, 2009, J WOMENS HLTH; GOLD PE, 1995, AM J CLIN NUTR, V61, p987S, DOI 10.1093/ajcn/61.4.987S; Gonzalez-Flores O, 2004, HORM BEHAV, V46, P151, DOI 10.1016/j.yhbeh.2004.02.006; GORZALKA BB, 1995, PHYSIOL BEHAV, V58, P1003, DOI 10.1016/0031-9384(95)00146-A; Grady D, 2002, AM J MED, V113, P543, DOI 10.1016/S0002-9343(02)01270-6; GRAHAM EA, 1985, PSYCHOSOM MED, V47, P26, DOI 10.1097/00006842-198501000-00003; Grigorova M, 2006, CLIMACTERIC, V9, P181, DOI 10.1080/13697130600727107; Grobin AC, 2001, DEV BRAIN RES, V131, P31; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Harburger LL, 2007, NEUROBIOL AGING, V28, P602, DOI 10.1016/j.neurobiolaging.2006.02.019; HEINSBROEK RPW, 1987, PHARMACOL BIOCHEM BE, V28, P371, DOI 10.1016/0091-3057(87)90455-2; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; ISWARI S, 1986, STEROIDS, V47, P189, DOI 10.1016/0039-128X(86)90088-7; JANES C, 1987, J PSYCHOSOM OBST GYN, V20, P80; Johansson IM, 2002, BRAIN RES, V934, P125, DOI 10.1016/S0006-8993(02)02414-9; Kahn HS, 2003, DIABETES CARE, V26, P216, DOI 10.2337/diacare.26.1.216; Kask K, 2008, PSYCHOPHARMACOLOGY, V199, P161, DOI 10.1007/s00213-008-1150-7; Keenan PA, 1998, AM J OBSTET GYNECOL, V179, P731, DOI 10.1016/S0002-9378(98)70073-0; Kellogg CK, 2006, BRAIN RES, V1067, P115, DOI 10.1016/j.brainres.2005.10.039; Kis Z, 2001, NEUROREPORT, V12, P2509, DOI 10.1097/00001756-200108080-00044; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Korneyev A, 1996, HORM BEHAV, V30, P37, DOI 10.1006/hbeh.1996.0006; Korol DL, 2002, BEHAV NEUROSCI, V116, P411, DOI 10.1037//0735-7044.116.3.411; Ladurelle N, 2000, BRAIN RES, V858, P371, DOI 10.1016/S0006-8993(00)01953-3; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Leskiewicz M, 1998, POL J PHARMACOL, V50, P355; Lewis MC, 2008, HORM BEHAV, V54, P455, DOI 10.1016/j.yhbeh.2008.05.010; Liu P, 2008, SYNAPSE, V62, P834, DOI 10.1002/syn.20563; LUINE V, 1994, BEHAV NEURAL BIOL, V62, P230, DOI 10.1016/S0163-1047(05)80021-4; Maki PM, 2007, NEUROLOGY, V69, P1322, DOI 10.1212/01.wnl.0000277275.42504.93; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nierop A, 2006, J CLIN ENDOCR METAB, V91, P1329, DOI 10.1210/jc.2005-1816; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; Nofrey BS, 2008, BRAIN COGNITION, V66, P156, DOI 10.1016/j.bandc.2007.06.003; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Osaka N, 2005, NEUROREPORT, V16, P1621, DOI 10.1097/01.wnr.0000181581.18636.a7; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Paris JJ, 2008, REPRODUCTION, V136, P105, DOI 10.1530/REP-07-0512; Patchev VK, 1996, NEUROPSYCHOPHARMACOL, V15, P533, DOI 10.1016/S0893-133X(96)00096-6; PATCHEV VK, 1994, NEUROSCIENCE, V62, P265, DOI 10.1016/0306-4522(94)90330-1; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; PFAFF D, 1977, J COMP PHYSIOL PSYCH, V91, P134, DOI 10.1037/h0077305; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P497, DOI 10.1016/0306-4530(92)90008-U; Ping SE, 2008, J NEUROSCI RES, V86, P1588, DOI 10.1002/jnr.21609; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; POSER CM, 1986, ACTA NEUROL SCAND, V73, P39, DOI 10.1111/j.1600-0404.1986.tb03239.x; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Resnick SM, 2002, JAMA-J AM MED ASSOC, V288, P2170, DOI 10.1001/jama.288.17.2170; Resnick SM, 2006, J CLIN ENDOCR METAB, V91, P1802, DOI 10.1210/jc.2005-2097; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P140, DOI 10.1016/j.yebeh.2004.11.019; Rhodes ME, 2004, EPILEPSIA, V45, P1531, DOI 10.1111/j.0013-9580.2004.16504.x; Rhodes ME, 2004, PHARMACOL BIOCHEM BE, V78, P551, DOI 10.1016/j.pbb.2004.03.025; Rhodes ME, 2004, PHARMACOL BIOCHEM BE, V78, P505, DOI 10.1016/j.pbb.2004.04.021; Rosenberg L, 2002, PSYCHONEUROENDOCRINO, V27, P835, DOI 10.1016/S0306-4530(01)00083-X; Rubinow MJ, 2004, BEHAV NEUROSCI, V118, P863, DOI 10.1037/0735-7044.118.4.863; Russo SJ, 2003, NEUROSCIENCE, V120, P523, DOI 10.1016/S0306-4522(03)00317-8; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Sato T, 2004, BEHAV BRAIN RES, V150, P33, DOI 10.1016/S0166-4328(03)00249-3; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; SHARP K, 1993, BRIT J OBSTET GYNAEC, V100, P209, DOI 10.1111/j.1471-0528.1993.tb15232.x; SHERIDAN PJ, 1984, CLIN NEUROPHARMACOL, V7, P281, DOI 10.1097/00002826-198412000-00003; Sherwin B B, 2000, Novartis Found Symp, V230, P188, DOI 10.1002/0470870818.ch14; Sherwin BB, 1996, OBSTET GYNECOL, V87, pS20, DOI 10.1016/0029-7844(95)00431-9; Sherwin BB, 1997, NEUROLOGY, V48, pS21, DOI 10.1212/WNL.48.5_Suppl_7.21S; SHERWIN BB, 1988, J AFFECT DISORDERS, V14, P177, DOI 10.1016/0165-0327(88)90061-4; Sherwin BB, 1999, J PSYCHIATR NEUROSCI, V24, P315; Shughrue PJ, 2001, J COMP NEUROL, V436, P64; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Smith CD, 2006, PSYCHOPHARMACOLOGY, V186, P481, DOI 10.1007/s00213-005-0186-1; Solis-Ortiz S, 2004, PSYCHONEUROENDOCRINO, V29, P1047, DOI 10.1016/j.psyneuen.2003.10.007; SPELLACY WN, 1972, ACTA ENDOCRINOL-COP, V70, P373, DOI 10.1530/acta.0.0700373; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; STEINMETZ JE, 1992, J NEUROSCI, V12, P4403; STEWART J, 1967, NATURE, V216, P1223, DOI 10.1038/2161223a0; Sundstrom I, 1998, PSYCHONEUROENDOCRINO, V23, P73, DOI 10.1016/S0306-4530(97)00064-4; Sundstrom I, 1998, BIOL PSYCHIAT, V44, P755, DOI 10.1016/S0006-3223(98)00012-2; van Wingen G, 2007, J NEUROSCI, V27, P11416, DOI 10.1523/JNEUROSCI.1715-07.2007; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VERMEULEN A, 1974, DIABETOLOGIA, V10, P253; Vongher JM, 1999, PHARMACOL BIOCHEM BE, V64, P777, DOI 10.1016/S0091-3057(99)00140-9; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Walf AA, 2008, NEUROBIOL LEARN MEM, V89, P513, DOI 10.1016/j.nlm.2008.01.008; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Wallace M, 2007, ANN NY ACAD SCI, V1097, P54, DOI 10.1196/annals.1379.026; Wang CS, 2007, NEUROSCI LETT, V415, P118, DOI 10.1016/j.neulet.2007.01.004; Wang JM, 2007, CURR ALZHEIMER RES, V4, P510, DOI 10.2174/156720507783018262; Wang MD, 1996, J CLIN ENDOCR METAB, V81, P1076, DOI 10.1210/jc.81.3.1076; Warren SG, 2000, NEUROBIOL LEARN MEM, V74, P229, DOI 10.1006/nlme.1999.3948; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; Yaffe K, 2003, JAMA-J AM MED ASSOC, V289, P2717, DOI 10.1001/jama.289.20.2717; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yates MA, 2008, BRAIN RES, V1218, P1, DOI 10.1016/j.brainres.2008.04.055; Yoon BK, 2003, FERTIL STERIL, V79, P274, DOI 10.1016/S0015-0282(02)04666-6; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zou LB, 2000, NEUROPHARMACOLOGY, V39, P1617, DOI 10.1016/S0028-3908(99)00228-2	182	4	4	0	6	FUTURE SCI LTD	LONDON	UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND	1756-8919	1756-8927		FUTURE MED CHEM	Future Med. Chem.	OCT	2009	1	7					1215	1231		10.4155/FMC.09.104			17	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	575UI	WOS:000276094000011	21426099				2022-02-06	
J	Fumiyo, I; Sumie, S; Akiko, O; Yasuko, S				Fumiyo, Ishikawa; Sumie, Suzuki; Akiko, Okumiya; Yasuko, Shimizu			Psychosocial Adjustment Process of Mothers Caring for Young Men With Traumatic Brain Injury: Focusing on the Mother-Son Relationship	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SOCIAL SUPPORT; HEAD-INJURY; FAMILIES; STRESS	This study focuses on the mother-son relationship of 13 mothers caring for single sons between the ages of 15 and 30 years who have higher brain dysfunction due to a traumatic brain injury. We aimed to elucidate the psychosocial adjustment process of mothers for 5 years following the injury to facilitate the social rehabilitation of both mother and son. Data obtained through a semistructured interview method were analyzed using a modified grounded theory approach. After 56 concepts were identified, 18 categories and then 8 core categories were semantically created. The 8 core categories were (a) avoid contact with son, (b) support son based on mother's own desire, (c) support son alone without external support, (d) realize mother's care limits and seek external support sources, (e) request and utilize external support, (f) support and work toward son's independence while monitoring his interactions with others, (g) mother considers own feelings and reenters society, and (h) strive for continued care of son with mother's acquired energy and efficient management skills. These were grouped into the following five stages: (a) avoidance, (b-c) closed, A support seeking, (e-f) withdrawal, and (g-h) reconstruction.	[Fumiyo, Ishikawa] Tokyo Univ Technol, Katayanagi Adv Res Labs, Hachioji, Tokyo, Japan; [Sumie, Suzuki] Dokkyo Med Univ, Dept Nursing, Mibu, Tochigi, Japan; [Akiko, Okumiya] Sapporo Med Univ, Dept Nursing, Sapporo, Hokkaido, Japan; [Yasuko, Shimizu] Osaka Univ, Div Hlth Sci, Osaka, Japan		Fumiyo, I (corresponding author), Tokyo Univ Technol, Katayanagi Adv Res Labs, Hachioji, Tokyo, Japan.	fishikawa@mt.teu.ac.jp					BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Carson P, 1993, J Neurosci Nurs, V25, P165; DALE FT, 1993, COMMUNITY BASED EMPL; DOHI K, 2003, J CLIN REHABILITATIO, V12, P674; DOUGLAS JM, 1990, NZSTA BIEBB C CHRIST; DROTAR D, 1975, PEDIATRICS, V56, P710; Duff Diane, 2002, Axone, V24, P14; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; FUJII C, 2005, J JAPANCSE SOC CHILD, V14, P52; HAMAMURA A, 1989, FAMILY LIFE STRESS, P108; Kinoshita, 2003, PRACTICE MODIFIED GR; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Man DWK, 2002, INT J REHABIL RES, V25, P287, DOI 10.1097/00004356-200212000-00006; OHASHI M, 2000, BRAIN DEV, V32, P116; OKADO T, 2006, STRESS FAMILY, P180; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; STANSFIELD K, 1990, AXONE, V12, P71; TANIGUCHI M, 1989, FAMILY LIFE STRESS, P88; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x	21	4	4	0	3	AMER ASSOC NEUROSCIENCE NURSES	GLENVIEW	4700 W LAKE AVENUE, GLENVIEW, IL 60025 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2009	41	5					277	286		10.1097/JNN.0b013e3181b2c73c			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	516XO	WOS:000271576900007	19835241				2022-02-06	
J	Barbosa, ALD; Schossler, JEW				da Trindade Barbosa, Anna Laeticia; Wallau Schossler, Joao Eduardo			Traumatic coxofemoral luxation in dogs and cats: retrospective study (1997-2006)	CIENCIA RURAL			Portuguese	Article						hip joint; traumatic dislocation; sense	STABILIZATION	The traumatic coxofemoral luxations are important orthopedics injuries in dogs and cats due to their great frequency. The main causes are the automobilistic accidents and craniodorsal appearance is the most frequent. This injury can affect any breed, sex and age, however, adult animals are most frequently involved. Close reduction is the first choice of treatment, but at some circumstances the use of open/surgical methods are necessary. This study aims to evaluate the incidence, predisposition, etiology and results of treatments of traumatic hip luxation at the Santa Maria Federal University Veterinary Hospital. For this, a retrospective study of surgical service was made between 1997 and 2006 in this hospital. It was observed a high incidence of traumatic luxations (75.8%), and the most frequent cause was hit t by a car trauma (58.6%), followed by falls (17.3%), unknown agents (17.2%) and fights (6.9%). The canine/feline proportion was 58/2, with the males being the most affected in both species: 65.5% at dogs and 100% at cats. The most predicts breed involved was the Poodle (44.8%) and the mixed breed dogs (20.7%). The treatments options used were suture of capsule (18.3%), transacetabular pinnig (56.7%) and femoral head and neck excision (25%). The success rate was 71.1% in the first two techniques, proving itself efficient in the traumatic coxofemoral luxation reduction, thus, femoral head and neck excision are recommended in complications and impossibility.	[da Trindade Barbosa, Anna Laeticia] Univ Fed Santa Maria, Lab Cirurgia Expt LACE, Programa Posgrad Med Vet, BR-97105900 Santa Maria, RS, Brazil; [Wallau Schossler, Joao Eduardo] Univ Fed Santa Maria, CCR, DCPA, BR-97105900 Santa Maria, RS, Brazil		Barbosa, ALD (corresponding author), Univ Fed Santa Maria, Lab Cirurgia Expt LACE, Programa Posgrad Med Vet, BR-97105900 Santa Maria, RS, Brazil.	laeticiatrindade@yahoo.com.br					ALVARENGA J, 1997, REV BRASILEIRA CIENC, V4, P45; ANDRIOLI LG, 2000, THESIS U FEDERAL SAN; BARDET JF, 1997, TRATADO MED INT VET, P188; BASHER AWP, 1986, VET SURG, V15, P356, DOI 10.1111/j.1532-950X.1986.tb00243.x; BONE DL, 1984, VET SURG, V13, P263, DOI 10.1111/j.1532-950X.1984.tb00807.x; Brandão Cláudia Valéria Seullner, 2002, Cienc. Rural, V32, P275, DOI 10.1590/S0103-84782002000200015; Brandts J, 2006, LABOUR ECON, V13, P1, DOI 10.1016/j.labeco.2004.08.003; BRINKER W.O., 1999, MANUAL ORTOPEDIA TRA, P394; DECAMP CE, 1995, SMALL ANIMAL ORTHOPE, P347; Evers P, 1997, J AM VET MED ASSOC, V210, P59; FOX E.M., 1991, COMPENDIUM EUROPEAN, V13, P153; FREUND JT, 2007, LUXATIO OSSIS FEMORI; HICKMAN J, 1983, ATLAS CIRURGIA VET; JOHNSON A.L., 2005, CIRURGIA PEQUENOS AN, P1095; Kilic E, 2002, J SMALL ANIM PRACT, V43, P341, DOI 10.1111/j.1748-5827.2002.tb00083.x; MANLEY P.A., 1998, MANUAL CIRURGIA PEQU, P2113; Martini FM, 2001, VET SURG, V30, P468, DOI 10.1053/jvet.2001.25875; MEIJ BP, 1992, J SMALL ANIM PRACT, V33, P320, DOI 10.1111/j.1748-5827.1992.tb01157.x; Rodaski S., 2002, Archives of Veterinary Science, V7, P179; Sia D. B., 2006, Acta Scientiae Veterinariae, V34, P187; THACHER C, 1985, J AM ANIM HOSP ASSOC, V21, P167; Tomlinson Jr JL, 1998, CURRENT TECHNIQUES S, P1178; WADSWORTH P.L., 1996, MECANISMO MOLESTIA C, P1213; WALLACE LJ, 1991, CIRURGIA PEQUENOS AN, P660; WHITTICK WG, 1978, TRAUMATOLOGIA ORTOPE	25	4	4	4	17	UNIV FEDERAL SANTA MARIA	SANTA MARIA	CIDADE UNIV, BAIRRO CAMOBI, SANTA MARIA, RS 97105-900, BRAZIL	0103-8478	1678-4596		CIENC RURAL	Cienc. Rural	SEP	2009	39	6					1823	1829					7	Agronomy	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	493GX	WOS:000269725100028		gold, Green Published			2022-02-06	
J	Phillips, LA; Voaklander, DC; Drul, C; Kelly, KD				Phillips, Leah A.; Voaklander, Don C.; Drul, Colleen; Kelly, Karen D.			The Epidemiology of Hospitalized Head Injury in British Columbia, Canada	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; PSYCHIATRIC-DISORDERS; HEALTH REGION; DEPRESSION; CDC; REGIONALIZATION; DISABILITY; PROGRAMS; ANXIETY	Objective: This descriptive study seeks to identify the incidence rates of head injuries in a large Canadian province, given incident cases for a ten year period. It describes cases in terms of age standardized rates, demographics, and health care utilization. Methods: The analyses were done using descriptive statistics. Incidence rates were calculated using the direct method. The indicators of hospital resource utilization were: mean length of hospital stay, number of intensive care unit (ICU) stays, and mean length of stay in an ICU. Results: In the ten year period, British Columbia saw 48,753 admissions due to an incident head injury. The most common head injury diagnosis was an "Intracranial" injury. The year with the highest total age standardized rate was 1991/92 (174.18/100 000). The mean length of hospital stay was 7.4 days. Ten percent had an ICU stay and the mean length of stay was 4.4 days (+/- 4.8). The diagnosis with the longest mean length of stay was a "Fractured Skull" while of the top five E-code categories; "Motor Vehicle Traffic" had the highest mean length of stay with 12.2 days. Conclusions: Our study provides a much needed analysis of the incidence of head injuries in British Columbia. These rates can be compared to other provinces using the 2001 Canadian population as the standardized population. Our results indicate that there are certain "at risk" groups that warrant attention, in particular, younger men with lower socioeconomic standing. Indicators of health care utilization presented in the study should generate policy discussions.	[Phillips, Leah A.] Univ Alberta, Sch Publ Hlth, Alberta Ctr Injury Control & Res, Edmonton, AB T6G 2E1, Canada; [Kelly, Karen D.] Univ Alberta, Sch Publ Hlth, Fac Nursing, Edmonton, AB T6G 2E1, Canada		Phillips, LA (corresponding author), Univ Alberta, Sch Publ Hlth, Alberta Ctr Injury Control & Res, 4075 RTF,8308-114st, Edmonton, AB T6G 2E1, Canada.						Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Biasca N, 2004, AM SOC TEST MATER, V1446, P98, DOI 10.1520/STP11612S; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; BISHOP PJ, 2001, PROTECTIVE EQUIPMENT, P57; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Crisp R, 2007, DISABIL REHABIL, V29, P267, DOI 10.1080/09638280600835267; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Hamilton SM, 1997, ARCH SURG-CHICAGO, V132, P605; Hamilton SM, 2001, CAN J SURG, V44, P51; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; McClelland RJ, 1996, J PSYCHOSOM RES, V40, P563, DOI 10.1016/0022-3999(95)00616-8; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; *NAT TRAUM REG REP, 2003, MAJ INJ CAN 2001 200; *NAT TRAUM REG REP, 2004, MAJ INJ CAN 2002 200; *NAT TRAUM REG REP, 2006, MAJ INJ CAN 2004 200; *NAT TRAUM REG REP, 2005, MAJ INJ CAN 2003 200; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Thurman DJ., 1995, GUIDELINES SURVEILLA; VAN ED, 2006, AM J IND MED, V49, P557; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	32	4	4	0	6	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	SEP	2009	36	5					605	611		10.1017/S0317167100008118			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	502UZ	WOS:000270487100013	19831130	Bronze			2022-02-06	
J	Reistetter, T; Abreu, BC; Bear-Lehman, J; Ottenbacher, KJ				Reistetter, Timothy; Abreu, Beatriz C.; Bear-Lehman, Jane; Ottenbacher, Kenneth J.			Unilateral and bilateral upper extremity weight-bearing effect on upper extremity impairment and functional performance after brain injury	OCCUPATIONAL THERAPY INTERNATIONAL			English	Article						hand impairment; hemiplegia; neuro-rehabilitation	INDEPENDENCE MEASURE; CHRONIC STROKE; INTERRATER RELIABILITY; CEREBRAL-PALSY; ACTIVATION; CHILDREN; EXERCISE; PATIENT; TRIAL	The purpose of the study was to investigate the effect of upper extremity (UE) weight bearing on UE impairment functional performance of persons with acquired brain injury (BI). A quasi-experimental design was used to examine a convenience sample of 99 persons with acquired BI and 22 without BI (WBI) living in a community re-entry centre. A computerized force-sensing array pressure map system was used to determine the UE pressure during unilateral and bilateral conditions. Differences between groups were examined using t-tests. Correlations were computed between UE weight bearing and hand function, and functional performance as measured by the Fugl-Meyer scale and functional independence measure (FIM) scale. The group of people with BI exerted significantly lower UE weight bearing during unilateral conditions as compared with persons WBI [left: t (119) = 2.34, p = 0.021; right: t (119) = 4.79, p = 0.043). UE weight-bearing measures correlated strongly with FIM motor scores with bilateral UE conditions yielded the highest signifi cant correlation (bilateral left r = 0.487, p < 0.001; bilateral right r = 0.469, p < 0.01). The results indicated that UE weight-bearing pressure differs in unilateral and bilateral conditions, between persons with and WBI and between persons with stroke and traumatic brain injury. These fi ndings may have implications for occupational therapists that use unilateral versus bilateral motor training for rehabilitation. There is a need to replicate the study design with a randomized and stratifi ed sample of persons with BI. Copyright (C) 2009 John Wiley & Sons, Ltd.	[Abreu, Beatriz C.] Transit Learning Ctr, Galveston, TX 77550 USA; [Reistetter, Timothy; Abreu, Beatriz C.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX USA; [Reistetter, Timothy] E Carolina Univ, Dept Occupat Therapy, Greenville, NC USA; [Bear-Lehman, Jane] New York Univ Steinhardt, Dept Occupat Therapy, New York, NY USA		Abreu, BC (corresponding author), Transit Learning Ctr, 1528 PO St, Galveston, TX 77550 USA.	babreu@tlc-galveston.org		Ottenbacher, Kenneth/0000-0001-5990-3982	National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K12-H0055929]; Moody Foundation; National Institute of Health, National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055929] Funding Source: NIH RePORTER	Funding from the National Institute of Health, National Institute for Child Health and Human Development and National Institute for Neurological Disorders and Stroke (K12-H0055929), and the Moody Foundation supported this research project.	ABREU BC, 1995, AM J OCCUP THER, V49, P517, DOI 10.5014/ajot.49.6.517; ABREU BC, 2007, ENHANCING HUMAN OCCU, P92; BARNES KJ, 1986, OCCUP THER J RES, V6, P227, DOI 10.1177/153944928600600404; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BROUWER BJ, 1994, ARCH PHYS MED REHAB, V75, P861, DOI 10.1016/0003-9993(94)90110-4; CHAKERIAN DL, 1993, DEV MED CHILD NEUROL, V35, P216; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P85; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; Kinghorn J, 1996, AM J OCCUP THER, V50, P807, DOI 10.5014/ajot.50.10.807; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Luke C, 2004, CLIN REHABIL, V18, P888, DOI 10.1191/0269215504cr793oa; Lum PS, 2006, J REHABIL RES DEV, V43, P631, DOI 10.1682/JRRD.2005.02.0044; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; OTTENBACHER KJ, 1994, ARCH PHYS MED REHAB, V75, P1297; Parker V M, 1986, Int Rehabil Med, V8, P69; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P267, DOI 10.1177/1545968308323928; Rosenstein L, 2008, AM J OCCUP THER, V62, P28, DOI 10.5014/ajot.62.1.28; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Shechtman O, 2001, OCCUP THER J RES, V21, P29, DOI 10.1177/153944920102100103; Stein J, 2004, AM J PHYS MED REHAB, V83, P720, DOI 10.1097/01.PHM.0000137313.14480.CE; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Uhl TL, 2003, J ORTHOP SPORT PHYS, V33, P109, DOI 10.2519/jospt.2003.33.3.109; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369	32	4	4	0	8	WILEY-HINDAWI	LONDON	ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	0966-7903	1557-0703		OCCUP THER INT	Occup. Ther. Int.	SEP-DEC	2009	16	3-4			SI		218	231		10.1002/oti.278			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	V16VG	WOS:000207896500005	19551694	Green Accepted			2022-02-06	
J	Kuchta, J; Wedekind, C; Ernestus, RI; Klug, N				Kuchta, J.; Wedekind, C.; Ernestus, R-I.; Klug, N.			The Hour-glass Model of Corpus Callosum Injury	CENTRAL EUROPEAN NEUROSURGERY			English	Article						trauma; brain injury; corpus callosum; blunt head injury; intensive care	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; FOCAL LESIONS; MR; PROGNOSIS; RECOVERY; COMA; STEM; CT	In this retrospective study, the authors analyze the frequency, anatomical distribution and the clinical outcome of 44 patients after severe head injury, with and without lesions of the corpus callosum (CC). 44 patients with severe head injury (GCS<9 on admission), who were admitted to the intensive care unit of the Department of Neurosurgery after trauma, underwent early MR-tomography (T1, T2 and FLAIR sequences) in addition to CCT performed on admission. CC lesions were found in about 1/3 of patients with severe head injury. Posterior (splenium) lesions of the CC were three times more common than anterior lesions. Patients with CC injury were much younger compared to patients without CC injury (25 versus 34 years). The Glasgow Outcome Scale (GOS) score after six months was poor (death, persistent vegetative state, severe disability, GOS>3) in all patients with CC injury when compared to patients without CC injury (GOS<4). CC lesions are an important parameter in the assessment of severe brain trauma, hinting at the mechanism of injury as well as the outcome of patients. If a patient does not awake after blunt head injury, MRT scans (including FLAIR sequences) are indicated. A CC lesion alone is not the cause of prolonged coma but indicates a severe diffuse injury resulting in functional deorganization of the brain. The mechanisms of CC injury are discussed and a new pathophysiological model, based on the hour-glass analogy, is presented.	[Kuchta, J.] MediaPk Klin Koln, Dept Neurosurg, D-50670 Cologne, Germany; [Wedekind, C.] Bruderwald Clin, Dept Neurosurg, Bamberg, Germany; [Ernestus, R-I.; Klug, N.] Univ Cologne, Dept Neurosurg, Cologne, Germany		Kuchta, J (corresponding author), MediaPk Klin Koln, Dept Neurosurg, Mediapk 3, D-50670 Cologne, Germany.	phonosphere@web.de					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bratzke H, 1988, Beitr Gerichtl Med, V46, P289; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; Graham D.I., 2000, HEAD INJ, P133; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Roob G, 1999, NERVENARZT, V70, P1082, DOI 10.1007/s001150050542; SHIGEMORI M, 1985, ACTA NEUROCHIR, V81, P36; TEASDALE G, 1974, LANCET, V2, P81; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328	32	4	4	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1868-4904	1868-4912		CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	AUG	2009	70	3					125	129		10.1055/s-0029-1214384			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	491ZG	WOS:000269622200003	19701870				2022-02-06	
J	Goold, D; Vane, DW				Goold, Daniel; Vane, Dennis W.			Evaluation of Functionality After Head Injury in Adolescents	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	38th Annual Meeting of the Western-Trauma-Association	FEB 24-MAR 01, 2008	Squaw Creek, CA	Western Trauma Assoc		Impairment after head injury; Posttraumatic function in children	TRAUMATIC BRAIN-INJURY; PRACTICAL SCALE; CHILDREN; PERFORMANCE	Background: The Occupational Therapy Head Injury Mini Screen (OT HIMS) is a screening tool for patients admitted with traumatic brain injury (TBI) in the acute care setting. It is a combination of the Galveston Orientation and Amnesia Test (GOAT) and the Cognistat (formally the Neurobehavioral Cognitive Status Examination). Its purpose is to identify cognitive deficits in patients and to provide education for patients on the impact of these deficits on daily living. Our hypothesis for this study was that cognitive functionality outcome varies with severity of head injury (manifested by Glasgow Coma Scale [GCSI) at admission and tests that identify cognitive deficits can be reserved for patients admitted with severe head injury. Methods: Data were prospectively collected for all patients with TBI (DRG International Classification of Diseases-9th Rev.-Clinical Modification codes 800.0-801.99 + 850-859.9), aged 13-21 years, over 10 years. The inclusion criteria are patients had to be awake and have adequate physical function to complete the test. Patients with cognitive deficits were identified using GOAT and Cognistat. Preexistent deficits were also identified. Scores on OT HIMS were compared with GCS at admission. Outcomes also included discharge to home or rehabilitation centers. Hospital deaths were not included in the study. Results: Six hundred nine patients were reviewed, and 248 were administered the OT HIMS. Eighty-three suffered some impairment. The mean GCS for the 248 patients was 13.96 (+/- 2.16). A coefficient of correlation between GCS and GOAT score of only 0.224 and an R-2 value of 0.050 indicated no correlation between these results. Comparing GCS and the presence of impairment identified by Cognistat yielded an R-2 value of 0.093, indicating no correlation between these parameters. Among the patients whose results showed cognitive deficits on OT HIMS, 38% had impairments before injury. Interestingly, only 58% of patients with deficits before injury also demonstrated impairments on OT HIMS. Of the 248 patients, 12 went to rehabilitation centers and this was not correlated with GCS. Conclusions: In this study, admission GCS did not predict performance on the OT HIMS after injury in this cohort of patients with adequate recovery to take the examination. Cognitive functionality can be impaired after TBI of even minimal degree, All patients admitted for TBI should be screened for cognitive deficits before discharge. Long-term follow-up for this group must be performed for maximal therapy and optimal outcomes.	[Vane, Dennis W.] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Pediat Surg, St Louis, MO 63104 USA; Univ Vermont, Coll Med, Div Pediat Surg, Burlington, VT USA		Vane, DW (corresponding author), St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Pediat Surg, St Louis, MO 63104 USA.	denvane@gmail.com					Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; BLOKLAND B, 2006, OT PRACTICE, V11, P11; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Langston J, 2001, MANUAL COGNISTAT NEU; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; TEASDALE G, 1974, LANCET, V2, P81; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015	13	4	4	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1					71	74		10.1097/TA.0b013e3181b021ae			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	470CZ	WOS:000267953100012	19590311				2022-02-06	
J	Nujaimin, U; Saufi, A; Rahman, GA; Badrisyah, I; Sani, S; Zamzuri, I; Kamarial, M; Jafri, A				Nujaimin, U.; Saufi, A.; Rahman, A. G.; Badrisyah, I; Sani, S.; Zamzuri, I; Kamarial, M.; Jafri, A.			Post Traumatic Cerebral Oedema in Severe Head Injury is Related to Intracranial Pressure and Cerebral Perfusion Pressure but not to Cerebral Compliance	ASIAN JOURNAL OF SURGERY			English	Article						cerebral oedema; severe head injury; intracranial pressure; cerebral perfusion pressure; cerebral compliance	SCAN; MANAGEMENT	This was a prospective cohort study, carried Out in the Neuro Intensive Care Unit, Department of Neurosciences, Hospital Universiti Sains Malaysia, Kubang Kerian Kelantan. The Study was approved by the local ethics committee and was conducted between November 2005 and September 2007 with a total of 30 patients included in the Study. In our study, univariate analysis showed a statistically significant relationship between mean intracranial pressure (ICP) as well as cerebral perfusion pressure (CPP) with both states of basal cistern and the degree of diffuse injury and oedema based on the Marshall classification system. The ICP was higher while CPP and compliance were lower whenever the basal cisterns were effaced in cases of cerebral oedema with Marshall III and IV. In comparison, the study revealed lower ICP, higher mean CPP and better mean cerebral compliance if the basal cisterns were opened or the post operative CT brain scan showed Marshall I and II. These Findings Suggested the surgical evacuation of clots to reduce the mass volume and. restoration of brain anatomy may reduce vascular engorgement and cerebral oedema, therefore preventing intracranial hypertension, and improving cerebral perfusion pressure and cerebral compliance. Nevertheless the study did not find any significant relationship between midline shifts and mean ICP, CPP or cerebral compliance even though lower ICP, higher CPP and compliance were frequently observed when the midline shift was less than 0.5 cm. As the majority of our patients had multiple and diffuse brain injuries, the absence of midline shift did not necessarily mean lower ICP as the pathology was bilateral and even when after excluding the multiple lesions, the result remained insignificant. We assumed that the CT brain scan obtained after evacuation of the mass lesion to assess the state basal cistern and classify the diffuse oedema may prognosticate the intracranial pressure and cerebral perfusion pressure thus assisting in the acute post operative management of severely head injured patients. Hence post operative CT brain scans may be done to verify the ICP and CPP readings postoperatively. Subsequently, withdrawal of sedation for neurological assessment after Surgery could be done if the CT brain scan showed an opened basal cistern and Marshall I and II coupled with ICP of less than 20 mmHg. [Asian J Surg 2009;32(3):157-62]	[Nujaimin, U.; Saufi, A.; Rahman, A. G.; Badrisyah, I; Sani, S.; Zamzuri, I; Kamarial, M.; Jafri, A.] Univ Sains Malaysia, Dept Neurosci, Dept Community Med, Kota Baharu 16150, Kelantan, Malaysia		Nujaimin, U (corresponding author), Univ Sains Malaysia, Dept Neurosci, Dept Community Med, Kota Baharu 16150, Kelantan, Malaysia.	deptneurosciencesppspusm@yahoo.com	Idris, Badrisyah/E-3201-2012; Idris, Badrisyah/C-8355-2016; Musa, Kamarul Imran/G-4864-2010; Musa, Kamarul Imran/N-3198-2015; Abdullah, J/C-2828-2011	Idris, Badrisyah/0000-0002-7753-7389; Idris, Badrisyah/0000-0002-7753-7389; Musa, Kamarul Imran/0000-0002-3708-0628; Abdullah, J/0000-0002-0258-7410			Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; DEARDEN NM, 1986, BRIT J HOSP MED, V36, P94; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KLAUBER MR, 1984, J NEUROSURG, V61, P695, DOI 10.3171/jns.1984.61.4.0695; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Wang D, 2004, J TRAUMA, V56, P972	18	4	5	0	2	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584	0219-3108		ASIAN J SURG	Asian J. Surg.	JUL	2009	32	3					157	162		10.1016/S1015-9584(09)60387-0			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	491DC	WOS:000269556600005	19656755	Bronze			2022-02-06	
J	Ottochian, M; Benfield, R; Inaba, K; Chan, LS; Demetriades, D				Ottochian, Marcus; Benfield, Rodd; Inaba, Kenji; Chan, Linda S.; Demetriades, Demetrios			Prospective Evaluation of a Predictive Model of Mortality in Patients With Isolated Head Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head trauma; Prediction; Survival; Mechanism of injury; Age; GCS; Head AIS	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; OUTCOME PREDICTION; SERUM; PRESSURE; S100B; SCORE; AGE	Background: In a previous retrospective study, we developed a predictive model of survival in isolated head injuries based on easily available parameters such as age, mechanism of injury, Glasgow Coma Scale, and head Abbreviated Injury Scale (AIS). The purpose of the present study is to prospectively evaluate this predictive model. Methods: Isolated head injuries admitted to a Level I urban trauma center were prospectively accrued from May 1, 2006 through April 30, 2007. Age, mechanism of injury, Glasgow Coma Scale, head AIS, and survival status were recorded for each patient. Patients with extracranial AIS >3, head AIS = 6, or hypotension were excluded. These data were entered into our previously developed predictive model and the percentage of correct classification was used to measure how well the predictive model predicted outcome. Sensitivity, specificity, positive and negative predictive values, and their 95% confidence intervals were calculated and compared with values obtained from our original, retrospective study. Results: Seven hundred eighty-six patients met the criteria for inclusion in the study with an overall mortality of 5.8% (46 patients). When entered into our predictive model, the percentage of correct classification rate was 92% compared with the 94% rate seen in the original study, which is better than other available predictive tools based on combined scoring systems such as the Trauma and Injury Severity Score methodology. Conclusion: When evaluated prospectively, our predictive model has similar accuracy in predicting survival of all patients with head trauma as our original retrospective study and performs better than other predictive models such as the Trauma and Injury Severity Score methodology. This study demonstrates that a simple table based on easily obtained admission patient characteristics can rapidly provide information about the probability of survival in patients with head injuries.	[Ottochian, Marcus; Benfield, Rodd; Inaba, Kenji; Chan, Linda S.; Demetriades, Demetrios] Univ So Calif, Med Ctr, Dept Surg, Div Trauma & Crit Care Los Angeles Cty, Los Angeles, CA USA		Demetriades, D (corresponding author), LAC USC Med Ctr, Dept Surg, Div Trauma & Crit Care, 1200 N State St,Impatient Tower,4th Floor,Room C4, Los Angeles, CA 90033 USA.	demetria@usc.edu	INABA, KENJI/AAC-8532-2020				Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Campbell LV, 2007, DIABETIC MED, V24, P1172, DOI 10.1111/j.1464-5491.2007.02261.x; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 1998, BRIT J SURG, V85, P379; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; Linn S, 2007, ANN EPIDEMIOL, V17, P142, DOI 10.1016/j.annepidem.2006.08.004; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Pillai SV, 2003, NEUROL INDIA, V51, P345; Valadka AB, 2004, J TRAUMA, V56, P489; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	26	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1					81	84		10.1097/TA.0b013e318188b934			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	470CZ	WOS:000267953100014	19590313				2022-02-06	
J	Rupich, K				Rupich, Kristin			The Use of Hypothermia as a Treatment for Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article							THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE	Hypothermia has been shown to have neuroprotective effects and may have benefit in the treatment of head injuries. However, it is a controversial treatment in traumatic brain injury, and to date, there are no specific recommendations for its use. This article examines six research studies investigating the use of hypothermia as a treatment in patients with traumatic brain injury. All studies were prospective trials and compared a controlled normothermia group with a hypothermia group. Studies were compared by sample population, methods of hypothermia, outcomes, and conclusions. The leading variable in each study was hypothermia. However, each study used a different method of cooling, goal temperature, and duration of cooling. Through the comparison of these studies, a recommendation for change in practice cannot be made. Nevertheless, there may be benefits to hypothermia in traumatic brain injury, and suggestions for future research are identified.	Hosp Univ Penn, Philadelphia, PA 19104 USA		Rupich, K (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	krupich@comcast.net					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; *CDCP, 2004, TRAUM BRAIN INJ TBI; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; FREEBORN K, 2004, TOPICS EMERGENCY MED, V26, P225; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; JENNETT B, 1975, LANCET, V1, P480; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; ODETTE HA, 2002, ARCH NEUROL-CHICAGO, V59, P1077; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Wright JE, 2005, CRIT CARE NURS Q, V28, P150, DOI 10.1097/00002727-200504000-00007	19	4	4	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2009	41	3					159	167		10.1097/JNN.0b013e3181a23ec1			9	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	516XK	WOS:000271576500006	19517766				2022-02-06	
J	Tsushima, WT; Tsushima, VG				Tsushima, William T.; Tsushima, Vincent G.			Comparison of MMPI-2 Validity Scales Among Compensation-Seeking Caucasian and Asian American Medical Patients	ASSESSMENT			English	Article						MMPI-2; validity scales; race; compensation-seeking	PERSONAL-INJURY LITIGANTS; TRAUMATIC BRAIN-INJURY; FAKE BAD SCALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC-INPATIENTS; SYMPTOM EXAGGERATION; LATENT STRUCTURE; HEAD-INJURY; BASE RATES; PERFORMANCE	Validity scales of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) are widely used for the detection of exaggerated psychological complaints, although little is known about the results of these scales with racial or ethnic minority individuals. Five validity scales derived from the MMPI-2, including the F Scale, the Back Infrequency Scale, the Symptom Validity Scale, the Infrequency-Psychopathology Scale, and the Dissimulation Scale-MMPI-2, were evaluated in 157 medical patients-109 Caucasian Americans and 48 Asian Americans. All patients were involved in personal injury litigation or seeking compensation for alleged psychological conditions. Analyses of variance (ANOVAs) conducted on the five validity scales revealed no significant group effects for race. The results were consistent with the limited available data on the MMPI-2 validity scales with minority group samples. Further research with other racial minorities, including relevant extra-test criteria for malingering, is encouraged.	[Tsushima, William T.] Straub Clin & Hosp, Honolulu, HI 96813 USA; [Tsushima, Vincent G.] Hawaii Pacific Univ, Honolulu, HI USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, 888 S King St, Honolulu, HI 96813 USA.	wtsushima@straub.net					Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Arbisi PA, 1998, PSYCHOL ASSESSMENT, V10, P221, DOI 10.1037/1040-3590.10.3.221; Arbisi PA, 2002, PSYCHOL ASSESSMENT, V14, P3, DOI 10.1037//1040-3590.14.1.3; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Butcher JN, 2003, ARCH CLIN NEUROPSYCH, V18, P473, DOI 10.1016/S0887-6177(02)00142-7; Carter RT, 2007, PROF PSYCHOL-RES PR, V38, P133, DOI 10.1037/0735-7028.38.2.133; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; CHEUNG FM, 1991, PSYCHOL ASSESSMENT, V3, P648, DOI DOI 10.1037/1040-3590.3.4.648; Dembe AE, 1998, INT J HEALTH SERV, V28, P227, DOI 10.2190/AHNQ-7D5R-4YN3-NX0F; DUALBA L, 1993, J CLIN PSYCHOL, V49, P913, DOI 10.1002/1097-4679(199311)49:6<913::AID-JCLP2270490619>3.0.CO;2-1; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; GOUGH HG, 1954, J CONSULT PSYCHOL, V18, P287; GREENE RL, 1987, J CONSULT CLIN PSYCH, V55, P497, DOI 10.1037/0022-006X.55.4.497; Hahn J, 2005, J PERS ASSESS, V85, P65, DOI 10.1207/s15327752jpa8501_06; Hall GCN, 1999, PSYCHOL ASSESSMENT, V11, P186, DOI 10.1037/1040-3590.11.2.186; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Keppel G., 1991, DESIGN ANAL RES HDB; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Rogers R., 1997, CLIN ASSESSMENT MALI; Rogers R., 1994, ASSESSMENT, V1, P227, DOI DOI 10.1177/107319119400100302; ROTHKE SE, 1994, ASSESSMENT, V2, P1; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Schwarz LR, 2006, CLIN NEUROPSYCHOL, V20, P741, DOI 10.1080/13854040590967054; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Smith DW, 1996, PSYCHOL ASSESSMENT, V8, P3, DOI 10.1037/1040-3590.8.1.3; Strong DR, 2006, PSYCHOL ASSESSMENT, V18, P250, DOI 10.1037/1040-3590.18.3.250; SUE D, 1987, J CONSULT CLIN PSYCH, V55, P479, DOI 10.1037/0022-006X.55.4.479; Sue S., 1996, INT ADAPTATIONS MMPI, P206; SUINN RM, 1987, EDUC PSYCHOL MEAS, V47, P401, DOI 10.1177/0013164487472012; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P541, DOI 10.1080/13854040590967135; Temple RO, 2003, CLIN NEUROPSYCHOL, V17, P402, DOI 10.1076/clin.17.3.402.18080; TSUSHIMA WT, 2002, ADV MEDICAL PSYCHOTH, V11, P1; *US CENS BUR, 2000, CENS 2000 DAT STAT H; Witztum E, 1996, MIL MED, V161, P225, DOI 10.1093/milmed/161.4.225; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	47	4	5	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	JUN	2009	16	2					159	164		10.1177/1073191108327695			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	444AS	WOS:000265952800003	19202125				2022-02-06	
J	Finnerty, F; Glynn, L; Dineen, B; Colfer, F; MacFarlane, A				Finnerty, Fionnuala; Glynn, Liam; Dineen, Brendan; Colfer, Finbarr; MacFarlane, Anne			A postal survey of data in general practice on the prevalence of Acquired Brain Injury (ABI) in patients aged 18-65 in one county in the west of Ireland	BMC FAMILY PRACTICE			English	Article							QUESTIONNAIRES; ADULTS	Background: Very little is known about the prevalence of acquired brain injury (ABI) in Ireland. ABI prevalence has previously been obtained from Belgian general practitioners using a postal survey. We attempted to ascertain the prevalence of ABI in County Mayo through a postal survey of all general practitioners in the county. The specific objectives of this project were to: 1. identify whether general practitioners are a. aware of patients with ABI aged 18-65 in their practices b. able to provide prevalence data on ABI in patients aged 18-65 c. able to provide data on age, gender and patient diagnosis 2. analyse prevalence of ABI from any available data from general practitioners. Methods: A pilot postal survey was performed initially in order to assess the feasibility of the study. It was established that general practitioners did have the necessary information required to complete the questionnaire. A main postal survey was then undertaken. A postal questionnaire was administered to all general practices in County Mayo in the west of Ireland (n = 59). The response rate was 32.2% (n = 19). Results: General practitioners who replied on behalf of their practice could provide data on patient age, gender and diagnosis. In the nineteen practices, there were 57 patients with ABI. The age-specific prevalence of ABI in the area surveyed was estimated at 183.7 per 100,000. The mean patient population per practice was 2,833 (SD = 950). There were found to be significantly more patients with ABI in rural areas than urban areas (p = 0.006). There were also significant differences in the ages of patients in the different ABI categories. Patients whose ABI was of traumatic origin were significantly younger than those patients with ABI of haemorrhagic origin (p = 0.002). Conclusion: Although this is a small-scale study, we have ascertained that general practitioners do have data on patients with ABI. Also, some prevalence data now exist where none was available before. These can be used to form the basis of a more substantial programme of university/community partnership research which could provide medical and psychosocial benefits for people with ABI and their families.	[Finnerty, Fionnuala; Glynn, Liam; Dineen, Brendan; MacFarlane, Anne] Natl Univ Ireland, Dept Gen Practice, Galway, Ireland; [Finnerty, Fionnuala] Sch Med, Dept Med & Social Care Educ, Leicester LE1 9HN, Leics, England; [Colfer, Finbarr] Acquired Brain Injury Ireland W Reg, Galway, Ireland		MacFarlane, A (corresponding author), Natl Univ Ireland, Dept Gen Practice, Galway, Ireland.	ff21@leicester.ac.uk; liam.glynn@nuigalway.ie; Brendan.dineen@nuigalway.ie; f.colfer@abiireland.ie; anne.macfarlane@nuigalway.ie	MacFarlane, Anne E/A-2861-2014; Glynn, Liam/C-1586-2009	MacFarlane, Anne E/0000-0002-9708-5025; Dineen, Brendan/0000-0002-9619-8044; Glynn, Liam/0000-0002-6153-9363	Centre for Excellence in Learning and Teaching; National University of Ireland, Galway	We acknowledge funding from the Health Research Board Summer Scholarship scheme for Fionnuala Finnerty July-August 2007. We also acknowledge funding support from the Centre for Excellence in Learning and Teaching, National University of Ireland, Galway.	*AUSTR I HLTH WELF, DEF INC PREV ACQ BRA; *BRAIN INJ ASS, DEF ABI; *DEP HLTH CHILDR E, 2007, ACT AC PUBL HOSP IR; Dillman DA., 2000, MAIL INTERNET SURVEY; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Forbes RB, 1999, AM J EPIDEMIOL, V149, P1016; *GOV IR CENTR STAT, 2007, CENS 2006 PRINC DEM, P12; *IR HEART FDN DEP, 2008, IR NAT AUD STROK CAR; JOHNSTONE B, 2007, DISABIL REHABIL, V28, P1; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Martyn CN, 1998, J NEUROL NEUROSUR PS, V64, P2, DOI 10.1136/jnnp.64.1.2; McAvoy BR, 1996, BRIT MED J, V313, P732; OBrien DP, 1996, IRISH MED J, V89, P216; Stocks N, 2000, J EPIDEMIOL COMMUN H, V54, P940, DOI 10.1136/jech.54.12.940; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; ACQUIRED BRAIN INJUR	17	4	4	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2296		BMC FAM PRACT	BMC Fam. Pract.	MAY 19	2009	10								36	10.1186/1471-2296-10-36			7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467RD	WOS:000267759200001	19454016	Green Published, gold			2022-02-06	
J	Zong, ZW; Xiang, Q; Cheng, TM; Dong, SW; Su, YP; Li, N; Ran, XZ; Shi, CM; Ai, GP				Zong, Zhao-Wen; Xiang, Qiang; Cheng, Tian-Min; Dong, Shi-Wu; Su, Yong-Ping; Li, Nan; Ran, Xin-Ze; Shi, Chun-Men; Ai, Guo-Ping			CXCR4 Gene Transfer Enhances The Distribution of Dermal Multipotent Stem Cells to Bone Marrow in Sublethally Irradiated Rats	JOURNAL OF RADIATION RESEARCH			English	Article						Irradiation; Dermal multipotent cells; CXC chemokine receptor 4; Gene transfer	TRAUMATIC BRAIN INJURY; STROMAL CELLS; THERAPEUTIC BENEFIT; CHEMOKINE RECEPTORS; CEREBRAL-ISCHEMIA; RECRUITMENT; MIGRATION; SDF-1; TRANSPLANTATION; EXPRESSION	Our previous study indicated that systemically transplanted dermal multipotent cells (DMCs) were recruited more frequently to bone morrow (BM) of rats with sublethal irradiation than that of normal rats, and the interactions between stromal-derived factor (SDF-1) and its receptor (CXC chemokine receptor 4, CXCR4) played an important role in this process. In the present study, we aimed to investigate whether CXCR4 gene transfer could promote the distribution of DMCs into irradiated BM and accelerate its function recovery. Firstly, adenovirus vector of CXCR4 (Adv-CXCR4) and green fluorescent protein (Adv-GFP) were constructed. Then male DMCs infected by Adv-CXCR4 (group A), or infected by Adv-GFP (group B), and non-infected DMCs (group C) were transplanted into irradiated female rats, and real-time polymerase chain reaction for the sex-determining region of Y chromosome was employed to determined the amount of DMCs in BM. The functional recovery of BM was examined by hematopoietic progenitor colonies assay. The results showed that the amount of DMCs in BM of group A was greater than that in group B and group C from day 5 after injury (P < 0.05), and the amount of CFU-F, CFU-E and CFU-GM were greater than that in group B and group C from day 14 after injury (P < 0.05). These findings suggest that DMCs infected by Adv-CXCR4 distributed more frequently to the bone marrow of sublethally irradiated rats and could accelerate hematopoiesis function recovery.	[Zong, Zhao-Wen; Cheng, Tian-Min; Dong, Shi-Wu; Su, Yong-Ping; Li, Nan; Ran, Xin-Ze; Shi, Chun-Men; Ai, Guo-Ping] Third Mil Med Univ, Sch Mil Prevent Med, State Key Lab Trauma Burns & Combined Injury, Inst Combined Injury, Chongqing 400038, Peoples R China; [Xiang, Qiang] Third Mil Med Univ, Southwestern Hosp, Dept Emergency, Chongqing 400038, Peoples R China		Zong, ZW (corresponding author), Third Mil Med Univ, Sch Mil Prevent Med, State Key Lab Trauma Burns & Combined Injury, Inst Combined Injury, Chongqing 400038, Peoples R China.	zongzhaowen2006@yahoo.com.cn			National Key Project "973" for Development of Basic ResearchNational Basic Research Program of China [2005CB522605]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30500141]; Research Foundation of Third Military Medical University [XG200509]	This study was supported by Special Fund for National Key Project "973" for Development of Basic Research (2005CB522605), National Science Foundation of China (30500141) and Research Foundation of Third Military Medical University (XG200509).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beider K, 2008, FRONT BIOSCI-LANDMRK, V13, P6820, DOI 10.2741/3190; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591; Kahn J, 2004, BLOOD, V103, P2942, DOI 10.1182/blood-2003-07-2607; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kryczek I, 2005, CANCER RES, V65, P465; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Reckamp KL, 2008, EXPERT REV ANTICANC, V8, P887, DOI 10.1586/14737140.8.6.887; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Seibert C, 2004, CURR PHARM DESIGN, V10, P2041, DOI 10.2174/1381612043384312; Shi CM, 2004, J RADIAT RES, V45, P19, DOI 10.1269/jrr.45.19; Viola A, 2008, FRONT BIOSCI, V13, P6341, DOI 10.2741/3158; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zhong RK, 2004, EXP HEMATOL, V32, P470, DOI 10.1016/j.exphem.2004.01.011; Zong ZW, 2006, J RADIAT RES, V47, P287, DOI 10.1269/jrr.0531	24	4	5	1	2	JAPAN RADIATION RESEARCH SOC	CHIBA	C/O NAT INST RADIOLOGICAL SCI 9-1 ANAGAWA-4-CHOME INAGE-KU, CHIBA, 263, JAPAN	0449-3060			J RADIAT RES	J. Radiat. Res.	MAY	2009	50	3					193	201		10.1269/jrr.08113			9	Biology; Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Oncology; Radiology, Nuclear Medicine & Medical Imaging	455EE	WOS:000266739500003	19531922	gold, Green Submitted			2022-02-06	
J	Lange, B; Spagnolo, K; Fowler, B				Lange, Bridget; Spagnolo, Karren; Fowler, Bess			Using the Assessment of Motor and Process Skills to measure functional change in adults with severe traumatic brain injury: A pilot study	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						ADL; AMPS; TBI; adult	IN-HOME; PERFORMANCE; SENSITIVITY; ABILITY	To measure functional change in 10 adults following severe traumatic brain injury using the Assessment of Motor and Process Skills (AMPS). This clinical pilot study used a standardised occupational therapy tool, the AMPS, to measure motor and process scores during activities of daily living, for over 3 weeks of inpatient rehabilitation. Wilcoxon signed ranks tests indicate significant improvement in motor and process scores from initial assessment to repeat evaluation (z = -2.70, p = 0.01; z = -2.81, P = 0.01, respectively). The AMPS measured statistically and clinically significant change in motor and process abilities over 3 weeks of neurosurgical rehabilitation. Findings suggest that the AMPS is a sensitive measure of functional change for the study sample and timeframe.	[Lange, Bridget; Spagnolo, Karren; Fowler, Bess] Royal Perth Hosp, Occupat Therapy Dept, Perth, WA, Australia		Lange, B (corresponding author), Royal Perth Hosp, Occupat Therapy Dept, 6 Selby St, Shenton Pk, WA 6008, Australia.	bridget.lange@optusnet.com.au			Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Royal Perth Hospital	The authors wish to acknowledge the support provided by the Royal Perth Hospital Occupational Therapy Department and the financial assistance of the Medical Research Foundation, Royal Perth Hospital. We would like to thank Ms Melissa Nott for her extensive, invaluable contributions and efforts throughout this research project and finally, Ms Helen Margaria and Ms Julie Brayshaw for their support and encouragement.	Bernardo JM, 1999, BAYESIAN STATISTICS 6, P101; BERNSPANG B, 1995, ARCH PHYS MED REHAB, V76, P1144, DOI 10.1016/S0003-9993(95)80124-3; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Darragh AR, 1998, ARCH PHYS MED REHAB, V79, P418, DOI 10.1016/S0003-9993(98)90143-5; Duran LJ, 1996, ARCH PHYS MED REHAB, V77, P1019, DOI 10.1016/S0003-9993(96)90062-3; Fisher AG, 2001, ASSESSMENT MOTOR PRO, VI; Fricke J, 1996, AUST OCCUP THER J, V44, P22; GIRARD C, 1999, SCANDINAVIAN J OCCUP, V6, P119; Hagen C., 1972, LEVELS COGNITIVE FUN; Hartman ML., 1999, SCAND J OCCUP THER, V6, P111; Hocking C, 1999, CLIN REHABIL, V13, P141, DOI 10.1191/026921599668105029; Imms C., 2006, AUSTR OCCUPATIONAL T, V53, P65; Jennett B, 1981, MANAGEMENT HEAD INJU; KIELHOFNER G., 1995, MODEL HUMAN OCCUPATI; Kottorp A, 2003, J INTELL DISABIL RES, V47, P597, DOI 10.1046/j.1365-2788.2003.00475.x; Law M., 2001, MEASURING OCCUPATION; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; LUNZ ME, 1990, EVAL HEALTH PROF, V13, P425, DOI 10.1177/016327879001300405; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Merritt BK, 2003, ARCH PHYS MED REHAB, V84, P1872, DOI 10.1016/S0003-9993(03)00483-0; NYGARD L, 1994, AM J OCCUP THER, V48, P689, DOI 10.5014/ajot.48.8.689; Oakley F, 1997, Int Psychogeriatr, V9, P197, DOI 10.1017/S1041610297004341; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Robinson S. E., 1996, BRIT J OCCUPATIONAL, V59, P260, DOI DOI 10.1177/030802269605900603; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; TEASDALE G, 1974, LANCET, V2, P81; *UN DAT SET MED RE, 1999, GUID UN DAT SET MED; *WHO, 2006, COMM LANG FUNCT DIS	28	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2009	56	2					89	96		10.1111/j.1440-1630.2007.00698.x			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	425AD	WOS:000264608500003	20854497				2022-02-06	
J	Benitez, CIP; Vicente, B; Zlotnick, C; Kohn, R; Johnson, J; Valdivia, S; Rioseco, P				Benitez, Carlos I. Perez; Vicente, Benjamin; Zlotnick, Caron; Kohn, Robert; Johnson, Jennifer; Valdivia, Sandra; Rioseco, Pedro			Epidemiology of trauma, PTSD and other psychiatric disorders in a representative population 145 of Chile	SALUD MENTAL			Spanish	Article						Post-traumatic stress disorder; trauma; psychiatric epidemiology; Hispanics; Latinos	POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; MENTAL-HEALTH; RISK-FACTORS; COMMUNITY; PREVALENCE; EVENTS; LIFETIME	In the lost decade, our understanding of posttraumatic stress disorder (PTSD) has progressed from studies of war veterans and specific disaster victims to studies that examine the epidemiology of PTSD in the United States (USA) population. Epidemiologic data on PTSD in developing countries is on understudied area with the majority of studies were developed in the USA and other developed countries. Of the few epidemiological surveys undertaken in other countries, most of them have focused its interest on the prevalence rates of PTSD and its risk factors for following specific traumatic events. Besides increasing the international normative and descriptive data base on PTSD, on examination of prevalence rates and risk factors for PTSD in a socio-political and cultural context (that is markedly different to established market economies) can deepen our understanding of the phenomenology and determinants of PTSD. Although many psychiatric diagnoses can be related with previous traumatic experiences, PTSD has been identified as a disorder that requires a previous traumatic exposure for its diagnosis. A growing literature strongly suggests that early exposure to traumatic events disrupts crucial normal stages of childhood development and predisposes children to subsequent psychiatric sequelae. A series of epidemiological studies has demonstrated that childhood sexual abuse is associated with a range of psychiatric disorders in adulthood that includes mood, anxiety, and substance use disorders, even after adjusting for possible confounds, such as family factors and parental psychopathological disorders or other childhood adversities. There is little evidence of diagnostic specificity of childhood sexual abuse, although a consistent finding has been that alcohol and drug disorders are more strongly related to childhood sexual abuse than other psychiatric disorders. Other forms of childhood traumas have been less well studied. This article reviews the findings of an epidemiological study that took place in Chile and examined prevalence rates of PTSD, traumatic events most often associated with PTSD, comorbidity of PTSD with other lifetime psychiatric disorders, gender differences in PTSD as well as trauma exposure in a representative sample of Chileans. This article also reported a comparison of prevalence rates of various psychiatric disorders among persons who reported the first trauma during their childhood, those who reported the first trauma during their adulthood, and those with no trauma history. The study was based on a household-stratified sample of people defined by the health service system to be adults (aged 15 years and older). The study was designed to represent the population of Chile. This analysis is limited to three geographically distinct provinces, chosen as being representative of the distribution of much of the population. The interviews were administered to a representative sample of 2390 persons aged 15 to over 64 years. The measures used were the DSM-III-R PTSD and antisocial personality disorder modules from the Diagnostic Interview Schedule and modules for a range of DSM-III-R diagnoses from the Composite International Diagnostic. Traumatic events were categorized into one of 11 categories: military combat, rape, physical assault, seeing someone hurt or killed, disaster, threat, narrow escape, sudden injury/accident, news of a sudden death or accident, other event (e.g. kidnapping, torture), or other experience. The translation into Spanish was conducted using the protocol outlined by the World Health Organization. The interviewers were all university students in their senior year studying social sciences. Taylor series linearization method was used to estimate the standard errors due to the sample design and the need for weighting. The analysis was conducted using procedures without replacement for non-respondents. The region, province, comuna, and district selected were used as the defined strata. Logistic regression with the corresponding 95% confidence interval was used to examine associations among PTSD, demographic risk factors, and trauma type. To examine whether the association between PTSD and gender could be explained by other risk factors, multivariate logistic regression analyses were also conducted. The first analysis found that the lifetime prevalence of PTSD was 4.4% (2.5% for men and 6.2% for women). Among the traumatic events, rape was most strongly associated with PTSD diagnosis. Among those exposed to traumas, women were significantly more likely to develop PTSD than men, after controlling for assaultive violence. The second analysis revealed that exposure to a lifetime trauma was associated with a higher probability of psychiatric morbidity in comparison with no trauma exposure. Traumas with childhood onset were significantly related to lifetime panic disorder, independent of number of lifetime traumas and demographic differences. This revealed that women had more probabilities than men of developing PTSD once they are exposed to trauma, independent of previous traumas, experiences of sexual assault, other violent experiences or level of education. Some authors have proposed that women have a higher vulnerability than men to develop PTSD and that there are sex differences in brain morphology, in the social interpretation of trauma, or/and in the peritraumatic dissociative experience. Although many theories have been proposed to explain this gender difference in PTSD, more research is needed to evaluate them empirically. This study highlights the importance of investigating the prevalence of PTSD, the patterns of comorbidity of PTSD, as well as gender differences of PTSD in non-English speaking countries. Although Chile has a different historical and socio-cultural context with respect to other countries in which the epidemiology of PTSD has been examined, in general, this study achieved similar results as those found in other studies. The results showed that PTSD is not an uncommon psychiatric illness, it is associated with a high degree of psychiatric comorbidity, it is more likely to predate other psychiatric disorders. Also, the results showed that men are more likely to be exposed to traumas than women, women are more likely than men to develop PTSD, and that PTSD is associated with relatively high treatment utilization. However, compared to another country in Latin America, such as Mexico, Chile has a lower prevalence of PTSD and trauma exposure, which may due to socio-economic factors, such as less inequity between the wealthy and the poor and less violence, crime, and poverty in Chile than Mexico. These studies also suggest that traumatic events that occur in childhood are related to specific disorders rather than those that occurred later in life. Individuals with childhood interpersonal trauma exposure are more likely to suffer from lifetime panic disorder, agoraphobia or PTSD compared to those who experience interpersonal trauma as an adult. However, research should examine the specificity of these disorders in relation to various types of childhood traumas. Limitations of the current study include the use of lay interviewers who, despite acceptable levels of reliability and validity, may be less accurate than clinicians as interviewers. Also the retrospective recall of lifetime disorders is likely to be less accurate than a more recent time frame. The sample used in this study does not show nation wide perspective, because the Southern portion of the country which includes much of the indigenous population was excluded. This study, like most epidemiological studies, did not use an-depth or validated index of trauma, which may have diluted findings. Since this study was cross-sectional, a direct cause-effect relationship cannot be assumed between trauma exposure and subsequent disorders.	[Benitez, Carlos I. Perez; Zlotnick, Caron; Kohn, Robert; Johnson, Jennifer] Brown Univ, Dept Psychiat & Human Behav, Brown Med School, Providence, RI 02912 USA; [Vicente, Benjamin; Valdivia, Sandra; Rioseco, Pedro] Univ Concepcion, Dept Psiquiatria & Salud Mental, Concepcion, Chile; [Zlotnick, Caron; Kohn, Robert] Butler Hosp, Providence, RI 02906 USA		Benitez, CIP (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Brown Med School, Box G-BH, Providence, RI 02912 USA.	carlos_perez-benitez@brown.edu	Vicente, Benjamin/R-2563-2019				Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bodvarsdottir I, 2004, SCAND J PSYCHOL, V45, P3, DOI 10.1111/j.1467-9450.2004.00373.x; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P81; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; BRESLAU N, 1995, AM J PSYCHIAT, V152, P529; Bromet E, 1998, AM J EPIDEMIOL, V147, P353; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Fullerton CS, 2001, AM J PSYCHIAT, V158, P1486, DOI 10.1176/appi.ajp.158.9.1486; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Icaza MEMM, 2005, SALUD PUBLICA MEXICO, V47, P8, DOI 10.1590/S0036-36342005000100004; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kish L, 1965, SURVEY SAMPLING; Kohn R, 2005, REV PANAM SALUD PUBL, V18, P287, DOI 10.1590/S1020-49892005000900009; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; MULLEN PE, 1993, BRIT J PSYCHIAT, V163, P721, DOI 10.1192/bjp.163.6.721; Norris FH, 2004, J TRAUMA STRESS, V17, P283, DOI 10.1023/B:JOTS.0000038476.87634.9b; Norris FH, 2003, J ABNORM PSYCHOL, V112, P646, DOI 10.1037/0021-843X.112.4.646; Norris FH, 2001, J TRAUMA STRESS, V14, P741, DOI 10.1023/A:1013042222084; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Saxe G, 1999, POSTTRAUMATIC STRESS DISORDER, P160; SHORE JH, 1989, J NERV MENT DIS, V177, P681, DOI 10.1097/00005053-198911000-00004; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; van der Kolk BA, 2005, PSYCHIAT ANN, V35, P374, DOI 10.3928/00485713-20050501-02; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; ZLOTNICK C, 2006, PSYCHOL MED, P1; Zlotnick C, 2008, COMPR PSYCHIAT, V49, P163, DOI 10.1016/j.comppsych.2007.08.007	34	4	4	2	71	INST NAC PSIQUIATRIA RAMON FUENTE MUNIZ	MEXICO CITY	CALZ MEXICO-XOCHIMILCO #101, MEXICO CITY 22 DF, MEXICO	0185-3325			SALUD MENT	Salud Ment.	MAR-APR	2009	32	2					145	153					9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	439HO	WOS:000265618400007					2022-02-06	
J	Ghajar, J				Ghajar, Jamshid			Essay: The Future of Traumatic Brain Injury	MOUNT SINAI JOURNAL OF MEDICINE			English	Article							GUIDELINES		[Ghajar, Jamshid] Weill Cornell Ctr, New York, NY USA; [Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA		Ghajar, J (corresponding author), Weill Cornell Med Coll, New York, NY USA.	ghajar@braintrauma.org					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cearnal L, 2006, ANN EMERG MED, V48, P726, DOI 10.1016/j.annemergmed.2006.10.010; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FRANCIS T, 2008, WALL STREET J H 0417; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074	14	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					190	193		10.1002/msj.20095			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427OE	WOS:000264787800012	19306384				2022-02-06	
J	Thomas, M; Tyers, P; Lazic, SE; Barker, RA; Beazley, L; Ziman, M				Thomas, Meghan; Tyers, Pam; Lazic, Stanley E.; Barker, Roger A.; Beazley, Lyn; Ziman, Mel			Graft outcomes influenced by co-expression of Pax7 in graft and host tissue	JOURNAL OF ANATOMY			English	Article						dorsal mesencephalon; master control gene; neurotransplantation; Pax7; superior colliculus	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; EXPRESSION; RAT; BRAIN; SURVIVAL; DIFFERENTIATION	Cell replacement therapies offer promise in the treatment of neurotrauma and neurodegenerative disorders and have concentrated on the use of primary fetal brain tissue. However, there is a growing promise of using neural stem cells, in which case other factors may be important in their successful engraftment. We therefore investigated whether the co-expression of the major developmental transcription factor (Pax7 in this study) of donor tissue to graft site influences transplant survival and differentiation in the rat midbrain. Neural progenitor cells were prepared from either the Pax7-expressing dorsal (DM) or non-Pax7-expressing ventral mesencephalon (VM) of embryonic EGFP(+/+) rats. Cells were dissociated and grafted into the adult rat superior colliculus (SC) lesioned with quinolinic acid 3 days previously, a time shown to be associated with the up-regulation of Pax7. Grafts were then examined 4 weeks later. Our results suggest the origin of the graft tissue did not alter graft survival in the SC; however, dorsal grafts appear to have a higher incidence of neuronal survival, whereas ventral grafts have a higher incidence of astrocytic survivors.	[Thomas, Meghan; Ziman, Mel] Univ Western Australia, Sch Surg & Pathol, Perth, WA 6009, Australia; [Thomas, Meghan; Beazley, Lyn] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Tyers, Pam; Lazic, Stanley E.; Barker, Roger A.] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Beazley, Lyn] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia			m.thomas@ecu.edu.au	Lazic, Stanley/F-1160-2011	Caldwell, Maeve/0000-0001-7442-711X; Ziman, Mel/0000-0001-7527-3538; Thomas, Meghan/0000-0003-4374-1039; Barker, Roger Alistair/0000-0001-8843-7730	ARCAustralian Research Council [DP0772899]; Neurotrauma Research Program; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0300723B] Funding Source: researchfish	The authors would like to express their deep gratitude to Prof. Seong-Seng Tan for his expert advice and editorial assistance, and to Dr Maeve Caldwell for her expert assistance in the preparation of donor cells. The Pax7 monoclonal antibody developed by A. Kawakami was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242, USA. This work was funded by the ARC (Discovery Project DP0772899) and Neurotrauma Research Program.	Barker R A, 2000, Expert Opin Pharmacother, V1, P889, DOI 10.1517/14656566.1.5.889; Barker RA, 1999, NAT NEUROSCI, V2, P1047, DOI 10.1038/15969; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hall AC, 2003, GLIA, V43, P47, DOI 10.1002/glia.10229; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Hurelbrink CB, 2005, EUR J NEUROSCI, V21, P1503, DOI 10.1111/j.1460-9568.2005.03963.x; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Johann V, 2007, EXP BRAIN RES, V177, P458, DOI 10.1007/s00221-006-0689-y; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Lindvall O, 2005, KIDNEY INT, V68, P1937, DOI 10.1111/j.1523-1755.2005.00623.x; Lindvall Olle, 2004, NeuroRx, V1, P382; Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503; Lyng GD, 2007, BRAIN RES, V1133, P1, DOI 10.1016/j.brainres.2006.11.053; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Matsunaga E, 2001, DEVELOPMENT, V128, P4069; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Nomura T, 1998, DEV GROWTH DIFFER, V40, P485; Ojeda V, 2003, J NEUROSCI RES, V73, P686, DOI 10.1002/jnr.10705; Ostenfeld T, 1999, NEUROREPORT, V10, P1985, DOI 10.1097/00001756-199906230-00035; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Paxinos G., 1998, RAT BRAIN STEREOTAXI; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Thomas M, 2004, EXP BRAIN RES, V156, P263, DOI 10.1007/s00221-003-1775-z; Thomas MG, 2007, NEUROREPORT, V18, P105, DOI 10.1097/WNR.0b013e328010ff29; Thompson JA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-62; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Ziman MR, 2001, EXP CELL RES, V268, P220, DOI 10.1006/excr.2001.5282	43	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	MAR	2009	214	3					396	405		10.1111/j.1469-7580.2009.01049.x			10	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	412AY	WOS:000263696800010	19245506	Bronze, Green Published			2022-02-06	
J	Mulvey, JM; Renshaw, GMC				Mulvey, Jamin M.; Renshaw, Gillian M. C.			GABA is not elevated during neuroprotective neuronal depression in the hypoxic epaulette shark (Hemiscyllium ocellatum)	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY			English	Article						GABA; Hypoxia; Hypoxic preconditioning; Ischaemia; Metabolic depression; Neuroprotection; Stroke; Traumatic brain injury	CARP CARASSIUS-CARASSIUS; TURTLE BRAIN; METABOLIC DEPRESSION; ANOXIC SURVIVAL; ENERGY STATUS; NEUROTRANSMITTERS; TOLERANCE; STEM; RELEASE	Prolonged hypoxic exposure results in cell failure, glutamate excitotoxicity and apoptosis in the brain. The epaulette shark can withstand prolonged hypoxic exposure without brain injury, while maintaining normal function and activity at tropical temperatures. We examined whether the inhibitory neurotransmitter GABA was involved in hypoxia tolerance and neuroprotection during hypoxic preconditioning. Sharks were exposed to either cyclic hypoxic preconditioning or normoxic conditions. Whole brain GABA concentration was determined using high performance liquid chromatography: GABA distribution in neuronal structures was localised with immunohistochemistry and quantified. While the overall brain level of GABA was not significantly different, there was a significant heterogeneous change in GABA distribution. GABA immunoreactivity was elevated in key motor and sensory nuclei from preconditioned animals, including the nucleus motorius nervi vagi and the cerebellar crest (p < 0.001), corresponding to areas of previously reported neuronal hypometabolism. Since the neuroprotection in all other hypoxia and anoxia tolerant species examined so far relies in part on significant elevations in GABA and the phylogenetically older epaulette shark does not, it is reasonable to assume that further research in this unique animal model may yield clues to new key modulators of neuroprotection. Understanding such mechanisms may facilitate the development of therapeutic interventions in the treatment of transient ischaemic attacks, strokes and traumatic brain injury. (C) 2008 Elsevier Inc. All rights reserved.	[Mulvey, Jamin M.] Logan Hosp, Dept Anaesthesia, Loganholme, Qld 4129, Australia; [Mulvey, Jamin M.; Renshaw, Gillian M. C.] Griffith Univ, Hypoxia & Ischemia Res Unit, Heart Fdn, Res Ctr, Brisbane, Qld 4222, Australia; [Mulvey, Jamin M.; Renshaw, Gillian M. C.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Brisbane, Qld 4222, Australia		Mulvey, JM (corresponding author), Logan Hosp, Dept Anaesthesia, POB 4096, Loganholme, Qld 4129, Australia.	jmulvey@ausdoctors.net			Sea World Research and Rescue Foundation	We thank Dr. Michelle Cronin and the staff at the Heron Island Research Station for facilitating fieldwork. We thank Dr. David Pow for the supply of GABA antibody. The project was funded through the Sea World Research and Rescue Foundation.	BLAZKA P., 1958, PHYSIOL ZOOL, V31, P117; HADDAD GG, 1993, BRAIN RES, V625, P261, DOI 10.1016/0006-8993(93)91067-3; Hylland P, 1999, BRAIN RES, V823, P49, DOI 10.1016/S0006-8993(99)01096-3; KAUPPINEN RA, 1988, NEUROSCIENCE, V27, P175, DOI 10.1016/0306-4522(88)90228-X; Lutz P.L., 2003, BRAIN OXYGEN CAUSES; LUTZ PL, 1985, MOL PHYSIOL, V8, P411; Lutz PL, 2004, RESP PHYSIOL NEUROBI, V141, P285, DOI 10.1016/j.resp.2004.03.013; Lutz PL, 1997, J EXP BIOL, V200, P411; LUTZ PL, 1985, AM J PHYSIOL, V249, pR372, DOI 10.1152/ajpregu.1985.249.3.R372; Mulvey JM, 2000, NEUROSCI LETT, V290, P1, DOI 10.1016/S0304-3940(00)01321-5; NILSSON GE, 1993, COMP BIOCHEM PHYS C, V105, P329, DOI 10.1016/0742-8413(93)90069-W; NILSSON GE, 1991, AM J PHYSIOL, V261, pR32, DOI 10.1152/ajpregu.1991.261.1.R32; Nilsson GE, 2004, P ROY SOC B-BIOL SCI, V271, pS30, DOI 10.1098/rsbl.2003.0087; NILSSON GE, 1992, J EXP BIOL, V164, P243; NILSSON GE, 1990, AM J PHYSIOL, V259, pR376, DOI 10.1152/ajpregu.1990.259.2.R376; NILSSON GE, 1991, PHYSIOL ZOOL, V64, P638, DOI 10.1086/physzool.64.3.30158198; PIIRONEN J, 1986, ANN ZOOL FENN, V23, P335; Renshaw GMC, 1999, NEUROREPORT, V10, P1707; Renshaw GMC, 2002, COMP BIOCHEM PHYS B, V131, P133, DOI 10.1016/S1096-4959(01)00484-5; Routley MH, 2002, COMP BIOCHEM PHYS A, V131, P313, DOI 10.1016/S1095-6433(01)00484-6; SMEETS WJAJ, 1976, J COMP NEUROL, V165, P333, DOI 10.1002/cne.901650305; Smeets WJAJ., 1983, CENTRAL NERVOUS SYST; Soderstrom V, 1999, J EXP BIOL, V202, P829; vanGinneken V, 1996, COMP BIOCHEM PHYS A, V114, P189, DOI 10.1016/0300-9629(95)02127-2; Wise G, 1998, J EXP ZOOL, V281, P1, DOI 10.1002/(SICI)1097-010X(19980501)281:1<1::AID-JEZ1>3.0.CO;2-S	25	4	4	2	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1095-6433			COMP BIOCHEM PHYS A	Comp. Biochem. Physiol. A-Mol. Integr. Physiol.	FEB	2009	152	2					273	277		10.1016/j.cbpa.2008.10.017			5	Biochemistry & Molecular Biology; Physiology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Physiology; Zoology	400MU	WOS:000262873100022	19010436				2022-02-06	
J	Lopez, EA; Aznarez, SB; Fernandez, MC				Alted Lopez, Emilio; Bermejo Aznarez, Susana; Chico Fernandez, Mario			UPDATES OF SEVERE TRAUMATIC BRAIN INJURY MANAGEMENT	MEDICINA INTENSIVA			Spanish	Article						Traumatic brain injury; Epidemiology; Pathophysiology; Hypnotics and sedatives; Neuroprotection; Intracranial hypertension; Outcome	SEVERE HEAD-INJURY; MILD HYPOTHERMIA THERAPY; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; NEUROCRITICAL CARE; SODIUM-CHLORIDE; PRESSURE; MANNITOL; HYPERVENTILATION; MODERATE	Traumatic brain injury (TBI) is an important reason of morbidity-mortality all over the world, affecting young males more and generating Public Health problem. Unfortunately, the advances in the pathophysiology knowledge have not followed a similar development in therapeutic options, there currently not being any contrasted neuroprotectants. In this article, we have reviewed the epidemiology, pathophysiology and therapeutic measures used in the management of patient with severe TBI. The general measures as well as those aimed at controlling intracranial hypertension, the role of the surgery and some more innovative therapeutic options currently under evaluation in these patients are analyzed.	[Alted Lopez, Emilio; Bermejo Aznarez, Susana; Chico Fernandez, Mario] Hosp Univ 12 Octubre, UCI Trauma, Serv Med Intens, Madrid, Spain		Lopez, EA (corresponding author), Avda Cordoba S-N, Madrid 28041, Spain.	ealted.hdoc@salud.madrid.org					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Alted E, 2006, ACTUALIZACION MANEJO, P167; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Citerio Giuseppe, 2003, Curr Opin Crit Care, V9, P120, DOI 10.1097/00075198-200304000-00007; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Corbett SM, 2006, CRIT CARE MED, V34, P2479, DOI 10.1097/01.CCM.0000230238.72846.B3; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2007, CURR OPIN CRIT CARE, V13, P156, DOI 10.1097/MCC.0b013e32807f2aa5; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munch EC, 2001, CRIT CARE MED, V29, P976; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; ROBERTS I, 2007, BIBLIOTECA COCHRANE; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	61	4	4	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JAN-FEB	2009	33	1					16	30					15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642GD	WOS:000281191800003					2022-02-06	
J	Bayramoglu, A; Demiryurek, D; Firat, A; Oznur, A; Ozsoy, MH				Bayramoglu, Alp; Demiryurek, Deniz; Firat, Ayseguel; Oznur, Ali; Ozsoy, M. Hakan			Differential diagnosis in an professional basketball player with foot pain: is it an avulsion fracture or an os supranaviculare?	EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY			English	Article						Talus fracture; os supranaviculare; Pirie's bone; basketball player	SNOWBOARDING INJURIES; ANKLE; TALUS	The os supranaviculare is an accessory bone located on the dorsal aspect of the talonavicular joint close to the midpoint. This rare incidental skeletal variant has an estimated prevalence of 1%. It may rarely become symptomatic and should not be confused with cortical avulsion fractures of navicular or talar head. We present the case of a 25-year-old professional basketball player with pain on the dorsum of his right foot after twisting his ankle during a regular season match. Magnetic resonance imaging findings of the player's foot represented a flake of bone on the superior part of the talar head. The differential diagnosis and clinical outcome of this unusual case are briefly discussed.	[Bayramoglu, Alp; Demiryurek, Deniz; Firat, Ayseguel] Hacettepe Univ, Tip Fak, Anat Anabilim Dali, TR-06100 Ankara, Turkey; [Oznur, Ali] Ankara Guven Hosp, Dept Orthoped & Traumatol, Ankara, Turkey; [Ozsoy, M. Hakan] Ankara Numune Training & Res Hosp, Dept Orthoped & Traumatol 1, Ankara, Turkey		Bayramoglu, A (corresponding author), Hacettepe Univ, Tip Fak, Anat Anabilim Dali, TR-06100 Ankara, Turkey.	abayramo@hacettepe.edu.tr	FIRAT, AYSEGUL/I-8353-2013; DEMIRYUREK, MEHMET/I-8347-2013; Bayramoglu, Alp/W-9766-2018	Bayramoglu, Alp/0000-0002-2801-5293			BLADIN C, 1995, SPORTS MED, V19, P358, DOI 10.2165/00007256-199519050-00005; COLTART WD, 1952, J BONE JOINT SURG BR, V34, P545, DOI 10.1302/0301-620X.34B4.545; GOTTLIEB C, 1950, RADIOLOGY, V55, P423, DOI 10.1148/55.3.423; HECKMAN JD, 1985, CLIN ORTHOP RELAT R, P108; KARASICK D, 1994, SEMIN ROENTGENOL, V29, P152, DOI 10.1016/S0037-198X(05)80062-8; Keats TE., 1992, ATLAS NORMAL ROENTGE, P615; Kenwright J, 1970, J Bone Joint Surg Br, V52, P36; Kirkpatrick DP, 1998, AM J SPORT MED, V26, P271, DOI 10.1177/03635465980260021901; Mellado JM, 2003, EUR RADIOL, V13, pL164, DOI 10.1007/s00330-003-2011-8; Ribbans WJ, 2005, CLIN ORTHOP RELAT R, P107, DOI 10.1097/01.blo.000156451.40395.fc; SANTAVIRTA S, 1984, J TRAUMA, V24, P986, DOI 10.1097/00005373-198411000-00011; Sarrafian SK, 1993, ANATOMY FOOT ANKLE, P89; Tsuruta T, 1981, Nihon Seikeigeka Gakkai Zasshi, V55, P357; Young CC, 1999, AM FAM PHYSICIAN, V59, P131	14	4	4	1	4	TURKISH JOINT DISEASES FOUNDATION	KAVAKLIDERE	BUGDAY SOKAK 6-27, KAVAKLIDERE, ANKARA 06700, TURKEY	1305-8282	1309-0313		EKLEM HAST CERRAHISI	Eklem Hast. Cerrahisi		2009	20	1					59	61					3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	437KB	WOS:000265485300010	19522693				2022-02-06	
J	Carlesimo, GA; Formisano, R; Bivona, U; Barba, L; Caltagirone, C				Carlesimo, Giovanni A.; Formisano, Rita; Bivona, Umberto; Barba, Lina; Caltagirone, Carlo			Prospective memory in patients with severe closed-head injury: Role of concurrent activity and encoding instructions	BEHAVIOURAL NEUROLOGY			English	Article						Prospective memory; head trauma; attention; encoding	TRAUMATIC BRAIN-INJURY; IMPAIRMENT; EVENT; INDIVIDUALS; PERFORMANCE; DISEASE	Objectives: To assess the sensitivity of patients who suffered a severe closed-head injury to the manipulation of attentional resources and encoding instructions during the execution of prospective memory tasks. Material and Methods: A group of patients with chronic sequelae of severe closed-head injury and a group of matched normal controls were given an experimental procedure for the assessment of time-based and event-based prospective memory. Availability of attentional resources at the time of intention recall and encoding conditions at the time of giving instructions were varied across experimental sessions. Results: The simultaneous execution of a concurrent task was more detrimental to accuracy in the spontaneous recall of the prospective intention in the post-traumatic than in the normal control group. Moreover, the instruction to encode more extensively by rehearsing aloud and mentally imaging the actions to be performed at the time of the study improved recall accuracy more in the post-traumatic than in the normal control group. Conclusions: Based on these data, we suggest that a prospective memory deficit in post-traumatic patients is due, among other things, to reduced availability of attentional resources and to poor encoding of actions to be performed.	[Carlesimo, Giovanni A.; Formisano, Rita; Bivona, Umberto; Barba, Lina; Caltagirone, Carlo] Fdn IRCCS S Lucia, I-00179 Rome, Italy; [Carlesimo, Giovanni A.; Caltagirone, Carlo] Univ Roma Tor Vergata, Neurol Clin, Rome, Italy		Carlesimo, GA (corresponding author), Fdn IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.	memolab@hsantalucia.it	Caltagirone, Carlo/B-4930-2013		Italian Minister for University and ResearchMinistry of Education, Universities and Research (MIUR)	This research was supported by a grant from the Italian Minister for University and Research - COFIN 2005.	Adams JH, 1990, HDB CLIN NEUROLOGY, P43; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Carlesimo G, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carlesimo GA, 2003, J CLIN EXP NEUROPSYC, V25, P391, DOI 10.1076/jcen.25.3.391.13810; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Nocentini U, 2002, NEUROLOGIA, V12, P15; Otani H, 1997, MEMORY, V5, P343, DOI 10.1080/741941393; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; TEASDALE G, 1974, LANCET, V2, P81; Umeda S, 2006, REV NEUROSCIENCE, V17, P267	29	4	4	0	8	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2009	22	3-4					101	110		10.3233/BEN-2009-0251			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	629PG	WOS:000280211600004	20595742				2022-02-06	
S	Chen, AS; Springer, JE		Ottens, AK; Wang, KKW		Chen, Anshu; Springer, Joe E.			Neuroproteomic Methods in Spinal Cord Injury	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Spinal cord injury; Contusion; 2D gel electrophoresis; Rat	TRAUMATIC BRAIN-INJURY; CELL-DEATH; CONTUSION; REGENERATION; TECHNOLOGY; PROTEOMICS; NIM811; RAT	Spinal cord injury (SCI) is a major public health problem with no known effective treatment. Traumatic injury to the spinal cord initiates a host of pathophysiological events that are secondary to the initial insult leading to neuronal dysfunction and death; yet, the molecular mechanisms underlying its dysfunction are poorly understood. Furthermore, while use of imaging methods (e.g., computed tomography scans and magnetic resonance imaging) may help define injury severity and location, they do not elucidate biological mechanisms of SCI progression. The lack of comparable biomarkers for monitoring SCI makes accurate diagnosis and evaluation of SCI progression difficult. Spinal cord contusion is an extensively used SCI model in rats that best represents the etiology of SCI in humans. In this chapter, we describe a two-dimensional (2D) gel electrophoresis-based proteomic approach to investigate the injury-related differences in the proteome and phosphoproteome of spinal cord lesion epicenter at 24 h after spinal cord contusion in rats. The purpose of this study is to elucidate the mechanisms of acute spinal cord dysfunction, as well as discover novel biomarker candidates to evaluate the biological mechanisms of SCI progression and the injury severity.	[Chen, Anshu; Springer, Joe E.] Univ Kentucky, Dept Phys Med & Rehabil, Med Ctr, Lexington, KY 40536 USA; [Chen, Anshu; Springer, Joe E.] Univ Kentucky, Dept Anat & Neurobiol, Med Ctr, Lexington, KY USA; [Chen, Anshu; Springer, Joe E.] Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA		Chen, AS (corresponding author), Univ Kentucky, Dept Phys Med & Rehabil, Med Ctr, Lexington, KY 40536 USA.						Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215	17	4	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						57	67		10.1007/978-1-59745-562-6_4	10.1007/978-1-59745-562-6		11	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600004					2022-02-06	
B	Critchley, G; Memon, A		Whitfield, PC; Thomas, EO; Summers, F; Whyte, M; Hutchinson, PJ		Critchley, Giles; Memon, Anjum			Epidemiology of head injury	HEAD INJURY: A MULTIDISCIPLINARY APPROACH			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PEOPLE		[Critchley, Giles] Brighton & Sussex Univ Hosp NHS Trust, Hurstwood Pk Neurol Ctr, Haywards Heath, England; [Memon, Anjum] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England; [Memon, Anjum] Brighton & Hove City Teaching PCT, Brighton, E Sussex, England		Critchley, G (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Hurstwood Pk Neurol Ctr, Haywards Heath, England.			Memon, Anjum/0000-0001-8256-3015			Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Bellner J, 2003, J NEUROL NEUROSUR PS, V74, P351, DOI 10.1136/jnnp.74.3.351; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P369; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clarke K, 2000, NEUROLOGIC ATHLETIC; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; *DEP HLTH, 2000, HOSP EP STAT; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gillespie L, 2004, BMJ-BRIT MED J, V328, P653, DOI 10.1136/bmj.328.7441.653; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Jordan B, 2000, NEUROLOGIC ATHLETIC; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Murray CJL, 1996, GLOBAL HLTH STAT; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US R; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; SBNS Working Party, 2000, SAF NEUR 2000, P35; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; WHO, 2004, WORLD REP ROAD TRAFF; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	34	4	4	0	4	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-69762-0				2009							1	11			10.1017/CBO9780511576515		11	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BFF00	WOS:000319565700002					2022-02-06	
J	Elwatidy, S				Elwatidy, Sherif			Bifrontal decompressive craniectomy is a life-saving procedure for patients with nontraumatic refractory brain edema	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Brain oedema; CNS infection; cerebral aneurysm; brain tumour; decompressive craniectomy	MIDDLE CEREBRAL-ARTERY; INTRACRANIAL HYPERTENSION; HEAD-INJURY; CRANIOTOMY; INFARCTION; SURGERY; MANAGEMENT; ANEURYSM	Despite advances in understanding, monitoring, and treatment, the outcome of patients with refractory brain oedema (RBE) remains poor. The concept of wide bone removal for treatment of RBE has been recognized since the nineteenth century. Bifrontal decompressive craniectomy (BDC) is performed as last resort treatment for patients with posttraumatic RBE. In this series the author treated 5 adult patients with non traumatic RBE using BDC. This is a retrospective review of all patients who developed RBE and herniation syndrome, all of them deteriorated to GCS 4-5/15 and had their pupils were dilated and fixed and had surgery after trial of medical management (mannitol and hyperventilation). The primary pathology was aneurysmal SAH in 2 patients, CNS infection in 2 patients, and one large calcified olfactory groove meningioma. The follow-up ranged from 6 months to 7 years, mean 3.9; there were no complications related to bone flap, no mortality or vegetative patients, one patient (20%) had good outcome, 2 patients (40%) had moderate disability (independent), and 2 patients (40%) had severe disability (dependent). BDC is an effective method of surgical decompression in patients with RBE; the procedure should be performed quickly after clinical deterioration to prevent irreversible secondary brain damage. Although difficult to accomplish, a randomized clinical trial is necessary to define criteria for surgical interference in patients with nontraumatic RBE.	King Saud Univ, King Khalid Univ Hosp, Coll Med, Div Neurosurg, Riyadh 11472, Saudi Arabia		Elwatidy, S (corresponding author), King Saud Univ, King Khalid Univ Hosp, Coll Med, Div Neurosurg, POB 7805 37, Riyadh 11472, Saudi Arabia.	smfwat@yahoo.com					Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; El-Watidy S, 2005, PEDIATR NEUROSURG, V41, P151, DOI 10.1159/000085874; ELWATIDY S, 2004, INTERNET J ANAESTHIO, V8; Elwatidy S, 2006, NEUROSCIENCES, V11, P241; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JAEGER M, 2006, P 57 ANN M GERM SOC; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1997, NEUROSURGERY, V41, P92; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Miyazaki Y, 1966, Shujutsu, V20, P845; Ong YK, 2002, CHILD NERV SYST, V18, P340, DOI 10.1007/s00381-002-0597-9; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rosenorn J, 1987, Br J Neurosurg, V1, P33, DOI 10.3109/02688698709034339; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; TAYLOR B, 1991, BRIT J NEUROSURG, V5, P591, DOI 10.3109/02688699109002882; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; ZEIDMAN SM, 1995, NEUROSURGERY, V36, P189, DOI 10.1227/00006123-199501000-00026	27	4	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	1					56	62	PII 908931842	10.1080/02688690802571094			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	411II	WOS:000263642600010	19234910				2022-02-06	
J	Jian, X; Wang, JY; Liu, JF				Jian, Xi; Wang Junyu; Liu Jinfang			Post-traumatic mutism in children	BRAIN INJURY			English	Article						Children; brain injury; mutism; SPECT; brain region; ischaemia		Objective: To explore the pathological mechanism of post-traumatic mutism (PTM) in children. Methods: A retrospective study of 16 children who suffered from severe head injury and developed PTM. Results: Post-traumatic coma lasted from 2-72 days, average 15.5 days; while post-traumatic mutism lasted from 2-56 days, average 11.94 days. The correlation between duration of coma and mutism was significant (p 0.001). SPECT found that multiple persistent ischaemic brain regions occurred in all patients; the mean number of regions was 5.6. The patients were sub-divided into three groups based on the number of ischaemic regions: group 1, 4; group 2, 5 6; group 3, 7. The duration of mutism did not differ significantly between groups 1 and 2, but the difference between group 3 and the other two groups combined was significant (p 0.05). Conclusion: Most PTM occurred in patients with diffuse brain injury. The duration of mutism was related to the number of ischaemic brain regions and the duration of post-traumatic coma.	[Jian, Xi; Wang Junyu; Liu Jinfang] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China		Wang, JY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China.	wjy5907@yahoo.com.cn					Bramanti P, 1994, J Neurosurg Sci, V38, P117; Dayer A, 1998, Eur J Paediatr Neurol, V2, P109, DOI 10.1016/S1090-3798(98)80026-3; FERRARA VL, 1985, SURG NEUROL, V23, P573, DOI 10.1016/0090-3019(85)90005-9; Gaillard WD, 2000, NEUROLOGY, V54, P180, DOI 10.1212/WNL.54.1.180; Grippo J, 2001, REV NEUROLOGIA, V32, P244, DOI 10.33588/rn.3203.2000376; Koh S, 1997, PEDIATR NEUROL, V16, P218, DOI 10.1016/S0887-8994(97)00018-0; LEVIN HS, 1983, ARCH NEUROL-CHICAGO, V40, P601, DOI 10.1001/archneur.1983.04050090037004; NAKASU Y, 1991, ACTA NEUROCHIR, V110, P146, DOI 10.1007/BF01400683; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; STEVEN GO, 2003, J NEUROSURG, V98, P465; WANG J, 2001, CHINESE J TRAUMATOLO, V17, P26; Wang YJ, 2005, J PROTEOME RES, V4, P36, DOI 10.1021/pr049876l; Wood AG, 2004, NEUROLOGY, V63, P1035, DOI 10.1212/01.WNL.0000140707.61952.CA	13	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	5					445	449	PII 910864400	10.1080/02699050902838157			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439NL	WOS:000265633700008	19408166				2022-02-06	
J	Judd, T; DeBoard, R				Judd, Tedd; DeBoard, Roberta			Community-based neuropsychological rehabilitation in the cosmopolitan setting	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Community-based rehabilitation; Neuropsychological rehabilitation; Person-centered planning; Traumatic brain injury; Disability accommodation	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; SUPPORTED EMPLOYMENT; INTEGRATION PROGRAMS; RANDOMIZED-TRIAL; DISABILITIES; PEOPLE; WORK; WORKPLACE; RETURN	In the developed, urban world, professional neuropsychological rehabilitation services have increasingly tried to move into the community to facilitate community integration, acceptance of rehabilitation, acceptance of the person with disabilities in the community, and the generalisation of cognitive, emotional, and social skills. This promising trend has only partially realised its goals. In the developing, rural world, rehabilitation has worked directly with community resources towards similar goals through the World Health Organization's community-based rehabilitation model, but with limited focus on neuropsychological disabilities (Judd & DeBoard, 2007). We have previously proposed a neuropsychological extension of this model. We now propose a blending of these trends to address developed, urban community needs with respect to people with neuropsychological disabilities. The approach involves expanding objectives, funding, training, and research measures to address community change. Techniques include: (1) involvement of community members (including people with disabilities) in planning, decision-making, and evaluation of programmes; (2) discovering and using available community resources; (3) teaching community members about disabilities, rights, and attitudes and training them in rehabilitation and advocacy skills; and (4) coordination between rehabilitation, education, social, vocational, and other community resources.	[Judd, Tedd] Seattle Pacific Univ, Seattle, WA 98119 USA		Judd, T (corresponding author), 12 Bellwether Way,Suite 223, Bellingham, WA 98225 USA.	t.judd@comcast.net					Barnes MP, 2001, J REHABIL MED, V33, P244; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BRAGA LW, 2006, CHILD TRAUMATIC BRAI; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; Condeluci A., 1999, ESSENCE INTERDEPENDE; Crishna B, 1999, CHILD CARE HLTH DEV, V25, P27, DOI 10.1046/j.1365-2214.1999.00087.x; Crisp R, 2005, J REHABIL, V71, P30; Freeman EA, 1997, BRAIN INJURY, V11, P143, DOI 10.1080/026990597123746; Giaquinto S, 2007, DISABIL REHABIL, V29, P1313, DOI 10.1080/09638280701415282; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Glenn MB, 2005, BRAIN INJURY, V19, P1243, DOI 10.1080/02699050500309460; Glenn MB, 2004, J HEAD TRAUMA REHAB, V19, P482, DOI 10.1097/00001199-200411000-00005; Helander Einar, 1989, TRAINING COMMUNITY P; Holburn S, 1998, MENT RETARD, V36, P485, DOI 10.1352/0047-6765(1998)036<0485:HPPBTA>2.0.CO;2; Inthirat TRS, 1999, DISABIL REHABIL, V21, P469; JUDD T, 2007, INT HDB CROSS CULTUR; Judd T, 1999, NEUROPSYCHOTHERAPY C; Kassah AK, 1998, DISABIL REHABIL, V20, P66, DOI 10.3109/09638289809166056; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; KUIPERS P, 2004, INT ELECT J RURAL RE, V4; Lagerkvist B, 1992, Disabil Rehabil, V14, P44; Leake D., 2005, CULTURAL LINGUISTIC; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; MARSHALL M, 2001, COCHRANE DB SYST REV, V2; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Michel J A, 2006, Eura Medicophys, V42, P59; Mitchell R, 1999, DISABIL REHABIL, V21, P459, DOI 10.1080/096382899297251; MOMM W, 1998, ENCY OCCUPATIONAL HL; Mont D., 2007, MEASURING DISABILITY; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; MOUNT B, 2003, MOVING PERSONAL FUTU; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Nordholm LA, 1999, DISABIL REHABIL, V21, P515; O'Brien J, 1992, FINDING WAY EVERYDAY; O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114; OTOOLE B, 1988, INT J REHABIL RES, V11, P323, DOI 10.1097/00004356-198812000-00001; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Paterson J, 1999, INT J REHABIL RES, V22, P85, DOI 10.1097/00004356-199906000-00002; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sharma M, 2004, DISABIL REHABIL, V26, P326, DOI 10.1080/09638280410001662923; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Sohlberg M., 2001, COGNITIVE REHABILITA; Storey K, 1996, REHABIL COUNS BULL, V40, P62; Storey K, 2003, INT J REHABIL RES, V26, P79, DOI 10.1097/00004356-200306000-00001; Tamm M, 1999, DISABIL REHABIL, V21, P49, DOI 10.1080/096382899297963; Turmusani M, 2002, DISABIL REHABIL, V24, P558, DOI 10.1080/09638280110113449; U.S. Government Accountability Office, 2008, 08276 GAO; Valdez LS, 1999, DISABIL REHABIL, V21, P495; Velema JP, 2008, LEPROSY REV, V79, P65; Velema JP, 2003, DISABIL REHABIL, V25, P1252, DOI 10.1080/09638280310001599970; Vygotsky LS., 1978, MIND SOC DEV HIGHER; Wade DT, 2003, DISABIL REHABIL, V25, P875, DOI 10.1080/0963828031000122267; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; WERNER D, 1990, DISABLED VILLAGE CHI; WHITTAKER JK, 1983, SOCIAL SUPPORT NETWO; *WHO, 1976, RES DIS PREV REH; WHO, 2008, GLOB BURD DIS; Wiley-Exley E, 2007, SOC SCI MED, V64, P1231, DOI 10.1016/j.socscimed.2006.11.009; WILLER BS, 1993, CIRCLES SUPPORT INDI; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Zhuo D, 1999, DISABIL REHABIL, V21, P490, DOI 10.1080/096382899297305; Zivolich S., 1997, J VOCATIONAL REHABIL, V8, P211, DOI DOI 10.1016/S1052-2263(97)00004-4; 2008, CAREER ED WORKFORCE	69	4	4	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	6					841	866		10.1080/09602010903024943			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	539EL	WOS:000273236300005	20183189				2022-02-06	
J	Krause, M; Kennedy, MRT				Krause, Miriam; Kennedy, Mary R. T.			Metamemory adjustments over time in adults with and without traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; memory; executive functioning; self-awareness; self-monitoring; judgments of learning	SELF-AWARENESS; LEARNING JOLS; JUDGMENTS; ACCURACY; RECALL; PREDICTIONS; KNOWLEDGE	Primary objective: This study explored whether adults with and without traumatic brain injury (TBI) adjust their judgements of learning (JOLs) over the course of a verbal learning task. Research design: Regression analyses were performed of JOLs and recall over time, for both group means and individual performance. Procedures: Twenty adults with TBI and 16 healthy controls studied lists of noun-pairs, making Likert scale JOLs for each item during the study phase. Half of the JOLs were made immediately following item study; the other half after several minutes delay. Recall was tested for each list after all JOLs were complete. Outcomes: Analyses revealed significant differences between participants with TBI and controls in how JOLs changed over time. As a group, TBI survivors increased JOLs over the course of the learning experiment in the delayed condition, whereas the control group decreased JOL predictions in the immediate condition. Conclusions: These results support previous work showing that metamemory abilities of adults with TBI are heterogeneous, but show some differences from those of healthy adults. Possible explanations are derived from Koriat's findings that, with practice, individuals tend to shift toward basing metamemory predictions on mnemonic cues rather than cues intrinsic to task items.	[Krause, Miriam; Kennedy, Mary R. T.] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA		Krause, M (corresponding author), Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA.	krau0067@umn.edu		Krause, Miriam/0000-0002-6798-3991			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Brooks BM, 1999, PSYCHON B REV, V6, P479, DOI 10.3758/BF03210838; Dunlosky J, 2003, PSYCHOL AGING, V18, P340, DOI 10.1037/0882-7974.18.2.340; Dunlosky J, 2001, J EXP PSYCHOL LEARN, V27, P1180, DOI 10.1037//0278-7393.27.5.1180; Dunlosky J., 2005, COGNITIVE TECHNOLOGY, V10, P4; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Kelemen WL, 1997, J EXP PSYCHOL LEARN, V23, P1394, DOI 10.1037/0278-7393.23.6.1394; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KENNEDY MR, 1995, AM J SPEECH-LANG PAT, V4, P159; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2004, NEUROPSYCHOL REHABIL, V14, P449, DOI 10.1080/09602010443000038; Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kimball DR, 2003, MEM COGNITION, V31, P918, DOI 10.3758/BF03196445; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; McGuire MJ, 2001, J EXP PSYCHOL LEARN, V27, P1172, DOI 10.1037//0278-7393.27.5.1172; Nelson T. O., 1992, METACOGNITION CORE R; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Reitan RM, 1985, HALSTEADREITAN NEURO; Scheck P, 2004, J MEM LANG, V51, P71, DOI 10.1016/j.jml.2004.03.004; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Thiede KW, 2003, J EDUC PSYCHOL, V95, P66, DOI 10.1037/0022-0663.95.1.66; Thiede KW, 1999, PSYCHON B REV, V6, P662, DOI 10.3758/BF03212976; WESCHLER D, 1997, WESCHLER MEMORY SCAL, V3; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	31	4	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	12					965	972		10.3109/02699050903373485			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	529YL	WOS:000272555200004	19831493				2022-02-06	
B	McAuley, D		Whitfield, PC; Thomas, EO; Summers, F; Whyte, M; Hutchinson, PJ		McAuley, Duncan			Early phase care of patients with moderate and severe head injury	HEAD INJURY: A MULTIDISCIPLINARY APPROACH			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MORTALITY; RESUSCITATION; DISABILITY; LOCATION; SYSTEM; COHORT; ADULTS; TRIAL		Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England		McAuley, D (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.						American College of Surgeons Advanced Trauma Life Support (ATLS), 1997, STUD MAN; *ASS AN GREAT BRIT, 2006, REC TRANSF PAT AC HE; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; BUNN F, 2001, EFFECTIVENESS PREHOS; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Cihangiroglu M, 2002, NEUROL RES, V24, P7, DOI 10.1179/016164102101199440; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Department of Health, 2000, HOSP EP STAT 2000 20; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Hadley MN, 2002, NEUROSURGERY, V50, pS7; Karuppal R., 2007, J ORTHOP, V4, pe7; KOTWICA Z, 1990, ACTA NEUROCHIR, V103, P109, DOI 10.1007/BF01407515; MAGPAS guidelines, MAGPAS GUID; MENDELOW AD, 1979, BRIT MED J, V2, P134, DOI 10.1136/bmj.2.6182.134-a; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716; NICE, HEAD INJ TRIAG ASS I; NICE, 2003, HEAD INJ TRIAG ASS I; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; Orledge JD, 1998, ACAD EMERG MED, V5, P203, DOI 10.1111/j.1553-2712.1998.tb02612.x; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Price SJ, 2003, INJURY, V34, P834, DOI 10.1016/S0020-1383(03)00028-7; RCR Working Party, 2003, MAK BEST US DEP CLIN; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SBNS Working Party, 2000, REP SOC BRIT NEUR SB, P35; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1996, INT PERSPECTIVES TRA, V5, P10; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; WALLS RM, 2000, MANUAL EMERGENCY AIR; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	47	4	4	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-69762-0				2009							62	70			10.1017/CBO9780511576515		9	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BFF00	WOS:000319565700009					2022-02-06	
J	Qu, CQ; Guo, SG; Guo, HZ; Wang, CJ; Ma, L; He, Y; Wang, L; Lou, JW; Wang, XB				Qu Chuanqiang; Guo Shougang; Guo Hongzhi; Wang Chunjuan; Ma Lin; He Yan; Wang Lei; Lou Jianwei; Wang Xingbang			Increased Serum Endotoxin and Elevated CD14 and IL-1 beta Expression in a Rat Model of Cerebrogenic Multiple Organ Dysfunction Syndrome	MEDICINAL CHEMISTRY			English	Article						Multiple organ dysfunctio; endotoxins; CD14; IL-1 beta; gene expression	TRAUMATIC BRAIN-INJURY; SYSTEMIC INFLAMMATORY RESPONSE; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; RECEPTOR; INDUCTION; PLASMA; MICE	Objectives: To study the mechanisms underlying cerebrogenic multiple organ dysfunction syndrome (CMODS) through investigation of endotoxin levels and the expression of endotoxin receptor CD14 and interleukin IL-1 beta mRNAs in a rat CMODS model. Methods: Acute cerebral hemorrhage was induced in Wistar rats by focal intracerebral injection of collagenase into the caudate nucleus. Serum endotoxin levels were quantitated using a chromogenic limulus lysate method; CD14 endotoxin receptor mRNA and IL-1 beta mRNA levels in lung and intestine were determined by in situ hybridization. Results: Serum endotoxin levels increased after 12 h, reaching a peak after 24 h, and declined to control levels at 72 h. The increase was statistically significant (P<0.05) compared to unoperated controls and the sham-operated group respectively. CD14 mRNA in lung and intestine increased after 12 h, peaked after 24-36 h, and then declined after 48 h. IL-1 beta mRNA levels were also increased in lung and intestine (P<0.05), peaking at 36 h and declining thereafter. Expression levels of both CD14 and IL-1 beta mRNAs correlated significantly with serum endotoxin levels (P<0.01). We conclude that acute cerebral hemorrhage results in endotoxemia and widespread increases in CD14 and IL-1 beta expression. We suggest that acute cerebrovascular challenge leads to a stress/shock response that compromizes the intestinal mucosal barrier. In turn, this allows endotoxin translocation into the body that provokes the release of pro-inflammatory lymphokines, leading to a systemic inflammatory response syndrome (SIRS) that culminates in multiple organ dysfunction.	[Guo Shougang] Shandong Univ, Prov Hosp Affiliated, Dept Neurol, Jinan 250021, Peoples R China; [Qu Chuanqiang; Guo Hongzhi; Wang Chunjuan; Ma Lin; Lou Jianwei; Wang Xingbang] Shandong Univ, Qilu Hosp Affiliated, Dept Neurol, Jinan 250012, Peoples R China; [He Yan; Wang Lei] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurol, Jinan 250012, Peoples R China		Guo, SG (corresponding author), Shandong Univ, Prov Hosp Affiliated, Dept Neurol, Jinan 250021, Peoples R China.	wenzhong_sd@sina.com			Shandong Provincial youth Foundation of Medical Science and Technology of China [Y2007C043]; Shandong Province 'Eleventh Five Year' health science and technology development plan item [2007HW079]	This work was supported by a grant from Shandong Provincial youth Foundation of Medical Science and Technology of China (Y2007C043) and from Shandong Province 'Eleventh Five Year' health science and technology development plan item (2007HW079).	Bessler H, 2001, BIOL NEONATE, V80, P186, DOI 10.1159/000047141; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gruber A, 2000, J NEUROSURG ANESTH, V12, P297, DOI 10.1097/00008506-200010000-00001; IKEWAKI N, 1991, TISSUE ANTIGENS, V38, P117, DOI 10.1111/j.1399-0039.1991.tb02024.x; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; [梁临平 Liang Linping], 2005, [中华老年医学杂志, Chinese Journal of Geriatrics], V24, P296; LUSTER MI, 1994, HEPATOLOGY, V19, P480; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Neumann B, 1996, J IMMUNOL, V156, P1587; Oda Shigeto, 2003, Nihon Geka Gakkai Zasshi, V104, P511; SHENG ZY, 2000, MULTIPLE ORGAN DYSFU; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Takakuwa T, 1996, EUR J IMMUNOL, V26, P2686, DOI 10.1002/eji.1830261121; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	19	4	6	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4064	1875-6638		MED CHEM	Med. Chem.		2009	5	5					462	467					6	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	517MU	WOS:000271619300009	19534684				2022-02-06	
J	Smrcka, M; Duris, K; Juran, V; Neuman, E; Kyr, M				Smrcka, M.; Duris, K.; Juran, V.; Neuman, E.; Kyr, M.			Peroperative Monitoring of Tissue Oximetry and Peroperative Use of Hypothermia in Surgery on Cerebral Aneurysms	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						oxymetry; hypothermia; aneurysm	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; OXYGEN; PRESSURE	Introduction: During surgery on cerebral artery aneurysm, there is a risk of ischaemia caused by the use of temporary clips, brain tissue retraction or mechanically driven vasospasms caused by the manipulation of brain vessels. Nowadays, tissue oxymetry is experimentally used for early detection of ischaemia conditioned by vasospasms, The aim of the research is to evaluate the possible use of brain tissue oximetry during surgery on cerebral artery aneurysm. Material and methods. We enrolled 25 patients who had been operated on for aneurysm. Patients were maintained in mild controlled hypothermia during the operation. The monitored parameters were brain tissue oxygen pressure (PbtO(2)), jugular bulb oxygen saturation (SVjO(2)), mean arterial pressure (MAP), and fraction of inspired oxygen (FiO(2)). Results: In the study group, no correlation exists either between peroperative values of PbtO(2) and age, sex, Hunt Hess score, outcome, localization or side of aneurysm or between peroperative values of PbtO(2) and the SVjO(2) or FiO(2). A correlation between PbtO(2) and MAP (R = 0.44; p < 0.001) in the study group has been demonstrated. The increasing duration of the manipulation of brain vessels poses a significant risk factor for a fall in PbtO(2) values (p < 0.001). In all cases, the PbtO(2) values decreased after applying a temporary clip. In patients with peroperatively recorded periods of PbtO(2) decrease, the occurrence of ischemic changes on postoperative CT was comparable to the group in which no PbtO(2) decrease was peroperatively recorded. Conclusion: We consider PbtO(2) monitoring of surgery on cerebral artery aneurysms to be beneficial as it informs the surgeon about the length and depth of ischaemia, thus drawing attention to the need for a change in the tactic of the surgery.	[Smrcka, M.; Duris, K.; Juran, V.; Neuman, E.] Neurochirurg Klin LF MU, Brno 62500, Czech Republic; [Smrcka, M.; Duris, K.; Juran, V.; Neuman, E.] FN Brno, Brno, Czech Republic; [Kyr, M.] Inst Biostat & Anal MU, Brno, Czech Republic		Smrcka, M (corresponding author), Neurochirurg Klin LF MU, Jihlavska 20, Brno 62500, Czech Republic.	msmrcka@fnbrno.cz	Juran, Vilem/ABD-9854-2020; Smrcka, Martin/AAM-8872-2021	Juran, Vilem/0000-0003-1080-3520; Smrcka, Martin/0000-0002-9191-8700			Critchley GR, 1998, NEUROL RES, V20, pS44; Gal R, 2006, CESK SLOV NEUROL N, V69, P371; Gelabert-Gonzalez M, 2002, ACTA NEUROCHIR, V144, P863, DOI 10.1007/s00701-002-0975-9; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR SUPPL, V95, P79; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kett-White R, 2002, J NEUROSURG, V96, P1013, DOI 10.3171/jns.2002.96.6.1013; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; OHLSTEIN EH, 1992, J NEUROSURG, V77, P274, DOI 10.3171/jns.1992.77.2.0274; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805	19	4	4	0	3	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2009	72	3					245	249					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	459JD	WOS:000267097100007					2022-02-06	
J	Stasiukyniene, V; Pilvinis, V; Reingardiene, D; Janauskaite, L				Stasiukyniene, Virginija; Pilvinis, Vidas; Reingardiene, Dagmara; Janauskaite, Liuda			Epileptic seizures in critically ill patients	MEDICINA-LITHUANIA			Lithuanian	Article						epileptic seizures; status epilepticus; critical conditions	REFRACTORY STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; INTRAVENOUS VALPROATE; CARE; PREDICTORS; ADULTS; RISK	The aim of this article - to review the causes, clinical signs, pathophysiology, consequences, and treatment of seizures and status epilepticus in critically ill patients. Only 25% of people, who have seizures and status epilepticus, have epilepsy as well. In the intensive care settings, seizures and status epilepticus are a common neurologic complication, which is attributable to primary neurologic pathology (stroke, hemorrhage, tumor, central nervous system infection, head trauma) or secondary to critical illness (anoxic brain damage, intoxications, metabolic abnormalities) and clinical management. There are three main subtypes of status epilepticus in intensive care units: generalized convulsive status epilepticus, focal motor status epilepticus, and nonconvulsive status epilepticus. A seizure is a consequence of electrical neurological derangement because of sudden imbalance between the inhibitory and excitatory forces within the network of cortical neurons. The main inhibiting neurotransmitter in the brain is gamma-aminobutyric acid (GABA), which binds to GABA-A and GABA-B receptors. The main excitatory neurotransmitter is glutamate, which binds to N-methyl-D-aspartate receptors. Different ions (Cl-, K+, Na+, Ca2+) also play a role in the pathophysiology of seizures. Prolonged status epilepticus may lead to different systemic and neurologic consequences. Generalized convulsive status epilepticus is one of the most common emergencies encountered in clinical practice, which requires immediate treatment. The first-line drugs are benzodiazepines (lorazepam, diazepam), the second-line ones - phenytoin and fosphenytoin. For the treatment of refractory status epilepticus, barbiturates (phenobarbital, pentobarbital, thiopental), valproate, midazolam, propofol, and isoflurane are used. The dosage of drugs and parameters to monitor are referred in the article. The mortality from generalized convulsive status epilepticus is 15-50%; the main factors, influencing prognosis, are the cause and the duration of status epilepticus and age of a patient.	[Stasiukyniene, Virginija; Pilvinis, Vidas; Reingardiene, Dagmara] Kaunas Univ Med, Dept Intens Therapy, LT-50009 Kaunas, Lithuania		Stasiukyniene, V (corresponding author), Kaunas Univ Med, Dept Intens Therapy, Eiveniu 2, LT-50009 Kaunas, Lithuania.	virgasta@centras.lt					Agarwal P, 2007, SEIZURE-EUR J EPILEP, V16, P527, DOI 10.1016/j.seizure.2007.04.012; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; BLECK TB, 1999, OXFORD TXB CRITICAL, P447; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; CAVAZOS JE, SEIZURES EPILEPSY OV; CHEN JWY, 2006, LANCET NEUROL, V3, P1; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; HOLT P, STATUS EPILEPTICUS; Holtkamp M, 2005, ARCH NEUROL-CHICAGO, V62, P1428, DOI 10.1001/archneur.62.9.1428; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; HUFF JS, STATUS EPILEPTICUS; Kaplan PW, 2006, J CLIN NEUROPHYSIOL, V23, P221, DOI 10.1097/01.wnp.0000220837.99490.66; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Ma XP, 2001, EPILEPSY RES, V46, P33, DOI 10.1016/S0920-1211(01)00252-2; MAJER SA, 2002, ARCH NEUROL-CHICAGO, V59, P205; Masuhr F, 2006, EUR J NEUROL, V13, P852, DOI 10.1111/j.1468-1331.2006.01371.x; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; Nandhagopal R, 2006, POSTGRAD MED J, V82, P723, DOI 10.1136/pgmj.2005.043182; Narayanan JT, 2007, NEUROL INDIA, V55, P136; Ng YT, 2006, J NEUROSURG, V105, P378, DOI 10.3171/ped.2006.105.5.378; Pang Trudy, 2005, Curr Treat Options Neurol, V7, P247, DOI 10.1007/s11940-005-0035-x; Patwardhan RV, 2005, SURG NEUROL, V64, P170, DOI 10.1016/j.surneu.2004.11.026; PHILIPS CA, 2000, MANUAL INTENSIVE CAR, P784; Prasad K, 2007, BRIT J CLIN PHARMACO, V63, P640, DOI 10.1111/j.1365-2125.2007.02931.x; Shorvon S, 2001, J NEUROL NEUROSUR PS, V70, P22; Sinha S, 2000, NEUROLOGY, V55, P722, DOI 10.1212/WNL.55.5.722; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; Towne AR, 2007, INT REV NEUROBIOL, V81, P111, DOI 10.1016/S0074-7742(06)81007-X; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Treiman DM, 2007, INT REV NEUROBIOL, V81, P273, DOI 10.1016/S0074-7742(06)81018-4; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Van Ruckevorsel K, 2005, ACTA NEUROL BELG, V105, P111; Varelas PN, 2001, J NEUROSURG ANESTH, V13, P163, DOI 10.1097/00008506-200104000-00016; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WIJDICKS EFM, 1993, NEUROLOGY, V43, P1042, DOI 10.1212/WNL.43.5.1042; MANAGEMENT STATUS EP	41	4	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.		2009	45	6					501	507		10.3390/medicina45060066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476VH	WOS:000268473800012	19605972	gold			2022-02-06	
J	Tinard, V; Deck, C; Meyer, F; Bourdet, N; Willinger, R				Tinard, V.; Deck, C.; Meyer, F.; Bourdet, N.; Willinger, R.			Influence of pedestrian head surrogate and boundary conditions on head injury risk prediction	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						pedestrian head impact; head modelling; criteria; head impact standard	FINITE-ELEMENT MODEL	The objective of the present work is to investigate the influence of head models and boundary conditions on the head response in the case of pedestrian accidents. Simulations have been carried out, regarding results both in terms of global parameters and more detailed intracerebral mechanical parameters. Three head models have been used (ISO headform, Hybrid III head and ULP head Finite Element Model) for these simulations, either considered as isolated heads or coupled with the whole body. It was shown that inertial properties of Hybrid III head are closed to the human head, which strongly influences rotational acceleration and also intracerebral shearing. When coupled to the whole body, it appeared that initial car bonnet deformation induced by shoulder or back leads to dramatic head loading. As a whole, the results obtained demonstrate the necessity of taking into account more realistic head inertia and boundary conditions for future pedestrian head impact standard development.	[Tinard, V.; Deck, C.; Meyer, F.; Bourdet, N.; Willinger, R.] CNRS, UdS 7507, F-67000 Strasbourg, France		Tinard, V (corresponding author), CNRS, UdS 7507, IMFS 2 Rue Boussingault, F-67000 Strasbourg, France.	violaine.tinard@imfs.u-strasbg.fr		DECK, Caroline/0000-0003-2289-1222; Frank, Meyer/0000-0002-5863-5207; Tinard, Violaine/0000-0003-3984-7164			Deck C., 2007, P IRCOBI C MAASTR NE, P185; DECK C, 2007, SP511B APROSYS; DiMasi F. P., 1995, P 39 STAPP CAR CRASH; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; *EURONCAP, 2004, EURONCAP PED TEST PR; Ishikawa T., 2003, 18 ESV C NAG JAP; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; LAWRENCE GJL, 2005, S222CVF PED PROT PRO; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Martinez L, 2007, 20 ESV C LYON FRANC; NAHUM A, 1997, P 21 STAPP CAR CRASH, P339; Newman J, 2000, P 44 STAPP CAR CRASH; OKAMOTO Y, 2000, P IRCOBI C MONTP FRA; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; VEZIN P, 2005, 19 ESV C; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; YOGANANDAN N, 1994, P HEAD INJ S, P227; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	19	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1358-8265			INT J CRASHWORTHINES	Int. J. Crashworthiness		2009	14	3					259	268	PII 912992761	10.1080/13588260802434046			10	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	468MI	WOS:000267822700004					2022-02-06	
J	West, SL; Luck, RS; Capps, CF; Cifu, DX; Graham, CW; Hurley, JE				West, Steven L.; Luck, Richard S.; Capps, C. Fred; Cifu, David X.; Graham, Carolyn W.; Hurley, Jessica E.			Alcohol/Other Drug Problems Screening and Intervention by Rehabilitation Physicians	ALCOHOLISM TREATMENT QUARTERLY			English	Article						Rehabilitation medicine; substance abuse screening; persons with disabilities; traumatically acquired disabilities		Rates of substance abuse by individuals with traumatically acquired disabilities such as spinal cord injury and traumatic brain injury have been reported to approach 50%, yet these individuals are not seen in treatment at proportions reflective of their population size. A possible factor promoting such low treatment participation could be a failure to identify and refer these individuals to treatment. Rehabilitation physicians are the primary care providers to such individuals after initial inpatient admission and in many cases remain in frequent contact with them on a long-term outpatient basis. This research was undertaken to determine the rates of substance abuse screening and intervention in a sample of 142 rehabilitation physicians. Despite indicating that substance abuse is a significant issue among such patients, the majority of responding physicians failed to routinely screen for substance abuse. Surprisingly, more than 40% of those who diagnosed patients with an active substance use disorder did not refer such patients to treatment. Given the extensive contact rehabilitation physicians have with patients with traumatically acquired disabilities, significant opportunities for intervention appear to be lost. Implications for practice and clinical training are provided.	[West, Steven L.; Cifu, David X.; Hurley, Jessica E.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Luck, Richard S.] Virginia Dept Rehabilitat Serv, Charlottesville, VA 22901 USA; [Capps, C. Fred] Woodrow Wilson Rehabil Ctr, Fishersville, VA 22939 USA; [Graham, Carolyn W.] George Washington Univ, Washington, DC 20052 USA		West, SL (corresponding author), Virginia Commonwealth Univ, Dept Rehabil Counseling, POB 980330, Richmond, VA 23298 USA.	slwest2@vcu.edu		Cifu, David/0000-0003-1600-9387	Commonwealth of Virginia [05-0008]	This research was supported by a grant from the Commonwealth Neurotrauma Initiative (#05-0008) from the Commonwealth of Virginia.	Arndt S, 2002, J FAM PRACTICE, V51, P41; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P1301, DOI 10.1016/S0003-9993(03)00264-8; Basford JR, 2002, ARCH PHYS MED REHAB, V83, P517, DOI 10.1053/apmr.2002.30922; Bernstein Edward, 2007, Subst Abus, V28, P79, DOI 10.1300/J465v28n04_01; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; Bombardier CH, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P399, DOI 10.1037/10361-019; BRADLEY KA, 1995, J GEN INTERN MED, V10, P67, DOI 10.1007/BF02600228; Burgard JF, 2000, J PSYCHOACTIVE DRUGS, V32, P293, DOI 10.1080/02791072.2000.10400452; Cherpitel CJ, 2006, ADDICTION, V101, P1225, DOI 10.1111/j.1360-0443.2006.01567.x; Cornwell EE, 1998, AM SURGEON, V64, P461; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; DeVivo MJ, 1997, SPINAL CORD, V35, P509, DOI 10.1038/sj.sc.3100430; DILLMAN D, 1991, CONDUCT YOUR OWN SUR; Drubach D A, 1993, Md Med J, V42, P989; Ewing J, 1970, 29 INT C ALC DRUG DE; Friedmann PD, 2000, J GEN INTERN MED, V15, P84, DOI 10.1046/j.1525-1497.2000.03379.x; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hawkins DA, 1998, REHABIL PSYCHOL, V43, P219, DOI 10.1037/0090-5550.43.3.219; Heinemann A. W., 1989, ALCOHOL HEALTH RES W, V13, P110; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; McCrady BS, 1996, J ADDICT DIS, V15, P45, DOI 10.1300/J069v15n03_03; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Mello MJ, 2005, ANN EMERG MED, V45, P620, DOI 10.1016/j.annemergmed.2005.01.026; Miller F. G., 1999, ADULT SASSI 3 MANUAL; *NAT I ALC AB ALC, 2005, HELP PAT DRINK MUCH; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; ROCHE AM, 1995, ADDICTION, V90, P1357, DOI 10.1046/j.1360-0443.1995.901013577.x; Rockett IRH, 2003, ANN EMERG MED, V41, P802, DOI 10.1067/mem.2003.189; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; TATE DG, 1993, AM J PHYS MED REHAB, V72, P192, DOI 10.1097/00002060-199308000-00004; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; The National SCI Statistical Center, 2008, SPIN CORD INJ FACTS; Van Hook S, 2007, J ADOLESCENT HEALTH, V40, P456, DOI 10.1016/j.jadohealth.2006.12.007; von Heymann C, 2002, J TRAUMA, V52, P95, DOI 10.1097/00005373-200201000-00017; Voss C. P., 2002, TOPICS SPINAL CORD I, V7, P47; WENRICH MD, 1995, J GEN INTERN MED, V10, P631, DOI 10.1007/BF02602748; West S. L., J SUBSTANC IN PRESS; West SL, 2007, J SUBST ABUSE TREAT, V33, P1, DOI 10.1016/j.jsat.2006.11.001; West SL, 2007, ADDICT BEHAV, V32, P1494, DOI 10.1016/j.addbeh.2006.10.009; West SL, 2009, ALCOHOL TREAT Q, V27, P317, DOI 10.1080/07347320903008216; West SL, 2009, ALCOHOL TREAT Q, V27, P305, DOI 10.1080/07347320903008190; West SL, 2009, ALCOHOL TREAT Q, V27, P294, DOI 10.1080/07347320903008174; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Wilber N, 2002, MILBANK Q, V80, P393, DOI 10.1111/1468-0009.00009; WOODRUFF BA, 1994, AM J PREV MED, V10, P10, DOI 10.1016/S0749-3797(18)30640-8; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x	68	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0734-7324	1544-4538		ALCOHOL TREAT Q	Alcohol. Treat. Q.		2009	27	3					280	293		10.1080/07347320903008166			14	Substance Abuse	Emerging Sources Citation Index (ESCI)	Substance Abuse	V1W9P	WOS:000217310400006					2022-02-06	
J	Degos, V; Pereira, AR; Lescot, T; Sanchez-Pena, P; Daoudi, M; Zouaoui, A; Coriat, P; Puybasset, L				Degos, Vincent; Pereira, Ana-Rosa; Lescot, Thomas; Sanchez-Pena, Paola; Daoudi, Mounir; Zouaoui, Abderrezak; Coriat, Pierre; Puybasset, Louis			Does Brain Swelling Increase Estimated Specific Gravity?	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Specific gravity; Computed tomography; Subarachnoid hemorrhage; Brain swelling; Blood-brain barrier	INJURY	Objective At the acute phase of traumatic brain injury (TBI), brain swelling contributes substantially to the development of secondary neurological lesions. Elucidating the pathophysiology of brain swelling is crucial to improve TBI management. In a previous study, specific gravity (SG) of the noncontused hemisphere, as estimated by computed tomography (CT), was higher in patients with high Marshall CT scores and severe brain swelling. The aim of this study was to investigate the relationship between estimated specific gravity (eSG) and clinical variable suggestive of brain swelling. Design Retrospective study of data from a prospectively established database. Setting Neurology ICU in a teaching hospital in Paris, France. Participants We studied 20 patients with severe traumatic brain injury (TBI), 20 patients with high-grade subarachnoid hemorrhage (SAH) presenting similar brain-swelling criteria, 20 patients with low-grade SAH, and 20 healthy controls. Interventions None. Measurements Estimated brain specific gravity was acquired from CT images obtained at ICU admission. eSG was estimated in the overall intracerebral content and in a region-of-interest composed of white matter and the diencephalon. eSG in the region of interest was significantly higher in the TBI patients than in the high-grade SAH patients (1.0350 +/- 0.0041 vs. 1.0310 +/- 0.0019 g/ml, P < 0.05). eSG was similar in the high-grade SAH, low-grade SAH, and control groups. Conclusions Our findings do not support a causal link between brain swelling and eSG elevation. The eSG increase in severe TBI patients is not due to brain swelling.	[Puybasset, Louis] Hop La Pitie Salpetriere, Dept Anesthesie Reanimat, F-75013 Paris, France; [Degos, Vincent; Pereira, Ana-Rosa; Lescot, Thomas; Sanchez-Pena, Paola; Daoudi, Mounir; Coriat, Pierre; Puybasset, Louis] Univ Paris 06, Pitie Salpetriere Teaching Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Zouaoui, Abderrezak] Univ Paris 06, Pitie Salpetriere Teaching Hosp, AP HP, Dept Radiol, Paris, France		Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesie Reanimat, 47 Blvd Hop, F-75013 Paris, France.	louis.puybasset@psl.aphp.fr					BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Degos V, 2006, ANESTH ANALG, V103, P1229, DOI 10.1213/01.ane.0000237401.22688.22; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008	11	4	4	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2008	9	3					338	343		10.1007/s12028-008-9131-6			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	367HC	WOS:000260542100010	18818888				2022-02-06	
J	Heel, S; Fischer, S; Fischer, S; Grasser, T; Hammerlings, E; Wendel, C				Heel, Sabine; Fischer, Sonja; Fischer, Stefan; Graesser, Tobias; Haemmerlings, Ellen; Wendel, Claudia			Health Services Research in the Field of Clinical Neuropsychology - a Stocktaking	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article						Health Services Research; Neuropsychology; Neuropsychological Rehabilitation	TRAUMATIC BRAIN-INJURY; OUTPATIENT REHABILITATION; COGNITIVE REHABILITATION; CARE; PARTICIPATION; DEPARTMENTS; DEPRESSION; DISORDERS	The article adresses relevant terms and objectives of Health services Research initially. Then it conceptualises the subdisciplines (1) Research in Demand for Health Services, (2) Research in Health Service Utilisation, (3) Organizational Research, (4) Health Technology Assessment, (5) Health Economics and (7) Health Epidemiology. According to those subdisciplines, currently relevant. empirical studies in the field of neuropsychology are reported. As the article aims at encouraging controversies about further needs for Health services Research in the field of neuropsychological rehabilitation in Germany, only findings of german studies are reported.	[Heel, Sabine] Praxisgemeinschaft Ambulante Neuropsychol, D-10961 Berlin, Germany; [Fischer, Sonja] Ambulantes Neurol Rehabil Zentrum, Bonn, Germany; [Wendel, Claudia] Fachbereich Rehabil Psychol FH Magdeburg Stendal, Magdeburg, Germany		Heel, S (corresponding author), Praxisgemeinschaft Ambulante Neuropsychol, Schleiermacherstr 24, D-10961 Berlin, Germany.	info@neuropsychologie-ambulant.de					ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Arbeitskreis Versorgungsforschung beim wissenschaftlichen Beirat der Bundesarztekammer, 2004, DEF ABGR VERS; Baltensperger C, 2001, Z KL PSYCH PSYCHOTH, V30, P10, DOI 10.1026//1616-3443.30.1.10; BENGEL J, 2000, LEHRBUCH KLIN NEUROP, P250; Bock W, 2006, SCHADEL HIRN VERLETZ; BOWEN A, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003586.PUB2; Bundesarbeitsgemeinschaft fur Rehabilitation, 2005, RAHM AMB NEUR REH; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Chemerinski E, 2000, PSYCHOSOMATICS, V41, P5, DOI 10.1016/S0033-3182(00)71168-6; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cochrane Archibald Leman, 1972, EFFECTIVENESS EFFICI; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; Deb S, 1999, AM J PSYCHIAT, V156, P374; Der Vorstand der GNP, 2005, Z NEUROPSYCHOL, V16, P175; Dick F., 2007, Z NEUROPSYCHOL, V18, P41; DORNER K, 2003, GESUNDHEITSFALLE; FISCHER S, LEHRBUCH KL IN PRESS; FISCHER S, 2008, DRV SCHRIFTEN, V77, P389; GAUGGEL S, 2003, GRUNDLAGEN EMPIRIE N; GAUGGEL S, 2003, Z NEUROPSYCHOLOGIE, V4, P217; *GEM KOMM KLIN NEU, 1998, Z NEUROPSYCHOLOGIE, V9, P88; *GES NEUR, 1995, Z NEUROPSYCHOL, V6, P47; Granados A, 1999, INT J TECHNOL ASSESS, V15, P585, DOI 10.1017/S0266462399153121; HAFNER H, 1979, ESTIMATING NEEDS MEN; HAMMERLING E, 2006, Z NEUROPSYCHOL, V17, P113; Herrmann M, 1997, NERVENARZT, V68, P647, DOI 10.1007/s001150050175; Herrmann M, 1997, NERVENARZT, V68, P801, DOI 10.1007/s001150050197; HESSEL F, 2004, GESUNDHEITSOKONOMIE, P61; JACOBI F, 2006, PSYCHOSOZIALE VERSOR, P3; KAPLAN RM, 1994, HEALTH PSYCHOL, V13, P451, DOI 10.1037/0278-6133.13.6.451; KASTEN E, 1998, EFFEKTIVE NEUROPSYCH; KASTEN E, 1999, REPORT PSYCHOL, V3, P194; Kasten E., 1997, Z NEUROPSYCHOL, V8, P72; Kitze K, 2002, Rehabilitation (Stuttg), V41, P401; KOCH U, 1996, SCHRIFTENREIHE GESUN; *KOMM WEIT REH GES, 1991, ABSCHL, V3; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KUSCH M, 2003, VERSORGUNGSMANAGEMEN, V5; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Mieck T, 1997, AKTUEL NEUROL, V24, P253, DOI 10.1055/s-2007-1017818; Morrison V, 2005, J PSYCHOSOM RES, V59, P209, DOI 10.1016/j.jpsychores.2005.02.019; MUHLIG S, 2007, 22 JAHR GES NEUR GNP; MULLER S, 2000, REHABILITATION, V39, P1; MULLER SV, 2007, Z NEUROPSYCHOLOGIE, V18, P61; Pepping M, 2003, NEURO S B C, P313; Pfaff H, 2003, GESUNDHEITSVERSORGUN, P13; POTT C, EVALUATION TEI UNPUB; PREILOWSKI B, 2004, NEUROPSYCHOLOGIE PSY, P7; Prigatano G.P., 2004, NEUROPSYCHOLOGISCHE; Prigatano GP, 2003, NEURO S B C, P15; PROSIEGEL M, 2007, NEUROPSYCHOLOGISCHE; ROTHER A, 2007, THESIS TU CHEMNITZ; SARTORIUS N, 2000, UNMET NEED PSYCHIAT, P3; SCHEURICH A, 2007, 22 JAHR GES NEUR GNP; SCHMIDT J, 2004, GESUNDHEITSOKONOMIE, P32; SCHMIDT J, 1994, Z WISS GESPRACHSPSYC, V96, P15; SCHOOFTAMS K, 2007, Z NEUROPSYCHOLOGIE, V18, P55; SCHWARTZ FW, 2006, PSYCHOSOZIALE VERSOR, P378; SEASDALE TW, 1994, BRAIN INJURY NEUROPS, P235; Thode N, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P296, DOI 10.1007/s00103-004-1004-3; Thode N, 2004, EINFLUSSFAKTOREN INA; THYEN U, 2000, KINDERARZTL PRAX, V71, P276; WALLESCH CW, 1995, NERVENARZT, V66, P455; WENDEL C, 2007, REHABILITATION NACHS, P109; WENDEL C, 2003, THESIS; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WHO, 2005, INT KLASS FUNKT BEH; *WISS BEIR PSYCH, 2000, DTSCH ARZTEBLATT, V97, P60; WITTCHEN HU, 2002, PSYCHOTHERAPEUTENJOU, P6; ZIHL J, 2004, NEUROPSYCHOLOGIE PSY, P27	76	4	4	0	0	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	DEC	2008	19	4					253	269		10.1024/1016-264X.19.4.253			17	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	385OP	WOS:000261823800005					2022-02-06	
J	Larkins, B; Worrall, L; Hickson, L				Larkins, Brigette; Worrall, Linda; Hickson, Louise			Developing a Traumatic Brain Injury Index for Social and Vocational Communication Outcomes (SAVCO)	BRAIN IMPAIRMENT			English	Article						communication disability; needs assessment; outcome assessment; traumatic brain injuries	HEAD-INJURY; INDIVIDUALS; QUESTIONNAIRE; IMPAIRMENT; VALIDITY	Objective: To describe the development of a functional communication assessment. A secondary aim is to illustrate a process for identifying functional communication outcomes in clients with traumatic brain injury (TBI). The TBI Index for Social and Vocational Communication Outcomes (SAVCO) is designed to identify limitations to everyday communication activities that may present following TBI. It was constructed by anchoring communication activities derived from studies within New Zealand into an internationally recognised theoretical construct, the International Classification of Functioning, Disability and Health (ICF). Four key principles: authenticity of the items, attention to context, collaboration and transparency, underpin the assessment. Main outcomes: The article describes the process of developing a TBI measure that is authentic to an intended population. It provides a preliminary description of the SAVCO, its different constructs and the rationale for their inclusion. The SAVCO is an assessment that highlights everyday activities that are relevant targets for intervention for the individual. The client's performance on the identified activities is explored according to the efficiency and manner of executing the activity. The scope and level of the activity are also determined. Conclusions: The development of the SAVCO illustrates a process for identifying relevant and important functional communication activity items and promotes the use of the ICF framework and rating scales. The preliminary findings suggest that the SAVCO has clinical relevance providing speech-language therapists with a functional communication assessment that leads to the identification and measurement of client-centred therapy outcomes.	[Larkins, Brigette] Canterbury Dist Hlth Board, Older Persons Hlth Serv, Christchurch, New Zealand; [Worrall, Linda; Hickson, Louise] Univ Queensland, Brisbane, Qld 4072, Australia		Larkins, B (corresponding author), Canterbury Dist Hlth Board, Older Persons Hlth Serv, POB 800, Christchurch, New Zealand.	brigette.larkins@cdhb.govt.nz	Hickson, Louise MH/F-8748-2010; Worrall, Linda/D-2579-2010	Hickson, Louise MH/0000-0001-6832-4173; Worrall, Linda/0000-0002-3283-7038			BAKER R, 1995, AUST J AGEING, V14, P81, DOI 10.1111/j.1741-6612.1995.tb00702.x; BLOMERT L, 1994, APHASIOLOGY, V8, P381, DOI 10.1080/02687039408248666; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Davis GA, 2000, APHASIOLOGY DISORDER; Delbecq A.L., 1975, GROUP TECHNIQUES PRO; DOUGLAS J, 2005, BRAIN IMPAIRMENT, V6, P1; DOUGLAS J, 2004, BRAIN IMPAIRMENT S, P13; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; FRATTALI C, 1994, PROFESSIONAL ISSUES; Frattali C. M., 1995, AM SPEECH LANGUAGE H; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Holland A., 1999, COMMUNICATION ACTIVI; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; LARKINS B, 2000, NEUROGENIC COMMUNICA; LARKINS B, 2005, NZ J SPEECH LANGUAGE, V59, P13; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Minister for Disability Issues, 2001, NZ DIS STRAT MAK WOR; Sarno M. T., 1969, FUNCTIONAL COMMUNICA; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Wirz S.L, 1990, REVISED EDINBURGH FU; World Health Organization, 2001, INT CLASSIFICATION F; Worrall L., 2000, NEUROGENIC COMMUNICA, P3; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	39	4	5	0	9	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2008	9	3					247	266		10.1375/brim.9.3.247			20	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	390UT	WOS:000262189900002					2022-02-06	
J	Deininger, MH; Adam, A; Van Velthoven, V				Deininger, Martin H.; Adam, Abbas; Van Velthoven, Vera			Bedside Catheter Evacuation of Predominantly Isolated Traumatic Supratentorial Hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Hematoma; Traumatic hemorrhage; Urokinase-lysis; Catheter	SEVERE HEAD-INJURY; SPONTANEOUS INTRACEREBRAL HEMATOMAS; TISSUE-PLASMINOGEN ACTIVATOR; STEREOTAXIC ASPIRATION; BRAIN-INJURY; LYSIS; ANTICOAGULATION; MANAGEMENT	Background: Predominantly isolated intracerebral hemorrhage (ICH) is a rare complication after traumatic brain injury that tends to occur in patients with coagulation disorders. Methods: We developed a minimally-invasive free-hand bedside catheter evacuation procedure using 3D-computerized tomography reconstruction imaging. Twelve patients were retrospectively analyzed. Results: Average duration of the procedure was approximately 15 minutes. After catheter placement, urokinase-lysis ensured successful hemorrhage evacuation. Mean Glasgow coma scale at admission was 10 and mean hemorrhage diameter was 6.3 X 3.9 X 4.2 cm, or 55 mL. Mean hemorrhage reduction was 37 mL or 66% in a mean of 4 days. No catheter-related complications were observed. The 30-day and 6-month mortality rates were 16%. Mean extended Glasgow outcome scale at discharge was 4. After a mean of approximately 19 months, nine patients had a favorable, two an unfavorable outcome. One was lost to follow-up. Conclusions: In comparison with previously published results, free-hand bedside catheter evacuation is a quick and easy-to-apply technique to evacuate predominantly isolated traumatic supratentorial hemorrhage that can be performed in any intensive care unit.	[Deininger, Martin H.; Adam, Abbas; Van Velthoven, Vera] Univ Freiburg, Sch Med, Dept Neurosurg, D-79106 Freiburg, Germany		Deininger, MH (corresponding author), Univ Freiburg, Sch Med, Dept Neurosurg, Breisacher Str 64, D-79106 Freiburg, Germany.	martin.deininger@uniklinik-freiburg.de					ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 2006, NEUROSURGERY, V58; BULLOCK R, 2002, NEUROSURGERY, V58; BULLOCK R, 2002, NEUROSURGEN, V58; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; DOI E, 1982, Neurologia Medico-Chirurgica, V22, P461, DOI 10.2176/nmc.22.461; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; Kim M H, 1996, Neurosurg Focus, V1, pe2; LIPPITZ BE, 1994, ACTA NEUROCHIR, V127, P157, DOI 10.1007/BF01808759; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MATSUMOTO K, 1984, J NEUROSURG, V61, P440, DOI 10.3171/jns.1984.61.3.0440; MAYR U, 1983, NEUROCHIRURGIA, V26, P36; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; MOHADJER M, 1992, NEUROSURG REV, V15, P105, DOI 10.1007/BF00313504; NIIZUMA H, 1985, APPL NEUROPHYSIOL, V48, P427; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Rohde V, 2000, MINIM INVAS NEUROSUR, V43, P9, DOI 10.1055/s-2000-8411; ROPPER AH, 1980, ANN NEUROL, V8, P141, DOI 10.1002/ana.410080203; SCHALLER C, 1995, NEUROSURGERY, V36, P328, DOI 10.1227/00006123-199502000-00012; Teernstra OPM, 2003, STROKE, V34, P968, DOI 10.1161/01.STR.0000063367.52044.40; Tseng Sheng-Hong, 1992, Journal of the Formosan Medical Association, V91, P585; Tyler D, 1999, STEREOT FUNCT NEUROS, V72, P129, DOI 10.1159/000029712; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	28	4	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2008	65	5					1194	1199		10.1097/TA.0b013e318160dad5			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	372DD	WOS:000260881000038	19001993				2022-02-06	
J	Prigatano, GP				Prigatano, George P.			The Problem of Not Developing Normally and Pediatric Neuropsychological Rehabilitation: The Mitchell Rosenthal Lecture	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective disturbance; children; cognitive impairment; neuropsychological rehabilitation	TRAUMATIC BRAIN-INJURY; CHILDHOOD HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS; RECOVERY; OUTCOMES; FLUENCY; MEMORY; AGE	Children who suffer moderately severe-to-severe traumatic brain injury often fall I to develop normal cognitive and affective functioning necessary for independent adult living. The cognitive and psychiatric consequences of pediatric traumatic brain injury are outlined and 6 barriers to providing neuropsychological rehabilitation for these children are identified. Suggestions are made to help reduce the impact of those barriers.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,Ste 315, Phoenix, AZ 85013 USA.	george.prigatano@chw.edu					Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ARDILA A, 1994, BEHAV NEUROL, V7, P49, DOI 10.3233/BEN-1994-7202; BENDER L, 1951, Q J CHILD BEHAV, V3, P323; Bettelheim Bruno, 1975, USES ENCHANTMENT MEA; BIRCH HG, 1997, BRAIN DAMAGE CHILDRE; Braga LW, 2005, CHILD TRAUMATIC BRAI; Caplan, 1973, POWER PLAY; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR; Goldstein K, 1942, EFFECTS BRAIN INJURY; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lachar D, 1982, PERSONALITY INVENTOR; Levin H. S., 2000, CEREBRAL REORGANIZAT; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LILLARD AS, 2007, MONTESSORI SCI GENIU; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; MAX JE, 2004, PSYCHIAT SEQUELAE TR, P139; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Montessori M., 1971, SPONTANEOUS ACTIVITY; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Prigatano G. P., 2003, CLIN NEUROPSYCHOLOGY; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Prigatano GP, 2007, DEV NEUROPSYCHOL, V32, P757, DOI 10.1080/87565640701539469; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Prigatano GP, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P465; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 2005, BNI Q, V21, P4; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P81; RIVARA JMB, 1994, 4 C INT ASS STUD TRA; ROGERS SJ, 1989, J AM ACAD CHILD PSY, V28, P207, DOI 10.1097/00004583-198903000-00010; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; STRAUSS A, 1947, PSYCHOPATHOLOGY ED B; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	52	4	4	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					414	422		10.1097/01.HTR.0000341438.97745.ee			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300008	19033835				2022-02-06	
J	Yong, T; Huiyong, S; Lin, H; Yanfeng, W; Wei, Y; Yuanchen, M; Rui, Y; Jie, L; Peng, W				Yong, T.; Huiyong, S.; Lin, H.; Yanfeng, W.; Wei, Y.; Yuanchen, M.; Rui, Y.; Jie, L.; Peng, W.			Effect of intrathecal papaverine on blood flow and secondary injury in injured cord	SPINAL CORD			English	Article						acute spinal cord injury; spinal cord blood flow; papaverine; intrathecal injection	SPINAL-CORD; EVOKED-POTENTIALS; VASOSPASM; ANGIOGENESIS; IMPROVEMENT; RAT	Study design: Experimental laboratory investigations with a model of neurotrauma in Macaca rhesus. Object: The present study evaluates whether intrathecal papaverine induces changes in spinal cord blood flow (SCBF) of injured spinal cord and prevents secondary injury. Setting: Institute of Spinal Cord Injury, Sun Yat-sen University, China. Methods: After laminectomy was performed and contusive spinal cord injuries were induced in adult female Macaca rhesus, three received intrathecal papaverine, and three received saline 0.9% for control. SCBF was registered by laser-Doppler recording technique continuously for 180 min after injection. Histological analyses and microvessel density (MVD) were used for evaluation of spinal cord injury, and the percentage of spared spinal cord area was calculated. Results: Mean arterial blood pressure showed no significant change in both groups. In the papaverine group, SCBF recovered to 81.35 +/- 7.8% of baseline at 15 min, 75.24 +/- 6.3% at 30 min, 73.38 +/- 2.3% at 90 min and 72.57 +/- 4.1% at 180 min after the completion of infusion. SCBF was significantly higher than the control groups (P < 0.01). There was no occlusion of the arteries, but occluded veins were identified at the injured site. The MVD in the spinal cord of the control group was significantly lesser than the papaverine group (P < 0.01). Luxol Fast Blue staining showed that intrathecal papaverine reduced myelin loss in the lesion 2 weeks after injury (P < 0.05). Conclusion: Intrathecal administration of papaverine increased SCBF in non-human primates. It is likely that the effects of papaverine can reduce secondary injury in spinal cord injured Macaca rhesus.	[Yong, T.; Huiyong, S.; Lin, H.; Yanfeng, W.; Rui, Y.; Peng, W.] Sun Yat Sen Univ, Inst Spinal Cord Injury, Guangzhou 510120, Guangdong, Peoples R China; [Wei, Y.] GuangDong Med Coll, Dept Pharmacol, Zhanjian, Peoples R China; [Yuanchen, M.] GuangDong Prov Peoples Hosp, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Yuanchen, M.] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Anesthesia, Guangzhou 510120, Guangdong, Peoples R China		Huiyong, S (corresponding author), Sun Yat Sen Univ, Inst Spinal Cord Injury, YanJiangXi Rd 107, Guangzhou 510120, Guangdong, Peoples R China.	tangyong8888@hotmail.com					Anthes DL, 1996, NEUROSURGERY, V39, P804, DOI 10.1097/00006123-199610000-00032; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Daneyemez M, 1999, SPINE, V24, P2201, DOI 10.1097/00007632-199911010-00005; GUHA A, 1989, J TRAUMA, V29, P1440, DOI 10.1097/00005373-198910000-00025; Imamura H, 1998, SPINAL CORD, V36, P497, DOI 10.1038/sj.sc.3100662; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kiran S, 2005, J NEUROSURG, V102, P181; Kvasnicka HM, 2004, HISTOL HISTOPATHOL, V19, P1245, DOI 10.14670/HH-19.1245; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Milhorat TH, 1996, J NEUROSURG ANESTH, V8, P208, DOI 10.1097/00008506-199607000-00004; OGATA M, 1973, J NEUROSURG, V38, P20, DOI 10.3171/jns.1973.38.1.0020; SVENSSON LG, 1988, J THORAC CARDIOV SUR, V96, P823; SVENSSON LG, 1990, J VASC SURG, V11, P423, DOI 10.1067/mva.1990.17246; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; WESTMARK R, 1995, NEUROSCI LETT, V192, P173, DOI 10.1016/0304-3940(95)11638-D	18	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	NOV	2008	46	11					716	721		10.1038/sc.2008.30			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	368RH	WOS:000260639700003	18414428	Bronze			2022-02-06	
J	Bechor, R; Zadik, Y				Bechor, Ron; Zadik, Yehuda			An unusual lateral luxation of an upper incisor owing to long-term boxing without protection	DENTAL TRAUMATOLOGY			English	Article							ORAL TRAUMA; INJURIES; MOUTHGUARDS; CONCUSSION	This case report describes a lateral luxation of an upper incisor in a 19-year-old non-professional boxer. The tooth displacement gradually worsened over several months because the boxer received repeated blows to the head without using a mouthguard. Being a chronic dental trauma, rather than an acute lateral luxation, this case had several unique features: the labial plate of the alveolar bone was penetrated, the root apex was free in the vestibulum, the tooth was mobile (second degree) and radiographs revealed bone resorption. This case emphasized the need for a mouthguard to be used even with amateur boxing. The dental practitioner should educate his sportsmen-patients of the risk of sport-related dental trauma and the benefit of a mouthguard.	[Zadik, Yehuda] Israel Def Forces Med Corps, Zrifin Cent Dent Clin, Jerusalem, Israel; Israel Def Forces Med Corps, Ctr Hlth Promot & Prevent Med, Jerusalem, Israel		Zadik, Y (corresponding author), 16 Zemach St, IL-96190 Jerusalem, Israel.	yzadik@gmail.com	Zadik, Yehuda/H-7242-2019				Barth J T, 2000, Dent Clin North Am, V44, P67; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; *COUNC SCI AFF, 1983, JAMA-J AM MED ASSOC, V249, P254; CRONALARSSON G, 1989, ENDOD DENT TRAUMATOL, V5, P176; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Krasner P, 2000, Dent Clin North Am, V44, P111; Kumar S, 2004, NEUROL INDIA, V52, P270; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; LUZ JGC, 1994, ENDOD DENT TRAUMATOL, V10, P188; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; PERSSON LG, 1994, SCAND J DENT RES, V102, P367; Ranalli D N, 2000, Dent Clin North Am, V44, P35; Tulunoglu I, 2006, DENT TRAUMATOL, V22, P242, DOI 10.1111/j.1600-9657.2006.00386.x; Winters JE, 2001, J ATHL TRAINING, V36, P339	14	4	5	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	OCT	2008	24	5					550	552		10.1111/j.1600-9657.2007.00545.x			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	345UZ	WOS:000259024000021	18821961				2022-02-06	
J	O'Sullivan, JC; Fu, D; Alam, HB; McCabe, JT				O'Sullivan, Joseph C.; Fu, Dadin; Alam, Hasan B.; McCabe, Joseph T.			Diazoxide increases liver and kidney HSP25 and HSP70 after shock and stroke	JOURNAL OF SURGICAL RESEARCH			English	Article						brain ischemia; diazoxide; hyperglycaemia; lactate; mitochondria; resuscitation; shock; stroke	K-ATP CHANNELS; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; PRECONDITIONING PROTECTS; ISCHEMIA-REPERFUSION; RAT-BRAIN; MECHANISMS; SURVIVAL; LACTATE; GLYCOGEN	Background. The compound, diazoxide (DZ), is known to induce preconditioning through its effect as a mitochondrial K-ATP channel opener and succinate dehydrogenase inhibitor. Our team tested the hypothesis that pharmacological induction of ischemic preconditioning with DZ can offer cytoprotection and preserve vital tissues after hemorrhagic shock and stroke. Materials and methods. Sprague-Dawley male rats received an intraperitoneal injection of sterile saline or 5 mg/kg DZ in saline 24 h prior to I h of hemorrhagic shock, by similar to 40% total blood loss volume (Shock Study), or a permanent unilateral common carotid ligation just before shock (Stroke + Shock Study). While remaining under isoflurane anesthesia, animals then received 81 mL/kg intravenous sterile saline over the next 45 min for recovery and survived for another 24 h. Results. When DZ was administered 24 h prior to shock, it significantly reduced hyperglycemia, which in vehicle-treated animals persisted after resuscitation. DZ also attenuated hyperlactatemia during the 1-h shock period. With more severe trauma from combined stroke and shock, DZ also decreased hyperlactatemia and hyperglycemia levels but the reduction was only significant for hyperglycemia. The expression levels of heat shock proteins 25 (HSP25) and 70 (HSP70) were used as biomarkers for response of the kidney and liver to DZ and combined stroke and shock. Compared to vehicle-treated animals, DZ-treated rats subjected to shock and stroke exhibited increased HSP25 and HSP70 in kidney and liver tissue. Conclusions. DZ-attenuated physiological indicators of metabolic stress following shock or combined shock and stroke and enhanced the up-regulation of cytoprotective heat shock protein expression. (c) 2008 Elsevier Inc. All rights reserved.	[McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [O'Sullivan, Joseph C.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA; [Fu, Dadin] Armed Forces Radiobiol Res Inst, Bethesda, MD USA; [Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	JMcCabe@usuhs.mil	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442	Tri-Service Nursing Research Program [MDA905-04-1-TS06]; USUHS Exploratory [HO70PG]	The authors hereby state that there is no conflict of interest. The opinions or assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense or the Uniformed Services University of the Health Sciences. This study was supported by Grant MDA905-04-1-TS06 from the Tri-Service Nursing Research Program to LTC O'Sullivan and USUHS Exploratory Grant HO70PG to Dr. McCabe.	ANDERSON CT, 1977, AM J CLIN PATHOL, V68, P63; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Baines CP, 1999, AM J PHYSIOL-HEART C, V276, pH1361, DOI 10.1152/ajpheart.1999.276.4.H1361; Barnett V, 1994, OUTLIERS STAT DATA, V3rd; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Bidmon B, 2000, KIDNEY INT, V58, P2400, DOI 10.1046/j.1523-1755.2000.00423.x; Boeri D, 2003, EUR J CLIN INVEST, V33, P500, DOI 10.1046/j.1365-2362.2003.01157.x; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brustovetsky T, 2005, J PHYSIOL-LONDON, V568, P47, DOI 10.1113/jphysiol.2005.091199; Caparrelli DJ, 2002, ANN THORAC SURG, V74, P838, DOI 10.1016/S0003-4975(02)03716-5; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Drose S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hausenloy DJ, 2004, AM J PHYSIOL-HEART C, V287, pH841, DOI 10.1152/ajpheart.00678.2003; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jansson L, 2003, DIABETES, V52, P2043, DOI 10.2337/diabetes.52.8.2043; Kristiansen SB, 2005, J CARDIOVASC PHARM, V45, P456, DOI 10.1097/01.fjc.0000159045.35241.95; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Mannhold R, 2004, MED RES REV, V24, P213, DOI 10.1002/med.10060; Menguy R, 1978, Adv Shock Res, V1, P43; Minners J, 2007, MOL CELL BIOCHEM, V294, P11, DOI 10.1007/s11010-005-9066-6; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; Munoz A, 2003, STROKE, V34, P164, DOI 10.1161/01.STR.0000048215.36747.D1; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; O'Sullivan JC, 2007, J NEUROTRAUM, V24, P532, DOI 10.1089/neu.2006.0128; Ohno Y, 1997, INT J CARDIOL, V62, P181, DOI 10.1016/S0167-5273(97)00270-2; Pasupathy S, 2005, EUR J VASC ENDOVASC, V29, P106, DOI 10.1016/j.ejvs.2004.11.005; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Raeburn CD, 2002, J CARDIAC SURG, V17, P536, DOI 10.1046/j.1540-8191.2002.01009.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; RHODES RS, 1978, J SURG RES, V24, P507, DOI 10.1016/0022-4804(78)90049-5; Seharaseyon J, 2000, J MOL CELL CARDIOL, V32, P1923, DOI 10.1006/jmcc.2000.1226; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; STENE JK, 1991, TRAUMA ANESTHESIA; Sumioka I, 2004, LIFE SCI, V74, P2551, DOI 10.1016/j.lfs.2003.10.011; Tamion F, 2002, AM J PHYSIOL-GASTR L, V283, pG408, DOI 10.1152/ajpgi.00348.2001; Tsai BM, 2004, SHOCK, V21, P195, DOI 10.1097/01.shk.0000114828.98480.e0; Yellon DM, 2005, NAT CLIN PRACT CARD, V2, P568, DOI 10.1038/ncpcardio0346; Zindrou D, 2001, DIABETES CARE, V24, P1634, DOI 10.2337/diacare.24.9.1634	44	4	4	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2008	149	1					120	130		10.1016/j.jss.2007.12.750			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	340GD	WOS:000258633200018	18222477				2022-02-06	
J	Guan, JT; Xu, XH; Geng, YQ; Yu, XJ; Wu, RH				Guan, Ji-Tian; Xu, Xiao-Hu; Geng, Yi-Qun; Yu, Xiao-Jun; Wu, Ren-Hua			Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy	BRAIN RESEARCH			English	Article						proton magnetic; resonance spectroscopy; pons; metabolic ratios	TRAUMATIC BRAIN-INJURY; MR SPECTROSCOPY; CEREBELLUM; HIPPOCAMPUS; DISEASE; H-1; AGE	Objective: To determine the normal mean reference normal value for metabolic ratios in the pons of healthy adult Chinese subjects by using proton magnetic resonance spectroscopy (1HMRS). Materials and methods: Eighty healthy Chinese subjects, ranging in age from 21 to 60 years, were divided into four groups, each containing 20 subjects per decade. The pons of every subject was scanned on single-voxel 1HMRS by using the point-resolved proton spectroscopy sequence (PRESS) with echo time (TE) = 144 ms and repetition time (TR) = 1500 ms. Results: The total mean ratios of N-acetylasparate/creatine-phosphocreatine (NAA/Cr), NAA/choline-containing compounds (Cho) and Cho/Cr in subjects ranging from 21 to 60 years were 2.13 +/- 0.07, 1.22 +/- 0.11 and 1.81 +/- 0.09 respectively. The highest metabolite ratios were seen in the 41-50 year group. There was no significant difference with respect to age or gender. Conclusions: The ratios of NAA/Cr, NAA/Cho or Cho/Cr in the pons did not correlate with the age or gender of healthy subjects. (C) 2008 Elsevier B.V. All rights reserved.	[Geng, Yi-Qun] Joint Shantou Int Eye Ctr, Cent Lab, Shantou 515041, Guangdong, Peoples R China; [Guan, Ji-Tian; Wu, Ren-Hua] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Radiol, Shantou 515041, Guangdong, Peoples R China; [Xu, Xiao-Hu; Yu, Xiao-Jun] Shantou Univ Med Coll, Dept Forens Med, Shantou 515041, Guangdong, Peoples R China		Xu, XH (corresponding author), Shantou Univ Med Coll, Dept Forens Med, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	jtguan@126.com; xhxu@stu.edu.cn; yqgeng@126.com; xjyu@stu.edu.cn; rhwu@stu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30213914, 30570480]; Science and Technology Planning Project of Shantou	The authors are indebted to PhD. Zhw Shen for providing technical assistance. This study was supported in part by grants from National Natural Science Foundation of China (30213914 and 30570480) and Science and Technology Planning Project of Shantou.	Alchanatis M, 2004, EUR RESPIR J, V24, P980, DOI 10.1183/09031936.04.00127603; Angelie E, 2001, AM J NEURORADIOL, V22, P119; Appenzeller S, 2005, BRAIN, V128, P2933, DOI 10.1093/brain/awh646; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; Delamillieure P, 2002, SCHIZOPHRENIA BULL, V28, P329, DOI 10.1093/oxfordjournals.schbul.a006942; Dixon RM, 2002, BRAIN, V125, P2332, DOI 10.1093/brain/awf226; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Haselhorst T, 2005, BIOCHEM BIOPH RES CO, V327, P565, DOI 10.1016/j.bbrc.2004.12.040; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Mascalchi M, 2002, RADIOLOGY, V223, P371, DOI 10.1148/radiol.2232010722; Mascalchi M, 2002, J MAGN RESON IMAGING, V16, P532, DOI 10.1002/jmri.10189; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Raz N, 2001, AM J NEURORADIOL, V22, P1161; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Song X, 2007, BIOCHEM BIOPH RES CO, V360, P103, DOI 10.1016/j.bbrc.2007.06.014; Warmuth-Metz M, 2001, ARCH NEUROL-CHICAGO, V58, P1076, DOI 10.1001/archneur.58.7.1076	19	4	4	2	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 28	2008	1227						221	225		10.1016/j.brainres.2008.06.019			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352PY	WOS:000259510700023	18602897				2022-02-06	
J	Gschwentner, M; Arora, R; Wambacher, M; Gabl, M; Lutz, M				Gschwentner, Martin; Arora, Rohit; Wambacher, Markus; Gabl, Markus; Lutz, Martin			Distal forearm fracture in the adult: is ORIF of the radius and closed reduction of the ulna a treatment option in distal forearm fracture?	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						distal forearm fracture; young adult; radius plate fixation; ulna; closed reduction; pin fixation	INTRAARTICULAR FRACTURES; UNSTABLE FRACTURES; RADIOULNAR JOINT; YOUNG-ADULTS; FIXATION; LESIONS; END	Introduction Distal forearm fractures in younger adults are rare injuries resulting from high energy trauma. Treatment options vary from cast fixation, external fixator, percutaneus pinning and open reduction and internal fixation. Method We retrospectively reviewed 13 patients aged 18-59 from 1996 to 2005 with a distal unstable forearm fracture. All were treated with open reduction and internal fixation of the radius. The ulna was stabilized either by an open reduction and internal fixation or by a closed reduction with or without pin fixation and cast fixation in all cases. At follow-up, we evaluated the radiologic results in terms of forearm fracture retention and functional outcome according to the wrist score by Krimmer. Result Radial inclination amounted to 24 degrees at the injured side when compared to 27 degrees at the non-injured side, palmar tilt was 3 degrees versus 7 degrees and ulna variance was -2 versus -1 mm. According to the modified wrist score by Krimmer, seven excellent, two good and four fair results were achieved. The range of motion of the injured wrist joint was 149 degrees of rotation, in the sagittal plane 106 degrees, frontal plane 61 degrees and on the non-injured side rotation was 171 degrees, and movement in the sagittal plane was 146 degrees and 79 degrees in the frontal plane. Decreased forearm rotation (107 degrees vs. 162 degrees) and decreased range of motion in the sagittal plane (77 degrees vs. 114 degrees) were measured in patient following open reduction and internal fixation of radius and ulna compared to the outcome in patients with open reduction and internal fixation of the radius and closed reduction of the ulna. Grip strength of the injured side averaged 350 N versus 440 N which is 76% of that of the opposite side. All patients stated no pain at rest and some experienced slight pain at work. Three patients had an excellent performance at daily activities, nine patients presented problems with certain activities, and one patient showed severe limitations. Conclusions Open reduction and internal fixation of the radius is the keystone in treating distal forearm fracture. In case of stable retention of the ulnar head after closed reduction, cast fixation with or without percutaneus pin fixation is a sufficient method to treat unstable distal forearm fractures. In patients with remaining instability of the distal ulna fracture, ORIF is indicated.	[Gschwentner, Martin; Arora, Rohit; Wambacher, Markus; Gabl, Markus; Lutz, Martin] Med Univ Innsbruck, Dept Trauma Surg & Sportsmed, A-6020 Innsbruck, Austria		Gschwentner, M (corresponding author), Med Univ Innsbruck, Dept Trauma Surg & Sportsmed, Anichstr 35, A-6020 Innsbruck, Austria.	martin.gschwentner@i-med.ac.at; rohit.arora@uki.at; markus.wambacher@uki.at; markus.gabl@uki.at; martin.lutz@uki.at		Gabl, Markus/0000-0001-7459-2756; Wambacher, Markus/0000-0001-9190-3659			AUFRANC OE, 1968, JAMA-J AM MED ASSOC, V205, P296; BIYANI A, 1995, J HAND SURG-BRIT EUR, V20B, P357, DOI 10.1016/S0266-7681(05)80094-4; Bossi E, 1984, Ital J Orthop Traumatol, V10, P341; Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322; Dennison DG, 2007, J HAND SURG-AM, V32A, P801, DOI 10.1016/j.jhsa.2007.03.010; Flinkkila T, 2003, ARCH ORTHOP TRAUM SU, V123, P349, DOI 10.1007/s00402-003-0539-3; Forward DP, 2007, J BONE JOINT SURG AM, V89A, P2334, DOI 10.2106/JBJS.F.01537; Geissler WB, 1996, CLIN ORTHOP RELAT R, P135; Geissler WB, 1996, J BONE JOINT SURG AM, V78A, P357, DOI 10.2106/00004623-199603000-00006; Goldfarb CA, 2006, J HAND SURG-AM, V31A, P633, DOI 10.1016/j.jhsa.2006.01.008; Green D P, 1978, J Hand Surg Am, V3, P250; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HAGERT CG, 1992, CLIN ORTHOP RELAT R, P56; KNIRK JL, 1986, J BONE JOINT SURG AM, V68A, P647, DOI 10.2106/00004623-198668050-00003; Krimmer H, 2000, Handchir Mikrochir Plast Chir, V32, P369, DOI 10.1055/s-2000-10915; Lindau T, 1997, J HAND SURG-BRIT EUR, V22B, P638, DOI 10.1016/S0266-7681(97)80364-6; Lutz M, 2007, HANDCHIR MIKROCHIR P, V39, P54, DOI 10.1055/s-2007-964925; McKee MD, 1997, J ORTHOP TRAUMA, V11, P49, DOI 10.1097/00005131-199701000-00015; Muller M., 1990, COMPREHENSIVE CLASSI; PALMER AK, 1984, J HAND SURG-AM, V9A, P681, DOI 10.1016/S0363-5023(84)80013-1; Pechlaner S, 2002, Handchir Mikrochir Plast Chir, V34, P150, DOI 10.1055/s-2002-33682; PECHLANER S, 1993, ORTHOPADE, V22, P46; PRINCE H, 1988, J HAND SURG-BRIT EUR, V13B, P294, DOI 10.1016/0266-7681(88)90091-5; Ring D, 2004, J HAND SURG-AM, V29A, P103, DOI 10.1016/j.jhsa.2003.10.019; ROSSILLON D, 1987, Annales de Chirurgie de la Main, V6, P25, DOI 10.1016/S0753-9053(87)80004-2; Walz M, 2006, UNFALLCHIRURG, V109, P1058, DOI 10.1007/s00113-006-1185-3; Wigg AER, 2003, J TRAUMA, V55, P87, DOI 10.1097/01.TA.0000038544.45839.3D	27	4	4	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2008	128	8					847	855		10.1007/s00402-008-0645-3			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	330AU	WOS:000257912500013	18465137				2022-02-06	
J	Zhang, ZG; Tsui, KM; Chan, SC; Lau, WY; Aboy, M				Zhang, Z. G.; Tsui, K. M.; Chan, S. C.; Lau, W. Y.; Aboy, M.			A novel method for nonstationary power spectral density estimation of cardiovascular pressure signals based on a Kalman filter with variable number of measurements	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						cardiovascular pressure signal; Kalman filter; power spectral density; time-varying autoregressive process; traumatic brain injury		We present a novel parametric power spectral density (PSD) estimation algorithm for nonstationary signals based on a Kalman filter with variable number of measurements (KFVNM). The nonstationary signals under consideration are modeled as time-varying autoregressive (AR) processes. The proposed algorithm uses a block of measurements to estimate the time-varying AR coefficients and obtains high-resolution PSD estimates. The intersection of confidence intervals (ICI) rule is incorporated into the algorithm to generate a PSD with adaptive window size from a series of PSDs with different number of measurements. We report the results of a quantitative assessment study and show an illustrative example involving the application of the algorithm to intracranial pressure signals (ICP) from patients with traumatic brain injury (TBI).	[Zhang, Z. G.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Z. G.; Tsui, K. M.; Chan, S. C.; Lau, W. Y.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Aboy, M.] Oregon Inst Technol, Dept Elect Engn Technol, Portland, OR USA		Zhang, ZG (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	zgzhang@eee.hku.hk	Tsui, Kai Man/C-1768-2009; Zhang, Zhiguo/C-1775-2009; Aboy, Mateo/K-4060-2019	Aboy, Mateo/0000-0002-5168-4321			Aboy M, 2004, P ANN INT IEEE EMBS, V26, P129; Aboy M, 2005, IEEE T BIO-MED ENG, V52, P1485, DOI 10.1109/TBME.2005.851465; Akay M, 1998, TIME FREQUENCY WAVEL; Cohen L., 1995, TIME FREQUENCY ANAL, P113; Durovic ZM, 1999, IEEE T AUTOMAT CONTR, V44, P1292, DOI 10.1109/9.769393; GUSTAFSSON BD, 1995, LITHISYR1709 LINK U; Kay S. M., 1998, MODERN SPECTRAL ESTI; KITAGAWA G, 1985, IEEE T AUTOMAT CONTR, V30, P48, DOI 10.1109/TAC.1985.1103788; KITAGAWA G, 1983, J SOUND VIB, V89, P433, DOI 10.1016/0022-460X(83)90547-3; KOVACEVIC B, 1992, INT J CONTROL, V56, P547, DOI 10.1080/00207179208934328; MALLAT S, 1998, WAVELET TOUR SIGNAL, P76; MANOLAKIS DG, 2000, STAT ADAPTIVE SIGNAL, V260, P445; PROAKIS J, 2002, ALGORITHMS STAT SIGN, P432; QIAN S, 2002, INTRO TIME FREQUENCY, P99; RANGAYYAN RM, 2002, BIOMEDICAL SIGNAL AN, P277; Stankovic L, 1999, IEEE T SIGNAL PROCES, V47, P1099, DOI 10.1109/78.752607; Tkacenko A, 2001, J FRANKLIN I, V338, P517, DOI 10.1016/S0016-0032(01)00025-4	17	4	4	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	AUG	2008	46	8					789	797		10.1007/s11517-008-0351-x			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	332YB	WOS:000258117900006	18496723				2022-02-06	
J	Escobar, MI; Guzman, F; Buritica, E; Riascos, D; Villamil, L; Pimienta, H				Isabel Escobar, Martha; Guzman, Francisco; Buritica, Efrain; Riascos, David; Villamil, Liliana; Pimienta, Hernan			Changes in laminar and dendritic organization of the cerebral cortex after traumatic brain injury	COLOMBIA MEDICA			Spanish	Article						Traumatic brain injury; MAP2; NeuN; Human cerebral cortex	MICROTUBULE-ASSOCIATED PROTEIN-2; CELL LOSS; NEUN	Introduction: Traumatic brain injury (TBI) is a heterogeneous phenomenon from a molecular, cellular and pathological perspective. Clinical outcome is also extremely variable. It is considered that such a diversity response to TBI is related to the primary injury intensity, associated secondary events (hypoxia, ischemia, oedema and inflammation), metabolic patient state, genetic background, age, gender, etc. After injury the histopathological outcome is variable in time and space. In order to determine the anatomofunctional integrity of nerve cells in the cerebral cortex, it is important to verify the state of the cito and dendroarchitecture and the laminar preservation as a requisite to guarantee connectivity. Objective: The aim of the present work was to evaluate the response of human cortical neurons using two selective neuronal markers, NeuN and MAP2, which recognize citoarchitecture and dendritic arrangement, respectively. Materials and methods: In the present study we utilized six tissue samples (4 temporal and 2 frontal cortices) from TBI patients. Tissues from four post-mortem human brains were used as controls. Tissue samples were fixed in PLP, cut at 50 um in a vibratome, incubated with NeuN and MAP2 and processes with the avidin/biotin complex. Results: NeuN-IR was abnormal in all samples analyzed with some sectors showing slight NeuN-IR, others with NeuN-IR partial loss in supragranular layers, especially layer IIII, and other with a drastic reduction in staining in all cortical layers. MAP2-IR was altered across sections with sectors showing different degrees of changes in the normal pattern of MAP2-IR. Dendritic processes were difficult to follow because of its discontinuity. Layer V apical dendritic processes appear tortuous and its IR was fragmented in some cases they take aberrant orientations. Conclusions: in order to get new insights about the neuronal outcome after brain injury it is recommended to use MAP2- and NeuN-IR as a complement of classical histopathological methods. The present study shows a diversity of histopathological response in adjacent sectors of a same sample with both markers MAP2 and NeuN, as an indicative of different states of neurodegeneration.	[Isabel Escobar, Martha; Pimienta, Hernan] Univ Valle, Ctr Estudios Cerebrales, Fac Salud, Cali, Colombia		Escobar, MI (corresponding author), Univ Valle, Ctr Estudios Cerebrales, Fac Salud, Cali, Colombia.	maiesbe@yahoo.com; frangupe@hotmail.com; triburi@yahoo.com; davisdarm@gmx.net; lilika_villamil@hotmail.om; hernpim@yahoo.com	Escobar, Martha Isabel/C-3310-2011; Buritica, Efrain/C-3315-2011; Pimienta Jimenez, Hernan Jose/C-3147-2011; Escobar, Martha/E-4288-2015	Pimienta, Hernan/0000-0002-8254-2078; Escobar, Martha/0000-0002-0036-7473			Akulinin VA, 2003, NEUROCHEM RES, V28, P373, DOI 10.1023/A:1022401922669; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; DUBIN AB, 1977, RADIOLOGY, V122, P365; ESCOBAR MI, 1986, NEUROSCIENCE, V17, P975, DOI 10.1016/0306-4522(86)90074-6; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haranishi Y, 2005, EUR J ANAESTH, V22, P140, DOI 10.1017/S0265021505000268; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kuhn J, 2005, ACTA NEUROPATHOL, V110, P579, DOI 10.1007/s00401-005-1090-9; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Macaya A, 2000, REV NEUROLOGIA, V31, P784, DOI 10.33588/rn.3108.2000327; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com	20	4	4	0	4	CORPORACION EDITORA MEDICA VALLE	CALI	UNIV VALLE, BLDG 118 FACULTY HEALTH, CALLE 4B 36-00, CALI, 00000, COLOMBIA	1657-9534			COLOMB MEDICA	Colomb. Medica	JUL-SEP	2008	39	3		3			51	59					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383IW	WOS:000261668300008					2022-02-06	
J	Liu, BY; Tian, YJ; Zhang, YQ; Zhang, W				Liu, Baiyun; Tian, Yongji; Zhang, Yuqi; Zhang, Wen			Therapeutic effect analysis of acute traumatic brain injuries	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; retrospective analysis; intracranial pressure monitoring	DECOMPRESSIVE CRANIECTOMY; MANAGEMENT	Objective: To explore the factors determining the prognosis of acute traumatic brain injury (TBI) by retrospectively analysing the clinical data. Methods: During the last 5 years, 2500 acute TBI cases were admitted into our department. We analysed the survival and mortality rates to evaluate the therapeutic outcome, the effect of emergency operation and the effect of intracranial pressure monitoring (ICPM) on the mortality of severe TBI. Results: The mortalities of TBI in the severe (GCS <= 8), moderate (GCS=9-12) and slight (GCS=13-15) groups were 39, 12 and 0%, respectively. The clinical course could be classified into three different phases: the acute phase (, 1 week), the subacute phase or transition period (1-3 weeks) and the chronic phase (. 3 weeks). Of all the patients who became deceased in this study, similar to 80% was due to intractable intracranial hypertension during the acute phase, nearly 20% was due to multiple organ failure (including the lungs, kidneys, and heart), and <2% was due to chronic body consumption. A different therapeutic focus must be emphasized in each of the three phases. Emergency operation and ICPM could decrease the mortality to 32 and 36%, respectively. Conclusion: Recognition of clinical features during different phases is the key for the neurosurgeon to establish an early and appropriate treatment (including emergency operation and ICPM) to reduce the mortality.	[Liu, Baiyun; Tian, Yongji; Zhang, Yuqi] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Wen] Cent Hosp, Dept Neurosurg, Chaoyang City, Liaoning, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	liubaiyun1212@yahoo.com.cn					*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; WALD SL, 1995, SURG CLIN N AM, V75, P225, DOI 10.1016/S0039-6109(16)46585-0; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; YI SY, 2000, DIAGNOSIS TREATMENT, P3	11	4	6	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2008	30	6					594	597		10.1179/174313208X310296			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333FB	WOS:000258137300010	18647499				2022-02-06	
J	Padovani, AR; Moraes, DP; de Medeiros, GC; de Almeida, TM; de Andrade, CRF				Padovani, Aline Rodrigues; Moraes, Danielle Pedroni; de Medeiros, Gisele Chagas; de Almeida, Tatiana Magalhaes; Furquim de Andrade, Claudia Regina			Orotracheal intubation and dysphagia: comparison of patients with and without brain damage	EINSTEIN-SAO PAULO			English	Article						Deglutition disorders; Intubation; intratracheal; Brain injuries		Objectives: To compare the swallowing and feeding abilities in extubated patients with and without brain injury. Methods: A retrospective study including 44 patients aged 20 to 50 years submitted to prolonged orotracheal intubation (> 48 hours). Two groups were analyzed: Group 1 composed of nontraumatic brain injury patients, and Group 2 composed of patients with traumatic brain injury. Two scales for characterization of functional swallowing and feeding abilities were used to compare both groups; the levels of alertness, awareness and patient collaboration were also assessed. Results: The groups were equal in age, number and time of orotracheal intubation and extubation on the date of the assessment. Regarding the speech and language diagnosis, Group 1 presented higher percentage of functional swallowing and mild dysphagia, while Group 2 showed higher rates of moderate to severe dysphagia and severe dysphagia. The Functional Oral Intake Scale average was higher in Group 1. In addition, the injured brain group was sleepier, less collaborative and had less contact in the first evaluation. Conclusions: In this study, patients who underwent prolonged orotracheal intubation had dysphagia in different degrees, but the patients with brain injury presented more frequent and severe disorder. Thus, this study suggested that orotracheal intubation cannot be considered as the single factor causing dysphagia, especially in neurological patients. Moreover, some cognitive factors may influence the possibility of providing oral feeding.	[Padovani, Aline Rodrigues; Moraes, Danielle Pedroni; de Medeiros, Gisele Chagas; de Almeida, Tatiana Magalhaes] Univ Sao Paulo HC FMUSP, Hosp Clin, Fac Med, Inst Cent, Sao Paulo, SP, Brazil; [Furquim de Andrade, Claudia Regina] Univ Sao Paulo FMUSP, Fac Med, Dept Phys Therapy Speech Pathol Audiol & Occupat, Sao Paulo, SP, Brazil		de Andrade, CRF (corresponding author), Rua Cipotanea 51,Cidade Univ, BR-05360000 Sao Paulo, SP, Brazil.	clauan@usp.br	Andrade, Claudia F/D-2187-2012				Ajemian MS, 2001, ARCH SURG-CHICAGO, V136, P434, DOI 10.1001/archsurg.136.4.434; Barquist E, 2001, CRIT CARE MED, V29, P1710, DOI 10.1097/00003246-200109000-00009; Camargo F.A., 2003, THESIS; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; DELARMINAT V, 1995, CRIT CARE MED, V23, P486, DOI 10.1097/00003246-199503000-00012; El Solh A, 2003, INTENS CARE MED, V29, P1451, DOI 10.1007/s00134-003-1870-4; Garcia JM, 2005, DYSPHAGIA, V20, P325, DOI 10.1007/s00455-005-0034-9; Goldsmith T, 2000, INT ANESTHESIOL CLIN, V38, P219, DOI 10.1097/00004311-200007000-00013; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Kunigk Michele Ramos Grigio, 2007, Rev. soc. bras. fonoaudiol., V12, P287, DOI 10.1590/S1516-80342007000400006; Leder SB, 1998, DYSPHAGIA, V13, P208, DOI 10.1007/PL00009573; Logemann JA, 1999, DYSPHAGIA, V14, P44, DOI 10.1007/PL00009583; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Padovani Aline Rodrigues, 2007, Rev. soc. bras. fonoaudiol., V12, P199, DOI 10.1590/S1516-80342007000300007; Perlman AL, 2000, DYSPHAGIA, V15, P89, DOI 10.1007/s004550010006; Postma GN, 2007, LARYNGOSCOPE, V117, P1720, DOI 10.1097/MLG.0b013e31811ff906; de Leon AR, 2007, REV ESP ENFERM DIG, V99, P3, DOI 10.4321/s1130-01082007000100002; Terre R, 2006, NEUROGASTROENT MOTIL, V18, P200, DOI 10.1111/j.1365-2982.2005.00729.x; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Wilkins C.H., 2005, ANN LONG TERM CARE, V13, P17	24	4	7	0	0	INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN	SAO PAULO SP	AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL	1679-4508	2317-6385		EINSTEIN-SAO PAULO	Einstein	JUL-SEP	2008	6	3					343	349					7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V7C0O	WOS:000420822900017					2022-02-06	
J	Little, RD				Little, Robert D.			Increased Intracranial Pressure	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						intracranial hypertension; traumatic brain injury; intracranial pressure; child	TRAUMATIC-BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; PEDIATRIC-PATIENTS; UNITED-STATES; CHILDREN; HYPERTENSION; MANAGEMENT; HYPOTHERMIA	Increased intracranial pressure is associated with high morbidity and mortality, but prompt treatment can improve outcomes. Traumatic brain injury is the most common cause of increased intracranial pressure, and it results in many hospitalizations and emergency department visits every year. The optimal treatment of intracranial hypertension is not known, and further clinical studies are needed, particularly in children. However, there are many treatments available for increased intracranial pressure. This article reviews the pathophysiology of increased intracranial pressure, common clinical features of intracranial hypertension and cerebral herniation, and evidence for the treatment of increased intracranial pressure in children. (C) 2008 Elsevier Inc. All rights reserved.	[Little, Robert D.] Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA		Little, RD (corresponding author), Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	rlittle@phoenixchildrens.com					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bleck TP, 2003, TXB CLIN NEUROLOGY, P1; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; FANCONI S, 1988, INTENS CARE MED, V14, P163; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Haden RL, 1919, J AMER MED ASSOC, V73, P983, DOI 10.1001/jama.1919.02610390035011; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Posner J., 2007, DIAGNOSIS STUPOR COM, V4th; Ramani R, 2006, CURR OPIN ANESTHESIO, V19, P487, DOI 10.1097/01.aco.0000245272.84539.97; Ropper A. H., 2005, ADAMS VICTORS PRINCI, P529; ROPPER AH, 1989, NEUROLOGY, V39, P622, DOI 10.1212/WNL.39.5.622; ROPPER AH, 1993, J NEUROL NEUROSUR PS, V56, P932, DOI 10.1136/jnnp.56.8.932; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	42	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	JUN	2008	9	2					83	87		10.1016/j.cpem.2008.03.003			5	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5F0T	WOS:000219549400004					2022-02-06	
J	Murthy, TVSP				Murthy, T. V. S. P.			Propofol in Neurotrauma	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						propofol; neuroprotection; traumatic brain injury		Propofol (2,6-diisopropylphenol) is one of the most popular agents used for induction of anesthesia and long-term sedation, owing to its favorable pharmacokinetic profile, which ensures a rapid recovery even after prolonged administration. Propofol is used widely as a sedative agent in neurosurgical critical care because it is generally assumed that it has properties that are advantageous to the injured brain. Propofol is believed to maintain, or even improve, cerebral autoregulation, indeed even high doses of this drug do not obtund autoregulation or carbon dioxide reactivity. A neuroprotective effect, beyond that related to the decrease in cerebral metabolic rate for oxygen, has been shown to play an important role in the so-called multimodal neuroprotection, a global strategy for the treatment of acute injury of the brain that includes preservation of cerebral perfusion, temperature control, prevention of infections, and tight glycaemic control.	[Murthy, T. V. S. P.] Army Hosp Res & Referral, Dept Anesthesiol & Intens Care, Neuroanesthesiol, Delhi 110010, India		Murthy, TVSP (corresponding author), Army Hosp Res & Referral, Dept Anesthesiol & Intens Care, Neuroanesthesiol, Delhi 110010, India.	tvspmurthy@yahoo.com					Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; BORGEAT A, 1994, CAN J ANAESTH, V41, P1117, DOI 10.1007/BF03015664; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; FOX J, 1992, ANESTHESIOLOGY, V77, P453, DOI 10.1097/00000542-199209000-00008; Gupta A, 2004, ANESTH ANALG, V98, P632, DOI 10.1213/01.ANE.0000103187.70627.57; Ishii H, 2002, BRIT J ANAESTH, V88, P412, DOI 10.1093/bja/88.3.412; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; KANTO J, 1989, CLIN PHARMACOKINET, V17, P308, DOI 10.2165/00003088-198917050-00002; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kay B, 1977, Acta Anaesthesiol Belg, V28, P303; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Mortero RF, 2001, ANESTH ANALG, V92, P1465; NICOL B, 1995, BRIT J ANAESTH, V75, P61, DOI 10.1093/bja/75.1.61; ORSER BA, 1994, J NEUROSCI, V14, P7747; Patel P, 2004, ANESTHESIOLOGY, V100, P1049, DOI 10.1097/00000542-200405000-00003; Preckel B, 2006, ANESTHESIOLOGY, V105, P187, DOI 10.1097/00000542-200607000-00029; Ratnakumari L, 1997, ANESTHESIOLOGY, V86, P428, DOI 10.1097/00000542-199702000-00018; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; TODD MM, 1992, ANESTHESIOLOGY, V76, P161; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Walder B, 2002, NEUROLOGY, V58, P1327, DOI 10.1212/WNL.58.9.1327; Williams DB, 2002, J NEUROSCI, V22, P7417; Wysowski DK, 2006, ANESTHESIOLOGY, V105, P1047, DOI 10.1097/00000542-200611000-00027	25	4	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2008	5	1					41	44		10.1016/S0973-0508(08)80028-7			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0G	WOS:000218378100010					2022-02-06	
J	Prakash, R; Rai, R; Ranade, AV; Prabhu, LV; Pai, MM; Singh, G				Prakash, R.; Rai, Rajalakshmi; Ranade, Anu Vinod; Prabhu, Latha V.; Pai, Mangala M.; Singh, Gajendra			Multiple Variations of Extensor Muscles of Forearm in Relation to the Radial Nerve: a Case Report and Review	INTERNATIONAL JOURNAL OF MORPHOLOGY			English	Article						Anatomical variations; Development; Extensor carpi radialis longus and brevis muscles; Forearm; Radial nerve	TUNNEL; BREVIS	During routine dissection in the Department of Anatomy, multiple variations of forearm muscles in relation to the radial nerve and its branches were observed on the right side of a 34 year old male cadaver. Brachioradialis close to its origin was receiving muscle fibers from the brachialis and the radial nerve was passing in between them. Extensor carpi radialis brevis was absent and the extensor carpi radialis longus was giving two tendons in the second compartment of extensor retinaculum before its insertion while passing deep to the abductor pollicis longus. Absence of extensor carpi radialis brevis can be explained with the arrangement in lower mammals, where the two extensores carpi radiales are represented by one muscle. Ontogeny repeats phylogeny and anatomical variations have developmental basis. Hence, the pattern of muscular arrangement in this case can be said to be less evolved than the usual arrangement. The course of radial nerve between the two heads of brachioradialis makes it highly vulnerable to compression and injury, which may manifest as wrist drop (radial nerve palsy) or radial tunnel syndrome (compression of posterior interosseous nerve).	[Prakash, R.; Rai, Rajalakshmi; Ranade, Anu Vinod; Prabhu, Latha V.; Pai, Mangala M.] Kasturba Med Coll & Hosp, Ctr Basic Sci, Dept Anat, Mangalore 575004, Karnataka, India; [Singh, Gajendra] Banaras Hindu Univ, Inst Med Sci, Dept Anat, Varanasi 221005, Uttar Pradesh, India		Prakash, R (corresponding author), Kasturba Med Coll & Hosp, Ctr Basic Sci, Dept Anat, Mangalore 575004, Karnataka, India.	prakashrinku@rediffmail.com	Rai, Rajalakshmi/G-8727-2015; Ranade, Anu Vinod/AAU-4965-2020; BV, Murlimanju/T-8078-2018	Rai, Rajalakshmi/0000-0003-0776-2254; Ranade, Anu Vinod/0000-0002-7663-8532; BV, Murlimanju/0000-0003-1248-8296; Pai, Mangala/0000-0001-6995-5807; Prabhu, Latha/0000-0002-1386-0099			ANSON BJ, 1971, SURG ANATOMY, P1012; BERGMAN RA, 1988, COMPENDIUM HUMAN ANA, P138; Caetano M. F., 2004, INT J MORPHOL, V22, P245; Claassen H, 2002, ANN ANAT, V184, P489, DOI 10.1016/S0940-9602(02)80084-X; Ferdinand BD, 2006, RADIOLOGY, V240, P161, DOI 10.1148/radiol.2401050028; Hollinshead WH, 1969, ANATOMY SURG BACK LI, V3, P428; Kirici Y, 2004, NEUROL MED-CHIR, V44, P14, DOI 10.2176/nmc.44.14; Laulan J, 1994, Ann Chir Main Memb Super, V13, P366, DOI 10.1016/S0753-9053(05)80075-4; Loh Y C, 2004, J Orthop Surg (Hong Kong), V12, P83; PRASARTRITHA T, 1993, J HAND SURG-AM, V18A, P107, DOI 10.1016/0363-5023(93)90253-Y	10	4	4	0	3	SOC CHILENA ANATOMIA	TEMUCO	CASILLA 54-D, TEMUCO, 00000, CHILE				INT J MORPHOL	Int. J. Morphol.	JUN	2008	26	2					447	449		10.4067/S0717-95022008000200034			3	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	385IZ	WOS:000261809200034		Green Published, gold, Green Submitted			2022-02-06	
J	Trzaska, KA; Castillo, MD; Rameshwar, P				Trzaska, Katarzyna A.; Castillo, Marianne D.; Rameshwar, Pranela			Adult mesenchymal stem cells in neural regeneration and repair: Current advances and future prospects (Review)	MOLECULAR MEDICINE REPORTS			English	Article						stem cells; neural repair; regeneration; cell therapy	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; BONE-MARROW; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; NEURONAL DIFFERENTIATION; PARKINSONS-DISEASE; RODENT MODEL; RAT MODEL	Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine as they can be easily isolated from bone marrow (BM) aspirates and expanded in culture while maintaining their 'stemness'. In addition to differentiating into mesodermal cells, MSCs have shown considerable plasticity and generate ectodermal neurons and glia, which can be used to replace cells damaged by neurological diseases and injuries. These unique stem cells also exhibit immunomodulatory functions and secrete a variety of trophic factors which support regeneration and repair. This review focuses on the therapeutic usage of MSCs for neurodegenerative diseases and traumatic injuries to the nervous system. Animal studies demonstrate great promise for MSC transplantation in neurological disorders. In fact, a few clinical trials have already been initiated and show that MSCs are a safe cellular therapy and have great potential to become a viable treatment for neural disorders in the years to come.	[Trzaska, Katarzyna A.; Rameshwar, Pranela] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med Hematol Oncol, Newark, NJ 07103 USA; [Trzaska, Katarzyna A.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA		Rameshwar, P (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med Hematol Oncol, 185 S Orange Ave,MSB E-585, Newark, NJ 07103 USA.	rameshwa@umdnj.edu			F.M. Kirby Foundation	This study was supported by the F.M. Kirby Foundation.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Arnhold S, 2007, GRAEF ARCH CLIN EXP, V245, P414, DOI 10.1007/s00417-006-0382-7; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; BONAB MM, 2007, IRAN J IMMUNOL, V4, P50; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; CASTILLO M, 2007, J BIOMED SCI, V3, P76; CASTILLO MD, CLIN TRANSL IN PRESS; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen Y, 2006, CELL MOL LIFE SCI, V63, P1649, DOI 10.1007/s00018-006-6019-5; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Gregory C. A., 2005, SCI STKE, ppe37; Guo L, 2005, BIOMED ENVIRON SCI, V18, P36; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Horwitz EM, 2006, CYTOTHERAPY, V8, P194, DOI 10.1080/14653240600758562; Hu De-zhi, 2005, Chin J Traumatol, V8, P23; Hu DZ, 2004, CHINESE MED J-PEKING, V117, P1576; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37; Kan I, 2007, NEUROSCI LETT, V419, P28, DOI 10.1016/j.neulet.2007.03.070; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kicic A, 2003, J NEUROSCI, V23, P7742; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; MAHMOUD SS, 2004, MULTIMEDIA CYBERSPAC, V2, P1; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Muller I, 2006, EXP HEMATOL, V34, P1413, DOI 10.1016/j.exphem.2006.06.007; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Orrell RW, 2007, NEW ENGL J MED, V357, P822, DOI 10.1056/NEJMe078146; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495; Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; Smith LEH, 2004, J CLIN INVEST, V114, P755, DOI 10.1172/JCI200422930; Snyder BJ, 2005, CURR OPIN NEUROL, V18, P376, DOI 10.1097/01.wco.0000174298.27765.91; Suon S, 2006, BRAIN RES, V1106, P46, DOI 10.1016/j.brainres.2006.05.109; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2007, CURR NEUROVASC RES, V4, P99, DOI 10.2174/156720207780637199; Virley David J, 2005, NeuroRx, V2, P638, DOI 10.1602/neurorx.2.4.638; Weinshenker BG, 1996, NEUROL CLIN, V14, P291, DOI 10.1016/S0733-8619(05)70257-7; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zipori D, 2004, BLOOD CELL MOL DIS, V33, P211, DOI 10.1016/j.bcmd.2004.08.019	92	4	4	0	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY-JUN	2008	1	3					307	316					10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	374QE	WOS:000261058000003	21479411				2022-02-06	
J	Zimmer, A; Reith, W				Zimmer, A.; Reith, W.			Diagnostic imaging of traumatic brain injury	RADIOLOGE			English	Article						traumatic brain injury; primary and secondary brain damage; CT; MRI; diffuse axonal injury (DAI)	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; MAGNETIC-RESONANCE; CT; LESIONS; MRI; HEMORRHAGE; CHILDREN; CLASSIFICATION; DAMAGE	Traumatic brain injury (TBI) - either in isolation or within the context of multiple trauma - is a major cause of disability and death in young adults. The prognosis depends not only on the extent and localization of traumatic lesions, but also on the promptness of surgical intervention if indicated. The following article presents diagnostic imaging strategies in the acute and sub-acute phases of head injury, discussing their relevance with regard to various clinical situations. In addition to standard CT and MRI techniques, the use of other methods such as perfusion measurements, magnetic resonance spectroscopy or diffusion tensor imaging is briefly discussed. By means of these relatively new techniques it is possible to visualize not only structural changes but also gain information relating to functional and metabolic aspects of traumatic brain injury.	[Zimmer, A.; Reith, W.] Univ Saarland, Abt Neuroradiol, Radiol Klin, D-66421 Homburg, Germany		Zimmer, A (corresponding author), Univ Saarland, Abt Neuroradiol, Radiol Klin, D-66421 Homburg, Germany.	a.e.zimmer@gmx.de					ALAVI A, 1989, J NEUROPSYCHIATRY CL, V1, P45; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basso A, 2001, WORLD J SURG, V25, P1174; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BOULIS ZF, 1978, BRIT J RADIOL, V51, P851, DOI 10.1259/0007-1285-51-611-851; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Fiebach JB, 2004, NEURORADIOLOGY, V46, P44, DOI 10.1007/s00234-003-1132-8; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GREENBERG MS, 1997, HDB NEUROSURGERY, P727; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; HESSELINK JR, 1988, AM J NEURORADIOL, V9, P269; Hoelper BM, 2000, ACT NEUR S, V76, P265; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V1, P480; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MASTERS SJ, 1980, AM J ROENTGENOL, V135, P539, DOI 10.2214/ajr.135.3.539; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PIEK J, 2000, NOTFALL RETTUNGSMED, V3, P32; PROVENZALE JM, 1995, AM J ROENTGENOL, V165, P1099, DOI 10.2214/ajr.165.5.7572483; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; [No title captured]	39	4	4	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-832X			RADIOLOGE	Radiologe	MAY	2008	48	5					503	516		10.1007/s00117-008-1661-6			14	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	302ZG	WOS:000256008100010	18461297				2022-02-06	
J	Blake, H; Batson, M				Blake, Holly; Batson, Mindi			Exercise intervention in acquired brain injury rehabilitation: A discussion	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						brain injury; physical activity; exercise intervention; psychosocial outcomes; social support	SEVERE HEAD TRAUMA; TAI-CHI-CHUAN; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; INDIVIDUALS; PROGRAM; PEOPLE; STROKE; MILD; DISABILITY	Physical activity is essential for health and well-being. The importance of an active lifestyle is increasingly being recognized in rehabilitation for its benefits to quality of life and the prevention and management of secondary disease resulting from disability. However, there is a paucity of published evidence for lifestyle exercise intervention in traumatic brain injury. Most studies evaluate the impact of specific physical rehabilitation therapies or exercise intervention, with physical fitness or body composition as outcomes. Few studies also consider the psychosocial benefits of exercise. This article discusses the limited literature on lifestyle exercise interventions for people with traumatic brain injury together with future directions for intervention. Further research which investigates the impact of exercise intervention on health and well-being of brain injured individuals and their families is clearly needed.	[Blake, Holly] Univ Nottingham, Fac Med & Hlth Sci, Sch Nursing, B Floor, Nottingham, England; [Blake, Holly] Queens Med Ctr, Sch Med, Nottingham NG7 2UH, England; [Batson, Mindi] Univ Nottingham, Inst Work Hlth & Org, Nottingham, England		Blake, H (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Sch Nursing, B Floor, Nottingham, England.	Holly.Blake@nottingham.ac.uk	Blake, Holly/B-8855-2008	Blake, Holly/0000-0003-3080-2306			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; BIDDLE SJH, 2001, PSYCHOL PHYS ACTIVIT; Blake H, 2003, CLIN REHABIL, V17, P312, DOI 10.1191/0269215503cr613oa; Blake H, 2000, CLIN REHABIL, V14, P307, DOI 10.1191/026921500667530134; BROOKS GA, 2001, EXERCISE PHYSL; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Department of Health, 2008, LONG TERM CONDITIONS; Department of Health, 2004, CHOOS HLTH MAK HLTH; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver SJ, 2007, ADAPT PHYS ACT Q, V24, P160, DOI 10.1123/apaq.24.2.160; Dromerick Alexander W, 2006, NeuroRx, V3, P428, DOI 10.1016/j.nurx.2006.07.004; Dupoy M, 2002, J I AGEING HLTH, V8, P17; Gemmell C, 2006, BRAIN INJURY, V20, P151, DOI 10.1080/02699050500442998; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; HARKCOM TM, 1985, ARTHRITIS RHEUM, V28, P32, DOI 10.1002/art.1780280106; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; LaPier TLK, 1998, PHYS THER, V78, P417, DOI 10.1093/ptj/78.4.417; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Macko RF, 1997, STROKE, V28, P326, DOI 10.1161/01.STR.28.2.326; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Masanic CA, 1998, ARCH PHYS MED REHAB, V79, P811, DOI 10.1016/S0003-9993(98)90361-6; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Moulton C, 1999, LECT NOTES EMERGENCY; Petajan JH, 1996, ANN NEUROL, V39, P432, DOI 10.1002/ana.410390405; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; POWELL KE, 1994, MED SCI SPORT EXER, V26, P851; Quinn B, 2000, BRAIN INJURY, V14, P1063; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; SANTIAGO MC, 1993, ARCH PHYS MED REHAB, V74, P1192; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; Shapira MY, 2001, ARCH PHYS MED REHAB, V82, P1283, DOI 10.1053/apmr.2001.25152; Sosin DM, 1996, BRAIN INJURY, V10, P47; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Taylor WC, 1998, AM J PREV MED, V15, P334, DOI 10.1016/S0749-3797(98)00081-6; TORP M J, 1956, Phys Ther Rev, V36, P664; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742	45	4	4	1	1	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	APR	2008	15	4					180	185		10.12968/ijtr.2008.15.4.29037			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V04QH	WOS:000213819000008		Green Submitted			2022-02-06	
J	Davis, DP; Peay, J; Good, B; Sise, MJ; Kennedy, F; Eastman, AB; Velky, T; Hoyt, DB				Davis, Daniel P.; Peay, Jeremy; Good, Benjamin; Sise, Michael J.; Kennedy, Frank; Eastman, A. Brent; Velky, Thomas; Hoyt, David B.			Air medical response to traumatic brain injury: A computer learning algorithm analysis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	SAEM Annual Meeting	MAY, 2005	New York, NY	SAEM		artificial neural network; support vector machine; decision tree; learning algorithms; air medical; helicopter; traumatic brain injury	ARTIFICIAL NEURAL NETWORKS; GROUND AMBULANCE TRANSPORT; DECISION TREE; HELICOPTER TRANSPORT; SURVIVAL; CLASSIFICATION; PROBABILITY; REGRESSION; SUPPORT; HEALTH	Background: The role of air medicine in traumatic brain injury (TBI) has been studied extensively using trauma registries but remains unclear. Learning algorithms, such as artificial neural networks (ANN), support vector machines (SVM), and decision trees, can identify relationships between data set variables but are not empirically useful for hypothesis testing. Objective: To use ANN, SVM, and decision trees to explore the role of air medicine in TBI. Methods: Patients with Head Abbreviated Injury Score 3+ were identified from our county trauma registry. Predictive models were generated using ANN, SVM, and decision trees. The three best-performing ANN models were used to calculate differential survival values (actual and predicted outcome) for each patient. In addition, predicted survival values with transport mode artificially input as "air" or "ground" were calculated for each patient to identify those who benefit from air transport. For SVM analysis, chi(2) was used to compare the ratio of unexpected survivors to unexpected deaths for air- and ground-transported patients. Finally, decision tree analysis was used to explore the indications for various transport modes in optimized survival algorithms. Results: A total of 11,961 patients were included. All three learning algorithms predicted a survival benefit with air transport across all patients, especially those with higher Head Abbreviated Injury Score or Injury Severity Score values, lower Glasgow Coma Scale scores, or hypotension. Conclusion: Air medical response in TBI seems to confer a survival advantage, especially in more critically injured patients.	[Hoyt, David B.] Univ Calif San Diego, Div Emergency Med, San Diego, CA 92103 USA; [Davis, Daniel P.; Peay, Jeremy] Univ Calif San Diego, Div Trauma, San Diego, CA 92103 USA; [Davis, Daniel P.] Mercy Air Med Serv, Cardiff By The Sea, CA USA; [Good, Benjamin] Canadian Inst Hlth Res, Ottawa, ON, Canada; [Sise, Michael J.] Scripps Mercy Hosp, San Diego, CA USA; [Kennedy, Frank] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA; [Eastman, A. Brent] Scripps La Jolla Hosp, La Jolla, CA USA; [Velky, Thomas] Palomar Hosp, Escondido, CA USA		Davis, DP (corresponding author), Univ Calif San Diego, Div Emergency Med, 200 W Arbor Dr,8676, San Diego, CA 92103 USA.	davismd@cox.net		Good, Benjamin/0000-0002-7334-7852			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Becalick DC, 2001, J TRAUMA, V51, P123, DOI 10.1097/00005373-200107000-00020; Bledsoe BE, 2004, J TRAUMA, V56, P1325, DOI 10.1097/01.TA.0000109001.35996.AF; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; Brazier J, 1996, J Health Serv Res Policy, V1, P232; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; BURNEY RE, 1995, ANN EMERG MED, V25, P187, DOI 10.1016/S0196-0644(95)70322-5; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COWLEY RA, 1976, CLIN MED/US, V83, P16; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Dardis R, 2000, Ir Med J, V93, P50; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Dayhoff JE, 2001, CANCER, V91, P1615, DOI 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L; De Wing MD, 2000, J BURN CARE REHABIL, V21, P535, DOI 10.1097/00004630-200021060-00011; Diaz MA, 2005, J TRAUMA, V58, P148, DOI 10.1097/01.TA.0000124264.43941.41; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; Fasel B, 2003, ACTA NEUROL BELG, V103, P6; FORSSTROM JJ, 1995, ANN MED, V27, P509, DOI 10.3109/07853899509002462; Gearhart PA, 1997, ANN EMERG MED, V30, P500, DOI 10.1016/S0196-0644(97)70010-6; Hammer B, 2004, NEURAL NETWORKS, V17, P1061, DOI 10.1016/j.neunet.2004.06.009; Hautaniemi S, 2005, BIOINFORMATICS, V21, P2027, DOI 10.1093/bioinformatics/bti278; Hotvedt R, 1996, LANCET, V347, P1362, DOI 10.1016/S0140-6736(96)91010-7; Khan Zulfuquar Hossain, 1998, Indian Journal of Physiology and Pharmacology, V42, P321; LELOET X, 2005, ANN RHEUM DIS, V30, P30; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Matukaitis J, 2005, AM J MED QUAL, V20, P90, DOI 10.1177/1062860604274382; Mullins RJ, 2001, J TRAUMA, V50, P385, DOI 10.1097/00005373-200102000-00032; Newey VR, 1997, ULTRASOUND OBST GYN, V10, P5, DOI 10.1046/j.1469-0705.1997.10010005.x; Norton R, 1996, J TRAUMA, V41, P886, DOI 10.1097/00005373-199611000-00022; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Rodvold DM, 2001, PROSTATE, V46, P39; Rosenblatt WH, 2004, J CLIN ANESTH, V16, P312, DOI 10.1016/j.jclinane.2003.09.005; SHARPE PK, 1994, SCAND J CLIN LAB INV, V54, P3, DOI 10.3109/00365519409088571; Sibbritt David, 2004, Health Care Manag Sci, V7, P163, DOI 10.1023/B:HCMS.0000039379.32963.9e; Sternberg DJ, 2004, MARK HEALTH SERV, V24, P43; THOMAS F, 1990, WESTERN J MED, V153, P40; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Tortella B J, 1996, Air Med J, V15, P24, DOI 10.1016/S1067-991X(96)90015-2	49	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2008	64	4					889	897		10.1097/TA.0b013e318148569a			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	287UN	WOS:000254942100008	18404053				2022-02-06	
J	Whitfield, HW; Lloyd, R				Whitfield, Harold Wayne; Lloyd, Rosalind			American Indians/Native Alaskans With Traumatic Brain Injury Examining the Impairments of Traumatic Brain Injury, Disparities in Service Provision, and Employment Outcomes	REHABILITATION COUNSELING BULLETIN			English	Article						American Indians; Native Alaskans; traumatic brain injury; employment outcomes		The researchers analyzed data from fiscal year 2006 and found that American Indians/Native Alaskans (AI/NA) with traumatic brain injury experienced similar functional limitations at application as did non-AI/NA. Fewer funds were expended on purchased services for AI/NA than for non-AI/NA. The wages of AI/NA were equitable to those of non-AI/NA at case closure. AI/NA spent less time in the federal-state vocational rehabilitation program than did non-AI/NA. There were no significant differences in educational attainment at case closure for AI/NA and non-AI/NA.	[Whitfield, Harold Wayne; Lloyd, Rosalind] Texas Dept Assist & Rehabilitat Serv, Beaumont, TX USA		Whitfield, HW (corresponding author), Texas Dept Assist & Rehabilitat Serv, Beaumont, TX USA.						*CTR DIS CONTR PRE, 2002, MMWR WEEKLY, V51, P303; Ma GXQ, 1999, J REHABIL, V65, P11; *REH SERV ADM, 2006, 911 DAT; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001	4	4	4	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	APR	2008	51	3					190	192		10.1177/0034355207311316			3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	390LZ	WOS:000262167100006					2022-02-06	
J	Kothari, S; Flanagan, SR; Kwasnica, C; Brown, AW; Elovic, EP				Kothari, Sunil; Flanagan, Steven R.; Kwasnica, Christina; Brown, Allen W.; Elovic, Elie P.			Congenital and acquired brain injury. 5. Emerging concepts In prognostication, evaluation, and treatment	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; complementary medicine; neuronal plasticity; outcome assessment (health care); projections and predictions; rehabilitation	MAGNETIC-RESONANCE-SPECTROSCOPY; RANDOMIZED-TRIAL; HYPERBARIC-OXYGEN; CLINICAL-TRIAL; STROKE; REHABILITATION; POTENTIALS; PLASTICITY; RECOVERY; THERAPY	This self-directed learning module describes recent developments in the field of traumatic brain injury (TBI) rehabilitation. In particular, it focuses on the implications of recent technological advances for evaluation, prognostication, and treatment. It is part of the chapter on TBI medicine in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article specifically focuses on neuroplasticity and its implications for rehabilitation interventions, the role of innovative neuroimaging modalities, improvements in our ability to prognosticate, made possible by newer technologies, technologically based enhancement of motor rehabilitation, and the role of alternative and complementary medicine in TBI rehabilitation. Overall Article Objective: To describe recent advances in our ability to evaluate, prognosticate, and treat traumatic brain injury.	[Kothari, Sunil] Inst Rehabil & Res, Houston, TX 77030 USA; [Flanagan, Steven R.] Mt Sinai Hosp, New York, NY 10029 USA; [Kwasnica, Christina] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Elovic, Elie P.] Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ USA		Kothari, S (corresponding author), Inst Rehabil & Res, 1333 Moursund Ave, Houston, TX 77030 USA.	Sunil.Kothari@memorialhermann.org		Brown, Allen W./0000-0001-7228-3351; Flanagan, Steven/0000-0001-9005-5897			*AHRQ, 2003, AHRQ PUBL, P1133; ARTRU F, 1976, EUR NEUROL, V14, P310, DOI 10.1159/000114753; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Brazier Nicole C, 2003, Am J Ther, V10, P163, DOI 10.1097/00045391-200305000-00003; Brown RB, 2005, TXB TRAUMATIC BRAIN, P679; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; Conant Richard, 2004, Altern Med Rev, V9, P17; D'Esposito M, 2006, PROG BRAIN RES, V157, P123, DOI 10.1016/S0079-6123(06)57008-6; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Fregni F, 2006, INT J NEUROPSYCHOPH, V9, P641, DOI 10.1017/S1461145705006280; Hesse S, 2005, STROKE, V36, P1960, DOI 10.1161/01.STR.0000177865.37334.ce; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Loeb Gerald E, 2006, Neurosurg Focus, V20, pE2; Martin WRW, 2007, MOL IMAGING BIOL, V9, P196, DOI 10.1007/s11307-007-0087-2; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; MCELLIGOTT J, 2007, BRAIN INJURY MED PRI, P1061; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Payne GS, 2006, BRIT J RADIOL, V79, pS16, DOI 10.1259/bjr/84072695; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Signoretti S, 2002, ACT NEUR S, V81, P373; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Sugarman H, 2006, CYBERPSYCHOL BEHAV, V9, P178, DOI 10.1089/cpb.2006.9.178; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; *UND HYP SOC, 2003, HYP OX THER CHRON BR, P1133; Weber DJ, 2005, IEEE T NEUR SYS REH, V13, P242, DOI 10.1109/TNSRE.2005.847385; Werner C, 2002, STROKE, V33, P2895, DOI 10.1161/01.STR.0000035734.61539.f6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	39	4	4	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2008	89	3		1			S27	S31		10.1016/j.apmr.2007.12.014			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	276TX	WOS:000254167100006	18295646				2022-02-06	
J	Oh, H; Seo, W				Oh, HyunSoo; Seo, WhaSook			Validity for the critical patients severity classification system developed by the Korean Clinical Nurse Association	AUSTRALIAN JOURNAL OF ADVANCED NURSING			English	Article						severity classification; prediction; traumatic brain injury	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; APACHE-II; MORTALITY PREDICTION; INTENSIVE-CARE; COMA-SCALE; TRAUMA; SCORE	Objective This study aimed to evaluate whether the Critical Patient Severity Classification System (CPSCS) can be effectively used to predict mortality, functional disability, and cognitive ability of brain injury patients at 1 month and 6 months after admission to an intensive care unit. Design This study was conducted using a prospective prediction study design. Setting Data were collected at a university hospital located in Incheon, South Korea. Subjects The study subjects were 190 brain injury patients admitted to a surgical intensive care unit. Main outcome measures Mortality, functional disability, and cognitive ability were evaluated directly at 1 month and 6 months after admission to an intensive care unit. Results The probability of discriminating survival and death correctly using identified significant predictors of the Critical Patient Severity Classification System (CPSCS) was 77.3% and 81.3% respectively, which are considerably high. However this system was less reliable at predicting functional and cognitive recovery in brain injury patients. Conclusions The result of the present study showed that the Critical Patient Severity Classification System can be used to predict a restricted area of the outcome: mortality, in brain injury patients. To expand its applicability on functional or cognitive recovery, this system needs to include brain injury specific nursing activities such as, for example, managing brain oedema or brain tubes.	[Oh, HyunSoo; Seo, WhaSook] Inha Univ, Coll Med, Dept Nursing, Yonghyun Dong, South Korea		Oh, H (corresponding author), Inha Univ, Coll Med, Dept Nursing, Yonghyun Dong, South Korea.	wschang@inha.ac.kr					BION J, 1988, ANAESTHESIA, V43, P62, DOI 10.1111/j.1365-2044.1988.tb05434.x; CASSINELLO F, 1994, CHEST, V105, P76; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Giovannetti P, 1984, Nurs Manage, V15, P31; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HAM JH, 1997, THESIS U HANYANG SEO; Handschu R, 2005, J NEUROL, V252, P1249, DOI 10.1007/s00415-005-0853-5; HASS SA, 1988, NURSING MANAGEMENT, V19, P56; HYUN SY, 2003, THESIS INHA U INCHEO; KANG JH, 1993, THESIS U SEOUL SEOUL; *KCNA, 1994, STUD EST NURS COST; KIM KY, 2002, KOREAN ACAD NURSING, V8, P475; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; RUTLEDGE R, 1993, AM J SURG, V166, P244, DOI 10.1016/S0002-9610(05)80966-3; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Tan G. H., 1998, Annals Academy of Medicine Singapore, V27, P813; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Vincent JL, 2000, INTENS CARE MED, V26, P1023, DOI 10.1007/s001340051313; YU JS, 1996, KOREAN CLIN NURSING, V2, P75	24	4	4	0	1	AUSTRALIAN NURSING FEDERATION	KINGSTON	PO BOX 4239, KINGSTON, ACT 2604, AUSTRALIA	0813-0531	1447-4328		AUST J ADV NURS	Aust. J. Adv. Nurs.	MAR-MAY	2008	25	3					49	57					9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	453QF	WOS:000266625300007					2022-02-06	
J	Schmolke, S; Gosse, F				Schmolke, Stephan; Gosse, Frank			The halo fixator	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			German	Article						cervical spine; halo fixator; halo extension	CERVICAL-SPINE INJURIES; EXTERNAL FIXATION; VEST TREATMENT; COMPLICATIONS; DEVICE; FRACTURES; TRACTION	Objective Installation of an external fixator in combination with a body cast for temporary or definitive immobilization and retention of unstable fractures of the craniocervical junction and upper part of the cervical spine. Further established applications include presurgical extension treatment of paralytic scoliosis and temporary retention within complex spine deformity operations after ventral release or mobilized osteotomies. Indications Closed reposition and temporary retention of unstable injuries of the cervical spine up to operation. Extension treatment for careful reposition of fresh or dated malpositions of the cervical spine. Conservative treatment of injuries of the craniocervical junction and the upper part of the cervical spine. Presurgical extension of paralytic scoliosis. Temporary extension after ventral release. Contraindications Cranial fractures and intracranial injuries. Soft-tissue infections of the skull. Children < 3 years. Adiposity, chest injuries and paraplegia as relative contraindications using the halo body cast. Surgical Technique Halo traction is applied in two stages; first, the head ring is attached to the skull, then, the body cast and suspension assembly are added. Local anesthesia, depending on circumstances. Sizing of the components; the optimal size of the ring is about 1.5 '' larger than the circumference of the patient's head. Patient in sitting or supine position. The halo ring is held in proper position by stabilizer plates; the lower margin of the ring should be just above the ears and about 0.4 '' above the eyebrows. The anterior pins are placed in shallow groove on the forehead between supraorbital ridges and frontal protuberances. Threaded skull pins are screwed with defined torque (4-8 ''/pounds) in the lamina externa of the cranial calotte without perforating the lamina interna. To avoid side-to-side drifting, the diagonally opposite pins should be tightened simultaneously. Finally, connection of the halo ring with a body cast or putting on an extension device. Results Secure external stabilization of unstable injuries of upper cervical spine. Improvement of correction results of patients with neuromuscular scoliosis who underwent surgical treatment. Disadvantages are procedure-specific complications ( infection and loosening of head pins) with different published frequencies and decreased patient's acceptance at longer therapy duration.	[Schmolke, Stephan; Gosse, Frank] Diakoniekrankenhaus Annastift, Orthopad Klin 3, D-30625 Hannover, Germany		Schmolke, S (corresponding author), Diakoniekrankenhaus Annastift, Orthopad Klin 3, Anna von Borries Str 1-7, D-30625 Hannover, Germany.	stephan.schmolke@annastift.de					Anderson PA, 1991, SPINE S, V16, P501; Blauth M, 2000, ORTHOPADE, V29, P302; BLAUTH M, 1994, OPERAT ORTHOP TRAUMA, V6, P285; BOCKHORN J, 1982, UNFALLHEILKUNDE, V85, P19; Bullock SJ, 2001, J BIOMECH, V34, P129, DOI 10.1016/S0021-9290(00)00164-0; Esce, 2000, Curr Treat Options Neurol, V2, P517, DOI 10.1007/s11940-000-0030-1; GARFIN SR, 1986, J BONE JOINT SURG AM, V68A, P320, DOI 10.2106/00004623-198668030-00002; GIEBEL G, 1988, UNFALLCHIRURG, V91, P29; HAHNEL H, 1984, ZBL CHIR, V109, P1327; Jahna H, 1971, Hefte Unfallheilkd, V108, P72; Koivikko MP, 2000, ARCH ORTHOP TRAUM SU, V120, P448, DOI 10.1007/s004029900129; Lerman JA, 2001, SPINE, V26, P2102, DOI 10.1097/00007632-200110010-00011; LIND B, 1988, SPINE, V13, P425, DOI 10.1097/00007632-198804000-00010; LIPPERT H, 1974, MONATSSCHR UNFALL, V77, P129; Metz-Stavenhagen P, 2001, ORTHOPADE, V30, P925, DOI 10.1007/s001320170005; Minne HW, 2002, ORTHOPADE, V31, P681, DOI 10.1007/s00132-002-0348-3; Nemeth JA, 2001, J BONE JOINT SURG AM, V83A, P377, DOI 10.2106/00004623-200103000-00009; NICKEL VL, 1968, J BONE JOINT SURG AM, VA 50, P1400, DOI 10.2106/00004623-196850070-00009; Nottmeier EW, 2000, J NEUROSURG, V92, P233, DOI 10.3171/spi.2000.92.2.0233; PAPAGELOPOULOS PJ, 2001, SPINE, V26, P463; PERRY J, 1959, J BONE JOINT SURG AM, V41, P37, DOI 10.2106/00004623-195941010-00006; Reinhold M, 2006, UNFALLCHIRURG, V109, P1064, DOI 10.1007/s00113-006-1188-0; Rinella A, 2005, SPINE, V30, P475, DOI 10.1097/01.brs.0000153707.80497.a2; Schulze W, 2001, ZBL NEUROCHIR, V62, P2, DOI 10.1055/s-2001-16332; SPITALER R, 2002, J TRAUMA S, V1, P24; Strohm PC, 2007, ZBL CHIR, V132, P54, DOI 10.1055/s-2006-960479; STURMER KM, 1999, LEITLINIEN UNFALLCHI, P34; TSCHERNE H, 1998, TSCHERNE UNFALLCHIRU, P114; Vieweg U, 2001, ARCH ORTHOP TRAUM SU, V121, P50, DOI 10.1007/s004020000182; von Gumppenberg S, 1989, Aktuelle Traumatol, V19, P57; WETZEL FT, 1995, PARAPLEGIA, V33, P110, DOI 10.1038/sc.1995.25	31	4	4	0	2	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694			OPER ORTHOPADE TRAUM	Oper. Orthopade Traumatol.	MAR	2008	20	1					3	12		10.1007/s00064-008-1222-1			10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	316JK	WOS:000256945400002	18338114				2022-02-06	
J	Garcia-Molina, A				Garcia-Molina, A.			A historical view of behavioural alterations due to lesions in the prefrontal cortex: From Phineas Gage to Luria	REVISTA DE NEUROLOGIA			Spanish	Article						behaviour; brain damage; case reports; frontosubcortical circuits; history of neurology; prefrontal cortex	FRONTAL-LOBE DYSFUNCTION; SUBCORTICAL CIRCUITS; PHINEAS GAUGE; INJURY; NEUROPSYCHIATRY; DISORDERS; IRON	Introduction. Over the last 200 years, a number of authors have considered the prefrontal cortex to be the 'organ of civilisation, that is, the most characteristically human part of the brain, while others have seen this region of the brain as playing a far less important role in behaviour. Aim. To examine the study of behavioural alterations caused by lesions in the prefrontal cortex from a historical perspective. Development. Since the middle of the 19th century, reports have appeared in the scientific literature of patients with behavioural alterations caused by traumatic injuries to the prefrontal region or brain tumours located in this area of the brain. From the beginning of the 20th century onwards, most of the information for this field of study has been obtained from the results of treating brain tumours and psychiatric disorders by means of brain surgery. The observations that have been gathered over these two centuries have sparked a heated debate about the connection between behaviour and the prefrontal cortex. Conclusions. The fact that behavioural disorders and prefrontal lesions are constantly associated to each other seems to confirm the existence of a relation between the two. In recent decades, several theoretical approaches have appeared that continue to see the prefrontal cortex as playing an important role in performing the mental processes involved in human behaviour but also offer new points of view about the relation between behaviour and the brain. These new perspectives are based on the connections between the prefrontal cortex and other cortical and subcortical regions.	UAB, Inst Univ Neurorehabil Guttmann, E-08916 Badalona, Spain		Garcia-Molina, A (corresponding author), UAB, Inst Univ Neurorehabil Guttmann, Cami Can Ruti S-N, E-08916 Badalona, Spain.	agarciam.investigacio@guttmann.com					*AM PSYCH ASS, 2003, DSM4TR MAN DIAGN EST; BAKAY L, 1989, SURG NEUROL, V32, P159, DOI 10.1016/0090-3019(89)90206-1; Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1994, HANDB NEUR, V9, P3; BENTON AL, 2000, SELECTED PAPERS, P67; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BRICKNER RM, 1952, AMA ARCH NEUROL PSY, V68, P293, DOI 10.1001/archneurpsyc.1952.02320210003001; BRICKNER RM, 1932, RES NERV MENT DIS P, V13, P259; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; CARLSON NR, 2002, FISIOLOGIA CONDUCTA; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio AR, 2000, ARCH GEN PSYCHIAT, V57, P128, DOI 10.1001/archpsyc.57.2.128; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Feldman RP, 2001, NEUROSURGERY, V48, P647, DOI 10.1097/00006123-200103000-00041; FINGER S., 1994, ORIGINS NEUROSCIENCE; FREEMAN W, 1947, J COMP NEUROL, V86, P65, DOI 10.1002/cne.900860104; Fukatsu R, 1997, EUR NEUROL, V37, P230, DOI 10.1159/000117448; Fukutake T, 2002, EUR NEUROL, V47, P156, DOI 10.1159/000047974; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HEBB D, 1977, CAN MED ASSOC J, V116, P1373; Hebb DO, 1940, ARCH NEURO PSYCHIATR, V44, P421, DOI 10.1001/archneurpsyc.1940.02280080181011; HEBB DO, 1945, ARCH NEURO PSYCHIATR, V54, P10, DOI 10.1001/archneurpsyc.1945.02300070020002; HOFFMAN JL, 1949, NEW ENGL J MED, V241, P233, DOI 10.1056/NEJM194908112410604; HUTTON EL, 1947, J MENT SCI, V93, P31, DOI 10.1192/bjp.93.390.31; Jarquin-Valdivia AA, 2004, ARCH NEUROL-CHICAGO, V61, P1800, DOI 10.1001/archneur.61.11.1800; JARVIE HF, 1954, J NEUROL NEUROSUR PS, V17, P14, DOI 10.1136/jnnp.17.1.14; KERR PB, 2005, NEUROSURG FOCUS, V18, P1; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Macmillan M, 2000, J Hist Neurosci, V9, P46, DOI 10.1076/0964-704X(200004)9:1;1-2;FT046; Macmillan M, 1996, J Hist Neurosci, V5, P56; MACMILLAN M, 1992, BRAIN COGNITION, V19, P72, DOI 10.1016/0278-2626(92)90038-N; MACMILLAN MB, 1986, BRAIN COGNITION, V5, P67, DOI 10.1016/0278-2626(86)90062-X; Mataro M, 2001, ARCH NEUROL-CHICAGO, V58, P1139, DOI 10.1001/archneur.58.7.1139; McCloskey Michael S, 2005, Curr Psychiatry Rep, V7, P65, DOI 10.1007/s11920-005-0027-2; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; Mesulam M.-M., 2000, PRINC BEHAV COGN NEU, V2, P1, DOI [DOI 10.1017/9781108164320.002, 10.1017/9781108164320.002]; Mettler F. A., 1949, SELECTIVE PARTIAL AB; *ORG MUND SAL, 1994, CIE 10 TRAST MENT CO; Pantoni L, 2001, ACTA NEUROL SCAND, V104, P185, DOI 10.1034/j.1600-0404.2001.00370.x; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Preul MC, 2008, NEUROSURG FOCUS, V18, P1, DOI [10.3171/foc.2005.18.4.1, DOI 10.3171/FOC.2005.18.4.1]; Pridmore S, 2005, AUST NZ J PSYCHIAT, V39, P856, DOI 10.1111/j.1440-1614.2005.01679.x; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Ros, 1996, ERROR DESCARTES EMOC; Rosselli D, 2005, REV NEUROLOGIA, V40, P122, DOI 10.33588/rn.4002.2004501; ROSSITCH E, 1990, SURG NEUROL, V33, P150, DOI 10.1016/0090-3019(90)90026-L; RUSSELL WR, 1948, LANCET, V254, P356; RYLANDER G, 1948, Res Publ Assoc Res Nerv Ment Dis, V27 (1 vol.), P691; SANDSON TA, 1991, ARCH NEUROL-CHICAGO, V48, P1300, DOI 10.1001/archneur.1991.00530240106031; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; SWAYZE VW, 1995, AM J PSYCHIAT, V152, P505; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; TIZARD B, 1959, Med Hist, V3, P132; VALENSTEIN ES, 1990, PROG BRAIN RES, V85, P539; [No title captured]; [No title captured]	58	4	5	0	52	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	FEB 1	2008	46	3					175	181		10.33588/rn.4603.2007196			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273QA	WOS:000253945600010	18297626				2022-02-06	
J	Guskiewicz, KM				Guskiewicz, Kevin M.			Sports medicine and athletic training in the 21st century: Bridging the gap between research and clinical practice	QUEST			English	Article; Proceedings Paper	Conference of the American-Academy-of-Kinesiology-and-Physical-Education (AAKPE)	SEP 27, 2007	Savannah, GA	Amer Acad Kinesiol & Phys Educ			ASSOCIATION POSITION STATEMENT; COLLEGIATE FOOTBALL PLAYERS; HEAD IMPACTS; RECURRENT CONCUSSION; INJURY; MANAGEMENT; COST; RISK	Sport and recreational activity is a vital part of today's society, and athletic training researchers are playing an important role in gaining a better understanding of how to promote safe and healthy participation for athletes of all ages. This article aims to illustrate the importance of research to prevent and effectively treat sport and recreational injuries. Increased physical activity among Americans is helping to combat chronic diseases such as obesity and diabetes, but injuries related to increased activity are on the rise. We must be responsible in our approach to promoting physical activity and participation in sport, while minimizing risk of injury. Athletic training researchers and colleagues from other disciplines within kinesiology, allied health sciences, and medicine must work collaboratively to identify predispositions to athletic injuries and illnesses. They must further conduct prospective studies that will help clinicians better manage these injuries and prevent their recurrence. This article highlights the progress that athletic training researchers have made to bridge the gap between research and clinical practice.	Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	gus@emait.unc.edu					Binkley HM, 2002, J ATHL TRAINING, V37, P329; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hergenroeder AC, 1998, PEDIATRICS, V101, P1057, DOI 10.1542/peds.101.6.1057; Koester MC, 2000, J ATHL TRAINING, V35, P466; Marshall SW, 2003, INJURY PREV, V9, P100, DOI 10.1136/ip.9.2.100; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller MG, 2005, J ATHL TRAINING, V40, P224; *NFSHSA, 2005, 2004 05 NFHS HIGH SC; Perrin DH, 2007, QUEST, V59, P111, DOI 10.1080/00336297.2007.10483541; SHULTZ MR, 2004, AM J EPIDEMIOL, V160, P937; *US CONS PROD SAF, 2000, BAB BOOM SPORTS INJ; *USDHHS, 2002, HLTH PEOPL 2010; *USDHHS, 2002, PHYS ACT FUND PREV D; Wiersma LD, 2000, PEDIATR EXERC SCI, V12, P13, DOI 10.1123/pes.12.1.13; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; [No title captured]	27	4	4	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0033-6297	1543-2750		QUEST	Quest	FEB	2008	60	1					121	130		10.1080/00336297.2008.10483572			10	Education & Educational Research; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Education & Educational Research; Sport Sciences	263VR	WOS:000253245100010					2022-02-06	
J	Ferri-Campos, J; Chirivella-Garrido, J; Renau-Hernandez, O; Garcia-Blazquez, MC; Ferri-Salvador, N; Noguera-Escalera, P; Noe-Sebastian, E				Ferri-Campos, J.; Chirivella-Garrido, J.; Renau-Hernandez, O.; Garcia-Blazquez, M. C.; Ferri-Salvador, N.; Noguera-Escalera, P.; Noe-Sebastian, E.			When do patients with traumatic brain injury lose verbal information? Implications for cognitive rehabilitation	REVISTA DE NEUROLOGIA			Spanish	Article						California Verbal Learning Test; memory; neuropsychology; rehabilitation; retroactive interference; traumatic brain injury	CLOSED-HEAD-INJURY; SELF-AWARENESS; LEARNING TEST; TERM-MEMORY; AMNESIA; RESERVE; ADULTS; PERFORMANCE; RETRIEVAL; DEFICITS	Aim. Longitudinal study of verbal learning and memory processes after traumatic brain injury (TBI). Patients and methods. Twenty-six patients who had sustained a moderate-severe TBI were assessed with a Spanish version of the California Verbal Learning Test at the time of admission and 6-months after inclusion in a multidisciplinary rehabilitation program that comprised rehabilitation strategies for memory impairments. Global memory indexes were determined, including retroactive interference, proactive interference and recall indexes controlled for level of verbal acquisition. Memory change over time was correlated to demographic and clinical relevant variables, including the level of patients' self-awareness. Results. More than 75% of our patients presented learning, immediate memory and delayed memory deficits at baseline, with an important effect of retroactive interference (69%). At 6-month follow-up, 34.6% showed learning difficulties, 46.2% immediate memory deficits, and 53% delayed memory problems, with 34.6% of the patients showing retroactive interference. Chronicity, level of self-awareness and premorbid intelligence correlated to the degree of memory change over time. Conclusions. Prominent verbal memory problems developed, not only during the first months after TBI but also over time are mostly due to impaired consolidation related to an intense retroactive interference. These data should be considered when developing memory rehabilitation strategies.	[Ferri-Campos, J.; Chirivella-Garrido, J.; Renau-Hernandez, O.; Garcia-Blazquez, M. C.; Ferri-Salvador, N.; Noguera-Escalera, P.; Noe-Sebastian, E.] Hosp Valencia Al Mar Rio Tajo, Serv Dano Cerebral, E-46011 Valencia, Spain		Noe-Sebastian, E (corresponding author), Hosp Valencia Al Mar Rio Tajo, Serv Dano Cerebral, E-46011 Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			ATKINSON RC, 1971, SCI AM, V225, P82, DOI 10.1038/scientificamerican0871-82; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BENEDET MJ, 1999, TEST APRENDIZAJE VER; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Chirivella J, 2003, NEUROLOGIA, V18, P132; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CUMMINGS JL, 1984, ARCH NEUROL-CHICAGO, V41, P874, DOI 10.1001/archneur.1984.04050190080019; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Dennis M, 2000, BRAIN COGNITION, V42, P102, DOI 10.1006/brcg.1999.1174; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Jurado MA, 1998, J CLIN EXP NEUROPSYC, V20, P353, DOI 10.1076/jcen.20.3.353.816; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Numan B, 2000, J CLIN PSYCHOL, V56, P553, DOI 10.1002/(SICI)1097-4679(200004)56:4<553::AID-JCLP8>3.0.CO;2-Q; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OSHEA MF, 1994, J CLIN EXP NEUROPSYC, V16, P640, DOI 10.1080/01688639408402675; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	32	4	4	0	7	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JAN 16	2008	46	2					109	114		10.33588/rn.4602.2007424			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	264ZL	WOS:000253328800009	18247283				2022-02-06	
J	Cowley, NJ; da Silva, EJ				Cowley, Nicholas J.; da Silva, Egidio J.			Prevention of secondary brain injury following Head Trauma	TRAUMA-ENGLAND			English	Article						Brain injury; intracranial pressure; cerebral perfusion; trauma	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL HYPERTENSION; BLOOD-FLOW; PROTOCOL	Over half of admissions to hospital with severe trauma have associated head injury. Suboptimal management of traumatic brain injury greatly increases mortality and morbidity. This article reviews current practice in the management of head injury resulting from trauma with particular attention to management strategies that have been proven to minimise secondary brain injury in the early resuscitation period. Ongoing management of confirmed severe brain injury is detailed, including maintenance of cerebral perfusion and the control of raised intracranial pressure.	[Cowley, Nicholas J.] Univ Hosp Birmingham, Anaesthet & Intens Care, Birmingham, W Midlands, England; [da Silva, Egidio J.] Royal Orthopaed Hosp, Anaesthesia & High Dependency Care, Birmingham B31 2AP, W Midlands, England		da Silva, EJ (corresponding author), Royal Orthopaed Hosp, Anaesthesia & High Dependency Care, Birmingham B31 2AP, W Midlands, England.	drejs71@hotmail.com					Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Trauma: who cares, 2007, TRAUM WHO CAR; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	21	4	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JAN	2008	10	1					35	42		10.1177/1460408608089322			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V3C1S	WOS:000218121900005					2022-02-06	
J	Gal, R; Smrcka, M				Gal, R.; Smrcka, M.			Mild hypothermia for intracranial aneurysm surgery	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						intracranial aneurysm surgery; mild hypothermia; anesthesia management	TRAUMATIC BRAIN INJURY; CARDIAC-ARREST; TEMPERATURE; THERAPY	Background: Eighty nine patients with established intracranial aneurysm (Hunt-Hess score 1 to 3), who were operated at The Department of Neurosurgery, University Hospital Brno in 2003-2006, were enrolled in to the study group. Methods: After introduction of anesthesia, we started cooling with two circulating-water mattresses (Blanketrol III, Cincinnatti Sub Zero). Body temperature was maintained at 34 degrees C during preparation of cerebral vessels. Active rewarming was started after clip putting. Cooling rate was 0.9 +/- 0.3 degrees C per hour and rewarming rate was 0.7 +/- 0.3 degrees C per hour. The required core body temperature was achieved in all patients, i.e. in 100 % of cases. Measured values of both esophageal and bladder temperature were not significantly different (p=0.4475). No significant difference was found when preoperative coagulation parameters and values measured during managed hypothermia were compared. Neurological condition was evaluated as good in 82 patients (92 %). Two patients died and one patient was in vegetative status. Conclusion: When compared with similar group of patients, who underwent surgery in 1998 to 2002, where good treatment results were achieved in 80 %, final good neurological treatment results increased statistically significantly by 12 % due to managed hypothermia as well.	[Gal, R.] Univ Hosp Brno, Dept Anesthesia & Intens Care, CZ-62500 Brno, Czech Republic; [Smrcka, M.] Univ Hosp Brno, Dept Neurosurg, CZ-62500 Brno, Czech Republic		Gal, R (corresponding author), Univ Hosp Brno, Dept Anesthesia & Intens Care, Jihlavska 20, CZ-62500 Brno, Czech Republic.	rgal@atlas.cz	Smrcka, Martin/AAM-8872-2021	Smrcka, Martin/0000-0002-9191-8700			Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975	11	4	4	0	1	COMENIUS UNIV	BRATISLAVA I	SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA	0006-9248			BRATISL MED J	Bratisl. Med. J.		2008	109	2					66	70					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276YF	WOS:000254178900005	18457312				2022-02-06	
S	Gulrez, T; Kavakli, M; Tognetti, A		Hassanien, AE; Abraham, A; Kacprzyk, J		Gulrez, Tauseef; Kavakli, Manolya; Tognetti, Alessandro			Robotics and Virtual Reality: A Marriage of Two Diverse Streams of Science	COMPUTATIONAL INTELLIGENCE IN MULTIMEDIA PROCESSING: RECENT ADVANCES	Studies in Computational Intelligence		English	Article; Book Chapter							MOTOR; HIPPOCAMPUS; INTERFACES; POSTURE; MEMORY; REHABILITATION; REPRESENTATION; INTEGRATION; PRIMITIVES; CORTEX	In an immersive computationally intelligent virtual reality (VR) environment, humans can interact with a virtual 3D scene and navigate a robotic device. The non-destructive nature of VR makes it an ideal testbed for many applications and a prime candidate for use in rehabilitation robotics simulation and patient training. We have developed a testbed for robot mediated neurorehabilitation therapy that combines the use of robotics, computationally intelligent virtual reality and haptic interfaces. We have employed the theories of neuroscience and rehabilitation to develop methods for the treatment of neurological injuries such as stroke, spinal cord injury, and traumatic brain injury. As a sensor input we have used two state-of-the-art technologies, depicting the two different approaches to solve the mobility loss problem. In our first experiment we have used a 52 piezoresistive sensor laden shirt as an input device to capture the residual signals arising from the patient's body. In our second experiment, we have used a precision position tracking (PPT) system to capture the same signals from the patient's upper body movement. The key challenge in both of these experiments was to accurately localise the movement of the object in reality and map its corresponding position in 3D VR. In this book chapter, we describe the basic theory of the development phase and of the operation of the complete system. We also present some preliminary results obtained from subjects using upper body postures to control the simulated wheelchair.	[Gulrez, Tauseef; Kavakli, Manolya] Macquarie Univ, Dept Comp, Div Informat & Commun Sci, Virtual Interact Simulat Real VISOR Res Grp, Sydney, NSW 2109, Australia; [Tognetti, Alessandro] Univ Pisa, Fac Engn, Interdept Res Ctr E Piaggio, I-56100 Pisa, Italy		Gulrez, T (corresponding author), Macquarie Univ, Dept Comp, Div Informat & Commun Sci, Virtual Interact Simulat Real VISOR Res Grp, Sydney, NSW 2109, Australia.	gtauseef@ics.mq.edu.au	Tognetti, Alessandro/Q-6711-2017	Tognetti, Alessandro/0000-0001-9848-4071			*ABS, 1999, 1998 DIS AG CAR AUST; *ABS, 2000, 32220 ABS; *AIHW, 2000, 19 AIHW DIS; Baker C. L., 2006, ADV NEURAL INFORM PR, V18; BARNARD GA, 1958, BIOMETRIKA, V45, P293, DOI 10.1093/biomet/45.3-4.293; BLISS TVP, NATURE, V361, P31; BROWN D, 1998, 2 EUR C DIS VIRT REA; BUCKERTDONELSON A, 1995, VR WORLD, V3, P9; BYUNGMOON K, 2002, IEEE T ROBOTIC AUTOM, V18, P294; CHALLA S, 2005, 8 IEEE INT C INF FUS; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Clynes Manfred E., 1960, ASTRONAUTICS, V14, P26; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Fehr L, 2000, J REHABIL RES DEV, V37, P353; Flynn C C, 1995, Assist Technol, V7, P111; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Giles LC, 2003, MED J AUSTRALIA, V179, P130, DOI 10.5694/j.1326-5377.2003.tb05470.x; Griffiths T.L., 2006, SIGNIF, V3, P130, DOI [10.1111/j.1740-9713.2006.00185.x, DOI 10.1111/J.1740-9713.2006.00185.X]; GULREZ T, 2005, 1 IEEE INT WORKSH CO; GULREZ T, 2006, IEEE C ROB AUT MECH; Hoffman HG, 2000, PAIN, V85, P305, DOI 10.1016/S0304-3959(99)00275-4; HOGAN N, 1992, SPIE C TEL TECHN, P28; JOHNSON A, 2000, P IPT 2000 AM IOW US; KAVAKLI M, 2005, INISTA, P231; Keefe J. O., 1978, HIPPOCAMPUS COGNITIV; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Lorussi F, 2005, IEEE T INF TECHNOL B, V9, P372, DOI 10.1109/TITB.2005.854510; Lorussi F, 2004, IEEE SENS J, V4, P807, DOI 10.1109/JSEN.2004.837498; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; *MED READ TRAIN TE, 2000, MED MEETS VIRTUAL RE, P207; Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180; Mussa-Ivaldi FA, 2004, IEEE J OCEANIC ENG, V29, P640, DOI 10.1109/JOE.2004.833102; Mussa-Ivaldi FA, 2003, TRENDS NEUROSCI, V26, P329, DOI 10.1016/S0166-2236(03)00121-8; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; MUSSAIVALDI FA, 2006, NEUROSCIENCE 2006; OSHUGA M, 1998, CYBERPSYCHOL BEHAV, V1, P105; PATTON J, 2001, 7 INT C REH ROB ICOP; Penfield W., 1950, CEREBRAL CORTEX MAN; PFINGST BE, 2000, NEURAL PROSTHESES RE; PLATTS RGS, 1993, PARAPLEGIA, V31, P280, DOI 10.1038/sc.1993.51; POST MW, 1997, ARCH PHYS MED REHAB, V87, P59; PUGNETTI L, 1996, 1 EUR C DIS VIRT REA, P239; Riva G, 1997, VIRTUAL REALITY NEUR; Rothbaum BO, 1999, J TRAUMA STRESS, V12, P263, DOI 10.1023/A:1024772308758; ROTHBAUM BO, 1997, J PSYCHOTHERAPY PRAC, V6, P291; Satava RM, 1996, ST HEAL T, V29, P100; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; TAKEZAWA S, 2005, INT J JAPAN SOC MECH, V3, P904; Taya M, 1998, MECH MATER, V28, P53, DOI 10.1016/S0167-6636(97)00064-1; Tenebaum JB, 2001, BEHAV BRAIN SCI, V24, P629, DOI 10.1017/S0140525X01000061; Tognetti Alessandro, 2005, J Neuroeng Rehabil, V2, P8, DOI 10.1186/1743-0003-2-8; WANG P, 2004, J MAT SCI, V39; [王鹏 Wang Peng], 2004, [复合材料学报, Acta Materiae Compositae Sinica], V21, P34; *WHO, 2006, WORLD REP DIS REH; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZHANG X, 2000, J POLYM SCI, V38	62	4	4	0	1	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	1860-949X		978-3-540-76826-5	STUD COMPUT INTELL			2008	96						99	118			10.1007/978-3-540-76827-2		20	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Book Citation Index – Science (BKCI-S)	Computer Science	BLY37	WOS:000271430000004					2022-02-06	
J	Lescot, T; Degos, V; Puybasset, L				Lescot, T.; Degos, V.; Puybasset, L.			Does the brain become heavier or lighter after trauma?	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			brain injury; trauma; blood-brain barrier; brain oedema	RESPIRATORY-DISTRESS-SYNDROME; COMPUTED-TOMOGRAPHY; REGIONAL-DISTRIBUTION; HEAD TRAUMA; INJURY; DENSITY; TISSUE; VOLUME; GRAVITY; WATER	An uncontrolled rise in intracranial pressure is probably the most common cause of death in traumatic brain-injured patients. The intracranial pressure rise is often due to cerebral oedema. Diffusion-weighted imaging has been extensively used to study cerebral oedema formation after trauma in experimental studies. Nevertheless, this technology is difficult to perform at the acute phase, especially in unstable head trauma patients. For these reasons, a safe examination allowing us to better understand the pathophysiology of cerebral oedema formation in such patients would be of great interest. Radiological attenuation is linearly correlated with estimated specific gravity in human tissue. This property gives the opportunity to measure in vivo the volume, weight and specific gravity of any tissue by computed tomography. We recently developed a software package (BrainView) for Windows workstations, providing semi-automatic tools for brain analysis from DICOM images obtained from cerebral computed tomography. In this review, we will discuss the-results of the in vivo analysis of brain weight, volume and specific gravity and consider the use of this software as a new technology to improve our knowledge of cerebral oedema formation after trauma and to evaluate the severity of traumatic brain-injured patients.	[Lescot, T.; Degos, V.; Puybasset, L.] Hop La Pitie Salpetriere, Dept Anesthesie Reanim, F-75013 Paris, France		Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesie Reanim, 47 Blvd Hop, F-75013 Paris, France.	louis.puybasset@psl.aphp.fr					Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BLACQUEBELAIR A, 1965, DICT CONSTANTES BIOL; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; KITA H, 1994, ACTA NEUROCHIR, P452; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; MARMAROU A, 1993, ACTA NEUROCHIR, P18; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; PHELPS ME, 1975, RADIOLOGY, V117, P585, DOI 10.1148/117.3.585; Puybasset L, 2000, INTENS CARE MED, V26, P1215, DOI 10.1007/s001340051340; Puybasset L, 1998, AM J RESP CRIT CARE, V158, P1644, DOI 10.1164/ajrccm.158.5.9802003; Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317; Routly JJ, 2003, CRIT CARE MED, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017	17	4	4	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			110	114		10.1017/S0265021507003304			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100019	18289427				2022-02-06	
J	McAuliffe, MJ; Lin, E; Robb, MP; Murdoch, BE				McAuliffe, Megan J.; Lin, Emily; Robb, Michael P.; Murdoch, Bruce E.			Influence of a standard electropalatography artificial palate upon articulation	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						electropalatography; artificial palate; articulation	TRAUMATIC BRAIN-INJURY; VOICE ONSET TIME; SPEECH PRODUCTION; PARKINSONS-DISEASE; CONTACT PATTERNS; DYSARTHRIA; DISORDERS; THERAPY; SCLEROSIS; CHILDREN	Objective: This study investigated the influence of a standard electropalatography (EPG) palate upon speech articulation in 3 normal speakers under standard EPG testing conditions. Patients and Methods: Three adult females aged 26, 31 and 34 years read the experimental phrase 'say CV again' 5 times under 3 experimental conditions: normal speech ( without a palate in situ), 45 min after EPG palate insertion and 3 h after EPG palate insertion. Consonants and vowels commonly used in EPG research were studied and included /t/, /s/ and /integral/ in the /i/, /a/ and /u/ vowel environments. Perceptual and acoustic analysis of the data was completed. Results: The results revealed varied patterns of adaptation across the 3 participants. Perceptual analysis suggested that 2 of the participants adapted to the presence of the palate; however, 1 did not. The presence of the palate resulted in significant changes to consonant duration for all 3 participants. Spectrally, production of /t/ was unaffected by the presence of the palate, while articulation of fricatives varied across the participants. Conclusion: Paired with a previous study examining the effects of an EPG palate upon speech articulation [McLeod S, Searl J: Am J Speech Lang Pathol 2006; 15: 192-206], the present data suggest that researchers and clinicians alike should be aware of the potential perturbing effects of the palate. Copyright (c) 2007 S. Karger AG, Basel.	[McAuliffe, Megan J.; Lin, Emily; Robb, Michael P.] Univ Canterbury, Dept Commun Disorders, Christchurch 8020, New Zealand; [Murdoch, Bruce E.] Univ Queensland, Motor Speech Res Ctr, Div Speech Pathol, Brisbane, Qld, Australia		McAuliffe, MJ (corresponding author), Univ Canterbury, Dept Commun Disorders, Private Bag 4800, Christchurch 8020, New Zealand.	megan.mcauliffe@canterbury.ac.nz	Murdoch, Bruce E/C-1397-2012	McAuliffe, Megan/0000-0003-3827-2215; Robb, Michael/0000-0003-2529-0510			Carter P, 2004, CLIN LINGUIST PHONET, V18, P359, DOI 10.1080/02699200410001703637; EDWARDS S, 1989, CLIN LINGUIST PHONET, V3, P111, DOI 10.3109/02699208908985275; FORREST K, 1988, J ACOUST SOC AM, V84, P115, DOI 10.1121/1.396977; GIBBON F, 1987, BRIT J DISORD COMMUN, V22, P203; GIBBON F, 1993, CLIN LINGUIST PHONET, V7, P247, DOI 10.1080/02699209308985565; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Gibbon FE, 2003, INT J LANG COMM DIS, V38, P47, DOI 10.1080/13682820304816; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1987, J SPEECH HEAR RES, V30, P171, DOI 10.1044/jshr.3002.171; Ladefoged P., 1993, COURSE PHONETICS; LOFQVIST A, 1987, FOLIA PHONIATR, V39, P221; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430152928357; McAuliffe MJ, 2006, NEUROREHABILITATION, V21, P189; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P1, DOI 10.1080/02699200400001044; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McAuliffe MJ, 2005, J MED SPEECH-LANG PA, V13, P149; McFarland DH, 1996, J ACOUST SOC AM, V100, P1093, DOI 10.1121/1.416286; McLeod S, 2006, AM J SPEECH-LANG PAT, V15, P192, DOI 10.1044/1058-0360(2006/018); Murdoch BE, 2000, J MED SPEECH-LANG PA, V8, P359; Robb M, 2005, FOLIA PHONIATR LOGO, V57, P125, DOI 10.1159/000084133; Searl Jeff, 2006, Logoped Phoniatr Vocol, V31, P107, DOI 10.1080/14015430500390961; Tjaden K, 1997, J SPEECH LANG HEAR R, V40, P1358, DOI 10.1044/jslhr.4006.1358; Weismer G, 1999, J ACOUST SOC AM, V105, P2882, DOI 10.1121/1.426902; Whiteside SP, 1997, PERCEPT MOTOR SKILL, V85, P459	26	4	4	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2008	60	1					45	53		10.1159/000112216			9	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	263WW	WOS:000253248200007	18065861	Bronze, Green Submitted			2022-02-06	
J	McCartan, DP; Fleming, FJ; Motherway, C; Grace, PA				McCartan, D. P.; Fleming, F. J.; Motherway, C.; Grace, P. A.			Management and outcome in patients following head injury admitted to an Irish Regional Hospital	BRAIN INJURY			English	Article						CT scan; head injury; outcome; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CONSEQUENCES; DISABILITY; SCALE; SCORE	Primary objective: Each year in Ireland, 11 000 patients are admitted to hospital with a traumatic brain injury (TBI) but there are no data on subsequent disability in such patients. The objective of this study was to assess the management and outcome in patients of working age admitted with TBI to the unit. Methods: Two hundred and sixteen patients admitted with TBI aged 16-65 were identified. Self-reported incidence of disability and access to appropriate services was assessed using the Glasgow outcome scale and a problem-orientated questionnaire. Results: Eighty-five per cent of patients eligible for review agreed to participate. The majority of injuries (86%) were mild. An intracranial injury was identified on 35% of CT brain scans performed. Patients with an abnormality on CT scanning were more likely to report difficulties with headache, concentration and memory at time of follow-up. When questioned, 34% of patients still perceived difficulties since their injury. Of this group, 60% didn't receive any input from rehabilitation services. One year post-injury, 11% of patients remained unfit for work. Conclusion: A significant number of patients, even with mild TBI, continue to suffer sequelae from their injury augmented by difficulty in accessing appropriate rehabilitation services.	[McCartan, D. P.; Fleming, F. J.] Mid Western Reg Hosp, Dept Surg, Limerick, Ireland; [Motherway, C.] Mid Western Reg Hosp, Limerick, Ireland; [Grace, P. A.] Univ Limerick, Limerick, Ireland		McCartan, DP (corresponding author), Mid Western Reg Hosp, Dept Vasc Surg, Limerick, Ireland.	pagrace@eircom.net	Fleming, Fergal/C-3735-2013	Fleming, Fergal/0000-0003-0553-1591			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; *CENTR STAT OFF, 2006 CENS POP; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; *ESRI, 2006, ACT AC PUBL HOSP IR; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENNETT B, 1975, LANCET, V1, P480; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MILLER EC, 1993, ANN EMERG MED, V22, P1148; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; OBrien DP, 1996, IRISH MED J, V89, P216; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	26	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	4					305	312		10.1080/02699050801995124			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	279HS	WOS:000254346900003	18365844				2022-02-06	
J	Pontius, AA				Pontius, Anneliese A.			Kindled non-convulsive behavioral seizures, analogous to primates. A 24th case of 'limbic psychotic trigger reaction': Bizarre parental infanticide - might nonvoluntariness during LPTR become objectified by primate model?	NEUROCASE			English	Article; Proceedings Paper	3rd International Interdisciplinary Conference on Neuroscience for Medicine and Psychology	2007	Sudak, UKRAINE			partial limbic seizures; seizure kindling; primate model; limbic psychotic trigger reaction; social loners; paleo-consciousness; nonvolitional; motiveless criminal acts; social misbehavior; memory retention	TEMPORAL-LOBE EPILEPSY; QUESTIONABLE ASPECTS; FRONTAL-LOBE; HOMICIDE; STIMULATION; AGGRESSION; MEMORIES; VIOLENCE; BRAIN	Limbic psychotic trigger reaction (LPTR) includes paroxysmal, out-of-character, motiveless, unplanned felonies (or similarly bizarre social misbehavior), all committed during flat affect, autonomic arousal and a fleeting de novo psychosis. A transient limbic hyperactivation is implicated that impairs prefrontal monitoring (judgment, planning, intent, volition, emotional participation) but preserves memory for the acts. It is hypothesized that LPTR implicates an atavistic regression to a limbic 'paleo-consciousness', exemplified by a 24th patient (parental infanticide), presented herein. He had closed head injury and borderline abnormal posterior brain pathology (EEG/CT), which might have contributed to his unusually numerous visual hallucinations.	[Pontius, Anneliese A.] Harvard Univ, Sch Med, Boston, MA USA		Pontius, AA (corresponding author), Waldschmidt St 6, D-60316 Frankfurt, Germany.	anneliese_pontius@hms.harvard.edu					ADAMEC RE, 1987, INTEGRATIVE PSYCHIAT, V5, P130; Aziz MA, 2005, PSYCHOPATHOLOGY, V38, P97, DOI 10.1159/000085351; BEAR D, 1987, INTEGRATIVE PSYCHIAT, V5, P125; CAIN D P, 1992, P539; CLORE GL, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P133; CORCORAN ME, 2005, ADV BEHAV BIOL, V6; CROMIE WJ, 2002, HARV U GAZ, V47, P1; CROMIE WJ, 1996, HARVARD U GAZETTE, V41, P5; Damasio A., 1999, FEELING WHAT HAPPENS; DELGADOESCUETA AV, 1981, NEW ENGL J MED, V305, P711, DOI 10.1056/NEJM198109173051231; DEVINSKY O, 1988, NEUROLOGY, V38, P1347, DOI 10.1212/WNL.38.9.1347; EBERT U, 1999, NEUROFORUM, V3, P76; Fried I, 1997, LANCET, V350, P1845, DOI 10.1016/S0140-6736(97)09385-9; Fuchs T, 2005, NERVENARZT, V76, P1, DOI 10.1007/s00115-004-1816-2; GARLAND E, 2004, NEUROSCIENCE LAW; GESCHWIND N, 1967, ARCH NEUROL-CHICAGO, V16, P25, DOI 10.1001/archneur.1967.00470190029003; GESCHWIND N, 1984, SCIENCE, V224, P239, DOI 10.1126/science.6710141; GLOOR P, 1982, ANN NEUROL, V12, P129, DOI 10.1002/ana.410120203; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; GODDARD GV, 1986, LIMBIC SYSTEM FUNCTI, P95; Halleck S L, 1992, Bull Am Acad Psychiatry Law, V20, P221; Hanson NR (, 1965, PATTERNS DISCOVERY; Harre R., 1970, PRINCIPLES SCI THINK; Hayek F.A., 1964, THEORY COMPLEX PHENO, P332; HEATH RG, 1955, AM J PSYCHIAT, V111, P862, DOI 10.1176/ajp.111.11.862; JAEGER M, 1923, NERVENARZT, V78, P745; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Krishnamoorthy ES, 1998, FORCED NORMALIZATION, P193; Kuhn T.S., 1977, ESSENTIAL TENSION SE; Kuzma John M, 2004, Curr Psychiatry Rep, V6, P58, DOI 10.1007/s11920-004-0040-x; LANDAU M, 1996, FOCUS HARVARD MED SC, V4, P10; Levin H.S., 1989, MILD HEAD INJURY; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; Loddenkemper T, 2005, EPILEPSY BEHAV, V7, P1, DOI 10.1016/j.yebeh.2005.04.004; LoPiccolo P, 1996, TECHNOL REV, V99, P52; MacLean P.D., 1990, TRIUNE BRAIN EVOLUTI; MACLEAN PD, 1992, TEMPORAL LOBES LIMBI, P1; Marneros A, 2004, ACUTE TRANSIENT PSYC; MORRELL F, 1985, ARCH NEUROL-CHICAGO, V42, P318, DOI 10.1001/archneur.1985.04060040028009; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Pontius A. A., 2002, EVOLUTIONARY NEUROET, P167; Pontius AA, 2004, EPILEPSY BEHAV, V5, P775, DOI 10.1016/j.yebeh.2004.05.013; PONTIUS AA, 1987, INTEGRATIVE PSYCHIAT, V5, P116; Pontius AA, 1997, AGGRESS VIOLENT BEH, V2, P125, DOI 10.1016/S1359-1789(96)00002-X; Pontius AA, 1996, B AM ACAD PSYCH LAW, V24, P125; PONTIUS AA, 1981, J FORENSIC SCI, V26, P123; Pontius AA, 2000, AGGRESS VIOLENT BEH, V5, P423, DOI 10.1016/S1359-1789(98)00041-X; Pontius AA, 2004, AGGRESS VIOLENT BEH, V9, P503, DOI 10.1016/S1359-1789(03)00046-6; PONTIUS AA, 1984, PERCEPT MOTOR SKILL, V59, P299, DOI 10.2466/pms.1984.59.1.299; PONTIUS AA, 1990, PSYCHOL REP, V67, P935, DOI 10.2466/PR0.67.7.935-945; Pontius AA, 2003, AGGRESS VIOLENT BEH, V8, P547, DOI 10.1016/S1359-1789(02)00099-X; Pontius AA, 1999, PERCEPT MOTOR SKILL, V88, P970, DOI 10.2466/PMS.88.3.970-982; PONTIUS AA, 1995, PSYCHOL REP, V76, P55, DOI 10.2466/pr0.1995.76.1.55; Pontius AA, 2001, INT J OFFENDER THER, V45, P515, DOI 10.1177/0306624X01454010; Pontius AA, 2001, J DEV PHYS DISABIL, V13, P191, DOI 10.1023/A:1016617526205; PONTIUS AA, 1993, PSYCHOL REP, V73, P615, DOI 10.2466/pr0.1993.73.2.615; PONTIUS AA, 1993, PSYCHOL REP, V73, P875, DOI 10.2466/pr0.1993.73.3.875; Pontius AA, 2003, AGGRESS VIOLENT BEH, V8, P245, DOI 10.1016/S1359-1789(01)00069-6; PONTIUS AA, 2002, CLIN CASE STUD, V1, P341; PONTIUS AA, 1986, ANN M ASS ADV SCI; PONTIUS AA, 2005, 20 MUN U FALL M FOR; PONTIUS AA, 1996, ANN M ASS ADV SCI; Pontius Anneliese A., 1993, Integrative Psychiatry, V9, P151; POST RM, 1975, LANCET, V1, P409; Proust Marcel., 1913, RECHERCHE TEMPS PERD; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; RACINE RJ, 1982, ELECTROPHYSIOLOGY EP, P153; RACINE RJ, 1980, NEUROSURGERY, V3, P324; Shostakovich B.V., 2004, RUSSIAN J PSYCHIAT, V1, P60; SRAMKA M, 1984, NEUROSURGICAL TREATM, P651; Wada JA, 1998, ADV BEHAV BIOL, V48, P1; WADA JA, 1978, LIMBIC MECHANISMS, P369; WADA JA, 1990, KINDLING, V4, P383; WIESER HG, 1983, EPILEPTIC FOCUS, P113; WIESER HG, 1993, ELECTROCLINIAL FEATU	76	4	4	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2008	14	1					29	43		10.1080/13554790801992750			15	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychiatry; Psychology	317QW	WOS:000257035700004	18569729				2022-02-06	
J	Zhang, XF; Liang, B; Liang, ZF; Lin, J				Zhang, Xiaofan; Liang, Bo; Liang, Zhifeng; Lin, Jun			Effects of Gingko biloba leaf extract on learning, memory, and hippocampal amyloid precursor protein mRNA expressions in diabetic rats	NEURAL REGENERATION RESEARCH			English	Article						Gingko biloba leave extract; diabetes; hippocampus; amyloid precursor protein	IMPAIRMENT	BACKGROUND: The mechanisms of brain injury Following diabetes could be related to amyloid precursor protein (APP) mRNA overexpression. Studies have shown that Gingko biloba leaf extract (EGb) is effective in promoting functional recovery of the brain after traumatic injury. EGb is also effective in improving central nervous system plasticity and learning and memory functions of the elderly. OBJECTIVE: To study the effects of EGb oil learning and memory, as well as hippocampal APP mRNA expression in the brains of diabetic rats. Using Morris water maze behavioral testing and reverse transcription polymerase chain reaction (RT-PCR), respectively. DESIGN: Complete random design, controlled experimental study. SETTING: Department of Pharmacology, Pharmaceutical School, Guangxi Medical University. MATERIALS: A total of 70 male Wistar rats (180-220 g), 8 weeks old and specific pathogen free, were used for this Study. GbE (containing 24.8% flavone glycosides and 6.2% diterpene lactone) was purchased from Guilin Sitejia Natural Plants Pharmaceutical Factory (Guangxi Province, Lot NO. 200405). Streptozotocin was purchased from Sigma (USA). Prolamine zinc insulin injection was purchased from WANBANG Biochemical Pharmaceutical Co., Ltd. (Xuzhou Jiangsu, China). METHODS: The experiment was performed in the Experimental Center of Guangxi Medical University from March to October 2005. (1) Experimental intervention: 70 rats were divided randomly into normal control group. diabetic model group (DM group), diabetic model +10 mu g/kg insulin group (DM + Ins group), diabetic model + 100 mg/kg ginkgo leaf extract group (DM + EGb high-dose group), and diabetic model + 50 mg/kg ginkgo leaf extract group (DM + EGb low-dose group); there were 14 rats in each group. Rats with an intraperitoneal (i.p.) injection of citrate buffer solution (pH 4.4) served as the control group. To establish the diabetes model. rats were treated with i.p. injection of 55 mg/kg streptozotocin. Insulin (10 U/kg) was injected Subcutaneously (s.c.) every day for 6 months in the DM group. EGb (100 mg/kg) and EGb (50 mg/kg) was administered intragastrically every day for 6 months in the DM + EGb high-close group and DM + EGb low-dose group, respectively. The DM group and control group were administered distilled water intragastrically every day for 6 months. Drugs were administered once every morning. (2) Experimental evaluation: Six month after intervention, learning and memory of diabetic rats was tested by Morris water maze. Rats were allowed to train for 4 days, and the escape latency and platform-searching score were measured at days 5 and 8. Changes in hippocampal APP mRNA expression were measured with RT-PCR. MAIN OUTCOME MEASURES: Morris water maze performances and hippocampal APP mRNA expression in rats. RESULTS: A total of 70 Wistar rats were included in the final analysis, without any loss. (1) Learning and memory dysfunction of diabetic rats: After 4 days of Morris water maze training, escape latency was longer in the DM group on days 5 and 8, and the platform-searching score was lower in the DM group compared to the control group. In the DM + EGb group, the escape latency score was shorter and platform-searching score was significantly increased compared to the DM group. (2) APP mRNA expression: in the hippocampus of diabetic rats, a 340 bp mRNA product was amplified, which is comparable to the APP mRNA amplification length of design. The expression of APP mRNA from the hippocampus of diabetic rats with learning and memory dysfunctions was significantly increased. EGb extract significantly inhibited the APP mRNA expression in these rats. CONCLUSION: EGb not only ameliorated the learning and memory dysfunctions in diabetic rats, but also significantly inhibited APP mRNA expression. Results from this study led to the hypothesis that diabetes could be one of the fisk factors for AD.	[Lin, Jun] Guangxi Univ Tradit Chinese Med, Pharmaceut Sch, Dept Pharmacol, Nanning 530021, Guangxi Zhuang, Peoples R China; [Zhang, Xiaofan; Liang, Bo] Guangxi Univ Tradit Chinese Med, Grad Pharmaceut Sch 2003, Nanning 530021, Guangxi Zhuang, Peoples R China; [Liang, Zhifeng] Guangxi Univ Tradit Chinese Med, Dept Physiol, Nanning 530021, Guangxi Zhuang, Peoples R China		Lin, J (corresponding author), Guangxi Univ Tradit Chinese Med, Pharmaceut Sch, Dept Pharmacol, Nanning 530021, Guangxi Zhuang, Peoples R China.	jullin989@sina.com					Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Ikeda E, 2000, NUCL MED COMMUN, V21, P933, DOI 10.1097/00006231-200010000-00007; LAKHMAN SS, 1994, NEUROCHEM INT, V24, P159, DOI 10.1016/0197-0186(94)90102-3; Lin L, 1998, NEUROREPORT, V9, P547, DOI 10.1097/00001756-199802160-00030; LIU F, 2007, ZHONGGUO ZUZHI GONGC, V11, P4159; Mufson EJ, 2007, CURR ALZHEIMER RES, V4, P340, DOI 10.2174/156720507781788855; ZHANG JT, 2002, STUDY ADVANCEMENT NE, P100; ZHANG WM, 2003, HANK BOOK MODERN MOL, P80; Zou G., 1999, BASIC NERVE PHAR, P153	10	4	4	0	9	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	JAN	2008	3	1					29	32					4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	344JH	WOS:000258922300007					2022-02-06	
J	Tilford, JM; Aitken, ME; Goodman, AC; Adelson, PD				Tilford, John M.; Aitken, Mary E.; Goodman, Allen C.; Adelson, P. David			Measuring the cost-effectiveness of technologic change in the treatment of pediatric traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Pediatric Trauma Care Workshop on Costs and Outcomes	MAR 08-09, 2007	Washington, DC				ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; SEVERE HEAD-INJURY; ECONOMIC-EVALUATION; CHILD HEALTH; CARE; PRODUCTIVITY; MEDICINE; OUTCOMES; QUALITY	Substantial variation exists with respect to the management of traumatic brain injuries (TBI) in children. Centers that practice aggressive treatment of TBI may improve survival, but it is not clear that the outcomes can be justified using cost-effectiveness criteria. This study illustrates the use of cost-effectiveness analysis to assess interventions for improving outcomes in children by assessing the cost per quality-adjusted life year (QALY) gained from technological change in the treatment of TBI. Cost and survival data associated with technological, change in the treatment of pediatric TBI was based on nationally representative hospital administrative data for all children <21 years with a TBI who required endotracheal intubation or mechanical ventilation. With QALYs of pediatric TBI survivors based on life expectancies ranging between 5 and 30 years and on an estimated preference score of approximately 0.5, the estimated incremental cost-effectiveness ratio ranges between $19,000 and $109,000 per QALY gained. Adding estimated rehabilitation costs increases the cost-effectiveness ratio to between $57,000 and $244,000 per QALY. Sensitivity analysis indicates that estimates of life years gained are critical to the estimated ratio. If TBI survivors live more than 5 years, then the estimated cost-effectiveness ratio seems favorable.	[Tilford, John M.] Arkansas Childrens Hosp, Dept Pediat, Ctr Appl Res & Evaluat, Little Rock, AR 72202 USA; [Tilford, John M.; Aitken, Mary E.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Ctr Appl Res & Evaluat, Little Rock, AR 72205 USA; [Goodman, Allen C.] Wayne State Univ, Dept Econ, Detroit, MI USA; [Adelson, P. David] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA		Tilford, JM (corresponding author), Arkansas Childrens Hosp, Dept Pediat, Ctr Appl Res & Evaluat, Little Rock, AR 72202 USA.	tilfordmickj@uams.edu	Aitken, Mary/ABG-6119-2021; Adelson, David/W-2083-2019		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H34MC00105] Funding Source: Medline		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Basu A, 2005, J HEALTH ECON, V24, P751, DOI 10.1016/j.jhealeco.2004.12.002; BELL CM, 1999, MED DECIS MAKING, V19, P519; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cutler DM, 2003, J HEALTH ECON, V22, P187, DOI 10.1016/S0167-6296(02)00125-X; Drummond MF, 2015, METHODS EC EVALUATIO; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Friedman Bernard, 2002, J Health Care Finance, V29, P1; Glied S, 2001, STUD INCOME, V62, P511; Gold MR., 1996, COST EFFECTIVENESS H, P82; GOLD MR, 1996, COST EFFECTIVENESS H, P1; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; GROSSE SD, 2007, IN PRESS IMPACTS SPI; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; *HCUP DAT, 2004, HEALTHC COST UT PROJ; Heidenreich PA, 2001, AM J MED, V110, P165, DOI 10.1016/S0002-9343(00)00712-9; Koopmanschap M, 2005, PHARMACOECONOMICS, V23, P47, DOI 10.2165/00019053-200523010-00004; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Murphy K, 2003, PERSPECT BIOL MED, V46, pS108, DOI 10.1353/pbm.2003.0077; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; O'Brien BJ, 2003, HEALTH ECON, V12, P975, DOI 10.1002/hec.789; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tilford JM, 2002, AMBUL PEDIATR, V2, P330, DOI 10.1367/1539-4409(2002)002<0330:CEAAEM>2.0.CO;2; TILFORD JM, 2007, EC EVALUATION INTENS; TILFORD JM, 2004, IN PRESS LABOR MARKE; Tilford JM, 2007, NEUROCRIT CARE, V7, P64, DOI 10.1007/s12028-007-0037-5; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	37	4	4	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2007	63	6		S			S113	S120		10.1097/TA.0b013e31815acc8b			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	245MO	WOS:000251939400011	18091201				2022-02-06	
J	Yamasato, M; Satoh, S; Ikejima, C; Kotani, I; Senzaki, A; Asada, T				Yamasato, Michihiko; Satoh, Shinji; Ikejima, Chiaki; Kotani, Izumi; Senzaki, Akira; Asada, Takashi			Reliability and validity of Questionnaire for Neurobehavioral Disability following traumatic brain injury	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						factor analysis; neurobehavioral disability; personality change; questionnaire; traumatic brain injury	CLOSED HEAD-INJURY; BEHAVIOR; MIND	The neurobehavioral disability recognized in traumatic brain injury (TBI) is a severe sequela, but there is no appropriate classification due to its various manifestations. In the present study a questionnaire for a simple investigation of this disability was prepared, and its reliability and validity verified. The survey was conducted on 72 patients with TBI by the caregiver of each patient. As a result, good reliability was indicated by the split-half method (coefficient of reliability: 0.95, obtained using Spearman-Brown correction formula). The total score of the questionnaire had a significant correlation with the total score of the simultaneously conducted Japanese version of Neuropsychiatry Inventory at the 0.01 level (Spearman's rank correlation, 0.47). It also had a significant correlation with the total score of the simultaneously conducted Japanese version of the Dysexecutive Questionnaire at the 0.05 level (Spearman's rank correlation, 0.36). Six factors constituting this neurobehavioral disability were extracted from a factor analysis of the questionnaire survey. These factors are angry outburst, avolition, deficits of sympathy, depressed mood, discourse deficits, and degradation of appearance. Each factor indicated good internal consistency (Cronbach alpha, 0.86-0.94). The present results indicate that this questionnaire has good reliability and validity, therefore it can be a significant indicator in TBI neurobehavioral disability study.	[Yamasato, Michihiko; Satoh, Shinji] Tsukuba Mem Hosp, Dept Psychiat, Tsukuba, Ibaraki 3002622, Japan; [Yamasato, Michihiko; Satoh, Shinji; Ikejima, Chiaki; Kotani, Izumi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kotani, Izumi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Tsukuba, Ibaraki, Japan		Yamasato, M (corresponding author), Tsukuba Mem Hosp, Dept Psychiat, 1187-299 Kaname, Tsukuba, Ibaraki 3002622, Japan.	yamasato@mail1.accsnet.ne.jp					Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Burgess P, 1996, BEHAV ASSESSMENT DYS; CUMMINGS JL, 1996, CONCISE GUIDE NEUROP; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DEVINSKY O, 1992, BEHAV NEUROLOGY 100; DOMEN K, 2005, PRACTICAL GUIDE UNDE, P23; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Frowein R A, 1988, Acta Neurochir Suppl (Wien), V44, P70; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hirono Nobutsugu, 1997, Brain and Nerve (Tokyo), V49, P266; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Levy M, 2005, NEUROREHABILITATION, V20, P279; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MIMURA S, 2004, HDB NEUROPSYCHOLOGIC, P111; Nakagawa Y, 1985, MANUAL JAPANESE VERS; Oikawa N., 2006, JPN J NEUROPSYCHOL, V22, P138; OKUMA T, 2003, CURRENT CLIN PSYCHIA; PONSFORD JL, 1995, TRAUMATIC BRAIN INQU; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Robinson R. G., 2000, NEUROPSYCHOLOGY EMOT, P239; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Schneider K, 1935, NERVENARZT, V8, P567; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TOYOKURA J, 2000, PATIENTS TRAUMATIC B, P63; WEIGER WA, 1988, J PSYCHIAT RES, V22, P85, DOI 10.1016/0022-3956(88)90073-8; YAMASATO M, 2006, HIGHER BRAIN FUNCT R, V26, P200	34	4	4	2	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2007	61	6					658	664		10.1111/j.1440-1819.2007.01720.x			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	240UV	WOS:000251614600013	18081628				2022-02-06	
J	Poomthavorn, P; Zacharin, M				Poomthavorn, Preamrudee; Zacharin, Margaret			Traumatic brain injury-mediated hypopituitarism. Report of four cases	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						hypopituitarism; traumatic brain injury; growth hormone deficiency	GROWTH-HORMONE DEFICIENCY; ANTERIOR-PITUITARY DYSFUNCTION; HEAD TRAUMA; SUBARACHNOID HEMORRHAGE; CHILDHOOD; TBI	Hypopituitarism has been increasingly recognised following traumatic brain injury. We report four children involved in motor vehicle accidents who had traumatic brain injury-mediated hypopituitarism. Various hormone defects are described. Growth hormone was the most commonly affected pituitary hormone. The time interval between the injury and diagnosis of pituitary hormone deficiency was between 2.5 weeks to 1.5 years. Hormone replacement therapy permitted normal completion of growth and development. Awareness among physicians treating children with traumatic brain injury of the risk of hypopituitarism is necessary to optimise the outcome.	Royal Childrens Hosp, Dept Endocrinol & Diabet, Parkville, Vic 3052, Australia		Zacharin, M (corresponding author), Royal Childrens Hosp, Dept Endocrinol & Diabet, Parkville, Vic 3052, Australia.	margaret.zacharin@rch.org.au					Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Dogru O, 2005, NEUROENDOCRINOL LETT, V26, P311; EICHLER I, 1988, J ENDOCRINOL INVEST, V11, P409, DOI 10.1007/BF03349069; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; GNEHM H E, 1979, Helvetica Paediatrica Acta, V34, P529; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lamberts SWJ, 1998, LANCET, V352, P127; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lim H S, 1990, Ann Acad Med Singap, V19, P851; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; SHAH A, 1992, BRIT MED J, V304, P173, DOI 10.1136/bmj.304.6820.173; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482	22	4	4	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	NOV	2007	166	11					1163	1168		10.1007/s00431-006-0406-7			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	213HC	WOS:000249656500009	17225948				2022-02-06	
J	Barker-Collo, S; Feigin, VL; Dudley, M				Barker-Collo, Suzanne; Feigin, Valery L.; Dudley, Margaret			Post-stroke fatigue-where is the evidence to guide practice?	NEW ZEALAND MEDICAL JOURNAL			English	Article								A significant proportion of stroke survivors suffer from persistent and significant fatigue which is linked to reduced independence and case fatality. Despite its high prevalence and detrimental effects, studies of post-stroke fatigue (PSF) interventions are scarce. Only one randomised controlled trial of post-stroke fatigue treatment (i.e. fluoxetine) was identified, and though improving post-stroke emotional incontinence and depression in patients with fatigue this did not improve PSF itself. Despite there being no literature on its efficacy, patient and family education/counselling has been identified as an important rehabilitation intervention for the management of stroke-related fatigue, which has been found effective in other patient groups (i.e. cancer, multiple sclerosis, and those with traumatic brain injury). Factors contributing to the lack of evidence for PSF management are identified and it is concluded that there is a need to better differentiate those most likely to suffer PSF, to validate existing assessments of fatigue, and to evaluate the efficacy of fatigue management and treatment strategies in stroke survivors.	[Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Fac Sci, Private Bag 92019, Auckland, New Zealand; [Feigin, Valery L.; Dudley, Margaret] Univ Auckland, Fac Hlth & Med Sci, Clin Trials Res Unit, Sch Populat Hlth, Auckland, New Zealand; [Feigin, Valery L.; Dudley, Margaret] Univ Auckland, Fac Hlth & Med Sci, Dept Med, Sch Populat Hlth, Auckland, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Dept Psychol, Fac Sci, Private Bag 92019, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Feigin, Valery/AAF-2313-2019				Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Anderson C, 1996, STROKE, V27, P1812, DOI 10.1161/01.STR.27.10.1812; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; Appelros P, 2006, INT J REHABIL RES, V29, P329, DOI 10.1097/MRR.0b013e328010c7b8; ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976; BAUGHMAN OL, 1994, J FAM PRACTICE, V39, P373; BELZA BL, 1995, J RHEUMATOL, V22, P639; Buck D, 2004, CEREBROVASC DIS, V17, P143, DOI 10.1159/000075783; Choi-Kwon S, 2007, CEREBROVASC DIS, V23, P103, DOI 10.1159/000097045; Clark P M, 1998, Clin J Oncol Nurs, V2, P45; Colle F., 2006, Annales de Readaptation et de Medecine Physique, V49, P361, DOI 10.1016/j.annrmp.2006.04.010; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Fawzy NW, 1995, CANCER NURS, V18, P427; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferrell B, 1996, ONCOL NURS FORUM, V23, P1539; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Glanz M, 1997, J ROY SOC MED, V90, P33, DOI 10.1177/014107689709000110; Glaus A, 1996, EUROPEAN J CANC CARE, V5; Goh M, 2001, NATL RES REGISTER; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Harmon R L, 1999, Phys Med Rehabil Clin N Am, V10, P651; Hjollund NH, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-12; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Keyes SJ, 2001, EVALUATION FATIGUE M, P168; Krupp LB, 2003, CNS DRUGS, V17, P225, DOI 10.2165/00023210-200317040-00002; LEEGAARD OF, 1983, ACTA NEUROL SCAND, V67, P348; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lieberman JA, 2003, J CLIN PSYCHIAT, V64, P40; Malley D, 2006, THEORY THERAPY SOCIA; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Matsen FA., 2000, FATIGUE MANAGEMENT; Michael Kathleen, 2002, Rehabil Nurs, V27, P89; Michael KM, REHABILITATION NURSI; Morley W, 2005, AGE AGEING, V34, P313, DOI 10.1093/ageing/afi082; Mota Dalete D C F, 2006, Res Theory Nurs Pract, V20, P49, DOI 10.1891/rtnp.20.1.49; New Zealand Guidelines Group, 2003, LIF STROK NZ GUID MA; PARTY ISW, 2004, NATL CLIN GUIDELINES; PICKARDHOLLEY S, 1991, CANCER NURS, V14, P13; Rabkin JG, 2004, J CLIN PSYCHIAT, V65, P1688, DOI 10.4088/JCP.v65n1215; Riley NA, 2002, DISABIL REHABIL, V24, P961, DOI 10.1080/0963828021000007932; Romani A, 2004, MULT SCLER J, V10, P462, DOI 10.1191/1352458504ms1051oa; Sandberg O, 2001, J AM GERIATR SOC, V49, P391, DOI 10.1046/j.1532-5415.2001.49081.x; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Schwartz CE, 1996, ARCH PHYS MED REHAB, V77, P165, DOI 10.1016/S0003-9993(96)90162-8; Sharpe Michael, 1998, American Journal of Medicine, V105, p104S, DOI 10.1016/S0002-9343(98)00170-3; Sisson R A, 1998, Rehabil Nurs, V23, P198; Sisson R A, 1995, J Neurosci Nurs, V27, P152; Snyder M, 1999, Annu Rev Nurs Res, V17, P3; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Sutherland JK, 2005, PSYCHIATR BULL, V29, P388, DOI 10.1192/pb.29.10.388; Underwood J, 2006, PHYS THER, V86, P1241, DOI 10.2522/ptj.20050357; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; van der Werf SP, 2001, EUR NEUROL, V45, P28, DOI 10.1159/000052085; van Zandvoort MJE, 2005, CLIN NEUROL NEUROSUR, V107, P385, DOI 10.1016/j.clineuro.2004.10.012; Ward Nicki, 2003, Br J Nurs, V12, P1075; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wester PO, 1998, RIKS STROKE REPORT A; Wilkes C N, 1989, Health Educ, V20, P6	59	4	4	0	0	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	OCT 26	2007	120	1264											9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V7P1W	WOS:000421164300012					2022-02-06	
J	Kim, DK; Jwa, CS; Kim, GH; Kang, JK				Kim, Dae Ki; Jwa, Cheol Su; Kim, Gang Hyeon; Kang, Jae Kyu			An experience of management of homeless neurosurgical patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						homeless persons; craniocerebral trauma; treatment outcome	PREVALENCE; HEPATITIS; HEALTH	Objective : Homeless patients probably have epidemiologic features that are different from those of general population. However, there have been no published articles about clinical characteristics of neurosurgical homeless patients. The authors tried to assess the clinical characteristics and treatment outcome of homeless neurosurgical patients. Methods : We retrospectively reviewed the medical records and radiological films of 76 homeless patients and 72 non-homeless patients following head trauma who were admitted to our neurosurgical department between June 2001 and June 2005. We compared two groups of the patients with the demographics, the clinical and laboratory characteristics. Also, 30-day mortality was determined according to Glasgow Coma Scale (GCS) score. Results : Age of homeless patients was younger than that of non-homeless patients. Homeless patients had previous craniotomy evidences in skull x-rays more frequently (10.5% vs. 1.4%). Acute subdural hematoma was the most common type of head injury in the two groups. Moderate and severe head injury, based on GCS score on admission was more frequent in homeless patients (64% vs. 39%). Fifty percent of homeless patients underwent operation for traumatic head injury. However, 30-day mortality according to GCS score was not significantly higher in homeless patients. Conclusion : Most homeless neurological patients were relatively young men. Also, moderate or severe brain injuries were observed more frequently. However, mortality rate of homeless patients in neurosurgical field is not significantly higher in the present study.	[Kim, Dae Ki; Jwa, Cheol Su; Kim, Gang Hyeon; Kang, Jae Kyu] Natl Med Ctr, Dept Neurosurg, Seoul 100799, South Korea		Jwa, CS (corresponding author), Natl Med Ctr, Dept Neurosurg, 243 Euljiro, Seoul 100799, South Korea.	chsjwa@hanmail.net					Boivin JF, 2005, CAN J PUBLIC HEALTH, V96, P432, DOI 10.1007/BF03405183; Crowe C, 1993, Can Nurse, V89, P21; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; Galperim Bruno, 2006, Arq. Gastroenterol., V43, P81, DOI 10.1590/S0004-28032006000200004; Han Oh-Su, 2001, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V40, P804; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Jencks C., 1994, HOMELESS; Kim DH, 2002, J KOREAN SOC EMERG M, V13, P294; KIM JC, 2001, KOREAN J PUBLIC HLTH, V2, P38; Lecomte T, 1997, B ACAD NAT MED PARIS, V181, P1715; Nelson J. A., 1994, SIECUS REP       AUG, P8; Noell J, 2001, SEX TRANSM DIS, V28, P4, DOI 10.1097/00007435-200101000-00003; North CS, 1997, SOC PSYCH PSYCH EPID, V32, P236, DOI 10.1007/BF00788244; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; ROTHERAMBORUS MJ, 1991, JAMA-J AM MED ASSOC, V266, P1237, DOI 10.1001/jama.266.9.1237; Roy N, 1998, LANCET, V352, P32, DOI 10.1016/S0140-6736(05)79510-6; Shin HR, 2005, J KOREAN MED SCI, V20, P985, DOI 10.3346/jkms.2005.20.6.985; Soliman AED, 2001, PSYCHIATR SERV, V52, P75, DOI 10.1176/appi.ps.52.1.75; Vacha E., 1993, J SOCIAL DISTRESS HO, V2, DOI [10.1007/BF01074225, DOI 10.1007/BF01074225]; Wolff N, 1997, AM J PSYCHIAT, V154, P341; Wood D., 1992, DELIVERING HLTH CARE; Wright J, 1987, ALCOHOL HEALTH RES W, V11, P22	22	4	4	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2007	42	3					191	194					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	279VN	WOS:000254383300009					2022-02-06	
J	Mghaieth, S; Othman, S; Bouden, A; Halayem, MB				Mghaieth, S.; Othman, S.; Bouden, A.; Halayem, M. B.			Post-traumatic stress disorder in children: clinical aspects and comorbidity	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						adolescent; children; comorbidity; ESPT; semiology		Introduction - Like adults, children and teenagers are increasingly confronted with threatening and traumatizing events. Clinical practice shows that serious psychological disorders may occur during these events, which frequently engenders disturbance of the adaptation of these young people. Nevertheless, research on this disorder has overlooked the young population, despite being subject to the same traumatic experiences as adults. Aim of the study - This clinical study therefore focused on young subjects aged from 4 to 17 and who were victims of road accidents in May 2004. Methods - The size of the sample was of 15 children and teenagers : 10 boys and 5 girls. Their disorders were evaluated by a clinical interview that made use of a semi-structured questionnaire K-SADS-PL two months after the trauma, then another after six months. Clinical aspects - The diagnosis of PTSD was found among 14 out of the 15 patients during the first evaluation and among the entire sample after six months. Among these children, four (26.7%) were injured during the accident (fracture, brain damage, superficial injuries). About half of the sample (46.6%) lost a member of their families (6 lost their mother, 1 lost his brother) and 40% lost a relative (grand-mother, aunt, or cousin). Results - Using the clinical analysis with the K-SADS has shown validity of DSM IV criteria. The symptoms of dissociation, observed after two months, disappeared significantly six months later. This fact maybe due to the emotional collapse which accompanies the most violent types of stress. An important comorbidity of depressive and anxious disorders - especially separation anxiety - was found constant during both evaluations. It represents a supplementary handicap and risk for important psychological after-effects, even after some years. Some disorders such as separation anxiety, regressive symptoms and psychosomatic manifestations are frequently associated with the PTSD. Conclusion - We hypothesise that these disorders should be considered as diagnostic criteria and not as comorbid disorders.	[Mghaieth, S.; Othman, S.; Bouden, A.; Halayem, M. B.] Hop Razi, Serv Pedopsychiat, La Manouba 2010, Tunisia		Bouden, A (corresponding author), Hop Razi, Serv Pedopsychiat, Rue Orangers, La Manouba 2010, Tunisia.		Hamlet, Erin/F-8070-2011				Amaya-Jackson I, 1995, ANXIETY DISORDERS CH, P276; American Academy of Child and Adolescent Psychiatry, 1998, J AM ACAD CHILD ADOL, V37, P4; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Foy DW, 1996, J SCHOOL PSYCHOL, V34, P133, DOI 10.1016/0022-4405(96)00003-9; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; GOENJIAN AK, 1995, J AM ACAD CHILD PSY, V34, P1174, DOI 10.1097/00004583-199509000-00015; JOLLY A, 2003, J INTERN VICTIMOL, V2; Kaminer Debra, 2005, World Psychiatry, V4, P121; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Moro M. R., 1995, PSYCHIAT HUMANITAIRE; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; *OMS, 1993, CLASS INT MAL 10 REV, pCH5; Pfefferbaum B, 1997, J AM ACAD CHILD PSY, V36, P1503, DOI 10.1016/S0890-8567(09)66558-8; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; SCHMITT L, 2004, ENCEPHALE, P117; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; TAIEB O, 2004, ENCY MED CHIR; TERR LC, 1991, AM J PSYCHIAT, V148, P10; Vila G, 1999, ENFANT VICTIME AGRES; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705	21	4	4	1	9	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2007	33	4					598	602					5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	257IX	WOS:000252793600010	18033149				2022-02-06	
J	Easton, A; Atkin, K; Hare, P				Easton, Ava; Atkin, Karl; Hare, Philippa			'A light in a very dark place': The role of a voluntary organisation providing support for those affected by encephalitis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; REHABILITATION; STATE; MODEL; NEED	Voluntary organisations are seen as contributing to the "democratisation" of health and social care. Little, however, is written about their role and this paper, by focusing on the work of the Encephalitis Society, provides valuable insights into the challenges facing voluntary organisations that represent the needs of those with neurological disorders. Two empirical studies are presented: a review conducted by the Society, focusing on patients' experiences of neurological services; and an external evaluation of the Society's current provision. The first, based on a postal survey of its members affected by encephalitis (n = 339), illustrates the Society's advocacy role. The survey specifically supports the Association of British Neurologists' recommendation for nationally agreed standards of care. The second study, based on a postal survey of recent contacts (n = 76) and in-depth telephone interviews (n = 22), demonstrates the Society's value as a service provider and its role in helping to rehabilitate affected individuals and their families. In responding to these findings, the Encephalitis Society is reminded of the importance of maintaining credibility among its members as well as health care providers. Developing strategies, on the basis of informed action and partnership working with service champions, continues to inform the organisation's sense of purpose, as it responds to the changing context of welfare provision in the UK.	Encephalit Soc, Malton YO17 7LL, Yorks, England; Univ York, York YO10 5DD, N Yorkshire, England; Act Shapiro, Malton, Yorks, England		Easton, A (corresponding author), Encephalit Soc, 7B Saville St, Malton YO17 7LL, Yorks, England.	ava@encephalitis.info		Easton, Ava/0000-0002-1739-2915			Adamson J, 2005, HDB HLTH RES METHODS; ALVESSON M, 2000, REFLEXIVE METHDOLOGY; *ASS BRIT NEUR, 2003, UK NEUR NEXT 10 TENS; *ASS BRIT NEUR, 2002, ACUT NEUR EM AD LOND; ATKIN K, IN PRESS DILEMMAS PR; ATKIN K, 2006, PROVIDING SUPPORT PE; Barnes C., 2000, EXPLORING DISABILITY; BARNETT JR, SOCIAL SCI MED; BODDY M, 2004, CITY MATTERS; BOURDIEU PIERRE, 1990, LOGIC PRACTICE; Bury M, 2005, RAPID REV CURRENT ST; Butcher J, 2002, LANCET NEUROL, V1, P4, DOI 10.1016/S1474-4422(02)00024-8; Chwalisz K, 1996, Appl Neuropsychol, V3, P28, DOI 10.1207/s15324826an0301_5; Coid DR, 2003, PUBLIC HEALTH, V117, P317, DOI 10.1016/S0033-3506(03)00073-8; CRACK S, IN PRESS CHANGING FA; Crombie IK, 2000, BMJ-BRIT MED J, V320, P392, DOI 10.1136/bmj.320.7232.392; Dahlberg L, 2006, HEALTH SOC CARE COMM, V14, P302, DOI 10.1111/j.1365-2524.2006.00621.x; DOWELL E, 2001, CONSEQUENCES ENCEPHA; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Fox N, 2001, SOC SCI MED, V52, P155, DOI 10.1016/S0277-9536(00)00290-2; Fyfe NR, 2005, ANTIPODE, V37, P536, DOI 10.1111/j.0066-4812.2005.00510.x; Habermas, 1987, KNOWLEDGE HUMAN INTE; Hussain-Gambles M, 2004, HEALTH TECHNOL ASSES, V8, P1; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Moorthi S, 1999, BRAIN INJURY, V13, P139, DOI 10.1080/026990599121809; O'Connor RJ, 2005, J NEUROL, V252, P814, DOI 10.1007/s00415-005-0751-x; Pisecky T, 2003, VACCINE, V21, pS73, DOI 10.1016/S0264-410X(02)00817-4; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; RYAN M, 2001, HLTH TECHNOLOGY ASSE; SILVERMAN D, 2001, INTERPRETING QUALITI; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Taylor J, 2005, POLICY POLIT, V33, P601, DOI 10.1332/030557305774329127; Tyrer S, 2003, NEUROPSYCHOL REHABIL, V13, P189, DOI 10.1080/09602010244000381; WILLIAMS F, 1996, RACE COMMUNITY CARE; WISTOW G, 1994, SOCIAL CARE MIXED EC	38	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG-OCT	2007	17	4-5					638	647		10.1080/09602010601155205			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	210AV	WOS:000249430000013	17676539	Green Accepted			2022-02-06	
J	Allen, EA				Allen, Elizabeth A.			Interventions for postconcussion syndrome	TRAUMA-ENGLAND			English	Article						postconcussion syndrome; mild traumatic brain injury; interventions		Although Postconcussion syndrome (PCS) only develops in a minority of cases of mild traumatic brain injury, affected individuals can experience significant distress and prove challenging for services. This paper outlines the risk factors for PCS, relevant theoretical models are discussed, and studies of therapeutic interventions reviewed. It is concluded that early intervention is beneficial, but much further research is required in order to determine which aspects of interventions are most effective for chronic PCS.	[Allen, Elizabeth A.] James Cook Univ Hosp, Dept Neuropsychol, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England		Allen, EA (corresponding author), James Cook Univ Hosp, Dept Neuropsychol, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England.	liz.allen@stees.nhs.uk					Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Davies R, 2005, BRAIN INJURY, V19, P941, DOI 10.1080/02699050400000565; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McIntosh G C, 1997, Appl Neuropsychol, V4, P62, DOI 10.1207/s15324826an0401_8; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W., 1992, J NEUROL NEUROSUR PS, V41, P611; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845	36	4	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2007	9	3					181	187		10.1177/1460408607087717			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V3C0C	WOS:000218117700005					2022-02-06	
J	Gofin, R; Avitzour, M				Gofin, Rosa; Avitzour, Malka			Outcome of head and other injuries among Israeli children: Physical limitations and stress symptoms	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Article						traumatic brain injury; activity limitations; stress symptoms	TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC ACCIDENTS; UNITED-STATES; MORTALITY; DISORDER; OLDS	Background: Head injuries, especially in young children, are frequent and may cause long-lasting impairments. Objectives: To investigate the outcome of head and other injuries casued by diverse mechanisms and of varied severity. Methods: The study population consisted of Jews and Arabs (n=792), aged 0-17 years old, hospitalized for injuries in six hospitals in Israel. Caregivers were interviewed during hospitalization was gathered from the medical files. Five months post-injury the caregivers were interviewed by phone regarding physical limitations and stress symptoms.	Hebrew Univ Jerusalem, Hadassah Med Ctr, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel		Gofin, R (corresponding author), Hadassah Med Ctr, Sch Publ Hlth & Community Med, PO Box 12000, IL-91120 Jerusalem, Israel.	gofin@cc.huji.ac.il					ABRAMSON JH, 2004, EINPEPI PEPI WINDOWS; *AM PSYCH ASS DIAG, 2000, TEXT REV, P468; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; *CTR BUR STAT, 2001, 52 CTR BUR STAT; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Gofin R, 1997, Inj Prev, V3, P120, DOI 10.1136/ip.3.2.120; Gofin R, 2002, INT J EPIDEMIOL, V31, P593, DOI 10.1093/ije/31.3.593; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stallard P, 2004, EUR CHILD ADOLES PSY, V13, P172, DOI 10.1007/s00787-004-0399-6; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285; World Health Organization, 1977, INT CLASS DIS 9 REV	23	4	4	0	5	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	JUL	2007	9	7					531	536					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195FQ	WOS:000248398300009	17710785				2022-02-06	
J	Idris, Z; Ghani, RI; Musa, KI; Ibrahim, MI; Abdullah, M; Nyi, NN; Abdullah, JM				Idris, Zamzuri; Ghani, Rahman Izaini; Musa, Kamarul Imran; Ibrahim, Mohd Ismail; Abdullah, Mazlan; Nyi, Naing Nyi; Abdullah, Jafri Malin			Prognostic study of using different monitoring modalities in treating severe traumatic brain injury	ASIAN JOURNAL OF SURGERY			English	Article						multimodality monitoring; outcome in head injury; severe head injury	SEVERE HEAD-INJURY	OBJECTIVE: To determine whether or not multimodality monitoring technique would result in a better outcome score than single modality monitoring in severely head injured patients. METHODS: This was a prospective randomized study that included all adults with traumatic severe head injury who had a Glasgow Coma Score < 9 and computed tomography scan features that did not reveal significant infratentorial pathology. Subjects were randomized into a multimodality group where they received multiple cerebral monitoring or into a standard single modality group where they received only intracranial pressure monitoring. The outcome was analysed 6 months post treatment using the Barthel Index. RESULTS: The outcome at 6 months post treatment between the two groups was not statistically significant (p < 0.48). However, the percentage of subjects who were independent at 6 months was higher in the multimodality group (21.2%) compared with the single modality group (17.3%). CONCLUSION: Multimodality monitoring for severely head-injured patients has no effect on outcome. However, study with a larger sample size and improvement in groups comparison are required to ascertain the above findings.	USM, Sch Med Sci, Dept Neurosci, Kubang Kerian, Kelantan, Malaysia; USM, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian, Kelantan, Malaysia		Idris, Z (corresponding author), Hosp USM, Dept Neurosci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	neuroscienceszamzuri@yahoo.com	Idris, Zamzuri/AAB-6764-2022; Musa, Kamarul Imran/G-4864-2010; Abdullah, Mazlan/AAD-9128-2019; Naing, Nyi Nyi/AAB-3851-2021; Ibrahim, Mohd Ismail/C-8347-2016; Musa, Kamarul Imran/N-3198-2015; Abdullah, J/C-2828-2011; Naing, Nyi Nyi/M-3455-2015	Idris, Zamzuri/0000-0002-9470-0571; Ibrahim, Mohd Ismail/0000-0002-5470-4180; Musa, Kamarul Imran/0000-0002-3708-0628; Abdullah, J/0000-0002-0258-7410; Naing, Nyi Nyi/0000-0001-8308-5625			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Charbel FT, 1997, SURG NEUROL, V48, P414, DOI 10.1016/S0090-3019(96)00473-9; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; DICKMAN CA, 1991, NEUROSURGERY, V28, P467, DOI 10.1227/00006123-199103000-00026; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NEWELL WD, 1994, STROKE, V25, P793; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; [No title captured]	13	4	4	0	0	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584			ASIAN J SURG	Asian J. Surg.	JUL	2007	30	3					200	208		10.1016/S1015-9584(08)60023-8			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	196YC	WOS:000248518300008	17638640	Bronze			2022-02-06	
J	Joung, YI; Yi, HJ; Lee, SK; Im, TH; Cho, SH; Ko, Y				Joung, Young Il; Yi, Hyeong-Joong; Lee, Seung Ku; Im, Tai-Ho; Cho, Seok Hyun; Ko, Yong			Posttraumatic anosmia and ageusia: Incidence and recovery with relevance to the hemorrhage and fracture on the frontal base	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						ageusia; anosmia; fracture; frontal base; hemorrhage; traumatic brain injury (TBI)	HEAD-INJURY; TASTE; SMELL; DISTURBANCES; IMPAIRMENT; DISABILITY	Objective : We studied whether frontal skull base fracture has an impact on the occurrence and recovery of anosmia and/or ageusia following frontal traumatic brain injury (TBI). Methods: Between May 2003 and April 2005, 102 consecutive patients who had hemorrhage or contusion on the frontal lobe base were conservatively treated. Relevant clinical and radiographic data were collected, and assessment of impaired smell and taste sensation were also surveyed up to at least 12 months post-injury. Results : Among 102 patients, anosmia was noted in 22 (21.6%), of whom 10 had ageusia at a mean 4.4 days after trauma. Bilateral frontal lobe injuries were noted in 20 of 22 patients with anosmia and in all 10 patients with ageusia. Frontal skull base fracture was noted in 41 patients, of whom 9 (21.4%) had anosmia and 4 (9.5%) had ageusia. There was no statistical difference in the occurrence of anosmia and ageusia between patients with or without fracture. Of the 22 patients with anosmia, recovery from anosmia occurred in nine (40.9%) at the interval of 6 to 24 months after trauma, of whom six had frontal skull base fracture and three were not associated with fracture. Recovery of anosmia was significantly higher in patients without fracture than those with fracture (p<0.05). Recovery from ageusia occurred in only two of 10 patients at the interval of 18 to 20 months after trauma and was not eminent in patients without fracture. Conclusion : One should be alert and seek possibile occurrence of the anosmia and/or ageusia following frontal TBI. It is suggested that recovery is quite less likely if such patients have fractures on the frontal base, and these patients should wait for at least 6 to 18 months to anticipate such recovery if there is no injury to the central olfactory structures.	[Joung, Young Il; Yi, Hyeong-Joong; Lee, Seung Ku; Ko, Yong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul 133792, South Korea; [Im, Tai-Ho] Hanyang Univ, Med Ctr, Dept Emergency Med, Seoul 133792, South Korea; [Cho, Seok Hyun] Hanyang Univ, Med Ctr, Dept Otolaryngol, Seoul 133792, South Korea		Yi, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, Haengdang Dong, Seoul 133792, South Korea.	hjyi8499@hanyong.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020				AHN JY, 2000, J KOREAN NEUROSURG S, V29, P1570; *AM MED ASS, 1984, GUID EV PERM IMP, P153; Costanzo R. M., 1995, NEUROL DIS, P493; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty R L, 1979, Am J Otolaryngol, V1, P57, DOI 10.1016/S0196-0709(79)80010-1; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; JENNETT B, 2005, HEAD INJURY PATHOPHY, P441; Jimenez D F, 1997, J Craniomaxillofac Trauma, V3, P8; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; SHIP JA, 1996, J GERONTOL A-BIOL, V51, pM85; Spilker B., 1996, QUALITY LIFE PHARMAC, P337; TEASDALE G, 1974, LANCET, V2, P81; VANDAMME PA, 1992, J CRANIO MAXILL SURG, V20, P248, DOI 10.1016/S1010-5182(05)80436-6; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	23	4	4	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JUL	2007	42	1					1	5					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	279VI	WOS:000254382800001					2022-02-06	
J	Venkatachalam, SG; Selvaraj, DAP; Rangarajan, M; Mani, K; Palanivelu, C				Venkatachalam, Sengoda Gounder; Selvaraj, D. A. Palaniswamy; Rangarajan, Muthukumaran; Mani, Kumarasami; Palanivelu, Chinnusamy			An unusual case of penetrating tracheal ("Cut throat") injury due to chain snatching: The ideal airway management	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Penetrating tracheal injury; orotracheal intubation; tracheostomy		Background: Traumatic airway injuries are fortunately rare. Though injuries can be obvious and initial management straightforward, the diagnosis can be difficult. We present a case of penetrating cervical tracheal injury due to 'chain snatching' in a young female. Case Report: The young female patient presented in the Emergency Department with a bleeding neck wound. Orotracheal intubation was done after resuscitation, revealing a transected trachea. There was no injury to major vessels or nerves, so the wound was debrided and closed in layers and a tracheostomy tube was placed through the transected trachea. Postoperatively, the patient was ventilated for 72h, after which she completely recovered. Discussion: Initial management can be complicated by associated head, neck and thoracic injuries. Orotracheal intubation or tracheostomy through the tracheal wound is the ideal way to manage these cases. Surgical repair of the trachea is not always necessary. Mortality rates and the incidence of late complications remain high and have been related to delays in diagnosis and definitive treatment,	[Venkatachalam, Sengoda Gounder; Selvaraj, D. A. Palaniswamy; Rangarajan, Muthukumaran; Mani, Kumarasami; Palanivelu, Chinnusamy] GEM Hosp, 45-A Pankaja Mill Rd, Coimbatore 641045, Tamil Nadu, India		Selvaraj, DAP (corresponding author), GEM Hosp, 45-A Pankaja Mill Rd, Coimbatore 641045, Tamil Nadu, India.	rangy68@gmail.com					Beiderlinden M, 2005, ANESTH ANALG, V100, P210, DOI 10.1213/01.ANE.0000140780.14175.5A; Cicala R S, 1991, J Clin Anesth, V3, P91, DOI 10.1016/0952-8180(91)90003-6; Glinjongol Chanin, 2005, Journal of the Medical Association of Thailand, V88, P32; Gonzalez RP, 2003, J TRAUMA, V54, P61, DOI 10.1097/00005373-200301000-00008; GREWAL H, 1995, HEAD NECK-J SCI SPEC, V17, P494, DOI 10.1002/hed.2880170607; HURFORD WE, 2003, CAN J ANESTH S, V50, pR1; Peralta R, 2000, INT ANESTHESIOL CLIN, V38, P111, DOI 10.1097/00004311-200007000-00008; Rao B, 2004, IND J CRITIC CARE ME, V8, P98; Rao PM, 1996, EMERG RADIAL, V3, P87; Rossbach MM, 1998, ANN THORAC SURG, V65, P182, DOI 10.1016/S0003-4975(97)01001-1; SYMBAS PN, 1976, ANN THORAC SURG, V22, P473, DOI 10.1016/S0003-4975(10)64456-6	11	4	4	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JUL-SEP	2007	11	3					151	154		10.4103/0972-5229.35359			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3B3J	WOS:000218100200009		Green Submitted			2022-02-06	
J	Gundogar, D; Demirci, S				Gundogar, Duru; Demirci, Serpil			Confabulation: A symptom which is intriguing but not adequately known	TURK PSIKIYATRI DERGISI			Turkish	Article						confabulation; frontal lobe; memory	ANTERIOR COMMUNICATING ARTERY; FRONTAL LOBES; MEMORY; REALITY; MECHANISMS; NEUROPSYCHOLOGY; RECOGNITION; DYSFUNCTION; CONFUSION; PATTERNS	Confabulation has been defined as the falsification of memory occurring in clear consciousness in association with an organically-derived amnesia. It was first described by Korsakaff in 1889 in alcoholic amnesic patients. Later studies showed that confabulation is also seen in a variety of other pathologies, such as anterior communicating artery rupture, traumatic brain injury, Alzheimer's disease, and brain tumors. Two forms of confabulation have been described: Momentary (provoked) confabulation which is produced in response to questions, for compensating the gaps in memory; and fantastic (spontaneous) confabulation consisting of grandiose and wish-fulfilling characteristics. There is no specific localization for provoked confabulations. However spontaneous confabulations appear as a result of basal forebrain and posterior orbito frontal cortex lesions. There are numerous hypotheses for explaining the specific nature of confabulations with reference to impairment of general executive dysfunction, temporality, and memory-control processes. Commonly, these interpretations explain memory distortion in terms of frontal network dysfunction. There is a general consensus that confabulation is primarily the result of a deficit of memory retrieval, rather than one of encoding, consolidation, or storage. The normal process of memory recall consists of the evaluation of the cues for retrieval, matching the cues with episodic memory, and reality monitoring. One possible explanation for confabulation is that these patients have lost the checking procedure in memory retrieval, i.e. reality monitoring. This article aimed to describe confabulation and to review its clinical, neuroanotomical, and neuropsychological correlates in an effort to raise clinicians' awareness of the phenomenon and the problematic areas that need to be clarified.	Suleyman Demirel Univ, Tip Fak, Psikiyatri AD, Isparta, Turkey; Suleyman Demirel Univ, Tip Fak, Norol AD, Isparta, Turkey		Gundogar, D (corresponding author), Suleyman Demirel Univ, Tip Fak, Psikiyatri AD, Isparta, Turkey.	durugundogar2000@yahoo.com	Demirci, Serpil/A-8223-2012; Demirci, Serpil/N-4638-2019	Demirci, Serpil/0000-0003-1561-1296; Demirci, Serpil/0000-0003-1561-1296			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM, P225; BARBIZET J, 1963, J NEUROL NEUROSUR PS, V26, P127, DOI 10.1136/jnnp.26.2.127; Barbizet J., 1970, HUMAN MEMORY ITS PAT; Benson DF, 1996, NEUROLOGY, V46, P1239, DOI 10.1212/WNL.46.5.1239; BERLYNE N, 1972, BRIT J PSYCHIAT, V120, P31, DOI 10.1192/bjp.120.554.31; Berrios G E, 1998, J Hist Neurosci, V7, P225, DOI 10.1076/jhin.7.3.225.1855; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; CHOW TW, 2000, COMPREHENSIVE TXB PS, V7, P221; Dab S, 1999, COGN NEUROPSYCHOL, V16, P215, DOI 10.1080/026432999380771; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DALLABARBA G, 1990, CORTEX, V26, P197; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; DELBECQDEROUESNE J, 1990, BRAIN, V113, P1045, DOI 10.1093/brain/113.4.1045; DELUCA J, 1993, CORTEX, V29, P639, DOI 10.1016/S0010-9452(13)80287-0; DELUCA J, 1991, CORTEX, V27, P417, DOI 10.1016/S0010-9452(13)80036-6; DEMIRCI S, 2004, TURKIYE KLIN J PSYCH, V5, P116; DOWNES JJ, 1995, CASE STUDIES MEMORY, P115; Feinberg T.E., 1997, BEHAV NEUROLOGY NEUR, P369; Feinstein A, 2000, MULT SCLER J, V6, P186, DOI 10.1177/135245850000600309; FISCHER RS, 1995, J CLIN EXP NEUROPSYC, V17, P20, DOI 10.1080/13803399508406577; Fotopoulou A, 2004, NEUROPSYCHOLOGIA, V42, P727, DOI 10.1016/j.neuropsychologia.2003.11.008; Johnson MK, 1998, TRENDS COGN SCI, V2, P137, DOI 10.1016/S1364-6613(98)01152-8; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KERN RS, 1992, BRAIN COGNITION, V19, P172, DOI 10.1016/0278-2626(92)90043-L; KOPELMAN MD, 1987, J NEUROL NEUROSUR PS, V50, P482; Korsakoff SS, 1996, CONSCIOUS COGN, V5, P2, DOI 10.1006/ccog.1996.0002; LURIA AR, 1980, HIGHER CORTICAL FUNC, V2, P338; McDermott KB, 2005, TRENDS COGN SCI, V9, P561, DOI 10.1016/j.tics.2005.10.008; MERCER B, 1977, ARCH NEUROL-CHICAGO, V34, P429, DOI 10.1001/archneur.1977.00500190063009; Mohamed FB, 2006, RADIOLOGY, V238, P679, DOI 10.1148/radiol.2382050237; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; OZTURK O, 2002, RUH SAGLIGI BOZUKLUK, V9, P514; Parkin AJ, 1997, LEARN INDIVID DIFFER, V9, P341, DOI 10.1016/S1041-6080(97)90013-3; Ptak R, 1999, NEUROCASE, V5, P243, DOI 10.1080/13554799908402729; REY Alain, 1995, DICT HIST LANGUE FRA; Salazar-Fraile J, 2004, COMPR PSYCHIAT, V45, P281, DOI 10.1016/j.comppsych.2004.03.007; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 2000, NEUROPSYCHOLOGIA, V38, P175, DOI 10.1016/S0028-3932(99)00064-0; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Shallice T, 1999, NAT NEUROSCI, V2, P588, DOI 10.1038/10137; SHAPIRO BE, 1981, NEUROLOGY, V31, P1070, DOI 10.1212/WNL.31.9.1070; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Talland G.A, 1965, DERANGED MEMORY PSYC; TALLAND GA, 1961, J NERV MENT DIS, V132, P361, DOI 10.1097/00005053-196105000-00001; Turnbull OH, 2004, BRAIN COGNITION, V55, P490, DOI 10.1016/j.bandc.2004.02.069; WHITLOCK FA, 1981, BRIT J MED PSYCHOL, V54, P213, DOI 10.1111/j.2044-8341.1981.tb01451.x	55	4	4	0	2	TURKIYE SINIR VE RUH SAGLIGI DERNEGI	YENISEHIR	PK 401, YENISEHIR, 06442, TURKEY	1300-2163			TURK PSIKIYATR DERG	Turk. Psikiyatr. Derg.	SUM	2007	18	2					172	178					7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	179AC	WOS:000247260700009	17566883				2022-02-06	
J	Caballero-Coulon, MC; Ferri-Campos, J; Garcia-Blazquez, MC; Chirivella-Garrido, J; Renau-Hernandez, O; Ferri-Salvador, N; Noe-Sebastian, E				Caballero-Coulon, M. C.; Ferri-Campos, J.; Garcia-Blazquez, M. C.; Chirivella-Garrido, J.; Renau-Hernandez, O.; Ferri-Salvador, N.; Noe-Sebastian, E.			The 'awareness climbing': An educational board game for improving self-awareness following acquired brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						acquired brain injury; neuropsychology; rehabilitation; self-awareness; traumatic head injury	IMPAIRED AWARENESS; PRACTICAL SCALE; DEFICITS; KNOWLEDGE	Aim. To establish the effectiveness of an educational board game for improving self-awareness following acquired brain injury. Patients and methods. The 'awareness climbing' is a board game format intervention for improving awareness of patients with acquired brain injury (ABI) and for facilitating the use of anticipatory and compensatory strategies. 17 patients with ABI (traumatic brain injury, 10; stroke, 5; others, 2) were included in a self-awareness rehabilitation program using the 'awareness climbing'. Self-awareness was assessed with the Self-Awareness of Deficit Interview (SADI) before (and after game intervention. According to the SADI self-awareness consists of three-interdependent levels: intellectual awareness (impairments), emergent awareness (disability) and anticipatory awareness, which involve the client predicting when impairments will affect his or her performance. Results. Initially five patients showed impaired intellectual awareness, four patients had difficulties on emergent awareness and time patients showed deficits on anticipatory awareness. Intellectual awareness improved in 10 patients, while six patients experienced improvements in emergent awareness over the intervention period. The most striking change was an improvement in 70% of the sample (n = 11) in anticipatory awareness after game sessions. Conclusion. According to SADI scores we suggest that the 'awareness climbing' may, be a useful tool for improving self-awareness after acquired brain injury.	Hosp NISA, Serv Dano Cerebral, IVAN, Valencia, Spain		Noe-Sebastian, E (corresponding author), Hosp Valencia Mar, Serv Dano Cerebral, Rio Tajo 1, E-46601 Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			Chittum WR, 1996, BRAIN INJURY, V10, P763; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Fleming JM, 1996, BRAIN INJURY, V10, P1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; TEASDALE G, 1974, LANCET, V2, P81; Zhou J, 1996, J HEAD TRAUMA REHAB, V11, P51, DOI 10.1097/00001199-199602000-00007	13	4	4	0	8	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	MAR 16	2007	44	6					334	338		10.33588/rn.4406.2006190			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154AM	WOS:000245479200003	17385168				2022-02-06	
J	Bardgett, ME; Schultheis, PJ; Muzny, A; Riddle, MD; Wagge, JR				Bardgett, Mark E.; Schultheis, Patrick J.; Muzny, Ashley; Riddle, Michael D.; Wagge, Jordan R.			Magnesium deficiency reduces fear-induced conditional lick suppression in mice	MAGNESIUM RESEARCH			English	Article						conditional fear; NMDA; glutamate; spatial learning; mice	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; COGNITIVE FUNCTION; CONTEXTUAL CUES; NEURONAL LOSS; WATER MAZE; MEMORY; RATS; LESIONS; AMYGDALA	The consequences of broad-scale alterations in magnesium (Mg2+) levels on learning and memory are poorly understood. We have recently demonstrated that adult male mice maintained on an Mg2+-deficient diet exhibit reduced conditional freezing behavior. The purpose of the present study was to determine if the detrimental effect of Mg2+ deficiency in mice extended to another measure of conditional fear, conditioned lick suppression (CLS), as well as to another form of learning, spatial learning in the swim maze task. Adult male C57BI/6J mice were provided with a normal or Mg2+-deficient diet and were trained and tested ten days later for conditional fear, using CLS and freezing as indicators of learning. Learning in the swim maze was tested in a separate cohort of mice during days 14-18 of diet exposure. Mg2+-deficient mice showed reduced CLS as well as conditional freezing behavior in comparison to control mice. However, learning in the swim maze task was normal in Mg2+-deficient mice. These studies indicate that the detrimental effects of Mg2+ deficiency extend to other measures of conditional fear but not to all forms of learning.	No Kentucky Univ, Dept Psychol, Highland Hts, KY 41099 USA; No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41099 USA		Bardgett, ME (corresponding author), No Kentucky Univ, Dept Psychol, 1 Nunn Dr, Highland Hts, KY 41099 USA.	bardgettm@nku.edu		Bardgett, Mark/0000-0001-7028-2603; Riddle, Michael/0000-0002-7455-2815	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016481] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR016481-077399, P20 RR16481, P20 RR016481-067168, P20 RR016481-050022, P20 RR016481, P20 RR016481-086258] Funding Source: Medline		Bardgett ME, 2005, BRAIN RES, V1038, P100, DOI 10.1016/j.brainres.2005.01.020; Bardgett ME, 2003, BRAIN RES BULL, V60, P131, DOI 10.1016/S0361-9230(03)00023-6; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Billard JM, 2006, MAGNESIUM RES, V19, P199; DAVIS S, 1992, J NEUROSCI, V12, P21; Debling D, 2006, J DIABETES COMPLICAT, V20, P238, DOI 10.1016/j.jdiacomp.2005.06.016; Enomoto T, 2005, J NEUROTRAUM, V22, P783, DOI 10.1089/neu.2005.22.783; Garland H O, 1992, Magnes Res, V5, P193; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; LeDoux J., 1996, EMOTIONAL BRAIN MYST; MAREN S, 1994, BEHAV NEUROSCI, V108, P645, DOI 10.1037/0735-7044.108.3.645; McNish KA, 1997, J NEUROSCI, V17, P9353; Mochizuki H, 2005, CLIN NEUROPHYSIOL, V116, P223, DOI 10.1016/j.clinph.2004.07.007; Morris RGM, 2001, NEUROPHARMACOLOGY, V41, P272, DOI 10.1016/S0028-3908(01)00058-2; Pouzet B, 2001, BEHAV BRAIN RES, V119, P49, DOI 10.1016/S0166-4328(00)00337-5; Rogers DC, 2001, PSYCHOPHARMACOLOGY, V158, P114; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; UESHIMA K, 2005, MAGNESIUM RES, V18, P75; Vamvakas S, 1998, CLIN NEPHROL, V49, P205; van Exel E, 2003, NEUROLOGY, V61, P1695, DOI 10.1212/01.WNL.0000098877.07653.7C; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vazdarjanova A, 1998, P NATL ACAD SCI USA, V95, P15003, DOI 10.1073/pnas.95.25.15003; VIAUD MD, 1989, BEHAV BRAIN RES, V32, P31, DOI 10.1016/S0166-4328(89)80069-5; WHITE NM, 1991, BEHAV NEURAL BIOL, V55, P255, DOI 10.1016/0163-1047(91)90609-T; WHITE NM, 1988, LIFE SCI, V43, P7, DOI 10.1016/0024-3205(88)90230-5; Yin H, 2002, NEUROBIOL LEARN MEM, V77, P389, DOI 10.1006/nlme.2001.4037	31	4	5	0	1	JOHN LIBBEY & CO LTD	LONDON	13 SMITHS YARD, SUMMERLEY ST, LONDON SW18 4HR, ENGLAND	0953-1424			MAGNESIUM RES	Magnes. Res.	MAR	2007	20	1					58	65					8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	163VG	WOS:000246190700009	17536490				2022-02-06	
J	Brooks, DA				Brooks, David A.			Use of computer based testing of youth hockey players with concussions	NEUROREHABILITATION			English	Article						concussion; athletes; ice hockey; youth sports; postconcussion syndrome; head injury; neuropsychological testing	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; ICE HOCKEY; HEAD-INJURIES; PREDICTORS; COLLEGIATE; MANAGEMENT; FOOTBALL; CHILDREN	Concussion is a potentially serious injury for athletes. Recent statistics suggest that approximately 300 000 sports-related traumatic brain injuries occur annually in the United States. Soccer, rugby, football, and ice hockey are all considered high-risk team sports for concussion. Hockey-related concussions are of particular concern in Canada, where over 500 000 players compete annually in ice hockey. The United States is now registering similar numbers of players. Return to play issues are one of the most difficult issues for physicians caring for concussed athletes. The advent of computerized neuropsychological testing adds another tool to assist in this process. It also appears to enhance the education process for players, coaches, and parents on the potential seriousness of concussion for these young athletes.	Performance Athletics Sportsmed Clin, Summerland, BC V0H 1Z0, Canada		Brooks, DA (corresponding author), Performance Athletics Sportsmed Clin, POB 20051,10707 Giants Head Rd, Summerland, BC V0H 1Z0, Canada.	drdaveb@shaw.ca					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; CANTU RC, 1988, CLIN SPORT MED, V7, P459; Cantu Robert C, 2003, Curr Sports Med Rep, V2, P117; *COL MED SOC, 1991, GUID MAN CONC SPORTS; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; DELANEY JS, 2001, BRIT J SPORT MED, V35, P367; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Iverson GL, 2004, BRAIN INJURY, V18, P1; IVERSON GL, 2003, ANN C INT NEUR SOC H; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Randolph C, 2001, J ATHL TRAINING, V36, P288; Roos R, 1996, PHYSICIAN SPORTSMED, V24, P67, DOI 10.3810/psm.1996.10.1327; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; 2006, WIKIPEDIA ICE HOCKEY	47	4	4	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					169	179					11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800003	17917167				2022-02-06	
S	Chen, SS; Haskins, WE; Ottens, AK; Hayes, RL; Denslow, N; Wang, KKW		Pardalos, PM; Boginski, VL; Vazacopoulos, A		Chen, Su-Shing; Haskins, William E.; Ottens, Andrew K.; Hayes, Ronald L.; Denslow, Nancy; Wang, Kevin K. W.			Bioinformatics for Traumatic Brain Injury: Proteomic Data Mining	DATA MINING IN BIOMEDICINE	Springer Series in Optimization and Its Applications		English	Article; Book Chapter							TANDEM MASS-SPECTROMETRY; ALPHA-II-SPECTRIN; 2-DIMENSIONAL ELECTROPHORESIS; CEREBROSPINAL-FLUID; PROTEIN; IDENTIFICATION; SYSTEMS; ACCUMULATION; RESOLUTION; CALPAIN	The importance of neuroproteomic studies is that they will help elucidate the currently poorly understood biochemical mechanisms or pathways underlying various psychiatric, neurological and neurodegenerative diseases. In this chapter, we focus on traumatic brain injury (TBI), a neurological disorder currently with no FDA approved therapeutic treatment. This chapter describes data mining strategies for proteomic analysis in traumatic brain injury research so that the diagnosis and treatment of TBI can be developed. We should note that brain imaging provides only coarse resolutions and proteomic analysis yields much finer resolutions to these two problems. Our data mining approach is not only at the collected data level, but rather an integrated scheme of animal modeling, instrumentation and data analysis.	[Chen, Su-Shing; Haskins, William E.; Ottens, Andrew K.; Denslow, Nancy; Wang, Kevin K. W.] Univ Florida, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA; [Haskins, William E.; Ottens, Andrew K.; Hayes, Ronald L.; Wang, Kevin K. W.] Univ Florida, Ctr Traumat Brain Injury Studies, Gainesville, FL 32610 USA; [Hayes, Ronald L.; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA; [Haskins, William E.; Ottens, Andrew K.; Hayes, Ronald L.; Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Denslow, Nancy] Univ Florida, Interdisciplinary Ctr Biomed Res, Gainesville, FL 32610 USA		Chen, SS (corresponding author), Univ Florida, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA.	suchen@cise.ufl.edu; aottens@mbi.ufl.edu; hayes@ufbi.ufl.edu; ndenslow@ufl.edu; kwangl@ufl.edu		Wang, Kevin/0000-0002-9343-6473			Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Aebersold R, 2002, NAT BIOTECHNOL, V20, P651, DOI 10.1038/nbt0702-651; Appel RD, 1999, METH MOL B, V112, P383; AXELROD R, 1976, STRUCTURE DECISION; Bienvenut WV, 2002, PROTEOMICS, V2, P868, DOI 10.1002/1615-9861(200207)2:7<868::AID-PROT868>3.0.CO;2-D; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BOGULAVSKY J, 2003, DRUG DISCOVERY DEV, V6, P57; CHAKRAVARTI DN, 2002, BIOTECHNIQUES, V32, pS4; CHEN S, 2000, 1 INT C SYST BIOL TO; CHEN S, 2000, IEEE BIOINF BIOM ENG; CHEN S, 1998, DIGITAL LIB LIFE CYC; CHEN S, 1986, P AAAI WORKSH UNC AR, P43; CHEN S, 1987, IEEE 1 INT C NEUR NE; CHEN S, 1988, LECT NOTES COMPUTER, V281, P313; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; DERRA S, 2003, DRUG DISC DEV, V6, P40; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Fountoulakis M, 2000, ELECTROPHORESIS, V21, P673, DOI 10.1002/(SICI)1522-2683(20000201)21:3<673::AID-ELPS673>3.0.CO;2-Y; Fountoulakis M, 1999, ELECTROPHORESIS, V20, P3572; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GOLDKNOPF HR, 2003, IVD TECHNOLOGY, V9, P1; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Grant SGN, 2001, TRENDS BIOTECHNOL, V19, pS49, DOI 10.1016/S0167-7799(01)01799-1; Grant SGN, 2001, J NEUROSCI, V21, P8315, DOI 10.1523/JNEUROSCI.21-21-08315.2001; Graslund S, 2002, BIOTECHNOL APPL BIOC, V35, P75, DOI 10.1042/BA20010097; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; GYGI SP, 2000, CURRENT OPINION CHEM, V4; Hanash S, 2004, MOL CELL PROTEOMICS, V3, P298, DOI 10.1074/mcp.R400004-MCP200; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hochstrasser DF, 2002, PROTEOMICS, V2, P807, DOI 10.1002/1615-9861(200207)2:7<807::AID-PROT807>3.0.CO;2-4; HUSI H, 2001, J NEUROSCI, V21, P8315; James P, 2002, BIOTECHNIQUES, P4; JANSSEN D, 2003, GENOMICS PROTEOMICS, V3, P38; Jungblut P, 1996, ELECTROPHORESIS, V17, P839, DOI 10.1002/elps.1150170505; Kitano H, 2000, NEW GENERAT COMPUT, V18, P199, DOI 10.1007/BF03037529; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2; KUSNEZOW W, 2002, BIOTECHNIQUES S, V33, P1423; Lemkin PF, 1997, ELECTROPHORESIS, V18, P2759, DOI 10.1002/elps.1150181510; Lu BW, 2003, BIOINFORMATICS, V19, pII113, DOI 10.1093/bioinformatics/btg1068; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Meyer HE, 2003, LANCET NEUROL, V2, P657, DOI 10.1016/S1474-4422(03)00580-5; Moody MD, 2001, BIOTECHNIQUES, V31, P186, DOI 10.2144/01311dd03; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; REDDY VN, 1993, P ISMB; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Schaefer H, 2003, ANAL BIOANAL CHEM, V376, P966, DOI 10.1007/s00216-003-1983-1; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Service RF, 2001, SCIENCE, V294, P2074, DOI 10.1126/science.294.5549.2074; Smith RD, 2000, NAT BIOTECHNOL, V18, P1041, DOI 10.1038/80226; SOMOGYI R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wiesner A, 2004, CURR PHARM BIOTECHNO, V5, P45, DOI 10.2174/1389201043489675; Yates Jr, 1999, METH MOL B, V112, P553; Yates JR, 1998, ANAL CHEM, V70, P3557, DOI 10.1021/ac980122y; ZHANG WR, 1992, IEEE T SYST MAN CYB, V22, P103, DOI 10.1109/21.141315; ZHANG WR, 1989, IEEE T SYST MAN CYB, V19, P31, DOI 10.1109/21.24529; [No title captured]	69	4	4	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	1931-6828		978-0-387-69319-4; 978-0-387-69318-7	SPRINGER SER OPTIM A			2007	7						363	387			10.1007/978-0-387-69319-4		25	Computer Science, Information Systems; Mathematical & Computational Biology; Mathematics, Applied	Book Citation Index – Science (BKCI-S)	Computer Science; Mathematical & Computational Biology; Mathematics	BLI09	WOS:000270224500021					2022-02-06	
J	Manchester, D; Wall, G; Dawson, P; Jackson, H				Manchester, David; Wall, Gemma; Dawson, Pippa; Jackson, Howard			A forensic peer group approach to bullying after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; AGGRESSION; OFFENDERS; BEHAVIOR; MANAGEMENT; SCHEDULE; THERAPY; PROGRAM; IMPACT; YOUNG	A forensic peer group programme adapted for bullying behaviour and antisocial attitudes in three young men with traumatic brain injury (TBI) is presented. Three TBI clients who had previously been resistant to an intensive neurobehavioural rehabilitation residential programme were enrolled into the EQUIP programme. EQUIP focused on teaching pro-social skills as they related to aggression, increasing moral development, and altering pro-aggressive attitudes. The group ran four days per week over six weeks, with each session lasting 30 minutes. Post-group assessment indicated that two of the three participants altered their beliefs regarding antisocial behaviour. At three-month follow up, of the two who demonstrated change one had returned to baseline while the other had maintained his progress. Aggression and bullying behaviour reduced in all three clients during the EQUIP programme and these improvements were maintained at three-month follow up. Self-esteem measures did not alter across the assessment period. Antisocial beliefs and their potential for change in clients with severe TBI are discussed.	MLR Consulting Psychol, Manchester, Lancs, England; Univ Liverpool, Div Clin Psychol, Liverpool L69 3BX, Merseyside, England		Manchester, D (corresponding author), Anson Med Ctr, 23 Anson Rd,Victoria Pk, Manchester M14 5BZ, Lancs, England.	enquiry@mlrpsych.com					Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; Alderman N, 1999, BRAIN INJURY, V13, P669; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDREWS DA, 1990, CRIM JUSTICE BEHAV, V17, P19, DOI 10.1177/0093854890017001004; Barriga A.Q., 2001, I THINK HIT QUESTION; Barriga AQ, 1996, AGGRESSIVE BEHAV, V22, P333; Baumeister RF, 1996, PSYCHOL REV, V103, P5, DOI 10.1037/0033-295X.103.1.5; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BOND MR, 1984, CLOSED HEAD INJURY; Brendtro L. K., 1989, RESIDENTIAL TREATMEN, P81; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BURGESS PW, 1990, REHABILITATION DYSCO; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037//0022-3514.75.1.219; CARDUCCI DJ, 1980, BEHAV DISORDERS, V5, P156; Connell A, 1996, J ADOLESCENCE, V19, P75, DOI 10.1006/jado.1996.0007; Coopersmith S., 1989, SELF ESTEEM INVENTOR; Damon W., 1977, SOCIAL WORLD CHILD; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Eames P, 1985, Int Rehabil Med, V7, P130; Eames P. G., 1990, NEUROBEHAVIOURAL SEQ; Gibbs J. C., 1995, EQUIP PROGRAMME TEAC; Gibbs J. C, 1993, GANG INTERVENTION HD, P159; Gibbs J. C., 2001, I THINK QUESTIONNAIR; Goldstein A.P., 2002, OFFENDER REHABILITAT, P169; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HOLLIN CR, 1990, BRIT J SOC WORK, V20, P483; Ireland JL, 2003, LEGAL CRIMINOL PSYCH, V8, P159, DOI 10.1348/135532503322362942; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jackson HF, 1991, NEUROPSYCHOLOGY, V5, P89; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEEMAN LW, 1993, AGGRESSIVE BEHAV, V19, P281, DOI 10.1002/1098-2337(1993)19:4<281::AID-AB2480190404>3.0.CO;2-W; LIPSEY MW, 1998, SERIOUS VIOLENT JUVE; Long SJ, 1985, CHILD FAMILY BEHAV T, V6, P1, DOI [10.1300/J019v06n04_01, DOI 10.1300/J019V06N04_01]; MACHESTER D, 2001, NEUROBEHAVIOURAL DIS; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Manchester D, 1997, BRAIN INJURY, V11, P271; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McGuire James, 2002, OFFENDER REHABILITAT, P3; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MILLER L, 1994, J OFFENDER REHABILIT, V21, P91, DOI DOI 10.1300/J076; MONROE RR, 1982, J NERV MENT DIS, V170, P711, DOI 10.1097/00005053-198212000-00001; MONROE RR, 1986, LIMBIC SYSTEM FUNCTI, P251; Muller-Isberner R., 2001, VIOLENCE CRIME MENTA, P7; NEDOPIL N, 2001, VIOLENCE CRIME MENTA, P7; Olweus D., 1991, DEV TREATMENT CHILDH; Ross R, 1985, TIME THINK COGNITIVE; Siddle R, 2003, BEHAV COGN PSYCHOTH, V31, P69, DOI 10.1017/S1352465803001073; SLABY RG, 1988, DEV PSYCHOL, V24, P580, DOI 10.1037/0012-1649.24.4.580; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Sturmey P., 2001, FUNCTIONAL ANAL CLIN; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Watt B. D., 1999, LEGAL CRIMINOL PSYCH, V4, P285, DOI DOI 10.1348/135532599167914; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wood R. L., 1987, BRAIN INJURY REHABIL; [No title captured]	62	4	4	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2007	17	2					206	229		10.1080/09602010600696472			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	165IP	WOS:000246298400005	17454694				2022-02-06	
B	McDonald, S		Ball, MJ; Damico, JS		McDonald, Skye			The social and neuropsychological underpinnings of communication disorders after severe traumatic brain injury	CLINICAL APHASIOLOGY: FUTURE DIRECTIONS			English	Article; Book Chapter							CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; NARRATIVE DISCOURSE; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTIONS; TEXT COMPREHENSION; WRITTEN DISCOURSE; VERBAL IMPAIRMENT; WORKING-MEMORY; CHILDHOOD		Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Bechara A, 2002, BRAIN, V125, P1673, DOI 10.1093/brain/awf169; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Body R, 1998, BRAIN INJURY, V12, P963, DOI 10.1080/026990598122016; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Brown P., 1978, QUESTIONS POLITENESS; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; CLARK HH, 1980, COGNITION, V8, P111, DOI 10.1016/0010-0277(80)90009-8; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Coelho C. A., 1999, BRAIN DAM B; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); CORRIGAN PW, 1995, SCHIZOPHRENIA BULL, V21, P395, DOI 10.1093/schbul/21.3.395; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Darby D, 2005, WALSHS NEUROPSYCHOLO; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; DAVIS HL, 1995, AUST J PSYCHOL, V47, P25, DOI 10.1080/00049539508258765; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; DOUGLAS JM, APHASIOLOGY IN PRESS; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Flood J., 1984, UNDERSTANDING READIN; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GIBBS RW, 1991, J PRAGMATICS, V16, P523, DOI 10.1016/0378-2166(91)90101-3; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; GORDON D, 1975, SYNTAX SEMANTICS SPE, V3; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; GRICE H, 1975, SYNTAX SEMANTICS SPE, V3; GRICE HP, 1978, SYNTAX SEMANTICS PRA, V9; HAGAN C, 1984, LANGUAGE DISORDERS A; Halliday M. A. K., 1985, INTRO FUNCTIONAL GRA; Halliday Michael Alexander Kirkwood, 1989, LANGUAGE CONTEXT TEX; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hasan Ruqaiya, 1985, LANGUAGE CONTEXT TEX; HAVERKATE H, 1990, J PRAGMATICS, V14, P77, DOI 10.1016/0378-2166(90)90065-L; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOUGH MS, 1990, BRAIN LANG, V38, P253, DOI 10.1016/0093-934X(90)90114-V; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Hughes C, 1998, BRIT J DEV PSYCHOL, V16, P233, DOI 10.1111/j.2044-835X.1998.tb00921.x; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Karafin MS, 2004, J COGNITIVE NEUROSCI, V16, P1796, DOI 10.1162/0898929042947856; Keenan T, 1998, NEW ZEAL J PSYCHOL, V27, P36; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonald S., 1998, HDB NEUROLINGUISTICS, P487; MCDONALD S, 1999, COMMUNICATION DISORD; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; MCFALL RM, 1982, BEHAV ASSESS, V4, P1; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MILTON SB, 1986, CLIN NEUROPSYCHOLOGY; Mortensen L, 2005, CLIN LINGUIST PHONET, V19, P227, DOI 10.1080/02699200410001698652; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; PATRY R, 1990, DISCOURSE ABILITY BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Prince S, 2002, J MED SPEECH-LANG PA, V10, P19; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SEARLE JR, 1975, SYNTAX SEMANTICS SPE, V3; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Snow PC, 2000, BRAIN INJURY, V14, P397; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TagerFlusberg H, 1997, DEV NEUROPSYCHOL, V13, P487, DOI 10.1080/87565649709540689; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; TOGHER L, 1999, COMMUNICATION DISORD; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Van Dijk TA., 1983, STRATEGIES DISCOURSE; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248; Wilson D., 1986, RELEVANCE COMMUNICAT; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	151	4	5	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH ROAD, HOVE BN3 2FA, E SUSSEX, ENGLAND			978-0-20396-255-8				2007							42	71					30	Linguistics; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Linguistics; Rehabilitation	BUF01	WOS:000289065700005					2022-02-06	
J	Mehta, S; Agarwal, V; Jiandani, P				Mehta, Salil; Agarwal, Vinay; Jiandani, Prakash			Ocular injuries in survivors of improvised explosive devices (lED) in commuter trains	BMC EMERGENCY MEDICINE			English	Article								Background: Ocular injuries are common in survivors of terror incidents that involve the use of explosive materials. These explosives are commonly of a High Explosive type ( HE) and may be fashioned into improvised explosive devices (lED) that incorporate additional materials to maximise trauma and injuries. Serial lED explosions have occurred in commuter trains in several cities including London and Madrid but data on ocular injuries is limited. We report the ocular injuries of the survivors of a series of lED explosions in crowded commuter trains. Methods: 28 patients ( 56 eyes, 28 male, ages ranging from 22 to 52 years ( mean 35.27 years) were screened in the triage area or the Intensive Care Unit (ICU). Testing included bedside visual acuity testing, torchlight examination of the anterior segment and dilated ( or if necessary, undilated) fundus examination. Selected patients underwent B-scan examination, magnetic resonance imaging of the brain, orbits and the optic nerves or visual evoked potential assessment. The injuries, investigations and procedures were entered into the patient's case sheet as well as into a standardised format suggested by the Indian eye injury registry (IER). Results: 16 of 28 patients (57.1%) had ocular injuries whereas 12 (42.8%) were found to be normal. Injuries were seen unilaterally in 10 patients and bilaterally in six yielding a total of 22 injured eyes. The common injuries were periorbital haemorrhages ( 09 eyes, 40%); first or second degree burns to the upper or lower lids ( seen in 07 eyes, 31.8 %) and corneal injuries ( seen in 08 eyes, 36.3%). Open globe injuries were seen in two eyes of two patients ( 09%). One patient ( 4.5%) had a traumatic optic neuropathy. Conclusion: Ophthalmologists and traumatologists should be aware of these patterns of ocular injuries. Protocols need to include the screening of large numbers of patients in a short time, diagnostic tests (B scan, visual evoked potential (VEP) etc) and early surgery preferably at the initial triage itself as most of the serious injuries in our studies had been missed or not treated at an initial assessment.	[Mehta, Salil; Agarwal, Vinay] Lilavati Hosp & Res Ctr, Dept Ophthalmol, Mumbai, Maharashtra, India; [Jiandani, Prakash] Lilavati Hosp & Res Ctr, Dept Crit Care Med, Mumbai, Maharashtra, India		Mehta, S (corresponding author), Lilavati Hosp & Res Ctr, Dept Ophthalmol, Mumbai, Maharashtra, India.	doc@retinaconsultant.com; drvinay.agarwal@gmail.com; darkhorse2@mailcity.com	Mehta, Salil/ABG-1687-2020	Mehta, Salil/0000-0003-4175-459X			Arya Sudesh K., 2001, Indian Journal of Ophthalmology, V49, P189; Chowdhury S, 2006, INDIAN EXPRESS; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Lavonas E, BLAST INJURIES; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Mines M, 2000, OPHTHALMOLOGY, V107, P837, DOI 10.1016/S0161-6420(00)00030-0; Odhiambo WA, 2002, INT J ORAL MAX SURG, V31, P374, DOI 10.1054/ijom.2001.0199; Sacu S, 2002, OPHTHALMOLOGICA, V216, P55, DOI 10.1159/000048298; Thach AB, 2000, OPHTHALMOLOGY, V107, P844, DOI 10.1016/S0161-6420(00)00029-4; VERNON SA, 1988, J ROY SOC MED, V81, P569, DOI 10.1177/014107688808101006	10	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.		2007	7								16	10.1186/1471-227X-7-16			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V55AC	WOS:000210464500016	17900340	Green Published, gold			2022-02-06	
J	Mitchko, J; Huitric, M; Sarmiento, K; Hayes, G; Pruzan, M; Sawyer, R				Mitchko, Jane; Huitric, Michele; Sarmiento, Kelly; Hayes, Gail; Pruzan, Marcia; Sawyer, Richard			CDC's Approach to Educating Coaches about Sports-related Concussion	AMERICAN JOURNAL OF HEALTH EDUCATION			English	Article								Sports-related concussions can happen to any athlete in any sport. Each year in the United States, an estimated 1.63.8 million sports and recreation-related traumatic brain injuries (TBIs) occur, most of which can be classified as concussions. To help coaches prevent, recognize, and better manage sports-related concussions, the Centers for Disease Control and Prevention's (CDC) National Center for Injury Prevention and Control (CDC's Injury Center) applied a comprehensive health-education approach to developing a multimedia tool kit for high school athletic coaches. From developing an expert panel and pretesting message concepts to pilot testing, promoting, and evaluating the final product, CDC has shown that this undertaking is highly effective. Results of the pilot study and promotion efforts show that the tool kit is well received by coaches and school officials and that it meets a critical health education need.	[Mitchko, Jane; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, 4770 Buford Hwy,NW,Mail Stop F-41, Atlanta, GA 30341 USA; [Huitric, Michele] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA; [Hayes, Gail] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Off Commun Resources, Atlanta, GA 30341 USA; [Pruzan, Marcia; Sawyer, Richard] Acad Educ Dev, Washington, DC 20001 USA		Mitchko, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, 4770 Buford Hwy,NW,Mail Stop F-41, Atlanta, GA 30341 USA.	jpmitchko@cdc.gov					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; GRONWALL D, 1975, LANCET, V2, P995; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538	9	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1932-5037	2168-3751		AM J HEALTH EDUC	Am. J. Health Educ.		2007	38	2					99	103		10.1080/19325037.2007.10598951			5	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	V93QI	WOS:000213075500005					2022-02-06	
J	Rabin, LA; Barr, WB; Burton, LA				Rabin, Laura A.; Barr, William B.; Burton, Leslie A.			Effects of patient occupation and education variables on the choice of neuropsychological assessment instruments	APPLIED NEUROPSYCHOLOGY			English	Article						clinical neuropsychology; instrument utilization rates; neuropsychological assessment; survey	TRAUMATIC BRAIN-INJURY; UNITED-STATES; EMPLOYMENT; VALIDITY	The current study surveyed test-usage practices of clinical neuropsychologists to determine whether respondents varied their assessment batteries based on specific patient demographic characteristics. Respondents were 747 doctorate-level psychologists (40% usable response rate) affiliated with Division 40 of the American Psychological Association, National Academy of Neuropsychology, or the International Neuropsychological Society. Respondents read a vignette about a traumatic brain injury patient and subsequently reported the instruments they would utilize to assess this patient's memory, attention, executive functioning, and ability to return to work. There were three versions of the case study, which varied according to the patient's occupation and level of education. Results revealed that the reported proportion of only 9 of 516 instruments (1.7%) varied across classifications, indicating that some neuropsychologists slightly modified their test batteries based on patients' demographic characteristics. The implications of these findings are discussed in relation to enhancing predictions of real-world outcomes based on neuropsychological test data.	[Rabin, Laura A.] CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11201 USA; [Barr, William B.] NYU, Sch Med, Comprehens Epilepsy Ctr, New York, NY USA; [Burton, Leslie A.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA		Rabin, LA (corresponding author), CUNY Brooklyn Coll, Dept Psychol, 2900 Bedford Ave, Brooklyn, NY 11201 USA.	lrabin@brooklyn.cuny.edu		Barr, William/0000-0001-7711-7758			Acker MB, 1990, NEUROPSYCHOLOGY EVER, P19; BECK SJ, 1944, RORSCHACHS TEST 1 BA; BENTON A, 1975, NEUROLOGY, V25, P907, DOI 10.1212/WNL.25.10.907; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CRAIG RJ, 2005, PERSONALITY GUIDED F, P55; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; FARR JM, 2001, ONET DICT OCCUPATION; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GRAHAM JR, 1990, MMPI2 ASSESSING PERS; Guilmette T. J., 1996, ECOLOGICAL VALIDITY, P387; Hathaway SR, 1943, MANUAL MINNESOTA MUL; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; HINKLE JE, 1968, PSYCHOTHER-THEOR RES, V5, P210, DOI 10.1037/h0088691; HURT GD, 2000, NEUROPSYCHOLOGICAL M, P215; Jones R. D., 1996, P395; KLINE PL, 2000, HDB PSYCHOLOGICAL TE; LEESHALEY PR, 1990, PERCEPT MOTOR SKILL, V70, P1383, DOI 10.2466/PMS.70.4.1383-1386; LEFKOWITZ J, 1975, J SOC ISSUES, V31, P3, DOI 10.1111/j.1540-4560.1975.tb00736.x; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pelham M. F., 2005, TXB TRAUMATIC BRAIN, P159; Power P., 2000, GUIDE VOCATIONAL ASS; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RABIN LA, 2003, DIS ABSTR INT, V63, P3934; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Rizzo Matthew, 1996, P1; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Schatz P, 2001, NEUROREHABILITATION, V16, P281; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; Wolfson, 1993, HALSTEAD REITAN NEUR; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	40	4	4	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2007	14	4					247	254		10.1080/09084280701719161			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	250OY	WOS:000252311100002	18067420				2022-02-06	
J	Terre, R; Mearin, F				Terre, R.; Mearin, F.			Videofluoroscopy quantification of laryngotracheal aspiration outcome in traumatic brain injury-related oropharyngeal dysphagia	REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS			Spanish	Article						traumatic brain injury; deglutition; dysphagia; aspiration; videofluoroscopy; quantification	FORMAL SWALLOWING EVALUATION; SILENT ASPIRATION; ELDERLY-PATIENTS; THERAPY; STROKE; DISORDERS; PROGRESSION; ADULTS	Introduction: swallowing impairments are frequent after severe traumatic brain injury (TBI). Objective: to define and prospectively quantify the videofluoroscopic symptoms in patients after TBI, and to evaluate the evolution of patients with laryngotracheal aspiration. Method: we studied 10 patients with TBI, and a clinical suspicion of aspiration confirmed by means of a videofluoroscopic exploration (VDF). VDF was repeated at 1, 3, 6, and 12 months thereafter. Results: 30% of patients had an impaired gag reflex, and 40% cough during oral feeding. In the first VDF exploration the following was observed: increased oral transit time (OTT) in 70% (average: 3.8 sec.; range: 0.8-15 sec.), altered lingual control in 60%, and dysfunctional palatoglossal closure in 20%. Mean pharyngeal transit time (PTT) was 0.72 sec. (range: 0.34-1.50 sec.), and time to swallowing reflex (TSR) was 0.32 sec. (range: 0.10-0.80 sec.). After one year only 3 patients had aspiration -with a normal OTT in 7 patients, a normal PTT in 9, and a normal TSR in all; 80% had an exclusively oral diet, and 20% combined oral intake and gastrostomy feeding. Conclusion: videofluoroscopic evaluation allows to confirm and quantite swallowing dysfunction in patients with severe TBI. Most frequent early findings included an increase in OTT and alterations in lingual control; aspirations were quite frequent, and more than half were silent. After one year the majority of patients showed a favorable outcome.	UAB, Unidad Rehabil Func Digest, Inst Guttmann, Hosp Neurorehabil,Inst Univ Adscrito, Barcelona 08916, Spain		Terre, R (corresponding author), UAB, Unidad Rehabil Func Digest, Inst Guttmann, Hosp Neurorehabil,Inst Univ Adscrito, Cami de Can Ruti S-N, Barcelona 08916, Spain.	metges@guttmann.com					Arai T, 1998, LANCET, V352, P115, DOI 10.1016/S0140-6736(98)85021-6; Arai T, 2003, NEUROLOGY, V61, P1625, DOI 10.1212/01.WNL.0000096395.80826.23; Arai T, 2003, J AM GERIATR SOC, V51, P1815, DOI 10.1046/j.1532-5415.2003.51572_2.x; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; DEPIPPO KL, 1994, NEUROLOGY, V44, P1655, DOI 10.1212/WNL.44.9.1655; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Hagen C, 1981, TOP LANG DIS, V1, P73; Jurkovich GJ, 1999, J TRAUMA, V46, P821; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Logemann JA, 1998, EVALUATION TREATMENT, P307; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Morgan A, 2004, J HEAD TRAUMA REHAB, V19, P226, DOI 10.1097/00001199-200405000-00004; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Morgan A, 2002, J HEAD TRAUMA REHAB, V17, P220, DOI 10.1097/00001199-200206000-00004; NEUMANN S, 1995, DYSPHAGIA, V10, P1, DOI 10.1007/BF00261272; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Ramsey D, 2005, DYSPHAGIA, V20, P218, DOI 10.1007/s00455-005-0018-9; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; SPLAINGARD ML, 1988, ARCH PHYS MED REHAB, V69, P637; Terre R, 2006, NEUROGASTROENT MOTIL, V18, P200, DOI 10.1111/j.1365-2982.2005.00729.x; TERRE R, IN PRESS OROPHARYNGE; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	27	4	8	0	3	ARAN EDICIONES, S A	MADRID	CASTELLO, 128, 1O, 28006 MADRID, SPAIN	1130-0108	2340-4167		REV ESP ENFERM DIG	Rev. Esp. Enferm. Dig.	JAN	2007	99	1					7	12					6	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	155ZI	WOS:000245617100003	17295592				2022-02-06	
J	Babbs, CF				Babbs, Charles F.			A new biomechanical head injury criterion	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						acceleration; biomechanics; brain; concussion; deformation; diffuse axonal injury; HIC; impact; shear; strain; threshold; tolerance	DIFFUSE AXONAL INJURY; BRAIN-TISSUE; MECHANICAL-PROPERTIES; DAMAGE; RESPONSES	This paper presents a new analysis of the physics of closed head injury caused by intense acceleration of the head. At rest a I cm gap filled with cerebrospinal fluid (CSF) separates the adult human brain from the skull. During impact, whole head acceleration induces artificial gravity within the skull. Because its density differs slightly from that of CSF, the brain accelerates, strikes the inner aspect of the rigid skull, and undergoes viscoelastic deformation. Analytical methods for a lumped paxameter model of the brain predict internal brain motions that correlate well with published high-speed photographic studies. The same methods predict a truncated hyperbolic strength-duration curve for impacts that produce a given critical compressive strain. A family of such curves exists for different critical strains. Each truncated hyperbolic curve defines a head injury criterion (HIC) or threshold for injury, which is little changed by small offsetting corrections for curvature of the brain and for viscous damping. Such curves predict results of experimental studies of closed head injury, known limits for safe versus dangerous falls, and the relative resistance of smaller versus larger animals to acceleration of the head. The underlying theory provides improved understanding of closed head injury and better guidance to designers of protective equipment and to those extrapolating research results from animals to man.	Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Babbs, CF (corresponding author), Purdue Univ, Dept Basic Med Sci, 1246 Lynn Hall, W Lafayette, IN 47907 USA.	babbs@purdue.edu					Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Babbs CF, 2005, J MECH MED BIOL, V5, P277, DOI 10.1142/S0219519405001540; Bain A.C., 1999, P 43 STAPP CAR CRASH, P295, DOI [10.4271/99sc19, DOI 10.4271/99SC19]; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Brekhovskikh L. M., 1994, MECH CONTINUA WAVE D, V2nd; DACEY RG, 1993, HEAD INJURY, P159; DIRESTA GR, 1991, J NEUROSCI METH, V39, P245, DOI 10.1016/0165-0270(91)90103-7; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Duck FA, 1990, PHYS PROPERTIES TISS, P226; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; FUNG YC, 1981, BIOMECHANICS MECH PR, P23; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1993, HEAD INJURY, P137; GOSCH H H, 1969, Surgical Forum (Chicago), V20, P425; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; GRAHAM DI, 1993, HEAD INJURY, P91; GRAY JAB, 1954, J PHYSIOL-LONDON, V124, P84, DOI 10.1113/jphysiol.1954.sp005087; Gurdjian ES, 1973, HEAD INJURY ANTIQUIT, p[24, 54, 72]; HIRSCH AE, 1966, HEAD INJ C U CHIC J; Kornhauser M, 1961, P 4 AFBMD STL S ADV, V3, P368; Kraus JF, 1993, HEAD INJURY, P1; Lighthall JW, 1993, BIOMECHANICS IMPACT, P621; LOCKETT FJ, 1985, J BIOMECH, V18, P217, DOI 10.1016/0021-9290(85)90207-6; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; MUVDI BB, 1991, ENG MECH MAT; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Ommaya AK, 1993, BIOMECHANICS IMPACT, P265; OMMAYA AK, 1966, HEAD INJURY, P260; PARIS A, 1882, SUBTLE IS LORD SCI L, P552; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SAHAY KB, 1992, J BIOMECH, V25, P319, DOI 10.1016/0021-9290(92)90029-Z; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; STRICH SJ, 1961, LANCET, V2, P443; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; YARNELL P, 1969, B NEW YORK ACAD MED, V45, P39	47	4	4	0	12	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	DEC	2006	6	4					349	371		10.1142/S021951940600200X			23	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	265TT	WOS:000253384500002		Green Submitted			2022-02-06	
J	Lee, CH; Casey, ATH; Allibone, JB; Chelvarajah, R				Lee, Cheong H.; Casey, Adrian T. H.; Allibone, James B.; Chelvarajah, Ramesh			Trombone tongue: a new clinical sign for significant medullary compression at the craniovertebral junction	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cervical spine; medulla oblongata; Chiari malformation; cervicomedullary junction; craniovertebral junction	TRAUMATIC BRAIN-INJURY; LINGUAL MYOCLONUS; MOVEMENTS; ENDURANCE; DYSTONIA; STRENGTH; DISEASE; TREMOR	The authors describe a previously unreported clinical sign that may indicate the onset of significant compression of the medulla oblongata in cases of craniovertebral junction abnormalities. This 17-year-old boy presented with mild bilateral leg weakness. Imaging studies revealed severe basilar invagination and a marked Chiari malformation. While awaiting surgery, his tongue developed an involuntary constant protrusion-intrusion repetitive motion. The onset of this so-named "trombone tongue" sign was followed shortly afterward by rapidly progressive spastic tetraparesis. After the authors performed a transmaxillary clivectomy, foramen magnum decompression, and occipitocervical fusion, they noted that the abnormal tongue motion promptly resolved and the tetraparesis gradually improved. The authors discuss their current understanding of the central control of tongue movements and present a hypothesis on the pathogenesis of trombone tongue based on the neuroanatomical basis of another abnormal tongue movement sign, lingual myoclonus.	London Hosp NHS Fdn Trust, Univ Coll, Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; Royal Natl Orthopaed Hosp, Spinal Surg Unit, Stanmore HA7 4LP, Middx, England		Chelvarajah, R (corresponding author), London Hosp NHS Fdn Trust, Univ Coll, Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.	r.chelvarajah@ucl.ac.uk					BENDER MB, 1952, AMA ARCH NEUROL PSY, V67, P44, DOI 10.1001/archneurpsyc.1952.02320130050004; COMBARROS O, 1990, J NEUROL NEUROSUR PS, V53, P168, DOI 10.1136/jnnp.53.2.168; De Letter M, 2003, ACTA NEUROL BELG, V103, P35; Factor SA, 1997, MOVEMENT DISORD, V12, P783, DOI 10.1002/mds.870120528; GOBERNADO JM, 1992, MOVEMENT DISORD, V7, P367, DOI 10.1002/mds.870070413; Goel A, 1998, J NEUROSURG, V88, P962, DOI 10.3171/jns.1998.88.6.0962; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Goyal M, 2000, AM J NEURORADIOL, V21, P1073; Higgins DS, 2001, NEUROL CLIN, V19, P707, DOI 10.1016/S0733-8619(05)70041-4; HUNKER CJ, 1990, MOVEMENT DISORD, V5, P71, DOI 10.1002/mds.870050117; JABBARI B, 1981, NEUROLOGY, V31, P1364, DOI 10.1212/WNL.31.10.1364; JAMES D, 1991, NEUROSURGERY, V29, P411, DOI 10.1227/00006123-199109000-00012; KEANE JR, 1984, NEUROLOGY, V34, P251, DOI 10.1212/WNL.34.2.251; KULISEVSKY J, 1994, J NEUROL NEUROSUR PS, V57, P660, DOI 10.1136/jnnp.57.5.660-a; KUMAR A, 1986, ANN OTO RHINOL LARYN, V95, P487, DOI 10.1177/000348948609500510; Menezes A.H., 1998, SURG CRANIOVERTEBRAL, P3; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Raja M, 1996, MOVEMENT DISORD, V11, P585, DOI 10.1002/mds.870110521; Rapoport A, 1998, INT CLIN PSYCHOPHARM, V13, P115, DOI 10.1097/00004850-199805000-00004; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; TROUPIN AS, 1974, DIS NERV SYST, V35, P378	22	4	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2006	5	6					550	553		10.3171/spi.2006.5.6.550			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	111DI	WOS:000242431200013	17176022				2022-02-06	
J	Kolsen-Petersen, JA; Rasmussen, TB; Krog, J; Hokland, M; Tonnesen, EK				Kolsen-Petersen, Jens Aage; Rasmussen, Torsten Bogh; Krog, Jan; Hokland, Marianne; Tonnesen, Else Kirstine			Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hypertonicity; integrin; reactive oxygen species; selectin; surgery	HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ACTIVATED PROTEIN-KINASE; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; CONTROLLED-TRIAL; IN-VITRO; RESUSCITATION; ATTENUATION; DEXTRAN; P38	Background: Previous studies found hypertonicity to affect neutrophils in intact laboratory animals and in human blood cell cultures. We investigated whether infusion of hypertonic saline in a clinical relevant dose before hysterectomy affected peripheral blood neutrophils and their response to surgery. Methods: Fifteen women scheduled for open abdominal hysterectomy were randomized double-blindly to infusion of 4 mL/kg 7.5% NaCl, 4 mL/kg 0.9% NaCl, or 32 mL/kg 0.9% NaCl over 20 minutes. Blood,was collected at baseline, after infusion, 1, 4, and 24 hours postoperatively for the determination of leukocyte and differential count, neutrophil membrane expression of endothelial adhesion molecules by flow cytometry, and O-2(-)-generation by superoxide dismutase-inhibitable reduction of cytochrome C. Results: Surgery induced well-known changes in the number and distribution of white blood cells, reduced the expression of adhesion molecules, and halved the superoxide production unrelated to the tonicity or volume of the infused fluids. Conclusion: Infusion of a clinically relevant dose of hypertonic saline has no detectable effect on the membrane expression of endothelial adhesion molecules or O-2(-)-generation in circulating neutrophils after elective abdominal hysterectomy.	Viborg Cty Hosp, Dept Anesthesia & Intens Care, DK-8800 Viborg, Denmark; Aarhus Univ Hosp, Dept Anesthesia & Intens Care, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark		Kolsen-Petersen, JA (corresponding author), Viborg Cty Hosp, Dept Anesthesia & Intens Care, DK-8800 Viborg, Denmark.	jaakp@dadlnet.dk	Krog, Jan/ABD-2700-2021				Alam HB, 2004, RESUSCITATION, V60, P91, DOI 10.1016/j.resuscitation.2003.08.006; Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Balogh Z, 2002, J TRAUMA, V52, P1062, DOI 10.1097/00005373-200206000-00007; BORREGAARD N, 1979, BIOCHEM BIOPH RES CO, V90, P214, DOI 10.1016/0006-291X(79)91612-7; CHAUDRY IH, 1990, AM J PHYSIOL, V259, pR663, DOI 10.1152/ajpregu.1990.259.4.R663; Ciesla DJ, 2000, SHOCK, V14, P265, DOI 10.1097/00024382-200014030-00004; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Drbal K, 2001, BLOOD, V98, P1561, DOI 10.1182/blood.V98.5.1561; *EUR AG EV MED PRO, 1997, NOT GUID GOOD CLIN P; Fahrner SL, 2002, J TRAUMA, V52, P285, DOI 10.1097/00005373-200202000-00014; HAMPTON MB, 1994, J INFECT DIS, V169, P839, DOI 10.1093/infdis/169.4.839; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Kolsen-Petersen JA, 2004, ANESTHESIOLOGY, V100, P1108, DOI 10.1097/00000542-200405000-00012; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; LECULIER C, 1993, THROMB RES, V69, P519, DOI 10.1016/0049-3848(93)90056-T; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Murao Y, 2000, SHOCK, V14, P18, DOI 10.1097/00024382-200014010-00004; NOLTE D, 1992, AM J PHYSIOL, V263, pH1411, DOI 10.1152/ajpheart.1992.263.5.H1411; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Partrick DA, 1998, J TRAUMA, V44, P592, DOI 10.1097/00005373-199804000-00006; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Repo H, 1999, ANN MED, V31, P156, DOI 10.3109/07853899909115974; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rhee P, 1998, J TRAUMA, V44, P313, DOI 10.1097/00005373-199802000-00014; Rivera-Chavez F, 1998, J TRAUMA, V45, P440, DOI 10.1097/00005373-199809000-00003; Rizoli SB, 1999, J SURG RES, V83, P130, DOI 10.1006/jsre.1999.5581; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Rizoli SB, 1999, J TRAUMA, V46, P794, DOI 10.1097/00005373-199905000-00006; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Rotstein OD, 2003, J TRAUMA, V54, pS203, DOI 10.1097/01.TA.0000064512.62949.92; SALO M, 1992, ACTA ANAESTH SCAND, V36, P201, DOI 10.1111/j.1399-6576.1992.tb03452.x; Sauaia A, 1996, WORLD J SURG, V20, P392, DOI 10.1007/s002689900062; Spera PA, 1998, SPINE, V23, P2444, DOI 10.1097/00007632-199811150-00018; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VOLLMAR B, 1994, AM J PHYSIOL, V266, pH1927; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wichmann MW, 2003, LANGENBECK ARCH SURG, V387, P397, DOI 10.1007/s00423-002-0346-2; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001; YOUNES RN, 1992, SURGERY, V111, P380	50	4	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2006	61	5					1100	1106		10.1097/01.ta.0000195992.80809.7d			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	105TB	WOS:000242054100011	17099514				2022-02-06	
J	Pavawalla, SP; Schmitter-Edgecombe, M				Pavawalla, Shital P.; Schmitter-Edgecombe, Maureen			Long-term retention of skilled visual search following severe traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						closed-head injury; diffuse axonal injury; automatic processes; automatic cognitive skills; rehabilitation; cognitive skill retention	MEMORY; RETRIEVAL; ACQUISITION; PERFORMANCE; DEFICITS	We examined the long-term retention of a learned automatic cognitive process in 17 severe TBI participants and 10 controls. Participants had initially received extensive consistent-mapping (CM) training (i.e., 3600 trials) in a semantic category visual search task (Schmitter-Edgecombe & Beglinger, 2001). Following CM training, TBI and control groups demonstrated dramatic performance improvements and the development of an automatic attention response (AAR), indicating task-specific and stimulus-specific skill learning. After a 5- or 10-month retention interval, participants in this study performed a New CM task and the originally trained CM task to assess for retention of task-specific and stimulus-specific visual search skills, respectively. No significant group differences were found in the level of retention for either skill type, indicating that individuals with severe TBI were able to retain the learned skills over a long-term retention interval at a level comparable to controls. Exploratory analyses revealed that TBI participants who returned at the 5-month retention interval showed nearly complete skill retention, and greater skill retention than TBI participants who returned at the 10-month interval, suggesting that "booster" or retraining sessions may be needed when a skill is not continuously in use.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838, R03 HD035838-02] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690, R01 NS047690-01, R01 NS047690] Funding Source: Medline		Batsakes PJ, 2000, J GERONTOL B-PSYCHOL, V55, pP332, DOI 10.1093/geronb/55.6.P332; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; COLLEN A, 1975, J EXP PSYCHOL-HUM L, V1, P629; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FISK AD, 1994, PSYCHOL AGING, V9, P206, DOI 10.1037/0882-7974.9.2.206; FISK AD, 1992, COGNITIVE APPROACHES TO AUTOMATED INSTRUCTION, P171; FISK AD, 1995, PSYCHOL AGING, V10, P255, DOI 10.1037/0882-7974.10.2.255; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1984, J EXP PSYCHOL LEARN, V10, P1; Shiffrin, 1988, STEVENS HDB EXPT PSY, V1-2, P739; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1981, COGNITIVE SKILLS THE, P11; TEASDALE G, 1974, LANCET, V2, P81; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL	25	4	4	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2006	12	6					802	811		10.1017/S135561770606098X			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	104CA	WOS:000241932300005	17064444	Green Accepted			2022-02-06	
J	Wen, JH; Boone, K; Kim, K				Wen, Johnny H.; Boone, Kyle; Kim, Kevin			Ecological validity of neuropsychological assessment and perceived employability	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE MENTAL-ILLNESS; HEAD-INJURY; RECOGNITION TRIAL; EMPLOYMENT STATUS; SUSPECT EFFORT; NORMATIVE DATA; WORK STATUS; PREDICTORS; REHABILITATION	Ecological validity studies that have examined the relationship between cognitive abilities and employment in psychiatric and medical populations have found that a wide range of cognitive domains predict employability, although memory and executive skills appear to be the most important. However, no information is available regarding a patient's self-perceived work attributes and objective neuropsychological performance, and whether the same cognitive domains associated with successful employment are also related to a patient's self-perception of work competence. In the present study, 73 medical and psychiatric patients underwent comprehensive neuropsychological assessment. Step-wise multiple regression analyses revealed that the visual-spatial domain was the only significant predictor of self-perceived work attributes and work competence as measured by the Working Inventory (WI) and the Work Adjustment Inventory (WAI), accounting for 7% to 10% of inventory score variability. The results raise the intriguing possibility that targeting of visual spatial skills for remediation and development might play a separate and unique role in the vocational rehabilitation of a lower SES population, specifically, by leading to enhanced self-perception of work competence as these individuals attempt to enter the job market.	Univ Calif Los Angeles, Harbor Med Ctr, Dept Psychiat, Inst Biomed, Torrance, CA 90509 USA; Univ Pittsburgh, Dept Educ Psychol, Pittsburgh, PA USA		Boone, K (corresponding author), Univ Calif Los Angeles, Harbor Med Ctr, Dept Psychiat, Inst Biomed, 1000 W Carson St,Box 495,Bld F-9, Torrance, CA 90509 USA.	kboone@labiomed.org					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BADIKIAN T, IN PRESS CLIN NEUROP; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Boone K., 2002, DOT COUNTING TEST; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DELANEY RC, 1992, ARCH CLIN NEUROPSYCH, V7, P523, DOI 10.1016/0887-6177(92)90142-A; Demick J., 1997, ROLE COGNITIVE STYLE; Dickerson FB, 2004, PSYCHIAT SERV, V55, P54, DOI 10.1176/appi.ps.55.1.54; DIKMEN S, 1980, J NERV MENT DIS, V168, P236, DOI 10.1097/00005053-198004000-00008; Evans JD, 2004, SCHIZOPHR RES, V70, P331, DOI 10.1016/j.schres.2004.01.011; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; GILLIAM J, 1994, WORK ADJUSTMENT INVE; Gold JM, 2002, AM J PSYCHIAT, V159, P1395, DOI 10.1176/appi.ajp.159.8.1395; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEATON RK, 1994, PSYCHOSOM MED, V56, P8, DOI 10.1097/00006842-199401000-00001; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; McGurk SR, 2004, SCHIZOPHR RES, V70, P147, DOI 10.1016/j.schres.2004.01.009; McGurk SR, 2003, PSYCHIAT SERV, V54, P1129, DOI 10.1176/appi.ps.54.8.1129; McGurk SR, 2003, J NERV MENT DIS, V191, P789, DOI 10.1097/01.nmd.0000100921.31489.5a; MILES C, 1996, WORKING ASSESSING SK; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Ready RE, 2001, CLIN NEUROPSYCHOL, V15, P314, DOI 10.1076/clin.15.3.314.10269; Ruff R. M, 1996, RUFF FIGURAL FLUENCY; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; TRAHAN DE, 1987, 15 ANN M INT NEUR SO; Van Gorp WG, 1999, J INT NEUROPSYCH SOC, V5, P534, DOI 10.1017/S1355617799566071; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	42	4	4	1	13	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV	2006	28	8					1423	1434		10.1080/13803390500409609			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	091UQ	WOS:000241054200011	17043034				2022-02-06	
J	Bechtel, K; Berger, R				Bechtel, Kirsten; Berger, Rachel			Inflicted Traumatic Brain Injury: Making the Diagnosis in the Emergency Department	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						inflicted traumatic brain injury; noninflicted traumatic brain injury; subdural hemorrhage; retinal hemorrhage; rib fractures; metaphyseal fractures; child protective services		Inflicted traumatic brain injury ( iTBI) is a common cause of morbidity and mortality in young children. Inflicted traumatic brain injury can present with a wide spectrum of symptoms and clinical findings. Children who have milder forms of iTBI and less ominous symptoms, such as vomiting and irritability, may not be recognized until they present later with more serious injury. Although retinal hemorrhages, rib fractures, and subdural hemorrhage are the triad typically associated with iTBI, a minority of patients will have all 3 findings. The importance of recognizing iTBI in a timely manner in the emergency department is vital to protect the child from future and possibly more severe brain injury. (C) 2006 Published by Elsevier Inc.	[Bechtel, Kirsten] Yale Univ, Sch Med, Dept Pediat, Sect Pediat Emergency Med, WP 143 Yale New Haven Childrens Hosp 20, New Haven, CT 06504 USA; [Berger, Rachel] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA		Bechtel, K (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Pediat Emergency Med, WP 143 Yale New Haven Childrens Hosp 20, New Haven, CT 06504 USA.	kirsten.bechtel@yale.edu	Bechtel, Kirsten/K-2147-2019				Annable WL, 1994, OCULAR MANIFESTATION; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Beers SR, 2004, PEDIATR RES, V55, p70A; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Ettaro L, 2004, CHILD ABUSE NEGL, V28; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Feldman K., 1997, EVALUATION PHYS ABUS, P175; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; HELFER RE, 1977, PEDIATRICS, V60, P533; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Hymel KP, 2005, PEDIATR ANN, V34, P358, DOI 10.3928/0090-4481-20050501-10; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; JOFFE M, 1988, PEDIATRICS, V82, P457; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; ONEILL JA, 1973, J TRAUMA, V13, P332, DOI 10.1097/00005373-197304000-00012; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; Smith WL, 1997, BATTERED CHILD, P221	38	4	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	SEP	2006	7	3					138	142		10.1016/j.cpem.2006.05.002			5	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E7B	WOS:000219539800002					2022-02-06	
J	Gagnon, N; Debien, B; Baccialone, J; Perez, JP; Pats, B				Gagnon, N.; Debien, B.; Baccialone, J.; Perez, J. -P.; Pats, B.			Carotido-cavernous fistula after traumatic brain injury: an unusual vascular complication	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						carotid-cavernous fistula; cerebral angiography; head trauma	SINUS FISTULA; CT ANGIOGRAPHY; CLASSIFICATION; DIAGNOSIS; ARTERY	The authors reported the case of a young man who suffered a cranial traumatism and showed neurological, ophthalmic and orbital signs with orbital bruit, cranial nerve palsy and chemosis while he was in the intensive care unit. Further examinations of imagery made it possible to highlight a high-flow carotid-cavernous fistula which was the origin of these symptoms and which was successfully treated by endovascular way. The aim of this article is to remind the reader of the characteristics of this pathology, in terms of epidemiology, physiopathology, clinical and paraclinical presentation, and therapeutic care. (c) 2006 Elsevier SAS. Tous droits reserves.	Hop Instruct Armees Percy, Serv Anesthesie Reanimat, F-92141 Clamart, France		Gagnon, N (corresponding author), Hop Instruct Armees Percy, Serv Anesthesie Reanimat, 101 Ave Henri Barbusse,BP 406, F-92141 Clamart, France.	nicogagnon69@hotmail.com					Anderson K, 2001, CLIN RADIOL, V56, P514, DOI 10.1053/crad.2000.0459; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Carrillo A, 1998, INTENS CARE MED, V24, P71, DOI 10.1007/s001340050517; CHANG CJ, 1990, J TRAUMA, V30, P1335, DOI 10.1097/00005373-199011000-00005; Chen CCC, 2005, AM J NEURORADIOL, V26, P2349; Chen YW, 2000, STROKE, V31, P701, DOI 10.1161/01.STR.31.3.701; COGAN J F, 1960, Br J Ophthalmol, V44, P185, DOI 10.1136/bjo.44.3.185; Coskun O, 2000, AM J NEURORADIOL, V21, P712; DEBRUN GM, 1995, SURG NEUROL, V44, P75, DOI 10.1016/0090-3019(95)00162-X; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; Desal H, 1997, J NEURORADIOLOGY, V24, P141; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; HALBACH VV, 1987, AM J NEURORADIOL, V8, P627; Hmamouchi B, 2001, ANN FR ANESTH, V20, P494; Ishida F, 2003, NEUROL MED-CHIR, V43, P369, DOI 10.2176/nmc.43.369; Phatouros CC, 2000, NEUROSURG CLIN N AM, V11, P67, DOI 10.1016/S1042-3680(18)30147-5; Rucker JC, 2004, BRIT J OPHTHALMOL, V88, P311, DOI 10.1136/bjo.2003.026575; SOMMER C, 1992, NEUROSURGERY, V30, P522; Yanik B, 2003, J ULTRAS MED, V22, P1107, DOI 10.7863/jum.2003.22.10.1107	19	4	5	0	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	AUG	2006	25	8					891	894		10.1016/j.annfar.2006.04.011			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	087OH	WOS:000240751200018	16859884				2022-02-06	
J	Hernandez, IA; Fyfe, KR; Heo, G; Major, PW				Hernandez, I. . A.; Fyfe, K. R.; Heo, G.; Major, P. W.			Mandibular kinematics associated with simulated low-velocity rear-end impacts	JOURNAL OF ORAL REHABILITATION			English	Article						whiplash; kinematics of mandibular movement; angular mandibular acceleration; angular mandibular displacement; angular head acceleration; temporomandibular joint	TEMPOROMANDIBULAR-JOINT; EXTENSION-FLEXION; WHIPLASH; NECK; INJURY; HEAD; DISORDERS; PERTURBATIONS; ACCELERATION; AWARENESS	Rear-end-impact motor vehicle accidents may result in cervical and temporomandibular-related pain complaints. Head kimematics in simulated low-impact rear-end impacts have been investigated but mandibular kinematics have not been described. Thirty healthy adult subjects underwent three impacts (4.5 m s(-2) expected, 10.0 m s(-2) unexpected, and 10.0 m s(-2) expected). Onset time and peak magnitude of angular head acceleration, angular mandibular acceleration and angular mandibular displacement were measured. Significant mandibular opening acceleration was not identified with rearward head rotation. The peak magnitude of mandibular closing angular acceleration approximately doubled with increased impact magnitude. No differences in peak angular mandibular acceleration regarding expectation were identified. Gender differences were detected in the fast unexpected impact. The peak time for the angular mandibular acceleration (mandibular closure) was approximately 84-120 ms later than peak rearward angular head acceleration for all impacts. Onset and peak times for angular mandibular acceleration (mandibular closure) were similar to the onset and peak times for forward head acceleration. There was also a positive correlation between the magnitude of the forward angular acceleration of the head and angular acceleration of the mandible for the slow (0.65, P = 0.015) and fast expected (0.844, P = 0.001) impacts. The average angular mandibular angular displacement (mandibular closure) was approximately 6 degrees. The hyperextension hypothesis regarding mechanism of temporomandibular joint injury in low-impact rear-end collisions cannot be supported.	Univ Alberta, Fac Med & Dent, Dept Dent, Dent Pharm Ctr, Edmonton, AB T6G 2N8, Canada; Univ Alberta, Fac Engn, Dept Mech Engn, Edmonton, AB T6G 2N8, Canada		Major, PW (corresponding author), Univ Alberta, Fac Med & Dent, Dept Dent, Dent Pharm Ctr, Room 4051B, Edmonton, AB T6G 2N8, Canada.	major@ualberta.ca					ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Bergman H, 1998, AM J ROENTGENOL, V171, P1237, DOI 10.2214/ajr.171.5.9798853; Brault JR, 2000, CLIN BIOMECH, V15, P426, DOI 10.1016/S0268-0033(99)00097-2; BRAUN B L, 1992, Journal of Craniomandibular Disorders, V6, P24; BURGESS J, 1991, Journal of Craniomandibular Disorders, V5, P251; Burgess JA, 1996, J AM DENT ASSOC, V127, P1767, DOI 10.14219/jada.archive.1996.0138; Castro W H, 1997, Eur Spine J, V6, P366, DOI 10.1007/BF01834062; Castro WHM, 2001, INT J LEGAL MED, V114, P316, DOI 10.1007/s004140000193; Friedman MH, 2000, CRANIO, V18, P163, DOI 10.1080/08869634.2000.11746128; Herring SW, 2001, CELLS TISSUES ORGANS, V169, P193, DOI 10.1159/000047882; Howard RP, 1998, ACCIDENT ANAL PREV, V30, P525, DOI 10.1016/S0001-4575(97)00091-2; HOWARD RP, 1991, J ORAL MAXIL SURG, V49, P1210, DOI 10.1016/0278-2391(91)90418-L; HOWARD RP, 1995, J ORAL MAXIL SURG, V53, P256, DOI 10.1016/0278-2391(95)90220-1; HUANG SC, 1909, BIOMED MAT ENG, V9, P233; Kaneoka K, 1999, SPINE, V24, P763, DOI 10.1097/00007632-199904150-00006; Kasch H, 2002, J OROFAC PAIN, V16, P118; Kolbinson DA, 1998, ORAL SURG ORAL MED O, V85, P665, DOI 10.1016/S1079-2104(98)90033-6; Kolbinson Dean A., 1997, Journal of Orofacial Pain, V11, P206; Kronn Estelle, 1993, Journal of Orofacial Pain, V7, P209; Kumar S, 2002, SPINE, V27, P1044, DOI 10.1097/00007632-200205150-00009; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Magnusson ML, 1999, EUR SPINE J, V8, P118, DOI 10.1007/s005860050140; MATSUSHITA T, 1994, 38 STAPP CAR CRASH C, P55; May B, 2001, CLIN BIOMECH, V16, P489, DOI 10.1016/S0268-0033(01)00037-7; MCCONNELL W, 1995, 39 STAPP CAR CRASH C, P3106; McConnell WE, 1993, SAE INT C EXP WARR P, P21; MCNAMARA JA, 1984, AM J ORTHOD DENTOFAC, V86, P449, DOI 10.1016/S0002-9416(84)90352-X; ONO K, 1997, 41 STAPP CAR CRASH C, P339; SCHNEIDER K, 1989, J DENT RES, V68, P1360, DOI 10.1177/00220345890680091401; Siegmund G.P., 2001, THESIS U BRIT COLUMB; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2000, ACCIDENT ANAL PREV, V32, P207, DOI 10.1016/S0001-4575(99)00109-8; Siegmund GP, 2000, FRONTIERS WHIPLASH T, P295; SIEGMUND GP, 1997, 41 STAPP CAR CRASH C, P357; Siegmund GP, 2002, J WHIPLASH RELATED D, V1, P23; Szabo TJ, 1996, STAPP CAR C, VP-30, P295; Szabo TJ, 1994, 38 STAPP CAR CRASH C; WEINBERG S, 1987, J ORAL MAXIL SURG, V45, P653, DOI 10.1016/0278-2391(87)90302-8; WELCHER J, 2001, SAE 2001 WORLD C WAR; West D.H., 1993, ACCID RECONSTR J, V5, P22	41	4	4	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0305-182X			J ORAL REHABIL	J. Oral Rehabil.	AUG	2006	33	8					566	575		10.1111/j.1365-2842.2005.01555.x			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	059UO	WOS:000238757900003	16856954				2022-02-06	
J	Yamamoto, S; Steers, JL; Wharen, RE; Eckman, CB; Nguyen, JH				Yamamoto, Satoshi; Steers, Jeffery L.; Wharen, Robert E., Jr.; Eckman, Christopher B.; Nguyen, Justin H.			Cerebrospinal fluid drainage and cranial decompression prolong survival in rats with fulminant hepatic failure	TRANSPLANT INTERNATIONAL			English	Article						brain edema; craniectomy; cerebrospinal fluid; liver failure	ACUTE LIVER-FAILURE; TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; INTRACRANIAL HYPERTENSION; CRANIECTOMY; PRESSURE; TRANSPLANTATION; INFARCTION; RESOLUTION; CHILDREN	Fulminant hepatic failure (FHF) is a devastating disease. Liver transplantation is the definitive treatment. However, a third of these patients die due to brain edema before a donor becomes available. Cerebrospinal fluid (CSF) drainage and decompressive craniectomy have been used to treat brain edema in brain trauma and hemispheric stroke. However, their role in brain edema associated with FHF has not been examined. In this study we evaluated the potential effects of CSF drainage and decompressive craniectomy on survival in FHF using an experimental model in rats. In CSF drainage experiments all animals had ventriculostomy placed. Five days later FHF was induced with D-galactosamine. Those FHF rats that progressed into comatose stages either received CSF aspiration or did not. In separate experiments the study rats had either a decompressive craniectomy or a sham procedure. FHF was induced 5 days later. We found that both CSF drainage and decompressive craniectomy significantly increased survival of FHF rats compared with the controls: 53.2 +/- 1.1 vs. 48.7 +/- 1.5 h (P = 0.031), and 69.4 +/- 3.9 vs. 53.7 +/- 3.2 h (P = 0.009), respectively. In conclusion, these findings suggest that CSF drainage and decompressive craniectomy may increase the window of opportunity for liver transplantation.	Mayo Clin, Coll Med, Dept Transplantat, Div Transplant Surg, Jacksonville, FL 32216 USA; Mayo Clin, Coll Med, Dept Neurosurg, Jacksonville, FL 32216 USA; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32216 USA; Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan		Nguyen, JH (corresponding author), Mayo Clin, Coll Med, Dept Transplantat, Div Transplant Surg, 4205 Belfort Rd,Suite 1100, Jacksonville, FL 32216 USA.	nguyen.justin@mayo.edu			NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK064361, R21 DK064361-02, R21 DK064361-01, R21 DK064361] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R21DK064361] Funding Source: NIH RePORTER		Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alper G, 1998, PEDIATR NEUROL, V18, P299, DOI 10.1016/S0887-8994(97)00218-X; ASCHER NL, 1993, ARCH SURG-CHICAGO, V128, P677; Ausman J I, 1976, Surg Neurol, V6, P97; Bernal W, 1999, EUR J GASTROEN HEPAT, V11, P977, DOI 10.1097/00042737-199909000-00005; BINGAMAN WE, 1995, NEUROL CLIN, V13, P479, DOI 10.1016/S0733-8619(18)30031-8; BISMUTH H, 1995, ANN SURG, V222, P109, DOI 10.1097/00000658-199508000-00002; Blei A T, 1995, Prog Liver Dis, V13, P311; Blei AT, 1999, J HEPATOL, V31, P771, DOI 10.1016/S0168-8278(99)80361-4; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; BRAKKEE JH, 1979, LAB ANIM SCI, V29, P78; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Chestnut Randall M., 1996, P1401; Cordoba J, 1995, Liver Transpl Surg, V1, P187, DOI 10.1002/lt.500010310; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Dixit V, 1990, ASAIO Trans, V36, P21; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Goss JA, 1998, ARCH SURG-CHICAGO, V133, P839, DOI 10.1001/archsurg.133.8.839; Gove CD, 1997, HEPATOLOGY, V25, P295; Greenwald B M, 1995, Adv Pediatr, V42, P47; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Lane PL, 2000, CAN J SURG, V43, P442; Larsen FS, 2001, J HEPATOL, V34, P548, DOI 10.1016/S0168-8278(00)00069-6; Lee WM, 2003, SEMIN LIVER DIS, V23, P217; LIVINGSTONE AS, 1977, GASTROENTEROLOGY, V73, P697; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1994, AM J PHYSIOL, V267, pH514, DOI 10.1152/ajpheart.1994.267.2.H514; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; McGuire Brendan M, 2003, Semin Gastrointest Dis, V14, P39; MELTON JE, 1984, AM J PHYSIOL, V246, pR533, DOI 10.1152/ajpregu.1984.246.4.R533; Mussack T, 2005, J TRAUMA, V58, P1061, DOI 10.1097/01.TA.0000171989.63817.8c; NGUYEN JH, 2002, LIVER TRANSPLANT, V8, pC52; REULEN HJ, 1978, J NEUROSURG, V48, P754, DOI 10.3171/jns.1978.48.5.0754; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; Riordan SM, 1999, LIVER TRANSPLANT SUR, V5, P86, DOI 10.1002/lt.500050107; Rose C, 2000, HEPATOLOGY, V31, P872, DOI 10.1053/he.2000.5923; Rose C, 1999, HEPATOLOGY, V30, P636, DOI 10.1002/hep.510300311; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schneider GH, 2002, ACT NEUR S, V81, P77; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; SILK DBA, 1977, LANCET, V2, P1; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; THUOMAS KA, 1993, ACTA RADIOL, V34, P289; TRABER PG, 1986, GASTROENTEROLOGY, V91, P1347, DOI 10.1016/0016-5085(86)90186-1; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; WEBSTER S, 1991, HEPATOLOGY, V14, P715, DOI 10.1002/hep.1840140423; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; ZIMMERMANN C, 1989, HEPATOLOGY, V9, P594, DOI 10.1002/hep.1840090414	54	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	AUG	2006	19	8					675	682		10.1111/j.1432-2277.2006.00322.x			8	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	059RX	WOS:000238751000009	16827685	Green Accepted, Bronze			2022-02-06	
J	Morgalla, MH; Bauer, J; Ritz, R; Tatagiba, M				Morgalla, M. H.; Bauer, J.; Ritz, R.; Tatagiba, M.			Coma	ANAESTHESIST			German	Article						head injury; evoked potentials; somatosensory evoked potentials; acoustic evoked potentials; outcome prognosis	SOMATOSENSORY-EVOKED-POTENTIALS; SEVERE HEAD-INJURY; OUTCOME PREDICTION; CONDUCTION TIME; PROGNOSIS; TRAUMA	The prognosis after traumatic coma is often unclear. We investigated the prognostic value of somatosensory (SSEP) and early acoustic (EAEP) evoked potentials on comatous patients in the intensive care unit regarding long-term outcome. Different evaluation systems were investigated. This was a retrospective analysis of 100 patients. SSEP and EAEP were examined at different times and analysed according to the Riffel score. Combinations of the different types of potentials were evaluated regarding possible improvement of outcome prediction. The positive predictive value of at least one missing peak V of the EAEP regarding a fatal prognosis was 83%. The negative predictive value of the EAEP was 96%. A good outcome (GOS 4+5) could be predicted by bilateral normal SSEP and EAEP with a positive predictive value of 98%. Early evaluation of SSEP and EAEP allows reliable prognostic predictions regarding a later outcome in patients with severe traumatic brain injury and should therefore be used more often for intensive care patients.	Univ Tubingen, Neurochirurg Klin, D-72076 Tubingen, Germany		Morgalla, MH (corresponding author), Univ Tubingen, Neurochirurg Klin, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	matthias.morgalla@med.uni-tuebingen.de					ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BARELLI A, 1991, CRIT CARE MED, V19, P1374, DOI 10.1097/00003246-199111000-00013; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BRADLEY GC, 2001, CRIT CARE MED, V29, P178; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Facco E, 2000, INTENS CARE MED, V26, P998, DOI 10.1007/s001340051294; Facco E, 1998, ELECTROEN CLIN NEURO, V107, P332, DOI 10.1016/S0013-4694(98)00080-7; FACCO E, 1988, INTENS CARE MED, V14, P422, DOI 10.1007/BF00262900; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1982, ELECTROEN CLIN NEURO, V54, P49, DOI 10.1016/0013-4694(82)90230-9; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; Maurer E, 1998, ANASTH INTENSIV NOTF, V33, P430, DOI 10.1055/s-2007-994280; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; RIFFEL B, 1989, ANAESTHESIST, V38, P51; RIFFEL B, 1994, PSYCHIAT NEUROLOGIE; RIFFEL B, 1989, EVOZIERTE POTENTIALE, P465; Ritz R, 2002, NEUROL RES, V24, P756, DOI 10.1179/016164102101200852; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; SCHWARZ G, 1994, ANASTH INTENSIVMED, V35, P376; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; Wilson WJ, 2002, J NEUROSURG, V97, P1062, DOI 10.3171/jns.2002.97.5.1062	30	4	7	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JUL	2006	55	7					760	768		10.1007/s00101-006-1036-1			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	061GQ	WOS:000238859800004	16718461				2022-02-06	
J	Wang, HC; Lu, CH; Lee, RJ; Yang, TM; Hung, KS				Wang, Hung-Chen; Lu, Cheng-Hsien; Lee, Reng-Jye; Yang, Tzu-Ming; Hung, Kuo-Sheng			Post-traumatic hemifacial spasm	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						brain stem haemorrhage; hemifacial spasm; head injury; facial nucleus	FACIAL-NERVE; PATHO-PHYSIOLOGY; LATERAL SPREAD; EXCITABILITY; REFLEX	We report an early-onset post-traumatic hemifacial spasm and discuss possible aetiology. A 20-year-old man was admitted to our hospital for observation because of an injury to the right frontotemporal region, resulting in drowsiness. On the second day in hospital, he developed peripheral paresis of the facial nerve on the right, followed by hernifacial spasm on the same side. He improved after corticosteroid treatment, and was discharged one week later almost completely recovered. The neuroradiology and clinical response suggest that the patient's hemifacial spasm was due to hyperexcitability of the facial nerve nucleus induced by a haematoma in the lower central pons. (c) 2006 Elsevier Ltd. All rights reserved.	Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Neurosurg, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Neurol, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Radiol, Kaohsiung, Taiwan		Hung, KS (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Neurosurg, 123 Ta Pei Rd, Kaohsiung, Taiwan.	kshung25@cgmh.org.tw		WANG, HUNG-CHEN/0000-0003-3962-1958			Chang JW, 2002, NEUROSURGERY, V50, P720, DOI 10.1097/00006123-200204000-00007; DIGRE K, 1988, ADV NEUROLOGY FACIAL, V49; Ho SL, 1999, NEUROLOGY, V53, P2132, DOI 10.1212/WNL.53.9.2132; Ito M, 2004, ACTA OTO-LARYNGOL, V124, P217, DOI 10.1080/00016480310000719; JANNETTA PJ, 1977, J NEUROSURG, V47, P321, DOI 10.3171/jns.1977.47.3.0321; MARTINELLI P, 1992, MOVEMENT DISORD, V7, P181, DOI 10.1002/mds.870070214; MOLLER AR, 1985, EXPERIENTIA, V41, P415, DOI 10.1007/BF02004535; NIELSEN VK, 1984, NEUROLOGY, V34, P427, DOI 10.1212/WNL.34.4.427; NIELSEN VK, 1984, NEUROLOGY, V34, P418, DOI 10.1212/WNL.34.4.418; Ogawara K, 2004, NEUROLOGY, V62, P1749, DOI 10.1212/01.WNL.0000125183.81555.E4; Parisi L, 1990, Zentralbl Neurochir, V51, P223; Pavesi G, 2003, MOVEMENT DISORD, V18, P587, DOI 10.1002/mds.10405; VALLSSOLE J, 1989, NEUROLOGY, V39, P1061, DOI 10.1212/WNL.39.8.1061; VANDENBERGH P, 1995, MUSCLE NERVE, V18, P720, DOI 10.1002/mus.880180708; Yamashita S, 2002, MUSCLE NERVE, V25, P845, DOI 10.1002/mus.10123	15	4	4	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2006	13	6					681	683		10.1016/j.jocn.2005.10.006			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079FE	WOS:000240160100016	16860719				2022-02-06	
J	Boto, GR; Gomez, PA; De la Cruz, J; Lobato, RD				Boto, G. R.; Gomez, P. A.; De la Cruz, J.; Lobato, R. D.			Prognostic models in severe head injury	NEUROCIRUGIA			Spanish	Article						prognostic models; prediction methods; outcome; severe head injury	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; OUTCOME PREDICTION; MOTOR RESPONSE; STEM REFLEXES; MORTALITY; MANAGEMENT; SURVIVAL; PATIENT; SCALE	Severe head injury (SHI) is one of the most important health, social, and economic problems in industrialized countries. Most of the recent studies related to this entity still show pessimistic results, with percentages of mortality and unfavourable outcomes very similar than those reported in the last quarter of century. In order to make predictions for patients with SHI, different "prognostic formulas or models" reviewed in this manuscript, have been developed with the main objective of performing reliable predictions for patients with this pathology. These models are constructed by using a group of "prognostic indicators or factors" and different "prognostic scales" useful for measuring the final outcome. The different "statistical techniques or methods" necessary to develop these prognostic models are also analyzed in this paper.	Hosp 12 Octubre, Serv Neurocirug, E-28041 Madrid, Spain; Hosp 12 Octubre, Unidad Epidemiol Clin, E-28041 Madrid, Spain		Boto, GR (corresponding author), Avda Dr Garcia Tapia,159 Escalera D 4-B, Madrid 28030, Spain.		Gomez, Pedro/N-5051-2019; Rodriguez-Boto, Gregorio/AAR-9035-2021	Gomez, Pedro/0000-0002-4185-5238; Rodriguez-Boto, Gregorio/0000-0001-6361-5713			Adachi S, 2000, NEUROL MED-CHIR, V40, P200, DOI 10.2176/nmc.40.200; *AN BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P561; Auer L, 1979, Acta Neurochir Suppl (Wien), V28, P171; BALDWIN NG, 1991, AANS 59 ANN M, P456; BARLOW O, 1987, MED APPL MICROCOMPUT, P105; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; BOUZARTH WF, 1978, J TRAUMA, V18, P571, DOI 10.1097/00005373-197808000-00003; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Braakman R, 1986, Acta Neurochir Suppl (Wien), V36, P112; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; CABRERA A, 1991, THESIS U AUTONOMA MA; CHANG RWS, 1989, CRIT CARE MED, V17, P1091, DOI 10.1097/00003246-198911000-00001; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CHOI SC, 1996, NEUROTRAUMA, P779; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; CONTANT CF, 1996, NEUROLOGICAL SURG, V3, P1792; CONTANT CF, 1996, NEUROTRAUMA, P923; DOWLING JL, 1996, PRACTICE NEUROSURGER, V2, P1633; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FELDMAN Z, 1991, LANCET, V337, P1451, DOI 10.1016/0140-6736(91)93137-X; FELDMAN Z, 1996, NEUROTRAUMA, P805; FOLTZ EL, 1988, SURG NEUROL, V30, P273, DOI 10.1016/0090-3019(88)90298-4; FOULKES MA, 1991, J NEUROSURG, V75, pS1, DOI 10.3171/sup.1991.75.1s.00s1; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GIANNOTTA SL, 1987, HEAD INJURY, P464; GIBSON RM, 1989, LANCET, V2, P369; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; Habbema J D, 1979, Acta Neurochir Suppl (Wien), V28, P158; HARTUNG HJ, 1992, ANAESTHESIST, V41, P468; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; Jennett B, 1975, Ciba Found Symp, P309; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; JENNETT B, 1976, LANCET, V1, P1031; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; KAUKINEN L, 1984, ANN CHIR GYNAECOL FE, V73, P261; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1984, J NEUROSURG, V61, P695, DOI 10.3171/jns.1984.61.4.0695; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LANGFITT TW, 1978, J NEUROSURG, V49, P77; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1990, HEAD INJURY HDB CLIN, V13, P367; Lewin W, 1979, Acta Neurochir Suppl (Wien), V28, P128; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MARION DW, 1996, NEUROTRAUMA, P767; Marshall L F, 1988, Clin Neurosurg, V34, P549; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mukherjee K, 2000, NEUROL INDIA, V48, P43; MURRAY GD, 1986, STAT MED, V5, P403, DOI 10.1002/sim.4780050504; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NARAYAN RK, 1989, TXB HEAD INJURY, P420; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; STEWART WA, 1979, ACTA NEUROCHIR, V45, P199, DOI 10.1007/BF01769134; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P205; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; TOFOVIC P, 1976, ACTA NEUROCHIR, V34, P99, DOI 10.1007/BF01405866; VAPALAHTI M, 1971, BMJ-BRIT MED J, V3, P404, DOI 10.1136/bmj.3.5771.404; VOLLMER DG, 1993, HEAD INJURY, P553; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	91	4	4	0	4	SOCIEDAD LUSO-ESPANOLA NEUROCIRUGIA	SANTANDER	C/O J M IZQUIERDO HOSPITAL VALDECILLA, 39908 SANTANDER, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JUN	2006	17	3					215	225					11	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	065RA	WOS:000239175800001	16855779				2022-02-06	
J	So, KF; Ho, LSH; Tay, DKC; Lee, TMC				So, KF; Ho, LSH; Tay, DKC; Lee, TMC			Light delays synaptic deafferentation and potentiates the survival of axotomized retinal ganglion cells	NEUROSCIENCE LETTERS			English	Article						synaptic deafferentation; optic nerve transection; neuroprotection; environmental stimulation; cognitive rehabilitation	C-FOS; ELECTRICAL-STIMULATION; AXONAL REGENERATION; EXPRESSION; NEURONS; RAT; ELEVATION; PATHWAYS; RECOVERY; STROKE	Knowledge of the cellular mechanism underlying the therapeutic effect Of Stimulation and the optimal doses of such stimulation to maximize neuronal recovery is essential to guide clinical practice in neural rehabilitation. Using hamsters, we transected the optic nerve to demonstrate how light Stimulation affects neuronal recovery. The c-fos protein was used as a neuronal connectivity marker. Here we show that: (a) in addition to cell death, a Population of cells undergoes synaptic deafferentation and (b) light stimulation delays cell death and deafferentation. Among the three rearing conditions studied (6:18LD, 12:12LD, and 18:6LD), the 12:12LD condition appears to be the one achieving the optimal therapeutic effect. This Study provides a solid base in the understanding of the neuroanatomical changes after traumatic brain injury and the need to establish an optimal level and timing for the environmental Stimulation. (c) 2005 Elsevier Ireland Ltd. All rights reserved.	Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Inst Clin Neuropsychol, Hong Kong, Hong Kong, Peoples R China; MacLehose Rehabil Ctr, Hong Kong, Hong Kong, Peoples R China		Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	tmclee@hkusua.hku.hk		So, Kwok-Fai/0000-0003-4039-4246			Aonuma H, 1999, JPN J OPHTHALMOL, V43, P171, DOI 10.1016/S0021-5155(99)00011-8; CHEN DH, 1977, EXP NEUROL, V57, P1026, DOI 10.1016/0014-4886(77)90125-X; Cheung ZH, 2004, MOL CELL NEUROSCI, V25, P383, DOI 10.1016/j.mcn.2003.11.001; Cheung ZH, 2002, J NEUROTRAUM, V19, P369, DOI 10.1089/089771502753594936; *COMM AG GROUP ASS, 1988, PSYCH TREATM ALZH DI, V53; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; de Kroon JR, 2002, CLIN REHABIL, V16, P350, DOI 10.1191/0269215502cr504oa; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; FLAMM RE, 1987, J NEUROPHYSIOL, V58, P1370, DOI 10.1152/jn.1987.58.6.1370; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; HANS L, 2000, J COMP NEUROL, V425, P10; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jin X, 1998, Yan Ke Xue Bao, V14, P215; KOLB B, 2001, INTRO BRAIN BEHAV; Liberson W., 1961, ARCH PHYS MED REHAB, V42, P202; Masuda K, 2000, JPN J OPHTHALMOL, V44, P615, DOI 10.1016/S0021-5155(00)00285-9; McGregor IS, 2004, J NEUROSCI, V24, P4134, DOI 10.1523/JNEUROSCI.0187-04.2004; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Richerson GB, 2004, NAT MED, V10, P25, DOI 10.1038/nm0104-25; ROUILLER EM, 1992, NEUROSCI LETT, V144, P19, DOI 10.1016/0304-3940(92)90706-D; Rushton DN, 2003, MED ENG PHYS, V25, P75, DOI 10.1016/S1350-4533(02)00040-1; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SOKOLOFF L, 1980, JAMA-J AM MED ASSOC, V244, P1612; Takao M, 2002, EXP NEUROL, V177, P171, DOI 10.1006/exnr.2002.7958; Tappen RM, 2000, ALZ DIS ASSOC DIS, V14, P196, DOI 10.1097/00002093-200010000-00002; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WAN XST, 1992, NEUROSCIENCE, V49, P749, DOI 10.1016/0306-4522(92)90353-4; Watanabe M, 2002, PROG RETIN EYE RES, V21, P529, DOI 10.1016/S1350-9462(02)00037-X; Watanabe M, 1999, EXP NEUROL, V160, P133, DOI 10.1006/exnr.1999.7208; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	32	4	5	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 13	2006	395	3					255	260		10.1016/j.neulet.2005.11.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016CH	WOS:000235597800017	16352397				2022-02-06	
J	Setkowicz, Z; Nowak, B; Janeczko, K				Setkowicz, Z; Nowak, B; Janeczko, K			Neocortical injuries at different developmental stages determine different susceptibility to seizures induced in adulthood	EPILEPSY RESEARCH			English	Article						developing brain; mechanical injury; kainic acid model of epilepsy; susceptibility to seizures	TEMPORAL-LOBE EPILEPSY; INDUCED STATUS EPILEPTICUS; FLUID PERCUSSION INJURY; TRAUMATIC BRAIN-INJURY; AGE-DEPENDENT CHANGES; IMMATURE RAT; POSTTRAUMATIC EPILEPSY; NERVOUS-SYSTEM; PROLIFERATIVE RESPONSE; NEURONAL INJURY	Gliosis, axonal sprouting and remodelling of nerve connections in the injured brain have been regarded as epileptogenic processes dependent on the age when the injury was inflicted. The present study examines whether brains injured at different developmental stages may acquire different susceptibility to experimental status epilepticus induced in adulthood. In 6- and 30-day-old Wistar rats (P6s and P30s, respectively), a mechanical injury was performed in the left cerebral hemisphere. On postnatal day 60, all the animals and controls received single injections of kainic acid to evoke status epilepticus. During a 6-h period following the injection, the animals were observed continuously and motor symptoms of seizure activity were recorded and rated. P6s showed significantly lower intensity of kainic acid-induced epileptic symptoms and significantly longer survival than controls or P30s. In P30s, no significant change was detected. The data provide evidence that the developmental stage when the brain is injured determines epileptogenecity of the lesion. However, a considerable discrepancy between these data and those obtained previously following pilocarpine administration in the same experimental models of brain injury shows that each of the two models of epilepsy may display different aspects of the same age-dependent process triggered by the brain injury. (c) 2005 Elsevier B.V. All rights reserved.	Jagiellonian Univ, Inst Zool, Dept Neuroanat, PL-30060 Krakow, Poland		Janeczko, K (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neuroanat, 6 Ingardena St, PL-30060 Krakow, Poland.	jape@zuk.iz.uj.edu.pl		Setkowicz, Zuzanna/0000-0002-7213-8194; Janeczko, Krzysztof/0000-0002-9544-918X			Acarin L, 2001, Prog Brain Res, V132, P375; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BERNARDO LS, 2003, EPILIPSIA, V44, P27; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; CASSEL JC, 1997, EXP NEUROL, V97, P564; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2004, PHARMACOL THERAPEUT, V103, P95, DOI 10.1016/j.pharmthera.2004.05.004; DORETTO MC, 1995, PHYSIOL BEHAV, V58, P273, DOI 10.1016/0031-9384(95)00050-S; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jacobs KM, 2000, EPILEPSIA, V41, pS153, DOI 10.1111/j.1528-1157.2000.tb01574.x; JANECZKO K, 1994, INT J DEV NEUROSCI, V12, P431, DOI 10.1016/0736-5748(94)90027-2; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; JENSEN FE, 1992, EPILEPSIA, V33, P971, DOI 10.1111/j.1528-1157.1992.tb01746.x; Koh S, 1999, NEUROLOGY, V53, P915, DOI 10.1212/WNL.53.5.915; KOLASA K, 1992, PHARMACOL BIOCHEM BE, V41, P99, DOI 10.1016/0091-3057(92)90066-O; Kolb B, 1998, BEHAV BRAIN RES, V91, P127, DOI 10.1016/S0166-4328(97)00112-5; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; MAROSI M, 1994, EPILEPSY RES, V19, P63, DOI 10.1016/0920-1211(94)90089-2; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; MOSHE SL, 1985, BRAIN RES, V337, P368, DOI 10.1016/0006-8993(85)90077-0; Nehlig A, 2002, EPILEPSY RES, V51, P189, DOI 10.1016/S0920-1211(02)00125-0; OKADA R, 1984, DEV BRAIN RES, V15, P177, DOI 10.1016/0165-3806(84)90095-6; Priel MR, 1996, EPILEPSY RES, V26, P115, DOI 10.1016/S0920-1211(96)00047-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rice DC, 2000, ENVIRON HEALTH PERSP, V108, P405, DOI 10.2307/3454528; ROMIJN HJ, 1994, EPILEPSY RES, V17, P31, DOI 10.1016/0920-1211(94)90077-9; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Salin P, 1995, J NEUROSCI, V15, P8234; Sankar R, 1998, J NEUROSCI, V18, P8382; Sawaishi Y, 2005, TOHOKU J EXP MED, V205, P287, DOI 10.1620/tjem.205.287; Schmid R, 1999, NEUROLOGY, V53, P1754, DOI 10.1212/WNL.53.8.1754; Setkowicz Z, 2003, EPILEPSY RES, V53, P216, DOI 10.1016/S0920-1211(03)00029-9; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; TEMKIN NR, 2000, EPILIPSIA, V44, P18; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Wong M, 2001, DEV BRAIN RES, V128, P113, DOI 10.1016/S0165-3806(01)00149-3; XIA Y, 1995, BRAIN RES, V675, P224, DOI 10.1016/0006-8993(95)00079-6	49	4	4	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAR	2006	68	3					255	263		10.1016/j.eplepsyres.2005.11.012			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	025VH	WOS:000236294500007	16387474				2022-02-06	
J	Wyrwich, W; Heyde, CE				Wyrwich, W; Heyde, CE			Problems involved in expert opinions on acceleration injuries of the cervical spine	ORTHOPADE			German	Article						acceleration injuries of the cervical spine; problems involved in expert opinions; inadequate documentation; legal aspects; pathophysiology	WHIPLASH-ASSOCIATED DISORDERS; QUEBEC CLASSIFICATION; PSYCHOLOGICAL-FACTORS; INTERVERTEBRAL DISC; PROGNOSTIC-FACTORS; ALAR LIGAMENTS; DIAGNOSIS; SYMPTOMS; MECHANISMS; KINEMATICS	Reasons for problems in stating an expert opinion on acceleration injuries of the cervical spine are numerous. The presence of unexpected or the absence of expected symptoms, the lack of objective proof for alterations or the presence of complaints that are difficult to prove, the discrepancy between recognizable force of the impact versus the resulting damage to the injured as well as the chance of being completely incapable of rendering proof that unquestionably a potentially damage-causing event is - beyond any reasonable doubt - the origin of an observed alteration in an injured individual are some of the problems a medical expert has to face when dealing with the analysis of injuries of the cervical spine. Unsatisfactory documentation in the patient's records, discussions about the reliability of diagnostic means or the interpretation of their results, difficult to procure evidence of accident-specific biomechanics and their direct or indirect impact on the body or neck of the injured person as well as distinguishing cervical sprain from mild brain damage, post-traumatic distress syndrome, cognitive disorder, psychiatric disease, aggravation, or malingering makes it hard for an expert to state an expert opinion.	Univ Med Berlin, Charite, Klin Unfall & Wiederherstellungschirurg, Zentrum Spezielle Chirurg Bewegungsapparates, D-12200 Berlin, Germany		Wyrwich, W (corresponding author), Univ Med Berlin, Charite, Klin Unfall & Wiederherstellungschirurg, Zentrum Spezielle Chirurg Bewegungsapparates, Hindenburgdamm 30, D-12200 Berlin, Germany.	werner.wyrwich@charite.de	Heyde, Christoph - E./AAV-9440-2021				*ADAC EXP, HWS VERL SCH 11 11 1; AWERBUCH MS, 1992, MED J AUSTRALIA, V157, P193, DOI 10.5694/j.1326-5377.1992.tb137087.x; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; BURHMANN R, 1997, THESIS FACHHOCHSCHUL; Bylund PO, 1998, SPINE, V23, P1023, DOI 10.1097/00007632-199805010-00012; CASTR WHM, 2001, Z VERKEHRSRECHT, V3, P112; Castro WHM, 2001, INT J LEGAL MED, V114, P316, DOI 10.1007/s004140000193; CASTRO WHM, 1998, DTSCH ARZTEBL A, V95, P3285; CRAMER BM, 1998, DTSCH ARZTEBL A, V95, P3079; CROWE HE, 1928, W ORTH ASS SAN FRANC; ERDMANN H, 1973, SCHLEUDERTRAUMA HALS; Ferrari R, 2002, Versicherungsmedizin, V54, P138; Ferrari R, 2001, ORTHOPADE, V30, P551, DOI 10.1007/s001320170065; Ferrari R, 2001, J NEUROL NEUROSUR PS, V70, P722, DOI 10.1136/jnnp.70.6.722; Grifka J, 1998, ORTHOPADE, V27, P802; Hartling L, 2001, SPINE, V26, P36, DOI 10.1097/00007632-200101010-00008; HAUSOTTER W, 1999, DTSCH ARZTEBL A, V96, P1481; HEHLING W, 2002, FACHT OPT DIAGN THER; Hendriks EJM, 2005, PAIN, V114, P408, DOI 10.1016/j.pain.2005.01.006; Illgner A, 1996, UNFALLCHIRURG, V99, P351; Ishii T, 2004, SPINE, V29, P2826, DOI 10.1097/01.brs.0000147806.31675.6b; Ito S, 2005, EUR SPINE J, V14, P356, DOI 10.1007/s00586-004-0783-4; Ito S, 2004, SPINE, V29, P1330, DOI 10.1097/01.BRS.0000127186.81814.4A; Ito S, 2004, SPINE, V29, P979, DOI 10.1097/00007632-200405010-00006; Ivancic PC, 2004, EUR SPINE J, V13, P61, DOI 10.1007/s00586-003-0590-3; KEIDEL M, 2000, NEUROLOGISCHE GUTACH; KOCH C, 2004, SACHVERSTANDIGENGUTA; KRAMER J, 2005, Z ORTHOP, V143, P10; Kramer J, 1994, BANDSCHEIBENBEDINGTE; KUGELGEN B, 2001, TRAUMA BERUFSKRAN S3, V3, P334; KUGELGEN B, 2003, SOGENANNTE SCHLEUDER; Kwan O, 2003, MED SCI MONITOR, V9, P203; LEMKE H, 1996, NEUE Z VERKEHRSRECHT, V9, P337; Lucka J, 1998, Versicherungsmedizin, V50, P124; LUDOLPH E, 2004, PRAXIS UNFALLCHIRURG; MAZZOTTI I, 2002, BEURTEILUNG BEGUTACH; McGill University Press, 2002, WHIPLASH OTHER USEFU; MEYER S, 1999, VERKEHRSUNFALL FAHRZ, V37, P13; MEYER S, 1998, SCHLEUDERTRAUMA HALS; Moller J, 1992, Eur Spine J, V1, P178, DOI 10.1007/BF00301310; MOORAHREND U, 1993, BESCHLEUNIGUNGSVERLE; MOORAHREND U, 1995, NEUROORTHOPADIE, V6; Muhle C, 2002, ROFO-FORTSCHR RONTG, V174, P416, DOI 10.1055/s-2002-25124; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Panjabi MM, 2004, SPINE, V29, P1217, DOI 10.1097/00007632-200406010-00011; Panjabi MM, 2004, CLIN BIOMECH, V19, P1, DOI 10.1016/j.clinbiomech.2003.09.006; Partheni M, 2000, CLIN EXP RHEUMATOL, V18, P67; Pearson AM, 2004, SPINE, V29, P390, DOI 10.1097/01.BRS.0000090836.50508.F7; Pfirrmann CWA, 2000, SCHWEIZ MED WSCHR, V130, P645; Poeck K, 2002, AKTUEL NEUROL, V29, P288, DOI 10.1055/s-2002-32913; POECK K, 1999, DTSCH ARZTEBLATT, V96, P2596; Radanov BP, 1998, ORTHOPADE, V27, P846; Richter M, 2000, UNFALLCHIRURG, V103, P22, DOI 10.1007/s001130050004; Richter M, 2004, J NEUROL NEUROSUR PS, V75, P758, DOI 10.1136/jnnp.2003.026963; Rodriquez AA, 2004, MUSCLE NERVE, V29, P768, DOI 10.1002/mus.20060; Rompe G, 1998, ORTHOPADE, V27, P854; ROMPE G, 2004, BEGUTACHTUNG HALTUNG; Schmidt J, 2003, Versicherungsmedizin, V55, P118; Schnabel M, 2004, UNFALLCHIRURG, V107, P300, DOI 10.1007/s00113-004-0740-z; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Seckmeyer M, 1997, Versicherungsmedizin, V49, P48; Seffinger MA, 2004, SPINE, V29, pE413, DOI 10.1097/01.brs.0000141178.98157.8e; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Strender L E, 1997, J Manipulative Physiol Ther, V20, P516; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; Suissa S, 2001, EUR SPINE J, V10, P44, DOI 10.1007/s005860000220; Tenenbaum A, 2002, J REHABIL MED, V34, P114, DOI 10.1080/165019702753714138; Thomann K D, 2004, Versicherungsmedizin, V56, P131; Thomann Klaus-Dieter, 2003, Medizinhist J, V38, P103; Thompson DR, 2004, EUR J CARDIOV PREV R, V11, P183, DOI 10.1097/01.hjr.0000131015.60342.ba; Welter FL, 1998, ORTHOPADE, V27, P834	73	4	4	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0085-4530	1433-0431		ORTHOPADE	Orthopade	MAR	2006	35	3					319	+		10.1007/s00132-005-0917-3			11	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	031CG	WOS:000236681100008	16402181				2022-02-06	
J	Kalichman, L; Livshits, G; Kobyliansky, E				Kalichman, Leonid; Livshits, Gregory; Kobyliansky, Eugene			Association between morbidity and skeletal biomarkers of biological aging	HUMAN BIOLOGY			English	Article						osseographic score; morbidity skeletal aging; Chuvashians	BONE-MINERAL DENSITY; POPULATION BIOLOGY; GENERAL-PRACTICE; OSTEOARTHRITIS; DISEASE; AGE; COMORBIDITY; PREVALENCE; DETERMINANTS; OSTEOPOROSIS	The Osseographie Scoring System (OSS) is a synthetic measure of skeletal aging that combines osteoporotic and osteoarthritic changes of the hand. The OSS is used to evaluate biological age in a population. The aim of the present study was to evaluate the association between certain chronic morbidities and the skeletal biomarker of biological aging. We performed a population-based study on a large sample of individuals who were receiving no medications to treat or prevent chronic morbidities [668 male (age 18-89 years) and 608 female (age 18-81 years) Chuvashians]. Morbidity data obtained from the individuals' medical records was sorted into 16 categories. A one-way ANOVA was used to elucidate the association between morbidity and age-adjusted OSS score. Statistically significant differences between means of OSS scores in affected vs. nonaffected individuals were found in the rheumatic diseases group. Ischemic heart disease, pulmonary diseases, traumatic brain injuries, and gynecological diseases also showed differences; however, after correction for multiple testing, the results were statistically nonsignificant. We conclude, that individuals who suffer from the mentioned chronic morbidities will show a higher degree of skeletal aging. Further research is needed to clarify the biological mechanisms of association between certain types of morbidities and changes in skeletal aging.	Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Human Populat Biol Res Unit, Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, Lilian & Marcel Pollak Chair Biol Anthropol, IL-69978 Tel Aviv, Israel		Kalichman, L (corresponding author), Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel.		Livshits, Gregory/AAG-7051-2019; Kalichman, Leonid/C-6266-2008; Kalichman, Leonid/Q-7547-2019	Livshits, Gregory/0000-0003-3766-7493; Kalichman, Leonid/0000-0003-2987-4396; Kalichman, Leonid/0000-0003-2987-4396			Al-Maatouq MA, 2004, SAUDI MED J, V25, P1423; Arnaiz-Villena A, 2003, HUM BIOL, V75, P375, DOI 10.1353/hub.2003.0040; Benjamini Y, 2001, ANN STAT, V29, P1165; BORKAN GA, 1980, J GERONTOL, V35, P177, DOI 10.1093/geronj/35.2.177; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crews Douglas E., 1994, P154; DEAN W, 1988, ARCH GERONTOL GERIAT, V7, P191, DOI 10.1016/0167-4943(88)90002-7; Gabriel SE, 1999, J RHEUMATOL, V26, P2475; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Haara MM, 2003, ANN RHEUM DIS, V62, P151, DOI 10.1136/ard.62.2.151; HOCHBERG MC, 1995, J RHEUMATOL, V22, P2291; Imhof H, 1997, SKELETAL RADIOL, V26, P398, DOI 10.1007/s002560050254; Johansson C, 1998, CALCIFIED TISSUE INT, V63, P190, DOI 10.1007/s002239900513; Kadam UT, 2004, ANN RHEUM DIS, V63, P408, DOI 10.1136/ard.2003.007526; Karasik D, 1999, AM J HUM BIOL, V11, P31, DOI 10.1002/(SICI)1520-6300(1999)11:1<31::AID-AJHB3>3.0.CO;2-L; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Karasik D, 2004, J GERONTOL A-BIOL, V59, P218; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; KOBYLIANSKY E, 1995, HUM BIOL, V67, P87; Livshits G, 1996, HUM BIOL, V68, P539; Malinin T, 2000, OSTEOARTHR CARTILAGE, V8, P483, DOI 10.1053/joca.1999.0324; Marks Ray, 2002, Med Sci Monit, V8, pCR305; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Moran CE, 1997, AM J GASTROENTEROL, V92, P867; PAVLOVSKY OM, 1997, POPULATION BIOL HUMA; PAVLOVSKY OM, 1987, BIOL AGE MAN; PLATO CC, 1987, COLLEGIUM ANTROPOL, V11, P59; Plato Chris C., 1994, P272; Pollak RD, 1998, AM J GASTROENTEROL, V93, P1483; Rogers J, 2004, ARTHRITIS RHEUM-US, V50, P452, DOI 10.1002/art.20136; SCHELLEVIS FG, 1993, J CLIN EPIDEMIOL, V46, P469, DOI 10.1016/0895-4356(93)90024-U; Shane E, 1997, AM J MED, V103, P197, DOI 10.1016/S0002-9343(97)00142-3; Shane E, 1996, AM J MED, V101, P262, DOI 10.1016/S0002-9343(96)00155-6; Singh G, 2002, AM J MANAG CARE, V8, pS383; *STATSOFT INC, 2000, STAT WIND; Warner HR, 2004, J GERONTOL A-BIOL, V59, P692	37	4	5	0	1	WAYNE STATE UNIV PRESS	DETROIT	4809 WOODWARD AVE, DETROIT, MI 48201-1309 USA	0018-7143	1534-6617		HUM BIOL	Hum. Biol.	FEB	2006	78	1					77	88		10.1353/hub.2006.0025			12	Anthropology; Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Anthropology; Life Sciences & Biomedicine - Other Topics; Genetics & Heredity	064MU	WOS:000239094600006	16900883				2022-02-06	
J	Reed, MJ; Clegg, GR				Reed, Matthew J.; Clegg, Gareth R.			Paroxysmal sympathetic surge associated with gamma hydroxybutyrate	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						gamma hydroxybutyrate; paroxysmal sympathetic surge; sympathetic nervous system; toxicology		Gamma hydroxybutyrate is increasingly being used recreationally in the United Kingdom. We present a case of gamma hydroxybutyrate overdose associated with paroxysmal sympathetic storm, a phenomenon usually confined to patients who have sustained traumatic brain injury. (C) 2006 Lippincott Williams & Wilkins.	[Reed, Matthew J.; Clegg, Gareth R.] Royal Infirm Edinburgh NHS Trust, Dept Emergency Med, Edinburgh EH16 4SA, Midlothian, Scotland		Reed, MJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Emergency Dept, 51 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.	mattreed1@hotmail.com		Reed, Matthew/0000-0003-1308-4824; Clegg, Gareth/0000-0002-4314-611X			Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Koury R, 1999, Eur J Emerg Med, V6, P149; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010	4	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	FEB	2006	13	1					41	42		10.1097/00063110-200602000-00011			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V41AK	WOS:000209518900011	16374249				2022-02-06	
J	Bernard, F; Outtrim, J; Lynch, AG; Menon, DK; Matta, BF				Bernard, Francis; Outtrim, Joanne; Lynch, Andrew G.; Menon, David K.; Matta, Basil F.			Hemodynamic steroid responsiveness is predictive of neurological outcome after traumatic brain injury	NEUROCRITICAL CARE			English	Article						adrenal insufficiency; adrenal dysfunction; traumatic brain injury; high-dose stimulation test; cortisol; hydrocortisone replacement therapy	ADRENAL INSUFFICIENCY; GLUCOCORTICOIDS	Introduction: To determine the impact of physiologic doses of hydrocortisone on neurologic outcome after traumatic brain injury (TBI). Methods: We conducted a retrospective study in a neurocritical care unit at a university teaching hospital. We included 29 patients with moderate and severe TBI requiring vasoactive drugs to maintain adequate arterial blood pressure who received corticosteroid. Infected patients were excluded. Blood cortisol levels were measured before and 30 and 60 minutes after the administration of a high-dose corticotropin stimulation test (HDST). Patients received hydrocortisone replacement therapy (200-300 mg/day) and vasoactive drugs requirements were noted. Intracranial pressure was managed according to a predefined protocol. Results: A total of 14 out of 29 (48%) of patients were classified as responders to hydrocortisone (stopping vasoactive drugs within 3 days of starting hydrocortisone). The Glasgow Outcome Score (GOS) was used to assess neurologic outcome at 6 months. A favorable outcome (GOS 4 and 5) was observed in 11 out of 14 (79%) of responders and five out of 15 (33%) of nonresponders (p=0.03). Of the responders, 12 out of 14 (85%) had a baseline cortisol below 414 nmol/L, and five out of 14 (36%) had primary adrenal insufficiency (AI) (primary AI: low baseline cortisol, and poor response to the HDST). Age, severity of injury, and response to hydrocortisone were predictive of outcome in multiple logistic regression analysis. Conclusions: Adrenal insufficiency is frequent after TBI, and hydrocortisone replacement therapy seems to be associated with a favorable neurologic outcome.	Hop Sacre Coeur, Univ Dept Crit Care Med & Gen Internal Med, Montreal, PQ H4J 1C5, Canada; Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England		Bernard, F (corresponding author), Hop Sacre Coeur, Dept Intens Care, 5400 Boul Gouin, Montreal, PQ H4J 1C5, Canada.	bernard.francis@gmail.com		Outtrim, Joanne/0000-0001-8118-6430; Lynch, Andy/0000-0002-7876-7338	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI		Abraham IM, 2001, J NEUROENDOCRINOL, V13, P749, DOI 10.1046/j.1365-2826.2001.00705.x; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; Glezer I, 2004, NEUROSCIENTIST, V10, P538, DOI 10.1177/1073858404263494; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Marik PE, 2004, CRIT CARE MED, V32, P596, DOI 10.1097/01.CCM.0000110729.73061.4B; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Rhodes Jonathan K J, 2003, Curr Opin Crit Care, V9, P86; Venkatesh B, 2005, ANAESTH INTENS CARE, V33, P201, DOI 10.1177/0310057X0503300208	13	4	5	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2006	5	3					176	179		10.1385/NCC:5:3:176			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	132AD	WOS:000243913200002	17290084				2022-02-06	
B	Jagoda, A; Bruns, J		LeonCarrion, J; vonWild, KRH; Zitnay, GA		Jagoda, Andy; Bruns, John, Jr.			Prehospital management of traumatic brain injury	BRAIN INJURY TREATMENT: THEORIES AND PRACTICES	Studies on Neuropsychology Development and Cognition		English	Article; Book Chapter							SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; INTUBATION; CARE; HYPERGLYCEMIA; PREDICTORS; HEMORRHAGE; PROGNOSIS; SURVIVAL; CRITERIA		[Jagoda, Andy; Bruns, John, Jr.] Mt Sinai Sch Med, Dept Emergency Med, New York, NY USA		Jagoda, A (corresponding author), Mt Sinai Sch Med, Dept Emergency Med, New York, NY USA.						*AM COLL SURG, 1993, ADV TRAUM LIF SUPP; Anglin D, 1998, ACAD EMERG MED, V5, P672, DOI 10.1111/j.1553-2712.1998.tb02484.x; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; BROWNSTEIN D, 1996, ANN EMERG MED, V21, P664; CAMPBELL JE, 1995, BASIC TRAUMA LIFE SU, P23; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GOTTESFELD SH, 2000, EMERG MED PRACT, V2, P1; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KOKSKA ER, 1998, J PEDIATR SURG, V33, P333; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Luber SD, 1996, AM J EMERG MED, V14, P543, DOI 10.1016/S0735-6757(96)90094-7; MA OJ, 1998, AM J EMERG MED, V31, P228; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MEYER S, 1993, ANN EMERG MED, V22, P1052, DOI 10.1016/S0196-0644(05)82750-7; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; NORWOOD S, 1995, J TRAUMA, V39, P240, DOI 10.1097/00005373-199508000-00009; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RHEE KJ, 1994, ANN EMERG MED, V23, P37, DOI 10.1016/S0196-0644(94)70005-2; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; Sing RF, 1996, ACAD EMERG MED, V3, P41, DOI 10.1111/j.1553-2712.1996.tb03301.x; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; SNYDER JA, 1995, ANN EMERG MED, V25, P768, DOI 10.1016/S0196-0644(95)70205-9; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Walls RM, 2000, EMERGENCY AIRWAY MAN, P159; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	48	4	4	0	1	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-0-203-96523-8	STUD NEUROPSYCH DEV			2006							1	16					16	Critical Care Medicine; Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology; Rehabilitation	BUE32	WOS:000289000800002					2022-02-06	
J	Levett, D; Vercueil, A; Grocott, M				Levett, Denny; Vercueil, Andre; Grocott, Michael			Resuscitation fluids in trauma 1: why give fluid and how to give it	TRAUMA-ENGLAND			English	Article						resuscitation fluids; trauma; resuscitation strategies; pre-hospital; perioperative; critical care; organ dysfunction	RAPID INFUSION SYSTEM; END-POINTS; OXYGEN-CONSUMPTION; MAJOR TRAUMA; DELIVERY; INJURY; VALUES; TRIAL; CARE; INTERLEUKIN-6	Fluid resuscitation following trauma is necessary to restore compromised organ perfusion and hypoxic tissue damage. The activation of the Systemic Inflammatory Response Syndrome in response to both traumatic and subsequent hypoxic insults has implications for what represents the optimal fluid resuscitation strategy. There is no single resuscitation strategy that can be applied to all patients with traumatic injury. This article reviews the evidence available to help guide fluid therapy. A number of studies have suggested that timing of fluid therapy with respect to surgical intervention is crucial. Prior to definitive treatment of injury permissive hypotension confers advantage, particularly in the setting of penetrating trauma. The situation is less clear in cases of blunt trauma, where further studies comparing restrictive with liberal fluid regimes are required. The site of injury will also influence the strategy to be adopted. Following traumatic brain injury, maintenance of cerebral perfusion pressure is likely to be of overriding importance. Once definitive surgical control of haemorrhage has been achieved, fluid therapy to maximise stroke volume and cardiac output is advised. Following the development of established critical illness, goal-directed therapy may increase mortality.	[Levett, Denny] UCL, Ctr Aviat Space & Extreme Environm Med, Inst Human Hlth & Performance, London, England; [Vercueil, Andre] Royal Brompton Hosp, London, England; [Grocott, Michael] UCL, Intens Care Med, London, England; [Grocott, Michael] Whittington Hosp, London, England		Levett, D (corresponding author), UCL, Ctr Aviat Space & Extreme Environm Med, Inst Human Hlth & Performance, London, England.		Grocott, Michael/C-4394-2008; Levett, Denny Zelda Hope/AAY-4627-2021	Grocott, Michael/0000-0002-9484-7581; Levett, Denny Zelda Hope/0000-0002-8418-1675			Ba ZF, 2000, CRIT CARE MED, V28, P2837, DOI 10.1097/00003246-200008000-00026; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; BURCH JM, 1992, ANN SURG, V215, P476, DOI 10.1097/00000658-199205000-00010; Chang MC, 2000, J TRAUMA, V49, P26, DOI 10.1097/00005373-200007000-00004; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dretzke J, 2004, HEALTH TECHNOL ASSES, V8, P1; DUNHAM CM, 1991, RESUSCITATION, V21, P207, DOI 10.1016/0300-9572(91)90047-3; Durham RM, 1996, J TRAUMA, V41, P32, DOI 10.1097/00005373-199607000-00007; FLEMING A, 1992, ARCH SURG-CHICAGO, V127, P1175; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Girolami A, 2002, CRIT CARE MED, V30, P385, DOI 10.1097/00003246-200202000-00020; Hambly PR, 1996, RESUSCITATION, V31, P127, DOI 10.1016/0300-9572(95)00910-8; Hameed SM, 2003, CHEST, V123, p475S, DOI 10.1378/chest.123.5_suppl.475S; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Ivatury RR, 1996, J AM COLL SURGEONS, V183, P145; Kern JW, 2002, CRIT CARE MED, V30, P1686, DOI 10.1097/00003246-200208000-00002; Kim P, 2004, CAN J SURG, V47, P295; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; LESSARD MR, 1995, NEW ENGL J MED, V332, P682; LUCAS CE, 1990, CAN J SURG, V33, P451; MCCLELLAND RN, 1971, AM J SURG, V121, P134, DOI 10.1016/0002-9610(71)90090-0; Miami Trauma Clinical Trials Group, 2005, Am Surg, V71, P252; Miller PR, 1998, J TRAUMA, V44, P107, DOI 10.1097/00005373-199801000-00013; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Revell M, 2002, EMERG MED J, V19, P494, DOI 10.1136/emj.19.6.494; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SCHULTZ RJ, 1985, J TRAUMA, V25, P309, DOI 10.1097/00005373-198504000-00005; SHOEMAKER WC, 1967, ARCH SURG-CHICAGO, V95, P492; Sinclair S, 1997, BMJ-BRIT MED J, V315, P909; Tang G J, 1996, Acta Anaesthesiol Sin, V34, P141; Turner J, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4310; VANE JR, 1990, NEW ENGL J MED, V323, P27; Velmahos GC, 2000, ANN SURG, V232, P409, DOI 10.1097/00000658-200009000-00013; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002	37	4	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JAN	2006	8	1					47	53		10.1191/1460408606ta358oa			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V3B5D	WOS:000218104800006					2022-02-06	
J	Matsui, T; Ishikawa, T; Takeuchi, H; Okabayashi, K; Maekawa, T				Matsui, T; Ishikawa, T; Takeuchi, H; Okabayashi, K; Maekawa, T			Mild hypothermia promotes pro-inflammatory cytokine production in monocytes	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						hypothermia; monocytes; pro-inflammatory cytokines; anti-inflammatory cytokines; cytokine balance	BLOOD MONONUCLEAR-CELLS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; MODERATE HYPOTHERMIA; PERIOPERATIVE HYPOTHERMIA; CARDIOPULMONARY BYPASS; ESCHERICHIA-COLI; INFECTION; RELEASE	Hypothermia is often associated with compromised host defenses and infection. Deteriorations of immune functions related to hypothermia have been investigated, but the involvement of cytokines in host defense mechanisms and in infection remains unclear. We have previously shown that mild hypothermia modifies cytokine production by peripheral blood mononuclear cells. To this study, the effects of hypothermia on the monocytic production of several cytokines and nitric oxide (NO) were determined. Monocytes obtained from 10 healthy humans were cultured with lipopolysaccharide (LPS) under hypothermic (33 degrees C) or normothermic (37 degrees C) conditions for 48 hours. We performed flow cytometric analysis for simultaneous measurement of interleukin (IL)-8, IL-1 beta, IL-6, IL-10, IL-12p70,and tumor necrosis factor (TNF)-alpha in culture supernatants. NO production was quantified as accumulation of nitrite in the medium by a colorimetric assay. Compared with normothermia, mild hypothermia raised the levels of IL-1 beta, IL-6, IL-12p70, and TNF-alpha produced by monocytes stimulated with LPS. On calculating the ratios of these elevated cytokines to IL-10, however, only IL-12p70/IL-10 and TNF-alpha/IL-10 ratios were significantly elevated under hypothermic conditions. In contrast, hypothermia did not affect NO production. This study demonstrates that mild hypothermia affects the balance of cytokines produced by monocytes, leading to a pro-inflammatory state. Specifically, monocytic IL-12 and TNF-alpha appear to be involved in the immune alterations observed in mild hypothermia. However, the clinical significance of these phenomena remains to be clarified.	Yamaguchi Univ, Sch Med, Dept Lab Sci, Yamaguchi 7558505, Japan; Kochi Univ, Sch Med, Fac Med, Dept Clin Lab Med, Kochi 780, Japan; Yamaguchi Univ, Sch Med, Dept Emergency & Crit Care Med, Yamaguchi, Japan		Matsui, T (corresponding author), Yamaguchi Univ, Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.	giants-ygc@umin.ac.jp					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 1999, RESUSCITATION, V41, P263, DOI 10.1016/S0300-9572(99)00052-0; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51, DOI 10.1002/jlb.37.1.51; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cook EB, 2001, J IMMUNOL METHODS, V254, P109, DOI 10.1016/S0022-1759(01)00407-0; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Forstot RM, 1995, J CLIN ANESTH, V7, P657, DOI 10.1016/0952-8180(95)00099-2; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GIRARDIN E, 1992, IMMUNOLOGY, V76, P20; Goebel A, 2000, ANN SURG, V231, P253, DOI 10.1097/00000658-200002000-00015; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Ishikawa T, 1999, CELL MOL NEUROBIOL, V19, P199, DOI 10.1023/A:1005401926320; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Luhm J, 1998, EUR J BIOCHEM, V256, P325, DOI 10.1046/j.1432-1327.1998.2560325.x; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2004, ACTA ANAESTH SCAND, V48, P205, DOI 10.1111/j.0001-5172.2004.00293.x; MILLER LC, 1993, LANCET, V341, P146, DOI 10.1016/0140-6736(93)90006-3; OSuilleabhain C, 1996, SURGERY, V120, P290, DOI 10.1016/S0039-6060(96)80300-X; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pigula FA, 2001, J THORAC CARDIOV SUR, V121, P366, DOI 10.1067/mtc.2001.112207; Qing M, 2001, SHOCK, V15, P372, DOI 10.1097/00024382-200115050-00007; REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; SHEFFIELD CW, 1994, ACTA ANAESTH SCAND, V38, P201, DOI 10.1111/j.1399-6576.1994.tb03873.x; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; WAAGE A, 1988, J EXP MED, V167, P1987, DOI 10.1084/jem.167.6.1987; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; ZARRABEITIA MT, 1991, BONE MINER, V14, P161, DOI 10.1016/0169-6009(91)90093-F; ZEMBALA M, 1994, EUR J IMMUNOL, V24, P435, DOI 10.1002/eji.1830240225	42	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2006	18	1					32	36					5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	000YF	WOS:000234497700006	16369138				2022-02-06	
J	Tsai, MD; Chiu, WT; Lin, JW; Chen, CF; Huang, SJ; Chang, CK; Chen, WL; Tsai, SH				Tsai, Ming-dar; Chiu, Wen-Ta; Lin, Jia-Wei; Chen, Chun-Fu; Huang, Sheng-Jean; Chang, Cheng-Kuei; Chen, Wan-Lin; Tsai, Shin-Han			Current experiences in the use of the severe head-injury guidelines in Taiwan	SURGICAL NEUROLOGY			English	Article						severe head injury; outcome; guideline; cerebral perfusion pressure; intracranial pressure; sedative; hyperventilation	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; AGGRESSIVE TREATMENT; HYPERVENTILATION; MANAGEMENT; MORTALITY; DOPAMINE; TRIAL; COMA	Background: Head injury is the leading cause of death and disability for patients who experienced a major accident. It has been suggested that a well-planned neurointensive care management can effectively reduce the secondary brain insults. The BTF and the AANS proposed the Guidelines for the Management of Severe Head Injury in 1995. The purpose of this study was to obtain a consensus on whether the guidelines are suitable for treating patients with severe head injury in Taiwan. Methods: Data from patients with severe head injury were collected from 6 different medical centers in Taiwan. The methods for controlling ICP, CPP, and hyperventilation, and the medical treatment with vasopressors and sedatives have been analyzed. Results: Ninety-four patients with severe head injury (GCS <= 8) were included in the study. The male-to-female ratio was 2.9: 1. Mean age was 43.9 +/- 21.8 years. The GOS score for those patients with ICP higher than 20 mm Hg that resulted in poor outcome was approximately 2.91 times (P < .05) higher than that of patients with ICP lower than 20 min Hg. Conclusions: The most beneficial feature of the guidelines was the close control of ICP with an ICP monitor. Patients who received prophylactic sedatives had a favorable outcome (odds ratio, 2.8; CI, 1.0-7.5). There were no significant statistical differences between patients with and those without application of hyperventilation for maintenance of CPP. (c) 2006 Elsevier Inc. All rights reserved.	Taipei Med Univ, Wan Fang Med Ctr, Inst Injury Prevent & Control, Taipei 110, Taiwan; Taipei Med Univ, Wan Fang Med Ctr, Dept Neurol Surg, Taipei 110, Taiwan; Taipei Med Univ, Wan Fang Med Ctr, Dept Emergency Med, Taipei 110, Taiwan; Fu Jen Catholic Univ, Sch Med, Taipei 242, Taiwan; Shin Kong W Ho Su Mem Hosp, Dept Neurol Surg, Taipei 111, Taiwan; Lo Tung POHAI Hosp, Dept Neurol Surg, Ilan 265, Taiwan; Natl Taiwan Univ Hosp, Dept Neurol Surg, Taipei 100, Taiwan; MacKay Mem Hosp, Dept Neurol Surg, Taipei 104, Taiwan; Taipei City Hosp, Renai Branch, Div Neurosurg, Taipei 106, Taiwan		Tsai, SH (corresponding author), Taipei Med Univ, Wan Fang Med Ctr, Inst Injury Prevent & Control, Taipei 110, Taiwan.	shtsai@tmu.edu.tw					Beaumont A, 2000, ACT NEUR S, V76, P147; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Biestro A, 1998, ACT NEUR S, V71, P5; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock R, 1995, GUIDELINES MANAGEMEN; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Chiu WT, 2003, J TRAUMA, V55, P391, DOI 10.1097/01.TA.0000079368.15678.6D; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; CLARK WC, 1989, NEUROSURGERY, V25, P20; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; CROCKARD HA, 1973, BMJ-BRIT MED J, V4, P634, DOI 10.1136/bmj.4.5893.634; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GORDON E, 1970, ACTA ANAESTH SCAND, V14, P97, DOI 10.1111/j.1399-6576.1970.tb00763.x; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Roberts E, 2001, SIGCSE BULL, V33, P1, DOI 10.1145/364447.364525; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schierhout G, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000566, 10.1002/14651858. CD000566]; SINGBARTL G, 1983, ANAESTHESIST, V32, P382; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	29	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2006	66			2			S3	S7		10.1016/j.surneu.2006.08.046			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	107OW	WOS:000242181900002	17071252				2022-02-06	
J	Hall, SRR; Wang, L; Milne, B; Hong, M				Hall, SRR; Wang, L; Milne, B; Hong, M			Mannitol but not dantrolene prevents myocardial dysfunction following intra-cranial hypertension in rats	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						mannitol; dantrolene; cardiac injury; intra-cranial hypertension; calcium	CALCIUM-RELEASE CHANNEL; TROPONIN-I DEGRADATION; TRAUMATIC BRAIN-INJURY; HEART-FAILURE; SKELETAL-MUSCLE; DEFECTIVE REGULATION; RYANODINE RECEPTORS; MANAGEMENT; MODEL; DETERMINANTS	Cardiac complications stemming from intra-cranial hypertension may result from impaired intra-cellular Ca2+ homeostasis. The aim of this study was to examine the effects of dantrolene, a blocker of sarcoplasmic reticulum (SR) Ca2+ release, on myocardial dysfunction associated with intra-cranial hypertension in rats. Dantrolene (10 mg) with and without 15% mannitol was administered to halothane-anesthetized rats prior to induction of intra-cranial hypertension by subdural balloon inflation. Its effects were compared to 3% and 15% mannitol and 5% Pentaspan((R)). Dantrolene with mannitol or 15% mannitol alone prevented the transient intra-cranial hypertension-induced hyperdynamic response and ensuing circulatory collapse that was found in animals pre-treated with 3% mannitol solution or pentaspan. Moreover, hemodynamic function was preserved irrespective of TnI cleavage. However, only animals treated with high dose 15% mannitol exhibited lower lipid peroxidation content in the heart. In contrast, pre-treatment with dantrolene alone did not prevent the cardiac complications associated with intra-cranial hypertension. In conclusion, 15% mannitol attenuated the cardiopulmonary complications associated with intra-cranial hypertension. Dantrolene without mannitol was without effect. Since mannitol exhibits free radical scavenging properties, protection could be the result of a decrease in oxidative stress after intra-cranial hypertension.	Queens Univ, Dept Anesthesiol, Kingston, ON, Canada; Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada		Wang, L (corresponding author), Queens Univ, Dept Anesthesiol, Kingston, ON, Canada.	wangl@kgh.kari.net					Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Buege J A, 1978, Methods Enzymol, V52, P302; BUSSON M, 1995, TRANSPLANT P, V27, P1662; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DARBY JM, 1989, JAMA-J AM MED ASSOC, V261, P2222, DOI 10.1001/jama.261.15.2222; Dhalla KS, 1996, CARDIOVASC DRUG THER, V10, P231, DOI 10.1007/BF00120492; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; ELLIS KO, 1976, ARCH INT PHARMACOD T, V224, P118; Feng J, 2001, CIRCULATION, V103, P2035; FLEWELLEN EH, 1980, ANESTHESIOLOGY, V52, P303, DOI 10.1097/00000542-198004000-00003; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GILBERT EM, 1988, J THORAC CARDIOV SUR, V95, P1003; HALL SR, IN PRESS J HEART LUN; Hall SRR, 2004, CAN J ANAESTH, V51, P1025, DOI 10.1007/BF03018493; Hall SRR, 2002, ANESTH ANALG, V94, P948; Horton JW, 1999, J SURG RES, V87, P39, DOI 10.1006/jsre.1999.5726; Huttemann E, 2002, INTENS CARE MED, V28, P1084, DOI 10.1007/s00134-002-1355-x; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Preckel B, 2000, ACTA ANAESTH SCAND, V44, P194, DOI 10.1034/j.1399-6576.2000.440211.x; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Thomas SA, 1999, CIRC RES, V85, P446, DOI 10.1161/01.RES.85.5.446; van der Laarse A, 2002, CARDIOVASC RES, V56, P8, DOI 10.1016/S0008-6363(02)00534-5; Van Eyk JE, 2001, CORONARY ARTERY DIS, V12, P343, DOI 10.1097/00019501-200108000-00002; Verbeke G, 1998, STAT MED, V17, P1391, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1391::AID-SIM851>3.0.CO;2-4; Wehrens XHT, 2004, ANN MED, V36, P70, DOI 10.1080/17431380410032481; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; Yu GY, 2000, BASIC RES CARDIOL, V95, P137, DOI 10.1007/s003950050175	35	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	DEC	2005	5	12					2862	2869		10.1111/j.1600-6143.2005.01127.x			8	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	985WW	WOS:000233410400007	16302998				2022-02-06	
J	O'Neil-Pirozzi, TM; Goldstein, R				O'Neil-Pirozzi, TM; Goldstein, R			Test-re-test reliability of the virtual planning test	BRAIN INJURY			English	Article						test-re-test reliability; executive functioning; healthy adults; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ECOLOGICAL VALIDITY; DISORDERS; MEMORY	Primary objective: To determine test-re-test reliability of the virtual planning test (VIP), an executive functioning test of planning and organization, in a group of healthy young adults as a pre-cursor to determining the appropriateness of using the VIP with individuals with traumatic brain injury (TBI). Research design: Single-group repeated measures design. Methods and procedures: Seventy-five healthy university students were administered the VIP and the Hopkins Verbal Learning Test-Revised (HVLT-R) twice, with 6-8 weeks between each subject's two test sessions. Main outcomes and results: VIP test-re-test reliability ranged from 0.194-0.489. Conclusions: Knowing how well a healthy young adult performs the first time taking the VIP predicts little about how well that adult will perform the second time. However, given limitations of other tests of planning and organization and potential clinical benefits of the VIP, research of the test with individuals with TBI is warranted.	Northeastern Univ, CCC SLP, Boston, MA 02115 USA; Spaulding Rehabil Hosp, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, CCC SLP, 103 Forsyth Bldg, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Dirette D, 2004, BRAIN INJURY, V18, P1219, DOI 10.1080/02699050410001720112; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; KAPLAN E, 1988, CLIN NEUROPSYCHOLOGY, P00129, DOI DOI 10.1037/10063-000; Kennedy MRT, 2002, J MED SPEECH-LANG PA, V10, pIX; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, pVI, DOI 10.1097/00001199-200008000-00001; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Long, 1996, ECOLOGICAL VALIDITY, P15; Makatura TJ, 1999, BRAIN INJURY, V13, P355; Miotto EC, 1998, CORTEX, V34, P639, DOI 10.1016/S0010-9452(08)70770-6; MIOTTO EC, IN PRESS VIRTUAL PLA; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	24	4	4	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1191	1196		10.1080/02699050500149916			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200002	16286334				2022-02-06	
J	Bolin, D; Goforth, M				Bolin, D; Goforth, M			Sideline documentation and its role in return to sport	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						medical record; return to play; athletic injury tracking	INJURY	Objective: To determine common sideline practices for the management of clinical information in the collegiate setting and review available literature oil sideline documentation. Data Sources: A survey was distributed to member schools of the Atlantic Coast Conference (ACC) to elicit the individual School practices with regard to injury evaluation, medication dispensation, extent of medical record availability, and means and timing of documentation. Articles were retrieved from Pubmed and SportDiscus searches for combinations of terms sports injuries, athletic injuries, return to play, documentation, medical record, injury report, injury card, and injury tracking for items relevant to sideline documentation methods for return to play decision making. Results: We obtained responses from 100% of member schools. One hundred percent of ACC member schools dispense prescription medication following injury evaluation on the sideline. Four of I I schools do not perform sonic elemental documentation at that time. Four of 11 ACC schools use some form of electronic medical record for injury documentation. Most schools have access to elemental medical information (such as allergy and medical conditions) oil the sideline. A literature search yielded several references to concussion and injury tracking; however, no systematic reports examining sideline documentation systems were obtained. Two articles utilizing card-based systems for injury tracking in the collegiate setting were retrieved. Conclusions: On-field documentation of return to play decision making has not been widely discussed or systematically Studied. Ill the ACC, most institutions record clinically relevant athletic injury data oil-site at the time of evaluation and later prepare a full note describing the evaluation and return to play decisions. We discuss a laminated card-based and a handheld computer-based system as 2 methods for efficient documentation of sideline treatment and return to play decisions. Commercial products and sideline information management and data collection are also discussed.	Virginia Tech Athlet, Blacksburg, VA 24061 USA; Virginia Coll Osteopath Med, Blacksburg, VA USA		Bolin, D (corresponding author), Virginia Tech Athlet, Eddie Ferrell Mem Training Room,112 Merryman Ctr, Blacksburg, VA 24061 USA.	Ab8641@vt.edu					Galasko C S, 1982, Br J Sports Med, V16, P23; GOFORTH M, 2003, PHYSICIAN SPORTSMED, V31, P43; GOMEZ JE, 1993, AM J DIS CHILD, V147, P1109, DOI 10.1001/archpedi.1993.02160340095022; HERRING S, 2001, MED SCI SPORTS EXERC, V33, P846; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; KRAUS JF, 1970, J AMER MED ASSOC, V213, P438, DOI 10.1001/jama.213.3.438; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MEEUWISSE WH, 1988, CAN J SPORT SCI, V13, P35; Roberts WO, 2000, MED SCI SPORT EXER, V32, P1549; SMITH DM, 2005, PREPARTICIPATION PHY; Wingfield K, 2004, CLIN J SPORT MED, V14, P109, DOI 10.1097/00042752-200405000-00002	12	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2005	15	6					405	409		10.1097/01.jsm.0000187078.20348.2c			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	012BL	WOS:000235313100002	16278542				2022-02-06	
J	Chua, KSG; Kong, KH				Chua, KSG; Kong, KH			An unusual case of Dantrolene sodium-induced urinary retention in post-traumatic minimally responsive state	BRAIN INJURY			English	Article						Detrusor acontractility; Dantrolene sodium; urinary retention; minimally responsive state; traumatic brain injury	STROKE PATIENTS; SPASTICITY	Introduction: An unusual case of urinary retention is reported occurring during the inpatient rehabilitation of minimally responsive state (MRS) following severe traumatic brain injury (TBI). Clinical picture: Urodynamic evaluation showed detrusor acontractility and subsequent management involved intermittent bladder catheterization and treatment of a single urinary tract infection. Treatment: Factors contributing to her bladder paralysis included severe immobility, tetraplegia and treatment of diffuse spasticity with oral Dantrolene sodium 250 mg per day. Constipation, diabetes and spinal cord injury were absent. In addition, she received unilateral partial sciatic neurolysis with 50% alcohol for severe knee flexor spasticity and intra-muscular Botulinum toxin A to both spastic upper limbs. Outcome: Bladder acontractility resolved completely when Dantrolene was reduced with subsequent achievement of a catheter-free status and small post-void residual volumes. Repeat urodynamics showed spontaneous detrusor contractions. Conclusion: A discussion of possible aetiologic factors for detrusor acontracility following TBI is presented including a brief review of the literature.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore		Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.	karen_chua@ttsh.com.sg					*AM C REH MED, 1985, ARCH PHYS MED REHAB, V76, P205; AYYAT FM, 1984, J UROLOGY, V132, P372, DOI 10.1016/S0022-5347(17)49630-3; Beseler-Soto B, 2003, REV NEUROLOGIA, V37, P444, DOI 10.33588/rn.3705.2003250; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Chua KSG, 1996, ARCH PHYS MED REHAB, V77, P194, DOI 10.1016/S0003-9993(96)90167-7; Francisco GE, 1997, PHYS MED REHABIL CLI, V8, P707; GRAVES S, 1978, EUR J PHARMACOL, V47, P29, DOI 10.1016/0014-2999(78)90370-9; HACKLER RH, 1980, J UROLOGY, V124, P78, DOI 10.1016/S0022-5347(17)55305-7; Hagen C, 1979, REHABILITATION HEAD; HARRIS JP, 1980, SCOT J GEOL, V16, P231, DOI 10.1144/sjg16020231; JOYNT RL, 1976, ARCH PHYS MED REHAB, V69, P254; KETEL WB, 1984, CURR MED RES OPIN, V9, P161, DOI 10.1185/03007998409109576; KHALAF IM, 1979, INVEST UROL, V17, P188; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; LOGRANO MD, 1979, B SOC ITAL BIOL SPER, V15, P484; LUISTO M, 1982, ACTA NEUROL SCAND, V65, P355, DOI 10.1111/j.1600-0404.1982.tb03092.x; MURDOCK M M, 1976, Urology, V8, P133, DOI 10.1016/0090-4295(76)90340-X; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; PEDERSON E, 1976, J UROLOGY, V119, P403; PORGES P, 1985, ANAESTHESIST, V34, P627	20	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2005	19	12					1063	1066		10.1080/02699050500110181			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZA	WOS:000233269700014	16263650				2022-02-06	
J	Stein, SC; Graham, DI; Chen, XH; Dunn, L; Smith, DH				Stein, SC; Graham, DI; Chen, XH; Dunn, L; Smith, DH			Apo E genotype not associated with intravascular coagulation in traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; coagulopathy; disseminated intravascular coagulation; intravascular microthombosis; apolipoprotein	APOLIPOPROTEIN-E GENOTYPE; HEAD-INJURY; APOE-EPSILON-4 ALLELE; E POLYMORPHISM; COAGULOPATHY; DEPOSITION; THROMBOSIS; RECOVERY; RISK; RATS	There is considerable evidence linking both genotype and coagulopathy to vascular complications of traumatic brain injury (TBI) and other cerebral insults. The authors explored a possible connection between the apolipoprotein E (Apo E) genotype, coagulopathy and intravascular microthombosis (IMT) in TBI. The predicted association was not confirmed. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Glasgow, Dept Neuropathol, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Neurosurg, Glasgow G12 8QQ, Lanark, Scotland		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, 105B Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	smith, douglas/A-1321-2007	Dunn, Laurence/0000-0002-8990-4334	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38104] Funding Source: Medline		Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; de Beer F, 1999, ARTERIOSCL THROM VAS, V19, P633, DOI 10.1161/01.ATV.19.3.633; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; HOOTS WK, 1996, NEUROTRAUMA, P673; HOOTS WK, 1983, BLOOD S, V62, P1003; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Loktionov A, 1998, BRIT J NUTR, V79, P133, DOI 10.1079/BJN19980024; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NICOLL JAR, 1992, J NEUROL SCI, V113, P144, DOI 10.1016/0022-510X(92)90242-D; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Texereau J, 2004, CRIT CARE MED, V32, pS313, DOI 10.1097/01.CCM.0000126363.46191.DC; Weir CJ, 2001, NEUROLOGY, V57, P1097, DOI 10.1212/WNL.57.6.1097; Welty FK, 1997, CIRCULATION, V95, P825; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	37	4	4	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 14	2005	387	1					28	31		10.1016/j.neulet.2005.07.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YF	WOS:000231483400006	16084020				2022-02-06	
J	De Visscher, G; Rooker, S; Jorens, P; Verlooy, J; Borgers, M; Reneman, RS; Van Rossem, K; Flameng, W				De Visscher, G; Rooker, S; Jorens, P; Verlooy, J; Borgers, M; Reneman, RS; Van Rossem, K; Flameng, W			Pentobarbital fails to reduce cerebral oxygen consumption early after non-hemorrhagic closed head injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						barbiturate; CBF; CMRO2; near infrared spectroscopy; neurotrauma	NEAR-INFRARED SPECTROSCOPY; BOLUS TRANSIT DETECTION; INDOCYANINE GREEN; BLOOD-FLOW; INTRACRANIAL-PRESSURE; NONINVASIVE MEASUREMENT; BARBITURATE COMA; REDOX STATE; BRAIN; MANAGEMENT	It is unknown whether barbiturates suppress cerebral oxygen metabolism after cerebral trauma as they do in normal individuals. We evaluated the influence of pentobarbital on cerebral oxygen handling of normal rats and rats subjected to non-hemorrhagic closed head injury (CHI). Oxygen delivery was assessed by measuring cerebral perfusion and oxygen extraction, enabling the calculation of cerebral metabolic rate of oxygen (CMRO2). Mitochondrial function was assessed by studying changes in the oxidized cytochrome oxidase concentration. CHI caused changes in both systemic and cerebral hemodynamics. Cerebral blood flow was reduced to 66% of its control value, but the cerebral metabolic rate of oxygen remained unchanged. Pentobarbital administration induced a significant lowering of the cerebral oxygen consumption in normal rats associated with a secondary decrease in cerebral perfusion. In rats subjected to CHI, pentobarbital was unable to lower the cerebral metabolic demand and did not cause a further decrease in perfusion. Pentobarbital was unable to significantly modulate mitochondrial function in traumatized rats, whereas it exerted this effect in all control animals. We therefore conclude that, in rats subjected to CHI, pentobarbital is unable to perform its beneficial effects on the cerebral metabolism.	Catholic Univ Louvain, CEHA, Cardiovasc Res Lab, B-3000 Louvain, Belgium; Univ Maastricht, CARIM, Dept Mol Cell Biol, Maastricht, Netherlands; Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; Univ Antwerp Hosp, Dept Intens Care Med, Antwerp, Belgium; Univ Maastricht, CARIM, Dept Physiol, Maastricht, Netherlands; Johnson & Johnson Pharmaceut Res & Dev, Ctr Excellence Cardiovasc Safety Res, Beerse, Belgium		De Visscher, G (corresponding author), Katholieke Univ Leuven, CEHA, Minderbroedersstr 17, B-3000 Louvain, Belgium.	geofrey.devisscher@med.kuleuven.ac.be	Rooker, Servan/AAD-4316-2020; De Visscher, geofrey/B-9318-2012; De Visscher, Geofrey/ABH-8607-2020	De Visscher, Geofrey/0000-0002-2317-392X			*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P527; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cooper CE, 1998, BIOCHEM J, V332, P627, DOI 10.1042/bj3320627; Cope M, 1989, Adv Exp Med Biol, V248, P33; De Mulder G, 2000, ACT NEUR S, V76, P409; De Visscher G, 2003, ADV EXP MED BIOL, V540, P37; De Visscher G, 2002, COMP BIOCHEM PHYS A, V132, P87, DOI 10.1016/S1095-6433(01)00533-5; DEVISSCHER G, 2000, J CEREB BLOOD FLOW M, V22, P515; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Engelborghs K, 1997, ACT NEUR S, V70, P123; HOFF JT, 1977, ACTA NEUROL SCAND, V56, P158; Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007; KASSELL NF, 1980, NEUROSURGERY, V7, P593, DOI 10.1227/00006123-198012000-00010; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; MATCHER SJ, 1994, PHYS MED BIOL, V39, P1295, DOI 10.1088/0031-9155/39/8/008; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; PAPPAS TN, 1981, AM J HOSP PHARM, V38, P494, DOI 10.1093/ajhp/38.4.494; RENAULT G, 1987, LASER SURG MED, V7, P339, DOI 10.1002/lsm.1900070408; ROBERTS I, 2000, COCHRANE DATABASE SY; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; SAPRU HN, 1979, EUR J PHARMACOL, V53, P151, DOI 10.1016/0014-2999(79)90160-2; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SHAABAN AM, 2001, ANAESTHESIA, V56, P24; SMITH AL, 1977, ANESTHESIOLOGY, V47, P285, DOI 10.1097/00000542-197709000-00010; Springett R, 2000, AM J PHYSIOL-HEART C, V279, pH2202, DOI 10.1152/ajpheart.2000.279.5.H2202; Steen P A, 1991, Agressologie, V32, P323; THORNILEY MS, 1994, KIDNEY INT, V45, P1489, DOI 10.1038/ki.1994.194; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; VANROSSEM K, 1999, J CEREB BLOOD FLOW M, V19, pS391; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012; WILSON RP, 1993, PHARMACOL BIOCHEM BE, V44, P1, DOI 10.1016/0091-3057(93)90274-W; WIXSON SK, 1987, LAB ANIM SCI, V37, P736	42	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					793	806					14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800007	16004582				2022-02-06	
J	Williams, SE; Rivera, S; Reiss, AL				Williams, SE; Rivera, S; Reiss, AL			Functional MRI of working memory in paediatric head injury	BRAIN INJURY			English	Article						fMRI; paediatric head injury; working memory	TRAUMATIC BRAIN-INJURY; CHILDREN	A case study examining the recovery of a 9 year old boy who sustained a severe head injury is reported. The subject sustained damage to the left parietal-occipital and right frontal-parietal regions. Structural and functional imaging and cognitive data were collected at the time of injury and 1 year post-injury. Cognitive assessment revealed improvement over time. Functional imaging at the time of injury revealed minimal activation in the right posterior temporal region. Imaging 1 year post-injury revealed increased activation in the right pre-frontal cortex, bilateral pre-motor cortex and bilateral posterior parietal cortex. This activation pattern is consistent with the performance of unaffected individuals on working memory tasks. These findings differ from those in the adult literature and suggest an alternative pattern of recovery of function in children.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Div Child & Adolescent Psychiat & Child Dev, Stanford, CA 94305 USA; Univ Calif Davis, Davis, CA 95616 USA		Williams, SE (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Div Child & Adolescent Psychiat & Child Dev, 401 Quarry Rd, Stanford, CA 94305 USA.	sharonw@Stanford.edu					Achenbach T.M., 2001, MANUAL CHILD BEHAV C; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Glover GH, 1998, RADIOLOGY, V207, P289, DOI 10.1148/radiology.207.2.9577469; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Wechsler D., 1991, WISC 3 WECHSLER INTE; WOODCOCK R, 2000, WOODCOCKJOHNSON TEST; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	14	4	4	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2005	19	7					549	553		10.1080/02699050400013576			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IQ	WOS:000229622500010	16134743				2022-02-06	
J	Audibert, G; Steinmann, G; Charpentier, C; Mertes, PM				Audibert, G; Steinmann, G; Charpentier, C; Mertes, PM			Anaesthetic. management of the patient, with acute intracranial hypertension	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						anaesthesia; intracranial pressure; mannitol	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; EARLY FRACTURE FIXATION; PERFUSION-PRESSURE; HYPERTONIC SALINE; MULTIPLE TRAUMA; NONOPERATIVE MANAGEMENT; RANDOMIZED-TRIAL; THORACIC AORTA	Transcranial Doppler and, if possible, measurement of intracranial pressure (ICP) allow preoperative diagnosis of acute intracranial hypertension (ICH) after brain trauma. The main goal of the anaesthesiologist is to prevent the occurrence of secondary brain injuries and to avoid cerebral ischaemia. Treatment of high ICP is mainly achieved with osmotherapy. High-dose mannitol administration (1.4 to 2 g/kg given in bolus doses) may be considered a better option than conventional doses, especially before emergency evacuation of a cerebral mass lesion. Hypertonic saline seems as effective as mannitol without rebound effect and without diuresis increase. Haemostasis should be normalized before neurosurgery and invasive blood pressure monitoring is mandatory. For anaesthesia induction, thiopental or etomidate may be used. In case of ICH, halogenated and nitrous oxide should be avoided. Until the dura is open, mean arterial pressure should be maintained around 90 mmHg (or cerebral perfusion pressure around 70 mmHg). If a long-lasting (several hours) extracranial surgery is necessary, ICP should be monitored and treatment of ICH should have been instituted before. (c) 2005 Elsevier SAS. Tons droits reserves.	CHU Nancy, Hop Cent, Dept Anesthesie Reanimat, F-54000 Nancy, France		Audibert, G (corresponding author), CHU Nancy, Hop Cent, Dept Anesthesie Reanimat, F-54000 Nancy, France.	g.audibert@chu-nancy.fr					Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Amorim P, 1997, ANESTHESIOLOGY, V87, P642, DOI 10.1097/00000542-199709000-00026; Archer LP, 1996, ARCH SURG-CHICAGO, V131, P309; Bhandari M, 2003, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000043051.62337.bd; Brundage SI, 2002, J TRAUMA, V52, P299, DOI 10.1097/00005373-200202000-00016; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CONFORTI PJ, 1993, J ORAL MAXIL SURG, V51, P298, DOI 10.1016/S0278-2391(10)80179-X; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Dunham CM, 2001, J TRAUMA, V50, P958, DOI 10.1097/00005373-200105000-00037; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Engelhard K, 2004, ACTA ANAESTH SCAND, V48, P396, DOI 10.1111/j.0001-5172.2004.00348.x; Galli R, 1998, ANN THORAC SURG, V65, P461, DOI 10.1016/S0003-4975(97)01302-7; Gavant ML, 1999, RADIOL CLIN N AM, V37, P553, DOI 10.1016/S0033-8389(05)70111-1; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hara M, 1998, NEUROL RES, V20, P225, DOI 10.1080/01616412.1998.11740510; HOLTZER S, 2001, TRAUMATISMES CRANIEN, P31; HUANG MS, 1995, J TRAUMA, V38, P154, DOI 10.1097/00005373-199501000-00035; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kerr ME, 1996, CRIT CARE MED, V24, P785, DOI 10.1097/00003246-199605000-00010; KIRKEBY OJ, 1995, J NEUROSURG, V83, P1067, DOI 10.3171/jns.1995.83.6.1067; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Leone M, 2002, ANN FR ANESTH, V21, P50, DOI 10.1016/S0750-7658(01)00550-0; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; May AK, 1997, AM SURGEON, V63, P233; McKee MD, 1997, J TRAUMA, V42, P1041, DOI 10.1097/00005373-199706000-00009; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Meites G, 2004, ANN FR ANESTH, V23, P700, DOI 10.1016/j.annfar.2004.04.016; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Moraine JJ, 2000, J NEUROSURG, V92, P606, DOI 10.3171/jns.2000.92.4.0606; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; O'Malley C, 2001, Anesthesiol Clin North Am, V19, P1, DOI 10.1016/S0889-8537(05)70208-X; PROUGH DS, 2001, ASA REFRESHER COURSE, P144; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rapenne T, 1997, PRESSE MED, V26, P1661; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; Scalea TM, 2000, J TRAUMA, V48, P613, DOI 10.1097/00005373-200004000-00006; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; *SFAR, 1999, REC PRAT ANT CHIR; Shapiro MB, 2001, AM SURGEON, V67, P793; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; TEASDALE G, 1974, LANCET, V2, P81; Tentillier E, 2000, ANN FR ANESTH, V19, P275; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Thiagarajan A, 1998, ANESTH ANALG, V87, P850, DOI 10.1097/00000539-199810000-00019; THOMASON M, 1993, J TRAUMA, V34, P40, DOI 10.1097/00005373-199301000-00007; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; WISNER DH, 1993, J TRAUMA, V35, P271, DOI 10.1097/00005373-199308000-00017; 1999, ANN FR ANESTH REANIM, V18, P1	79	4	6	0	3	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAY	2005	24	5					492	501		10.1016/j.annfar.2005.03.006			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	930XZ	WOS:000229451700007	15885971				2022-02-06	
J	Baumann, P; Oester, H; Stauffacher, M				Baumann, P; Oester, H; Stauffacher, M			The use of a cat-flap at the nest entrance to mimic natural conditions in the breeding of fattening rabbits (Oryctolagus cuniculus)	ANIMAL WELFARE			English	Article						animal welfare; cat-flap; maternal behaviour; nest access; pup mortality; rabbit	DOMESTIC RABBITS; SUCKLING BEHAVIOR; PUP SURVIVAL	Management systems allowing free nest access are widely used in commercial rabbit breeding, but these produce a potential conflict with the doe's behavioural goal of a closed nest entrance. Furthermore, the restricted space in commercial breeding units prevents the doe from achieving a sufficient distance between her and the nest another highly adaptive behavioural goal. This can lead to behavioural problems and pup mortality higher than 20%, attributable to hypothermia, injuries, weakness caused by the scattering and crushing of pups, or even cannibalism. In this study we tested a type of nest entrance (a metal cat-flap) that visually closed the nest box while still allowing the doe free access during the first 15 days after parturition. The effects of a cat-flap access (group CF) and of a permanently open nest box (group O) on nest-related behaviour, general activity, and plasma corticosterone concentration of the does, and on the mortality and weight of the pups, were compared using 15 ZIKA does in each group. Over 24 h, there was no difference between the groups in the frequency of 'nest controls' (approaches or entries to the nest without nursing of pups). However, outside nursing hours, does in group O showed more 'head contacts' with the nest, whereas does in group CF performed more nose contacts and nesting activities outside the nest. Does in group O performed twice as many potentially disturbing nest contacts in this time than does in group CF and had a higher increase of corticosterone after the administration of exogenous adrenocorticotrophic hormone. Pup mortality from days 16 to 35 was significantly higher in group O, and pups born to does in group O left the nest earlier. There was no significant difference in the weaning weights of pups between the two groups. As does with a cat-flap at the nest entrance still showed repeated nest approaches, the cat-flap possibly did not block all nest stimuli from the does. Alternatively, it is possible that the repeated approaches to the next box result from its being one of very few attractive or interesting features in an otherwise barren environment. Removal of the nest box from the cage is an effective method to eliminate nest stimuli, but this increases work for the staff without improving the barren environment for the rabbits. A better way of increasing the distance between the doe and the nest, as well as presenting a number of other attractive features, is group-housing of does.	Swiss Fed Vet Off, Ctr Proper Housing, CH-3052 Zollikofen, Switzerland; ETH Zentrum, Swiss Fed Inst Technol, Inst Anim Sci INW Physiol & Anim Husb, CH-8092 Zurich, Switzerland		Oester, H (corresponding author), Swiss Fed Vet Off, Ctr Proper Housing, Burgerweg 21, CH-3052 Zollikofen, Switzerland.	Hans.Oester@bvet.admin.ch					Baumann P, 2005, APPL ANIM BEHAV SCI, V91, P167, DOI 10.1016/j.applanim.2004.08.026; Coureaud G, 2000, ETHOLOGY, V106, P207, DOI 10.1046/j.1439-0310.2000.00521.x; DRESCHER B, 1993, TIERARZTL UMSCHAU, V48, P30; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; JILGE B, 1993, J BIOL RHYTHM, V8, P247, DOI 10.1177/074873049300800307; KRAFT R, 1979, Z TIERZ ZUCHTUNGSBIO, V95, P140; Loliger H.-C., 1976, Tierarztliche Umschau, V31, P488; Martinez RV, 1999, ARCH GEFLUGELKD, V63, P169; MYERS K., 1964, CSIRO WILDLIFE RES, V9, P138; ROSS SHERMAN, 1963, ANIMAL BEHAVIOUR, V11, P283, DOI 10.1016/S0003-3472(63)80110-4; RUSHEN J, 1991, APPL ANIM BEHAV SCI, V28, P381, DOI 10.1016/0168-1591(91)90170-3; Schulte I, 1997, BERL MUNCH TIERARZTL, V110, P134; Seitz K, 1998, BERL MUNCH TIERARZTL, V111, P48; STODART E., 1964, CSIRO WILDLIFE RES, V9, P144; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	4	4	1	14	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	MAY	2005	14	2					135	142					8	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	924MC	WOS:000228981900006					2022-02-06	
J	McIntosh, BC; Strugar, J; Narayan, D				McIntosh, BC; Strugar, J; Narayan, D			Traumatic frontal bone fracture resulting in intracerebral pneumocephalus	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						intracerebral pneumocephalus; head trauma	SINUS OSTEOMA; PNEUMATOCELE; AIR	Gas within the brain parenchyma, known as intracerebral pneumocephalus, has been infrequently reported. Head trauma is the most common cause. A case of intracerebral pneumocephalus resulting from a golf club injury and a review of the literature are presented.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06528 USA; Hosp St Raphael, New Haven, CT USA; Yale Univ, Sch Med, Sect Plast Surg, New Haven, CT 06528 USA		Narayan, D (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 330BB,POB 208041,330 Cedar St, New Haven, CT 06528 USA.	deepak.narayan@yale.edu					Agarwal SA, 2002, OPHTHAL PLAST RECONS, V18, P469, DOI 10.1097/00002341-200211000-00017; DACOSTA A, 1994, J TRAUMA, V36, P255, DOI 10.1097/00005373-199402000-00021; GOLDMANN RW, 1986, JAMA-J AM MED ASSOC, V255, P3154, DOI 10.1001/jama.255.22.3154; HARDWIDGE C, 1985, SURG NEUROL, V24, P401, DOI 10.1016/0090-3019(85)90299-X; Hashimoto Y, 2004, J NEUROSURG, V100, P367, DOI 10.3171/spi.2004.100.4.0367; Markham J W, 1967, Acta Neurochir (Wien), V16, P1; MENDELSOHN DB, 1984, J LARYNGOL OTOL, V98, P543, DOI 10.1017/S002221510014705X; MENDELSOHN DB, 1985, RADIOLOGY, V154, P115, DOI 10.1148/radiology.154.1.3964928; OREBAUGH SL, 1990, J TRAUMA, V30, P1577, DOI 10.1097/00005373-199012000-00025; OSBORN AG, 1978, J NEUROSURG, V48, P355, DOI 10.3171/jns.1978.48.3.0355; RAPPAPORT JM, 1994, J OTOLARYNGOL, V23, P430; Takinami K, 2003, NEUROL SURG TOKYO, V31, P425; TANAKA A, 1986, NEUROSURGERY, V18, P499, DOI 10.1227/00006123-198604000-00024; Williams TR, 1999, ARCH OPHTHALMOL-CHIC, V117, P1090	14	4	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2005	16	3					461	463		10.1097/01.SCS.0000157249.31826.B7			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	932LQ	WOS:000229555600025	15915116				2022-02-06	
J	Rosenberg, RI; Zirkle, DL; Neuwelt, EA				Rosenberg, RI; Zirkle, DL; Neuwelt, EA			Program self-evaluation: the evolution of an injury prevention foundation	JOURNAL OF NEUROSURGERY			English	Article						injury prevention; program evaluation; traumatic brain injury; spinal cord injury	HEAD	Object. Injuries are a leading cause of morbidity and mortality in the US. The authors provide a brief discussion of a national injury prevention foundation's self-evaluation of its efforts to decrease the incidence of traumatic injuries through educational programs, legislative efforts, and community programming. Methods. The authors performed a literature review of evaluation studies and activities of the Think First National Injury Prevention Foundation accomplished between 1986 and 2002 and summarized their findings. Suggestions generated from research studies were incorporated into the foundation ' s programs. Efficacy studies show that the injury prevention programs have a significant impact on knowledge, attitudes, and practice, and demonstrate the need for injury prevention to be recognized as a valuable component of the US medical system. Conclusions. After a self-evaluation, the Think First National Injury Prevention Foundation has made strides in developing a multilevel approach to injury prevention by combining education with legislative initiatives, community-wide safety programming, and a large public presence, similar to what has been accomplished with successful smoking cessation programs and seat-belt use campaigns.	Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97239 USA; Think First Natl Injury Prevent Fdn, San Diego, CA USA; Think First Natl Injury Prevent Fdn, Chicago, IL USA		Neuwelt, EA (corresponding author), Oregon Hlth Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L603, Portland, OR 97239 USA.	neuwelte@ohsu.edu					AVOLIO AEC, 1992, NEUROSURGERY, V31, P557, DOI 10.1227/00006123-199209000-00019; *BRAIN INJ ASS AM, COMP ANN INC; *FIRST NAT INJ PRE, HIST; FRANK RG, 1992, AM PSYCHOL, V47, P1045, DOI 10.1037/0003-066X.47.8.1045; Frank RG, 1992, PSYCHOL HEALTH, V6, P129; Greene A, 2002, INJ PREV, V8, P257, DOI 10.1136/ip.8.3.257; Gresham L S, 2001, J Pediatr Nurs, V16, P79, DOI 10.1053/jpdn.2001.23148; GROSS PA, 1982, HLTH ED          SEP; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; National Center for Injury Prevention and Control, 2001, INJ FACT BOOK 2001 2, P6; NEUWELT EA, 1989, NEUROSURGERY, V24, P453, DOI 10.1227/00006123-198903000-00027; SCHAUFFLER HH, 1994, AM J PREV MED, V10, P1; Warnell P, 1997, Axone, V19, P6; WATTS C, 1992, J NEUROTRAUM, V9, pS307; Wright M, 1995, Inj Prev, V1, P81, DOI 10.1136/ip.1.2.81	15	4	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2005	102	5					847	849		10.3171/jns.2005.102.5.0847			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	954KO	WOS:000231154200007	15926708				2022-02-06	
J	Bellon, R				Bellon, Richard			A question of merit: John Hutton Balfour, Joseph Hooker and the 'concussion' over the Edinburgh chair of botany	STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDICAL SCIENCES			English	Article						John Hutton Balfour; Joseph Hooker; William Hooker; Robert Graham; University of Edinburgh; Edinburgh Royal Botanic Garden	PROFESSIONALIZATION; SCIENCE; MEN	In 1845, Robert Graham's death created a vacancy for the traditionally dual appointment to the University of Edinburgh's chair of botany and the Regius Keepership of the Edinburgh Royal Botanic Garden. John Hutton Balfour and Joseph Hooker emerged as the leading candidates. The contest quickly became embroiled in long running controversies over the nature and control of Scottish university education at a time of particular social and political tension after a recent schism in Church of Scotland. The politics of the appointment were complicated by the fact that the Edinburgh Town Council (which preferred Balfour) chose the chair while the keepership was under the patronage of the Westminster government (which preferred Hooker). Balfour eventually emerged triumphant after a bitter campaign marked on all sides by intense politicking. The struggle to replace Graham provides a case study in how Victorian men of science adapted their aspirations to the practical realities of life in industrial, reforming, imperial, multinational Britain. (C) 2005 Published by Elsevier Ltd.	[Bellon, Richard] Michigan State Univ, Lyman Briggs Sch, E-30 Holmes Hall, E Lansing, MI 48825 USA		Bellon, R (corresponding author), Michigan State Univ, Lyman Briggs Sch, E-30 Holmes Hall, E Lansing, MI 48825 USA.	bellonr@msu.edu			National Science Foundation Dissertation Improvement GrantNational Science Foundation (NSF); Department of History at the University of Washington	For their valuable comments and criticism I would like to thank Sam Alberti, Vicky Bellon, Keith Benson, Paul Brinkman, Tom Hankins, Bruce Hevly, Don Opitz, John Waller and an anonymous referee. Quotations from the papers of J. H. Balfour and Robert Graham are reproduced with the kind permission of the Royal Botanic Garden, Edinburgh. Research for this article was supported in part by a National Science Foundation Dissertation Improvement Grant and a Rondeau Evans Dissertation Fellowship from the Department of History at the University of Washington.	Allan M, 1967, HOOKERS KEW 1785 191; Anderson R., 1984, MARTYR SCI D BREWSTE, P31; [Anonymous], 1884, NATURE, V29, P384; [Anonymous], 1845, SCOTSMAN; [Anonymous], 1844, LANCET, V1844, P170; [Anonymous], 1845, CALEDONIAN MERC 1009; Arnott G. A. W., 1845, PHYTOLOGIST, V2, P366; Babington C. C., 1843, MANUAL BRIT BOT; Balfour I. B, 1913, MAKERS BRIT BOT, P280; Balfour J. H., 1870, LESSONS BIBLE PLANTS; Balfour J. H., 1862, OUTLINES OF BOT; Balfour J. H., 1854, OUTLINES OF BOT; Balfour J. H., 1872, 41 M BRIT ASS ADV SC, P127; Balfour J. H., 1885, PLANTS BIBLE; Barton R, 2003, HIST SCI, V41, P73, DOI 10.1177/007327530304100103; Baxter P., 1993, SCOTLAND AGE DISRUPT, P98; Baxter P., 1984, MARTYR SCI D BREWSTE, P45; Bellon R, 2001, J HIST BIOL, V34, P51, DOI 10.1023/A:1010368323221; Bellon R., 2000, THESIS; Bellon R., 2004, DICT 19 CENTURY BRIT; Brewster D, 1842, EDINBURGH REV, V74, P265; Brewster D., 1837, EDINBURGH REV, V66, P110; Brock, 1997, JUSTUS LIEBIG CHEM G; Brock W H, 2000, Ambix, V47, P121; Brooke J. H., 1999, EVANGELICALS SCI HIS, P17; BROWN C, 1987, SOCIAL HIST RELIG SC; Brown S. J., 1993, SCOTLAND AGE DISRUPT, P1; Brown S. J., 1993, SCOTLAND AGE DISRUPT; Brown SJ, 1997, J ECCLESIAST HIST, V48, P682, DOI 10.1017/S0022046900013464; Browne J., 1983, SECULAR ARK STUDIES; Browne J., 1995, C DARWIN VOYAGING; Burkhardt F., 1985, CORRES C DARWIN; CHALMERS T, 1833, POWER WISDOM GOODNES; Davie George E., 1961, DEMOCRATIC INTELLECT; Desmond A, 2001, J HIST BIOL, V34, P3, DOI 10.1023/A:1010346828270; Desmond A., 1991, DARWIN; Desmond R., 1999, J HOOKER TRAVELLER P; Devine T.M., 1999, SCOTTISH NATION HIST; Drayton Richard, 2000, NATURES GOVT SCI IMP; DRUMMOND AL, 1975, CHURCH VICTORIAN SCO; Egerton F. N., 2003, HC WATSON VICTORIAN; Endersby J., 2004, DICT 19 CENTURY BRIT; Endersby J., 2002, THESIS; Endersby Jim, 2001, Pacific Science, V55, P343, DOI 10.1353/psc.2001.0032; FERGUSON N, 2002, EMPIRE RISE DEMISE B; FRY M, 1993, SCOTLAND AGE DISRUPT, P00031; Fry M., 1987, PATRONAGE PRINCIPLE; Golinski J., 1998, MAKING NATURAL KNOWL; Hamilton W., 1836, EDINBURGH REV, V62, P409; Hamilton W., 1834, EDINBURGH REV, V59, P196; Hooker J., 1869, 38 M BRIT ASS ADV SC, plviii; Hooker J., 1853, FLORA NZ 2; Hooker J., 1845, CALEDONIAN MERC 1027; Hooker J. D, 1860, BOT ANTARCTIC VOYAGE; Hooker JD, 1860, FLORA TASMANIAE 3, VI; HOOKER JD, 1847, FLORA ANTARCTICA 1; Hooker Joseph, 1854, HIMALAYAN J NOTES NA; Hooker W., 1845, TESTIMONIALS FAVOUR; Horn D. B., 1967, SHORT HIST U EDINBUR; Hutcheon J., 2004, DICT 19 CENTURY BRIT; HUXLEY L., 1918, LIFE LETT JD HOOKER; Kohler R. E., 1994, LORDS FLY DROSOPHILA; Lankester E., 1845, ATHENAEUM, V923, P659; Livingstone D., 2004, STUD HIST PHILOS M P, V35, P1; Livingstone D. N., 2003, PUTTING SCI ITS PLAC; Livingstone David N., 1999, DISSEMINATING DARWIN, P7; Morrell J B, 1969, Br J Hist Sci, V4, P245; Morrell J. B., 1997, SCI CULTURE POLITICS, P1; Morrell J. B., 1969, AMBIX, V16, P66; Morrell J. B., 1984, MARTYR SCI SIR DAVID, P25; Morrell Jack, 1981, GENTLEMEN SCI EARLY; Murray J. F., 1843, THE WORLD OF LONDON; Napier Jr M., 1879, SELECTION CORRES LAT; Playfair L., 1886, 55 M BRIT ASS ADV SC, P3; Ransford C., 1846, BIOGRAPHICAL SKETCH; ROTHBLATT S, 1968, REVOLUTION DONS CAMB; Rupke Nicolaas, 1994, R OWEN VICTORIAN NAT; Scotland J, 1969, HIST SCOTTISH ED; Secord J. A., 1986, CONTROVERSIES VICTOR; Secord James, 2000, VICTORIAN SENSATION; Shapin S., 1984, MARTYR SCI SIR D BRE, P17; Smith Crosbie, 1989, ENERGY EMPIRE BIOGRA; Waller JC, 2001, J HIST BIOL, V34, P83, DOI 10.1023/A:1010357526856; Walters S. M., 2001, D MENTOR JS HENSLOW; Yanni C., 1999, NATURES MUSEUMS VICT; YEO R, 1993, DEFINING SCI W WHEWE; [No title captured]; [No title captured]; [No title captured]	89	4	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1369-8486	1879-2499		STUD HIST PHI PART C	Stud. Hist. Philos. Sci. Part C-Stud. Hist. Philos. Biol. Biomed. Sci.	MAR	2005	36	1					25	54		10.1016/j.shpsc.2004.12.007			30	History & Philosophy Of Science	Emerging Sources Citation Index (ESCI)	History & Philosophy of Science	VD5YS	WOS:000437193800002	16120259				2022-02-06	
J	Mohan, AL; Slim, M; Benzil, DL				Mohan, AL; Slim, M; Benzil, DL			Knife wound to the posterior fossa in a child	CHILDS NERVOUS SYSTEM			English	Article						craniocerebral trauma; open head injury; penetrating head injury; posterior cranial fossa; stab wound	STAB WOUNDS; HEAD	Background: Knife wounds to the posterior fossa are a rare occurrence, especially in children. We report an 8-year-old girl who sustained a penetrating knife injury through the occipital bone into the posterior fossa. On presentation, the large knife blade was firmly embedded in her head. Methods: Radiographic evaluation was limited to plain X-rays because of the large size and sharpness of the embedded blade. Innovative positioning was used during intubation and then the patient was positioned semi-prone on the operating room table. The blade was surgically removed and the dura was closed. Conclusions: Atypical penetrating cranial injuries in children may require the treatment team to take a creative approach to the evaluation and repair of the lesion in order to maximize patient safety and minimize the risk of neurological injury.	New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; New York Med Coll, Dept Surg, Div Pediat, Valhalla, NY 10595 USA		Benzil, DL (corresponding author), New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA.	deborah_benzil@nymc.edu					COOPER A, 1987, J PEDIATR SURG, V22, P24, DOI 10.1016/S0022-3468(87)80008-8; Cosan T E, 2001, Eur J Emerg Med, V8, P51, DOI 10.1097/00063110-200103000-00010; Deb S, 2000, J TRAUMA, V48, P1159, DOI 10.1097/00005373-200006000-00026; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; HERRING CJ, 1988, NEUROSURGERY, V23, P658, DOI 10.1227/00006123-198811000-00022; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; VANDELLEN JR, 1978, SURG NEUROL, V10, P110	9	4	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2005	21	3					255	258		10.1007/s00381-004-0955-x			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	902OY	WOS:000227367600018	15071753				2022-02-06	
J	Sandifer, H; Frank, E; Montgomery, A; Nichols, M; Cooper, W				Sandifer, H; Frank, E; Montgomery, A; Nichols, M; Cooper, W			Arizona battery for communication disorders of dementia test performance: Can this test be used with Caucasian and African American adolescents with traumatic brain injury?	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								Evaluation of individuals with traumatic brain injury has included a number of test measures, some of which are adapted for use from other disordered populations. One assessment, the Arizona Battery for Communication Disorders of Dementia (ABCD), has been utilized for this purpose (Bayles E Tomoeda, 1993). Historically, normative data for most assessments of patients with traumatic brain injury and dementia have been developed primarily from Caucasian and middle-class populations. Culturally and linguistically diverse populations often are not reflected in the normative data developed for outcome measures in communication. The purpose of this study was to determine whether there were differences in the ABCD score performance between groups by gender, race, or age among individuals between 15 and 25 years of age. The ABCD was given to 97 Caucasian and African American adolescents (15-17:11 years) and young adults (18-25 years). No significant differences were noted between test scores based on gender or between the adolescent and the young adult groups. A significant difference in scores was noted by race, with Caucasians scoring significantly higher than African Americans. Therefore, clinicians utilizing this battery for assessing language function among younger multicultural groups should consider race differences when interpreting scores on this battery, and future investigation of potential effects of race among other disease groups should be conducted.	Univ S Carolina, Columbia, SC 29208 USA		Sandifer, H (corresponding author), 333 Pike Blvd, Orangeburg, SC 29115 USA.	hdsandifer@hotmail.com					*ASHA DESK REF, 1997, MULT ACT AG 2000 REL; BAYLES KA, 1989, J SPEECH HEAR DISORD, V54, P74, DOI 10.1044/jshd.5401.74; Cotrell VC, 1997, J APPL GERONTOL, V16, P71, DOI 10.1177/073346489701600104; Frattali C. M., 1998, MEASURING OUTCOMES S; GREEN BS, 1997, MILD TRAUMATIC BRAIN; HOWELL DC, 1992, STAT METHODS PSYCHOL; MOLINE CJ, 2002, AM J SPEECH-LANG PAT, V11, P139; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomoeda C., 1993, ARIZONA BATTERY COMM; [No title captured]	10	4	4	0	5	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2005	13	1					1	5					5	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	914WM	WOS:000228258700002					2022-02-06	
J	Settle, F; Lawrence, D; Kummerow, M				Settle, F; Lawrence, D; Kummerow, M			Pre-ambulatory infants with head trauma: A three-year retrospective study	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						assessment process; child abuse; head injury; closed; infant; process; tomography; X-ray computed	SKULL FRACTURE; CHILDREN; INJURY; FALLS; YOUNGER	Objectives: (i) To present the severity and documented mechanism of injury and clinical features of all infants less than 6 months old who presented with head trauma to a paediatric emergency department over a 3-year period; (ii) to evaluate the quality of their assessment; and (iii) to present the clinical features of those referred for assessment of possible inflicted injury. Methods: Demographics, documented mechanism of injury, clinical features and management were retrospectively collected from the case notes. Adequacy of assessment was judged in terms of documentation of the history and examination, investigations performed and nature of any observation period. Results: Two hundred and fifty-one cases were analysed. Twenty-seven (11%) had sustained a major injury. Infants reported as dropped by a care giver were significantly more likely to have sustained a major injury. Infants with major injury were more likely to have vomited (P < 0.05), or to have external signs of injury (P < 0.0005). All patients with major injury had symptoms or signs or both. One hundred and thirty-four infants had been inadequately assessed. Fourteen infants were referred for possible inflicted injury (confirmed in six cases). Conclusion: The mechanism of injury and clinical findings can provide some guide as to the likelihood of an infant having sustained a major injury after head trauma. The assessment of infants with head trauma could be improved if currently available guidelines for children under 2 years old were adopted. However, infant-specific guidelines should be developed.	Womens & Childrens Hosp, Paediat Emergency Dept, Adelaide, SA, Australia		Settle, F (corresponding author), Starship Childrens Hosp, Childrens Emergency Dept, Pk Rd, Auckland, New Zealand.	FranS@adhb.govt.nz					*AM AC PED, 1999, AM ACAD PEDIAT, V104, P1407; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; LYONS TJ, 1993, PEDIATRICS, V92, P125; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; QUAYLE KS, 1997, PEDIATRICS, V99, P11; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	13	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	MAR	2005	41	3					130	135		10.1111/j.1440-1754.2005.00562.x			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	906VV	WOS:000227673300009	15790324				2022-02-06	
J	Mussack, T; Briegel, J; Schelling, G; Jochum, M				Mussack, T; Briegel, J; Schelling, G; Jochum, M			Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article						septic shock; sepsis; hemofiltration; hydrocortisone; S-100B; brain damage	SYSTEMIC INFLAMMATORY RESPONSE; CRITICALLY-ILL PATIENTS; BRAIN-DAMAGE; NEUROLOGICAL COMPLICATIONS; NEUROBIOCHEMICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; ORGAN FAILURE; HEAD TRAUMA; SEPSIS	Background: The prognosis in patients with hyperdynamic septic shock correlates with the presence and the severity of septic encephalopathy. However, the neurological evaluation is considerably influenced by the use of analgesia sedation during mechanical ventilation. An early concentration peak of the neuroprotein S-100B in serum reflects both cellular damage at an increased permeability of the blood-brain-barrier and a delayed renal elimination. Thus, the objective of this study was to analyze the effect of continuous veno-venous hemofiltration (CVVH) on early S-100B serum levels in septic shock patients, who were treated with either stress doses of hydrocortisone or placebo. Methods: Twenty-four consecutive patients, who met the ACCP / SCCM criteria for septic shock, were enrolled in this prospective, randomised, double-blind, single-center trial. The severity of illness at recruitment was graded using the APACHE 11 and SAPS II scoring systems; the MODS was described by the SOFA score. All patients were prospectively randomised to receive either stress doses of hydrocortisone or placebo. Hydrocortisone was started in 12 patients with a loading dose of 100 mg and followed by a continuous infusion of 0.18 mg/kg/h for 6 days. Results: Median S-100B serum levels of the hydrocortisone group decreased from 0.32 ng/ml (0.19-3.60) at study entry to 0.07 ng/ml (0.04-0.32) 6 days later without significant differences compared to the placebo group. Patients undergoing CVVH showed significantly higher S-100B serum values compared to patients without CVVH (p<0.001). However, initial median S-100B serum levels of the CVVH group even increased from 0.92 ng/ml (0.16 - 4.63) to 2.33 ng/ml (0359 - 2.44) 30 hours after study entry, reaching data ranges already known in patients with out-of-hospital cardiac arrest or severe traumatic brain injury. Conclusion: Early S-100B serum levels in septic shock patients receiving either stress doses of hydrocortisone or placebo were not influenced by CVVH. For the first time, we observed a similar extent of S-100B serum increase in CVVH patients, who had significantly higher S-100B serum values compared to those without CVVH, as reported for out-of-hospital cardiac arrest or severe traumatic brain injury. Hypercortisolemia induced by the infusion of stress doses of hydrocortisone did not significantly reduce early S-100B serum concentrations with time.	Klinikum Univ Munich, Dept Surg Innenstadt, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Anaesthesiol Grosshadern, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Clin Chem & Clin Biochem Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Klinikum Univ Munich, Dept Surg Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	Thomas.Mussack@med.uni-muenchen.de	Josef, Briegel/ABF-3522-2021; Briegel, Josef/AAG-3774-2019				Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Astudillo R, 1996, Eur J Cardiothorac Surg, V10, P1107, DOI 10.1016/S1010-7940(96)80358-7; Barie PS, 1998, J TRAUMA, V44, P1108, DOI 10.1097/00005373-199806000-00032; BARIE PS, 1994, J TRAUMA, V37, P660, DOI 10.1097/00005373-199410000-00022; BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; BRIEGEL J, 1994, CLIN INVESTIGATOR, V72, P782; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Briegel J, 2001, J AM SOC NEPHROL, V12, pS70; Cole L, 2002, CRIT CARE MED, V30, P100, DOI 10.1097/00003246-200201000-00016; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; GROENEVELD ABJ, 1990, INTENS CARE MED, V16, P489, DOI 10.1007/BF01709397; HAIMOTO H, 1987, LAB INVEST, V57, P489; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hoffmann JN, 1996, INTENS CARE MED, V22, P1360, DOI 10.1007/BF01709552; Hund E, 2001, J NEUROL, V248, P929, DOI 10.1007/s004150170043; Hund E, 1999, CRIT CARE MED, V27, P2544, DOI 10.1097/00003246-199911000-00036; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Lindner A, 1998, INTERNIST, V39, P485, DOI 10.1007/s001080050200; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mussack T, 2000, ACT NEUR S, V76, P393; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Schwarz S, 1997, NERVENARZT, V68, P292, DOI 10.1007/s001150050127; USUI A, 1989, CLIN CHEM, V35, P1942; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; YOUNG GB, 1990, CLIN INVEST MED, V13, P297	38	4	5	0	1	I HOLZAPFEL VERLAG GMBH	MUNICH	RAUCHSTR 8, D-81679 MUNICH, GERMANY	0949-2321			EUR J MED RES	Eur. J. Med. Res.	FEB 28	2005	10	2					81	87					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	910QP	WOS:000227947600007	15817428				2022-02-06	
J	Lee, N; Neitzel, KL; Di Marco, A; Laufer, R; MacLennan, AJ				Lee, N; Neitzel, KL; Di Marco, A; Laufer, R; MacLennan, AJ			Penetrating brain injury leads to activation of ciliary neurotrophic factor receptors	NEUROSCIENCE LETTERS			English	Article						growth factor receptors; STAT3; rat; brain ittiury; motor neuron; neurotrauma	FACTOR CNTF; ADULT-RAT; IN-VIVO; MOTONEURONS; SURVIVAL; AXOTOMY; STAT3; CYTOKINES; NEURONS; SIGNAL	Endogenous injury response mechanisms likely reduce secondary neuronal loss following CNS trauma by activating growth factor receptors. Therefore, it is important to determine which growth factor receptors are activated in vivo by CNS trauma and which signal transduction pathways are affected in which cell types. We present a model of penetrating brain injury utilizing stereotaxic insertion of a fine needle. This procedure can be used to anatomically characterize injury response mechanisms through immediate, local application of pharmacological agents. We find, through immunohistochemistry, that injury of the rat facial motor nucleus leads to activation of STAT3, a neuronal survival factor, in the dendrites, nuclei and cytoplasm of the motor neurons. A similar response was observed with the trigeminal motor nucleus. Use of the ciliary neurotrophic factor (CNTF) receptor antagonist, AADH-CNTF, indicated that the STAT3 activation resulted largely, and perhaps entirely, from injury-induced activation of CNTF receptors. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; Merck Sharp & Dohme Res Labs, Ist Ric Biol Mol P Angeletti, I-00040 Rome, Italy		MacLennan, AJ (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA.	john.maclen@uc.edu	Laufer, Ralph/H-9336-2013		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35224] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035224] Funding Source: NIH RePORTER		CLATTERBUCK RE, 1993, P NATL ACAD SCI USA, V90, P2222, DOI 10.1073/pnas.90.6.2222; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; Dolcet X, 2001, MOL CELL NEUROSCI, V18, P619, DOI 10.1006/mcne.2001.1058; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; HAM AW, 1974, HISTOLOGY; Ikeda K, 1996, J NEUROL SCI, V135, P109, DOI 10.1016/0022-510X(95)00263-2; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; Kirsch M, 2003, MOL CELL NEUROSCI, V24, P130, DOI 10.1016/S1044-7431(03)00130-1; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LO AC, 1995, EXP NEUROL, V134, P49, DOI 10.1006/exnr.1995.1035; MacLennan AJ, 2000, NEUROSCIENCE, V99, P761, DOI 10.1016/S0306-4522(00)90236-7; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x	17	4	4	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 21	2005	374	3					161	165		10.1016/j.neulet.2004.10.048			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	895XE	WOS:000226896700002	15663954				2022-02-06	
J	Shimonkevitz, R; Northrop, J; Harris, L; Craun, M; Bar-Or, D				Shimonkevitz, R; Northrop, J; Harris, L; Craun, M; Bar-Or, D			Interleukin-16 expression in the peripheral blood and CD8 T lymphocytes after traumatic injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						CD4/CD8 ratio; CD8; IL-16; T lymphocyte; trauma	CHEMOATTRACTANT FACTOR; HEAD-INJURY; MEDICAL CONDITIONS; MULTIPLE INJURIES; SEVERITY SCORE; BRAIN-INJURY; CELLS; IL-16; ACTIVATION; CD4(+)	Background: Expressed in several pathologic conditions, interleukin (IL-16) can induce chemotaxis and regulate the activation of CD4-positive leukocytes. This study investigated the expression of IL-16 in trauma patient plasma and peripheral blood leukocytes to determine its involvement in the physiologic response to injury. Methods: In this study, 25 consecutive patients requiring trauma team activation and 15 noninjured subjects were evaluated for plasma IL-16 by enzyme-linked immunosorbent assay and peripheral blood leukocyte expression of intracellular cytokine by flow cytometry. Results: Trauma patient plasma IL-16 was transiently increased after injury in comparison with levels in noninjured control subjects. In patients with worse outcome, both peripheral blood T lymphocyte intracellular IL-16 levels and CD4/CD8 lymphocyte ratios were lower than those for less severely injured patients and control subjects. Conclusion: Posttraumatic changes in IL-16 expression were found to be associated with worse patient outcome, suggesting an innate immune mechanism with a role in regulation of the T lymphocyte response to injury.	HealthOne Swedish Med Ctr, Trauma Res Lab, Trauma Res Dept, Englewood, CO 80113 USA		Shimonkevitz, R (corresponding author), HealthOne Swedish Med Ctr, Trauma Res Lab, Trauma Res Dept, Room 4-454,501 E Hampden Ave, Englewood, CO 80113 USA.		Bar-Or, David/AAE-9328-2020				Angele MK, 2002, CRIT CARE, V6, P298, DOI 10.1186/cc1514; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Chupp GL, 1998, J IMMUNOL, V161, P3114; CIOFFI WG, 1993, ARCH SURG-CHICAGO, V128, P1260; Cruikshank WW, 1996, J IMMUNOL, V157, P5240; De AK, 1997, CLIN IMMUNOL IMMUNOP, V82, P73, DOI 10.1006/clin.1996.4289; De AK, 2000, CLIN IMMUNOL, V96, P52, DOI 10.1006/clim.2000.4879; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; ENNIS M, 1990, AGENTS ACTIONS, V30, P271, DOI 10.1007/BF01969058; FAIST E, 1987, J TRAUMA, V27, P837, DOI 10.1097/00005373-198708000-00001; GROOM DA, 1990, ARCH PATHOL LAB MED, V114, P570; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; JABADO N, 1994, EUR J IMMUNOL, V24, P2646, DOI 10.1002/eji.1830241112; Kivioja J, 2001, J CLIN IMMUNOL, V21, P272, DOI 10.1023/A:1010931309088; Laberge S, 1996, J IMMUNOL, V156, P310; LABERGE S, 1995, J IMMUNOL, V155, P2902; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Lim KG, 1996, J IMMUNOL, V156, P2566; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; MILLERGRAZIANO CL, 1991, J CLIN IMMUNOL, V11, P95, DOI 10.1007/BF00917745; NAYAK AK, 1980, J NEUROL SCI, V47, P211, DOI 10.1016/0022-510X(80)90005-2; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Ogasawara H, 1999, IMMUNOLOGY, V96, P215; OMAHONY JB, 1985, ANN SURG, V202, P580, DOI 10.1097/00000658-198511000-00008; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Parada NA, 1998, J IMMUNOL, V160, P2115; PINKERTON PH, 1989, J TRAUMA, V29, P749, DOI 10.1097/00005373-198906000-00009; Puyana JC, 1998, J TRAUMA, V44, P1037, DOI 10.1097/00005373-199806000-00017; RHEE KJ, 1990, CRIT CARE MED, V18, P827, DOI 10.1097/00003246-199008000-00006; RICHTER M, 1990, J TRAUMA, V30, P590, DOI 10.1097/00005373-199005000-00011; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; TEASDALE G, 1974, LANCET, V2, P81; TEGGATZ JR, 1987, ARCH PATHOL LAB MED, V111, P712; THOMMASEN HV, 1986, AM J CLIN PATHOL, V86, P480, DOI 10.1093/ajcp/86.4.480; Wick M, 2000, ARCH SURG-CHICAGO, V135, P1309, DOI 10.1001/archsurg.135.11.1309; Wu DMH, 1999, J IMMUNOL, V162, P1287	39	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2005	58	2					252	258		10.1097/01.TA.0000141884.49076.53			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898VA	WOS:000227103100005	15706184				2022-02-06	
J	Bartanusz, V; Daniel, RT; Villemure, JG				Bartanusz, V; Daniel, RT; Villemure, JG			Conjugate eye deviation due to traumatic striatal-subthalamic lesion	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						conjugate eye deviation; traumatic brain injury; striatum; subthalamus	STIMULATION; PURSUIT; MONKEYS; FIELD; GAZE	We report the case of a 22-year-old man after severe cranial trauma, who was noted to have conjugate eye deviation (CED) to the left. A magnetic resonance imaging (MRI) scan demonstrated a lesion in the left (ipsilateral) striatal-subthalamic region. The involvement of supranuclear fibres from the left frontal eye field (FEF) traveling to the right parapontine reticular formation (PPRF) could explain this clinical finding. Alternatively, involvement of deep brain nuclei, such as the striatum and the subthalamic nucleus, could be responsible for this phenomenon. This neurological presentation is unusual after severe cranial trauma. (C) 2004 Elsevier Ltd. All rights reserved.	CHU Vaudois, Dept Neurosurg, Lausanne, Switzerland		Daniel, RT (corresponding author), CHU Vaudois, Dept Neurosurg, Lausanne, Switzerland.	roymercy@hotmail.com					Anagnostou E, 2001, NEUROLOGY, V56, P1396, DOI 10.1212/WNL.56.10.1396; Chung CS, 2000, BRAIN, V123, P1850, DOI 10.1093/brain/123.9.1850; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; KOMPF D, 1979, BRAIN, V102, P527, DOI 10.1093/brain/102.3.527; MOHR J P, 1984, Neurology, V34, P199; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; PierrotDeseilligny C, 1997, J NEUROL, V244, P65, DOI 10.1007/s004150050051; SACHSENWEGER R, 1969, HDB CLIN NEUROLOGY, V2; SOLOMON D, 1995, J NEURO-OPHTHALMOL, V15, P26; Tanaka H, 2002, STROKE, V33, P642, DOI 10.1161/str.33.2.642; TIJSSEN CC, 1994, STROKE, V25, P1516, DOI 10.1161/01.STR.25.7.1516; TIJSSEN CC, 1991, NEUROLOGY, V41, P846, DOI 10.1212/WNL.41.6.846	12	4	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2005	12	1					92	94		10.1016/j.jocn.2004.03.033			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	897PX	WOS:000227018200024	15639424				2022-02-06	
J	Bergeron, L; Gagnon, I; l'Ecuyer, C; Caouette-Laberge, L				Bergeron, L; Gagnon, I; l'Ecuyer, C; Caouette-Laberge, L			Treatment outcomes of unstable proximal phalangeal head fractures of the finger in children	ANNALS OF PLASTIC SURGERY			English	Article						finger injuries; fractures; traction; proximal interphalangeal joint; children	INTERPHALANGEAL JOINT; INTRAARTICULAR FRACTURES; DYNAMIC TRACTION; DISLOCATIONS; MANAGEMENT; MOVEMENT	The authors reviewed 37 children presenting with closed, unstable fractures of the proximal phalangeal head. Fractures were classified as intra-articular (n = 15), including 14 unicondylar and 1 bicondylar, or extra-articular (n = 22), including 20 subcondylar and 2 comminuted subcondylar. Eighteen patients underwent closed reduction with K-wire fixation (n = 11) or dynamic skeletal traction (n = 7). Nineteen patients underwent open reduction with K-wire fixation (n = 14) or miniscrews (n = 5). Results were considered excellent when the active range of motion (ROM) of the proximal interphalangeal joint was greater than or equal to 90degrees (n = 26); fair, active ROM, 70 to 89degrees (n = 6); and poor, active ROM < 70 degrees (n = 5). The intra-articular fractures were rated 9 excellent, 5 fair, and 1 poor. The extra-articular fractures were rated 17 excellent, 1 fair, and 4 poor. The 18 closed reductions, K-wire fixation (n = 11) and traction (n = 7), were rated 16 excellent and 2 fair. The 19 open reductions, K-wire fixation (n = 14) and miniscrew fixation (n = 5), were rated 10 excellent, 4 fair, and 5 poor. Closed reduction showed better results than open reduction. Dynamic skeletal traction proved to be simple and effective in treating these injuries.	Univ Montreal, Hop St Justine, Div Plast Surg, Montreal, PQ H3C 3J7, Canada		Caouette-Laberge, L (corresponding author), 3175 Cote Ste Catherine O, Montreal, PQ H3T 1C5, Canada.	louise_laberge@SSSS.gouv.qc.ca		Gagnon, Isabelle/0000-0003-2043-1644			BARTON NJ, 1979, HAND, V11, P134, DOI 10.1016/S0072-968X(79)80025-X; Blazar P E, 2000, J Am Acad Orthop Surg, V8, P383; Duteille F, 2003, PLAST RECONSTR SURG, V111, P1623, DOI 10.1097/01.PRS.0000054160.46502.D0; FORD DJ, 1987, J HAND SURG-BRIT EUR, V12B, P28, DOI 10.1016/0266-7681(87)90049-0; FREELAND AE, 1994, HAND CLIN, V10, P239; KEARNEY LM, 1994, HAND CLIN, V10, P199; LEIBOVIC SJ, 1994, HAND CLIN, V10, P169; LEONARD MH, 1970, CLIN ORTHOP RELAT R, P160; London P S, 1971, Hand, V3, P155, DOI 10.1016/0072-968X(71)90035-0; MORGAN JP, 1995, J HAND SURG-AM, V20A, P565, DOI 10.1016/S0363-5023(05)80268-0; OROURKE SK, 1989, J HAND SURG-BRIT EUR, V14B, P183, DOI 10.1016/0266-7681(89)90123-X; Schenck RR, 1997, CLIN PLAST SURG, V24, P175; SCHENCK RR, 1994, HAND CLIN, V10, P187; SCHENCK RR, 1986, J HAND SURG-AM, V11A, P850, DOI 10.1016/S0363-5023(86)80236-2; SCHENCK RR, 1994, HAND CLIN, V10, P179; WEISS APC, 1993, J HAND SURG-AM, V18A, P594, DOI 10.1016/0363-5023(93)90297-G; WIDGEROW AD, 1987, J HAND SURG-AM, V12A, P134, DOI 10.1016/S0363-5023(87)80178-8	17	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	JAN	2005	54	1					28	32		10.1097/01.sap.0000141945.03201.c9			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	884EA	WOS:000226066200007	15613879				2022-02-06	
J	Fox, DD; Greiffenstein, MF; Lees-Haley, PR				Fox, DD; Greiffenstein, MF; Lees-Haley, PR			Commentary on "Cognitive Impairment Associated with Toxigenic Fungal Exposure"	APPLIED NEUROPSYCHOLOGY			English	Article						toxic mold; cognitive impairment; mycotoxins; neuropsychological	BASE RATES; NEUROPSYCHOLOGICAL TESTS; PERFORMANCE; SYMPTOMS; DISEASE	Recently, Gordon et al. (2004) published an article entitled "Cognitive Impairment Associated with Toxigenic Fungal Exposure: A Replication and Extension of Previous Findings." That article claims that neurocognitive deficits are pervasive in persons self-diagnosed with "toxic" mold exposure relative to historical norms. Further, Gordon et al. argue exposure to household molds causes brain damage similar to closed head injury. Examination of their methodology reveals unfounded and unreliable conclusions due to deviations from sound epidemiological principles, bias in participant selection, misleading data analysis, and implausible causal reasoning. The purpose of this critique is to outline the specific design and reasoning flaws that, if not addressed, would lead to unwarranted conclusions regarding the effects of mold exposure.	Psychol Assessment, Glendale, CA USA; Psychol Syst Inc, Royal Oak, MI USA		Fox, DD (corresponding author), 410 W Arden Ave,Suite 201, Glendale, CA 91203 USA.	fox@psychotherapy.org					BROWN AP, 1991, J CLIN PATHOL, V44, P452; *COMM DAMP SPAC HL, 2004, DAMP IND SPAC HLTH; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gordon WA, 2004, APPL NEUROPSYCHOL, V11, P65, DOI 10.1207/s15324826an1102_1; HARDIN BD, 2002, AM COLL OCCUPATIONAL; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hodgson MJ, 1998, J OCCUP ENVIRON MED, V40, P241, DOI 10.1097/00043764-199803000-00006; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Ledbetter M., 2003, CLIN INTERPRETATION, P211, DOI 10.1016/B978-012703570-3/50011-0; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; van Hout MSE, 2003, NEUROTOXICOLOGY, V24, P547, DOI 10.1016/S0161-813X(03)00054-8	13	4	4	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	3					129	133		10.1207/S15324826AN1203_1			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965OR	WOS:000231960500001	16131338				2022-02-06	
J	Laske, C; Stransky, E; Eschweiler, GW; Wittorf, A; Richartz-Salzburger, E; Buchkrerner, G; Schott, K				Laske, Christoph; Stransky, Elke; Eschweiler, Gerhard W.; Wittorf, Andreas; Richartz-Salzburger, Elke; Buchkrerner, Gerhard; Schott, Klaus			Correlation of BDNF and IL-6 serum concentrations in Alzheimer's disease	NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH			English	Article						Alzheimer's disease (AD); BDNF; IL-6; healthy controls; MMSE	NEUROTROPHIC FACTOR; MESSENGER-RNA; BRAIN; HIPPOCAMPUS; NEURONS; CELLS	Alzheimer's disease (AD) is characterized by cognitive decline and loss of neurons in specific brain regions. Recent findings have suggested an involvement of the pro-inflammatory cytokine interleukin-6 (IL-6) and brain-derived neurotrophic factor (BDNF) in the pathogenesis of AD. BDNF is an endogenous protein involved in neuronal survival and synaptic plasticity. The present pilot study assessed BDNF and IL-6 serum concentrations in 15 patients with AD in later stages with moderate to severe dementia in comparison to 10 age-matched healthy controls. As main result, we found in AD patients a significant negative correlation between the BDNF and IL-6 serum concentrations (r=-0,407, p=0,043), but not with Mini-Mental State (MMS; rBDNF-MMS=-0,152, p=0,447; rIL-6-MMS= 0,023, p=0,910). Mean BDNF serum concentration in AD patients (17,3 ng/ml) showed a tendency towards decreased values compared to healthy controls (20,7 ng/ml, p=0,086), whereas mean IL-6 serum concentration in AD patients (2,2 pg/ml) were slightly increased as compared to healthy controls (1,7 pg/ml), but without reaching statistical significance (p=0,269). In conclusion, our findings point to the possible existence of a dysbalance between neurotrophins such as BDNF and pro-inflammatory cytokines such as IL-6 in the etiology of Alzheimer's disease. There is need for further examinations, especially enrolling more patients with different stages of AD and including other differential diagnoses, to prove the specificity and sensitivity of these potential surrogate markers. Especially BDNF and IL-6 concentrations of patients with vascular dementia and traumatic brain injury have to be examined for proving the specificity of this finding to AD pathology or to brain damage in general.	Univ Tubingen, Dept Psychiat & Psychotherapy, D-72076 Tubingen, Germany		Laske, C (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Osianderstr 24, D-72076 Tubingen, Germany.	christoph.laske@med.uni-tuebingen.de	Wittorf, Andreas/E-7814-2010				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blasko I, 2003, DRUG AGING, V20, P101, DOI 10.2165/00002512-200320020-00002; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Holmlund L, 2002, INT J MOL MED, V10, P245; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hull M, 1999, NEUROSCI LETT, V261, P33, DOI 10.1016/S0304-3940(98)01003-9; Kalman J, 1997, ACTA NEUROL SCAND, V96, P236; Kircher T, 1997, J GERIATR PSYCH NEUR, V10, P127, DOI 10.1177/089198879701000307; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Strohmeyer R, 2001, J ALZHEIMERS DIS, V3, P131, DOI 10.3233/JAD-2001-3118; Tang YP, 2000, MOL BRAIN RES, V80, P188, DOI 10.1016/S0169-328X(00)00158-3; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; *WHO, Y0 REV INT CLASS DIS, pCH5	21	4	4	0	2	UNIVERSITATSVERLAG ULM GMBH	ULM	BAHNHOFSTRASSE 20, D-89073 ULM, GERMANY	0941-9500			NEUROL PSYCHIAT BR	Neurol. Psychiatr. Brain Res.		2005	12	1					21	24					4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	212DR	WOS:000249574300004					2022-02-06	
J	Schiff, E; Kim, YH; Maizes, V				Schiff, E; Kim, YH; Maizes, V			Vegetative states - An integrative approach	ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL-FUNCTION; SENSORY STIMULATION; DOUBLE-BLIND; THERAPY; VINPOCETINE; COMA		Coll Med, Program Integrat Med, Tucson, AZ USA; Univ Arizona, Program Integrat Med, Tucson, AZ 85721 USA; Univ Arizona, Ctr Hlth Sci, Tucson, AZ 85721 USA								Andriollo M, 1999, INT J APPL ELECTROM, V10, P1; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Barrett K, 1998, UNDERSEA HYPERBAR M, V25, P9; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; Cho ZH, 2002, J ALTERN COMPLEM MED, V8, P399, DOI 10.1089/107555302760253577; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Glenn MB, 2001, J HEAD TRAUMA REHAB, V16, pVII, DOI 10.1097/00001199-200102000-00002; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HENDERSON CT, 1992, J AM COLL NUTR, V11, P309; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lim SY, 2000, J NUTR, V130, P1629, DOI 10.1093/jn/130.6.1629; Linde K, 1999, ESSENTIALS COMPLEMEN, P57; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Maizes V, 2002, ACAD MED, V77, P851, DOI 10.1097/00001888-200209000-00003; Maizes Victoria, 2002, Adv Mind Body Med, V18, P31; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; MINDELL A, 1989, COMA KEY AWAKENING, P102; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Munno I, 1998, IMMUNOPHARM IMMUNOT, V20, P519, DOI 10.3109/08923979809031513; NEUBAUER RA, 1990, LANCET, V335, P1217, DOI 10.1016/0140-6736(90)92736-2; Noda R, 2003, ACTA NEUROCHIR SUPPL, V87, P23; Pereira C, 2000, FREE RADICAL RES, V33, P497, DOI 10.1080/10715760000301041; REISS G, 2004, SELF SOC; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; ROCKSWOLD GL, 1994, HYPERBARIC MED PRACT, P641; Scherder EJA, 2000, BEHAV BRAIN RES, V111, P223, DOI 10.1016/S0166-4328(00)00170-4; Schneider WN, 1999, BRAIN INJURY, V13, P863; SHENGXU W, 2001, INTERN J ACUPUNCTURE, V6, P4; Szakall S, 1998, J NEUROIMAGING, V8, P197, DOI 10.1111/jon199884197; SZARMARL SZ, 2003, COCHRANE DATABASE SY, V1; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; WALKER JB, 1975, DEV NEUROPSYCHOL, P160; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; WOOD RL, 1991, BRAIN INJURY, V4, P393; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15; Yokoyama T, 1996, SOC TREAT COMA, V5, P117; ZIMMER C, 2003, NEW YORK TIMES  0928; [No title captured]; [No title captured]; 1996, CHINESE ACUMOXATHERA, V16, P10; 1998, CHINESE ACUMOXATHERA, P23; 2004, COMA WORK ASSISTING; 1997, MED REPORTS, V10, P11; 1997, CHINESE J CUTATIVE M, P22	50	4	7	0	10	INNOVISION COMMUNICATIONS	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1078-6791			ALTERN THER HEALTH M	Altern. Ther. Health Med.	JAN-FEB	2005	11	1					26	33					8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	888FT	WOS:000226360300008	15712763				2022-02-06	
J	Stavinoha, PL				Stavinoha, Peter L.			Integration of Neuropsychology in Educational Planning Following Traumatic Brain Injury	PREVENTING SCHOOL FAILURE			English	Article						assessment; neuro-psychological aspects of traumatic brain injury (TBI); neuropsychological outcomes; physical aspects of TBI		Traumatic brain injuries (TBIs) have the potential to significantly disrupt a student's cognitive, academic, social, emotional, behavioral, and physical functioning. It is important for educators to appreciate the array of difficulties students with TBI may experience in order to appropriately assess needs and create an educational plan that targets the needs. The purpose of this article is to provide an overview of the neuropsychological aspects of TBI and the implications these have on the role of educators. The author reviews the physical aspects of TBI, and summarizes the neuropsychological outcomes, with particular attention given to injury variables that impact assessment decisions. The author describes common challenges with the assessment of educational needs with emphasis placed on developing a hypothesis testing approach to information gathering and formal assessment.	[Stavinoha, Peter L.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Psychiat, Dallas, TX 75390 USA		Stavinoha, PL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Psychiat, Dallas, TX 75390 USA.						Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bigler E. D., 1997, CHILDHOOD TRAUMATIC, P7; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Novack T. A., 1996, J CLIN; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; [No title captured]	20	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					11	16		10.3200/PSFL.49.4.11-16			6	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100003					2022-02-06	
J	Kristensen, OS				Kristensen, OS			Changing goals and intentions among participants in a neuropsychological rehabilitation programme: an explorative case study evaluation	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; IMPAIRED AWARENESS; DEFICITS; ANOSOGNOSIA	Primary objective: The objective is to describe how persons with brain injury become aware of their difficulties and recreate their lives during a rehabilitation programme. Method: Thirteen individuals with brain injuries were interviewed in a pre-post design, using a structured interview guide. Results: Two types of changes during rehabilitation were observed: First, a change has happened during the rehabilitation process from preserving the former self to self-autonomy or self-realization. Secondly, a change happened in the participants' perception of difficulties from attempts to handle critical situations to avoiding anticipated critical situations. Influential factors were identified as the settings in which the person is embedded, the emotional reactions, attributions and attitudes towards the injury and the future time perspective. Conclusion: Self-presentation may be described as the ability to foresee critical situations and to intentionally choose not to get involved in that kind of situation. The way the persons present themselves has changed during the rehabilitation process.	Aarhus Univ, Dept Psychol, DK-8000 Aarhus C, Denmark		Kristensen, OS (corresponding author), Aarhus Univ, Dept Psychol, Nobelpk,Jens Chr Skous Vej 4, DK-8000 Aarhus C, Denmark.	olesteen@psy.au.dk					Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; EDWARDS DJA, 1996, COGNITIVE THERAPY CH, P10; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Folkman S., 1984, STRESS; Gallagher S., 1999, MODELS SELF, P273; GIORGI A, 1994, J PHENOMENOL PSYCHOL, V25, P190, DOI 10.1163/156916294X00034; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Kelly G., 1955, PERSONAL CONSTRUCT P; LANGANFOX J, 1991, INT J PSYCHOL, V26, P409, DOI 10.1080/00207599108247132; LEARY MR, 1986, SOCIAL PSYCHOL DYSFU; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Newman AC, 2000, BRAIN INJURY, V14, P333; Nuttin J., 1985, FUTURE TIME PERSPECT; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SKOU CV, 1995, KIT KVALITATIV INTER; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; [No title captured]	29	4	4	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2004	18	10					1049	1062		10.1080/02699050410001672279			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	845LQ	WOS:000223244600008	15370903				2022-02-06	
J	Murrey, GJ; Starzinski, DT; LeBlanc, AJ				Murrey, GJ; Starzinski, DT; LeBlanc, AJ			Base rates of traumatic brain injury history in adults admitted to state psychiatric hospitals: A 3-year study	REHABILITATION PSYCHOLOGY			English	Article							PREVALENCE	Objectives: To determine the base rate of traumatic brain injury (TBI) in adults admitted to state psychiatric hospitals. Participants: A total of 3,133 psychiatric patients between the ages of 18 and 60 years old from 7 state facilities were screened for TBI and associated sequelae daring a 3-year study period. Method: Comprehensive medical chart/documentation review and treating psychiatrist assessment. Results: A total of 524 (16.73%) had a documented history of TBI, 195 (6.22%) held a previous diagnosis of organic mental disorder at time of admission, 57 (1.82%) had clinical symptoms considered to be consistent with TBI sequelae, and 201 (6.42%) were diagnosed with dysfunction of thinking secondary to TBI. Conclusions: Findings support specific assessment for TBI in these populations, especially in light of previous studies suggesting that psychiatric patients with a history of TBI may require more specialized treatments.	Minnesota Neurorehabil Hosp, Brainerd, MN 56401 USA; Fielding Grad Inst, Santa Barbara, CA USA		Murrey, GJ (corresponding author), Minnesota Neurorehabil Hosp, 11615 State Ave, Brainerd, MN 56401 USA.	gregory.murrey@state.mn.us					BENYISHAY Y, 1997, J HEAD TRAUMA REHAB, V2, P35; BURG J, 1997, DISS ABSTR INT B, V57, P7717; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; LEVEN HS, 1989, MILD HEAD INJURY; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; MURREY GJ, 2002, UNPUB INPATIENT NEUR; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861	13	4	4	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2004	49	3					259	261		10.1037/0090-5550.49.3.259			3	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	847BX	WOS:000223364900010					2022-02-06	
J	Shah, MN; Bazarian, JJ; Mattingly, AM; Davis, EA; Schneider, SM				Shah, MN; Bazarian, JJ; Mattingly, AM; Davis, EA; Schneider, SM			Patients with head injuries refusing emergency medical services transport	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MILD; PREDICTORS	Primary objective: To characterize patients with head injury who refuse emergency medical services ( EMS) transport to an emergency department (ED). To identify predictors of patients with head injury who refuse EMS transport. Research design: Retrospective chart review. Methods: Patients with a head injury cared for by EMS during 2001 were identified. Medical records were abstracted for demographic and clinical information and reasons for refusing transport. Patients accepting transport were compared to those refusing. Reasons for refusing transport were described. Results: Three hundred and thirty-three patients with head injuries were identified. Sixteen per cent refused EMS transport. Patients refusing transport were more likely to be male, younger and victims of assault and less likely to have lost consciousness. Patients refusing transport often felt they did not need care or could obtain care later. Conclusions: Patients with head injuries frequently refuse EMS transportation. Individuals accepting care differ significantly from those refusing care. Sufficient awareness of the risk of head injury seems to be lacking among patients.	Univ Rochester, Sch Med & Dent, Rochester, NY USA		Shah, MN (corresponding author), Dept Emergency Med, Box 655,601 Elmwood Ave, Rochester, NY 14642 USA.	manish_shah@urmc.rochester.edu		Shah, Manish/0000-0001-6331-1074	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS41952-3] Funding Source: Medline		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BOREZUK P, 1997, EMERGENCY MED CLIN N, V15, P563; Burstein JL, 1996, AM J EMERG MED, V14, P23, DOI 10.1016/S0735-6757(96)90007-8; Cone D C, 1995, Prehosp Disaster Med, V10, P3; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jaslow D, 1998, Prehosp Emerg Care, V2, P18, DOI 10.1080/10903129808958834; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Schmidt TA, 1998, ACAD EMERG MED, V5, P796, DOI 10.1111/j.1553-2712.1998.tb02506.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Sosin DM, 1996, BRAIN INJURY, V10, P47; STARK G, 1990, AM J EMERG MED, V8, P509, DOI 10.1016/0735-6757(90)90152-P; SUCOV A, 1992, PREHOSP DISASTER MED, V7, P365; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Zachariah BS, 1992, PREHOSP DISASTER MED, V7, P359, DOI DOI 10.1017/S1049023X00039777	25	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2004	18	8					765	773		10.1080/02699050410001671801			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300003	15204317				2022-02-06	
J	Ferri, J; Chirivella, J; Caballero, MC; Simo, M; Ramirez, RM; Noe, E				Ferri, J; Chirivella, J; Caballero, MC; Simo, M; Ramirez, RM; Noe, E			Intelligence and prognosis in severe traumatic brain injury: a neuropsychological study with the Wechsler adult intelligence scale (WAIS-III)	NEUROLOGIA			Spanish	Article						intelligence; WAIS-III; prognosis; neuropsychology; head injury	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; PRACTICAL SCALE; PERFORMANCE; RECOVERY; SCORES; SPEED; SEQUELAE; SAMPLES; UTILITY	Objective. To evaluate the utility of the Wechsler adult intelligence scale III (WAIS-III) as a measure of intelligence after severe brain injury, and to elucidate prognostic factors associated with intelligence coefficients (IQs). Methods. Forty-six patients (age: 27.4 +/- 12.8 years) attending our service after a severe head injury were included in our study (chronicity: 315.3 +/- 330 days after injury). All patients were assessed with the WAIS-III. WAIS-III IQs were correlated (Pearson and Spearman) with clinical and demographic data. A significance level of p < 0.05 was used in all comparisons. IQs between I and 2 standard deviation (SD) below normative data were considered ((mild abnormal)) while indexes below 2 SD were considered "abnormal"). Results. Only eleven patients (25 %) showed normal total IQ with predominance of manipulative (77.7 %) compared to verbal (64.5 %) impairment. Thirty-eight patients (95 %) had difficulties in speed processing, thirty-six (85.6 %) had problems with working-memory, twenty-five (62.5 %) showed impairments in perceptual organization, and twenty-six (62 %) had verbal comprehension deficits. WAIS-III IQs showed significant correlations with length of coma and posttraumatic amnesia duration (p < 0.05). Conclusions. The WATS-III is a valid and sensible tool to detect cognitive deficits associated with brain injury. Almost all patients with severe brain injury show abnormal IQs with a slow processing speed as predominant symptom. Length of coma and posttraumatic amnesia seems to be the most relevant parameter related to intelligence in severe brain-injured patients.	Hosp NISA Valencia Mar, Serv Dano Cebrebral, Valencia, Spain		Noe, E (corresponding author), Hosp NISA Valencia Mar, Serv Dano Cebrebral, Rio Tajo 1, Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CORRELL RE, 1993, PERCEPT MOTOR SKILL, V76, P99, DOI 10.2466/pms.1993.76.1.99; Donders J, 1999, ARCH PHYS MED REHAB, V80, P346, DOI 10.1016/S0003-9993(99)90150-8; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; KAUFMAN AS, 1999, CLAVES EVALUACION WA; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; PANIAK CE, 1992, J CLIN PSYCHOL, V48, P219, DOI 10.1002/1097-4679(199203)48:2<219::AID-JCLP2270480212>3.0.CO;2-K; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; TEASDALE G, 1974, LANCET, V2, P81; van der Heijden P, 2003, J CLIN EXP NEUROPSYC, V25, P59, DOI 10.1076/jcen.25.1.59.13627; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WECHSLER D, 1999, ESCALA INTELIGENCAI; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WECHSLER D, 1977, ESCALA INTELLIGENCIA; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	34	4	4	0	4	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	JUL-AUG	2004	19	6					285	291					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844QK	WOS:000223174500002	15199416				2022-02-06	
J	Arco, L; Cohen, L; Geddes, K				Arco, L; Cohen, L; Geddes, K			Verbal self-regulation of impulsive behavior of persons with frontal lobe brain injury	BEHAVIOR THERAPY			English	Article; Proceedings Paper	38th Annual Conference of the Australian-Psychological-Society	OCT, 2003	Perth, AUSTRALIA	Australian Psychol Soc			CLOSED HEAD-INJURY; SKILLS; REMEDIATION; FEEDBACK; ADULTS; BOYS	A multiple-baseline across participants design was used to examine effects of a verbal self-regulatory procedure on direct measures of impulsivity associated with frontal lobe brain damage. Four young men participated in socially interactive group sessions with a therapist who (a) assisted the participants in selecting individualized instructions on how to behave, (b) provided participants with feedback on their correspondence between instructions and nonverbal behavior, and (c) gradually reduced assistance while participants maintained self-monitoring. Results show that the verbal self-regulation was efficacious in reducing impulsive behavior to clinically significant levels during the group sessions, although effects with I participant were variable.	Edith Cowan Univ, Sch Psychol, Joondalup, WA 6027, Australia		Arco, L (corresponding author), Edith Cowan Univ, Sch Psychol, Joondalup, WA 6027, Australia.	l.arco@ecu.edu.au					AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Arnie Zencius, 1991, BEHAV RESIDENTIAL TR, V6, P1, DOI DOI 10.1002/BIN.2360060102; BARLOW DH, 1984, SINGLE CASE EXPT DES; Bellack AS, 1997, SOCIAL SKILLS TRAINI; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; COX JL, 1991, J HEAD TRAUMA REHAB, V6, P35; DEATON AV, 1991, COGNITIVE REHABILITA, P201; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FINCH AJ, 1975, J ABNORM CHILD PSYCH, V3, P49, DOI 10.1007/BF00916030; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; Graves N., 1990, PART PLAY TIPS TECHN; GUEVREMONT DC, 1988, J APPL BEHAV ANAL, V21, P45, DOI 10.1901/jaba.1988.21-45; HANCOCK K, 1989, PEOPLE INTERACTING S; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Iwata B. A., 1993, BEHAV ANAL TREATMENT, P101; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; LURIA A R, 1973, P3; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; OREILLY MF, 1990, J APPL BEHAV ANAL, V23, P431, DOI 10.1901/jaba.1990.23-431; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; PANIAGUA FA, 1990, BEHAV ANALYST, V13, P107, DOI 10.1007/BF03392528; PANIAGUA FA, 1992, BEHAV MODIF, V16, P226, DOI 10.1177/01454455920162005; RACHLIN H, 1995, BEHAV BRAIN SCI, V18, P109, DOI 10.1017/S0140525X00037602; RALPH A, 1986, APPL RES MENT RETARD, V7, P415, DOI 10.1016/S0270-3092(86)80015-7; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; Skinner, 1969, CONTINGENCIES REINFO, P133; Taylor I, 1997, J APPL BEHAV ANAL, V30, P43, DOI 10.1901/jaba.1997.30-43; WOOD MM, 1994, NEUROPSYCHOLOGY CCLI, P343; [No title captured]	32	4	4	0	5	ASSOC ADV BEHAVIOR THERAPY	NEW YORK	305 7TH AVE #16A, NEW YORK, NY 10001-6008 USA	0005-7894			BEHAV THER	Behav. Therapy	SUM	2004	35	3					605	619		10.1016/S0005-7894(04)80034-0			15	Psychology, Clinical; Psychiatry	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology; Psychiatry	848ED	WOS:000223449300008					2022-02-06	
J	Berardino, M; Morrone, O; Sciacca, PF; Rosato, R; Ciccone, G; Massaro, F				Berardino, M; Morrone, O; Sciacca, PF; Rosato, R; Ciccone, G; Massaro, F			Discharge criteria from intensive care unit in brain injured patients	ACTA NEUROCHIRURGICA			English	Article						neurosurgery intensive care discharge; intermediate care unit; resource allocation	ACUTE PHYSIOLOGY SCORE; MANPOWER USE SCORE; INTERMEDIATE CARE; 9 EQUIVALENTS; SAPS-II; ADMISSIONS; CANDIDATES; SERVICES	Objective. We investigated the value of information on clinical features and intensity of treatment activity in the Intensive Care Unit (ICU) in predicting the need for further interventions after a patient is discharged from the Intensive Care Unit. Our aim was to assess if this could aid in making decisions about transfer to an Immediate Care Unit (sub-ICU). Methods. We studied 39 patients with acute brain damage (traumatic or vascular causes). They ranged in age from 15 to 75 years and none had an associated spinal cord injury. The SAPS II, Glasgow Coma Scale (GCS), length of stay in ICU, duration of hospital stay and daily NEMS scores were recorded for each patient. We recorded the activities performed after transfer to an sICU, including complications that required active "life-saving" treatment. The role of each factor was assessed by using the odds ratio (OR), and with linear logistic regression. Findings. 8 of the 39 patients developed a complication in the Sub-ICU. A linear logistic regression analysis demonstrated that the principal features having significant predictive value were: a) age, with an increase in risk of over 10 times for patients that were older than 50 (p=0.011); b) SAPS II scores greater than or equal to50 points, with 24 times an increase in risk (p=0.002); and c) a GCS score less than or equal to5 points, with an increase in risk of almost 7 times (p=0.024). Interpretation. Complications in Sub-ICU are less likely in patients younger than 50 and who have SAPS II and GCS scores within predetermined limits. These indices can help in making decisions about discharge of a patient from ICU to Sub-ICU.	San Giovanni Battista Hosp, Dept Neurosci, Neuroanesthesia & ICU, I-10126 Turin, Italy; Univ Turin, Turin, Italy; San Giovanni Battista Hosp, Canc Epidemiol Unit, Turin, Italy; CPO Piemonte, Turin, Italy; CTO Hosp, Turin, Italy		Berardino, M (corresponding author), San Giovanni Battista Hosp, Dept Neurosci, Neuroanesthesia & ICU, Corso Bramante 88, I-10126 Turin, Italy.	maurizio_berardino@fastwebnet.it	Ciccone, Giovannino/K-3136-2016; Stocchetti, Nino/O-7444-2017	Ciccone, Giovannino/0000-0001-7644-9574; Stocchetti, Nino/0000-0003-3250-6834; ROSATO, Rosalba/0000-0002-4921-374X			Apolone G, 1996, INTENS CARE MED, V22, P1368, DOI 10.1007/s001340050266; Apolone G, 1994, New Horiz, V2, P350; Iapichino G, 1994, Monaldi Arch Chest Dis, V49, P493; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Miranda DR, 1997, INTENS CARE MED, V23, P760, DOI 10.1007/s001340050406; MIRANDA DR, 1994, EURICUS 1 NEWSLETTER, V5, P3; Nasraway SA, 1998, CRIT CARE MED, V26, P607, DOI 10.1097/00003246-199803000-00039; Rothen HU, 1999, INTENS CARE MED, V25, P606, DOI 10.1007/s001340050910; Zimmerman JE, 1998, NEUROSURGERY, V42, P91, DOI 10.1097/00006123-199801000-00019; Zimmerman JE, 1996, CRIT CARE MED, V24, P1626, DOI 10.1097/00003246-199610000-00005; ZIMMERMAN JE, 1995, CHEST, V108, P490, DOI 10.1378/chest.108.2.490	12	4	5	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	MAY	2004	146	5					453	456		10.1007/s00701-003-0176-1			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	816MU	WOS:000221114800005	15118881				2022-02-06	
J	Grapperon, J; Vidal, F; Bruschera, D; Cantais, E; Salinier, L; Costes, O; Palmier, B				Grapperon, J; Vidal, F; Bruschera, D; Cantais, E; Salinier, L; Costes, O; Palmier, B			Auditive and somato-sensory event-related potentials in comas: prognostic value for awakening, social and professional reinstatement	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						auditory evoked potentials; somato-sensory evoked potentials; sedation; readaptation	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; EVOKED-POTENTIALS; MISMATCH NEGATIVITY; PROPOFOL SEDATION; CARDIAC-SURGERY; P300; RECOVERY; ANESTHESIA; EMERGENCE	Objective.-To appreciate prognostical value of event-related potentials in comatose states and the influence of the stimulation's modality. Patients and methods.-Thirty-five patients were recorded with the auditory modality whose thirteen were also recorded,with the somesthetic modality. They were free of sedation except for five. For 21 patients out of coma, it was possible to get information about their social readaptation 14 months later. Results.-When present, cognitive components predict awakening in 100% of the cases, but only 50% of the patients who awake had these components. The somesthetic modality seemed to enlarge their detection, but did not improve short-term forecasts. We could not confirm their absence could hamper social reinstatement. Conclusion.-Event-related potentials are strengthened as having excellent positive prognostic value. Further studies should clarify the interest of the somesthetic modality, and the possibility to get remote prognostic. (C) 2003 Elsevier SAS. Tous droits reserves.	Hop Instruct Armees St Anne, Clin Neurophysiol Lab, F-83800 Toulon, France; Serv Sante Armees, Inst Med Navale, F-83800 Toulon, France; Hop Instruct Armees St Anne, Serv Reanimat, F-83800 Toulon, France; Hop Chalucet, Serv Med Phys & Readaptat, F-83800 Toulon, France		Grapperon, J (corresponding author), Hop Instruct Armees St Anne, Clin Neurophysiol Lab, BP 600, F-83800 Toulon, France.	neurostann@yahoo.fr					Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; ENGELHARDT W, 1992, BRIT J ANAESTH, V69, P75, DOI 10.1093/bja/69.1.75; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Kane NM, 2000, AUDIOL NEURO-OTOL, V5, P186, DOI 10.1159/000013879; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; Mainardi LT, 2000, COMPUT METH PROG BIO, V63, P219, DOI 10.1016/S0169-2607(00)00112-7; MAROSI M, 1993, LANCET, V342, P1248; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Morlet D, 2000, AUDIOL NEURO-OTOL, V5, P198, DOI 10.1159/000013881; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6; PLOURDE G, 1993, ANESTHESIOLOGY, V78, P498, DOI 10.1097/00000542-199303000-00014; REINSEL RA, 1991, ANESTH ANALG, V73, P612; REINSEL RA, 1995, BRIT J ANAESTH, V74, P674, DOI 10.1093/bja/74.6.674; Reuter B., 1989, TOPOGRAPHIC BRAIN MA, P192; Signorino M, 1997, J PSYCHOPHYSIOL, V11, P59; vanHooff JC, 1997, ELECTROEN CLIN NEURO, V103, P268, DOI 10.1016/S0013-4694(97)00012-6; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; Ypparila H, 2002, CLIN NEUROPHYSIOL, V113, P1357, DOI 10.1016/S1388-2457(02)00158-X	27	4	4	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAR	2004	23	2					102	108		10.1016/j.annfar.2003.12.018			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	810DH	WOS:000220684500002	15030858				2022-02-06	
J	Rougier, A; Auvergne, R				Rougier, A; Auvergne, R			Adult brain neurogenesis and pathology	NEUROCHIRURGIE			French	Article						neurogenesis; adulthood; regulation; pathology	GRANULE CELL-PROLIFERATION; NEURAL PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; STEM-CELLS; RECEPTOR ACTIVATION; SUBVENTRICULAR ZONE; PRECURSOR CELLS; OLFACTORY-BULB	In the central nervous system, neuron generation continues throughout adulthood. This neurogenesis is involved in a continual adaptative process in relation with the environmental complexity. It decreases with age and is reduced in several types of experimental conditions mimicking stress, depression, addiction and neurodegenerative diseases. It may be enhanced after excitotoxic, ischemic or traumatic injuries suggesting a compensatory adaptative response. Available data on this new concept in the field of neurosciences and possible therapeutic relevance are reported.	Hop Pellegrin, Serv Neurochirurg, F-33076 Bordeaux, France; Univ Bordeaux 2, Lab Epileptol Expt & Clin, EA 2967, F-33076 Bordeaux, France		Rougier, A (corresponding author), Hop Pellegrin, Serv Neurochirurg, F-33076 Bordeaux, France.	alain.rougier@ar-luni.u-bordeaux2.fr	Auvergne, Romane M/N-2624-2016	Auvergne, Romane M/0000-0002-9497-0184			Abrous DN, 2002, J NEUROSCI, V22, P3656; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Auvergne R, 2002, BRAIN RES, V954, P277, DOI 10.1016/S0006-8993(02)03355-3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Covolan L, 2000, HIPPOCAMPUS, V10, P169, DOI 10.1002/(SICI)1098-1063(2000)10:2<169::AID-HIPO6>3.0.CO;2-W; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dong HX, 2003, J NEUROSCI, V23, P1742; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Goldman SA, 2002, CLIN NEUROSCI RES, V2, P70, DOI 10.1016/S1566-2772(02)00008-7; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1038/sj.npp.1395369; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hellsten J, 2002, EUR J NEUROSCI, V16, P283, DOI 10.1046/j.1460-9568.2002.02093.x; Jacobs BL, 2002, BRAIN BEHAV IMMUN, V16, P602, DOI 10.1016/S0889-1591(02)00015-6; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; Kato T, 2001, NEUROSCI LETT, V307, P17, DOI 10.1016/S0304-3940(01)01914-0; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Liu JL, 1998, J NEUROSCI, V18, P7768; Magavi SS, 2001, NEUROPSYCHOPHARMACOL, V25, P816, DOI 10.1016/S0893-133X(01)00357-8; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mathern GW, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.43.s.5.28.x; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Nakagawa E, 2000, EPILEPSIA, V41, P10, DOI 10.1111/j.1528-1157.2000.tb01498.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7; Pevny L, 2003, TRENDS NEUROSCI, V26, P351, DOI 10.1016/S0166-2236(03)00169-3; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Radley JJ, 2003, BRAIN RES, V966, P1, DOI 10.1016/S0006-8993(02)03989-6; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Rietze R, 2000, J COMP NEUROL, V424, P397; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100; Zitnik G, 2002, J NEUROSCI RES, V70, P258, DOI 10.1002/jnr.10384	82	4	4	0	8	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAR	2004	50	1					33	41		10.1016/S0028-3770(04)98303-8			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	816TJ	WOS:000221131900004	15097918				2022-02-06	
J	Glass, TF; Knapp, J; Amburn, P; Clay, BA; Kabrisky, M; Rogers, SK; Garcia, VF				Glass, TF; Knapp, J; Amburn, P; Clay, BA; Kabrisky, M; Rogers, SK; Garcia, VF			Use of artificial intelligence to identify cardiovascular compromise in a model of hemorrhagic shock	CRITICAL CARE MEDICINE			English	Article						shock; artificial intelligence; hemorrhage; cardiovascular; trauma; monitoring	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; NEURAL-NETWORK; PREDICTION; MORTALITY; DYNAMICS; SURVIVAL; SYSTEM	Objective: To determine whether a prototype artificial intelligence system can identify volume of hemorrhage in a porcine model of controlled hemorrhagic shock. Design: Prospective in vivo animal model of hemorrhagic shock Setting: Research foundation animal surgical suite; computer laboratories of collaborating industry partner. Subjects: Nineteen, juvenile, 25- to 35-kg, male and female swine. Interventions: Anesthetized animals were instrumented for arterial and systemic venous pressure monitoring and blood sampling, and a splenectomy was performed. Following a 1-hr stabilization period, animals were hemorrhaged in aliquots to 10, 20, 30, 35, 40, 45 and 50% of total blood volume with a 10-min recovery between each aliquot. Data were downloaded directly from a commercial monitoring system into a proprietary PC-based software package for analysis. Measurements and Main Results: Arterial and venous blood gas values, glucose, and cardiac output were collected at specified intervals. Electrocardiogram, electroencephalogram, mixed venous oxygen saturation, temperature (core and blood), mean arterial pressure, pulmonary artery pressure, central venous pressure, pulse oximetry, and end-tidal CO2 were continuously monitored and downloaded. Seventeen of 19 animals (89%) died as a direct result of hemorrhage. Stored data streams were analyzed by the prototype artificial intelligence system. For this project, the artificial intelligence system identified and compared three electrocardiographic features (R-R interval, QRS amplitude, and R-S interval) from each of nine unknown samples of the QRS complex. We found that the artificial intelligence system, trained on only three electrocardiographic features, identified hemorrhage volume with an average accuracy of 91% (95% confidence interval, 84-96%). Conclusions: These experiments demonstrate that an artificial intelligence system, based solely on the analysis of QRS amplitude, R-R interval, and R-S interval of an electrocardiogram, is able to accurately identify hemorrhage volume in a porcine model of lethal hemorrhagic shock. We suggest that this technology may represent a noninvasive means of assessing the physiologic state during and immediately following hemorrhage. Point of care application of this technology may improve outcomes with earlier diagnosis and better titration of therapy of shock.	Cincinnati Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Beaver Creek, OH 45431 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Pediat Surg, Beaver Creek, OH USA; CADx Syst, Beaver Creek, OH USA; Wright State Univ, Dept Elect Engn, Dayton, OH 45435 USA; Sci Applicat Int Corp, Dayton, OH USA		Glass, TF (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat Emergency Med, Beaver Creek, OH 45431 USA.						Boswell WC, 1996, SOUTHERN MED J, V89, P218, DOI 10.1097/00007611-199602000-00012; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Buchman TG, 1996, J TRAUMA, V41, P599, DOI 10.1097/00005373-199610000-00002; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Edwards DF, 1999, NEUROLOGY, V53, P351, DOI 10.1212/WNL.53.2.351; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Goldstein B, 1999, CRIT CARE MED, V27, P2239, DOI 10.1097/00003246-199910000-00029; Gutierrez-Osuna R, 2002, IEEE SENS J, V2, P189, DOI 10.1109/JSEN.2002.800688; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Heden B, 1997, CIRCULATION, V96, P1798, DOI 10.1161/01.CIR.96.6.1798; Hunter A, 2000, COMPUT METH PROG BIO, V62, P11, DOI 10.1016/S0169-2607(99)00046-2; Izenberg SD, 1997, AM SURGEON, V63, P275; KRANTZ BE, 1997, ATLS COURSE MANUAL, P296; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Marble RP, 1999, ARTIF INTELL MED, V15, P299, DOI 10.1016/S0933-3657(98)00059-1; MCGONIGAL MD, 1993, J TRAUMA, V34, P863, DOI 10.1097/00005373-199306000-00018; ME Tumbleson, 1986, SWINE BIOMEDICAL RES, V1; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; ORR JA, 1994, J CLIN MONITOR, V10, P101, DOI 10.1007/BF02886822; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pradhan N, 1996, COMPUT BIOMED RES, V29, P303, DOI 10.1006/cbmr.1996.0022; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Sherman D. A., 1998, HERZSCHR ELECTROPHYS, V9, P42; Shoemaker W C, 1996, New Horiz, V4, P300; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Stork D.G., 2001, PATTERN CLASSIFICATI; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Toweill DL, 1998, NEW HORIZ-SCI PRACT, V6, P155; WALDMAN HB, 1996, ASDC J DENT CHILD, V1, P54	33	4	4	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2004	32	2					450	456		10.1097/01.CCM.0000109444.02324.AD			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774ME	WOS:000188982600020	14758163				2022-02-06	
J	Morgan, A; Ward, E; Murdoch, B				Morgan, A; Ward, E; Murdoch, B			A case study of the resolution of paediatric dysphagia following brainstern injury: clinical and instrumental assessment	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article							STEM STROKE; SWALLOWING DISORDERS; RISK-FACTORS; REHABILITATION; PNEUMONIA; SECONDARY; CHILDREN; SCALE	The coexistance of a swallowing impairment can severely impact upon the medical condition and recovery of a child with traumatic brain injury [ref.(1): Journal of Head Trauma Rehabilitation 9 (1) (1994) 43]. Limited data exist on the progression or outcome of dysphagia in the paediatric population with brainstem injury. The present prospective study documents the resolution of dysphagia in a 14-year-old female post-brainstem injury using clinical, radiological and endoscopic evaluations of swallowing. The subject presented with a pattern of severe oral-motor and oropharyngeal swallowing impairment post-injury that resolved rapidly for the initial 12 weeks, slowed to gradual progress for weeks 12-20, and then plateaued at 20 weeks post-injury. Whilst a clinically functional swallow was present at 10 months post-injury, radiological examination revealed a number of residual physiological impairments, reduced swallowing efficiency, and reduced independence for feeding, indicating a potential increased risk for aspiration. The data highlight the need for early and continued evaluation and intensive treatment programs, to focus on the underlying physiological swallowing impairment post-brainstem injury, and to help offset any potential deleterious effects of aspiration that may affect patient recovery, such as pneumonia. (C) 2003 Elsevier Ltd. All rights reserved.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Morgan, A (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.	a.morgan1@uq.edu.au	Ward, Elizabeth/F-9652-2010; Murdoch, Bruce E/C-1397-2012; Morgan, Angela/J-5235-2017	Ward, Elizabeth/0000-0002-2680-8978; Morgan, Angela/0000-0003-1147-7405			ARVEDSON J, 1994, INT J PEDIATR OTORHI, V28, P173, DOI 10.1016/0165-5876(94)90009-4; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; BASTIAN RW, 1991, OTOLARYNG HEAD NECK, V104, P339, DOI 10.1177/019459989110400309; Buchholz David W., 1993, Dysphagia, V8, P235, DOI 10.1007/BF01354544; Burd R S, 2001, Respir Care Clin N Am, V7, P79, DOI 10.1016/S1078-5337(05)70024-1; Crary MA, 1997, DYSPHAGIA, V12, P180, DOI 10.1007/PL00009534; CRARY MA, 1995, DYSPHAGIA, V10, P6, DOI 10.1007/BF00261273; DONNER MW, 1974, SEMIN ROENTGENOL, V9, P273, DOI 10.1016/0037-198X(74)90045-5; Enderby P, 1983, FRENCHAY DYSARTHRIA; Hagen C, 1979, REHABILITATION HEAD; Hayden D., 1999, VERBAL MOTOR PRODUCT; Hoppers P, 1999, J HEAD TRAUMA REHAB, V14, P475, DOI 10.1097/00001199-199910000-00008; HORNER J, 1991, ARCH NEUROL-CHICAGO, V48, P1170, DOI 10.1001/archneur.1991.00530230078026; Huckabee ML, 1999, DYSPHAGIA, V14, P93, DOI 10.1007/PL00009593; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Lefton-Greif MA, 1998, PEDIAT VIDEOFLUOROSC; Logeman JA, 1993, MANUAL VIDEOFLUOROGR; LOGEMANN JA, 1989, ARCH PHYS MED REHAB, V70, P767; LOGEMANN JA, 1990, NEUROLOGY, V40, P1136, DOI 10.1212/WNL.40.7.1136; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Morgan A, 2002, J HEAD TRAUMA REHAB, V17, P220, DOI 10.1097/00001199-200206000-00004; Newman L A, 2000, Semin Speech Lang, V21, P281, DOI 10.1055/s-2000-8382; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; SALTZMAN LS, 1993, ARCH PHYS MED REHAB, V74, P214; Silbiger M L, 1967, Invest Radiol, V2, P442; TANIGUCHI MH, 1994, DEV MED CHILD NEUROL, V36, P495; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P1013, DOI 10.1053/apmr.2002.33102; VEIS SL, 1985, ARCH PHYS MED REHAB, V66, P372; Ward E, 1999, ASIA PACIFIC J SPEEC, V4, P109, DOI DOI 10.1179/136132899805577051; *WESTM HOSP COMM H, 1998, PARR HOSP ASS DYSPH	36	4	5	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2004	11	2					182	190		10.1016/S0967-5868(03)00195-4			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	779DM	WOS:000189280200016	14732381				2022-02-06	
S	Kimelberg, HK		Lauf, PK; Adragna, NC		Kimelberg, HK			Volume activated anion channel and astrocytic cellular edema in traumatic brain injury and stroke	CELL VOLUME AND SIGNALING	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	International Symposium on Cell Volume and Signaling	SEP 20-24, 2003	Wright State Univ, Dayton, OH	Natl Inst Hlth, Natl Inst Diabetes Digest & Kidney Dis	Wright State Univ		APPARENT DIFFUSION-COEFFICIENT; CEREBRAL-ARTERY OCCLUSION; CHLORIDE CHANNELS; TAMOXIFEN; ISCHEMIA; MECHANISMS; ESTROGEN; INHIBITION; ADENOSINE; RELEASE		Ordway Res Inst, Albany, NY 12208 USA		Kimelberg, HK (corresponding author), Ordway Res Inst, 150 New Scotland Ave, Albany, NY 12208 USA.	hkimelberg@ordwayresearch.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023750, R01NS035205] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 35205, NS 23750] Funding Source: Medline		Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; Biegon A, 1996, CANCER RES, V56, P4328; BOURKE RS, 1981, J NEUROSURG, V55, P364, DOI 10.3171/jns.1981.55.3.0364; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CRAGOE EJ, 1986, J MED CHEM, V29, P825, DOI 10.1021/jm00155a038; CRAGOE EJ, 1987, MED RES REV, V7, P271, DOI 10.1002/med.2610070302; CRAGOE EJ, 1982, J MED CHEM, V25, P567, DOI 10.1021/jm00347a017; DeBow SB, 2003, CAN J NEUROL SCI, V30, P368, DOI 10.1017/S0317167100003097; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Devuyst O, 2002, AM J PHYSIOL-RENAL, V283, pF1176, DOI 10.1152/ajprenal.00184.2002; Duong TQ, 2001, MAGN RESON MED, V45, P801, DOI 10.1002/mrm.1108; FEUSTEL PJ, 2004, IN PRESS STROKE; GARCIA JH, 1977, VIRCHOWS ARCH B, V25, P191; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; GINSBERG MD, 1995, NEUROSCIENTIST, V1, P164; Ginsberg MD, 1995, NEUROSCIENTIST, V1, P95; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; KIMELBERG HK, 1989, MOL CHEM NEUROPATHOL, V11, P1, DOI 10.1007/BF03160036; Kimelberg HK, 2000, NEUROSCIENTIST, V6, P14, DOI 10.1177/107385840000600110; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Maher AD, 2003, INT J BIOCHEM CELL B, V35, P1182, DOI 10.1016/S1357-2725(02)00310-2; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; NELSON LR, 1979, NEURAL TRAUMA; NELSON LR, 1982, HEAD INJURY BASIC CL; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Osuka K, 2001, J NEUROCHEM, V76, P1842, DOI 10.1046/j.1471-4159.2001.00198.x; Pearson T, 2000, EUR J NEUROSCI, V12, P3064, DOI 10.1046/j.1460-9568.2000.00201.x; Rutledge EM, 1998, AM J PHYSIOL-CELL PH, V274, pC1511, DOI 10.1152/ajpcell.1998.274.6.C1511; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; Silva MD, 2002, MAGN RESON MED, V48, P826, DOI 10.1002/mrm.10296; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Tuz K, 2001, J NEUROCHEM, V79, P143, DOI 10.1046/j.1471-4159.2001.00546.x; WISEMAN H, 1994, TRENDS PHARMACOL SCI, V15, P83, DOI 10.1016/0165-6147(94)90283-6	46	4	5	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598	2214-8019	0-387-23299-0	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2004	559						157	167					11	Cell Biology; Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	BDB39	WOS:000232359300015	18727237				2022-02-06	
J	Rice, SA; Allaire, J; Elgin, K; Farrell, W; Conaway, M; Blackman, JA				Rice, SA; Allaire, J; Elgin, K; Farrell, W; Conaway, M; Blackman, JA			Effect of shortened length of stay on functional and educational outcome after pediatric rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article; Proceedings Paper	Meeting of the American-Academy-of-Cerebral-Palsy-and-Developmental-Medicine	SEP, 2002	NEW ORLEANS, LOUISIANA	Amer Acad Cerebral Palsy & Dev Med		child; pediatrics; rehabilitation; length of stay; rehabilitation outcome	TRAUMATIC BRAIN INJURY; CHILDREN; DISABILITIES	Objective: The purpose of this study was to assess changes in the length of stay and its effect on effectiveness and return to school in an inpatient pediatric rehabilitation unit during a 5-yr period from fiscal year 1997 through 2001. Design: We reviewed prospectively collected data for a cohort of 321 children during fiscal years 1997-2001. Results: Length of stay was significantly shortened, with mean lengths of stay of 58.9, 43.5, 30.7, 40.9, and 24.0 days in years 1997 through 2001, respectively. Change in length of stay remained significantly decreased after adjusting for age, sex, admission diagnosis, admission severity, and type of health insurance. There was no difference in mean change in effectiveness measured by change in admission and discharge WeeFlM(R) ratings. There were significant differences across years in the educational placement of children at discharge, with a declining trend in the proportion of children discharged to classroom-based educational services. Conclusion: There was a reduction in inpatient length of stay during a 5-yr period for children in this pediatric rehabilitation setting. During this time, there was no change in the effectiveness of rehabilitation as measured by functional outcome. However, using return to a classroom setting as a marker of reintegration into routine activities, fewer children returned to a similar level of community participation.	Univ Virginia, Kluge Childrens Rehabil Ctr, Hlth Syst, Charlottesville, VA 22903 USA; Univ Virginia, Dept Pediat, Charlottesville, VA 22903 USA; Univ Virginia, Dept Hlth Evaluat Sci, Charlottesville, VA 22903 USA		Rice, SA (corresponding author), Univ Virginia, Kluge Childrens Rehabil Ctr, Hlth Syst, 2270 Ivy Rd, Charlottesville, VA 22903 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007956] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5 T32 HL 7956-4] Funding Source: Medline		*CDC NAT CTR HLTH, 2001, DISCH DAYS CAR AV LE; *CDC NAT CTR HLTH, 2001, GROSS DOM PROD NAT H; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; *STAT U NEW YORK B, 2000, WEEFIM SYSTEMSM CLIN; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002	9	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2004	83	1					27	32		10.1097/01.PHM.0000104667.81620.FA			6	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	758FM	WOS:000187623100005	14709972				2022-02-06	
J	Mussack, T; Wiedemann, E; Hummel, T; Biberthaler, P; Kanz, KG; Mutschler, W				Mussack, T; Wiedemann, E; Hummel, T; Biberthaler, P; Kanz, KG; Mutschler, W			Secondary decompressive craniectomy due to increasing post-traumatic brain edema after primary trepanation	UNFALLCHIRURG			German	Article						traumatic brain injury; decompressive craniectomy; ICP; CPP	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE; MANAGEMENT; MECHANISMS; TRAUMA	The objectives of this study were to register the incidence of increasing brain edema after isolated TBI and primary craniectomy to identify possible decision criteria for secondary decompressive trepanation, and to evaluate the neurological performance 6 months after discharge with the Glasgow Outcome Score (GOS). Of 131 patients who suffered from isolated TBI and had to be primarily operated between January 1997 and December 2001,58 (male:female = 48:10; median age of 50.9 years) were included in this analysis. In 11 patients (male:female = 9:2; median age of 40.0 years) a secondary unilateral extensive or contralateral decompressive craniectomy had to be performed in the clinical course. In the group of secondary decompressive craniectomy we recorded admission (80.0 min after TBI) 35 min later (p=0.009) than in the group of primary trepanation. Prehospital otorrhagia was observed more frequently (p=0.036). In univariate analysis, arterial hypotension (p=0.018) and otorrhagia at admission (p=0.035), intracranial pressure (ICP) immediately after primary operation (p=0.024), and decrease of maximal postoperative cerebral perfusion pressure (CPP;p=0.031) below the median cutoff value of 70 mmHg correlated with the event of secondary decompression craniectomy. Multivariate analysis identified decreased maximal CPP after primary trepanation as the only independent prognostic parameter (score 10.496; df=1; p=0.043) for the necessity of secondary trepanation and unfavorable GOS 6 months after discharge. In patients with isolated moderate or severe TBI, prehospital arterial hypotension as well as otorrhagia negatively influenced the mortality and morbidity. Therefore, early adjustment of arterial hypotension and the rapid transport into a neurotraumatological center are to be required for prehospital management of TBI patients. The decrease of maximal CPP below 70 mmHg despite administration of catecholamines representing the only independent prognostic parameter during monitoring in the intensive care unit seems to indicate the necessity of an operative revision as well as an unfavorable GOS 6 months after discharge.	Univ Munchen Klinikum, Chirurg Klin & Poliklin Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Univ Munchen Klinikum, Chirurg Klin & Poliklin Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	mussack@ch-i.med.uni-muenchen.de					BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Burkert W, 1989, Zentralbl Neurochir, V50, P106; BUXTON RL, 1970, LANCET, V2, P498; Chesnut Randall M., 1993, P203; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; GAAB MR, 1990, ACT NEUR S, V51, P326; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Hieu PD, 1996, CHILD NERV SYST, V12, P270; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; PARZHUBER A, 1994, UNFALLCHIRURG, V97, P615; Parzhuber A, 1996, UNFALLCHIRURG, V99, P541; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; REILLY P, 1997, HEAD INJURY, P385; RINALDI A, 1990, ACT NEUR S, V51, P394; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Ruchholtz S, 1998, J TRAUMA, V45, P505, DOI 10.1097/00005373-199809000-00013; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Silvestri S, 1997, MT SINAI J MED, V64, P329; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	38	4	6	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	OCT	2003	106	10					815	824		10.1007/s00113-003-0663-0			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	745NH	WOS:000186694400004	14652724				2022-02-06	
J	Festoff, BW				Festoff, BW			Proteinase-activated receptors (PARs) in the nervous system: Roles in neuroplasticity and neurotrauma	DRUG DEVELOPMENT RESEARCH			English	Article						neurodegeneration; CNS trauma; signal transduction; protein kinases; antagonists	PROTHROMBIN MESSENGER-RNA; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEASE INHIBITORY ACTIVITY; NEURITE-PROMOTING FACTOR; MODEL MOTOR-NEURONS; INDUCED BRAIN EDEMA; RAT SPINAL-CORD; THROMBIN RECEPTOR; PLASMINOGEN-ACTIVATOR; SYNAPSE ELIMINATION	A brief overview is presented of the rapidly evolving effects of thrombin, other serine proteinases, their proteinase-activated receptors (PARs), and their downstream signaling pathways in the peripheral (PNS) and central nervous system (CNS). In other articles presented in this volume of Drug Development Research, emphasis on the role of thrombin and PARs in astrocyte and microglial function is emphasized and will only be touched upon herein. This overview focuses on the PAR family, principally PAR,, in neuronal dysfunction and what appears to be a differential vulnerability to thrombin in neuronal subsets. It also emphasizes upregulation of PARs in neurodegeneration and neurotrauma as part of a neuroplastic response, but which may be maladaptive as well as adaptive in effect. Finally, regulation of PAR signaling will be mentioned-through one or more G-protein-coupled receptor regulated protein kinases-as they relate to microglial responses. The role(s) of thrombin and PAR signaling in neuroplasticity is in keeping with emerging roles for these pathways in pathophysiologic responses, and demands a careful evaluation by the pharmacologic community in terms of drug development in the CNS. (C) 2003 Wiley-Liss, Inc.	Univ Kansas, Med Ctr, Dept Vet Affairs Med Ctr, Neurobiol Res Lab 151, Kansas City, MO 64128 USA; Univ Kansas, Sch Med, Dept Neurol, Kansas City, MO USA; Univ Kansas, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, MO USA		Festoff, BW (corresponding author), Univ Kansas, Med Ctr, Dept Vet Affairs Med Ctr, Neurobiol Res Lab 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	bfestoff@kumc.edu					Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BEACH RL, 1986, J NEUROL SCI, V72, P49, DOI 10.1016/0022-510X(86)90035-3; BEECHER KL, 1994, J NEUROSCI RES, V37, P108, DOI 10.1002/jnr.490370115; Brewer GJ, 1996, J NEUROCHEM, V67, P119; BREWER GJ, 1995, BRAIN RES, V683, P258, DOI 10.1016/0006-8993(95)00332-K; Carreno-Muller E, 2003, J NEUROCHEM, V84, P1201, DOI 10.1046/j.1471-4159.2003.01634.x; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; Cirino G, 2000, TRENDS PHARMACOL SCI, V21, P170, DOI 10.1016/S0165-6147(00)01469-3; Citron BA, 1997, NEUROSCI LETT, V230, P25, DOI 10.1016/S0304-3940(97)00468-0; Citron BA, 1997, THROMB RES, V87, P303, DOI 10.1016/S0049-3848(97)00132-1; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; CZUBAYKO U, 1995, NEUROREPORT, V6, P1249, DOI 10.1097/00001756-199506090-00005; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Dary O, 1999, BIOCHEM SOC T, V27, P246, DOI 10.1042/bst0270246; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; FERNANDEZ HL, 1979, J NEUROBIOL, V10, P441, DOI 10.1002/neu.480100503; Festoff B W, 1987, Adv Exp Med Biol, V209, P25; Festoff BW, 1987, PROG BRAIN RES <D>, V71, P423; Festoff BM, 2000, MOL MED, V6, P410, DOI 10.1007/BF03401784; FESTOFF BW, 1991, J CELL PHYSIOL, V147, P76, DOI 10.1002/jcp.1041470111; FESTOFF BW, 1980, MED HYPOTHESES, V6, P121, DOI 10.1016/0306-9877(80)90078-X; FESTOFF BW, 1982, J CELL PHYSIOL, V110, P190, DOI 10.1002/jcp.1041100213; FESTOFF BW, 1986, J CELL BIOL, V103, P1415, DOI 10.1083/jcb.103.4.1415; Festoff BW, 1996, J NEUROBIOL, V30, P255, DOI 10.1002/(SICI)1097-4695(199606)30:2<255::AID-NEU7>3.0.CO;2-4; FESTOFF BW, 1997, NEUROPROTECTIVE SIGN, P221; Gil W, 2001, PERFUSION-UK, V16, P27, DOI 10.1177/026765910101600105; Glazner GW, 1997, DEV BRAIN RES, V99, P148, DOI 10.1016/S0165-3806(96)00213-1; GLOOR S, 1986, CELL, V47, P687; GRABHAM P, 1995, J NEUROCHEM, V64, P583; GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; GURWITZ D, 1990, J CELL PHYSIOL, V142, P155, DOI 10.1002/jcp.1041420119; HANTAI D, 1990, P NATL ACAD SCI USA, V87, P2926, DOI 10.1073/pnas.87.8.2926; HANTAI D, 1989, P NATL ACAD SCI USA, V86, P362, DOI 10.1073/pnas.86.1.362; HANTAI D, 1987, EXP NEUROL, V95, P44, DOI 10.1016/0014-4886(87)90005-7; HANTAI D, 1988, REV NEUROL, V144, P680; Hantai Daniel, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P541; HAYNES LW, 2003, IN PRESS J NEUROBIOL; HEYWOOD D, 1999, BR NEUR ASS ABSTR; Hollenberg MD, 1999, TRENDS PHARMACOL SCI, V20, P271, DOI 10.1016/S0165-6147(99)01333-4; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kim S, 1998, J NEUROSCI RES, V53, P304, DOI 10.1002/(SICI)1097-4547(19980801)53:3<304::AID-JNR4>3.0.CO;2-E; Kim S, 1998, J BIOL CHEM, V273, P11923, DOI 10.1074/jbc.273.19.11923; Lanuza MA, 2001, J NEUROSCI RES, V63, P330, DOI 10.1002/1097-4547(20010215)63:4<330::AID-JNR1027>3.0.CO;2-W; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; LIU Y, 1994, J NEUROBIOL, V25, P325, DOI 10.1002/neu.480250312; LIU Y, 1994, P NATL ACAD SCI USA, V91, P10300, DOI 10.1073/pnas.91.22.10300; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Masada T, 2000, BRAIN RES, V867, P173, DOI 10.1016/S0006-8993(00)02302-7; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; MONARD D, 1983, PROG BRAIN RES, V58, P359, DOI 10.1016/S0079-6123(08)60037-0; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; Okajima K, 2001, IMMUNOL REV, V184, P258, DOI 10.1034/j.1600-065x.2001.1840123.x; Pindon A, 1998, EUR J BIOCHEM, V255, P766, DOI 10.1046/j.1432-1327.1998.2550766.x; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Salcedo RM, 1998, J MOL NEUROSCI, V10, P113, DOI 10.1007/BF02737122; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.3.CO;2-4; Smirnova IV, 1998, J MOL NEUROSCI, V10, P31, DOI 10.1007/BF02737083; Smirnova IV, 2001, J NEUROBIOL, V48, P87, DOI 10.1002/neu.1044; SOIFER SJ, 1994, AM J PATHOL, V144, P60; SOMMER J, 1987, BIOCHEMISTRY-US, V26, P6407, DOI 10.1021/bi00394a016; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Strukova SM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P8, DOI 10.1023/A:1002869310180; SUO Z, IN PRESS J BIOL CHEM; SUO Z, 2003, IN PRESS J BIOL CHEM; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Turgeon VL, 1998, J NEUROSCI, V18, P6882; Ubl JJ, 1997, GLIA, V21, P361, DOI 10.1002/(SICI)1098-1136(199712)21:4<361::AID-GLIA3>3.0.CO;2-6; Ubl JJ, 2000, J PHYSIOL-LONDON, V525, P319, DOI 10.1111/j.1469-7793.2000.00319.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang H, 2003, J NEUROCHEM, V84, P1349, DOI 10.1046/j.1471-4159.2003.01637.x; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Xi G, 2000, ACT NEUR S, V76, P511; Xi GH, 1999, STROKE, V30, P1247, DOI 10.1161/01.STR.30.6.1247; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Zoubine MN, 1996, DEV BIOL, V179, P447, DOI 10.1006/dbio.1996.0274	92	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4391	1098-2299		DRUG DEVELOP RES	Drug Dev. Res.	SEP	2003	60	1					58	64		10.1002/ddr.10321			7	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	719HA	WOS:000185196500010					2022-02-06	
J	Nimgade, A; Costello, MC				Nimgade, A; Costello, MC			Return to work for a company president with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						leadership; milieu-based rehabilitation; rehabilitation; return to work; traumatic brain injury	SUPPORTED EMPLOYMENT	Return to work remains a central issue for many traumatic brain injury (TBI) patients. The present literature generally ignores the complex work issues involved for high-functioning individuals, in whose hands may lie the fate of many other workers. This case discusses return-to-work challenges facing a 64-year-old high-technology company founder and president. Following a bicycling accident, he sustained intracerebral hemorrhage with an initial Glasgow Coma Scale of score 12. Although postmorbidly he still maintained a relatively high level of cognitive functioning, his case highlights special challenges during workplace rehabilitation of patients with cognitively demanding jobs, including (a) a higher potential for patient frustration given the gap between function and job expectations and (b) confidentiality issues regarding business employees and competitors. Rehabilitation health care providers can benefit from lessons learned here, including tapping into these patients' strong motivation for return to work, accessing the likely higher remaining cognitive level, and drawing upon the likely strong social and professional networks available. Finally, the importance of the role of stress-management techniques in order to cope with high frustration levels is highlighted.	Argus Int Inc, Ringoes, NJ 08551 USA; Harvard Univ, Sch Publ Hlth, Occupat Hlth Serv Res Occupat & Environm Med, Boston, MA 02115 USA		Costello, MC (corresponding author), Argus Int Inc, POB 559, Ringoes, NJ 08551 USA.						Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200	9	4	4	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2003	18	5					464	467		10.1097/00001199-200309000-00008			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	725BF	WOS:000185522200008	12973276				2022-02-06	
J	Kim, B; Lee, SK; terBrugge, KG				Kim, B; Lee, SK; terBrugge, KG			Endovascular treatment of traumatic intracranial aneurysm in an infant - A case report	INTERVENTIONAL NEURORADIOLOGY			English	Article						brain aneurysms; endovascular treatment; trauma	INTERNAL CAROTID-ARTERY; SUBARACHNOID HEMORRHAGE; DISSECTING ANEURYSMS; VERTEBRAL ARTERY; CHILDHOOD	Traumatic intracranial aneurysms in children are rare and mostly related to skull fracture or rapid decelerating closed head injury. We report the case of an infant who developed intracranial aneurysm after minor head trauma and managed by endovascular treatment. A seven-month-old infant presented with delayed intracranial hemorrhage following minor head trauma. Cerebral angiography disclosed a multilobulated fusiform aneurysm involving the right anterior cerebral artery (ACA) distal to the anterior communicating artery. Endovascular treatment of the aneurysm was performed and the infant made an excellent recovery during six months clinical and radiological follow-up. Delayed presentation of intracranial hemorrhage with acute deterioration in the infant after head trauma warrants angiography for proper diagnosis and management of the traumatic aneurysm, which has a high mortality rate after rupture and rebleeding. Endovascular treatment of traumatic aneurysm is feasible in infants, and occlusion of distal intracranial arterial aneurysms can be safely and precisely achieved using current cot. I technology.	Catholic Univ Korea, Dept Radiol, Seoul, South Korea; Toronto Western Hosp, Dept Med Imaging, Toronto, ON, Canada		Kim, B (corresponding author), Catholic Univ Korea, Dept Radiol, Kangnam St Marys Hosp, 505 Banpo Dong, Seoul 137701, South Korea.			Kim, Bum-soo/0000-0002-3870-6813			BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HEISKANEN O, 1989, CHILD NERV SYST, V5, P66, DOI 10.1007/BF00571112; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; Lasjaunias P L, 1997, Interv Neuroradiol, V3, P215; Laughlin S, 1997, Interv Neuroradiol, V3, P205; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; MATSUYAMA T, 1983, J CEREBR BLOOD F MET, V3, P381, DOI 10.1038/jcbfm.1983.55; MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Suh DC, 2001, ACTA NEUROCHIR, V143, P997; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; terBrugge KG, 1999, CHILD NERV SYST, V15, P751, DOI 10.1007/s003810050465; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; YAMAURA A, 1990, J NEUROSURG, V72, P183, DOI 10.3171/jns.1990.72.2.0183; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	24	4	4	0	1	EDIZIONI CENTAURO	BOLOGNA	VIA DEL PRATELLO, 8, 40122 BOLOGNA, ITALY	1123-9344			INTERV NEURORADIOL	Interv. Neuroradiol.	JUN	2003	9	2					199	204		10.1177/159101990300900210			6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	738KN	WOS:000186285900010	20591271	Green Published			2022-02-06	
J	Borgaro, SR; Kwasnica, C; Cuuer, N; Alcott, S				Borgaro, SR; Kwasnica, C; Cuuer, N; Alcott, S			The use of the BNI Screen for Higher Cerebral Functions in assessing disorientation after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute rehabilitation; disorientation; TBI	ORIENTATION; REHABILITATION	Objective: To examine the use of the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) in assessing disorientation in patients with traumatic brain injury (TBI) during the acute phases of rehabilitation. Design: Persons with TBI (n = 65) were compared with patients with spinal cord injury (SCI; n = 18) and to controls (n = 35). Setting: Inpatient neurorehabilitation unit. outcome measures: Orientation items from the BNIS measuring time (day, month, date of month, year) and place (city and hospital). Results: TBI patients showed a significantly greater proportion of incorrect responses to time and place compared with the SCI and normal control groups. There was a greater accuracy on orientation to place compared with orientation to time, and date of month produced the lowest rate of accuracy in all three groups. The single best predictor of disorientation to time was increasing age, and increasing age was most associated with disorientation to date of month. Conclusions: The BNIS was shown to be a sensitive measure of disorientation in TBI patients and yielded similar patterns of performance as documented by other measures.	St Josephs Hosp, Dept Clin Neuropsychol, Sect Neuropsychol, Barrow Neurol Inst, Phoenix, AZ 85013 USA		Borgaro, SR (corresponding author), Barrow Neurol Inst, Dept Clin Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	sborgar@cbw.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Israelian MK, 2000, REHABIL PSYCHOL, V45, P284, DOI 10.1037/0090-5550.45.3.284; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1974, MANAGEMENT HEAD INJU; LEVIN H, 1979, J NERV MENT DIS, V167, P657; Littlefield LM, 2001, REHABIL PSYCHOL, V46, P68; Prigatano GP, 1993, BNI Q, V9, P2; ROSENSTEIN I, 1992, BNI Q, V8, P24; Rosenstein LD, 1997, NEUROPSY NEUROPSY BE, V10, P113; Rosenstein LD., 1995, ADM SCORING MANUAL B; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178	14	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2003	18	3					284	291		10.1097/00001199-200305000-00006			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	682HM	WOS:000183085700006	12802170				2022-02-06	
J	Haffajee, MR; Naidoo, S				Haffajee, MR; Naidoo, S			Giant intracavernous internal carotid artery aneurysm with fatal epistaxis	CLINICAL ANATOMY			English	Article						giant intracranial aneurysm; intracavernous; internal carotid artery; delayed epistaxis; skull base erosion	INTRACRANIAL ANEURYSMS; MASSIVE EPISTAXIS; MR	The case history and autopsy findings of a 32-year-old male, who suffered a mild closed-head injury and then had repeated epistaxis beginning 5 months later, is presented. The condition culminated in an episode of fatal epistaxis 1 year after the injury. At one time during the course of his work-up, the etiology of his repeated epistaxis was thought to be a vascular nasopharyngeal neoplasm. The diagnosis of an intracavernous internal carotid artery aneurysm was made only at autopsy. The principles of management of traumatic intracavernous internal carotid artery aneurysm presenting with epistaxis are discussed. Clin. Anat. 16: 277-281, 2003. (C) 2003 Wiley-Liss, Inc.	Univ KwaZulu Natal, Dept Anat, ZA-4000 Durban, South Africa; Univ KwaZulu Natal, Dept Forens Med, ZA-4001 Durban, South Africa		Haffajee, MR (corresponding author), Univ KwaZulu Natal, Dept Anat, POB X54001, ZA-4000 Durban, South Africa.	rashidh@pixie.udw.ac.za					ARAKI C, 1965, J NEUROSURG, V23, P64, DOI 10.3171/jns.1965.23.1.0064; ATLAS SW, 1987, RADIOLOGY, V162, P111, DOI 10.1148/radiology.162.1.3786749; BHATOE HS, 1995, J LARYNGOL OTOL, V109, P650, DOI 10.1017/S0022215100130932; CAIRNS H, 1942, LISBOA MED, V19, P375; CHAMBERS EF, 1981, AM J NEURORADIOL, V2, P405; FISHER A, 1994, J COMPUT ASSIST TOMO, V18, P939, DOI 10.1097/00004728-199411000-00018; HAN MH, 1994, LARYNGOSCOPE, V104, P370; Handa J, 1976, Surg Neurol, V5, P241; HOSOBUCHI Y, 1979, J NEUROSURG, V51, P743, DOI 10.3171/jns.1979.51.6.0743; ILDAN F, 1994, J TRAUMA, V36, P565, DOI 10.1097/00005373-199404000-00018; Jefferson G, 1938, BRIT J SURG, V26, P267, DOI 10.1002/bjs.18002610208; LEE JP, 1990, J TRAUMA, V30, P619, DOI 10.1097/00005373-199005000-00017; LINSKEY ME, 1990, NEUROSURGERY, V26, P933, DOI 10.1227/00006123-199006000-00002; MAHMOUD NA, 1979, J LARYNGOL OTOL, V93, P629, DOI 10.1017/S0022215100087508; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; MCCORMICK WF, 1964, J NEUROSURG, V21, P678, DOI 10.3171/jns.1964.21.8.0678; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; ROMANIUK CS, 1993, BRIT J RADIOL, V66, P942, DOI 10.1259/0007-1285-66-790-942; SEFTEL DM, 1959, ARCHIV OTOLARYNGOL, V70, P52; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5	21	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAY	2003	16	3					277	281		10.1002/ca.10127			5	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	669JJ	WOS:000182347900014	12673826				2022-02-06	
J	Bresler, S; Scalora, MJ; Elbogen, EB; Moore, YS				Bresler, S; Scalora, MJ; Elbogen, EB; Moore, YS			Attempted suicide by cop: A case study of traumatic brain injury and the insanity defense	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; suicide by cop; police-assisted suicide; forensic psychiatry; forensic psychology; traumatic brain injury; frontal lobe dysfunction; insanity defense	VIOLENCE	Over the years, there have been a number of well-publicized incidents involving persons who seemingly maneuver police officers into shooting them. Such cases, while relatively rare compared with most forms of violence, nevertheless pose difficult challenges to law enforcement agencies. Relatively little is known about persons who engage in suicide by cop incidents. To our knowledge, there has been no published indepth research on instigators of suicide by cop who survived. In this paper, we present a case study of an individual who engaged in and lived through three separate "attempted suicide by cop" incidents. After describing relevant history as well as events of the most recent incident, we compare the case with the extant literature on suicide by cop and analyze commonalities and differences. Finally, we examine the legal considerations involved, with particular attention devoted to the role the individual's traumatic brain injury played in applying the insanity defense.	Bridgewater State Hosp, Forens Serv, Bridgewater, MA USA; Univ Nebraska, Lincoln, NE USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; Lincoln Reg Ctr, Forens Mental Hlth Serv, Lincoln, NE USA		Bresler, S (corresponding author), Forens Serv, 20 Adm Rd, Bridgewater, MA 02324 USA.						Berkowitz L., 1993, AGGRESSION ITS CAUSE; Berman ME, 1998, BEHAV SCI LAW, V16, P303, DOI 10.1002/(SICI)1099-0798(199822)16:3<303::AID-BSL309>3.0.CO;2-C; Cornell DG, 1996, J CONSULT CLIN PSYCH, V64, P783, DOI 10.1037/0022-006X.64.4.783; Hall H, 1993, DISORDERS EXECUTIVE; Hutson HR, 1998, ANN EMERG MED, V32, P665, DOI 10.1016/S0196-0644(98)70064-2; Kennedy D. B., 1998, FBI LAW ENFORCEMENT, V67, P21; LITMAN ROBERT E., 1968, J FORENSIC SCI, V13, P46; MELTON GB, 1997, PSYCHOL EVALUATIONS; Mohandie K, 2000, J FORENSIC SCI, V45, P384; Monahan J., 1994, VIOLENCE MENTAL DISO; Sbordone RJ, 1996, ECOLOGICAL VALIDITY; Shneidman E, 1996, SUICIDAL MIND; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; TARDIFF K, 1998, J PRAC PSYCHIAT BEHA, V1, P12; TRANEL D, 2000, BEHAV MOOD DISORDERS; VALCIUKAS TA, 1995, FORENSIC NEUROPSYCHO; VANZANDT CR, 1993, POLICE CHIEF     JUL, P24; Wilson EF, 1998, J FORENSIC SCI, V43, P46; WOLFGANG MARVIN E., 1959, JOUR CLIN AND EXPTL PSYCHOPATH, V20, P335; 1999, SUICIDE COP SATELLIT, P22	20	4	4	0	11	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	JAN	2003	48	1					190	194					5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	634PV	WOS:000180350300036	12570227				2022-02-06	
J	Gilmore, R; Aram, J; Powell, J; Greenwood, R				Gilmore, R; Aram, J; Powell, J; Greenwood, R			Treatment of oro-facial hypersensitivity following brain injury	BRAIN INJURY			English	Article							DYSPHAGIA; ADULTS	A 56 year old man who was 10 months post-severe traumatic brain injury was unable to tolerate oral hygiene. He had oro-facial hypersensitivity, oral dyspraxia and limited oral function. Poor oral hygiene with coating of oral structures and infection was present. An intensive systematic desensitization programme over 2 weeks, even at this late stage post-injury, increased oral tolerance and allowed full oral hygiene. Participation in oral hygiene and functional patterns of movement also improved, enabling some oral nutritional intake. This case study provides controlled evidence, very little of which exists in the literature, to demonstrate the effectiveness of these treatment techniques.	Homerton Hosp, RNRU, London E9 6SR, England; Univ London, Univ London Goldsmiths Coll, Dept Psychol, London WC1E 7HU, England		Gilmore, R (corresponding author), Homerton Hosp, RNRU, Homerton Row, London E9 6SR, England.						ASHER EI, 1986, OCCUPATIONAL THERAPY, V3, P5; BROWN G E, 1992, Dysphagia, V7, P138, DOI 10.1007/BF02493445; DAVIES PM, 1994, STARTING AGAIN, P213; FABER SC, 1982, NEUROREHABILITATION; LANGMORE SE, 1994, ARCH PHYS MED REHAB, V75, P1154, DOI 10.1016/0003-9993(94)90094-9; MILLER AJ, 1972, BRAIN RES, V43, P147, DOI 10.1016/0006-8993(72)90280-6; Miller AJ, 1986, DYSPHAGIA, V1, P91, DOI [10.1007/BF02407121, DOI 10.1007/BF02407121]; SILVERMAN EH, 1979, AM J OCCUP THER, V33, P382; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	9	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	4					347	354		10.1080/0269905031000070233			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MP	WOS:000181837200007	12637186				2022-02-06	
J	Mennel, HD; Riegel, T; Lonic, D; Bertalanffy, H				Mennel, HD; Riegel, T; Lonic, D; Bertalanffy, H			Helium (Argon) Plasma coagulation in neurosurgery. Morphology of tissue damage and reparation	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Helium (Argon) Plasma coagulation; H(A)PC; experimental brain trauma; nervous tissue reparation; dark neurons; apoptosis; brain trauma, experimental; neurons, dark	HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRAUMATIC BRAIN INJURY; PAPILLOMATOSIS; SURGERY; CORTEX; RATS	Plasma coagulation, used in some neurosurgical operative settings, is currently under experimental investigation for the precise assessment of the kind and extent of tissue damage. We established a standardised trial to investigate the effects of helium (argon) plasma coagulation - H(A)PC - on rat brain tissue. The tissue reactions were observed with common methods of morphology including immunohistology and electron microscopy. A time dependent profile of the tissue reactions was performed from day I after operation up to 6 weeks. The tissue reaction consisted of clearly demarcated concentric zones. The depth of the lesion was about 1 mm maximally, at the beginning. Reparative forces acted at variance both in the different layers and at the edges versus the center of the damage. A manifold but reproducible picture emerges in the various compartments allowing the study of different aspects of organisation and/or elimination of tissue components. This study has demonstrated that a defined circumscribed and reproducible small lesion can be performed with H(A)PC. As in other areas of surgery, this technique has proven to be minimally traumatic. Clinical application of this technique in neurosurgery is therefore promising. In addition, H(A)PC lesions are obviously best suited for morphological studies of early and late reparative reactions in cells and tissues.	Univ Marburg, Dept Neuropathol, Marburg, Germany; Univ Marburg, Neurosurg Clin, Marburg, Germany		Mennel, HD (corresponding author), Univ Klin, Abt Neuropathol, D-35033 Marburg, Germany.						BAUER BL, 1994, ACT NEUR S, V61, P1; Berger J, 1998, Z SOZIOL, V27, P1; Bergler W, 1997, J LARYNGOL OTOL, V111, P381, DOI 10.1017/S0022215100137387; Bergler W, 1999, LARYNGOSCOPE, V109, P15, DOI 10.1097/00005537-199901000-00004; Bergler W, 1997, DEUT MED WOCHENSCHR, V122, P1033, DOI 10.1055/s-2008-1047725; Bergler W, 1998, HNO, V46, P228, DOI 10.1007/s001060050230; Bergler W, 1997, LARYNGO RHINO OTOL, V76, P709, DOI 10.1055/s-2007-997512; Brand CU, 1998, DERMATOLOGY, V197, P152, DOI 10.1159/000017988; CHEHRAZI B, 1981, J NEUROSURG, V54, P197, DOI 10.3171/jns.1981.54.2.0197; DRUCKREY H, 1971, ARZNEI-FORSCHUNG, V21, P1274; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hermann DM, 2000, ACTA NEUROPATHOL, V99, P147, DOI 10.1007/PL00007418; KALIMO H, 1997, GREENFIELDS NEUROPAT, P315; KATSCH J, 1997, DTSCH DERMATOLOGE, V45, P2; KERL J, 1988, ACTA NEUROCHIR, V92, P123, DOI 10.1007/BF01401982; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; MENNEL HD, 1988, EXP PATHOL-JENA, V35, P219, DOI 10.1016/S0232-1513(88)80091-4; Mennel HD, 2000, EXP TOXICOL PATHOL, V52, P395, DOI 10.1016/S0940-2993(00)80070-6; Mennel HD, 1997, EXP TOXICOL PATHOL, V49, P425, DOI 10.1016/S0940-2993(97)80130-3; Miyazawa T, 2000, ACTA NEUROCHIR, V142, P1247, DOI 10.1007/s007010070021; PLATE KH, 1995, EXP TOXICOL PATHOL, V47, P89, DOI 10.1016/S0940-2993(11)80292-7; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RIEGEL T, 2001, 52 JAHR DTSCH GES NE; RIEGEL T, IN PRESS HELIUM ARGO; Schreiber J, 2000, RESPIRATION, V67, P287, DOI 10.1159/000029512; SODERFELDT B, 1983, ACTA NEUROPATHOL, V62, P87; Stumm G, 2001, EXP TOXICOL PATHOL, V53, P45, DOI 10.1078/0940-2993-00165; YAO H, 1995, J CEREBR BLOOD F MET, V15, P398, DOI 10.1038/jcbfm.1995.50; [No title captured]; [No title captured]	31	4	4	0	0	URBAN & FISCHER VERLAG	JENA	BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY	0940-2993			EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	NOV	2002	54	3					255	263		10.1078/0940-2993-3110258			9	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Toxicology	619GE	WOS:000179466800012	12484564				2022-02-06	
J	Kornecki, A; Constantini, S; Adani, LB; Nagar, H; Halberthal, M; Sivan, Y				Kornecki, A; Constantini, S; Adani, LB; Nagar, H; Halberthal, M; Sivan, Y			Survey of critical care management of severe traumatic head injury in Israel	CHILDS NERVOUS SYSTEM			English	Article						brain injury; intracranial pressure; pediatric; critical care; trauma; hyperventilation	BRAIN-INJURY; UNITED-KINGDOM; INTENSIVE-CARE; INTRACRANIAL HYPERTENSION; HYPERVENTILATION; HYPOTHERMIA; GUIDELINES; PRESSURE; CHILDREN; THERAPY	Objective: To survey the current monitoring and treatment policies for patients with severe traumatic brain injury (STBI) in Israel, and to compare the management of pediatric and adult intensive care units (ICUs). Design: Questionnaires were sent to the medical directors of all ICUs managing STBI patients. Results: All 21 ICUs responded to the questionnaire. All of the units were within tertiary hospitals. An intracranial pressure (ICP) monitoring device was used in over 75% of the patients in 6 out of7 (86%) of the pediatric intensive care units (PICUs), compared with 11 out of 14 (79%) of the adults ICUs. Mannitol was used in all of the units for documented elevated ICP. Mild hyperventilation (4-4.6 kPa) was applied in 52% of the units. Mild hypothermia was routinely used in 4 out of 7 (57%) and hypertonic solutions (NaCl 3%) in 3 out of 7 (43%) of the PICUs, compared with only 2 out of 14 (14%) and none (0%) of the adults ICUs respectively. PICUs aimed for a lower ICP (less than or equal to15 mm Hg) and cerebral perfusion pressure (greater than or equal to50 mm Hg) than adult ICUs (less than or equal to20 mm Hg and greater than or equal to60 mmHg respectively). Barbiturates were used only in patients with refractory intracranial hypertension. Conclusion: This survey reveals a relatively high degree of homogeneity in the treatment of STBI patients in Israel. Most patients are treated in accordance with recently published literature. We attribute this uniformity to the fact that all patients are being treated within tertiary care, university-affiliated centers. PICUs are faster at implementing new modalities of treatment and tend to adopt more aggressive treatment strategies.	Tel Aviv Univ, Dana Childrens Hosp, Sackler Fac Med, Sourasky Med Ctr,Pediat Crit Care Unit, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Dana Childrens Hosp, Sackler Fac Med, Sourasky Med Ctr,Pediat Neurosurg Dept, IL-64239 Tel Aviv, Israel; Rambam Med Ctr, Pediat Crit Care Unit, Haifa, Israel		Kornecki, A (corresponding author), Tel Aviv Univ, Dana Childrens Hosp, Sackler Fac Med, Sourasky Med Ctr,Pediat Crit Care Unit, 6 Weizmann St, IL-64239 Tel Aviv, Israel.						Bullock MR, 1996, J NEUROTRAUM, V13, P643; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; Chesnut RM, 1997, CRIT CARE MED, V25, P1275, DOI 10.1097/00003246-199708000-00011; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Drobetz H, 2000, ANASTH INTENSIV NOTF, V35, P630, DOI 10.1055/s-2000-7365; EISNBERG HM, 1988, J NEUROSURG, V69, P15; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; SCHIERHOUT G, 2000, COCHRANE DATABASE SY, V320, P1308; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037	23	4	4	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	AUG	2002	18	8					375	379		10.1007/s00381-002-0613-0			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	591QM	WOS:000177891800003	12192497				2022-02-06	
J	Mattos, P; Saboya, E; Araujo, C				Mattos, P; Saboya, E; Araujo, C			Post-traumatic brain injury behavioural sequelae: the man who lost his charm	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						traumatic brain injury; frontal lobe; frontal lobe syndrome		We portray a case of traumatic brain injury followed by symptoms of disexecutive or frontal lobe syndrome: apathy, lack of pragmatism and loss of previous abilities, specially those concerning social interaction - in particular with opposite sex - resulting in impairment of his characteristic charm. The results of the neuropsychological examination included retrieval mnemic deficits with normal recognition, impaired motor dexterity and cognitive flexibility in the presence of normal intelligence. The cognitive-behavioural symptomatology contrasted with a normal neurologic examination.	Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil			centro@attglobal.net	de Mattos, Paulo Eduardo Luiz/D-2328-2014	de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783			BLUMER D, 1977, ASPECTOS PSIQIUIATRI, P163; Damassio AR, 1993, CLIN NEUROPSYCHOLOGY, P410; Fuster J. M., 1997, PREFRONTAL CORTEX AN, P150; GRADY C, 1999, HUMAN FRONTAL LOBES, P205; HALL HV, 1993, DISORDERS EXECUTIVE, P37; JOSEPH R, 1996, NEUROPSY NEUROPSY BE, P393; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, P42; Lovell Mark R., 1994, P133; LURIA AR, 1981, FUNDAMETNTOS NEUROPS, P50; MATTOS P, 1998, PSIQUIATRIA CLIN DIA, P63; MATTOS P, 1998, CLIN NEUROLOGICA, P319; MATTOS P, 2000, TECNOLOGIA HABILITAC, P176; MATTOS P, 1993, DOCUMED, V3, P13; SCHNIDER A, 1999, SCI PRACT NEUROPSYCH, P487; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SOUZA CA, 1999, J BRAS PSIQUIATRIA, V48, P325; SOUZA CA, 2000, THESIS U FEDERAL RIO; SOUZA CA, 1999, REV BRAS NEUROL, V35, P167	19	4	4	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2002	60	2A					319	323		10.1590/S0004-282X2002000200027			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	557CV	WOS:000175890500028	12068369	Green Published, gold, Green Submitted			2022-02-06	
J	Stoffel, M; Rinecker, M; Graf, R; Baethmann, A; Plesnila, N				Stoffel, M; Rinecker, M; Graf, R; Baethmann, A; Plesnila, N			Nitric oxide in the penumbra of a focal cortical necrosis in rats	NEUROSCIENCE LETTERS			English	Article						cerebral contusion; cold injury; lesion growth; nitrate; nitrite; nitric oxide synthase; rat; traumatic brain injury	TRAUMATIC BRAIN INJURY; COLD INJURY; IN-VIVO; SYNTHASE; CEREBELLUM; LESION; EXPRESSION; KINETICS; MODELS; TISSUE	After a focal cortical freezing lesion in rats, nitric oxide (NO) end products were studied with microdialysis in the extracellular space of the penumbra throughout the whole period of secondary expansion of the cortical necrosis (i.e. 24 h). Under baseline conditions, the dialysate concentration of nitrate (nitrite) was 1.88+/-0.78 muM (5.00+/-1.50 muM) in the sham-operated group and 2.28+/-0.62 muM (3.25+/-1.32 muM) in the trauma group. In animals of both groups, these parameters neither showed significant alterations within the observation period compared with baseline values nor between the groups at each individual study time point. After focal cortical trauma, NO does not mediate secondary necrosis expansion via the extracellular space. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-81366 Munich, Germany; Max Planck Inst Neurol Res, D-50931 Cologne, Germany		Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; EGGERT HR, 1985, NEUROSURGERY, V16, P443, DOI 10.1227/00006123-198504000-00001; ERISKAT J, 1994, ACTA NEUROCHIR, P425; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HU JG, 1994, NEUROSCI LETT, V175, P41, DOI 10.1016/0304-3940(94)91073-1; Huk I, 1997, CIRCULATION, V96, P667; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; OHTA K, 1994, NEUROSCI LETT, V176, P165, DOI 10.1016/0304-3940(94)90073-6; PLESNILA N, 1997, J CEREB BLOOD FLOW M, V17, pS73; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; RENGASAMY A, 1991, J PHARMACOL EXP THER, V259, P310; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Sharma AC, 1998, NEUROL RES, V20, P632; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; STOFFEL M, 2002, IN PRESS J NEUROTRAU; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yamada K, 1997, NEUROSCI RES, V28, P93, DOI 10.1016/S0168-0102(97)00032-1; Zecca L, 1997, NEUROREPORT, V8, P2121, DOI 10.1097/00001756-199707070-00007	24	4	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 24	2002	324	3					201	204	PII S0304-3940(02)00196-9	10.1016/S0304-3940(02)00196-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566ZN	WOS:000176458300009	12009523				2022-02-06	
J	Zee, CS; Hovanessian, A; Go, JL; Kim, PE				Zee, CS; Hovanessian, A; Go, JL; Kim, PE			Imaging of sequelae of head trauma	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; BRAIN INJURY; PROGNOSTIC IMPLICATIONS; COMPUTED TOMOGRAPHY; EARLY DIAGNOSIS; CSF-FISTULAS; MRI; CT; CHILDREN; HEMATOMA	The imaging of head trauma has been one of the fundamental cornerstones of neuroradiology. As the practice of neuroimaging has matured, great strides have been made in the diagnostic as well as prognostic armamentarium available to physicians. Given the vast diversity of trauma mechanisms and clinical pathways, new advanced imaging technologies have had a lasting impact on the detection, description, and depiction of head trauma. Furthermore, these new tools are allowing the imaging specialist to function not only as an interpreter of what is seen but as a 21st century radiographic oracle. We present a comprehensive review of the imaging findings of sequalae of traumatic brain injury and the growing correlation of new neuroimaging techniques and neurotraumatic outcomes.	Univ So Calif, Dept Radiol, Keck Sch Med, Los Angeles, CA 90033 USA		Zee, CS (corresponding author), Univ So Calif, Dept Radiol, Keck Sch Med, 1500 San Pablo St, Los Angeles, CA 90033 USA.						Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bigler E D, 1999, Appl Neuropsychol, V6, P217, DOI 10.1207/s15324826an0604_4; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Charfi N, 2001, PRESSE MED, V30, P59; CLARK JA, 1980, J NEUROSURG, V52, P266, DOI 10.3171/jns.1980.52.2.0266; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; DRAYER BP, 1975, JAMA-J AM MED ASSOC, V231, P174, DOI 10.1001/jama.231.2.174; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HANS JS, 1984, RADIOLOGY, V150, P71; Hoelper BM, 2000, ACT NEUR S, V76, P265; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Husson B, 1996, PEDIATR RADIOL, V26, P744, DOI 10.1007/BF01383396; Jennet B, 1975, EPILEPSY NONMISSILE; Kastner S, 2001, NERVENARZT, V72, P307, DOI 10.1007/s001150050755; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; KIM KS, 1978, RADIOLOGY, V128, P71, DOI 10.1148/128.1.71; Klein S, 2000, ZBL NEUROCHIR, V61, P150, DOI 10.1055/s-2000-10998; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lewin W, 1964, Clin Neurosurg, V12, P237; Lund VJ, 2000, J LARYNGOL OTOL, V114, P988; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; MCGAULEY JL, 1975, J NEUROSURG, V43, P374, DOI 10.3171/jns.1975.43.3.0374; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Miner ME, 1996, NEUROSURGERY, P2809; Ommaya AK, 1996, NEUROSURGERY, P2773; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; POON WS, 1992, NEUROSURGERY, V30, P681; PRESTON FE, 1974, J NEUROL NEUROSUR PS, V37, P241, DOI 10.1136/jnnp.37.3.241; PRETORIUS ME, 1982, ACTA NEUROCHIR, V65, P103, DOI 10.1007/BF01405446; RAHIMIZADEH A, 1986, NEUROSURGERY, V19, P675; RAPPORT RL, 1975, ARCH NEUROL-CHICAGO, V32, P539, DOI 10.1001/archneur.1975.00490500059007; SCHNEIDER RC, 1957, ANN SURG, V145, P517, DOI 10.1097/00000658-195704000-00008; Server A, 2001, ACTA RADIOL, V42, P254; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; Udstuen GJ, 2001, NEUROIMAG CLIN N AM, V11, P433; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; WEHRLE PF, 1967, CLIN NEUROSURG, V14, P72; YOUNG B, 1996, NEUROSURGERY, P2841; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; ZEE CS, 1996, NEUROSURGERY, P2675	57	4	4	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1052-5149			NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	MAY	2002	12	2					325	+	PII S1052-5149(02)00004-7	10.1016/S1052-5149(02)00004-7			15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	609GA	WOS:000178894200012	12391639				2022-02-06	
J	Faillace, WJ				Faillace, WJ			Management of childhood neurotrauma	SURGICAL CLINICS OF NORTH AMERICA			English	Article							SPINAL-CORD INJURY; SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; CONTROLLED TRIAL; TRAUMA CENTER; CHILDREN; METHYLPREDNISOLONE; EPIDEMIOLOGY; CONCUSSION	A summary of some of the more important aspects of brain, spinal, peripheral nerve and sport injuries of childhood is presented. Guidelines for the treatment of severe brain injury have been developed for adults, are currently employed with success to treat children, but much information still needs to be acquired about childhood brain injury so that better age specific treatment modalities could be implemented. The unique anatomy of the spine during childhood predisposes to cervical spinal injury without radiographic abnormality; immobilization is the primary treatment and a minority of cases require surgery. Peripheral nerve injuries are uncommon, often missed, and require skillful evaluation and early treatment by physical therapy and oftentimes surgery. Appreciation of the sequelae of cerebral concussion, education on proper sport techniques, body conditioning, and equipment upkeep are the mainstay of vigilant sport injury treatment and prevention.	Univ Florida Jacksonville, Dept Neurosurg, Jacksonville, FL 32209 USA		Faillace, WJ (corresponding author), Univ Florida Jacksonville, Dept Neurosurg, 653-1 W 8th St, Jacksonville, FL 32209 USA.						AVOLIO AEC, 1992, NEUROSURGERY, V31, P557, DOI 10.1227/00006123-199209000-00019; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BAILEY DK, 1952, RADIOLOGY, V59, P712, DOI 10.1148/59.5.712; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; *BRAIN TUM FDN, 2000, MAN PROGN SEV TRAUM, P1; BULLOCK R, 1996, NEUROTRAUMA, P375; CANTU R, 1996, NEUROTRAUMA, P1301; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; *COMM TRAUM AM COL, 1997, ADV TRAUM LIF SUPP I; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; FEHLINGS MG, 1991, J NEUROSURG SPINE S1, V91, P1; GILLES FH, 1979, AM J DIS CHILD, V133, P30, DOI 10.1001/archpedi.1979.02130010036005; GODERSKY J C, 1989, Contemporary Neurosurgery, V11, P1; HAFFNER DL, 1993, SPINE, V18, P679, DOI 10.1097/00007632-199305000-00001; HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700; HAMILTON MG, 1992, J NEUROSURG, V77, P705, DOI 10.3171/jns.1992.77.5.0705; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KLINE DG, 1995, NERVE INJURIES, P461; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LAURENT JP, 1994, PEDIAT NEUROSURGERY, P344; LEVENTHAL HR, 1960, J PEDIATR-US, V56, P447, DOI 10.1016/S0022-3476(60)80356-3; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; PANG D, 1982, J NEUROSURG, V57, P1114; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Rosner Michael J., 1993, P57; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SEDDON H, 1972, SURGICAL DISORDERS P, P9; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; YOUNG W, 1996, NEUROTRAUMA, P1075	43	4	4	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0039-6109			SURG CLIN N AM	Surg. Clin.-North Am.	APR	2002	82	2					349	+	PII S0039-6109(02)00010-5	10.1016/S0039-6109(02)00010-5			16	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	567XZ	WOS:000176513500008	12113371				2022-02-06	
J	Angelino, E; Miglioretti, M; Zotti, AM				Angelino, E; Miglioretti, M; Zotti, AM			Agitation assessment in severe traumatic brain injury: methodological and clinical issues	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; REHABILITATION; BEHAVIOR; DESIGNS; SCALE	The aim of this single case study was to evaluate the applicability of a graphic and statistical time-series analyses in the observation of an agitation disturbance in a 16-year-old patient who had sustained a severe traumatic brain injury. The agitation was measured using the Agitated Behaviour Scale. The experimental model was of the A-B type: phase A corresponded to the period of vegetative state, and phase B to the period following the reawakening from coma. The data were submitted to visual and statistical analysis by the split-middle trend line method, function of autocorrelation, and C statistic. The results show the different nature and frequency of the agitated behaviour during the vegetative state and after reawakening from coma. The application of a statistical analysis to establish whether the behavioural disturbance is random or a response to the environment allows the adoption of specific and potentially more efficacious treatments.	Salvatore Maugeri Fdn, IRCCS, Sci Inst Veruno, Psychol Unit, I-28010 Veruno, NO, Italy; Univ Turin, Postgrad Sch Hlth Psychol, Turin, Italy		Angelino, E (corresponding author), Salvatore Maugeri Fdn, IRCCS, Sci Inst Veruno, Psychol Unit, Via Revislate 13, I-28010 Veruno, NO, Italy.						Alderman N, 1999, BRAIN INJURY, V13, P669; BENGALI MK, 1998, AM J OCCUPATIONAL TH, V8, P650; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Caracciolo E., 1986, B PSICOLOGIA APPL, V175, P41; COLLA N, 1993, SPSS PER WINDOWS 6 0; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CROSBIE J, 1989, BEHAV ASSESS, V11, P315; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Godbout A, 1997, BRAIN INJURY, V11, P629, DOI 10.1080/026990597123188; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; OTTENBACHER KJ, 1991, AM J PHYS MED REHAB, V70, pS144; OTTENBACHER KJ, 1992, AM J PHYS MED REHAB, V71, P202, DOI 10.1097/00002060-199208000-00002; PERINI S, 1996, PSICOTERAPIA COGNITI, V2, P19; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; TRYON WW, 1982, J APPL BEHAV ANAL, V15, P423, DOI 10.1901/jaba.1982.15-423; von Neumann J, 1941, ANN MATH STAT, V12, P367, DOI 10.1214/aoms/1177731677; WOLERY M, 1982, PHYS THER, V62, P445, DOI 10.1093/ptj/62.4.445	22	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2002	16	3					269	275		10.1080/02699050110103968			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	526HP	WOS:000174124800008	11874618				2022-02-06	
J	Goldblum, D; Gygax, M; Bohnke, M; Garweg, JG				Goldblum, D; Gygax, M; Bohnke, M; Garweg, JG			In vitro toxicity of rivastigmine and donepezil in cells of epithelial origin	OPHTHALMIC RESEARCH			English	Article						toxicology; cholinesterase inhibitor; rivastigmine; donepezil; glaucoma; neuroprotection	SELECTIVE ACETYLCHOLINESTERASE INHIBITOR; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; APROTININ; RABBITS; MODEL; RAT	Neurospecific acetylcholinesterase inhibitors have been shown to lower intraocular pressure (IOP) in normal rabbits and might have additional neuroprotective effects. This study was set out to explore and compare the toxicity of two selective acetylcholinesterase inhibitors, rivastigmine and donepezil, on two standardized cell lines of epithelial origin. Chang and Vero cells were incubated with various concentrations of rivastigmine or donepezil. Acute toxicity (4 h) was assessed by monitoring the permeability of cells to propidium iodide. Chronic toxicity (7 days) was determined by monitoring the effect of the two drugs on esterase activity and cell proliferation. The viability of cells was also assessed morphologically by microscopic inspection. Signs of acute toxicity became manifest at a rivastigmine concentration of 50 mg/ml in both Chang and Vero cells. Indications of chronic toxicity became obvious at concentrations of as low as 1 x 10(-5) mg/ml. In contrast, degenerative morphological changes became manifest only at a concentration of as high as 1 mg/ml. In donepezil-treated cells, acute toxicity was not observed in the concentration range tested, whereas chronic toxicity was detected at 1 x 10(-1) mg/ml in both Chang and Vero cells, a concentration at which degenerative morphological changes became evident as well. In contrast to rivastigmine, donepezil elicited no signs of acute or chronic toxicity in either Chang or Vero cells at the IOP-lowering concentration of 1 X 10(-4) mg/ml. At this dose, the drug is therefore unlikely to evoke deleterious effects on ocular surface tissues in the clinical setting. Introduction Copyright (C) 2002 S. Karger AG, Basel.	Univ Bern, Dept Ophthalmol, Bern, Switzerland		Goldblum, D (corresponding author), Univ Bern, Inselspital, Lab Ocular Pharmacol, Dept Ophthalmol, CH-3010 Bern, Switzerland.	goldblum@vsao.ch	Goldblum, David/G-8559-2014	Goldblum, David/0000-0002-2119-1710			BARILE FA, 1994, CELL BIOL TOXICOL, V10, P155, DOI 10.1007/BF00757558; BOISJOLY HM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1758, DOI 10.1001/archopht.1990.01070140112040; BRAODWAY D, 1993, BRIT J OPHTHALMOL, V77, P590, DOI 10.1136/bjo.77.9.590; CEJKOVA J, 1989, HISTOCHEMISTRY, V92, P441, DOI 10.1007/BF00492502; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Cottin M, 1997, TOXICOL IN VITRO, V11, P399, DOI 10.1016/S0887-2333(97)00020-9; De Saint Jean M, 2000, CURR EYE RES, V20, P85, DOI 10.1076/0271-3683(200002)20:2;1-D;FT085; DEROETTH A, 1966, AM J OPHTHALMOL, V62, P619, DOI 10.1016/0002-9394(66)92182-9; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Enz A, 1996, ALZHEIMERS DIS MOL B, P211; Goldblum D, 2000, J OCUL PHARMACOL TH, V16, P29, DOI 10.1089/jop.2000.16.29; GOLDBLUM D, 1999, OPHTHALMIC RES S1, V31, P130; GUNTHER K, 1993, BIOMED TECH, V38, P249, DOI 10.1515/bmte.1993.38.10.249; HARRIS LS, 1972, OPHTHALMOLOGICA, V166, P153, DOI 10.1159/000308480; Hiscox P E, 1966, Can J Ophthalmol, V1, P274; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; KASHII S, 2000, 3 INT S OC PHARM PHA; Kronfeld P C, 1970, Surv Ophthalmol, V14, P479; LACHMAN C, 1974, EXP EYE RES, V19, P195, DOI 10.1016/0014-4835(74)90036-0; LEOPOLD IH, 1971, AM J OPHTHALMOL, V72, P460, DOI 10.1016/0002-9394(71)91320-1; Lin CP, 1999, J OCUL PHARMACOL TH, V15, P59, DOI 10.1089/jop.1999.15.59; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; Mckinnon SJ, 2000, INVEST OPHTH VIS SCI, V41, pS536; MIETZ H, 1994, GRAEF ARCH CLIN EXP, V232, P561, DOI 10.1007/BF00182000; Polinsky RJ, 1998, CLIN THER, V20, P634, DOI 10.1016/S0149-2918(98)80127-6; ROGERS SL, 1991, CHOLINERGIC BASIS AL, V3, P314; SUGIMOTO H, 1995, J MED CHEM, V38, P4821, DOI 10.1021/jm00024a009; Svensson AL, 1998, NEUROREPORT, V9, P1519, DOI 10.1097/00001756-199805110-00050; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tripathi B J, 1992, Lens Eye Toxic Res, V9, P361; TSAI CS, 1991, ARCH OPHTHALMOL-CHIC, V109, P199, DOI 10.1001/archopht.1991.01080020045040; Ventura ACS, 1999, J OCUL PHARMACOL TH, V15, P525, DOI 10.1089/jop.1999.15.525; Vickers JC, 1997, AUST NZ J OPHTHALMOL, V25, P105, DOI 10.1111/j.1442-9071.1997.tb01290.x; WENZEL DG, 1983, TOXICOLOGY, V29, P173, DOI 10.1016/0300-483X(83)90049-5; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152	36	4	4	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0030-3747	1423-0259		OPHTHALMIC RES	Ophthalmic Res.	MAR-APR	2002	34	2					97	103		10.1159/000048336			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	540JF	WOS:000174925200008	11914613				2022-02-06	
J	Pantovic, R; Draganic, P; Blagovic, B; Erakovic, V; Simonic, A; Milin, C				Pantovic, R; Draganic, P; Blagovic, B; Erakovic, V; Simonic, A; Milin, C			Effect of indomethacin on the level of arachidonic acid in an experimental model of neurotrauma	PERIODICUM BIOLOGORUM			English	Article; Proceedings Paper	2rd Croatian Congress of Pharmacology with International Participetion	SEP 18-21, 2000	ZAGREB, CROATIA			arachidonic acid; gas chromatography; indomethacin; rabbit; spinal cord injury	SPINAL-CORD; INJURY	Introduction: Fatty acids are essential components of membrane phospholipids, having therefore an important role in maintaining the structure and a function of cell membranes. Accumulation of free arachidonic acid, C20:4, a precursor of prostaglandins and leukotriens, is an indicator of nervous cell damage caused by neuro-trauma, In this study we followed the effect of indomethacin, a potent inhibitor of endogenous prostaglandin synthesis, on the level of arachidonic acid in an experimental model of spinal cord injury in rabbits. Material and Methods: Indomethacin was tested in the doses of 0,1; 0.3; 1.0 and 3.0 mg/kg of body weight. Spinal cord samples from the impact injury site were taken and frozen in liquid nitrogen. Modified method by Folch was used for isolation and purification of total lipids, The FFAs were separated from the total lipid extract by preparative thin-layer chromatography. Arachidonic acid was identified and quantified using gas chromatography. Results and Conclusion: The level of arachidonic acid was increased in the spinal cord of experimental animals after neuro-trauma. Indomethacin treatment induced significant decrease in free arachidonic level caused by neurotrauma.	Univ Rijeka, Fac Med, Dept Chem & Biochem, Rijeka 51000, Croatia; Univ Rijeka, Fac Med, Dept Pharmacol, Rijeka 51000, Croatia; PLIVA Res Div, Zagreb 10000, Croatia		Pantovic, R (corresponding author), Univ Rijeka, Fac Med, Dept Chem & Biochem, Brace Branchetta 20, Rijeka 51000, Croatia.		Blagovic, Branka/S-4391-2018	Blagovic, Branka/0000-0001-5075-8256			ALBIN MS, 1968, J NEUROSURG, V29, P113, DOI 10.3171/jns.1968.29.2.0113; Banik NL, 2000, NEUROCHEM RES, V25, P1509, DOI 10.1023/A:1007684311023; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; FOLCH J, 1957, J BIOL CHEM, V227, P107; Guven MB, 1999, PEDIATR NEUROSURG, V31, P189, DOI 10.1159/000028860; Toborek M, 1999, J NEUROCHEM, V73, P684, DOI 10.1046/j.1471-4159.1999.0730684.x	7	4	4	0	0	PERIODICUM BIOLOGORUM	ZAGREB	HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA	0031-5362			PERIOD BIOL	Period. Biol.	MAR	2002	104	1					95	97					3	Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	556QP	WOS:000175860700016					2022-02-06	
J	Lynch, WJ				Lynch, WJ			Assessment in traumatic brain injury: Update on recent developments	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									Vet Affairs Palo Alto Hlth Syst, Brain Injury Rehabil Unit, Palo Alto, CA USA		Lynch, WJ (corresponding author), Vet Affairs Palo Alto Hlth Syst, Brain Injury Rehabil Unit, Palo Alto, CA USA.						Benedict, 2001, HOPKINS VERBAL LEARN; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; DELIS D, 2000, COMPREHENSIVE SCORIN; DELIS DC, 2000, CALIFORNIA VERBAL LE; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Lynch WJ, 2000, J HEAD TRAUMA REHAB, V15, P1172, DOI 10.1097/00001199-200010000-00013; Psychological Corporation, 1999, WECHSL ABBR SCAL INT	8	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2002	17	1					66	70		10.1097/00001199-200202000-00009			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	519MM	WOS:000173730100010	11860331				2022-02-06	
J	Marshall, RC; Karow, CM				Marshall, RC; Karow, CM			Retrospective examination of failed rate-control intervention	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						speech; rate control; dyscontrol; intervention	TRAUMATIC BRAIN INJURY; SPEAKING RATE; PARKINSONIAN DYSARTHRIA; SPEECH; INTELLIGIBILITY; NATURALNESS; DISCOURSE	Individuals with motor-speech disorders are frequently admonished by clinicians to "slow down" to improve speech intelligibility and comprehensibility. Although most reports of rate-control therapy highlight the benefits of specific procedures, all patients are not candidates for these interventions. The subject of this clinical report is AC, a 40-year-old man who had spoken with an extremely rapid speech rate for 17 years following a traumatic brain injury but was never treated for the problem. Traditional rate-control interventions were not effective in slowing AC's speech rate nor in reducing its handicapping effects. In this report we supply background information on AC; initial assessment data from speech-language pathology, neurology, and neuropsychology; and describe rate-control interventions that were not effective with AC. A retrospective examination of this case was conducted to elucidate possible reasons why treatment was unsuccessful. This involved (a) an instrumental assessment of selected features of AC's speech rate (using equipment not available for the initial evaluation) and (b) a reinterpretation of other assessment information. Findings revealed how AC's speech differed from that of a normally speaking control subject and other normative data and provided insights on how he accomplished his rapid speech rate. This prompted us to consider (a) possible explanations for AC's fast rate, (b) reasons for failed rate-control intervention, and (c) what we learned from this case that would be useful to clinicians in management of similar patients.	Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40536 USA; Univ Rhode Isl, Kingston, RI USA		Marshall, RC (corresponding author), Univ Kentucky, Dept Rehabil Sci, CAHP Bldg,121 Washington Ave, Lexington, KY 40536 USA.						ANDREWS G, 1971, BRIT J DISORD COMMUN, V6, P129; ARNOLD G, 1960, LOGOS, V3, P82; Babcock H., 1930, ARCH PSYCHOL, V117; BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; BEUKELMAN DR, 1977, J SPEECH HEAR DISORD, V42, P265, DOI 10.1044/jshd.4202.265; BRADFORD D, 1970, FOLIA PHONIATR, V22, P272, DOI 10.1159/000263404; Brown J.R., 1975, MOTOR SPEECH DISORDE; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CALIGIURI MP, 1989, BRAIN LANG, V36, P493, DOI 10.1016/0093-934X(89)90080-1; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; CROW E, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P99; CRYSTAL TH, 1982, J ACOUST SOC AM, V72, P705, DOI 10.1121/1.388251; CURLEE RF, 1969, J SPEECH HEAR DISORD, V34, P245, DOI 10.1044/jshd.3403.245; DALTON P, 1977, DISORDERS FLUENCY TH, P107; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; DARLEY FL, 1978, DIAGNOSTIC METHDOS S; DEFUSCO EM, 1979, BRAIN LANG, V8, P25, DOI 10.1016/0093-934X(79)90037-3; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DONGILLI JP, 1992, J HEAD TRAUMA REHAB, V7, P91; DOWNIE AW, 1981, BRIT J DISORD COMMUN, V16, P135; Duffy JR., 2020, MOTOR SPEECH DISORDE; Fairbanks G., 1960, VOICE ARTICULATION D; GOLDMANEISLER F, 1961, LANG SPEECH, V4, P171, DOI 10.1177/002383096100400305; GOLPER LC, 2001, LANGUAGE INTERVENTIO, P194; GOODGLASS H, 1981, ASSESSMENT APHASIA R; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HANSON W, 1980, J SPEECH HEAR DISORD, V45, P244; Hardy J, 1967, CORTEX, V3, P128; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hathaway S.R., 1951, MINNESOTA MULTIPHASI; HELM N, 1979, J SPEECH HEAR DISORD, V44, P353; HENDERSON A, 1966, LANG SPEECH, V9, P207, DOI 10.1177/002383096600900402; INCE LP, 1973, ARCH PHYS MED REHAB, V54, P233; Kaplan E, 1983, BOSTON NAMING TEST; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCHENRY M, 1994, BRAIN INJURY, V8, P363, DOI 10.3109/02699059409150987; McNeil M., 1997, CLIN MANAGEMENT SENS, P311; McNeil M.R, 1991, CLIN APHASIOLOGY C; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Metter E., 1983, CLIN DYSARTHRIA, P231; NETSELL R, 1975, J SPEECH HEAR DISORD, V40, P170, DOI 10.1044/jshd.4002.170; NETSELL R, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P3; NETSELL R, 1994, AM J SPEECH-LANG PAT, V3, P9; RAMIG LO, 1995, J SPEECH HEAR RES, V38, P1332; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosenbek J.C., 1985, CLIN MANAGEMENT NEUR, V2nd ed., P97; SCHIAVETTI N, 1997, NATURE TREATMENT STU, P398; Schmidt RA., 1991, MOTOR LEARNING PERFO; SIMMONS N, 1983, CLIN DYSARTHRIA, P283; Simmons N. N., 1978, CLIN APHASIOLOGY C P, P174; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Southwood H, 1987, CLIN APHASIOLOGY C P, P277; STLOUIS KO, 1995, LANG SPEECH HEAR SER, V26, P187; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TIKOFSKY RS, 1970, J SPEECH HEAR RES, V13, P59, DOI 10.1044/jshr.1301.59; TILL J, 1990, J COMPUTER USERS SPE, V6, P134; TILL JA, 1988, J SPEECH HEAR DISORD, V53, P449, DOI 10.1044/jshd.5304.449; Tsao YC, 1997, J SPEECH LANG HEAR R, V40, P858, DOI 10.1044/jslhr.4004.858; TSENG CH, 1993, BRAIN LANG, V45, P276, DOI 10.1006/brln.1993.1046; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; VERRIPS A, 1998, J MED SPEECH-LANG PA, V6, P161; VOGEL D, 1991, TREATING DISORDERED, P87; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WEISS DA, 1972, CLUTTERING; WOLK L, 1986, BRIT J DISORD COMMUN, V21, P199; Yorkston K, 1991, COMMUNICATION DISORD, P251; Yorkston K. M., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI [10.1044/1058-0360.0501.55, DOI 10.1044/1058-0360.0501.55]; YORKSTON KM, 1990, J SPEECH HEAR DISORD, V55, P550, DOI 10.1044/jshd.5503.550; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P26; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; YORKSTON KM, 1992, INTELLIGIBILITY SPEE, P00265; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P393; [No title captured]; [No title captured]	81	4	4	0	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1058-0360			AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2002	11	1					3	16		10.1044/1058-0360(2002/002)			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	598CC	WOS:000178256700002					2022-02-06	
J	Trabold, F; Meyer, P; Orliaguet, G				Trabold, F; Meyer, P; Orliaguet, G			Initial management of severely head-injured infants.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head trauma; emergency management; infant	BLUNT TRAUMA; BRAIN INJURY; COMA SCALE; CHILDREN; HYPOTENSION; RADIOGRAPHY	The initial management of severely head-injured patients, including infants and children, is aimed at preventing and treating secondary brain damage, which mainly result from systemic insults (hypoxaemia, hypercarbia, arterial hypotension). Orotracheal intubation, followed by continuous sedation-analgesia, is mandatory when the Glasgow Coma Scale score (GCS) is less than or equal to 8 (crush induction is recommended). The goal of mechanical ventilation is to maintain normoxaemia and normocarbia. Moreover, the maintenance of an optimal cerebral perfusion pressure, usually 50 mmHg in infants, requires volume loading (isotonic fluids and colloids), and catecholamines if arterial hypotension persists. Intravenous mannitol is used only in case of life threatening intracranial hypertension, keeping in mind the potential for aggravating an hypovolaemia. Cerebral tomodensitometry is the most relevant imaging procedure for diagnosing surgical brain lesion. However, it should be noted, that severe head trauma is frequently associated with extra-cranial traumatic injuries, which may be responsible for (avoidable) deaths if the diagnosis is not made or delayed. Therefore, infants and small children presenting with severe head trauma should be considered as multiple injured and treated accordingly. Adequate initial management of severely head-injured children may participate to improved neurological outcome. (C) 2002 Editions scientifiques et medicales Elsevier SAS.	Hop Necker Enfants Malad, Dept Anesthesie Reanimat Chirurg, F-75743 Paris 15, France		Orliaguet, G (corresponding author), Hop Necker Enfants Malad, Dept Anesthesie Reanimat Chirurg, 149 Rue Sevres, F-75743 Paris 15, France.	gilles.orliaguet@nck.ap-hop-paris.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Orliaguet, Gilles/0000-0003-0930-2251			*AN SFAR SRLF, 1999, ANN FR ANESTH, V18, P1; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Claudet I, 1999, ANN FR ANESTH, V18, P313, DOI 10.1016/S0750-7658(99)80057-4; Cox L A, 1996, Radiol Technol, V67, P513; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; KEWALRAMANI LS, 1980, PARAPLEGIA, V18, P206, DOI 10.1038/sc.1980.36; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; MALOMO AO, 1995, E AFR MED J, V72, P186; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAMUNDO GB, 1995, ANESTHESIOLOGY, V82, P317, DOI 10.1097/00000542-199501000-00049; RENIER D, 2001, CONS C PED NEUR HEAD; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SIMPSON D, 1982, LANCET, V2, P450; Societe francaise d'anesthesie et de reanimation, 2000, ANN FR ANESTH, V19, pfi56; Suominen P, 1998, INJURY, V29, P425; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	31	4	4	0	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2002	21	2					141	147		10.1016/S0750-7658(01)00513-5			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	534CL	WOS:000174567000011	11915473				2022-02-06	
J	Arco, L				Arco, L			Using self-generated feedback for generalising and maintaining staff performance in a rehabilitation program	BEHAVIOUR CHANGE			English	Article							INSTITUTIONAL STAFF; TRAINING-PROGRAM; LARGE-SCALE; MANAGEMENT; BEHAVIOR; STUDENTS	The aim of this study was to examine whether a low cost self-generated feedback procedure was sufficient for generalising and maintaining staff performance. Two staff members were trained to implement a communication skills program with a client with severe closed head injuries. Staff were first trained to perform competently via written instructions, videotaped models, discussion, and on-the-job supervisory feedback. Posttraining conditions consisted of staff continuing with recording and graphing gains in client skills, or rating their own performance (i,e,, they continued with self-generated feedback). A multiple baseline design across client skills and staff was used to observe generalised effects on staff performance (prompts and positive consequences) and client skills. Results show that after staff attained competency, and without further supervisory feedback, their performance generalised to topographically similar performance. and the staff member who consistently participated in the study maintained her performance for 16 weeks.	Edith Cowan Univ, Joondalup, WA 6027, Australia		Arco, L (corresponding author), Edith Cowan Univ, Joondalup, WA 6027, Australia.						Arco L, 1997, J ORGAN BEHAV MANAGE, V17, P37, DOI 10.1300/J075v17n01_03; Arco L, 1996, BEHAV MODIF, V20, P300, DOI 10.1177/01454455960203004; ARCO L, 1997, THESIS MURDOCH U PER; ARCO L, 1991, BEHAV RESIDENTIAL TR, V6, P231, DOI DOI 10.1002/BIN.2360060402; BALCAZAR F, 1986, J ORGAN BEHAV MANAGE, V7, P65; BURGION LD, 1990, J APPL BEHAV ANAL, V23, P111, DOI 10.1901/jaba.1990.23-111; DEMCHAK M, 1990, AM J MENT RETARD, V94, P603; FLEMING RK, 1993, BEHAV RESIDENTIAL TR, V8, P29; GREEN CW, 1991, J APPL BEHAV ANAL, V24, P459, DOI 10.1901/jaba.1991.24-459; Hall LJ, 1997, BEHAV CHANGE, V14, P174, DOI 10.1017/S0813483900003478; HARCHIK AE, 1992, J APPL BEHAV ANAL, V24, P459; HRYDOWY ER, 1994, BEHAV MODIF, V18, P66, DOI 10.1177/01454455940181005; HUTCHISON JM, 1980, BEHAV MODIF, V4, P57, DOI 10.1177/014544558041003; IVANCIC MT, 1981, J APPL BEHAV ANAL, V14, P95, DOI 10.1901/jaba.1981.14-95; Jahr E, 1998, RES DEV DISABIL, V19, P73, DOI 10.1016/S0891-4222(97)00030-9; KIRBY KC, 1988, BEHAV ANALYST, V11, P115, DOI 10.1007/BF03392465; KISSEL RC, 1983, J APPL BEHAV ANAL, V16, P395, DOI 10.1901/jaba.1983.16-395; LATTIMORE J, 1984, MENT RETARD, V22, P79; Leech D., 1999, ED PSYCHOL, V19, P441, DOI [10.1080/0144341990190405, DOI 10.1080/0144341990190405]; Methot LL, 1996, J ORGAN BEHAV MANAGE, V16, P3, DOI 10.1300/J075v16n02_02; PAGE TJ, 1982, J APPL BEHAV ANAL, V15, P335, DOI 10.1901/jaba.1982.15-335; PARSONS MB, 1987, J APPL BEHAV ANAL, V20, P139, DOI 10.1901/jaba.1987.20-139; QUILITCH HR, 1975, J APPL BEHAV ANAL, V8, P59, DOI 10.1901/jaba.1975.8-59; REID DH, 1989, STAFF MANAGEMENT HUM; SHORE BA, 1995, J APPL BEHAV ANAL, V28, P323, DOI 10.1901/jaba.1995.28-323; STOKES TF, 1989, BEHAV THER, V20, P337, DOI 10.1016/S0005-7894(89)80054-1; Suda K.T., 1993, BEHAV INTERVENT, V8, P69, DOI [https://doi.org/10.1002/bin.2360080202, DOI 10.1002/BIN.2360080202]	27	4	4	0	0	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	0813-4839			BEHAV CHANGE	Behav. Change		2002	19	2					75	89		10.1375/bech.19.2.75			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	642LP	WOS:000180806100002					2022-02-06	
J	Chan, RCK; Hoosain, R; Lee, TMC				Chan, RCK; Hoosain, R; Lee, TMC			Talking while performing a task: A better attentional performance in patients with closed head injury?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							QUESTIONNAIRE; FAILURES	This study explored the potentially beneficial effect of explicit verbalization on the attentional performance in patients with closed head injury (CHI) in both distracting and nondistracting environments. Ten patients with CHI and 10 normal controls were recruited. The findings indicated that in the absence of distractors, the two groups did not differ significantly on the total actual time of off-task behaviour. When distractors were present, the patients performed worse than their controls; whereas verbalization tended to reduce total actual time of off-task behaviour in patients more than normal controls (z = 1.965, p = .049), the controls were at ceiling under the verbalization condition. Although the findings must be considered tentative because of this ceiling effect and the small sample sizes, our results do suggest that patients with CHI benefit more from self-instructional cues in a complex and distracting environment.	Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China		Chan, RCK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Psychiat, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X			BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; CHAN CM, 1984, COGNITIVE THER RES, V8, P501, DOI 10.1007/BF01173287; Chan RCK, 1999, ARCH CLIN NEUROPSYCH, V14, P735, DOI 10.1016/S0887-6177(99)80228-5; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Cole PG, 1998, INT J DISABIL DEV ED, V45, P411; DELIA LF, 1996, COLOUR TRAILS TEST P; Goldstein, 1996, ECOLOGICAL VALIDITY, P75; GOODMAN SH, 1984, J GENET PSYCHOL, V145, P127; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; KERNS KA, 1996, ECOLOGICAL VALIDITY, P147; Long, 1996, ECOLOGICAL VALIDITY, P15; Luria A.R., 1961, ROLE SPEECH REGULATI; MEICHENBAUM D, 1978, DEV SELF REGULATION; MEINCHENBAUM D, 1973, BEHAV THER, V4, P515; MEINCHENBAUM D, 1971, J ABNORM PSYCHOL, V77, P115; POSNER MI, 1993, ATTENTION SELECTION, P391; Posner MI., 1994, IMAGES MIND; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Vygotsky L. S., 1962, THOUGHT LANGUAGE; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; [No title captured]	27	4	4	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	5					695	704		10.1076/jcen.24.5.695.1003			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	573RJ	WOS:000176844400012	12187452				2022-02-06	
J	Hunt, EA				Hunt, EA			Phenytoin in traumatic brain injury	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							SEIZURES						Hunt, Elizabeth/K-7869-2012				Anderson GD, 2000, ANN PHARMACOTHER, V34, P697; BAUER LA, 1983, J TRAUMA, V23, P1058, DOI 10.1097/00005373-198312000-00007; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P549, DOI DOI 10.1089/NEU.2000.17.549; GABL M, 1986, Zentralblatt fuer Neurochirurgie, V47, P339; GUERRA IC, 1986, J ALLERGY CLIN IMMUN, V77, P603, DOI 10.1016/0091-6749(86)90353-2; Mahadeva U, 1999, POSTGRAD MED J, V75, P734, DOI 10.1136/pgmj.75.890.734; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; RAPP RP, 1983, NEUROSURGERY, V13, P272, DOI 10.1227/00006123-198309000-00010; SANDYK R, 1983, S AFR MED J, V64, P493; SCHIERHOUT RI, 2001, ANTIEPILEPTIC DRUGS, V3; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; YOUNG B, 1983, CHILD BRAIN, V10, P185	13	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	JAN	2002	86	1					62	63		10.1136/adc.86.1.62			2	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	514ZK	WOS:000173470800024	11806891	Green Published, Bronze, Green Submitted			2022-02-06	
J	Lippert-Gruner, M; Wedekind, C; Wenzel, SC; Lefering, R; Klug, N				Lippert-Gruner, M; Wedekind, C; Wenzel, SC; Lefering, R; Klug, N			Intermediate and long-term outcome in traumatic brain injury is not influenced by additional multiple organ injury	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						brain injury; multiple organ injury; outcome	SEVERE HEAD-INJURY; SYSTEM	Background: This investigation aims at evaluating the influence of additional multiple organ injury in traumatic brain injury on the outcome in terms of the ability to perform the activities of daily life, of the need of care, and of job ability. Methods: 62 victims (male to female ratio 4: 1; age range 15-68 years) of traumatic brain injury were studied. Group 1 (n = 24) consisted of patients who suffered from traumatic brain injury with additional multiple organ injury, group 2 (n = 38) comprised patients with isolated brain injury. Outcome was assessed at 6 and 12 months after trauma by means of different rehabilitation scores. Results: After 6 as well as after 12 months, the majority of both groups were independent in the activities of daily living. Furthermore, no differences were observed concerning the need of care. job ability was almost equal for both groups. Conclusion: Additional multiple organ injury does not pertain to prognosis of traumatic brain injury.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany; Hosp Merheim, Dept Expt Biochem, Cologne, Germany								BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Dereeper E, 1998, RESUSCITATION, V36, P15, DOI 10.1016/S0300-9572(97)00080-4; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Keith R A, 1987, Adv Clin Rehabil, V1, P6; MAHONEY F I, 1965, Md State Med J, V14, P61; McKee MD, 1997, J TRAUMA, V42, P1041, DOI 10.1097/00005373-199706000-00009; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SACHS L, 1997, ANGEW STAT, P380; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010	14	4	4	0	1	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2002	63	3					116	119		10.1055/s-2002-35825			4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	619NK	WOS:000179482300004	12457337				2022-02-06	
J	McEwen, ML; Stehouwer, DJ				McEwen, ML; Stehouwer, DJ			Kinematic analyses of air-stepping of neonatal rats after mid-thoracic spinal cord compression	JOURNAL OF NEUROTRAUMA			English	Article						contusion; coordination; infant; injury; L-DOPA; locomotion; ontogeny	ISCHEMIC BRAIN-DAMAGE; L-DOPA; POSTNATAL-DEVELOPMENT; HINDLIMB LOCOMOTION; GRADED COMPRESSION; PREWEANLING RATS; AMINO-ACIDS; INJURY; TRANSECTION; APOPTOSIS	Although human infants suffer traumatic spinal cord injury, appropriate animal models have not been developed. The consequences of neonatal injury are not necessarily the same as in adults, so treatments designed for adults may not generalize to infants. Therefore, understanding the effects of traumatic injury to the developing cord is important. In this experiment, mid-thoracic spinal cords of 4-day-old rats were compressed with forceps by 0% (sham), 90% or 95% of the uncompressed width. On postoperative day (POD) 1 or 11, rats were suspended in harnesses and administered L-DOPA to activate locomotor circuits. Slight modifications of interlimb coordination remained on POD 11 following the lesser compression, whereas the amount of hindlimb air-stepping, step rates, step lengths and coordination were reduced and declined post-operatively following the greater compression. Lesions were proportional to severity of compression. Progressive motor dysfunction during air-stepping revealed deficits in descending control of lumbar circuits, whereas previous reports of recovery of overground walking probably reflect activation of reflex mechanisms caudal to the transection.	Univ Florida, Dept Psychol, Gainesville, FL 32611 USA		Stehouwer, DJ (corresponding author), Univ Florida, Dept Psychol, Gainesville, FL 32611 USA.	steh@ufl.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH15737] Funding Source: Medline		ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; ARAMANT RB, 1986, DEV BRAIN RES, V25, P161, DOI 10.1016/0165-3806(86)90205-1; ARNAIZ CO, 1997, DEV PSYCHOBIOL, V30, P241; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; Bjugn R, 1997, EXP NEUROL, V148, P179, DOI 10.1006/exnr.1997.6610; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BREGMAN BS, 1983, DEV BRAIN RES, V9, P103, DOI 10.1016/0165-3806(83)90045-7; BREGMAN BS, 1982, SCIENCE, V217, P553, DOI 10.1126/science.7089581; BREGMAN BS, 1987, DEV BRAIN RES, V34, P245, DOI 10.1016/0165-3806(87)90213-6; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; COMMISSIONG JW, 1979, LIFE SCI, V25, P83, DOI 10.1016/0024-3205(79)90493-4; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; CUMMINGS JP, 1981, EXP NEUROL, V74, P615, DOI 10.1016/0014-4886(81)90196-5; EIDELBERG E, 1989, BRAIN RES BULL, V22, P39, DOI 10.1016/0361-9230(89)90125-1; Faden A I, 1997, Adv Neurol, V72, P377; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GOLDSTEIN M, 1971, NATURE-NEW BIOL, V233, P179, DOI 10.1038/newbio233179a0; GORGELS TGMF, 1989, ANAT EMBRYOL, V179, P377, DOI 10.1007/BF00305064; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; Hansebout R R, 1975, Surg Neurol, V4, P531; HOLLISTER AS, 1979, J PHARMACOL EXP THER, V208, P37; HOWLAND DR, 1995, EXP NEUROL, V135, P108, DOI 10.1006/exnr.1995.1071; IKONOMIDOU C, 1989, BRAIN RES, V487, P184, DOI 10.1016/0006-8993(89)90956-6; IWAHARA T, 1991, DEV BRAIN RES, V58, P257, DOI 10.1016/0165-3806(91)90013-9; JOOSTEN EAJ, 1987, DEV BRAIN RES, V36, P121, DOI 10.1016/0165-3806(87)90070-8; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kremer E, 1997, J NEUROPHYSIOL, V77, P1155, DOI 10.1152/jn.1997.77.3.1155; Kuchner EF, 1976, DYNAMICS BRAIN EDEMA, P315; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Liu XZ, 1997, J NEUROSCI, V17, P5395; MCCREA AE, 1994, DEV BRAIN RES, V82, P136, DOI 10.1016/0165-3806(94)90156-2; McEwen ML, 1997, BEHAV NEUROSCI, V111, P825, DOI 10.1037/0735-7044.111.4.825; McEwen ML, 1997, DEV PSYCHOBIOL, V30, P313, DOI 10.1002/(SICI)1098-2302(199705)30:4<313::AID-DEV5>3.0.CO;2-R; MCEWEN ML, 1998, DEV PSYCHOBIOL, V32, P155; MOUCHET P, 1986, BRAIN RES BULL, V16, P341, DOI 10.1016/0361-9230(86)90055-9; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; RAJAOFETRA N, 1989, J NEUROSCI RES, V22, P305, DOI 10.1002/jnr.490220311; RAJAOFETRA N, 1992, DEV BRAIN RES, V67, P237, DOI 10.1016/0165-3806(92)90224-K; Reier P.J., 1989, NEURAL REGENERATION, P183; ROBINSON GA, 1986, EXP BRAIN RES, V62, P373, DOI 10.1007/BF00238857; SABEL BA, 1985, EXP NEUROL, V88, P95, DOI 10.1016/0014-4886(85)90116-5; SCHAPIRO S, 1970, SCIENCE, V168, P147, DOI 10.1126/science.168.3927.147; SENG KL, 1984, J COMP NEUROL, V228, P18, DOI 10.1002/cne.902280104; STEHOUWER DJ, 1994, DEV BRAIN RES, V82, P143, DOI 10.1016/0165-3806(94)90157-0; STELZNER DJ, 1975, EXP NEUROL, V46, P156, DOI 10.1016/0014-4886(75)90039-4; Tanaka H, 1996, PEDIATR NEUROL, V14, P21, DOI 10.1016/0887-8994(95)00258-8; TANAKA H, 1992, DEV BRAIN RES, V65, P1, DOI 10.1016/0165-3806(92)90002-E; VANHARTESVELDT C, 1991, DEV BRAIN RES, V58, P251, DOI 10.1016/0165-3806(91)90012-8; Vogel L, 1997, DEV MED CHILD NEUROL, V39, P202; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; ZilkhaFalb R, 1997, CELL MOL NEUROBIOL, V17, P101, DOI 10.1023/A:1026333222008	57	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2001	18	12					1383	1397		10.1089/08977150152725678			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	504RE	WOS:000172869000008	11780868				2022-02-06	
J	McCleary, AJ; Raptis, S				McCleary, AJ; Raptis, S			Closing the loop: The role of audit in reducing groin complications associated with coronary angiography	CLINICAL RADIOLOGY			English	Article						audit; false aneurysm; coronary angiography	FEMORAL-ARTERY INJURIES; PERCUTANEOUS THROMBIN INJECTION; US-GUIDED COMPRESSION; VASCULAR COMPLICATIONS; PSEUDOANEURYSM; ANGIOPLASTY; MANAGEMENT; REPAIR; CATHETERIZATION; BALLOON	BACKGROUND: Local vascular complications of coronary angiography present a significant but often ignored clinical problem. This audit was performed because of a perception that the number of false aneurysms requiring surgical repair was increasing. STANDARD: An acceptable incidence of false aneurysm was derived from series in which ultrasound examinations were only performed if a false aneurysm was suspected (0.06-0.7%). The success rate of ultrasound (US) directed compression ranged from 50% to 93%. ASSESSMENT OF LOCAL PRACTICE: Data were retrieved from cardiology, radiology and vascular surgery databases in addition to case note review. The incidence of false aneurysm was significantly higher than that of historical control groups from the authors' institution (1.5% vs 0.5%, P < 0.05) and in published series used as the standard. The success rate of US directed compression was also poor compared to historical controls (25% vs 55%, P < 0.05) and previously published series. IMPLEMENTATION OF CHANGE: Recommended changes included the use of fluoroscopy to identify the femoral head to avoid low puncture, strict adherence to the existing protocol for sheath removal and the use of adequate analgesia and sedation prior to attempted US compression. REASSESSMENT OF LOCAL PRACTICE: The incidence of false aneurysm fell to that of the standard set by previous studies. US directed compression was successful in 100%. CONCLUSIONS: The audit was successful in that the incidence of false aneurysm fell and the success rate of US directed compression increased, but the specific reasons for the improvements remain unclear. (C) 2001 The Royal College of Radiologists.	Royal Adelaide Hosp, Dept Vasc Surg, Adelaide, SA 5000, Australia		McCleary, AJ (corresponding author), York Dist Gen Hosp, Wigginton Rd, York YO31 8HE, N Yorkshire, England.						ALDERMAN JD, 1987, J AM COLL CARDIOL, V9, P524, DOI 10.1016/S0735-1097(87)80044-X; ALTIN RS, 1989, AM J ROENTGENOL, V152, P629, DOI 10.2214/ajr.152.3.629; BLAIS C, 1994, AM J ROENTGENOL, V162, P238, DOI 10.2214/ajr.162.1.8273682; COLEY BD, 1995, RADIOLOGY, V194, P307, DOI 10.1148/radiology.194.2.7824703; COPE C, 1986, AM J ROENTGENOL, V147, P383, DOI 10.2214/ajr.147.2.383; DELACEY G, 2000, CLIN GOVERNANCE REVA; DIPRETE DA, 1992, J ULTRAS MED, V11, P489; DORROS G, 1983, CIRCULATION, V67, P723, DOI 10.1161/01.CIR.67.4.723; FELLMETH BD, 1992, RADIOLOGY, V182, P570, DOI 10.1148/radiology.182.2.1732983; FELLMETH BD, 1991, RADIOLOGY, V178, P671, DOI 10.1148/radiology.178.3.1994400; FIELD R, 1992, J VASC SURG, V16, P832; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; KATZENSCHLAGER R, 1995, RADIOLOGY, V195, P463, DOI 10.1148/radiology.195.2.7724767; KENT KC, 1993, J VASC SURG, V17, P125, DOI 10.1016/0741-5214(93)90016-F; KRESOWIK TF, 1991, J VASC SURG, V13, P328, DOI 10.1016/0741-5214(91)90226-K; Liau CS, 1997, J VASC SURG, V26, P18, DOI 10.1016/S0741-5214(97)70141-1; McGlinchey I, 1997, CLIN RADIOL, V52, P621, DOI 10.1016/S0009-9260(97)80256-5; MULLER DWM, 1990, CORONARY ARTERY DIS, V1, P438, DOI 10.1097/00019501-199007000-00005; MULLER DWM, 1992, AM J CARDIOL, V69, P63, DOI 10.1016/0002-9149(92)90677-Q; O'Sullivan GJ, 1999, ANN ROY COLL SURG, V81, P226; Rivers S P, 1992, Ann Vasc Surg, V6, P45, DOI 10.1007/BF02000667; ROBERTS SR, 1987, AM J SURG, V154, P676, DOI 10.1016/0002-9610(87)90242-X; SAFIAN RD, 1990, CIRCULATION, V82, P69, DOI 10.1161/01.CIR.82.1.69; SAITO S, 1992, CATHETER CARDIO DIAG, V26, P229, DOI 10.1002/ccd.1810260313; SHARMA RP, 1987, AM J ROENTGENOL, V149, P1279, DOI 10.2214/ajr.149.6.1279; SHAWL FA, 1990, AM HEART J, V120, P195, DOI 10.1016/0002-8703(90)90178-Z; STEINSAPIR ES, 1993, J SURG RES, V55, P109, DOI 10.1006/jsre.1993.1116	27	4	4	0	0	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0009-9260			CLIN RADIOL	Clin. Radiol.	NOV	2001	56	11					917	921		10.1053/crad.2001.0739			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	491GK	WOS:000172100500009	11603895				2022-02-06	
J	Eker, C; Hagstadius, S; Linden, A; Schalen, W; Nordstrom, CH				Eker, C; Hagstadius, S; Linden, A; Schalen, W; Nordstrom, CH			Neuropsychological assessments in relation to CBF after severe head injuries	ACTA NEUROLOGICA SCANDINAVICA			English	Article						head injury; cerebral blood flow; neuropsychological test; rehabilitation	CEREBRAL BLOOD-FLOW; METABOLISM; ACTIVATION; CHILDREN; SCALE; ICP	Objective-To determine whether neuropsychological outcome is related to cerebral blood flow (CBF) early in the recovery phase. Material and methods-Twelve consecutive patients (mean age of 30 years, range 15-48 years) with severe traumatic brain injuries were subjected to a neuropsychological test battery at admission to the rehabilitation unit and after 3, 6 and 12 months. CBF measurements were performed at admission and 6 and 12 months later with a high-resolution, two-dimensional regional cerebral blood flow system with 254 stationary detectors after 1 min pf Xe-133 inhalation (70-100 MBq/l). Results and conclusion-Mean CBF values were within normal range already in the early post-acute phase and remained virtually unchanged during the first year of rehabilitation. A correlation was found between the individual CBF level and neuropsychological outcome 1 year after injury, particularly with regard to verbal memory capacity, reasoning capacity, and information processing speed.	Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden		Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden.	carl-henrik.nordstrom.@swipnet.se					BENTON AL, 1974, REVISED VISUAL RETEN, P1; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CRONHOLM B, 1957, ACTA PSYCH NEUROL, V32, P280, DOI 10.1111/j.1600-0447.1957.tb09467.x; DUREMAN I, 1971, MANUAL TILL DS BATTE; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Graham FK, 1960, PERCEPT MOTOR SKILL, V11, P147, DOI DOI 10.2466/PMS.11.6.147-188; HAGSTADIUS S, 1989, BRAIN COGNITION, V10, P28, DOI 10.1016/0278-2626(89)90073-0; MAXIMILIAN VA, 1980, STROKE, V11, P342, DOI 10.1161/01.STR.11.4.342; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; OVERGAARD J, 1976, J NEUROSURG, V45, P292, DOI 10.3171/jns.1976.45.3.0292; Rey A., 1964, EXAMEN CLIN PSYCHOL; RISBERG J, 1987, ARCH GERONTOL GERIAT, V6, P225, DOI 10.1016/0167-4943(87)90023-9; ROBERTSON C, 1993, ACTA NEUROCHIR, P25; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SMITH GJW, 1972, MANUAL TILL SERIALT; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wechsler D., 1958, MEASUREMENT APPRAISA; WENDT PE, 1994, BRAIN COGNITION, V24, P87, DOI 10.1006/brcg.1994.1005	24	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	SEP	2001	104	3					142	147		10.1034/j.1600-0404.2001.00345.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472EW	WOS:000170971400004	11551233				2022-02-06	
J	Dhillon, HS; Dong, GX; Yurek, DM; Estus, S; Rangnekar, VM; Dendle, P; Prasad, RM				Dhillon, HS; Dong, GX; Yurek, DM; Estus, S; Rangnekar, VM; Dendle, P; Prasad, RM			Regional expression of Par-4 mRNA and protein after fluid percussion brain injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						brain injury; fluid percussion; prostate apoptosis response-4 protein	PROSTATE APOPTOSIS RESPONSE-4; SIGNAL-TRANSDUCTION PATHWAY; EVANS BLUE EXTRAVASATION; EXCITATORY AMINO-ACIDS; PROGRAMMED CELL-DEATH; FREE FATTY-ACIDS; CORTICAL IMPACT; PHOSPHATIDYLINOSITOL BISPHOSPHATE; LIPID-PEROXIDATION; KINASE-C	Regional levels of prostate apoptosis response-4 (Par-4) protein and mRNA were measured after lateral fluid percussion (FP) brain injury in rats. Immunochemical studies indicated that Par-4 immunoreactivity (ir) is present in cortical neurons and hippocampal CA1-CA3 pyramidal neurons in uninjured rats. Increases of Par-4-ir were observed in the CA3 neurons of the ipsilateral hippocampus (IH), but not in injured left cortex (IC) at 48 h after FP brain injury. Levels of the Par-4 mRNA measured by RT-PCR assay and protein measured by Western blot procedure were significantly increased in the injured IC and IH, but not in the contralateral right cortex and hippocampus after brain injury. Levels of both Par-4 protein and mRNA were significantly increased in the IC and IH as early as 2 h and stayed elevated at 24 and 48 h after injury. These data show that the induction of proapoptotic Par-4 mRNA and protein occurs only in the IC and IH that have been observed to undergo apoptosis and neuronal cell loss after lateral FP brain injury. Because increased expression of Par-4 has been observed to contribute to apoptosis and cell death in cultured neurons, the present temporal pattern of Par-4 expression is consistent with a role for Par-4 in apoptosis and neuronal cell death after traumatic brain injury. (C) 2001 Academic Press.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Surg, Div Neurosurg, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Dept Radiat Med, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Prasad, RM (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Surg, Div Neurosurg, Lexington, KY 40536 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 34264] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034264] Funding Source: NIH RePORTER		Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Boghaert ER, 1997, CELL GROWTH DIFFER, V8, P881; Carman HM, 1998, BRAIN RES, V808, P116, DOI 10.1016/S0006-8993(98)00824-5; Chan SL, 1999, J NEUROCHEM, V73, P502, DOI 10.1046/j.1471-4159.1999.0730502.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; Dhillon HS, 1995, J NEUROTRAUM, V12, P1035, DOI 10.1089/neu.1995.12.1035; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Duan WZ, 1999, ANN NEUROL, V46, P587, DOI 10.1002/1531-8249(199910)46:4<587::AID-ANA6>3.0.CO;2-M; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; Hoffman SW, 1996, J NEUROSCI METH, V68, P133; Homayoun P, 1997, J NEUROCHEM, V69, P199; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; JOHNSON KR, 1996, SOC ANIM, V4, P1; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Qiu GF, 1999, ONCOGENE, V18, P623, DOI 10.1038/sj.onc.1202344; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RINK A, 1995, AM J PATHOL, V147, P1575; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x; Zhang DQ, 1999, NEUROSCI LETT, V272, P57, DOI 10.1016/S0304-3940(99)00455-3	61	4	6	0	0	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JUL	2001	170	1					140	148		10.1006/exnr.2001.7685			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	452CW	WOS:000169840400013	11421591				2022-02-06	
J	Baumer, M; Schneider, H; Frank, B; Wallesch, CW				Baumer, M; Schneider, H; Frank, B; Wallesch, CW			Physicians' estimates of rehabilitation requirements after stroke and traumatic brain injury - a questionnaire survey in East Germany	DISABILITY AND REHABILITATION			English	Article								Purpose. The provision of rehabilitation services is organized differently in Germany than most other countries, with large indication-specific in-patient centres. This study is aimed at the rehabilitative knowledge of physicians who initiate and conduct rehabilitation in Germany. Methods. Medical specialists routinely involved in the treat ment and rehabilitation of patients with stroke and traumatic brain injury (TBI) from acute hospitals, rehabilitation centres, and the Medical Services of the Workers' Pension Funds of Sachsen-Anhalt and Mecklenburg-Vorpommern were included in a systematic questionnaire survey aiming at the rehabilitation requirements of patients under their care or evaluation. These specialists are crucial for decision-making in rehabilitation resource allocation. Results: According to these experts, rehabilitation requirements for stroke and TBI patients are dominated by deficits in motor functions and daily-living. They are aware that TBI rehabilitation includes a greater focus on memory functions, problem-solving and attention, and in stroke on language functions. According to the surveyed specialists, the present system of medical rehabilitation in Germany covers the requirements of stroke and TBI patients only partially. Deficits are identified in out-patient and day clinic rehabilitation. Conclusions. Although the knowledge of rehabilitation requirements is adequate in general, its large ranges reflect the necessity for further analysis. The opinions of the surveyed specialists reflect their respective professional setting. Advantages and disadvantages of the German system require further investigation.	Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; LVA Sachsen Anhalt, Med Serv, Halle, Germany; Inst Neurol Neurosurg Rehabil Res, Magdeburg, Germany; Klin Leezen, Schwerin, Germany		Wallesch, CW (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.						BARNES M, 1993, NEUROLOGICAL REHABIL, P29; Henschen S. E, 1920, LIVING APHASIA PSYCH; Herrmann M, 1997, NERVENARZT, V68, P801, DOI 10.1007/s001150050197; JANZIK HH, 1992, HILFEN VERSORGUNG SC; KOCH U, 1993, SPEKTRUM NEUROREHABI, P102; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; Maier-Riehle B, 1999, Rehabilitation (Stuttg), V38 Suppl 1, pS3; Mieck T, 1997, AKTUEL NEUROL, V24, P253, DOI 10.1055/s-2007-1017818; Seidel C, 1991, Rehabilitation (Stuttg), V30, P199; WOOD R, 1993, NEUROLOGICAL REHABIL, P41	10	4	4	1	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	MAY 10	2001	23	7					306	312					7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	428RC	WOS:000168473800006	11354584				2022-02-06	
J	Burrows, SC; Moore, KM; Lemkau, HL				Burrows, SC; Moore, KM; Lemkau, HL			Creating a Web-accessible, point-of-care, team-based information system (PoinTIS): the librarian as publisher	BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION			English	Article							HEALTH; MEDICINE	The Internet has created new opportunities for librarians to develop information systems that are readily accessible at the point of care. This paper describes the multiyear process used to justify, fund, design, develop, promote, and evaluate a rehabilitation prototype of a point-of-care, team-based information system (PoinTIS) and train health care providers to use this prototype for their spinal cord injury and traumatic brain injury patient care and education activities. PoinTIS is a successful model for librarians in the twenty-first century to serve as publishers of information created or used by their parent organizations and to respond to the opportunities for information dissemination provided by recent technological advances.	Univ Miami, Sch Med, Louis Calder Mem Lib, Miami, FL 33101 USA		Burrows, SC (corresponding author), Univ Miami, Sch Med, Louis Calder Mem Lib, POB 016950, Miami, FL 33101 USA.				NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [LM06583] Funding Source: Medline		CHONIN AT, 2000, AM J NURS, V100, P78; D'Alessandro MP, 1998, B MED LIBR ASSOC, V86, P602; Dahn M, 2000, ONLINE, V24, P35; DEJONG G, 1993, ARCH PHYS MED REHAB, V74, pS2; HALL EF, 1995, B MED LIBR ASSOC, V83, P196; Lindberg DAB, 1998, JAMA-J AM MED ASSOC, V280, P1303, DOI 10.1001/jama.280.15.1303; Lynch C, 1999, B MED LIBR ASSOC, V87, P408; MEYER C, 1993, AM J NURS, V93, P76, DOI 10.2307/3427008; Royle J A, 1995, Comput Nurs, V13, P25; Stover M., 1996, Computers in Libraries, V16, P40	10	4	4	0	2	MEDICAL LIBRARY ASSOC	CHICAGO	65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA	0025-7338			B MED LIBR ASSOC	Bull. Med. Libr. Assoc.	APR	2001	89	2					154	164					11	Information Science & Library Science	Social Science Citation Index (SSCI)	Information Science & Library Science	544DE	WOS:000175142300002	11337946				2022-02-06	
J	Abdolvahabi, RM; Dutcher, SA; Wellwood, JM; Michael, DB				Abdolvahabi, RM; Dutcher, SA; Wellwood, JM; Michael, DB			Craniocerebral missile injuries	NEUROLOGICAL RESEARCH			English	Article						missile injuries; trauma care; brain injury; pathophysiology	HEAT-SHOCK PROTEIN; TRAUMATIC BRAIN INJURY; MESSENGER-RNA; RAT-BRAIN; TRANSIENT ISCHEMIA; GENE-EXPRESSION; WAR; POPULATION; APOPTOSIS; PATTERNS	Gun shot wounds to the brain are among the most devastating causes of morbidity and mortality in the civilian population. The majority of the victims will nor survive and for a great number of survivors life becomes an uphill battle with permanent deficits and complications. While the fundamental surgical care of these patients is essentially unchanged, our scientific understanding of the pathophysiological changes and the post-injury care of the victims has been evolving. The purpose of this article is to provide an overview of the current clinical and laboratory advances in understanding and treating gun shot injuries to the brain.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI USA; Detroit Receiving Hosp, Dept Neurol Surg, Detroit, MI USA		Abdolvahabi, RM (corresponding author), Wayne State Univ, Univ Hlth Ctr, 4201 St Antoine,Suite 6E, Detroit, MI 48201 USA.						AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; Aarabi B, 1999, MISSILE WOUNDS HEAD, P3; ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; Amin V, 1996, NEUROSCI LETT, V206, P45, DOI 10.1016/0304-3940(96)12421-6; BENEVISTE H, 1984, J NEUROCHEM, V43, P1369; BOHY R, 1994, DETROIT MONTHLY  JUL, P54; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P177; COOPER P, 1993, GUNSHOT WOUNDS BRAIN, P355; COTRAN RS, 1989, CELLULAR INJURY ADAP, P1; CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; CURRIE RW, 1981, SCIENCE, V214, P72, DOI 10.1126/science.7280681; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FACKLER ML, 1991, SURG GYNECOL OBSTET, V172, P153; FERRER I, 1995, ACTA NEUROPATHOL, V90, P504; FERRIERO DM, 1990, DEV BRAIN RES, V53, P145, DOI 10.1016/0165-3806(90)90136-M; Goodman J. C., 1995, Journal of Neurotrauma, V12, P371; Greenberg MD, 1994, HDB NEUROSURGERY; Gurdjian ES, 1958, HEAD INJURIES, P3; JACEWICZ M, 1986, J CEREBR BLOOD F MET, V6, P263, DOI 10.1038/jcbfm.1986.48; KAUFMAN HH, 1993, J NEUROSURG, V78, P838, DOI 10.3171/jns.1993.78.5.0838; KOCHER T, 1875, CORBLATT SCHWEIZ ARZ, V5, P69; KOCHER T, 1875, CORRESPONDENZ BLATT, V5, P3; KOCHER T, 1875, CORBLATT SCHWEIZ ARZ, V5, P29; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LEVY M, 1999, MISSILE WOUNDS HEAD, P135; LIAU L, 1996, PATHOLOGY PATHOPHYSI, P1549; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; Marcikic M, 1998, INJURY, V29, P613, DOI 10.1016/S0020-1383(98)00146-6; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; SCHWARZ DF, 1994, JAMA-J AM MED ASSOC, V271, P755, DOI 10.1001/jama.271.10.755; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; UNEY JB, 1988, FEBS LETT, V235, P215, DOI 10.1016/0014-5793(88)81265-1; Vassar MJ, 1996, JAMA-J AM MED ASSOC, V275, P1734, DOI 10.1001/jama.275.22.1734; WALKER PD, 1993, J NEUROSCI RES, V36, P588, DOI 10.1002/jnr.490360511	47	4	6	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					210	218		10.1179/016164101101198361			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200015	11320602				2022-02-06	
J	Cao, Q; Ong, WY; Halliwell, B				Cao, Q; Ong, WY; Halliwell, B			Lipid peroxidation in the postnatal rat brain - Formation of 4-hydroxynonenal in the supraventricular corpus callosum of postnatal rats	EXPERIMENTAL BRAIN RESEARCH			English	Article						free radicals; lipid peroxidation; corpus callosum; iron; microglia; electron microscopy; rat	MODIFIED PROTEINS; AMEBOID MICROGLIA; OXIDATIVE STRESS; IRON; ISCHEMIA; CELLS	Lipid peroxidation is known to be associated with many neurodegenerative diseases and with traumatic brain injury, but its occurrence in the normal developing brain has not been reported. The present study was carried out using a specific antibody that recognises proteins modified by the end-product of lipid peroxide decomposition, 4-hydroxynonenal (HNE), to evaluate evaluate possible lipid peroxidation products in the brains of developing rats by immunocytochemistry and electron microscopy. Moderately dense labelling was observed in the supraventricular corpus callosum in the 7- and 8-day-old rats, whilst very dense labelling was observed in the same region, in the 9- and I0-day-old rats. Very little immunoreactivity was observed at 14 days, and no staining was observed in the corpus callosum in adult rats. HNE staining was not observed in neuronal cell bodies that give rise to callosal axons in the overlying cerebral cortex. Electron microscopy showed dense HNE staining on the basal laminae of blood vessels and on the plasma membranes of unmyelinated axons. Large numbers of rounded cells with features of oligodendrocyte precursor cells were labelled by Perl's stain in the supraventricular corpus callosum at postnatal day 7 and postnatal day 10, i.e. at times cor responding to high levels of HNE immunoreactivity. In contrast, very few such cells were observed in the adult brain, corresponding to the very little or no Perl's staining in the adult. These results suggest that lipid peroxidation observed in the supraventricular corpus callosum at postnatal day 10 could result from an accumulation of iron in this region, at this time.	Natl Univ Singapore, Dept Anat, Singapore 119260, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore		Ong, WY (corresponding author), Natl Univ Singapore, Dept Anat, Singapore 119260, Singapore.		Halliwell, Barry/C-8318-2009	Halliwell, Barry/0000-0002-3560-7123			Baldwin SA, 1998, J NEUROSURG, V88, P874, DOI 10.3171/jns.1998.88.5.0874; CHEESEMAN KH, 1993, DNA FREE RADICALS, P110; CONNOR JR, 1995, J COMP NEUROL, V355, P111, DOI 10.1002/cne.903550112; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; KLEGERIS A, 1994, J NEUROIMMUNOL, V53, P83, DOI 10.1016/0165-5728(94)90067-1; Kruman I, 1997, J NEUROSCI, V17, P5089; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Montine KS, 1998, J NEUROPATH EXP NEUR, V57, P415, DOI 10.1097/00005072-199805000-00005; NGUYENLEGROS J, 1980, HISTOCHEMISTRY, V66, P239, DOI 10.1007/BF00495737; Ong WY, 2000, FREE RADICAL BIO MED, V28, P1214, DOI 10.1016/S0891-5849(00)00238-0; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; Springer JE, 1997, J NEUROCHEM, V68, P2469; SUBBARAO KV, 1990, J NEUROCHEM, V55, P342, DOI 10.1111/j.1471-4159.1990.tb08858.x; Takeda H, 1998, NEUROSCI LETT, V240, P5, DOI 10.1016/S0304-3940(97)00917-8; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P5611, DOI 10.1073/pnas.89.12.5611; Urabe T, 1998, NEUROSCI LETT, V247, P159, DOI 10.1016/S0304-3940(98)00311-5; Waeg G, 1996, FREE RADICAL RES, V25, P149, DOI 10.3109/10715769609149920; XU J, 1994, J ANAT, V184, P227; [No title captured]	24	4	4	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0014-4819			EXP BRAIN RES	Exp. Brain Res.	MAR	2001	137	2					205	213		10.1007/s002210000625			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	414LF	WOS:000167667600009	11315549				2022-02-06	
J	Davis, GG; Glass, JM				Davis, GG; Glass, JM			Case report of sudden death after a blow to the back of the neck	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article; Proceedings Paper	51st Annual Meeting of the American-Academy-of-Forensic-Sciences	FEB 15-21, 1999	ORLANDO, FL	Amer Acad Forens Sci		blunt trauma; cervical spine; concussion; neurogenic shock; commotio cerebri	COMMOTIO CORDIS; INJURY	A 13-year-old girl experienced a fall during gym class that caused immediate unresponsiveness and death. The lone witness reported that the decedent lost her balance as she approached a hurdle and fell, striking her head on a crossbar of the hurdle near the ground. Autopsy revealed no external injury. Internal injury that could be demonstrated anatomically was confined to a contusion within the right semicapitis muscle at the base of the skull. In the absence of an anatomic cause of death, possible explanations of the death include a cardiac dysrhythmia, a vasovagal stimulus, and diffuse axonal injury caused by a concussive force to the junction of the medulla and spinal cord. Animal studies have shown that severe concussion can cause death via profound autonomic dysfunction without leaving anatomic evidence of injury, and that the essential component of concussion is an element of rotational injury to the brain. The authors believe that the blow to the neck caused this death by the transmission of a concussive force through the reticular activating system. The prompt work of police in distinguishing the Zone witness from several people in the area who thought they knew what had happened was essential for diagnosis. On reaching our conclusions, the authors notified first the family, then the superintendent of the school system, and finally the news media. The authors told each party in turn that they would be contacting the others.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL USA		Davis, GG (corresponding author), Med Examiner Off, 1515 6th Ave S,Room 611, Birmingham, AL 35233 USA.		Davis, Gregory/AAE-9608-2019				COURVILLE CYRIL B., 1964, BULL LOS ANGELES NEUROL SOC, V29, P59; Deady B, 1999, J EMERG MED, V17, P459, DOI 10.1016/S0736-4679(99)00006-2; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FREYTAG E, 1963, ARCH PATHOL, V75, P402; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GREENHOOT JH, 1972, ARCH NEUROL-CHICAGO, V26, P524, DOI 10.1001/archneur.1972.00490120064007; Holbourn AHS, 1943, LANCET, V2, P438; Jefferson G, 1944, BRIT MED J, V1944, P1; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2; LEHMANN KG, 1987, J AM COLL CARDIOL, V10, P46, DOI 10.1016/S0735-1097(87)80158-4; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; MCLAURIN RL, 1975, J TRAUMA, V15, P447, DOI 10.1097/00005373-197505000-00012; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; STRICH SJ, 1961, LANCET, V2, P443; VOIGT GE, 1981, AM J FOREN MED PATH, V2, P115, DOI 10.1097/00000433-198106000-00005; [No title captured]; [No title captured]; 1994, DORLANDS ILLUSTRATED, P366	20	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2001	22	1					13	18		10.1097/00000433-200103000-00002			6	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Legal Medicine; Pathology	405JM	WOS:000167156300002	11444655				2022-02-06	
J	Ishii, N; Hirano, K; Mouri, Y; Imamura, K; Kamata, M; Watanabe, A; Suzuki, Y; Ishii, R				Ishii, N; Hirano, K; Mouri, Y; Imamura, K; Kamata, M; Watanabe, A; Suzuki, Y; Ishii, R			A case of infected subdural hematoma due to Campyrobacter fetus	NEUROLOGICAL SURGERY			Japanese	Article						Campylobacter fetus; enhanced MRI; infected subdural hematoma	HEMATOGENOUS DISSEMINATION; EMPYEMA	A 20-year-old male presented lever, nausea and headache 1 week after eating uncooked liver. On admission, it was revealed he had sufferd a closed head injury 3 months before without unconsciousness. On admission, computed tomography scan showed a left chronic subdural hematoma. Gd-DTPA magnetic resonance images revealed unusual enhancement of the capsule and linear enhancement of the subarachnoid space. The patient underwent burr hole irrigation and drainage. The culture of the hematoma content showed Campylobacter fetus. Therefore, the diagnose was infected subdural hematoma. A drainage operation and administration of antibiotcis were effective. Our case suggests that enhanced magnetic resonance images are useful for diagnosis and follow-up of infected subdural hematoma.	Kawasaki Med Sch, Dept Neurosurg, Kawasaki, Kanagawa 7010192, Japan								Aoki Nobuhiko, 1997, Neurologia Medico-Chirurgica, V37, P637, DOI 10.2176/nmc.37.637; BAKKER S, 1995, CLIN INFECT DIS, V21, P458, DOI 10.1093/clinids/21.2.458; CASSON IR, 1981, NEW YORK STATE J MED, V81, P389; Clifton WM, 1938, AM J DIS CHILD, V55, P553, DOI 10.1001/archpedi.1938.01980090101011; COONROD JD, 1972, AM J MED, V53, P85, DOI 10.1016/0002-9343(72)90118-0; DILL SR, 1995, CLIN INFECT DIS, V20, P372, DOI 10.1093/clinids/20.2.372; GENEST AS, 1963, J NEUROSURG, V20, P524, DOI 10.3171/jns.1963.20.6.0524; Hamada Jun-Ichiro, 1993, Neurologia Medico-Chirurgica, V33, P40, DOI 10.2176/nmc.33.40; Kawamoto S, 1998, NEUROL MED-CHIR, V38, P743, DOI 10.2176/nmc.38.743; PATTISAPU JV, 1987, PEDIATR NEUROSCI, V13, P251, DOI 10.1159/000120338; TOMAS ND, 1989, AM J MED, V87, P593	11	4	4	0	0	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	MAR	2001	29	3					265	269					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	431VR	WOS:000168652900010	11321797				2022-02-06	
J	Fei, Z; Zhang, X; Li, ZG; Liu, EY; Bai, HM; Chen, JZ; Jia , KY				Fei, Z; Zhang, X; Li, ZG; Liu, EY; Bai, HM; Chen, JZ; Jia , KY			The changes and significance of TXA(2) and PGI(2) metabolism after rat infrasonic brain damage	JOURNAL OF LOW FREQUENCY NOISE VIBRATION AND ACTIVE CONTROL			English	Article						infrasonic brain injury; TXA(2); PGI(2)	INJURY	In this paper we study the changes and significance of the TXA(2) and PGI(2) metabolism after infrasonic damage to rats so as to probe the mechanism of infrasonic biological effects. Some 40 SD rats were randomized into control, infrasonic damage once, 7 times, 14 times, and treatment five groups. A stimulus of 8Hz 120dB infrasound was applied to the infrasonic damage groups for 2 hours once according to the planned times. Radioimmunoassay was used for the examination of brain TXB2 and 6-keto-PGF1a (metabolites of TSA(2) and PG) contents. The results showed that there were no changes in TXB2 and 6-keto-PGF1a levels in the 'once' group while TXB2 level elevated significantly and 6-keto-PGF1a level decreased remarkably in the 7 times and the 4 times groups with an augmentation of TXA(2)/PGI(2) value. In the treatment group both TXB2 and PGI(2) levels nearly reached normal. It is concluded that the augmentation of the TXA(2)/PGI(2) value in the 7 times and 14 times groups suggests that an imbalance in TXA(2)-PGI(2) production contributes to the traumatic secondary processes, which include ischemia and edema. Also, the extent of TXA(2) and PGI(2) metabolism disturbance is closely related to the times of infrasonic injury. It is hypothesized that mGluR antagonist may exert its protective properties through increasing PGI(2) production in the injured brain by improving the blood supply to injured blood vessels.	Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; Fourth Mil Med Univ, Dept Physiotherapy, Xijing Hosp, Xian 710032, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn					Fei Z, 2000, J LOW FREQ NOISE V A, V19, P93, DOI 10.1260/0263092001492840; FEI Z, 1999, J CLIN NEUROSCIENCES, V6, P306; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; Izmerov N F, 1997, Vestn Ross Akad Med Nauk, P39; JOHNSON DL, 1979, AER MED ASS M, V5, P37; Katayama Y, 1990, Adv Neurol, V52, P105; Kuralesin N. A., 1997, Meditsina Truda i Promyshlennaya Ekologiya, V0, P8; Landstrom U., 1987, Journal of Low Frequency Noise & Vibration, V6, P29; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Nishisho T, 1996, NEUROSURGERY, V39, P950, DOI 10.1097/00006123-199611000-00014; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; Xing XH, 1998, J LOW FREQ NOISE V A, V17, P133, DOI 10.1177/026309239801700303	14	4	6	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1461-3484	2048-4046		J LOW FREQ NOISE V A	J. Low Freq. Noise Vib. Act. Control		2001	20	1					33	37		10.1260/0263092011492966			5	Acoustics	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics	487EN	WOS:000171860800004		Bronze			2022-02-06	
J	Hutter, BO; Gilsbach, JM				Hutter, BO; Gilsbach, JM			Background and first results about methodological characteristics of the Aachen Life Quality Inventory	ZENTRALBLATT FUR NEUROCHIRURGIE			German	Article						brain damage; health-related quality of life; psychometric evaluation; Sickness Impact Profile	ANEURYSMAL SUBARACHNOID HEMORRHAGE; SICKNESS IMPACT PROFILE; OF-LIFE; HEALTH; DEFICITS; STROKE	Health-related quality of life has become an important criterion for assessing disease impact and treatment outcome. Therefore, we developed a questionnaire called Aachen Life Quality Inventory (ALQI) for the use in neurosurgical patients with brain damage. The ALQI is derived from the German version of the Sickness Impact Profile (SIP). The 117 items are formulated on a concrete behavioral level covering the following dimensions of health-related quality of life: 1. activation 2. mobility; 3. house-work 4. social contact; 5. family relations; 6. ambulation; 7. work; 8. free-time activities; 9. autonomy; 10. communication; 11. cognitive capacity. As in the SIP, a summary score of total impairment (ALQI Total score), a summary score covering the psycho-social dimension (ALQI Psycho-social score) and a summary score covering aspects of physical functioning (ALQI Physical score) can be calculated. The ALQI consists of a self-rating and a parallel proxy-rating version. The ALQI was validated and psychometrically verified using the data of as yet 231 neurosurgical patients with brain damage of mixed etiology (subarachnoid hemorrhage, closed-head injury, benign brain tumors). Internal consistency (Cronbach's Alpha) ranged from .68 to .91 for the subscales, while it was .97 for the whole instrument, .94 for the psycho-social and .93 for the physical score. The internal consistency for the subscales of the proxy-rating version of the ALQI ranged between .77 and .92, while it was .97 for the whole inventory and .94 for the psycho-social and the physical scores., respectively. Examination of construct validity revealed substantial correlations with a wide range of relevant neurological, neurosurgical and neuropsychological parameters. Beyond other findings, substantial associations emerged with several neuropsychological tests (r=.30 to r=.50), the Glasgow Outcome Scale (r=.39; p<.00) and in patients after subarachnoid hemorrhage with the Hunt&Hess grading (r=.28; p<.001). According to these results, the ALQI promises to become a valid and reliable means for assessing quality of life in patients with brain damage. Nevertheless, further analyses using larger patient samples and with particular emphasis on the investigation of the retest-reliability and the prognostic validity are called for in the future.	Univ Klinikum RWTH Aachen, Neurochirurg Klin, D-52057 Aachen, Germany								Aboderin I, 1996, J INTERN MED, V240, P173, DOI 10.1046/j.1365-2796.1996.39861000.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Beristain X, 1996, SURG NEUROL, V45, P422, DOI 10.1016/0090-3019(95)00454-8; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Bullinger M, 1997, PSYCHOTHER PSYCH MED, V47, P76; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; EBRAHIM S, 1986, J EPIDEMIOL COMMUN H, V40, P166, DOI 10.1136/jech.40.2.166; Fertl E, 1999, ACTA NEUROCHIR, V141, P571, DOI 10.1007/s007010050345; Gerszten PC, 1998, NEUROSURGERY, V43, P1146, DOI 10.1097/00006123-199811000-00072; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hutter BO, 1997, PSYCHOL HEALTH, V12, P149, DOI 10.1080/08870449708407396; HUTTER BO, 1993, NEUROSURGERY, V33, P999; HUTTER BO, 1995, J CLIN EXP NEUROPSYC, V17, P499, DOI 10.1080/01688639508405141; HUTTER BO, 1996, BEFUNDERHEBUNG PSYCH, P83; HUTTER BO, 2000, AMBULANTE KOMPLEX BE, P32; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Norman, 1995, HLTH MEASUREMENT SCA; Vickrey Barbara G., 1993, P623; VIEFHUES H, 1991, CHRONIC HEART FAILUR, P66	19	4	4	0	4	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2001	62	2					37	42		10.1055/s-2002-19476			6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	515FB	WOS:000173483800003	11786934				2022-02-06	
J	Sahuquillo, J; Biestro, A; Amoros, S; Poca, MA; Baguena, M; Ibanez, J; Noguer, M; Garnacho, A				Sahuquillo, J; Biestro, A; Amoros, S; Poca, MA; Baguena, M; Ibanez, J; Noguer, M; Garnacho, A			Reflections on the use of model ate hypothermia in the management of severely head injured patients.	NEUROCIRUGIA			Spanish	Article						moderate hypothermia; severe head injury.; review; neuroprotection	TRAUMATIC BRAIN INJURY; EXCITATORY AMINO-ACIDS; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; CEREBRAL-ISCHEMIA; GLUTAMATE; DAMAGE; TEMPERATURE; EFFICACY; THERAPY	Traumatic brain injury initiates several metabolic processes that can increase the primary injury. It is well established that in severe head injuries, posttraumatic secondary insults, such as brain hypoxia, hypotension or anemia, exacerbate neuronal injury and lead to a poorer outcome. Experimental and clinical evidence suggests that moderate hypothermia (32-34 degreesC), may limit some of these deleterious secondary metabolic responses. Recent laboratory studies and prospective controlled clinical trials of induced moderate hypothermia for relatively short periods (24-48 h) in patients with severe head injury, have demonstrated good intracranial pressure control and better outcome when compared with patients maintained in normothermia and given conventional treatment. Despite its proven clinical role in neuroprotection, hypothermia research has been inconstantly followed for various reasons. In this paper we review the mechanisms of neuroprotection in hypothermia, the different preclinical and clinical studies that favor its use as a neuroprotector in severe head injury or in patients in whom high intracranial pressure is refractory to first tier measures. The evidence that favors hypothermia is discussed. We also discuss the negative results of the still unpublished multicentre trial on prophylactic moderate hypothermia developed in the USA. The main problem with moderate hypothermia is the lack of a systematic methodology to induce and maintain it. Also, optimal duration of its use and the methodology and timing for rewarming have not been determined. Consequently, the results of different trials are difficult to analyze and compare. However, most evidence suggests that hypothermia provides remarkable protection against the adverse effects of neuronal damage that is exacerbated by secondary injury. Further prospective controlled trials with clearly defined methodology are needed before this method is implemented in daily clinical practice. The most important task for the years to come may be to focus on refining this procedure, defining the optimal time of cooling and rewarming and to optimize the methods of rapidly inducing and maintaining low temperature. It is also essential to define the most appropriate method and velocity of the rewarming phase, in which many successfully controlled patients deteriorate and die.	Hosp Univ Vall Hebron, Serv Neurocirug, Barcelona, Spain; Hosp Clin Montevideo, Unidad Cuidados Intensivos, Montevideo, Uruguay; Hosp Univ Vall Hebron, Unidad Invest Neurotraumatol, Barcelona, Spain; Hosp Univ Vall Hebron, Unidad Cuidados Intensivos Neurotraumatol, Barcelona, Spain; Hosp Univ Hebron, Serv Anestesiol & Reanimac, Gen Hosp, Barcelona, Spain				Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Garnacho, Angel/A-9309-2013	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Baguena, Marcelino/0000-0001-9598-4791			ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P103, DOI 10.1111/j.1399-6576.1995.tb04285.x; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Berger C, 1999, STROKE, V30, P460, DOI 10.1161/01.STR.30.2.460; Bissonnette B, 1999, ANESTHESIOLOGY, V91, P1763, DOI 10.1097/00000542-199912000-00030; BOBA A, 1960, HYPOTHERMIA NEUROSUR; BRAUGHLER JM, 1992, J NEUROTRAUMA, V9, P1; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock R, 1995, GUIDELINES MANAGEMEN; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; CLIFTON GL, 1996, NEUROTRAUMA, P401; COOPER PR, 1985, CENTRAL NERVOUS SYST, P117; DEXTER F, 1995, ANESTHESIOLOGY, V83, P405, DOI 10.1097/00000542-199508000-00021; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Ginsberg M. D, 1995, NEUROSCIENTIST, P164; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HALL ED, 1992, J NEUROTRAUMA, V9, P425; HARTUNG J, 1994, J NEUROSURG ANESTH, V6, P1; Hochachka P.W., 1987, METABOLIC ARREST CON; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1996, NEUROTRAUMA, P3; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KALB RG, 1995, NEUROSCIENTIST, V1, P60, DOI 10.1177/107385849500100201; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LUTZ PL, 1994, BRAIN OXYGEN CAUSES; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 1997, ACT NEUR S, V70, P68; MARMAROU A, 1994, TRAUMATIC BRAIN EDEM, P421; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 1991, J NEUROSURG S, V75, P14; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MICHENFELDER JD, 1970, ANESTHESIOLOGY, V33, P430, DOI 10.1097/00000542-197010000-00013; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; PITTS LH, 1990, HDB CLIN NEUROLOGY, V13, P65; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; SAHUQUILLO J, IN PRESS ACTA NEUR S; Shapiro S, 1997, NEUROSURGERY, V40, P168, DOI 10.1097/00006123-199701000-00037; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; SIGNORINI DF, 2000, COCHRANE LIB; Small DL, 1999, NEUROL DIS, V48, P341; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; VISE WM, 1994, INT C REC ADV NEUR I, P95; WHITE RJ, 1969, SURGERY, V66, P224; WHITE RJ, 1969, BRIT J SURG, V56, P630; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	61	4	5	0	0	SOCIEDAD LUSO-ESPANOLA NEUROCIRUGIA	SANTANDER	C/O J M IZQUIERDO HOSPITAL VALDECILLA, 39908 SANTANDER, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia		2001	12	1					23	35					13	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	413TZ	WOS:000167629100003	11706432				2022-02-06	
J	Temple, MD; Delahunty, TM; Hamm, RJ; Phillips, LL; Lyeth, BG; Povlishock, JT				Temple, MD; Delahunty, TM; Hamm, RJ; Phillips, LL; Lyeth, BG; Povlishock, JT			Subtle alterations in NMDA-stimulated cyclic GMP levels following lateral fluid percussion brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cyclic GMP; hippocampus; N-methyl-D-aspartate receptor; radioimmunoassay; rats; traumatic brain injury	FOREBRAIN CHOLINE-ACETYLTRANSFERASE; LONG-TERM POTENTIATION; NITRIC-OXIDE; COGNITIVE IMPAIRMENT; RECEPTOR ANTAGONIST; RAT HIPPOCAMPUS; D-CYCLOSERINE; ACTIVATION; ACID; PERFORMANCE	This study examined whether NMDA-stimulated cyclic GMP levels were altered at two different time points following lateral fluid percussion injury. At 60 min and 15 days postinjury, the left and right hippocampi were dissected and chopped into mini-prisms. Each hippocampus was divided into five equal parts and incubated with either the phosphodiesterase inhibitor IBMX (3-isobutyl-1-methylxanthine, 500 muM) alone, IBMX and N-methyl-D-aspartic acid (NMDA) OR IBMX, NMDA, and glycine (10 MM), Two concentrations of NMDA were used: 500 or 1,000 muM, Tissues were then assayed for levels of cyclic GMP, Results indicated that there were no changes in basal levels of cyclic GMP at either postinjury time point. At 60 min postinjury, there were no significant main effects for injury or drug concentration. There was a significant injury x side interaction effect with increased levels of NMDA-stimulated cyclic GMP in the hippocampus ipsilateral to the injury impact and decreased cyclic GMP levels in the contralateral hippocampus. There were no significant alterations in NMDA-stimulated cyclic GMP levels at 15 days postinjury, The data from this study indicated that NMDA-stimulated cyclic GMP accumulation is differentially altered in the hippocampus ipsilateral and contralateral to the site of the injury at 1 h after injury, but is normalized by 15 days postinjury, These findings implicate NMDA-mediated intracellular signaling processes in the acute excitotoxic response to injury.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat, Richmond, VA 23298 USA		Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychol, POB 842018, Richmond, VA 23284 USA.	rhamm@vcu.edu		Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587] Funding Source: Medline		ARNOLD GW, 1977, APPL ANIM ETHOL, V3, P263, DOI 10.1016/0304-3762(77)90007-4; Chalimoniuk M, 1998, J NEUROSCI RES, V54, P681, DOI 10.1002/(SICI)1097-4547(19981201)54:5<681::AID-JNR13>3.0.CO;2-L; DANYSZ W, 1989, BRAIN RES, V479, P270, DOI 10.1016/0006-8993(89)91628-4; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P405; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DeWitt D S, 1995, New Horiz, V3, P376; Dhillon HS, 1995, J NEUROTRAUM, V12, P1035, DOI 10.1089/neu.1995.12.1035; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRUMMOND GI, 1984, CYCLIC NUCL NERVOUS; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; EMMETT MR, 1991, NEUROPHARMACOLOGY, V30, P1167, DOI 10.1016/0028-3908(91)90161-4; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LINCOLN TM, 1994, CYCLIC GMP BIOCH PHY; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MAIESE K, 1994, NEUROSCI LETT, V166, P43, DOI 10.1016/0304-3940(94)90836-2; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MIKI N, 1977, BIOCHEM BIOPH RES CO, V75, P851, DOI 10.1016/0006-291X(77)91460-7; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Temple M. D., 1997, Society for Neuroscience Abstracts, V23, P946; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; WEI JW, 1993, INT J BIOCHEM, V25, P1579; WOOD PL, 1991, PROG NEURO-PSYCHOPH, V15, P229, DOI 10.1016/0278-5846(91)90085-F	47	4	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2001	18	1					47	55		10.1089/089771501750055767			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	390EU	WOS:000166283400005	11200249				2022-02-06	
J	Colantonio, A; Ratcliff, G; Chase, S; Escobar, M				Colantonio, A; Ratcliff, G; Chase, S; Escobar, M			Is cognitive performance related to level of community integration many years after traumatic brain injury?	BRAIN AND COGNITION			English	Article								The aim of this study was to investigate the association between measures of cognition and level of community integration 7 to 24 years after moderate/severe traumatic brain injury (TBI). Subjects were recruited from in-patient health records of a large rehabilitation hospital in Pennsylvania. Eligible subjects were traced and then invited to participate in a face-to-face interview which included the Community Integration Scale (CIQ), and cognitive tests such as Trails A Br B, the Rivermead Story Recall subtest, and the Neurobehavioral Cognitive Status Exam (NCSE). Linear regression analyses on 207 subjects showed that Trails A, Trails B, and story recall measure were significantly associated with CIQ scores (p < .0005) controlling for age and education. Results with other cognitive measures are discussed. (C) 2000 Academic Press.	Univ Toronto, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto, ON, Canada.			Escobar, Michael/0000-0001-9055-4709			WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	1	4	4	0	3	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					19	20					2	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300005					2022-02-06	
J	Lorber, A; Artru, AA; Lam, AM; Mueller, AL; Karpas, Z; Roytblat, L; Shapira, S				Lorber, A; Artru, AA; Lam, AM; Mueller, AL; Karpas, Z; Roytblat, L; Shapira, S			NPS 1506: A novel NMDA receptor antagonist - Neuroprotective effects in a model of closed head trauma in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain, tissue, ions; edema, brain; head injury, closed; ischemia, brain, tissue volume; neuroprotection; NMDA receptor antagonist	EXPERIMENTAL BRAIN INJURY; REGIONAL CEREBRAL EDEMA; CONDITIONED FREEZING DEFICIT; RIGHT PARIETAL CORTEX; GLUTAMATE-RECEPTOR; 5-PERCENT DEXTROSE; RAPID INFUSION; INFARCT VOLUME; AMINO-ACIDS; MAGNESIUM	We examined whether NPS 1506, a novel uncompetitive N-methyl-D-aspartate receptor antagonist, influences neurological outcome following closed head trauma (CHT) in rats. One hundred ten rats were divided into 11 groups: CHT (yes/no), treatment with NPS 1506 (yes/no), and time of euthanization (24 h/48 h). The dose of NPS 1506 was 1 mg/kg IV at 1 and 4 hours following CHT or sham operation. Closed head trauma induced the following changes in the injured hemisphere: Decreased specific gravity (sg) (1.036 +/- 0.006) and magnesium (Mg) (0.042 +/- 0.005 mu g/mg) at 24 hours, and potassium (K) at 24 (1.145 +/- 9.376 mu g/mg) and 48 hours, and increased water content (W) (84.9 +/- 2.5%) and sodium (Na) (2.135 +/- 0.699 mu g/mg) at 24 hours, and calcium (Ca) at 24 (0.543 +/- 0.157 mu g/mg) and 48 hours. These were reversed by NPS 1506; sg of 1.043 +/- 0.004, Mg of 0.077 +/- 0.009 mu g/mg, K of 1.930 +/- 0.238 mu g/mg, W of 81.5 +/- 1.9%, Ca of 0.043 +/- 0.023 mu g/mg, and Na of 0.688 +/- 0.110 mu g/mg. In groups not given NPS 1506, a nonsignificant decrease in neurological severity score (NSS) occurred at 24 and 48 hours as compared to NSS at 1 hour after CHT. In groups given NPS 1506, NSS at 24 and 48 hours decreased significantly (improved) compared to NSS at 1 hour, but not compared to NSS at 24 and 48 hours in groups not given NPS 1506. NPS 1506 caused no significant change in ischemic tissue volume or hemorrhagic necrosis volume in the injured hemisphere at 24 hours or 48 hours. These findings indicate that NPS 1506 improved measures of brain tissue edema (at 24 hours but not at 48 hours) and ion homeostasis, and this improvement was not related to other measures of outcome.	Univ Washington, Dept Anesthesiol, Sch Med, Seattle, WA 98195 USA; Nucl Res Ctr Negev, Dept Analyt Chem, IL-84190 Beer Sheva, Israel; NPS Pharmaceut Inc, Salt Lake City, UT USA; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel		Artru, AA (corresponding author), Univ Washington, Dept Anesthesiol, Sch Med, Box 356540, Seattle, WA 98195 USA.						Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Bullock R, 1995, ANN NY ACAD SCI, V765, P272, DOI 10.1111/j.1749-6632.1995.tb16584.x; CHOI DW, 1990, J NEUROSCI, V10, P2493; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; Hawkinson JE, 1997, BRAIN RES, V744, P227, DOI 10.1016/S0006-8993(96)01064-5; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Hogg S, 1998, J NEUROTRAUM, V15, P545, DOI 10.1089/neu.1998.15.545; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KOHMURA E, 1990, J CEREBR BLOOD F MET, V10, P877, DOI 10.1038/jcbfm.1990.144; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; Kroppenstedt SN, 1998, ACT NEUR S, V71, P114; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MATSUMIYA N, 1991, STROKE, V22, P1193, DOI 10.1161/01.STR.22.9.1193; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; MORLEY P, 1994, BRAIN PATHOL, V4, P37; Mueller AL, 1999, ANN NY ACAD SCI, V890, P450, DOI 10.1111/j.1749-6632.1999.tb08023.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nordqvist ACS, 1997, NEUROREPORT, V8, P455, DOI 10.1097/00001756-199701200-00016; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SHAPIRA Y, 1992, ANESTH ANALG, V74, pS282; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SUN FY, 1994, BRAIN RES, V661, P63, DOI 10.1016/0006-8993(94)91181-9; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3	63	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2000	12	4					345	355		10.1097/00008506-200010000-00007			11	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	360PL	WOS:000089676400007	11147383				2022-02-06	
J	Waran, V; Menon, DK				Waran, V; Menon, DK			Multimodality monitoring and the diagnosis of traumatic caroticocavernous fistula following head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						caroticocavernous fistula; cerebral oximetry; head injury; multimodality monitoring; transcranial Doppler	CEREBRAL BLOOD-FLOW; VENOUS OXYGEN-SATURATION; BRAIN INJURY; INTRACRANIAL HYPERTENSION; METABOLISM; HYPEREMIA; PRESSURE	Increases in jugular bulb saturations (SjO(2)) following head injury are usually due to hyperaemia. Less commonly this may be due to the development of an arteriovenous fistula. We describe how SjO(2) monitoring can be used in conjunction with transcranial Doppler ultrasound to make the distinction between these two conditions, which require distinct therapies. Multimodality monitoring in acute injury provides information regarding underlying pathophysiology and permits individualization of therapy.	Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England		Menon, DK (corresponding author), Addenbrookes Hosp, Neurosci Crit Care Unit, Box 93, Cambridge CB2 2QQ, England.		Mathaneswaran, Vickneswaran/E-5180-2010; Mathaneswaran, Vickneswaran/A-1228-2011				BARTHELEMY C, 1995, J NEUROSURG, V83, P910; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kirkpatrick PJ, 1996, J NEUROL NEUROSUR PS, V60, P131, DOI 10.1136/jnnp.60.2.131; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090	11	4	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2000	14	5					469	471					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	369ZZ	WOS:000165098800015	11198772				2022-02-06	
J	Nakayama, Y; Aoki, Y				Nakayama, Y; Aoki, Y			Mechanism responsible for the formation of focal swellings on injured neuronal processes using a novel in vitro model of axonal injury	FORENSIC SCIENCE INTERNATIONAL			English	Article; Proceedings Paper	4th International Symposium on Adances in Legal Medicine (ISALMIV)	SEP 22-25, 1999	ACAD SCI & LITERATURE, MAINZ, GERMANY		ACAD SCI & LITERATURE	axon reaction; cell culture; cytoskeleton; head injuries; closed; PC12 cells	HEAD-INJURY	A novel in vitro model of axonal injury using PC12 cells was designed to introduce traumatic alterations on neuronal processes and to identify mechanisms responsible for the formation of focal swellings by observation with phase-contrast and transmission electron microscopes. The injury on the processes was developed by one-dimensional, horizontal oscillation, phase-contrast microscopic observation on the injured processes showed their terminal increase in diameter. Long term observation of cellular responses to the mechanical insult disclosed that the terminal swelling coincided with the detachment of growth cones from the culture plate. The finding suggests that the detachment of the growth cone would destroy a cytoskeletal network, which determines and maintains the cell shapes, and then cause the spherical deformation of the processes. Ultramicroscopically, the processes with terminal swellings regenerated the growth cones by the cytoskeletal reconstruction. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 0208505, Japan		Nakayama, Y (corresponding author), Iwate Med Univ, Sch Med, Dept Legal Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.						ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Hotani H, 1990, Adv Biophys, V26, P135, DOI 10.1016/0065-227X(90)90010-Q; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; NAKAYAMA Y, 1998, 6 IND PAC C LEG MED, P991; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Schweitzer ES, 1996, J NEUROSCI RES, V46, P519; Smith DH, 1999, J NEUROSCI, V19, P4263	10	4	6	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	SEP 11	2000	113	1-3			SI		245	249		10.1016/S0379-0738(00)00217-6			5	Medicine, Legal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	358AJ	WOS:000089534800043	10978633				2022-02-06	
J	Sayal, K; Ford, T; Pipe, R				Sayal, K; Ford, T; Pipe, R			Case study: Bipolar disorder after head injury	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						head injury; adolescent; mania; bipolar disorder; psychosocial factors	TRAUMATIC BRAIN INJURY; CHILDREN; MANIA; ADOLESCENTS; SEQUELAE; HYPOMANIA; LITHIUM	A case of bipolar disorder subsequent to a mild head injury in a 15-year-old girl is reported. Review of the literature indicates that this is an extremely rare outcome. Lack of adequate follow-up studies makes it difficult to accurately predict type and severity of psychiatric outcome. Assessment and management involves ongoing consideration of both organic and psychosocial factors even after initial negative investigations.	Bethlem Hosp, London, England; Maudsley Hosp, London, England		Sayal, K (corresponding author), Inst Psychiat, Dept Child Psychiat, De Crespigny Pk, London SE5 8AF, England.		Ford, Tamsin/V-5908-2019; anand, amit/A-7222-2009	Ford, Tamsin/0000-0001-5295-4904; Sayal, Kapil/0000-0002-2050-4316			BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess P, 1996, BEHAV ASSESSMENT DYS; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P72; COHN CK, 1977, DIS NERV SYST, V38, P630; GILLBERG C, 1995, CLIN CHILD NEUROPSYC, P274; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JOSHI P, 1985, J DEV BEHAV PEDIATR, V6, P352; KHANNA S, 1985, CAN J PSYCHIAT, V30, P236, DOI 10.1177/070674378503000325; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; LIVINGSTON M G, 1990, Pediatrician, V17, P255; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1997, NEUROCASE, V3, P119; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SOLLEE ND, 1987, J ABNORM CHILD PSYCH, V15, P479, DOI 10.1007/BF00917235; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; TEASDALE G, 1974, LANCET, V2, P81	24	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	APR	2000	39	4					525	528		10.1097/00004583-200004000-00023			4	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	299GG	WOS:000086190000023	10761356				2022-02-06	
J	Bernhardt, DT				Bernhardt, DT			Football: A case-based approach to mild traumatic brain injury	PEDIATRIC ANNALS			English	Article							MENTAL STATUS; MANAGEMENT; CONCUSSION	Concussion is a common injury among most contact and collision sports. The author highlights the issues surrounding diagnosis, imaging, ability to play, and the second impact and postconcussive syndromes by following a clinical example from the playing field to the office.	Univ Wisconsin, Dept Pediat & Sports Med, Madison, WI 53792 USA		Bernhardt, DT (corresponding author), Univ Wisconsin, Dept Pediat & Sports Med, 600 Highland Ave H6-440, Madison, WI 53792 USA.						CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kelly JP, 1997, NEUROLOGY, V48, P581; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; MCGUINE T, 1996, ASTM STP, V1305, P83; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008	9	4	4	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481			PEDIATR ANN	Pediatr. Annu.	MAR	2000	29	3					172	+		10.3928/0090-4481-20000301-11			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	294ZZ	WOS:000085942200008	10734651				2022-02-06	
J	Cespedes, JMM; Tobal, JJM; Vindel, AC				Cespedes, JMM; Tobal, JJM; Vindel, AC			The assesment of emotional disturbances in head-injured patients.	PSICOTHEMA			Spanish	Article							TRAUMATIC BRAIN INJURY; PSYCHOSOCIAL RECOVERY; ADJUSTMENT; PREDICTION; BEHAVIOR; SEQUELAE; FAMILY; ADULTS; SCALE	Emotional and behavioral disorders associated to traumatic brain injury (T.B.L) have not been sufficiently well studied due to several reasons; among them, the complexity of the underlying aetiological factors and the lack of adequate assessment protocols postraumatic emotional disorders are addressed. In the present paper, the Neurobehavioral Rating Scale-Revised (N.R.S-R) was applied to a sample of 60 T.B.I. patients ranging from very severe to mild severity. Results are consistent with the presence of diffuse damage, although it is remarkable that there is a poor performance in items which assess factors related to frontal lobes functioning. A new factor structure for the N.R.S.-R is proposed. Moreover, results are analysed in relation with severity classification criteria (Glasgow Coma Score and postraumatic amnesia). Finally, it is also remarkable the lack of direct relationship between brain injury severity and some emotional disorders (anxiety and depression), pointing out the importance of awareness as a fundamental variable in explaining the emotional adjustment after a T.B.I.	Univ Complutense Madrid, Fac Psicol, Madrid 28223, Spain		Cespedes, JMM (corresponding author), Univ Complutense Madrid, Fac Psicol, Madrid 28223, Spain.		Cano-Vindel, Antonio/A-2089-2011	Cano-Vindel, Antonio/0000-0002-5449-5454			BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CESPEDES JMM, 1997, ADV NEUTORAUMA RES C; CESPEDES JMM, 1997, POLIBEA, V44, P28; CESPEDES JMM, 1995, ANSIEDAD ESTRES, V1, P81; Chiu Wen-Ta, 1993, Journal of the Formosan Medical Association, V92, P255; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CRIPE LL, 1996, CLIN NEUROPSYCHOLOGY; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIXON J, 1992, BMDP BIOMEDICAL STAT; EARNES P, 1988, J HEAD TRAUMA REHAB, V3, P1; Folkman S., 1984, STRESS; FORDYCE D, 1994, BRAIN INJURY REHABIL; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; HERMANN D, 1994, NEUROREHABILITATION, V4, P133; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; JACOBS HE, 1990, NEUROBEHAVIOURAL SEQ; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kluwe R. H., 1987, METACOGNITION MOTIVA; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1989, ORGANIC PSYCHIAT CON; Lobo A., 1980, REV PSIQ PSICOL MED, V5, P39; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MITCHLEY N, 1996, CLIN REHABIL, V10, P3; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Munoz Cespedes JM., 1997, MAPFRE MED, V8, P41; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pelegrin C, 1995, ANALES PSIQUIATRIA, V11, P88; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; PUENTE AE, 1991, NEUROPSYCHOLOGY LAW; SARNO MT, 1986, J NEUROL NEUROSUR PS, V39, P1062; Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554; TURKSTRA LLS, 1995, BRAIN INJURY, V10, P329; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; [No title captured]	54	4	4	0	3	COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS	OVIEDO	ILDEFONSO S. DEL RIO, 4-1 B, 33001 OVIEDO, SPAIN	0214-9915			PSICOTHEMA	Psicothema	FEB	2000	12	1					99	106					8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	277UL	WOS:000084951900013					2022-02-06	
J	Johnstone, B; Vieth, AZ; Johnson, JC; Shaw, JA				Johnstone, B; Vieth, AZ; Johnson, JC; Shaw, JA			Recall as a function of single versus multiple trials: Implications for rehabilitation	REHABILITATION PSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; MEMORY; PATTERNS	Objective: To empirically demonstrate that recall based on multiple presentations of material (i.e., "learning") is statistically distinct from recall based on singular presentations of material (i.e., "memory"). Participants: Two hundred ninety-one individuals referred to an outpatient neuropsychology laboratory, including 199 with a primary diagnosis of traumatic brain injury, 13 who experienced a cerebral vascular accident, 3 with progressive dementia, and 76 with an unknown etiology. Main Outcome Measures: Raw-standard scores from the Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction subtests, the Rey Auditory Verbal Learning Test (RAVLT), the Tactual Performance Test (TPT), the Category Test, and indices of "learning" based on difference scores: RAVLT Trial 5 minus Trial 1; TPT Trial 3 minus Trial 1. Results: A promax factor analysis of 291 participants with cognitive dysfunction revealed a 4-factor solution (verbal memory, spatial memory, verbal learning, and tactile-motor learning), supporting the distinction between learning and memory constructs. Conclusions: Recall based on multiple presentations of information should be evaluated to provide the most functionally relevant assessments.	Univ Missouri, Dept Phys Med & Rehabil, Sch Med, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Dept Phys Med & Rehabil, Sch Med, Rusk Rehabil Ctr DC046-00,1 Hosp Dr, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649; Johnson, Jane/0000-0002-8825-5926			Brooks D. N, 1990, REHABILITATION ADULT, P163; CHELUNE GJ, 1983, J CONSULT CLIN PSYCH, V51, P920; COHEN NJ, 1981, ANN M SOC NEUR LOS A; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DELIS D, 1987, CALIFORNIA VERBAL LE; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DILLER L, 1984, REHABILITATION MEMOR, pR7; GASS CS, 1995, ARCH CLIN NEUROPSYCH, V10, P475, DOI 10.1016/0887-6177(95)98192-G; HADDAD L B, 1989, Clinical Gerontologist, V9, P53; Halstead WC, 1947, BRAIN INTELLIGENCE Q; HARRIS J, 1984, CLIN MANAGEMENT MEMO, P46; HAUT MW, 1992, PHYSICAL MED REHABIL, V6, P451; HINTZMAN DL, 1990, ANNU REV PSYCHOL, V41, P109, DOI 10.1146/annurev.psych.41.1.109; Irion A. L., 1952, PSYCHOL HUMAN LEARNI; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Rapaport D., 1951, ORG PATHOLOGY THOUGH, P58; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds C.R., 1994, TEST MEMORY LEARNING; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; STARR A, 1970, NEUROPSYCHOLOGIA, V8, P75, DOI 10.1016/0028-3932(70)90027-8; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	35	4	4	0	1	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2000	45	1					3	19		10.1037/0090-5550.45.1.3			17	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	285CX	WOS:000085372800001					2022-02-06	
J	Bouvier-Peyrou, M; Landis, T; Annoni, JM				Bouvier-Peyrou, M; Landis, T; Annoni, JM			Self-duplication shifted in time: A particular form of delusional misidentification syndrome	NEUROCASE			English	Article						delusional misidentification syndrome; paramnesia; Capgras syndrome; brain injury	REDUPLICATIVE PARAMNESIA; CAPGRAS-SYNDROME; CLASSIFICATION; SUBSTITUTION; MECHANISMS; SYMPTOM; MEMORY	Reduplicative paramnesia refers more often to places than to time or to persons. We report here the case of a 16-year-old student who, after a severe brain injury, presented the delusion of a double who was 1 year younger than himself and with no physical impairment, This patient presented a severe memory deficit, particularly in the verbal modality, uninhibited behaviour, decreased self-awareness, difficulties in planning and impaired mental flexibility. There were no visuo-spatial or autotopognosic deficits, His delusion diminished over 2.5 years and, at the same time, learning and executive functions returned to normal, However, a retrograde amnesia of 1 year persisted. This observation is in line with Staton et al.'s (Cortex 1982; 18: 23-36) hypothesis about reduplicative paramnesia being a functional disconnection between past mnesic information and the ability to integrate it with actual experiences, Magnetic resonance imaging showed bilateral frontal contusions more severe on the left side, a small left anterior thalamic contusion, and a secondary atrophy of the left hippocampus and the left anterior temporal pole, The role of the left temporal paralimbic post-traumatic lesions in relation to reduplication of self is discussed.	Univ Hosp Geneva, Dept Neurol, Neuropsychol Unit, CH-1211 Geneva 14, Switzerland		Bouvier-Peyrou, M (corresponding author), Univ Hosp Geneva, Dept Neurol, Neuropsychol Unit, CH-1211 Geneva 14, Switzerland.	jean-marie.annoni@hcuge.ch					ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; Brickenkamp R., 1981, AUFMERKSAMKEITS BELA; Brugger P, 1997, Cogn Neuropsychiatry, V2, P19, DOI 10.1080/135468097396397; CAPGRAS J, 1923, SOC CLIN MED MENTALE, P6; CHRISTODOULOU GN, 1978, AM J PSYCHIAT, V135, P249; COLOMBO FT, 1992, EUR REV APPL PSYCHOL, V42, P67; Coltheart M, 1997, TRENDS COGN SCI, V1, P157, DOI 10.1016/S1364-6613(97)01053-X; DEPAUW KW, 1994, PSYCHOPATHOLOGY, V27, P123, DOI 10.1159/000284858; ELLIS HD, 1994, PSYCHOPATHOLOGY, V27, P177, DOI 10.1159/000284867; Feinberg TE, 1997, SEMIN NEUROL, V17, P129, DOI 10.1055/s-2008-1040922; FEINBERG TE, 1989, NEUROPSY NEUROPSY BE, V2, P34; FLEMINGER S, 1994, PSYCHOPATHOLOGY, V27, P161, DOI 10.1159/000284865; HOOPER EH, 1958, HOOPER VISUAL ORG TE; KAPUR N, 1988, J NEUROL NEUROSUR PS, V51, P579, DOI 10.1136/jnnp.51.4.579; LURIA AR, 1965, BRAIN, V88, P1, DOI 10.1093/brain/88.1.1; MARKOVA IS, 1994, PSYCHOPATHOLOGY, V27, P136, DOI 10.1159/000284860; Mesulam M., 1985, CEREB CORTEX, V4, P179, DOI [10.1007/978-1-4757-9619-3_5, DOI 10.1007/978-1-4757-9619-3_5]; Murai T, 1997, NEUROPSY NEUROPSY BE, V10, P190; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Pick A, 1903, BRAIN, V26, P242, DOI 10.1093/brain/26.2.242; POPPELREUTER W, 1917, PSYCHISCHEN SCHADIG; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Rey A., 1964, AUDITORY VERBAL LEAR; REY A, 1964, REY OSTERRIETH COMPL; Rohrenbach C., 1995, BROKEN MEMORIES CASE, P93; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; Sellal F, 1996, J CLIN EXP NEUROPSYC, V18, P234, DOI 10.1080/01688639608408278; SIGNER SF, 1994, PSYCHOPATHOLOGY, V27, P232, DOI 10.1159/000284875; SIGNER SF, 1994, PSYCHOPATHOLOGY, V27, P168, DOI 10.1159/000284866; SILVA JA, 1990, PSYCHOPATHOLOGY, V23, P27; SILVA JA, 1995, CAN J PSYCHIAT, V40, P498, DOI 10.1177/070674379504000820; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Weinstein E.A., 1991, AWARENESS DEFICIT BR, P240; WEINSTEIN EA, 1994, PSYCHOPATHOLOGY, V27, P130, DOI 10.1159/000284859	39	4	4	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2000	6	1					57	63		10.1080/13554790008402758			7	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	311RT	WOS:000086899200006					2022-02-06	
J	Fontani, G; Maffei, D; Lodi, L				Fontani, G; Maffei, D; Lodi, L			Policosanol, reaction time and event-related potentials	NEUROPSYCHOBIOLOGY			English	Article						policosanol; event-related potentials; contingent negative variations; P300; reaction time	CLOSED HEAD-INJURY; P300; CAFFEINE; BRAIN; OCTACOSANOL; ATTENTION; HUMANS; RATS; CNV	The aim of the present study was to compare the results of a 1-week, double-blind placebo-controlled trial investigating the effects of isopolicosanol and octacosanol on reactivity and related brain activity. In particular, reaction time (RT) and event-related potentials such as contingent negative variations (CNV) and P300 (P3) have been studied. Thirty sedentary healthy students were tested before and after treatment (3.6 mg/die for 7 days) with orally administered tablets of placebo (group A), isopolicosanol (B) and octacosanol (C), RT were studied according to three procedures: simple RT (SRT), go/no-go RT (GRT) and choice RT (CRT), Results show that before treatment, there were no significant differences between groups A, B and C. After treatment, the RT of group A was unchanged, while the RT of groups B and C were reduced. In group B, in the SRT test, the reduction of RT was accompanied by electrical data exhibiting increased amplitudes of CNV and shorter latencies of P3. These results show that the main effect on reactivity and event-related potentials can be ascribed to policosanol and is mainly evident in the SRT test. Copyright (C) 2000 S. Karger AG, Basel.	Univ Siena, Ist Fisiol Umana, I-53100 Siena, Italy		Fontani, G (corresponding author), Univ Siena, Ist Fisiol Umana, Via A Moro, I-53100 Siena, Italy.						ABT K, 1991, STAT MED, V10, P777, DOI 10.1002/sim.4780100513; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; CURETON TK, 1972, PHYSL EFFECTS WHEAT; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; FONTANI G, IN PRESS EUR J APPL; HORST RL, 1980, MEM COGNITION, V8, P476, DOI 10.3758/BF03211144; Hull C. L., 1951, ESSENTIALS BEHAV; KABIR Y, 1994, NAHRUNG, V38, P373; KABIR Y, 1993, ANN NUTR METAB, V37, P33, DOI 10.1159/000177746; KING DJ, 1992, BRIT J PSYCHIAT, V160, P647, DOI 10.1192/bjp.160.5.647; Kolev V, 1997, NEUROREPORT, V8, P2061, DOI 10.1097/00001756-199705260-00050; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LORIST MM, 1994, PSYCHOPHARMACOLOGY, V113, P411, DOI 10.1007/BF02245217; LOW MD, 1966, PERCEPT MOTOR SKILL, V22, P443, DOI 10.2466/pms.1966.22.2.443; Menendez R, 1997, BRIT J NUTR, V77, P923, DOI 10.1079/BJN19970090; NAATANEN R, 1975, BIOL PSYCHOL, V2, P237, DOI 10.1016/0301-0511(75)90038-1; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; NOUGIER V, 1987, RECHERCHES APS, V2, P209; Picton TW, 1988, HDB ELECTROENCEPHALO, V3, P361; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; RIEDEL W, 1995, PSYCHOPHARMACOLOGY, V122, P158; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SAMAR VJ, 1995, BRAIN COGNITION, V27, P398, DOI 10.1006/brcg.1995.1028; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; TAGHAVY A, 1988, INT J NEUROSCI, V38, P179, DOI 10.3109/00207458809000495; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; TECCE JJ, 1969, SCIENCE, V164, P331, DOI 10.1126/science.164.3877.331; TECCE JJ, 1982, ELECTROENCEPHALOGRAP, P543; TECCE JJ, 1970, ATTENTION CONT THEOR; WALTER W G, 1965, Br J Physiol Opt, V22, P1; WEI JH, 1990, CHINESE SCI BULL, V35, P227	34	4	4	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0302-282X			NEUROPSYCHOBIOLOGY	Neuropsychobiology		2000	41	3					158	165		10.1159/000026649			8	Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	303PU	WOS:000086431900008	10754431				2022-02-06	
J	Friedman, RM; Ritz, LA; Reier, PJ; Vierck, CJ				Friedman, RM; Ritz, LA; Reier, PJ; Vierck, CJ			Effects of sacrocaudal spinal cord transection and transplantation of fetal spinal tissue on withdrawal reflexes of the tail	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						fetal transplantation; spastic syndrome; spinal cord injury; cutaneous reflexes; segmental reflexes; spinal transection	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN INJURY; CYCLOSPORINE-A; ADULT-RATS; CELL-DEATH; RECEPTOR ANTAGONISTS; NUCLEUS NEURONS; STRETCH REFLEX; CAT; LESIONS	Reflex responses to electrocutaneous stimulation of the tail were characterized in awake cats, before and after transection of the spinal cord at sacrocaudal levels S-3-Ca-1. Consistent with effects of spinal transection at higher levels, postoperative cutaneous reflexes were initially depressed, and the tail was flaccid. Recovery ensued ol-er the course of 70-90 days after sacrocaudal transection. Preoperative and chronic postlesion reflexes elicited by electrocutaneous stimulation were graded in amplitude as a function of stimulus intensity. Chronic postlesion testing of e electrocutaneous reflexes revealed greater than normal peak amplitudes, peak latencies, total amplitudes (power), and durations, particularly for higher stimulus intensities. Thus, sacrocaudal transection produced effects representative of the spastic syndrome. In contrast, exaggerated reflex responsivity did nut develop for a group of cats that received transplants of fetal spinal cord tissue within sacrocaudal transection cavities at the time of injury, in conjunction with long-term immunosuppression by cyclosporine. We conclude that gray matter replacement and potential neuroprotective actions of the grafts and/or immunosuppression prevent development of the spastic syndrome. This argues that the spastic syndrome does nor result entirely from interruption of long spinal pathways.	Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; Univ Florida, Coll Med, McNight Brain Inst, Gainesville, FL 32610 USA		Vierck, CJ (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.	vierck@ufbi.ufl.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-31706, NS-35702, NS-27511] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031706, P01NS027511, P01NS035702] Funding Source: NIH RePORTER		Afelt Z, 1970, Acta Neurobiol Exp (Wars), V30, P129; ANDERSON DK, 1991, RESTOR NEUROL NEUROS, V2, P309, DOI 10.3233/RNN-1991-245621; ASHBY P, 1999, NEUROPHYSIOLOGY SPIN; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BREGMAN BS, 1991, EXP NEUROL, V112, P49, DOI 10.1016/0014-4886(91)90113-Q; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Burke D, 1988, Adv Neurol, V47, P401; BURKE D, 1972, BRAIN, V95, P31, DOI 10.1093/brain/95.1.31; BURKE D, 1970, J NEUROL NEUROSUR PS, V33, P216, DOI 10.1136/jnnp.33.2.216; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; DIMITRIJEVIC MR, 1967, BRAIN, V90, P333, DOI 10.1093/brain/90.2.333; DIMITRIJEVIC MR, 1967, BRAIN, V90, P1, DOI 10.1093/brain/90.1.1; DIMITRIJEVIC MR, 1968, BRAIN, V91, P349, DOI 10.1093/brain/91.2.349; FERINGA ER, 1975, ARCH NEUROL-CHICAGO, V32, P676, DOI 10.1001/archneur.1975.00490520046007; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Fulton JF, 1932, J PHYSIOL-LONDON, V75, P17, DOI 10.1113/jphysiol.1932.sp002869; GUIZARSAHAGUN G, 1994, RESTOR NEUROL NEUROS, V7, P61, DOI 10.3233/RNN-1994-7201; HAGBARTH K E, 1952, Acta Physiol Scand Suppl, V26, P1; Hagbarth K. E., 1963, PROG BRAIN RES, V1, P65; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hao JX, 1996, PAIN, V66, P279; HAO JX, 1992, J NEUROPHYSIOL, V68, P384, DOI 10.1152/jn.1992.68.2.384; HAO JX, 1992, EXP NEUROL, V118, P143, DOI 10.1016/0014-4886(92)90031-K; HIMES BT, 1994, J COMP NEUROL, V339, P117, DOI 10.1002/cne.903390111; Horner PJ, 1996, J COMP NEUROL, V364, P690, DOI 10.1002/(SICI)1096-9861(19960122)364:4<690::AID-CNE7>3.0.CO;2-Z; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P405, DOI 10.1111/j.1748-1716.1983.tb07357.x; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KATO M, 1985, EXP NEUROL, V90, P350, DOI 10.1016/0014-4886(85)90024-X; KITAMURA Y, 1994, J NEUROIMMUNOL, V50, P221; KOZAK W, 1966, S SOC EXP BIOL, V20, P419; KUHN RA, 1949, B JOHNS HOPKINS HOSP, V84, P43; KUHN RA, 1950, BRAIN, V73, P1, DOI 10.1093/brain/73.1.1; KUNKELBAGDEN E, 1992, EXP NEUROL, V116, P40, DOI 10.1016/0014-4886(92)90174-O; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LITTLE JW, 1986, EXP NEUROL, V93, P510, DOI 10.1016/0014-4886(86)90171-8; LIU CN, 1966, BRAIN, V89, P349, DOI 10.1093/brain/89.2.349; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; MCCOUCH GP, 1947, NEUROPHYSIOLOGY, V10, P425; Meinck HM, 1985, CLIN NEUROPHYSIOL, P41; NOTHIAS F, 1990, J COMP NEUROL, V301, P520, DOI 10.1002/cne.903010404; PALLINI R, 1989, J NEUROSURG, V70, P454, DOI 10.3171/jns.1989.70.3.0454; Pedersen E, 1954, ACTA PSYCH NEUROL SC, V88, P9; Pedhazur E. J., 1982, MULTIPLE REGRESSION; POWERS RK, 1988, J NEUROPHYSIOL, V59, P1540, DOI 10.1152/jn.1988.59.5.1540; Ranson SB, 1930, AM J PHYSIOL, V94, P471; Reier P J, 1988, Adv Neurol, V47, P87; REIER PJ, 1992, EXP NEUROL, V115, P177, DOI 10.1016/0014-4886(92)90245-L; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; REIER PJ, 1993, NEURAL CELL GRAFTING; Riddoch G, 1917, BRAIN, V40, P264, DOI 10.1093/brain/40.2-3.264; RITZ LA, 1992, J NEUROTRAUM, V9, P219, DOI 10.1089/neu.1992.9.219; ROBYBRAMI A, 1989, J NEUROL NEUROSUR PS, V52, P1390, DOI 10.1136/jnnp.52.12.1390; ROBYBRAMI A, 1987, BRAIN, V110, P707, DOI 10.1093/brain/110.3.707; RUSHWORTH G, 1966, PARAPLEGIA, V4, P141; SHAHANI BT, 1971, J NEUROL NEUROSUR PS, V34, P616, DOI 10.1136/jnnp.34.5.616; SHAHANI BT, 1973, NEW DEVELOPMENTS ELE, V3, P734; Sherrington C S, 1898, J Physiol, V22, P319; Shibayama M, 1998, J COMP NEUROL, V390, P102; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Taylor J, 1999, EUR J NEUROSCI, V11, P363, DOI 10.1046/j.1460-9568.1999.00468.x; Taylor JS, 1997, J NEUROSCI, V17, P5004; THILMANN AF, 1991, BRAIN, V114, P233; THOMAS KA, 1993, J MOLLUS STUD, V59, P175, DOI 10.1093/mollus/59.2.175; THOR KB, 1989, J COMP NEUROL, V288, P263, DOI 10.1002/cne.902880206; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; UTZSCHNEIDER DA, 1994, P NATL ACAD SCI USA, V91, P53, DOI 10.1073/pnas.91.1.53; Walker C, 1998, BEHAV BRAIN RES, V91, P41, DOI 10.1016/S0166-4328(97)00101-0; Walshe FMR, 1923, ARCH NEURO PSYCHIATR, V10, P1; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; Young RR, 1986, MANAGEMENT SPINAL CO, P241; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479	84	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair		2000	14	4					331	343		10.1177/154596830001400409			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439YH	WOS:000169144800009	11402883				2022-02-06	
J	Skvortsova, VL; Platonova, IA; Ostrovtsev, IV; Zhuravlyeva, EY; Chigrai, ZA; Efremova, NM; Ogareva, NV				Skvortsova, VL; Platonova, IA; Ostrovtsev, IV; Zhuravlyeva, EY; Chigrai, ZA; Efremova, NM; Ogareva, NV			The influence of the hormones of stress-realizing system on the course of the acute period of ischemic stroke	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article							TRAUMATIC BRAIN INJURY; NONTHYROIDAL ILLNESS; SERUM INTERLEUKIN-6; PEPTIDE MODULATION; CEREBRAL-ISCHEMIA; THYROID-HORMONES; HEAD-INJURY; RAT-BRAIN; GLYCINE; RECEPTOR	Experimental and clinical studies have proved an important role of the reaction of a stress-realizing endocrine system for both a course and an outcome of acute somatic diseases. That is why plasma concentrations of thyroxine (T-4), triiodo-thyronine (T-3), thyrotropic (TTH) and adrenocorticotropic (ACTH) hormones as well as of renin were measured during the 1-st week of acute ischemic stroke (AIS) in relevant patients for determination of their prognostic significance. 16 patients with hemispheric AIS were examined. A complex clinical biochemical investigation performed in patients with acute disorders of cerebral circulation revealed the presence of the "low T-3 syndrome" accompanied by an increase of blood plasma levels of T-4 by the 7-th day of the disease as well as an increase of the concentrations of TTH, ACTH and renin on the 2-nd day of the stroke. That reflected the severity of cerebral ischemia. Close correlation observed between the degree of normalization of hormonal concentrations and manifestations of neurologic disorders' regression by the 7-th and the 21-st days gave a good ground to consider these indices as a prognostic criterion for determination of an outcome of the acute period of ischemic stroke.	Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia; Moscow Consult Diagnost Ctr 4, Moscow, Russia		Skvortsova, VL (corresponding author), Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia.						AREM R, 1993, METABOLISM, V42, P1102, DOI 10.1016/0026-0495(93)90266-Q; BARTON RN, 1987, BAILLIERE CLIN ENDOC, V1, P355, DOI 10.1016/S0950-351X(87)80067-8; BOADO RJ, 1991, NEUROENDOCRINOLOGY, V53, P360, DOI 10.1159/000125742; BOELEN A, 1993, J CLIN ENDOCR METAB, V77, P1695, DOI 10.1210/jcem.77.6.8263160; Brunetti L, 1994, Clin Ter, V144, P147; CALOGERO A, 1968, J CLIN INVEST, V82, P839; Catania A, 1998, ANN NY ACAD SCI, V856, P62; CHAN PH, 1992, J NEUROTRAUM, V9, pS417; CHIKHIKSHVILI TS, 1990, GIPERTONICHESKAYA BO, P207; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Chiolero R, 1994, New Horiz, V2, P432; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Davies PH, 1996, CLIN ENDOCRINOL, V44, P199, DOI 10.1046/j.1365-2265.1996.668489.x; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; FABER J, 1987, J CLIN ENDOCR METAB, V65, P315, DOI 10.1210/jcem-65-2-315; FILCHER L, 1991, J CLIN ENDOCR METAB, V5, P35; Fliers E, 1997, J CLIN ENDOCR METAB, V82, P4032, DOI 10.1210/jc.82.12.4032; GANNUSHKINA IV, 1989, ZH NEVROPATOL PSIKH, V89, P3; Giroux C, 1996, EUR NEUROL, V36, P61, DOI 10.1159/000117208; GORDON G, 1997, VNUTRENNIE BOLEZNI, V9, P134; Gusev EI, 1999, ZH NEVROPATOL PSIKH, V99, P12; GUSEV EI, 1992, ISHEMICHESKAYA BOLEZ; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HENDERSON G, 1990, J PHYSIOL-LONDON, V430, P189, DOI 10.1113/jphysiol.1990.sp018288; HOSSMANN KA, 1987, GERONTOLOGY, V33, P213, DOI 10.1159/000212880; HUANG TS, 1987, ENDOCRINOLOGY, V121, P498, DOI 10.1210/endo-121-2-498; Huang XC, 1998, ENDOCRINOLOGY, V139, P245, DOI 10.1210/en.139.1.245; Iniguez MA, 1996, ENDOCRINOLOGY, V137, P1032, DOI 10.1210/en.137.3.1032; KALININ AP, 1991, ZH NEVROPATOL PSIKH, V91, P134; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KRACHKEVICH NG, 1986, VOPR NEIROKHIR, V3, P35; KRACHKEVICH NG, 1980, VOPR NEIROKHIR, V3, P517; LIM CF, 1993, J CLIN ENDOCR METAB, V76, P1165, DOI 10.1210/jc.76.5.1165; Lipton JM, 1998, ANN NY ACAD SCI, V840, P373, DOI 10.1111/j.1749-6632.1998.tb09576.x; Lipton JM, 1998, NEUROIMMUNOMODULAT, V5, P178, DOI 10.1159/000026335; LITVITSKII PF, 1995, PATOFIZIOLOGIYA, P121; Martin JV, 1996, NEUROSCIENCE, V73, P705, DOI 10.1016/0306-4522(96)00052-8; MCLARTY DG, 1975, LANCET, V2, P275; Mooney CT, 1996, J AM VET MED ASSOC, V208, P2004; NORMURA T, 1987, NIPPON NAIBUNPI GAKK, V63, P752; ONEILL M, 1995, EUR NEUROL, V35, P28, DOI 10.1159/000119496; PATEL J, 1990, J NEUROCHEM, V54, P849, DOI 10.1111/j.1471-4159.1990.tb02329.x; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHUTOV AA, 1987, VOPR NEIROKHIR, V3, P7; SLAG MF, 1961, JAMA-J AM MED ASSOC, V245, P43; SONG YM, 1991, CHUNG HUA I HSUEN TS, V47, P242; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; TRIGGS WJ, 1984, J NEUROCHEM, V42, P976, DOI 10.1111/j.1471-4159.1984.tb12699.x; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VERMAAK WJH, 1986, J ENDOCRINOL INVEST, V9, P121, DOI 10.1007/BF03348081; WANG GL, 1991, J CLIN MED, V104, P764; WILHNORE L, 1990, EPILEPSIA, V31, P667; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; ZIEGLER MG, 1990, CRIT CARE MED, V18, P253, DOI 10.1097/00003246-199003000-00001; Zou LL, 1998, J NEUROCHEM, V71, P887	58	4	5	0	2	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		2000	100	4					22	27					6	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology; Psychiatry	308EE	WOS:000086696900004	10812666				2022-02-06	
J	Block, EFJ; Cheatham, ML; Parrish, GA; Nelson, LD; Beam, N				Block, EFJ; Cheatham, ML; Parrish, GA; Nelson, LD; Beam, N			Ingested endotracheal tube in an adult following intubation attempt for head injury	AMERICAN SURGEON			English	Article; Proceedings Paper	67th Annual Meeting of the Southeastern-Surgical-Congress	FEB 13-17, 1999	TAMPA, FL	SE Surg Congress				General surgeons are often consulted for assistance in the management of ingested foreign bodies. Deglutition of an endotracheal tube is an unusual complication of airway management, In these cases, the artificial airway is "lost" when it becomes lodged deep into the esophagus. Endoscopic extraction has been described as therapeutic. We report a case in which prehospital endotracheal intubation attempt for the management of closed head injury resulted in a swallowed endotracheal tube. The tube remained undetected until radiographs were performed for a second unrelated traumatic event 2 years later. Endoscopic extraction Tvas unsuccessful, due to rigidity of the tube. Surgical extraction via gastrotomy was uneventful. Surgeons involved in trauma and other emergency settings should be aware of this complication and options in management.	Orlando Reg Med Ctr Inc, Dept Surg Educ, Orlando, FL 32806 USA; Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA		Block, EFJ (corresponding author), Orlando Reg Med Ctr Inc, Dept Surg Educ, 86 W Underwood St, Orlando, FL 32806 USA.						BOWEN A, 1981, PEDIATR RADIOL, V10, P178, DOI 10.1007/BF00975196; DORSCH JA, 1979, ANESTH ANALG, V58, P156, DOI 10.1213/00000539-197903000-00027; GUPTA JK, 1977, GASTROINTEST ENDOSC, V24, P31, DOI 10.1016/S0016-5107(77)73435-2; HOFFMAN S, 1984, ANESTH ANALG, V63, P457; KALAYC C, 1994, ENDOSCOPY, V26, P364, DOI 10.1055/s-2007-1008993; KATZ SH, 1998, ACAD EMERG MED, V5, P429; MITCHELL SA, 1978, ANESTH ANALG, V57, P590, DOI 10.1213/00000539-197857050-00016; Velitchkov NG, 1996, WORLD J SURG, V20, P1001, DOI 10.1007/s002689900152	8	4	4	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	1999	65	12					1134	1136					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	261FA	WOS:000083997600011	10597060				2022-02-06	
J	Callahan, CD; Johnstone, B				Callahan, CD; Johnstone, B			Predicting rehabilitation outcomes: The twisted pear revisited	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	106th Annual Convention of the American-Psychological-Association	AUG   15, 1998	SAN FRANCISCO, CALIFORNIA	Amer Psychol Assoc			NEUROPSYCHOLOGICAL ASSESSMENT; HEAD-INJURY; JUDGMENT; SYMPTOMS; ABILITY	Prediction of rehabilitation outcome occurs with few unifying theories or practices. The authors propose J. Fisher's (1959) neglected twisted pear model as central to understanding perplexing problems such as somatoform disorders, mild traumatic brain injury, likelihood of therapeutic benefit from rehabilitation interventions, and assessment of driving competence. Fisher argued that many psychological and biological behaviors were predictable in only one segment of the distribution. The 2 x 2 twisted pear matrix demonstrates this nonuniform scatter (heteroscedasticity), limiting acceptable classification accuracy to individuals with poor-impaired predictor scores. Outcomes become increasingly variable as scores improve to average or better. Examples from clinical practice support the conclusion that the twisted pear model is a useful paradigm for rehabilitation professionals. It's hard to make predictions, especially about the future.	Mem Med Ctr, Ctr Neuromuscular Sci, Springfield, IL 62781 USA; Univ Missouri, Columbia Sch Med, Dept Phys Med & Rehabil, Columbia, MO USA		Callahan, CD (corresponding author), Mem Med Ctr, Ctr Neuromuscular Sci, 701 N 1st St, Springfield, IL 62781 USA.			Johnstone, Brick/0000-0001-8845-9649			BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1995, ARCH CLIN NEUROPSYCH, V10, P27, DOI 10.1016/0887-6177(93)E0004-U; Ceci SJ, 1997, AM PSYCHOL, V52, P1051, DOI 10.1037/0003-066X.52.10.1051; Colarelli SM, 1998, AM PSYCHOL, V53, P1044; FAUST D, 1995, COPING PSYCHIAT PSYC, P916; FISHER J, 1959, J CONSULT PSYCHOL, V23, P400, DOI 10.1037/h0044080; GARB HN, 1989, PSYCHOL BULL, V105, P387, DOI 10.1037/0033-2909.105.3.387; Garb HN, 1996, PSYCHOL BULL, V120, P140, DOI 10.1037/0033-2909.120.1.140; GLASS AL, 1986, COGNITION; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; JENNETT B, 1976, LANCET, V1, P1031; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kareken DA, 1997, ARCH CLIN NEUROPSYCH, V12, P699, DOI 10.1016/S0887-6177(97)00045-0; Kareken DA, 1997, ARCH CLIN NEUROPSYCH, V12, P701, DOI 10.1016/S0887-6177(97)00053-X; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; KAYE SH, 1998, DISABILITY STAT ABST, V20, P1; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luke DA, 1998, PSYCHOL ASSESSMENT, V10, P360, DOI 10.1037/1040-3590.10.4.360; MARSDEN CD, 1986, PSYCHOL MED, V16, P277, DOI 10.1017/S0033291700009090; MEEHL PE, 1957, J COUNS PSYCHOL, V4, P268, DOI 10.1037/h0047554; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Myers D. G., 1983, SOCIAL PSYCHOL; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; OLIVER WD, 1962, J INDIV PSYCHOL, V18, P114; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PUENTE AE, 1992, ARCH CLIN NEUROPSYCH, V7, P297, DOI 10.1016/0887-6177(92)90024-H; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI [DOI 10.1016/S0065-2601(08)60357-3, 10.1016/s0065-2601(08)60357-3]; Senge P.M., 1990, 5 DISCIPLINE ART PRA; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VANZOMMEREN AH, 1994, CLIN NEUROPSYCHOLOGY; WHITLOCK FA, 1967, ACTA PSYCHIAT SCAND, V43, P144, DOI 10.1111/j.1600-0447.1967.tb11023.x; ZASLER ND, 1990, VOCATIONAL REHABILIT, P71; 1992, PSYCHOL LICENSING EX, V3	37	4	4	0	2	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	1999	44	3					274	283		10.1037/0090-5550.44.3.274			10	Psychology, Clinical; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology; Rehabilitation	224HN	WOS:000081892100004					2022-02-06	
J	Pender, N; Fleminger, S				Pender, N; Fleminger, S			Outcome measures on inpatient cognitive and behavioural units: An overview	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; FOLLOW-UP; NEUROPSYCHOLOGICAL REHABILITATION; RATING-SCALE; DISABILITY; AGGRESSION; DEMENTIA; PROGRAM; FAMILY	An overview of outcome measurements for use in cognitive behavioural units is presented. Various measures have been used in published studies evaluating outcome of these units, but with little consistency. This compares unfavourably with outcome measurement in inpatient neurophysical rehabilitation. Theoretical problems related to outcome measurement in this setting are discussed, in particular the changes in behaviour which may occur at times of admission and discharge, and the difficulty rating measures of handicap in this setting. Key measures for different areas of function are reviewed. These include: global measures of outcome; behavioural measures including agitation and aggression; measures of psychosocial outcome; residential status and independence.	Royal Hosp Neurodisabil, Dept Clin Psychol, London SW15 3SW, England; Maudsley Hosp, Lishman Brain Injury Unit, London SE5 8AZ, England					Pender, Niall/0000-0002-4172-0704			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Ashaye O, 1997, INT J GERIATR PSYCH, V12, P548, DOI 10.1002/(SICI)1099-1166(199705)12:5<548::AID-GPS543>3.0.CO;2-S; BARLOW DH, 1984, SINGLE CASE EXPT DES; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; BOAKE C, 1996, ARCH PHYSICAL MED RE, V77, P65; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BOND MR, 1990, REHABILITATION ADULT; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS DN, 1989, BRAIN INJURY, V3, P325; BUNNEY WE, 1963, ARCH GEN PSYCHIAT, V9, P280; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Coccaro E F, 1991, J Neuropsychiatry Clin Neurosci, V3, pS44; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1995, NEUROREHABILITATION, V5, P205, DOI 10.3233/NRE-1995-5303; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DAVIS JR, 1994, BRAIN INJURY, V8, P589, DOI 10.3109/02699059409151011; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; Finset Arnstein, 1995, Tidsskrift for den Norske Laegeforening, V115, P210; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pS10; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; JACKSON H, 1992, BRAIN INJURY, V6, P9; JEFFREY LIH, 1993, BRIT J OCCUPATIONAL, V56, P394; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSON M, 1997, J THERAY REHABILITAT, V4, P472; JOHNSON O, 1991, POLYCYCL AROMAT COMP, V2, P155; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JORM AF, 1989, INT J GERIATR PSYCH, V4, P35, DOI 10.1002/gps.930040109; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Ling JS, 1997, J HEAD TRAUMA REHAB, V12, P51, DOI 10.1097/00001199-199702000-00009; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MacKay G, 1996, EDUC RES, V38, P161, DOI 10.1080/0013188960380204; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 1994, J HEAD TRAUMA REHAB, V9, P116; Marks JA, 1995, CLIN REHABIL, V9, P320; MARSHALL JC, 1984, J CLIN NEUROPSYCHOL, V6, P65, DOI 10.1080/01688638408401197; MCGRATH JR, 1992, CLIN REHABIL, V6, P225; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MORLEY S, 1989, BEHAV MENTAL HLTH RE; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ratey J J, 1991, J Neuropsychiatry Clin Neurosci, V3, pS57; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Thomas M D, 1990, Arch Psychiatr Nurs, V4, P154, DOI 10.1016/0883-9417(90)90003-4; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WING J, 1996, HONOS HLTH NATL OUTC; WING JK, 1996, PSYCHIATRIC B, V18, P690; WOOD RL, 1990, NEURO BEHAV SEQUELAE; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	75	4	4	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					345	361		10.1080/096020199389428			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900010					2022-02-06	
J	Zhou, F; Xiang, Z; Yu, YS; Jun, SS; Piper, IR; Thomson, D; Miller, JD				Zhou, F; Xiang, Z; Yu, YS; Jun, SS; Piper, IR; Thomson, D; Miller, JD			Brain TXA(2) and PGI(2) levels related to diffuse brain injury with secondary insults	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; thromboxane A(2); prostacyclin	ARACHIDONIC-ACID; RATS	Secondary insults such as hypotension and hypoxia with head injury are associated with increased mortality and morbidity in comparison with head injury alone, in the present study the changes of brain thromboxane A(2) (TXA(2)) and prostacyclin (PGI(2)) levels in a Marmarou's rodent model of diffuse brain injury with hypotension and hypoxia were observed and the effect of diaspirin cross linked haemoglobin solution (DCLHb) were also investigated. Thirty-two male Sprague-Dawley (SD) rats were randomized into four groups: sham; head injury alone; head injury with secondary insults; and injury with insults followed by DCLHb administration. The results showed that there were no changes in TXB2 and 6-keto-PFG(1a) (metabolites of TXA(2) and PGI(2)) levels in the injury alone group, while TXB2 levels in the secondary insults group were elevated significantly; both TXB2 and 6-keto-PGF(ta) levels in the injury with insults followed by DCLHb administration group were augmented significantly in comparison with the corresponding value of sham at 4 postimpact. The only increase in TXA, levels in the secondary insults rats suggests that an imbalance in TXA(2)-PGI(2) production contributes to the traumatic secondary processes, which include ischaemia and oedema. It is hypothesized that DCLHb may exert its protective properties through increasing PGI(2) production in injured brain by improving blood supply to injured blood vessels.	Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland		Zhou, F (corresponding author), Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.						COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; COLE DJ, 1996, ANESTH ANALG, V83, P324; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FEI Z, 1993, J MED PLA, V8, P276; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Katayama Y, 1990, Adv Neurol, V52, P105; KONG DL, 1991, CRIT CARE MED, V19, P532, DOI 10.1097/00003246-199104000-00013; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nishisho T, 1996, NEUROSURGERY, V39, P950, DOI 10.1097/00006123-199611000-00014; PICKARD JD, 1984, LERS MONOGRAPH SERIE, V2, P191; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922	15	4	4	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	1999	6	4					306	308		10.1016/S0967-5868(99)90052-8			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230LJ	WOS:000082252400003	10844752				2022-02-06	
J	Mariak, Z; Obuchowska, I; Mariak, Z; Stankiewicz, A; Ustymowicz, A; Proniewska-Skretek, E				Mariak, Z; Obuchowska, I; Mariak, Z; Stankiewicz, A; Ustymowicz, A; Proniewska-Skretek, E			High-dose steroid therapy of traumatic optic neuropathy may fail to protect the optic nerve permanently	NEURO-OPHTHALMOLOGY			English	Article						traumatic optic neuropathy; conservative treatment; late results	DECOMPRESSION; CORTICOSTEROIDS; INJURIES	Background: The optimal treatment of traumatic optic neuropathy (TON) is still unresolved due to the poor understanding of the pathology involved and the relatively small number of cases in the published clinical series. It is currently held that the results of conservative treatment with high-dose corticosteroids are similar to those obtained with surgical decompression. Purpose: To assess the late results of conservative treatment for traumatic optic neuropathy. Patients and methods: 15 patients (3 women and It men, age 14-64 years) who sustained a direct injury to the optic nerve as a consequence of closed head trauma. All were treated conservatively with high-dose dexamethasone therapy. Ten patients presented for follow-up examination 3-11 years after the injury, on average 5.3+/-2.4 years (SD). A full ophthalmologic examination and color-coded Doppler (CCD) study of the orbital vessels was performed in all subjects. Results: Full blindness of the affected eye, persisting since the injury, was noted in six patients. Their visual acuity did not improve in spite of vigorous treatment and their eyes remained without sight at the follow-up examination. The finding of an absence of flow in central retinal arteries at follow-up suggests structural damage to the nerve. Moreover, in five of these patients, distinct features of eyeball atrophy had evolved between the time of injury and the follow-up examination. Four patients, who on admission presented only with the ability to perceive light, responded to 2-3 weeks of steroid therapy with improvement of visual acuity to 3/50, 5/50, 5/10, and 5/7 After 4-6 years, however, the visual acuity of all of these patients had deteriorated, resulting in nearly total blindness in one case, light perception in two, and 1/50 in the fourth. Optic nerve atrophy was diagnosed in all of the affected eyes. Conclusion: Conservative treatment of TON, even if giving transient improvement in visual function, may not be reliable in providing permanent relief from the sequelae of traumatic optic neuropathy.	Univ Med Sch, Dept Ophthalmol, Bialystok, Poland; Univ Med Sch, Dept Neurosurg, Bialystok, Poland		Mariak, Z (corresponding author), Klin Okulistyczna PSK, Ul MC Sklodowskiej 24A, PL-15276 Bialystok, Poland.			Mariak, Zenon/0000-0003-4132-9278			BRAUGHLER JM, 1985, J NEUROSURG, V62, P806, DOI 10.3171/jns.1985.62.6.0806; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; GIRARD BC, 1992, J CLIN NEURO-OPHTHAL, V12, P142; JOSEPH MP, 1990, ARCH OPHTHALMOL-CHIC, V108, P1091, DOI 10.1001/archopht.1990.01070100047032; LESSELL S, 1989, ARCH OPHTHALMOL-CHIC, V107, P382, DOI 10.1001/archopht.1989.01070010392031; LEVIN LA, 1994, OPHTHALMOLOGY, V101, P566; Lieb W. E., 1996, Ophthalmologe, V93, P194; MESSERLI J, 1990, KLIN MONATSBL AUGENH, V196, P398, DOI 10.1055/s-2008-1046206; MILLER NR, 1990, ARCH OPHTHALMOL-CHIC, V108, P1086, DOI 10.1001/archopht.1990.01070100042030; SCHRODER M, 1989, LARYNGO RHINO OTOL, V68, P534, DOI 10.1055/s-2007-998394; SEIFF SR, 1990, OPHTHALMIC SURG LAS, V21, P389; Soudant J, 1990, Ann Otolaryngol Chir Cervicofac, V107, P299; SPOOR TC, 1990, AM J OPHTHALMOL, V110, P665, DOI 10.1016/S0002-9394(14)77065-5; TANDON DA, 1994, CLIN OTOLARYNGOL, V19, P98, DOI 10.1111/j.1365-2273.1994.tb01190.x; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433	16	4	5	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0165-8107			NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.	JUN	1999	21	4					255	260		10.1076/noph.21.4.255.3895			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	253GL	WOS:000083548400008					2022-02-06	
J	Stanley, AC; Vittemberger, F; Napolitano, LM; O'Hara, KP; McGinnis, K; Lockhart, D; Silva, WE				Stanley, AC; Vittemberger, F; Napolitano, LM; O'Hara, KP; McGinnis, K; Lockhart, D; Silva, WE			The use of delayed computerized tomography in the evaluation of blunt abdominal trauma: A preliminary report	AMERICAN SURGEON			English	Article; Proceedings Paper	55th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / 13th Annual Meeting of the Trauma-Association-of-Canada	SEP 27-30, 1995	HALIFAX, CANADA	Amer Assoc Surg Trauma, Trauma Assoc Canada			NONOPERATIVE MANAGEMENT; PERITONEAL-LAVAGE; HEPATIC-TRAUMA; CT SCAN; ADULTS	This purpose of this study was to analyze the use of abdominal computed tomography (CT) imaging in patients with possible blunt abdominal trauma. A retrospective analysis of all trauma patients over a 1-year period (1993-1994) was conducted, with prospective study protocol in 52 patients using serial abdominal exam and hematocrits (Hcts) instead of abdominal CT for evaluation of blunt abdominal trauma. Urgent abdominal CT was used as the initial diagnostic test for evaluation of blunt abdominal trauma in 813 patients over this 1-year period. CT was obtained in 379 (46.6%) of these patients who arrived hemodynamically stable (admission systolic blood pressure greater than or equal to 90), had a Glasgow Coma Scale > 13, and had admission Hct greater than or equal to 35 because of distracting injuries, possible traumatic brain injury, or alcohol/drug use, which might render the abdominal physical exam unreliable, Only 47 CT scans (12.4%) were positive, and three patients (0.8%) required laparotomy. In an effort to more efficiently use abdominal CT, we performed a prospective study in 52 patients with possible blunt abdominal trauma, admission systolic blood pressure greater than or equal to 90, Hct greater than or equal to 35, Glasgow Coma Scale > 13, and a normal abdominal exam on admission. These patients were followed with serial:abdominal examinations and Hcts every 6 hours for 24 hours, and delayed CT, when applicable. CT was obtained in seven patients (13.5%) for evaluation of fall in Hct or abnormal abdominal examination; all were negative for abdominal injury. A protocol using serial abdominal exams, Hcts, and delayed abdominal CT imaging may be useful in select patients to decrease the high number of negative routine abdominal CTs that are obtained in the evaluation of blunt abdominal trauma.	Univ Maryland, Med Ctr, Dept Surg, Baltimore, MD 21201 USA; Univ Massachusetts, Med Ctr, Dept Surg, Worcester, MA USA		Napolitano, LM (corresponding author), Univ Maryland, Med Ctr, Dept Surg, 22 S Greene St, Baltimore, MD 21201 USA.						BECKER CD, 1994, AM J ROENTGENOL, V162, P343, DOI 10.2214/ajr.162.2.8310923; Brasel KJ, 1996, SURGERY, V120, P780, DOI 10.1016/S0039-6060(96)80031-6; FABIAN TC, 1986, J TRAUMA, V26, P602, DOI 10.1097/00005373-198607000-00003; FEDERLE MP, 1981, RADIOLOGY, V138, P637, DOI 10.1148/radiology.138.3.6450962; FRESHMAN SP, 1993, J TRAUMA, V34, P337, DOI 10.1097/00005373-199303000-00005; FRIED AM, 1992, J COMPUT ASSIST TOMO, V16, P717, DOI 10.1097/00004728-199209000-00009; GOLETTI O, 1994, J TRAUMA, V36, P178, DOI 10.1097/00005373-199402000-00004; KOHN JS, 1994, J TRAUMA, V36, P385, DOI 10.1097/00005373-199403000-00018; MATSUBARA TK, 1990, J TRAUMA, V30, P410, DOI 10.1097/00005373-199030040-00006; MEREDITH JW, 1994, J TRAUMA, V36, P529, DOI 10.1097/00005373-199404000-00012; MEYER AA, 1985, ARCH SURG-CHICAGO, V120, P550; MIRVIS SE, 1989, RADIOLOGY, V171, P27, DOI 10.1148/radiology.171.1.2928537; PACHTER HL, 1995, AM J SURG, V169, P442; PADHANI AR, 1992, CLIN RADIOL, V46, P304, DOI 10.1016/S0009-9260(05)80373-3; PARVIN S, 1975, ANN SURG, V181, P255; PEVEC WC, 1991, SURG GYNECOL OBSTET, V173, P262; RIZZO AG, 1995, J TRAUMA, V38, P338, DOI 10.1097/00005373-199503000-00005; Ross P Jr, 1991, Conn Med, V55, P330; ROZYCKI GS, 1995, J TRAUMA, V39, P492; SODERSTROM CA, 1980, SURG GYNECOL OBSTET, V151, P513; SRIUSSADAPORN S, 1993, INJURY, V24, P541, DOI 10.1016/0020-1383(93)90033-3	21	4	4	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	APR	1999	65	4					369	374					6	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	180KR	WOS:000079385500018	10190366				2022-02-06	
J	Hermann, DM; Mies, G; Hossmann, KA				Hermann, DM; Mies, G; Hossmann, KA			Lesion-remote metabolic changes after neocortical cold injury in rats	NEUROREPORT			English	Article						bioluminescent imaging; cerebral protein synthesis autoradiography; pH-dependent fluoroscopy	CEREBRAL GLUCOSE-UTILIZATION; PROTEIN-SYNTHESIS; FOCAL ISCHEMIA; BLOOD-FLOW; BRAIN; NEURONS	LESION-REMOTE metabolic changes were examined 1-7 days after neocortical cold injury using tissue ATP, glucose and lactate bioluminescent imaging, pH-dependent fluoroscopy and cerebral protein synthesis (CPS) autoradiography. One day after lesioning an alkaline DH shift (0.35 +/- 0.19 units above contralateral) was noticed in the lesion-remote cortex, the underlying white matter, the striatum, hippocampus and thalamus, which slowly resolved within 7 days and probably reflected the spread of vasogenic edema. Closely associated with the pH shift, elevations in tissue glucose and lactate levels were found, which reached maximum levels after 3 days (7.4 +/- 2.4 vs 4.2 +/- 1.2 mu mol/g glucose, 6.6 +/- 2.3 vs 2.1 +/- 0.6 mu mol/g lactate) but, in contrast to the alkalosis, remained elevated after 1 week. Thus, neocortical trauma is associated with long-lasting metabolic changes, which are intimately linked with the distribution of post-traumatic alkalosis. NeuroReport 10:759-763 (C) 1999 Lippincott Williams & Wilkins.	Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany		Hermann, DM (corresponding author), Max Planck Inst Neurol Res, Dept Expt Neurol, Gleueler Str 50, D-50931 Cologne, Germany.		Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk M./AAT-3652-2021	Hermann, Dirk M./0000-0003-0198-3152			BACK T, 1994, STROKE, V25, P494, DOI 10.1161/01.STR.25.2.494; BUCZEK M, 1991, J CEREBR BLOOD F MET, V11, P845, DOI 10.1038/jcbfm.1991.144; CSIBA L, 1983, BRAIN RES, V289, P334, DOI 10.1016/0006-8993(83)90037-9; Hermann DM, 1999, NEUROSCIENCE, V88, P599, DOI 10.1016/S0306-4522(98)00249-8; Hermann DM, 1998, NEUROREPORT, V9, P1917, DOI 10.1097/00001756-199806010-00046; KOGURE K, 1978, BRAIN RES, V154, P273, DOI 10.1016/0006-8993(78)90700-X; LOBERG EM, 1991, ACTA NEUROPATHOL, V81, P479, DOI 10.1007/BF00310126; Maeda M, 1997, ACTA NEUROPATHOL, V94, P116, DOI 10.1007/s004010050682; MIES G, 1993, J NEUROCHEM, V60, P360, DOI 10.1111/j.1471-4159.1993.tb05860.x; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P414, DOI 10.1038/jcbfm.1986.74; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; PAPPIUS HM, 1982, ANN NEUROL, V12, P157, DOI 10.1002/ana.410120205; PASCHEN W, 1981, J NEUROCHEM, V36, P513, DOI 10.1111/j.1471-4159.1981.tb01622.x; PASCHEN W, 1985, J CEREBR BLOOD F MET, V5, P609, DOI 10.1038/jcbfm.1985.90; SCHROCK H, 1989, AM J PHYSIOL, V257, pH1220, DOI 10.1152/ajpheart.1989.257.4.H1220; TENGVAR C, 1986, ACTA NEUROPATHOL, V71, P177, DOI 10.1007/BF00688038; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011; WELSH FA, 1991, J CEREBR BLOOD F MET, V11, P459, DOI 10.1038/jcbfm.1991.88	20	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAR 17	1999	10	4					759	763		10.1097/00001756-199903170-00018			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	180PA	WOS:000079393300020	10208544				2022-02-06	
J	Kotter, A; Ecker, M; Braun, W; Ruter, A				Kotter, A; Ecker, M; Braun, W; Ruter, A			Dislocation of the elbow: therapy and results of treatment	CHIRURG			German	Article						dislocation of elbow; fracture dislocation of elbow; radial head; coronoid process; paraarticular ossifications	HETEROTOPIC OSSIFICATION	At our hospital, closed dislocations of the elbow without neurovascular or osseous lesion are treated conservatively after successful reduction in the absence of a tendency to redislocation. Indications for surgery are irreducible dislocations and those with a tendency to redislocation as well as open soft tissue injuries, neurovascular and osseous concomitant injuries. During a period of 10 years 113 patients were treated according to this strategy. Of these patients, 46 had simple dislocations of the elbow and 67 suffered from dislocations with osseous lesions. In 95 patients follow-ups could be performed after a mean period of 55 months. In more than 75 % of cases good or excellent functional results were documented; unfavourable results were seen only in patients with osseous lesions; Nearly all of the patients had a stable elbow joint at the end of therapy.	Zent Klinikums, Klin Unfall & Wiederherstellungschirurg, D-86156 Augsburg, Germany		Kotter, A (corresponding author), Zent Klinikums, Klin Unfall & Wiederherstellungschirurg, Stenglinstr, D-86156 Augsburg, Germany.						BOCKLAMBERLIN PR, 1989, CHIR PRAX, V40, P473; BOSSE A, 1996, AKTUELLE TRAUMATOL, V26, P237; BRAUN W, 1989, CHIRURG, V60, P795; BREITFUSS H, 1992, HEIFT UNFALLHEILKD, V226; Eulert J, 1997, UNFALLCHIRURG, V100, P667, DOI 10.1007/s001130050173; HABERMEYER P, 1988, ORTHOPADE, V17, P313; HABERNEK H, 1991, DIAGNOSTIK THERAPIE, V17, P19; KUNDEL K, 1992, UNFALLCHIRURG, V95, P219; Meeder P J, 1985, Aktuelle Traumatol, V15, P89; Regel G, 1996, UNFALLCHIRURG, V99, P92; RIEL KA, 1993, UNFALLCHIRURG, V96, P529; SLOWIK GM, 1993, J ORTHOP TRAUMA, V7, P558, DOI 10.1097/00005131-199312000-00012; WALTER E, 1988, ORTHOPADE, V17, P306; WINKER H, 1908, AKTUELLE TRAUMATOL, V18, P145	14	4	4	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0009-4722			CHIRURG	Chirurg	MAR	1999	70	3					285	289		10.1007/s001040050644			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	181KM	WOS:000079440600010	10230541				2022-02-06	
